Citrus Sinensis ID: 013354

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440----
Protein Sequence
MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccEEccccccEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHHcccccccEEEEcEEEEccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEcccccccccccccccccccccccccccEEEEccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEEcccccEEEEEEEcccHHHcccHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEccccccccHHHccHHHHHHHccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHcccccccccHHHHHccHHHHccccccccccccccccccHHHHHHHHHHHc
Coil and Loop (DISEMBL)
MRAFGQEQVLnaglwtgkpysdiallgsghcsspgsghnsghnsvggdmsgqlfwphsrcspecspipsprmtspgpssrihsgavtplhpragggvsespssrpddvkqqshrlplppltisntcpfspsystatspsvprspgrvenptspgsrwkkgrllgrgtfghvylgfnsesgemcaMKEVTLFSDDAKSKESAQQLGQEIALLSRlrhpnivryygsetlddKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHakntvhrdikganilvdpsgrvkladfgmakhitgqscplsikgspywmapeviknsngcnlAVDIWSLGCTviemattkppwsqyegvpamfkignskelpaipdhlsdEGKDFVRKclqrnplhrptaawllehpfvgnaaplerpilsaepsetkptLTVAMRILVT
Flexible Loop (DISEMBL)
MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYStatspsvprspgrvenptspgsrwkkgrllGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIallsrlrhpNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPilsaepsetkptltvAMRILVT
Low Complexity Region (SEG)
MRAFGQEQVLNAGLWTGKPYSDIALLgsghcsspgsghnsghnsvggDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT
Disordered region (IsUnstruct)
********VLNAGLWTGKPYSDIALLG***********************************************************************************************************************************KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLF***************EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK*L*AI*******GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP**************************
Disordered Region (DISOPRED)
************************************************************************************************************************************************************WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV******************EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS*PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV*******************************
Disordered Region (DISEMBL)
MRAFGQEQVLNAGLWTGKPYSDIALLGSGHC**********HNSVGGDMSGQLFWPHSRCSPECSPI**************HSGAVTPLHP*********************HRLPLPPLTISNTCPFSP************************SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD***********GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT
Disordered Region (DISPRO)
*****QEQVLNAGLWTGKPYSDIALLG****************************************************************************************************************************SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	444	2.2.26 [Sep-21-2011]
Q9FZ36	651	Mitogen-activated protein	no	no	0.686	0.468	0.482	1e-77
O22040	666	Mitogen-activated protein	no	no	0.716	0.477	0.474	2e-75
O22042	651	Mitogen-activated protein	no	no	0.585	0.399	0.511	3e-70
Q39008	608	Mitogen-activated protein	no	no	0.646	0.472	0.490	5e-70
Q54R82	942	Mitogen-activated protein	no	no	0.583	0.274	0.477	2e-68
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.650	0.152	0.465	8e-64
Q99759	626	Mitogen-activated protein	yes	no	0.587	0.416	0.442	5e-62
Q61084	626	Mitogen-activated protein	yes	no	0.590	0.418	0.44	1e-61
Q9Y2U5	619	Mitogen-activated protein	no	no	0.628	0.450	0.423	1e-60
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.639	0.430	0.425	2e-60

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  290 bits (743), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 155/321 (48%), Positives = 207/321 (64%), Gaps = 16/321 (4%)

Query: 103 SRPDDVKQQSHRLPLPPL---TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKK 159
           S  DD  Q++H  P P L    I++    S  ++ + SP     P        P  RW+K
Sbjct: 16  STTDDENQENHPPPFPSLLADKITSCIRKSMVFAKSQSP-----PNNSTVQIKPPIRWRK 70

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---KSKESAQQLGQEIALLSRLRH 216
           G+L+GRG FG VY+G N +SGE+ A+K+V + S+ A   K++   Q+L +E+ LL  L H
Sbjct: 71  GQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSH 130

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNIVRY G+   D+ L I LE+V GGSI  +L+ +G   ES +R+YT Q+L GLEYLH  
Sbjct: 131 PNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYLHNH 190

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNG 333
             +HRDIKGANILVD  G +KLADFG +K +      S   S+KG+PYWMAPEVI  + G
Sbjct: 191 AIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVILQT-G 249

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
            + + DIWS+GCTVIEM T K PWS QY+ + A+F IG +K  P IPD++S +  DF+ K
Sbjct: 250 HSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLK 309

Query: 393 CLQRNPLHRPTAAWLLEHPFV 413
           CLQ+ P  RPTA+ LL+HPFV
Sbjct: 310 CLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  283 bits (724), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 155/327 (47%), Positives = 201/327 (61%), Gaps = 9/327 (2%)

Query: 95  GGVSESPSSRPD-DVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSP 153
           G V  S   RP  D   Q ++ P P +                 PS    P       +P
Sbjct: 6   GSVRRSLVFRPSSDDDNQENQPPFPGVLADKITSCIRKSKIFIKPSFSPPPPANTVDMAP 65

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL---FSDDAKSKESAQQLGQEIAL 210
              W+KG+L+GRG FG VY+G N +SGE+ A+K+V +   F+   K++   Q+L +E+ L
Sbjct: 66  PISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKL 125

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  L HPNIVRY G+   DD L I LE+V GGSI  +L+ +G   ES +R+YT+Q+L GL
Sbjct: 126 LKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGL 185

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
           EYLH    +HRDIKGANILVD  G +KLADFG +K +      +   S+KG+PYWMAPEV
Sbjct: 186 EYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEV 245

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           I  + G + + DIWS+GCTVIEM T K PWS QY+ V A+F IG +K  P IPD LS + 
Sbjct: 246 ILQT-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDA 304

Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           KDF+ KCLQ  P  RPTA+ LL+HPFV
Sbjct: 305 KDFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  266 bits (679), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 138/270 (51%), Positives = 179/270 (66%), Gaps = 10/270 (3%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ----QLGQE 207
           +P  RW+KG L+G G FG VY+G N +SGE+ A+K+V L +  + SKE  Q    +L +E
Sbjct: 63  APSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEE 121

Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
           + LL  L HPNIVRY G+    D L I +E+V GGSI  +L+ +G   E  I  YT+Q+L
Sbjct: 122 VQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLL 181

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMA 324
            GLEYLH    +HRDIKGANILVD  G ++LADFG +K +   +      S+KG+PYWMA
Sbjct: 182 LGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMA 241

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKIGNSKELPAIPDHLS 383
           PEVI  + G + + DIWS+GCTVIEMAT KPPWS QY+   A+  IG +K  P IP+ LS
Sbjct: 242 PEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLS 300

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            E KDF+ KCL + P  R +A  LL+HPFV
Sbjct: 301 PEAKDFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  265 bits (677), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 150/306 (49%), Positives = 196/306 (64%), Gaps = 19/306 (6%)

Query: 121 TISNTCPF------SPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLG 174
           T   TC F      S S  + TSP  P     +       + W+KG+LLGRG+FG VY G
Sbjct: 298 TADETCSFTTNEGDSSSTVSNTSPIYPDGGAII-------TSWQKGQLLGRGSFGSVYEG 350

Query: 175 FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI 234
            + + G+  A+KEV+L    ++++E  QQL  EI LLS+L+H NIVRY G+      LYI
Sbjct: 351 ISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYI 409

Query: 235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG 294
           +LE V+ GS+ K+ Q Y QL +S +  YT+QIL GL+YLH K  +HRDIK ANILVD +G
Sbjct: 410 FLELVTQGSLLKLYQRY-QLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANG 468

Query: 295 RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAVDIWSLGCTVIEMAT 352
            VKLADFG+AK ++  +   S KG+P+WMAPEVI  K+S+G     DIWSLGCTV+EM T
Sbjct: 469 AVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCT 527

Query: 353 TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            + P+S  E V A+F+IG    LP +PD LS + + F+ KCL+ NP  RPTAA LL HPF
Sbjct: 528 GQIPYSDLEPVQALFRIGRGT-LPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPF 586

Query: 413 VGNAAP 418
           V    P
Sbjct: 587 VRRPLP 592

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  260 bits (664), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 126/264 (47%), Positives = 174/264 (65%), Gaps = 5/264 (1%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMK--EVTLFSDDAKSKESAQQLGQEIALLSR 213
           +W+KG++LGRG +G VYLG N ++GE+ A+K  E+   + D K K       +EI ++  
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           LRH NIVRY G+      L ++LEY+ GGSI  +L  +G   E+ I+ YT+QIL GL +L
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFL 288

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSN 332
           HA + +HRDIKGANIL+D  G VKL+DFG +K  +G      S++G+PYWMAPEVIK + 
Sbjct: 289 HANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQT- 347

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDFVR 391
           G   + DIWSLGC ++EMAT +PPWS    + A M+ I +S  +P IP H+S E  DF+ 
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 407

Query: 392 KCLQRNPLHRPTAAWLLEHPFVGN 415
            C +R+P  RP A  LL+HPF+ N
Sbjct: 408 LCFKRDPKERPDANQLLKHPFIMN 431

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  244 bits (624), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 142/305 (46%), Positives = 191/305 (62%), Gaps = 16/305 (5%)

Query: 119  PLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSE 178
            PL    TC F+ +   ++      SP    +  S  + W+KG+LLGRG+ G VY G +++
Sbjct: 1589 PLGDKETCSFTVNKGDSSRTISNTSP-IYASEGSFITCWQKGQLLGRGSLGSVYEGISAD 1647

Query: 179  SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
             G+  A KEV+L    +++ E  QQ+   IALLS+L+H NIVRY G+   +  LYI+LE 
Sbjct: 1648 -GDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLEL 1706

Query: 239  VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL 298
            V+ GS+ K+ Q   QLG+S +  YT+QIL GL+YLH K  +HR+IK AN+LVD +G VKL
Sbjct: 1707 VTQGSLRKLYQ-RNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765

Query: 299  ADFGMAKHITGQSCPLSIKGSPY--WMAPEVI---KNSNGCNLAVDIWSLGCTVIEMATT 353
            ADFG+AK        +S+  +PY  WMAPEVI   K+ +G     DIWSLGCTV+EM T 
Sbjct: 1766 ADFGLAK-------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTG 1818

Query: 354  KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            + P+S  E   A++ IG  K LP IPD LS + +DF+  CL+ NP  RPTAA LL HPFV
Sbjct: 1819 QIPYSDLEIGTALYNIGTGK-LPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFV 1877

Query: 414  GNAAP 418
                P
Sbjct: 1878 NMPLP 1882

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  238 bits (608), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 122/276 (44%), Positives = 171/276 (61%), Gaps = 15/276 (5%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
            ++P++P + W++G+LLG+G FG VYL ++ ++G   A K+V    D  ++ +    L  
Sbjct: 353 TKSPSAPIN-WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411

Query: 207 EIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
           EI LL  L+H  IV+YYG   +  +  L I++EY+ GGS+   L+ YG L ES  R YT+
Sbjct: 412 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 471

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           QIL G+ YLH+   VHRDIKGANIL D +G VKL DFG +K +       TG     S+ 
Sbjct: 472 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVT 528

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+PYWM+PEVI +  G     D+WSLGCTV+EM T KPPW++YE + A+FKI      P 
Sbjct: 529 GTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ 587

Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           +P H+S+ G+DF+R+        RP+A  LL H F 
Sbjct: 588 LPSHISEHGRDFLRRIFV-EARQRPSAEELLTHHFA 622

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  238 bits (606), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 121/275 (44%), Positives = 172/275 (62%), Gaps = 13/275 (4%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
            ++P++P + W++G+LLG+G FG VYL ++ ++G   A K+V    D  ++ +    L  
Sbjct: 353 TKSPSAPIN-WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411

Query: 207 EIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
           EI LL  L+H  IV+YYG   +  +  L I++EY+ GGS+   L+ YG L ES  R YT+
Sbjct: 412 EIQLLKNLQHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 471

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL------SIKG 318
           QIL G+ YLH+   VHRDIKGANIL D +G VKL DFG +K +  Q+  +      S+ G
Sbjct: 472 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRSVTG 529

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
           +PYWM+PEVI +  G     D+WSLGCTV+EM T KPPW++YE + A+FKI      P +
Sbjct: 530 TPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 588

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           P H+S+ G+DF+R+        RP+A  LL H F 
Sbjct: 589 PSHISEHGRDFLRRIFV-EARQRPSAEELLTHHFA 622

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  234 bits (597), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 130/307 (42%), Positives = 180/307 (58%), Gaps = 28/307 (9%)

Query: 128 FSPSYSTATSPSVPRSPGRVENPT------SPGSR-------WKKGRLLGRGTFGHVYLG 174
           F+P Y  +    + R    ++NPT      SP SR       W+ G+LLG+G FG VYL 
Sbjct: 317 FTPEYDDS---RIRRRGSDIDNPTLTVMDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLC 373

Query: 175 FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG--SETLDDKL 232
           ++ ++G   A+K+V    D  ++ +    L  EI LL  L H  IV+YYG   +  +  L
Sbjct: 374 YDVDTGRELAVKQVQFDPDSPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTL 433

Query: 233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP 292
            I++EY+ GGSI   L+ YG L E+  R YT+QIL G+ YLH+   VHRDIKGANIL D 
Sbjct: 434 SIFMEYMPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDS 493

Query: 293 SGRVKLADFGMAKHITGQSCPL------SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCT 346
           +G VKL DFG +K +  Q+  L      S+ G+PYWM+PEVI +  G     DIWS+ CT
Sbjct: 494 TGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVACT 550

Query: 347 VIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAW 406
           V+EM T KPPW+++E + A+FKI      P +P H+SD  +DF+++      L RP+A  
Sbjct: 551 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPKLPPHVSDYTRDFLKRIFVEAKL-RPSADE 609

Query: 407 LLEHPFV 413
           LL H FV
Sbjct: 610 LLRHMFV 616

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  233 bits (595), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 129/303 (42%), Positives = 180/303 (59%), Gaps = 19/303 (6%)

Query: 122 ISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGE 181
           I    P SP+ +T+   +        E+      +W +G L+G G+FG VYLG N+ SGE
Sbjct: 364 IEQPSPISPTSTTSEDTNTLE-----EDTDDQSIKWIRGALIGSGSFGQVYLGMNASSGE 418

Query: 182 MCAMKEVTLFSDDAKSKESAQ---QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
           + A+K+V L S        A+    L  EIALL  L H +IV+Y GS    D L I+LEY
Sbjct: 419 LMAVKQVILDSVSESKDRHAKLLDALAGEIALLQELSHEHIVQYLGSNLNSDHLNIFLEY 478

Query: 239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL 298
           V GGS+  +L  YG   E+ ++++ +Q L GLEYLH++  VHRDIKGANILVD  G++K+
Sbjct: 479 VPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEYLHSRGIVHRDIKGANILVDNKGKIKI 538

Query: 299 ADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
           +DFG++K +        TG + P S +GS +WMAPEV+K +       DIWSLGC VIEM
Sbjct: 539 SDFGISKKLELNSTSTKTGGARP-SFQGSSFWMAPEVVKQTMHTE-KTDIWSLGCLVIEM 596

Query: 351 ATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
            T+K P+   + + A+F+IG +  LP  P ++S    DF+ K    +   RPTA+ LL H
Sbjct: 597 LTSKHPYPNCDQMQAIFRIGENI-LPEFPSNISSSAIDFLEKTFAIDCNLRPTASELLSH 655

Query: 411 PFV 413
           PFV
Sbjct: 656 PFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	444
359474195	901	PREDICTED: uncharacterized protein LOC10	0.988	0.487	0.881	0.0
224053887	711	predicted protein [Populus trichocarpa]	1.0	0.624	0.835	0.0
255537505	885	ATP binding protein, putative [Ricinus c	0.977	0.490	0.843	0.0
224074943	900	predicted protein [Populus trichocarpa]	0.990	0.488	0.831	0.0
359490486	892	PREDICTED: uncharacterized protein LOC10	0.995	0.495	0.843	0.0
224137054	902	predicted protein [Populus trichocarpa]	0.993	0.488	0.816	0.0
147792548	919	hypothetical protein VITISV_040851 [Viti	0.995	0.480	0.836	0.0
38049268	883	YDA [Arabidopsis thaliana]	0.988	0.497	0.813	0.0
15222512	883	YODA MAPKK kinase [Arabidopsis thaliana]	0.988	0.497	0.813	0.0
297837021	883	hypothetical protein ARALYDRAFT_474980 [	0.988	0.497	0.813	0.0

>gi|359474195|ref|XP_003631415.1| PREDICTED: uncharacterized protein LOC100263296 [Vitis vinifera] gi|297742508|emb|CBI34657.3| unnamed protein product [Vitis vinifera]

 Score =  819 bits (2116), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/440 (88%), Positives = 415/440 (94%), Gaps = 1/440 (0%)

Query: 4   FGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPE 63
           F  EQV+N+  WTGKPY+DIALLGSGHCSSPGSGHNSGHNS+GGDMSGQLFWPHSRCSPE
Sbjct: 260 FSPEQVMNSSFWTGKPYADIALLGSGHCSSPGSGHNSGHNSIGGDMSGQLFWPHSRCSPE 319

Query: 64  CSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTIS 123
           CSPIPSPRMTSPGPSSRI SGAVTPLHPRAG   +ESP++RPDD KQQSHRLPLPP+TIS
Sbjct: 320 CSPIPSPRMTSPGPSSRIQSGAVTPLHPRAGAAAAESPTNRPDDGKQQSHRLPLPPITIS 379

Query: 124 NTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC 183
           N+CPFSP+YST+T+PSVPRSPGR ENP SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC
Sbjct: 380 NSCPFSPTYSTSTTPSVPRSPGRAENPISPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC 439

Query: 184 AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGS 243
           AMKEVTLFSDDAKSKESAQQLGQEI+LLSRLRHPNIV+YYGSET+DDKLYIYLEYVSGGS
Sbjct: 440 AMKEVTLFSDDAKSKESAQQLGQEISLLSRLRHPNIVQYYGSETVDDKLYIYLEYVSGGS 499

Query: 244 IYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
           IYK+LQ+YGQLGE AIRSYTQQILSGL YLHAKNTVHRDIKGANILVDP+GRVKLADFGM
Sbjct: 500 IYKLLQEYGQLGEIAIRSYTQQILSGLAYLHAKNTVHRDIKGANILVDPNGRVKLADFGM 559

Query: 304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           AKHITGQSCPLS+KGSPYWMAPEVIKNSNGCNLAVD+WSLGCTV+EMATTKPPWSQYEGV
Sbjct: 560 AKHITGQSCPLSLKGSPYWMAPEVIKNSNGCNLAVDLWSLGCTVLEMATTKPPWSQYEGV 619

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
            AMFKIGNSKELP IPDHLS+EGKDFVR+CLQRNPLHRPTAAWLLEHPFV NAAPLERP 
Sbjct: 620 AAMFKIGNSKELPTIPDHLSEEGKDFVRQCLQRNPLHRPTAAWLLEHPFVRNAAPLERPS 679

Query: 424 LSAEPSETKPTLTVAMRILV 443
           LS+E  E  P +T A+R + 
Sbjct: 680 LSSE-LEPPPAVTNAVRSMA 698

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053887|ref|XP_002298029.1| predicted protein [Populus trichocarpa] gi|222845287|gb|EEE82834.1| predicted protein [Populus trichocarpa]

 Score =  776 bits (2005), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/444 (83%), Positives = 398/444 (89%)

Query: 1   MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRC 60
           MRAFG EQV+N   WTGK YSDI LLGSG CSSPGSG+NSG NS+GGDMSGQL WP+SRC
Sbjct: 69  MRAFGTEQVINNSFWTGKTYSDIGLLGSGQCSSPGSGYNSGQNSIGGDMSGQLLWPNSRC 128

Query: 61  SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
           SPECSP+PSPRMTSPGPSSRIHSGAVTPLH RA G   ESP+S PDD KQQSHRLPLPP+
Sbjct: 129 SPECSPLPSPRMTSPGPSSRIHSGAVTPLHHRAVGVTIESPTSCPDDGKQQSHRLPLPPI 188

Query: 121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
           T SNTCPFSP+YST TSPSVPRSP R+ENPTSPGSRWKKGRLLGRG+FG VYLG NSESG
Sbjct: 189 TTSNTCPFSPTYSTTTSPSVPRSPNRMENPTSPGSRWKKGRLLGRGSFGDVYLGLNSESG 248

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
           E+C MKEVTLFSDDAKSKESAQQLGQEI LLSRLRHPNIV+YYGSET++DKLYIYLEYVS
Sbjct: 249 ELCTMKEVTLFSDDAKSKESAQQLGQEIMLLSRLRHPNIVQYYGSETVEDKLYIYLEYVS 308

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GGSIYK+LQ+YGQ GE AIRSYTQQILSGL YLHAK TVHRDIKGANILVDP+GRVKLAD
Sbjct: 309 GGSIYKLLQEYGQFGEIAIRSYTQQILSGLAYLHAKKTVHRDIKGANILVDPTGRVKLAD 368

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           FGMAKHI+GQSCP S +GSPYWMAPEVIKNSNGCNLAVDIWSLGCTV+EMATTKPPWSQY
Sbjct: 369 FGMAKHISGQSCPFSFRGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVLEMATTKPPWSQY 428

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           EGVPAMFKIGNSKELP IPDHLSD+GKDFVR+CLQRNP HRPTAA LL+HPFV N A +E
Sbjct: 429 EGVPAMFKIGNSKELPEIPDHLSDDGKDFVRQCLQRNPSHRPTAAQLLDHPFVKNVASME 488

Query: 421 RPILSAEPSETKPTLTVAMRILVT 444
           RP +S EPSE  P    + R + T
Sbjct: 489 RPFVSIEPSEELPPFMNSGRSMGT 512

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537505|ref|XP_002509819.1| ATP binding protein, putative [Ricinus communis] gi|223549718|gb|EEF51206.1| ATP binding protein, putative [Ricinus communis]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/442 (84%), Positives = 399/442 (90%), Gaps = 8/442 (1%)

Query: 1   MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRC 60
           +RAFG EQVLN GLW G        LGSGHCSSPGSGHNSGHNS+GGDMSGQLF P+S C
Sbjct: 251 IRAFGPEQVLNCGLWAG--------LGSGHCSSPGSGHNSGHNSIGGDMSGQLFRPNSHC 302

Query: 61  SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
           SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGG   ESP+SRP+D KQQSHRLPLPP+
Sbjct: 303 SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGSAIESPTSRPEDGKQQSHRLPLPPI 362

Query: 121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
           TISNTCPFSP+YSTATSPSVPRSP R ENPTSPGSRWKKGRLLGRGTFGHVYLGFN ESG
Sbjct: 363 TISNTCPFSPAYSTATSPSVPRSPNRAENPTSPGSRWKKGRLLGRGTFGHVYLGFNRESG 422

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
           EMCAMKEVTLFSDD KSKE AQQLGQEIALLSRL+HPNIV+YYGSET+DDKLYIYLEYVS
Sbjct: 423 EMCAMKEVTLFSDDPKSKECAQQLGQEIALLSRLQHPNIVQYYGSETVDDKLYIYLEYVS 482

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GGSIYK+LQ+YGQ GE AIRSYTQQILSGL YLHAKNTVHRDIKGANILVDP+GRVKLAD
Sbjct: 483 GGSIYKLLQEYGQFGEIAIRSYTQQILSGLAYLHAKNTVHRDIKGANILVDPTGRVKLAD 542

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           FGMAKHITGQSCPLS KGSPYWMAPEVI+  NGCNLAVDIWSLGCTV+EMATTKPPWSQ+
Sbjct: 543 FGMAKHITGQSCPLSFKGSPYWMAPEVIRKPNGCNLAVDIWSLGCTVLEMATTKPPWSQH 602

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           EGV A+FKIGNSKELP IPDHLS++GKDFVR+CLQR+P HRPTAA LLEHPFV N APLE
Sbjct: 603 EGVAALFKIGNSKELPTIPDHLSEKGKDFVRQCLQRDPSHRPTAAQLLEHPFVKNVAPLE 662

Query: 421 RPILSAEPSETKPTLTVAMRIL 442
           +PI +AE SE    +T + R +
Sbjct: 663 KPIPTAELSEPPSAVTNSGRSM 684

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074943|ref|XP_002304501.1| predicted protein [Populus trichocarpa] gi|222841933|gb|EEE79480.1| predicted protein [Populus trichocarpa]

 Score =  768 bits (1982), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/440 (83%), Positives = 395/440 (89%)

Query: 3   AFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSP 62
           AFG EQV+N G W GK YSDI LLGSG CSSPGSG+NSG NS+GGDMSGQL WP+SRCSP
Sbjct: 261 AFGTEQVINNGFWAGKTYSDIGLLGSGQCSSPGSGYNSGQNSIGGDMSGQLLWPNSRCSP 320

Query: 63  ECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTI 122
           ECSP+PSPR+ SPGPSSRIHSGAVTPLHPRA G   ESP+SRPDD KQQSHRLPLPP+TI
Sbjct: 321 ECSPLPSPRVISPGPSSRIHSGAVTPLHPRAAGVTIESPTSRPDDGKQQSHRLPLPPITI 380

Query: 123 SNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEM 182
           SNT PFSP+YS +TSPSVPRSP R+ENPTS G+RW+KGR+LGRG+FG VYLGFN E GEM
Sbjct: 381 SNTHPFSPTYSASTSPSVPRSPSRMENPTSSGTRWQKGRMLGRGSFGDVYLGFNRERGEM 440

Query: 183 CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG 242
           CAMKEVTLFSDDAKSKESAQQLGQEI LLSRLRHPNIV+YYGSET+DDKLYIYLEYVSGG
Sbjct: 441 CAMKEVTLFSDDAKSKESAQQLGQEIGLLSRLRHPNIVQYYGSETVDDKLYIYLEYVSGG 500

Query: 243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG 302
           SIYK+LQ+YGQ GE AIRSYTQQIL GL YLHAK TVHRDIKGANILVDP+GRVKLADFG
Sbjct: 501 SIYKLLQEYGQFGEIAIRSYTQQILRGLAYLHAKKTVHRDIKGANILVDPTGRVKLADFG 560

Query: 303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG 362
           MAKHI+GQSCPLS KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV+EMATTKPPWSQYEG
Sbjct: 561 MAKHISGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVLEMATTKPPWSQYEG 620

Query: 363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERP 422
           VPAMFKIGNSKELP IPD+LSD+GKDFVR+CLQRN  HRPTAA LLEHPFV N AP+ERP
Sbjct: 621 VPAMFKIGNSKELPEIPDNLSDDGKDFVRQCLQRNLSHRPTAAQLLEHPFVKNVAPMERP 680

Query: 423 ILSAEPSETKPTLTVAMRIL 442
            LS E SE  P +  + R +
Sbjct: 681 FLSPELSEELPAIMNSGRSM 700

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490486|ref|XP_003634098.1| PREDICTED: uncharacterized protein LOC100242348 [Vitis vinifera] gi|302143826|emb|CBI22687.3| unnamed protein product [Vitis vinifera]

 Score =  755 bits (1950), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/442 (84%), Positives = 400/442 (90%)

Query: 1   MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRC 60
           +RAFG +Q LN+  W GKPYSD+ LLGSG CSSPGSG NSGHNS+GGDMSGQLFW  SR 
Sbjct: 254 LRAFGTDQGLNSAFWAGKPYSDVTLLGSGQCSSPGSGQNSGHNSMGGDMSGQLFWQPSRG 313

Query: 61  SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
           SPE SPIPSPRMTSPGPSSRIHSGAVTPLHPRAGG  SES +S PD+ KQQSHRLPLPP+
Sbjct: 314 SPEYSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGAASESQTSWPDEGKQQSHRLPLPPV 373

Query: 121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
            +S++ PFS S S A SPSVPRSPGR E PTSPGSRWKKG+LLGRGTFGHVY+GFNSESG
Sbjct: 374 AVSSSSPFSHSNSPAASPSVPRSPGRAEAPTSPGSRWKKGKLLGRGTFGHVYVGFNSESG 433

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
           EMCAMKEVTLFSDDAKSKESA+QLGQEI LLSRL HPNIV+YYGSET+ DKLYIYLEYVS
Sbjct: 434 EMCAMKEVTLFSDDAKSKESAKQLGQEIVLLSRLCHPNIVQYYGSETVGDKLYIYLEYVS 493

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GGSIYK+LQ+YGQLGE AIRSYTQQILSGL YLHAKNTVHRDIKGANILVDPSGRVKLAD
Sbjct: 494 GGSIYKLLQEYGQLGELAIRSYTQQILSGLAYLHAKNTVHRDIKGANILVDPSGRVKLAD 553

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           FGMAKHITGQSCPLS KGSPYWMAPEVI+NSNGCNLAVDIWSLGCTV+EMATTKPPWSQ+
Sbjct: 554 FGMAKHITGQSCPLSFKGSPYWMAPEVIRNSNGCNLAVDIWSLGCTVLEMATTKPPWSQF 613

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           EGV AMFKIGNSK+LPAIPDHLSDEGKDFVR+CLQRNPLHRPTAA LLEHPFV NAAPLE
Sbjct: 614 EGVAAMFKIGNSKDLPAIPDHLSDEGKDFVRQCLQRNPLHRPTAAQLLEHPFVKNAAPLE 673

Query: 421 RPILSAEPSETKPTLTVAMRIL 442
           RPILS E S+  P +T  ++ L
Sbjct: 674 RPILSPETSDPPPGVTNGVKSL 695

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137054|ref|XP_002322482.1| predicted protein [Populus trichocarpa] gi|222869478|gb|EEF06609.1| predicted protein [Populus trichocarpa]

 Score =  754 bits (1946), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/442 (81%), Positives = 400/442 (90%), Gaps = 1/442 (0%)

Query: 1   MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRC 60
           MRAFG EQV+N+  W GKPY D+ LLGSGHCSSPGSG+NSGHNS+GGDMSGQLFW  SR 
Sbjct: 260 MRAFGAEQVINSAFWAGKPYPDVNLLGSGHCSSPGSGYNSGHNSMGGDMSGQLFWQQSRG 319

Query: 61  SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
           SPECSPIPSPRMTSPGPSSR+ SGAVTP+HPRAGG + ES +S PDD KQQSHRLPLPP+
Sbjct: 320 SPECSPIPSPRMTSPGPSSRVQSGAVTPIHPRAGGTI-ESQTSWPDDGKQQSHRLPLPPV 378

Query: 121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
           T+S+  PFS S S A SPSVPRSPGR ENPTSPGSRWKKG+LLGRGTFGHVYLGFNSESG
Sbjct: 379 TVSSPSPFSHSNSAAASPSVPRSPGRAENPTSPGSRWKKGKLLGRGTFGHVYLGFNSESG 438

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
           EMCAMKEVTLFSDDAKSKESA+QL QEI+LLSR +HPNIV+YYGSET+ D+LYIYLEYVS
Sbjct: 439 EMCAMKEVTLFSDDAKSKESAKQLMQEISLLSRFQHPNIVQYYGSETVGDRLYIYLEYVS 498

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GGSIYK+LQ+YGQLGE  IRSYTQQILSGL +LH+K+TVHRDIKGANILVDP+GRVKLAD
Sbjct: 499 GGSIYKLLQEYGQLGELVIRSYTQQILSGLAFLHSKSTVHRDIKGANILVDPNGRVKLAD 558

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           FGMAKHITGQSCPLS KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV+EMATTKPPWSQ+
Sbjct: 559 FGMAKHITGQSCPLSFKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVLEMATTKPPWSQF 618

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           EGV AMFKIGNSK+LP IP+ LSDEGKDFVR+CLQRNP+HRPTA+ LLEHPFV  AAPLE
Sbjct: 619 EGVAAMFKIGNSKDLPEIPEDLSDEGKDFVRQCLQRNPVHRPTASQLLEHPFVKLAAPLE 678

Query: 421 RPILSAEPSETKPTLTVAMRIL 442
           RPIL  +P++  P ++  ++IL
Sbjct: 679 RPILCLDPTDPPPGVSNGVKIL 700

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147792548|emb|CAN65619.1| hypothetical protein VITISV_040851 [Vitis vinifera]

 Score =  747 bits (1929), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/446 (83%), Positives = 400/446 (89%), Gaps = 4/446 (0%)

Query: 1   MRAFGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRC 60
           +RAFG +Q LN+  W GKPYSD+ LLGSG CSSPGSG NSGHNS+GGDMSGQLFW  SR 
Sbjct: 254 LRAFGTDQGLNSAFWAGKPYSDVTLLGSGQCSSPGSGQNSGHNSMGGDMSGQLFWQPSRG 313

Query: 61  SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
           SPE SPIPSPRMTSPGPSSRIHSGAVTPLHPRAGG  SES +S PD+ KQQSHRLPLPP+
Sbjct: 314 SPEYSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGAASESQTSWPDEGKQQSHRLPLPPV 373

Query: 121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
            +S++ PFS S S A SPSVPRSPGR E PTSPGSRWKKG+LLGRGTFGHVY+GFNSESG
Sbjct: 374 AVSSSSPFSHSNSPAASPSVPRSPGRAEAPTSPGSRWKKGKLLGRGTFGHVYVGFNSESG 433

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
           EMCAMKEVTLFSDDAKSKESA+QLGQEI LLSRL HPNIV+YYGSET+ DKLYIYLEYVS
Sbjct: 434 EMCAMKEVTLFSDDAKSKESAKQLGQEIVLLSRLCHPNIVQYYGSETVGDKLYIYLEYVS 493

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GGSIYK+LQ+YGQLGE AIRSYTQQILSGL YLHAKNTVHRDIKGANILVDPSGRVKLAD
Sbjct: 494 GGSIYKLLQEYGQLGELAIRSYTQQILSGLAYLHAKNTVHRDIKGANILVDPSGRVKLAD 553

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPE----VIKNSNGCNLAVDIWSLGCTVIEMATTKPP 356
           FGMAKHITGQSCPLS KGSPYWMAPE    VI+NSNGCNLAVDIWSLGCTV+EMATTKPP
Sbjct: 554 FGMAKHITGQSCPLSFKGSPYWMAPELFAQVIRNSNGCNLAVDIWSLGCTVLEMATTKPP 613

Query: 357 WSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           WSQ+EGV AMFKIGNSK+LPAIPDHLSDEGKDFVR+CLQRNPLHRPTAA LLEHPFV NA
Sbjct: 614 WSQFEGVAAMFKIGNSKDLPAIPDHLSDEGKDFVRQCLQRNPLHRPTAAQLLEHPFVKNA 673

Query: 417 APLERPILSAEPSETKPTLTVAMRIL 442
           APLERPILS E S+  P +T  ++ L
Sbjct: 674 APLERPILSPETSDPPPGVTNGVKSL 699

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38049268|gb|AAR10436.1| YDA [Arabidopsis thaliana]

 Score =  743 bits (1919), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/439 (81%), Positives = 388/439 (88%)

Query: 4   FGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPE 63
           F  +QV N GL   KPYSD++LLGSG CSSPGSG+NSG+NS+GGDM+ QLFWP SRCSPE
Sbjct: 247 FIPDQVSNHGLLISKPYSDVSLLGSGQCSSPGSGYNSGNNSIGGDMATQLFWPQSRCSPE 306

Query: 64  CSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTIS 123
           CSP+PSPRMTSPGPSSRI SGAVTPLHPRAGG  + SP+ R DD +QQSHRLPLPPL IS
Sbjct: 307 CSPVPSPRMTSPGPSSRIQSGAVTPLHPRAGGSTTGSPTRRLDDNRQQSHRLPLPPLLIS 366

Query: 124 NTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC 183
           NTCPFSP+YS ATSPSVPRSP R E   SPGSRWKKGRLLG G+FGHVYLGFNSESGEMC
Sbjct: 367 NTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMC 426

Query: 184 AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGS 243
           AMKEVTL SDD KS+ESAQQLGQEI++LSRLRH NIV+YYGSET+DDKLYIYLEYVSGGS
Sbjct: 427 AMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGS 486

Query: 244 IYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
           IYK+LQ+YGQ GE+AIR+YTQQILSGL YLHAKNTVHRDIKGANILVDP GRVK+ADFGM
Sbjct: 487 IYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGM 546

Query: 304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           AKHIT QS PLS KGSPYWMAPEVIKNSNG NLAVDIWSLGCTV+EMATTKPPWSQYEGV
Sbjct: 547 AKHITAQSGPLSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQYEGV 606

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
           PAMFKIGNSKELP IPDHLS+EGKDFVRKCLQRNP +RPTAA LL+H FV N  P+ERPI
Sbjct: 607 PAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPMERPI 666

Query: 424 LSAEPSETKPTLTVAMRIL 442
           +S EP+E     +  MR L
Sbjct: 667 VSGEPAEAMNVASSTMRSL 685

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15222512|ref|NP_176557.1| YODA MAPKK kinase [Arabidopsis thaliana] gi|12324947|gb|AAG52426.1|AC011622_14 putative protein kinase; 39749-43572 [Arabidopsis thaliana] gi|38049264|gb|AAR10434.1| YDA [Arabidopsis thaliana] gi|38049266|gb|AAR10435.1| YDA [Arabidopsis thaliana] gi|332196014|gb|AEE34135.1| YODA MAPKK kinase [Arabidopsis thaliana]

 Score =  743 bits (1918), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/439 (81%), Positives = 388/439 (88%)

Query: 4   FGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPE 63
           F  +QV N GL   KPYSD++LLGSG CSSPGSG+NSG+NS+GGDM+ QLFWP SRCSPE
Sbjct: 247 FIPDQVSNHGLLISKPYSDVSLLGSGQCSSPGSGYNSGNNSIGGDMATQLFWPQSRCSPE 306

Query: 64  CSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTIS 123
           CSP+PSPRMTSPGPSSRI SGAVTPLHPRAGG  + SP+ R DD +QQSHRLPLPPL IS
Sbjct: 307 CSPVPSPRMTSPGPSSRIQSGAVTPLHPRAGGSTTGSPTRRLDDNRQQSHRLPLPPLLIS 366

Query: 124 NTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC 183
           NTCPFSP+YS ATSPSVPRSP R E   SPGSRWKKGRLLG G+FGHVYLGFNSESGEMC
Sbjct: 367 NTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMC 426

Query: 184 AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGS 243
           AMKEVTL SDD KS+ESAQQLGQEI++LSRLRH NIV+YYGSET+DDKLYIYLEYVSGGS
Sbjct: 427 AMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGS 486

Query: 244 IYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
           IYK+LQ+YGQ GE+AIR+YTQQILSGL YLHAKNTVHRDIKGANILVDP GRVK+ADFGM
Sbjct: 487 IYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGM 546

Query: 304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           AKHIT QS PLS KGSPYWMAPEVIKNSNG NLAVDIWSLGCTV+EMATTKPPWSQYEGV
Sbjct: 547 AKHITAQSGPLSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQYEGV 606

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
           PAMFKIGNSKELP IPDHLS+EGKDFVRKCLQRNP +RPTAA LL+H FV N  P+ERPI
Sbjct: 607 PAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPMERPI 666

Query: 424 LSAEPSETKPTLTVAMRIL 442
           +S EP+E     +  MR L
Sbjct: 667 VSGEPAEAMNVASSTMRSL 685

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297837021|ref|XP_002886392.1| hypothetical protein ARALYDRAFT_474980 [Arabidopsis lyrata subsp. lyrata] gi|297332233|gb|EFH62651.1| hypothetical protein ARALYDRAFT_474980 [Arabidopsis lyrata subsp. lyrata]

 Score =  743 bits (1917), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/439 (81%), Positives = 388/439 (88%)

Query: 4   FGQEQVLNAGLWTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPE 63
           F  +QV N GL   KPYSD++LLGSG CSSPGSG+NSG+NS+GGDM+ QLFWP SRCSPE
Sbjct: 247 FVPDQVSNHGLLISKPYSDVSLLGSGQCSSPGSGYNSGNNSIGGDMATQLFWPQSRCSPE 306

Query: 64  CSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTIS 123
           CSP+PSPRMTSPGPSSRI SGAVTPLHPRAGG  + SP+ R DD +QQSHRLPLPPL IS
Sbjct: 307 CSPVPSPRMTSPGPSSRIQSGAVTPLHPRAGGSTTGSPTRRLDDNRQQSHRLPLPPLLIS 366

Query: 124 NTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC 183
           NTCPFSP+YS ATSPSVPRSP R E   SPGSRWKKGRLLG G+FGHVYLGFNSESGEMC
Sbjct: 367 NTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMC 426

Query: 184 AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGS 243
           AMKEVTL SDD KS+ESAQQLGQEI++LSRLRH NIV+YYGSET+DDKLYIYLEYVSGGS
Sbjct: 427 AMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGS 486

Query: 244 IYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
           IYK+LQ+YGQ GE+AIR+YTQQILSGL YLHAKNTVHRDIKGANILVDP GRVK+ADFGM
Sbjct: 487 IYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGM 546

Query: 304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           AKHIT QS PLS KGSPYWMAPEVIKNSNG NLAVDIWSLGCTV+EMATTKPPWSQYEGV
Sbjct: 547 AKHITAQSGPLSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQYEGV 606

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
           PAMFKIGNSKELP IPDHLS+EGKDFVRKCLQRNP +RPTAA LL+H FV N  P+ERPI
Sbjct: 607 PAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPSNRPTAAQLLDHAFVRNVIPMERPI 666

Query: 424 LSAEPSETKPTLTVAMRIL 442
           +  EP+ET    +  MR L
Sbjct: 667 VCGEPAETMNVASSTMRSL 685

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	444
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.995	0.500	0.773	6.4e-186
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.756	0.551	0.608	1.2e-106
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.765	0.474	0.551	6.8e-95
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.662	0.426	0.498	2.3e-71
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.713	0.475	0.478	2.9e-71
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.608	0.414	0.5	1.1e-66
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.596	0.473	0.505	2.9e-66
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.659	0.481	0.493	4.5e-66
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.623	0.218	0.463	9.2e-66
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.684	0.393	0.451	2e-63

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1803 (639.7 bits), Expect = 6.4e-186, P = 6.4e-186
 Identities = 342/442 (77%), Positives = 371/442 (83%)

Query:     1 MRAFGQEQVLNAGLWTGKPYSDIALLXXXXXXXXXXXXXXXXXXXXXDMSGQLFWPHSRC 60
             MR+F  +QV N GL   KPYSD++LL                     DM+ QLFWP SRC
Sbjct:   244 MRSFIPDQVSNHGLLISKPYSDVSLLGSGQCSSPGSGYNSGNNSIGGDMATQLFWPQSRC 303

Query:    61 SPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL 120
             SPECSP+PSPRMTSPGPSSRI SGAVTPLHPRAGG  + SP+ R DD +QQSHRLPLPPL
Sbjct:   304 SPECSPVPSPRMTSPGPSSRIQSGAVTPLHPRAGGSTTGSPTRRLDDNRQQSHRLPLPPL 363

Query:   121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
              ISNTCPFSP+YS ATSPSVPRSP R E   SPGSRWKKGRLLG G+FGHVYLGFNSESG
Sbjct:   364 LISNTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESG 423

Query:   181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
             EMCAMKEVTL SDD KS+ESAQQLGQEI++LSRLRH NIV+YYGSET+DDKLYIYLEYVS
Sbjct:   424 EMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVS 483

Query:   241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
             GGSIYK+LQ+YGQ GE+AIR+YTQQILSGL YLHAKNTVHRDIKGANILVDP GRVK+AD
Sbjct:   484 GGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVAD 543

Query:   301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
             FGMAKHIT QS PLS KGSPYWMAPEVIKNSNG NLAVDIWSLGCTV+EMATTKPPWSQY
Sbjct:   544 FGMAKHITAQSGPLSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQY 603

Query:   361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
             EGVPAMFKIGNSKELP IPDHLS+EGKDFVRKCLQRNP +RPTAA LL+H FV N  P+E
Sbjct:   604 EGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPME 663

Query:   421 RPILSAEPSETKPTLTVAMRIL 442
             RPI+S EP+E     +  MR L
Sbjct:   664 RPIVSGEPAEAMNVASSTMRSL 685

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 213/350 (60%), Positives = 255/350 (72%)

Query:    69 SPRMTSPGPSSRIHSGAVTPLHPRAGGGVS-ESPSSRPDDVKQQS--HRLPLPPLTISNT 125
             SP   SP  ++ I +   +P H R  G VS ES + R DD +  S  H LP PP     T
Sbjct:   134 SPERVSP-KAATITTRPTSPRHQRLSGVVSLESSTGRNDDGRSSSECHPLPRPP-----T 187

Query:   126 CPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAM 185
              P SPS   A   S  R  G  E   S  S WKKG+ LG GTFG VYLGFNSE G+MCA+
Sbjct:   188 SPTSPS---AVHGS--RIGGGYETSPSGFSTWKKGKFLGSGTFGQVYLGFNSEKGKMCAI 242

Query:   186 KEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIY 245
             KEV + SDD  SKE  +QL QEI LL++L HPNIV+YYGSE  ++ L +YLEYVSGGSI+
Sbjct:   243 KEVKVISDDQTSKECLKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIH 302

Query:   246 KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK 305
             K+L+DYG   E  I++YT+QIL+GL YLH +NTVHRDIKGANILVDP+G +KLADFGMAK
Sbjct:   303 KLLKDYGSFTEPVIQNYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAK 362

Query:   306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
             H+T  S  LS KGSPYWMAPEV+ + NG   AVDIWSLGCT++EMAT+KPPWSQ+EGV A
Sbjct:   363 HVTAFSTMLSFKGSPYWMAPEVVMSQNGYTHAVDIWSLGCTILEMATSKPPWSQFEGVAA 422

Query:   366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
             +FKIGNSK+ P IPDHLS++ K+F+R CLQRNP  RPTA+ LLEHPF+ N
Sbjct:   423 IFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLRN 472

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 209/379 (55%), Positives = 262/379 (69%)

Query:    61 SPECSPIP-SPR--MTSPGPS---SRIHS---------GAVTPLHPRAGGGVSESPSSRP 105
             SP  SP P SPR  + SP PS   S +HS            +PLHPR    V+   + R 
Sbjct:   248 SPIHSPQPRSPRKQIRSPQPSRPSSPLHSVDSSAPPRDSVSSPLHPRLSTDVT---NGRR 304

Query:   106 DDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVEN-PTSPGSRWKKGRLLG 164
             D      H LPLPP     TC  S   S A+ PS P++P ++++ P +  S+WKKG+L+G
Sbjct:   305 DCCNV--HPLPLPP---GATCSSS---SAASVPS-PQAPLKLDSFPMN--SQWKKGKLIG 353

Query:   165 RGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG 224
             RGTFG VY+  NSE+G +CAMKEV LF DD KS E  +QL QEI LLS L+HPNIV+Y+G
Sbjct:   354 RGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQHPNIVQYFG 413

Query:   225 SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDI 283
             SET++D+ +IYLEYV  GSI K ++D+ G + ES +R++T+ ILSGL YLH K TVHRDI
Sbjct:   414 SETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVHRDI 473

Query:   284 KGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI-----KNSN-GCNLA 337
             KGAN+LVD SG VKLADFGMAKH+TGQ   LS+KGSPYWMAPE++     K+SN     A
Sbjct:   474 KGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQKDSNPDLAFA 533

Query:   338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
             VDIWSLGCT+IEM T KPPWS++EG  AMFK+   ++ P IP+ +S EGKDF+R C QRN
Sbjct:   534 VDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKV--MRDSPPIPESMSPEGKDFLRLCFQRN 591

Query:   398 PLHRPTAAWLLEHPFVGNA 416
             P  RPTA+ LLEH F+ N+
Sbjct:   592 PAERPTASMLLEHRFLKNS 610

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
 Identities = 153/307 (49%), Positives = 201/307 (65%)

Query:   128 FSPSYSTATSPSVPRS--PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAM 185
             FS ++  A  PS+ ++  P +     +P  RW+KG ++G G FG VY+G N +SGE+ A+
Sbjct:    50 FSKAHVPAL-PSISKAELPAKARKDDTPPIRWRKGEMIGCGAFGRVYMGMNVDSGELLAI 108

Query:   186 KEVTLFSDDAKSKESAQ----QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSG 241
             KEV++  + A S+E AQ    +L +E+ LL  L HPNIVRY G+      L I LE+V G
Sbjct:   109 KEVSIAMNGA-SRERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPG 167

Query:   242 GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF 301
             GSI  +L  +G   ES IR YT+Q+L GLEYLH    +HRDIKGANILVD  G +KLADF
Sbjct:   168 GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 227

Query:   302 GMAKHITGQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS 358
             G +K +   +      S+KG+PYWMAPEVI  + G + + DIWS+GCT+IEMAT KPPWS
Sbjct:   228 GASKKVVELATMTGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTIIEMATGKPPWS 286

Query:   359 Q-YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
             Q Y+ V A+F IG +K  P IP+HLS E KDF+ KCLQ+ P  R +A+ LL+HPFV    
Sbjct:   287 QQYQEVAALFHIGTTKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVTAEH 346

Query:   418 PLERPIL 424
                RP L
Sbjct:   347 QEARPFL 353

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
 Identities = 157/328 (47%), Positives = 203/328 (61%)

Query:    95 GGVSESPSSRPD-DVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSV-PRSPGRVENPTS 152
             G V  S   RP  D   Q ++ P P +                 PS  P  P    +   
Sbjct:     6 GSVRRSLVFRPSSDDDNQENQPPFPGVLADKITSCIRKSKIFIKPSFSPPPPANTVDMAP 65

Query:   153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL---FSDDAKSKESAQQLGQEIA 209
             P S W+KG+L+GRG FG VY+G N +SGE+ A+K+V +   F+   K++   Q+L +E+ 
Sbjct:    66 PIS-WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVK 124

Query:   210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
             LL  L HPNIVRY G+   DD L I LE+V GGSI  +L+ +G   ES +R+YT+Q+L G
Sbjct:   125 LLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLG 184

Query:   270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMAPE 326
             LEYLH    +HRDIKGANILVD  G +KLADFG +K +   +      S+KG+PYWMAPE
Sbjct:   185 LEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPE 244

Query:   327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-YEGVPAMFKIGNSKELPAIPDHLSDE 385
             VI  + G + + DIWS+GCTVIEM T K PWSQ Y+ V A+F IG +K  P IPD LS +
Sbjct:   245 VILQT-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSD 303

Query:   386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              KDF+ KCLQ  P  RPTA+ LL+HPFV
Sbjct:   304 AKDFLLKCLQEVPNLRPTASELLKHPFV 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
 Identities = 142/284 (50%), Positives = 186/284 (65%)

Query:   138 PSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS 197
             P +P +P + E   +P  RW+KG L+G G FG VY+G N +SGE+ A+K+V L +  + S
Sbjct:    53 PGLP-APRKEE---APSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSAS 107

Query:   198 KESAQ----QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ 253
             KE  Q    +L +E+ LL  L HPNIVRY G+    D L I +E+V GGSI  +L+ +G 
Sbjct:   108 KEKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGS 167

Query:   254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC- 312
               E  I  YT+Q+L GLEYLH    +HRDIKGANILVD  G ++LADFG +K +   +  
Sbjct:   168 FPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATV 227

Query:   313 --PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKI 369
                 S+KG+PYWMAPEVI  + G + + DIWS+GCTVIEMAT KPPWS QY+   A+  I
Sbjct:   228 NGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHI 286

Query:   370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             G +K  P IP+ LS E KDF+ KCL + P  R +A  LL+HPFV
Sbjct:   287 GRTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFV 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 625 (225.1 bits), Expect = 2.9e-66, Sum P(2) = 2.9e-66
 Identities = 138/273 (50%), Positives = 180/273 (65%)

Query:   147 VENPTSPG--SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
             +EN   P   + W KG+LLGRG++  VY    SE G+  A+KEV+L     +++E  QQL
Sbjct:   291 IENFRKPEDITSWLKGQLLGRGSYASVYEAI-SEDGDFFAVKEVSLLDKGIQAQECIQQL 349

Query:   205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
               EIALLS+L+H NIVRY G+     KLYI+LE V+ GS+ K+ + Y QL  + +  YT+
Sbjct:   350 EGEIALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERY-QLSYTVVSLYTR 408

Query:   265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
             QIL+GL YLH K  VHRDIK AN+LVD +G VKLADFG+A+        +S KG+ +WMA
Sbjct:   409 QILAGLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDI-MSCKGTLFWMA 467

Query:   325 PEVI--KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
             PEVI  K+S+G     DIWSLGCTV+EM T + P+S  + + A FKIG    LP +PD L
Sbjct:   468 PEVINRKDSDGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGT-LPDVPDTL 526

Query:   383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
             S + + F+  CL+ NP  RPTAA LL HPFV N
Sbjct:   527 SLDARHFILTCLKVNPEERPTAAELLHHPFVIN 559

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 672 (241.6 bits), Expect = 4.5e-66, P = 4.5e-66
 Identities = 148/300 (49%), Positives = 196/300 (65%)

Query:   121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
             T   TC F+ +   ++S     SP   +      S W+KG+LLGRG+FG VY G + + G
Sbjct:   298 TADETCSFTTNEGDSSSTVSNTSPIYPDGGAIITS-WQKGQLLGRGSFGSVYEGISGD-G 355

Query:   181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
             +  A+KEV+L    ++++E  QQL  EI LLS+L+H NIVRY G+      LYI+LE V+
Sbjct:   356 DFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVT 415

Query:   241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
              GS+ K+ Q Y QL +S +  YT+QIL GL+YLH K  +HRDIK ANILVD +G VKLAD
Sbjct:   416 QGSLLKLYQRY-QLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLAD 474

Query:   301 FGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAVDIWSLGCTVIEMATTKPPWS 358
             FG+AK ++  +   S KG+P+WMAPEVI  K+S+G     DIWSLGCTV+EM T + P+S
Sbjct:   475 FGLAK-VSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYS 533

Query:   359 QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
               E V A+F+IG    LP +PD LS + + F+ KCL+ NP  RPTAA LL HPFV    P
Sbjct:   534 DLEPVQALFRIGRGT-LPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPLP 592

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 662 (238.1 bits), Expect = 9.2e-66, Sum P(2) = 9.2e-66
 Identities = 133/287 (46%), Positives = 188/287 (65%)

Query:   156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL--FSDDAKSKESAQQLGQEIALLSR 213
             +W+KG++LGRG +G VYLG N ++GE+ A+K++ +   + D K K       +EI ++  
Sbjct:   494 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 553

Query:   214 LRHPNIVRYYGSETLDDK-LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
             LRH NIVRY G+ +LD   L ++LEY+ GGSI  +L  +G   E+ I+ YT+QIL GL +
Sbjct:   554 LRHDNIVRYLGT-SLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSF 612

Query:   273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNS 331
             LHA + +HRDIKGANIL+D  G VKL+DFG +K  +G      S++G+PYWMAPEVIK +
Sbjct:   613 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIKQT 672

Query:   332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDFV 390
              G   + DIWSLGC ++EMAT +PPWS    + A M+ I +S  +P IP H+S E  DF+
Sbjct:   673 -GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFL 731

Query:   391 RKCLQRNPLHRPTAAWLLEHPFVGNAAP-LERPILSAEPSETKPTLT 436
               C +R+P  RP A  LL+HPF+ N    ++ P +S  P+ T  T T
Sbjct:   732 NLCFKRDPKERPDANQLLKHPFIMNLDDNIQLPTIS--PTTTLSTNT 776

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 624 (224.7 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
 Identities = 143/317 (45%), Positives = 197/317 (62%)

Query:   121 TISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
             T    C F+ +   ++S     SP  V    S  + W+KG+LL +G+FG VY    SE G
Sbjct:   466 TTDEACSFTTNEGDSSSTVSNTSPICVSGG-SINTSWQKGQLLRQGSFGSVYEAI-SEDG 523

Query:   181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
             +  A+KEV+L    ++++E  QQL  EIALLS+L H NI+RY G++     LYI+LE V+
Sbjct:   524 DFFAVKEVSLLDQGSQAQECIQQLEGEIALLSQLEHQNILRYRGTDKDGSNLYIFLELVT 583

Query:   241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
              GS+ ++ + Y Q+ +S I  YT+QIL GL+YLH K  +HRDIK A ILVD +G VKLAD
Sbjct:   584 QGSLLELYRRY-QIRDSLISLYTKQILDGLKYLHHKGFIHRDIKCATILVDANGTVKLAD 642

Query:   301 FGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAVDIWSLGCTVIEMATTKPPWS 358
             FG+AK ++  +   S K + +WMAPEVI  K+++G     DIWSLGCTV+EM T + P+S
Sbjct:   643 FGLAK-VSKLNDIKSRKETLFWMAPEVINRKDNDGYRSPADIWSLGCTVLEMCTGQIPYS 701

Query:   359 QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
               E V A+F+I     LP +PD LS + + F+ KCL+ NP  RPTA  LL HPFV     
Sbjct:   702 DLEPVEALFRIRRGT-LPEVPDTLSLDARHFILKCLKLNPEERPTATELLNHPFV----- 755

Query:   419 LERPILSAEPSETKPTL 435
               RP+ S+    T P +
Sbjct:   756 -RRPLPSSGSGSTSPLI 771

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00000435001 SubName- Full=Chromosome chr2 scaffold_105, whole genome shotgun sequence; (901 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	444
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-164
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-133
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-104
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-103
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-96
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-95
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-93
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-91
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-90
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-88
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-86
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-83
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-76
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-76
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-76
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-75
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-74
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-74
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-73
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-73
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-70
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-69
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-64
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-64
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-62
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-62
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-61
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-60
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-58
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-58
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-57
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-56
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-56
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-55
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-55
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-54
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-54
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-53
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-53
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-52
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-52
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-51
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-49
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-49
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-49
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-49
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-49
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-48
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-48
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-48
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-48
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-47
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-46
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-46
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-45
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-45
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-45
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-45
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-45
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-45
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-44
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-44
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-44
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-43
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-43
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-43
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-43
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-42
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-42
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-42
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-42
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-42
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-42
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-41
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-41
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-41
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-40
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-40
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-39
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-39
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-39
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-38
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-38
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-38
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-38
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-38
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-38
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-37
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-37
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-37
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-37
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-37
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-37
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-36
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-36
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-36
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-36
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-34
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-34
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-33
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-32
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-32
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-32
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-32
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-32
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-31
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-31
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-31
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-31
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-31
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-31
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-31
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-30
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-30
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-30
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-30
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-30
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-29
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-29
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-29
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-29
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-29
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-29
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-29
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-29
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-28
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-28
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-28
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-28
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-28
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-28
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-27
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-27
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-27
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-27
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-27
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-26
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-26
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-26
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-26
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-26
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-26
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-25
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-25
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-25
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-24
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-24
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-24
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-23
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-23
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-23
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-23
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-22
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-22
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-22
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-22
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-22
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-22
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-22
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-22
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-21
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-21
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-21
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-21
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-20
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-20
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-20
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-19
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-19
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-16
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-15
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-15
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-14
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-11
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	4e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.003

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  461 bits (1187), Expect = e-164
 Identities = 172/258 (66%), Positives = 198/258 (76%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           RW+KG LLG G+FG VY G N + G+  A+KEV+L  D    +E+ +QL QEIALLS+L+
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HPNIV+Y G+E  +D LYI+LE V GGS+ K+L+ YG   E  IR YT+QIL GLEYLH 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           +NTVHRDIKGANILVD +G VKLADFGMAK +   S   S KGSPYWMAPEVI    G  
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           LA DIWSLGCTV+EMAT KPPWSQ EGV A+FKIG SKELP IPDHLSDE KDF+ KCLQ
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 396 RNPLHRPTAAWLLEHPFV 413
           R+P  RPTAA LLEHPFV
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  383 bits (985), Expect = e-133
 Identities = 150/264 (56%), Positives = 189/264 (71%), Gaps = 10/264 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W +G LLGRG+FG VYL  + ++GE+ A+K V L  D   S+E  + L +EI +LS L+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---SEEELEALEREIRILSSLQ 57

Query: 216 HPNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           HPNIVRYYGSE  ++K  L I+LEYVSGGS+  +L+ +G+L E  IR YT+QIL GL YL
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKN 330
           H+   VHRDIKGANILVD  G VKLADFG AK +          S++G+PYWMAPEVI+ 
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDF 389
                 A DIWSLGCTVIEMAT KPPWS+    + A++KIG+S E P IP+HLS+E KDF
Sbjct: 178 EEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           +RKCL+R+P  RPTA  LL+HPF+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  309 bits (795), Expect = e-104
 Identities = 106/259 (40%), Positives = 155/259 (59%), Gaps = 7/259 (2%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++    LG G+FG VYL  + ++G++ A+K +       K K+  +++ +EI +L +L+H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI----KKKKIKKDRERILREIKILKKLKH 56

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNIVR Y     +DKLY+ +EY  GG ++ +L+  G+L E   R Y +QILS LEYLH+K
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             VHRD+K  NIL+D  G VKLADFG+A+ +       +  G+P +MAPEV+    G   
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGK 175

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRKCL 394
           AVDIWSLG  + E+ T KPP+   + +  +FK     + P  P    +S E KD +RK L
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235

Query: 395 QRNPLHRPTAAWLLEHPFV 413
            ++P  R TA   L+HPF 
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  306 bits (787), Expect = e-103
 Identities = 120/259 (46%), Positives = 165/259 (63%), Gaps = 6/259 (2%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            ++ G L+GRG FG VY G N E+G+  A+K+++L       +E+ + + QEI LL  L+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLK 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HPNIV+Y GS    D LYI LEY   GS+ +I++ +G   ES +  Y  Q+L GL YLH 
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIKGSPYWMAPEVIKNSNGC 334
           +  +HRDIK ANIL    G VKLADFG+A  +   S    S+ G+PYWMAPEVI+ S G 
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GA 176

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           + A DIWSLGCTVIE+ T  PP+     + A+F+I      P +P+ +S E KDF+ +C 
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISPELKDFLMQCF 235

Query: 395 QRNPLHRPTAAWLLEHPFV 413
           Q++P  RPTA  LL+HP++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  289 bits (740), Expect = 5e-96
 Identities = 120/264 (45%), Positives = 167/264 (63%), Gaps = 11/264 (4%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W++G+LLG+G FG VYL ++ ++G   A+K+V    D  ++K+    L  EI LL  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
             IV+YYG    D+ L I++EY+ GGS+   L+ YG L E+  R YT+QIL G+EYLH+ 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-------HITGQSCPLSIKGSPYWMAPEVIK 329
             VHRDIKGANIL D +G VKL DFG +K         TG     S+ G+PYWM+PEVI 
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVI- 179

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
           +  G     D+WS+GCTV+EM T KPPW+++E + A+FKI      P +P H+S + ++F
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           +R+    N   RP+A  LL H FV
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  288 bits (738), Expect = 1e-95
 Identities = 122/268 (45%), Positives = 172/268 (64%), Gaps = 14/268 (5%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           RW++G  +G GTFG VY   N ++GE+ A+KE+ +  +D K+    +++  E+ +L  L+
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HPN+V+YYG E   +K+YI++EY SGG++ ++L+    L E  IR YT Q+L GL YLH+
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-----SIKGSPYWMAPEVIKN 330
              VHRDIK ANI +D +G +KL DFG A  +   +  +     S+ G+P +MAPEVI  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 331 SN--GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDH--LSDE 385
               G   A DIWSLGC V+EMAT K PWS+ +     MF +G +   P IPD   LS E
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           GKDF+ +CL+ +P  RPTA+ LL+HPFV
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  283 bits (726), Expect = 1e-93
 Identities = 126/270 (46%), Positives = 169/270 (62%), Gaps = 13/270 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ-----LGQEIAL 210
           +W KG L+G+GT+G VYL  N  +GEM A+K+V L +  A   +S Q+     L  EI  
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  L H NIV+Y G ET ++ L I+LEYV GGSI   L+ YG+  E  +R +T+Q+L GL
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH---ITGQSCPLSIKGSPYWMAPEV 327
            YLH+K  +HRD+K  N+LVD  G  K++DFG++K    I      +S++GS +WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 328 IKN-SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD----HL 382
           I + S G +  VDIWSLGC V+EM   + PWS  E + AMFK+GN +  P IP     +L
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           S    DF+  C   NP +RPTA  LL+HPF
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  276 bits (708), Expect = 3e-91
 Identities = 113/259 (43%), Positives = 162/259 (62%), Gaps = 10/259 (3%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++    +G+G FG VY   +  +G+  A+K + L     +SKE  +++  EI +L + +H
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           PNIV+YYGS    D+L+I +E+ SGGS+  +L+   Q L ES I    +++L GLEYLH+
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
              +HRDIK ANIL+   G VKL DFG++  ++      ++ G+PYWMAPEVI      +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDEGKDFVRKC 393
              DIWSLG T IE+A  KPP+S+   + A+FKI  +    L   P+  SDE KDF++KC
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLKKC 234

Query: 394 LQRNPLHRPTAAWLLEHPF 412
           LQ+NP  RPTA  LL+HPF
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  273 bits (701), Expect = 7e-90
 Identities = 103/266 (38%), Positives = 153/266 (57%), Gaps = 9/266 (3%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             +     +G+G+FG VY   +  + ++ A+K + L     ++++  + + QEI  LS+ 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           R P I +YYGS     KL+I +EY  GGS   +L+  G+L E+ I    +++L GLEYLH
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLH 115

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNG 333
            +  +HRDIK ANIL+   G VKLADFG++  +T       +  G+P+WMAPEVIK S G
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-G 174

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-SDEGKDFVRK 392
            +   DIWSLG T IE+A  +PP S    +  +F I  +   P++  +  S   KDFV  
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSL 233

Query: 393 CLQRNPLHRPTAAWLLEHPFVGNAAP 418
           CL ++P  RP+A  LL+H F+  A  
Sbjct: 234 CLNKDPKERPSAKELLKHKFIKKAKK 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  268 bits (687), Expect = 6e-88
 Identities = 127/269 (47%), Positives = 173/269 (64%), Gaps = 13/269 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALL 211
           +W KG L+G G+FG VYLG N+ SGE+ A+K+V L S  A SK+  +     L +EIALL
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             L+H NIV+Y GS    D L I+LEYV GGS+  +L +YG   E+ +R++ +QIL GL 
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-------SIKGSPYWMA 324
           YLH +  +HRDIKGANILVD  G +K++DFG++K +   S          S++GS +WMA
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PEV+K ++    A DIWSLGC V+EM T K P+     + A+FKIG     P IP ++S 
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS 238

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E  DF+ K  + +   RPTAA LL+HPF+
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  263 bits (674), Expect = 5e-86
 Identities = 103/263 (39%), Positives = 148/263 (56%), Gaps = 9/263 (3%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++  R LG G+FG VY   +  +G++ A+K +       KSK+  Q   +EI +L RL H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKK-DQTARREIRILRRLSH 57

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNIVR   +    D LY+ +EY  GG ++  L   G L E   +    QIL GLEYLH+ 
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             +HRD+K  NIL+D +G VK+ADFG+AK  +   S   +  G+P++MAPEV+   NG  
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-----LSDEGKDFV 390
             VD+WSLG  + E+ T KPP+S    +  +  I      P   D       S+E KD +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
           +KCL ++P  RPTA  +L+HP+ 
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  255 bits (654), Expect = 5e-83
 Identities = 118/266 (44%), Positives = 164/266 (61%), Gaps = 11/266 (4%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-QQLGQEIALLSRLR 215
           W KG +LG+G +G VY G  ++ G++ A+K+V L + +  + E   ++L +E+ LL  L+
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H NIV+Y G+   D+ + I++E+V GGSI  IL  +G L E     YT+QIL G+ YLH 
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAK-------HITGQSCPLSIKGSPYWMAPEVI 328
              VHRDIKG N+++ P+G +KL DFG A+       H T  +   S+ G+PYWMAPEVI
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPDHLSDEGK 387
            N +G     DIWS+GCTV EMAT KPP +  + + AMF IG  + L P +PD  S    
Sbjct: 181 -NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
           DFV  CL R+   RP+A  LL H F+
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  239 bits (611), Expect = 1e-76
 Identities = 124/266 (46%), Positives = 167/266 (62%), Gaps = 14/266 (5%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W+ G+LLGRG FG VYL +++++G   A+K+V    D  ++ +    L  EI LL  LRH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 217 PNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
             IV+YYG   +  + KL I++EY+ GGSI   L+ YG L E+  R YT+QIL G+ YLH
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAPEV 327
           +   VHRDIKGANIL D +G VKL DFG +K I       TG     S+ G+PYWM+PEV
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPYWMSPEV 180

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
           I +  G     D+WS+ CTV+EM T KPPW++YE + A+FKI      P +PD +SD  +
Sbjct: 181 I-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
           DF+++        RPTA +LL HPFV
Sbjct: 240 DFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  239 bits (610), Expect = 2e-76
 Identities = 120/265 (45%), Positives = 165/265 (62%), Gaps = 14/265 (5%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W++G+LLG+G FG VYL ++ ++G   A K+V    +  ++ +    L  EI LL  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 217 PNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
             IV+YYG   +  +  L I++EY+ GGS+   L+ YG L ES  R YT+QIL G+ YLH
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAPEV 327
           +   VHRDIKGANIL D +G VKL DFG +K +       TG     S+ G+PYWM+PEV
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPEV 180

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
           I +  G     D+WSLGCTV+EM T KPPW++YE + A+FKI      P +P H+S+  +
Sbjct: 181 I-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPF 412
           DF+  C+     HRP+A  LL HPF
Sbjct: 240 DFLG-CIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  238 bits (610), Expect = 2e-76
 Identities = 107/256 (41%), Positives = 154/256 (60%), Gaps = 13/256 (5%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG G++G VY   + E+G++ A+K V +  D        Q++ +EI++L +   P IV+
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-------QEIIKEISILKQCDSPYIVK 62

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           YYGS   +  L+I +EY   GS+  I++     L E  I +   Q L GLEYLH+   +H
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  NIL++  G+ KLADFG++  +T   +   ++ G+P+WMAPEVI+     N A D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-D 181

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLSDEGKDFVRKCLQRN 397
           IWSLG T IEMA  KPP+S    + A+F I N K  P  + P+  S E  DFV+KCL ++
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-KPPPTLSDPEKWSPEFNDFVKKCLVKD 240

Query: 398 PLHRPTAAWLLEHPFV 413
           P  RP+A  LL+HPF+
Sbjct: 241 PEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  235 bits (603), Expect = 2e-75
 Identities = 91/260 (35%), Positives = 143/260 (55%), Gaps = 14/260 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G+FG VYL      G++  +KE+ L +   K +E A     E+ +L +L HPNI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNII 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQILSGLEYLHAK 276
           +YY S     KL I +EY  GG + + ++   + G    E  I  +  Q+   L+YLH++
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRDIK  NI +  +G VKL DFG++K    T       + G+PY+++PE+ +N    
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQN-KPY 180

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDFVRKC 393
           N   DIWSLGC + E+ T K P+ + E +     KI    + P IP   S E ++ V   
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI-LKGQYPPIPSQYSSELRNLVSSL 238

Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           LQ++P  RP+ A +L+ PF+
Sbjct: 239 LQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  234 bits (598), Expect = 3e-74
 Identities = 109/264 (41%), Positives = 161/264 (60%), Gaps = 14/264 (5%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G  G VY   +  +G+  A+K++ L   + +       +  EI ++   +HPNIV Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKHPNIVDY 80

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           Y S  + D+L++ +EY+ GGS+  I+ Q++ ++ E  I    +++L GLEYLH++N +HR
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 282 DIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSN-GCNLAVD 339
           DIK  NIL+   G VKLADFG A  +T  +S   S+ G+PYWMAPEVIK  + G    VD
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK--VD 198

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDEGKDFVRKCLQRN 397
           IWSLG   IEMA  +PP+ +   + A+F I  +K +P +  P+  S E KDF+ KCL ++
Sbjct: 199 IWSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257

Query: 398 PLHRPTAAWLLEHPFVGNAAPLER 421
           P  RP+A  LL+HPF+  A P E 
Sbjct: 258 PEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  232 bits (595), Expect = 4e-74
 Identities = 110/260 (42%), Positives = 145/260 (55%), Gaps = 18/260 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   +  +GE+ A+K + L   D         + QEI++L   RHPNIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-----IIQQEISMLKECRHPNIVAY 65

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           +GS    DKL+I +EY  GGS+  I Q   G L E  I    ++ L GL YLH    +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKNS--NGCNLAV 338
           DIKGANIL+   G VKLADFG++  +T   +   S  G+PYWMAPEV       G +   
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK------DFVRK 392
           DIW+LG T IE+A  +PP      + A+F I  S      P  L D+ K      DF++K
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSN---FPPPKLKDKEKWSPVFHDFIKK 242

Query: 393 CLQRNPLHRPTAAWLLEHPF 412
           CL ++P  RPTA  LL+HPF
Sbjct: 243 CLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  230 bits (587), Expect = 4e-73
 Identities = 118/268 (44%), Positives = 166/268 (61%), Gaps = 14/268 (5%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + W+ G+LLG+G FG VYL +++++G   A+K+V    +  ++ +    L  EI LL  L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 215 RHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
            H  IV+YYG   + ++  L I++E++ GGSI   L+ YG L E+  R YT+QIL G+ Y
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAP 325
           LH+   VHRDIKGANIL D  G VKL DFG +K +       TG     S+ G+PYWM+P
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM---KSVTGTPYWMSP 178

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
           EVI +  G     DIWS+GCTV+EM T KPPW+++E + A+FKI      P +P H+SD 
Sbjct: 179 EVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +DF+++      L RP+A  LL H FV
Sbjct: 238 CRDFLKRIFVEAKL-RPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  228 bits (583), Expect = 5e-73
 Identities = 93/252 (36%), Positives = 135/252 (53%), Gaps = 40/252 (15%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG VYL  + ++G+  A+K +        S    ++L +EI +L +L HPNIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           YG    ++ LY+ +EY  GGS+  +L++  G+L E  I     QIL GLEYLH+   +HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 282 DIKGANILVD-PSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  NIL+D  +G+VKLADFG++K +T     L +I G+P +MAPEV+      +   D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           IWSLG  + E+                                  E KD +RK LQ++P 
Sbjct: 177 IWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE 203

Query: 400 HRPTAAWLLEHP 411
            RP+A  +LEH 
Sbjct: 204 KRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  222 bits (566), Expect = 7e-70
 Identities = 100/265 (37%), Positives = 161/265 (60%), Gaps = 11/265 (4%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-QQLGQEIALLSRLR 215
           W KG+ LG G F   Y   + ++G + A+K+VT   + +  +E   + L +EI L++RL 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP+I+R  G+   D    +++E+++GGS+  +L  YG   E+ I +YT+Q+L GL YLH 
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 276 KNTVHRDIKGANILVDPSGR-VKLADFG----MAKHITGQS-CPLSIKGSPYWMAPEVIK 329
              +HRD+KGAN+L+D +G+ +++ADFG    +A   TG       + G+  +MAPEV++
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAIPDHLSDEG 386
                  + D+WS+GC +IEMAT KPPW+  +    +  +FKI ++   P+IP+HLS   
Sbjct: 182 GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHP 411
           +D   +CL+  P  RP +  LL+HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  221 bits (565), Expect = 1e-69
 Identities = 113/259 (43%), Positives = 158/259 (61%), Gaps = 12/259 (4%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +LG+GT+G VY   +  +    A+KE+       +     Q L +EIAL S L+H NIV+
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLG--ESAIRSYTQQILSGLEYLHAKNT 278
           Y GS++ +    I++E V GGS+  +L+  +G L   E  I  YT+QIL GL+YLH    
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 279 VHRDIKGANILVDP-SGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVI-KNSNGCN 335
           VHRDIKG N+LV+  SG VK++DFG +K + G   C  +  G+  +MAPEVI K   G  
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQY-EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
              DIWSLGCT++EMAT KPP+ +  E   AMFK+G  K  P IP+ LS E K+F+ +C 
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249

Query: 395 QRNPLHRPTAAWLLEHPFV 413
           + +P  R +A  LL+ PF+
Sbjct: 250 EPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  208 bits (531), Expect = 1e-64
 Identities = 90/260 (34%), Positives = 147/260 (56%), Gaps = 10/260 (3%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G+ G VY   +  +G++ A+K++ +  D+   K    QL +E+  L     P +V+ 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSCESPYVVKC 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHR 281
           YG+   + ++ I LEY+ GGS+  +L+  G++ E  +    +QIL GL+YLH K + +HR
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124

Query: 282 DIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           DIK +N+L++  G VK+ADFG++K +        +  G+  +M+PE I      + A DI
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGESYSYAADI 183

Query: 341 WSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELPAIPDHL-SDEGKDFVRKCLQRN 397
           WSLG T++E A  K P+          + +       P++P    S E +DF+  CLQ++
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKD 243

Query: 398 PLHRPTAAWLLEHPFVGNAA 417
           P  RP+AA LL+HPF+  A 
Sbjct: 244 PKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  207 bits (529), Expect = 5e-64
 Identities = 103/274 (37%), Positives = 151/274 (55%), Gaps = 14/274 (5%)

Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
            +P   W+    LG G FG VY   + E+G   A K +       +S+E  +    EI +
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII-----QIESEEELEDFMVEIDI 55

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSG 269
           LS  +HPNIV  Y +   ++KL+I +E+  GG++  I+ +  + L E  IR   +Q+L  
Sbjct: 56  LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMAPEVI 328
           L +LH+   +HRD+K  NIL+   G VKLADFG+ AK+ +      +  G+PYWMAPEV+
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175

Query: 329 K----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHL 382
                  N  +   DIWSLG T+IE+A  +PP  +   +  + KI  S E P +  P   
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQPSKW 234

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           S    DF++ CL ++P  RPTAA LL+HPFV + 
Sbjct: 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  203 bits (518), Expect = 2e-62
 Identities = 106/276 (38%), Positives = 151/276 (54%), Gaps = 11/276 (3%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S +++  L+GRG +G VY G +  +G + A+K + L + D    +    + +E+ALLS+L
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD----DDVSDIQREVALLSQL 56

Query: 215 RH---PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           R    PNI +YYGS     +L+I +EY  GGS+ + L   G + E  I    +++L  L+
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALK 115

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKN 330
           Y+H    +HRDIK ANILV  +G VKL DFG+A  +   S   S   G+PYWMAPEVI  
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD-HLSDEGKDF 389
               +   DIWSLG T+ EMAT  PP+S  +   AM  I  SK  P + D   S   ++F
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-PRLEDNGYSKLLREF 234

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILS 425
           V  CL   P  R +A  LL+  ++   +     IL 
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILK 270

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  201 bits (515), Expect = 2e-62
 Identities = 93/269 (34%), Positives = 138/269 (51%), Gaps = 39/269 (14%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ------EIALLSRLRH 216
           LG+G+FG V L    ++G++ AMK +         K+   +  +      E  +LSR+ H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL--------KKKKIIKRKEVEHTLTERNILSRINH 52

Query: 217 PNIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           P IV+ +Y  +T ++KLY+ LEY  GG ++  L   G+  E   R Y  +I+  LEYLH+
Sbjct: 53  PFIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
              ++RD+K  NIL+D  G +KL DFG+AK   +  S   +  G+P ++APEV+    G 
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGY 170

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--------PAIPDHLSDEG 386
             AVD WSLG  + EM T KPP          F   + KE+           P+ LS E 
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP----------FYAEDRKEIYEKILKDPLRFPEFLSPEA 220

Query: 387 KDFVRKCLQRNPLHRPTAAWLLE---HPF 412
           +D +   LQ++P  R  +    E   HPF
Sbjct: 221 RDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  200 bits (511), Expect = 1e-61
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 16/262 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G    VY      + E  A+K + L     K + S  +L +E+  +S+  HPN+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQ---DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           Y S  + D+L++ + Y+SGGS+  I++     G L E+ I +  +++L GLEYLH+   +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIK---GSPYWMAPEVIKNSNGC 334
           HRDIK  NIL+   G VK+ADFG++  +   G       K   G+P WMAPEV++  +G 
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--GNSKELPAIPDH--LSDEGKDFV 390
           +   DIWS G T IE+AT   P+S+Y  +  +      +   L    D+   S   +  +
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMI 244

Query: 391 RKCLQRNPLHRPTAAWLLEHPF 412
             CLQ++P  RPTA  LL+H F
Sbjct: 245 SLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  198 bits (505), Expect = 2e-60
 Identities = 97/287 (33%), Positives = 147/287 (51%), Gaps = 41/287 (14%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   ++   ++G GT+G VY   + ++G++ A+K + +  D    +E  ++   E  +L 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKE---EYNILR 57

Query: 213 RL-RHPNIVRYYG------SETLDDKLYIYLEYVSGGSI---YKILQDYGQ-LGESAIRS 261
           +   HPNI  +YG          DD+L++ +E   GGS+    K L+  G+ L E  I  
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-----QSCPLSI 316
             ++ L GL YLH    +HRDIKG NIL+  +  VKL DFG++  +        +     
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF---- 173

Query: 317 KGSPYWMAPEVIKNSNGCNLA--------VDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
            G+PYWMAPEVI     C+           D+WSLG T IE+A  KPP      + A+FK
Sbjct: 174 IGTPYWMAPEVI----ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229

Query: 369 IGNSKELPAI--PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           I  +   P +  P++ S +  DF+ +CL +N   RP    LLEHPF+
Sbjct: 230 IPRNPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  191 bits (488), Expect = 3e-58
 Identities = 79/259 (30%), Positives = 125/259 (48%), Gaps = 23/259 (8%)

Query: 158 KKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           + G+ LG G FG VY G        +    A+K +   + + + +E      +E +++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKK 57

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEY 272
           L HPNIVR  G  T  + LYI  EY+ GG +   L+ +G+ L    +     QI  G+EY
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAP 325
           L +KN VHRD+   N LV  +  VK++DFG+++ I             L IK    WMAP
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           E +K+        D+WS G  + E+ T  + P+        +  + +   LP  P++  D
Sbjct: 174 ESLKD-GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR-PENCPD 231

Query: 385 EGKDFVRKCLQRNPLHRPT 403
           E  + + +C   +P  RPT
Sbjct: 232 ELYELMLQCWAYDPEDRPT 250

Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  192 bits (488), Expect = 3e-58
 Identities = 105/262 (40%), Positives = 155/262 (59%), Gaps = 8/262 (3%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   + K   +G+G+FG VY G ++ + E+ A+K + L     ++++  + + QEI +LS
Sbjct: 2   PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLS 57

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           +   P I RYYGS     KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL+Y
Sbjct: 58  QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDY 116

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNS 331
           LH++  +HRDIK AN+L+   G VKLADFG+A  +T       +  G+P+WMAPEVIK S
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              +   DIWSLG T IE+A  +PP S    +  +F I  +   P +    S   K+FV 
Sbjct: 177 -AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVE 234

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
            CL ++P  RPTA  LL+H F+
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  188 bits (480), Expect = 6e-57
 Identities = 84/249 (33%), Positives = 122/249 (48%), Gaps = 21/249 (8%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ------EIALLSRLRH 216
           LG G FG V L          A+K V         K    + GQ      E  +L    H
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV--------KKRHIVETGQQEHIFSEKEILEECNH 52

Query: 217 PNIVRYYGSETLDDKLYIY--LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           P IV+ Y   T  DK YIY  +EY  GG ++ IL+D G   E   R Y   ++   EYLH
Sbjct: 53  PFIVKLY--RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            +  ++RD+K  N+L+D +G VKL DFG AK +       +  G+P ++APE+I N  G 
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGY 169

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + +VD WSLG  + E+ T +PP+ + +  P      I         P+++    KD +++
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229

Query: 393 CLQRNPLHR 401
            L+RNP  R
Sbjct: 230 LLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  187 bits (476), Expect = 1e-56
 Identities = 106/256 (41%), Positives = 148/256 (57%), Gaps = 11/256 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N  +GE+ A+K + L     +  E    + QEI ++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           +GS    DKL+I +E+  GGS+  I    G L ES I   +++ L GL YLH+K  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEV--IKNSNGCNLAVD 339
           IKGANIL+  +G VKLADFG++  IT       S  G+PYWMAPEV  ++   G N   D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHL--SDEGKDFVRKCLQR 396
           IW++G T IE+A  +PP      + A+F +  S  + P + D +  S+    FV+  L +
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251

Query: 397 NPLHRPTAAWLLEHPF 412
           NP  RPTA  LL+HPF
Sbjct: 252 NPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  186 bits (474), Expect = 5e-56
 Identities = 102/262 (38%), Positives = 157/262 (59%), Gaps = 8/262 (3%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   + K   +G+G+FG V+ G ++ + ++ A+K + L     ++++  + + QEI +LS
Sbjct: 2   PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLS 57

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           +   P + +YYGS   D KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL+Y
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDY 116

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNS 331
           LH++  +HRDIK AN+L+   G VKLADFG+A  +T      +   G+P+WMAPEVIK S
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              +   DIWSLG T IE+A  +PP S+   +  +F I  +   P +  + S   K+FV 
Sbjct: 177 -AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVE 234

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
            CL + P  RPTA  LL+H F+
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  186 bits (473), Expect = 2e-55
 Identities = 102/278 (36%), Positives = 146/278 (52%), Gaps = 27/278 (9%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   +   R +G G+FG VY   +  + E+ A+K++  +S   +S E  Q + +E+  L 
Sbjct: 13  PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGK-QSNEKWQDIIKEVRFLQ 70

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLE 271
           +LRHPN + Y G    +   ++ +EY  G S   IL+ + + L E  I +     L GL 
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLA 129

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKN 330
           YLH+   +HRDIK  NIL+   G VKLADFG A  +     P  S  G+PYWMAPEVI  
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFVGTPYWMAPEVI-- 183

Query: 331 SNGCNLA---------VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-PD 380
                LA         VD+WSLG T IE+A  KPP      + A++ I  + + P +  +
Sbjct: 184 -----LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSN 237

Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
             SD  ++FV  CLQ+ P  RP++  LL+H FV    P
Sbjct: 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  182 bits (465), Expect = 8e-55
 Identities = 89/263 (33%), Positives = 129/263 (49%), Gaps = 17/263 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G+FG V        G++   KE+   +   K K   QQL  E+ +L  L+HPNIVRY
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK---QQLVSEVNILRELKHPNIVRY 64

Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLH-- 274
           Y          LYI +EY  GG + +++Q        + E  I     Q+L  L   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 275 --AKNTV-HRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKN 330
               NTV HRD+K ANI +D +  VKL DFG+AK +    S   +  G+PY+M+PE + N
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL-N 183

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               +   DIWSLGC + E+    PP++    +    KI   K    IP   S E  + +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVI 242

Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
           +  L  +P  RP+   LL+ P +
Sbjct: 243 KSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  182 bits (464), Expect = 2e-54
 Identities = 104/275 (37%), Positives = 151/275 (54%), Gaps = 14/275 (5%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V     P   W+    LG G FG VY   N E+G + A K +     + KS+E  +    
Sbjct: 4   VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYMV 58

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HP IV+  G+   D KL+I +E+  GG++  I+ +  + L E  I+   +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMA 324
           +L  L+YLH+   +HRD+K  N+L+   G +KLADFG+ AK++       S  G+PYWMA
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178

Query: 325 PEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-- 378
           PEV+          +   DIWSLG T+IEMA  +PP  +   +  + KI  S E P +  
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLSQ 237

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           P   S E +DF++  L ++P  RP+AA LLEHPFV
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  181 bits (462), Expect = 4e-54
 Identities = 94/291 (32%), Positives = 139/291 (47%), Gaps = 47/291 (16%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +K   LG GT+G VY   + ++GE+ A+K++ L +++     +A +   EI+LL  L+HP
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKHP 58

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           NIV+       + KLY+  EY     + K L    G L  + I+S   Q+L GL Y H+ 
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-------WM-APEVI 328
             +HRD+K  NIL++  G +KLADFG+A+          I    Y       W  APE++
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVVTLWYRAPEIL 170

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKI---------------- 369
             S   + AVDIWS+GC   EM T KP +   S+ + +  +F+I                
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 370 GNSKELP---AIPDH-----LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 P             L  EG D + K LQ NP  R +A   L+HP+
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  181 bits (460), Expect = 5e-54
 Identities = 99/262 (37%), Positives = 154/262 (58%), Gaps = 8/262 (3%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   + K   +G+G+FG V+ G ++ + ++ A+K + L     ++++  + + QEI +LS
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLS 57

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           +   P + +YYGS     KL+I +EY+ GGS   +L+  G   E  I +  ++IL GL+Y
Sbjct: 58  QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDY 116

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNS 331
           LH++  +HRDIK AN+L+   G VKLADFG+A  +T  Q    +  G+P+WMAPEVI+ S
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              +   DIWSLG T IE+A  +PP S    +  +F I  +   P +    S   K+F+ 
Sbjct: 177 -AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-PTLTGEFSKPFKEFID 234

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
            CL ++P  RPTA  LL+H F+
Sbjct: 235 ACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  179 bits (456), Expect = 3e-53
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 49/288 (17%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIALLSR 213
           G+++G G+F  V L    E+ +  A+K +         K    +         E  +L+R
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKIL--------DKRQLIKEKKVKYVKIEKEVLTR 57

Query: 214 L-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           L  HP I++ Y +   ++ LY  LEY   G + + ++ YG L E   R Y  +IL  LEY
Sbjct: 58  LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--------------- 317
           LH+K  +HRD+K  NIL+D    +K+ DFG AK +   S P S K               
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 318 ------GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFK 368
                 G+  +++PE++        + D+W+LGC + +M T KPP+   ++Y       K
Sbjct: 178 RFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQK 233

Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAW----LLEHPF 412
           I   K   + P +   + KD + K L  +P  R         L  HPF
Sbjct: 234 I--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  178 bits (452), Expect = 5e-53
 Identities = 106/256 (41%), Positives = 144/256 (56%), Gaps = 11/256 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N  +GE+ A+K + L   D  S      + QEI ++   +H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVKECKHCNIVAY 71

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           +GS    +KL+I +EY  GGS+  I    G L E  I    ++ L GL YLH+K  +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEV--IKNSNGCNLAVD 339
           IKGANIL+  +G VKLADFG+A  IT       S  G+PYWMAPEV  ++ + G N   D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHL--SDEGKDFVRKCLQR 396
           IW++G T IE+A  +PP      + A+F +  S  + P + D    S    +FV+  L +
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK 251

Query: 397 NPLHRPTAAWLLEHPF 412
           NP  RPTA  LL H F
Sbjct: 252 NPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  178 bits (453), Expect = 6e-53
 Identities = 90/264 (34%), Positives = 137/264 (51%), Gaps = 19/264 (7%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           + +G +G V+L     +G++ A+K +     D   K    Q+  E  +LS+ + P +V+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           Y S      LY+ +EY+ GG +  +L++ G L E   R Y  +I+  LEYLH+   +HRD
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 283 IKGANILVDPSGRVKLADFGMAKH-ITGQSCPLS--------IKGSPYWMAPEVIKNSNG 333
           +K  NIL+D +G +KL DFG++K  +  +   L+        I G+P ++APEVI    G
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-G 177

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSK-ELPAIPDHLSDEGKDFVR 391
            +  VD WSLGC + E     PP+   E    +F  I N K E P   + +SDE  D + 
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVE-VSDEAIDLIS 235

Query: 392 KCLQRNPLHRPTAAWLLE---HPF 412
           K L  +P  R  A  + E   HPF
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  180 bits (456), Expect = 2e-52
 Identities = 93/281 (33%), Positives = 141/281 (50%), Gaps = 30/281 (10%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++  R LG G+FG VYL  + +     A+K   L        +  ++  +EI +L+ L H
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKV--LAKKLESKSKEVERFLREIQILASLNH 56

Query: 217 P-NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG---ESAIRSYTQQILSGLEY 272
           P NIV+ Y     +  LY+ +EYV GGS+  +L+  G+ G   ES       QILS LEY
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 273 LHAKNTVHRDIKGANILVDPSG-RVKLADFGMAK-------HITGQSCPLSIKGSPYWMA 324
           LH+K  +HRDIK  NIL+D  G  VKL DFG+AK         +  + P +  G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 325 PEVIKNSNGCNL--AVDIWSLGCTVIEMATTKPPW------SQYEGVPAMFKIGNSKELP 376
           PEV+   +      + DIWSLG T+ E+ T  PP+      S       +     +  L 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 377 A-----IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           +      P+ +S    D ++K L ++P +R +++  L H  
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 3e-52
 Identities = 80/261 (30%), Positives = 128/261 (49%), Gaps = 28/261 (10%)

Query: 158 KKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             G+ LG G FG VY G       +     A+K +    +DA  ++  + L +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFL-REARIMRK 57

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           L HPN+V+  G  T ++ LYI +EY+ GG +   L+    +L  S + S+  QI  G+EY
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPE 326
           L +KN +HRD+   N LV  +  VK++DFG+++ +        +   L I+    WMAPE
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPE 173

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP---AMFKIGNSKELPAIPDHL 382
            +K         D+WS G  + E+ T  + P   Y G+     +  + N   LP  P + 
Sbjct: 174 SLKEG-KFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYRLP-QPPNC 228

Query: 383 SDEGKDFVRKCLQRNPLHRPT 403
             E  D + +C   +P  RPT
Sbjct: 229 PPELYDLMLQCWAEDPEDRPT 249

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  176 bits (448), Expect = 4e-52
 Identities = 94/276 (34%), Positives = 151/276 (54%), Gaps = 13/276 (4%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +  +  +G   A+K++     D + ++  + L  
Sbjct: 11  VVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQRRELLFN 65

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +HPNIV  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLAV 124

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L +LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P   S+ G+PYWMA
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMA 183

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--L 382
           PEVI         VDIWSLG  VIEM   +PP+     + AM +I ++   P + +   +
Sbjct: 184 PEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKNLHKV 241

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           S   + F+ + L R+P  R TAA LL HPF+  A P
Sbjct: 242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  176 bits (449), Expect = 4e-52
 Identities = 87/247 (35%), Positives = 129/247 (52%), Gaps = 19/247 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + LG G+FG V L  +  SG+  A+K +   +   K K+  + +  E  +L  +RHP +V
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALK-ILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             YGS   D  LY+ +EYV GG ++  L+  G+  E   R Y  Q++  LEYLH+ + V+
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVY 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D  G +K+ DFG AK + G++  L   G+P ++APE+I +  G   AVD 
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEIILSK-GYGKAVDW 181

Query: 341 WSLGCTVIEMATTKPP------WSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           W+LG  + EM    PP         YE      KI   K     P   S + KD +R  L
Sbjct: 182 WALGILIYEMLAGYPPFFDDNPIQIYE------KILEGK--VRFPSFFSPDAKDLIRNLL 233

Query: 395 QRNPLHR 401
           Q +   R
Sbjct: 234 QVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  172 bits (438), Expect = 8e-51
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 29/262 (11%)

Query: 158 KKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             G+ LG G FG VY G             A+K +     +  S++  ++  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRK 57

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLE 271
           L HPNIV+  G  T ++ L I +EY+ GG +   L+     +L  S + S+  QI  G+E
Sbjct: 58  LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAP 325
           YL +KN +HRD+   N LV  +  VK++DFG+++ +        +   L I+    WMAP
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAP 173

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP---AMFKIGNSKELPAIPDH 381
           E +K         D+WS G  + E+ T  + P   Y G+     +  +     LP  P +
Sbjct: 174 ESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLP-KPPN 228

Query: 382 LSDEGKDFVRKCLQRNPLHRPT 403
              E    + +C   +P  RPT
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPT 250

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  170 bits (432), Expect = 8e-50
 Identities = 102/270 (37%), Positives = 146/270 (54%), Gaps = 14/270 (5%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           +P   W+    LG G FG VY   N E+G + A K +     D KS+E  +    EI +L
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI-----DTKSEEELEDYMVEIDIL 56

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGL 270
           +   HPNIV+   +   ++ L+I +E+ +GG++  ++ +  + L E  IR   +Q L  L
Sbjct: 57  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMAPEVI- 328
            YLH    +HRD+K  NIL    G +KLADFG+ AK+        S  G+PYWMAPEV+ 
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176

Query: 329 ---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLS 383
                    +   D+WSLG T+IEMA  +PP  +   +  + KI  S E P +  P   S
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS 235

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            E KDF++KCL++N   R T   LL+HPFV
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (429), Expect = 2e-49
 Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 36/266 (13%)

Query: 161 RLLGRGTFGHVYLGF---NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           + LG G FG VY G            A+K +   + + + K+      +E  ++ +L HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----FLKEARVMKKLGHP 56

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR---------SYTQQILS 268
           N+VR  G  T ++ LY+ LEY+ GG +   L+    +  S  +         S+  QI  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+EYL +K  VHRD+   N LV     VK++DFG+++ +             L I+    
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA--MFKIGNSKELPA 377
           WMAPE +K+        D+WS G  + E+ T    P    Y G+    + +         
Sbjct: 173 WMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRLP 227

Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPT 403
            P++  DE  + +  C Q +P  RPT
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPT 253

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  169 bits (429), Expect = 3e-49
 Identities = 98/285 (34%), Positives = 158/285 (55%), Gaps = 13/285 (4%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  ++ +   +G+G  G VY   +  +G+  A+K++ L     + +   + +  EI ++ 
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-----QQQPKKELIINEILVMR 71

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
             +HPNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +  ++ L  LE+
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEF 130

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVI-KN 330
           LH+   +HRDIK  NIL+   G VKL DFG    IT  QS   ++ G+PYWMAPEV+ + 
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG-NSKELPAIPDHLSDEGKDF 389
           + G    VDIWSLG   IEM   +PP+     + A++ I  N       P+ LS   +DF
Sbjct: 191 AYGPK--VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER--PILSAEPSETK 432
           + +CL+ +   R +A  LL+HPF+  A PL    P+++A    TK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAKEATK 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  169 bits (429), Expect = 4e-49
 Identities = 94/259 (36%), Positives = 137/259 (52%), Gaps = 7/259 (2%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+FG VY   NS + E+ A+K+++      ++ E  Q + +E+  L +L+HPN + Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
            G    +   ++ +EY  G +   +      L E  I + T   L GL YLH+ N +HRD
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAVDI 340
           IK  NIL+   G+VKLADFG A   +  +   S  G+PYWMAPEVI   +    +  VD+
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
           WSLG T IE+A  KPP      + A++ I  +       +  +D  + FV  CLQ+ P  
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263

Query: 401 RPTAAWLLEHPFVGNAAPL 419
           RP +A LL H FV    P 
Sbjct: 264 RPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  167 bits (424), Expect = 6e-49
 Identities = 90/260 (34%), Positives = 136/260 (52%), Gaps = 8/260 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +   R+LG+G FG   L   +E   +   KEV L     K +  A     EI +LS L+
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQ 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIY-KILQDYGQL-GESAIRSYTQQILSGLEYL 273
           HPNI+ YY     D+ L I +EY +GG++Y KI++  GQL  E  +  Y  QI+S + Y+
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSN 332
           H    +HRDIK  NI +  +G +KL DFG++K + +  S   ++ G+PY+M+PE+ +   
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
             N   DIW+LGC + E+ T K  +     +  + KI        +    S E    V  
Sbjct: 178 -YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHS 235

Query: 393 CLQRNPLHRPTAAWLLEHPF 412
            LQ++P  RPTA  +L+ P 
Sbjct: 236 LLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 6e-49
 Identities = 98/293 (33%), Positives = 143/293 (48%), Gaps = 60/293 (20%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           LG GTFG VYL  N E+GE+ A+K++   F     S E    L +E+  L +L  HPNIV
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNL-REVKSLRKLNEHPNIV 61

Query: 221 RYYGSETL--DDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAK 276
           +    E    +D+LY   EY+ G ++Y++++D       ES IRS   QIL GL ++H  
Sbjct: 62  KLK--EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-------WM-APEVI 328
              HRD+K  N+LV     VK+ADFG+A+ I  +S P      PY       W  APE++
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRP------PYTDYVSTRWYRAPEIL 170

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKP------------------------PWSQ-YEGV 363
             S   +  VDIW+LGC + E+ T +P                         W + Y+  
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 364 PAM-FKIGNSKELPA---IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             + F+            IP+  S E  D ++  L+ +P  RPTA+  L+HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  166 bits (422), Expect = 2e-48
 Identities = 90/259 (34%), Positives = 142/259 (54%), Gaps = 15/259 (5%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V    +  +G++ A+K + L  ++A  K    Q+ +E+ +L +   P IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKCNSPYIVGF 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAK-NTVH 280
           YG+   +  + I +EY+ GGS+ KIL +  G++ E  +      +L GL YLH K   +H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K +NILV+  G++KL DFG++  +   S   +  G+  +MAPE I   N  ++  DI
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERI-QGNDYSVKSDI 182

Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMF-----KIGNSKELPAIPDH-LSDEGKDFVRKCL 394
           WSLG ++IE+AT + P+      P         I N +  P +P    S + +DFV  CL
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCL 241

Query: 395 QRNPLHRPTAAWLLEHPFV 413
            ++P  RP+   LLEHPF+
Sbjct: 242 IKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  167 bits (423), Expect = 3e-48
 Identities = 95/262 (36%), Positives = 142/262 (54%), Gaps = 9/262 (3%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L +LRHPN +
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTV 279
           +Y G    +   ++ +EY  G S   +L+ + + L E  I + T   L GL YLH+ N +
Sbjct: 79  QYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLA 337
           HRD+K  NIL+   G VKL DFG A  +   +      G+PYWMAPEVI   +    +  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           VD+WSLG T IE+A  KPP      + A++ I  ++       H S+  ++FV  CLQ+ 
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254

Query: 398 PLHRPTAAWLLEHPFVGNAAPL 419
           P  RPT+  LL+H FV    P 
Sbjct: 255 PQDRPTSEVLLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  165 bits (419), Expect = 4e-48
 Identities = 90/260 (34%), Positives = 130/260 (50%), Gaps = 16/260 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + LG+G++G VY        +  A+KEV L S   K +E A     EI +L+ + HPNI+
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRILASVNHPNII 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQILSGLEYLHAK 276
            Y  +    +KL I +EY   G + K +    +      E  I     Q+L GL+ LH +
Sbjct: 63  SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN---SNG 333
             +HRD+K ANIL+  +  VK+ D G++K +        I G+P++MAPEV K    S  
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPYSYK 181

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
                DIWSLGC + EMAT  PP+         +K+   K  P IP   S + ++F+R  
Sbjct: 182 S----DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSM 236

Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           LQ  P  RP    +L  P V
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  165 bits (419), Expect = 4e-48
 Identities = 87/255 (34%), Positives = 145/255 (56%), Gaps = 12/255 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +G+G F  VY       G + A+K+V +F   DAK++   Q   +EI LL +L HPN+++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIK 66

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQILSGLEYLHAKN 277
           Y  S   +++L I LE    G + ++++ + +      E  I  Y  Q+ S LE++H+K 
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNL 336
            +HRDIK AN+ +  +G VKL D G+ +  + ++    S+ G+PY+M+PE I   NG N 
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNF 185

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYE-GVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCL 394
             DIWSLGC + EMA  + P+   +  + ++ K     + P +P DH S+E +D V +C+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245

Query: 395 QRNPLHRPTAAWLLE 409
             +P  RP  +++L+
Sbjct: 246 NPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  165 bits (418), Expect = 2e-47
 Identities = 95/260 (36%), Positives = 140/260 (53%), Gaps = 7/260 (2%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L R++HPN +
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            Y G    +   ++ +EY  G +   +      L E  I + T   L GL YLH+ N +H
Sbjct: 89  EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAV 338
           RDIK  NIL+   G+VKLADFG A   +  +   S  G+PYWMAPEVI   +    +  V
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           D+WSLG T IE+A  KPP      + A++ I  ++      +  SD  ++FV  CLQ+ P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 399 LHRPTAAWLLEHPFVGNAAP 418
             RPT+  LL+H FV    P
Sbjct: 266 QDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  161 bits (408), Expect = 2e-46
 Identities = 77/252 (30%), Positives = 129/252 (51%), Gaps = 8/252 (3%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G+FG V+         + AMK++ L   + + +E A     E  +L++L    I+RY
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID---EARVLAKLDSSYIIRY 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY-GQ-LGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y S     KL I +EY   G ++K+L+   G+ L E  +  +  QIL GL +LH+K  +H
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+ +D    VK+ D G+AK ++  +    +I G+PY+++PE+ ++    N   D
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSD 183

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +W+LG  + E  T K P+        + KI      P +    S +    + +CL ++  
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYR 242

Query: 400 HRPTAAWLLEHP 411
            RP    LL +P
Sbjct: 243 QRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  159 bits (404), Expect = 6e-46
 Identities = 80/260 (30%), Positives = 129/260 (49%), Gaps = 16/260 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R++G+G FG V +    ++ +M AMK +         K S + +  E  +L  L HP +V
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLV 63

Query: 221 RYYGSETLDDKLYIYLEYVSGGSI-YKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
             + S   ++ +Y+ ++ + GG + Y + Q   +  E  ++ +  +I+  LEYLH+K  +
Sbjct: 64  NLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGII 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  NIL+D  G V + DF +A  +T  +   S  G+P +MAPEV+    G ++AVD
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC-RQGYSVAVD 181

Query: 340 IWSLGCTVIEMATTKPPW-----SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            WSLG T  E    K P+     +  + + A  +          P   S E  D + K L
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----TADVLYPATWSTEAIDAINKLL 237

Query: 395 QRNPLHR--PTAAWLLEHPF 412
           +R+P  R       L  HP+
Sbjct: 238 ERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  160 bits (405), Expect = 8e-46
 Identities = 88/262 (33%), Positives = 142/262 (54%), Gaps = 16/262 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G +G VY   +  +G   AMKE+ L  D++K      Q+  E+ +L +   P IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDF 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG---ESAIRSYTQQILSGLEYLHAK-NT 278
           YG+  ++  +Y+ +EY+  GS+ K+           E  +R  T  ++ GL++L  + N 
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +HRD+K  N+LV+ +G+VKL DFG++ ++       +I G   +MAPE IK+        
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPT 183

Query: 339 -----DIWSLGCTVIEMATTKPPW--SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
                D+WSLG +++EMA  + P+    Y  + A        + P +P   SD+ +DFV 
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           KCL + P  RPT A LLEHP++
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  159 bits (402), Expect = 2e-45
 Identities = 92/270 (34%), Positives = 152/270 (56%), Gaps = 11/270 (4%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  ++ +   +G+G  G V+   +  +G+  A+K++ L     + +   + +  EI ++ 
Sbjct: 17  PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMK 71

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
            L++PNIV +  S  + D+L++ +EY++GGS+  ++ +   + E+ I +  ++ L  LE+
Sbjct: 72  ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEF 130

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNS 331
           LHA   +HRDIK  N+L+   G VKL DFG    IT  QS   ++ G+PYWMAPEV+   
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TR 189

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAIPDHLSDEGKDF 389
                 VDIWSLG   IEM   +PP+     + A++ I    + EL   P+ LS   +DF
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSPIFRDF 248

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
           + +CL+ +   R +A  LL+HPF+  A PL
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  158 bits (401), Expect = 4e-45
 Identities = 97/281 (34%), Positives = 156/281 (55%), Gaps = 14/281 (4%)

Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A+K++ L     + +   
Sbjct: 9   RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNL-----QQQPKK 60

Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 61  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 119

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSP 320
             ++ L  L++LH+   +HRDIK  NIL+   G VKL DFG    IT  QS   ++ G+P
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I    + EL   
Sbjct: 180 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN- 237

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
           P+ LS   +DF+ +CL+ +   R +A  LL+HPF+  A PL
Sbjct: 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 6e-45
 Identities = 85/293 (29%), Positives = 135/293 (46%), Gaps = 56/293 (19%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N ++GE+ A+K++ + ++    +       +EI LL +LRHPNIVR 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIVRL 63

Query: 223 YGSETLDDK--LYIYLEYV----SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
               T   K  +Y+  EY+    +G     +     +  ES I+ Y +Q+L GL+YLH+ 
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-------WM-APEVI 328
             +HRDIKG+NIL++  G +KLADFG+A+  T ++         Y       W   PE++
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA------DYTNRVITLWYRPPELL 173

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPW---------------------SQYEGVPAMF 367
             +      VD+WS+GC + E+   KP +                       + GV  + 
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233

Query: 368 KIGNSKELPAIPDHLSDEGK--------DFVRKCLQRNPLHRPTAAWLLEHPF 412
              N K        L +  K        D + K L  +P  R +A   L+H +
Sbjct: 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  156 bits (396), Expect = 7e-45
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 10/262 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K R++GRG FG V+L       ++  +K++ +       + +AQ    E  +L  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLS 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYL 273
           HPNI+ YY +   D  L I +EY  GG++ + +Q      L E  I  +  QIL  L ++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 274 HAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           H K  +HRD+K  NIL+D    V K+ DFG++K ++ +S   ++ G+P +++PE+ +   
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE-GK 176

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLSDEGKDFVR 391
             N   DIW+LGC + E+A+ K  + +   +PA+  KI +    P I D  S + +  + 
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAF-EAANLPALVLKIMSGTFAP-ISDRYSPDLRQLIL 234

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
             L  +P  RP  + ++  P  
Sbjct: 235 SMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  158 bits (402), Expect = 8e-45
 Identities = 92/313 (29%), Positives = 145/313 (46%), Gaps = 51/313 (16%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G G +G V    +  +G   A+K+++   DD      A+++ +EI LL  LRH NI+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD---LIDAKRILREIKLLRHLRHENII 62

Query: 221 RYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
                      E  +D +YI  E +    ++K+++    L +  I+ +  QIL GL+YLH
Sbjct: 63  GLLDILRPPSPEDFND-VYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY----WM-APEVIK 329
           + N +HRD+K +NILV+ +  +K+ DFG+A+ +           + Y    W  APE++ 
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELLL 179

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVPA---MFKIGNSK- 373
           +S+    A+DIWS+GC   E+ T KP  P   Y           G P+   +  I + K 
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239

Query: 374 --------ELPAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
                   + P  P        S E  D + K L  +P  R TA   L HP++   A L 
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL---AQLH 296

Query: 421 RPILSAEPSETKP 433
            P    EP    P
Sbjct: 297 DP--EDEPVAKPP 307

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  157 bits (398), Expect = 9e-45
 Identities = 99/296 (33%), Positives = 160/296 (54%), Gaps = 16/296 (5%)

Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A++++ L     + +   
Sbjct: 10  RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKK 61

Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 120

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSP 320
             ++ L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT +    S + G+P
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I    + EL   
Sbjct: 181 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN- 238

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER--PILSAEPSETK 432
           P+ LS   +DF+ +CL  +   R +A  LL+H F+  A PL    P+++A    TK
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  156 bits (396), Expect = 2e-44
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 26/269 (9%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V       +G + A+K +T   +    K    Q+ +E+ +    + P IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK----QILRELEINKSCKSPYIVKY 64

Query: 223 YGSETL--DDKLYIYLEYVSGGS---IYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           YG+        + I +EY  GGS   IYK + +  G++GE  +    + +L GL YLH++
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             +HRDIK +NIL+   G+VKL DFG++  +   S   +  G+ ++MAPE I+     ++
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQGKP-YSI 182

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPA------MFKIGNSKELPAIPDHL------SD 384
             D+WSLG T++E+A  + P+   EG P       +  I N    P + D        S+
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPIELLSYIVNM-PNPELKDEPGNGIKWSE 240

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E KDF+++CL+++P  RPT   +LEHP++
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  155 bits (393), Expect = 2e-44
 Identities = 86/261 (32%), Positives = 142/261 (54%), Gaps = 17/261 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G G+FG +YL       E C +KE+ L     K KE++++   E+ LL++++HPNIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQL-GESAIRSYTQQILSGLEYLHAKNT 278
            ++ S   + +L+I +EY  GG + K I +  G L  E  I S+  QI  GL+++H +  
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 279 VHRDIKGANILVDPSGRV-KLADFGMAKHIT-----GQSCPLSIKGSPYWMAPEVIKNSN 332
           +HRDIK  NI +  +G V KL DFG+A+ +        +C     G+PY+++PE+ +N  
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC----VGTPYYLSPEICQNRP 178

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
             N   DIWSLGC + E+ T K P+        + KI      P  P + S + +  + +
Sbjct: 179 YNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDLRSLISQ 236

Query: 393 CLQRNPLHRPTAAWLLEHPFV 413
             + +P  RP+   +L+ PF+
Sbjct: 237 LFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  155 bits (395), Expect = 3e-44
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 53/292 (18%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G G +G V    N  +GE+ A+K+     DD   K++A +   E+ +L +LRH NIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
              +     +LY+  EYV   ++ ++L+   G L   A+RSY  Q+L  + Y H+ N +H
Sbjct: 65  LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-------WM-APEVIKNSN 332
           RDIK  NILV  SG +KL DFG A+ +  +        SP        W  APE++    
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARP------ASPLTDYVATRWYRAPELLVGDT 177

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPW------------------------------SQYEG 362
                VD+W++GC + E+   +P +                               ++ G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 363 V--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           V  P   +  + +     P  +S    DF++ CL+ +P  R T   LL+HP+
Sbjct: 238 VAFPEPSQPESLERRY--PGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  154 bits (390), Expect = 1e-43
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 34/286 (11%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   +  +GE+ A+K++ L  +     ++A +   EI LL  L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR---EIKLLKELNH 57

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           PNI++          LY+  E++    +YK+++D  + L ES I+SY  Q+L GL + H+
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGC 334
              +HRD+K  N+L++  G +KLADFG+A+       P +      W  APE++    G 
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 335 NLAVDIWSLGCTVIEMATTKPPW------SQ-------------------YEGVPAM--- 366
           +  VDIWS+GC   E+ + +P +       Q                             
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236

Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           F       LP +  + S +  D + + L  +P  R TA   L HP+
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  154 bits (389), Expect = 2e-43
 Identities = 89/254 (35%), Positives = 140/254 (55%), Gaps = 11/254 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+ G V +     SG   A+K +     D + ++  + L  E+ ++   +H N+V  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           Y S  + ++L++ +E++ GG++  I+    +L E  I +  + +L  L YLH++  +HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCP--LSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           IK  +IL+   GRVKL+DFG    I+ +  P   S+ G+PYWMAPEVI  +      VDI
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDI 200

Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFVRKCLQRNPL 399
           WSLG  VIEM   +PP+     V AM ++ +S        H +S   +DF+ + L R P 
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260

Query: 400 HRPTAAWLLEHPFV 413
            R TA  LL+HPF+
Sbjct: 261 ERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  151 bits (383), Expect = 7e-43
 Identities = 89/273 (32%), Positives = 144/273 (52%), Gaps = 32/273 (11%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++ K + +G G+FG   L  + E G+   +KE+ +     K +E +++   E+A+LS ++
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMK 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQILSGLE 271
           HPNIV+Y  S   +  LYI ++Y  GG +YK +    Q G    E  I  +  QI   L+
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN--AQRGVLFPEDQILDWFVQICLALK 115

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIK 329
           ++H +  +HRDIK  NI +   G +KL DFG+A+  + T +     I G+PY+++PE+ +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL---------PAIPD 380
           N    N + DIW+LGC + EM T K            F+ GN K L         P +  
Sbjct: 175 NRPYNNKS-DIWALGCVLYEMCTLK----------HAFEAGNMKNLVLKIIRGSYPPVSS 223

Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           H S + ++ V +  +RNP  RP+   +LE  F+
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 8e-43
 Identities = 83/234 (35%), Positives = 123/234 (52%), Gaps = 7/234 (2%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            +G GTFG V+L  +  S    A+K + +   +    +  Q +  E  +L  + HP I+R
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAI--PEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
            + +E     LY+ +EYV GG ++  L++ G+   S    Y  +I+  LEYLH+K  V+R
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
           D+K  NIL+D  G +KL DFG AK +  ++  L   G+P ++APEVI+ S G N AVD W
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC--GTPEYLAPEVIQ-SKGHNKAVDWW 182

Query: 342 SLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           +LG  + EM    PP+          KI   K     P HL    KD ++K L 
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKLLV 234

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  151 bits (382), Expect = 1e-42
 Identities = 94/278 (33%), Positives = 147/278 (52%), Gaps = 24/278 (8%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   W+    +G+GT+G V+   N ++G   A+K +    D  +  E+      E  +L 
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA------EYNILK 69

Query: 213 RLR-HPNIVRYYG-----SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----IRSY 262
            L  HPN+V++YG          D+L++ LE  +GGS+  +++ + + GE      I   
Sbjct: 70  ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPY 321
             + L GL++LH   T+HRD+KG NIL+   G VKL DFG++  +T      +   G+P+
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 322 WMAPEVIKNSNGCNLA----VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           WMAPEVI      +       D+WSLG T IE+    PP +    + A+FKI  +   P 
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-PT 248

Query: 378 I--PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           +  P+  S+E  DF+RKCL ++   RPT + LL+H F+
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  150 bits (379), Expect = 3e-42
 Identities = 85/253 (33%), Positives = 140/253 (55%), Gaps = 12/253 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +GRG F  VY       G   A+K+V +F   DAK++       +EI LL +L HPN+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIK 66

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSGLEYLHAKN 277
           YY S   D++L I LE    G + ++++ + +    + E  +  Y  Q+ S LE++H++ 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCNL 336
            +HRDIK AN+ +  +G VKL D G+ +  + ++    S+ G+PY+M+PE I + NG N 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNF 185

Query: 337 AVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCL 394
             DIWSLGC + EMA  + P +     + ++ K     + P +P DH S+E +  V  C+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245

Query: 395 QRNPLHRPTAAWL 407
             +P  RP   ++
Sbjct: 246 NPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  149 bits (377), Expect = 4e-42
 Identities = 88/251 (35%), Positives = 138/251 (54%), Gaps = 9/251 (3%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R++G G+FG   L  +  S +  AMKE+ L     KS  + +   +E  LL++++HPNIV
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIY-KILQDYGQL-GESAIRSYTQQILSGLEYLHAKNT 278
            +  S   D  LYI +EY  GG +  KI    G+L  E  I  +  Q+  G++++H K  
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKNSNGCNLA 337
           +HRDIK  NI +  +G+VKL DFG A+ +T   +   +  G+PY++ PE+ +N    N +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS 181

Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
            DIWSLGC + E+ T K P+        + K+      P +P H S E +  +++  +RN
Sbjct: 182 -DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRN 239

Query: 398 PLHRPTAAWLL 408
           P  RP+A  +L
Sbjct: 240 PRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  149 bits (378), Expect = 5e-42
 Identities = 91/269 (33%), Positives = 146/269 (54%), Gaps = 24/269 (8%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNI 219
            ++G GT+G VY G + ++G++ A+K + +      +++  +++  EI +L +   H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDV------TEDEEEEIKLEINMLKKYSHHRNI 75

Query: 220 VRYYGS------ETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLE 271
             YYG+         DD+L++ +E+   GS+  ++++     L E  I    ++IL GL 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVI 328
           +LHA   +HRDIKG N+L+  +  VKL DFG++  +    G+    +  G+PYWMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVI 193

Query: 329 ---KNSNGC-NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
              +N +   +   DIWSLG T IEMA   PP      + A+F I  +          S 
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           +  DF+  CL +N L RP+   LL+HPF+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  151 bits (384), Expect = 5e-42
 Identities = 109/361 (30%), Positives = 170/361 (47%), Gaps = 43/361 (11%)

Query: 81  IHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHR-------LPLPPLTISNTCPFSPSYS 133
           I      PL   A       P  RPD       R       LPLPP     +   S S S
Sbjct: 4   IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPP----PSSSSSSSSS 59

Query: 134 TATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
           ++ S S P +           S  ++   +G G  G VY   +  +G + A+K +    +
Sbjct: 60  SSASGSAPSAA-------KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE 112

Query: 194 DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ 253
           D   +    Q+ +EI +L  + HPN+V+ +     + ++ + LE++ GGS    L+    
Sbjct: 113 DTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHI 164

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-- 311
             E  +    +QILSG+ YLH ++ VHRDIK +N+L++ +  VK+ADFG+++ I  Q+  
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMD 223

Query: 312 -CPLSIKGSPYWMAPEVIKNS------NGCNLAVDIWSLGCTVIEMATTKPPWS---QYE 361
            C  S+ G+  +M+PE I         +G   A DIWSLG +++E    + P+    Q +
Sbjct: 224 PCNSSV-GTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEFYLGRFPFGVGRQGD 280

Query: 362 GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
               M  I  S+  P  P   S E + F+  CLQR P  R +A  LL+HPF+  A P + 
Sbjct: 281 WASLMCAICMSQP-PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339

Query: 422 P 422
            
Sbjct: 340 Q 340

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  148 bits (375), Expect = 9e-42
 Identities = 83/257 (32%), Positives = 142/257 (55%), Gaps = 16/257 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSD-DAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +GRG F  VY        +  A+K+V +F   DAK++   Q   +EI LL +L HPN+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIK 66

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSGLEYLHAKN 277
           Y  S   D++L I LE    G + ++++ + +    + E  +  Y  Q+ S +E++H++ 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCNL 336
            +HRDIK AN+ +  +G VKL D G+ +  + ++    S+ G+PY+M+PE I + NG N 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNF 185

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---LPAIP-DHLSDEGKDFVRK 392
             DIWSLGC + EMA  + P+  Y     +F +    E    P +P +H S++ ++ V  
Sbjct: 186 KSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 393 CLQRNPLHRPTAAWLLE 409
           C+  +P  RP   ++ +
Sbjct: 244 CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  148 bits (374), Expect = 1e-41
 Identities = 91/277 (32%), Positives = 148/277 (53%), Gaps = 24/277 (8%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   ++   L+G GT+G VY G + ++G++ A+K + +  D+       +++ QEI +L 
Sbjct: 4   PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLK 57

Query: 213 RL-RHPNIVRYYGS------ETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYT 263
           +   H NI  YYG+        +DD+L++ +E+   GS+  ++++     L E  I    
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117

Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSP 320
           ++IL GL +LH    +HRDIKG N+L+  +  VKL DFG++  +    G+    +  G+P
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTP 175

Query: 321 YWMAPEVI---KNSNGC-NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           YWMAPEVI   +N +   +   D+WSLG T IEMA   PP      + A+F I  +    
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                 S + + F+  CL +N   RPT   L++HPF+
Sbjct: 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  148 bits (375), Expect = 2e-41
 Identities = 93/283 (32%), Positives = 145/283 (51%), Gaps = 22/283 (7%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           +E+   P   W+    +G+GT+G VY   N + G + A+K +   SD  +  E+   + Q
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73

Query: 207 EIALLSRLRHPNIVRYYGSETLDDK-----LYIYLEYVSGGSIYKILQDY---GQLGESA 258
            +       HPN+V++YG     DK     L++ LE  +GGS+ ++++     GQ  + A
Sbjct: 74  SLP-----NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 259 IRSYT-QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
           + SY     L GL++LH    +HRD+KG NIL+   G VKL DFG++  +T      +  
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 318 -GSPYWMAPEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS 372
            G+P+WMAPEVI    +     +   D+WSLG T IE+    PP      V  +FKI  +
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248

Query: 373 KELPAI--PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              P +  P+        F+ +CL ++   RP+   LLEHPF+
Sbjct: 249 PP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  146 bits (370), Expect = 4e-41
 Identities = 85/258 (32%), Positives = 147/258 (56%), Gaps = 11/258 (4%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R++G+G++G V L  +   G+   +K++ L +   + +++A+Q   E  LLS+L+HPNIV
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62

Query: 221 RYYGS-ETLDDKLYIYLEYVSGGSIY-KILQDYGQL-GESAIRSYTQQILSGLEYLHAKN 277
            Y  S E  D  LYI + +  GG +Y K+ +  G+L  E+ +  +  QI   L+YLH K+
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEVIKNSNGCN 335
            +HRD+K  N+ +  +  +K+ D G+A+ +  Q C +  ++ G+PY+M+PE+  N    N
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDMASTLIGTPYYMSPELFSNKP-YN 180

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
              D+W+LGC V EMAT K  ++  +    +++I   K LP +P   S E  + +   L 
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATMLS 239

Query: 396 RNPLHRPTAAWLLEHPFV 413
           + P  RP+   +L  P++
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  144 bits (366), Expect = 4e-40
 Identities = 87/288 (30%), Positives = 142/288 (49%), Gaps = 49/288 (17%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY G N ++G++ AMK++ L S++     +A +   EI+LL  L+HPNIV  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIVCL 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQILSGLEYLHA 275
                 + +LY+  E++S       L+ Y         +    ++SY  QIL G+ + H+
Sbjct: 65  QDVLMQESRLYLIFEFLSMD-----LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG----SPYWMAPEVIKNS 331
           +  +HRD+K  N+L+D  G +KLADFG+A+       P+ +      + ++ APEV+  S
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI------GNSKELP---AIPDH- 381
              +  VDIWS+G    EMAT KP +     +  +F+I            P   ++PD+ 
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236

Query: 382 -----------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                            L ++G D + K L  +P  R +A   L HP+
Sbjct: 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  144 bits (364), Expect = 7e-40
 Identities = 94/277 (33%), Positives = 150/277 (54%), Gaps = 15/277 (5%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P +       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 12  VVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM-----DLRKQQRRELLFN 66

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 125

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P   S+ G+PYWMA
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMA 184

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 185 PELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPKLKNLHK 241

Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 2e-39
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)

Query: 165 RGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG 224
           +G FG VYL     +G+  A+K +      AK++ +  +  + I ++ +   P + + Y 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64

Query: 225 SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIK 284
           S    D LY+ +EY++GG    +++  G L E   + Y  +++ G+E LH +  +HRDIK
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 285 GANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLG 344
             N+L+D +G +KL DFG++++           G+P ++APE I    G +   D WSLG
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGL---ENKKFVGTPDYLAPETI-LGVGDDKMSDWWSLG 180

Query: 345 CTVIEMATTKPPWSQYEGVPAMFK------IGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           C + E     PP+   E   A+F       I   +E   + +  S E  D + + L  +P
Sbjct: 181 CVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEE---VKEFCSPEAVDLINRLLCMDP 236

Query: 399 LHRPTAAWLLE---HPF 412
             R  A    E   HPF
Sbjct: 237 AKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  142 bits (360), Expect = 4e-39
 Identities = 85/301 (28%), Positives = 135/301 (44%), Gaps = 61/301 (20%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIA 209
           R++KG+ LG GT+  VY   + E+G + A+K++ L       +    + G      +EI 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL------GERKEAKDGINFTALREIK 54

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILS 268
           LL  L+HPNI+           + +  E++    + K+++D    L  + I+SY    L 
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-------- 320
           GLEYLH+   +HRD+K  N+L+   G +KLADFG+A+            GSP        
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF----------GSPNRKMTHQV 163

Query: 321 ---YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQY----------- 360
              ++ APE++  +    + VD+WS+GC   E+    P         Q            
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223

Query: 361 -EGVPAMFKIGNS---KELPAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
            E  P +  + +    K  P  P        SD+  D +++ L  NP  R TA   LEHP
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 412 F 412
           +
Sbjct: 284 Y 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 6e-39
 Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 58/295 (19%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPN 218
            +G G +G VY   +  +G   A+K+V +   +     S  +   EIALL +L    HPN
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---EIALLKQLESFEHPN 62

Query: 219 IVR-------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------LGESAIRSY 262
           IVR             L   L +  E+V         QD            L    I+  
Sbjct: 63  IVRLLDVCHGPRTDRELK--LTLVFEHVD--------QDLATYLSKCPKPGLPPETIKDL 112

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYW 322
            +Q+L G+++LH+   VHRD+K  NILV   G+VK+ADFG+A+  + +    S+  + ++
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW-SQYE-----------GVPA----- 365
            APEV+  S+     VD+WS+GC   E+   +P +    E           G+P+     
Sbjct: 173 RAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 366 --------MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                    F     +   +    + +EG D ++K L  NP  R +A   L+HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 1e-38
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 62/294 (21%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   +  +GE+ A+K++ L ++D     +A +   EI+LL  L HPNIVR 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63

Query: 223 YGSETLDDKLYIYLEYVSGG------SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
                 ++KLY+  E++         S          L    I+SY  Q+L G+ Y H+ 
Sbjct: 64  LDVVHSENKLYLVFEFLDLDLKKYMDSSPLT-----GLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-----------YWMAP 325
             +HRD+K  N+L+D  G +KLADFG+A+            G P           ++ AP
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF----------GVPVRTYTHEVVTLWYRAP 168

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GNSKE-----LP 376
           E++  S   +  VDIWS+GC   EM   +P +     +  +F+I    G   E     + 
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228

Query: 377 AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           ++PD+                  L ++G D + K L  +P  R +A   L+HP+
Sbjct: 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 1e-38
 Identities = 91/262 (34%), Positives = 137/262 (52%), Gaps = 13/262 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNIV 220
           +G+GTFG VY     ++  + AMK ++     AK KE A  +G+   L+  L    P IV
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIV 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               S   D  LY+  +Y+SGG ++  LQ  G+  E   + Y  +++  LE+LH  + V+
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RD+K  NIL+D +G + L DFG++K ++T      +  G+  ++APEV+ +  G    VD
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179

Query: 340 IWSLGCTVIEMATTKPPWSQY--EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
            WSLG  V EM      WS +  E    M++     ++    + LSDEG+ FV+  L RN
Sbjct: 180 FWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236

Query: 398 PLHR----PTAAWLLEHPFVGN 415
           P HR      A  L EHPF  +
Sbjct: 237 PQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  140 bits (355), Expect = 1e-38
 Identities = 87/264 (32%), Positives = 140/264 (53%), Gaps = 21/264 (7%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+ G V +     +G+  A+K++     D + ++  + L  E+ ++    H N+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHENVVDM 84

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +L  L YLH +  +HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCP--LSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           IK  +IL+   GR+KL+DFG    ++ +  P   S+ G+PYWMAPEVI         VDI
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDI 201

Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK------DFVRKCL 394
           WSLG  VIEM   +PP+     + AM +I ++     +P  + D  K       F+   L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-----LPPRVKDSHKVSSVLRGFLDLML 256

Query: 395 QRNPLHRPTAAWLLEHPFVGNAAP 418
            R P  R TA  LL+HPF+  A P
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  140 bits (354), Expect = 2e-38
 Identities = 90/283 (31%), Positives = 140/283 (49%), Gaps = 37/283 (13%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           L+G G++G V    + E+G++ A+K+     DD   K+ A +   EI +L +LRH N+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR---EIRMLKQLRHENLVN 64

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
                    +LY+  E+V   ++   L+ Y   L ES +R Y  QIL G+E+ H+ N +H
Sbjct: 65  LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHIT--GQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           RDIK  NILV  SG VKL DFG A+ +   G+     +  + ++ APE++        AV
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRAV 182

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GNSKE----------------LPAI 378
           DIW++GC V EM T +P +     +  ++ I    GN                   LP +
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242

Query: 379 PD---------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            +          LS    D  ++CL+ +P  RP+++ LL H F
Sbjct: 243 KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  139 bits (352), Expect = 4e-38
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 56/291 (19%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L HPNIV+ 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE---SAIRSYTQQILSGLEYLHAKNTV 279
                 ++KLY+  E++      K   D   L       I+SY  Q+L GL + H+   +
Sbjct: 65  LDVIHTENKLYLVFEFLHQD--LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-----------YWMAPEVI 328
           HRD+K  N+L++  G +KLADFG+A+            G P           ++ APE++
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEIL 172

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GNSKE-----LPAIP 379
                 + AVDIWSLGC   EM T +  +     +  +F+I    G   E     + ++P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 380 DH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           D+                  L ++G+D + + L  +P  R +A   L HPF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  137 bits (347), Expect = 9e-38
 Identities = 80/260 (30%), Positives = 137/260 (52%), Gaps = 16/260 (6%)

Query: 163 LGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           LG+G+FG VYL  +        +  +KE+ +   +    E+ Q   QE  LLS+L HP I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV--GELNPNETVQA-NQEAQLLSKLDHPAI 64

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQILSGLEYLHA 275
           V+++ S    D   I  EY  G  +   L++    G    E+ +  +  Q+L G+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEVIKNSNG 333
           +  +HRD+K  NI +  +  +K+ DFG+++ + G SC L  +  G+PY+M+PE +K+  G
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALKH-QG 181

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +   DIWSLGC + EM      +     +  + +I      P++P+  S +    ++  
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPETYSRQLNSIMQSM 240

Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           L ++P  RP+AA +L +PF+
Sbjct: 241 LNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  138 bits (349), Expect = 1e-37
 Identities = 81/284 (28%), Positives = 139/284 (48%), Gaps = 42/284 (14%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG GT+  VY G N  +GE+ A+KE+ L +++     + +    EI+L+  L+H NIVR 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVRL 63

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE---SAIRSYTQQILSGLEYLHAKNTV 279
           +     ++KL +  EY+    + K +  +G  G    + ++S+T Q+L G+ + H    +
Sbjct: 64  HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCN 335
           HRD+K  N+L++  G +KLADFG+A+       P++   +     ++ AP+V+  S   +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179

Query: 336 LAVDIWSLGCTVIEMATTKP------------------------PWSQYEGVP---AMFK 368
            ++DIWS+GC + EM T +P                         W     +P     F 
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239

Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
               ++L  +  H    G D + + LQ NP  R +A   L+HP+
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  139 bits (351), Expect = 1e-37
 Identities = 82/255 (32%), Positives = 131/255 (51%), Gaps = 18/255 (7%)

Query: 155 SRWK-----KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           S WK      G  LG G+FG V +  +  +GE  A+K   L   +    +  Q + QE +
Sbjct: 13  SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKS 70

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +L  L HP IV    S   ++++Y  LE+V GG ++  L+  G+      + Y  +++  
Sbjct: 71  ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            EYLH+K+ ++RD+K  N+L+D  G VK+ DFG AK +  ++  L   G+P ++APEVI+
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--GTPEYLAPEVIQ 188

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA---IPDHLSDEG 386
            S G   AVD W++G  + E     PP+  ++  P  F+I   K L      P+      
Sbjct: 189 -SKGHGKAVDWWTMGVLLYEFIAGYPPF--FDDTP--FRI-YEKILAGRLKFPNWFDGRA 242

Query: 387 KDFVRKCLQRNPLHR 401
           +D V+  LQ +   R
Sbjct: 243 RDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 2e-37
 Identities = 79/248 (31%), Positives = 122/248 (49%), Gaps = 18/248 (7%)

Query: 163 LGRGTFGHVYLGFNSESGEMCA---MKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           +G+G +G V+L    ++GE+ A   MK+  LF  +         +  E  +L+  +   +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR-----HVLTERDILTTTKSEWL 63

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V+   +   D+ LY+ +EYV GG    +L + G L E   R Y  ++   ++ LH    +
Sbjct: 64  VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N L+D SG +KL DFG++K I   +   S+ GSP +MAPEV+    G +  VD
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVL-RGKGYDFTVD 180

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD------HLSDEGKDFVRKC 393
            WSLGC + E     PP+S          +   KE    P       +LSDE  D + K 
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240

Query: 394 LQRNPLHR 401
           +  +P  R
Sbjct: 241 IN-DPSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  137 bits (346), Expect = 3e-37
 Identities = 86/291 (29%), Positives = 136/291 (46%), Gaps = 42/291 (14%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K   +G GT+G V+   N E+ E+ A+K V L  DD     SA +   EI LL  L+
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGL 270
           H NIVR Y     D KL +  EY       + L+ Y     G +    ++S+  Q+L GL
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIK 329
            + H+ N +HRD+K  N+L++ +G +KLADFG+A+         S +    W   P+V+ 
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-------------------PAMFKIG 370
            +   + ++D+WS GC   E+A    P      V                   P + K+ 
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 371 NSKELPAIP---------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           + K  P  P           L+  G+D ++  L  NP+ R +A   L+HP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  138 bits (348), Expect = 4e-37
 Identities = 89/262 (33%), Positives = 139/262 (53%), Gaps = 15/262 (5%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           ++LG+G +G V+       +++G++ AMK +   +     K++A     E  +L  ++HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHP 60

Query: 218 NIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            IV   Y  +T   KLY+ LEY+SGG ++  L+  G   E     Y  +I   LE+LH +
Sbjct: 61  FIVDLIYAFQT-GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  NIL+D  G VKL DFG+ K  I   +   +  G+  +MAPE++  S G  
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHG 178

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD WSLG  + +M T  PP++       + KI   K    +P +L+ E +D ++K L+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLK 236

Query: 396 RNPLHR-----PTAAWLLEHPF 412
           RNP  R       AA +  HPF
Sbjct: 237 RNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  137 bits (347), Expect = 4e-37
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 34/270 (12%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V L     + E+ A+K    +V L  DD +         + +  L+  +H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT----MTEKRVLALAG-KH 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P + + +      D+L+  +EYV+GG +   +Q  G+  E   R Y  +I+ GL++LH +
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  N+L+D  G +K+ADFGM K  I G     +  G+P ++APE++       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YG 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--------PAIPDHLSDEGK 387
            AVD W+LG  + EM   + P          F+  +  EL           P  LS E K
Sbjct: 175 PAVDWWALGVLLYEMLAGQSP----------FEGDDEDELFQSILEDEVRYPRWLSKEAK 224

Query: 388 DFVRKCLQRNPLHR----PTAAW-LLEHPF 412
             ++  L +NP  R    PT    +  HPF
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  136 bits (343), Expect = 2e-36
 Identities = 81/259 (31%), Positives = 137/259 (52%), Gaps = 16/259 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V L     + E  A+K    +V L  DD +     +++   +AL     H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV---LALAWE--H 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   + +    + L+  +EY++GG +   +Q  G+  E+  R Y  +I+ GL++LH K
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  N+L+D  G +K+ADFGM K ++ G+    +  G+P ++APE++K     N
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YN 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCL 394
            +VD WS G  + EM   + P+   E    +F  I N  + P  P  +S E KD + K  
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILN--DRPHFPRWISKEAKDCLSKLF 231

Query: 395 QRNPLHR-PTAAWLLEHPF 412
           +R+P  R      + +HPF
Sbjct: 232 ERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  135 bits (342), Expect = 2e-36
 Identities = 84/298 (28%), Positives = 134/298 (44%), Gaps = 48/298 (16%)

Query: 160 GRLLGRGTFGH--VYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
             L+G+       V+L  +  +  + A+K++ L   D+ SKE  + L QEI    +L+HP
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHP 59

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLHA 275
           NI+ Y  S  +D +LY+    ++ GS   +L+ +   G  E AI    + +L+ L+Y+H+
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 276 KNTVHRDIKGANILVDPSGRVKLADF----GMAKHITGQSC----PLSIKGSPYWMAPEV 327
           K  +HR +K ++IL+   G+V L+       M KH   Q      P S   +  W++PEV
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 328 I-KNSNGCNLAVDIWSLGCTVIEMATTKPPWS--------------------------QY 360
           + +N  G N   DI+S+G T  E+A    P+                            Y
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239

Query: 361 EGVPAMFKIGNSKELPAIPDH------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           E   +  +  N                 S+    FV  CLQR+P  RP+A+ LL H F
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  134 bits (340), Expect = 5e-36
 Identities = 91/310 (29%), Positives = 133/310 (42%), Gaps = 75/310 (24%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE----SAQQLGQEIALLSRLRHPN 218
           LG GTFG VY     ++G + A+K++ + +     K+    +A +   EI +L +L+HPN
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN----EKDGFPITALR---EIKILKKLKHPN 68

Query: 219 IVRYYGSETLDDKLYIYLEYVSG--GSIYKIL--QDYG----------QLGESAIRSYTQ 264
           +V       L D      +      GS+Y +    D+           +L ES I+ Y  
Sbjct: 69  VVP------LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP---- 320
           Q+L G+ YLH  + +HRDIK ANIL+D  G +K+ADFG+A+   G   P + KG      
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG--PPPNPKGGGGGGT 180

Query: 321 ----------YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWS----QYE--- 361
                     ++  PE++        AVDIW +GC   EM T +P         Q     
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240

Query: 362 ---GVPAMFKIGNSKELPAIPD----------------HLSDEGKDFVRKCLQRNPLHRP 402
              G P        + LP                     L  EG D + K L  +P  R 
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 403 TAAWLLEHPF 412
           TA+  LEHP+
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  133 bits (337), Expect = 6e-36
 Identities = 84/265 (31%), Positives = 138/265 (52%), Gaps = 23/265 (8%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVR 221
           LGRG +G V    +  +G + A+K +    +  + K    +L  ++ +  R    P  V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLDISMRSVDCPYTVT 64

Query: 222 YYGSETLDDKLYIYLEYV--SGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAK-N 277
           +YG+   +  ++I +E +  S    YK + D G  + E  +      I+  LEYLH+K +
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI---KNSNGC 334
            +HRD+K +N+L++ +G+VKL DFG++ ++          G   +MAPE I    N  G 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI------GNSKELPAIPDHLSDEGKD 388
           ++  D+WSLG T+IE+AT + P+  ++     F+         S +LPA  +  S E +D
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWK---TPFQQLKQVVEEPSPQLPA--EKFSPEFQD 239

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFV 413
           FV KCL++N   RP    LL+HPF 
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  132 bits (335), Expect = 1e-35
 Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 41/291 (14%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES--AQQLGQEIALLSR 213
           R+K    +G G  G V+   + E+GE  A+K+V L     +  E     Q  +EI  L  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVAL-----RRLEGGIPNQALREIKALQA 55

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEY 272
            +HP +V+            + +EY+    + ++L+D  + L E+ ++SY + +L G+ Y
Sbjct: 56  CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEVIKN 330
           +HA   +HRD+K AN+L+   G +K+ADFG+A+  + +   L      + ++ APE++  
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKP--------------------P----WSQYEGVPAM 366
           +   +  VD+W++GC   E+    P                    P    W     +P  
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 367 FKIG--NSKELP---AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            KI    SK +P     PD  S E  D ++  L  +P  R +AA  L HP+
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  130 bits (329), Expect = 6e-35
 Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 24/265 (9%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V       +G+M A K+  L     K ++  Q    E  +L ++    IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK--LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 223 -YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLHAKNTV 279
            Y  ET  D L + +  ++GG +   + + G+ G  E+    Y  QI+ GLE+LH +  V
Sbjct: 59  AYAFET-KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +RD+K  N+L+D  G V+++D G+A  + G        G+P +MAPEV++     + +VD
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVD 176

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------SKELPA-IPDHLSDEGKDFVRK 392
            ++LGCT+ EM   + P+ Q +      K+        + E+    PD  S E KD    
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKE-----KVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231

Query: 393 CLQRNPLHR-----PTAAWLLEHPF 412
            LQ++P  R      +A  + EHP 
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  129 bits (326), Expect = 1e-34
 Identities = 76/253 (30%), Positives = 127/253 (50%), Gaps = 13/253 (5%)

Query: 162 LLGRGTFGHVY-LGFNSESGEMCAMKEVTL----FSDDAKSK-ESAQQLGQEIALL-SRL 214
            LG G FG VY +   +    + A+KE+ +    F  D + + +S   +  E+ ++  +L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSI---YKILQDYGQ-LGESAIRSYTQQILSGL 270
           RHPNIVRYY +   +D+LYI ++ + G  +   +  L++  Q   E  I +   Q++  L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 271 EYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            YLH  K  VHRD+   NI++    +V + DFG+AK    +S   S+ G+  +  PE++K
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
           N      A D+W+ GC + +M T +PP+     +    KI  +   P      S++  D 
Sbjct: 187 NEPYGEKA-DVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDV 245

Query: 390 VRKCLQRNPLHRP 402
           +  CL  +   RP
Sbjct: 246 ITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  129 bits (326), Expect = 2e-34
 Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 32/272 (11%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K  + LG G FG V L         +GE  A+K +    ++    +      +EI +L  
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRT 62

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
           L H NIV+Y G   +     L + +EY+  GS+   LQ +  Q+    +  ++ QI  G+
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG---SP-YWMAPE 326
           +YL ++  +HRD+   NILV+    VK++DFG+AK +        +K    SP +W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMAT----TKPPWSQY-------EGVPAMFKIGN---- 371
            ++ S   + A D+WS G T+ E+ T    ++ P +++       +G   + ++      
Sbjct: 183 CLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            + LP  P    DE  D ++ C +  P  RP+
Sbjct: 242 GERLPR-PPSCPDEVYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  129 bits (325), Expect = 3e-34
 Identities = 89/265 (33%), Positives = 140/265 (52%), Gaps = 15/265 (5%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH- 216
           R+LG G +G V+L       ++G++ AMK +   +   K+K +A+    E  +L  +R  
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAK-TAEHTRTERQVLEAVRRC 64

Query: 217 PNIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           P +V  +Y  +T D KL++ L+YV+GG ++  L       ES +R Y  +I+  L++LH 
Sbjct: 65  PFLVTLHYAFQT-DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--PLSIKGSPYWMAPEVIKN-SN 332
              ++RDIK  NIL+D  G V L DFG++K    +      S  G+  +MAPEVI+  S 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDEGKDFV 390
           G + AVD WSLG    E+ T   P++      +  +I     K  P  P  +S E +DF+
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFI 243

Query: 391 RKCLQRNPLHR---PTAAWLLEHPF 412
           +K L+++P  R     A  +  HPF
Sbjct: 244 QKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 1e-33
 Identities = 84/289 (29%), Positives = 126/289 (43%), Gaps = 41/289 (14%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
             +++GRG FG V+L  + ++G++ AMK V   SD  K  + A  +  E  +L+    P 
Sbjct: 5   VIKVIGRGAFGEVWLVRDKDTGQVYAMK-VLRKSDMIKRNQIAH-VRAERDILADADSPW 62

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           IV+ Y S   ++ LY+ +EY+ GG +  +L       E   R Y  +++  L+ +H    
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAK--------------------------HITGQSC 312
           +HRDIK  NIL+D  G +KLADFG+ K                                 
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 313 P----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
                 S  G+P ++APEV++      L  D WSLG  + EM    PP+          K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 369 IGNSKE---LPAIPDHLSDEGKDFVRKCL--QRNPLHRPTAAWLLEHPF 412
           I N KE    P  P  +S E  D + + L    + L       +  HPF
Sbjct: 242 IINWKESLRFPPDP-PVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  124 bits (312), Expect = 2e-32
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 33/287 (11%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K   +G G++G V+   N E+G++ A+K+     DD   K+ A +   EI +L +L+
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLK 58

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HPN+V          KL++  EY     + ++ ++   + E  I+    Q L  + + H 
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGC 334
            N +HRD+K  NIL+   G++KL DFG A+ +TG     +   +  W  APE++      
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI------------------------- 369
              VD+W++GC   E+ T +P W     V  ++ I                         
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 370 ----GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                  + L +   ++S     F++ CLQ +P  R +   LLEHP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  124 bits (315), Expect = 3e-32
 Identities = 100/322 (31%), Positives = 151/322 (46%), Gaps = 58/322 (18%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-KSKESAQQLGQEIALLSR 213
            +++  + LG+G +G V+   +  + E+ A+K++  F  DA ++   AQ+  +EI  L  
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI--F--DAFRNATDAQRTFREIMFLQE 62

Query: 214 LR-HPNIVRYYGSETLDDKLYIYL--EYVSG---GSIYK-ILQDYGQLGESAIRSYTQQI 266
           L  HPNIV+       ++   IYL  EY+       I   IL+D         R    Q+
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIMYQL 116

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPY---- 321
           L  L+Y+H+ N +HRD+K +NIL++   RVKLADFG+A+ ++  +  P +   + Y    
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWS----QYE------GVPAMFK 368
           W  APE++  S      VD+WS+GC + EM   KP  P +    Q E      G P+   
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 369 I-------GNS----------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
           I         +          K L  +    SD+  D ++K L  NP  R TA   LEHP
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296

Query: 412 FVGNAAPLERPILSAEPSETKP 433
           +V   A    P  S EP    P
Sbjct: 297 YV---AQFHNP--SDEPVLPYP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 86/306 (28%), Positives = 132/306 (43%), Gaps = 63/306 (20%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             +KK +LLG+G  G V+L     +G++ A+K +       ++K   +++  E  +L+ L
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATL 58

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEY 272
            HP +   Y S   +  L + ++Y  GG ++++L  Q    L E   R Y  ++L  LEY
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPY-------- 321
           LH    V+RD+K  NIL+  SG + L+DF ++K              KGS          
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 322 -------------------WMAPEVIKNSNGCNLAVDIWSLGCTVIEM--ATTKPPWSQY 360
                              ++APEVI   +G   AVD W+LG  + EM   TT P     
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTT-P----- 231

Query: 361 EGVPAMFKIGNSKEL--------PAIPDH--LSDEGKDFVRKCLQRNPLHR----PTAAW 406
                 FK  N  E            P    +S   +D +RK L ++P  R      AA 
Sbjct: 232 ------FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285

Query: 407 LLEHPF 412
           + +HPF
Sbjct: 286 IKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  123 bits (309), Expect = 4e-32
 Identities = 75/267 (28%), Positives = 139/267 (52%), Gaps = 22/267 (8%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G VY  ++  +  + A+K + L      + E  +Q+  E+ +L +   P I+ +
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL----DITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           YG+  +++++ I  E++ GGS    L  Y ++ E  +      ++ GL YL +   +HRD
Sbjct: 65  YGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWS 342
           +K +N+LV+  G+VKL DFG++  +   S   +  G+  +MAPE I       +  D+WS
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQ-YGIHSDVWS 178

Query: 343 LGCTVIEMATTKPPWSQYEG-----VP-AMFKIGNSKELPAIPDHL-SDEGKDFVRKCLQ 395
           LG + +E+A  + P+ Q +      +P  + +    ++ P +P    S++   F+ +C++
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238

Query: 396 RNPLHRPTAAWLLEHPFV-----GNAA 417
           + P  RP    L++HPF+     GNA 
Sbjct: 239 KQPKERPAPENLMDHPFIVQYNDGNAE 265

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  123 bits (311), Expect = 4e-32
 Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 49/294 (16%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   + ++GE+ A+K+V L  D+ K       + +EI +L +L H NIV  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71

Query: 223 YGSETLDDK------------LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSG 269
              E + DK             Y+  EY+    +  +L+       E  I+S+ +Q+L G
Sbjct: 72  K--EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWM-APEV 327
           L Y H KN +HRDIK +NIL++  G++KLADFG+A+ + + +S P + K    W   PE+
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPW------SQYE------GVPAMFKIGNSKEL 375
           +        A+D+WS GC + E+ T KP +      +Q E      G P      +  +L
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL 248

Query: 376 PAIP----------------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           P                     +     D +   L  +P  R TA   L  P++
Sbjct: 249 PYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  122 bits (307), Expect = 8e-32
 Identities = 88/279 (31%), Positives = 130/279 (46%), Gaps = 36/279 (12%)

Query: 158 KKGRLLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           KK R+LG G FG V    Y   N  +GEM A+K  TL  +  +   S  +  +EI +L  
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWK--KEINILKT 62

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           L H NIV+Y G  SE     L + +EYV  GS+   L  + +L  + +  + QQI  G+ 
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMA 121

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQS-CPLSIKG-SP-YWMAPEV 327
           YLH+++ +HRD+   N+L+D    VK+ DFG+AK +  G     +   G SP +W A E 
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF------KIGNSKELPAI--- 378
           +K  N  + A D+WS G T+ E+ T        +  P  F      K G    +  I   
Sbjct: 182 LK-ENKFSYASDVWSFGVTLYELLTHCDS---KQSPPKKFEEMIGPKQGQMTVVRLIELL 237

Query: 379 --------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                   P +   E    ++ C +     RPT   L+ 
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  122 bits (308), Expect = 2e-31
 Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 3/198 (1%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++G+G+FG V L  +   G+  A+K V       K KE    + +   LL  ++HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVK-VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             + S    DKLY  L+YV+GG ++  LQ      E   R Y  +I S L YLH+ N ++
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119

Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RD+K  NIL+D  G V L DFG+ K  I       +  G+P ++APEV++     +  VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVD 178

Query: 340 IWSLGCTVIEMATTKPPW 357
            W LG  + EM    PP+
Sbjct: 179 WWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  121 bits (305), Expect = 2e-31
 Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 48/280 (17%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIV 220
            +GRG FG V    +  SG + A+K +    D    ++  ++L  ++ ++ R    P IV
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 221 RYYGS-----------ETLD---DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           ++YG+           E +D   DK Y Y        +Y++L+    + E  +       
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKY--------VYEVLKSV--IPEEILGKIAVAT 116

Query: 267 LSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS------ 319
           +  L YL  +   +HRD+K +NIL+D +G +KL DFG++  +       SI  +      
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-----SIAKTRDAGCR 171

Query: 320 PYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           PY MAPE I  S  +G ++  D+WSLG T+ E+AT K P+ ++  V         G+   
Sbjct: 172 PY-MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI 230

Query: 375 L-PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           L  +     S    +F+  CL ++   RP    LLEHPF+
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  122 bits (307), Expect = 2e-31
 Identities = 76/248 (30%), Positives = 117/248 (47%), Gaps = 20/248 (8%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL---SRLRHPNI 219
           LGRG FG V L    ++GE+ A+K   L   D  +++  + L  E  +    +  RHP +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V  +     +D +   +EY +GG +   +       E     Y   ++ GL+YLH    V
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNSNG 333
           +RD+K  N+L+D  G VK+ADFG+ K        T   C     G+P ++APEV+  ++ 
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEFLAPEVLTETS- 177

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
              AVD W LG  + EM   + P+   +       I N +     P  LS E    +R+ 
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRRL 235

Query: 394 LQRNPLHR 401
           L+RNP  R
Sbjct: 236 LRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  121 bits (306), Expect = 3e-31
 Identities = 85/263 (32%), Positives = 133/263 (50%), Gaps = 21/263 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +LLG+GTFG V L     +G+  AMK    EV +  D     E A  L  E  +L   RH
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD-----EVAHTL-TESRVLQNTRH 54

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +     S    D+L   +EY +GG ++  L       E   R Y  +I+S L YLH+ 
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + V+RD+K  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N   
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 173

Query: 336 LAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            AVD W LG  + EM   + P ++Q      +F++   +E+   P  LS E K  +   L
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-RFPRTLSPEAKSLLAGLL 230

Query: 395 QRNPLHR-----PTAAWLLEHPF 412
           +++P  R       A  ++EH F
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  121 bits (305), Expect = 4e-31
 Identities = 79/250 (31%), Positives = 132/250 (52%), Gaps = 20/250 (8%)

Query: 161 RLLGRGTFGHVYLG---FNSESGEMCAMK---EVTL-FSDDAKSKESAQQLGQEIALLSR 213
           ++LG+G+FG V+L       ++G++ AMK   + TL   D  ++K        E  +L+ 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-------MERDILAE 54

Query: 214 LRHPNIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           + HP IV+ +Y  +T + KLY+ L+++ GG ++  L       E  ++ Y  ++   L++
Sbjct: 55  VNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 113

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNS 331
           LH+   ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+ N 
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 172

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
            G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +R
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLR 230

Query: 392 KCLQRNPLHR 401
              +RNP +R
Sbjct: 231 ALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  121 bits (304), Expect = 4e-31
 Identities = 93/297 (31%), Positives = 143/297 (48%), Gaps = 55/297 (18%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V    +  SG + A K + L   + K      Q+ +E+ +L     P IV +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL---EIKP-AIRNQIIRELKVLHECNSPYIVGF 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV-HR 281
           YG+   D ++ I +E++ GGS+ ++L+  G++ E+ +   +  +L GL YL  K+ + HR
Sbjct: 65  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           D+K +NILV+  G +KL DFG    ++GQ   S   S  G+  +M+PE ++   G +  V
Sbjct: 125 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQ---GTHYTV 177

Query: 339 --DIWSLGCTVIEMAT-------------------------TKPPWSQYEGVP------- 364
             DIWSLG +++EMA                           K       G P       
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237

Query: 365 AMFK----IGNSKELPAIPD-HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           A+F+    I N    P +P    SDE +DFV KCL++NP  R     L +HPF+  A
Sbjct: 238 AIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  120 bits (304), Expect = 7e-31
 Identities = 83/304 (27%), Positives = 147/304 (48%), Gaps = 55/304 (18%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSES--GEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
           R++  + LG+G +G V    N+E+   E  A+K++T +FS     K  A++  +E+ LL 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS----KKILAKRALRELKLLR 56

Query: 213 RLR-HPNIVRYYGSETLD----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
             R H NI   Y  + +     ++LY+Y E +    +++I++    L ++  +S+  QIL
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------ 321
            GL+Y+H+ N +HRD+K  N+LV+    +K+ DFG+A+  +        + + +      
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS----ENPGENAGFMTEYVA 171

Query: 322 --WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS------------QYEGVP-- 364
             W  APE++ +      A+D+WS+GC + E+   KP +             Q  G P  
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231

Query: 365 -AMFKIGNSK------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
             + +IG+ K       LP IP         + +    D + K L  +P  R +    LE
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291

Query: 410 HPFV 413
           HP++
Sbjct: 292 HPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 8e-31
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 68/312 (21%)

Query: 164 GRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLG-QEIALLSRLRHPNIV 220
           GRGT+G VY     N + G+  A+K+   F  D +      Q   +EIALL  L+H N+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 221 RYYGS--ETLDDKLYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEYL 273
                  E  D  +Y+  +Y +   +++I++ +       +  S ++S   QIL+G+ YL
Sbjct: 66  SLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 274 HAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWM-A 324
           H+   +HRD+K ANILV       G VK+ D G+A+       PL+    P     W  A
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA-DLDPVVVTIWYRA 183

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS------------QYEGVPAMFKI-GN 371
           PE++  +     A+DIW++GC   E+ T +P +             Q + +  +F++ G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243

Query: 372 SKE-----LPAIPDH--------------------------LSDEGKDFVRKCLQRNPLH 400
             E     +  +P++                             +G D +RK L+ +P  
Sbjct: 244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303

Query: 401 RPTAAWLLEHPF 412
           R TA   LEHP+
Sbjct: 304 RITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  120 bits (301), Expect = 1e-30
 Identities = 80/246 (32%), Positives = 127/246 (51%), Gaps = 14/246 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +LLG+GTFG V L     +G   AMK    EV +  D     E A  +  E  +L   RH
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTV-TESRVLQNTRH 54

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +     +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH++
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + V+RDIK  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N   
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 173

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLK 231

Query: 396 RNPLHR 401
           ++P  R
Sbjct: 232 KDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  118 bits (298), Expect = 2e-30
 Identities = 85/294 (28%), Positives = 138/294 (46%), Gaps = 47/294 (15%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K   +G GT+G VY   +  + E  A+K++ L  +D     +A +   EI+LL  ++
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQ 59

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--IRSYTQQILSGLEYL 273
           H NIVR       + +LY+  EY+    + K +       ++   I++Y  QIL G+ Y 
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 274 HAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAP 325
           H+   +HRD+K  N+L+D     +KLADFG+A+         T +   L      ++ AP
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL------WYRAP 172

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GNSKE-----LP 376
           E++  S   +  VDIWS+GC   EM   KP +     +  +FKI    G   E     + 
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 377 AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           ++PD+                  L   G D + K L+ +P  R TA   LEH +
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 3e-30
 Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 27/259 (10%)

Query: 163 LGRGTFGHVYLG-FNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           LG G FG V  G +  +SG+    A+K  TL  +   + +  ++  +E +++++L HP I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVK--TLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           VR  G     + L + +E    G + K L+   ++  S ++    Q+  G+ YL +K+ V
Sbjct: 59  VRLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSPYWMAPEVIK 329
           HRD+   N+L+    + K++DFGM++ +          T    PL       W APE I 
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------WYAPECI- 170

Query: 330 NSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
           N    +   D+WS G T+ E  +    P+ + +G   +  + + + LP  P+    E   
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-PEECPQEIYS 229

Query: 389 FVRKCLQRNPLHRPTAAWL 407
            +  C +  P  RPT + L
Sbjct: 230 IMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  118 bits (297), Expect = 6e-30
 Identities = 75/261 (28%), Positives = 116/261 (44%), Gaps = 13/261 (4%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           L+GRG FG V +     +G++ AMK   +      ++E+     +E  +LS    P I +
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMK--VMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
              +    D LY+ +EY  GG +  +L  Y  Q  E   + Y  +++  +  +H    VH
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHIT--GQSCPLSIKGSPYWMAPEVIKNSNGC---- 334
           RDIK  N+L+D +G +KLADFG A  +T           G+P ++APEV+   NG     
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 335 -NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL--SDEGKDFVR 391
             +  D WSLG    EM   + P+ +         I N +     P+    S +  D ++
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQ 245

Query: 392 KCLQRNPLHRPTAAWLLEHPF 412
             L      R     L  HPF
Sbjct: 246 SLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  118 bits (296), Expect = 6e-30
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 9/254 (3%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G+FG V      ++  + A+K  T+      S+        E  +L+++  P IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
             S    +KLY+ L +++GG ++  LQ  G+   S  R YT ++L  LE LH  N ++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 283 IKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
           +K  NIL+D  G + L DFG+ K ++       +  G+P ++APE++   +G   AVD W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL-LGHGYTKAVDWW 177

Query: 342 SLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR 401
           +LG  + EM T  PP+   E V  M++    + L   PD    + KD +   L R+P  R
Sbjct: 178 TLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL-RFPDGFDRDAKDLLIGLLSRDPTRR 235

Query: 402 ---PTAAWLLEHPF 412
                A  +  HPF
Sbjct: 236 LGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 7e-30
 Identities = 82/296 (27%), Positives = 123/296 (41%), Gaps = 46/296 (15%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L    ++G + AMK   L   +   KE    +  E  +L+   +P +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMK--KLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + Y S   ++ LY+ +EY+ GG +  +L       E   R Y  + +  ++ +H    +H
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-----------HITGQSCPL--------------- 314
           RDIK  N+L+D  G +KL+DFG+              I   + P                
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 315 -------------SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE 361
                        S  G+P ++APEV     G N   D WSLG  + EM    PP+    
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Query: 362 GVPAMFKIGNSKELPAIPD--HLSDEGKDFVRK--CLQRNPLHRPTAAWLLEHPFV 413
                 KI N KE    PD   LS E KD +++  C     L       +  HPF 
Sbjct: 244 PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  117 bits (294), Expect = 2e-29
 Identities = 84/270 (31%), Positives = 134/270 (49%), Gaps = 24/270 (8%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH- 216
           ++LG G +G V+L       ++G++ AMK +   +   K+K + +    E  +L  +R  
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAK-TVEHTRTERNVLEHVRQS 64

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +V  + +   + KL++ L+YVSGG ++  L       E  +R Y+ +I+  LE+LH  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--PLSIKGSPYWMAPEVIKNSNGC 334
             V+RDIK  NIL+D  G V L DFG++K    +      S  G+  +MAPE+I+   G 
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 335 NLAVDIWSLGCTVIEMATTKPPW-------SQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
             AVD WSLG  + E+ T   P+       +Q E    + K       P  P  +  E +
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-----PPFPSFIGPEAQ 239

Query: 388 DFVRKCLQRNPLHRPTAAW-----LLEHPF 412
           D + K L+++P  R  A       + EHPF
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  116 bits (292), Expect = 2e-29
 Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 23/265 (8%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNI 219
            +G GT G VY     ++G + A+K++    +  ++K     L  ++ L S   H  P I
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKS---HDCPYI 76

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNT 278
           V+ YG    D  ++I +E +S   + K+L+   G + E  +   T  I+  L YL  K+ 
Sbjct: 77  VKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 279 V-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNG-C 334
           V HRD+K +NIL+D SG VKL DFG++  +          G   +MAPE I   + N   
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF----KIGNSKELPAIPDH--LSDEGKD 388
           ++  D+WSLG +++E+AT + P   Y+     F    KI    E P++P +   S +   
Sbjct: 196 DIRADVWSLGISLVELATGQFP---YKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCS 251

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFV 413
           FV  CL ++   RP    LL+HPF+
Sbjct: 252 FVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  116 bits (292), Expect = 2e-29
 Identities = 75/269 (27%), Positives = 133/269 (49%), Gaps = 16/269 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V L      GE  A+K    +V L  DD +     +++     L     +
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRV-----LALAWEN 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   Y +    + L+  +E+++GG +   +QD G+        Y  +I+ GL++LH+K
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  N+++D  G +K+ADFGM K ++ G +   +  G+P ++APE+++      
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YT 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            +VD WS G  + EM   + P+   +       I    + P  P  ++ E KD + K  +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLFE 232

Query: 396 RNPLHR-PTAAWLLEHPFVG--NAAPLER 421
           R+P  R      +  HPF    N   LE+
Sbjct: 233 RDPTRRLGVVGNIRGHPFFKTINWTALEK 261

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  114 bits (288), Expect = 4e-29
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 49/287 (17%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVR 221
           +G GTF  V    + ++G+  A+K +       KS E    L +EI  L RL  HPNI+R
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVNNL-REIQALRRLSPHPNILR 62

Query: 222 YYGSETLDDKLYIYLEYV---SGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKN 277
               E L D+    L  V      ++Y++++   + L E  ++SY  Q+L  L+++H   
Sbjct: 63  LI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCNL 336
             HRDIK  NIL+     +KLADFG  + I  +  P +   S  W  APE +        
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGP 178

Query: 337 AVDIWSLGCTVIEMATTKP------------------------------PWSQYE-GVPA 365
            +DIW++GC   E+ +  P                                       P+
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
               G  K LP    + S EG D ++K L  +P  R TA   L HP+
Sbjct: 239 KKGTGLRKLLP----NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 4e-29
 Identities = 85/264 (32%), Positives = 127/264 (48%), Gaps = 33/264 (12%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K G  +G+G FG V LG     G+  A+K +    DD+ +   AQ    E ++++ LRHP
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKCL---KDDSTA---AQAFLAEASVMTTLRHP 60

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL------SGLE 271
           N+V+  G     + LYI  EY++ GS    L DY +    A+ +  QQ+        G+E
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGS----LVDYLRSRGRAVITLAQQLGFALDVCEGME 116

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQ-SCPLSIKGSPYWMAPEVIK 329
           YL  KN VHRD+   N+LV      K++DFG+AK  + GQ S  L +K    W APE ++
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALR 172

Query: 330 NSNGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
                  + D+WS G  + E+ +      P     + VP + K G   E    P+    E
Sbjct: 173 EKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRME---APEGCPPE 227

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLE 409
               ++ C + +P  RPT   L E
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  115 bits (289), Expect = 6e-29
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 36/272 (13%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V L     + E+ A+K    +V L  DD     + ++    I  L+  +H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALAA-KH 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   +      D+L+  +EYV+GG +   +Q   +  E   R Y  ++   L +LH  
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  NIL+D  G  KLADFGM K  I       +  G+P ++APE+++      
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YG 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAI-------PDHLSDEGK 387
            +VD W+LG  + EM   +PP          F+  N  +L  +I       P  LS E  
Sbjct: 175 PSVDWWALGVLMYEMMAGQPP----------FEADNEDDLFESILHDDVLYPVWLSKEAV 224

Query: 388 DFVRKCLQRNPLHR-------PTAAWLLEHPF 412
             ++  + +NP  R            + +HPF
Sbjct: 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  114 bits (287), Expect = 6e-29
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 20/273 (7%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +    LG G  G V    +  +G + A K V +    AKS    Q L +E+ ++   R P
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKSSVRKQIL-RELQIMHECRSP 63

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            IV +YG+   ++ + + +E++  GS+ +I +  G +    +      ++ GL YL+  +
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 278 -TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             +HRDIK +NILV+  G++KL DFG++  +   S   +  G+  +M+PE I+      +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQ-GGKYTV 181

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPA-----------MFKIGNSKELPAIP-DHLSD 384
             D+WSLG ++IE+A  K P++                  + +I   +  P +P     +
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSDFPE 240

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
           + +DFV  CL ++P  RPT   L   P    A 
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 6e-29
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 46/299 (15%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R++    +G G +G V    +  +G   A+K+++ F      +   Q+  +EI +L R
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRR 59

Query: 214 LRHPNIVRYYG---SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +H NI+         + +    +YI  E +    +YK+++    L    I+ +  QIL 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILR 117

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY----WM- 323
           GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+    +    +   + Y    W  
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVATRWYR 176

Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVPAM---FK 368
           APE++ NS G   A+DIWS+GC + EM + +P  P   Y           G P+      
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 369 IGNSKEL---------PAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           I + +           P +P      +   +  D + K L  NP  R T    L HP++
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  115 bits (290), Expect = 6e-29
 Identities = 88/321 (27%), Positives = 147/321 (45%), Gaps = 61/321 (19%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           GSR+   R LG G+ G V+   +S+  +  A+K++ L        +S +   +EI ++ R
Sbjct: 4   GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-----TDPQSVKHALREIKIIRR 58

Query: 214 LRHPNIVRYY--------------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           L H NIV+ Y              GS T  + +YI  EY+   +    + + G L E   
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME--TDLANVLEQGPLSEEHA 116

Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKG 318
           R +  Q+L GL+Y+H+ N +HRD+K AN+ ++    V K+ DFG+A+ +       S KG
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH---YSHKG 173

Query: 319 -------SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ----------YE 361
                  + ++ +P ++ + N    A+D+W+ GC   EM T KP ++            E
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233

Query: 362 GVPAM-------------FKIGNSKELPAIP-----DHLSDEGKDFVRKCLQRNPLHRPT 403
            VP +               + N    P  P       ++ E  DF+ + L  NP+ R T
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293

Query: 404 AAWLLEHPFVGN-AAPLERPI 423
           A   L HP++   + P + P+
Sbjct: 294 AEEALMHPYMSCYSCPFDEPV 314

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  115 bits (289), Expect = 7e-29
 Identities = 81/246 (32%), Positives = 126/246 (51%), Gaps = 14/246 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +LLG+GTFG V L     SG+  AMK    EV +  D     E A  L  E  +L   RH
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKD-----EVAHTL-TESRVLKNTRH 54

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +     S    D+L   +EYV+GG ++  L       E   R Y  +I+S L+YLH+ 
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             V+RD+K  N+++D  G +K+ DFG+ K  IT  +   +  G+P ++APEV+++ N   
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYG 173

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD W LG  + EM   + P+   +    +F++   +++   P  LS + K  +   L 
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEDI-KFPRTLSADAKSLLSGLLI 231

Query: 396 RNPLHR 401
           ++P  R
Sbjct: 232 KDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  115 bits (288), Expect = 7e-29
 Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 14/258 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V+L     + +  A+K    +V L  DD +     +++     L     H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-----LSLAWEH 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   Y +    + L+  +EY++GG +   +Q   +        Y  +I+ GL++LH+K
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             V+RD+K  NIL+D  G +K+ADFGM K ++ G +   +  G+P ++APE++      N
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YN 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            +VD WS G  + EM   + P+  ++       I    + P  P  L+ E KD + K   
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFV 232

Query: 396 RNPLHR-PTAAWLLEHPF 412
           R P  R      + +HPF
Sbjct: 233 REPERRLGVKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  115 bits (288), Expect = 8e-29
 Identities = 75/242 (30%), Positives = 118/242 (48%), Gaps = 5/242 (2%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++G+G+FG V L      G   A+K V       K KE    + +   LL  L+HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             + S    +KLY  L+YV+GG ++  LQ      E   R Y  ++ S + YLH+ N ++
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119

Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RD+K  NIL+D  G V L DFG+ K  +  +    +  G+P ++APEV++     +  VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVD 178

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM    PP+   + V  M+     K L  +P   +    D +   L ++  
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHKDQR 236

Query: 400 HR 401
            R
Sbjct: 237 RR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  114 bits (287), Expect = 1e-28
 Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 60/292 (20%)

Query: 166 GTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIALLSRLRHPNI 219
           GT+G VY   + ++GE+ A+K++ +     K KE     G      +EI +L +L+HPNI
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKME----KEKE-----GFPITSLREINILLKLQHPNI 66

Query: 220 VRY----YGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYL 273
           V       GS    DK+Y+ +EYV      K L +       +S ++    Q+LSG+ +L
Sbjct: 67  VTVKEVVVGSN--LDKIYMVMEYVEHD--LKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSN 332
           H    +HRD+K +N+L++  G +K+ DFG+A+       P +      W  APE++  + 
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAK 182

Query: 333 GCNLAVDIWSLGCTVIEMATTKP--------------------P----WSQYEGVPAMFK 368
             + A+D+WS+GC   E+ T KP                    P    W  +  +P   K
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242

Query: 369 I------GN--SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                   N   K+ PA+   LSD G D + + L  +P  R +A   L+HP+
Sbjct: 243 KTFTKYPYNQLRKKFPALS--LSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  114 bits (287), Expect = 2e-28
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 57/305 (18%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ---------EIA 209
           KG  LG GT+G V   +++ +G++ A+K+V +        +  Q +G          E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 210 LLSRLRHPNI---VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           +++ ++H NI   V  Y      D + + ++ ++   + K++    +L ES ++    QI
Sbjct: 73  IMNEIKHENIMGLVDVYVEG---DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSP-- 320
           L+GL  LH    +HRD+  ANI ++  G  K+ADFG+A+         +           
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 321 ---------YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP---------------- 355
                    ++ APE++  +   + AVD+WS+GC   E+ T KP                
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248

Query: 356 --------PWSQYEGVPAM--FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                    W Q + +P    F     K+L  I  + SD+  D ++  L+ NPL R +A 
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 406 WLLEH 410
             L+H
Sbjct: 309 EALKH 313

Length = 335

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 77/265 (29%), Positives = 113/265 (42%), Gaps = 31/265 (11%)

Query: 161 RLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG G FG V+LG  ++ E      +  V    + A S ++ +   +E  LL+  +H N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHEN 69

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKIL--------------QDYGQLGESAIRSYTQ 264
           IV++YG  T  D   +  EY+  G + K L                 G+L  S +     
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           QI SG+ YL +++ VHRD+   N LV     VK+ DFGM++ +        G    L I+
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELP 376
               WM PE I          D+WS G  + E+ T  K PW        +  I   + L 
Sbjct: 190 ----WMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHR 401
             P     E  D +  C +R+P  R
Sbjct: 245 R-PRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  114 bits (286), Expect = 2e-28
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 18/261 (6%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++   +AL  +   P
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV---LALPGK--PP 61

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +LH+K 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K +I G     +  G+P ++APE+I        
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGK 180

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
           +VD W+ G  + EM   +PP+   E    +F+    +   + P  LS E     +  L +
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQ-SIMEHNVSYPKSLSKEAVSICKGLLTK 238

Query: 397 NPLHR----PTAAW-LLEHPF 412
           +P  R    PT    + EH F
Sbjct: 239 HPAKRLGCGPTGERDIREHAF 259

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  113 bits (284), Expect = 3e-28
 Identities = 82/263 (31%), Positives = 133/263 (50%), Gaps = 19/263 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           R+LG+G+FG V L    ESG + A+K    +V L  DD +   + ++    I  L+R  H
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKR----ILSLAR-NH 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P + + Y      D+L+  +E+V+GG +   +Q   +  E+  R Y  +I S L +LH K
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  N+L+D  G  KLADFGM K         S   G+P ++APE+++      
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YG 174

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            +VD W++G  + EM     P+ + E    +F+   + E+   P  LS +  D ++  + 
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMT 232

Query: 396 RNPLHRPTAAWL------LEHPF 412
           +NP  R  +  L      L HPF
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPF 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  111 bits (280), Expect = 8e-28
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 27/274 (9%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +L+  G +G VYL  + E+ +  AMK++     +   +   QQ+  E  +L+   +P +V
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             + S      L + +EYV GG    +L++ G L     R Y  + +  LEYLH    VH
Sbjct: 65  SMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-------------HI---TGQSCPLSIKGSPYWMA 324
           RD+K  N+L+   G +KL DFG++K             HI   T +     + G+P ++A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFK--IGNSKELPAIPDH 381
           PEVI    G    VD W++G  + E      P+  +   P  +F   I +  E P   + 
Sbjct: 185 PEVILR-QGYGKPVDWWAMGIILYEFLVGCVPF--FGDTPEELFGQVISDDIEWPEGDEA 241

Query: 382 LSDEGKDFVRKCLQRNPLHR---PTAAWLLEHPF 412
           L  + +D + + L++NPL R     A  + +H F
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  111 bits (279), Expect = 8e-28
 Identities = 79/269 (29%), Positives = 140/269 (52%), Gaps = 15/269 (5%)

Query: 161 RLLGRGTFGHVYLG---FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH- 216
           ++LG G +G V+L       +SG++ AMK +   +   K+K + +    E  +L  +R  
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQS 64

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +V  + +   D KL++ L+Y++GG ++  L    +  E  ++ Y+ +I+  LE+LH  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIKNSN-G 333
             ++RDIK  NIL+D +G V L DFG++K  H        S  G+  +MAP++++  + G
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDEGKDFVR 391
            + AVD WS+G  + E+ T   P++      +  +I     K  P  P  +S   KD ++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQ 244

Query: 392 KCLQRNPLHR----PTAA-WLLEHPFVGN 415
           + L ++P  R    P+ A  + +HPF   
Sbjct: 245 RLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  111 bits (278), Expect = 1e-27
 Identities = 89/301 (29%), Positives = 147/301 (48%), Gaps = 55/301 (18%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   +  +G++ A+K+  L  D+     +A +   EI+LL  L  
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSE 59

Query: 217 -PNIVRYYGSETLDDK-----LYIYLEYVSGGSIYKILQDYGQ-----LGESAIRSYTQQ 265
              IVR    E +++K     LY+  EY+    + K +   G+     L    I+S+  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKG------ 318
           +L G+ + H    +HRD+K  N+LVD   G +K+AD G+ +  +     + +K       
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIV 173

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKI------ 369
           + ++ APEV+  S   +  VDIWS+GC   EM+  +P +   S+ + +  +FK+      
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 370 ----GNSK-----ELP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
               G SK     E P         A+PD LS EG D ++K L+ +P  R +A   L HP
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Query: 412 F 412
           +
Sbjct: 293 Y 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  112 bits (280), Expect = 1e-27
 Identities = 85/263 (32%), Positives = 132/263 (50%), Gaps = 20/263 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +LLG+GTFG V L     +G   AMK    EV +  D     E A  L  E  +L   RH
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-----EVAHTL-TENRVLQNSRH 54

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA- 275
           P +     S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ 
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           KN V+RD+K  N+++D  G +K+ DFG+ K  I   +   +  G+P ++APEV+++ N  
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDY 173

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
             AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLSPEAKSLLSGLL 231

Query: 395 QRNPLHR-----PTAAWLLEHPF 412
           +++P  R       A  +++H F
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 34/270 (12%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P    K  R LG G FG V++G  + + ++    +K  T+         S +   QE  +
Sbjct: 4   PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQI 54

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE-SAIR-----SYTQ 264
           + +LRH  +V+ Y   + ++ +YI  EY+S GS    L D+ + GE   +R         
Sbjct: 55  MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS----LLDFLKSGEGKKLRLPQLVDMAA 110

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------TGQSCPLSIKG 318
           QI  G+ YL ++N +HRD+   NILV  +   K+ADFG+A+ I        +     IK 
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK- 169

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPA 377
              W APE   N     +  D+WS G  + E+ T  + P+        + ++     +P 
Sbjct: 170 ---WTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP- 224

Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
            P +  +E  D + +C  ++P  RPT  +L
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (275), Expect = 2e-27
 Identities = 76/258 (29%), Positives = 122/258 (47%), Gaps = 26/258 (10%)

Query: 161 RLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           + LG G FG V++G+  NS    +  +K  T+         S Q   +E  L+  L+H  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDK 62

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEYLHAK 276
           +VR Y   T ++ +YI  EY++ GS+   L   + G++    +  ++ QI  G+ Y+  K
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKN 330
           N +HRD++ AN+LV  S   K+ADFG+A+ I        +     IK    W APE I N
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEAI-N 177

Query: 331 SNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
                +  D+WS G  + E+ T  K P+        M  +     +P   ++  DE  D 
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDELYDI 236

Query: 390 VRKCLQRNPLHRPTAAWL 407
           ++ C +     RPT  +L
Sbjct: 237 MKTCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  110 bits (276), Expect = 3e-27
 Identities = 77/314 (24%), Positives = 125/314 (39%), Gaps = 72/314 (22%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S+++K   +G+GTFG V+   + ++ ++ A+K+V +  ++ K       L +EI +L  L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITAL-REIKILQLL 68

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL------------QDYGQLGESAIRSY 262
           +H N+V     E    K   Y  Y   GS Y +                 +   S I+  
Sbjct: 69  KHENVVNLI--EICRTKATPYNRY--KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-- 320
            + +L+GL Y+H    +HRD+K ANIL+   G +KLADFG+A+  +     LS    P  
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS-----LSKNSKPNR 179

Query: 321 --------YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-------------------- 352
                   ++  PE++         +D+W  GC + EM T                    
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 353 ----TKPPWSQYEGVPAMFKIGNSKELP-----AIPDHL-----SDEGKDFVRKCLQRNP 398
               T   W   + +     +    ELP      + + L          D + K L  +P
Sbjct: 240 CGSITPEVWPGVDKLE----LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295

Query: 399 LHRPTAAWLLEHPF 412
             R  A   L H F
Sbjct: 296 AKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  108 bits (271), Expect = 7e-27
 Identities = 76/263 (28%), Positives = 116/263 (44%), Gaps = 26/263 (9%)

Query: 162 LLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
            LG G+FG V  G +++  G++  +    L SD  K  +      +E A++  L H N++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD--KLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQD--YGQLGESAIRSYTQQILSGLEYLHAKNT 278
           R YG   L   L +  E    GS+   L+    G    S +  Y  QI +G+ YL +K  
Sbjct: 60  RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-----------WMAPEV 327
           +HRD+   NIL+    +VK+ DFG+ +        L      Y           W APE 
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMR-------ALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           ++     + A D+W  G T+ EM T  + PW+   G   + KI    E    P+    + 
Sbjct: 172 LRTRTFSH-ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI 230

Query: 387 KDFVRKCLQRNPLHRPTAAWLLE 409
            + + +C   NP  RPT A L E
Sbjct: 231 YNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  109 bits (274), Expect = 7e-27
 Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +++G+G+FG V L      G+  A+K    ++ L       KE    + +   LL  ++H
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKH 55

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +V  + S    +KLY  L++V+GG ++  LQ      E   R Y  +I S L YLH+ 
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIKGSPYWMAPEVIKNSNGCN 335
           N V+RD+K  NIL+D  G V L DFG+ K    QS    +  G+P ++APEVI+     N
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 336 LAVDIWSLGCTVIEMATTKPPW 357
             VD W LG  + EM    PP+
Sbjct: 176 -TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 8e-27
 Identities = 79/267 (29%), Positives = 120/267 (44%), Gaps = 37/267 (13%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R LG G FG V+ G  + +  + A+K  TL       K+       E  ++ +LRHP ++
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPV-AVK--TLKPGTMDPKD----FLAEAQIMKKLRHPKLI 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ------QILSGLEYLH 274
           + Y   TL++ +YI  E +  GS    L +Y Q G        Q      Q+ SG+ YL 
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGS----LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPE 326
           A+N +HRD+   N+LV  +   K+ADFG+A+ I         G   P  IK    W APE
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IK----WTAPE 174

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
                N  ++  D+WS G  + E+ T  + P+        + ++     +P  P     E
Sbjct: 175 AA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKE 232

Query: 386 GKDFVRKCLQRNPLHRPT---AAWLLE 409
             D +  C + +P  RPT     W LE
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  108 bits (271), Expect = 8e-27
 Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 18/253 (7%)

Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           GR +G G FG VY G + S   E  A+   T  +  + S    ++  QE  ++ +  HP+
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV--REKFLQEAYIMRQFDHPH 68

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKN 277
           IV+  G  T ++ ++I +E    G +   LQ     L  +++  Y+ Q+ + L YL +K 
Sbjct: 69  IVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQS------CPLSIKGSPYWMAPEVIKNS 331
            VHRDI   N+LV     VKL DFG+++++  +S        L IK    WMAPE I N 
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESI-NF 182

Query: 332 NGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
                A D+W  G  + E +     P+   +    + +I N + LP +P +        +
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLM 241

Query: 391 RKCLQRNPLHRPT 403
            KC   +P  RP 
Sbjct: 242 TKCWAYDPSKRPR 254

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  108 bits (271), Expect = 9e-27
 Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 32/278 (11%)

Query: 158 KKGRLLGRGTFGHVYL-GFNSE---SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K+ R LG G FG V L  ++ E   +GE  A+K +               L +EI +L  
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRN 62

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGL 270
           L H NIV+Y G  +E   + + + +E++  GS+ + L ++  ++       Y  QI  G+
Sbjct: 63  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGM 122

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPE 326
           +YL ++  VHRD+   N+LV+   +VK+ DFG+ K I       ++K    SP +W APE
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMAT---------------TKPPWSQYEGVPAMFKIGN 371
            +  S    +A D+WS G T+ E+ T                 P   Q      +  +  
Sbjct: 183 CLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241

Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            K LP  P +  +E    +RKC +  P  R T   L+E
Sbjct: 242 GKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  109 bits (274), Expect = 9e-27
 Identities = 81/265 (30%), Positives = 125/265 (47%), Gaps = 21/265 (7%)

Query: 161 RLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSK----ESAQQLGQEIALLSRLR 215
           R LG G+FG V L  + +E     A+K         KSK    +    +  E  +L+ + 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFE------KSKIIKQKQVDHVFSERKILNYIN 89

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP  V  YGS   +  LY+ LE+V GG  +  L+   +        Y  QI+   EYL +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
            N V+RD+K  N+L+D  G +K+ DFG AK +  ++  L   G+P ++APE++ N  G  
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYIAPEILLNV-GHG 206

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            A D W+LG  + E+    PP+  Y   P +      + +   P  L +  K  ++K L 
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF--YANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLS 264

Query: 396 RNPLHR-----PTAAWLLEHPFVGN 415
            +   R       A  + EHP+ GN
Sbjct: 265 HDLTKRYGNLKKGAQNVKEHPWFGN 289

Length = 340

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  108 bits (272), Expect = 1e-26
 Identities = 85/295 (28%), Positives = 132/295 (44%), Gaps = 62/295 (21%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   ++ SGE+ A+K+V +  D+ +       L +EI LL  LRHPNIV  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNLRHPNIVEL 71

Query: 223 Y----GSETLDDKLYIYLEYVSGGSIYKILQDYGQL--------GESAIRSYTQQILSGL 270
                G     D +++ +EY          QD   L         ES ++    Q+L GL
Sbjct: 72  KEVVVGKHL--DSIFLVMEYCE--------QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIK 329
           +YLH    +HRD+K +N+L+   G +K+ADFG+A+     + P++ K    W  APE++ 
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKP--------------------P----WSQYEGVPA 365
                  A+D+W++GC + E+   KP                    P    W  +  +P 
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 366 MFKIGNSKELPAIPDH--------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           + K      LP  P +        LS+ G   +   L  +P  R TA   LE  +
Sbjct: 242 VGKF----TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  110 bits (277), Expect = 1e-26
 Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 50/301 (16%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           SP   +K G ++G G+FG VY     ++ E  A+K+V          +  Q   +E+ ++
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---------QDPQYKNRELLIM 113

Query: 212 SRLRHPNIV---RYYGSETLDDK-----LYIYLEYVSGGSIYKILQDYGQLGESA----I 259
             L H NI+    YY +E          L + +E++   +++K ++ Y +   +     +
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172

Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQSCPLSIKG 318
           + Y+ Q+   L Y+H+K   HRD+K  N+L+DP +  +KL DFG AK++      +S   
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS------------QYEGVPA- 365
           S ++ APE++  +      +D+WSLGC + EM    P +S            Q  G P  
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292

Query: 366 -MFKIGN------------SKELPAI-PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
              K  N             K+L  + P    D+  +F+ + L+  PL R      L  P
Sbjct: 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352

Query: 412 F 412
           F
Sbjct: 353 F 353

Length = 440

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  108 bits (271), Expect = 2e-26
 Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 3/198 (1%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++G+G+FG V L  +    +  A+K V       K KE    + +   LL  ++HP +V
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             + S    DKLY  L+Y++GG ++  LQ      E   R Y  +I S L YLH+ N V+
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RD+K  NIL+D  G + L DFG+ K +I       +  G+P ++APEV+ +    +  VD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTVD 178

Query: 340 IWSLGCTVIEMATTKPPW 357
            W LG  + EM    PP+
Sbjct: 179 WWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 32/275 (11%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-----LSRLR 215
           R+LG+G FG V       +G+M A K++       + K   ++ G+ +AL     L ++ 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKQILEKVN 58

Query: 216 HPNIVRY-YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEY 272
              +V   Y  ET  D L + L  ++GG +   + + G  G  E     Y  +I  GLE 
Sbjct: 59  SRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           LH +  V+RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEV+KN  
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER 177

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQY------EGVPAMFKIGNSKELPAIPDHLSDEG 386
               + D W LGC + EM   K P+ Q       E V    K    +E     +  S+  
Sbjct: 178 -YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--EDQE--EYSEKFSEAA 232

Query: 387 KDFVRKCLQRNPLHR-----PTAAWLLEHPFVGNA 416
           +   R+ L ++P  R       A  +  HPF   A
Sbjct: 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  108 bits (272), Expect = 3e-26
 Identities = 81/293 (27%), Positives = 140/293 (47%), Gaps = 52/293 (17%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
             +G G +G V   F++++G   A+K+    S   +S   A++  +E+ LL  + H N++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKK---LSRPFQSAIHAKRTYRELRLLKHMDHENVI 77

Query: 221 R----YYGSETLDDKLYIYLEYVS---GGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
                +  + +L+D   +YL  V+   G  +  I++   +L +  I+    QIL GL+Y+
Sbjct: 78  GLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK-CQKLSDDHIQFLVYQILRGLKYI 134

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKH----ITGQSCPLSIKGSPYWMAPEVIK 329
           H+   +HRD+K +NI V+    +K+ DFG+A+H    +TG         + ++ APE++ 
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATRWYRAPEIML 188

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVPA---MFKIGNS-- 372
           N    N  VDIWS+GC + E+ T K          Q +      G P    + KI +   
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248

Query: 373 ----KELPAIP----DHL----SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               + LP +P      +    +    D + K L  +P  R TAA  L HP++
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  107 bits (267), Expect = 4e-26
 Identities = 87/289 (30%), Positives = 134/289 (46%), Gaps = 47/289 (16%)

Query: 163 LGRGTFGHVYLGFN-SESGEMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLR---H 216
           +G G +G V+   +    G   A+K V +     ++ E    L   +E+A+L  L    H
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 217 PNIVRYYGSETL-----DDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSG 269
           PN+VR +   T+     + KL +  E+V    +   L    + G     I+    Q+L G
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L++LH+   VHRD+K  NILV  SG++KLADFG+A+  + Q    S+  + ++ APEV+ 
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA------------ 377
            S+     VD+WS+GC   EM   KP +     V  + KI +   LP             
Sbjct: 183 QSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241

Query: 378 --------------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                         + D + + GKD + KCL  NP  R +A   L HP+
Sbjct: 242 QAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  107 bits (270), Expect = 4e-26
 Identities = 83/305 (27%), Positives = 144/305 (47%), Gaps = 56/305 (18%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           GSR+K    +G G +G V    ++ SG+  A+K++    D       A++  +E+ +L  
Sbjct: 4   GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRH 60

Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            +H NI+      R  G++  D  +Y+ ++ +    ++ I+     L E  IR +  Q+L
Sbjct: 61  FKHDNIIAIRDILRPPGADFKD--VYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM---- 323
            GL+Y+H+ N +HRD+K +N+LV+    +++ DFGMA+ ++  S P   K   Y+M    
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS--SSPTEHK---YFMTEYV 172

Query: 324 ------APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVPA 365
                 APE++ +      A+D+WS+GC   EM   +   P   Y           G P+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232

Query: 366 ---MFKIGNS---KELPAIPDH-----------LSDEGKDFVRKCLQRNPLHRPTAAWLL 408
              + +IG+    K +  +P              S E  D + + LQ +P  R T    L
Sbjct: 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292

Query: 409 EHPFV 413
           +HPF+
Sbjct: 293 QHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  106 bits (266), Expect = 4e-26
 Identities = 88/297 (29%), Positives = 126/297 (42%), Gaps = 64/297 (21%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLR---HP 217
           +G G +G VY   +  SG   A+K V +     ++ E    L   +E+ALL RL    HP
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV-----QTNEDGLPLSTVREVALLKRLEAFDHP 62

Query: 218 NIVRYYGS----------------ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           NIVR                    E +D  L  YL+ V              L    I+ 
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG----------LPAETIKD 112

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY 321
             +Q L GL++LHA   VHRD+K  NILV   G+VKLADFG+A+  + Q     +  + +
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW 172

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA---- 377
           + APEV+  S      VD+WS+GC   EM   KP +        + KI +   LP     
Sbjct: 173 YRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231

Query: 378 ----------------------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                                 +P+ + + G   + + L  NP  R +A   L+HPF
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  107 bits (269), Expect = 7e-26
 Identities = 82/266 (30%), Positives = 133/266 (50%), Gaps = 16/266 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  S ++ AMK ++ F +  K  +SA    +E  +++      IV
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAF-FWEERDIMAHANSEWIV 106

Query: 221 R-YYGSETLDDK-LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           + +Y  +  DDK LY+ +EY+ GG +  ++ +Y  + E   R YT +++  L+ +H+   
Sbjct: 107 QLHYAFQ--DDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGF 163

Query: 279 VHRDIKGANILVDPSGRVKLADFG--MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           +HRD+K  N+L+D SG +KLADFG  M     G     +  G+P +++PEV+K+  G   
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 337 ---AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVR 391
                D WS+G  + EM     P+     V    KI + K     PD   +S + KD + 
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283

Query: 392 KCLQRNP--LHRPTAAWLLEHPFVGN 415
             L      L R     +  HPF  N
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (265), Expect = 8e-26
 Identities = 74/240 (30%), Positives = 119/240 (49%), Gaps = 30/240 (12%)

Query: 162 LLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
            LG+G FG V    Y      +GE+ A+K++        + E  +   +EI +L  L+H 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL-----QHSTAEHLRDFEREIEILKSLQHD 65

Query: 218 NIVRY----YGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           NIV+Y    Y +   +  L + +EY+  GS+   LQ +  +L    +  Y  QI  G+EY
Sbjct: 66  NIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVI 328
           L +K  VHRD+   NILV+   RVK+ DFG+ K +        ++    SP +W APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 329 KNSNGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
              +  ++A D+WS G  + E+ T    +  P +++     M  +GN K+   I  HL +
Sbjct: 184 -TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-----MRMMGNDKQGQMIVYHLIE 237

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  107 bits (268), Expect = 1e-25
 Identities = 82/307 (26%), Positives = 124/307 (40%), Gaps = 53/307 (17%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S + K + +G G FG V L    ++  + AMK  TL   D   +  A  +  E  +L+  
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMK--TLRKADVLMRNQAAHVKAERDILAEA 58

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            +  +V+ Y S    D LY  ++Y+ GG +  +L   G   E   R Y  ++   +E +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGM---------------AKHITGQS-------- 311
               +HRDIK  NIL+D  G +KL DFG+                 H    S        
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 312 ----CPL-----------------SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
               C L                 S+ G+P ++APEV+  + G     D WS+G  + EM
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM 237

Query: 351 ATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRKCLQRNP---LHRPTAA 405
              +PP+          K+ N +    IP    LS E  D + + L       L +  A 
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGAD 296

Query: 406 WLLEHPF 412
            +  HPF
Sbjct: 297 EIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  105 bits (262), Expect = 2e-25
 Identities = 76/250 (30%), Positives = 127/250 (50%), Gaps = 19/250 (7%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI--ALLSRLRHPNI 219
           ++GRG FG VY    +++G+M AMK +       K  E+   L + I  +L+S    P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 59

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V    +    DKL   L+ ++GG ++  L  +G   E  +R Y  +I+ GLE++H +  V
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++     + + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSAD 178

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--------AIPDHLSDEGKDFVR 391
            +SLGC + ++     P+ Q+       K  +  E+          +PD  S E K  + 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231

Query: 392 KCLQRNPLHR 401
             LQR+   R
Sbjct: 232 GLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 78/259 (30%), Positives = 131/259 (50%), Gaps = 10/259 (3%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI--ALLSRLRHPNI 219
           ++GRG FG VY    +++G+M AMK +       K  E+   L + I  +L+S    P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 59

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE++H +  V
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++     + + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSAD 178

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
            +SLGC + ++     P+ Q++                 +PD  S E +  +   LQR+ 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 399 LHR-----PTAAWLLEHPF 412
             R       A  + EHPF
Sbjct: 239 NRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  103 bits (259), Expect = 3e-25
 Identities = 83/265 (31%), Positives = 120/265 (45%), Gaps = 35/265 (13%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA--KSKESAQQ-LGQEIALLSRLRHPNI 219
           LG G FG V+L   +E   +   ++  L +  A  ++ ESA+Q   +E  LL+ L+H +I
Sbjct: 13  LGEGAFGKVFL---AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG---------------QLGESAIRSYTQ 264
           VR+YG  T    L +  EY+  G + + L+ +G               QL    + +   
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           QI SG+ YL + + VHRD+   N LV     VK+ DFGM++ I        G    L I+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELP 376
               WM PE I        + DIWS G  + E+ T  K PW Q     A+  I   +EL 
Sbjct: 190 ----WMPPESILYRKFTTES-DIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHR 401
             P     E    ++ C QR P  R
Sbjct: 245 R-PRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  104 bits (261), Expect = 5e-25
 Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++     L  + + P
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRV-----LALQDKPP 61

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +LH + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K H+       +  G+P ++APE+I        
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGK 180

Query: 337 AVDIWSLGCTVIEMATTKPPW 357
           +VD W+ G  + EM   +PP+
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  105 bits (262), Expect = 7e-25
 Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 14/265 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  + ++ AMK ++ F +  K  +SA    +E  +++    P +V
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-EMIKRSDSAF-FWEERDIMAFANSPWVV 106

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y    + A R YT +++  L+ +H+   +H
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLALDAIHSMGFIH 165

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNL- 336
           RD+K  N+L+D SG +KLADFG    +  +    C  ++ G+P +++PEV+K+  G    
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224

Query: 337 --AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRK 392
               D WS+G  + EM     P+     V    KI N K     PD   +S E K+ +  
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 284

Query: 393 CLQRNP--LHRPTAAWLLEHPFVGN 415
            L      L R     +  H F  N
Sbjct: 285 FLTDREVRLGRNGVEEIKRHLFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 1e-24
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 27/256 (10%)

Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V++G+        + ++K+ ++         S +    E  L+ +L+HP +V
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ--DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           R Y   T  + +YI  EY+  GS+   L+  +  +L  + +     QI  G+ ++  KN 
Sbjct: 65  RLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKNSN 332
           +HRD++ ANILV  +   K+ADFG+A+ I        +     IK    W APE I N  
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAI-NYG 178

Query: 333 GCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              +  D+WS G  + E+ T  + P+        +  +     +P  PD+  +E  + +R
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PDNCPEELYELMR 237

Query: 392 KCLQRNPLHRPTAAWL 407
            C +  P  RPT  +L
Sbjct: 238 LCWKEKPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 75/254 (29%), Positives = 117/254 (46%), Gaps = 26/254 (10%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK--EVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
             +G+G FG VY G    + E+ A+K    TL  D        ++  QE  +L +  HPN
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLK------RKFLQEAEILKQYDHPN 53

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL---SGLEYLHA 275
           IV+  G       +YI +E V GGS+   L+   +     ++   Q  L   +G+EYL +
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--IKGSPY-WMAPEVIKNSN 332
           KN +HRD+   N LV  +  +K++DFGM++   G    +S  +K  P  W APE + N  
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL-NYG 170

Query: 333 GCNLAVDIWSLGCTVIEM----ATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                 D+WS G  + E      T  P  S  +      +I +   +PA P    +E   
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESGYRMPA-PQLCPEEIYR 226

Query: 389 FVRKCLQRNPLHRP 402
            + +C   +P +RP
Sbjct: 227 LMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  102 bits (255), Expect = 2e-24
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 48/291 (16%)

Query: 153 PGSRWKKGRLLGRGTFGHV----YLGFNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQE 207
           P  R   G+ LG G FG V     +G ++ +     A+K   +  DDA  K+ +  L  E
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK---MLKDDATEKDLSD-LVSE 65

Query: 208 IALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------------- 251
           + ++  + +H NI+   G  T +  LY+ +EY + G++   L+                 
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 252 -GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA------ 304
              L +  + S+  Q+  G+E+L +K  +HRD+   N+LV     +K+ADFG+A      
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 305 ----KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
               K   G+   L +K    WMAPE +          D+WS G  + E+ T     S Y
Sbjct: 186 DYYRKTTNGR---LPVK----WMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGG--SPY 235

Query: 361 EGVPA--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            G+P   +FK+         P + + E    +R C    P  RPT   L+E
Sbjct: 236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 19/256 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + LG G FG V+LG    +    A+K +   ++ A S+E      +E  ++ +L HP +V
Sbjct: 10  KELGSGQFGVVHLG-KWRAQIKVAIKAI---NEGAMSEED---FIEEAKVMMKLSHPKLV 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           + YG  T    LYI  E++  G +   L Q  G+L +  + S  Q +  G+EYL   + +
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNL 336
           HRD+   N LV  +G VK++DFGM +++       S  G+ +   W  PEV  N +  + 
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVF-NFSKYSS 180

Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKDFVRKC 393
             D+WS G  + E+ T  K P+ +      +  I     L  P +      E    +  C
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE---VMYSC 237

Query: 394 LQRNPLHRPTAAWLLE 409
               P  RPT A LL 
Sbjct: 238 WHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  102 bits (254), Expect = 3e-24
 Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 38/280 (13%)

Query: 160 GRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL- 214
           G+ LG G FG V     LG + +  +      V +  DDA  K+ +  L  E+ ++  + 
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIG 78

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG---------QLGESA 258
           +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y          Q+    
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-------QS 311
           + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ +          +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--MFKI 369
             L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P   +FK+
Sbjct: 199 GRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEELFKL 251

Query: 370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                    P + ++E    +R C    P HRPT   L+E
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 79/292 (27%), Positives = 138/292 (47%), Gaps = 43/292 (14%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+   + +G G +G V    +  +GE  A+K++   S   +S+  A++  +E+ LL  ++
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKRAYRELTLLKHMQ 72

Query: 216 HPNIVR----YYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H N++     +  + + D+    Y+ + Y+    + KI+     L E  ++    Q+L G
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH--PLSEDKVQYLVYQMLCG 129

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+   +HRD+K  N+ V+    +K+ DFG+A+H   +     +  + ++ APEVI 
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVIL 187

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWS------------QYEGVPA---MFKIGNS-- 372
           N    N  VDIWS+GC + EM T K  +             +  GVP    + K+ +   
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247

Query: 373 ----KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
               K LP  P           S +  D + K L+ +   R TA   LEHP+
Sbjct: 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 4e-24
 Identities = 73/244 (29%), Positives = 116/244 (47%), Gaps = 42/244 (17%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           +  +K ++LG G FG VY G     GE      A+K +     +  S ++ +++  E  +
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL----REETSPKANKEILDEAYV 62

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSG 269
           ++ + HP++VR  G   L  ++ +  + +  G +   ++++   +G   + ++  QI  G
Sbjct: 63  MASVDHPHVVRLLGI-CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---------HITGQSCPLSIKGSP 320
           + YL  K  VHRD+   N+LV     VK+ DFG+AK         H  G   P  IK   
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--IK--- 176

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPAMFKIGNSKELPAI 378
            WMA E I +    + + D+WS G TV E+ T   KP    YEG+PA        E   I
Sbjct: 177 -WMALESILHRIYTHKS-DVWSYGVTVWELMTFGAKP----YEGIPA-------VE---I 220

Query: 379 PDHL 382
           PD L
Sbjct: 221 PDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  100 bits (252), Expect = 1e-23
 Identities = 87/314 (27%), Positives = 143/314 (45%), Gaps = 60/314 (19%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN---- 218
           +GRG +G V    NSE+ E  A+K++    D+   +  A++  +EI LL  L H N    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN---RIDAKRTLREIKLLRHLDHENVIAI 69

Query: 219 --IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
             I+     E  +D +YI  E +    +++I++    L +   + +  Q+L GL+Y+H+ 
Sbjct: 70  KDIMPPPHREAFND-VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG--------SPYWMAPEVI 328
           N +HRD+K +N+L++ +  +K+ DFG+A+         S KG        + ++ APE++
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSEKGDFMTEYVVTRWYRAPELL 180

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVPAMFKIGNS---- 372
            N +    A+D+WS+GC   E+   KP  P   Y           G P+   +G      
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 373 -----KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
                + LP  P         H +    D + K L  +P  R T    L HP++   A L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL---ASL 297

Query: 420 ERPILSAEPSETKP 433
             P  S EP    P
Sbjct: 298 HDP--SDEPVCQTP 309

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 88/315 (27%), Positives = 144/315 (45%), Gaps = 64/315 (20%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKE-VTLFSDDAKSKESAQQLGQEIALLSR 213
           +R+   + +G G FG V    +  +G+  A+K+ +  FS    +K    +  +E+ LL  
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK----RTYRELKLLKH 65

Query: 214 LRHPNIVRYYGSETLDD-------KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           LRH NI+      +L D        +Y   E + G  ++++L     L +  I+ +  QI
Sbjct: 66  LRHENII------SLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQI 117

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYW 322
           L GL+Y+H+   VHRD+K +NIL++ +  +K+ DFG+A+     +TG    +S +   Y+
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY---VSTR---YY 171

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVPAMFKIG 370
            APE++      ++ VDIWS GC   EM   KP        +Q+       G P    I 
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231

Query: 371 N---------SKELP---AIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                      + LP    +P      +      D + K L  +P  R +AA  L HP++
Sbjct: 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 414 GNAAPLERPILSAEP 428
              AP   P  + EP
Sbjct: 292 ---APYHDP--TDEP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 72/248 (29%), Positives = 120/248 (48%), Gaps = 17/248 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 67

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +  +    +     QI S +EYL  KN +H
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           RD+   N LV  +  VK+ADFG+++ +TG   +     K    W APE +   N  ++  
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNKFSIKS 186

Query: 339 DIWSLGCTVIEMAT---TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           D+W+ G  + E+AT   +  P      V  + + G   E    P+    +  + +R C Q
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER---PEGCPPKVYELMRACWQ 243

Query: 396 RNPLHRPT 403
            NP  RP+
Sbjct: 244 WNPSDRPS 251

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 53/294 (18%)

Query: 153 PGSRWKKGRLLGRGTFGHVYL-------GFNSESGEMCAMK-EVTLFS-----DDAKSKE 199
           P         LG G FG V+L        F+ ++           L +      DA S  
Sbjct: 3   PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDN 61

Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA- 258
           + +   +E+ +LSRL  PNI R  G  T+D  L + +EY+  G + + LQ +        
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 259 --IRSYTQ--------QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-- 306
              +S +         QI SG+ YL + N VHRD+   N LV  +  +K+ADFGM+++  
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 307 ------ITGQSCPLSIKGSPYWMAPEVI---KNSNGCNLAVDIWSLGCTVIEMAT--TKP 355
                 + G++ PL I+    WMA E +   K +       D+W+ G T+ E+ T   + 
Sbjct: 182 SSDYYRVQGRA-PLPIR----WMAWESVLLGKFTT----KSDVWAFGVTLWEILTLCREQ 232

Query: 356 PWSQY------EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           P+         E     F+    +     P +   +  + + +C +R+   RPT
Sbjct: 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 31/270 (11%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V       +G++ A K+  L     K ++  +    E  +L+++    IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK--LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 223 -YGSETLDDKLYIYLEYVSGGS----IYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            Y  +T  D L + +  ++GG     IY + ++     E     YT QI+SGLE+LH + 
Sbjct: 59  AYAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+L+D  G V+++D G+A  +  GQS      G+P +MAPE+++     + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDF 176

Query: 337 AVDIWSLGCTVIEMATTKPPW-SQYEGVPAMFKIGNSKELP--------AIPDHLSDEGK 387
           +VD ++LG T+ EM   + P+ ++ E V        +KEL           PD  S   K
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKV-------ENKELKQRILNDSVTYPDKFSPASK 229

Query: 388 DFVRKCLQRNPLHR-----PTAAWLLEHPF 412
            F    L ++P  R          L  HP 
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  100 bits (249), Expect = 2e-23
 Identities = 66/245 (26%), Positives = 123/245 (50%), Gaps = 12/245 (4%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G +G V    +  +G   A+K++       +S+  A++  +E+ LL  +
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 71

Query: 215 RHPNIVR----YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +H N++     +    +LD     YL     G+    L  + +L E  I+    Q+L GL
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+HA   +HRD+K  N+ V+    +K+ DFG+A+    +     +  + ++ APEVI N
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV--TRWYRAPEVILN 189

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA---IPDHLSDEGK 387
                  VDIWS+GC + EM T KP +  ++ +  + +I      P+   +    S++ K
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249

Query: 388 DFVRK 392
           ++V+K
Sbjct: 250 NYVKK 254

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 18/264 (6%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   +   R LG G FG V+ G       + A+K   L SDD       Q   +E+  L 
Sbjct: 4   PREEFTLERKLGSGYFGEVWEGLWKNRVRV-AIK--ILKSDD---LLKQQDFQKEVQALK 57

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQ-LGESAIRSYTQQILSGL 270
           RLRH +++  +   ++ + +YI  E +  GS+   L+   GQ L  +++     Q+  G+
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-WMAPEVIK 329
            YL  +N++HRD+   NILV      K+ADFG+A+ I       S K  PY W APE   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA- 176

Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDE 385
           +    +   D+WS G  + EM T  + P   Y G+       +I     +P  P     E
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVP---YPGMNNHEVYDQITAGYRMPC-PAKCPQE 232

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLE 409
               + +C    P  RP+   L E
Sbjct: 233 IYKIMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  100 bits (250), Expect = 3e-23
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 14/265 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  S ++ AMK ++ F +  K  +SA    +E  +++    P +V
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF-EMIKRSDSAF-FWEERDIMAFANSPWVV 106

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   + YT +++  L+ +H+   +H
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIH 165

Query: 281 RDIKGANILVDPSGRVKLADFG--MAKHITGQ-SCPLSIKGSPYWMAPEVIKNSNGCNL- 336
           RD+K  N+L+D  G +KLADFG  M    TG   C  ++ G+P +++PEV+K+  G    
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224

Query: 337 --AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRK 392
               D WS+G  + EM     P+     V    KI + K     P+   +S   K+ +  
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICA 284

Query: 393 CLQRNP--LHRPTAAWLLEHPFVGN 415
            L      L R     + +HPF  N
Sbjct: 285 FLTDREVRLGRNGVEEIKQHPFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 76/278 (27%), Positives = 131/278 (47%), Gaps = 34/278 (12%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AMK V   L +DD    E    +  E  +  +   HP
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH + 
Sbjct: 57  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GTPNYIAPEILRGE 171

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWS--------QYEGVPAMFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  LS
Sbjct: 172 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLS 229

Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGN 415
            +    ++  L ++P  R    P   +  +  HPF  N
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 41/283 (14%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG GT+  VY G +  +  + A+KE+ L  ++     + +    E++LL  L+H NIV  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQL-GESAIRSYTQQILSGLEYLHAKNTVHR 281
           +     +  L +  EY+    + + L D G       ++ +  Q+L GL Y H +  +HR
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLA 337
           D+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+++  S   +  
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185

Query: 338 VDIWSLGCTVIEMATTKP--PWSQYE----------GVPA-----------MFKIGNSKE 374
           +D+W +GC   EM+T +P  P S  E          G P             FK  N  +
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245

Query: 375 LPAIPDH-----LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             A   H     L  +G + + K LQ     R +A   ++HP+
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 98.6 bits (245), Expect = 7e-23
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 16/251 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRLR-HP 217
           R++GRG++  V L    ++ ++ AMK V   L  DD    E    +  E  +  +   +P
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNP 56

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +       +L++ +EYV+GG +   +Q   +L E   R Y  +I   L +LH + 
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+L+D  G +KL D+GM K   G     S   G+P ++APE+++       
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGF 175

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAM------FKIGNSKELPAIPDHLSDEGKDFV 390
           +VD W+LG  + EM   + P+      P M      F++   K +  IP  LS +    +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RIPRFLSVKASHVL 234

Query: 391 RKCLQRNPLHR 401
           +  L ++P  R
Sbjct: 235 KGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG GT+  V+ G +  +  + A+KE+ L  ++     + +    E++LL  L+H NIV  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHR 281
           +     D  L +  EY+    + + + D G  +    ++ +  QIL GL Y H +  +HR
Sbjct: 70  HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLA 337
           D+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+V+  S+  +  
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 338 VDIWSLGCTVIEMATTKP 355
           +D+W +GC   EMA+ +P
Sbjct: 186 IDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 82/299 (27%), Positives = 139/299 (46%), Gaps = 51/299 (17%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     P IV +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVGF 68

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV-HR 281
           YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K+ + HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
           D+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  ++  DIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YSVQSDIW 186

Query: 342 SLGCTVIEMATTKPP-------------WSQYEGVPAMFKIGNSKELPAIP--------- 379
           S+G +++EMA  + P                 EG PA  +       P  P         
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR 246

Query: 380 ---------DHLSDEG-------------KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                    D++ +E              +DFV KCL +NP  R     L+ H F+  +
Sbjct: 247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG GT+  V+ G +  +  + A+KE+ L  ++     + +    E++LL  L+H NIV  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQL-GESAIRSYTQQILSGLEYLHAKNTVHR 281
           +     +  L +  EY+    + + L + G L     ++ +  Q+L GL Y H +  +HR
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLA 337
           D+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+V+  S   +  
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184

Query: 338 VDIWSLGCTVIEMATTKP 355
           +D+W +GC + EMAT +P
Sbjct: 185 IDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 93/338 (27%), Positives = 138/338 (40%), Gaps = 60/338 (17%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S + K + LG G FG V L    ++  + AMK  TL   D   +     +  E  +L+  
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEA 58

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            +  +VR Y S    D LY  ++Y+ GG +  +L   G   E   R Y  ++   +E +H
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGM---------------AKHITGQS-------- 311
               +HRDIK  NIL+D  G +KL DFG+                 H+   S        
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 312 ----C-------PL--------------SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCT 346
               C       PL              S+ G+P ++APEV+  +    L  D WS+G  
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC-DWWSVGVI 237

Query: 347 VIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRKCLQRNP---LHR 401
           + EM   +PP+     +    K+ N +    IP    LS E  D + K L R P   L +
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGK 296

Query: 402 PTAAWLLEHPF---VGNAAPLERPILSAEPSETKPTLT 436
             A  +  HPF   +  ++ L +      P  T PT T
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDT 334

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 81/266 (30%), Positives = 122/266 (45%), Gaps = 35/266 (13%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS----DDAKSKESAQQLGQEIALLSRLRH 216
           R LG G FG V+L   +E   +C  ++  L +     DA S  + +   +E  LL+ L+H
Sbjct: 11  RELGEGAFGKVFL---AECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQH 66

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-------------QLGESAIRSYT 263
            +IV++YG     D L +  EY+  G + K L+ +G             +L +S +    
Sbjct: 67  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSI 316
           QQI +G+ YL +++ VHRD+   N LV  +  VK+ DFGM++ +        G    L I
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKEL 375
           +    WM PE I        + D+WSLG  + E+ T  K PW Q      +  I   + L
Sbjct: 187 R----WMPPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHR 401
              P     E  D +  C QR P  R
Sbjct: 242 QR-PRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 97.1 bits (241), Expect = 2e-22
 Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 27/217 (12%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           +G  +GRGT+GHVY     +  +    KE  L     +    +    +EIALL  L+HPN
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDE---KEYAL--KQIEGTGISMSACREIALLRELKHPN 59

Query: 219 IV---RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG---------QLGESAIRSYTQQI 266
           ++   + + S + D K+++  +Y     ++ I++ +          QL  S ++S   QI
Sbjct: 60  VIALQKVFLSHS-DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 267 LSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLS----IKG 318
           L G+ YLHA   +HRD+K ANILV       GRVK+AD G A+       PL+    +  
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           + ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 42/285 (14%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G++  VY G +  +G++ A+K +++ +++     + +    E +LL  L+H NIV  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIVLL 68

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           +      + L    EY+       ++Q  G L    +R +  Q+L GL Y+H ++ +HRD
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128

Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLAV 338
           +K  N+L+   G +KLADFG+A+    +S P     S     ++  P+V+  +   + A+
Sbjct: 129 LKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185

Query: 339 DIWSLGCTVIEMATTKPPWS-------QYE------GVPA----------------MFKI 369
           DIW  GC  IEM   +P +        Q E      GVP                  F  
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245

Query: 370 GNSKELPAIPDHLSD--EGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
              ++L  +   LS   + +D   + L   P  R +A   L HP+
Sbjct: 246 CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  100 bits (249), Expect = 2e-22
 Identities = 80/307 (26%), Positives = 140/307 (45%), Gaps = 37/307 (12%)

Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG+ ++  S  + ++  + +G G FG V+L  +  + E    K ++      + K    Q
Sbjct: 2   PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK---SQ 58

Query: 204 LGQEIALLSRLRHPNIVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQD----YGQLGES 257
           L  E+ ++  L+H NIVRY        + KLYI +E+   G + + +Q     +G++ E 
Sbjct: 59  LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 258 AIRSYTQQILSGLEYLH-------AKNTVHRDIKGANILVDPSGR--------------- 295
           AI   T+Q+L  L Y H        +  +HRD+K  NI +    R               
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 296 --VKLADFGMAKHITGQSCPLSIKGSPYWMAPE-VIKNSNGCNLAVDIWSLGCTVIEMAT 352
              K+ DFG++K+I  +S   S  G+PY+ +PE ++  +   +   D+W+LGC + E+ +
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 353 TKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
            K P+ +      +  I   K  P +P    S E    ++  L  +   RP+A   L + 
Sbjct: 239 GKTPFHKANNFSQL--ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296

Query: 412 FVGNAAP 418
            + N  P
Sbjct: 297 IIKNVGP 303

Length = 1021

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 17/263 (6%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFN-SESGEMCAMK-EVTLFSDDAKSKESAQQLGQEIAL 210
           P +    G+ LG G FG V        S     MK  V +    A S E  + L  E+ +
Sbjct: 33  PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKI 91

Query: 211 LSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQIL 267
           +S L  H NIV   G+ T+   + +  EY   G +   L+   +  L    + S++ Q+ 
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY----WM 323
            G+ +L +KN +HRD+   N+L+     VK+ DFG+A+ I   S  +  KG+      WM
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV-KGNARLPVKWM 210

Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSKELPAIPD 380
           APE I N        D+WS G  + E+ +     + Y G+P     +K+       A P+
Sbjct: 211 APESIFN-CVYTFESDVWSYGILLWEIFSLGS--NPYPGMPVDSKFYKLIKEGYRMAQPE 267

Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           H   E  D ++ C   +PL RPT
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 96.3 bits (239), Expect = 3e-22
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 36/294 (12%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G++  VY G +  +G++ A+K + L  ++     + +    E +LL  L+H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLKGLKH 62

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            NIV  +      + L +  EYV       + +  G L    ++ +  Q+L GL Y+H +
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCN 335
             +HRD+K  N+L+  +G +KLADFG+A+  +  S   S +    W   P+V+  S   +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 336 LAVDIWSLGCTVIEM----------------------ATTKPPWSQYEGV-------PAM 366
             +D+W +GC  +EM                          P    + GV       P  
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242

Query: 367 FKIGNSKELPAIPDHLS--DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           F + + K L    + LS  +  +D   K LQ  P +R +A   L H +  +  P
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 29/262 (11%)

Query: 160 GRLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
            + LG G FG V+LG         +  ++E  +  DD           +E  ++ +L HP
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           N+V+ YG  T    ++I  EY++ G +   L++  G+LG   +      +   +EYL + 
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVI 328
             +HRD+   N LV     VK++DFG+A+++         G   P  +K    W  PEV 
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VK----WAPPEVF 173

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
             S   + + D+WS G  + E+ +  K P+ ++     +  +     L   P     E  
Sbjct: 174 DYSRFSSKS-DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTEVY 231

Query: 388 DFVRKCLQRNPLHRPTAAWLLE 409
             +  C    P  RP    LL 
Sbjct: 232 TIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 42/289 (14%)

Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V      G +    +      V +  D+A  K+ A  L  E+
Sbjct: 10  PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEM 68

Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DY--------- 251
            L+  + +H NI+   G  T +  LY+ +EY + G++ + L+       DY         
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128

Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA------- 304
            QL    + S   Q+  G+EYL ++  +HRD+   N+LV     +K+ADFG+A       
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 305 --KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG 362
             K  +    P+       WMAPE + +    + + D+WS G  + E+ T     S Y G
Sbjct: 189 YYKKTSNGRLPVK------WMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGG--SPYPG 239

Query: 363 VPA--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           +P   +FK+         P + + E    +R+C    P  RPT   L+E
Sbjct: 240 IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 34/278 (12%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AMK +   L +DD    E    +  E  +      HP
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +E+VSGG +   +Q   +L E   R Y+ +I   L +LH + 
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-----GTPNYIAPEILRGE 171

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--------MFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  LS
Sbjct: 172 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RIPRSLS 229

Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGN 415
            +    ++  L ++P  R    P   +  +  HPF  N
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 98.2 bits (244), Expect = 4e-22
 Identities = 72/226 (31%), Positives = 113/226 (50%), Gaps = 11/226 (4%)

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKI----LQDYGQLGESAIRSY 262
           E+  L+   H  IV+++     DDKL + +EY SGG + K     L+++    E  +   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----SIKG 318
             QI+  L+ +H++  +HRD+K ANI + P+G +KL DFG +K  +  S  L    S  G
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCG 233

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
           +PY++APE+ +       A D+WSLG  + E+ T   P+        M ++   K  P  
Sbjct: 234 TPYYLAPELWERKRYSKKA-DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-F 291

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPIL 424
           P  +S   K  +   L +NP  RPT   LL   F+   A L + I+
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337

Length = 478

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 5e-22
 Identities = 85/306 (27%), Positives = 124/306 (40%), Gaps = 59/306 (19%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++G+G FG V L    ++G++ AMK  TL   +   K+    +  E  +L+    P +V
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64

Query: 221 RYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
             Y S    D  Y+YL  E++ GG +  +L  Y    E   R Y  + +  +E +H    
Sbjct: 65  SLYYS--FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAK--HITGQSC------------------------ 312
           +HRDIK  NIL+D  G +KL+DFG++   H    S                         
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 313 ----------------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
                                   S  G+P ++APE I    G     D WSLG  + E 
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241

Query: 351 ATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRK--CLQRNPLHRPTAAW 406
               PP+          KI N +E    PD  HLS E +D +R+      N L R  A  
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301

Query: 407 LLEHPF 412
           +  HPF
Sbjct: 302 IKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 42/287 (14%)

Query: 155 SRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           +R   G+ LG G FG V +    G + +         V +  DDA  K+ +  L  E+ +
Sbjct: 12  TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEM 70

Query: 211 LSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG---------Q 253
           +  + +H NI+   G+ T D  LY+ +EY S G++ + L+       DY          Q
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------ 307
           L    + S   Q+  G+EYL ++  +HRD+   N+LV     +K+ADFG+A+ +      
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 308 ---TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
              T    P+       WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 191 KKTTNGRLPVK------WMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGG--SPYPGIP 241

Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + + E    +R+C    P  RPT   L+E
Sbjct: 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 33/261 (12%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G ++G G FG V  G    +G+  A+K +       K   +AQ   +E A++++L H N+
Sbjct: 11  GEIIGEGEFGAVLQG--EYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKLHHKNL 61

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR--SYTQQILSGLEYLHAKN 277
           VR  G   L + LYI +E +S G++   L+  G+   S I+   ++  +  G+EYL +K 
Sbjct: 62  VRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
            VHRD+   NILV   G  K++DFG+A+   +   +  L +K    W APE +K+    +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKH-KKFS 175

Query: 336 LAVDIWSLGCTVIEM-ATTKPPWSQY------EGVPAMFKIGNSKELPAIPDHLSDEGKD 388
              D+WS G  + E+ +  + P+ +       E V   +++   +  PA   ++      
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA-DVYV------ 228

Query: 389 FVRKCLQRNPLHRPTAAWLLE 409
            +  C +  P  RP+   L E
Sbjct: 229 LMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 11/201 (5%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++   +AL  +   P
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRV---LALSGK--PP 61

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +LH+K 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K ++       +  G+P ++APE+I        
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK- 180

Query: 337 AVDIWSLGCTVIEMATTKPPW 357
           +VD W+ G  + EM   + P+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 80/271 (29%), Positives = 126/271 (46%), Gaps = 18/271 (6%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +++ R+LG+G FG V       +G+M A K   L     K ++       E  +L ++  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKR--LEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 217 PNIVRY-YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYL 273
             +V   Y  ET  D L + L  ++GG +   + + G  G  E     Y  +IL GLE L
Sbjct: 60  QFVVNLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
           H +NTV+RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEV+ N   
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR- 177

Query: 334 CNLAVDIWSLGCTVIEMATTKPPW-SQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDF 389
             L+ D W LGC + EM   + P+  + E V       ++  ++E        S+E K  
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--VYSAKFSEEAKSI 235

Query: 390 VRKCLQRNPLHR-----PTAAWLLEHPFVGN 415
            +  L ++P  R       A  +  HPF  N
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 31/219 (14%)

Query: 159 KGRLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +G  +GRGT+GHVY     + +     A+K++       +    +    +EIALL  L+H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-------EGTGISMSACREIALLRELKH 57

Query: 217 PNIV---RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG---------QLGESAIRSYTQ 264
           PN++   + + S   D K+++  +Y     ++ I++ +          QL    ++S   
Sbjct: 58  PNVISLQKVFLSHA-DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115

Query: 265 QILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLS----I 316
           QIL G+ YLHA   +HRD+K ANILV       GRVK+AD G A+       PL+    +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
             + ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 85/295 (28%), Positives = 133/295 (45%), Gaps = 39/295 (13%)

Query: 148 ENPTSPGSRWKK-------GRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAK 196
           E P  P  RW+        G+ LG G FG V +    G + E         V +   DA 
Sbjct: 6   ELPEDP--RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT 63

Query: 197 SKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ------ 249
            K+ +  L  E+ ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+      
Sbjct: 64  EKDLSD-LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 250 -DYG---------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA 299
            +Y          QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+A
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182

Query: 300 DFGMAK---HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP 356
           DFG+A+   HI       + +    WMAPE + +    + + D+WS G  + E+ T    
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG- 240

Query: 357 WSQYEGVPA--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            S Y GVP   +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 241 -SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 19/212 (8%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-----L 211
           +++ R+LG+G FG V       +G+M A K++       + K   ++ G+ +AL     L
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGESMALNEKQIL 54

Query: 212 SRLRHPNIVRY-YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS--YTQQILS 268
            ++    +V   Y  ET  D L + L  ++GG +   +   G+ G    R+  Y  +I  
Sbjct: 55  EKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEV 327
           GLE LH +  V+RD+K  NIL+D  G ++++D G+A H+  GQ+    + G+  +MAPEV
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEV 172

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ 359
           +KN      + D W+LGC + EM   + P+ Q
Sbjct: 173 VKNER-YTFSPDWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 67/245 (27%), Positives = 119/245 (48%), Gaps = 10/245 (4%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V       +G+M A K++       KS E    L +EI  L ++  P IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 223 -YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLHAKNTV 279
            Y  E+    L + +  ++GG +   + + G+ G     +  Y+ QI  G+ +LH+ + V
Sbjct: 59  AYAFES-KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +RD+K  N+L+D  G  +L+D G+A  +          G+  +MAPE++K     +  VD
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVD 176

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---SKELPAIPDHLSDEGKDFVRKCLQR 396
            +++GC++ EM   + P+  ++   A  ++       E+     + ++E KD  R  L +
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236

Query: 397 NPLHR 401
            P  R
Sbjct: 237 KPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 73/257 (28%), Positives = 126/257 (49%), Gaps = 29/257 (11%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G FG V LG     G   A+K +       K+  +AQ    E +++++LRH N+V+ 
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNT 278
            G   +++K  LYI  EY++ GS+   L+  G+  LG   +  ++  +   +EYL A N 
Sbjct: 65  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE ++       
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 179

Query: 337 AVDIWSLGCTVIEMAT-TKPPWSQY---EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + D+WS G  + E+ +  + P+ +    + VP   ++    ++ A PD       D +++
Sbjct: 180 S-DVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEKGYKMDA-PDGCPPVVYDVMKQ 234

Query: 393 CLQRNPLHRPTAAWLLE 409
           C   +   RP+   L E
Sbjct: 235 CWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 77/276 (27%), Positives = 117/276 (42%), Gaps = 46/276 (16%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L    ++G + AMK   L   D   KE    +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMK--ILRKADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + S      LY+ +E++ GG +  +L     L E   + Y  + +  ++ +H    +H
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-----HIT------GQSCP---------------- 313
           RDIK  N+L+D  G VKL+DFG+       H T        S P                
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 314 ---------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                     S  G+P ++APEV     G N   D WSLG  + EM    PP+       
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 365 AMFKIGNSKEL----PAIPDHLSDEGKDFV-RKCLQ 395
              K+ N KE     P +P  +S++ KD + R C +
Sbjct: 244 TYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCE 277

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 83/310 (26%), Positives = 122/310 (39%), Gaps = 55/310 (17%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S + K + LG G FG V L    ++  + AMK  TL   D  ++     +  E  +L+  
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEA 58

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            +  +V+ Y S    D LY  ++Y+ GG +  +L       E   R Y  ++   +E +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGM---------------AKHI------------ 307
               +HRDIK  NIL+D  G +KL DFG+                 HI            
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 308 --------------------TGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCT 346
                                 Q C   S+ G+P ++APEV+       L  D WS+G  
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC-DWWSVGVI 237

Query: 347 VIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRK--CLQRNPLHRP 402
           + EM   +PP+          K+ N +    IP    LS E  D + K  C     L R 
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297

Query: 403 TAAWLLEHPF 412
            A  +  HPF
Sbjct: 298 GADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 51/276 (18%)

Query: 160 GRLLGRGTFGHVYLG----FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R LG+G+FG VY G          E   A+K V   +++A  +E  + L  E +++   
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFL-NEASVMKEF 66

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY------------GQLGESAIRSY 262
              ++VR  G  +      + +E ++ G     L+ Y            G    +  +  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGD----LKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 263 --TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSC 312
               +I  G+ YL AK  VHRD+   N +V     VK+ DFGM + I         G+  
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVP---AMF 367
            L ++    WMAPE +K+        D+WS G  + EMAT   +P    Y+G+     + 
Sbjct: 183 -LPVR----WMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP----YQGLSNEEVLK 232

Query: 368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            + +   L  +P++  D+  + +R C Q NP  RPT
Sbjct: 233 FVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 80/275 (29%), Positives = 117/275 (42%), Gaps = 50/275 (18%)

Query: 161 RLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG G FG V+L   +N    +   +  V    D   +     Q  +E  LL+ L+H +
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--REAELLTNLQHEH 68

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKIL----------------QDYGQLGESAIRSY 262
           IV++YG     D L +  EY+  G + K L                Q  G+LG S +   
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLS 315
             QI SG+ YL +++ VHRD+   N LV  +  VK+ DFGM++ +        G    L 
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKE 374
           I+    WM PE I        + D+WS G  + E+ T  K PW         F++ N++ 
Sbjct: 189 IR----WMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPW---------FQLSNTEV 234

Query: 375 LPAI--------PDHLSDEGKDFVRKCLQRNPLHR 401
           +  I        P     E  D +  C QR P  R
Sbjct: 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 81/319 (25%), Positives = 140/319 (43%), Gaps = 60/319 (18%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+K   ++G+G++G V    ++ +GE  A+K++    +       A ++ +EI LL  LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV---SDATRILREIKLLRLLR 57

Query: 216 HPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           HP+IV               D +Y+  E +    ++++++    L     + +  Q+L  
Sbjct: 58  HPDIVEIKHIMLPPSRREFKD-IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRA 115

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-----WMA 324
           L+Y+H  N  HRD+K  NIL +   ++K+ DFG+A+     + P +I  + Y     + A
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-PTAIFWTDYVATRWYRA 174

Query: 325 PEVIKNSNGC-----NLAVDIWSLGCTVIEMATTKPPW------SQYE------GVPAMF 367
           PE+     G        A+DIWS+GC   E+ T KP +       Q +      G P+  
Sbjct: 175 PELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230

Query: 368 ---KIGNSK---------ELPAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
              ++ N K         +   +P      +        + + L  +P  RPTA   L  
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 411 PFVGNAAPLERPILSAEPS 429
           P+    A +ER     EPS
Sbjct: 291 PYFKGLAKVER-----EPS 304

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 93.6 bits (232), Expect = 6e-21
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 47/294 (15%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L    ++G + AMK   L   D   KE    +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMK--ILRKADMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + S      LY+ +E++ GG +  +L     L E A + Y  + +  ++ +H    +H
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124

Query: 281 RDIKGANILVDPSGRVKLADFGMA------------KHITG------------------- 309
           RDIK  N+L+D  G VKL+DFG+             +++T                    
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                +    S  G+P ++APEV   + G N   D WSLG  + EM    PP+       
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 365 AMFKIGNSKEL----PAIPDHLSDEGKDFV-RKCL-QRNPLHRPTAAWLLEHPF 412
              K+ N KE     P +P  +S++ KD + R C    N +       +  HPF
Sbjct: 244 TYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 70/254 (27%), Positives = 114/254 (44%), Gaps = 20/254 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++G G FG V  G     G+      +      +  K+    L  E +++ +  HPNI+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT-EASIMGQFDHPNII 68

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
           R  G  T    + I  EY+  GS+ K L++  G+     +    + I SG++YL   N V
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG--SPY-WMAPEVI---KNSNG 333
           HRD+   NILV+ +   K++DFG+++ +       + KG   P  W APE I   K ++ 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS- 187

Query: 334 CNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPA---IPDHLSDEGKDF 389
              A D+WS G  + E M+  + P+        +  + +   LP     P  L     D 
Sbjct: 188 ---ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLD- 243

Query: 390 VRKCLQRNPLHRPT 403
              C Q++   RPT
Sbjct: 244 ---CWQKDRNERPT 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 46/287 (16%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG-QEIALLSRLRHPNIVR 221
           LG G++  VY G +  +G++ A+KE+ L     + +E A     +E +LL  L+H NIV 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRL-----EHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVH 280
            +        L +  EY+    + + + D G  L    +R +  Q+L GL Y H +  +H
Sbjct: 68  LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNL 336
           RD+K  N+L+   G +KLADFG+A+    +S P     +     ++  P+V+  S   + 
Sbjct: 127 RDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 337 AVDIWSLGCTVIEMATTKP-------------------------PW----SQYEGVPAMF 367
           ++D+W +GC   EMAT +P                          W    S  E  P  F
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243

Query: 368 KIGNSKELPAIPDHLSD--EGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                + L      L     G++   K LQ  P  R +AA  ++HP+
Sbjct: 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 24/270 (8%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-----LSRLR 215
           R+LG+G FG V       +G+M A K++       + K   ++ G+ +AL     L ++ 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKRILEKVN 58

Query: 216 HPNIVRY-YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS--YTQQILSGLEY 272
              +V   Y  ET  D L + L  ++GG +   + + G  G    R+  Y  ++  GLE 
Sbjct: 59  SRFVVSLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           L  +  V+RD+K  NIL+D  G ++++D G+A  I          G+  +MAPEVI N  
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAIPDHLSDEGKDFV 390
               + D W LGC + EM   + P+ + +      ++     ++     +  S++ K   
Sbjct: 178 -YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236

Query: 391 RKCLQRNPLHR-----PTAAWLLEHPFVGN 415
           R  L +NP  R       AA + +HP   N
Sbjct: 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 57/187 (30%), Positives = 96/187 (51%), Gaps = 11/187 (5%)

Query: 216 HPNIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +PN ++ YY   TL   + I ++Y+  G ++ +L+  G+L E+ ++   +Q++  L  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLI-MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 275 AKNTVHRDIKGANILVD-PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
             N +H DIK  N+L D    R+ L D+G+ K I   SC     G+  + +PE IK  N 
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC---YDGTLDYFSPEKIKGHN- 182

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEG---VPAMFKIGNSKELPAIPDHLSDEGKDFV 390
            +++ D W++G    E+ T K P+ + E              K+LP I  ++S    DFV
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK-NVSKNANDFV 241

Query: 391 RKCLQRN 397
           +  L+ N
Sbjct: 242 QSMLKYN 248

Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 47/281 (16%)

Query: 163 LGRGTFGHVYL------------GFNSESGEMCAM-KEVTLFSDDAKSKESAQQLGQEIA 209
           LG G FG V+L             F+ +      +   V +  +DA +K +     +EI 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIK 71

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-----QDYGQLGESAIRSYTQ 264
           ++SRL+ PNI+R        D L +  EY+  G + + L     Q+  +  +    SY+ 
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 265 ------QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH--------ITGQ 310
                 QI SG++YL + N VHRD+   N LV  +  +K+ADFGM+++        I G+
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGR 191

Query: 311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQY------EG 362
           +  L I+    WM+ E I        A D+W+ G T+ E+ T   + P+SQ       E 
Sbjct: 192 AV-LPIR----WMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Query: 363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
               F+    +     P    D     +  C +RN   RP+
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 27/256 (10%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 66

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----SAIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 67  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKNSN 332
           VHRD++ ANILV  +   K+ADFG+A+ I        Q     IK    W APE      
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR 179

Query: 333 GCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + 
Sbjct: 180 -FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMC 237

Query: 392 KCLQRNPLHRPTAAWL 407
           +C ++ P  RPT  +L
Sbjct: 238 QCWRKEPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 65/301 (21%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKE-VTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           R +G G FG V+   +   G+  A+K+   +F +      S +++ +E+ +L   +H N+
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNV 61

Query: 220 VRYYGSETLD----------DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +       LD          +++Y+  E +    ++KI+     L    ++ +  QIL G
Sbjct: 62  LS-----ALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA--------KHITGQSCPLSIKGSPY 321
           L+YLH+   +HRDIK  N+LV+ +  +K+ DFG+A        KH+T +        + Y
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV------TQY 169

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK------PPWSQ------YEGVPAMFKI 369
           + APE++  S     AVDIWS+GC   E+   +       P  Q        G P++  +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 370 GNSKE------------LPAIP------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
            ++ E             P++P         + E    + + L  +P  R +AA  L HP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289

Query: 412 F 412
           +
Sbjct: 290 Y 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 71/282 (25%), Positives = 124/282 (43%), Gaps = 41/282 (14%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRLRHP 217
           G+ LG G FG V                V   +  ++A S E  + L  E  LL ++ HP
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVNHP 63

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR----------------- 260
           ++++ YG+ + D  L + +EY   GS+   L++  ++G S +                  
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 261 -------SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                  S+  QI  G++YL     VHRD+   N+LV    ++K++DFG+++ +  +   
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 314 L--SIKGSPY-WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-----A 365
           +  S    P  WMA E + +      + D+WS G  + E+ T     + Y G+       
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGG--NPYPGIAPERLFN 240

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
           + K G   E    P++ S+E  + +  C ++ P  RPT A +
Sbjct: 241 LLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 72/301 (23%), Positives = 141/301 (46%), Gaps = 43/301 (14%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR- 221
           +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++H N++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81

Query: 222 ---YYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
              +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL+Y+H+ +
Sbjct: 82  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
            +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N    N  
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWMHYNQT 198

Query: 338 VDIWSLGCTVIEMATTK---------------------PPWSQYEGVPAMFKIGNSKELP 376
           VDIWS+GC + E+ T +                     P     + + +       + L 
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258

Query: 377 AIPD-HLSD-------EGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGNAAPLERPILSAE 427
            +P  + ++          D + K L  +   R TAA  L H  F     P + P+  A+
Sbjct: 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV--AD 316

Query: 428 P 428
           P
Sbjct: 317 P 317

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 19/250 (7%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +GRG FG V+ G         A+K       +    +   +  QE  +L +  HPNIVR 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR----ETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHR 281
            G  T    +YI +E V GG     L+  G +L    +    +   +G+EYL +K+ +HR
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118

Query: 282 DIKGANILVDPSGRVKLADFGMAKH-------ITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           D+   N LV     +K++DFGM++         TG    + +K    W APE + N    
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK----WTAPEAL-NYGRY 173

Query: 335 NLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
           +   D+WS G  + E  +    P++          I     LP  P+   D     + +C
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPELCPDAVYRLMERC 232

Query: 394 LQRNPLHRPT 403
            + +P  RP+
Sbjct: 233 WEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 69/261 (26%), Positives = 130/261 (49%), Gaps = 49/261 (18%)

Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSY 262
           Q+ +E+ +L     P IV +YG+   D ++ I +E++ GGS+ ++L++  ++ E  +   
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 263 TQQILSGLEYLHAKNTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY 321
           +  +L GL YL  K+ + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRS 167

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT----------------------------- 352
           +M+PE ++ ++  ++  DIWS+G +++E+A                              
Sbjct: 168 YMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226

Query: 353 ------TKPPWSQYEG-----VPAM--FKIGN---SKELPAIPDHL-SDEGKDFVRKCLQ 395
                  +PP     G      PAM  F++ +   ++  P +P+ + + + ++FV KCL 
Sbjct: 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286

Query: 396 RNPLHRPTAAWLLEHPFVGNA 416
           +NP  R     L+ H F+  +
Sbjct: 287 KNPAERADLKMLMNHTFIKRS 307

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 26/270 (9%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     +G++ AMK +  + +  K  E+A    +   L++  R     
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-EMLKRAETACFREERDVLVNGDRRWITN 65

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTV 279
            +Y  +  ++ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H    V
Sbjct: 66  LHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 280 HRDIKGANILVDPSGRVKLADFG----MAKHITGQSCPLSIKGSPYWMAPEVI------K 329
           HRDIK  N+L+D +G ++LADFG    +    T QS      G+P +++PE++      K
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS--NVAVGTPDYISPEILQAMEDGK 182

Query: 330 NSNG--CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH---LSD 384
              G  C    D WSLG  + EM   + P+     V    KI N KE    P     +S+
Sbjct: 183 GRYGPEC----DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238

Query: 385 EGKDFVRK--CLQRNPLHRPTAAWLLEHPF 412
           E KD +R+  C     L R       +HPF
Sbjct: 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 19/253 (7%)

Query: 163 LGRGTFGHVYLG-FNSESGEMCAM-KEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V  G +  +      M KE ++  D+           +E  ++ +L H  +V
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEKLV 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTV 279
           + YG  T    +YI  EY+S G +   L+++G+    S +    + +  G+ YL +K  +
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNL 336
           HRD+   N LVD  G VK++DFG+++++       S+ GS +   W  PEV+  S   + 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSK 181

Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           + D+W+ G  + E+ +  K P+ ++     + K+     L   P   S++    +  C  
Sbjct: 182 S-DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYAIMYSCWH 239

Query: 396 RNPLHRPTAAWLL 408
                RPT   LL
Sbjct: 240 EKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 75/293 (25%), Positives = 140/293 (47%), Gaps = 22/293 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     + ++ AMK +  +    +++ +  +  +++ +    +    +
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y   +  ++ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H  + V
Sbjct: 67  HYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 280 HRDIKGANILVDPSGRVKLADFGMA-KHITGQSCPLSIK-GSPYWMAPEVIK----NSNG 333
           HRDIK  NIL+D +G ++LADFG   K +   +   S+  G+P +++PE+++        
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---LPAIPDHLSDEGKDFV 390
                D WSLG  + EM   + P+     V    KI N KE    PA    +S++ KD +
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244

Query: 391 RK--CLQRNPLHRPTAAWLLEHPFVG-----NAAPLERPILSAEPSETKPTLT 436
           R+  C + + L +       +HPF       N    E P +   P  + PT T
Sbjct: 245 RRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYI---PEVSSPTDT 294

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 73/281 (25%), Positives = 107/281 (38%), Gaps = 47/281 (16%)

Query: 160 GRLLGRGTFGHVY----LGFNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R LG G FG VY     G + ++ E+  A+K +        S++       E  ++S+ 
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKF 66

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQIL 267
            H NIVR  G        +I LE ++GG +   L++          L    +    + + 
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 268 SGLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQS-------CPLSIK 317
            G +YL   + +HRDI   N L+    P    K+ADFGMA+ I   S         L IK
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 318 GSPYWMAPEV----IKNSNGCNLAVDIWSLGC---TVIEMATTKPPWSQYEGVPAMFKIG 370
               WM PE     I  S       D+WS G     +  +     P    + V      G
Sbjct: 187 ----WMPPEAFLDGIFTSK-----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237

Query: 371 NSKELPA-IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
              + P   P  +       +  C Q  P  RP  A +LE 
Sbjct: 238 GRLDPPKGCPGPVY----RIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.4 bits (211), Expect = 6e-19
 Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 19/249 (7%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG----QEIALLSRLRHP 217
           LLG+G FG V+ G          +K+ T  +     ++  Q+L      E  +L +  HP
Sbjct: 2   LLGKGNFGEVFKG---------TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHP 52

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAK 276
           NIV+  G  T    +YI +E V GG     L +   +L    +  +     +G+ YL +K
Sbjct: 53  NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPY-WMAPEVIKNSNGC 334
           N +HRD+   N LV  +  +K++DFGM++         S +K  P  W APE + N    
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171

Query: 335 NLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
           +   D+WS G  + E  +    P+       A  ++     +   P    D+    +++C
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-PQKCPDDVYKVMQRC 230

Query: 394 LQRNPLHRP 402
               P +RP
Sbjct: 231 WDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 47/281 (16%)

Query: 161 RLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           R +G+G FG V+     G      E   M  V +  ++A S +      +E AL++   H
Sbjct: 11  RDIGQGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDH 67

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL----------------------QDYGQL 254
           PNIV+  G   +   + +  EY++ G + + L                       +   L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------- 307
             +      +Q+ +G+ YL  +  VHRD+   N LV  +  VK+ADFG++++I       
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWS-QYEGVP 364
             ++  + I+    WM PE I   N      D+W+ G  + E+ +   +P +   +E V 
Sbjct: 188 ASENDAIPIR----WMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242

Query: 365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
              + GN   + + PD+   E  + +R C  + P  RP+ A
Sbjct: 243 YYVRDGN---VLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 60/212 (28%), Positives = 114/212 (53%), Gaps = 10/212 (4%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G G +G V    + E+ E+ A+K+   F D  +++E  +   +E+ +L  L+  NIV 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTV 279
              +     KLY+  EYV   ++ ++L++   G   E  +RSY  Q++  + + H  + V
Sbjct: 65  LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIV 122

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWM-APEVIKNSNGCNLA 337
           HRDIK  N+L+  +  +KL DFG A++++ G +   +   +  W  +PE++  +     A
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKA 181

Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           VD+WS+GC + E++  +P +     +  +F I
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 27/266 (10%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P    K  + LG G FG V++   ++  ++    MK  ++         S +    E  +
Sbjct: 4   PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANV 54

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGE-SAIRSYTQQILS 268
           +  L+H  +V+ +   T  + +YI  E+++ GS+   L+ D G       +  ++ QI  
Sbjct: 55  MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK------HITGQSCPLSIKGSPYW 322
           G+ ++  +N +HRD++ ANILV  S   K+ADFG+A+      +   +     IK    W
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----W 169

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
            APE I N     +  D+WS G  ++E+ T  + P+        +  +     +P   ++
Sbjct: 170 TAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-EN 227

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWL 407
             +E  + + +C +  P  RPT  ++
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 26/224 (11%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 215 RHPNIVRYYG-----SETLDDKLYIY---LEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
            +P++ R  G     +  L  +L  +   L+YV         +    +G   + ++  QI
Sbjct: 67  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--------EHKDNIGSQYLLNWCVQI 118

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WM 323
             G+ YL  +  VHRD+   N+LV     VK+ DFG+AK +         +G      WM
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
           A E I +    + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 179 ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 2/141 (1%)

Query: 165 RGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG 224
           RG FG VYLG    + ++ A+K V     D  +K    Q+  E   L+  + P IV  Y 
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVK--KADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 225 SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIK 284
           S    + +Y+ +EY+ GG +  +L  YG   E     Y  ++   L+YLH    +HRD+K
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 285 GANILVDPSGRVKLADFGMAK 305
             N+L+   G +KL DFG++K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 33/214 (15%)

Query: 163 LGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG VY G               +    ++A+ K   Q+  QE  L+S L+HPNIV
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIV 71

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKIL------QDYG----------QLGESAIRSYTQ 264
              G  T +    +  EY++ G +++ L       D G           L  S       
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSI 316
           QI +G+EYL + + VHRD+   N LV     VK++DFG+++ I          +S  L +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS-LLPV 190

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
           +    WM PE I          DIWS G  + E+
Sbjct: 191 R----WMPPEAIL-YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 76/293 (25%), Positives = 140/293 (47%), Gaps = 27/293 (9%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     +  + AMK +  +    +++ +  +  + + +    +    +
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y   +  ++ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  +  +H  + V
Sbjct: 67  HYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124

Query: 280 HRDIKGANILVDPSGRVKLADFG----MAKHITGQSCPLSIK-GSPYWMAPEVIKN-SNG 333
           HRDIK  N+L+D +G ++LADFG    M +  T QS   S+  G+P +++PE+++   +G
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS---SVAVGTPDYISPEILQAMEDG 181

Query: 334 CNL---AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD---EGK 387
                   D WSLG  + EM   + P+     V    KI N +E    P H++D   E K
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241

Query: 388 DFVRK--CLQRNPLHRPTAAWLLEHPFVG-----NAAPLERPILS--AEPSET 431
           D +++  C +   L +       +H F       N   LE P +   + PS+T
Sbjct: 242 DLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDT 294

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.5 bits (214), Expect = 3e-18
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 22/276 (7%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
               ++   R+LG G  G V        GE  A+K V +       K  AQ    E+  L
Sbjct: 29  EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQA---EVCCL 85

Query: 212 SRLRHPNIVRYYGSETLDDK--------LYIYLEYVSGGSIYKILQDYGQLGESAIRSYT 263
                 +IV+ +      D         + + L+Y + G + + ++   +      R + 
Sbjct: 86  LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR-TFREHE 144

Query: 264 Q-----QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG---QSCPLS 315
                 Q+L  + ++H+K+ +HRDIK ANIL+  +G VKL DFG +K            +
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+PY++APE+ +       A D++SLG  + E+ T K P+        M K    +  
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
           P +P  +S E ++ V   L  +P  RP+++ LL  P
Sbjct: 264 P-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.0 bits (207), Expect = 6e-18
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 19/225 (8%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K+ ++LG G FG VY G     GE   +       ++    ++  +   E  +++ + HP
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           ++VR  G   L   + +  + +  G +   + ++   +G   + ++  QI  G+ YL  +
Sbjct: 70  HLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNG 333
             VHRD+   N+LV     VK+ DFG+A+ + G     +  G      WMA E I     
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 334 CNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPAMFKIGNSKELP 376
            + + D+WS G T+ E+ T   KP    Y+G+P       ++E+P
Sbjct: 189 THQS-DVWSYGVTIWELMTFGGKP----YDGIP-------TREIP 221

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 65/254 (25%), Positives = 116/254 (45%), Gaps = 23/254 (9%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + + ++ A+K +             +   QE  ++ +LRH  +V  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLK------PGTMMPEAFLQEAQIMKKLRHDKLVPL 66

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQ--DYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   + ++ +YI  E++  GS+   L+  D   L    +     QI  G+ Y+   N +H
Sbjct: 67  YAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKNSNGC 334
           RD++ ANILV  +   K+ADFG+A+ I        Q     IK    W APE        
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR-F 180

Query: 335 NLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +  D+WS G  + E+ T  + P+        + ++     +P  P    +   + ++ C
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQGCPESLHELMKLC 239

Query: 394 LQRNPLHRPTAAWL 407
            +++P  RPT  ++
Sbjct: 240 WKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 42/230 (18%)

Query: 163 LGRGTFGHVYL------------GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           LG G FG V+L            G     G+   +  V +   D  +K +     +EI +
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQP-VLVAVKMLRADV-TKTARNDFLKEIKI 70

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD---YGQLGESA--------- 258
           +SRL++PNI+R  G    DD L +  EY+  G + + L           +          
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH--------ITGQ 310
           +     QI SG++YL + N VHRD+   N LV     +K+ADFGM+++        I G+
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
           +  L I+    WMA E I        A D+W+ G T+ EM T   + P+S
Sbjct: 191 AV-LPIR----WMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 68/257 (26%), Positives = 119/257 (46%), Gaps = 29/257 (11%)

Query: 163 LGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V++G  + + ++    +K  T+         S +   +E  ++ +LRH  +V
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---------SPESFLEEAQIMKKLRHDKLV 64

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKN 277
           + Y   + ++ +YI  EY+S GS+   L+D G+   L    +     Q+ +G+ Y+   N
Sbjct: 65  QLYAVVS-EEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKNS 331
            +HRD++ ANILV      K+ADFG+A+ I        Q     IK    W APE     
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYG 178

Query: 332 NGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               +  D+WS G  + E+ T  + P+        + ++     +P  P        + +
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQDCPISLHELM 236

Query: 391 RKCLQRNPLHRPTAAWL 407
            +C +++P  RPT  +L
Sbjct: 237 LQCWKKDPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 23/197 (11%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V+LG+  E  ++ A+K +    + A S+E      +E  ++ +L HP +V+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTI---REGAMSEE---DFIEEAQVMMKLSHPKLVQL 64

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           YG  T    + +  E++  G +   L+   G+  +  +      +  G+ YL + N +HR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVIKNSNG 333
           D+   N LV  +  VK++DFGM + +        TG   P+       W +PEV   S  
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSKY 178

Query: 334 CNLAVDIWSLGCTVIEM 350
            + + D+WS G  + E+
Sbjct: 179 SSKS-DVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 64/292 (21%)

Query: 179 SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
           +GE   ++ + L   +A + E    L  E+ +     HPNIV Y  +   D++L++   +
Sbjct: 24  TGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80

Query: 239 VSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV 296
           ++ GS   ++  +    + E AI    Q +L  L+Y+H    VHR +K ++IL+   G+V
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 140

Query: 297 KL----ADFGMAKHITGQSCPL-------SIKGSPYWMAPEVI-KNSNGCNLAVDIWSLG 344
            L    ++  M  H  GQ   +       S+K  P W++PEV+ +N  G +   DI+S+G
Sbjct: 141 YLSGLRSNLSMINH--GQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVG 197

Query: 345 CTVIEMATTKPPWSQYEG-----------VPAMFKIGN--SKEL---------------- 375
            T  E+A    P+                VP +       ++EL                
Sbjct: 198 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES 257

Query: 376 PAIPDHLSDEGK---------------DFVRKCLQRNPLHRPTAAWLLEHPF 412
             +       G+                FV +CLQRNP  RP+A+ LL H F
Sbjct: 258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 27/259 (10%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK---SKESAQQLGQEIALLSRLR 215
           K +++G G FG V+ G     G     KEV +     K   +++  Q    E +++ +  
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLH 274
           H NI+R  G  T      I  EY+  G++ K L+D+ G+     +    + I +G++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSPYWMA 324
             N VHRD+   NILV+ +   K++DFG+++ +          +G   P+       W A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------WTA 178

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLS 383
           PE I      + A D+WS G  + E M+  + P+        M  I +   LPA P    
Sbjct: 179 PEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-PMDCP 236

Query: 384 DEGKDFVRKCLQRNPLHRP 402
                 + +C Q++   RP
Sbjct: 237 SAVYQLMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 83.3 bits (206), Expect = 6e-17
 Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 33/238 (13%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           RL+G+G  G VYL ++       A+K++    D +++    ++  +E  + + L HP IV
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------LGES--AIRSYTQQILSG 269
             Y   +  D +Y  + Y+ G ++  +L+   Q            S  A  S   +I + 
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-------------SC---- 312
           +EY+H+K  +HRD+K  NIL+   G V + D+G A     +              C    
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 313 --PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
             P  I G+P +MAPE +      + + DI++LG  + +M T   P+ + +G    ++
Sbjct: 186 TIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242

Length = 932

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 80.9 bits (199), Expect = 9e-17
 Identities = 77/318 (24%), Positives = 145/318 (45%), Gaps = 53/318 (16%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   +++   +  A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKL---SRPFQSLIHARRTYRELRLLKHMK 72

Query: 216 HPNIVR----YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           H N++     +  + ++++   +YL     G+    +    +L +  ++    Q+L GL+
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH----ITGQSCPLSIKGSPYWMAPEV 327
           Y+H+   +HRD+K +N+ V+    +++ DFG+A+     +TG         + ++ APE+
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV------ATRWYRAPEI 186

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY----------EGVPA---MFKIGNS 372
           + N    N  VDIWS+GC + E+   K   P + Y           G P+   + KI + 
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246

Query: 373 ------KELPAIPDHLSDEGK----------DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
                 + LP +P    D  K          D + K L  +   R +A+  L HP F   
Sbjct: 247 HARKYIQSLPHMPQQ--DLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 416 AAPLERPILSAEPSETKP 433
             P + P   AEP +  P
Sbjct: 305 HDPEDEP--EAEPYDESP 320

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 73/273 (26%), Positives = 114/273 (41%), Gaps = 44/273 (16%)

Query: 161 RLLGRGTFGHVYLG-----FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             LG G FG VY G         SG +  A+K +   + D + KE      +E  L+S  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE----FLKEAHLMSNF 56

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQ------QIL 267
            HPNIV+  G   L++  YI +E + GG +   L+D   +     + +  +       + 
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGR-----VKLADFGMAKHI--------TGQSCPL 314
            G  YL   + +HRD+   N LV   G      VK+ DFG+A+ I         G+   L
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL-L 175

Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIG 370
            ++    WMAPE + +        D+WS G  + E+ T      P  +  E V      G
Sbjct: 176 PVR----WMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAG 229

Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
              +    P++  D+    +  C  ++P  RPT
Sbjct: 230 GRLQK---PENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 217 PNIV---RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           PN+V   +Y  SE   D +++ L++  GG ++  +  +  + E  ++ +  +++  L+ L
Sbjct: 45  PNMVCLHKYIVSE---DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDAL 101

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
           H +  V RD+   NIL+D  G ++L  F     +       ++     + APEV   S  
Sbjct: 102 HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEE 159

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
              A D WSLG  + E+ T K   +  E  P+   I     L  IP+ +S+E +  +++ 
Sbjct: 160 TE-ACDWWSLGAILFELLTGK---TLVECHPS--GINTHTTL-NIPEWVSEEARSLLQQL 212

Query: 394 LQRNPLHRPTAAW-----LLEHPF 412
           LQ NP  R  A       +  HPF
Sbjct: 213 LQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 49/229 (21%)

Query: 163 LGRGTFGHVYL--------------GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           LG G FG V+L               FN   G    +  V +   DA +K +     +E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL-LVAVKILRPDA-NKNARNDFLKEV 70

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-------------GQLG 255
            +LSRL+ PNI+R  G    +D L +  EY+  G + + L  +                 
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 256 ESAIRSYTQ------QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH--- 306
                SY+       QI SG++YL + N VHRD+   N LV  +  +K+ADFGM+++   
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190

Query: 307 -----ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
                I G++  L I+    WMA E I        A D+W+ G T+ E+
Sbjct: 191 GDYYRIQGRAV-LPIR----WMAWECILMGK-FTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 162 LLGRGTFGHVYLGF--NSESGEMCA--MKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           LL  GTFG ++ G   + + G+     +K V     D  S+     L QE  LL  L H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQ 68

Query: 218 NIVRYYGSETLD-DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ--------QILS 268
           NI+        D +  ++   Y++ G++   LQ       +  ++ +         QI  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLAD-------FGMAKHITGQSCPLSIKGSPY 321
           G+ YLH +  +H+DI   N ++D   +VK+ D       F M  H  G +    +K    
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
           WMA E + N    + A D+WS G  + E+ T
Sbjct: 185 WMALESLVNKE-YSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 72/267 (26%), Positives = 113/267 (42%), Gaps = 35/267 (13%)

Query: 163 LGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG   FG VY G  F +  GE      +    D A+     ++   E  + SRL+HPNIV
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKHEAMMRSRLQHPNIV 71

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKIL------QDYGQLGES-AIRSYTQ--------- 264
              G  T +  L +   Y S   +++ L       D G   +   ++S  +         
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSI 316
           QI +G+E+L + + VH+D+   N+LV     VK++D G+ + +         G S  L I
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL-LPI 190

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGVPAMFKIGNSKEL 375
           +    WM+PE I      ++  DIWS G  + E+ +    P+  Y     +  I N + L
Sbjct: 191 R----WMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRP 402
           P  PD         + +C    P  RP
Sbjct: 246 PC-PDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 48/270 (17%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           KK ++LG G FG VY G     GE   +        +  S ++ +++  E  +++ +  P
Sbjct: 10  KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEY 272
            + R  G       L   ++ V+    Y  L DY      ++G   + ++  QI  G+ Y
Sbjct: 70  YVCRLLGI-----CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---------HITGQSCPLSIKGSPYWM 323
           L     VHRD+   N+LV     VK+ DFG+A+         H  G   P+       WM
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WM 178

Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPAMFKIGNSKELPAI--- 378
           A E I +    + + D+WS G TV E+ T   KP    Y+G+PA       +E+P +   
Sbjct: 179 ALESILHRRFTHQS-DVWSYGVTVWELMTFGAKP----YDGIPA-------REIPDLLEK 226

Query: 379 ------PDHLSDEGKDFVRKCLQRNPLHRP 402
                 P   + +    + KC   +   RP
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRP 256

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 34/275 (12%)

Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G++LG G FG V  G  + + G    +   T+  D     E  + L  E A +    HPN
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHPN 62

Query: 219 IVRYYG-SETLDD-----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL----- 267
           +++  G            K  + L ++  G ++  L  Y +LG    +   Q +L     
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMVD 121

Query: 268 --SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
              G+EYL  +N +HRD+   N ++     V +ADFG++K I        G+   + +K 
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---TKPPWSQYEGVPAMFKIGNSKEL 375
              W+A E + +    + + D+W+ G T+ E+AT   T  P  +   +    + GN  + 
Sbjct: 181 ---WIAIESLADRVYTSKS-DVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           P       DE  D +  C + +P  RPT   L E 
Sbjct: 237 PE---DCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 63/262 (24%), Positives = 105/262 (40%), Gaps = 28/262 (10%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ-LGQEIALLSRLRHPNIV 220
            LGRG FG V+L       E      V + +      E+ Q    +E+ +  +L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ---------DYGQLGESAIRSYTQQILSGLE 271
           R  G     +  Y+ LEY   G + + L+             L      +   QI  G++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--------HITGQSCPLSIKGSPYWM 323
           +L     VHRD+   N LV     VK++   ++K         +     PL       W+
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WL 185

Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK-ELPAIPDH 381
           APE ++  +  +   D+WS G  + E+ T  + P+        + ++   K ELP +P+ 
Sbjct: 186 APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP-VPEG 243

Query: 382 LSDEGKDFVRKCLQRNPLHRPT 403
                   + +C   NP  RP+
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 42/275 (15%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           ++G G FG V      + G    M        +  SK+  +    E+ +L +L  HPNI+
Sbjct: 14  VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQD---------YGQLGESAIRSYTQQILS--- 268
              G+      LY+ +EY   G++   L+          +     +A    +QQ+L    
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 269 ----GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSP 320
               G++YL  K  +HRD+   NILV  +   K+ADFG+++    ++      L ++   
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 188

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPW------SQYEGVPAMFKIGNSK 373
            WMA E + N +      D+WS G  + E+ +    P+        YE +P  +++    
Sbjct: 189 -WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 244

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
                P +  DE  D +R+C +  P  RP+ A +L
Sbjct: 245 -----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 67/311 (21%)

Query: 163 LGRG--TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +GRG      VYL  ++ +G +  ++   L   +  ++E  + L  E+ L    RHPNI+
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLHAKNT 278
             +   T    L++   +++ GS   +L+ Y   G  E+ I +     L GL YLH    
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 279 VHRDIKGANILVDPSGRVKLAD----FGMAKHITGQSCPLSIKGSPY------WMAPEVI 328
           +HR+IK ++IL+   G V L+     + + ++  GQ   +      +      W++PE++
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRN--GQKAKVVYDFPQFSTSVLPWLSPELL 180

Query: 329 KNS-NGCNLAVDIWSLGCTVIEMATTKPPW----------SQYEGVP------------- 364
           +    G N+  DI+S+G T  E+AT + P+           + +G P             
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240

Query: 365 ---------------------AMFKIGNSKEL--PAIPDHLSDEGKDFVRKCLQRNPLHR 401
                                 M +   S+ L  P+     S   ++ V  CLQ++P  R
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAFQNLVELCLQQDPEKR 299

Query: 402 PTAAWLLEHPF 412
           P+A+ LL H F
Sbjct: 300 PSASSLLSHAF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 19/250 (7%)

Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V  G     +S +  A+K +   ++D   K+   +L +E  ++ +L +P IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKD---ELLREANVMQQLDNPYIV 59

Query: 221 RYYG-SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           R  G  E   +   + +E    G + K LQ    + E  I     Q+  G++YL   N V
Sbjct: 60  RMIGICEA--ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS---PY-WMAPEVIKNSNGCN 335
           HRD+   N+L+      K++DFG++K +         K     P  W APE + N    +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFS 176

Query: 336 LAVDIWSLGCTVIE-MATTKPPWSQYEG--VPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
              D+WS G  + E  +  + P+   +G  V  M + G   E P        E  D ++ 
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ---RCPPEMYDLMKL 233

Query: 393 CLQRNPLHRP 402
           C       RP
Sbjct: 234 CWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 17/252 (6%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ---LGQEIALLSRLRHPN 218
           ++G G FG V  G     G+    +E+ +     KS  + +Q      E +++ +  HPN
Sbjct: 11  VIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           I+   G  T    + I  E++  G++   L Q+ GQ     +    + I +G++YL   N
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCP-----LSIKGSPYWMAPEVIKNS 331
            VHRD+   NILV+ +   K++DFG+++ +    S P     L  K    W APE I   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 332 NGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
              + A D+WS G  + E M+  + P+        +  I     LP   D         +
Sbjct: 187 KFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD-CPTALHQLM 244

Query: 391 RKCLQRNPLHRP 402
             C Q++   RP
Sbjct: 245 LDCWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 36/269 (13%)

Query: 160 GRLLGRGTFGHV---YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           GR+LG+G FG V    L     S +  A+K   +   D  S    ++  +E A +    H
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVK---MLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 217 PNIVRYYG---SETLDDKLYI---YLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL--- 267
           PN+++  G         +L I    L ++  G ++  L    ++GE    +   Q L   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPF-TLPLQTLVRF 118

Query: 268 -----SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLS 315
                SG+EYL +KN +HRD+   N +++ +  V +ADFG++K I        G +  L 
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKE 374
           +K    W+A E + + N      D+W+ G T+ E+ T  + P++  E       +     
Sbjct: 179 VK----WLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233

Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           L   PD L ++  + + +C    P  RP+
Sbjct: 234 LKQPPDCL-EDVYELMCQCWSPEPKCRPS 261

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 59/172 (34%), Positives = 90/172 (52%), Gaps = 15/172 (8%)

Query: 242 GSIYKILQDYGQLGESA--IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA 299
             +  +L D G  G +   + S+T Q+  G+E+L +KN VHRD+   N+L+     VK+ 
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279

Query: 300 DFGMAKHITGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           DFG+A+ I   S  +S KGS +    WMAPE I ++    L+ D+WS G  + E+ +   
Sbjct: 280 DFGLARDIMHDSNYVS-KGSTFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGG 337

Query: 356 PWSQYEG--VPAMF--KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
             + Y G  V + F  KI +   + A PDH + E  D + KC    P  RP+
Sbjct: 338 --TPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 13/201 (6%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+++ + +G G  G V   F++  G   A+K++   S   +++  A++  +E+ LL  + 
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL---SRPFQNQTHAKRAYRELVLLKCVN 78

Query: 216 HPNIVR----YYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +Y+ +E +       I  +   L    +     Q+L G
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCG 135

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+             + Y+ APEVI 
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 330 NSNGCNLAVDIWSLGCTVIEM 350
              G    VDIWS+GC + E+
Sbjct: 196 GM-GYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 6/199 (3%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +K +LLG G FG V+ G     G+   +        D   +++ Q++   +  +  L H 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            IVR  G       L +  +    GS+   + Q    L    + ++  QI  G+ YL   
Sbjct: 70  YIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMAPEVIKNSNG 333
             VHR++   NIL+     V++ADFG+A  +            K    WMA E I     
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 334 CNLAVDIWSLGCTVIEMAT 352
            + + D+WS G TV EM +
Sbjct: 189 THQS-DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 72.0 bits (177), Expect = 7e-15
 Identities = 50/190 (26%), Positives = 74/190 (38%), Gaps = 26/190 (13%)

Query: 242 GSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
            S+  IL+  G+ L E  I +   Q L  L  LH +      +   + L+   G V    
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV---- 56

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
                       P   +  PY+MAPEVI+  +      DI+SLG T+ E    + P+++ 
Sbjct: 57  --------AFKTPEQSRPDPYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEE 107

Query: 361 EGVPAMFKI----------GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             + A+ +I           +   L  +    S E  DF+R C  R P  R  A   L H
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARSFE--DFMRLCASRLPQRREAANHYLAH 165

Query: 411 PFVGNAAPLE 420
                A  LE
Sbjct: 166 CRALFAETLE 175

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 11/248 (4%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLRHPN 218
           R+LG G FG +  G      +      +         K   Q+ G   E   L +  H N
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK---QRRGFLAEALTLGQFDHSN 67

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKN 277
           IVR  G  T  + + I  EY+S G++   L+ + GQL    +      + SG++YL    
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG-SP-YWMAPEVIKNSNGCN 335
            VH+ +    +LV+     K++ F   +    ++   ++ G SP  W APE I+  +  +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187

Query: 336 LAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A D+WS G  + E M+  + P+    G   +  + +   LPA P +  +     +  C 
Sbjct: 188 -ASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCPNLLHQLMLDCW 245

Query: 395 QRNPLHRP 402
           Q+    RP
Sbjct: 246 QKERGERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.4 bits (188), Expect = 1e-14
 Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 17/191 (8%)

Query: 178 ESGEMCAMKEVTLFSDDAKSKESA-QQLGQEIALLSRLRHPNIVRYYGS-ETLDDKLYIY 235
            +G   A+K   L   DA  +E    +  +E AL +RL HPNIV    S E     L+  
Sbjct: 1   MTGHEVAIK---LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAV 57

Query: 236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG- 294
            EYV G ++ ++L   G L          Q+L  L   H +  VHRD+K  NI+V  +G 
Sbjct: 58  FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 295 --RVKLADFGMAKHITGQSCPLSIK--------GSPYWMAPEVIKNSNGCNLAVDIWSLG 344
               K+ DFG+   + G                G+P + APE ++         D+++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE-PVTPNSDLYAWG 176

Query: 345 CTVIEMATTKP 355
              +E  T + 
Sbjct: 177 LIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 37/269 (13%)

Query: 160 GRLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           G+ LG G FG V  G     +S    A+K + +      ++   +    E   +    HP
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI---AICTRSEMEDFLSEAVCMKEFDHP 60

Query: 218 NIVRYYGS--ETLDDKLY----IYLEYVSGGSIYKILQDYGQLGESAIRSYTQ------- 264
           N++R  G   +T++ + Y    + L ++  G ++  L  Y +LG+      TQ       
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMT 119

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
            I SG+EYL +K+ +HRD+   N +++ +  V +ADFG++K I        G+   + +K
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---TKPPWSQYEGVPAMFKIGNSKE 374
               W+A E + +      + D+WS G T+ E+AT   T  P  +   +    + GN  +
Sbjct: 180 ----WIAIESLADRVYTTKS-DVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234

Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            P  PD L D     +  C   NP  RP+
Sbjct: 235 QP--PDCL-DGLYSLMSSCWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 53/155 (34%), Positives = 79/155 (50%), Gaps = 13/155 (8%)

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY 321
           ++ Q+ +G+E+L +KN VHRD+   N+L+     VK+ DFG+A+ I   S  +S KGS +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302

Query: 322 ----WMAPEVIKNSNGCNLAVDIWSLGCTVIEM----ATTKPPWSQYEGVPAMFKIGNSK 373
               WMAPE I N+    L+ D+WS G  + E+     T  P     E      K G   
Sbjct: 303 LPLKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
             PA   H SDE  + ++KC +     RP  + L+
Sbjct: 362 AKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 42/269 (15%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           ++G G FG V      + G    M        +  S+   +    E+ +L +L  HPNI+
Sbjct: 9   VIGEGNFGQVIRAMIKKDGL--KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQD---------YGQLGESAIRSYTQQIL---- 267
              G+      LYI +EY   G++   L+          + +   +A    +QQ+L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 268 ---SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSP 320
              +G++YL  K  +HRD+   N+LV  +   K+ADFG+++    ++      L ++   
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPW------SQYEGVPAMFKIGNSK 373
            WMA E + N +      D+WS G  + E+ +    P+        YE +P  +++    
Sbjct: 184 -WMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK-- 239

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRP 402
                P +  DE  + +R+C +  P  RP
Sbjct: 240 -----PRNCDDEVYELMRQCWRDRPYERP 263

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 42/272 (15%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           ++G G FG V      + G    M        +  SK+  +    E+ +L +L  HPNI+
Sbjct: 2   VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-------------DYGQ---LGESAIRSYTQ 264
              G+      LY+ +EY   G++   L+                    L    +  +  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSP 320
            +  G++YL  K  +HRD+   NILV  +   K+ADFG+++    ++      L ++   
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 176

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPW------SQYEGVPAMFKIGNSK 373
            WMA E + N +      D+WS G  + E+ +    P+        YE +P  +++    
Sbjct: 177 -WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 232

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P +  DE  D +R+C +  P  RP+ A
Sbjct: 233 -----PLNCDDEVYDLMRQCWREKPYERPSFA 259

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 18/253 (7%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMK--EVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG+GTF  ++ G   E G+   +   EV L   D   +  ++   +  +++S+L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR-SYTQQILSGLEYLHAKNTV 279
             YG     D+  +  EYV  GS+   L+    L   + +    +Q+   L +L  K   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122

Query: 280 HRDIKGANILV-----DPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           H ++   N+L+       +G    +KL+D G++  IT     + ++  P W+ PE I+N 
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECIENP 179

Query: 332 NGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
              +LA D WS G T+ E+ +    P S  +    +    +  +LPA P     E  + +
Sbjct: 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPA-PKWT--ELANLI 236

Query: 391 RKCLQRNPLHRPT 403
            +C+   P  RP+
Sbjct: 237 NQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 21/254 (8%)

Query: 163 LGRGTFGHVYLGF---NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPN 218
           LG+GTF ++Y G     S+   +   +EV++      S         E A L+S+L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYT-QQILSGLEYLHAKN 277
           +V+ YG   + D+  +  EYV  G +   L           +    +Q+ S L YL  K 
Sbjct: 63  LVKLYGV-CVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 278 TVHRDIKGANILV-------DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
            VH ++ G NILV            +KL+D G+   +  +   +     P W+APE I+N
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--RIP-WIAPECIRN 178

Query: 331 -SNGCNLAVDIWSLGCTVIEMATTKP-PWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                 +A D WS G T++E+ +    P S            +   LP +PD    E  +
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-MPD--CAELAN 235

Query: 389 FVRKCLQRNPLHRP 402
            + +C   +P  RP
Sbjct: 236 LINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 58/211 (27%), Positives = 114/211 (54%), Gaps = 31/211 (14%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++ +G+  A+K++   S   ++   A++  +E+ L+  +
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL---SRPFQNVTHAKRAYRELVLMKLV 72

Query: 215 RHPNIVR----YYGSETLDD--KLYIYLEYVSGGSIYKILQ---DYGQLGESAIRSY-TQ 264
            H NI+     +   ++L++   +Y+ +E +   ++ +++Q   D+ ++      SY   
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERM------SYLLY 125

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP---- 320
           Q+L G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  +    +P    
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM----TPYVVT 180

Query: 321 -YWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
            Y+ APEVI    G    VDIWS+GC + EM
Sbjct: 181 RYYRAPEVILGM-GYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 23/156 (14%)

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGS 319
           S++ Q+  G+ +L +KN +HRD+   NIL+   GR+ K+ DFG+A+ I   S    +KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDS-NYVVKGN 275

Query: 320 PY----WMAPEVIKNSNGC--NLAVDIWSLGCTVIEMATTKPPWSQYEGVPA------MF 367
                 WMAPE I N   C      D+WS G  + E+ +     S Y G+P       M 
Sbjct: 276 ARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGS--SPYPGMPVDSKFYKMI 330

Query: 368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           K G        P+    E  D ++ C   +PL RPT
Sbjct: 331 KEGYRML---SPECAPSEMYDIMKSCWDADPLKRPT 363

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 31/265 (11%)

Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V   ++ A  +E  + L  E +++    
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV---NEAASMRERIEFL-NEASVMKEFN 67

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-------QDYGQLGESAIRSYTQ---Q 265
             ++VR  G  +      + +E ++ G +   L       ++       +++   Q   +
Sbjct: 68  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186

Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 187 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 243 PDNCPDMLFELMRMCWQYNPKMRPS 267

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 55/277 (19%)

Query: 163 LGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLG---QEIALLSRLR 215
           LG   FG +Y G       +  ++ A+K +       K   + QQ G   QE +L++ L 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-------KDINNPQQWGEFQQEASLMAELH 65

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL----------------------QDYGQ 253
           HPNIV   G  T +  + +  EY++ G +++ L                       D+G 
Sbjct: 66  HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--- 310
               AI     QI +G+EYL +   VH+D+   NIL+     VK++D G+++ I      
Sbjct: 126 FLHIAI-----QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 311 ----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGVPA 365
                  L I+    WM PE I      + + DIWS G  + E+ +    P+  +     
Sbjct: 181 RVQPKSLLPIR----WMPPEAIMYGKFSSDS-DIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRP 402
           +  +   + LP   +         + +C Q  P  RP
Sbjct: 236 IEMVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ---LGQEIALL 211
           S  K  +++G G FG V  G     G+    +E+ +     K+  + +Q      E +++
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGK----REIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
            +  HPNI+   G  T    + I  EY+  GS+   L+ + GQ     +    + I SG+
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSP 320
           +YL     VHRD+   NILV+ +   K++DFG+++ +           G   P+      
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR----- 174

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
            W APE I      + A D+WS G  + E+ +   +P W
Sbjct: 175 -WTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 53/205 (25%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 74

Query: 216 HPNIVR----YYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +Y+ +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 131

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+             + Y+ APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTK 354
              G    VDIWS+GC + EM   K
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 39/265 (14%)

Query: 161 RLLGRGTFGHVYLGFNSESGEM---CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           R++G+G FG VY G   +S      CA+K +   +D     E  +Q  +E  ++    HP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHP 56

Query: 218 NIVRYYGSETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESA------IRSYTQQILSGL 270
           N++   G     +    + L Y+  G +   ++      E+       +  +  Q+  G+
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGM 111

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-----------TGQSCPLSIKGS 319
           EYL +K  VHRD+   N ++D S  VK+ADFG+A+ I           TG   P+     
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK---- 167

Query: 320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAI 378
             WMA E ++         D+WS G  + E+ T   PP+   +       +   + L   
Sbjct: 168 --WMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ- 223

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           P++  D   + +  C    P  RPT
Sbjct: 224 PEYCPDPLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 41/270 (15%)

Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 70

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--- 378
           WMAPE +K+      + D+WS G  + E+ +       Y+G      + N + L  +   
Sbjct: 187 WMAPESLKDGVFTTSS-DMWSFGVVLWEITSLAE--QPYQG------LSNEQVLKFVMDG 237

Query: 379 -----PDHLSDEGKDFVRKCLQRNPLHRPT 403
                PD+  +   D +R C Q NP  RPT
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81

Query: 216 HPNIVR----YYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 138

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197

Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 65/259 (25%), Positives = 95/259 (36%), Gaps = 67/259 (25%)

Query: 207 EIALLSRLRHPNIVR-----YYGSET------LDDKLYIYLEYVSGGSIYKILQDYGQLG 255
           E  LL  + HP+++R       G+ T          LY YL   S             L 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR-----------PLP 155

Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS 315
                   +QIL GL YLHA+  +HRD+K  NI ++   +V + D G A+        L 
Sbjct: 156 IDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT------TKPPWSQYEGVPA---- 365
           + G+    APEV+      N   DIWS G  + EM          PP +  E V +    
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 366 ------MFKIGNSKELPAIPD---------------------------HLSDEGKDFVRK 392
                   K+ + +E P  P                            +L  +G+  V K
Sbjct: 275 LLKIISTLKV-HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333

Query: 393 CLQRNPLHRPTAAWLLEHP 411
            L  +   RP+A  +L +P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 29/237 (12%)

Query: 163 LGRGTFGHVYLG-FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V  G +     ++  A+K   L +++ KS     ++ +E  ++ +L +P IV
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK--VLKNENEKSVR--DEMMREAEIMHQLDNPYIV 58

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           R  G     + L + +E  SGG + K L     ++  S +     Q+  G++YL  KN V
Sbjct: 59  RMIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSPYWMAPEVIK 329
           HRD+   N+L+      K++DFG++K +          +    PL       W APE I 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------WYAPECI- 170

Query: 330 NSNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKEL---PAIPDHL 382
           N    +   D+WS G T+ E  +  + P+ + +G   M  I   K L      P  +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 18/155 (11%)

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
           E  +L  + HP+I++  G+ T +    + L  Y +   +Y  L     +    I +  + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYW--- 322
           +L  ++YLH    +HRDIK  NI ++  G V L DFG A        P+ I  + Y+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF------PVDINANKYYGWA 244

Query: 323 -----MAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
                 APE++   +    AVDIWS G  + EMAT
Sbjct: 245 GTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 38/264 (14%)

Query: 163 LGRGTFGHVYLGF-------NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           LGRGT   +Y G          +        +V L   D   ++ +    +  +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR-SYTQQILSGLEYLH 274
           H +IV  YG    D +  +  E+V  G +   +     +  +  +    +Q+ S L YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 275 AKNTVHRDIKGANILVDPSGR-------VKLADFGMAKHI-TGQSCPLSIKGSPYWMAPE 326
            K+ VH ++   NIL+   G        +KL+D G+   + + Q C   I     W+APE
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP----WIAPE 178

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKE-------LPAI 378
            +++S   ++A D WS G T+ E+         Y G +P   K    KE       +   
Sbjct: 179 CVEDSKNLSIAADKWSFGTTLWEIC--------YNGEIPLKDKTLAEKERFYEGQCMLVT 230

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRP 402
           P     E  D +  C+  +P  RP
Sbjct: 231 PS--CKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 23/163 (14%)

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-------SCP 313
           SY+ Q+  G+E+L ++  +HRD+   NIL+  +  VK+ DFG+A+ I             
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP------AMF 367
           L +K    WMAPE I +      + D+WS G  + E+ +     S Y GV          
Sbjct: 237 LPLK----WMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGA--SPYPGVQIDEEFCRRL 289

Query: 368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           K G        P++ + E    +  C   NP  RPT + L+E 
Sbjct: 290 KEGTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 11/150 (7%)

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
            ++ Q+  G+++L +KN +HRD+   N+L+      K+ DFG+A+ I   S    +KG+ 
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNA 274

Query: 321 Y----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEM-ATTKPPWSQYEGVPAMFKIGNSK 373
                WMAPE I +   C   V  D+WS G  + E+ +  K P+         +K+    
Sbjct: 275 RLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
              + PD    E    ++ C    P  RPT
Sbjct: 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 27/217 (12%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V LG  +  G   A   V      A   E    L QE+     L HPN+++ 
Sbjct: 3   IGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQC 60

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ-----ILSGLEYLHAKN 277
            G         + LE+   G +   L+    +     +    Q     + SGL +LH  +
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMA-------KHITGQSCPLSIKGSPYWMAPEVIKN 330
            +H D+   N  +     VK+ D+G+A        +IT     + ++    W+APE++  
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELV-E 175

Query: 331 SNGCNLAV-------DIWSLGCTVIEMATTKP-PWSQ 359
             G +L         +IWSLG T+ E+ T    P+  
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 45/236 (19%)

Query: 154 GSRWKKGRLLGRGTFGHVY-------------LGFNSESGEMCAMKEVTLFSDDAKSKES 200
           G  WK  +L+G G FG VY                  E+ E   +   TL  ++    + 
Sbjct: 11  GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDID- 69

Query: 201 AQQLGQEIALLSRLR---HPNIVRYYGSETLD-DKLY---IYLE--YVSGGSIYKILQDY 251
                 +IAL   +    H  I +YYG  +    ++Y   I LE    +   I+K ++  
Sbjct: 70  ------KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK 123

Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH--ITG 309
            +     I++  + +L+ LEY+H     H DIK  NI+VD + R  + D+G+A H  I G
Sbjct: 124 NK---KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180

Query: 310 QSCPLSI------KGSPYWMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPW 357
           +    S       +G+ Y+     +   NG  +    D+ SLG  +++ A  K PW
Sbjct: 181 KHIEYSKEQKDLHRGTLYYAG---LDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233

Length = 294

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 19/160 (11%)

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK-------HITGQSCPL 314
           Y+ Q+  G+E+L ++  +HRD+   NIL+  +  VK+ DFG+A+       ++      L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKIG 370
            +K    WMAPE I +     +  D+WS G  + E+ +     S Y GV        ++ 
Sbjct: 244 PLK----WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRLK 296

Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
               + A PD+ + E    +  C    P  RPT + L+EH
Sbjct: 297 EGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 19/159 (11%)

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-------SCPL 314
           Y+ Q+  G+E+L ++  +HRD+   NIL+  +  VK+ DFG+A+ I          S  L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM----ATTKPPWSQYEGVPAMFKIG 370
            +K    WMAPE I +      + D+WS G  + E+    A+  P     E      K G
Sbjct: 239 PLK----WMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293

Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                   P++ + E    +  C Q +P  RPT + L+E
Sbjct: 294 TRMR---APENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 19/164 (11%)

Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL-----EYVSGGSIYKILQDYG-QL 254
           A QL  EI  L RL H NI++    E L  +   Y+     ++     +Y  + D     
Sbjct: 207 AIQLENEILALGRLNHENILKI--EEILRSEANTYMITQKYDF----DLYSFMYDEAFDW 260

Query: 255 GESAI----RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ 310
            +  +    R+  +Q+L  +EY+H K  +HRDIK  NI ++  G++ L DFG A     +
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 311 SCPLSIK--GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
                    G+    +PE++     C +  DIWS G  +++M +
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 52/160 (32%), Positives = 71/160 (44%), Gaps = 26/160 (16%)

Query: 206 QEIALLSRLRHPNI-----VRYYGSET------LDDKLYIYLEYVSGGSIYKILQDYGQL 254
            E  LL RL HP +     VR  G  T          LY YL                 L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLR-----------PL 257

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCP 313
           G + + +  +Q+LS ++Y+H +  +HRDIK  N+LV+    + L DFG A    G  S P
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317

Query: 314 L--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMA 351
               I G+    APEV+   +    +VDIWS G  + E A
Sbjct: 318 FHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 44/274 (16%)

Query: 163 LGRGTFGHVYLGF-------NSESGEMCAMKE------------VTLFSDDAKSKESAQQ 203
           LG+GT  ++Y G          E  EM                 V L   D   ++ A  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSY 262
             +  +L+S++ H ++   +G      +  +  E+V  G +   L ++ G++  +   + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-------VKLADFGMAKHITGQSCPLS 315
            QQ+ S L YL  KN VH ++   NIL+   G        +KL+D G++   T  S    
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREER 180

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKE 374
           ++  P W+APE +   N  + A D WS G T++E+         ++G VP   +  + KE
Sbjct: 181 VERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEIC--------FDGEVPLKERTPSEKE 231

Query: 375 L-----PAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
                   +P+    E    + +CL   P  RP+
Sbjct: 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 24/206 (11%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V LG    SG   A   V      A  +E  + L +E      L+H N+++ 
Sbjct: 3   IGNGWFGKVILG-EVNSGYTPAQVVVKELRVSASVQEQMKFL-EEAQPYRSLQHSNLLQC 60

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ-----ILSGLEYLHAKN 277
            G  T      + +E+   G +   L+   +         T Q     I  GL +LH  N
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-------HITGQSCPLSIKGSPYWMAPEVIKN 330
            +H D+   N L+     VK+ D+G++        ++T     + ++    W+APE++  
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELVDE 176

Query: 331 SNGCNLAVD------IWSLGCTVIEM 350
            +G  L VD      +WSLG T+ E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 48/287 (16%)

Query: 92  RAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPT 151
             G   S+S  +  D             +T   T   +   S +    V + P    + +
Sbjct: 26  TGGTDTSDSKDTTGDKFDDCDELGDSDDVTH-ATDYDADEESLSPQTDVCQEPCETTSSS 84

Query: 152 SPGS----RWKKGRLLGRGTFGHVYL--GFNSESGEMCAMKEVTLFSDDAKSKESAQQLG 205
            P S    ++     L  G+ G V++      E  +   +K VT            +  G
Sbjct: 85  DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT----------GGKTPG 134

Query: 206 QEIALLSRLRHPNIVR----YYGSETL-------DDKLYIYLEYVSGGSIYKILQDYGQL 254
           +EI +L  + H  I+     Y    T+          L+ Y++      + + +      
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI------ 188

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
                 +  +++L  L YLH +  +HRD+K  NI +D      L DFG A  +   + P 
Sbjct: 189 ------TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD--AHPD 240

Query: 315 SIK-----GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP 356
           + +     G+    +PE++     C    DIWS G  + EM+     
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 44/228 (19%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMK---EVTLFSDDAKSKESAQQLGQEIALLS 212
           R+K   LLG GTFG V   ++ +  E CA+K    V  ++ DAK          EI  + 
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKI---------EIQFME 180

Query: 213 RLRHPN---------IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYT 263
           ++R  +         I RY+ +ET      +  +Y  G  +   +  +G      +    
Sbjct: 181 KVRQADPADRFPLMKIQRYFQNET-GHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQII 237

Query: 264 QQILSGLEYLHAK-NTVHRDIKGANIL-------VDPSG---------RVKLADFGMAKH 306
            Q    L+Y H + + +H D+K  NIL       VDP           RV++ D G    
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295

Query: 307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK 354
              +    +I  + ++ +PEV+    G   + D+WS+GC + E+ T K
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 35/267 (13%)

Query: 163 LGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +G G FG V L   +         +KE+     +A SKE  + L Q+      L+HPNI+
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKEL---KANASSKEQNEFL-QQGDPYRILQHPNIL 58

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAK 276
           +  G         +  EY   G +   L              ++    +I +G+ ++H  
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA------KHIT---GQSCPLSIKGSPYWMAPEV 327
           N +H D+   N  +     VK+ D+G+        +I     +  PL       W+APE+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WLAPEL 172

Query: 328 IKNSNGCNLAVD------IWSLGCTVIEM-ATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           +   +G  +  +      +W+LG T+ E+      P+S       +  +   +++     
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232

Query: 381 HLSDEGKDFVRKCLQ---RNPLHRPTA 404
            L     +   + LQ    +P  R TA
Sbjct: 233 QLELPYSERWYEVLQFCWLSPEKRATA 259

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 23/48 (47%), Positives = 31/48 (64%)

Query: 257 SAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA 304
           + I+   +Q+L+GL  LH    VHRDIK  N+LV   G+VK+ DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 49/188 (26%), Positives = 71/188 (37%), Gaps = 64/188 (34%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES-----AQQLGQ-EIALLSR 213
           G+ LG G FG VY              + +L +  +K +       A + G  EI +  R
Sbjct: 137 GKKLGEGAFGVVY--------------KASLVNKQSKKEGKYVLKKATEYGAVEIWMNER 182

Query: 214 LRH--PN-----------------------IVRYYGSETLDD----KLYIY-LEYVSGGS 243
           +R   PN                       + RY G  TL D    K + Y +E      
Sbjct: 183 VRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEP----- 237

Query: 244 IYKILQDYGQLGESA------IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRV 296
              +L     L +        I++  +QIL  L+ LH+   VHRD+K  NI+    SG  
Sbjct: 238 --YLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF 295

Query: 297 KLADFGMA 304
           K+ D G A
Sbjct: 296 KIIDLGAA 303

Length = 566

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 18/117 (15%)

Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ------DYGQ 253
           +A++  +       +  P +   Y +  +     + +E++ G  I  I        D  +
Sbjct: 214 NAERFRENFKDDPDVYVPKVYWEYTTRRV-----LTMEWIDGIKISDIAALKSAGIDRKE 268

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ 310
           L E  +R++ +Q+L    + HA      D    NILV   GR+ L DFG+   +  +
Sbjct: 269 LAELLVRAFLRQLL-RDGFFHA------DPHPGNILVRSDGRIVLLDFGIVGRLDPK 318

Length = 517

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 15/229 (6%)

Query: 186 KEVTL--FSDDAK-SKESAQQLGQEIALLSRLRHPNIVRYYG--SETLDD--KLYIYLEY 238
           KEV +  F    K  K        EI  L R+   NI++ YG   + +DD  +L + LEY
Sbjct: 44  KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103

Query: 239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVK 297
            + G + ++L     L              GL  L+   N  ++++   + LV  + ++K
Sbjct: 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLK 163

Query: 298 LADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPP 356
           +   G+ K     S P        + + +++ +  +   +  DI+SLG  + E+ T K P
Sbjct: 164 IICHGLEK--ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221

Query: 357 WSQ--YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           +     + +  +  I  +  L  +P     E K  V  C   + + RP 
Sbjct: 222 FENLTTKEIYDLI-INKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPN 268

Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S  K+  ++ RG  G  Y G + ++G    +KE+    +D  S  S+     EIA + +L
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSS-----EIADMGKL 740

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +HPNIV+  G    +   Y+  EY+ G ++ ++L++   L     R     I   L +LH
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLH 797

Query: 275 ---AKNTVHRDIKGANILVDPSG--RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
              +   V  ++    I++D      ++L+  G+    T   C +S   S Y +APE  +
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLL--CTDTKCFIS---SAY-VAPET-R 850

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPP 356
            +       DI+  G  +IE+ T K P
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	444
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
KOG1243	690	consensus Protein kinase [General function predict	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.1
COG4248	637	Uncharacterized protein with protein kinase and he	99.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.93
PRK09902	216	hypothetical protein; Provisional	98.79
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.6
PF01636	239	APH: Phosphotransferase enzyme family This family	98.52
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.25
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.97
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.79
PRK10593	297	hypothetical protein; Provisional	97.72
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.68
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
KOG2270	520	consensus Serine/threonine protein kinase involved	97.61
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
PRK05231	319	homoserine kinase; Provisional	97.48
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.13
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.91
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.85
PLN02756	418	S-methyl-5-thioribose kinase	96.64
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.61
PRK12396	409	5-methylribose kinase; Reviewed	96.57
PLN02236	344	choline kinase	96.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.3
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.13
PRK06148	1013	hypothetical protein; Provisional	96.06
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.96
PRK11768	325	serine/threonine protein kinase; Provisional	95.95
COG2334	331	Putative homoserine kinase type II (protein kinase	95.92
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.87
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.8
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.75
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.51
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.37

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-58  Score=438.05  Aligned_cols=266  Identities=32%  Similarity=0.507  Sum_probs=234.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccH--HHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK--ESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ...+.|.+.+.||+|+||.|-+|..+.||+.||||++..........  .....+.+|+++|++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            35567999999999999999999999999999999998654443332  2234467999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC---CcEEEEecccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS---GRVKLADFGMAKH  306 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~  306 (444)
                      +..|+||||++||+|.+.+-.++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999999998999999999999999999999999999999999999999766   6699999999999


Q ss_pred             ccCCCCcccccCCCcccCcccccCcC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhcCCCC--CCCCCCC
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSKE--LPAIPDH  381 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~--~~~~~~~  381 (444)
                      ........+.|||+.|.|||++.+..  .+..++|||||||+||-+|+|.+||.+..... ...++..++.  .|.....
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            98888888999999999999997543  24458899999999999999999998877666 5566665543  2445577


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ++++.++||++||..||++|||+.|+|+||||+.+.
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999999999999999765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-56  Score=423.44  Aligned_cols=261  Identities=31%  Similarity=0.572  Sum_probs=234.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-E
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-K  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~  231 (444)
                      ..++.+..+.||+|..|+||+++++.|++.+|+|++..    ..+....+++.+|+++++.++|||||.+||.|..++ .
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            34578888999999999999999999999999999953    355667789999999999999999999999999988 5


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++|+||||++|+|++++++.++++|..+..++.+|++||.|||+ ++||||||||+||||+..|+|||||||.++.+.+.
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999999999999999999999999999999996 89999999999999999999999999999988666


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCC-----CChhhhHHhcCCCCCCCCCCC-CCH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-----EGVPAMFKIGNSKELPAIPDH-LSD  384 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~-~s~  384 (444)
                       ...+++||..|||||.+.+.. |+.++||||||++|+||++|+.||...     ...+.+..|.. ...|.+|.. +++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCH
Confidence             556788999999999998877 999999999999999999999999774     22344445544 345678886 999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCc
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~  420 (444)
                      |+++||..||++||.+||++.|+++|||++......
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            999999999999999999999999999999765433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-56  Score=445.41  Aligned_cols=260  Identities=35%  Similarity=0.633  Sum_probs=237.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|+.+++||+|+|++||++++..+|+.||+|++.+  .........+.+.+||++.++|+|||||+++++|++.+.+||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk--~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPK--KLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeeh--HHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            689999999999999999999999999999999864  233445567889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~  313 (444)
                      |.|+|..++|..++++++.++|.+++.+++||+.||.|||+++|||||||..|+|++++.+|||+|||+|..+..+ ...
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            9999999999999999899999999999999999999999999999999999999999999999999999988754 677


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      .+.+|||.|+|||++. ..+.+..+||||+||+||-||.|++||+...-.+.+.++.....  .+|..++.++++||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence            8899999999999997 55599999999999999999999999988777777777766554  57789999999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCC-CCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVG-NAAPL  419 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~-~~~~~  419 (444)
                      |++||.+|||+.+||.|+||+ .-.+.
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence            999999999999999999994 33333

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=411.61  Aligned_cols=260  Identities=34%  Similarity=0.585  Sum_probs=236.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.++||+|+||+||+++.+++++.||+|++++..  .......+....|..+|..++||+||.++..|++.+.+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~--iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKK--IVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhH--hhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            4568999999999999999999999999999999987532  23334567888999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc-ccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~-~~~~~  311 (444)
                      |+|+||+.||.|+..|++.+.|+|..++-++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++. +..+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999995 44445


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ...+++||+.|||||++.... |+.++|.||||+++|||++|.+||...+....+.++...+ .+..+..++.++++||+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK  258 (357)
T ss_pred             ccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence            666789999999999998775 9999999999999999999999999988778888887766 34667779999999999


Q ss_pred             HHhhhCCCCCc----CHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRP----TAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rp----t~~elL~hp~~~~~  416 (444)
                      .+|++||++|.    .+++|-+||||...
T Consensus       259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            99999999995    78899999999854

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=420.87  Aligned_cols=261  Identities=30%  Similarity=0.581  Sum_probs=234.2

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      ....+|.+++.||+|+|++||+|+++.+++.||||++.+  .....+...+.+.+|-.+|.+| .||.|++|+-.|+++.
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K--~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDK--RYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhH--HHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            345689999999999999999999999999999998853  2233344456788899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|+|+||+++|+|.++|++.+.|++..++.++.||+.||+|||++|||||||||+|||+|.|++++|+|||.|+.+.+.
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999876443


Q ss_pred             CCc--------------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC
Q 013354          311 SCP--------------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP  376 (444)
Q Consensus       311 ~~~--------------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~  376 (444)
                      ...              .+++||..|.+||++.+.. .+..+|+|+||||||+|+.|.+||...+..-.+++|.....  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc--
Confidence            211              3578999999999997766 89999999999999999999999999887777777765443  


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .+|..+++.+++||+++|..||.+|+|++||.+||||.+..
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            78999999999999999999999999999999999999653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-53  Score=406.44  Aligned_cols=261  Identities=33%  Similarity=0.582  Sum_probs=236.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|...+.||+|+|++||+|+++.++..||||.+.+..   ......+.+..|+++|+.++|||||++++++..++.+|+
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            46999999999999999999999999999999987521   245667788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC------CcEEEEecccccccc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS------GRVKLADFGMAKHIT  308 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~------~~vkL~DFGla~~~~  308 (444)
                      |||||+||+|.++|++++.+++..++.++.||+.||++||+++||||||||.|||++..      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999764      459999999999999


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGK  387 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~  387 (444)
                      +.....+.+|++.|||||+++..+ |+.|+|+||+|+++|+|++|+.||......+.+..+..... .+.++..++..+.
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~  245 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR  245 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence            888888899999999999998777 99999999999999999999999998777777666655443 4667788899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      +|+...|+.++.+|.++.+-+.|+++......
T Consensus       246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~  277 (429)
T KOG0595|consen  246 ELLISLLQRNPKDRISFEDFFDHPFLAANPQD  277 (429)
T ss_pred             hhhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence            99999999999999999999999998865543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-53  Score=407.77  Aligned_cols=260  Identities=53%  Similarity=0.954  Sum_probs=230.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--E
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--K  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~  231 (444)
                      ..+|..++.||+|+||.||++.++.+|+.+|||.+...     .....+.+.+|+.+|++++|||||+++|.....+  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc-----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            35699999999999999999999999999999988753     1122678999999999999999999999755444  6


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~  309 (444)
                      ++++|||+.+|+|.+++.+++ .+++..++.+.+||++||+|||++||||+||||+|||++. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999999987 7999999999999999999999999999999999999999 79999999999987764


Q ss_pred             ----CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC-CCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 ----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-YEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ----~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                          ........||+.|||||++.++.....++|||||||++.||+||+.||.. .+....+..+......|.+|..++.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence                22234577999999999998643234599999999999999999999988 5666777777777788899999999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ++++||.+|+.+||++||||.++|+|||+++...
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999987544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-53  Score=388.51  Aligned_cols=259  Identities=26%  Similarity=0.491  Sum_probs=224.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +.|+....+|+|+||.||++++++||+.||||.+.   +..++....+-.++||++|++|+|+|+|.++++|.....+++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~---Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV---ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeec---cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            46888899999999999999999999999999875   344556677788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CCCCc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~~~~  313 (444)
                      |+|||+..-|+++-+....++.+.++.++.|++.|+.|+|++++|||||||+||||+.++.+||||||+|+.+. +.+.+
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99999775555544444569999999999999999999999999999999999999999999999999999887 45555


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------CC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------SK  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~~  373 (444)
                      ...+-|.+|+|||++.+...|...+||||+||++.||++|.+.|.+.++.+++..|..                    +.
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            5677899999999999987899999999999999999999999999888877665432                    11


Q ss_pred             CCCCCC---------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          374 ELPAIP---------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       374 ~~~~~~---------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+|+..         ..++.-+.+|++.||+.||.+|++.+|+|.|+||.+.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            112211         3457788999999999999999999999999999643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=410.28  Aligned_cols=261  Identities=34%  Similarity=0.558  Sum_probs=232.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~  231 (444)
                      ....|.+++.||+|+||+|++|.+..++..||+|++.............+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345899999999999999999999999999999977542111111234566779999999999 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEeccccccc-cC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHI-TG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~-~~  309 (444)
                      +|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++... ..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE  174 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence            99999999999999999998899999999999999999999999999999999999999999 99999999999988 46


Q ss_pred             CCCcccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCC-CHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-SDEGK  387 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~  387 (444)
                      .....+.+||+.|+|||++.+.. ....++||||+||+||.|++|+.||...+....+.++.....  .+|.++ +.+++
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~~p~~~~S~~~~  252 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--KIPSYLLSPEAR  252 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--cCCCCcCCHHHH
Confidence            66777889999999999998766 446899999999999999999999998666666666655443  678888 99999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      +||.+||..||.+|+|+.+|++||||+.
T Consensus       253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  253 SLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-52  Score=381.82  Aligned_cols=256  Identities=32%  Similarity=0.566  Sum_probs=236.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|+..+.||.|+||+|.+++.+.+|..||+|++.+.  ........+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~--~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ--KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH--HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            46799999999999999999999999999999988742  2334455678889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.+...  .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998765  6


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      .+.||||.|+|||++.... +..++|.|||||++|||+.|.+||...+....+.+|...+.  .+|..++.++++||+.+
T Consensus       199 ~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKL  275 (355)
T ss_pred             EEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHH
Confidence            7789999999999997666 99999999999999999999999999888888888887765  68899999999999999


Q ss_pred             hhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          394 LQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      |+.|-.+|.     -.++|.+||||+..
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCcccccc
Confidence            999999993     46789999999954

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-51  Score=412.14  Aligned_cols=260  Identities=32%  Similarity=0.554  Sum_probs=240.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      -|++++-||.|+-|.|-+|++..||+.+|||++.+..  .........+.+||.+|+.+.||||+++|+++++...+|+|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            4999999999999999999999999999999997532  23344556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      .||+.||.|++++-+++++++.++.+++.||+.|+.|||..+|+||||||+|+|+|..++|||+|||+|..-.+.....+
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998777777888


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      .||++.|.|||++++.++.+.++||||.|||||.||+|++||.+.+-...+.++..+..  ++|..++.++++||++||.
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHhc
Confidence            99999999999999998778999999999999999999999998777777788877765  7889999999999999999


Q ss_pred             hCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          396 RNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       396 ~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      .||++|.|.+||++|||+......
T Consensus       249 VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  249 VDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             cCccccccHHHHhhCchhhcCCCC
Confidence            999999999999999999875443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-52  Score=402.42  Aligned_cols=262  Identities=31%  Similarity=0.517  Sum_probs=228.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC-
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD-  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-  230 (444)
                      ..++|...+.||.|+||.||+|+.+.+++.||||.++..-   ...+ .-.-.||++.|++|+ ||||+++.+++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf---~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF---YSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh---ccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            3468999999999999999999999999999999886421   1111 123358999999999 999999999998877 


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+|+||||| ..+|+++++.++ .|++..++.|+.||++||+|+|++|+.|||+||||||+..+..|||+|||+|+.+..
T Consensus        84 ~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            999999999 569999998764 499999999999999999999999999999999999999888999999999999988


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC----------------
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK----------------  373 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~----------------  373 (444)
                      ...+...+.|.+|+|||++.....|+.++||||+|||++|+++-++.|.+.+..+++.+|-..-                
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            8888888999999999999888779999999999999999999999999988877776653211                


Q ss_pred             ----CCC--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          374 ----ELP--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       374 ----~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                          .+|        .+-..++.++.+||.+||..||.+||||.|+|+||||+.....
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                111        1224479999999999999999999999999999999976554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-50  Score=400.11  Aligned_cols=260  Identities=36%  Similarity=0.647  Sum_probs=231.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+...|...+.||+|..|.||.|+...+++.||||.+.+.     .....+.+.+|+.+|+..+|+|||.+++.|...+.
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE  344 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec-----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence            4456788899999999999999999999999999998752     22334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +++||||++||+|.|++... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+....
T Consensus       345 LWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999999999999874 69999999999999999999999999999999999999999999999999998876665


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~L  389 (444)
                       ...+.+||++|||||++.... |+.++||||||++++||+-|++||-.......+..+..... .-..++.+|.++++|
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             CccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence             556788999999999997655 99999999999999999999999988676666666654332 234567899999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      |.+||+.|+++|+++.|||+||||+-+.+
T Consensus       503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            99999999999999999999999965543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=377.98  Aligned_cols=247  Identities=32%  Similarity=0.609  Sum_probs=218.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEee-eEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG-SETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~  231 (444)
                      ...+|++.+.||+|.||.||++.+..+|+.+|.|.+..   ...+....+.+..|+.+|++|+|||||++++ .+..+..
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            34579999999999999999999999999999998873   3445566788999999999999999999998 4444444


Q ss_pred             -EEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCceEECCCCcEEEEecc
Q 013354          232 -LYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHA--KN--TVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       232 -~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                       ++||||+|.+|+|..+++..    ..++|..+|+++.|++.||.++|.  ..  |+||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             89999999999999999764    359999999999999999999999  44  9999999999999999999999999


Q ss_pred             ccccccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC-C
Q 013354          303 MAKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-D  380 (444)
Q Consensus       303 la~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~  380 (444)
                      +++.+..... ..+.+|||+||+||.+.... |+.++||||+||++|||+.-+.||.+.+-.....+|... ..+.+| +
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDE  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHH
Confidence            9998866543 34678999999999998776 999999999999999999999999988766777777776 445667 7


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCH
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTA  404 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~  404 (444)
                      .+|.++..||..|+..|++.||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            899999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-49  Score=392.28  Aligned_cols=261  Identities=31%  Similarity=0.517  Sum_probs=230.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|+..+.||+|+||.||+|+.+.||+.||+|++++  .........+.++.|-.+|...++++||+++..|++.+.
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkK--S~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKK--SEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccH--HHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            345789999999999999999999999999999998874  344556677888999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC--
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG--  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~--  309 (444)
                      +||||||++||++..+|.+.+.+++..++.++.+++.|+..||+.|+|||||||+|+|||..|++||+|||++.-+..  
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999852210  


Q ss_pred             ---------------------CCC-------------------------cccccCCCcccCcccccCcCCCChhhhHHHH
Q 013354          310 ---------------------QSC-------------------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSL  343 (444)
Q Consensus       310 ---------------------~~~-------------------------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSl  343 (444)
                                           +..                         ..+.+|||.|+|||++.+.. |+..+|.|||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSL  374 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSL  374 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHH
Confidence                                 000                         11356999999999998766 9999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          344 GCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       344 Gvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      ||||||||.|.+||......+.+.++.+.+..-..|  ..++.+++|||.+||. ||++|.-   ++||.+||||++.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            999999999999999988888888887766433333  4578999999999999 9999975   8899999999953

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-50  Score=392.61  Aligned_cols=257  Identities=31%  Similarity=0.516  Sum_probs=223.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  232 (444)
                      +.|+..+.||+|+||.||+|++..+|+.||+|.+++..   ...+......+||.+|++|+||||+++.+.....  +.+
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN---EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc---CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            56999999999999999999999999999999998643   3344556778999999999999999999987765  789


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |+|+|||+ -+|..++... -+|++.+++.+++||+.||+|||.+||+|||||.+|||||++|.+||+|||+|+++....
T Consensus       194 YlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            99999995 5898888763 369999999999999999999999999999999999999999999999999999876654


Q ss_pred             --CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-----------CCC--
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-----------ELP--  376 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-----------~~~--  376 (444)
                        .....+-|++|+|||++.+...|+.++|+||.||||.||++|++.|.+....+++.+|-+..           .+|  
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence              34556689999999999999999999999999999999999999999888877776653211           111  


Q ss_pred             --------------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          377 --------------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       377 --------------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                                    +....++....+|+..||..||.+|.||.++|+|+||..
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                          111356889999999999999999999999999999943

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-49  Score=361.78  Aligned_cols=260  Identities=29%  Similarity=0.487  Sum_probs=223.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|...+.||+|.||.||+|++..+|+.||||.+++...   .........|||+.|+.++|+||+.++++|...+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~---kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA---KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc---ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            468889999999999999999999999999999986422   22234567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |+||+ ..+|+.+|+... .++..+++.++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+++.+......
T Consensus        79 VfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            99999 569999998754 4899999999999999999999999999999999999999999999999999988765443


Q ss_pred             cc-ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC------CCCC----------
Q 013354          314 LS-IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS------KELP----------  376 (444)
Q Consensus       314 ~~-~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------~~~~----------  376 (444)
                      .. .+-|..|+|||++.+.+.|+..+||||.|||+.||+.+.+-|.+.++.+++..+-..      ..+|          
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            32 357899999999999999999999999999999999999999887777766544211      1111          


Q ss_pred             ----------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          377 ----------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       377 ----------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                                .+...++.++.||+..||..||.+|+|+.|+|+|+||+..+.
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                      122346788899999999999999999999999999997543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-49  Score=396.33  Aligned_cols=259  Identities=28%  Similarity=0.485  Sum_probs=232.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  230 (444)
                      ....+|++.++||+|+||+|+++..+.+++.||||++++  +.....+..+..+.|.+++...+ ||.++.++..|+..+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK--~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKK--GDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeec--cceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            345689999999999999999999999999999999985  33445556678888999888885 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-C
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-G  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~  309 (444)
                      ++|+||||+.||++..+.+ .+.|++..++.++..|+.||.|||++||||||||.+|||+|.+|.+||+|||+++..- .
T Consensus       443 ~l~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999999999555544 3689999999999999999999999999999999999999999999999999998754 5


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .....+++|||.|||||++.+.. |+.++|.|||||+|||||.|..||.+.+..+....|.+..  +.+|.+++.|+.++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSKEAIAI  598 (694)
T ss_pred             CCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCcccHHHHHH
Confidence            56677899999999999998777 9999999999999999999999999988888887776654  46899999999999


Q ss_pred             HHHHhhhCCCCCcCH-----HHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTA-----AWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~-----~elL~hp~~~~~  416 (444)
                      |+++|.+||++|.-.     ++|.+||||+..
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            999999999999864     689999999953

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-50  Score=395.12  Aligned_cols=255  Identities=31%  Similarity=0.569  Sum_probs=229.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|.||+||+|+.+.+.+.||||.+.+   ....+...+.+.+|+++++.++||||+.++++|+....+++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K---~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDK---SGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehh---cCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            479999999999999999999999999999999864   33445567889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc-
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~-  313 (444)
                      |.|||.| +|+.+|...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++.++.+|+||||+|+.+...... 
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9999976 99999999999999999999999999999999999999999999999999999999999999988765543 


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ..+.|||.|||||++.+.. |+..+|+||||||+|||+.|++||...+-......|....  ...|..++.++++||..+
T Consensus       158 tsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CCCcccccHHHHHHHHHH
Confidence            4567999999999998666 9999999999999999999999997655555555554433  345668999999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |.+||.+|.|..+++.|||.+..
T Consensus       235 L~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  235 LIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999854

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=376.55  Aligned_cols=264  Identities=32%  Similarity=0.587  Sum_probs=227.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...+.|++..+||.|.-++||+|+...+++.||||++.+.    ......+.+.+|+..|+.++||||++++..|..+..
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            4567899999999999999999999999999999999763    223347889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +|+||.|+.+|++.++++..  ..+.|..+..|.+++++||.|||.+|-||||||+.||||+.+|.|||+|||.+..+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999999999875  3499999999999999999999999999999999999999999999999998765543


Q ss_pred             CCCc-----ccccCCCcccCccc-ccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-C------
Q 013354          310 QSCP-----LSIKGSPYWMAPEV-IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-P------  376 (444)
Q Consensus       310 ~~~~-----~~~~gt~~y~APE~-~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~------  376 (444)
                      ....     ..+.||++|||||+ ..+..+|+.|+||||||++..||.+|..||..+.....+....+.... +      
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            3211     34579999999999 666778999999999999999999999999998877655433222211 1      


Q ss_pred             -CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          377 -AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       377 -~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                       +....++..++.+|..||++||++|||+.++|+|+||+.....
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence             1123467789999999999999999999999999999976443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-49  Score=388.55  Aligned_cols=251  Identities=32%  Similarity=0.514  Sum_probs=220.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcE-EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-E
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-K  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~-vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~  231 (444)
                      ...+...+.||+|+||+||+|.++  |.. ||+|++.....   .....+.|.+|+.+|.+++|||||+++|++.... .
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF---DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            345666677999999999999887  555 99998864222   2222789999999999999999999999999877 7


Q ss_pred             EEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCceEECCCC-cEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD--YGQLGESAIRSYTQQILSGLEYLHAKN-TVHRDIKGANILVDPSG-RVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~  307 (444)
                      +++||||+.+|+|.+++.+  ...++...+..++.||+.||.|||+++ |||||||++||||+.++ .+||+|||+++..
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999999988  578999999999999999999999999 99999999999999997 9999999999877


Q ss_pred             cCC-CCcccccCCCcccCcccccC-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          308 TGQ-SCPLSIKGSPYWMAPEVIKN-SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       308 ~~~-~~~~~~~gt~~y~APE~~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ... .......||+.|||||++.+ ...|+.++|||||||+||||+||+.||...........+......+.++..+++.
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            654 33344679999999999985 2449999999999999999999999999988877777777677778899999999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +..||.+||+.||++||++.+|+.
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999998654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-48  Score=385.92  Aligned_cols=256  Identities=30%  Similarity=0.539  Sum_probs=224.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|++...  ........+.+.+|+.++++++||||+++++++..++.++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            35799999999999999999999999999999998632  1122334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998764432  


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+....  ..++..++.++++||++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~  249 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGRARDLVKGL  249 (329)
T ss_pred             ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCCCCHHHHHHHHHH
Confidence            3456999999999997665 7899999999999999999999998765555555554432  356778999999999999


Q ss_pred             hhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      |+.||++|++     ++++++||||++.
T Consensus       250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        250 LQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            9999999997     7999999999863

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-48  Score=379.02  Aligned_cols=255  Identities=33%  Similarity=0.521  Sum_probs=223.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++...  ........+.+.+|+.+++.++||||+++++++.++..+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            3689999999999999999999999999999988642  11222345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  ..
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~  156 (291)
T cd05612          79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TW  156 (291)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999876432  23


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...|++.|+|||++.+.. ++.++|||||||++|||++|+.||...........+....  ..++..++.++++||++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHHHHHHHHc
Confidence            456899999999987655 8999999999999999999999998766555555554433  3567778999999999999


Q ss_pred             hhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          395 QRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       395 ~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      +.||.+|++     ++++++||||+..
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCC
Confidence            999999995     9999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-48  Score=383.93  Aligned_cols=251  Identities=30%  Similarity=0.475  Sum_probs=217.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      ++||+|+||.||+|+++.+|+.||+|+++..  ..........+.+|+.+++.++||||+++++++..++.+++||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKE--VIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999999999999999998642  11223445677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccCC
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGS  319 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  319 (444)
                      +++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            999999999888899999999999999999999999999999999999999999999999999875422 2223345699


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||++||+
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999997665 8999999999999999999999997765544444443322  356778999999999999999999


Q ss_pred             CCc-----CHHHHHhCCCCCCC
Q 013354          400 HRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       400 ~Rp-----t~~elL~hp~~~~~  416 (444)
                      +||     ++.++++||||...
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCC
Confidence            999     89999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=362.74  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=229.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+.|.+.++||+|.|+.||++.+..+|+.+|+|++...+...   ...+.+.+|+.+.+.|+|||||++++....++..|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            457899999999999999999999999999999987543322   25678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~~~~~~  310 (444)
                      +|+|++.|++|..-|-.+--++|..+-.+++||+++|.|+|.+||||||+||+|+|+..   ..-+||+|||++..+...
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999999999766655457899999999999999999999999999999999999943   345999999999999866


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~  388 (444)
                      .......|||.|||||+++... |+..+|||+-||+||-||.|++||.+.+....+++|..+...  +...+.+++++++
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            6667788999999999998777 999999999999999999999999987777777777655432  2345789999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||..||.+|.|+.|.|+|||+.+-
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999863

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-49  Score=374.32  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=238.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..-+|++.+.||+|+||.|-+|.....|+.||||.|++  +...++...-.+.+||++|+.|+||||+.+|++|+..+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK--dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK--DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh--hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            34579999999999999999999988999999998874  4556777788999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      .|||||..+|.|+|++.+++.+++.+++.+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+.....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999888888


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ..+++|++-|.+||++.+..+-.+.+|-|||||+||-|..|.+||.+.+......+|.++...   ...-+.++.-||+.
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRw  285 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRW  285 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHH
Confidence            889999999999999988886678999999999999999999999998888888888776653   22346778899999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ||..||++|.|+++|..|-|++=
T Consensus       286 mLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHhcCcccchhHHHHhhhheeec
Confidence            99999999999999999999873

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.9e-47  Score=377.48  Aligned_cols=257  Identities=30%  Similarity=0.468  Sum_probs=212.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|+..+.||+|+||.||+|++..+++.||||++...    ......+.+.+|+.+++.++|+||+++++++..++.+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            346788999999999999999999999999999988531    2344557788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+.    ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999999999998653    3467788899999999999999999999999999999999999999999999987643321


Q ss_pred             -cccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh--hhHHhcCCCCCCCCCCCCCHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~s~~  385 (444)
                       .....||..|+|||++...    ...+.++|||||||++|||++|+.||.......  ...........+..+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence             2345689999999987432    224568999999999999999999997432211  111111122234566788999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      +++||.+||+.||++|||+.|+|+||||....
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            99999999999999999999999999998863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-50  Score=384.90  Aligned_cols=258  Identities=41%  Similarity=0.716  Sum_probs=232.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ...|...++||+|.||.||+|.+..+++.||||++.+.    ..+...+.+.+|+.+|.+++++||.++|+.+..+..++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            34688889999999999999999999999999999763    34455678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      ++||||.||++.++++....+.+..+.-++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+..... 
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999999999876679999999999999999999999999999999999999999999999999988765443 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ..+++||+.|||||+++ ..+|+.++||||||++.|||++|.+||.+......++-|.+. ..|.+...++..+++||..
T Consensus       168 r~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~-~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS-APPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             cccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC-CCCccccccCHHHHHHHHH
Confidence            36788999999999998 445999999999999999999999999988876666655544 4467778999999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||++||+.||+|.++|+|+|++.+.
T Consensus       246 CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HhhcCcccCcCHHHHhhhHHHHhcC
Confidence            9999999999999999999999843

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-49  Score=352.71  Aligned_cols=256  Identities=31%  Similarity=0.548  Sum_probs=233.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++++.||+|-||.||+|+.+.++-.||+|++.+.  ........+++.+|+++-+.|+||||+++|++|.++..+|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs--qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS--QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH--HHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            46799999999999999999999999999999998642  2333445578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQ--DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +++||..+|+|+..|+  ...++++...+.++.|++.||.|+|.++||||||||+|+|++.++.+||+|||-+.... ..
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CC
Confidence            9999999999999999  55679999999999999999999999999999999999999999999999999998765 55


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ...+.+||..|.+||+..+.. ++..+|+|++|++.||++.|.+||......+.+.++.+...  .+|..++.+++|||.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p~~is~~a~dlI~  254 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFPSTISGGAADLIS  254 (281)
T ss_pred             CceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCCcccChhHHHHHH
Confidence            667889999999999997766 89999999999999999999999999888888888876654  567999999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      +||.++|.+|.+..|+++|||+..
T Consensus       255 ~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-47  Score=379.03  Aligned_cols=256  Identities=30%  Similarity=0.501  Sum_probs=220.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...  .......+.+.+|+.++..++|+||+++++++...+..|+|
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            6999999999999999999999999999999986421  12233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ....
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999999888899999999999999999999999999999999999999999999999999986544  2334


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC---CCCC---CCCCHHHHHH
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL---PAIP---DHLSDEGKDF  389 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~---~~~s~~l~~L  389 (444)
                      ..||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+......   +...   ..++.++.+|
T Consensus       158 ~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l  236 (333)
T cd05600         158 VVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL  236 (333)
T ss_pred             cccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence            56999999999997765 899999999999999999999999876655544444322211   1111   2568999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |.+||..+|++||+++++++||||++.
T Consensus       237 i~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         237 ITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-47  Score=369.77  Aligned_cols=259  Identities=26%  Similarity=0.409  Sum_probs=218.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |+..+.||+|+||.||+|.+..+++.||+|.+....  .........+.+|+.++++++|+||+++++.+..++.+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            788999999999999999999999999999886421  112223356778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          237 EYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       237 e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||+.+++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..........
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            999999999888653  358999999999999999999999999999999999999999999999999998765444444


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCCCCCCCCCCCCHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ...|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.  .......++..++.++.+||++
T Consensus       160 ~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  238 (285)
T cd05631         160 GRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM  238 (285)
T ss_pred             CCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence            556899999999997665 8999999999999999999999997654322211111  1112234667789999999999


Q ss_pred             HhhhCCCCCcC-----HHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPT-----AAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt-----~~elL~hp~~~~~~~  418 (444)
                      ||+.||++||+     ++++++||||.+...
T Consensus       239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            99999999997     899999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-47  Score=382.17  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=217.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|.++.+++.||+|+++..  ..........+.+|+.++.+++|+||+++++.+.+...+|+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3689999999999999999999999999999998632  11233445678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      ||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987543211   


Q ss_pred             ---------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 013354          312 ---------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       312 ---------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~  358 (444)
                                                       .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             012346999999999997655 8999999999999999999999998


Q ss_pred             CCCChhhhHHhcCCCCCCCCCC--CCCHHHHHHHHHHhh--hCCCCCcCHHHHHhCCCCCCC
Q 013354          359 QYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCLQ--RNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~Li~~~L~--~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .......+..+........++.  .+++++++||.+|+.  .++..||+++||++||||++.
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            7666666665554332223332  478999999999765  233356899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=378.43  Aligned_cols=263  Identities=29%  Similarity=0.463  Sum_probs=220.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---------cccHHHHHHHHHHHHHHHccCCCCeeeEee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---------AKSKESAQQLGQEIALLSRLRHPNIVRYYG  224 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---------~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~  224 (444)
                      ..+|++.+.||+|.||.|-+|++..+++.||||++.+....         .......+...+||.+|++|+|+|||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            45799999999999999999999999999999998643211         011112468899999999999999999999


Q ss_pred             eEEc--CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          225 SETL--DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       225 ~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                      +..+  .+.+|||+|||..|.+...-.....+++.+++.++++++.||+|||.+|||||||||+|+||+.+|.+||+|||
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG  255 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG  255 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence            8765  57899999999988876654433339999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC------CCCcccccCCCcccCcccccCc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC
Q 013354          303 MAKHITG------QSCPLSIKGSPYWMAPEVIKNS---NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       303 la~~~~~------~~~~~~~~gt~~y~APE~~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      .+..+..      +.......|||.|+|||+...+   ...+.+.||||+||+||.|+.|+.||-.....+.+.+|.+..
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p  335 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP  335 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence            9886622      2222346699999999998763   335689999999999999999999998877778888877655


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ..-.....+.+++++||++||++||++|.++.+|..|||....
T Consensus       336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            4322233579999999999999999999999999999999754

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-48  Score=362.41  Aligned_cols=259  Identities=29%  Similarity=0.464  Sum_probs=220.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  232 (444)
                      ++|+....|++|+||.||+|+++.|++.||+|.++......   ..--.-.+||.+|.+++|||||.+-++...  -+.+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~---GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE---GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC---CCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            47999999999999999999999999999999998754221   122345689999999999999999987654  4679


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |+|||||+ -+|..++..-+ +|.+.+++.++.|++.||+|||.+.|+|||||++|+|+...|.+||+|||+|+.+....
T Consensus       153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999996 59999998765 79999999999999999999999999999999999999999999999999999987764


Q ss_pred             Cc-ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC------CCCCCC-------
Q 013354          312 CP-LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------SKELPA-------  377 (444)
Q Consensus       312 ~~-~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~~-------  377 (444)
                      .. ...+-|++|+|||++.+.+.|+.++||||+|||+.||+++++.|.+....+++.+|-.      ...+|.       
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            43 3456799999999999999999999999999999999999999988776666555422      111110       


Q ss_pred             ----------------CCC-CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          378 ----------------IPD-HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       378 ----------------~~~-~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                      ++. .+++...+|++.+|.+||.+|.|++|.|+|+||.+.+
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                            111 1568999999999999999999999999999999853

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3e-47  Score=376.41  Aligned_cols=251  Identities=31%  Similarity=0.480  Sum_probs=217.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +.||+|+||.||+++++.+|+.||+|+++...  .........+.+|+.+++.++||||+++++.+..++.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            46999999999999999999999999987421  1223445677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccCC
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGS  319 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  319 (444)
                      +++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            999999998878899999999999999999999999999999999999999999999999999875322 2223345699


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..+++++++||.+||+.||+
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999997665 8999999999999999999999998765555444443322  246778999999999999999999


Q ss_pred             CCc-----CHHHHHhCCCCCCC
Q 013354          400 HRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       400 ~Rp-----t~~elL~hp~~~~~  416 (444)
                      +|+     ++.++++||||.+.
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            998     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-47  Score=378.06  Aligned_cols=257  Identities=30%  Similarity=0.460  Sum_probs=223.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC-cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|++.+.||+|+||.||+|.++.++ ..||+|++....  .......+.+.+|+.+++.++||||+++++++..++.
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            3457999999999999999999876654 789999886321  1223345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999999876432 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                       .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+....  ..++..++.++++||+
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             -cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence             23456999999999997655 7899999999999999999999998766555555554433  2467789999999999


Q ss_pred             HHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +||+.||++|+     +++++++||||++.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999995     89999999999874

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.6e-47  Score=376.66  Aligned_cols=251  Identities=30%  Similarity=0.473  Sum_probs=216.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +.||+|+||.||++.++.+++.||+|++...  ..........+.+|+.+++.++||||+++++++..++.+++||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKE--VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999999999999999998642  11233445678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccCC
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGS  319 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~gt  319 (444)
                      +++|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ........||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            999999998878899999999999999999999999999999999999999999999999999875432 2223345699


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      +.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||++||+
T Consensus       159 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHH
Confidence            9999999997665 8999999999999999999999997755544444443222  356788999999999999999999


Q ss_pred             CCc-----CHHHHHhCCCCCCC
Q 013354          400 HRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       400 ~Rp-----t~~elL~hp~~~~~  416 (444)
                      +|+     ++.|+++||||.+.
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCC
Confidence            997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-47  Score=374.48  Aligned_cols=249  Identities=31%  Similarity=0.475  Sum_probs=215.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|+||.||+|++..+++.||+|+++..  ..........+.+|+.++.+++||||+++++++...+.+++||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA--HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999999999999999988631  1123344567888999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccccCCCc
Q 013354          243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY  321 (444)
Q Consensus       243 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~  321 (444)
                      +|.+++.+.+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++..... .......||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            99999988888999999999999999999999999999999999999999999999999998754322 22334569999


Q ss_pred             ccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 013354          322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR  401 (444)
Q Consensus       322 y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  401 (444)
                      |+|||++.+.. ++.++|||||||++|||++|+.||...........+...  ...++..++.++++||.+||+.||++|
T Consensus       159 y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         159 YLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            99999997655 899999999999999999999999876555544444433  235678899999999999999999999


Q ss_pred             c---CHHHHHhCCCCCCC
Q 013354          402 P---TAAWLLEHPFVGNA  416 (444)
Q Consensus       402 p---t~~elL~hp~~~~~  416 (444)
                      |   ++.++|+||||.+.
T Consensus       236 ~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            7   57999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8e-49  Score=357.51  Aligned_cols=261  Identities=29%  Similarity=0.454  Sum_probs=231.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc---ccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---KSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      ..|...+.||.|..+.|.++.++.+|+.+|+|++.......   ...+..+...+|+.+|+++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            35778899999999999999999999999999997654322   2344556777899999999 6999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++++|+|+|..|.|+|+|.+.-.++|...+.|++||++|+.|||.++||||||||+|||++++.++||+|||+++.+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999999888


Q ss_pred             CCcccccCCCcccCccccc-----CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCC
Q 013354          311 SCPLSIKGSPYWMAPEVIK-----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLS  383 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~-----~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s  383 (444)
                      ......+|||+|+|||.++     +..+|+..+|+|++|||||-||.|.+||......-.+..|..++..  ....+.++
T Consensus       177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis  256 (411)
T KOG0599|consen  177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS  256 (411)
T ss_pred             hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence            8888899999999999875     4567899999999999999999999999776555555656555443  23345689


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .+.++||.+||+.||.+|.|++|+|.||||..
T Consensus       257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             ccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            99999999999999999999999999999964

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=381.09  Aligned_cols=247  Identities=31%  Similarity=0.500  Sum_probs=216.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+.+++.+.||+|.||.||+|.+.. ...||+|.++..      ....+.|.+|+.+|++|+|+|||+++++|..++.+|
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG------SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc------ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            3456667789999999999999875 457999998732      223357779999999999999999999999988999


Q ss_pred             EEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQD--YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |||||+..|+|.++|+.  ...+...+.+.++.||++||+||+++++|||||.+.||||+++..+||+|||+|+...++.
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999999997  4569999999999999999999999999999999999999999999999999999544332


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      -.  ....-...|.|||.+..+. ++.+||||||||+||||+| |+.||.++...+.+..+..+.++| .|+.||+++.+
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-~P~~CP~~vY~  435 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-RPEGCPDEVYE  435 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-CCCCCCHHHHH
Confidence            11  1122346799999998777 9999999999999999999 999999999999999999999996 48899999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +|+.||+.+|++|||++.+..
T Consensus       436 lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  436 LMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999996543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=363.54  Aligned_cols=269  Identities=28%  Similarity=0.467  Sum_probs=227.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----  228 (444)
                      ..+|...+.||+|+||.|..|+++.+|+.||||.+.   +.....-..++..+|+++|+.++|+||+.+++++..     
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~---~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL---NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhh---hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            346777889999999999999999999999999875   223555667889999999999999999999998765     


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      -..+|+|+|++ +.+|.++++....+++..+..++.||+.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+...
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence            35689999999 77999999987779999999999999999999999999999999999999999999999999999886


Q ss_pred             C---CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------
Q 013354          309 G---QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------  371 (444)
Q Consensus       309 ~---~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------  371 (444)
                      .   .......+-|..|.|||++.+...|+.++||||+||||.||++|++.|.+.+...++..+..              
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   33334566899999999999888899999999999999999999999988776555443321              


Q ss_pred             ----------CCCCC-----CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC-CCCcCCCCCC
Q 013354          372 ----------SKELP-----AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA-APLERPILSA  426 (444)
Q Consensus       372 ----------~~~~~-----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~-~~~~~~~~~~  426 (444)
                                ....+     .+-.+.++++.+|+.+||..||.+|+|++|+|+||||... .+...|..+.
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~  327 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP  327 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence                      11111     1225789999999999999999999999999999999864 4444454443

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-47  Score=381.50  Aligned_cols=258  Identities=30%  Similarity=0.505  Sum_probs=219.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|++..+++.||||++...  ..........+.+|+.++..++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS--EMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            3699999999999999999999999999999998642  11223445678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      ||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....   
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987543211   


Q ss_pred             ------------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCC
Q 013354          312 ------------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP  355 (444)
Q Consensus       312 ------------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~  355 (444)
                                                          .....+||+.|+|||++.... ++.++|||||||++|||++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCC
Confidence                                                011245899999999987655 8999999999999999999999


Q ss_pred             CCCCCCChhhhHHhcCCCCCCCCCC--CCCHHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          356 PWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       356 Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      ||...+.......+........++.  .+++++++||++||. +|.+|++   ++|+++||||++.
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9987665555555443332222232  578999999999996 9999998   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8e-47  Score=381.73  Aligned_cols=258  Identities=29%  Similarity=0.462  Sum_probs=216.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|++.+.||+|+||+||+|+++.+++.||+|++...  ........+.+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK--DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            589999999999999999999999999999998631  122344557789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC----
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS----  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~----  311 (444)
                      |||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999875321000    


Q ss_pred             --------------------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHH
Q 013354          312 --------------------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV  347 (444)
Q Consensus       312 --------------------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil  347 (444)
                                                                  ......||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence                                                        012346999999999997655 89999999999999


Q ss_pred             HHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHHHHHHh--hhCCCCCcCHHHHHhCCCCCCC
Q 013354          348 IEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCL--QRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       348 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L--~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |||++|+.||...........+........++  ..++.++++||.+|+  ..++..|++++++++||||.+.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999998766544444443322222233  357999999999955  4555669999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-47  Score=367.00  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=211.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|+++.+++.||+|+++...   ......+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            6999999999999999999999999999999987422   2233456778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--Cc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--CP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--~~  313 (444)
                      |||+.++.+..+......+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            9999988777666555679999999999999999999999999999999999999999999999999998764322  22


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------------C
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------------K  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------------~  373 (444)
                      ....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...                    .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            2346899999999997665 899999999999999999999999865443322211100                    0


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 ELP----------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ~~~----------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..+          .....++.++++||++||++||++|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000          0112478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-46  Score=365.51  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=210.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|+++....    ......+.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc----CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            579999999999999999999999999999999864321    1123456789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            999996 49999887654 47999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------------  372 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------------  372 (444)
                      .....+++.|+|||++.+...++.++|||||||++|||++|+.||......+.+..+...                    
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            233457899999999876556899999999999999999999999765543322211100                    


Q ss_pred             CCCC--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 KELP--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ~~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ...+        .....++.++++||++||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0000        1123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-47  Score=381.67  Aligned_cols=257  Identities=30%  Similarity=0.506  Sum_probs=216.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.++.+++.||||++...  ........+.+.+|+.++++++||||+++++++.....+|+|
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            689999999999999999999999999999988632  112234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC----
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS----  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~----  311 (444)
                      |||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999986332100    


Q ss_pred             --------------------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHH
Q 013354          312 --------------------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV  347 (444)
Q Consensus       312 --------------------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil  347 (444)
                                                                  ......||+.|+|||++.+.. ++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhh
Confidence                                                        001245899999999997655 89999999999999


Q ss_pred             HHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCC--CCCHHHHHHHHHHhhhCCCCC---cCHHHHHhCCCCCCC
Q 013354          348 IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCLQRNPLHR---PTAAWLLEHPFVGNA  416 (444)
Q Consensus       348 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~Li~~~L~~dP~~R---pt~~elL~hp~~~~~  416 (444)
                      |||++|..||........+..+........++.  .++.++++||.+||. +|.+|   +++.|+++||||++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999987665555555543322223333  578999999999997 66665   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-47  Score=379.00  Aligned_cols=258  Identities=31%  Similarity=0.497  Sum_probs=221.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...  .........+.+|+.++..++|+||+++++++..++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD--MIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH--HhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            36999999999999999999999999999999987421  1222345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      ||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998654433   


Q ss_pred             ---------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh
Q 013354          312 ---------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP  364 (444)
Q Consensus       312 ---------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  364 (444)
                                                 ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       123345899999999997765 8999999999999999999999998877555


Q ss_pred             hhHHhcCCCCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcC-HHHHHhCCCCCCC
Q 013354          365 AMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPT-AAWLLEHPFVGNA  416 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt-~~elL~hp~~~~~  416 (444)
                      ....+........++  ..++.++.+||.+||. ||++|++ ++++++||||++.
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            555554422211222  2369999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=375.08  Aligned_cols=261  Identities=33%  Similarity=0.538  Sum_probs=231.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  230 (444)
                      .....|.+.+.||+|.||.||+++.+.+|+.+|+|.+.+...  ......+.+.+|+.+|+++. |||||.++++|+...
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~--~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKL--RGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhc--cccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            345679999999999999999999999999999999975332  22225578899999999998 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC----CcEEEEecccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS----GRVKLADFGMAKH  306 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~  306 (444)
                      .+++|||+|.||.|++.+.+. .+++..+..++.||+.+++|||+.||+||||||+|+|+...    +.+|++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999886 59999999999999999999999999999999999999543    4799999999999


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC--CCCCCCCCCH
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE--LPAIPDHLSD  384 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~  384 (444)
                      ..........+||++|+|||++.... |+..+||||+||++|.|++|..||...........+.....  .....+.++.
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            88766677888999999999997555 99999999999999999999999998777666666665543  2334466899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+++||+.||..||.+|+|+.++|+|||+++.
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999999875

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-46  Score=354.86  Aligned_cols=258  Identities=45%  Similarity=0.869  Sum_probs=225.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|+..+.||+|+||.||+|.+..+++.||+|.+.............+.+.+|+.++++++|+||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            35899999999999999999999999999999987543333334445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc-
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~-  313 (444)
                      |+||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998765432211 


Q ss_pred             ---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          314 ---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       314 ---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                         ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...+..............+.++..++.++.+||
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence               2345788999999998766 889999999999999999999999876666555555555455567888999999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ++||..+|++|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.2e-46  Score=369.38  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=218.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||++++..++..+|+|.+...    ......+.+.+|+.++++++|+||+++++++..++.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999999999999999988642    23345578899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++.+...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999999999888899999999999999999999986 69999999999999999999999999987664332 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC---------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---------------------  371 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------------------  371 (444)
                      .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+..                     
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            23456899999999997665 89999999999999999999999965432221111000                     


Q ss_pred             ------------------------CCCCCCC-CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          372 ------------------------SKELPAI-PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       372 ------------------------~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                                              ....+.. ...++.++++||++||++||++|||+++|++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  310 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence                                    0001111 22468899999999999999999999999999999875443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-46  Score=380.27  Aligned_cols=257  Identities=30%  Similarity=0.484  Sum_probs=217.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|...+.||+|+||+||+|++..+++.||+|++...  ........+.+.+|+.++++++|+||+++++.+..++.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            589999999999999999999999999999988631  122344567888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-----
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-----  310 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-----  310 (444)
                      |||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+...     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            999999999999988788999999999999999999999999999999999999999999999999997532100     


Q ss_pred             -------------------------------------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHH
Q 013354          311 -------------------------------------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV  347 (444)
Q Consensus       311 -------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil  347 (444)
                                                                 .......||+.|+|||++.+.. ++.++|||||||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence                                                       0012346899999999997655 89999999999999


Q ss_pred             HHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          348 IEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       348 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      |||++|+.||...+.......+........++  ..+++++.+||.+|+ .+|++|++   ++++++||||+..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999998766555554444322222222  467999999999987 59999997   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-46  Score=371.66  Aligned_cols=251  Identities=30%  Similarity=0.484  Sum_probs=215.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|+++.+++.||+|++....  .......+.+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999886321  11223445677788888776 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            9999999999888899999999999999999999999999999999999999999999999999875432 222334569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++++||++||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCH
Confidence            99999999997655 8899999999999999999999998766655555554433  35677899999999999999999


Q ss_pred             CCCcCH------HHHHhCCCCCCC
Q 013354          399 LHRPTA------AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~------~elL~hp~~~~~  416 (444)
                      ++|+++      +++++||||.+.
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCC
Confidence            999998      899999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-47  Score=361.71  Aligned_cols=260  Identities=30%  Similarity=0.448  Sum_probs=224.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+.|++.+.||+|.-|+||++..+.++..+|+|++.+  ..........+...|-+||+.++||.++.+|..++.+...
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK--~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDK--ESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecH--HHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            34679999999999999999999999999999999864  2233355567778899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-
Q 013354          233 YIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-  309 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-  309 (444)
                      |+|||||.||+|+.++++..  .|++..++.++.+++.||+|||-.|||+|||||+||||-++|+|.|+||.++..... 
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999999998753  599999999999999999999999999999999999999999999999998742200 


Q ss_pred             --------------------------------C-C-----------------------CcccccCCCcccCcccccCcCC
Q 013354          310 --------------------------------Q-S-----------------------CPLSIKGSPYWMAPEVIKNSNG  333 (444)
Q Consensus       310 --------------------------------~-~-----------------------~~~~~~gt~~y~APE~~~~~~~  333 (444)
                                                      . .                       ...+++||-+|+|||++.+.. 
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-
Confidence                                            0 0                       012356999999999998665 


Q ss_pred             CChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHHHHhhhCCCCCcC----HHHHH
Q 013354          334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVRKCLQRNPLHRPT----AAWLL  408 (444)
Q Consensus       334 ~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt----~~elL  408 (444)
                      .+.++|.|+|||+|||||.|..||.+.+..+.+..+..... .|..+ .++..++|||+++|.+||++|.-    +.||-
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            89999999999999999999999999888888777654332 33333 67899999999999999999999    99999


Q ss_pred             hCCCCCCC
Q 013354          409 EHPFVGNA  416 (444)
Q Consensus       409 ~hp~~~~~  416 (444)
                      +||||+..
T Consensus       391 ~HpFF~gV  398 (459)
T KOG0610|consen  391 RHPFFEGV  398 (459)
T ss_pred             cCccccCC
Confidence            99999964

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.7e-47  Score=380.32  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=217.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...  ........+.+.+|+.+++.++|+||+++++.+..++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            3699999999999999999999999999999988631  11223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC----
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ----  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~----  310 (444)
                      ||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...    
T Consensus        79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999997532100    


Q ss_pred             ----------------------------------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHH
Q 013354          311 ----------------------------------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM  350 (444)
Q Consensus       311 ----------------------------------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~el  350 (444)
                                                              .......||+.|+|||++.+.. ++.++|||||||++|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeeh
Confidence                                                    0011246999999999997655 89999999999999999


Q ss_pred             HcCCCCCCCCCChhhhHHhcCCCCCCCC--CCCCCHHHHHHHHHHhhhCCCCCc---CHHHHHhCCCCCCC
Q 013354          351 ATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDEGKDFVRKCLQRNPLHRP---TAAWLLEHPFVGNA  416 (444)
Q Consensus       351 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~Li~~~L~~dP~~Rp---t~~elL~hp~~~~~  416 (444)
                      ++|+.||...+.......+........+  ...++.++.+||.+|+ .+|++|+   ++.++++||||+..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999999876655544444332222222  2368999999999987 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.6e-47  Score=373.66  Aligned_cols=251  Identities=31%  Similarity=0.487  Sum_probs=216.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +.||+|+||.||++.+..+++.||+|++....  .........+.+|++++..++|+||+++++++..++.+++||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV--IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999999999999999987421  1223345677789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccccC
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKG  318 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~~g  318 (444)
                      +++|.+++.+...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++..... .......|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999999887889999999999999999999997 79999999999999999999999999998754322 22234569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhhcCH
Confidence            99999999997665 8999999999999999999999997765544444443322  25677899999999999999999


Q ss_pred             CCCc-----CHHHHHhCCCCCCC
Q 013354          399 LHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ++|+     ++.++++||||.+.
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCC
Confidence            9997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-46  Score=366.82  Aligned_cols=259  Identities=26%  Similarity=0.460  Sum_probs=210.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++....    ......+.+|+.+++.++|+||+++++++..+...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE----EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc----cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            579999999999999999999999999999999864321    1122456789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++.+. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999995 6788777654 568999999999999999999999999999999999999999999999999987543222 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhcC---C---C------CCCC--
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGN---S---K------ELPA--  377 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~---~---~------~~~~--  377 (444)
                      .....+++.|+|||++.+...++.++|||||||++|||++|..||....... .+..+..   .   .      ..+.  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            2345588999999998766558899999999999999999999997654321 1111100   0   0      0000  


Q ss_pred             -------C---------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          378 -------I---------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       378 -------~---------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                             .         ....+.++++||.+||+.||++|||++|+|+||||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                   0         0124578999999999999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-46  Score=369.85  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=210.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC-----C
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD-----D  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~  230 (444)
                      +|++.+.||+|+||.||+|+++.+++.||||++....   ........+.+|+.+++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            5899999999999999999999999999999886321   2223345788999999999999999999987543     3


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|+||||+ +++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            589999999 5799999988788999999999999999999999999999999999999999999999999999764322


Q ss_pred             CC----cccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh----------------
Q 013354          311 SC----PLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----------------  369 (444)
Q Consensus       311 ~~----~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----------------  369 (444)
                      ..    .....|++.|+|||++.+. ..++.++|||||||++|||++|+.||...+....+..+                
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21    1234689999999998652 34789999999999999999999999765432211110                


Q ss_pred             -----------cCCCCC--CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          370 -----------GNSKEL--PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       370 -----------~~~~~~--~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                                 ......  ......++.++.+||.+||+.||++|||++|+|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                       000000  0111346788999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-46  Score=368.00  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=219.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC-CeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP-NIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~l  234 (444)
                      +|++.+.||+|+||.||+|+++.+++.||+|++....  .......+.+..|+.++..++|+ +|+++++++...+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            4889999999999999999999999999999987421  12233456778899999999765 68889999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CCCCc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~~~~  313 (444)
                      ||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987532 22223


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+....  ..++..++.++.+||++|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHH
Confidence            3456899999999997665 8899999999999999999999998766555555554432  356778999999999999


Q ss_pred             hhhCCCCCcCH-----HHHHhCCCCCCC
Q 013354          394 LQRNPLHRPTA-----AWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt~-----~elL~hp~~~~~  416 (444)
                      |++||++|++.     +++++||||+..
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999986     799999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-46  Score=370.00  Aligned_cols=258  Identities=31%  Similarity=0.510  Sum_probs=216.8

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      +|++.+.||+|+||.||++++.   .+++.||+|++..... .......+.+.+|+.++..+ +|+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            4889999999999999999874   4789999999863211 12233456778899999999 58999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +++||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998653322


Q ss_pred             --CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhh-HHhcCCCCCCCCCCCCCHH
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM-FKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~-~~~~~~~~~~~~~~~~s~~  385 (444)
                        ......||+.|+|||++.+...++.++|||||||++|||++|+.||......   ... ..+.  ...+.++..++.+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  237 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGPE  237 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHH
Confidence              2234569999999999976555788999999999999999999999643322   111 1222  2234567789999


Q ss_pred             HHHHHHHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +++||.+||+.||++||     +++++++||||++.
T Consensus       238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-46  Score=369.87  Aligned_cols=251  Identities=27%  Similarity=0.471  Sum_probs=212.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|++..+++.||+|+++..  ........+.+.+|+.++..+ +||||+++++++..+..+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE--LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4699999999999999999999999998742  112234456788899999988 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc-cCCCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-~~~~~~~~~~g  318 (444)
                      .+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..........|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999999988888999999999999999999999999999999999999999999999999998753 22333345679


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--------hhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--------VPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||.....        ........... ...+|..++.++.+||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCCCCCHHHHHHH
Confidence            99999999997655 88999999999999999999999963211        11112211122 2356788999999999


Q ss_pred             HHHhhhCCCCCcC------HHHHHhCCCCCC
Q 013354          391 RKCLQRNPLHRPT------AAWLLEHPFVGN  415 (444)
Q Consensus       391 ~~~L~~dP~~Rpt------~~elL~hp~~~~  415 (444)
                      ++||+.||++|++      ++++++||||.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999987      789999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-46  Score=368.01  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=215.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHH---HccCCCCeeeEeeeEEcCCEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL---SRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      |++.+.||+|+||.||+|.++.+++.||||+++...  .......+.+.+|++++   +.++||||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD--IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            678899999999999999999999999999987421  11223345566666554   5678999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~  312 (444)
                      +||||+.+++|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus        79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence            99999999999998865 5799999999999999999999999999999999999999999999999999875332 222


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~  234 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIMRR  234 (324)
T ss_pred             ccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence            33456999999999997655 8999999999999999999999998766555555554433  24677899999999999


Q ss_pred             HhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ||+.||.+||     ++.++++||||++.
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999999     79999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.8e-46  Score=369.00  Aligned_cols=250  Identities=28%  Similarity=0.446  Sum_probs=215.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|+++.+++.||+|+++..  ........+.+..|.+++..+ +||||+++++++..++.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4699999999999999999999999998642  112233445677888888866 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            9999999998888899999999999999999999999999999999999999999999999999875432 222334568


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+....  ..++..++.++.+||++||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCH
Confidence            99999999997655 8999999999999999999999998776656555554433  24567889999999999999999


Q ss_pred             CCCc-------CHHHHHhCCCCCC
Q 013354          399 LHRP-------TAAWLLEHPFVGN  415 (444)
Q Consensus       399 ~~Rp-------t~~elL~hp~~~~  415 (444)
                      ++|+       +++++++||||..
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCC
Confidence            9999       9999999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-46  Score=375.16  Aligned_cols=261  Identities=27%  Similarity=0.446  Sum_probs=221.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+.+|+.+++.++||||+++++++..+..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            346899999999999999999999999999999998631  112223345677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999999976 4689999999999999999999999999999999999999999999999999987643321


Q ss_pred             --cccccCCCcccCcccccCcC---CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCC--CCCHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSN---GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDE  385 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~  385 (444)
                        .....||+.|+|||++.+..   .++.++|||||||++|||++|+.||........+..+........++.  .++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence              23456999999999986432   378899999999999999999999988766666666654433233444  57999


Q ss_pred             HHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      +++||++||+.+|++  |++++++++||||++.
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-46  Score=368.17  Aligned_cols=252  Identities=33%  Similarity=0.535  Sum_probs=215.8

Q ss_pred             eeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|+||.||++++.   .+++.||+|+++.... .........+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            67999999999999863   4689999999864211 1122334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSI  316 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~  316 (444)
                      |+.+++|.+++.+.+.+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999998754332 223345


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR  396 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~  396 (444)
                      .|++.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||++
T Consensus       161 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccc
Confidence            6999999999997655 7899999999999999999999998766555555554433  356788999999999999999


Q ss_pred             CCCCCc-----CHHHHHhCCCCCCC
Q 013354          397 NPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       397 dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ||++||     +++++++||||...
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-46  Score=371.46  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=220.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+++++.+++.||+|+++..  .....+..+.+.+|+.+++.++|+||+++++++..++.+++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS--VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            689999999999999999999999999999998742  112334556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc-
Q 013354          236 LEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~-  313 (444)
                      |||+++++|.+++.+. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+...... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999999876 67999999999999999999999999999999999999999999999999999876543322 


Q ss_pred             -ccccCCCcccCcccccC-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHH
Q 013354          314 -LSIKGSPYWMAPEVIKN-----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDE  385 (444)
Q Consensus       314 -~~~~gt~~y~APE~~~~-----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~  385 (444)
                       ....||+.|+|||++..     ...++.++|||||||++|||++|+.||........+..+........++  ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence             23458999999999863     3347889999999999999999999998766655555554433322333  357999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +.+||..||+ ||++||+++++++||||...
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999997 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.8e-45  Score=376.81  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC------CCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR------HPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv~l~~~~  226 (444)
                      ...+|++.++||+|+||+||+|.+..+++.||||+++..      ......+..|+.++..++      |.+++++++++
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            346899999999999999999999999999999998631      112234455666666654      45688898888


Q ss_pred             EcC-CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCC----------
Q 013354          227 TLD-DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSG----------  294 (444)
Q Consensus       227 ~~~-~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~----------  294 (444)
                      ..+ ..+++|||++ +++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++          
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            764 5789999988 78999999888889999999999999999999998 5999999999999998665          


Q ss_pred             ------cEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHH
Q 013354          295 ------RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK  368 (444)
Q Consensus       295 ------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~  368 (444)
                            .+||+|||.+....  .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999876432  2233466999999999997765 89999999999999999999999976554332221


Q ss_pred             hcCC-------------------------CCCCCC---------------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHH
Q 013354          369 IGNS-------------------------KELPAI---------------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       369 ~~~~-------------------------~~~~~~---------------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL  408 (444)
                      +...                         ...+..               ....+..+.+||.+||++||++|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            1100                         000000               001245678999999999999999999999


Q ss_pred             hCCCCCCCCC
Q 013354          409 EHPFVGNAAP  418 (444)
Q Consensus       409 ~hp~~~~~~~  418 (444)
                      +||||....+
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999997544

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-46  Score=374.43  Aligned_cols=258  Identities=28%  Similarity=0.473  Sum_probs=219.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|+..+.||+|+||.||+++++.+++.||+|+++..  ..........+.+|+.++..++|+||+++++.+..++.+|+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3689999999999999999999999999999998631  12233455678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      ||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987542210   


Q ss_pred             ---------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 013354          312 ---------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       312 ---------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~  358 (444)
                                                       ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCC
Confidence                                             012346999999999997665 8999999999999999999999998


Q ss_pred             CCCChhhhHHhcCCCCCCCCCC--CCCHHHHHHHHHHhhhCCCCCc---CHHHHHhCCCCCCC
Q 013354          359 QYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCLQRNPLHRP---TAAWLLEHPFVGNA  416 (444)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~Li~~~L~~dP~~Rp---t~~elL~hp~~~~~  416 (444)
                      .......+..+........++.  .++.++++||.+|+ .||++|+   +++++++||||++.
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            7666665555544332222333  37899999999987 4999998   48999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-46  Score=355.49  Aligned_cols=262  Identities=32%  Similarity=0.549  Sum_probs=221.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCC--
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDD--  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~--  230 (444)
                      ...|...+.||+|+||+||+|+++.+|+.||+|++++..+.   +..-....+|+.+++.|+|+| ||++++++..+.  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            34588888899999999999999999999999999875442   112345678999999999999 999999998877  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          231 ----KLYIYLEYVSGGSIYKILQDYG----QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                          .+++||||+ .-+|.+++....    .++...++.++.||+.||+|||+++|+||||||.||||+++|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                899999999 579999998865    47788999999999999999999999999999999999999999999999


Q ss_pred             cccccc-CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC------CCC
Q 013354          303 MAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS------KEL  375 (444)
Q Consensus       303 la~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------~~~  375 (444)
                      +|+... +.......++|..|+|||++.+...|+..+||||+|||++||++++..|.+.....++..+-..      +.+
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999766 3334556679999999999999878999999999999999999999999987776666554221      111


Q ss_pred             C----------CCC------------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          376 P----------AIP------------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       376 ~----------~~~------------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      |          .++            ...+.+..+++.+||+.+|.+|.|++.+|+||||.+....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            1          001            2234588999999999999999999999999999987443

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=367.59  Aligned_cols=259  Identities=29%  Similarity=0.469  Sum_probs=236.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .-|.+.+.||+|.|+.|-+|++..+|+.||||++.+.+   .+......+.+|+++|+.++|||||++|++......+||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK---lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK---LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc---cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            35889999999999999999999999999999997533   334445688899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE-CCCCcEEEEeccccccccCCCC
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV-DPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |+|+-++|+|+|+|-+. ..+.|+.+++++.||+.|+.|+|+..+|||||||+||.+ ..-|-|||.|||++..+.+...
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999999765 459999999999999999999999999999999999877 5568899999999999888888


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ..+.+|++.|.|||++.+..+..+++||||||||||.|..|++||...+..+.+.+|..-+.  .+|..++.++++||..
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQS  252 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHH
Confidence            88999999999999999888667899999999999999999999999888888888877665  6899999999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||..||.+|.+.++|..|+|++....
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999987533

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.4e-46  Score=365.57  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=219.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|++.+.||+|+||.||+|+++.+++.||+|+++...  .......+.+..|..++..+ +|++|+++++++...+.+++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            4889999999999999999999999999999987421  12233345567788888777 58999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~  313 (444)
                      ||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999875432 2223


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....||+.|+|||++.... ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHHHH
Confidence            3456899999999997665 8999999999999999999999998766655555554433  356778999999999999


Q ss_pred             hhhCCCCCcCH-----HHHHhCCCCCCC
Q 013354          394 LQRNPLHRPTA-----AWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt~-----~elL~hp~~~~~  416 (444)
                      |++||++|++.     .++++||||+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999984     899999999854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.5e-46  Score=366.23  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=213.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|+++.+++.||+|+++....  ......+.+..|..++.. ++|+||+++++++..++.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            469999999999999999999999999874211  112233456667777765 48999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... ........|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            9999999998878899999999999999999999999999999999999999999999999999875322 222344569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+...  .+.++..++.++++||++||+.||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHccCCH
Confidence            99999999997665 899999999999999999999999876555444444332  346678899999999999999999


Q ss_pred             CCCcCH-HHHHhCCCCCCC
Q 013354          399 LHRPTA-AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~-~elL~hp~~~~~  416 (444)
                      ++|+++ +++++||||+..
T Consensus       236 ~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHcCCChHHHHcCCCcCCC
Confidence            999998 589999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-46  Score=367.05  Aligned_cols=251  Identities=30%  Similarity=0.486  Sum_probs=211.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHH-HHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||+||+|+++.+++.||+|++....  .......+.+.+|.. +++.++||||+++++.+...+.+++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA--ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            46999999999999999999999999986421  112222344445544 568899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            9999999999888899999999999999999999999999999999999999999999999999875422 223334569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||+.||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCH
Confidence            99999999997665 8999999999999999999999998766555544444332  24566789999999999999999


Q ss_pred             CCCcCH----HHHHhCCCCCCC
Q 013354          399 LHRPTA----AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~----~elL~hp~~~~~  416 (444)
                      ++||++    .++++||||...
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            999987    699999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.7e-46  Score=364.83  Aligned_cols=251  Identities=29%  Similarity=0.519  Sum_probs=212.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|++..+++.||+|+++....  ......+.+..|..++.. .+||||+++++++..++.+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999999999999999999874211  122233445566666664 48999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~~g  318 (444)
                      .+++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .......|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999764332 23334569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..  ..+.++..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            99999999997665 89999999999999999999999987665555555433  2346778899999999999999999


Q ss_pred             CCCcCHH-HHHhCCCCCCC
Q 013354          399 LHRPTAA-WLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~~-elL~hp~~~~~  416 (444)
                      ++||++. ++++||||...
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHcCCChHHHHcCcccCCC
Confidence            9999865 89999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-45  Score=358.37  Aligned_cols=253  Identities=32%  Similarity=0.529  Sum_probs=204.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEc---
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETL---  228 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~---  228 (444)
                      +|++.+.||+|+||.||+|++.. +++.||+|.++......   .....+.+|+.+++.+   +||||+++++++..   
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC---CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            68999999999999999999854 46889999887533221   1223445666666655   69999999998752   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                        ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence              456899999995 6999998764  34899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC----------
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE----------  374 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----------  374 (444)
                      .............|++.|+|||++.+.. ++.++|||||||++|||++|++||........+..+.....          
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            8765554444566899999999997655 88999999999999999999999987655444433321100          


Q ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          375 ---------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       375 ---------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                     ...+...++..+++||.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                           001123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.7e-46  Score=365.10  Aligned_cols=251  Identities=29%  Similarity=0.485  Sum_probs=215.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||+||+|.++.+++.||+|+++...  .........+.+|+.++..+ +|+||+++++++...+.+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999987421  12233445677888888887 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            9999999999888899999999999999999999999999999999999999999999999999875322 222334568


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      ++.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||+.||
T Consensus       159 ~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHccCCH
Confidence            99999999997665 8999999999999999999999998766555444444332  35677899999999999999999


Q ss_pred             CCCcCH-----HHHHhCCCCCCC
Q 013354          399 LHRPTA-----AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~-----~elL~hp~~~~~  416 (444)
                      ++||++     .++++||||++.
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-47  Score=373.02  Aligned_cols=257  Identities=34%  Similarity=0.577  Sum_probs=234.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE-E
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK-L  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~  232 (444)
                      .++|..++.+|+|+||.+++++++.+++.|++|.+.+....   ....+...+|+.+++++.|||||.+.+.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC---chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            35799999999999999999999999999999999874432   2233477889999999999999999999999988 9


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +|||+||+||+|.+.|.+.+  .|+++.+..|+.||+.|+.|||++.|+|||||+.|||++.++.|+|+|||+|+.+...
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999998754  4999999999999999999999999999999999999999999999999999999887


Q ss_pred             C-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          311 S-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       311 ~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      . ...+..||+.|+.||++.+.. |..++|||||||++|||++-+.+|...+-.....++.... ...+|...+.+++.+
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL  237 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence            6 566788999999999998777 9999999999999999999999999988888877877766 457899999999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      |+.||.++|+.||++.++|.+|.+..
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhh
Confidence            99999999999999999999998874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-45  Score=366.30  Aligned_cols=252  Identities=28%  Similarity=0.487  Sum_probs=211.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|+++.+++.||+|+++...  .......+.+.+|+.++.++ +||||+++++++..++.+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            46999999999999999999999999987421  12334456678888888776 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.... ........|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            9999999998888899999999999999999999999999999999999999999999999999875322 222334568


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--------hhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--------VPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||.....        .......... ....+|..++.++.+||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHH
Confidence            99999999997665 88999999999999999999999953111        1111121112 22357788999999999


Q ss_pred             HHHhhhCCCCCcC------HHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPT------AAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt------~~elL~hp~~~~~  416 (444)
                      ++||+.||++|++      +.++++||||++.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-46  Score=367.17  Aligned_cols=250  Identities=29%  Similarity=0.510  Sum_probs=215.1

Q ss_pred             eeecccCceEEEEEEE---cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~---~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|+||.||++++   ..+|+.||+|++....   ........+.+|+.++++++|+||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH---hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999976   3578999999987421   112234567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSI  316 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~  316 (444)
                      |+.+++|.+++.+...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ......
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999999988778999999999999999999999999999999999999999999999999998765443 223445


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR  396 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~  396 (444)
                      .|++.|+|||++.... ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++.+||++||++
T Consensus       159 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         159 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhc
Confidence            6899999999997655 7899999999999999999999998766555555554332  256778999999999999999


Q ss_pred             CCCCCcC-----HHHHHhCCCCCCC
Q 013354          397 NPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       397 dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      ||++||+     ++++++||||...
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=356.41  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=217.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..++||+|+||.||++.+..+++.||+|++....  .........+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh--hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            3888999999999999999999999999999886321  12223345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |||+.+++|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||++++++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999999999988653  35899999999999999999999999999999999999999999999999999876544433


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ....|++.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.  .......++..++..+++||.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR  237 (285)
T ss_pred             ccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence            4456899999999997655 8899999999999999999999998754432222111  112223456678999999999


Q ss_pred             HHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +||+.||++||     +++++++||||.+.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-46  Score=357.75  Aligned_cols=255  Identities=32%  Similarity=0.520  Sum_probs=218.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--C--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--D--  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~--  230 (444)
                      -.|...+++|+|+||.||+|+...+++.||||.+-....         .-.+|+.+|+.++|||||++.-+|...  .  
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            368899999999999999999999999999997743211         224699999999999999999877642  2  


Q ss_pred             -EEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEecccc
Q 013354          231 -KLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMA  304 (444)
Q Consensus       231 -~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla  304 (444)
                       .+.+||||+ ..+|.++++.    +.+++...++-++.||++||+|||+.||+||||||.|+|||.+ |.+||||||.|
T Consensus        95 ~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             456899999 5699999985    3679999999999999999999999999999999999999987 89999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-----------
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-----------  373 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-----------  373 (444)
                      +.+.......+..-|..|+|||.+.+...|+.+.||||.||+|.||+.|++.|.+.+...++..+.+.-           
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            998888777788889999999999999999999999999999999999999999877666554432100           


Q ss_pred             -------CCC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          374 -------ELP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       374 -------~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                             ..+         .+....++++.+|+.++|+++|.+|.++.|+|.||||.+....
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                   001         1335679999999999999999999999999999999976443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.6e-45  Score=363.12  Aligned_cols=260  Identities=29%  Similarity=0.497  Sum_probs=216.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+...    ........+.+|++++++++|+||+++++++..++.++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            46899999999999999999999999999999988642    22344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+.... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999999999878899999999999999999999985 79999999999999999999999999987654322 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh-----------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI-----------------------  369 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----------------------  369 (444)
                      .....|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+                       
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             cccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            23345899999999997655 889999999999999999999999653322111100                       


Q ss_pred             --------------------cCCCCCCCCC-CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          370 --------------------GNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       370 --------------------~~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                                          ......+.++ ..++.++++||.+||++||++|||++|+++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  308 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE  308 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence                                0000111111 2367899999999999999999999999999999876443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-45  Score=371.39  Aligned_cols=261  Identities=26%  Similarity=0.448  Sum_probs=219.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+++++.+++.||+|++....  .......+.+.+|+.+++.++||||+++++++..+..+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            3468999999999999999999999999999999986321  12223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |+||||+.+++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999999976 4689999999999999999999999999999999999999999999999999987643322


Q ss_pred             --cccccCCCcccCcccccCcC---CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCC--CCCHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSN---GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDE  385 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~  385 (444)
                        .....||+.|+|||++....   .++.++|||||||++|||++|+.||...+....+..+........++.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence              23456999999999986532   267899999999999999999999987665555555554333223343  56999


Q ss_pred             HHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      +++||..||..++.+  |+++.|+++||||++.
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999865544  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-45  Score=379.18  Aligned_cols=255  Identities=28%  Similarity=0.486  Sum_probs=208.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD---  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---  229 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||||++...      .   ....+|+.+|+.++|+||+++++++...   
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------P---QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------c---chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            345799999999999999999999999999999987521      1   1234699999999999999998876432   


Q ss_pred             -----CEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEE
Q 013354          230 -----DKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLA  299 (444)
Q Consensus       230 -----~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~  299 (444)
                           ..+++||||+. ++|.+++..    ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence                 25779999996 578777653    35689999999999999999999999999999999999998664 69999


Q ss_pred             eccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC------
Q 013354          300 DFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK------  373 (444)
Q Consensus       300 DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------  373 (444)
                      |||+++.+..........||+.|+|||++.+...++.++|||||||+||||++|.+||........+..+....      
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99999877655555556789999999998766568999999999999999999999998765444333221100      


Q ss_pred             ------------CC---------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          374 ------------EL---------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       374 ------------~~---------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                  ..         ..++...+.++++||.+||++||++|||+.|+|+||||.+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                        00         123456789999999999999999999999999999998753

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-45  Score=362.56  Aligned_cols=251  Identities=29%  Similarity=0.494  Sum_probs=213.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      +.||+|+||.||+|++..+++.||+|+++....  ......+.+..|..++.. ++||||+++++++...+.+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            469999999999999999999999999874211  112233455667777775 48999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            9999999998877899999999999999999999999999999999999999999999999999875322 222334568


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  +.++..++.++++||.+||+.||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhccCH
Confidence            99999999997665 8999999999999999999999998766555554444332  35677899999999999999999


Q ss_pred             CCCcCHH-HHHhCCCCCCC
Q 013354          399 LHRPTAA-WLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~~-elL~hp~~~~~  416 (444)
                      ++||++. ++++||||++.
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             hhcCCChHHHHcCcccCCC
Confidence            9999997 89999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-44  Score=344.40  Aligned_cols=258  Identities=67%  Similarity=1.100  Sum_probs=226.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+..........+..+.+.+|+.+++.++|+||+++++++..+..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47888999999999999999998899999999876444334456677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      +||+.+++|.+++.+...+++..++.++.||+.||+|||+.+|+|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998877799999999999999999999999999999999999999999999999999887654443344


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      ..++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+......+.++..++.++++||++||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            56889999999986544478999999999999999999999987665555555555455567788899999999999999


Q ss_pred             hCCCCCcCHHHHHhCCCC
Q 013354          396 RNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       396 ~dP~~Rpt~~elL~hp~~  413 (444)
                      .+|++||++.++++|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6e-45  Score=352.83  Aligned_cols=253  Identities=32%  Similarity=0.509  Sum_probs=203.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc---cCCCCeeeEeeeEEc----
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR---LRHPNIVRYYGSETL----  228 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~---l~hpnIv~l~~~~~~----  228 (444)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++.......   ....+.+|+.+++.   ++|+||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            58899999999999999999999999999998875322111   11234456665555   479999999998764    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          229 -DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       229 -~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                       ...++++|||+. ++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             345899999996 58998887643  48999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC------------
Q 013354          306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK------------  373 (444)
Q Consensus       306 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------  373 (444)
                      ............++..|+|||++.+.. ++.++|||||||++|||++|++||........+.++....            
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            765544444556899999999997665 8999999999999999999999997655443332221100            


Q ss_pred             -------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 -------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 -------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                   ....+...++.++++||.+||++||++|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         0001223578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-45  Score=361.24  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=216.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+.+|+.++..++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            3699999999999999999999999999999998631  11223345668889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||+.+++|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999976 356999999999999999999999999999999999999999999999999998765443322


Q ss_pred             --ccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC---CCCCCCCCCCH
Q 013354          314 --LSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK---ELPAIPDHLSD  384 (444)
Q Consensus       314 --~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~s~  384 (444)
                        ....||+.|+|||++..    ...++.++|||||||++|||++|+.||...+....+..+....   ..+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence              22458999999999863    2336789999999999999999999998765555554443322   22233345899


Q ss_pred             HHHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      ++++||++||..++++  |++++++++||||.+.
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999998765444  8899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.9e-45  Score=352.48  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=209.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|+||+||++.++.+++.||+|.+...  ........+.+..|+.+++.++|+||+++++++..+..+++||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHH--HHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999999999999999988632  1122234466788999999999999999999999999999999999999


Q ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-ccccc
Q 013354          243 SIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PLSIK  317 (444)
Q Consensus       243 sL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~~~~~  317 (444)
                      +|.+++..    ...+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..+..... .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99988743    24589999999999999999999999999999999999999999999999999976544322 23456


Q ss_pred             CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       318 gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      |++.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.  .......++..++.++.+|+.+||+
T Consensus       159 g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            899999999997665 8899999999999999999999997643321111111  1111224567789999999999999


Q ss_pred             hCCCCCc-----CHHHHHhCCCCCCC
Q 013354          396 RNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       396 ~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      .||++||     +++++++||||++.
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            9999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.1e-45  Score=359.88  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=218.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|+..+.||+|+||.||+|.++.+++.||+|++....  .......+.+..|+.++..+. |++|+++++++..++.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            3788899999999999999999999999999886421  122334456778888888886 5778889999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      ||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987543222 23


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+....  ..++..++.++.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHH
Confidence            3456899999999997655 8999999999999999999999998766555555544332  256778999999999999


Q ss_pred             hhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      |++||.+|++     .+++++||||+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            9999999997     5789999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=372.70  Aligned_cols=254  Identities=31%  Similarity=0.529  Sum_probs=215.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-C-----CCeeeEeeeEEc
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-H-----PNIVRYYGSETL  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~~  228 (444)
                      .+|.+.++||+|+||.|.+|.+..|++.||||+++      +......+...|+.+|..|+ |     -|||+++++|..
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK------NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeec------cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            37899999999999999999999999999999997      56677788889999999997 3     489999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC--CcEEEEecccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS--GRVKLADFGMA  304 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~vkL~DFGla  304 (444)
                      .+++|||+|++ ..+|.++|+.+.  .++...++.++.||+.||.+||+.+|||+||||||||+..-  ..|||+|||.+
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999999 679999998864  48899999999999999999999999999999999999643  46999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-------------
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-------------  371 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------  371 (444)
                      ++.....  .+...+..|+|||++.+.. |+.+.||||||||++||++|.+.|.+.+..+++..|..             
T Consensus       339 c~~~q~v--ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRV--YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcc--eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8865433  3667889999999999888 99999999999999999999999987665554433210             


Q ss_pred             ----------------------------------------CCCCC-C-------CCCCCCHHHHHHHHHHhhhCCCCCcC
Q 013354          372 ----------------------------------------SKELP-A-------IPDHLSDEGKDFVRKCLQRNPLHRPT  403 (444)
Q Consensus       372 ----------------------------------------~~~~~-~-------~~~~~s~~l~~Li~~~L~~dP~~Rpt  403 (444)
                                                              ....| .       +...-...+.+||++||..||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                                                    00001 0       00122456789999999999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 013354          404 AAWLLEHPFVGNAAP  418 (444)
Q Consensus       404 ~~elL~hp~~~~~~~  418 (444)
                      +.|+|+||||.....
T Consensus       496 p~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  496 PAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHhcCcccccccc
Confidence            999999999995433

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.7e-45  Score=360.72  Aligned_cols=252  Identities=26%  Similarity=0.459  Sum_probs=212.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|.++.+++.||+|+++..  ........+.+.+|+.++.++ +|+||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE--LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            4699999999999999999999999998742  122334456788899999888 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CCCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~~~~~~~~g  318 (444)
                      .+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .........|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            999999999887889999999999999999999999999999999999999999999999999987532 2233345669


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC------ChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE------GVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||....      ............. ..+|..++.++.++|++
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Confidence            99999999997665 8999999999999999999999996422      1122222222222 34677899999999999


Q ss_pred             HhhhCCCCCcC------HHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRPT------AAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rpt------~~elL~hp~~~~~  416 (444)
                      ||++||++|++      ++++++||||+..
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.3e-45  Score=364.01  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      ..+|++.+.||+|+||.||++++..+++.||+|++...   .........+.+|+.+++.++|+||+++++++....   
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc---ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            46899999999999999999999999999999988642   123344567789999999999999999999886543   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                         .+|+||||+. ++|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               5799999996 467776653  5889999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc-----------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG-----------------  370 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-----------------  370 (444)
                      ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.                 
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            5444444566899999999997665 8999999999999999999999998654332211110                 


Q ss_pred             ------CCCCC-----------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          371 ------NSKEL-----------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       371 ------~~~~~-----------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                            .....                 .......+.++++||.+||+.||++|||+.|+|+||||..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                  00000                 0111234678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=362.74  Aligned_cols=248  Identities=30%  Similarity=0.471  Sum_probs=213.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +++.++..||+|.||+||+|++-   ..||||++++.   ....+..+.|.+|+.++++-+|-||+-+.|++..... .|
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             HHhhccceeccccccceeecccc---cceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            45667788999999999999885   45999999863   3445588999999999999999999999999988776 99


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc---ccCC
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH---ITGQ  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~---~~~~  310 (444)
                      |..+|+|.+|+.+|+-. .+|.+...+.|++||++|+.|||.++|||||||..|||+.+++.|||+|||++..   ...+
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            99999999999999753 4699999999999999999999999999999999999999999999999999863   3333


Q ss_pred             CCcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC---CCCCCCCHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPDHLSDE  385 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~s~~  385 (444)
                      .......|...|||||+++..  ..|++.+||||||+++|||++|..||.....+..++++..+...+   .+...++++
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence            334445588899999998643  348999999999999999999999999666667778888774443   444678899


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +++|+..||.+++++||.+.+||.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999887

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.9e-45  Score=361.70  Aligned_cols=251  Identities=29%  Similarity=0.461  Sum_probs=210.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHH-HHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI-ALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||.||+|++..+++.||+|++....  .........+.+|. .+++.++|+||+++++.+...+..|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46999999999999999999999999986321  11222234444554 4678899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CCCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~~~~~~~~g  318 (444)
                      .+++|.+++.+...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++... .........|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            999999999887789999999999999999999999999999999999999999999999999987532 2223334568


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+....  ..++...+.++.++|.+||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCH
Confidence            99999999997655 8899999999999999999999998765444444443322  35677889999999999999999


Q ss_pred             CCCcCH----HHHHhCCCCCCC
Q 013354          399 LHRPTA----AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~----~elL~hp~~~~~  416 (444)
                      ++|+++    .++++|+||...
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCCC
Confidence            999875    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-45  Score=363.09  Aligned_cols=251  Identities=30%  Similarity=0.461  Sum_probs=211.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHH-HHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+||+||+|+++.+|+.||+|++....  .........+.+|.. +++.++||||+++++.+..++.+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI--VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            46999999999999999999999999986421  112223344555554 577899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            9999999998888899999999999999999999999999999999999999999999999999875422 223344569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      ++.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+....  ..++..++.++.++|++||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCH
Confidence            99999999997665 8899999999999999999999998766555555444322  23455689999999999999999


Q ss_pred             CCCcCH----HHHHhCCCCCCC
Q 013354          399 LHRPTA----AWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~----~elL~hp~~~~~  416 (444)
                      ++||++    .++++||||...
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCC
Confidence            999976    589999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.8e-45  Score=366.90  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=218.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|++...  ........+.+.+|+.+++.++||||+++++.+..+..+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            446899999999999999999999999999999998632  112223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999999999976 4689999999999999999999999999999999999999999999999999987643322


Q ss_pred             --cccccCCCcccCcccccCcC---CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSN---GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDE  385 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~  385 (444)
                        .....||+.|+|||++....   .++.++|||||||++|||++|..||...+....+..+........++  ..++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence              23456999999999986532   26789999999999999999999998766555555554433222233  368999


Q ss_pred             HHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      +++||.+||..++.+  |++++++++|+||++.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999844443  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5e-45  Score=367.39  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=213.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-----
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-----  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  230 (444)
                      +|++.+.||+|+||.||++.+..+++.||||.+...   .......+.+.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            478889999999999999999999999999987531   122334567889999999999999999999988766     


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            7899999995 689998887778999999999999999999999999999999999999999999999999999865432


Q ss_pred             C--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------------
Q 013354          311 S--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------------  371 (444)
Q Consensus       311 ~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------  371 (444)
                      .  ......+++.|+|||++.+...++.++|||||||++|||++|+.||........+..+..                 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2  122345789999999997766588999999999999999999999976554332222110                 


Q ss_pred             -------CCCCC------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 -------SKELP------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 -------~~~~~------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                             ....+      .+....++++.+||.+||+.||++|||+.|+|+||||.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                   00001      2334568999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-44  Score=345.65  Aligned_cols=257  Identities=46%  Similarity=0.871  Sum_probs=220.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~  233 (444)
                      .|+..+.||+|+||.||+|.+..++..|++|++.............+.+.+|+.++++++|+||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            5889999999999999999999999999999887543333334455778899999999999999999998765  46789


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--  311 (444)
                      ++|||+.+++|.+++.+...+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++..+....  
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            999999999999999887789999999999999999999999999999999999999999999999999987653211  


Q ss_pred             --CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+......+.++..+++.+++|
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             CCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence              112344788999999997655 88999999999999999999999987766555555554444567778889999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      | +||..+|++||+++||++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=365.24  Aligned_cols=250  Identities=34%  Similarity=0.535  Sum_probs=209.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ||+|+||+||+|+++.+++.||+|++....  .........+..|..++..+   +||||+++++.+.....+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE--IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHH--HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            799999999999999999999999986311  11222334455566666655   6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            9999999999888899999999999999999999999999999999999999999999999999875432 223345669


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC-CCCCHHHHHHHHHHhhhC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCLQRN  397 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~Li~~~L~~d  397 (444)
                      |+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+.....  .++ ..++.++++||++||+.|
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~~~  236 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLNRN  236 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCC
Confidence            99999999987665588999999999999999999999987655554444443322  223 357999999999999999


Q ss_pred             CCCCc----CHHHHHhCCCCCCC
Q 013354          398 PLHRP----TAAWLLEHPFVGNA  416 (444)
Q Consensus       398 P~~Rp----t~~elL~hp~~~~~  416 (444)
                      |++||    +++++++||||.+.
T Consensus       237 P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         237 PQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHHCCCCCCCHHHHhcCccccCC
Confidence            99998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-44  Score=366.50  Aligned_cols=250  Identities=25%  Similarity=0.350  Sum_probs=206.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||+|...           .+.+.+|+.++++++||||+++++++..+...+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            357999999999999999999999999999999643           134678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC--C
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--S  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~--~  311 (444)
                      +|||++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++......  .
T Consensus       160 lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            999999 5789999988778999999999999999999999999999999999999999999999999999754322  2


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-------hhhHHhc--------------
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-------PAMFKIG--------------  370 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-------~~~~~~~--------------  370 (444)
                      ......||+.|+|||++.... ++.++|||||||++|||++|..||...+..       ..+..+.              
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            233456999999999997655 899999999999999999999876432210       0000000              


Q ss_pred             ------------C-CCCCC-CCC-----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 ------------N-SKELP-AIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 ------------~-~~~~~-~~~-----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                  . ....+ ..+     ..++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                        0 00000 000     1346789999999999999999999999999999874

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-45  Score=361.76  Aligned_cols=250  Identities=29%  Similarity=0.471  Sum_probs=209.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHH-HHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE-IALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~E-i~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      +.||+|+||+||+|++..+++.||+|++.....  ........+..| ..+++.++|+||+++++++...+.+++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            469999999999999999999999999864211  111222334444 44578899999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKG  318 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~g  318 (444)
                      .+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            9999999999878899999999999999999999999999999999999999999999999999875432 223345569


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      |+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++.+||++||++||
T Consensus       159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCH
Confidence            99999999997655 8899999999999999999999998766555554443322  24556789999999999999999


Q ss_pred             CCCcCHH----HHHhCCCCCC
Q 013354          399 LHRPTAA----WLLEHPFVGN  415 (444)
Q Consensus       399 ~~Rpt~~----elL~hp~~~~  415 (444)
                      .+|+++.    ++++|+||..
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCC
Confidence            9999876    8999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.9e-45  Score=356.04  Aligned_cols=260  Identities=26%  Similarity=0.455  Sum_probs=213.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|.+.+.||+|+||.||+|+++.+++.||+|+++.....    .....+.+|+.++++++|+||+++++++..++..++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC----CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            5799999999999999999999999999999998753221    122356689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            999996 48888887644 48999999999999999999999999999999999999999999999999987643322 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------------  372 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------------  372 (444)
                      .....+++.|+|||++.+...++.++|||||||++|||++|+.||...+..+....+...                    
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223457899999999876555889999999999999999999999765433222111100                    


Q ss_pred             CCCC--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          373 KELP--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       373 ~~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ...+        .....++.++++||.+||+.||++|||+.|+|+||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            0000        1123578899999999999999999999999999999986544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-44  Score=359.16  Aligned_cols=260  Identities=25%  Similarity=0.432  Sum_probs=217.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+.+|+.++..++|+||+++++.+...+.+++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3699999999999999999999999999999988531  11223334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      ||||+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            99999999999999873 5789999999999999999999999999999999999999999999999999876533322 


Q ss_pred             -cccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC---CCCCCCCCCH
Q 013354          313 -PLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---LPAIPDHLSD  384 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~  384 (444)
                       .....||+.|+|||++..    ...++.++|||||||++|||++|+.||...+....+..+.....   .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             223469999999999862    23478899999999999999999999987766666665544332   2333356799


Q ss_pred             HHHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      ++++||++||..++++  |++++++++||||.+.
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            9999999999665444  7899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-44  Score=374.21  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=219.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+..     ........+.+|+.+++.++||||+++++++..++.+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            34599999999999999999998877 78899987643     2334446778899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      |+||||+.+++|.+++..    ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999999999988754    3458999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ....   ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+..... ..++..++.+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~s~~  298 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DPFPCPVSSG  298 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCccCCHH
Confidence            4322   23456999999999997655 89999999999999999999999987665555555544333 3456778999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      +++||.+||++||++||++++++.|+|++.
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999999863

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-44  Score=342.74  Aligned_cols=258  Identities=44%  Similarity=0.821  Sum_probs=220.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  232 (444)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+.+|+.++++++|+||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46999999999999999999999999999999886533333334556788999999999999999999998766  3568


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC--
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~--  310 (444)
                      +++|||+.+++|.+++.+...+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988778999999999999999999999999999999999999999999999999998765321  


Q ss_pred             --CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          311 --SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 --~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                        .......++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+......+.++..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence              1122345888999999987655 8899999999999999999999998765555555544444445677788999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      +|.+||. +|++||+++++++|||++
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999994 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-44  Score=343.69  Aligned_cols=256  Identities=48%  Similarity=0.866  Sum_probs=220.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc----cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK----SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      +|.+++.||+|+||.||+|.+..+++.+|+|.+........    .....+.+.+|+.++++++|+||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47888999999999999999998899999998865332211    22344678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      .++||||+.+++|.+++...+.+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999988664321


Q ss_pred             C-------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          312 C-------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       312 ~-------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      .       .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.. ...+.++..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCH
Confidence            1       11234788999999987655 78899999999999999999999987665555544433 233567778999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ++.++|++||+.||++||++.++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-44  Score=349.39  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|+||.||+++++.+|+.||+|.+....  .........+..|++++++++||||+++++.+..+..+++||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHH--hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            799999999999999999999999886311  111222345567999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCC
Q 013354          243 SIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP  320 (444)
Q Consensus       243 sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  320 (444)
                      +|.+++....  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.............|+.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            9999886543  48899999999999999999999999999999999999999999999999998765544334456899


Q ss_pred             cccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhC
Q 013354          321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN  397 (444)
Q Consensus       321 ~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~d  397 (444)
                      .|+|||++.+.. ++.++|||||||++|||++|+.||.......   .................++.++++||++||++|
T Consensus       159 ~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  237 (277)
T cd05607         159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK  237 (277)
T ss_pred             CccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence            999999997766 8999999999999999999999997543221   111111111222223468999999999999999


Q ss_pred             CCCCcCH----HHHHhCCCCCCC
Q 013354          398 PLHRPTA----AWLLEHPFVGNA  416 (444)
Q Consensus       398 P~~Rpt~----~elL~hp~~~~~  416 (444)
                      |++||++    +++++||||+..
T Consensus       238 P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         238 PEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             HhhCCCCccchhhhhcChhhcCC
Confidence            9999999    678899999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-44  Score=359.26  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=205.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|+++..    ......+.+.+|+.++..+ +||||+++++++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            346899999999999999999975     234578999987631    2233456788999999999 899999999987


Q ss_pred             EcC-CEEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 013354          227 TLD-DKLYIYLEYVSGGSIYKILQDY------------------------------------------------------  251 (444)
Q Consensus       227 ~~~-~~~~lv~e~~~ggsL~~~l~~~------------------------------------------------------  251 (444)
                      ... ..+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            754 4689999999999999999753                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc---ccccCCC
Q 013354          252 --------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---LSIKGSP  320 (444)
Q Consensus       252 --------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~  320 (444)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........   ....++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    13677888999999999999999999999999999999999999999999999865332211   1233567


Q ss_pred             cccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       321 ~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      .|+|||++.+.. ++.++|||||||+||||++ |..||........+............+..++.++.+||.+||+.||+
T Consensus       241 ~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            899999997665 8999999999999999997 99999875544333332222233455778899999999999999999


Q ss_pred             CCcCHHHHHh
Q 013354          400 HRPTAAWLLE  409 (444)
Q Consensus       400 ~Rpt~~elL~  409 (444)
                      +|||+.||++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-44  Score=374.10  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=220.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-  230 (444)
                      ....+|++.+.||+|+||+||+|++..+++.||||++....   ........+.+|+.++..++|+||+++++.+...+ 
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            44579999999999999999999999999999999986422   23445567889999999999999999988765432 


Q ss_pred             -------EEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEE
Q 013354          231 -------KLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       231 -------~~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                             .+++||||+.+|+|.+++...    ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence                   478999999999999999753    358999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCC---CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC
Q 013354          300 DFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP  376 (444)
Q Consensus       300 DFGla~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~  376 (444)
                      |||+++.+...   .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+.... ..
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-~~  263 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-YD  263 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-CC
Confidence            99999865432   1223456999999999997665 8999999999999999999999998765544444444333 33


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .++..++.++.+||.+||+.||++||++.++++|||++..
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            5678899999999999999999999999999999998754

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-44  Score=348.51  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=216.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....  .........+.+|+.++++++|+||+.+++.+..++.+++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            3788899999999999999999999999999886321  12233345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          236 LEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |||+.+++|.+++....  .+++..+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            99999999999986543  5899999999999999999999999999999999999999999999999998766544443


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ....|+..|+|||++.+.. ++.++|||||||++|||++|+.||.......   ....... .....++..++.++++||
T Consensus       159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHH
Confidence            4456899999999997665 8999999999999999999999997643321   1111111 111245667899999999


Q ss_pred             HHHhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      .+||+.||++|||     ++|+++||||+..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-44  Score=341.61  Aligned_cols=256  Identities=44%  Similarity=0.822  Sum_probs=218.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|+..+.||+|+||.||+|.+. +++.+|+|.+...... .......+.+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4888999999999999999864 6899999988753221 1223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC----
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ----  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~----  310 (444)
                      ||||+.+++|.+++.+...+++..+..++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998764321    


Q ss_pred             ---CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHH
Q 013354          311 ---SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEG  386 (444)
Q Consensus       311 ---~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l  386 (444)
                         .......++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ...+.++..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence               1112345889999999987655 789999999999999999999999876655444333322 34456778899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+||++||+.+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-45  Score=346.96  Aligned_cols=254  Identities=37%  Similarity=0.563  Sum_probs=211.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |++.+.||+|+||+||++++..+++.||+|++...   ...........+|+.++++++|+||+++++++..+...++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKS---EIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEEST---THHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccc---cccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999998742   222233334566999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc-cCCCCccc
Q 013354          237 EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLS  315 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-~~~~~~~~  315 (444)
                      |++.+++|.+++.....+++..++.++.||+.||++||+++|+|+||||+||+++.++.++|+|||.+... ........
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999997789999999999999999999999999999999999999999999999999998764 22333345


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh---hHHhcCCCCCC--CCCCCCCHHHHHHH
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSKELP--AIPDHLSDEGKDFV  390 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~~~~~--~~~~~~s~~l~~Li  390 (444)
                      ..++..|+|||++.....++.++||||||+++|+|++|..||........   ..+........  ......+.++.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            56899999999987344489999999999999999999999987622222   21111100000  11112248999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+||+.||++||++.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-44  Score=358.92  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=209.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|++.+.||+|+||.||++.+..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            468999999999999999999999999999999886421   2233456778899999999999999999987543    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ...|+||||+. ++|.+++..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence              35799999995 578877754  5889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-------------  374 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  374 (444)
                      ..........+|..|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.....             
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            5544444556899999999997665 89999999999999999999999976554332222110000             


Q ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          375 ---------------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       375 ---------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                                 ........+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                       001112235688999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-44  Score=357.09  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=216.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...  ........+.+.+|+.++..++|+||+++++++..++..|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3699999999999999999999999999999988631  11223344567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||+.+++|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999987 457999999999999999999999999999999999999999999999999999766443321


Q ss_pred             --ccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC---CCCCCCCCCH
Q 013354          314 --LSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---LPAIPDHLSD  384 (444)
Q Consensus       314 --~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~  384 (444)
                        ....||+.|+|||++...    ..++.++|||||||++|||++|+.||...+....+..+.....   .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence              234599999999998642    2378899999999999999999999987665555555443322   2222345789


Q ss_pred             HHHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      ++++||.+||..++++  |++++++++||||++.
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            9999999999876654  5789999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.8e-44  Score=359.54  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=209.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD---  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---  229 (444)
                      ...+|++.+.||+|+||.||++.+..+++.||+|++...   .......+.+.+|+.+++.++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc---ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            346899999999999999999999999999999988632   12334456778899999999999999999987643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          230 ---DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       230 ---~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                         ...++||||+. ++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          92 EEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             cccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence               35799999996 467777754  588999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc----------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG----------------  370 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----------------  370 (444)
                      ...........+|..|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.                
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            65544444566899999999997655 8999999999999999999999997654322211100                


Q ss_pred             -------CCCC-----------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 -------NSKE-----------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 -------~~~~-----------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                             ....                 ....+...+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                   0000                 001122346788999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.9e-44  Score=346.34  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=217.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....  .........+.+|+.+++.++|+||+.+++.+..++..++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR--IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh--hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            3788899999999999999999999999999886421  12223345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |||+.+++|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            9999999999888653  35999999999999999999999999999999999999999999999999998765444333


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--CCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ....|+..|+|||++.+.. ++.++|+|||||++|||++|..||...........+..  ......++..++.++.+|+.
T Consensus       159 ~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             cCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            4456899999999997665 89999999999999999999999976544322222211  11122456678999999999


Q ss_pred             HHhhhCCCCCcC-----HHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPT-----AAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt-----~~elL~hp~~~~~~~  418 (444)
                      .||+.||++||+     +.++++|+||++...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999999999     889999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=370.37  Aligned_cols=250  Identities=45%  Similarity=0.802  Sum_probs=224.8

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCC
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSG  241 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~g  241 (444)
                      +||+|+||+||-|++..|....|||.+..     ......+-+.+||.+-++|+|.|||+++|.+.+++++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            69999999999999999999999998852     3444567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-CCCcEEEEeccccccccC-CCCcccc
Q 013354          242 GSIYKILQD-YGQL--GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-PSGRVKLADFGMAKHITG-QSCPLSI  316 (444)
Q Consensus       242 gsL~~~l~~-~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~-~~~~~~~  316 (444)
                      |+|.++|+. .+++  +|..+-.+.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++++.. .....++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            999999976 4676  8999999999999999999999999999999999995 468999999999998755 3345678


Q ss_pred             cCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCC-ChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          317 KGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYE-GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       317 ~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      .||+.|||||++..+ .+|..++|||||||++.||.||++||-... ....++++...+.-|.+|..++.+++.||.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            899999999999754 468999999999999999999999997654 346678888888889999999999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+||.+||++.++|..||++..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCcccCccHHHhccCcccccC
Confidence            9999999999999999999866

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.9e-44  Score=345.37  Aligned_cols=256  Identities=32%  Similarity=0.555  Sum_probs=223.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...  ........+.+.+|++++++++|+||+++++++.....+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            3689999999999999999999999999999988632  11223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||+.+++|.+++.+...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......  ..
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999876544  33


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+...  ...++..++..++++|.+||
T Consensus       157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         157 TLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCCHHHHHHHHHHc
Confidence            445889999999987665 788999999999999999999999876644444444322  23567778999999999999


Q ss_pred             hhCCCCCc-----CHHHHHhCCCCCCCC
Q 013354          395 QRNPLHRP-----TAAWLLEHPFVGNAA  417 (444)
Q Consensus       395 ~~dP~~Rp-----t~~elL~hp~~~~~~  417 (444)
                      ..||.+|+     +++|+++||||+...
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999     999999999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=363.45  Aligned_cols=238  Identities=32%  Similarity=0.577  Sum_probs=216.2

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      .+-||+|+.|.||+|+..  ++.||||+++-            .-..+|+-|++|+|+||+.+.|+|.....+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            456999999999999765  78999997751            1224789999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS  319 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt  319 (444)
                      ..|-|..+|+....++......|.++|+.||.|||.++|||||||.-||||..+..|||+|||.++.........++.||
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence            99999999999889999999999999999999999999999999999999999999999999999988877778889999


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      ..|||||++++.. .+.|+|||||||+|||||||..||.+.+....++-+.....--..|..+++.++-||++||+-.|.
T Consensus       275 VaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  275 VAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             HhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            9999999999887 899999999999999999999999987776666666554444467899999999999999999999


Q ss_pred             CCcCHHHHHhCCC
Q 013354          400 HRPTAAWLLEHPF  412 (444)
Q Consensus       400 ~Rpt~~elL~hp~  412 (444)
                      .||++.+||.|-=
T Consensus       354 NRPSFrqil~Hld  366 (904)
T KOG4721|consen  354 NRPSFRQILLHLD  366 (904)
T ss_pred             CCccHHHHHHHHh
Confidence            9999999999943

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-43  Score=347.22  Aligned_cols=255  Identities=32%  Similarity=0.537  Sum_probs=213.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...    .......++.+|++++++++||||+++++.+..++.+++|
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            689999999999999999999999999999987632    2234556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++....... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~  156 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-AN  156 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cc
Confidence            9999999999999988889999999999999999999998 599999999999999999999999999987653322 23


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------------------
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------------------  371 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------------  371 (444)
                      ...++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+..                       
T Consensus       157 ~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         157 SFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             cCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            456889999999986655 88999999999999999999999964332221111110                       


Q ss_pred             ------------CCCCCCCC-CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 ------------SKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ------------~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                  ....+.++ ..++.++++||.+||..||++|||+.++++||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                        00011122 2368899999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-43  Score=339.63  Aligned_cols=255  Identities=41%  Similarity=0.651  Sum_probs=212.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...     .......+.+|+.++++++|+||+++++++..++.+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            346799999999999999999999999999999988632     122335677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++||||+.+++|.+++.+...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+.... 
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999999999999999887889999999999999999999999999999999999999999999999999998664322 


Q ss_pred             CcccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC-C--CCCCCCHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-A--IPDHLSDEG  386 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~--~~~~~s~~l  386 (444)
                      ......++..|+|||.+..  ...++.++|||||||++|||++|+.||...........+......+ .  ....++.++
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            2233458899999998742  2336789999999999999999999996554333322222221111 1  123568999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~  412 (444)
                      .+||++||+.||++||++++||+|+|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-43  Score=334.36  Aligned_cols=253  Identities=29%  Similarity=0.516  Sum_probs=218.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...   .......+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS---KMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh---hCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            478889999999999999999999999999988642   12244556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999999874  4689999999999999999999999999999999999999999999999999886644322 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....+++.|+|||++.+.. ++.++|+|||||++|||++|+.||...........+... ..+.++..++.++.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCccccCHHHHHHHHH
Confidence            22345788999999997665 889999999999999999999999876644444444333 3445666889999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ||+.+|++||++.++++|||+
T Consensus       236 ~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-43  Score=342.06  Aligned_cols=263  Identities=38%  Similarity=0.646  Sum_probs=219.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+.+.|++.+.||+|+||.||+|++..+++.+++|.+..     ......+.+.+|+.+++.++|+||+++++.+..++.
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence            445779999999999999999999999999999998863     334456778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++||||+.+++|..++.+ ...+++..++.++.||+.+|.|||+++++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            9999999999999988765 346899999999999999999999999999999999999999999999999988754322


Q ss_pred             -CCcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCH
Q 013354          311 -SCPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSD  384 (444)
Q Consensus       311 -~~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~  384 (444)
                       .......++..|+|||++..    ...++.++|||||||++|||++|..||...+......++..... ....+..++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM  243 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence             12233457889999999852    22367899999999999999999999977654444433332221 1234567889


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ++.+||++||..||++||+++++++||||......
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            99999999999999999999999999999875443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-43  Score=340.82  Aligned_cols=255  Identities=35%  Similarity=0.654  Sum_probs=211.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL---  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~---  228 (444)
                      +...|+..+.||+|+||.||+|.+..+++.||+|.+....      .....+.+|+.+++++ +|+||+++++.+..   
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            3457899999999999999999999999999999886321      1234677899999998 69999999998865   


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                         +..+++||||+.+++|.+++...  ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence               34689999999999999999863  3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-CcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          304 AKHITGQS-CPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       304 a~~~~~~~-~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      +....... ......|+..|+|||++..    ...++.++|||||||++|||++|..||...........+.........
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK  237 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence            87654322 2234558899999999853    223788999999999999999999999765544444433333222334


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +..++.++++||.+||..||++|||+.++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            45688999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=346.25  Aligned_cols=258  Identities=30%  Similarity=0.475  Sum_probs=218.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+...  ........+.+.+|+++++.++|+||+++++.+......++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecc--ccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            699999999999999999999999999999988642  222234557788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |||+.+++|.+++.+.  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999999864  4689999999999999999999999999999999999999999999999999875422110 


Q ss_pred             -----------------------------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh
Q 013354          313 -----------------------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV  363 (444)
Q Consensus       313 -----------------------------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  363 (444)
                                                   .....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                         11235788999999997665 789999999999999999999999877665


Q ss_pred             hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcC----HHHHHhCCCCCCC
Q 013354          364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT----AAWLLEHPFVGNA  416 (444)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt----~~elL~hp~~~~~  416 (444)
                      ..+..+............++.++++||++||..||++||+    ++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            5555444322211122237999999999999999999999    9999999999874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-43  Score=342.72  Aligned_cols=254  Identities=33%  Similarity=0.543  Sum_probs=208.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|+++.+++.||+|+++....   .....+.+.+|+.++++++|+||+++++++..+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE---EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc---cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            48899999999999999999999999999998865321   222335677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          236 LEYVSGGSIYKILQDY---GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |||+. ++|.+++...   ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++........
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99996 6898888653   4589999999999999999999999999999999999999999999999999876533221


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc---------------------
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG---------------------  370 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------------------  370 (444)
                       .....+++.|+|||++.+...++.++|||||||++|||++|+.||.............                     
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence             1223468899999998766557889999999999999999999997644322211110                     


Q ss_pred             ------CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          371 ------NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       371 ------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                            ...........++.++++||++||+.||++|||+.+|++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                  0000111234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-43  Score=338.06  Aligned_cols=251  Identities=30%  Similarity=0.509  Sum_probs=217.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||.|+||.||+|++..+++.||+|++....  .......+.+.+|+.+++.++|+||+++++.+..+...+++|||+.++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhc--chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            699999999999999999999999886421  222344577899999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcc
Q 013354          243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYW  322 (444)
Q Consensus       243 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y  322 (444)
                      +|.+++.+...+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++.............++..|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            99999988778999999999999999999999999999999999999999999999999999877655434445688999


Q ss_pred             cCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC--ChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCC
Q 013354          323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH  400 (444)
Q Consensus       323 ~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  400 (444)
                      ++||.+.... ++.++|+||||+++|+|++|..||....  .......+.........+..++.++++||.+||+.||++
T Consensus       159 ~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  237 (262)
T cd05572         159 VAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE  237 (262)
T ss_pred             cChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence            9999987655 8899999999999999999999997765  333344444334445667777999999999999999999


Q ss_pred             CcC-----HHHHHhCCCCCCC
Q 013354          401 RPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       401 Rpt-----~~elL~hp~~~~~  416 (444)
                      ||+     ++|+++||||++.
T Consensus       238 R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         238 RLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CcCCcccCHHHHhcChhhhCC
Confidence            999     9999999999874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=342.70  Aligned_cols=259  Identities=38%  Similarity=0.662  Sum_probs=220.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||.|+||.||++.+..+++.+|+|.+..     ......+.+.+|+.+++.++|+||+++++.+..+...+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            3579999999999999999999988999999998864     33445577889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      +||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++....... 
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999999999774 469999999999999999999999999999999999999999999999999887653322 


Q ss_pred             CcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEG  386 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l  386 (444)
                      ......++..|+|||++..    ...++.++||||||+++|||++|+.||...+.......+..... ....+..++.++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            2233458899999999752    23367899999999999999999999987765555544443322 123356789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .+||.+||+.+|.+||+++++++||||.+..
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=340.13  Aligned_cols=254  Identities=40%  Similarity=0.704  Sum_probs=220.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||.|+||.||+|++..+++.||+|.+...    ........+.+|+.+++.++|+||+++++.+..+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            688899999999999999999999999999988642    2233446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~  314 (444)
                      +||+.+++|.+++... .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            9999999999999874 8999999999999999999999999999999999999999999999999999876544 2233


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC-CCHHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFVRKC  393 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~  393 (444)
                      ...++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+... ..+.++.. ++.++.++|.+|
T Consensus       157 ~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence            455888999999997766 899999999999999999999999776544444433332 23344444 899999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |..||++|||++++++||||++.
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-44  Score=356.23  Aligned_cols=256  Identities=24%  Similarity=0.431  Sum_probs=209.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...   .......+.+.+|+.++++++|+||+++++++...    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP---FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch---hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            46899999999999999999999999999999988632   12223345677899999999999999999887543    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ...+++++++ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              3578999998 8899988864 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------  372 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------  372 (444)
                      ...  .....||+.|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+...               
T Consensus       169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            443  234568999999999977555889999999999999999999999765433322221100               


Q ss_pred             ------CCCCC--------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ------KELPA--------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ------~~~~~--------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                            ..++.        .....++.+.+||.+||+.||++|||+.|+|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                  00011        112456788999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-43  Score=343.81  Aligned_cols=262  Identities=31%  Similarity=0.495  Sum_probs=216.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++..............+..|+.+++.++|+||+++++++..+..+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48889999999999999999999999999999875332222233456677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          236 LEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      |||+ +++|.+++.... .+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 899999998765 799999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC--------------------
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--------------------  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------------------  373 (444)
                      ....+++.|+|||.+.+...++.++|||||||++|||++|.++|........+.++....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            233467889999998665557899999999999999999988887655433322221100                    


Q ss_pred             ------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          374 ------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       374 ------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                            ........++.++.+||.+||+.||++|||+.|+++|+||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                  000112446789999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-43  Score=342.27  Aligned_cols=256  Identities=28%  Similarity=0.520  Sum_probs=213.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|+..+.||+|+||.||+|+++.+++.||+|++.....   .....+.+.+|+.++++++|+||+++++++......++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            368999999999999999999999999999998864221   12233567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      ||||+++++|..++.....+++..++.++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++....... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            99999999998888776779999999999999999999999999999999999999999999999999998765443 22


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------CC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------SK  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~~  373 (444)
                      ....++..|+|||++.+...++.++||||||+++|||++|+.||......+....+..                    ..
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            2344788899999987655578899999999999999999999987654433322110                    00


Q ss_pred             CCCC---------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 ELPA---------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ~~~~---------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..+.         ....++..+.+||.+||+.||++||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0000         013468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6e-43  Score=332.78  Aligned_cols=253  Identities=32%  Similarity=0.596  Sum_probs=215.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-CCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-DDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~l  234 (444)
                      .|++.+.||+|+||.||++.++.+++.||+|.+...   .......+.+.+|+.++++++|+|++++++.+.. +..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR---NASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh---hcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            489999999999999999999999999999988642   2233445678889999999999999999998764 456899


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          235 YLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      +|||+.+++|.+++...  ..+++..++.++.||+.+|.+||++||+|+||||+||+++.++.++|+|||++....... 
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999999763  358999999999999999999999999999999999999999999999999998664332 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+.. ...+..+..++.++.+||.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence            223345889999999987665 78999999999999999999999976554444333333 2344567788999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +||+.||++||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-43  Score=339.08  Aligned_cols=253  Identities=26%  Similarity=0.502  Sum_probs=210.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.++||+|+||.||+|++..+++.||+|.+...    ......+.+.+|+.++++++||||+++++.+..++..++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            588889999999999999999999999999988642    2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      |||+++++|..+    ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++....... ...
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  152 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKT  152 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccC
Confidence            999999999654    367899999999999999999999999999999999999999999999999998654332 233


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-------hhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-------AMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..++..|+|||++.+.. ++.++|||||||++|+|++|+.||.......       ....+.............+.++++
T Consensus       153 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         153 YVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            56899999999997665 8999999999999999999999996532211       111111111111123457889999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||.+||+.||++||+++++++||||.....
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-43  Score=337.90  Aligned_cols=258  Identities=47%  Similarity=0.843  Sum_probs=216.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-----ccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-----KSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      +|...+.||+|+||.||+|.+..+++.+|+|.++......     ......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5889999999999999999999899999999886432211     11223467888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ..++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999998765432


Q ss_pred             C---CcccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCC----CCCCC
Q 013354          311 S---CPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA----IPDHL  382 (444)
Q Consensus       311 ~---~~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~  382 (444)
                      .   ......++..|+|||++.... .++.++|+||||+++|||++|..||...+.......+........    ....+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            1   122345788999999986543 478899999999999999999999976555444444332222222    22356


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +.++.+||.+||+++|++||+++++|+||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-43  Score=345.78  Aligned_cols=258  Identities=26%  Similarity=0.455  Sum_probs=212.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|.++.....    .....+.+|+.+++.++|+||+++++++..++..++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc----CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            5799999999999999999999999999999998743221    122356689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            999996 5898888764 458999999999999999999999999999999999999999999999999987643322 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------C
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------S  372 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~  372 (444)
                      .....+++.|+|||++.+...++.++|||||||++|||++|++||...+.......+..                    .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            22344788999999987666678899999999999999999999976543322211100                    0


Q ss_pred             CCCC--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 KELP--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 ~~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ...+        .....++.++++||.+||+.||.+|||++|+|+||||+..-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0001        11235788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=344.86  Aligned_cols=257  Identities=38%  Similarity=0.637  Sum_probs=226.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +-|.+...||+|+||.||+|+++++|+.+|||.+.+       +..++++..|+.+|++++.+++|++||.+.....+++
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            468999999999999999999999999999998753       2346788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      |||||..|++.|+++.+ +.+++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.+..+...- .
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999999999999754 569999999999999999999999999999999999999999999999999998765432 3


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-CCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~Li~  391 (444)
                      ..++.||+.|||||++..-. |+.++||||||++..||..|++||.+......++.+...... -..|...+.++.+||+
T Consensus       186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~  264 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR  264 (502)
T ss_pred             hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence            45677999999999997554 899999999999999999999999987777767666543221 1234567899999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      +||.++|++|-|+.++++|||++++..-
T Consensus       265 ~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  265 SCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             HHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence            9999999999999999999999987654

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-43  Score=343.45  Aligned_cols=261  Identities=33%  Similarity=0.624  Sum_probs=220.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||++.+..+++.||+|.+...     .....+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-----ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            46899999999999999999999999999999988642     1223356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.++|+|||++.........
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999999999976 56899999999999999999999999999999999999999999999999998765443322


Q ss_pred             -ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHHHHHHH
Q 013354          314 -LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 -~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li~  391 (444)
                       ....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+... ......+..++..+++||.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence             2345788999999987655 789999999999999999999999765443333222221 1222345678899999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCCCcC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAPLER  421 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~  421 (444)
                      +||+.||++||+++++++||||+...+.+.
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcccccccc
Confidence            999999999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=339.22  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=228.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|...++||+|.||.|.+++.+.+++.||||++++.  -...++....-..|-++|+..+||.+..+.-.|+..+.+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe--viiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE--VIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh--heeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            46799999999999999999999999999999998753  2344555667778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc-ccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~-~~~~~~  312 (444)
                      +||||+.||.|+-.|.+...|++...+.+...|+.||.|||+++||+||||.+|+|+|.+|++||.|||+++. +.....
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999985 344556


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ..+++|||.|+|||++.... |+.++|.|.+||+||||+.|+.||...+......-|.... + .+|..++++++.|+.-
T Consensus       325 ~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~-kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-L-KFPRTLSPEAKTLLSG  401 (516)
T ss_pred             eccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-c-cCCccCCHHHHHHHHH
Confidence            67899999999999997666 9999999999999999999999998866555444443322 2 5788999999999999


Q ss_pred             HhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +|.+||.+|.     .+.||.+|+||...
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            9999999996     47899999999853

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-43  Score=337.13  Aligned_cols=258  Identities=38%  Similarity=0.776  Sum_probs=218.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-ccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-KSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|+.++.||+|+||.||++.+..+++.+|+|++....... ......+.+.+|++++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999999999999999987533222 223346788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEeccccccccCCCC-
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~~-  312 (444)
                      ||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998775 599999999876644321 


Q ss_pred             ----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHH
Q 013354          313 ----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       313 ----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~  385 (444)
                          .....++..|+|||++.+.. ++.++||||||+++|+|++|..||.......   ....+......+.++..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                12235788999999986654 8899999999999999999999997544322   222232333445677789999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      ++++|.+||+.+|++||++.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-43  Score=338.76  Aligned_cols=254  Identities=41%  Similarity=0.684  Sum_probs=212.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||+|+++..     .......+.+|+.+++.++|+||+++++.+...+..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            35799999999999999999999999999999988642     2233456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ 
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            9999999999999998888899999999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-CCC--CCCCCHHHH
Q 013354          313 PLSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAI--PDHLSDEGK  387 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~--~~~~s~~l~  387 (444)
                      .....|+..|+|||++.  ....++.++|||||||++|||++|..||.................. +..  ...++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            22345899999999874  2233788999999999999999999999765443333322222111 111  124678999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~  412 (444)
                      +||.+||+.||++||++++|++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-43  Score=348.79  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             eeeeeccc--CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          159 KGRLLGRG--TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       159 ~~~~LG~G--~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      +.++||+|  +|++||+++++.+|+.||+|.+....   ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh---ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            45789999  78999999999999999999886421   22344567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC--
Q 013354          237 EYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--  312 (444)
Q Consensus       237 e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--  312 (444)
                      ||+.+++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++++||+..........  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999999753  3589999999999999999999999999999999999999999999999986543321111  


Q ss_pred             ------cccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-----------
Q 013354          313 ------PLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----------  374 (444)
Q Consensus       313 ------~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-----------  374 (444)
                            .....++..|+|||++.+. ..++.++|||||||++|||++|+.||.................           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                  1122366789999998753 3488999999999999999999999975433221111110000           


Q ss_pred             ---------------------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          375 ---------------------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       375 ---------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                                       .......+++++++||++||+.||++|||++|+++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                             001122357889999999999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=324.20  Aligned_cols=262  Identities=29%  Similarity=0.495  Sum_probs=222.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~  232 (444)
                      ..+.+....||.|+.|+|++++.+.+|...|||.+..    ...++..++++..+.++...+ +|+||+++|+|..+...
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            3456667789999999999999999999999999873    345666778888888877664 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++.||.+ +--+++++++ +++++|..+-++...++.||.||.++ +|||||+||+|||+|+.|++||||||++.++-+.
T Consensus       167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            9999988 4456666655 45799999999999999999999876 8999999999999999999999999999998877


Q ss_pred             CCcccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCCCC--CCCHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPD--HLSDE  385 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~--~~s~~  385 (444)
                      .......|.+.|||||.+.-  ...|+.++||||||++++||.||+.||...+.. +.+.++.+ ...|.++.  .+++.
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPD  324 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHH
Confidence            77777779999999999863  345899999999999999999999999886544 55556555 33355554  37999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCcC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER  421 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~~  421 (444)
                      +++|+..||++|+.+||...++|+|||+......++
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~  360 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEV  360 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeecchhhc
Confidence            999999999999999999999999999987655443

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.9e-43  Score=341.27  Aligned_cols=257  Identities=33%  Similarity=0.620  Sum_probs=217.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.|++|.+...     .....+.+.+|+.+++.++|+||+++++.+......
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC-----CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            345899999999999999999999999999999988642     122346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999999999999875 4689999999999999999999999999999999999999999999999999876543322


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHHHHHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li  390 (444)
                       .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+... ......+..++..+.+||
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             ccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence             22345889999999987655 789999999999999999999999765543333322221 112234567889999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+||.+||++||++.++++||||...
T Consensus       251 ~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHCcCCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-45  Score=364.09  Aligned_cols=263  Identities=38%  Similarity=0.670  Sum_probs=230.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+.+-|.+...||.|+||.||+|.++.++-..|.|+|.     ....+.++.+.-||.+|..++||+||++++.|..++.
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence            34567999999999999999999999998888999885     3667788899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc-cC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-~~  309 (444)
                      ++|+.|||.||-++.++-+-+ .+++.++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+... ..
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            999999999999998887654 5999999999999999999999999999999999999999999999999987543 22


Q ss_pred             CCCcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-CCCCCCCCH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPDHLSD  384 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~  384 (444)
                      .....++.|||+|||||+++.    ...|++++||||||++|.||..+.+|....+....+.++.+.... -..|...+.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            334557889999999999752    334899999999999999999999999888877777777665432 234677899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      .+.|||++||.+||..||++.+||+||||.++...
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            99999999999999999999999999999987655

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-43  Score=340.88  Aligned_cols=243  Identities=20%  Similarity=0.255  Sum_probs=207.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----CCEEEEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----DDKLYIYL  236 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv~  236 (444)
                      ..||+|+++.||+|.+  +|+.||+|+++..  ........+.+.+|+.+|++++||||+++++++.+    ...+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccc--ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            6799999999999987  5899999988642  22334456788899999999999999999998876    35789999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          237 EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      ||+.+|+|.+++.+...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+....  ..
T Consensus       102 Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~  179 (283)
T PHA02988        102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FK  179 (283)
T ss_pred             EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cc
Confidence            9999999999999888899999999999999999999985 99999999999999999999999999988654322  23


Q ss_pred             ccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          316 IKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ..++..|+|||++.+. ..++.++|||||||++|||++|+.||...........+......+.++..++.++++||.+||
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl  259 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT  259 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence            4588999999998652 348999999999999999999999998776555555554333344566678999999999999


Q ss_pred             hhCCCCCcCHHHHHh
Q 013354          395 QRNPLHRPTAAWLLE  409 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~  409 (444)
                      +.||++|||+.++++
T Consensus       260 ~~dp~~Rps~~ell~  274 (283)
T PHA02988        260 SHDSIKRPNIKEILY  274 (283)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999885

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-43  Score=380.03  Aligned_cols=262  Identities=27%  Similarity=0.480  Sum_probs=217.3

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--  228 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  228 (444)
                      .....+|++.+.||+|+||+||+|++..+++.||+|++....   ........+.+|+.++++|+|||||+++++|..  
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            344568999999999999999999999999999999886422   233455778899999999999999999998754  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCceEECC-----
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAK-------NTVHRDIKGANILVDP-----  292 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivH~Dlkp~NIll~~-----  292 (444)
                      ...+||||||+.+++|.++|...    ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            46799999999999999999753    4699999999999999999999985       4999999999999964     


Q ss_pred             ------------CCcEEEEeccccccccCCCCcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 013354          293 ------------SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQ  359 (444)
Q Consensus       293 ------------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~  359 (444)
                                  .+.+||+|||++..+..........||+.|+|||++... ..++.++||||||||||||++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        234899999999876554444456799999999998543 3478899999999999999999999976


Q ss_pred             CCChhhhHHhcCCCCCCCC-CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          360 YEGVPAMFKIGNSKELPAI-PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ......+.......  +.+ ....+.++.+||..||+.+|++||++.|+|.|+||++..
T Consensus       246 ~~~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        246 ANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCcHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            65544443332222  122 245789999999999999999999999999999998653

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-43  Score=343.25  Aligned_cols=254  Identities=30%  Similarity=0.525  Sum_probs=206.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|++..+|+.||+|.++....   .......+.+|+.++++++|+||+++++++.....+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            48899999999999999999999999999999875321   122334667899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          236 LEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      +||+. ++|.+++.+ ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++........ .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            99996 588887765 45699999999999999999999999999999999999999999999999999886543221 2


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hhhhHHhc------------------CCCC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIG------------------NSKE  374 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~------------------~~~~  374 (444)
                      ....++..|+|||++.+...++.++|||||||++|||++|..||..... ...+..+.                  ....
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            2345788999999987766578999999999999999998888643222 22111110                  0000


Q ss_pred             CC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          375 LP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       375 ~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+         .....++.++++||++||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            01         1123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=333.58  Aligned_cols=254  Identities=42%  Similarity=0.689  Sum_probs=215.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++...     .....+.+.+|+.++++++|+||+++++.+.....++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            35799999999999999999999989999999998742     2234578889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++|||+.+++|.+++... ..+++..++.++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++....... 
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999999999999876 679999999999999999999999999999999999999999999999999987654432 


Q ss_pred             CcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC---CCCCCCCCHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL---PAIPDHLSDEG  386 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~l  386 (444)
                      ......++..|+|||++...  ..++.++|||||||++|||++|..||...........+......   ...+...+.++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            22334578899999998655  13788999999999999999999999876654444333322111   11234567899


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~  412 (444)
                      ++||++||..||.+|||+.++++|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=361.95  Aligned_cols=259  Identities=32%  Similarity=0.546  Sum_probs=223.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--EEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--KLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~  233 (444)
                      -.+...+||+|+|-+||+|.|..+|..||.-.++.. +-....+..++|..|+.+|+.|+|+||+++|+++.+..  .+.
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~-d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR-DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHH-HhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            345567899999999999999999999997766542 23355667899999999999999999999999988754  488


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCceEECC-CCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--NTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~  310 (444)
                      +|.|++..|+|..|+++.++++...++.|++||++||.|||++  .|||||||-+||||+. .|.|||+|+|+|+.+...
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999999999999999999999999999999999999  5999999999999965 489999999999987554


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      ... .+.|||.|||||++.  ..|+..+||||||++|+||.|+..||.......+ +.++..+.....+..--++++++|
T Consensus       200 ~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  200 HAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             ccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence            433 377999999999986  3489999999999999999999999988776655 455555555445555568999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      |.+||.. .++|+|+.|||+||||......
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d~g~  305 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDEDGGI  305 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhcccccc
Confidence            9999998 9999999999999999976443

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.6e-43  Score=340.23  Aligned_cols=258  Identities=33%  Similarity=0.635  Sum_probs=220.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||.|+||.||+|++..+++.|++|.+...     .....+.+.+|+.+++.++|+||+++++.+...+.++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            45799999999999999999999999999999988642     1223456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +|+||+.+++|.+++.+ ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999999999999876 4689999999999999999999999999999999999999999999999999876544332 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li~  391 (444)
                      .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+... ......+..++.++.+||+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            22345888999999987655 789999999999999999999999876654444433222 2222345678999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +||..||++||++.++++||||+....
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=333.21  Aligned_cols=257  Identities=47%  Similarity=0.865  Sum_probs=220.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  232 (444)
                      ..|++.+.||+|+||.||+|++..+++.||+|.+...............+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            469999999999999999999999999999998764322223345567889999999999999999999988653  568


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC--
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~--  310 (444)
                      ++|+||+.+++|.+++.+...+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            899999999999999988778999999999999999999999999999999999999999999999999999765321  


Q ss_pred             --CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          311 --SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 --~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                        .......++..|+|||++.+.. ++.++|+|||||++|||++|+.||..........++......+.++..+++++++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence              1112345888999999997655 7899999999999999999999998766555555555554556788899999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +|.+||+ ++.+||++.++++|||+
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999998 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-43  Score=333.31  Aligned_cols=254  Identities=35%  Similarity=0.667  Sum_probs=215.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||.|+||+||+|.+..++..+++|++...    ......+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE----KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccC----CcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            3689999999999999999999889999999988532    112256788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDY---GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |||++.+++|.+++...   ..+++..++.++.||+.||+|||++||+|+||+|+||++++++.++|+|||++..+....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999999764   358999999999999999999999999999999999999999999999999987665432


Q ss_pred             Cc-----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC-----CC
Q 013354          312 CP-----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-----DH  381 (444)
Q Consensus       312 ~~-----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~  381 (444)
                      ..     ....++..|+|||++.....++.++|+|||||++|||++|+.||................. +.++     ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCcccccc
Confidence            22     2345888999999987664588999999999999999999999987655444433322211 1111     25


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ++.++++||.+||+.||++||++++|++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.4e-43  Score=337.97  Aligned_cols=258  Identities=38%  Similarity=0.631  Sum_probs=216.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|++.+.||+|+||.||++.+..++..+++|.+..     ......+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            47888999999999999999999999999998753     2334456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          236 LEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      |||+.+++|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999999998865 3568999999999999999999999999999999999999999999999999987653322 22


Q ss_pred             ccccCCCcccCccccc----CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCCCCCCCHHHHH
Q 013354          314 LSIKGSPYWMAPEVIK----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHLSDEGKD  388 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~----~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~  388 (444)
                      ....++..|+|||++.    ....++.++|||||||++|||++|+.||...+.......+.... .....+..++.++++
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            3345889999999984    22336789999999999999999999998765444443333221 122345678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||.+||+.||++||++.++++||||+....
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-43  Score=347.93  Aligned_cols=246  Identities=30%  Similarity=0.489  Sum_probs=192.7

Q ss_pred             eeeecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLYIY  235 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv  235 (444)
                      ++.||+|+||.||+|+++  .+++.||+|.+....       ....+.+|+.++++++||||+++++++..  +..++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            468999999999999975  467899999875311       12346789999999999999999998854  4678999


Q ss_pred             EeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE----CCCCcEEEEecc
Q 013354          236 LEYVSGGSIYKILQDY---------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFG  302 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~vkL~DFG  302 (444)
                      |||+ +++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            9998 46888887632         248899999999999999999999999999999999999    455789999999


Q ss_pred             ccccccCCC----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---------hhhHHh
Q 013354          303 MAKHITGQS----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---------PAMFKI  369 (444)
Q Consensus       303 la~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------~~~~~~  369 (444)
                      +++......    ......+|+.|+|||++.+...++.++|||||||++|||++|++||......         ..+..+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            998764332    1224568999999999977666899999999999999999999999643221         011100


Q ss_pred             cCC------------CCC------------------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          370 GNS------------KEL------------------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       370 ~~~------------~~~------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ...            ...                        .......+.++.+||++||+.||++|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000            000                        00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-43  Score=336.54  Aligned_cols=254  Identities=30%  Similarity=0.485  Sum_probs=220.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...  ........+.+.+|+.++++++||||+++++.+......++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--KCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehh--hhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            488999999999999999999999999999988642  122334567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      +||+.+++|.+++.....+++..+..++.||++||.|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999887655443444


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--hhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--VPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ..++..|+|||++.+.. ++.++|+||||+++|+|++|..||.....  ...+...... .....+..++.++.++|.+|
T Consensus       159 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             cCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHH
Confidence            56888999999987665 88999999999999999999999987654  2222222221 33466778899999999999


Q ss_pred             hhhCCCCCcCH--HHHHhCCCC
Q 013354          394 LQRNPLHRPTA--AWLLEHPFV  413 (444)
Q Consensus       394 L~~dP~~Rpt~--~elL~hp~~  413 (444)
                      |+.||.+||++  .|+++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.9e-43  Score=338.02  Aligned_cols=255  Identities=35%  Similarity=0.656  Sum_probs=211.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL---  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~---  228 (444)
                      ....|++.+.||+|+||.||+|.+..+++.+|+|++..      .......+..|+.+++++ +|+||+++++++..   
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~------~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV------TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec------ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            34679999999999999999999999999999998753      122335677899999998 79999999998753   


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                         ...++++|||+.+++|.+++...  ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence               46789999999999999999763  3488999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CCcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          304 AKHITGQ-SCPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       304 a~~~~~~-~~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      +...... .......|+..|+|||++..    ...++.++|||||||++|||++|..||...........+.........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK  247 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence            8765432 22334568899999998752    233778999999999999999999999765544444333333222233


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ...++.++.+||++||+.||.+|||+.|||+||||
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            45689999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-42  Score=350.70  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=206.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ..+|++.+.||+|+||.||++...  .+++.||+|.+...          ....+|+.++++++|+||+++++++..+..
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            457999999999999999999764  35678999977521          134579999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      .++|||++ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus       161 ~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99999999 47899999777789999999999999999999999999999999999999999999999999997654432


Q ss_pred             C---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhhHHhc---------------
Q 013354          312 C---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIG---------------  370 (444)
Q Consensus       312 ~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~---------------  370 (444)
                      .   .....||+.|+|||++.... ++.++|||||||++|||++|+.||......   ..+..+.               
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2   23456999999999997665 899999999999999999999999654321   1111100               


Q ss_pred             -----------CCCCC-CCCC-----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          371 -----------NSKEL-PAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       371 -----------~~~~~-~~~~-----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                 ..... ..++     ..++.++++||++||+.||++|||+.|+|.||||+...
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                       00000 0011     23577899999999999999999999999999998743

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-42  Score=331.38  Aligned_cols=255  Identities=46%  Similarity=0.858  Sum_probs=216.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|+||.||+|++..+++.|++|.++...   ......+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            5889999999999999999999899999999987432   2245678899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc-
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~-  314 (444)
                      +||+.+++|.+++.+...+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++.......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999999999887679999999999999999999999999999999999999999999999999988764433221 


Q ss_pred             ----cccCCCcccCcccccCcC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCC--CHHH
Q 013354          315 ----SIKGSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL--SDEG  386 (444)
Q Consensus       315 ----~~~gt~~y~APE~~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--s~~l  386 (444)
                          ...++..|+|||++....  .++.++||||||+++|||++|+.||...+..............+.++...  +..+
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG  237 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence                245788999999986543  26889999999999999999999997654332222222223334555544  8999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+||++||+.+|++||++.+++.|||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         238 KDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=331.34  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=214.8

Q ss_pred             CCCCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc--
Q 013354          153 PGSRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL--  228 (444)
Q Consensus       153 ~~~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--  228 (444)
                      ..++|.+. ++||-|-.|.|..+.++.|++.+|+|++.      +.    +..++|+++--.. .|+|||.++++|++  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------DS----PKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------cC----HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            44566664 57999999999999999999999999874      11    3445677764444 69999999998765  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEec
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADF  301 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DF  301 (444)
                        ...+.+|||.++||.|+..+++++.  |+|.++..|++||..|+.|||+.+|.||||||+|+|...   |..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              4678899999999999999998876  999999999999999999999999999999999999954   456999999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh----hhHHhcCCCCC--
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP----AMFKIGNSKEL--  375 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~--  375 (444)
                      |+|+.........+.+.|++|.|||++...+ |+...|+||+||+||-||.|.+||....+..    .-.+|..+...  
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            9999887777777888999999999996655 9999999999999999999999997766542    22344443331  


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCc
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~  420 (444)
                      ..-...+|++.+++|+.+|..+|.+|.|++++++|||+......+
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence            112245899999999999999999999999999999998765544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-43  Score=353.27  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|++.+.||+|+||.||+|++..+++.||+|+...           .....|+.++++++|+||+++++++......++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            469999999999999999999999999999996431           122458999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            999994 688888765 356999999999999999999999999999999999999999999999999999765444444


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCC-CCCCCCCCh---------hhhHHhcC-----CCCCC--
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGV---------PAMFKIGN-----SKELP--  376 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~-~Pf~~~~~~---------~~~~~~~~-----~~~~~--  376 (444)
                      ....||..|+|||++.+.. ++.++|||||||++|||+++. .+|......         ..+..+..     ....+  
T Consensus       214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            4566999999999997665 899999999999999999854 444332111         00100000     00000  


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          377 -------------------------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       377 -------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                                               .....++.++.+||.+||+.||++|||++|+|+||||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     001245778889999999999999999999999999986

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-42  Score=329.16  Aligned_cols=253  Identities=33%  Similarity=0.564  Sum_probs=219.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..++||.|+||.||.+++..+++.+++|.+....   ......+.+.+|+.++++++|+||+++++++...+.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            5889999999999999999999999999999886422   2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      |||+.+++|.+++.+.  ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.+||+|||++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999999875  458999999999999999999999999999999999999999999999999988664433 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....+++.|+|||++.+.. ++.++||||||+++|||++|..||...........+..... ...+..++.++.++|.+
T Consensus       158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-TPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHHH
Confidence            23455889999999987665 78899999999999999999999987655555555544333 34457789999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ||..+|++||+++++|+|+|+
T Consensus       236 ~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.1e-43  Score=337.11  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=212.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc---ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            5889999999999999999999999999999987422   1233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC--
Q 013354          236 LEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--  312 (444)
                      |||+ +++|.+++... ..+++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++........  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 99999998753 4689999999999999999999999999999999999999999999999999887654331  


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-------------------  373 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------------  373 (444)
                      .....++..|+|||++.+...++.++|||||||++|||++|.++|........+..+....                   
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            2334588999999998766657899999999999999999988886654333222211100                   


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          374 ---------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       374 ---------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                               ....+....+.++.+||++||+.||++||+++++|+||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                     00111235679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-42  Score=330.36  Aligned_cols=253  Identities=32%  Similarity=0.573  Sum_probs=217.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~  233 (444)
                      +|++.+.||.|+||.||++.+..+++.||+|++...   .......+.+.+|+.+++.++|+||+++++.+..  ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            488899999999999999999999999999988632   2234455778899999999999999999997753  45689


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          234 IYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLH-----AKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      ++|||+.+++|.+++...    ..+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999999763    56899999999999999999999     889999999999999999999999999999


Q ss_pred             ccccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          305 KHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       305 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ........ .....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...+.......+.. ...+.++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccC
Confidence            87655433 23446899999999997666 88999999999999999999999987664443444433 34456778899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .++.+|+.+||+.+|++||++++|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-42  Score=327.31  Aligned_cols=254  Identities=59%  Similarity=1.038  Sum_probs=223.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  233 (444)
                      +|+..+.||+|++|.||+|.+..+++.|++|++.....   .....+.+.+|+.++++++|+||+++++.+...  ...+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            48889999999999999999998999999998864321   245567889999999999999999999999988  8999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +++||+.+++|.+++.+...+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999999999877899999999999999999999999999999999999999999999999999987765543 


Q ss_pred             --cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        .....++..|+|||.+.... .+.++||||||+++|+|++|..||...+. ......+......+.++..++.++++|
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence              34456888999999987665 88999999999999999999999987652 233344444455567788889999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      |.+||+.||++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=354.99  Aligned_cols=260  Identities=29%  Similarity=0.471  Sum_probs=234.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|.+.+.||+|.|+.|.+|++..++..||||.+.+   ........+.+.+|+++|+.|+|||||+++.+......+|+
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idk---t~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDK---TQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehh---cccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            469999999999999999999999999999998864   33444555669999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||+.+|.+++++.+.+++.+..++.++.|+++|++|||+++|||||||++|||++.+.++||+|||++.++.......
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      +.+|++.|.|||++.+.....+.+|+||+|+++|-|+.|.+||.+..-.+.-.+...++.  .++..++.++.+||+++|
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~l  290 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKFL  290 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccceeechhHHHHHHhh
Confidence            999999999999999888778999999999999999999999987554444444433333  567789999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      -++|.+|++.+++++|.|.......
T Consensus       291 vl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  291 VLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999875443

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-42  Score=329.60  Aligned_cols=253  Identities=30%  Similarity=0.534  Sum_probs=218.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+....   ......+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            5889999999999999999999999999999986422   2233457888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEeccccccccCCCC
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~~~~~  312 (444)
                      |||+.+++|.+++...  ..+++..++.++.|++.+|+|||+++|+|+||||+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999999764  348999999999999999999999999999999999999865 4589999999987765544


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....++..|+|||++.... ++.++||||||+++|+|++|..||...+.......+.... ...++..++.+++++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-CCCCCCCcCHHHHHHHHH
Confidence            44456888999999997655 7889999999999999999999998765544444443332 235667789999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ||+.||++|||+.|++.||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-42  Score=330.13  Aligned_cols=251  Identities=41%  Similarity=0.708  Sum_probs=214.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|+..+.||+|+||.||+|++..+++.+++|.+...       ...+.+.+|+.+++.++|+||+++++.+..+...++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            5799999999999999999999988999999988631       115788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ++||+.+++|.+++... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            99999999999999763 468999999999999999999999999999999999999999999999999988765443 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~Li~  391 (444)
                      .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... .....+..++.++.+||.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            23344788999999987655 8999999999999999999999997655443333322211 111234567889999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +||+.||++|||+.|+|+||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.9e-44  Score=370.57  Aligned_cols=249  Identities=29%  Similarity=0.488  Sum_probs=219.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ...+.+..+.||+|.||.||+|+-.     .+...||||.++    +..+....++|.+|+++|..++|||||+++|+|.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK----d~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK----DKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc----ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3455677788999999999999763     345789999886    3344557789999999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG--------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      +++.+++|+||+..|+|.++|....              +++..+.+.|+.||+.||.||-++.+|||||..+|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            9999999999999999999997532              27788999999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccCCCCccccc----CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHH
Q 013354          294 GRVKLADFGMAKHITGQSCPLSIK----GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFK  368 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~~~~~~----gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  368 (444)
                      ..|||+|||+++..-..+- +...    -..+|||||.++.++ ++.+|||||+||+|||+++ |+.||.+....+.+..
T Consensus       640 l~VKIsDfGLsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             eEEEecccccchhhhhhhh-hcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            9999999999986544332 2121    246899999999888 9999999999999999999 9999999999999999


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHH
Q 013354          369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       369 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL  408 (444)
                      +..++.+ ..|+.+|.++++||..||+.+|++||++.||-
T Consensus       718 i~~g~lL-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAGQLL-SCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcCCcc-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9988886 67999999999999999999999999999863

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-43  Score=339.00  Aligned_cols=260  Identities=32%  Similarity=0.568  Sum_probs=217.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||++++..+++.||+|.++..    ........+.+|+.++++++|+||+++++.+..++.+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3688999999999999999999999999999988632    233345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          235 YLEYVSGGSIYKILQDY---GQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ||||+.+++|..++...   ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++..+...
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999998763   368999999999999999999997 59999999999999999999999999998765433


Q ss_pred             CCcccccCCCcccCcccccCcC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCCCCCCCCCCCC
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSN-----GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLS  383 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s  383 (444)
                      . .....++..|+|||++....     .++.++|||||||++|+|++|+.||...........+.  .....+.++..++
T Consensus       157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         157 L-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             c-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence            2 22344788999999985432     25789999999999999999999997644333222211  1223345677799


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      .++.+||.+||+.+|++||+++++++||||......
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999999876443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-42  Score=330.88  Aligned_cols=256  Identities=34%  Similarity=0.611  Sum_probs=221.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|++|.||+|++..+++.|++|++....    .....+.+.+|+..+.+++|+||+++++.+......++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            5889999999999999999999999999999886421    114567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999999999987889999999999999999999999 999999999999999999999999999988765443332


Q ss_pred             -cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC--ChhhhHHhcCCCCCCCCCCC-CCHHHHHHH
Q 013354          315 -SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELPAIPDH-LSDEGKDFV  390 (444)
Q Consensus       315 -~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li  390 (444)
                       ...++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....  ..............+.++.. ++..+.++|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         158 NTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             cceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence             445788999999987664 8899999999999999999999997764  22222222223333455666 899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+||..+|++||++.++++||||+..
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-42  Score=356.33  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      .+..|.+.+.||+|+||.||+|.+..+++.||||...           ...+.+|+++|++++|+|||++++++..++..
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            3557999999999999999999999999999999542           12356799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||++ .++|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus       236 ~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        236 CLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9999999 46888888664 469999999999999999999999999999999999999999999999999998654322


Q ss_pred             C---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC-C------hhhhHH-hcCCCC-CCCC-
Q 013354          312 C---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE-G------VPAMFK-IGNSKE-LPAI-  378 (444)
Q Consensus       312 ~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~-~------~~~~~~-~~~~~~-~~~~-  378 (444)
                      .   .....||+.|+|||++.+.. ++.++|||||||+||||++|..++.... .      ...+.+ +..... ...+ 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            1   22356999999999997765 8999999999999999999776542211 0      011111 111000 0000 


Q ss_pred             -------------------------C-----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          379 -------------------------P-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       379 -------------------------~-----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                                               +     ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                     0     134668999999999999999999999999999974

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.7e-43  Score=335.73  Aligned_cols=254  Identities=33%  Similarity=0.596  Sum_probs=215.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|+||.||++.++.+++.+|+|.+...    ......+.+.+|+.+++.++|+||+++++.+..+...+++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE----INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc----cChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            578889999999999999999999999999988642    1234556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          236 LEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||+.+++|.+++... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999999999999876 679999999999999999999999 99999999999999999999999999998765433222


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC----Ch-hhhHHhcCCCCCCCCCCC-CCHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE----GV-PAMFKIGNSKELPAIPDH-LSDEGK  387 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~----~~-~~~~~~~~~~~~~~~~~~-~s~~l~  387 (444)
                      . ..++..|+|||++.+.. ++.++||||||+++|+|++|..||....    .. .....+.. ...+.++.. ++.+++
T Consensus       158 ~-~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (265)
T cd06605         158 T-FVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             c-ccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHHH
Confidence            2 55888999999987664 8999999999999999999999996542    11 22222222 222344444 899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||.+||..||++|||+.+++.||||+..
T Consensus       235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         235 DFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=357.45  Aligned_cols=259  Identities=38%  Similarity=0.632  Sum_probs=226.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|...+.||.|+||.||.|++..+.+.||||.+..  ......+.++++..|+.+|++++|||++.+-|+|..+...||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy--SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccc--cccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence            458888999999999999999999999999998764  334556677899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||| -|+-.|++.-. +++-+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|..+.+.   
T Consensus       104 VMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  104 VMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            99999 56888888643 57999999999999999999999999999999999999999999999999999877654   


Q ss_pred             ccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      .+++|||+|||||++.  +...|+-++||||||++..||...++|+-+++....+..|.......-.....++.+++||.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd  259 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  259 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence            4677999999999974  23338999999999999999999999999998888888776544332234567899999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      .||++-|.+|||.+++|+|+|+.-..+.
T Consensus       260 ~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  260 SCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            9999999999999999999998765443

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-42  Score=337.79  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=216.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.+..+++.|++|.+...  ........+.+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--NLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh--hhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            689999999999999999999999999999987632  112233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC----
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS----  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~----  311 (444)
                      |||+.|++|.+++...+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999886321100    


Q ss_pred             ------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCC
Q 013354          312 ------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAI  378 (444)
Q Consensus       312 ------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~  378 (444)
                                  ......++..|+|||.+.+.. ++.++|+|||||++|||++|..||................ ..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG  238 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence                        011234778899999987655 8999999999999999999999997655444444433222 22333


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      ...++.++++||.+||++||++||+   +.++|+||||...
T Consensus       239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            4468999999999999999999998   7899999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-42  Score=333.05  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.++..    ........+.+|+.++.+++||||+++++++...+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            457999999999999999999875   34678999988632    22334467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999874 4689999999999999999999999999999999999999999999999998765432


Q ss_pred             CCCcc--cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSCPL--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~~~--~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      .....  ...++..|+|||++.+.. ++.++|||||||++||+++ |..||...........+...... ..+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-PAPRNCPNLL  237 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence            22111  223467899999987665 8999999999999999875 99999877666555555544433 4577899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+++.+||+.+|++||++++|++
T Consensus       238 ~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-42  Score=329.07  Aligned_cols=253  Identities=32%  Similarity=0.588  Sum_probs=217.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....   ......+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK---MSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh---CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            5889999999999999999999999999999886421   1233446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          236 LEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |||+.+++|.+++....  .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999999997643  478999999999999999999999999999999999999999999999999876544321 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.......+.... .+..+..++.++.++|.+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHHH
Confidence            12334788999999987665 7889999999999999999999997655544444443333 345677889999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ||+.+|++||++.++++||||
T Consensus       236 ~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         236 LFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-42  Score=334.05  Aligned_cols=253  Identities=30%  Similarity=0.432  Sum_probs=205.7

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHH---HHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA---LLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~---~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      +||+|+||.||++.+..+++.+|+|.+.......  ......+.+|..   ++...+|+||+.+++.+..++..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc--chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            4899999999999999999999999886432211  111122333433   34445799999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccC
Q 013354          239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG  318 (444)
Q Consensus       239 ~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~g  318 (444)
                      +.+++|.+++...+.+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... .....|
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~  157 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVG  157 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCC
Confidence            9999999999888889999999999999999999999999999999999999999999999999987554332 223458


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR  396 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~  396 (444)
                      +..|+|||.+.....++.++|||||||++|||++|..||......  ....... ......++..++.++++||++||+.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcC
Confidence            999999999865555789999999999999999999999754322  1222211 1222356778999999999999999


Q ss_pred             CCCCCc-----CHHHHHhCCCCCCCCC
Q 013354          397 NPLHRP-----TAAWLLEHPFVGNAAP  418 (444)
Q Consensus       397 dP~~Rp-----t~~elL~hp~~~~~~~  418 (444)
                      ||++|+     ++.++++||||++...
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccCCCH
Confidence            999999     6999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.5e-43  Score=352.52  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=207.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSET  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  227 (444)
                      ..+|++++.||+|+||.||+|++     ..++..||+|+++..    ......+.+.+|+.++..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC----cCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            45799999999999999999974     345778999988632    1223346788999999999 8999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC-------------------------------------------------------
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG-------------------------------------------------------  252 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~-------------------------------------------------------  252 (444)
                      ..+..++||||+.+|+|.+++.+..                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999996532                                                       


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          253 --------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       253 --------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                                          .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                367788999999999999999999999999999999999999999999999986644322


Q ss_pred             cc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          313 PL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       313 ~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..   ...++..|+|||++.+.. ++.++|||||||++|||++ |..||..........+..........+...+.++++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence            11   122456799999997665 8999999999999999998 899997765444443333333333456678899999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ||.+||+.||++||++.||++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=334.37  Aligned_cols=257  Identities=39%  Similarity=0.690  Sum_probs=216.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcCCEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPNIVRYYGSETLDDKL  232 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~  232 (444)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+...    ......+.+.+|+.+++.++   |+|++++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            477889999999999999999999999999988642    12334456788999999986   99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.++++. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999999999876 4799999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCC-CCCHHHHHHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD-HLSDEGKDFV  390 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~Li  390 (444)
                       .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+... ..+.++. .++.++.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  235 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV  235 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence             233458889999999876665789999999999999999999999765543333222222 2233443 3789999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      .+||+.||++||++.++++|+||++...
T Consensus       236 ~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         236 AACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            9999999999999999999999987543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-42  Score=329.92  Aligned_cols=252  Identities=44%  Similarity=0.731  Sum_probs=210.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      +.....||+|+||.||+|++..++..|++|.+..     ......+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecC-----CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            4444689999999999999999999999998753     23344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccccccccCCCC
Q 013354          237 EYVSGGSIYKILQDY-GQL--GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       237 e~~~ggsL~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~~  312 (444)
                      ||+.+++|.+++... ..+  ++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999999864 445  88889999999999999999999999999999999976 67899999999876543222


Q ss_pred             -cccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                       .....++..|+|||++... ..++.++||||||+++|+|++|+.||...... ............+.++..+++++++|
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence             2234578899999998543 23788999999999999999999999764432 22222222233456778899999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +.+||+.+|++|||+.|+++||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.8e-43  Score=352.21  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSET  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  227 (444)
                      .++|++.+.||+|+||.||+|++...     ++.||+|+++..    ......+.+.+|+.+++.+ +|+||+++++.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS----AHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC----CCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            35799999999999999999986443     457999988632    2233456788999999999 8999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC-------------------------------------------------------
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG-------------------------------------------------------  252 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~-------------------------------------------------------  252 (444)
                      ..+..++||||+.+|+|.+++.+..                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999986421                                                       


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc---c
Q 013354          253 ---------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---L  314 (444)
Q Consensus       253 ---------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~---~  314 (444)
                                     .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........   .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                           3678889999999999999999999999999999999999999999999999765433211   1


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...++..|+|||++.+.. ++.++|||||||++|||++ |+.||..................+..+..++.+++++|.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            122456799999987665 8999999999999999997 99999876554444444333333455677899999999999


Q ss_pred             hhhCCCCCcCHHHHHh
Q 013354          394 LQRNPLHRPTAAWLLE  409 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~  409 (444)
                      |+.||++|||+.++++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-42  Score=339.43  Aligned_cols=259  Identities=29%  Similarity=0.457  Sum_probs=210.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DK  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~  231 (444)
                      ..+|++.+.||+|+||.||+|+++.+|+.||+|.++.....   ......+.+|+.++++++|+||+++++++...  +.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER---DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC---CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            45799999999999999999999999999999988743211   11223456799999999999999999998754  56


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++||||+. ++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            899999996 5888888763 56899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC---------------
Q 013354          311 SC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---------------  374 (444)
Q Consensus       311 ~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---------------  374 (444)
                      .. .....++..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+.....               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            21 22233578899999987656588999999999999999999999987655443332211000               


Q ss_pred             -----CCC--------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          375 -----LPA--------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       375 -----~~~--------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                           .+.        .....+.++.+||.+||+.||++|||++++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                 000        012358899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=331.65  Aligned_cols=254  Identities=34%  Similarity=0.657  Sum_probs=210.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC--
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD--  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~--  230 (444)
                      ..+|++.+.||+|+||.||+|.++.+++.+++|++...      ....+.+.+|+.+++++ +|+||+++++++....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            46899999999999999999999988999999988632      12346788999999999 7999999999986543  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          231 ----KLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                          .+++||||+.+++|.+++...    ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                589999999999999998753    468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC-CcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC-
Q 013354          303 MAKHITGQS-CPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-  376 (444)
Q Consensus       303 la~~~~~~~-~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-  376 (444)
                      ++....... ......++..|+|||++..    ...++.++|||||||+||+|++|+.||...........+....... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            987654322 2233458889999998753    2336789999999999999999999997655544444443322211 


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..+..++.++++||.+||..||++|||+.++++|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1223478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-42  Score=333.51  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=211.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|+||+||+|.+..+|+.||+|++...  ........+.+.+|+.++++++|+||+++++++...+..|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKK--RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehh--hhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            69999999999999999999999988632  1122233456678999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCC
Q 013354          243 SIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP  320 (444)
Q Consensus       243 sL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  320 (444)
                      +|.+++.+..  .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            9999998765  69999999999999999999999999999999999999999999999999988765443334455788


Q ss_pred             cccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       321 ~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      .|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.  ........+..+++++.+||.+||+.||
T Consensus       159 ~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (277)
T cd05577         159 GYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP  237 (277)
T ss_pred             CcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence            999999987666 8899999999999999999999997654321111111  1112234566789999999999999999


Q ss_pred             CCCc-----CHHHHHhCCCCCCCC
Q 013354          399 LHRP-----TAAWLLEHPFVGNAA  417 (444)
Q Consensus       399 ~~Rp-----t~~elL~hp~~~~~~  417 (444)
                      ++||     ++.++++||||.+..
T Consensus       238 ~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         238 EKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hHccCCCcccHHHHHhChhhhcCC
Confidence            9999     888999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-42  Score=334.51  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=212.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCC-----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESG-----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.++.    .........+.+|+.++.+++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE----NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEeccc----CCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            46899999999999999999876554     6799998753    12344556788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      +..+++|||+.+++|.+++...                ..+++..++.++.||+.||.|||+++++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999764                347888999999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHh
Q 013354          294 GRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~  369 (444)
                      +.++|+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||...........+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999876533221   12234678899999987665 8999999999999999998 99999876665555555


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .... .+..+..++.++.+|+.+||+.||++||++.||+++
T Consensus       240 ~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4433 345678899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=334.70  Aligned_cols=255  Identities=29%  Similarity=0.543  Sum_probs=213.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++..   .......+.+.+|++++++++|+||+++++++..++..++|
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES---EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhh---cccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            699999999999999999999999999999987632   12234457788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--Cc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--CP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--~~  313 (444)
                      |||+.++.|..++.+...+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            9999987777777666679999999999999999999999999999999999999999999999999988765543  22


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------CC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------SK  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~~  373 (444)
                      ....++..|+|||++.....++.++||||||+++|+|++|+.||...........+..                    ..
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            3355788999999998774589999999999999999999999976543332221100                    00


Q ss_pred             CCC----------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 ELP----------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ~~~----------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..+          ..+..++.++++||++||..+|++||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000          1233458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-42  Score=336.72  Aligned_cols=255  Identities=32%  Similarity=0.532  Sum_probs=211.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....   ......+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            6899999999999999999999899999999875321   2223445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-cc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~~  314 (444)
                      |||+.+++|..+......+++..++.++.||+.||+|||+.+|+|+||+|+||+++.++.++|+|||++........ ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            99999999998887666799999999999999999999999999999999999999999999999999886544322 22


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------CCC
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------SKE  374 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~~~  374 (444)
                      ...++..|+|||++.+...++.++||||||+++|||++|++||......+....+..                    ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            345788999999987655578899999999999999999999975443322211110                    000


Q ss_pred             CC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          375 LP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       375 ~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+         .....++..+.+||.+||+.+|++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            01         1124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.4e-42  Score=332.44  Aligned_cols=256  Identities=35%  Similarity=0.656  Sum_probs=210.2

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEE---
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSET---  227 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~---  227 (444)
                      ....+|++.+.||+|+||.||+++++.+++.+|+|++...      ......+.+|+.+++.+ +|+||+++++++.   
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3456899999999999999999999999999999987531      11234677899999999 6999999999873   


Q ss_pred             --cCCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          228 --LDDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       228 --~~~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                        .++..++||||+++++|.+++..    ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence              34678999999999999998763    245889999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCC-CcccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-C
Q 013354          302 GMAKHITGQS-CPLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-L  375 (444)
Q Consensus       302 Gla~~~~~~~-~~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~  375 (444)
                      |++....... ......|++.|+|||++...    ..++.++|||||||++|||++|+.||........+..+..... .
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT  248 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence            9987654322 22334589999999997532    2378899999999999999999999977654444433322221 1


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ...+..++.++.+||.+||+.||++|||+.|+++|+||
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            12345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-42  Score=336.17  Aligned_cols=254  Identities=31%  Similarity=0.547  Sum_probs=208.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..+.||.|+||.||+|+++.+++.||||.+....   ........+.+|++++++++|+||+++++++..++..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            3888999999999999999999999999999886422   2222345788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |||+. ++|.+++...  ..+++..++.++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99995 6899888653  4589999999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-------------------  373 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------------  373 (444)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||...+......++....                   
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            2223467889999998766556889999999999999999999997654433322211100                   


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 --------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 --------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                              ....+...++.++++||.+||+.||++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                    0001123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.7e-42  Score=332.88  Aligned_cols=257  Identities=38%  Similarity=0.707  Sum_probs=219.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|+..+.||.|+||.||+|.+..+++.||+|++...    ......+.+.+|+.++++++|+||+++++.+..+...++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3588889999999999999999999999999988632    223455788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      ||||+.+++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            9999999999999875 5789999999999999999999999999999999999999999999999999976544332 2


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....++..|+|||++.+.. ++.++|+|||||++|||++|..||...........+.. ...+.++..++.++.+||.+|
T Consensus       159 ~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCchhhhHHHHHHHHHH
Confidence            2345788999999987655 88999999999999999999999987654444433322 223456667889999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      |+.+|++||+++++++|+||.+...
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-42  Score=336.92  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcC----------------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSE----------------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP  217 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp  217 (444)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|++...    ........+.+|+.++.+++|+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCCC
Confidence            4579999999999999999997643                3457999988632    2344567789999999999999


Q ss_pred             CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013354          218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-------------------QLGESAIRSYTQQILSGLEYLHAKNT  278 (444)
Q Consensus       218 nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~~i  278 (444)
                      ||+++++++...+..++||||+.+++|.+++....                   .+++..++.++.||+.||.|||++||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999986532                   35678899999999999999999999


Q ss_pred             ccCCCCCCceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc--C
Q 013354          279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--T  353 (444)
Q Consensus       279 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt--G  353 (444)
                      +||||||+|||++.++.+||+|||+++.+.....   .....++..|+|||++.... ++.++|||||||++|||++  +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999986543321   11233577899999987665 8999999999999999987  6


Q ss_pred             CCCCCCCCChhhhHHhc------CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          354 KPPWSQYEGVPAMFKIG------NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       354 ~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..||.............      ........+..++..+.+||.+||+.||++|||+.+|.+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            67887655443332211      111112345678999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-42  Score=332.62  Aligned_cols=257  Identities=30%  Similarity=0.522  Sum_probs=208.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHH-HHccCCCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-LSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|++.+.||+|+||.||+++++.+|+.||+|+++...   .... ...+..|+.. ++.++|+||+++++++..++..++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC---CcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            6899999999999999999999999999999886421   1122 2344455554 677799999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          235 YLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +|||++ ++|.+++...    ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999995 6888887652    3589999999999999999999997 999999999999999999999999999987654


Q ss_pred             CCCcccccCCCcccCcccccCc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hhhhHHhcCCCCCCCC-CCCCCH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNS---NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKELPAI-PDHLSD  384 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~-~~~~s~  384 (444)
                      ........++..|+|||++.+.   ..++.++|+|||||++|||++|+.||..... ...+........ +.+ ...++.
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-PQLPAEKFSP  235 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-CCCCccccCH
Confidence            3333334588899999988542   3367899999999999999999999975432 233333322222 223 245799


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ++.+||.+||..+|++||++.++++||||.....
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            9999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.4e-42  Score=331.38  Aligned_cols=256  Identities=30%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeeccccccc-HHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS-KESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +||+|+||.||+|.+..+++.||+|.+......... .........++..++..+|++|+++++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999988642211111 1111122233445566689999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCC
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP  320 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  320 (444)
                      |++|.+++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... .....|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            99999999887789999999999999999999999999999999999999999999999999987654322 23446899


Q ss_pred             cccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCC
Q 013354          321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       321 ~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP  398 (444)
                      .|+|||++.+...++.++||||+||++|||++|+.||......  ........ .....++..++.++.++|.+||..+|
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-ccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            9999999876555889999999999999999999999765322  11121111 12235667789999999999999999


Q ss_pred             CCCc-----CHHHHHhCCCCCCCCCC
Q 013354          399 LHRP-----TAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       399 ~~Rp-----t~~elL~hp~~~~~~~~  419 (444)
                      .+||     ++.++++||||++....
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCCCch
Confidence            9999     99999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.4e-42  Score=331.68  Aligned_cols=256  Identities=34%  Similarity=0.627  Sum_probs=211.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLD--  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--  229 (444)
                      ...+|++.+.||+|+||.||++.+..+++.+|+|++...      ......+.+|+.++.++ +|+||+++++++...  
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            346799999999999999999999999999999988531      12235677899999998 899999999988653  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          230 ---DKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       230 ---~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                         +..++||||+.+++|.++++.    ...+++..++.++.||+.||+|||+.+|+|+||||+||+++.++.++|+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               368999999999999998863    3468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC-CcccccCCCcccCcccccCcC----CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-C
Q 013354          303 MAKHITGQS-CPLSIKGSPYWMAPEVIKNSN----GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-P  376 (444)
Q Consensus       303 la~~~~~~~-~~~~~~gt~~y~APE~~~~~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~  376 (444)
                      ++....... ......++..|+|||++....    .++.++|||||||++|||++|+.||...........+...... .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            988654322 122345888999999975432    2578999999999999999999999876655544444332211 1


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      ..+...+.++.+||.+||+.+|++||++.++++||||+
T Consensus       254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22445778999999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-42  Score=340.46  Aligned_cols=246  Identities=30%  Similarity=0.469  Sum_probs=191.7

Q ss_pred             eeeecccCceEEEEEEEcC--CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLYIY  235 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv  235 (444)
                      ++.||+|+||.||+|+++.  ++..||+|.+....       ....+.+|+.+++.++|+||+++++++..  +..+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            4689999999999998754  56889999875311       12356789999999999999999998753  5678999


Q ss_pred             EeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE----CCCCcEEEEecc
Q 013354          236 LEYVSGGSIYKILQDY---------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFG  302 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~vkL~DFG  302 (444)
                      |||+. ++|.+++...         ..+++..++.++.||+.||.|||+++|+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            99985 5888877532         247899999999999999999999999999999999999    456789999999


Q ss_pred             ccccccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---------hhHH-
Q 013354          303 MAKHITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---------AMFK-  368 (444)
Q Consensus       303 la~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---------~~~~-  368 (444)
                      +++.......    .....+|+.|+|||++.+...++.++|||||||++|||++|++||.......         .... 
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9986643321    2234588999999998766558899999999999999999999996432110         0000 


Q ss_pred             --------------hcCCC---------------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          369 --------------IGNSK---------------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       369 --------------~~~~~---------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                    +....                     .........+..+++||.+||+.||++|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                          00000                     0001112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-42  Score=333.47  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=215.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||+||++.+..+++.||+|++...    ......+.+.+|+.+++.++|+||+++++.+.....++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            35789999999999999999999999999999987642    22334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++.+.+.+++..+..++.+++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999999999887889999999999999999999997 589999999999999999999999999987553322 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-----------hhhHHhcCCCCCCCCCC-
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-----------PAMFKIGNSKELPAIPD-  380 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----------~~~~~~~~~~~~~~~~~-  380 (444)
                      .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||......           .....+... ..+.++. 
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPSS  236 (284)
T ss_pred             cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCch
Confidence            22346899999999987664 889999999999999999999999754431           111222211 1222333 


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .++.++.+||.+||++||++|||+.|+++|+||...
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            378899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-42  Score=332.25  Aligned_cols=251  Identities=29%  Similarity=0.452  Sum_probs=203.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcC--CEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLD--DKLY  233 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~  233 (444)
                      |++.+.||+|+||.||+|.+..+++.||+|.++....   .... ....+|+.++.++. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            6788999999999999999999999999998764211   1111 23457888888885 99999999999887  8899


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+++||||||+||+++. +.+||+|||++........
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9999996 5888877753 46899999999999999999999999999999999999999 9999999999987655444


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC---------------CC----
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---------------SK----  373 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------------~~----  373 (444)
                      .....++..|+|||++.....++.++|||||||++|||++|..||...+..+....+..               ..    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            44455789999999875555478899999999999999999999976554332221110               00    


Q ss_pred             CC--------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 EL--------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ~~--------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..        ..+...++.++.+||.+||++||++||+++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00        01123568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.8e-42  Score=336.03  Aligned_cols=266  Identities=33%  Similarity=0.627  Sum_probs=220.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||++.+..+++.||+|.+..     ......+.+.+|+.+++.++||||+++++.+...+..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecc-----ccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            4689999999999999999999988899999998753     12223467888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +|+||+++++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999999999976 4688999999999999999999999999999999999999999999999998876543322 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li~  391 (444)
                      .....+++.|+|||++.... ++.++|||||||++|+|++|+.||...........+... ......+..++.++++||+
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            22345888999999987655 789999999999999999999999765544333222211 1111234457889999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCC--CCcCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAA--PLERPILSA  426 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~--~~~~~~~~~  426 (444)
                      +||+.+|++||++.+++.|+||+...  .+-.|++..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~~  287 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAA  287 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCcccccccchHHH
Confidence            99999999999999999999999875  333454443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.3e-42  Score=331.29  Aligned_cols=257  Identities=35%  Similarity=0.615  Sum_probs=216.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|...+.||+|++|.||++.+..+++.+++|++..     ......+.+.+|+.+++.++|+||+++++++...+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec-----cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            356667899999999999999998999999998753     222334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      ++||+.+++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ..
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            9999999999999987 679999999999999999999999999999999999999999999999999887554322 12


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~~  392 (444)
                      ....|+..|+|||.+.+.. ++.++|||||||++|||++|+.||...+.......+..... ....+..++.++.+||.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             ccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            2345889999999987655 88999999999999999999999977555444444433211 111233478999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||+.+|++||++.++++||||++...
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-42  Score=334.84  Aligned_cols=255  Identities=41%  Similarity=0.728  Sum_probs=217.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|+..+.||+|+||.||+|.+..+++.||+|.+...    ......+.+.+|+.+++.++|+||+++++.+..+...++
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            3578889999999999999999999999999987632    223445688899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      ||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            9999999999999875 5789999999999999999999999999999999999999999999999999876544322 1


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ....++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+... ..+.+...++.++.++|.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-SPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-CCCCCCcccCHHHHHHHHHH
Confidence            2345788999999997665 889999999999999999999999765544433333222 23455667889999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |+.+|++||++.++++||||...
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         237 LNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             ccCCcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999999764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-41  Score=333.89  Aligned_cols=259  Identities=37%  Similarity=0.626  Sum_probs=215.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|+..+.||+|+||.||+|.+..+++.||+|++...  .....+..+.+.+|+.+++.++|+||+++++++..++..
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecc--ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            345799999999999999999999989999999988632  223344556788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++...... 
T Consensus        91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99999996 577777654 456899999999999999999999999999999999999999999999999998765433 


Q ss_pred             CcccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        ....++..|+|||++..  ...++.++||||||+++|||++|+.||...+.......+.........+..++.++++|
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              23457889999998742  23378899999999999999999999977655444444433222222234578899999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      |.+||+.||++||++.+++.||||....
T Consensus       247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         247 VDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            9999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-41  Score=322.78  Aligned_cols=253  Identities=34%  Similarity=0.645  Sum_probs=219.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.+..+++.|++|++....   ......+.+.+|+++++.++|+|++++++.+...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            5889999999999999999999999999999886422   2345566788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          236 LEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||+++++|.+++.+.    ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999999874    569999999999999999999999999999999999999999999999999988664433


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                       ......+++.|+|||.+.... ++.++||||||+++|+|++|..||...+.......... ...+.++..++.++.++|
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence             222345888999999987665 78999999999999999999999977654444444433 334567778999999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ++||..+|++|||+.++|+||||
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-42  Score=334.26  Aligned_cols=255  Identities=28%  Similarity=0.489  Sum_probs=209.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  232 (444)
                      .+|++.+.||+|+||.||+|.+..+++.+++|.++.....   ......+.+|+.++++++|+||+++++++...  ...
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            4689999999999999999999999999999998753221   22334667899999999999999999998877  889


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |+||||+. ++|.+++.... .+++..++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999996 59999987644 48999999999999999999999999999999999999999999999999988765432


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC------------------
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS------------------  372 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------  372 (444)
                       ......+++.|+|||.+.+...++.++||||||+++|||++|..||..........++...                  
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence             2223447889999999876555688999999999999999999999765443322221100                  


Q ss_pred             -----------CCCCCCCCC-CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 -----------KELPAIPDH-LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 -----------~~~~~~~~~-~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                 .....++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                       000122233 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.7e-42  Score=329.36  Aligned_cols=256  Identities=40%  Similarity=0.726  Sum_probs=219.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      -|+..+.||+|+||.||+|.+..+++.||+|.+...    ......+.+.+|+.++++++|+||+++++.+..+...++|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            478889999999999999999989999999987531    2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-cc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~~  314 (444)
                      |||+.+++|.+++.. ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            999999999999875 5789999999999999999999999999999999999999999999999999876544321 12


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+.. ...+.++..++.++.++|.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHc
Confidence            345788999999987654 78899999999999999999999987654444444332 2334566778999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +.+|++||++.++++||||.+...
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhhh
Confidence            999999999999999999988633

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=347.42  Aligned_cols=253  Identities=32%  Similarity=0.497  Sum_probs=219.4

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      .++||+|.||+||-|+++.+|+.||||+|.+.+...+.+   .++++|+.+|+.++||.||.+.-.|+..+.+++|||.+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence            478999999999999999999999999998765543333   68899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC---CcEEEEeccccccccCCCCccc
Q 013354          240 SGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS---GRVKLADFGMAKHITGQSCPLS  315 (444)
Q Consensus       240 ~ggsL~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~~~~~~~~~~  315 (444)
                      .|.-|+-+|. +.+++++...+.++.||+.||+|||-++|+|+||||+|||+...   .++||||||+|+.+.+.....+
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            6655555553 45789999999999999999999999999999999999999543   4699999999999999888889


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC--CCCCCCCCCHHHHHHHHHH
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE--LPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~Li~~~  393 (444)
                      ++||+.|+|||++++.. |...-||||+|||+|.-|+|..||...++..  .+|.+...  .+.-...++.++.+||..+
T Consensus       726 VVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            99999999999998765 9999999999999999999999997654433  33433333  2333456899999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      |+..-++|.+..+.|.|||+++.-.
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcchH
Confidence            9999999999999999999997543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=385.45  Aligned_cols=258  Identities=44%  Similarity=0.804  Sum_probs=228.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|+.+..||.|.||.||-|.+.++|+..|+|.++.....   ....+.+.+|..++..++|||+|+++|+..+++..+
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            35788999999999999999999999999999998764322   556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |.||||++|+|.++++..+-.+|.....+..|++.|+.|||++|||||||||+|||++.+|.+|++|||.|..+.+... 
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            9999999999999999876788889999999999999999999999999999999999999999999999988766531 


Q ss_pred             ----cccccCCCcccCcccccCcC--CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCCCCCCCCCCCCHH
Q 013354          313 ----PLSIKGSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       313 ----~~~~~gt~~y~APE~~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~s~~  385 (444)
                          .....||+.|||||++.+.+  +...+.|||||||++.||+||+.||.+++..-++ +++. ....|.+|..++.+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSE 1469 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHh
Confidence                12456999999999997543  4567999999999999999999999988766444 4444 44568999999999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .++||..||..||++|.++.|||+|-|-+.
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            999999999999999999999999998764

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-41  Score=324.04  Aligned_cols=249  Identities=33%  Similarity=0.594  Sum_probs=214.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.++.+++.+|+|.++..    ......+.+.+|+.+++.++|+||+++++.+..++.++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            488999999999999999999999999999988642    2233456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          236 LEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ 
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999999999988653  3489999999999999999999999999999999999999999999999999876644322 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.... ...++..++.++++||.+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCCCCcccCHHHHHHHHH
Confidence            23355888999999987665 8899999999999999999999998765544444444333 335677889999999999


Q ss_pred             HhhhCCCCCcCHHHHHhC
Q 013354          393 CLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~h  410 (444)
                      ||+.||++||++.+++.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-41  Score=320.37  Aligned_cols=250  Identities=44%  Similarity=0.783  Sum_probs=216.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|+..+.||+|++|.||++.+..+++.+++|++...     .....+.+.+|+.+++.++|+||+++++.+..+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-----SKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEeccc-----chhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            478889999999999999999989999999988642     124557888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          236 LEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      +||+.+++|.+++... ..+++..+..++.|++.+|.+||+++++||||+|+||+++.++.++|+|||.+..........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999999876 579999999999999999999999999999999999999999999999999998776544334


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC--CCHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRK  392 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~l~~Li~~  392 (444)
                      ...++..|+|||.+.... ++.++||||||+++|+|++|+.||...+.......... ...+.++..  ++.++.++|.+
T Consensus       156 ~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence            455889999999987665 78999999999999999999999987654444443333 222233333  38999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~  412 (444)
                      ||+.||++|||+.|+++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.6e-42  Score=336.20  Aligned_cols=257  Identities=33%  Similarity=0.577  Sum_probs=215.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +.|.....||+|+||.||++.+..+++.||||.+..     ......+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            456667889999999999999998999999998753     223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      ||||+.+++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++........ .
T Consensus        97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999999999998865 5789999999999999999999999999999999999999999999999999876533222 2


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~~  392 (444)
                      ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...........+..... .......++..+.+||.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            2345889999999986555 88999999999999999999999986555444433322111 111223578899999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||..||++|||++++++||||+....
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCC
Confidence            99999999999999999999986533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=333.22  Aligned_cols=254  Identities=30%  Similarity=0.507  Sum_probs=204.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.......    ....+.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            57999999999999999999999899999999986432111    12345679999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++....... .
T Consensus        81 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            999997 4999988764 358999999999999999999999999999999999999999999999999987543221 1


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCC-------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNS-------------------  372 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~-------------------  372 (444)
                      .....++..|+|||++.+...++.++||||||+++|||++|+.||...... +....+...                   
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            122346788999999876555789999999999999999999999654421 111111000                   


Q ss_pred             ---------CCCCCCCCCCC--HHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 ---------KELPAIPDHLS--DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ---------~~~~~~~~~~s--~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                               .........++  .++.++|.+||+.||++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     00000011234  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=320.60  Aligned_cols=253  Identities=47%  Similarity=0.849  Sum_probs=222.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|++|.||++++..+++.|++|.+....   ......+.+.+|++++++++|+|++++++++......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            4888999999999999999999899999999886422   2234567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-cc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~~  314 (444)
                      |||+.+++|.+++.....+++..++.++.|++.+|.|||++||+||||+|+||+++.++.++|+|||++........ ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987654433 23


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...++..|+|||.+.... ++.++|||+||+++|+|++|..||.............. ...+.++..++.++.++|.+||
T Consensus       158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHH
Confidence            345888999999987665 78999999999999999999999987665555544443 3334677889999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~  413 (444)
                      ..+|++||++.+++.||||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6e-42  Score=332.98  Aligned_cols=255  Identities=30%  Similarity=0.496  Sum_probs=206.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCE---
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDK---  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~---  231 (444)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ........+.+|+.+++.+. |+||+++++++...+.   
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            6899999999999999999999999999999876422   11223356778999999995 6999999999887665   


Q ss_pred             --EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccc
Q 013354          232 --LYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGM  303 (444)
Q Consensus       232 --~~lv~e~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGl  303 (444)
                        .|+||||+.+ +|.+++...     ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||+
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence              8999999975 888888653     24799999999999999999999999999999999999998 88999999999


Q ss_pred             cccccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC---------
Q 013354          304 AKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK---------  373 (444)
Q Consensus       304 a~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------  373 (444)
                      +........ .....+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            876533221 2223467889999998765557899999999999999999999997655443332211100         


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          374 -----------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       374 -----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                                       ........++.++.+||.+||++||.+||++.|++.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                             00011135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=359.87  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeee-EEc---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGS-ETL---  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~-~~~---  228 (444)
                      .-++++.++|.+|||+.||+|.+...|..||+|++..     .++...+.+.+||.+|+.|+ |+|||.+++. ...   
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            3468888999999999999999998789999998763     46778899999999999996 9999999993 221   


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEEEec
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                         .-.++|.||||.||.|-|+++.+  ..|+|.++++|+.|+++|+.+||...  |||||||-|||||+.++.+|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence               12578999999999999999864  35999999999999999999999997  999999999999999999999999


Q ss_pred             cccccccCCC-Cc---------ccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh
Q 013354          302 GMAKHITGQS-CP---------LSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       302 Gla~~~~~~~-~~---------~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  369 (444)
                      |.++...... ..         .....|+.|+|||++.  .+..++.|+|||||||+||-|+....||++....    .|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence            9987432222 11         1233789999999975  3334899999999999999999999999764322    23


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+.+..-.-.+.++..+++||+.||+.||++||++.|++++
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            33333212225789999999999999999999999988775

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-41  Score=325.15  Aligned_cols=253  Identities=30%  Similarity=0.556  Sum_probs=211.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+....  .........+.+|+.+++.++||||+++++++...+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            47999999999999999999999999999999876422  2334455678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          235 YLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      |+||+.+++|.+++..    ...+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999998863    234899999999999999999999999999999999999999999999999998866433


Q ss_pred             CC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--hhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--VPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .. .....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||.....  ......+......+.....++.+++
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR  238 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence            22 12345888999999987655 78999999999999999999999965432  2223333333333333456789999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +||.+||+.+|++||++.++++.
T Consensus       239 ~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         239 ELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.4e-42  Score=329.90  Aligned_cols=253  Identities=31%  Similarity=0.533  Sum_probs=208.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||.|++|.||+|++..+++.||||+++....    ......+.+|+.++++++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            48899999999999999999999999999999875322    12234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          236 LEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      |||+.+ +|.+++....   .+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||++....... 
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999974 8988887643   58999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-------------------
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-------------------  372 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------------------  372 (444)
                      ......++..|++||++.....++.++|||||||++|+|++|+.||...+..+....+...                   
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            1223447889999999876655789999999999999999999999865544332221110                   


Q ss_pred             CCC--------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 KEL--------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ~~~--------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ...        ..+...++.+++++|.+||+.||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000        01123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5e-42  Score=343.11  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=208.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|+..+.||+|+||.||+|.+..+++.||+|++...   .........+.+|+.+++.++|+||+++++++...    
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc---ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            46799999999999999999999999999999987532   12233445677899999999999999999987643    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ...|+||||+. ++|.+.+...  +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence              35799999995 5888888753  899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC----------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----------------  371 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----------------  371 (444)
                      ..........++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+..                
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            5544444456889999999997655 89999999999999999999999976543222211100                


Q ss_pred             -------CCC--------------CC----CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          372 -------SKE--------------LP----AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       372 -------~~~--------------~~----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                             ...              .+    ..+...+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                   000              00    001234677899999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-42  Score=343.67  Aligned_cols=257  Identities=31%  Similarity=0.530  Sum_probs=211.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  230 (444)
                      ..+..|++.+.||+||.+.||++.... ...||+|.+..   ...+......+.+|+.+|.+|+ |.+|++++++...++
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            456789999999999999999997654 56777776653   4456778889999999999994 899999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQL-GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+|+||||- ..+|.++|+++... +.-.++.+..||+.|+.++|++||||.||||.|+|+- .|.+||+|||.|..+..
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            999999986 67999999987653 3358889999999999999999999999999999995 57899999999998877


Q ss_pred             CCCc---ccccCCCcccCcccccCcC----------CCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCC--
Q 013354          310 QSCP---LSIKGSPYWMAPEVIKNSN----------GCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSK--  373 (444)
Q Consensus       310 ~~~~---~~~~gt~~y~APE~~~~~~----------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~--  373 (444)
                      +...   .+.+||+.||+||.+....          +.+.++||||||||||+|+.|+.||..+... ..+..|....  
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            6543   3467999999999985322          2567999999999999999999999875532 2333333322  


Q ss_pred             -CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          374 -ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       374 -~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                       ..|.++.  ..++.++++.||..||++||++.++|+|||++..
T Consensus       592 Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  592 IEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence             2233333  3349999999999999999999999999999873

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.2e-42  Score=332.47  Aligned_cols=257  Identities=28%  Similarity=0.482  Sum_probs=208.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l  234 (444)
                      +|+..+.||+|+||.||++.+..+++.||+|.+....    .......+.+|+.++.++. |+||+++++++..+...++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            5677789999999999999999999999999886422    1244567888999999996 9999999999998899999


Q ss_pred             EEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          235 YLEYVSGGSIYKILQ-----DYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       235 v~e~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +|||+. .+|.++..     ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999985 56655432     235699999999999999999999985 99999999999999999999999999998765


Q ss_pred             CCCCcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCC---CCCCCCCC
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKE---LPAIPDHL  382 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~---~~~~~~~~  382 (444)
                      .........++..|+|||++...  ..++.++|||||||++|||++|+.||...... .....+.....   ....+..+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            44433445688999999998765  35889999999999999999999999765421 12222211111   11122357


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      +.++.+||.+||++||++|||+++|++||||+...
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            89999999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.6e-42  Score=326.02  Aligned_cols=249  Identities=34%  Similarity=0.575  Sum_probs=212.8

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||.|+||.||++++..+++.+++|++...  ........+.+.+|+.++++++|+||+++++.+..+...|++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKA--DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecch--hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            68999999999999999999999988632  2223455678889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---------Cc
Q 013354          243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---------CP  313 (444)
Q Consensus       243 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---------~~  313 (444)
                      +|.+++.+.+.+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......         ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            999999987789999999999999999999999999999999999999999999999999987543321         12


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC--CCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~l~~Li~  391 (444)
                      ....++..|+|||.+.... .+.++||||||+++|||++|..||...........+.....  ..+..  ++.++.+||+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI--EWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--CCCccccCCHHHHHHHH
Confidence            2345788999999987666 78899999999999999999999987665555544443222  23333  4899999999


Q ss_pred             HHhhhCCCCCcCH---HHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTA---AWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~---~elL~hp~~~~~  416 (444)
                      +||+.+|++|||+   .++|+||||++.
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-42  Score=330.05  Aligned_cols=246  Identities=32%  Similarity=0.548  Sum_probs=204.6

Q ss_pred             eeeeeecccCceEEEEEEEc----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          158 KKGRLLGRGTFGHVYLGFNS----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.++.    ....+..+.+.+|++.+++++|+||++++|++...+..+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999998    4467899998852    234455788999999999999999999999999888899


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +|+||+.+++|.++|...  ..+++..++.++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999986  579999999999999999999999999999999999999999999999999998763221


Q ss_pred             C---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          312 C---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       312 ~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .   .........|+|||++.... ++.++||||||+++|||++ |+.||.+.........+..... ...+..++..+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TTSBTTSBHHHH
T ss_pred             cccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc-ceeccchhHHHH
Confidence            1   12233667899999997766 8999999999999999999 7899988866666666654444 356778999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++|.+||..||++||++.+|++
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-41  Score=322.82  Aligned_cols=243  Identities=26%  Similarity=0.443  Sum_probs=203.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +.||+|+||.||+|+++.+++.+|+|.+..    ....+....+.+|+++++.++|+||+++++++......++||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCc----cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            368999999999999999999999998752    2234455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc---cc
Q 013354          241 GGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SI  316 (444)
Q Consensus       241 ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~---~~  316 (444)
                      +++|.+++.+.. .+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..........   ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999999997644 58999999999999999999999999999999999999999999999999987654321111   11


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      ..+..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.++.+|+.+||+
T Consensus       157 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-LPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCCcccCCHHHHHHHHHHcC
Confidence            1245699999987666 8999999999999999998 9999976554444444433322 35567789999999999999


Q ss_pred             hCCCCCcCHHHHHh
Q 013354          396 RNPLHRPTAAWLLE  409 (444)
Q Consensus       396 ~dP~~Rpt~~elL~  409 (444)
                      .||++|||+.++++
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-41  Score=323.49  Aligned_cols=253  Identities=31%  Similarity=0.609  Sum_probs=214.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++.++.++..+|+|.+....   ......+.+.+|+.+++.++|+||+++++.+..+...++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            4889999999999999999999999999999886421   1122345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc-EEEEeccccccccCCCC
Q 013354          236 LEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHITGQSC  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-vkL~DFGla~~~~~~~~  312 (444)
                      +||+.+++|.+++.+..  .+++..++.++.||+.||.|||+++++|+||||+||+++.++. ++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999999997643  4789999999999999999999999999999999999988754 79999999876644322


Q ss_pred             c-ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          313 P-LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~-~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      . ....|++.|+|||++.+.. ++.++|+||||+++|||++|..||...........+... ..+.+...++.++.++|.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-cCCCCCCCCCHHHHHHHH
Confidence            2 2235888999999987665 889999999999999999999999765544444333322 334556678999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +||..+|++|||+.++++||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-41  Score=323.69  Aligned_cols=247  Identities=29%  Similarity=0.438  Sum_probs=207.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||++.++. +..+|+|.+...      ......+.+|+.+++.++|+||+++++++..++..+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG------AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC------CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            3579999999999999999998764 568999977521      112346788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++... ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++........
T Consensus        76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999999999999753 4689999999999999999999999999999999999999999999999999886543222


Q ss_pred             c--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 P--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 ~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .  ....++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+...+.++.+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l  233 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPKLASMTVYEV  233 (256)
T ss_pred             eccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHH
Confidence            1  1223456899999987655 8899999999999999999 9999987766665555554433 23456678999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHh
Q 013354          390 VRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.+||+.||++||+++++++
T Consensus       234 i~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-41  Score=329.19  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=203.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++.....    ......+.+|+.+++.++|+||+++++++..++..++
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc----CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            579999999999999999999999999999998864221    1122355689999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            999995 677766654 3457888999999999999999999999999999999999999999999999987543322 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhc------------------CC-
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIG------------------NS-  372 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~------------------~~-  372 (444)
                      .....+++.|+|||++.+...++.++|||||||++|||++|..||....... .+..+.                  .. 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            2334478899999998765557889999999999999999999997544321 111100                  00 


Q ss_pred             ---------CCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 ---------KELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ---------~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                               .....+.  ...+.++.+||.+||+.||++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                     0000000  1136789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-41  Score=325.10  Aligned_cols=248  Identities=26%  Similarity=0.449  Sum_probs=210.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|.+.+.||+|+||.||+|.++.+++.||+|++..      .......+.+|+.+++.++|+||+++++++..++.++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC------CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            3469999999999999999999999999999998752      1223456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||+.+++|.+++....  .+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999999999997643  58899999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc--cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CPL--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~~--~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ...  ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||...+.......+.... .+..+..++.++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RMERPEGCPPKVYE  236 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHH
Confidence            211  122456799999987655 8899999999999999998 999998765554444444332 34567789999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +|.+||+.||++||++.++++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-42  Score=340.57  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ++++|++.+.||+|+||.||+|.+..     +++.||+|+++..    ......+.+.+|+.++.++ +|+||+++++++
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            45689999999999999999997533     4578999987631    2233456778899999999 899999999987


Q ss_pred             Ec-CCEEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 013354          227 TL-DDKLYIYLEYVSGGSIYKILQDY------------------------------------------------------  251 (444)
Q Consensus       227 ~~-~~~~~lv~e~~~ggsL~~~l~~~------------------------------------------------------  251 (444)
                      .. +..++++|||+.+++|.+++...                                                      
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 46789999999999999998642                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC---cccccCCCc
Q 013354          252 -------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPY  321 (444)
Q Consensus       252 -------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~  321 (444)
                             ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..+.....   .....++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578899999999999999999999999999999999999999999999999987643321   112335678


Q ss_pred             ccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCC
Q 013354          322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH  400 (444)
Q Consensus       322 y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~  400 (444)
                      |+|||++.+.. ++.++|||||||++|||++ |..||......+.+............+...+.++.+++.+||+.+|++
T Consensus       241 y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         241 WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             ccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            99999987765 8999999999999999998 999997654433333322222333456678999999999999999999


Q ss_pred             CcCHHHHHhC
Q 013354          401 RPTAAWLLEH  410 (444)
Q Consensus       401 Rpt~~elL~h  410 (444)
                      ||++.||++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-42  Score=330.19  Aligned_cols=253  Identities=32%  Similarity=0.571  Sum_probs=208.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |++.+.||.|++|.||+|.++.+|+.||+|++.....   .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            5678899999999999999999999999998874321   1223356778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          237 EYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      ||+ +++|.+++....  .+++..++.++.||+.||+|||+++++||||+|+||+++.++.++|+|||++....... ..
T Consensus        78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            999 469999998765  68999999999999999999999999999999999999999999999999987653322 12


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------------
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------------  372 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------------  372 (444)
                      ....++..|+|||++.+...++.++||||||+++|+|++|+.||...+.......+...                     
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            22346888999998866554788999999999999999999999765433222221100                     


Q ss_pred             ------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 ------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                            .........++.++.++|.+||+.||++|||++|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                  00112234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.8e-42  Score=328.38  Aligned_cols=254  Identities=31%  Similarity=0.563  Sum_probs=218.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~  233 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...  ........+.+.+|+.++++++ |+||+++++++..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechH--hccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3699999999999999999999999999999988632  1123334467889999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +||||+.+++|.+++.+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999876544321 


Q ss_pred             --------------------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC
Q 013354          313 --------------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       313 --------------------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~  372 (444)
                                          .....++..|+|||++.... ++.++||||||++++++++|+.||...........+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                12234788999999987655 889999999999999999999999876654444443322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCH----HHHHhCCCC
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTA----AWLLEHPFV  413 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~----~elL~hp~~  413 (444)
                        ...++..++..+.+||.+||+.||++||++    +++++||||
T Consensus       238 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 --EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             --CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence              225667789999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-41  Score=335.17  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=207.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..+|+..+.||+|+||.||+|++..+++.    ||+|+++.    .......+++.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            35799999999999999999998766664    88887752    22344556788999999999999999999988765


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ..++++||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             5789999999999999998743 58899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          309 GQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       309 ~~~~~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ......   ...++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+...... ..+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTI  238 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC-CCCCCCCH
Confidence            433222   122456899999997665 8999999999999999998 99999765443333333333333 44667899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.+++.+||..||++||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.2e-42  Score=333.88  Aligned_cols=256  Identities=34%  Similarity=0.588  Sum_probs=216.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|.....||+|+||.||+|.+..+++.||+|.+...     .....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-----KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-----ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            4566677899999999999999989999999988642     12234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      ||||+++++|.+++.. ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++........ .
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            9999999999998865 5789999999999999999999999999999999999999999999999999875543321 2


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~~  392 (444)
                      ....++..|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..... .......++.++.++|.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            3355889999999997655 88999999999999999999999987665555444432211 122344678999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||+.+|++||+++++++||||.+..
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccCC
Confidence            9999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-41  Score=326.01  Aligned_cols=256  Identities=32%  Similarity=0.558  Sum_probs=209.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~  233 (444)
                      +|+..+.||.|++|.||++.+..+++.+|+|.+...    ........+.+|++++++++|+||+++++++..  ...++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            688999999999999999999999999999988642    222445678899999999999999999998765  34789


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          234 IYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999999988754    23588999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-----hhhhHHhcCCCCCCCCC-----
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-----VPAMFKIGNSKELPAIP-----  379 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~-----  379 (444)
                      ... ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.....     .+....+... ..+.++     
T Consensus       158 ~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (287)
T cd06621         158 SLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGN  234 (287)
T ss_pred             ccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCC
Confidence            222 2344788899999987655 88999999999999999999999976521     1222222211 111111     


Q ss_pred             -CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          380 -DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       380 -~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                       ...++++.+||.+||..||++|||+.|+++||||++...
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence             234678999999999999999999999999999976533

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-41  Score=330.84  Aligned_cols=250  Identities=25%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCc--EEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGE--MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ++|++.++||+|+||.||+|.++.++.  .+++|.++.    .......+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE----FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc----cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            479999999999999999999887765  467887652    12334456788999999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                      .++||||+.+++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            999999999999999997642                4788999999999999999999999999999999999999999


Q ss_pred             EEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCC
Q 013354          296 VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKE  374 (444)
Q Consensus       296 vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~  374 (444)
                      +||+|||++..............+..|+|||++.... ++.++|||||||++|||++ |..||...........+.... 
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence            9999999986432221122222355799999987655 8899999999999999997 999998766555555554332 


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ....+..++.++++||.+||+.+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            234567789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=324.22  Aligned_cols=250  Identities=28%  Similarity=0.494  Sum_probs=206.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHH-HHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-LSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      +.||+|+||.||+|.+..+++.||+|++....  .........+..|..+ ....+|+||+++++.+..++..++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSD--MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchh--hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            56899999999999999999999999886321  1112223334445444 44568999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCC
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS  319 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt  319 (444)
                      .+++|.++++....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++......   ....++
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  156 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGT  156 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccCCCC
Confidence            99999999998788999999999999999999999999999999999999999999999999998765432   234578


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC--CCCCCCCCCCHHHHHHHHHHhhhC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAIPDHLSDEGKDFVRKCLQRN  397 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~s~~l~~Li~~~L~~d  397 (444)
                      ..|+|||.+.+.. ++.++||||||+++|||++|..||...+.......+....  ........++.++.++|.+||+.|
T Consensus       157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            8999999987665 7899999999999999999999998765544444332221  122344568999999999999999


Q ss_pred             CCCCc---CHHHHHhCCCCCCC
Q 013354          398 PLHRP---TAAWLLEHPFVGNA  416 (444)
Q Consensus       398 P~~Rp---t~~elL~hp~~~~~  416 (444)
                      |++||   +++|++.||||++.
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcC
Confidence            99999   45799999999774

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-41  Score=330.97  Aligned_cols=259  Identities=31%  Similarity=0.498  Sum_probs=209.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+....   ......+.+.+|+.++++++|+||+++++++......++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            46999999999999999999999999999999876422   122334567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~  311 (444)
                      ||||+. ++|.+++.....  +++..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            999995 588888765443  578889999999999999999999999999999999985 4579999999997653322


Q ss_pred             C-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC------------------
Q 013354          312 C-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS------------------  372 (444)
Q Consensus       312 ~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------  372 (444)
                      . .....+++.|+|||++.+...++.++|||||||++|+|++|+.||...........+...                  
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            1 123346889999999876555789999999999999999999999765443333221100                  


Q ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 ---------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 ---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                               .........++.++.++|.+||+.||++||++.++++||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                     000001235788999999999999999999999999999998753

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-41  Score=345.12  Aligned_cols=252  Identities=31%  Similarity=0.431  Sum_probs=206.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~  226 (444)
                      +..+|+++++||+|+||.||+|++...     +..||||+++..    ......+.+.+|+.++++++ ||||+++++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            356899999999999999999987432     357999988632    23344567899999999996 99999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY-------------------------------------------------------  251 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~-------------------------------------------------------  251 (444)
                      ...+.+|+||||+.+|+|.+++.+.                                                       
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999988653                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE
Q 013354          252 -----------------------------------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV  290 (444)
Q Consensus       252 -----------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  290 (444)
                                                               ..+++..++.++.||+.||+|||+++|+|+||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     136778889999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhh
Q 013354          291 DPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAM  366 (444)
Q Consensus       291 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~  366 (444)
                      +.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.........
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            9999999999999986543322   12233667899999987665 8999999999999999997 99999775443333


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       367 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ............+..++.++++||.+||+.||++||++.+|.+
T Consensus       350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3222222233456788999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.3e-42  Score=339.75  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=211.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|++.+.||+|+||+||+|++..+++.||||.+....   ........+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            357999999999999999999999999999999886421   1222345667899999999999999999987643    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 -DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 -~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ...++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence             34899999995 7999999887889999999999999999999999999999999999999999999999999998664


Q ss_pred             CC-CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc-----------------
Q 013354          309 GQ-SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG-----------------  370 (444)
Q Consensus       309 ~~-~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-----------------  370 (444)
                      .. .......++..|+|||++.+...++.++|||||||++|+|++|+.||...+.......+.                 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            43 222334578899999998764448899999999999999999999997654322111100                 


Q ss_pred             ----------CC--CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 ----------NS--KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 ----------~~--~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                ..  .........++.++++||++||+.||++|||++++++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                      00  00011234678999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.4e-41  Score=327.25  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=210.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+...    ........+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34689999999999999999997652     3558999976521    22233456788999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEE
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG----------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vk  297 (444)
                      .....++||||+.+++|.+++.+..          .++...+..++.||+.||.|||+++|+||||||+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999999997532          245678899999999999999999999999999999999999999


Q ss_pred             EEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC
Q 013354          298 LADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       298 L~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      |+|||+++........   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+... 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-  237 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-  237 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence            9999998765332211   1223467899999987665 8999999999999999998 88999775554444443332 


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh------CCCCCCC
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE------HPFVGNA  416 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~------hp~~~~~  416 (444)
                      .....+..++.+++++|.+||+.||++|||+.++++      ||||++.
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            223456678899999999999999999999999887      9999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=337.82  Aligned_cols=257  Identities=28%  Similarity=0.507  Sum_probs=207.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      +++|++.+.||+|+||.||+|++..+++.||+|++...    ........+.+|+.++++++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            46899999999999999999999999999999988531    2233446677899999999999999999876543    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 -DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 -~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ...++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence             35899999995 588888865 579999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh---------------
Q 013354          309 GQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI---------------  369 (444)
Q Consensus       309 ~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------------  369 (444)
                      ....    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+               
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221    123457899999998766555889999999999999999999999754322211110               


Q ss_pred             cC------------CCCC--CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          370 GN------------SKEL--PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       370 ~~------------~~~~--~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ..            ....  .......+.++.+||.+||+.||++|||+.|+++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            00            0000  00113467889999999999999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=348.21  Aligned_cols=251  Identities=28%  Similarity=0.486  Sum_probs=214.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCc---E-EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGE---M-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~---~-vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      +....+.||+|+||.||+|..+..+.   . ||+|..+.  .....++...++.+|+++|++++|||||++||++..+..
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            34456889999999999998876432   3 89997763  223557788999999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++|||+|.||+|.++|++++. ++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+++.....
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            9999999999999999999874 999999999999999999999999999999999999999999999999998765421


Q ss_pred             CCcc-cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          311 SCPL-SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~-~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      .... ...-...|+|||.+.... |+.++|||||||++||+++ |..||.+........++.........+...+.++..
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             eeccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence            1111 112446899999998775 9999999999999999999 899999988888888884444444667789999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++.+||..||++||++.++.+
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHhccCChhhccCHHHHHH
Confidence            999999999999999987654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=339.75  Aligned_cols=261  Identities=28%  Similarity=0.428  Sum_probs=227.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ...|+.-++||+|+||.||-++.+.||+.||+|.+.+  ...+.+........|-.+|.+++.+.||.+-..|+..+.++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K--KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK--KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHH--HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3568888999999999999999999999999997643  23333444456678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +|+..|.||+|.-.|.+.+  .|++..++.++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999998887765  69999999999999999999999999999999999999999999999999999998887


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh---h-HHhcCCCCCCCCCCCCCHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---M-FKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~-~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .....+||.+|||||++++.. |+...|.|||||+||||+.|+.||.+......   . +++.  .....+++.++++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~~kFS~eak  418 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--EDPEEYSDKFSEEAK  418 (591)
T ss_pred             ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cchhhcccccCHHHH
Confidence            777778999999999999888 99999999999999999999999987543322   1 2222  222367899999999


Q ss_pred             HHHHHHhhhCCCCCcC-----HHHHHhCCCCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPT-----AAWLLEHPFVGNAAPL  419 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt-----~~elL~hp~~~~~~~~  419 (444)
                      +|.+.+|++||++|.-     +.++.+||||++..-+
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            9999999999999974     5689999999986543

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-41  Score=322.68  Aligned_cols=242  Identities=25%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             eecccCceEEEEEEE--cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          162 LLGRGTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      .||+|+||.||+|.+  +.+++.+|+|+++..   .......+.+.+|+.+++.++|+||+++++++.. +..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC---CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence            589999999999965  456889999987632   2334456788999999999999999999998764 5678999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc----cc
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP----LS  315 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~----~~  315 (444)
                      .+++|.+++.....+++..+..++.||+.||+|||++||+||||||.||+++.++.+||+|||++..+......    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999999988778999999999999999999999999999999999999999999999999999876443321    11


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ..++..|+|||++.... ++.++|||||||++|||++ |..||...........+..... +..+..++.++++||.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         158 GKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHh
Confidence            22457899999986555 8889999999999999998 9999987766666666655443 4677889999999999999


Q ss_pred             hhCCCCCcCHHHHHh
Q 013354          395 QRNPLHRPTAAWLLE  409 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~  409 (444)
                      +.||++||++.+|.+
T Consensus       236 ~~~p~~Rp~~~~i~~  250 (257)
T cd05116         236 TYGVDERPGFAVVEL  250 (257)
T ss_pred             ccCchhCcCHHHHHH
Confidence            999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=324.06  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=211.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      ++||+|+|+.|--+++..+|..||||++.+     .......++.+|++++.++ .|+||++++++|+++..+|||||.+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidK-----q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDK-----QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhc-----CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            579999999999999999999999999864     2344567899999999999 5999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEeccccccccCC------
Q 013354          240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKHITGQ------  310 (444)
Q Consensus       240 ~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~~~~------  310 (444)
                      .||+|...|+++..|+|.++.++.++|+.||.|||.+||.||||||+|||.....   -||||||.+...+...      
T Consensus       159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            9999999999999999999999999999999999999999999999999995443   3999999987543221      


Q ss_pred             --CCcccccCCCcccCccccc----CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---------------hhhHHh
Q 013354          311 --SCPLSIKGSPYWMAPEVIK----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---------------PAMFKI  369 (444)
Q Consensus       311 --~~~~~~~gt~~y~APE~~~----~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------------~~~~~~  369 (444)
                        ....+.+|+..|||||+..    ....|+.+.|.||||||+|-||.|.+||.+.-+.               ..+..|
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence              1223566889999999864    2334889999999999999999999999753321               123334


Q ss_pred             cCCCCCCCCC----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          370 GNSKELPAIP----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       370 ~~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ..++.  ++|    ..++.+.++||..+|..|+.+|.++.++++|||++...+
T Consensus       319 QEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  319 QEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             hccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            44433  344    358999999999999999999999999999999986544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=300.50  Aligned_cols=258  Identities=31%  Similarity=0.546  Sum_probs=220.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|...+.||+|.||+||+|+++++++.||+|.+++..++..   .-....+||-+++.++|.|||+++++...+..+.+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            57778899999999999999999999999999997554433   334667899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          236 LEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      +||| ..+|.++... ++.++.+.++.++.|++.||.|+|++++.|||+||.|+||+.+|.+||+|||+++.+.-.. ..
T Consensus        80 fe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            9999 5688888876 4679999999999999999999999999999999999999999999999999999775543 23


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCC------------------CC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNS------------------KE  374 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~------------------~~  374 (444)
                      ...+-|..|.+|.++.+.+-|+...|+||.|||+.|+.. |++.|.+.+-.+++.++-..                  +.
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            334578999999999999889999999999999999998 99999887766665554221                  11


Q ss_pred             CCCCC---------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          375 LPAIP---------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       375 ~~~~~---------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .|.++         +.++...++|++++|.-+|.+|.++++.|+||||.+..
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            11112         34566788999999999999999999999999998854

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.7e-41  Score=326.75  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=209.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEc----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNS----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ++|++.+.||+|+||.||+|.+.    .+++.+++|.+..    .........+.+|+.+++.++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD----INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            56899999999999999999863    3567899998763    123444567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      ..++||||+.+++|.+++...                 ..+++..+..++.||+.||.|||+++|+|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998632                 237788899999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHh
Q 013354          294 GRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~  369 (444)
                      +.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999986543221   12233567799999987655 8999999999999999998 99999765544444544


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..... ...+..++.++++++.+||+.||++||++.+|+++
T Consensus       240 ~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44333 35677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=333.03  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=204.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcC--CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~  231 (444)
                      +|++.+.||+|+||.||+|.+..  +++.||+|.+.....  ......+.+.+|+.+++.++||||+++++++...  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            48889999999999999999988  899999999874221  1223345677899999999999999999999888  88


Q ss_pred             EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC----CCcEEEEecc
Q 013354          232 LYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP----SGRVKLADFG  302 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~vkL~DFG  302 (444)
                      +++||||+. ++|.+++...     ..+++..++.++.||+.||.|||+++|+||||||+||+++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999999996 5777777532     25889999999999999999999999999999999999998    8999999999


Q ss_pred             ccccccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---------hhH--
Q 013354          303 MAKHITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---------AMF--  367 (444)
Q Consensus       303 la~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---------~~~--  367 (444)
                      ++........    .....++..|+|||++.+...++.++|||||||++|+|++|+.||.......         .+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9886543322    1234578899999998766657899999999999999999999997543321         000  


Q ss_pred             ----------------------HhcCCCCCCCCC-----------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          368 ----------------------KIGNSKELPAIP-----------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       368 ----------------------~~~~~~~~~~~~-----------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                            ...........+           ...+.++.++|.+||+.||++|||+.|+++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                  000000001111           1567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-41  Score=327.15  Aligned_cols=250  Identities=30%  Similarity=0.465  Sum_probs=210.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||+|.++.    ....+..+.+.+|+++++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE----TASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecc----cCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            3568899999999999999998743     468899998763    2233355788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG--------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG  294 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  294 (444)
                      ....++||||+.+++|.+++...+              .+++..+..++.||+.||.|||+++++||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            999999999999999999997642              378889999999999999999999999999999999999999


Q ss_pred             cEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhc
Q 013354          295 RVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIG  370 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~  370 (444)
                      .++|+|||++........   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999876533221   12223567899999997766 8999999999999999998 999998766655555544


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ... ....+..++.++++||.+||+.||++||+++|+++
T Consensus       239 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            333 33456778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.7e-41  Score=325.95  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=209.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ....|++.+.||+|+||.||+|.+..     ++..||+|.+...    ........+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34679999999999999999999987     6788999977531    22334457888999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEE
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG-------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVK  297 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vk  297 (444)
                      ..+..++||||+.+++|.+++.+..       .+++..++.++.||+.||+|||+++++|+||||+||+++.++   .+|
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence            8889999999999999999997653       488999999999999999999999999999999999998654   599


Q ss_pred             EEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC
Q 013354          298 LADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       298 L~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      |+|||+++.+......   .....+..|+|||++.+.. ++.++|||||||++|||++ |..||...........+....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  238 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG  238 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876332211   1112346799999997666 8999999999999999997 999998755544444443322


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                       ....+..++.++.+|+.+||+.+|++||++.++++|
T Consensus       239 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 -RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             235567889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-41  Score=332.29  Aligned_cols=251  Identities=26%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEE--EEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~v--aiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      ..+|++.+.||+|+||.||+|.++.++..+  ++|.++.    .......+.+.+|+.++.++ +|+||+++++++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            357999999999999999999998877654  5655431    22344557788999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG  294 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  294 (444)
                      ..++||||+.+++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999997543                478899999999999999999999999999999999999999


Q ss_pred             cEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC
Q 013354          295 RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      .+||+|||++.............++..|+|||++.... ++.++|||||||++|||++ |..||...........+....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            99999999986432211111222456799999986655 8899999999999999998 999997665544444443322


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                       ....+..++.++.+||.+||+.+|++||++.+++.+
T Consensus       241 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             224456688999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=366.80  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=218.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGE-----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ...+..++.+.||+|.||.||.|.......     .||||.++.    ..+.+...+|.+|..+|+.++|||||+++|++
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            345677888999999999999998865332     388888763    34566778999999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                      ...+..+|++|||+||+|..+|++.       ..++..+++.++.||++|+.||+++++|||||..+|+|++....+||+
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999999985       238899999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCcc-c--ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCC
Q 013354          300 DFGMAKHITGQSCPL-S--IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKEL  375 (444)
Q Consensus       300 DFGla~~~~~~~~~~-~--~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  375 (444)
                      |||+|+.+...+-+. .  ..-...|||||.++.+. ++.++|||||||+|||+++ |..||......+.+.....+.++
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            999999543322111 1  11235799999998876 9999999999999999999 99999999988888766666666


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                       ..|..|++.+.++|.+||+.+|++||++..|++.
T Consensus       924 -~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q  957 (1025)
T KOG1095|consen  924 -DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ  957 (1025)
T ss_pred             -CCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence             5689999999999999999999999999998873

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-41  Score=335.30  Aligned_cols=262  Identities=27%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             CCee-eeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHH---------HHHHHHHHHHHHHccCCCCeeeEee
Q 013354          155 SRWK-KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE---------SAQQLGQEIALLSRLRHPNIVRYYG  224 (444)
Q Consensus       155 ~~~~-~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~  224 (444)
                      .+|. +.+.||+|+||+||+|+++.+++.||+|+++..........         ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 46789999999999999999999999999864322111100         1125678999999999999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      ++..++..++||||+. ++|.+++.....+++..+..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999996 699999988778999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC---------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh
Q 013354          305 KHITGQ---------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       305 ~~~~~~---------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  369 (444)
                      ......               .......++..|+|||++.+...++.++|||||||++|||++|..||...+....+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            765411               11112336788999999876655789999999999999999999999876554433222


Q ss_pred             cCCC--------------------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          370 GNSK--------------------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       370 ~~~~--------------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ....                          ........++.++.+||++||+.+|++||+++|+|.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            1100                          00011235688999999999999999999999999999998753

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=320.52  Aligned_cols=244  Identities=31%  Similarity=0.493  Sum_probs=211.5

Q ss_pred             eeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|+||.||+|.+...   +..|++|.+....    .....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc----chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4699999999999999866   8999999886421    12246788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          238 YVSGGSIYKILQDY---------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       238 ~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      |+.+++|.+++...         ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999885         679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          309 GQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       309 ~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ...   ......++..|+|||.+.... ++.++|||||||++|||++ |..||...........+.... ....+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-RLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCh
Confidence            432   122344788999999987664 8999999999999999999 699998876655555555433 3356778899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=322.30  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=210.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+|++.+.||+|+||.||+|.++.+   ...||+|.++..    ........+.+|+.+++.++|+||+++++.+...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            5799999999999999999998654   457999987532    234445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+++|||+.+++|.+++... +.+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999764 46899999999999999999999999999999999999999999999999999877522


Q ss_pred             CCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          311 SCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       311 ~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...   ....++..|+|||.+.+.. ++.++||||||+++|||++ |..||...........+...... ..+..++.++
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-PPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence            211   1223457899999987655 8999999999999999998 99999776655555555443332 3456789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+|+.+||+.+|++||++.+++++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.1e-41  Score=331.06  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=203.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ..++|++.+.||+|+||.||+|++..+++.||+|.+.....   .......+.+|+.++++++||||+++++++...+  
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            34579999999999999999999999999999998864321   1122234567999999999999999999876543  


Q ss_pred             ------EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          231 ------KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       231 ------~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                            ..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                  4599999995 58888876643 689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCc-----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--CC---
Q 013354          304 AKHITGQSCP-----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SK---  373 (444)
Q Consensus       304 a~~~~~~~~~-----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--~~---  373 (444)
                      +..+......     ....++..|+|||++.+...++.++||||||+++|||++|+.||...+.......+..  +.   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9765432211     2234678899999987655578899999999999999999999976543322111110  00   


Q ss_pred             ---------------CCCC----------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 ---------------ELPA----------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ---------------~~~~----------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                     ..+.          .+...+..+++||.+||+.||++|||++++|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                           0000          011236778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.3e-41  Score=324.33  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=206.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      .++|++.+.||+|+||.||+|.++     .++..||+|.+..    .........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            467999999999999999999864     2357799998752    1222344678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEE
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG----------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL  298 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL  298 (444)
                      ....++||||+.+++|.+++.+..          .++...+..++.||+.||+|||+.+++|+||||+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999997532          2467788999999999999999999999999999999999999999


Q ss_pred             EeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCC
Q 013354          299 ADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKE  374 (444)
Q Consensus       299 ~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~  374 (444)
                      +|||++.........   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.. ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~  238 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME-GG  238 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CC
Confidence            999998755332211   1123567899999987655 8999999999999999999 7899977654444433332 23


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+..+..++.++++|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            345677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-41  Score=318.83  Aligned_cols=252  Identities=34%  Similarity=0.536  Sum_probs=217.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|++.+.||+|+||.||++++..+++.+++|.+....   ........+.+|+.+++.++|+||+++++++......++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            4889999999999999999999999999999886421   2234456778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          236 LEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |||+.+++|.+++.+    ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999999876    346899999999999999999999999999999999999999999999999999876554 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......++..|+|||.+.+.. ++.++|+||||+++|||++|+.||...+.......+.. ...+.++..++.+++++|.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchhhCHHHHHHHH
Confidence            233345888999999997655 78899999999999999999999987654443333333 3445666788999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +||+.+|++||++.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.7e-41  Score=325.63  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=209.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ...|.+.+.||+|+||.||++.+.     .++..+|+|.+..     ......+.+.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            457999999999999999999852     3456789997752     234455678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG-------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                      .+..++||||+.+++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997543             3899999999999999999999999999999999999999999


Q ss_pred             EEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcC
Q 013354          296 VKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGN  371 (444)
Q Consensus       296 vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  371 (444)
                      ++|+|||++........   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+..
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876543221   11223567899999987655 8999999999999999998 9999987665555555544


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ... ...+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            433 3456678999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.5e-41  Score=320.78  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|.+.. +..+|+|.+....      ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc------ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            3579999999999999999998764 4569999875311      12356788999999999999999999999888999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++.......
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999999999999764 3689999999999999999999999999999999999999999999999999876543321


Q ss_pred             c--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 P--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 ~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .  ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+..... ...+...+.+++++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  233 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAI  233 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHH
Confidence            1  1223456799999997665 8899999999999999998 9999987665444444444333 34456678999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||+.||++||++.+|+++
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-41  Score=337.13  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=211.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----C
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----D  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~  229 (444)
                      +.+|++.+.||+|+||.||+|.++.+++.||+|++....   ......+.+.+|+.++++++|+||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            367999999999999999999999999999999886421   122344667789999999999999999988753    3


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..+++||||+. ++|.+++.....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            56899999995 68999998777899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--------------
Q 013354          310 QSC-----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--------------  370 (444)
Q Consensus       310 ~~~-----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------------  370 (444)
                      ...     .....++..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+.              
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            221     1234588899999998765558899999999999999999999997654332211100              


Q ss_pred             ----------CCCCCC-----CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 ----------NSKELP-----AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 ----------~~~~~~-----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                ......     .+...++.++++||++||+.+|++||++.+++.||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                      000000     1124578999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-41  Score=325.64  Aligned_cols=259  Identities=41%  Similarity=0.716  Sum_probs=219.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ....|...+.||+|+||.||++.+..+++.+++|++....     . ..+.+.+|+.+++.++|+||+++++.+......
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----Q-NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc-----h-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            4556889999999999999999999889999999986421     1 456788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++++||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999999999876 79999999999999999999999999999999999999999999999999887654322


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC-CCCCCCCHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-AIPDHLSDEGKDF  389 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~~L  389 (444)
                       ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....... ..+..++.++++|
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence             122334788999999987655 8899999999999999999999998765544444433222211 1223378999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      |.+||+.+|.+||++.++++|+||+..-.
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999999998533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-41  Score=322.36  Aligned_cols=252  Identities=32%  Similarity=0.591  Sum_probs=209.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||++++..+++.+|+|.+....  .......+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            36888999999999999999999899999999876422  2233445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          235 YLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +|||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999999874    245899999999999999999999999999999999999999999999999998766443


Q ss_pred             CC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--hhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .. .....++..|+|||++.+.. ++.++||||||+++|+|++|..||......  .....+......+..+..++.+++
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence            22 22345888999999987655 889999999999999999999999653321  222223222222233456889999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +||.+||+.||++|||+.+|++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=324.25  Aligned_cols=253  Identities=31%  Similarity=0.527  Sum_probs=208.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--CEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKLYI  234 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  234 (444)
                      |++.+.||+|+||.||+|++..+++.+|+|.+....   ......+.+.+|+.+++.++|+|++++++++...  +..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678899999999999999999999999999987532   2233446678899999999999999999999888  88999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      ||||+. ++|.+++... ..+++..++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||++........ 
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            999996 5899888765 5799999999999999999999999999999999999999999999999999987654431 


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC------CC----------
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK------EL----------  375 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------~~----------  375 (444)
                       .....++..|+|||.+.+...++.++||||||+++|||++|+.||...........+....      ..          
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence             2233467889999987665557899999999999999999999997655433322221100      00          


Q ss_pred             -------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          376 -------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       376 -------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                   ..+...++.++.++|++||+.||++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         00112248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.4e-41  Score=322.09  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=200.0

Q ss_pred             Ceeeeee--ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          156 RWKKGRL--LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       156 ~~~~~~~--LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      .|++.+.  ||+|+||.||++.++.++..+|+|.+......        .  .|+.....+ +|+||+++++.+...+..
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4555555  49999999999999999999999988632110        0  122222222 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||+.+++||||||+||+++.++ .++|+|||++.......
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  164 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS  164 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence            99999999999999998877899999999999999999999999999999999999999888 99999999987664332


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh----hhHHhcCCCCCCCCCCCCCHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP----AMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                         ...++..|+|||++.... ++.++||||||+++|||++|+.||.......    .+....  ......+..++..++
T Consensus       165 ---~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  238 (267)
T PHA03390        165 ---CYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNAN  238 (267)
T ss_pred             ---cCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHH
Confidence               235889999999997655 8899999999999999999999997543221    111111  222244557899999


Q ss_pred             HHHHHHhhhCCCCCcC-HHHHHhCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPT-AAWLLEHPFVGN  415 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt-~~elL~hp~~~~  415 (444)
                      +||.+||+.||++|++ ++++|+||||++
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999975

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-41  Score=322.38  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      .++|++.+.||+|+||.||+|.++..     +..||+|.+..    .........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE----NASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC----ccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            46799999999999999999988643     47899998752    1223344678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEE
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG----------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL  298 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL  298 (444)
                      ....++||||+.+++|.+++....          .+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999997532          3677889999999999999999999999999999999999999999


Q ss_pred             EeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCC
Q 013354          299 ADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKE  374 (444)
Q Consensus       299 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~  374 (444)
                      +|||+++.+.....   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.. ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CC
Confidence            99999876543321   11233577899999987665 8899999999999999998 9999987665555544443 33


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+..++.++.+||.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            34567788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-41  Score=335.60  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=214.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-----
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-----  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  230 (444)
                      +|++.+.||+|+||.||+|++..+++.||||.+....   ......+.+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            5889999999999999999999899999999886421   22344567889999999999999999999987765     


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|++|||+. ++|.+++.+...+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            7899999996 589999988778999999999999999999999999999999999999999999999999999876554


Q ss_pred             C----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-------------
Q 013354          311 S----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-------------  373 (444)
Q Consensus       311 ~----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------  373 (444)
                      .    ......++..|+|||++.+...++.++||||||+++|+|++|+.||......+.+..+....             
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            3    12334578899999999877458999999999999999999999997655433222211100             


Q ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          374 ----------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       374 ----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                      ....+...++.++.+||.+||+.+|++||+++++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                            00112234788999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.7e-41  Score=319.42  Aligned_cols=247  Identities=29%  Similarity=0.504  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..      .....+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKP------GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccC------CchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            467999999999999999999865 467799998753      1223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||+.+++|.+++.+.  ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999763  458899999999999999999999999999999999999999999999999998764332


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....++..|+|||++.... ++.++|||||||++|+|++ |..||...........+...... .....++.++.+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-PRMENCPDELYD  235 (261)
T ss_pred             eeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence            11  1223567899999987655 8899999999999999998 99999876555555555444333 334568999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      |+.+||..+|++||+++++++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-40  Score=327.03  Aligned_cols=259  Identities=37%  Similarity=0.627  Sum_probs=215.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +.|...+.||+|+||.||+|++..+++.|++|++....  .......+.+.+|+.+++.++|+|++++++++......++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34777788999999999999999999999999886422  2233445678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||+. ++|.+++.. ...+++..++.++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++......   
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            999995 577777765 346899999999999999999999999999999999999999999999999988654322   


Q ss_pred             ccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ....++..|+|||++..  ...++.++|||||||++|||++|..||...+.......+............++..+++||.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  254 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD  254 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            23458889999999842  2337889999999999999999999998766555555444333322334457889999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      +||+++|++||++.++++||||+.....
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~~~  282 (313)
T cd06633         255 YCLQKIPQERPASAELLRHDFVRRDRPA  282 (313)
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCchh
Confidence            9999999999999999999999975543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-41  Score=351.85  Aligned_cols=265  Identities=26%  Similarity=0.314  Sum_probs=197.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEEee------------cccccccHHHHHHHHHHHHHHHccCCCCee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-GEMCAMKEVTL------------FSDDAKSKESAQQLGQEIALLSRLRHPNIV  220 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-g~~vaiK~i~~------------~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv  220 (444)
                      ..+|++.+.||+|+||+||+|..+.. +..+++|.+..            .+...........+.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            46899999999999999999876532 22222221100            000112233456788999999999999999


Q ss_pred             eEeeeEEcCCEEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       221 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                      ++++++...+..|+|++++ +++|.+++...     .......++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999999 56777776542     22446778899999999999999999999999999999999999


Q ss_pred             EEEEeccccccccCCCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCC-CCCCCCCh--hhhHHhc
Q 013354          296 VKLADFGMAKHITGQSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP-PWSQYEGV--PAMFKIG  370 (444)
Q Consensus       296 vkL~DFGla~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~-Pf~~~~~~--~~~~~~~  370 (444)
                      +||+|||++..+.....  .....||..|+|||++.+.. ++.++|||||||+||||++|.. ||......  ..+..+.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999987654332  23456999999999997665 8999999999999999999775 44332211  1111110


Q ss_pred             C---------------------CCCCCCC---------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCc
Q 013354          371 N---------------------SKELPAI---------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       371 ~---------------------~~~~~~~---------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~  420 (444)
                      .                     .......         ...++.++.++|.+||+.||++|||+.|+|.||||.......
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~  464 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE  464 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence            0                     0000000         123567788999999999999999999999999998765443

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=320.28  Aligned_cols=248  Identities=26%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||++.++ ++..+|+|.+....   .   ....+.+|+.++++++|+||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---M---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---C---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            346899999999999999999886 46789999875211   1   1245778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999999999999764 4689999999999999999999999999999999999999999999999999876543221


Q ss_pred             cc--cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 PL--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 ~~--~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      ..  ...++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..++.++.++
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  233 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LYRPKLAPTEVYTI  233 (256)
T ss_pred             cccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHHHH
Confidence            11  112345799999987655 8899999999999999999 8999977655555555443332 34566789999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||..+|++|||+.|+++.
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-40  Score=326.17  Aligned_cols=259  Identities=37%  Similarity=0.625  Sum_probs=217.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|+..+.||+|+||.||++++..++..+|+|++....  ....+..+.+.+|+.+++.++|+|++++++++..+...++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            45888999999999999999999999999999886422  2234455678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++......   
T Consensus       103 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         103 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            999996 477777754 456899999999999999999999999999999999999999999999999988754332   


Q ss_pred             ccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ....++..|+|||++..  ...++.++|||||||++|||++|..||...+.......+............++..+++||.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  258 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence            23458889999999742  2337889999999999999999999998766555555554444333445567899999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      +||+.+|++||++.++++|+|+......
T Consensus       259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         259 SCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             HHccCCcccCcCHHHHHhChhhhccCcc
Confidence            9999999999999999999999765444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-43  Score=368.06  Aligned_cols=262  Identities=28%  Similarity=0.437  Sum_probs=231.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|.+.++||+|+||.|.+++++.+++.||+|++.+.  ..........|..|-.+|..-+.+-|+.++-.|+++.+
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~--eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW--EMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH--HHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3457899999999999999999999999999999988642  11223334678889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +|+||||+.||+|-.++.++.++++..++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.+-.+..+.
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            99999999999999999999899999999999999999999999999999999999999999999999999998876554


Q ss_pred             C--cccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCC
Q 013354          312 C--PLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLS  383 (444)
Q Consensus       312 ~--~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s  383 (444)
                      .  ....+|||-|++||+++..    ..|+..+|.||+||++|||+.|..||....-.+.+.+|.+.+..-.+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            3  3456799999999998622    338899999999999999999999999888888888888876655666  5689


Q ss_pred             HHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      .++++||.+++ -+|+.|..   ++++..||||.+.
T Consensus       310 eeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  310 EEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence            99999999988 67888888   9999999999853

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.1e-41  Score=333.89  Aligned_cols=256  Identities=30%  Similarity=0.514  Sum_probs=206.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      +.+|++.+.||.|+||.||+|+++.+++.||+|.+....     ....+.+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            578999999999999999999999999999999886422     23446778899999999999999999776543    


Q ss_pred             ----------CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEE
Q 013354          230 ----------DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKL  298 (444)
Q Consensus       230 ----------~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL  298 (444)
                                ...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence                      35799999996 589888865 57999999999999999999999999999999999999974 557899


Q ss_pred             EeccccccccCCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--
Q 013354          299 ADFGMAKHITGQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--  372 (444)
Q Consensus       299 ~DFGla~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--  372 (444)
                      +|||++..+......    ....++..|+|||++.....++.++|||||||++|||++|+.||...........+...  
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998765332111    12347888999998766555888999999999999999999999765433322221100  


Q ss_pred             ---------------------CCCC-----CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ---------------------KELP-----AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ---------------------~~~~-----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                           ...+     .+...++.++++||.+||+.||++|||+.++|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                 0000     1123578999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.3e-41  Score=325.22  Aligned_cols=250  Identities=25%  Similarity=0.359  Sum_probs=209.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      .+|++.+.||+|+||.||+|.+..     +++.||+|+++..    ......+.+.+|+.++..++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            468889999999999999998754     3578999988632    2234456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      +..++++||+.+++|.+++...                ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532                247888899999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHh
Q 013354          294 GRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~  369 (444)
                      +.+||+|||+++.......   .....+++.|+|||++.... ++.++|||||||++|||++ |..||...........+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999876543221   11233567899999987665 8899999999999999998 88999876665555555


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..... ..++..++.++.+|+.+||+.+|++||++.+|+..
T Consensus       240 ~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            54443 35677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-41  Score=320.58  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=206.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE--
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK--  231 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--  231 (444)
                      |++.+.||+|+||.||+|.+..+   +..||+|.++..   .........+.+|+..++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56789999999999999987654   478999988642   2234445678999999999999999999998766543  


Q ss_pred             ----EEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          232 ----LYIYLEYVSGGSIYKILQDY------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       232 ----~~lv~e~~~ggsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                          .+++|||+.+++|..++...      ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                79999999999999998543      25899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCcc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCC
Q 013354          302 GMAKHITGQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPA  377 (444)
Q Consensus       302 Gla~~~~~~~~~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  377 (444)
                      |+++.+.......   ...++..|+|||.+.... ++.++|||||||++|||++ |..||...........+.... ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC
Confidence            9998664432211   122456899999986555 8899999999999999999 999998766555555554433 345


Q ss_pred             CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       378 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+..++.++.++|.+||+.||++||++.|++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            677899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.8e-41  Score=321.12  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCc--EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC-----
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGE--MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD-----  229 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----  229 (444)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.++..   .......+.+.+|+.+++.++|+||+++++++...     
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccC---cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            3567899999999999999877765  6899987642   23345567888999999999999999999976432     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          230 -DKLYIYLEYVSGGSIYKILQDY------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       230 -~~~~lv~e~~~ggsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                       ...+++|||+.+++|.+++...      ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence             2468999999999999987431      237899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          303 MAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       303 la~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      +++.+.....   .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+..... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCC
Confidence            9987643321   11223567899999987665 8999999999999999999 8999987665555555544433 245


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +..++..++++|.+||+.||++|||+.+|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            56789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-40  Score=321.47  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .+|++.+.||+|+||.||+|.+..+++.    +++|.+.    ..........+..|+..+.+++|+||+++++++. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            5799999999999999999999877775    5555543    2223344567888999999999999999999875 45


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++++||+.+++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            578899999999999999764 4689999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          310 QSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       310 ~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ...   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.... .+..+..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  239 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLAQPQICTID  239 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCCCCCCCHH
Confidence            322   12234667899999997665 8999999999999999998 999997765444333333333 33455668899


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.+++.+||..||++|||+.|+++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-41  Score=323.22  Aligned_cols=252  Identities=35%  Similarity=0.576  Sum_probs=208.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv  235 (444)
                      |++.+.||+|+||.||+|++..+++.|+||.+.....   . .......+|+..+.+++ |+||+++++++..++..++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            6788999999999999999998899999998763211   1 12233456899999999 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          236 LEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      |||+ +++|.+++....  .+++..++.++.||+.+|.|||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 889999888754  6899999999999999999999999999999999999999999999999999877654444


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------------
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------------  372 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------------  372 (444)
                      ....++..|+|||++.....++.++|+||||+++|||++|+.||..........++...                     
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            44568889999998866555789999999999999999999999765544333221100                     


Q ss_pred             -------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 -------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 -------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                             ..........+.++.+||++||+.||++|||++|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                   00001112346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.1e-41  Score=328.21  Aligned_cols=256  Identities=29%  Similarity=0.475  Sum_probs=207.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|+++....   .......+.+|+.++++++||||+++++++....   
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            3579999999999999999999999999999999875321   1222346678999999999999999999887654   


Q ss_pred             -------EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          231 -------KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       231 -------~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                             .+++|+||+.+ +|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   79999999975 777777653 468999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC--C----
Q 013354          303 MAKHITGQSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--E----  374 (444)
Q Consensus       303 la~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~----  374 (444)
                      ++........  .....++..|+|||++.+...++.++|||||||++|||++|++||...+....+..+....  .    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            9986644331  1223357789999988665557889999999999999999999997655433332221100  0    


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          375 ----------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       375 ----------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                            .......++..+.+||.+||+.||++||+++++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                  001123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=318.07  Aligned_cols=247  Identities=27%  Similarity=0.447  Sum_probs=207.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|.+.. ++.||+|.++...      ...+.+.+|+.++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            4579999999999999999998754 5789999876321      12356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997654  68999999999999999999999999999999999999999999999999998765322


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  .....+..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+...... ..+..++..+.+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-PCPPGCPKELYD  235 (261)
T ss_pred             ccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence            11  1112345799999987655 8999999999999999999 99999876655555555443332 456678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++.+||+.+|++||++.++++
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=316.89  Aligned_cols=242  Identities=25%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             eeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|+||.||+|++..++   ..+|+|.+...    ......+.+.+|+.+++.++|+||+++++++.. +..++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE----HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccc----cchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEE
Confidence            46999999999999876554   78999987632    112345678899999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc---
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---  314 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~---  314 (444)
                      |+.+++|.+++.+...+++..++.++.||+.||+|||..+++|+||||+|||++.++.+||+|||+++.........   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999999999987789999999999999999999999999999999999999999999999999998664433221   


Q ss_pred             -cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          315 -SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       315 -~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                       ...++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++..+++||.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHH
Confidence             112346799999997665 8999999999999999998 9999987666555555544433 35677889999999999


Q ss_pred             HhhhCCCCCcCHHHHHh
Q 013354          393 CLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~  409 (444)
                      ||..+|++||++.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.7e-41  Score=331.66  Aligned_cols=257  Identities=28%  Similarity=0.482  Sum_probs=207.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCC--CcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcC---
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSES--GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLD---  229 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~--g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~---  229 (444)
                      +|++.+.||+|+||.||++.+..+  ++.||+|.+....   ......+.+.+|+.+++++ +|+||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            488999999999999999999888  8999999876321   2233456778899999999 599999999865432   


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 -DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 -~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ..+++++||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence             45788999984 7999999887789999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCC-----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC------------
Q 013354          309 GQSC-----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------------  371 (444)
Q Consensus       309 ~~~~-----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------  371 (444)
                      ....     .....|+..|+|||++.+...++.++|||||||++|+|++|..||...+.......+..            
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            3221     12345889999999887655588999999999999999999999976543222111000            


Q ss_pred             -----------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 -----------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 -----------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                       ..........++.++.+||.+||+.||++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                             001112223468899999999999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-40  Score=321.05  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGE----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..+|++.+.||+|+||+||+|++..+++    .||+|+++.    .......+.+.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE----NTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecC----CCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            4579999999999999999999877776    478898753    12344456788999999999999999999988754


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ..++++||+.+|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             478999999999999999774 468999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          309 GQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       309 ~~~~~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ......   ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  238 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQPPICTI  238 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCCCccCCH
Confidence            433221   122467899999987665 8999999999999999998 9999976554444443433333 344667899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.++|.+||+.||++||++.++++.
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-40  Score=315.94  Aligned_cols=251  Identities=33%  Similarity=0.630  Sum_probs=209.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.++....  ......+.+.+|+.++++++|+||+++++.+..++..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            469999999999999999999998999999998864221  223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          235 YLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ||||+.+++|.+++.+.    ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999999999998652    34899999999999999999999999999999999999999999999999998765443


Q ss_pred             CC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--hhhHHhcCCCCCCCCCC-CCCHHH
Q 013354          311 SC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPD-HLSDEG  386 (444)
Q Consensus       311 ~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~-~~s~~l  386 (444)
                      .. .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||......  .....+.... .+..+. .++.++
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-YPPLPADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-CCCCChhhcCHHH
Confidence            22 22345888999999987555 889999999999999999999999653321  1222222222 233444 788999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++|.+||..+|++|||+.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-40  Score=325.17  Aligned_cols=252  Identities=28%  Similarity=0.464  Sum_probs=208.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ...+|++.+.||+|+||.||++.+     ..++..+|+|.++..    ......+.+.+|+.+++++ +|+||+++++.+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            345799999999999999999975     334568999987531    2234456788999999999 799999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      ...+..++||||+.+++|.+++.....  +++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999999999976432  899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCC
Q 013354          305 KHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD  380 (444)
Q Consensus       305 ~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  380 (444)
                      ........   .....++..|+|||++.... ++.++|||||||++|||++ |..||.....................+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            86543321   11223567899999987665 8899999999999999998 9999987655444433333222334556


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..+.++.+|+.+||+++|++|||+.|+++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            78999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.5e-41  Score=325.99  Aligned_cols=255  Identities=34%  Similarity=0.588  Sum_probs=213.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |.....||+|+||.||++.+..+++.||+|.+..     ........+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc-----cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            4445789999999999999999999999998753     22334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cccc
Q 013354          237 EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLS  315 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~~~  315 (444)
                      ||+.+++|.+++.. ..+++..++.++.||+.+|+|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657          97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            99999999998765 578999999999999999999999999999999999999999999999999887654332 1233


Q ss_pred             ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHHHHh
Q 013354          316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       316 ~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ..++..|+|||.+.... ++.++|+||||+++|+|++|..||...........+..... .......++.++.++|.+||
T Consensus       176 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            45889999999986555 78999999999999999999999976554443333322111 11123457899999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +.||.+||++.++++||||...-+
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCC
Confidence            999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=315.51  Aligned_cols=246  Identities=35%  Similarity=0.595  Sum_probs=213.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|+||.||++.+..+++.+++|++...  ..........+..|+.++++++|+||+++++.+..+...++||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehh--hhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            69999999999999988999999988642  1223345567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-CCcccccCCCc
Q 013354          243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY  321 (444)
Q Consensus       243 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~  321 (444)
                      +|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            99999998778999999999999999999999999999999999999999999999999998876543 22334557889


Q ss_pred             ccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 013354          322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR  401 (444)
Q Consensus       322 y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  401 (444)
                      |+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+..  ....++..++.++.+||++||..||++|
T Consensus       159 ~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         159 YLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999987655 78899999999999999999999977655444444433  2235677789999999999999999999


Q ss_pred             cCH---HHHHhCCCC
Q 013354          402 PTA---AWLLEHPFV  413 (444)
Q Consensus       402 pt~---~elL~hp~~  413 (444)
                      |++   +++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-40  Score=323.97  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=207.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCC----------------cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESG----------------EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP  217 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp  217 (444)
                      ..+|++.+.||+|+||.||+|.+...+                ..||+|.+...    ......+.+.+|+.++++++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCCC
Confidence            357999999999999999999876543                45789987632    2234567889999999999999


Q ss_pred             CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 013354          218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-----------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGA  286 (444)
Q Consensus       218 nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  286 (444)
                      ||+++++++..++..+++|||+.+++|.+++.+..           .+++..++.++.||+.||+|||+++|+|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999998765           6899999999999999999999999999999999


Q ss_pred             ceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc--CCCCCCCCC
Q 013354          287 NILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYE  361 (444)
Q Consensus       287 NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt--G~~Pf~~~~  361 (444)
                      ||+++.++.++|+|||++........   .....++..|+|||++.... ++.++|||||||++|||++  +..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999876533221   12234577899999987655 8999999999999999998  778887655


Q ss_pred             ChhhhHHhcCC------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          362 GVPAMFKIGNS------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       362 ~~~~~~~~~~~------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+......      ......+..++.++.+||.+||+.||++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            44443333211      1112334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.9e-41  Score=320.03  Aligned_cols=255  Identities=29%  Similarity=0.541  Sum_probs=212.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|.+.+.||+|+||.||++++..++..+++|+++..............+.+|+.+++.++||||+++++.+......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999999988777777777654332222233345677899999999999999999999988899999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          236 LEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |||+.+++|.+++.+    ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864    245899999999999999999999999999999999999975 569999999987664332


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                       ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+.. ...+..+..++.++.++|
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHH
Confidence             223445888999999986544 78899999999999999999999976554444444433 334456778899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      .+||+.||++||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-41  Score=333.05  Aligned_cols=254  Identities=26%  Similarity=0.442  Sum_probs=202.8

Q ss_pred             eeeccc--CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          161 RLLGRG--TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       161 ~~LG~G--~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      ..||+|  +||+||++.+..+|+.||+|++....   ......+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456666  99999999999999999999886422   2234457888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc---
Q 013354          239 VSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---  313 (444)
Q Consensus       239 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~---  313 (444)
                      +.+++|.+++.+..  .+++..+..++.||+.||+|||+++|+||||||+|||++.++.++++||+.+.........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999999998743  4899999999999999999999999999999999999999999999999865432211110   


Q ss_pred             -----ccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-------------
Q 013354          314 -----LSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-------------  374 (444)
Q Consensus       314 -----~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  374 (444)
                           ....++..|+|||++.+. ..++.++|||||||++|||++|+.||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                 112245679999998754 3378899999999999999999999976543332221111000             


Q ss_pred             --------------------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          375 --------------------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       375 --------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                                      ....+..++.++++||++||+.||++|||+.|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                            0011234677899999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=321.46  Aligned_cols=252  Identities=31%  Similarity=0.491  Sum_probs=205.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEcCCE--
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETLDDK--  231 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~--  231 (444)
                      |++.+.||+|+||.||+|+++.+++.||+|.++....   .......+.+|+.+++++   +|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            6788999999999999999998899999999875322   222234555677776655   69999999999988776  


Q ss_pred             ---EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          232 ---LYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       232 ---~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                         ++++|||+. ++|.+++....  .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               999999996 58999887643  489999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-------------  373 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------  373 (444)
                      ...........++..|+|||++.+.. ++.++|||||||++|||++|.+||......+.+.++....             
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            75554444455788999999997665 8899999999999999999999998755443332221100             


Q ss_pred             ------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 ------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 ------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                  ........++.++.+||.+||+.||++||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                        0001112356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-40  Score=322.66  Aligned_cols=248  Identities=29%  Similarity=0.460  Sum_probs=207.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+..     ......+.+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            46999999999999999999853     3456788887652     2334446788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      +..++||||+.+++|.+++....                .+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997542                37899999999999999999999999999999999999999


Q ss_pred             CcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHh
Q 013354          294 GRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~  369 (444)
                      +.++|+|||++........   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999876543221   12233678899999987655 8899999999999999998 99999776655544444


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ... ..+..+..++.++.+|+.+||++||++||++.++++
T Consensus       239 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            333 333556678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=314.74  Aligned_cols=244  Identities=29%  Similarity=0.469  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|...  ++.||+|.+...      ....+++.+|+.+++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccc------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            457999999999999999999764  789999988631      114577889999999999999999999999889999


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||||+.+++|.+++....  .+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999998765  68999999999999999999999999999999999999999999999999998764332


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      .  ....+..|+|||++.... ++.++||||||+++|||++ |..||...........+... .....+..+++++.+||
T Consensus       157 ~--~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li  232 (256)
T cd05039         157 D--SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             c--cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCccCCCHHHHHHH
Confidence            2  233466799999987665 8889999999999999997 99999766544433333332 22355677899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHh
Q 013354          391 RKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++||..+|++||++.++++
T Consensus       233 ~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         233 KDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.2e-41  Score=324.52  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=209.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ...+|++.+.||+|+||.||++.+...     ...+|+|.+...    ........+.+|+.++.++ +|+||+++++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            446899999999999999999987643     378999987631    2233446788999999999 899999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV  290 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  290 (444)
                      ..++..+++|||+.+++|.+++..+                ..+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            9999999999999999999999653                357899999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhh
Q 013354          291 DPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAM  366 (444)
Q Consensus       291 ~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~  366 (444)
                      +.++.+||+|||+++.+......   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.........
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999866443211   1122456799999986655 8899999999999999998 99999876554444


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       367 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..+... .....+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            444333 3345667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=319.81  Aligned_cols=243  Identities=26%  Similarity=0.453  Sum_probs=199.8

Q ss_pred             eeecccCceEEEEEEEcCCCcE--EEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~--vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      ++||+|+||.||+|+++.++..  +++|.++.    .......+.+.+|+.++.++ +||||+++++++..++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc----cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999999887764  57776652    12344556788999999999 89999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          238 YVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                      |+.+++|.+++.+..                .+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999997643                3788999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCC
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD  380 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  380 (444)
                      |++..............+..|+|||++.... ++.++|||||||++|||++ |..||...+.......+..... ...+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-CCCCC
Confidence            9986432211112222456799999986555 8899999999999999997 9999977655454444433322 24556


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.++.+|+.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            78899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-41  Score=333.72  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE-
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK-  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-  231 (444)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+.+|+.+++.++|+||+++++++..++. 
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc---cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            456899999999999999999999999999999987532   1223344667789999999999999999988766554 


Q ss_pred             -----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          232 -----LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       232 -----~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                           .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                 89999999 7799999876 5799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE------------  374 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------------  374 (444)
                      ....  .....++..|+|||.+.+...++.++|||||||++|||++|+.||...+....+..+.....            
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            6433  23345788999999986654578999999999999999999999976554433332211100            


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          375 -----------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       375 -----------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                                       .......++.++.+||.+||+.||++|||+.+|++||||++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                             001123468999999999999999999999999999999876443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-40  Score=318.18  Aligned_cols=246  Identities=28%  Similarity=0.474  Sum_probs=204.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+ ..||+|.++...      ...+.+.+|+.++++++|+||+++++.+. +...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc------cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            45799999999999999999988765 469999876311      12246788999999999999999999875 45589


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||||+.+++|.+++.+.  ..+++..++.++.||+.||+|||+.+|+|+||||+||+++.++.++|+|||.+..+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999763  347899999999999999999999999999999999999999999999999997664332


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+...... ..+..++..+.+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  234 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPESLHD  234 (262)
T ss_pred             cccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CCccccCHHHHH
Confidence            21  1233567899999986655 8999999999999999999 89999876655555554443322 345678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ||.+||++||++||++.++++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-40  Score=316.48  Aligned_cols=241  Identities=27%  Similarity=0.416  Sum_probs=200.9

Q ss_pred             eecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          162 LLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      .||+|+||.||+|.+.  .++..||+|++..    .......+.+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN----ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccc----ccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence            3899999999999875  4456799998753    1234455678999999999999999999998764 5689999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc----
Q 013354          240 SGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----  314 (444)
Q Consensus       240 ~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~----  314 (444)
                      .+++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........    
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999999975 3468999999999999999999999999999999999999999999999999997654332211    


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...++..|+|||++.... ++.++|||||||++|||++ |..||...........+..... ...+..++.++.++|.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         157 AGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHH
Confidence            112356899999987655 8899999999999999996 9999988766655555544443 456778899999999999


Q ss_pred             hhhCCCCCcCHHHHHh
Q 013354          394 LQRNPLHRPTAAWLLE  409 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~  409 (444)
                      |..||++||++.+|++
T Consensus       235 ~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         235 WIYKWEDRPNFAKVEE  250 (257)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=306.62  Aligned_cols=254  Identities=29%  Similarity=0.421  Sum_probs=207.2

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC-
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD-  229 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-  229 (444)
                      ..+.++|++.+.||+|||+-||++++..+++.||+|.+..     ...+..+..++|++..++++|||+++++++...+ 
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            4567899999999999999999999999999999999875     3356677889999999999999999999875443 


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEEE
Q 013354          230 ----DKLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       230 ----~~~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                          ...||++.|...|+|.+.+++.    ..++|.+++.|+.+|++||++||+..  +.||||||.|||+...+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                3599999999999999999763    25999999999999999999999998  9999999999999999999999


Q ss_pred             eccccccccCCCCc----------ccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--hhh
Q 013354          300 DFGMAKHITGQSCP----------LSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--VPA  365 (444)
Q Consensus       300 DFGla~~~~~~~~~----------~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--~~~  365 (444)
                      |||.++...-.-..          ....-|..|+|||++.-.  ...+.++|||||||+||+|+.|..||+....  ...
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998754221111          122367889999998533  2368899999999999999999999964221  122


Q ss_pred             hHHhcCCC-CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          366 MFKIGNSK-ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       366 ~~~~~~~~-~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...+.+.+ ..|. ...+++.+.+||++||+.||.+||++.+++.+
T Consensus       252 aLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  252 ALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22222222 2222 23489999999999999999999999999864

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-40  Score=323.12  Aligned_cols=260  Identities=29%  Similarity=0.503  Sum_probs=209.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++..    ........+.+|+.++..+ +|+||+++++++..+..
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc----CChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            446799999999999999999999988999999998642    1223345566677766666 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+++|||+ +++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||+|+||+++.++.++|+|||++..+..
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99999998 4578877765 3468999999999999999999997 5999999999999999999999999999887654


Q ss_pred             CCCcccccCCCcccCcccccCc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCCC--CCCC
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNS---NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIP--DHLS  383 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~--~~~s  383 (444)
                      ........++..|+|||++...   ..++.++||||||+++|||++|+.||...... +.+..+.... .+..+  ..++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCC
Confidence            4433444578899999998644   23678999999999999999999999764332 2222222221 12222  2478


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      .++.+||.+||+.||++||+++++++||||.....
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            99999999999999999999999999999987533

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-40  Score=325.69  Aligned_cols=259  Identities=37%  Similarity=0.631  Sum_probs=215.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ...|...+.||+|+||.||+|+++.+++.+|+|.+....  .......+++.+|+.+++.++|+|++++++++......+
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            456888899999999999999999999999999886421  123344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++++||||||+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9999996 688777754 345899999999999999999999999999999999999999999999999998765432  


Q ss_pred             cccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                       ....++..|+|||++..  ...++.++|||||||++|+|++|..||...+.......+............++..+.+||
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence             23457889999999742  223688999999999999999999999776655444444433332233456889999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ++||+.+|++||+++++++|||+.+...
T Consensus       248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         248 DSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHhhCCcccCCCHHHHhhCccccccCC
Confidence            9999999999999999999999988533

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.2e-40  Score=321.53  Aligned_cols=260  Identities=28%  Similarity=0.491  Sum_probs=213.6

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      .|++.+.||.|+||.||++.+.   .+|+.||+|+++.... .......+.+.+|+.++.++ +|+||+++++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            3788999999999999999874   4789999998863211 12223346778899999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      .++||||+.+++|.+++.....+++..+..++.||+.||.|||+.+++||||+|+|||++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999987654432


Q ss_pred             --CcccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHH
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~  385 (444)
                        ......|+..|+|||.+.... .++.++||||||+++|+|++|..||.......   .+.... ....+.++..++..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh-hccCCCCCccCCHH
Confidence              122345889999999986432 36789999999999999999999996432211   111111 11223556778999


Q ss_pred             HHHHHHHHhhhCCCCCc-----CHHHHHhCCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRP-----TAAWLLEHPFVGNAA  417 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~~  417 (444)
                      +.+|+.+||+.||++||     +++++++||||+...
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            99999999999999997     889999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-40  Score=320.99  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      +|++.+.||+|+||.||+|++..     ....+++|.+...    ......+.+.+|+.+++.++||||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47888999999999999998753     2356888877531    22334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY------------------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGA  286 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  286 (444)
                      ..+++|||+.+++|.+++...                        ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999998652                        23678899999999999999999999999999999


Q ss_pred             ceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 013354          287 NILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEG  362 (444)
Q Consensus       287 NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  362 (444)
                      |||++.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++||||||+++|||++ |..||.....
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999876543322   12233567899999986655 8999999999999999998 9999977654


Q ss_pred             hhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ......+..... ...+..++.++.+||.+||+.||++||++.++++
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            444444333322 3456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-40  Score=336.26  Aligned_cols=253  Identities=30%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~  226 (444)
                      ..++|.+++.||+|+||.||+|++.     .+++.||+|+++..    ......+.+.+|+.+|.++. |+||+++++.+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST----ARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC----CChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            3457888999999999999999864     34578999998642    22333457889999999997 99999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC------------------------------------------------------
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG------------------------------------------------------  252 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------  252 (444)
                      ...+..++||||+.+|+|.+++++..                                                      
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            99999999999999999999997532                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          253 --------------------------------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       253 --------------------------------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                                                                  .+++..++.++.||+.||+|||+.+|+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256677888999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      |++.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||......+
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999986533221   12234678899999997665 8899999999999999998 899997755544


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...........+..+..++.++.+||.+||..+|++||++.+|++.
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433322222335677789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=335.98  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-E
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-K  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~  231 (444)
                      ..+.|....+||+|+||.||+|.... +..||||++.....    .. .++|.+|+.++.+++|||+|+++|+|.+.+ .
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~----~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSG----QG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCC----cc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            34678888999999999999998765 58999997653211    11 345999999999999999999999999988 5


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCceEECCCCcEEEEecccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKN---TVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      .+||+||+.+|+|.++|....  .+++....+|+.+++.||+|||+..   |||||||++|||+|.+.+.||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            999999999999999998765  7899999999999999999999964   99999999999999999999999999976


Q ss_pred             ccC-CCCcccc-cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC---C--hhhh--HHhcCCCC---
Q 013354          307 ITG-QSCPLSI-KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---G--VPAM--FKIGNSKE---  374 (444)
Q Consensus       307 ~~~-~~~~~~~-~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~---~--~~~~--~~~~~~~~---  374 (444)
                      ... ....... .||.+|+|||++..+. .+.++|||||||+|+|+++|+.+.....   .  ...+  ..+.....   
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            554 3333333 7999999999998766 8999999999999999999998876422   1  1111  11111111   


Q ss_pred             -CCCCC-CCCC--HH---HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          375 -LPAIP-DHLS--DE---GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       375 -~~~~~-~~~s--~~---l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                       .+.+. ...+  .+   +..+..+|++.+|++||++.|+++
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             11222 2223  23   456777999999999999999754

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-40  Score=318.27  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=210.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||.|+||.||+|.++. ++.+++|++..     ........+.+|+.+++.++|+||+++++++...+..++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKS-----DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccc-----cchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            469999999999999999999987 89999998763     223345578889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          235 YLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ||||+.+++|.+++.+.  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999863  3589999999999999999999999999999999999999999999999999976643221


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                       .....++..|+|||.+.... ++.++||||||+++|+|++ |+.||...........+..... ...+..+++++.++|
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CCCCCCCCHHHHHHH
Confidence             11223567899999987655 8899999999999999998 8999987665555555544333 345678899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHh
Q 013354          391 RKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||+.||++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-40  Score=331.64  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSET  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  227 (444)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||.++..    ........+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            35799999999999999999984     346789999988632    2233456788999999999 6899999999876


Q ss_pred             c-CCEEEEEEeccCCCCHHHHHHhcC------------------------------------------------------
Q 013354          228 L-DDKLYIYLEYVSGGSIYKILQDYG------------------------------------------------------  252 (444)
Q Consensus       228 ~-~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------  252 (444)
                      . +..+++||||+.+++|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            5 456899999999999999986521                                                      


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc---ccc
Q 013354          253 -------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---LSI  316 (444)
Q Consensus       253 -------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~---~~~  316 (444)
                                   .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........   ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                         2577788899999999999999999999999999999999999999999998765332211   122


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      .++..|+|||++.+.. ++.++||||||+++|||++ |..||.....................+..++.++.+++.+||+
T Consensus       242 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            3567799999987655 8999999999999999997 9999976544333322222222334566788999999999999


Q ss_pred             hCCCCCcCHHHHHhC
Q 013354          396 RNPLHRPTAAWLLEH  410 (444)
Q Consensus       396 ~dP~~Rpt~~elL~h  410 (444)
                      .||++|||+.+|++|
T Consensus       321 ~~p~~Rps~~eil~~  335 (343)
T cd05103         321 GEPSQRPTFSELVEH  335 (343)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-40  Score=317.22  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=208.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+|++.+.||+|+||.||+|.++.+++   .||+|.+...    ......+.+..|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            468999999999999999999887665   5999987532    234456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .++||||+.+++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999999764 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCccc---cc---CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          311 SCPLS---IK---GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       311 ~~~~~---~~---gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      .....   ..   .+..|+|||++.... ++.++|||||||++|||++ |..||...+.......+...... ..+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~  237 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-PPPMDCP  237 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-CCcccCC
Confidence            22111   11   235799999987655 8999999999999999987 99999876655555555433333 3345689


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.+++.+||+.+|.+||++++|+.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-41  Score=322.19  Aligned_cols=253  Identities=32%  Similarity=0.569  Sum_probs=209.8

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |++.+.||+|++|.||+|.+..+++.+++|.+....   ........+.+|+.+++.++|+||+++++++......++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            567789999999999999999899999999886422   12234467888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Ccc
Q 013354          237 EYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPL  314 (444)
Q Consensus       237 e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~~  314 (444)
                      ||+.+ +|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99965 888888764 578999999999999999999999999999999999999999999999999988765543 222


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC----------------------
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----------------------  372 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------------------  372 (444)
                      ...++..|+|||.+.+...++.++||||||+++|+|++|+.||...+..+....+...                      
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            3447888999999877645899999999999999999999999776554433222110                      


Q ss_pred             ------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 ------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                            .....+...++.++++||.+||++||.+||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                  00011223478899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-40  Score=320.02  Aligned_cols=248  Identities=31%  Similarity=0.454  Sum_probs=207.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      .+|+..+.||+|+||.||++...     .++..+|+|.+..     ......+.+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            46888999999999999999642     3467888997652     2344556889999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG---------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG  294 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  294 (444)
                      +..+++|||+.+++|.+++....               .+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997642               478899999999999999999999999999999999999999


Q ss_pred             cEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhc
Q 013354          295 RVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIG  370 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~  370 (444)
                      .++|+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||...........+.
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999876543221   11223467899999987665 8999999999999999998 999997766555555554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .... ...+..++.++.+||.+||+.||++||++++|++
T Consensus       239 ~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            4333 3456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.9e-41  Score=327.13  Aligned_cols=256  Identities=31%  Similarity=0.529  Sum_probs=203.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.+|+|++......   ......+.+|+++++.++|+||+++++++...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC---CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            36899999999999999999999999999999988643211   11123566899999999999999999876443    


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          230 ----DKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       230 ----~~~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                          ..+++||||+. ++|...+.. ...+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                35799999995 477777664 346999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc------------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC
Q 013354          305 KHITGQSCP------------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       305 ~~~~~~~~~------------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~  372 (444)
                      .........            ....+++.|+|||++.+...++.++|||||||++|||++|++||...........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            765432211            12346788999999876555789999999999999999999999765543322221100


Q ss_pred             ---------------------CCCCCC-------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          373 ---------------------KELPAI-------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       373 ---------------------~~~~~~-------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                                           ......       ...++.++.+||.+||+.||++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                 000000       12345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-40  Score=316.76  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=208.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..+|++.+.||+|+||.||+|.++.++.   .+|+|.++..    ......+.+.+|+.++++++||||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3579999999999999999999865543   6888877531    22334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++..+..
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999999875 4589999999999999999999999999999999999999999999999999987644


Q ss_pred             CCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ....    ....++..|+|||++.+.. ++.++|+|||||++||+++ |..||...........+...... ..+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-PAPMDCPA  236 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-CCCCCCCH
Confidence            3221    1112356799999997655 8999999999999999887 99999876655545545444332 34566899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++++++.+||+++|++||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-40  Score=323.91  Aligned_cols=251  Identities=27%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGS  225 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  225 (444)
                      .++|.+.+.||+|+||.||++++..       +...+|+|.+...    ........+.+|+.+++.+ +|+||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4689999999999999999998643       2356999987631    2233456788899999999 79999999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceE
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL  289 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  289 (444)
                      +..++..++||||+.+++|.+++....                .++...++.++.||+.||+|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                3788899999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhh
Q 013354          290 VDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPA  365 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  365 (444)
                      ++.++.++|+|||++.........   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||........
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999998765432111   1122456899999987655 8899999999999999998 8899976443333


Q ss_pred             hHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       366 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...+.. ......+..++.++++||.+||..+|++||++.+++++
T Consensus       252 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            333333 33345677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-40  Score=329.65  Aligned_cols=259  Identities=27%  Similarity=0.454  Sum_probs=212.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+.+|+.+++.++|+||+++++++..+.  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            356899999999999999999999999999999987531   122334457789999999999999999999887653  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          231 ----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                          .+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence                468999999 7899988875 5799999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------  372 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------  372 (444)
                      ....  .....+++.|+|||++.+...++.++|+|||||++|+|++|+.||...+.......+...              
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            5432  223457889999999876445789999999999999999999999765433222211100              


Q ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          373 ---------------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       373 ---------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                                     .....+...++.++.++|.+||+.||++|||+.++++||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                           0011123467889999999999999999999999999999987533

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-42  Score=326.70  Aligned_cols=259  Identities=28%  Similarity=0.445  Sum_probs=226.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      ....+|.+..+||+|+||.|.+|..+.+.+.||||++++.....  .+..+--+.|-++|... +-|.+++++..|+.-+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            34467999999999999999999999999999999987543222  22223344566777666 4678999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc-ccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~-~~~  309 (444)
                      .+|+||||+.||+|--.++..+++.|..+..++.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++. +..
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999985 444


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .....+++|||.|+|||++.... |+..+|.||+||+|||||.|++||.+.+..+....|.....  .+|..+|.|+.++
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~i  580 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAI  580 (683)
T ss_pred             CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHH
Confidence            55667899999999999998776 99999999999999999999999999888887777765544  6899999999999


Q ss_pred             HHHHhhhCCCCCcCH-----HHHHhCCCCCC
Q 013354          390 VRKCLQRNPLHRPTA-----AWLLEHPFVGN  415 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~-----~elL~hp~~~~  415 (444)
                      .+..|.++|.+|.-.     .+|-+||||+.
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            999999999999654     47999999984

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-40  Score=355.33  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=204.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.++||+|+||.||+|++..+++.||+|++...  ........+++.+|+.+++.++||||+++++++..++..++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~--l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc--cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            4799999999999999999999999999999988632  12234455778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          235 YLEYVSGGSIYKILQDY-----------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      ||||++|++|.+++...           ..++...++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999998642           2345677889999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh
Q 013354          304 AKHITGQS-------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP  364 (444)
Q Consensus       304 a~~~~~~~-------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  364 (444)
                      ++......                   ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            98652110                   011245899999999997666 8999999999999999999999997644333


Q ss_pred             hhHHhcCCCCCC-CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELP-AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~-~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ............ .....++..+.+++.+||+.||++|++..+.+.
T Consensus       239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            222211111100 112367899999999999999999987665443

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.6e-40  Score=324.26  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-------ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYG  224 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  224 (444)
                      ...+|.+.+.||+|+||.||+|++.       .....+|+|.++..    ........+.+|+.+++++ +|+||+++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3468999999999999999999763       23457899987531    2234456788999999999 6999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ++..++.+++||||+.+++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999999999999999999999999763                2378889999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      |++.++.+||+|||+++........   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999866432211   1122446799999987655 8899999999999999999 899997765555


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+.... ....+..++.++++||.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            454444433 23556788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.6e-40  Score=314.22  Aligned_cols=249  Identities=26%  Similarity=0.429  Sum_probs=208.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+|+..+.||+|+||.||+|+++.+++   .+++|.+...    ......+.+.+|+.++++++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            468899999999999999999876665   6888877531    223345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .++||||+.+++|.+++.+. +.+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999764 56899999999999999999999999999999999999999999999999998766432


Q ss_pred             CCcc----cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          311 SCPL----SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       311 ~~~~----~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ....    ....+..|+|||++.... ++.++|||||||++|||++ |+.||...+.......+...... ..+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~  238 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-PAPMDCPSA  238 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-CCCCCCCHH
Confidence            2111    112345799999987655 8999999999999999997 99999776665555555544333 345568999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.+|+.+||+.+|++||++.++++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.1e-40  Score=312.67  Aligned_cols=247  Identities=29%  Similarity=0.485  Sum_probs=210.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCC----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESG----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      +.+.+.||.|+||.||++.+..++    ..||+|.+...    ......+.+.+|+.++..++|+||+++++++...+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356788999999999999998766    89999988632    2222557888999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++|||+.+++|.+++.....  +++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999999986544  999999999999999999999999999999999999999999999999999866544


Q ss_pred             CCcc--cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SCPL--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~~~--~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ....  ...+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+..... ...+..++.++.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-LPKPENCPPEIY  234 (258)
T ss_pred             cccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHH
Confidence            2221  123678899999986554 8999999999999999998 8999987665555555554443 355677899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +++.+||..||++|||+.|+++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.1e-40  Score=314.29  Aligned_cols=243  Identities=30%  Similarity=0.470  Sum_probs=203.6

Q ss_pred             eeecccCceEEEEEEEcC-CCc--EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSE-SGE--MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|+||.||+|.+.. .++  .||||.+.....    ....+.+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999998865 333  689998864211    1566789999999999999999999999888 88999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc--
Q 013354          238 YVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP--  313 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~--  313 (444)
                      |+.+++|.+++.+..  .+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+|||++..+......  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999998754  5899999999999999999999999999999999999999999999999999876442211  


Q ss_pred             --ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          314 --LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       314 --~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                        ....++..|+|||++.... ++.++|||||||++|||++ |..||...........+.........+..++.++.+++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM  234 (257)
T ss_pred             cccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence              1234677899999987655 8999999999999999998 99999776655555444433333345567889999999


Q ss_pred             HHHhhhCCCCCcCHHHHHh
Q 013354          391 RKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||+.+|++||++.++++
T Consensus       235 ~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         235 LQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHCCCCcccCCCHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-40  Score=317.67  Aligned_cols=247  Identities=29%  Similarity=0.447  Sum_probs=198.8

Q ss_pred             eeeeeeecccCceEEEEEEE----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CC
Q 013354          157 WKKGRLLGRGTFGHVYLGFN----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DD  230 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~  230 (444)
                      |++.+.||+|+||+||++..    ..+++.||+|.++..    ........+.+|+.+++.++|+||+++++++..  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            48899999999999988653    456889999988632    222345677889999999999999999998765  34


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .++++|||+.+++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            68999999999999999986 46999999999999999999999999999999999999999999999999999866443


Q ss_pred             CCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--------------hhhHHhcCC
Q 013354          311 SCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--------------PAMFKIGNS  372 (444)
Q Consensus       311 ~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--------------~~~~~~~~~  372 (444)
                      ...    ....++..|+|||++.+.. ++.++||||||+++|||++|..||......              .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            221    1223566799999987655 889999999999999999999998543211              001111111


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ......+..++.++.+|+.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1122346678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-40  Score=330.49  Aligned_cols=258  Identities=31%  Similarity=0.500  Sum_probs=209.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcC--C
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLD--D  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~  230 (444)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|++....   ........+.+|+.+++++ +|+||+++++++...  .
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            457999999999999999999999899999999875311   1222345677899999999 999999999987653  3


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ..++||||+. ++|..++.+. .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            6899999996 5999998875 7889999999999999999999999999999999999999999999999999865433


Q ss_pred             CC------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-------------
Q 013354          311 SC------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-------------  371 (444)
Q Consensus       311 ~~------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------  371 (444)
                      ..      .....++..|+|||++.+...++.++||||||+++|+|++|+.||..........++..             
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            21      12345788999999886655578899999999999999999999976443322211100             


Q ss_pred             ----------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 ----------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ----------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                      ..........++.++.+||.+||+.||++|||+.++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                            001112223478999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.3e-40  Score=321.33  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=208.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEe
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS-------ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYY  223 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~  223 (444)
                      ....+|++.+.||+|+||.||+|++.       .++..||+|.+..    .......+.+.+|+.+++.+ +|+||++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc----ccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence            34568999999999999999999752       2345789997752    12234457788999999999 899999999


Q ss_pred             eeEEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 013354          224 GSETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGAN  287 (444)
Q Consensus       224 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  287 (444)
                      +++......+++|||+.+++|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997642                36778899999999999999999999999999999


Q ss_pred             eEECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 013354          288 ILVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGV  363 (444)
Q Consensus       288 Ill~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  363 (444)
                      |+++.++.+||+|||+++.+......   ....++..|+|||++.+.. ++.++||||||+++|||++ |..||......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999876432211   1223567899999987655 8899999999999999998 88899776555


Q ss_pred             hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .....+..... ...+..++.++++||.+||+.+|++||++.++++.
T Consensus       247 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            54444443332 34567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.3e-40  Score=313.83  Aligned_cols=246  Identities=25%  Similarity=0.451  Sum_probs=203.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|.+.+.||+|+||.||+|.+..+ ..+|+|.+...      ....+.+.+|+.+++.++|+||+++++++. .+..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG------TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC------CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            35699999999999999999987654 46899977521      112356788999999999999999999875 45688


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||+.+++|.+++....  .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999997643  37899999999999999999999999999999999999999999999999997654322


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....++..|+|||.+.+.. ++.++||||||+++|||++ |..||...........+.... ....+..++.++++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMPCPQGCPESLHE  234 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHHHHH
Confidence            11  1233567899999987655 8999999999999999999 999998766555555544332 23456678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      |+++||.+||++||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-40  Score=327.10  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=208.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD---  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---  229 (444)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...   .......+.+.+|+.++++++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            457899999999999999999999999999999988632   12223345678899999999999999999987543   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          230 ---DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       230 ---~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                         ...+++++++ +++|.++++. ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence               3478888887 7899988875 4699999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------  372 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------  372 (444)
                      ....  .....++..|+|||.+.+...++.++|||||||++|||++|+.||...+.......+...              
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            5332  233457889999999876555788999999999999999999999764433222211000              


Q ss_pred             ----------CCC-----CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ----------KEL-----PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ----------~~~-----~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                ...     .......+.++++||.+||++||++||++.++++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                      000     01112468899999999999999999999999999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.6e-40  Score=314.82  Aligned_cols=246  Identities=26%  Similarity=0.466  Sum_probs=204.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+.....      ..+.+.+|+.++++++|+||+++++++. +...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            457999999999999999999776 467799998763211      1246889999999999999999999875 45689


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||+.+++|.+++.+.  ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999999763  358999999999999999999999999999999999999999999999999997654332


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....++..|+|||++.... ++.++||||||+++|||++ |..||...+..+....+..... ...+...+.++.+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MPCPQDCPISLHE  234 (260)
T ss_pred             cccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHHH
Confidence            11  1223456799999986655 8899999999999999999 9999987666555555544333 3456778999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      |+.+||.+||++|||+.++++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=339.03  Aligned_cols=262  Identities=28%  Similarity=0.440  Sum_probs=240.2

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ....++++....||-|+||.|=++........+|+|++++  ....+....+.+..|-.+|..++.+.||++|-.|.++.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK--~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKK--KHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhH--hhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            3445567778889999999999998776555689998874  23344555678889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|++||-|-||.|+..+++++.|.+..++.++..+++|++|||++|||+|||||+|++++.+|.+||.|||+|+.+...
T Consensus       494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ....+++||+.|.|||++.+.. .+.++|.||||+++||||+|.+||...+....+..|.++...-.+|..++....+||
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI  652 (732)
T ss_pred             CceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence            9999999999999999998766 899999999999999999999999999988888888888888889999999999999


Q ss_pred             HHHhhhCCCCCcC-----HHHHHhCCCCCC
Q 013354          391 RKCLQRNPLHRPT-----AAWLLEHPFVGN  415 (444)
Q Consensus       391 ~~~L~~dP~~Rpt-----~~elL~hp~~~~  415 (444)
                      ++++..+|.+|.-     +.+|-+|-||.+
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            9999999999986     679999999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-40  Score=326.12  Aligned_cols=249  Identities=30%  Similarity=0.476  Sum_probs=198.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHHH
Q 013354          167 TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYK  246 (444)
Q Consensus       167 ~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~  246 (444)
                      +++.||.++...+++.||+|++...   .......+.+.+|+.+++.++|+||+++++++..++..+++|||+.+++|.+
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            4455666666778999999998742   1234456789999999999999999999999999999999999999999999


Q ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC--------cccc
Q 013354          247 ILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--------PLSI  316 (444)
Q Consensus       247 ~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--------~~~~  316 (444)
                      ++.+.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||.+..+.....        ....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            99864  3589999999999999999999999999999999999999999999999998875532211        1223


Q ss_pred             cCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH-HhcCC-------CCC------------
Q 013354          317 KGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNS-------KEL------------  375 (444)
Q Consensus       317 ~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~-------~~~------------  375 (444)
                      .++..|+|||++... ..++.++|||||||++|||++|..||.......... ++...       ...            
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            467789999998653 347889999999999999999999997654332221 11000       000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          376 ------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       376 ------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                                  ......++.++.+||.+||+.||++|||++++|+||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence                        0111233578899999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-40  Score=329.31  Aligned_cols=256  Identities=28%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|...+.||+|+||.||+|++..+++.||+|++....   ........+.+|+.+++.++|+||+++++++...    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            357999999999999999999999999999999886321   1222345678899999999999999999987654    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ..+++|+||+. .+|..++.  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence              34699999995 57777653  36899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------  372 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------  372 (444)
                      ...  .....++..|+|||++.+...++.++|||||||++|||++|+.||...+....+..+...               
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 DAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            332  223457889999999876545789999999999999999999999765433322211110               


Q ss_pred             --------------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 --------------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 --------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                    .........++.++.+||.+||+.||++||++.+++.||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                          000011134678899999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-40  Score=314.26  Aligned_cols=247  Identities=30%  Similarity=0.512  Sum_probs=205.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+....      .....+.+|+.++++++|+||+++++++. ++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS------MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC------CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence            3467999999999999999999865 47889999876311      12356788999999999999999999864 4568


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++|||+.+++|.+++...  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999999998753  35889999999999999999999999999999999999999999999999999766532


Q ss_pred             CC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ..  .....++..|+|||++.... ++.++||||||+++|||++ |+.||...........+..... ...+..++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-MPRPDNCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCHHHH
Confidence            21  11233567899999987655 7899999999999999998 9999987665555555444333 345677899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +||.+||+.+|++||+++++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         234 ELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=319.79  Aligned_cols=253  Identities=36%  Similarity=0.571  Sum_probs=208.8

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |+..+.||+|+||.||+|++..+++.||+|++....   ......+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            567789999999999999999999999999987432   12333456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-cc
Q 013354          237 EYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-PL  314 (444)
Q Consensus       237 e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~~  314 (444)
                      ||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++|+||||+|+||+++.++.++|+|||++........ ..
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            9996 5999999876 5799999999999999999999999999999999999999999999999999886644332 22


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-------------------CCCC
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-------------------SKEL  375 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------------~~~~  375 (444)
                      ...++..|+|||++.+...++.++|||||||++|||++|+.||........+.++..                   ....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            234577899999987664588999999999999999999999976554333222110                   0000


Q ss_pred             C--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          376 P--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       376 ~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      +        .....++.++.++|++||..||++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0        1112347899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-40  Score=312.66  Aligned_cols=248  Identities=28%  Similarity=0.482  Sum_probs=208.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.+.. ++.+|+|.+....      ...+.+.+|+.++++++|+||+++++++..+...
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc------cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            45689999999999999999998764 5789999876311      1235688899999999999999999999988899


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++||||+.+++|.+++....  .+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..+...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999999997643  5899999999999999999999999999999999999999999999999998766432


Q ss_pred             CC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ..  ......+..|+|||.+.+.. ++.++||||||+++|||++ |+.||........+..+..... ...+..++.++.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-MPRPPNCPEELY  234 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHH
Confidence            11  11222456799999987655 8899999999999999998 9999987665555555544332 244566799999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +++.+||+.+|++||+++++++
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.9e-40  Score=312.14  Aligned_cols=243  Identities=28%  Similarity=0.455  Sum_probs=203.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE-cCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET-LDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~  232 (444)
                      ..+|++.+.||+|+||.||++...  +..+|+|.++..       ...+.+.+|+.++++++|+|++++++++. .++..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            357999999999999999999764  788999987521       12356889999999999999999999754 45678


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++|||+.+++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999998654  3789999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .  ....++..|+|||++.... ++.++|||||||++|||++ |+.||...........+... ..+..+..++.++.+|
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  231 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDV  231 (256)
T ss_pred             C--CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHH
Confidence            2  2233566899999987655 8899999999999999997 99999765544444444333 2345667889999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHh
Q 013354          390 VRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~  409 (444)
                      |.+||+.+|++|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-39  Score=309.31  Aligned_cols=242  Identities=26%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      ++||+|+||.||+|... ++..+|+|.+...    ........+.+|+.+++.++|+||+++++++...+..++||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            46899999999999865 5889999987531    223444578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc--ccc
Q 013354          241 GGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIK  317 (444)
Q Consensus       241 ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~--~~~  317 (444)
                      +++|.+++... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++..........  ...
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99999998764 357899999999999999999999999999999999999999999999999987543322111  122


Q ss_pred             CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013354          318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR  396 (444)
Q Consensus       318 gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~  396 (444)
                      ++..|+|||++.... ++.++||||||+++|||++ |..||...........+..... ...+..++.++.+|+.+||..
T Consensus       156 ~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         156 IPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-MSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             CcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHccc
Confidence            456799999987655 8899999999999999998 9999987655554444443332 345667899999999999999


Q ss_pred             CCCCCcCHHHHHh
Q 013354          397 NPLHRPTAAWLLE  409 (444)
Q Consensus       397 dP~~Rpt~~elL~  409 (444)
                      +|++||++.++++
T Consensus       234 ~p~~Rp~~~~l~~  246 (250)
T cd05085         234 KPENRPKFSELQK  246 (250)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.2e-40  Score=315.75  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      .+++|++.++||+|+||.||+|.+..    ++..|++|.+..    .......+.+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            45789999999999999999999876    358889997752    2344556778899999999999999999998765


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEE
Q 013354          229 -DDKLYIYLEYVSGGSIYKILQDY--------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       229 -~~~~~lv~e~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                       ....++++||+.+++|.+++...        ..+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             46789999999999999999763        348899999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCC
Q 013354          300 DFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKEL  375 (444)
Q Consensus       300 DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  375 (444)
                      |||+++.+......   ....++..|+|||++.+.. ++.++|||||||++||+++ |+.||...........+......
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence            99999865433211   1233567899999987655 8999999999999999999 99999776544444444333332


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                       ..+..+++++.+++.+||..||++|||+.++++
T Consensus       239 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 -AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             345668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-40  Score=320.01  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCC--------------CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCee
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSES--------------GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV  220 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~--------------g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv  220 (444)
                      .+|++.+.||+|+||.||++.+..+              ...||+|.++..    ........+.+|++++++++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            5799999999999999999987543              235899987631    2234456788999999999999999


Q ss_pred             eEeeeEEcCCEEEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       221 ~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ++++++..++..++||||+.+++|.+++....            .+++..++.++.||+.||+|||+++++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999996532            367888999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc--CCCCCCCCCCh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGV  363 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt--G~~Pf~~~~~~  363 (444)
                      +++.++.+||+|||++.........   ....++..|+|||++.+.. ++.++|||||||++|||++  +..||......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999998765332211   1223467899999987666 8999999999999999998  67788765544


Q ss_pred             hhhHHhc------CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          364 PAMFKIG------NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       364 ~~~~~~~------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .......      ........+..++..+.+|+.+||+.||++||++.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3332221      111122345568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.6e-40  Score=314.96  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=208.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ++|+..+.||+|+||.||+|+.+.     +.+.+++|.+..    .......+.+.+|++++++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC----ccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            579999999999999999999754     346788887642    22333567788999999999999999999999998


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEe
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG---------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                      +..++||||+.+++|.+++....         .+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999998765         689999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCC--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCC
Q 013354          301 FGMAKHITGQS--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPA  377 (444)
Q Consensus       301 FGla~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  377 (444)
                      ||++.......  ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            99987543221  112234567899999987665 7889999999999999998 8899976555444444443332223


Q ss_pred             CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       378 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+..++..+.++|.+||+.||++||++.|++..
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-40  Score=317.64  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=207.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ..+|+..+.||+|+||.||+|.+.     .++..||+|.+...    ......+.+.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            357999999999999999999874     36789999987631    223445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG----------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGA  286 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  286 (444)
                      +...++||||+.+++|.+++....                      .+++..++.++.||+.||.|||+++++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            999999999999999999997532                      3678889999999999999999999999999999


Q ss_pred             ceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 013354          287 NILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEG  362 (444)
Q Consensus       287 NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~  362 (444)
                      ||+++.++.++|+|||++..+.....   ......+..|+|||.+.+.. ++.++|||||||++|||++ |..||.....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999875533221   11222456799999987665 8999999999999999997 8889976665


Q ss_pred             hhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+....+...... ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            5555555444433 456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=314.81  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGE----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..+|++.+.||+|+||.||+|.++.+++    .+|+|.+...    ........+.+|+.+++.++|+||+++++++.. 
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            4579999999999999999999877665    5888876532    224456778899999999999999999999887 


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      ...++||||+.+++|.+++.+. ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7799999999999999999874 458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccc---ccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          309 GQSCPLS---IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       309 ~~~~~~~---~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      .......   ..++..|+|||.+.... ++.++|+||||+++||+++ |+.||...........+..... ...+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  238 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQPPICTI  238 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCCCCCCH
Confidence            4332211   22356799999986555 8899999999999999998 9999987655444444444333 345667889


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++.+++.+||..||++||++.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-39  Score=310.46  Aligned_cols=248  Identities=25%  Similarity=0.451  Sum_probs=206.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||++.+.. +..+|+|.+....   .   ....+.+|++++++++|+||+++++++......+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~---~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA---M---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC---C---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            3579999999999999999998764 7789999875311   1   1245778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.+++... ..+++..++.++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999999999999764 4589999999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 P--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 ~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .  ....++..|+|||++.+.. ++.++||||||+++|||++ |..||...........+..... ...+...+.++.+|
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  233 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-LYKPRLASQSVYEL  233 (256)
T ss_pred             cccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-CCCCCCCCHHHHHH
Confidence            1  1222456899999987655 8899999999999999998 9999977655444544443322 23455679999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||+.+|++||++.+++++
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.7e-40  Score=317.83  Aligned_cols=259  Identities=32%  Similarity=0.532  Sum_probs=211.8

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      +|++.+.||+|+||.||++++.   .+++.||+|+++.... .......+.+.+|+.++.++ +|+||+++++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4888999999999999999864   4678999998863211 12233446788899999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      .++||||+.+++|.+++.....+++..++.++.|++.+|.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            99999999999999999877789999999999999999999999999999999999999999999999999987654332


Q ss_pred             C--cccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhh-HHhcCCCCCCCCCCCCCH
Q 013354          312 C--PLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM-FKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       312 ~--~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~-~~~~~~~~~~~~~~~~s~  384 (444)
                      .  .....++..|+|||.+.+.. ..+.++||||||+++|||++|..||......   ..+ ..+.  ...+..+..++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCcccCH
Confidence            2  22345888999999986543 3678999999999999999999999643221   111 1111  122356677899


Q ss_pred             HHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNAA  417 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~~  417 (444)
                      ++++||.+||+.||++|||   +.++|+||||++..
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            9999999999999999998   56789999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.8e-40  Score=324.35  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=207.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-------CcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-------GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGS  225 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-------g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  225 (444)
                      ..+|++++.||+|+||.||+|.+...       +..||+|.++.    .......+.+.+|+.+++++ +|+||++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD----DATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc----ccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            45799999999999999999986432       23689997752    12334567888999999999 79999999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceE
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL  289 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  289 (444)
                      +..++.++++|||+.+++|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            999999999999999999999997632                3677888999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhh
Q 013354          290 VDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPA  365 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  365 (444)
                      ++.++.+||+|||+++.......   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||........
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999876543221   11222456799999997655 8899999999999999998 8999977655454


Q ss_pred             hHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       366 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...+... .....+..++.++.+||.+||+.+|++||++.+++++
T Consensus       246 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4444333 2335567789999999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-40  Score=315.58  Aligned_cols=238  Identities=24%  Similarity=0.336  Sum_probs=192.4

Q ss_pred             eecccCceEEEEEEEcCC------------------------CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC
Q 013354          162 LLGRGTFGHVYLGFNSES------------------------GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP  217 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~------------------------g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp  217 (444)
                      .||+|+||.||+|....+                        ...|++|++..     ........+.+|+.+++.++|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            699999999999975322                        23577887642     2234456788899999999999


Q ss_pred             CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC--
Q 013354          218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG--  294 (444)
Q Consensus       218 nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--  294 (444)
                      ||+++++++..+...++||||+.+++|..++.+ .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999999975 45689999999999999999999999999999999999997543  


Q ss_pred             -----cEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHH-cCCCCCCCCCChhhhHH
Q 013354          295 -----RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMA-TTKPPWSQYEGVPAMFK  368 (444)
Q Consensus       295 -----~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~  368 (444)
                           .++|+|||++.......   ...++..|+|||++.+...++.++|||||||++|||+ +|..||...........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCcccccccccc---ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 38999999876543221   2346788999999876555899999999999999985 69999976554433222


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       369 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ....   ..++...+.++.+||.+||+.+|++|||+.++|++
T Consensus       234 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2221   13344567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-39  Score=323.08  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=209.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-CCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-DDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~  231 (444)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|++....   ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            4568999999999999999999999999999999875321   122334667789999999999999999998865 567


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      .++++||+ +++|.++++. ..+++..+..++.||+.||+|||+++|+|+||+|.||+++.++.++|+|||++...... 
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            89999998 6789988875 46889999999999999999999999999999999999999999999999998765332 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHH-----------------------
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-----------------------  368 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-----------------------  368 (444)
                       .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......                       
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence             22345788999999986645589999999999999999999999976543211100                       


Q ss_pred             ----hcCCCCC--CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          369 ----IGNSKEL--PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       369 ----~~~~~~~--~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                          .......  ......++.+++++|.+||+.+|++|||+++++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                0000000  01123578999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-39  Score=317.97  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=202.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcC----------------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSE----------------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP  217 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp  217 (444)
                      ..+|++.+.||+|+||.||++.+..                ++..+|+|++...    ......+.+.+|+.+++.++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence            3579999999999999999986432                3457899987631    2344556888999999999999


Q ss_pred             CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 013354          218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-----------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGA  286 (444)
Q Consensus       218 nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  286 (444)
                      ||+++++++..++..++||||+.+++|.+++.+..           .+++..++.++.||+.||+|||++||+|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~  159 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR  159 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence            99999999999999999999999999999997642           3667789999999999999999999999999999


Q ss_pred             ceEECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc--CCCCCCCCC
Q 013354          287 NILVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYE  361 (444)
Q Consensus       287 NIll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt--G~~Pf~~~~  361 (444)
                      |||++.++.++|+|||++..+......   ....++..|+|||+..... ++.++|||||||++|||++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999998865433211   1122457899999886665 8999999999999999998  778997655


Q ss_pred             ChhhhHHhc------CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          362 GVPAMFKIG------NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       362 ~~~~~~~~~------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .........      ........+..++..+.+||.+||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            443332211      111112335668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-40  Score=315.74  Aligned_cols=239  Identities=23%  Similarity=0.384  Sum_probs=196.1

Q ss_pred             eeecccCceEEEEEEEcCCCcE-------EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESGEM-------CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~-------vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      +.||+|+||.||+|.++.++..       +++|.+..     ......+.+.+|+.+++.++|+||+++++++..+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            3689999999999998665443       77776542     23344567888999999999999999999999988999


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc--------EEEEecccc
Q 013354          234 IYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--------VKLADFGMA  304 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--------vkL~DFGla  304 (444)
                      +||||+.+++|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+||+++.++.        ++++|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999999998654 5899999999999999999999999999999999999977654        699999988


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ......   ....++..|+|||++.+...++.++|||||||++|||++| ..||...+..........   ...++...+
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQLPAPKW  229 (258)
T ss_pred             cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---cccCCCCCc
Confidence            765432   2245788999999997755578999999999999999998 566665444333222222   224566678


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++|||++++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         230 TELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-39  Score=311.98  Aligned_cols=250  Identities=28%  Similarity=0.431  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..+|.+.+.||+|+||.||+|.+...   ...|+||.....    ......+.+.+|+.+++.++|+||+++++++.. +
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            45689999999999999999987543   346888977531    224455688899999999999999999998875 4


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++.+.. .+++..++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            5789999999999999998754 589999999999999999999999999999999999999999999999999886644


Q ss_pred             CCCcc--cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSCPL--SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~~~--~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      .....  ...++..|+|||.+.... ++.++||||||+++|||++ |..||......+....+...... ..+..++.++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTL  237 (270)
T ss_pred             ccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHH
Confidence            32211  122446799999986554 8899999999999999986 99999877666655555554443 4567889999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+||.+||..+|++|||+.++++.
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=307.72  Aligned_cols=242  Identities=26%  Similarity=0.441  Sum_probs=202.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +.||+|+||.||++.+.. ++.|++|.+...    ......+.+.+|+.++++++|+||+++++++......++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRST----LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            468999999999999887 999999987642    122455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc---ccc
Q 013354          241 GGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---LSI  316 (444)
Q Consensus       241 ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~---~~~  316 (444)
                      +++|.+++.+. ..+++..+..++.|++.+|.|||+++++||||||+||+++.++.++|+|||++.........   ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99999999763 45889999999999999999999999999999999999999999999999998765422111   112


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      ..+..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.++.+||.+||.
T Consensus       156 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         156 QIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MPAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             cceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHhc
Confidence            2356799999987665 8999999999999999999 8999977654444444433322 24567789999999999999


Q ss_pred             hCCCCCcCHHHHHh
Q 013354          396 RNPLHRPTAAWLLE  409 (444)
Q Consensus       396 ~dP~~Rpt~~elL~  409 (444)
                      .+|++|||+.|+++
T Consensus       234 ~~p~~Rp~~~ell~  247 (251)
T cd05041         234 YDPENRPSFSEIYN  247 (251)
T ss_pred             cChhhCcCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=324.42  Aligned_cols=252  Identities=29%  Similarity=0.397  Sum_probs=210.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+.+...+++.||+|-||.|.++.-.. +..||+|.++.    ...+.....|.+|+++|.+|+||||++++|+|..++.
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~----~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRP----DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCc----ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            455678889999999999999997543 68999998873    2344456899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +++++||++.|+|.+++.+..  .+......+++.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+-.
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999999998863  234566778999999999999999999999999999999999999999999986544


Q ss_pred             CCCcc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc--CCCCCCCCCChhhhHHh------cCCCCCCCC
Q 013354          310 QSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPAMFKI------GNSKELPAI  378 (444)
Q Consensus       310 ~~~~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~~------~~~~~~~~~  378 (444)
                      ...+.   ..+-..+|||+|.+..++ ++.++|||+||++|||+++  ...||.+..........      ...+.....
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            33221   123457899999998888 8999999999999999887  78899876654433221      112233456


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      |.-|+.++.+||.+||..|-++||+++++..
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            7889999999999999999999999999865

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-39  Score=313.36  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=199.9

Q ss_pred             CCeeeeeeecccCceEEEEEEE----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFN----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  228 (444)
                      .+|++.+.||+|+||.||++..    ..+++.||+|.+..     ......+.+.+|+.+++.++|+||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-----STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            3689999999999999999974    45788999998753     234445778899999999999999999997653  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ...+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            35689999999999999999764 45899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcc----cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---------------hhHH
Q 013354          308 TGQSCPL----SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---------------AMFK  368 (444)
Q Consensus       308 ~~~~~~~----~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---------------~~~~  368 (444)
                      .......    ...++..|+|||++.+.. ++.++|||||||++|||++|..++.......               .+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            4433211    112345699999987665 8899999999999999999877654321110               0111


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       369 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..........+..++.++.+||.+||..+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11112222345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=335.90  Aligned_cols=245  Identities=26%  Similarity=0.395  Sum_probs=208.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ....|.+...+|.|+|+.|..+.++.+++.+++|++....         .+..+|+.++... +|+||+++++++.+...
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc---------cccccccchhhhhcCCCcceeecceecCCce
Confidence            3567888888999999999999999999999999986431         1223466444444 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE-CCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV-DPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-~~~~~vkL~DFGla~~~~~~  310 (444)
                      .|+|||++.|+-|.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++....+
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999999999999888755555 7888899999999999999999999999999999 58899999999999887655


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        ....+-|..|.|||++. ...|+.++|+||||++||+||+|+.||...... +.+.++..    +.+...+|+++++|
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----PKFSECVSDEAKDL  542 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----CccccccCHHHHHH
Confidence              33445788999999997 555999999999999999999999999876655 34444433    34458899999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      |.+||+.||++|+++.+++.||||-
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             HHHhccCChhhCcChhhhccCcchh
Confidence            9999999999999999999999993

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-39  Score=349.93  Aligned_cols=150  Identities=32%  Similarity=0.565  Sum_probs=137.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||+||+|.+..+++.||||+++..  ..........+.+|+.++..++|+||+++++++.....+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehh--hccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            35799999999999999999999999999999998642  2233445678889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      +||||+.+++|.+++...+.+++..++.++.||+.||+|||.++||||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-39  Score=311.55  Aligned_cols=254  Identities=28%  Similarity=0.497  Sum_probs=210.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-CCcEEEEEEEeecccc-----cccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEc
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDD-----AKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETL  228 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~-----~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~  228 (444)
                      .|++.+.||+|+||.||+|++.. +++.+|+|.+......     .........+.+|+.++.. ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999999987 6889999988643211     1234455677789988865 799999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      ++..+++|||+.+++|.+++..    ...+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998843    2458999999999999999999996 6899999999999999999999999999


Q ss_pred             cccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      +.............++..|+|||++.+.. ++.++||||||+++|||++|+.||...........+......+.....++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS  239 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence            98765554444556889999999997665 89999999999999999999999976554444444444333333334678


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++||++.|+..+
T Consensus       240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         240 EDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-39  Score=308.92  Aligned_cols=247  Identities=25%  Similarity=0.469  Sum_probs=205.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||++.+.. +..+|+|.+..      .....+.+.+|+.+++.++|+||+++++.+.. ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKP------GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCC------ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            35689999999999999999998654 56799998752      22334678889999999999999999999877 778


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++|||+.+++|.+++.+.  ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999999763  34788899999999999999999999999999999999999999999999998765432


Q ss_pred             CC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ..  .....++..|+|||++.... ++.++|+|||||++|++++ |+.||...+.......+...... ..+...+.++.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-PRPENCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-CCcccCCHHHH
Confidence            21  11223556799999987655 8889999999999999998 99999876655555544443332 44567899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +++.+||+.||++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-39  Score=316.01  Aligned_cols=249  Identities=31%  Similarity=0.466  Sum_probs=201.3

Q ss_pred             CeeeeeeecccCceEEEEEEE----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--
Q 013354          156 RWKKGRLLGRGTFGHVYLGFN----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--  229 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  229 (444)
                      -|++.+.||+|+||.||++++    +.+++.||+|.++..    ........+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            478899999999999999974    457889999987532    2234456789999999999999999999988775  


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      ...++||||+++++|.+++.+.. .+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..+.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            56899999999999999997643 58999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--------------hh-hhHHh
Q 013354          309 GQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--------------VP-AMFKI  369 (444)
Q Consensus       309 ~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--------------~~-~~~~~  369 (444)
                      .....    ....++..|+|||++.+.. ++.++|||||||++|||++++.|+.....              .. ....+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            43221    2234667899999987655 88999999999999999998765432110              00 11111


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..... ...+..++.++.+||.+||+.||++||++++++++
T Consensus       240 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            12222 23456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-39  Score=311.48  Aligned_cols=239  Identities=22%  Similarity=0.336  Sum_probs=192.0

Q ss_pred             eeecccCceEEEEEEEcCC------------CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          161 RLLGRGTFGHVYLGFNSES------------GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~------------g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      +.||+|+||.||+|+....            ...+++|++..     ........+.+|+.+++.++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3689999999999985422            23577786542     233445678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc-------EEEEe
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-------VKLAD  300 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-------vkL~D  300 (444)
                      +...++||||+.+++|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            88999999999999999998764 46899999999999999999999999999999999999986654       89999


Q ss_pred             ccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHH-cCCCCCCCCCChhhhHHhcCCCCCCCCC
Q 013354          301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMA-TTKPPWSQYEGVPAMFKIGNSKELPAIP  379 (444)
Q Consensus       301 FGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~  379 (444)
                      ||++......   ....++..|+|||++.+...++.++|||||||++|||+ .|..||......+... ......  ...
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--~~~  229 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--MLV  229 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--cCC
Confidence            9998765332   22347888999999875555899999999999999998 5888887644322222 111111  223


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...+.++.+||.+||+.||++||++.+|+++
T Consensus       230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            3456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-39  Score=311.37  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=193.3

Q ss_pred             eeecccCceEEEEEEEcC--CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      +.||+|+||.||+|....  ....+++|.+..    .........+.+|+.+++.++|+||+++++.+......++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA----SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCc----cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            358999999999996533  345677776542    12344456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          239 VSGGSIYKILQDYG-----QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       239 ~~ggsL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +.+++|.+++....     ..++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999999997643     246778899999999999999999999999999999999999999999999865433221 


Q ss_pred             --cccccCCCcccCcccccC------cCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC----CCCCCC
Q 013354          313 --PLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK----ELPAIP  379 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~------~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~----~~~~~~  379 (444)
                        .....++..|+|||++..      ...++.++|||||||++|||++ |..||........+.......    ..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              122235677999998743      2236789999999999999999 889997765544443332222    123445


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..++.++.+++..|| .||++|||+++|++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            678899999999999 59999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-39  Score=308.21  Aligned_cols=244  Identities=26%  Similarity=0.449  Sum_probs=196.8

Q ss_pred             eeecccCceEEEEEEEcC---CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE-cCCEEEEEE
Q 013354          161 RLLGRGTFGHVYLGFNSE---SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET-LDDKLYIYL  236 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lv~  236 (444)
                      ++||+|+||.||+|.+..   +...+|+|.+..    .......+.+.+|+.+++.++|+||+++++++. .++..+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCc----cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            468999999999998753   345799997642    123344567889999999999999999999765 456689999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC---
Q 013354          237 EYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC---  312 (444)
Q Consensus       237 e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~---  312 (444)
                      ||+.+++|.+++.+. ...++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.+.....   
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999999764 3467788899999999999999999999999999999999999999999999876533211   


Q ss_pred             --cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        .....++..|+|||.+.... ++.++|||||||++|||++ |.+||...+.......+..... +..+..++..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  234 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEYCPDPLYEV  234 (262)
T ss_pred             cccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHH
Confidence              11233567899999987655 8999999999999999999 5677766554444444433332 34456789999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||+.+|++||++.++++.
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-39  Score=310.15  Aligned_cols=244  Identities=22%  Similarity=0.352  Sum_probs=192.9

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          161 RLLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      +.||+|+||.||+|...  .++..+|+|.++..    ........+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS----ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            36899999999999864  34567899977532    1223345788899999999999999999999988899999999


Q ss_pred             cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          239 VSGGSIYKILQDYG-----QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       239 ~~ggsL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +.+++|.+++....     ..++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999999997532     356778889999999999999999999999999999999999999999999875433221 


Q ss_pred             --cccccCCCcccCcccccCcC------CCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC----CCCCCC
Q 013354          313 --PLSIKGSPYWMAPEVIKNSN------GCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK----ELPAIP  379 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~------~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~----~~~~~~  379 (444)
                        .....++..|+|||++.+..      .++.++||||||+++|||++ |+.||................    ..+.+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              11234678899999985421      25789999999999999996 999997755444332221111    112333


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ...++.+.++|..|| .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            457889999999999 68999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-39  Score=307.98  Aligned_cols=236  Identities=26%  Similarity=0.404  Sum_probs=192.9

Q ss_pred             eeecccCceEEEEEEEcCCC----------cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          161 RLLGRGTFGHVYLGFNSESG----------EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g----------~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      +.||+|+||.||+|.+..++          ..+++|.+..     . ......+.+|+.+++.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-----D-HRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeecccc-----c-hhhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46899999999999998766          3477776542     1 1115778899999999999999999999887 7


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-------cEEEEecc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-------RVKLADFG  302 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------~vkL~DFG  302 (444)
                      ..++||||+.+++|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            7899999999999999998765 689999999999999999999999999999999999998887       79999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCC
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD  380 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  380 (444)
                      ++......   ....++..|+|||++... ..++.++|||||||++|||++ |..||................   ..+.
T Consensus       154 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~---~~~~  227 (259)
T cd05037         154 IPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---RLPM  227 (259)
T ss_pred             cccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC---CCCC
Confidence            99876442   223366789999998765 348899999999999999999 688887654333322222222   2222


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....++.+||.+||..+|.+|||+.++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            23489999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.4e-41  Score=310.34  Aligned_cols=261  Identities=30%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCC----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESG----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-  228 (444)
                      ...|+..+.||+|+||.||+|..+++.    +.+|||.++-.++   .........+|+.+++.++|+|++.+..++.. 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---GTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            457999999999999999999776553    3789998864332   22234566789999999999999999999877 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC----CcEEEE
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS----GRVKLA  299 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~vkL~  299 (444)
                      +..+++++||.+ -+|..+|+-.     ..++...++.|+.||+.|+.|||++=|+||||||.||||..+    |.|||+
T Consensus       100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            889999999996 5888888632     358999999999999999999999999999999999999776    899999


Q ss_pred             eccccccccCCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---------hhh
Q 013354          300 DFGMAKHITGQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---------PAM  366 (444)
Q Consensus       300 DFGla~~~~~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------~~~  366 (444)
                      |||+++.+.+.-..    ..++-|..|+|||++.+...|+.+.|||++|||+.||++-.+.|...+..         .++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999987554322    34557899999999999999999999999999999999999888653311         112


Q ss_pred             HHhcC------CCCC------CCCC-----------------------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCC
Q 013354          367 FKIGN------SKEL------PAIP-----------------------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP  411 (444)
Q Consensus       367 ~~~~~------~~~~------~~~~-----------------------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp  411 (444)
                      .+|-.      .+.+      |+..                       ..-++...+|+.+||+.||.+|.|+++.|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            22111      1111      1110                       11245588999999999999999999999999


Q ss_pred             CCCCCCC
Q 013354          412 FVGNAAP  418 (444)
Q Consensus       412 ~~~~~~~  418 (444)
                      ||.....
T Consensus       339 yF~~d~l  345 (438)
T KOG0666|consen  339 YFTEDPL  345 (438)
T ss_pred             ccccCCC
Confidence            9987533

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=326.76  Aligned_cols=245  Identities=28%  Similarity=0.469  Sum_probs=211.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCC--C--cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSES--G--EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~--g--~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .....++||.|.||.||+|.+..-  |  -.||||+.+..    ...+..+.|.+|..+|+.++||||++++|+|.+. .
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            345566799999999999988543  2  35788877632    2334468899999999999999999999999865 4


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+||||++.-|.|..+|+.+. .++......++.||..||.|||+..+|||||...||||.....|||+|||+++.+..+
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            899999999999999998754 5899999999999999999999999999999999999999989999999999998776


Q ss_pred             CCcccccC--CCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SCPLSIKG--SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~~~~~~g--t~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .-+....|  ...|||||-+.-.. ++.++|||.|||+|||++. |..||......+.+-.++++.++ ..|+.|++.+.
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-P~P~nCPp~LY  622 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-PCPPNCPPALY  622 (974)
T ss_pred             chhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-CCCCCCChHHH
Confidence            54443333  45799999995544 9999999999999999988 99999998888888899998887 47999999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHH
Q 013354          388 DFVRKCLQRNPLHRPTAAWL  407 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~el  407 (444)
                      .|+.+||.+||.+||.+.+|
T Consensus       623 slmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             HHHHHHhccCcccCCcHHHH
Confidence            99999999999999998753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-39  Score=306.27  Aligned_cols=229  Identities=24%  Similarity=0.368  Sum_probs=191.8

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHH
Q 013354          166 GTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIY  245 (444)
Q Consensus       166 G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~  245 (444)
                      |.||.||+++++.+++.||+|.+....          .+.+|...+....||||+++++++...+..++||||+.+++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999886421          1223444555667999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCc
Q 013354          246 KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP  325 (444)
Q Consensus       246 ~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~AP  325 (444)
                      +++.+...+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||.+.......  ....++..|+||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aP  151 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAP  151 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCC
Confidence            999887789999999999999999999999999999999999999999999999999876654322  233457789999


Q ss_pred             ccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCH-
Q 013354          326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTA-  404 (444)
Q Consensus       326 E~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~-  404 (444)
                      |++.... ++.++||||+|+++|||++|+.||......     +.. .....++..++.++++||.+||+.||++|+++ 
T Consensus       152 E~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         152 EVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----INT-HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc-ccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            9986554 788999999999999999999887542211     111 11124567889999999999999999999996 


Q ss_pred             ----HHHHhCCCC
Q 013354          405 ----AWLLEHPFV  413 (444)
Q Consensus       405 ----~elL~hp~~  413 (444)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                899999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-39  Score=311.10  Aligned_cols=243  Identities=27%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             eeecccCceEEEEEEEcCCC------cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESG------EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g------~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +.||+|+||.||+|+++...      +.+|+|.+...    ........+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            36899999999999886543      78999987531    222345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-----cEEEEecc
Q 013354          235 YLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-----RVKLADFG  302 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-----~vkL~DFG  302 (444)
                      ||||+.+++|.+++.+.       ..+++..+..++.||+.||+|||+++++|+||||+||+++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999999753       2378899999999999999999999999999999999998877     89999999


Q ss_pred             ccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          303 MAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       303 la~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      ++........   .....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+.... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-ccCC
Confidence            9876533221   11223567899999997766 8999999999999999998 999997655544444443332 2345


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +..++.++.+||.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6778999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.4e-40  Score=348.71  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=203.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------  228 (444)
                      .+|+..++||+||||.||+++++.+|..||||+|.+.    ........+.+|+.++.+|+|||||+++..+.+      
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~----~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK----ASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc----hHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            4688889999999999999999999999999998752    245566789999999999999999998710000      


Q ss_pred             --------------------------------------------------------------------------------
Q 013354          229 --------------------------------------------------------------------------------  228 (444)
Q Consensus       229 --------------------------------------------------------------------------------  228 (444)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CEEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 013354          229 -------------------------D--------DKLYIYLEYVSGGSIYKILQDYGQL-GESAIRSYTQQILSGLEYLH  274 (444)
Q Consensus       229 -------------------------~--------~~~~lv~e~~~ggsL~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH  274 (444)
                                               +        -.+||-||||+..+|.++++++... ....+++++++|++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0        1478999999988888888775433 47889999999999999999


Q ss_pred             HCCcccCCCCCCceEECCCCcEEEEecccccccc-------------------CCCCcccccCCCcccCcccccCcC--C
Q 013354          275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------------------GQSCPLSIKGSPYWMAPEVIKNSN--G  333 (444)
Q Consensus       275 ~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~y~APE~~~~~~--~  333 (444)
                      ++|||||||||.|||++.++.|||+|||+|+...                   +.......+||.-|+|||++.+..  .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998621                   011223466999999999997766  5


Q ss_pred             CChhhhHHHHHHHHHHHHcCCCCCC-CCCChhhhHHhcCCCCCCCC---CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          334 CNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKIGNSKELPAI---PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       334 ~s~~sDvwSlGvil~elltG~~Pf~-~~~~~~~~~~~~~~~~~~~~---~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      |+.|+|||||||+|+||+.-   |. .++....+..+.+... |..   ...--.+-..+|++||+.||.+||||.|+|+
T Consensus       795 Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~i-P~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSI-PEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCC-CCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999963   53 3444455555553322 222   2233345578999999999999999999999


Q ss_pred             CCCCCC
Q 013354          410 HPFVGN  415 (444)
Q Consensus       410 hp~~~~  415 (444)
                      +.||-.
T Consensus       871 s~llpp  876 (1351)
T KOG1035|consen  871 SELLPP  876 (1351)
T ss_pred             ccCCCc
Confidence            999873

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.3e-39  Score=314.38  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=203.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..+|+..+.||+|+||.||+|.+..+++.    +|+|.+..    .........+.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE----TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            35789999999999999999999877764    67776642    12233345688999999999999999999988654


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ..++++||+.+|+|.+++.... .+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4678999999999999997754 58999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          309 GQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       309 ~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      .....   ....++..|+|||++.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  238 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LPQPPICTI  238 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCH
Confidence            33221   1223567899999987655 8999999999999999997 9999976543333333333322 344566889


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+.+++.+||..+|++||++.++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=339.08  Aligned_cols=251  Identities=26%  Similarity=0.432  Sum_probs=224.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .+..++.++||.|.||.|++|+.+..|   ..||||.++.    ...+....+|+.|+.+|-+++||||++|.|+.....
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            356788899999999999999998766   5799999873    455667789999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..+||.|||++|+|+.+|+++ ++|+..++..+++.|+.||+||-++++|||||...||||+.+...|++|||+++.+.+
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999999999875 5799999999999999999999999999999999999999999999999999997755


Q ss_pred             CC-Cccccc---CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QS-CPLSIK---GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~-~~~~~~---gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      +. ..++..   -..+|.|||.+...+ ++.++||||+||+|||.++ |..||-++.+.+.+..++.+.++|. |..|+.
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-PmDCP~  861 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-PMDCPA  861 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC-CCCCcH
Confidence            44 222222   236899999997766 9999999999999999888 9999999999999999999999865 778999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+..||..||++|..+||.+.||+.+
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999998764

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.9e-39  Score=305.37  Aligned_cols=241  Identities=27%  Similarity=0.461  Sum_probs=201.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||++.  .+++.||+|.++..       ...+.+.+|+.+++.++|+||+++++++..+. .++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEE
Confidence            579999999999999999985  46888999987531       12356788999999999999999999887654 799


Q ss_pred             EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          235 YLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ||||+.+++|.+++....  .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997643  4789999999999999999999999999999999999999999999999998764322  


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......+..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+..... ...+..++.++.+|+.
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-MEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-CCCCCcCCHHHHHHHH
Confidence            11223456799999987655 8899999999999999997 9999987665444444444332 3445678999999999


Q ss_pred             HHhhhCCCCCcCHHHHHh
Q 013354          392 KCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~  409 (444)
                      +||+.+|++||++.++++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=311.00  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHH------HHHHHHHHHHHHccCCCCeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKES------AQQLGQEIALLSRLRHPNIVRY  222 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~------~~~~~~Ei~~l~~l~hpnIv~l  222 (444)
                      ..+.+|++.++||+|+||+||+|.+..+   +..+|+|+..........+..      ......+...+..++|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4457899999999999999999998877   667777765432221111110      1122334455677789999999


Q ss_pred             eeeEEcCC----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEE
Q 013354          223 YGSETLDD----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL  298 (444)
Q Consensus       223 ~~~~~~~~----~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL  298 (444)
                      ++.+....    ..++++|++ ..++.+.+......++..++.++.||+.||+|||+++|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765443    447788887 4578888776656789999999999999999999999999999999999999999999


Q ss_pred             EeccccccccCCC--------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh----
Q 013354          299 ADFGMAKHITGQS--------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM----  366 (444)
Q Consensus       299 ~DFGla~~~~~~~--------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----  366 (444)
                      +|||+++.+....        ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.........    
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999998653221        112345999999999987665 899999999999999999999999876432211    


Q ss_pred             -----HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          367 -----FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       367 -----~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                           .++...+   .....++.++.++++.||..+|++||++.++++
T Consensus       247 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                 2222211   123456899999999999999999999999876

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=328.24  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=225.3

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      .+..++.++.++||+|.||.|++|.++..+   -.||||.++...    .......|.+|+.+|.+|+|+|++++||+..
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~----l~~~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS----LNAIMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc----cchhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            344567888899999999999999997643   358899886422    2226689999999999999999999999988


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      + ..+.+|||++..|+|.+.|++.  ..|....+..++.||+.||.||..+++|||||...|+|+.....|||+|||+.+
T Consensus       182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence            7 6689999999999999999872  358889999999999999999999999999999999999988899999999999


Q ss_pred             cccCCCCcccccC----CCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCC
Q 013354          306 HITGQSCPLSIKG----SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD  380 (444)
Q Consensus       306 ~~~~~~~~~~~~g----t~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  380 (444)
                      .+.....++...+    ...|+|||.++..+ ++.++|||+|||+||||++ |..||.+..+...+..+..+.++ .-|.
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL-pRPk  338 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL-PRPK  338 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-CCCC
Confidence            9887776664432    35699999998776 9999999999999999999 99999999999999999876666 4588


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .|+++++++++.||..+|++|||+..|.+.-++..+
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            999999999999999999999999999876665544

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-38  Score=307.45  Aligned_cols=249  Identities=29%  Similarity=0.470  Sum_probs=202.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  228 (444)
                      ..|++.+.||+|+||.||+|++..    +++.+|+|++.....    ....+.+.+|+.+++.++|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc----hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            468888999999999999998653    478999998864221    1456788999999999999999999998877  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ....+++|||+.+++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            557899999999999999998754 5899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcc----cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh--------------hh-HH
Q 013354          308 TGQSCPL----SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--------------AM-FK  368 (444)
Q Consensus       308 ~~~~~~~----~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--------------~~-~~  368 (444)
                      .......    ...++..|+|||.+.+.. ++.++||||||+++|||++|..||.......              .+ ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            5332211    122456699999987665 8899999999999999999999986432111              11 11


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       369 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +..... ...+..++.++.+|+.+||+.+|++|||+.|+++
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         239 LKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122222 2335667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-38  Score=305.05  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=201.5

Q ss_pred             eeeeeeecccCceEEEEEEEcC---CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSE---SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      |++.+.||+|+||.||+|.++.   +++.||||++...   .......+++.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            5678899999999999998653   5789999988632   233445677889999999999999999999876532   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDY------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                         ..++++||+.+++|.+++...      ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               347889999999999887532      14788999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCC
Q 013354          302 GMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPA  377 (444)
Q Consensus       302 Gla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  377 (444)
                      |+++.......   .....+++.|++||.+.... ++.++|||||||++|||++ |+.||...+.......+...... .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-K  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-C
Confidence            99886543221   11223567899999987655 7889999999999999999 89999776554444444433332 3


Q ss_pred             CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       378 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+..++.++.+++.+||+.+|++||++.++++.
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445688999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=323.47  Aligned_cols=244  Identities=26%  Similarity=0.452  Sum_probs=217.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      ......||-|.||.||.|.++.-.-.||||.++      .+....++|+.|+.+|+.++|||+|+++|+|..+..+|||.
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            444567999999999999999989999999886      44556789999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC--
Q 013354          237 EYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--  312 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--  312 (444)
                      |||..|+|.++|++..+  ++...++.++.||..||.||..+++|||||...|+||.++..||++|||+++.+..+.-  
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            99999999999988543  77888899999999999999999999999999999999999999999999999876542  


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      +........|.|||-+.... ++.++|||+|||+|||+.| |-.||.+.+....+.-++++.++ .-|..|++.+.+||+
T Consensus       423 HAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-~~PeGCPpkVYeLMr  500 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-DGPEGCPPKVYELMR  500 (1157)
T ss_pred             ccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-cCCCCCCHHHHHHHH
Confidence            12233456799999997666 8999999999999999999 99999998887888888888877 568999999999999


Q ss_pred             HHhhhCCCCCcCHHHHH
Q 013354          392 KCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL  408 (444)
                      +||+.+|.+||++.|+-
T Consensus       501 aCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  501 ACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHhcCCcccCccHHHHH
Confidence            99999999999998753

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-38  Score=303.29  Aligned_cols=243  Identities=20%  Similarity=0.286  Sum_probs=191.2

Q ss_pred             eecccCceEEEEEEEcCCC--cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEecc
Q 013354          162 LLGRGTFGHVYLGFNSESG--EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g--~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      .||+|+||.||++....++  ..+++|.+...    ......+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5899999999999764332  34556655421    22334578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---C
Q 013354          240 SGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---C  312 (444)
Q Consensus       240 ~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---~  312 (444)
                      .+++|.+++.+.    ..+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++.......   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999999763    236677888999999999999999999999999999999999999999999986432211   1


Q ss_pred             cccccCCCcccCcccccCc------CCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC----CCCCCCCC
Q 013354          313 PLSIKGSPYWMAPEVIKNS------NGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK----ELPAIPDH  381 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~------~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~  381 (444)
                      .....++..|+|||++...      ..++.++|||||||++|||++ +..||...+....+..+....    ..+.++..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2234578899999997532      125678999999999999997 677887655544444332222    12344556


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +++.+.+++..|| .+|++||++++|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            8899999999999 68999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=304.96  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=210.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHH-HHccCCCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-LSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..+-...||.|+||+|++-.++.+|+..|||.++...    .+...++++.|... ++.-++||||++||.+..++..++
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n----~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN----IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc----chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            3455677999999999999999999999999998532    23344566667765 555689999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          235 YLEYVSGGSIYKILQD-----YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      .||++ ..+|+.+.+.     ...++|..+-.+..-.+.||.||.+. +||||||||+|||++..|.+||||||.+..+.
T Consensus       141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99999 5687776643     34699999999999999999999876 89999999999999999999999999998876


Q ss_pred             CCCCcccccCCCcccCcccccCcCC-CChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCC--C---CC
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNG-CNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAI--P---DH  381 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~--~---~~  381 (444)
                      +.-......|...|||||.+..... |+.++||||||++|||+.||+.||...+.. +++.++..+.. |.+  +   -.
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp-p~l~~~~~~~~  298 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP-PILLFDKECVH  298 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC-CeecCcccccc
Confidence            6555555668899999999975544 999999999999999999999999886653 33444433322 222  1   24


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+..++.||..||.+|-..||...+++++||++.-
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            78999999999999999999999999999999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=313.93  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC--C----CeeeEeee
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--P----NIVRYYGS  225 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p----nIv~l~~~  225 (444)
                      ....+|.+.+.+|+|+||.|-++.+..++..||||+++      .-....+..+-|+++|.++.+  |    -+|.+.++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHH------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            34578999999999999999999999999999999886      333344556679999999942  2    37888889


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-----------
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-----------  292 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----------  292 (444)
                      |...+.+|||+|.+ |.++++++.++.  +++...++.++.||+++++|||+.+++|-||||+|||+..           
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            99999999999998 789999998754  5899999999999999999999999999999999999932           


Q ss_pred             ---------CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh
Q 013354          293 ---------SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV  363 (444)
Q Consensus       293 ---------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  363 (444)
                               +..|+|+|||.|++.....  ...+.|..|.|||++.+-. ++.++||||+||||+|+++|...|...+..
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     2358999999998765443  5667899999999998766 999999999999999999999999876655


Q ss_pred             hhh---HHhcC---------C--------CCC--C--------------CC--------CCCCCHHHHHHHHHHhhhCCC
Q 013354          364 PAM---FKIGN---------S--------KEL--P--------------AI--------PDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       364 ~~~---~~~~~---------~--------~~~--~--------------~~--------~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      +.+   +++..         .        ..+  +              ..        .+..-.++.|||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            532   22211         0        000  0              00        011234588999999999999


Q ss_pred             CCcCHHHHHhCCCCCCCC
Q 013354          400 HRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       400 ~Rpt~~elL~hp~~~~~~  417 (444)
                      +|+|+.|+|.||||+...
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=329.87  Aligned_cols=260  Identities=33%  Similarity=0.638  Sum_probs=223.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc--
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL--  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--  228 (444)
                      .+...|++.++||.|.+|.||+++++.+++..|+|+.....+      ..+++..|+++++.+ .|||++.+++++..  
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d------~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED------EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc------ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            344579999999999999999999999999999998864322      224566788888887 69999999998764  


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                         ++.++||||||.||+.-|++++.  .++.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence               57899999999999999999874  4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CCcccccCCCcccCcccccCcC----CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          304 AKHITGQ-SCPLSIKGSPYWMAPEVIKNSN----GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       304 a~~~~~~-~~~~~~~gt~~y~APE~~~~~~----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      +..+... ....+..||+.|||||++....    .|+.++|+||||++..||.-|.+|+.++.....++.|.........
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk  249 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK  249 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence            8876543 3345677999999999986443    3678999999999999999999999998888888887654433222


Q ss_pred             -CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          379 -PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       379 -~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                       |...++++.+||..||.+|.++||+..++|+|||+++..
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence             567799999999999999999999999999999999654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-39  Score=319.52  Aligned_cols=259  Identities=29%  Similarity=0.479  Sum_probs=218.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+-|..++-||-|+||.|-++...+|...||+|.+++  .+...+.....+..|-.||...+++-||+||-.|.+++.+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            3568889999999999999999999999999998874  34455566677888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc------
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------  307 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~------  307 (444)
                      +||+|+.||++-.+|-+.+-|.|+.++.++.++..|+++.|..|+|||||||+|||||.+|+|||.|||+++-+      
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999998622      


Q ss_pred             ---cCCC----------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHH
Q 013354          308 ---TGQS----------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM  350 (444)
Q Consensus       308 ---~~~~----------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~el  350 (444)
                         ...+                                  .....+||+.|+|||++.... |+..+|.||.|||||||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHH
Confidence               1000                                  001245999999999996544 89999999999999999


Q ss_pred             HcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcC---HHHHHhCCCCCCC
Q 013354          351 ATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPT---AAWLLEHPFVGNA  416 (444)
Q Consensus       351 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt---~~elL~hp~~~~~  416 (444)
                      +.|++||......+...++.+....-.++  ..++.|+.++|.+++ -+++.|.-   ++||-.||||+..
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence            99999998766665555555444333333  578999999999876 56677754   5679999999964

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=301.71  Aligned_cols=258  Identities=26%  Similarity=0.467  Sum_probs=222.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+|++.++||+|+|+.|.+++.+.|.+.||+|++++.-  .++.+...-...|-.+..+. +||.+|-++.+|+.+..+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel--~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHh--cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            457999999999999999999999999999999987532  22333344455566666665 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc-ccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~-~~~~~  311 (444)
                      ++|.||+.||+|--.+++..+++++.++.+...|..||.|||++|||+||||.+|||+|..|++||.|+|+++. +...+
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            99999999999998888888999999999999999999999999999999999999999999999999999985 45556


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC-------CCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-------YEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~-------~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ...+++|||.|+|||++++.. |...+|.|+|||+|+||+.|+.||.-       .+....++++...+.+ .+|..++-
T Consensus       407 ~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-riprslsv  484 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RIPRSLSV  484 (593)
T ss_pred             ccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cccceeeh
Confidence            677899999999999998777 99999999999999999999999952       2233445555444443 67888999


Q ss_pred             HHHHHHHHHhhhCCCCCcC------HHHHHhCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPT------AAWLLEHPFVGN  415 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt------~~elL~hp~~~~  415 (444)
                      .+..+++..|++||.+|.-      +.++-.|+||++
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            9999999999999999964      679999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-37  Score=289.92  Aligned_cols=242  Identities=40%  Similarity=0.709  Sum_probs=204.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHHH
Q 013354          167 TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYK  246 (444)
Q Consensus       167 ~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~  246 (444)
                      +||.||+|++..+++.+++|++.....    ....+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKI----KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccc----ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            589999999998899999998864221    1115788999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcc
Q 013354          247 ILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE  326 (444)
Q Consensus       247 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE  326 (444)
                      ++.....+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            99886668999999999999999999999999999999999999999999999999998876654444556888999999


Q ss_pred             cccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC--CCHHHHHHHHHHhhhCCCCCcCH
Q 013354          327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRKCLQRNPLHRPTA  404 (444)
Q Consensus       327 ~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~l~~Li~~~L~~dP~~Rpt~  404 (444)
                      .+.... ++.++|||+||+++|+|++|..||........................  ++.++.+++.+||..+|++||++
T Consensus       157 ~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      157 VLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence            987555 788999999999999999999999774433333332222222222222  88999999999999999999999


Q ss_pred             HHHHhCCCC
Q 013354          405 AWLLEHPFV  413 (444)
Q Consensus       405 ~elL~hp~~  413 (444)
                      .++++||||
T Consensus       236 ~~~~~~~~~  244 (244)
T smart00220      236 EEALQHPFF  244 (244)
T ss_pred             HHHhhCCCC
Confidence            999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=299.86  Aligned_cols=255  Identities=28%  Similarity=0.449  Sum_probs=203.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC--------CCCeeeEeeeE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR--------HPNIVRYYGSE  226 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~~  226 (444)
                      .+|.+.+.||.|.|++||+|.+..+.+.||+|+++      ..+...+....||++|++++        ..+||+|++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            68999999999999999999999999999999987      44555677788999999984        24799999998


Q ss_pred             EcC----CEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCC-----
Q 013354          227 TLD----DKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSG-----  294 (444)
Q Consensus       227 ~~~----~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-----  294 (444)
                      ...    .++|+|+|++ |.+|..+|.+.  +.++...+++|++||+.||.|||+. ||||-||||+|||+..+.     
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~  230 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK  230 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence            764    5799999998 88999999874  5699999999999999999999987 999999999999994220     


Q ss_pred             --------------------------------------------------------------------------------
Q 013354          295 --------------------------------------------------------------------------------  294 (444)
Q Consensus       295 --------------------------------------------------------------------------------  294 (444)
                                                                                                      
T Consensus       231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n  310 (590)
T KOG1290|consen  231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN  310 (590)
T ss_pred             hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013354          295 --------------------------------------------------------------------------------  294 (444)
Q Consensus       295 --------------------------------------------------------------------------------  294 (444)
                                                                                                      
T Consensus       311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d  390 (590)
T KOG1290|consen  311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD  390 (590)
T ss_pred             ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence                                                                                            


Q ss_pred             -cEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-----h-hhH
Q 013354          295 -RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-----P-AMF  367 (444)
Q Consensus       295 -~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~-~~~  367 (444)
                       ++||+|||-|+.+....  .....|..|+|||++.+.. |+..+||||++|+++||+||...|...++.     + .+.
T Consensus       391 i~vKIaDlGNACW~~khF--T~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  391 IRVKIADLGNACWVHKHF--TEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eeEEEeeccchhhhhhhh--chhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence             35677777766543322  2234688899999998877 999999999999999999999999643321     1 000


Q ss_pred             H-------------------------------hcCCCCCC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHH
Q 013354          368 K-------------------------------IGNSKELP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL  407 (444)
Q Consensus       368 ~-------------------------------~~~~~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~el  407 (444)
                      .                               |.+.+.++         .++.....++.+||.-||+.+|++||||.++
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            0                               11111111         2223345678899999999999999999999


Q ss_pred             HhCCCCCCCCCC
Q 013354          408 LEHPFVGNAAPL  419 (444)
Q Consensus       408 L~hp~~~~~~~~  419 (444)
                      |+|||+++....
T Consensus       548 l~hPwLn~~~~~  559 (590)
T KOG1290|consen  548 LKHPWLNPVAGP  559 (590)
T ss_pred             hcCccccCCCCC
Confidence            999999986554

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=307.92  Aligned_cols=265  Identities=27%  Similarity=0.429  Sum_probs=218.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccc--ccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD--DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-  228 (444)
                      ...++|-...+||+|+|+.||+|++....+.||+|+-.+.++  +.+.....+...+|..+-+.|+||.||++|++|.. 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            345678888999999999999999999999999998765443  22333445677899999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCceEECC---CCcEEEEeccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--NTVHRDIKGANILVDP---SGRVKLADFGM  303 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~---~~~vkL~DFGl  303 (444)
                      .+.+|-|+|||+|.+|+-+|+...-+++.+++.|+.||+.||.||.+.  .|||-||||.|||+.+   -|.+||.|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            467899999999999999999988999999999999999999999988  5999999999999954   37799999999


Q ss_pred             cccccCCCCc--------ccccCCCcccCcccccCc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh---HHh
Q 013354          304 AKHITGQSCP--------LSIKGSPYWMAPEVIKNS---NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM---FKI  369 (444)
Q Consensus       304 a~~~~~~~~~--------~~~~gt~~y~APE~~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~  369 (444)
                      ++.+..+...        ....||.+|++||++.-+   .+++.++||||+|||+|.++.|+.||........+   ..|
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            9998765432        234589999999998644   34788999999999999999999999764432222   122


Q ss_pred             cCCCCCC-CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          370 GNSKELP-AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       370 ~~~~~~~-~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+..... ...+.++.++++||++||++..++|....++..||+|...
T Consensus       700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            2222211 1124589999999999999999999999999999999863

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=324.38  Aligned_cols=205  Identities=34%  Similarity=0.563  Sum_probs=179.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC----
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD----  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  230 (444)
                      .-|...+.||+|+||.||+++++.+|+.||||.++...    .....+...+|+++|++++|+|||+++++-+...    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            35888899999999999999999999999999987432    3334567788999999999999999999865543    


Q ss_pred             --EEEEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC--CCC--cEEEEec
Q 013354          231 --KLYIYLEYVSGGSIYKILQDY---GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSG--RVKLADF  301 (444)
Q Consensus       231 --~~~lv~e~~~ggsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~--~vkL~DF  301 (444)
                        .-.+|||||.||+|+.++++-   ..+++.+++.+..++..||.|||++|||||||||.||++-  .+|  ..||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              457999999999999999763   3599999999999999999999999999999999999983  333  3899999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV  363 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  363 (444)
                      |.|+.+..+....+++||+.|++||++...+.|+..+|.|||||++|+++||..||....+.
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99999999888889999999999999986556999999999999999999999999765444

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-40  Score=295.15  Aligned_cols=259  Identities=26%  Similarity=0.447  Sum_probs=207.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----  228 (444)
                      ..+.|....+||+|.||.||+|+.+++|+.||+|++-....   .+..-....+|+++|..|+|+|++.++++|..    
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene---KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc---ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            45678888999999999999999999999999996643211   11122456789999999999999999987754    


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 ----DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ----~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                          ...+|+||.+|+ -+|..+|.+. .+++...+..++++++.||.|+|++.|+|||+|++|+||+.++.+||+|||+
T Consensus        92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence                345899999995 5899888765 5799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC------C
Q 013354          304 AKHITGQSC-----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------S  372 (444)
Q Consensus       304 a~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------~  372 (444)
                      ++.+.....     +...+-|+.|++||.+.+...|+.+.|||..||||.||+++.+.+.+......+..|..      .
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            976543221     22344589999999999999999999999999999999999988765444333322210      0


Q ss_pred             C--------------CCCCCC-------------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          373 K--------------ELPAIP-------------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       373 ~--------------~~~~~~-------------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .              ..+.++             -.-++++.+|+..+|..||.+|+++.++|+|.||..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            0              001111             123668899999999999999999999999999964

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.8e-38  Score=278.95  Aligned_cols=253  Identities=26%  Similarity=0.459  Sum_probs=211.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLD--  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--  229 (444)
                      ..++|++.+.+|+|-|+.||.|++..+.+.++||+++.        -..+.+.+|+.+|..|. ||||++++++..+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            34679999999999999999999999999999999873        23467889999999997 99999999987763  


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~  308 (444)
                      ....+++||+++.+...+.   ..++..+++.++.+|+.||.|+|++||+|||+||.|++||.. ..++|+|+|+|.++.
T Consensus       108 ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            4568999999887766654   468888999999999999999999999999999999999865 569999999999998


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCC-CCCChhhhHHhcCC---------------
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS-QYEGVPAMFKIGNS---------------  372 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~-~~~~~~~~~~~~~~---------------  372 (444)
                      +.......+.+.+|--||++.+.+.|+..-|+|||||++..|+..+.||- +.+..+++.++.+.               
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            88777777788899999999988889999999999999999999888874 33333333332110               


Q ss_pred             ---------------CC----C-CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ---------------KE----L-PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ---------------~~----~-~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                     +.    . ++-..-.++++.|||.++|..|-.+|+|+.|++.||||...
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                           00    0 01112246999999999999999999999999999999754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-36  Score=319.41  Aligned_cols=257  Identities=22%  Similarity=0.296  Sum_probs=179.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCC----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeee--
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSES----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGS--  225 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~--  225 (444)
                      ...++|.+.+.||+|+||.||+|++..+    +..||+|.+....   . .   +....|  .+....+.+++.++..  
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~-~---e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---A-V---EIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---h-h---HHHHHH--HHHhhchhhHHHHHHhhh
Confidence            3456899999999999999999999988    8999999875211   1 1   111111  1111122222222111  


Q ss_pred             ----EEcCCEEEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 013354          226 ----ETLDDKLYIYLEYVSGGSIYKILQDYGQ--------------------LGESAIRSYTQQILSGLEYLHAKNTVHR  281 (444)
Q Consensus       226 ----~~~~~~~~lv~e~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~~LH~~~ivH~  281 (444)
                          ...+..+++||||+.+++|.+++.....                    ..+..+..++.||+.||+|||+++|+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                2456679999999999999999875321                    1234567899999999999999999999


Q ss_pred             CCCCCceEECC-CCcEEEEeccccccccCCC--CcccccCCCcccCcccccCcC---------------------CCChh
Q 013354          282 DIKGANILVDP-SGRVKLADFGMAKHITGQS--CPLSIKGSPYWMAPEVIKNSN---------------------GCNLA  337 (444)
Q Consensus       282 Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~APE~~~~~~---------------------~~s~~  337 (444)
                      ||||+|||++. ++.+||+|||+++.+....  ......+++.|+|||.+....                     .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 5789999999998654322  223456899999999753221                     13446


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh--------------cCCCCCC------CCCCCCCHHHHHHHHHHhhhC
Q 013354          338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--------------GNSKELP------AIPDHLSDEGKDFVRKCLQRN  397 (444)
Q Consensus       338 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------------~~~~~~~------~~~~~~s~~l~~Li~~~L~~d  397 (444)
                      +|||||||+||||+++..++...  ...+...              ......+      .+.+....++.+||.+||++|
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            79999999999999977665321  1111110              0000000      111223445679999999999


Q ss_pred             CCCCcCHHHHHhCCCCCCCCCC
Q 013354          398 PLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       398 P~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      |++|||+.|+|+||||++....
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999886554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=309.01  Aligned_cols=264  Identities=22%  Similarity=0.267  Sum_probs=188.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc----------------CCCcEEEEEEEeeccccccc---------HHHHHHHHH
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS----------------ESGEMCAMKEVTLFSDDAKS---------KESAQQLGQ  206 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vaiK~i~~~~~~~~~---------~~~~~~~~~  206 (444)
                      ...++|++.++||+|+||+||+|.+.                ..++.||||.+.........         ....+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34568999999999999999999752                23567999988642211000         001122344


Q ss_pred             HHHHHHccCCCCe-----eeEeeeEEc--------CCEEEEEEeccCCCCHHHHHHhcC---------------------
Q 013354          207 EIALLSRLRHPNI-----VRYYGSETL--------DDKLYIYLEYVSGGSIYKILQDYG---------------------  252 (444)
Q Consensus       207 Ei~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~ggsL~~~l~~~~---------------------  252 (444)
                      |+.++.+++|.++     ++++++|..        ++..++||||+.+++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777766554     566666543        356899999999999999986421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc--cccCCCcccCccc
Q 013354          253 ---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEV  327 (444)
Q Consensus       253 ---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~--~~~gt~~y~APE~  327 (444)
                         .+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++..+.......  ...+++.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               13466788999999999999999999999999999999999999999999997654332222  2235789999998


Q ss_pred             ccCcCC---------------------CChhhhHHHHHHHHHHHHcCCC-CCCCCCChh-----------hhHHhcCCCC
Q 013354          328 IKNSNG---------------------CNLAVDIWSLGCTVIEMATTKP-PWSQYEGVP-----------AMFKIGNSKE  374 (444)
Q Consensus       328 ~~~~~~---------------------~s~~sDvwSlGvil~elltG~~-Pf~~~~~~~-----------~~~~~~~~~~  374 (444)
                      +.....                     ...+.||||+||++|+|+++.. ||.......           .+..+.....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            753221                     1124799999999999999875 765321111           1111111111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCC---CCCcCHHHHHhCCCCCC
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNP---LHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP---~~Rpt~~elL~hp~~~~  415 (444)
                      .-...+.+++++++|+.+||.++|   .+|+|++|+|+||||.+
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            112345678999999999999866   68999999999999965

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.9e-37  Score=304.00  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=207.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC------CCeeeEeeeEEc
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH------PNIVRYYGSETL  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~~  228 (444)
                      .+|.+....|+|-|++|.+|.+..-|..||||+|+      +.+-..+.=+.|+.+|++|+.      -|+++++-.|..
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR------nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR------NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEee------cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            57888888999999999999999999999999997      445556667789999999963      489999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEecccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMA  304 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla  304 (444)
                      ..++|||||.+ ..+|.++|++++.   +....++.++.||+.||..|...||+|.||||+||||++.. .+||||||.|
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            99999999988 6799999999875   77889999999999999999999999999999999998764 5999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--CCC---------
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSK---------  373 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--~~~---------  373 (444)
                      .+...+.... +.-+..|.|||++.+.. |+...|+||+||+||||+||+..|.+......+....  +++         
T Consensus       585 ~~~~eneitP-YLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENEITP-YLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccccccH-HHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            8876654322 22345699999998877 9999999999999999999999998765544332110  000         


Q ss_pred             -CC-------------------------------------------CCCCC---CCCHHHHHHHHHHhhhCCCCCcCHHH
Q 013354          374 -EL-------------------------------------------PAIPD---HLSDEGKDFVRKCLQRNPLHRPTAAW  406 (444)
Q Consensus       374 -~~-------------------------------------------~~~~~---~~s~~l~~Li~~~L~~dP~~Rpt~~e  406 (444)
                       ..                                           +.+++   .+-..+++||..||..||++|.|..|
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence             00                                           00111   12345789999999999999999999


Q ss_pred             HHhCCCCCC
Q 013354          407 LLEHPFVGN  415 (444)
Q Consensus       407 lL~hp~~~~  415 (444)
                      +|+||||..
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=315.67  Aligned_cols=249  Identities=30%  Similarity=0.495  Sum_probs=208.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      +..++.+.||+|.||.|++|.-..       ....||+|.++.   . ......+.+..|+++|+.+ +|+||+.++|.+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~---~-~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKE---N-ASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEeccc---c-cCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            344566789999999999997431       145788997763   2 2235668899999999999 599999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV  290 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  290 (444)
                      ..++.+++|+||+..|+|.+++++.+                .++..+.+.++.||+.|++||++.++|||||..+|||+
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI  451 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence            99999999999999999999998865                38899999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCCcccc--cC--CCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCC-Chh
Q 013354          291 DPSGRVKLADFGMAKHITGQSCPLSI--KG--SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYE-GVP  364 (444)
Q Consensus       291 ~~~~~vkL~DFGla~~~~~~~~~~~~--~g--t~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~-~~~  364 (444)
                      ..+..+||+|||+++.......+...  .+  ...|||||.+.... |+.++|||||||+|||+++ |..||.+.. ..+
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            99999999999999965444333211  12  24599999998744 9999999999999999999 999998855 334


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+..+..+.++ ..|..+++++.++|+.||+.+|++||++.++.+
T Consensus       531 l~~~l~~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            45556666665 679999999999999999999999999997654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=311.58  Aligned_cols=246  Identities=32%  Similarity=0.482  Sum_probs=194.7

Q ss_pred             eeeeeeecccCceE-EEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEE
Q 013354          157 WKKGRLLGRGTFGH-VYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       157 ~~~~~~LG~G~fg~-Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  234 (444)
                      |...+++|.|+-|+ ||+|...  |+.||||.+-        .+......+|+..|+.- +|||||++++...++.++||
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            44456799999886 8999764  8899999663        34455677899999988 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---C--CcEEEEeccccc
Q 013354          235 YLEYVSGGSIYKILQDY-GQ---LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---S--GRVKLADFGMAK  305 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~--~~vkL~DFGla~  305 (444)
                      ..|.| ..+|.++++.. ..   ......+.+..|+++||+|||+.+||||||||.||||+.   +  ..++|+|||+++
T Consensus       581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            99999 57999999873 11   122456788999999999999999999999999999965   3  469999999999


Q ss_pred             cccCCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCC-CCCCCCC
Q 013354          306 HITGQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNS-KELPAIP  379 (444)
Q Consensus       306 ~~~~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~-~~~~~~~  379 (444)
                      .+......    ....||-+|+|||++.... -+.++|||||||++|+.++ |..||.+....+  ..|.++ ..+..+.
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~  736 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE  736 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec
Confidence            88765543    2356999999999998777 5779999999999999999 599997633221  111111 1111122


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .....++.+||.+|++++|..||+|.++|.||||=+.
T Consensus       737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            2222289999999999999999999999999999654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=305.90  Aligned_cols=247  Identities=28%  Similarity=0.441  Sum_probs=214.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCc----EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGE----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      +.+..++||+|+||+||+|.+.-.|+    +||||++.    ........+++.+|+-+|.+++|||++++++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~----~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI----EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEee----ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            46677889999999999999966565    56777664    3344555678999999999999999999999998766 


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +.||.+|+++|.|.++++.. ..+.....+.|..||++||.|||++.+|||||..+||||..-..+||.|||+++.+..+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            88999999999999999874 46999999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccc---CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          311 SCPLSIK---GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       311 ~~~~~~~---gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...+...   -.+.|||-|.+.... |+.++|||||||++||++| |..||......+.-.-++.+.++ ..|..++.++
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL-sqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL-SQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC-CCCCCccHHH
Confidence            6555433   346799999998776 9999999999999999999 99999988877777777777776 5688999999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..+|.+||..|++.||+++++..
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999997654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=280.41  Aligned_cols=258  Identities=28%  Similarity=0.447  Sum_probs=210.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC-----C
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD-----D  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~  230 (444)
                      +.+..+-||.|+||.||.+.+..+|+.||+|++..   -...-...+++.+|+++|..++|.|++..+++..-.     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch---HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            45566889999999999999999999999997642   122333457889999999999999999988875532     2


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|++.|++ ..+|+++|-.-..++.+.++-+..||++||+|||+.+|.||||||.|+|++.|..+||||||+++....+
T Consensus       131 EiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            478888988 6799999988778999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------------
Q 013354          311 SCP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------------  371 (444)
Q Consensus       311 ~~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------  371 (444)
                      ...  ...+-|.+|+|||++++...|+.++||||+|||+.||+..+..|......+++..|..                 
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            322  2234678999999999999999999999999999999999988876555444333211                 


Q ss_pred             -------CCCCCCC--------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          372 -------SKELPAI--------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       372 -------~~~~~~~--------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                             ....|.+        ++....+..+++..+|..||.+|.+.++.+.|+++.+..
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                   1111111        234567788999999999999999999999999987643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=326.78  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=185.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..++||+|+||.||+|+++.+++.||+|.+.....         ...+|++.+++++|||||++++++..++..++|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            35566789999999999999998999999998753111         112457889999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH---AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |||+++++|.++++   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. |+........  
T Consensus       762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999999996   3889999999999999999999   6699999999999999988887775 6655433222  


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh----hhhHHh-cCCCC-----CCCC----
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV----PAMFKI-GNSKE-----LPAI----  378 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~-~~~~~-----~~~~----  378 (444)
                       ....++..|+|||++.+.. ++.++|||||||++|||++|+.||......    ..+.+. .....     .+.+    
T Consensus       836 -~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        836 -TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             -CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence             1235789999999997665 899999999999999999999998542211    011110 00000     0111    


Q ss_pred             --CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          379 --PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       379 --~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                        +.....++.+++.+||+.||++|||+.|+++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              11123457789999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=276.93  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=209.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      ..+|...+.+|.|.- .|--|.+.-.++.||+|.+...   .......++..+|..++..++|+||++++.+|.-..   
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            457888999999998 8888999999999999987653   222334567889999999999999999999876533   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                         ..|+|||++ ..+|...+..  .++-+.+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++..
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence               579999999 5699998883  6888999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC--------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--------------  373 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------------  373 (444)
                      .........+.|..|.|||++.+.. +...+||||+||++.||++|+..|.+.+..+++.++...-              
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            6664555677899999999998877 8999999999999999999999998766554443321100              


Q ss_pred             ------------------CCCC--------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          374 ------------------ELPA--------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       374 ------------------~~~~--------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                                        ..|.        -+..-...+++|+.+||-.||++|.+++++|+||||+
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                              0000        0011235678999999999999999999999999997

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=302.04  Aligned_cols=260  Identities=42%  Similarity=0.692  Sum_probs=222.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+..+|.....+|+|+||.||+|+++.+++..|+|++++...     +...-+.+|+-+++..+|+|||.+++.+..++.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-----dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-----ccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            455789999999999999999999999999999999987433     334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-  310 (444)
                      +++.||||.||+|.+..+-.+.+++.++...++..+.+|+|||++|-+|||||-.|||+++.|.+||.|||.+..+... 
T Consensus        87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999988765443 


Q ss_pred             CCcccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC-C--CCCCCCHH
Q 013354          311 SCPLSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-A--IPDHLSDE  385 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~--~~~~~s~~  385 (444)
                      ....++.||++|||||+..  ...+|...+|||++|++..|+-.-++|-........++...+....| .  -+...++.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            2345678999999999853  23348899999999999999999888865555545555444433222 1  23457889


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +.+|++.+|.++|++||+++.+|.|||+...
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            9999999999999999999999999999865

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=253.01  Aligned_cols=210  Identities=28%  Similarity=0.500  Sum_probs=173.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~  233 (444)
                      +....+..||+|+||.|-+.++..+|...|+|.++..   ...+ ..+++.+|+.+..+ ..+|++|.+||.+..++..+
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t---vn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---VNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh---cChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            4556667899999999999999999999999998742   2333 33566677776554 47999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          234 IYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +.||.+ ..+|+.+.++    .+.++|..+-+++..++.||.|||++ .+||||+||+||||+.+|++|+||||.+..+.
T Consensus       122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            999999 5688776643    46799999999999999999999998 89999999999999999999999999998876


Q ss_pred             CCCCcccccCCCcccCcccccC---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHh
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKN---SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKI  369 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~---~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~  369 (444)
                      +.-......|...|||||.+..   ..+|+.++||||||++|.||.+++.||...... +++.++
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            6554444558888999999853   335899999999999999999999999875543 334443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=268.73  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=212.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+++...++-+|+||.||.|++++.     .+.|.+|.++    ...++-....+..|.-++..+.|||+..+.+++
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk----~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK----QHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH----hcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4456788889999999999999987653     3445566554    334555677889999999999999999999987


Q ss_pred             EcC-CEEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEE
Q 013354          227 TLD-DKLYIYLEYVSGGSIYKILQDY--------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       227 ~~~-~~~~lv~e~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vk  297 (444)
                      .++ ...++++.+..-|+|..+|.-.        ..++..++..++.|++.|++|||++++||.||..+|++||+.-++|
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            654 5667888999889999999832        2367788899999999999999999999999999999999999999


Q ss_pred             EEeccccccccCCCCcc---cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCC
Q 013354          298 LADFGMAKHITGQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       298 L~DFGla~~~~~~~~~~---~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      |+|=.+++.+.+.+-+-   .......||++|.+.+.. |+.++|||||||+||||+| |+.||.+.+..+....+..+.
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            99999998765433211   111346799999998877 9999999999999999999 999999999888888888888


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++ ..|.+|++++..+|..||..+|++||+++|+..
T Consensus       516 Rl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            87 678999999999999999999999999999753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=274.12  Aligned_cols=247  Identities=24%  Similarity=0.390  Sum_probs=192.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc--cCCCCeeeEeeeEEcCC--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR--LRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~--  230 (444)
                      ....+.++||+|.||.||+|...  ++.||||++.        .+..+.+..|-++.+.  ++|+||+++++......  
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp--------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP--------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecC--------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            34667789999999999999654  6999999875        3345667777776655  58999999999866544  


Q ss_pred             --EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCceEECCCCcEEEE
Q 013354          231 --KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK---------NTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       231 --~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                        .++||+||.+.|+|.++|+. ..+++....+++..|++||+|||+.         .|+|||||.+||||.+|+...|+
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence              79999999999999999997 4799999999999999999999973         49999999999999999999999


Q ss_pred             eccccccccCCC---CcccccCCCcccCcccccCcCCCC-----hhhhHHHHHHHHHHHHcCCC------------CCCC
Q 013354          300 DFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCN-----LAVDIWSLGCTVIEMATTKP------------PWSQ  359 (444)
Q Consensus       300 DFGla~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~s-----~~sDvwSlGvil~elltG~~------------Pf~~  359 (444)
                      |||+|..+....   .....+||.+|||||++.+.-.+.     .+.||||+|.+||||++...            ||..
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999998775432   223466999999999997665444     47899999999999998543            3321


Q ss_pred             C----CChhhhHH-hcCCCCCCCCCCC-----CCHHHHHHHHHHhhhCCCCCcCHH------HHHhCCC
Q 013354          360 Y----EGVPAMFK-IGNSKELPAIPDH-----LSDEGKDFVRKCLQRNPLHRPTAA------WLLEHPF  412 (444)
Q Consensus       360 ~----~~~~~~~~-~~~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rpt~~------elL~hp~  412 (444)
                      .    ...+.++. ....+..|.+++.     -...+++.+..||+.|++.|.|+.      .-|.|.|
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            1    11122222 2234444555543     245688999999999999999986      3556666

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.3e-31  Score=244.04  Aligned_cols=212  Identities=43%  Similarity=0.725  Sum_probs=186.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG  242 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg  242 (444)
                      ||+|.+|.||++.+..+++.+++|++.....    ....+.+.+|+..++.+.|++|+++++++......+++||++.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc----hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            6899999999999988899999998864211    114578899999999999999999999999989999999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccccccccCCC-CcccccCC
Q 013354          243 SIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQS-CPLSIKGS  319 (444)
Q Consensus       243 sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~-~~~~~~gt  319 (444)
                      +|.+++... ..++...++.++.+++.+|++||+.+++|+||+|.||+++. ++.++|+|||.+....... ......+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999875 46899999999999999999999999999999999999998 8999999999998664432 12234477


Q ss_pred             CcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 013354          320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL  399 (444)
Q Consensus       320 ~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~  399 (444)
                      ..|++||.+......+.+.|+|++|+++++|                                 ..+.+++..|++.||+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcc
Confidence            8899999987653478999999999999999                                 7889999999999999


Q ss_pred             CCcCHHHHHhCC
Q 013354          400 HRPTAAWLLEHP  411 (444)
Q Consensus       400 ~Rpt~~elL~hp  411 (444)
                      +||++.++++|+
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=278.40  Aligned_cols=204  Identities=26%  Similarity=0.396  Sum_probs=177.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc---HHHHHHHHHHHHHHHccC---CCCeeeEeeeEEc
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS---KESAQQLGQEIALLSRLR---HPNIVRYYGSETL  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~---~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~  228 (444)
                      +.|...+.||+|+||.|++|+++.+...|+||.+.+.+.-.+.   ...+-.+-.||.+|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4688999999999999999999999999999988653221111   111123456999999997   9999999999999


Q ss_pred             CCEEEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYV-SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~-~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ++.+||+||-- +|.+|+++|..+..++|.++..|++|++.|+++||++||||||||-+||.++.+|-+||+|||.+...
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99999999954 57799999999899999999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ  359 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  359 (444)
                      ... ....++||..|.|||++.+.++....-|||+||++||-++....||.+
T Consensus       721 ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  721 KSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            543 455678999999999999888778889999999999999999988853

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-32  Score=260.88  Aligned_cols=247  Identities=28%  Similarity=0.444  Sum_probs=189.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc--cCCCCeeeEeeeEEcC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR--LRHPNIVRYYGSETLD  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~  229 (444)
                      +...+..+.+.||+|.||.||+|.++  |+.||||++.-     .++   +...+|.++.+.  |+|+||+.+++.-..+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s-----rdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS-----RDE---RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecc-----cch---hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            34567889999999999999999887  89999999862     111   234456666554  5999999999865433


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceEECCCCcEE
Q 013354          230 ----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--------NTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       230 ----~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~vk  297 (444)
                          .+++||.+|-+.|+|+|+|.+ ..++.+..++++..++.||+|||-.        .|.|||||.+||||..++...
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence                368999999999999999998 5899999999999999999999963        499999999999999999999


Q ss_pred             EEeccccccccCCCC-----cccccCCCcccCcccccCcCCC-----ChhhhHHHHHHHHHHHHcC----------CCCC
Q 013354          298 LADFGMAKHITGQSC-----PLSIKGSPYWMAPEVIKNSNGC-----NLAVDIWSLGCTVIEMATT----------KPPW  357 (444)
Q Consensus       298 L~DFGla~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~~-----s~~sDvwSlGvil~elltG----------~~Pf  357 (444)
                      |+|+|+|........     ....+||.+|||||++...-..     =..+||||||.+|||++-.          ++||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            999999987655432     3346799999999998654321     1368999999999999752          4677


Q ss_pred             CCCCC----hhhhHHhc-CCCCCCCCCCCC-C----HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          358 SQYEG----VPAMFKIG-NSKELPAIPDHL-S----DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       358 ~~~~~----~~~~~~~~-~~~~~~~~~~~~-s----~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+.-.    .+.++++. ..+..|.+|... +    ..+-.+|+.||..||.-|.|+-.|-+
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            65322    22333221 233334555432 2    34567899999999999999876543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.98  E-value=6.1e-33  Score=267.71  Aligned_cols=255  Identities=30%  Similarity=0.439  Sum_probs=203.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE---SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      ..|+..+.||+|.|++||++++..   ..+.||+|.+....       .-.++..|+++|..+ .+.||+.+.+.+..++
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            468999999999999999999887   78999999886421       224688999999999 5899999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~~  309 (444)
                      ...+|+||++.....+++..   ++..+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|.....
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            99999999999998888764   7789999999999999999999999999999999999754 6789999999972110


Q ss_pred             CC---------------------------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHH
Q 013354          310 QS---------------------------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLG  344 (444)
Q Consensus       310 ~~---------------------------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlG  344 (444)
                      ..                                             ......||++|.|||++.....-+.++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            00                                             001234999999999998877788999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCh-hhh------------HHhc--CCC-----------------------------------C
Q 013354          345 CTVIEMATTKPPWSQYEGV-PAM------------FKIG--NSK-----------------------------------E  374 (444)
Q Consensus       345 vil~elltG~~Pf~~~~~~-~~~------------~~~~--~~~-----------------------------------~  374 (444)
                      ||++-+++++.||-..... ..+            .+..  .+.                                   .
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            9999999999998542211 100            0000  000                                   0


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      .....+..+..+.+|+.+||..||.+|.|+++.|+||||.+....
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence            001113346689999999999999999999999999999965443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.4e-30  Score=240.03  Aligned_cols=211  Identities=39%  Similarity=0.653  Sum_probs=179.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |++.+.||+|++|.||++.+..+++.+++|.+......    ...+.+.+|+..++.++|+|++++++.+......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            56788999999999999999988999999988642111    35678889999999999999999999999989999999


Q ss_pred             eccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--Cc
Q 013354          237 EYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--CP  313 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--~~  313 (444)
                      |++.+++|.+++..... +++..+..++.+++.+|.+||+++++|+||++.||+++.++.++|+|||.+.......  ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999999999988766 8999999999999999999999999999999999999999999999999998765543  23


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC-CCCh-hhhHHhcC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-YEGV-PAMFKIGN  371 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~-~~~~~~~~  371 (444)
                      ....++..|++||++.....++.++|+|+||++++||++|+.||.. .+.. .....+..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF  216 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence            3445788899999984334477899999999999999999999966 3333 33344433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=243.75  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeee-EEcCCE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGS-ETLDDK  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~-~~~~~~  231 (444)
                      -+.|.+.+.||+|.||.+-++.++.+...+++|.+.      ......++|.+|...--.| .|.||+.-|++ |+..+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp------~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP------RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC------cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            457999999999999999999999999999999886      3334567889999876667 48999998875 677888


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-C-CCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-P-SGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~-~~~vkL~DFGla~~~~~  309 (444)
                      +++++||++.|+|..-+.. ..+.|...+.++.|+++||.|+|++++||||||.+||||- . ..+|||||||+.+..+.
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999999999998876 4689999999999999999999999999999999999993 2 34699999999876543


Q ss_pred             CCCcccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hh---hHHh--cCCCCCCCCC
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PA---MFKI--GNSKELPAIP  379 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~---~~~~--~~~~~~~~~~  379 (444)
                      -...  ...+..|.+||.....    ....+.+|+|.||+++|.+|+|++||....-. ..   +.+-  .....+|...
T Consensus       176 tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  176 TVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             eehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence            2221  1245568999976422    12467899999999999999999999742211 11   1111  1122334445


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCC---cCHHHHHhCCCCC
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHR---PTAAWLLEHPFVG  414 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~R---pt~~elL~hp~~~  414 (444)
                      ..+++.+..+.++-|..++++|   -++....+.-|..
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            5679999999999999999999   6666666666654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.6e-31  Score=290.21  Aligned_cols=198  Identities=19%  Similarity=0.216  Sum_probs=145.4

Q ss_pred             cCC-CCeeeEeeeE-------EcCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Q 013354          214 LRH-PNIVRYYGSE-------TLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIK  284 (444)
Q Consensus       214 l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  284 (444)
                      ++| .||++++++|       ...+.++++||++ +++|.++|... ..+++..++.++.||+.||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4677777765       2334677889987 67999999753 459999999999999999999999999999999


Q ss_pred             CCceEECCCC-------------------cEEEEeccccccccCCC-----------------CcccccCCCcccCcccc
Q 013354          285 GANILVDPSG-------------------RVKLADFGMAKHITGQS-----------------CPLSIKGSPYWMAPEVI  328 (444)
Q Consensus       285 p~NIll~~~~-------------------~vkL~DFGla~~~~~~~-----------------~~~~~~gt~~y~APE~~  328 (444)
                      |+||||+..+                   .+||+|||+++......                 ......||+.|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996544                   45566666654321100                 00113478899999999


Q ss_pred             cCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHH
Q 013354          329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       329 ~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL  408 (444)
                      .+.. ++.++|||||||+||||++|..|+.....  .+..+... ..+........+..+++.+||++||.+||++.|+|
T Consensus       188 ~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        188 NGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             ccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            7766 89999999999999999999988754221  11111111 11111112245677999999999999999999999


Q ss_pred             hCCCCCCC
Q 013354          409 EHPFVGNA  416 (444)
Q Consensus       409 ~hp~~~~~  416 (444)
                      +||||.+.
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4.6e-29  Score=224.20  Aligned_cols=161  Identities=32%  Similarity=0.392  Sum_probs=129.0

Q ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCC
Q 013354          242 GSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP  320 (444)
Q Consensus       242 gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~  320 (444)
                      |+|.++++.++ .+++..++.++.||+.||.|||+++      ||+|||++.++.+++  ||++.......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            68999998744 5999999999999999999999998      999999999999999  99988764432    25899


Q ss_pred             cccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHhcCCCCC--C---CCCCCCCH--HHHHHHHH
Q 013354          321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKEL--P---AIPDHLSD--EGKDFVRK  392 (444)
Q Consensus       321 ~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~--~---~~~~~~s~--~l~~Li~~  392 (444)
                      .|+|||++.+.. ++.++|||||||++|||++|+.||........ +..+......  +   ..+..++.  ++++||.+
T Consensus        69 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       69 YFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             cccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            999999997766 89999999999999999999999976543322 2222111110  0   11222333  69999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ||..||++||++.|+++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=9.5e-27  Score=218.48  Aligned_cols=245  Identities=22%  Similarity=0.356  Sum_probs=200.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  230 (444)
                      ..+-.|++++.||+|+||.+++|++.-+++.||||.-.       .+....++..|.+..+.|. .++|...+-+..+.-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-------rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-------RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecc-------ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            45668999999999999999999999999999999643       2233457788888888884 789999988888877


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-----CcEEEEecccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-----GRVKLADFGMA  304 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-----~~vkL~DFGla  304 (444)
                      .-.||+|++ |.+|+|+..-.+ +|+...+..++.||+.-++|+|++.+|.|||||+|+||..-     ..|.|+|||+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            888999998 899999998765 59999999999999999999999999999999999999543     35999999999


Q ss_pred             ccccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhhHHhcCCC
Q 013354          305 KHITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSK  373 (444)
Q Consensus       305 ~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~  373 (444)
                      +.+.+...        ..+..||.+||+-....+.. -+.+.|+-|||-+++++|-|.+||.+....   +.+++|...+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            97754332        23456999999999887766 789999999999999999999999876544   3455555444


Q ss_pred             CCC---CCCCCCCHHHHHHHHHHhhhCCCCCcCHH
Q 013354          374 ELP---AIPDHLSDEGKDFVRKCLQRNPLHRPTAA  405 (444)
Q Consensus       374 ~~~---~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~  405 (444)
                      +..   .+-..++.++...|+..-..+-.+-|..+
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            332   22356788888888888777878888765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-26  Score=228.79  Aligned_cols=248  Identities=24%  Similarity=0.285  Sum_probs=194.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCC-cEEEEEEEeecccccccHHHHHHHHHHHHHHHccC----CCCeeeEeeeE-EcC
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR----HPNIVRYYGSE-TLD  229 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~----hpnIv~l~~~~-~~~  229 (444)
                      +|++.+.||+|+||.||++.+..++ +.+|+|+........     ...+..|+.++..+.    ..++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            7999999999999999999987764 678898776421111     114566788888776    36899999988 577


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-----CcEEEEecc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-----GRVKLADFG  302 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-----~~vkL~DFG  302 (444)
                      ...|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999998 99999988665  469999999999999999999999999999999999999754     459999999


Q ss_pred             ccc--cccCCC---------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh--
Q 013354          303 MAK--HITGQS---------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--  369 (444)
Q Consensus       303 la~--~~~~~~---------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--  369 (444)
                      +++  .+....         ......||..|.++.+..+.. .+.+.|+||++.++.||+.|..||...+.......+  
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            998  321111         122355999999999997766 899999999999999999999999776643322222  


Q ss_pred             -cCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          370 -GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       370 -~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                       .............+.++..++..+-..+...+|....+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence             22222111344567888888888888999999999876554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3e-28  Score=256.53  Aligned_cols=259  Identities=26%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEEeecc-cccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~-~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      +...++|.|.+|.|+.+......+.++.|..++.. ...........+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999999988887777777777655320 11122222233778888889999999998888777666666669


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-----C
Q 013354          237 EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-----S  311 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-----~  311 (444)
                      |||++ +|+.++.+...+...++..+++||+.|++|||+.||.|||||++|+++..+|.+||+|||.+..+.-.     .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99998 99999998778999999999999999999999999999999999999999999999999998754322     2


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCC------CCCCCCCCCCH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSK------ELPAIPDHLSD  384 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~------~~~~~~~~~s~  384 (444)
                      ....++|+-.|+|||.+.....-....||||.|++++.|++|+.||......... .......      ....+...++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            2345679999999999988775557899999999999999999999765443332 1111111      11122345788


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      +.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            999999999999999999999999999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.5e-25  Score=214.90  Aligned_cols=255  Identities=35%  Similarity=0.565  Sum_probs=205.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC-CeeeEeeeEEcCCEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP-NIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lv  235 (444)
                      |...+.||.|+|+.||++.+.   +.+++|.+.....  ........+.+|+.++..+.|+ +|+++++.+......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLE--SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhc--cchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            778899999999999999887   7889998864221  1113567889999999999988 799999999888888999


Q ss_pred             EeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEeccccccccCCC
Q 013354          236 LEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQS  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~  311 (444)
                      ++++.+++|.+++....   .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999998887764   799999999999999999999999999999999999999888 69999999998654433


Q ss_pred             -------CcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC----hhhhHHhcCCCC---C
Q 013354          312 -------CPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG----VPAMFKIGNSKE---L  375 (444)
Q Consensus       312 -------~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~---~  375 (444)
                             ......|+..|+|||.+...  ..+....|+|++|++++++++|..||.....    ......+.....   .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                   23456699999999999763  3478999999999999999999999876553    222222222211   1


Q ss_pred             CCCCCCC----CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          376 PAIPDHL----SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       376 ~~~~~~~----s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .......    ...+.+++..|+..+|..|.+..+...++|....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            1111211    2578999999999999999999998888776644

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.2e-25  Score=223.05  Aligned_cols=167  Identities=19%  Similarity=0.225  Sum_probs=129.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeee-EeeeEEcCC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR-YYGSETLDD  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~  230 (444)
                      ...+|.+.+.||+|+||+||+|+++. +++.+|||++.............+.+.+|+++|++++|+||+. +++.    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            34679999999999999999998876 6788899976421110112334567899999999999999985 4432    4


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDI-KGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..|+||||+.|++|... .   ...   ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++.+..
T Consensus        92 ~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             CcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            57999999999999732 1   111   1467889999999999999999999 99999999999999999999986644


Q ss_pred             CCCc---------ccccCCCcccCcccccC
Q 013354          310 QSCP---------LSIKGSPYWMAPEVIKN  330 (444)
Q Consensus       310 ~~~~---------~~~~gt~~y~APE~~~~  330 (444)
                      ....         ....+++.|+|||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3321         13457888999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=6.2e-26  Score=204.59  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~  230 (444)
                      ..+..|++.+.||+|+||.+|+|....+|+.||||+-+.       .....++..|.++...|++ ..|..+.-+..+..
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-------~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-------KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-------cCCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence            446789999999999999999999999999999997542       2223467788999998864 67777777788888


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC---CcEEEEecccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS---GRVKLADFGMAKH  306 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~  306 (444)
                      .-.+||+.. |.+|+++++-. ..++...++.++-|++.-++|+|.+++|||||||+|+|+.-+   ..+.|+|||+++.
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            889999998 89999998753 469999999999999999999999999999999999999643   4599999999987


Q ss_pred             ccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH---HhcCCCC-
Q 013354          307 ITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF---KIGNSKE-  374 (444)
Q Consensus       307 ~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~-  374 (444)
                      +.+...        .....||.+|.+-....+.. .+.+.|+-|+|.+|.++.-|..||.+.......+   +|...+. 
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            644321        22345999999877765444 6789999999999999999999998866543332   3322211 


Q ss_pred             --CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHH
Q 013354          375 --LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA  405 (444)
Q Consensus       375 --~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~  405 (444)
                        +..+=..+|.|+.-.|..|-..--++-|...
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence              1122356789999999999888888888764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-27  Score=237.10  Aligned_cols=239  Identities=28%  Similarity=0.477  Sum_probs=203.0

Q ss_pred             eecccCceEEEEEEE---cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEEEEe
Q 013354          162 LLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~---~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      ++|+|.||.|++++.   .+.|..+|+|+.++.........   ....|-.++..++ ||.+|+++..++.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999988743   34578899998875433222221   4445667777776 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK  317 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~  317 (444)
                      +..|+.|...+.+...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....   +
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence            9999999999998888999999999999999999999999999999999999999999999999999876554433   7


Q ss_pred             CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhC
Q 013354          318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN  397 (444)
Q Consensus       318 gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~d  397 (444)
                      ||..|||||+++   +...++|.||||++++||++|..||..    +.+..|.+.+  ...|..++.++++++.+++..+
T Consensus       155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhC
Confidence            999999999997   357799999999999999999999976    4555555433  3678899999999999999999


Q ss_pred             CCCCcCH-----HHHHhCCCCCC
Q 013354          398 PLHRPTA-----AWLLEHPFVGN  415 (444)
Q Consensus       398 P~~Rpt~-----~elL~hp~~~~  415 (444)
                      |..|.-.     .|+++|+||..
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HHHHhccCcchhHHHhccchhee
Confidence            9999765     58999999984

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3e-24  Score=204.87  Aligned_cols=235  Identities=23%  Similarity=0.288  Sum_probs=154.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC----------CCeeeEeee
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH----------PNIVRYYGS  225 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~  225 (444)
                      .+..++.||.|+++.||.+++..|++.+|+|+.....+  ......+.+.+|.-....+.+          -.++-.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            57788899999999999999999999999999887652  233345666666654444322          122222222


Q ss_pred             EE---------cC---C-----EEEEEEeccCCCCHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHCCcccC
Q 013354          226 ET---------LD---D-----KLYIYLEYVSGGSIYKILQ---DYGQL----GESAIRSYTQQILSGLEYLHAKNTVHR  281 (444)
Q Consensus       226 ~~---------~~---~-----~~~lv~e~~~ggsL~~~l~---~~~~l----~~~~~~~i~~qi~~aL~~LH~~~ivH~  281 (444)
                      ..         ..   .     ..+++|+-+ .++|.+++.   .....    .......+..|++..+++||..|+||+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            11         11   1     236677777 678888764   22222    233345667899999999999999999


Q ss_pred             CCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCc-------CCCChhhhHHHHHHHHHHHHcCC
Q 013354          282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS-------NGCNLAVDIWSLGCTVIEMATTK  354 (444)
Q Consensus       282 Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~s~~sDvwSlGvil~elltG~  354 (444)
                      ||||+|+|++.+|.++|+||+.....+.....  ...+..|.+||.....       ..++.+.|.|+||+++|.|.++.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999999877655432221  2355779999976432       23788999999999999999999


Q ss_pred             CCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 013354          355 PPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR  401 (444)
Q Consensus       355 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  401 (444)
                      .||...........     .+.... .+++.++.||+.+|++||++|
T Consensus       248 lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99976443222211     222444 789999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-24  Score=204.29  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=180.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCc-----------------------------------EEEEEEEeecccccccHH
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGE-----------------------------------MCAMKEVTLFSDDAKSKE  199 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~-----------------------------------~vaiK~i~~~~~~~~~~~  199 (444)
                      ++|++++.||+|....||.|....+|.                                   +.|||.+-....+..+..
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            579999999999999999997654221                                   245554433333334444


Q ss_pred             HHHHHHHHHHH------H--------Hc--------cCCCCeeeEeeeEEc---------------------------CC
Q 013354          200 SAQQLGQEIAL------L--------SR--------LRHPNIVRYYGSETL---------------------------DD  230 (444)
Q Consensus       200 ~~~~~~~Ei~~------l--------~~--------l~hpnIv~l~~~~~~---------------------------~~  230 (444)
                      ..+.+.+|..-      +        +.        -+|||||++++.|.+                           ..
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence            55555555431      1        11        259999998876543                           22


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE--CCCC--cEEEEecccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV--DPSG--RVKLADFGMAKH  306 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~--~vkL~DFGla~~  306 (444)
                      .+|+||... ..+|..++..+ ..+.....-++.|+++|+.|||++||.|||+|.+||||  |+|+  .+.|+|||++-.
T Consensus       317 tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA  394 (598)
T KOG4158|consen  317 TLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA  394 (598)
T ss_pred             eEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence            689999988 46999999863 56777778889999999999999999999999999999  3333  489999998753


Q ss_pred             ccCC-------CCcccccCCCcccCcccccCcCCC-----ChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC
Q 013354          307 ITGQ-------SCPLSIKGSPYWMAPEVIKNSNGC-----NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE  374 (444)
Q Consensus       307 ~~~~-------~~~~~~~gt~~y~APE~~~~~~~~-----s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~  374 (444)
                      -...       ......-|.-.-||||+.....+.     =.+.|.|+.|.+.||++....||........-.+--....
T Consensus       395 d~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q  474 (598)
T KOG4158|consen  395 DDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ  474 (598)
T ss_pred             ccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh
Confidence            3221       112233477789999997543321     1489999999999999999999976332222222234556


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHH
Q 013354          375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA  405 (444)
Q Consensus       375 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~  405 (444)
                      +|.+|+.++..+++|+..+|+.||.+|++..
T Consensus       475 LPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  475 LPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            7899999999999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.8e-23  Score=189.49  Aligned_cols=145  Identities=19%  Similarity=0.153  Sum_probs=112.2

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccH---------------------HHHHHHHHHHHHHHccCCCC
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK---------------------ESAQQLGQEIALLSRLRHPN  218 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~---------------------~~~~~~~~Ei~~l~~l~hpn  218 (444)
                      ...||+|+||.||+|.+. +|+.||+|+++.........                     .......+|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 89999999997532211110                     01123346999999998777


Q ss_pred             eeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCceEECCCCcEE
Q 013354          219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL-HAKNTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       219 Iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~NIll~~~~~vk  297 (444)
                      +......... . .++||||+.|+++...+.+...+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            6443332222 2 389999999887766544456899999999999999999999 799999999999999998 47899


Q ss_pred             EEecccccccc
Q 013354          298 LADFGMAKHIT  308 (444)
Q Consensus       298 L~DFGla~~~~  308 (444)
                      |+|||++....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-24  Score=229.36  Aligned_cols=246  Identities=22%  Similarity=0.271  Sum_probs=185.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +++..+.||++.|=+|.+|++.+ |. |+||++.+..+...-.. ..+..+|++ ...+++||++.+.-+...+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            78999999999999999998764 44 88999876444433333 344445555 6677999999998887778888999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc-cCCCCcc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-~~~~~~~  314 (444)
                      -+|+ ..+|+|.|.-+.-+...+.+.|+.||+.||..+|+.||+|||||.+||||+.-.-+.|+||..-+-. -.++...
T Consensus       100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            9999 4599999988766888889999999999999999999999999999999998888999999866521 1222111


Q ss_pred             -------cccCCCcccCcccccCcC----------CCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCC-C
Q 013354          315 -------SIKGSPYWMAPEVIKNSN----------GCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKE-L  375 (444)
Q Consensus       315 -------~~~gt~~y~APE~~~~~~----------~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~  375 (444)
                             +...-.+|+|||.+....          ..+++.||||+||++.||++ |+++|.-    .++.....+.. .
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccC
Confidence                   112335799999875421          14679999999999999998 8999852    22222222210 0


Q ss_pred             C--CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          376 P--AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       376 ~--~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +  -+..--+..++++|..|++.||++|.++++.|+.
T Consensus       255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0  0011124578999999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.2e-23  Score=220.40  Aligned_cols=223  Identities=29%  Similarity=0.443  Sum_probs=170.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|..+|+|..|+||.||+++++.+.+.+|+|+-+       ..    .+.+-  ++....+|.+|            
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-------q~----lilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-------QN----LILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-------cc----hhhhc--cccccCCccee------------
Confidence            3467999999999999999999999999999995321       01    01110  33333444444            


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC---
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG---  309 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~---  309 (444)
                               |+-..+++.-+.++...        +.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++....   
T Consensus       136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                     45555666555665443        7899999999999999999999999999999999999864211   


Q ss_pred             -------------CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHH-hcCCCCC
Q 013354          310 -------------QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-IGNSKEL  375 (444)
Q Consensus       310 -------------~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~~~~~  375 (444)
                                   +.....++||+.|+|||++... +|...+|+|++|+|+||++-|..||.+....+.+.+ +.....+
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                         1112346799999999998654 499999999999999999999999988655555433 3344455


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCc---CHHHHHhCCCCCCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRP---TAAWLLEHPFVGNAAP  418 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~elL~hp~~~~~~~  418 (444)
                      ++-...++.|++++|.++|+.+|..|-   .+-++.+|+||+.+.-
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            666778899999999999999999994   5668999999997543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2e-22  Score=184.06  Aligned_cols=146  Identities=18%  Similarity=0.138  Sum_probs=114.3

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc---------------------HHHHHHHHHHHHHHHccCCCC
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS---------------------KESAQQLGQEIALLSRLRHPN  218 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~hpn  218 (444)
                      .+.||+|+||.||+|.+. +|+.||||+++........                     ......+.+|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999998864221110                     111233467999999999998


Q ss_pred             eeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEE
Q 013354          219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       219 Iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vk  297 (444)
                      |.....+....  .++||||+.|+++.........+++..+..++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            75444433332  48999999888655443334578889999999999999999999 9999999999999998 78999


Q ss_pred             EEeccccccccC
Q 013354          298 LADFGMAKHITG  309 (444)
Q Consensus       298 L~DFGla~~~~~  309 (444)
                      |+|||++.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=5.6e-23  Score=190.61  Aligned_cols=173  Identities=14%  Similarity=0.164  Sum_probs=132.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHH------HHHHHHHHHccCCCCeeeEeeeEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ------LGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~------~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ..+|+..++||.|+||.||++..  ++..+|+|+++...  ...+...+.      +.+|+..+.++.|++|..+.+++.
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~--~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV--KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhc--CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            46899999999999999999644  46789999886321  122222233      678999999999999999988755


Q ss_pred             cC--------CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEE
Q 013354          228 LD--------DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       228 ~~--------~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                      ..        ...++||||++|.+|.++.    .+++.    ...+|+.+|..||+.|++|||+||.||+++.++ ++|+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            33        3578999999999998873    23332    456999999999999999999999999999888 9999


Q ss_pred             eccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHH
Q 013354          300 DFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMA  351 (444)
Q Consensus       300 DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ell  351 (444)
                      |||.......+.....           ++. ...+..++|+|+||+++..+.
T Consensus       177 Dfg~~~~~~e~~a~d~-----------~vl-er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAKDR-----------IDL-ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhHHH-----------HHH-HhHhcccccccceeEeehHHH
Confidence            9998876533221111           122 223667899999999987665

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.9e-22  Score=181.46  Aligned_cols=187  Identities=18%  Similarity=0.136  Sum_probs=138.4

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEEEE
Q 013354          158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      .+...|++|+||+||++..  .+..++.+.+....-- ...-....+.+|+++|++|. +++|++++++    +..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~-~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW-LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhh-hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            3467899999999998754  5777777765421000 00111235789999999995 5889999885    3479999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCceEECCCCcEEEEeccccccccCCCCc--
Q 013354          237 EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDI-KGANILVDPSGRVKLADFGMAKHITGQSCP--  313 (444)
Q Consensus       237 e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~NIll~~~~~vkL~DFGla~~~~~~~~~--  313 (444)
                      ||+.|.+|.+.+..      . ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999999765432      1 1357789999999999999999999 799999999999999999999865443310  


Q ss_pred             ------------ccccCCCcccCcccccCcCCCC-hhhhHHHHHHHHHHHHcCCCCCC
Q 013354          314 ------------LSIKGSPYWMAPEVIKNSNGCN-LAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       314 ------------~~~~gt~~y~APE~~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~  358 (444)
                                  .-...++.|+.|+...--...+ .+.+.++.|+-+|.++|+..++-
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                        0122678888888654332233 57899999999999999887753

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=185.80  Aligned_cols=242  Identities=20%  Similarity=0.347  Sum_probs=192.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      ...+...|.+...|..|+|++.  |..++.|++.+   ..-.....+.|.+|.-.|+.+.||||+.+++.|.....+.++
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~v---r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNV---REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--Ccchhhhhhhh---hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            3444556888999999999886  45566777654   223334456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEEE--eccccccccC
Q 013354          236 LEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLA--DFGMAKHITG  309 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL~--DFGla~~~~~  309 (444)
                      ..|++.|+|+.+|.+...  .+..++.+++.+|+.|++|||+..  |.---|....|+||++...+|.  |--++...  
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe--  343 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--  343 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence            999999999999987543  678889999999999999999984  3344688899999998876654  32222211  


Q ss_pred             CCCcccccCCCcccCcccccCcCCC--ChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGC--NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~--s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                          .....++.||+||.+...+..  -.++|+|||++++|||.|...||.+....+---++.-......+|+.++..+.
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~  419 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN  419 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence                112257889999998765432  25799999999999999999999988776655566555666789999999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHH
Q 013354          388 DFVRKCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL  408 (444)
                      .|++-|+..||.+||.+..|+
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988653

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=9.5e-21  Score=174.80  Aligned_cols=136  Identities=21%  Similarity=0.299  Sum_probs=106.7

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-----CCCCeeeEeeeEEcCC--
Q 013354          158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-----RHPNIVRYYGSETLDD--  230 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~--  230 (444)
                      ...++||+|+||.||.  +..++.. +||++....     ....+.+.+|+.+++.+     +||||++++++++++.  
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            3457899999999995  6766655 688876421     12346789999999999     5799999999998863  


Q ss_pred             -EEE-EEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCceEECC----CCcEEEEec
Q 013354          231 -KLY-IYLEY--VSGGSIYKILQDYGQLGESAIRSYTQQILSGL-EYLHAKNTVHRDIKGANILVDP----SGRVKLADF  301 (444)
Q Consensus       231 -~~~-lv~e~--~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivH~Dlkp~NIll~~----~~~vkL~DF  301 (444)
                       .++ +|+||  +.+++|.+++++ ..+++.  ..++.|++.++ +|||+++|+||||||+|||++.    +..++|+||
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence             434 78999  557999999976 456666  35677888777 9999999999999999999964    347999995


Q ss_pred             ccc
Q 013354          302 GMA  304 (444)
Q Consensus       302 Gla  304 (444)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.4e-21  Score=204.91  Aligned_cols=193  Identities=22%  Similarity=0.329  Sum_probs=154.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~  229 (444)
                      .+..|.+.+.||+|+||.||+|...+ |+.||+|+-+....    .    +|.--.+++.+|+   -+.|..+...+...
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----W----EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----e----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            45679999999999999999999887 99999997653211    1    1111223344444   23455555555556


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-------CCcEEEEecc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-------SGRVKLADFG  302 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-------~~~vkL~DFG  302 (444)
                      +.-+||+||.+.|+|.++++..+.+++..+..+..||+..+++||..+||||||||+|+||..       ..-++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            677899999999999999998888999999999999999999999999999999999999932       2349999999


Q ss_pred             cccccc---CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCC
Q 013354          303 MAKHIT---GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP  355 (444)
Q Consensus       303 la~~~~---~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~  355 (444)
                      .+..+.   +........+|-.+-.+|+..+.. |++.+|.|.|+.+++-||.|+.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            987542   233445566888899999998777 9999999999999999999975

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.2e-20  Score=176.10  Aligned_cols=151  Identities=21%  Similarity=0.198  Sum_probs=117.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEE-EcCCCcEEEEEEEeeccccccc-------------------HHHHHHHHHHHHHHH
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGF-NSESGEMCAMKEVTLFSDDAKS-------------------KESAQQLGQEIALLS  212 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~-~~~~g~~vaiK~i~~~~~~~~~-------------------~~~~~~~~~Ei~~l~  212 (444)
                      .+.-|++.+.||+|+||.||+|. +..+|+.||+|+++........                   ......+.+|+.++.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34568899999999999999998 6678999999998753211000                   112234678999999


Q ss_pred             ccCCCC--eeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCceE
Q 013354          213 RLRHPN--IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN-TVHRDIKGANIL  289 (444)
Q Consensus       213 ~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIl  289 (444)
                      ++.+.+  +.++++.   . ..++||||+.|.+|.........+....+..++.||+.+|.+||++| |+||||||+||+
T Consensus       106 ~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      106 RLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            997533  3444432   2 35899999999888776544455677778899999999999999999 999999999999


Q ss_pred             ECCCCcEEEEecccccccc
Q 013354          290 VDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~  308 (444)
                      ++ ++.++|+|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 7889999999887543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=1.7e-21  Score=193.94  Aligned_cols=176  Identities=24%  Similarity=0.390  Sum_probs=140.0

Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      ..+||.|++|.-.+|.+||.++.   ..+...++.++.|++.+++|   ++.+|+|+||.||+...+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35889999999999999997643   36778899999999999999   9999999999999999999999999999987


Q ss_pred             ccCCC-------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          307 ITGQS-------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       307 ~~~~~-------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      .....       ......||..||+||++.+.. |+.++||||||++|+|++. =...|   +....+..+..+...+.+
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEF  481 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHH
Confidence            76555       445667999999999998777 9999999999999999998 22222   222233333333332222


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      -... ++-.+|+.+|+...|.+||++.+.-.|.|.
T Consensus       482 ~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2333 344799999999999999988888888775

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-19  Score=183.53  Aligned_cols=199  Identities=26%  Similarity=0.431  Sum_probs=157.4

Q ss_pred             HHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccCCCCCCce
Q 013354          211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNT-VHRDIKGANI  288 (444)
Q Consensus       211 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i-vH~Dlkp~NI  288 (444)
                      |+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+.. ...++.-....++++|+.||.|||.-.| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 3458888888999999999999999866 9999999999


Q ss_pred             EECCCCcEEEEeccccccccCC---CCcccccCCCcccCcccccCcCC------CChhhhHHHHHHHHHHHHcCCCCCCC
Q 013354          289 LVDPSGRVKLADFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNG------CNLAVDIWSLGCTVIEMATTKPPWSQ  359 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~~~~~~~------~s~~sDvwSlGvil~elltG~~Pf~~  359 (444)
                      +++..+.+||.|||+.......   .......-..-|.|||.++....      .+.+.||||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421   11111223456999999876421      35679999999999999999999976


Q ss_pred             CCC----hhhhHHhcCCCC---CCCCC--CCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          360 YEG----VPAMFKIGNSKE---LPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       360 ~~~----~~~~~~~~~~~~---~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ...    .+...++.+...   .|.+.  ....+++..++++||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            322    233444443122   22322  145668999999999999999999998654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6e-19  Score=163.30  Aligned_cols=139  Identities=21%  Similarity=0.329  Sum_probs=114.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeeccccc---ccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---KSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      +.||+|++|.||+|.+  +|..+++|+........   ........+.+|+.++..+.|++|+....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  57889999764321111   111223567889999999999988777766667777899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      |++|++|.+++.....    ....++.+|+.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999875322    7888999999999999999999999999999998 78899999998865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.1e-18  Score=160.00  Aligned_cols=136  Identities=25%  Similarity=0.338  Sum_probs=107.5

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeeccccc---ccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---KSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      +||+|+||.||+|..  ++..+++|.........   .......++.+|++++..+.|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999974  57889999854321111   1122346778899999999888755444444556667899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       239 ~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ++|++|.+++.....       .++.+|+.+|.+||+.|++|+|++|.||+++ ++.++|+|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999998865321       7889999999999999999999999999999 789999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1e-18  Score=160.43  Aligned_cols=143  Identities=20%  Similarity=0.256  Sum_probs=110.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc-----------------HHHHHHHHHHHHHHHccCCCC
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS-----------------KESAQQLGQEIALLSRLRHPN  218 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~-----------------~~~~~~~~~Ei~~l~~l~hpn  218 (444)
                      .|.+.+.||+|+||.||++.+. +|+.||||++.........                 ........+|+.++..+.+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4778899999999999999875 7999999987643211000                 011224667899999987774


Q ss_pred             --eeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcE
Q 013354          219 --IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV  296 (444)
Q Consensus       219 --Iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~v  296 (444)
                        ++..++    ....++||||+.|++|.++...      .....++.+|+.++.++|+.||+||||||+||+++.++.+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence              444443    2345899999999999876431      3456788999999999999999999999999999999999


Q ss_pred             EEEeccccccccC
Q 013354          297 KLADFGMAKHITG  309 (444)
Q Consensus       297 kL~DFGla~~~~~  309 (444)
                      +|+|||++.....
T Consensus       165 ~liDfg~~~~~~~  177 (198)
T cd05144         165 YIIDWPQMVSTDH  177 (198)
T ss_pred             EEEECCccccCCC
Confidence            9999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.4e-18  Score=181.38  Aligned_cols=142  Identities=21%  Similarity=0.271  Sum_probs=113.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ..|...+.||+|+||+||++.+..  ..+++|+.......   .......+.+.+|+.+++.++|++|+..+.++.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345678899999999999997754  34455543211111   1122234678899999999999999887777777677


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .++||||++|++|.+++.        ....++.||+.+|.+||+.+|+||||||+|||+ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999999886        346789999999999999999999999999999 5778999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=3.3e-20  Score=195.72  Aligned_cols=258  Identities=29%  Similarity=0.439  Sum_probs=207.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~  232 (444)
                      ..|.+.+.||+|.|+.|-...+.. +...+|.|.+....   ........+..|..+-+.+. |.|++.+++.....+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            347777889999999999987743 34556666554322   34455566777888888887 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCceEECCCC-cEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKIL-QDYG-QLGESAIRSYTQQILSGLEYLH-AKNTVHRDIKGANILVDPSG-RVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l-~~~~-~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~  308 (444)
                      +++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999998 5444 5778888999999999999999 99999999999999999999 99999999998765


Q ss_pred             C-CC---CcccccC-CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh--HHhcCC-CCCCCCCC
Q 013354          309 G-QS---CPLSIKG-SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM--FKIGNS-KELPAIPD  380 (444)
Q Consensus       309 ~-~~---~~~~~~g-t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~-~~~~~~~~  380 (444)
                      . ..   .....+| ++.|+|||...+........|+||.|+++.-+++|..||.........  ..+... ........
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 22   2233557 999999999876444577899999999999999999999764433322  111111 11234456


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78899999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=3.6e-17  Score=148.45  Aligned_cols=142  Identities=27%  Similarity=0.333  Sum_probs=99.6

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHH-------------------HHHHHHHHHHHccCCCC--
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-------------------QQLGQEIALLSRLRHPN--  218 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~-------------------~~~~~Ei~~l~~l~hpn--  218 (444)
                      .+.||+|+||+||+|.+. +++.||||+++............                   .....|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 79999999886422111111000                   01135666666664433  


Q ss_pred             eeeEeeeEEcCCEEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcE
Q 013354          219 IVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRV  296 (444)
Q Consensus       219 Iv~l~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~v  296 (444)
                      +.+.++.    ...++||||+.++.+.. .+... ... ..++.++.+++.++.++|. .+|+|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444443    23589999998844321 12211 111 6678899999999999999 9999999999999999 8899


Q ss_pred             EEEeccccccccC
Q 013354          297 KLADFGMAKHITG  309 (444)
Q Consensus       297 kL~DFGla~~~~~  309 (444)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.3e-16  Score=150.82  Aligned_cols=141  Identities=21%  Similarity=0.278  Sum_probs=106.9

Q ss_pred             eeeec-ccCceEEEEEEEcCCCcEEEEEEEeeccc--------ccccHHHHHHHHHHHHHHHccCCCCe--eeEeeeEEc
Q 013354          160 GRLLG-RGTFGHVYLGFNSESGEMCAMKEVTLFSD--------DAKSKESAQQLGQEIALLSRLRHPNI--VRYYGSETL  228 (444)
Q Consensus       160 ~~~LG-~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~--------~~~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~  228 (444)
                      ...|| .|+.|+||++...  +..++||.+.....        ..........+.+|+.++.+|.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 8889999988653  78899998753211        00112334578889999999998775  666665433


Q ss_pred             C-C---EEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          229 D-D---KLYIYLEYVSG-GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       229 ~-~---~~~lv~e~~~g-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      + .   ..++|||+++| .+|.+++.+ ..+++..    +.||+.+|.+||++||+|+||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            2 2   23599999997 699999875 4566543    56899999999999999999999999999888999999998


Q ss_pred             cccc
Q 013354          304 AKHI  307 (444)
Q Consensus       304 a~~~  307 (444)
                      +...
T Consensus       189 ~~~~  192 (239)
T PRK01723        189 GELR  192 (239)
T ss_pred             cccC
Confidence            8653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.6e-16  Score=161.27  Aligned_cols=253  Identities=23%  Similarity=0.236  Sum_probs=198.8

Q ss_pred             Ceeeeeeecc--cCceEEEEEEE--cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          156 RWKKGRLLGR--GTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       156 ~~~~~~~LG~--G~fg~Vy~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      .|...+.+|.  |.+|.||.+..  ..++..+|+|.-+.....   ......=.+|+...+.+ .|+|.++.+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~---p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP---PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC---ccccccccchhhcccccCccccccccCcccccCC
Confidence            4666778999  99999999988  888999999974432211   11112223466655566 4899999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCceEECCC-CcEEEEecccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILS----GLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMA  304 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~-l~~~~~~~i~~qi~~----aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla  304 (444)
                      .+|+-.|+| +.+|..+...... ++...++..+.+...    ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            999999999 5888888877655 889999999999999    9999999999999999999999999 88999999999


Q ss_pred             ccccCCCCcc------cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC
Q 013354          305 KHITGQSCPL------SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI  378 (444)
Q Consensus       305 ~~~~~~~~~~------~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  378 (444)
                      ..+.......      ...|...|++||..++.  ++...|+|++|.++.+..++..++... ....+..+.......++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g-~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVG-KNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCC-CCCCccccccccCchhh
Confidence            8776654221      22478889999998654  688999999999999999877655432 11233333333333455


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      -...+.++...+..|++.++..|++++.++.|+++..
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            5667788888999999999999999999999999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=7.5e-16  Score=133.28  Aligned_cols=131  Identities=24%  Similarity=0.284  Sum_probs=109.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC--CCeeeEeeeEEcCCEEEEEEe
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e  237 (444)
                      .+.||+|.++.||++...  +..+++|.+....    .   ...+.+|+..+..+.+  .++++++......+..+++||
T Consensus         3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~----~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSRE----K---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             ceecccccccceEEEEec--CCeEEEEecCCCC----c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            477999999999999874  4789999875311    1   4567889999999976  588999888887788999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK---NTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      |+.+..+..+       +......++.+++.+|++||..   +++|+|++|+||++++++.++++|||.+..
T Consensus        74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9988777654       5566677889999999999985   699999999999999888999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=1.1e-15  Score=162.75  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+.+.+.+-+-+|.++.++.+.-..+|...++|+..+...  ......+.+..+-.++....+|.+++..-.+......
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~--i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK--IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchh--hccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            44568888889999999999998888888888886653211  1122233444444454445667777777666677889


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc----
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT----  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~----  308 (444)
                      +++++|..+++|...++..+..+++.++.+...+..++++||...+.|+|++|.|+|+..++..++.||+......    
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            9999999999999999988778888888899999999999999999999999999999999999999998432110    


Q ss_pred             --CC--------------------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 013354          309 --GQ--------------------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY  360 (444)
Q Consensus       309 --~~--------------------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~  360 (444)
                        ..                          .......+|+.|.+||.+.+.. ....+|.|++|++++|.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence              00                          0112345899999999998776 678899999999999999999999876


Q ss_pred             CChhhhHHhcC-CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHH---HHHhCCCCCCCC
Q 013354          361 EGVPAMFKIGN-SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA---WLLEHPFVGNAA  417 (444)
Q Consensus       361 ~~~~~~~~~~~-~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~---elL~hp~~~~~~  417 (444)
                      ........+.+ ...++.-+...+.++++++..++..++.+|..+.   ++-.|+||++..
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            65555544433 3344566778899999999999999999999988   899999999653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=1.3e-13  Score=141.58  Aligned_cols=168  Identities=26%  Similarity=0.417  Sum_probs=132.7

Q ss_pred             EEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcC
Q 013354          173 LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG  252 (444)
Q Consensus       173 ~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~  252 (444)
                      .|..+.++.+|.+.+.+.     ...+......+-++.|+.++||||+++++.++.++.+|||.|.+.  .|..++++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~-----~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKR-----SNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeC-----CCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-
Confidence            567778899999998863     122555677888999999999999999999999999999999984  788888764 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc-cccCCCcccCcccccC
Q 013354          253 QLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKN  330 (444)
Q Consensus       253 ~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~-~~~gt~~y~APE~~~~  330 (444)
                        +...+..-+.||+.||.|||. .+++|++|.-..|+|+..|.+||++|.++.......... ...---.|..|+.+..
T Consensus       102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence              367777888999999999985 589999999999999999999999999886544332111 1111223667776533


Q ss_pred             cCCCChhhhHHHHHHHHHHHHcC
Q 013354          331 SNGCNLAVDIWSLGCTVIEMATT  353 (444)
Q Consensus       331 ~~~~s~~sDvwSlGvil~elltG  353 (444)
                      ..   -..|.|-|||+++|++.|
T Consensus       180 s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc---cchhhhhHHHHHHHHhCc
Confidence            22   357999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.2e-15  Score=143.89  Aligned_cols=241  Identities=26%  Similarity=0.351  Sum_probs=159.6

Q ss_pred             eEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----CCEEEEEEeccCCCC
Q 013354          169 GHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----DDKLYIYLEYVSGGS  243 (444)
Q Consensus       169 g~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~~~lv~e~~~ggs  243 (444)
                      -.||++.++..|..|+--.+..- ...+-++..+....-..-|-++.|.|||+++.++.+     .....++.||+..|+
T Consensus        80 d~v~lamd~e~g~evvwneVq~~-~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs  158 (458)
T KOG1266|consen   80 DDVYLAMDTEEGVEVVWNEVQFS-ERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS  158 (458)
T ss_pred             HHHHHHhhhccCchhhHHHHHHH-HhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchh
Confidence            35788888777766654433210 011111111222223344566679999999987654     345788999999999


Q ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCceEECCCCcEEEEeccccccc-----cCCCC
Q 013354          244 IYKILQDY----GQLGESAIRSYTQQILSGLEYLHAK--NTVHRDIKGANILVDPSGRVKLADFGMAKHI-----TGQSC  312 (444)
Q Consensus       244 L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-----~~~~~  312 (444)
                      |..+|++.    ..+.+....+|+-||+.||.|||+.  -|+|+++..+.|++..++-+|+.--......     .....
T Consensus       159 ~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~E  238 (458)
T KOG1266|consen  159 LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAE  238 (458)
T ss_pred             HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhh
Confidence            99999864    2488899999999999999999998  4999999999999999998887532211110     00111


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC-CCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      .....+-++|.+||.=...+ .+.++|||+||++..||.-+..--.. .........+.+.     +...-..--++++.
T Consensus       239 k~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-----i~~len~lqr~~i~  312 (458)
T KOG1266|consen  239 KSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-----IIGLENGLQRGSIT  312 (458)
T ss_pred             hhccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-----eeeccCccccCcCc
Confidence            11223668899999754333 56789999999999999887643211 1111111111111     11111222356899


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .|++.+|..||++.+++.||-+-+.
T Consensus       313 kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  313 KCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             ccccCCCCCCcchhhhhcCceeeec
Confidence            9999999999999999999986553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.1e-14  Score=151.35  Aligned_cols=147  Identities=18%  Similarity=0.213  Sum_probs=96.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-----------------------------ccHHHHHHHHH
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-----------------------------KSKESAQQLGQ  206 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-----------------------------~~~~~~~~~~~  206 (444)
                      .|.. +.||+|++|+||+|+.+.+|+.||||+++......                             .-.+..+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 67999999999999998889999999997431100                             00122223333


Q ss_pred             ------HHHHHHccC----CCCeeeEeeeEEc-CCEEEEEEeccCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 013354          207 ------EIALLSRLR----HPNIVRYYGSETL-DDKLYIYLEYVSGGSIYKI--LQDYG----QLGESAIRSYTQQILSG  269 (444)
Q Consensus       207 ------Ei~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~ggsL~~~--l~~~~----~l~~~~~~~i~~qi~~a  269 (444)
                            |+..+.++.    +.+.+.+-.++.+ ....++||||+.|+.|.++  +...+    .+.+..+..++.||   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence                  443333332    3333333333222 3456799999999999875  33322    13333344444444   


Q ss_pred             HHHHHHCCcccCCCCCCceEECCCC----cEEEEeccccccccCC
Q 013354          270 LEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHITGQ  310 (444)
Q Consensus       270 L~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~~~  310 (444)
                          ...|++|+|+||.||+++.++    .++++|||++..+...
T Consensus       277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                469999999999999999888    8999999999876543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=7.7e-14  Score=142.97  Aligned_cols=145  Identities=19%  Similarity=0.193  Sum_probs=99.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc-----------------------------HHHHH------HHH
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS-----------------------------KESAQ------QLG  205 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~-----------------------------~~~~~------~~~  205 (444)
                      +.||+|++|+||+|+.+ +|+.||||+.+......-.                             .+...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999875 6999999998642111000                             00011      244


Q ss_pred             HHHHHHHccC----CCCeeeEeeeE-EcCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 013354          206 QEIALLSRLR----HPNIVRYYGSE-TLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILS-GLEYLHAKNT  278 (444)
Q Consensus       206 ~Ei~~l~~l~----hpnIv~l~~~~-~~~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~-aL~~LH~~~i  278 (444)
                      +|+..+.++.    +.+-+.+-.++ ......++||||++|.+|.++.... ....   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            4555555552    22223332222 2234578999999999999877532 1222   3445566655 4788999999


Q ss_pred             ccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          279 VHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       279 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +|+|++|.||+++.++.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.2e-14  Score=147.70  Aligned_cols=251  Identities=25%  Similarity=0.192  Sum_probs=183.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEc-CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNS-ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~-~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      .+|.....||.|.|+.|+....+ .++..|++|.+....  ...... ..-..|+.+...+ .|.+++.++..+...+..
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            46888899999999999998755 678899999765321  111111 2223455555555 588899988888888888


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~~~~  311 (444)
                      |+-.|||+++++...+.-...+.+...+++..|++.++.++|++.++|+|+||+||++..+ +..++.|||+.+.+.-..
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence            9999999999988877544568889999999999999999999999999999999999876 778999999887532111


Q ss_pred             CcccccCCCccc-CcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 CPLSIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 ~~~~~~gt~~y~-APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                        ......-+++ ..|.+.....+..+.|+|+||..+.|.+++...-....   ....+. ....+..+... .+++.+.
T Consensus       422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~-~~~~p~~~~~~-~~~q~~~  494 (524)
T KOG0601|consen  422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIR-SGDTPNLPGLK-LQLQVLL  494 (524)
T ss_pred             --ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeee-cccccCCCchH-Hhhhhhh
Confidence              1111233344 35555555557889999999999999999875322211   111221 22233444444 8899999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      +.++.+++..||.+.++..|.-|..
T Consensus       495 kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhcCCccccchhhhhhcccchhhh
Confidence            9999999999999999998876643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=6.6e-13  Score=120.72  Aligned_cols=143  Identities=19%  Similarity=0.235  Sum_probs=102.5

Q ss_pred             eeecccCceEEEEEEEcC------CCcEEEEEEEeecccccc-----------------cHHHHHHHH----HHHHHHHc
Q 013354          161 RLLGRGTFGHVYLGFNSE------SGEMCAMKEVTLFSDDAK-----------------SKESAQQLG----QEIALLSR  213 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~------~g~~vaiK~i~~~~~~~~-----------------~~~~~~~~~----~Ei~~l~~  213 (444)
                      ..||.|--+.||.|....      .+..+|||+.+.......                 .....+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997653      357999999864211000                 011122333    79999999


Q ss_pred             cCC--CCeeeEeeeEEcCCEEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCceE
Q 013354          214 LRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYL-HAKNTVHRDIKGANIL  289 (444)
Q Consensus       214 l~h--pnIv~l~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~NIl  289 (444)
                      +..  -++.+.+++    ...++||||+.+..+.. .+++ ..+++..+..+..+++.+|..| |+.|||||||++.||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            854  355666654    34689999997654422 2332 3456667778889999999998 8999999999999999


Q ss_pred             ECCCCcEEEEeccccccccC
Q 013354          290 VDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~~  309 (444)
                      +. ++.+.|+|||.+.....
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            96 46799999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=4.3e-13  Score=119.42  Aligned_cols=128  Identities=17%  Similarity=0.160  Sum_probs=93.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEEEEEec
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  238 (444)
                      .+.|+.|.++.||++...  ++.|++|.......      ....+.+|+.+++.+.+.++ .+++....  ...++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEe
Confidence            356899999999999764  78899997642110      12245678888888865443 44554433  235799999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCceEECCCCcEEEEecccccc
Q 013354          239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT-----VHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       239 ~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-----vH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      ++|.++.+.     ..   ....++.+++.+|+.||..++     +|+|++|.||+++ ++.++|+||+.+..
T Consensus        73 i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999887653     11   123456799999999999985     9999999999998 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.2e-11  Score=109.20  Aligned_cols=136  Identities=20%  Similarity=0.270  Sum_probs=98.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecc--c-ccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEe
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS--D-DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~--~-~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  237 (444)
                      .++.+|+-+.+|.+.+.  |..+++|.-....  . ..+.+-...+..+|++++.++.--.|..-+-+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45789999999998553  4456666432111  1 12223345677889999999865444333333344555679999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       238 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      |++|..|.+.+...       ...++..+-..+.-||..||||+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999874       245677777888899999999999999999997654 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.29  E-value=3.6e-11  Score=105.85  Aligned_cols=146  Identities=23%  Similarity=0.254  Sum_probs=106.2

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEeeccc---ccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD---DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~---~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      ...+|-+|+-+.|+++.+  .|+.++||.-.....   ..+.+-..++..+|++.+.++.--.|.--.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            467899999999999965  488888885321111   123334457788999999988644443333334444556789


Q ss_pred             EeccCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEecccccc
Q 013354          236 LEYVSG-GSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKH  306 (444)
Q Consensus       236 ~e~~~g-gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~  306 (444)
                      |||++| .++.+++.....  ........++++|-+.+.-||.++||||||..+||++..++   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 478888876432  33334478999999999999999999999999999996544   369999999764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=4.4e-10  Score=112.71  Aligned_cols=213  Identities=17%  Similarity=0.194  Sum_probs=156.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----CCEEEEEEeccCC-
Q 013354          167 TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----DDKLYIYLEYVSG-  241 (444)
Q Consensus       167 ~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~~~g-  241 (444)
                      .-.+.|++....+|..|++|++...++....     ....-++.++++.|.|||++.+++..    +..+++|++|.++ 
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            3457899999999999999988533222211     12235678899999999999998773    5578999999864 


Q ss_pred             CCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          242 GSIYKILQDY---------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       242 gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      ++|.++....               ...+|..+|.++.||..||.++|+.|+.-+-|.+.+||++.+.+++|...|....
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence            5777765321               2367899999999999999999999999999999999999988999988887766


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCC-CCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      +..+..             |-+...    .+-|.=.||.+++.|.+|..- +..    ......    ....+...++.+
T Consensus       443 l~~d~~-------------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~----d~~~~s----~~~~I~~~yS~D  497 (655)
T KOG3741|consen  443 LQEDPT-------------EPLESQ----QQNDLRDLGLLLLALATGTENSNRT----DSTQSS----HLTRITTTYSTD  497 (655)
T ss_pred             ecCCCC-------------cchhHH----hhhhHHHHHHHHHHHhhcccccccc----cchHHH----HHHHhhhhhhHH
Confidence            654430             122222    367999999999999998542 111    111110    112445668899


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++++|..+...++++ -++++++.+
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999999886 567766654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=6.1e-11  Score=109.99  Aligned_cols=140  Identities=21%  Similarity=0.241  Sum_probs=102.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC--CeeeEeeeEEcC---CEEEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP--NIVRYYGSETLD---DKLYIY  235 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~~---~~~~lv  235 (444)
                      +.|+.|.++.||++...+ |+.+++|.......    ......+.+|+.++..+.+.  ++.+++.+....   +..++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~----~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGAL----LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCccc----CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            568999999999997643 68899997653211    11335678899999998753  456677665543   356899


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA----------------------------------------  275 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~----------------------------------------  275 (444)
                      |||++|.++.+.+.. ..+++.....++.+++.+|..||+                                        
T Consensus        79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999999888775532 346666666777777777777763                                        


Q ss_pred             ----------------CCcccCCCCCCceEECC--CCcEEEEecccccc
Q 013354          276 ----------------KNTVHRDIKGANILVDP--SGRVKLADFGMAKH  306 (444)
Q Consensus       276 ----------------~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~  306 (444)
                                      ..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23699999999999988  56689999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=1.9e-10  Score=104.15  Aligned_cols=131  Identities=25%  Similarity=0.324  Sum_probs=85.3

Q ss_pred             EEEEEEEcCCCcEEEEEEEeeccc---------------------ccccHHHHHHHHHHHHHHHccCCC--CeeeEeeeE
Q 013354          170 HVYLGFNSESGEMCAMKEVTLFSD---------------------DAKSKESAQQLGQEIALLSRLRHP--NIVRYYGSE  226 (444)
Q Consensus       170 ~Vy~a~~~~~g~~vaiK~i~~~~~---------------------~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~  226 (444)
                      .||.|... +|..+|+|+.+....                     ............+|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999764 488999998864210                     011122345677899999999766  466666543


Q ss_pred             EcCCEEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          227 TLDDKLYIYLEYVS--GGSIYKILQDYGQLGESAIRSYTQQILSGLEY-LHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       227 ~~~~~~~lv~e~~~--ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                        +  .+|||||+.  |..+..+...  .++......++.+++..+.. +|+.|||||||.+.||+++++ .+.|+|||.
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence              2  469999998  6556554432  22244566777888885555 579999999999999999877 899999998


Q ss_pred             ccccc
Q 013354          304 AKHIT  308 (444)
Q Consensus       304 a~~~~  308 (444)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=1.1e-09  Score=104.80  Aligned_cols=144  Identities=13%  Similarity=0.031  Sum_probs=97.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHH------HHHHHHHHHHHHHccCCCCe--eeEeeeEEc----
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE------SAQQLGQEIALLSRLRHPNI--VRYYGSETL----  228 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~------~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~----  228 (444)
                      +++-.-....|++...  .|+.|.||......-...-+.      -...+.+|...+.+|...+|  +..+.+.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3344444445666543  478899996632110000000      01136688888877743333  233333332    


Q ss_pred             -CCEEEEEEeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-------CCcEE
Q 013354          229 -DDKLYIYLEYVSGG-SIYKILQD--YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-------SGRVK  297 (444)
Q Consensus       229 -~~~~~lv~e~~~gg-sL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-------~~~vk  297 (444)
                       ....++|+|++++. +|.+++..  ....+......++.+|+..+..||..||+|+|+++.|||++.       +..+.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence             23578999999875 89999864  234667778899999999999999999999999999999975       46799


Q ss_pred             EEecccccc
Q 013354          298 LADFGMAKH  306 (444)
Q Consensus       298 L~DFGla~~  306 (444)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.10  E-value=3.9e-11  Score=124.06  Aligned_cols=153  Identities=24%  Similarity=0.351  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc----------cccCCCcccCcccccCcCC
Q 013354          265 QILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----------SIKGSPYWMAPEVIKNSNG  333 (444)
Q Consensus       265 qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~----------~~~gt~~y~APE~~~~~~~  333 (444)
                      +++.||.|+|.. ++||+.|.|++|.++.++.+||+.|+++....+.....          ...-...|.|||++.... 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence            445999999987 89999999999999999999999999886554422110          112456799999997644 


Q ss_pred             CChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhc--CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          334 CNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       334 ~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+.++|+||+||++|.+.. |+.-+.............  .....-.....++.|+++=|.+++..+..-||++.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            7889999999999999995 555554433222221111  1111223457889999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 013354          411 PFVGNAAP  418 (444)
Q Consensus       411 p~~~~~~~  418 (444)
                      |||.+...
T Consensus       266 ~ff~D~~~  273 (700)
T KOG2137|consen  266 PFFSDPGL  273 (700)
T ss_pred             cccCCchh
Confidence            99998643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.06  E-value=4.5e-09  Score=103.17  Aligned_cols=236  Identities=19%  Similarity=0.219  Sum_probs=153.7

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeee--------EeeeEEc
Q 013354          158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVR--------YYGSETL  228 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~--------l~~~~~~  228 (444)
                      ..++.||+|+-+.+|-.-.   -...+-|++......     ...+.   +..|... .||-+..        ++|- ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa-----~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~-~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPA-----AQAQK---VAELAATPDAPLLNYRVAWPQATLHGG-RR   81 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCch-----HHHHH---HHHhccCCCCcchhhhhcccHHHhhCC-Cc
Confidence            3457799999999997532   223455766532211     11111   2222332 4554333        2221 11


Q ss_pred             CCEEEEEEeccCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          229 DDKLYIYLEYVSGG-SIYKILQ------DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       229 ~~~~~lv~e~~~gg-sL~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                      ...+.++|..+.|. .+.+++.      .+....+..+++.++.|+.+.+.||+.|.+-||+.++|+||.+++.|.|+|=
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence            22378889888764 2334332      2234778899999999999999999999999999999999999999999987


Q ss_pred             cccccccCCCCcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCCh-----hhhHHhcC
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV-----PAMFKIGN  371 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~-----~~~~~~~~  371 (444)
                      ..-....+...+...+|...|.+||.-.-    +.+-+...|.|.||++|+++|.| +.||.+....     .....|..
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            65554455555666779999999998541    12246789999999999999985 9999753211     11111111


Q ss_pred             -------CCCC-----C-CCC-CCCCHHHHHHHHHHhhh--CCCCCcCHH
Q 013354          372 -------SKEL-----P-AIP-DHLSDEGKDFVRKCLQR--NPLHRPTAA  405 (444)
Q Consensus       372 -------~~~~-----~-~~~-~~~s~~l~~Li~~~L~~--dP~~Rpt~~  405 (444)
                             ....     | .+| .-++++++.|..+|+..  ++.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                   1111     1 111 23688999999999974  356899986

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=2.1e-09  Score=100.55  Aligned_cols=143  Identities=23%  Similarity=0.298  Sum_probs=104.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---------------ccc--HHHHHHHHHHHHHHHccCCC-
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---------------AKS--KESAQQLGQEIALLSRLRHP-  217 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---------------~~~--~~~~~~~~~Ei~~l~~l~hp-  217 (444)
                      -..++..||-|--+.||.|.+. .|..+|||.-+.....               ..+  ........+|.+.|.+|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3566788999999999999876 4899999975432110               011  11234556799999999655 


Q ss_pred             -CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcE
Q 013354          218 -NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV  296 (444)
Q Consensus       218 -nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~v  296 (444)
                       .+.+.+++    +...+||||++|..|...-     ++.+....++..|++-+..+-+.||||||+++-||+++++|.+
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence             66666653    3468999999997776542     2344555666667777776778999999999999999999999


Q ss_pred             EEEecccccccc
Q 013354          297 KLADFGMAKHIT  308 (444)
Q Consensus       297 kL~DFGla~~~~  308 (444)
                      .++||-.+....
T Consensus       242 ~vIDwPQ~v~~~  253 (304)
T COG0478         242 VVIDWPQAVPIS  253 (304)
T ss_pred             EEEeCcccccCC
Confidence            999998765543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=8.2e-09  Score=95.37  Aligned_cols=106  Identities=25%  Similarity=0.335  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHccCCCC--eeeEeeeEEcC----CEEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013354          202 QQLGQEIALLSRLRHPN--IVRYYGSETLD----DKLYIYLEYVSG-GSIYKILQDYGQLGESAIRSYTQQILSGLEYLH  274 (444)
Q Consensus       202 ~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~e~~~g-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH  274 (444)
                      ....+|...+..|..-.  +++.+.+....    ...++|+|++++ .+|.+++......+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            45677887777774332  33444444332    245899999987 489999987555777888899999999999999


Q ss_pred             HCCcccCCCCCCceEECCCC---cEEEEeccccccc
Q 013354          275 AKNTVHRDIKGANILVDPSG---RVKLADFGMAKHI  307 (444)
Q Consensus       275 ~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~  307 (444)
                      ++||+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999998887   7999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.79  E-value=7.5e-08  Score=88.07  Aligned_cols=141  Identities=13%  Similarity=0.150  Sum_probs=99.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeeccc-ccccHHHHHHHHHHHHHHHccCCCC--eeeEeeeEE-c----CCEEEE
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSD-DAKSKESAQQLGQEIALLSRLRHPN--IVRYYGSET-L----DDKLYI  234 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~-~----~~~~~l  234 (444)
                      -|+||-+-|+.....  |+.+-+|....... ......-...|.+|+..+.+|..-+  +.+.+ ++. .    .-..+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            367888889986443  55788886641111 1110223467888999888885332  34443 222 1    234689


Q ss_pred             EEeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc--EEEEecccccc
Q 013354          235 YLEYVSG-GSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKH  306 (444)
Q Consensus       235 v~e~~~g-gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~  306 (444)
                      |+|-+.| .+|.+++.+.  .+.++.....+..+|+.+++-||+.|+.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997743 6899998763  34577777899999999999999999999999999999986667  99999987653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.71  E-value=2.6e-07  Score=101.02  Aligned_cols=211  Identities=23%  Similarity=0.285  Sum_probs=154.5

Q ss_pred             HHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE----EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013354          199 ESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY----IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH  274 (444)
Q Consensus       199 ~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~----lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH  274 (444)
                      ...+....|+..+..+.|+|++.++.+...+....    +..++|...++...+...+.++....+.+..++.+||+|+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            34455566888889999999999998876654433    44678999999999999889999999999999999999999


Q ss_pred             HCCcccCCCCCC---ceEECCCCcEEEE--eccccccccCCCCcccccCCCcccCcccccCcCC-CChhhhHHHHHHHHH
Q 013354          275 AKNTVHRDIKGA---NILVDPSGRVKLA--DFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG-CNLAVDIWSLGCTVI  348 (444)
Q Consensus       275 ~~~ivH~Dlkp~---NIll~~~~~vkL~--DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~s~~sDvwSlGvil~  348 (444)
                      +....|.-+...   +.-++.++.+.+.  ||+....+..........-+..|.++|....... .....|+|.+|....
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            996666555444   4444556666666  9988887766555444555677889998765441 233479999999999


Q ss_pred             HHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCc
Q 013354          349 EMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       349 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~  420 (444)
                      .+..|..+-....   ...        ..++.....++.+++.+|+.-+.++|+++.+++.|+|.+.....+
T Consensus       384 ~~~~~~~i~~~~~---~~~--------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~  444 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA---VPV--------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNE  444 (1351)
T ss_pred             hhhhcCccccccc---chh--------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccc
Confidence            9998765321110   000        112222333788999999999999999999999999998654443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.69  E-value=2e-09  Score=110.42  Aligned_cols=242  Identities=24%  Similarity=0.236  Sum_probs=171.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~l  234 (444)
                      .+.....+++|+++.+|+.+...+...+ .+.+...          ....-++++|.+++||| .+..++.+..+...++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3455567899999999999877654444 6665421          33445888999999999 7888888888899999


Q ss_pred             EEeccCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          235 YLEYVSGG-SIYKIL-QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       235 v~e~~~gg-sL~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +++++.++ +-.... .....+.+.+...+.+.-++++++||+.-=+|+|    ||+..+ +..++.||+....+.....
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence            99999876 221111 1111244455566667778899999998778998    777765 6799999999887766656


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC---CCCCHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP---DHLSDEGKDF  389 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~s~~l~~L  389 (444)
                      .....+++.++|||+..... +....|+|++++--.+|.-|.+|-..  .......+.++...+.+.   .+-+.+-.++
T Consensus       387 ~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             cccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCC
Confidence            66777999999999887766 88899999999887778777776543  112222222222111111   1111222257


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ...|+...|..|+....++.|.+|..-
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccC
Confidence            888999999999999999999999854

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.1e-07  Score=98.59  Aligned_cols=145  Identities=20%  Similarity=0.250  Sum_probs=93.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeeccc----------------------c---ccc----HHHHH------HHH
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD----------------------D---AKS----KESAQ------QLG  205 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~----------------------~---~~~----~~~~~------~~~  205 (444)
                      +-|+.++-|+||+|+.+. |+.||||+.+..-.                      .   ...    .+..+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            458999999999999876 99999999863200                      0   000    11112      223


Q ss_pred             HHHHHHHccC-----CCCeeeEeeeE-EcCCEEEEEEeccCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013354          206 QEIALLSRLR-----HPNIVRYYGSE-TLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEYLHAKN  277 (444)
Q Consensus       206 ~Ei~~l~~l~-----hpnIv~l~~~~-~~~~~~~lv~e~~~ggsL~~~l--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  277 (444)
                      +|...+.+++     .++| ++=.++ +....-.++|||++|..+.++.  +. ..++...+.....++  -+..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence            3444444442     2332 222222 3345578999999999999884  44 445544443333332  223344589


Q ss_pred             cccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       278 ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++|.|..|.||+++.++.+.+.|||+...+...
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            999999999999999999999999998876554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.60  E-value=6.9e-07  Score=82.15  Aligned_cols=138  Identities=17%  Similarity=0.254  Sum_probs=87.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHH------HHHHHHHHHccCC---CCeeeEeee
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ------LGQEIALLSRLRH---PNIVRYYGS  225 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~------~~~Ei~~l~~l~h---pnIv~l~~~  225 (444)
                      .+|+..+++-......|.+-  .-+|+.+++|..+-..  ...+.....      ..+++..+..+..   ..++.++-+
T Consensus        31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            46777788877777777665  3358899999765311  111111111      2233343344432   222222222


Q ss_pred             -----EEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEe
Q 013354          226 -----ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       226 -----~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                           +......+++|||++|..|.+...    +++    .+...|.+++.-||+.|++|+|..|.|+++++++ ++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence                 122234678999999998877642    333    2445677889999999999999999999998655 99999


Q ss_pred             ccccc
Q 013354          301 FGMAK  305 (444)
Q Consensus       301 FGla~  305 (444)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.52  E-value=9.4e-07  Score=82.22  Aligned_cols=138  Identities=25%  Similarity=0.359  Sum_probs=81.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC--CeeeEeeeE---EcCCEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP--NIVRYYGSE---TLDDKLYI  234 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~---~~~~~~~l  234 (444)
                      .+.|+.|..+.||+.....  ..+++|....       ......+.+|..+++.+...  .+.+++...   ......++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            4678999999999997654  5899997641       14556777888888888533  345666533   23446799


Q ss_pred             EEeccCCCCHHH----------------HHH---hc-CC---CCH-H-----HHHHH---------------HHHHHH-H
Q 013354          235 YLEYVSGGSIYK----------------ILQ---DY-GQ---LGE-S-----AIRSY---------------TQQILS-G  269 (444)
Q Consensus       235 v~e~~~ggsL~~----------------~l~---~~-~~---l~~-~-----~~~~i---------------~~qi~~-a  269 (444)
                      +|++++|..+..                .+.   .. ..   +.. .     ....+               ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999988877                111   11 00   000 0     00000               111222 3


Q ss_pred             HHHHHH-------CCcccCCCCCCceEEC-CCCcEEEEecccccc
Q 013354          270 LEYLHA-------KNTVHRDIKGANILVD-PSGRVKLADFGMAKH  306 (444)
Q Consensus       270 L~~LH~-------~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~  306 (444)
                      +..+++       ..++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            333332       3599999999999998 566678999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=8.8e-07  Score=83.00  Aligned_cols=133  Identities=12%  Similarity=0.127  Sum_probs=81.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC--eeeEeeeEEcCCEEEEEEec
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN--IVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~  238 (444)
                      ..||+|..+.||+.    .+..+++|.....    .   ....+.+|.++++.+..-.  +.+.+++....+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----F---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCC----C---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            56899999999984    2556778876421    1   2234678999998886433  46777777777788999999


Q ss_pred             cCCCC-HHHHH--------------Hh-------c--CCCCHHH-HHHHHHH----------HHH-HHHHHHH----CCc
Q 013354          239 VSGGS-IYKIL--------------QD-------Y--GQLGESA-IRSYTQQ----------ILS-GLEYLHA----KNT  278 (444)
Q Consensus       239 ~~ggs-L~~~l--------------~~-------~--~~l~~~~-~~~i~~q----------i~~-aL~~LH~----~~i  278 (444)
                      ++|.+ +...+              .+       -  ....... ...+..+          +.. ...+|..    ..+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            98863 21111              10       0  0111111 0111111          111 1222221    147


Q ss_pred             ccCCCCCCceEECCCCcEEEEeccccc
Q 013354          279 VHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       279 vH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      +|+|+.|.||++++++ +.|+||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            8999999999999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.47  E-value=2e-06  Score=79.98  Aligned_cols=141  Identities=19%  Similarity=0.209  Sum_probs=91.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc-----------------HH--HHHHHHHHHHHHHccCC--CCe
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS-----------------KE--SAQQLGQEIALLSRLRH--PNI  219 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~-----------------~~--~~~~~~~Ei~~l~~l~h--pnI  219 (444)
                      ..|..|--+.||+|.. .++..+|+|+++........                 ..  ...=..+|+.-|+++..  -.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3577888899999975 45899999998743211111                 00  01112346666666642  233


Q ss_pred             eeEeeeEEcCCEEEEEEeccCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEE
Q 013354          220 VRYYGSETLDDKLYIYLEYVSGGS-IYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       220 v~l~~~~~~~~~~~lv~e~~~ggs-L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vk  297 (444)
                      .+-+.+..    -.|||||+.... -.-.|+.. .+...++..+..++++.+.-|-. .++||+||+.-|||+. ++.+.
T Consensus       133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeecC----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            44444332    469999994321 11122221 23333677888899998888876 8999999999999998 78899


Q ss_pred             EEecccccccc
Q 013354          298 LADFGMAKHIT  308 (444)
Q Consensus       298 L~DFGla~~~~  308 (444)
                      |+||+.+....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=6.7e-06  Score=77.78  Aligned_cols=133  Identities=17%  Similarity=0.096  Sum_probs=80.0

Q ss_pred             ecccCc-eEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          163 LGRGTF-GHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       163 LG~G~f-g~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      |-.|.. ..||+....  +..+++|.....     .   ...+.+|+++++.+. +--+.+++++....+..++|||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~-----~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSG-----P---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCC-----c---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            344544 789998543  467778865421     1   235667888888874 3446677777776667899999999


Q ss_pred             CCCHHHHHH----------------hcCCCC-------HH--HHHHHHH--------------------HHHHHHHHHHH
Q 013354          241 GGSIYKILQ----------------DYGQLG-------ES--AIRSYTQ--------------------QILSGLEYLHA  275 (444)
Q Consensus       241 ggsL~~~l~----------------~~~~l~-------~~--~~~~i~~--------------------qi~~aL~~LH~  275 (444)
                      |.+|.....                +-..++       ..  .......                    .+...+..|-.
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            987764320                000011       00  0000000                    01112222211


Q ss_pred             -------CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 -------KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 -------~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                             ..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                   248999999999999988778899998664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.26  E-value=2.4e-05  Score=71.59  Aligned_cols=133  Identities=23%  Similarity=0.324  Sum_probs=93.4

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-----------cccHHHHHHHHHHHHHHHccC------CCCeeeE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-----------AKSKESAQQLGQEIALLSRLR------HPNIVRY  222 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-----------~~~~~~~~~~~~Ei~~l~~l~------hpnIv~l  222 (444)
                      ...||+|+.-.||.-  .. .....||+.......           ........+..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            467999999999973  43 455678988653300           000112355566666655554      7899999


Q ss_pred             eeeEEcCCEEEEEEeccC------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC--C
Q 013354          223 YGSETLDDKLYIYLEYVS------GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS--G  294 (444)
Q Consensus       223 ~~~~~~~~~~~lv~e~~~------ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~  294 (444)
                      +|+.+++.-..+|+|.+.      .-+|.+++++ +.+++ .   +...+-+-.+||-+++|+.+|++|.||++..+  +
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999998999999874      3468888865 45666 3   33444555678889999999999999999433  2


Q ss_pred             --cEEEEe
Q 013354          295 --RVKLAD  300 (444)
Q Consensus       295 --~vkL~D  300 (444)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.25  E-value=4.4e-05  Score=69.52  Aligned_cols=130  Identities=25%  Similarity=0.288  Sum_probs=90.9

Q ss_pred             CCeeeeeeecccCc-eEEEEEEEcCCCcEEEEEEEeecccc--------cc--c------HHHHHHHHHHHHHHHccC--
Q 013354          155 SRWKKGRLLGRGTF-GHVYLGFNSESGEMCAMKEVTLFSDD--------AK--S------KESAQQLGQEIALLSRLR--  215 (444)
Q Consensus       155 ~~~~~~~~LG~G~f-g~Vy~a~~~~~g~~vaiK~i~~~~~~--------~~--~------~~~~~~~~~Ei~~l~~l~--  215 (444)
                      ..++..+.||.|.- |.||+++.  +|+.||+|+.+.....        ..  .      .....-|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67999999999999 99999965  4889999994321110        00  0      023346777888766664  


Q ss_pred             -CCCe--eeEeeeEEcC------------------CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013354          216 -HPNI--VRYYGSETLD------------------DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH  274 (444)
Q Consensus       216 -hpnI--v~l~~~~~~~------------------~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH  274 (444)
                       +.++  |+++|+..-.                  ....||.||+....         .+...    -+.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence             4455  9999986432                  12467888876533         22333    3456777788999


Q ss_pred             HCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          275 AKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       275 ~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      ..||+-+|+++.|..     .=+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999987     3578999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=5.8e-06  Score=73.02  Aligned_cols=130  Identities=22%  Similarity=0.242  Sum_probs=91.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCee-eEeeeEEcCCEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV-RYYGSETLDDKLYIY  235 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lv  235 (444)
                      .+..+.|++|++|.||++.++  |..+|+|+-+.       ......+..|+++|..+.--++. +++.+..    .++.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~   90 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIR   90 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecC-------CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhh
Confidence            455678999999999999876  66899997652       22345677899999998765553 4554433    3455


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCC-CceEECCCCcEEEEecccccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKG-ANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp-~NIll~~~~~vkL~DFGla~~  306 (444)
                      |||+.|-.|.++-...   +    .+-...+++.---|-..||-|+.|.- ..++|.+++.+.|+||..|+.
T Consensus        91 me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9999998888876531   2    22334566665567778999999964 444444555899999998874

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=8.5e-06  Score=84.56  Aligned_cols=144  Identities=22%  Similarity=0.242  Sum_probs=90.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccc--------------------------cccHHHHHHHHHHHHHHHc-
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD--------------------------AKSKESAQQLGQEIALLSR-  213 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~--------------------------~~~~~~~~~~~~Ei~~l~~-  213 (444)
                      +-|+.-+.|+||+|+.+. |+.||||+.+..-..                          ..-++..+.+..|+...+. 
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999876 999999987532110                          0111222333333333222 


Q ss_pred             ---------cCCCC------eeeEeeeEEcCCEEEEEEeccCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013354          214 ---------LRHPN------IVRYYGSETLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEYLHAK  276 (444)
Q Consensus       214 ---------l~hpn------Iv~l~~~~~~~~~~~lv~e~~~ggsL~~~l--~~~~~l~~~~~~~i~~qi~~aL~~LH~~  276 (444)
                               +.|-+      |.+++-.  ......|+||||+|..+.|+-  ++ ..++...+..-+.+...  ..|-..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence                     22334      3344332  234578999999998887653  33 34665544443333321  223456


Q ss_pred             CcccCCCCCCceEECC----CCcEEEEeccccccccCC
Q 013354          277 NTVHRDIKGANILVDP----SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~----~~~vkL~DFGla~~~~~~  310 (444)
                      |++|+|-.|.||++..    ++.+.+.|||+.......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            8999999999999984    667999999998766543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=1.8e-05  Score=88.04  Aligned_cols=80  Identities=20%  Similarity=0.265  Sum_probs=54.2

Q ss_pred             eeeecccCceEEEEEEEcCCC--cEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCe--eeEeeeEEcC---CE
Q 013354          160 GRLLGRGTFGHVYLGFNSESG--EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNI--VRYYGSETLD---DK  231 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g--~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~  231 (444)
                      .+.|+.|.+..+|+......+  ..+++|+....    ........+.+|+++|+.+. |.++  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~----~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPG----KLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCC----ccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            466899999999998765432  46777754311    11112246778999999995 6654  7777776653   46


Q ss_pred             EEEEEeccCCCC
Q 013354          232 LYIYLEYVSGGS  243 (444)
Q Consensus       232 ~~lv~e~~~ggs  243 (444)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=3.1e-05  Score=70.34  Aligned_cols=98  Identities=28%  Similarity=0.269  Sum_probs=79.0

Q ss_pred             HHHHHHHHccCC-CCeeeEeeeEEcCCEEEEEEeccCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Q 013354          205 GQEIALLSRLRH-PNIVRYYGSETLDDKLYIYLEYVSGGSIYK---ILQDYGQLGESAIRSYTQQILSGLEYLHAK---N  277 (444)
Q Consensus       205 ~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~ggsL~~---~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  277 (444)
                      ..|.-+|+.+.+ +++++++|.|-    .++|.||+..+++..   .+......++..+.+++.++++.+.+|+..   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888888876 69999999985    367899997766642   122223568999999999999999999883   4


Q ss_pred             cccCCCCCCceEECCCCcEEEEecccccc
Q 013354          278 TVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       278 ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      +.-.|++++|+-|+.++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            67789999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.11  E-value=1.1e-05  Score=75.94  Aligned_cols=72  Identities=14%  Similarity=0.143  Sum_probs=44.1

Q ss_pred             eeecccCce-EEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC---CeeeEeeeEEcC---CEEE
Q 013354          161 RLLGRGTFG-HVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP---NIVRYYGSETLD---DKLY  233 (444)
Q Consensus       161 ~~LG~G~fg-~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~---~~~~  233 (444)
                      +.|+.|+.. .||+.     +..+++|....       ......+.+|++++..+...   .+.++++.....   ...+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~   70 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW   70 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence            457777776 48976     23566775431       11234688899998887532   344455443332   2357


Q ss_pred             EEEeccCCCCH
Q 013354          234 IYLEYVSGGSI  244 (444)
Q Consensus       234 lv~e~~~ggsL  244 (444)
                      ++|++++|.++
T Consensus        71 ~l~~~i~G~~l   81 (235)
T cd05155          71 SVYRWLEGETA   81 (235)
T ss_pred             EEEEeecCCCC
Confidence            89999988776

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.97  E-value=4.7e-06  Score=80.18  Aligned_cols=142  Identities=17%  Similarity=0.192  Sum_probs=99.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc---------------ccHHH--HHHHHHHHHHHHccCC-
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---------------KSKES--AQQLGQEIALLSRLRH-  216 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~---------------~~~~~--~~~~~~Ei~~l~~l~h-  216 (444)
                      .-+.+++.||-|--+.||.+-+.. |...++|.-++.....               .....  .-...+|...|+.|.. 
T Consensus        92 ~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   92 SVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            346677889999999999998764 8889999654321110               00111  1234568888888843 


Q ss_pred             -CCeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          217 -PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       217 -pnIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                       --+.+.+++    ...++|||++.|..|.+.-+-      ..+..+...++.-+.-|-.+|+||+|..--||+|++++.
T Consensus       171 gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  171 GFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence             234445543    457899999999888765421      223345556667777888999999999999999999999


Q ss_pred             EEEEeccccccc
Q 013354          296 VKLADFGMAKHI  307 (444)
Q Consensus       296 vkL~DFGla~~~  307 (444)
                      ++++||-.....
T Consensus       241 i~vIDFPQmvS~  252 (465)
T KOG2268|consen  241 IVVIDFPQMVST  252 (465)
T ss_pred             EEEeechHhhcc
Confidence            999999865443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.95  E-value=1.5e-06  Score=97.02  Aligned_cols=215  Identities=15%  Similarity=0.058  Sum_probs=146.5

Q ss_pred             HHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 013354          200 SAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYL  273 (444)
Q Consensus       200 ~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~L  273 (444)
                      ..+....|..-++...|+++.....-...  ....+.+++|+.+|.+++.|-+.    ..+.+..+.....+.+....-+
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            34445556556666789888776654332  34568899999999999998653    2355555555555557777777


Q ss_pred             HHC-C----cccCCCCCCceEECCCCcEEEEeccccccccC-CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHH
Q 013354          274 HAK-N----TVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTV  347 (444)
Q Consensus       274 H~~-~----ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil  347 (444)
                      |+. +    .+|+++|+-|.+|..+..+++.++|+.+.... ........+++.|+.+++...-. ++.++|+|..++.+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSL 1430 (2724)
T ss_pred             hhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHH
Confidence            765 1    68999999999999999999999999983322 22233445788899999875544 78889999999999


Q ss_pred             HHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          348 IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       348 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |+...|..+|..... ..+..+......-.++.-.+.+.-.....+|-..-..||.-..++..+.|...
T Consensus      1431 y~rs~~n~~fi~flq-~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQ-PALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred             HHHhcccHHHHHHHH-HHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence            999999887742111 11122222222223344444444445555666667789999999998888754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.79  E-value=0.00055  Score=69.30  Aligned_cols=82  Identities=16%  Similarity=0.169  Sum_probs=53.3

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-ccc-HHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcCCEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AKS-KESAQQLGQEIALLSRLR---HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~~-~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+.||.|.+..||++.+...++.++||.-...... ... ....++...|.+.|..+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999988643358999974311110 010 123456667778777763   3457777765  3455789


Q ss_pred             EEeccCCCC
Q 013354          235 YLEYVSGGS  243 (444)
Q Consensus       235 v~e~~~ggs  243 (444)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997644

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.00036  Score=68.20  Aligned_cols=79  Identities=16%  Similarity=0.100  Sum_probs=54.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC---CCeeeEeeeEEc---CC
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---PNIVRYYGSETL---DD  230 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~---~~  230 (444)
                      ....+.||.|..+.||+....  +..+++|..+.       ......+..|...|+.|.-   -.+.++++++..   .+
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g   86 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--QGNPMPLMARS-------FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG   86 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--CCCEEEEEecc-------cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence            344567999999999998543  23466776431       0012467788888888843   357788877654   36


Q ss_pred             EEEEEEeccCCCCH
Q 013354          231 KLYIYLEYVSGGSI  244 (444)
Q Consensus       231 ~~~lv~e~~~ggsL  244 (444)
                      ..+||||+++|.++
T Consensus        87 ~~~LVmE~i~G~~~  100 (297)
T PRK10593         87 PDVLLLERLRGVSV  100 (297)
T ss_pred             CeEEEEeccCCEec
Confidence            68999999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.68  E-value=0.0002  Score=67.13  Aligned_cols=75  Identities=11%  Similarity=0.136  Sum_probs=45.5

Q ss_pred             eeeecccCceEEEEEEEcC-CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCCEEEEEEe
Q 013354          160 GRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDDKLYIYLE  237 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e  237 (444)
                      .+.|..|-...||+..... +++.|++|+......      ......+|+.+++.+...+ .++++..+.  +  .++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence            3567788888999986443 357888886642111      1112336788888775333 344444332  2  37999


Q ss_pred             ccCCCCH
Q 013354          238 YVSGGSI  244 (444)
Q Consensus       238 ~~~ggsL  244 (444)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00015  Score=69.20  Aligned_cols=132  Identities=20%  Similarity=0.268  Sum_probs=73.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEEEEEeccCC
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLYIYLEYVSG  241 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~g  241 (444)
                      +..|-...+|+..  .+++.+++|.....     .....-...+|..+++.+....+ .+++....    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~-----~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPV-----CKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcc-----cccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence            4557777899885  45677888864321     11100123567888888754333 33443322    2689999988


Q ss_pred             CCHHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcccCC
Q 013354          242 GSIYK--------------ILQD---YG----QLGE-SAIRSYTQQI---------LSGLEYLHA--------KNTVHRD  282 (444)
Q Consensus       242 gsL~~--------------~l~~---~~----~l~~-~~~~~i~~qi---------~~aL~~LH~--------~~ivH~D  282 (444)
                      ..+..              .+.+   ..    .++. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            66532              1111   00    1111 1122221111         122222222        1489999


Q ss_pred             CCCCceEECCCCcEEEEecccccc
Q 013354          283 IKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       283 lkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      +.+.||++++++ +.|+||..+..
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCc
Confidence            999999998877 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.61  E-value=0.00047  Score=67.74  Aligned_cols=146  Identities=18%  Similarity=0.169  Sum_probs=96.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc--------------------cccHHHH-HHHHHHHHHHHccC
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD--------------------AKSKESA-QQLGQEIALLSRLR  215 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~--------------------~~~~~~~-~~~~~Ei~~l~~l~  215 (444)
                      -.+..+|..|--+.||.|... +|..+|||+++...-.                    .+..... -=...|++-|.+|+
T Consensus       146 ~~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             eecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            344556888999999999754 5888999988532000                    0111111 11235777788877


Q ss_pred             CCCeeeEeeeEEcCCEEEEEEeccCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCceEECCC
Q 013354          216 HPNIVRYYGSETLDDKLYIYLEYVSGGSI-YKILQDYGQLGESAIRSYTQQILSGLEYLH-AKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       216 hpnIv~l~~~~~~~~~~~lv~e~~~ggsL-~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~  293 (444)
                      ...|.----+..  ....|||+|+....- .-.|+. ..++...+..+-.|++.-|.-|- ..++||.||+--|+|+. +
T Consensus       225 ~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  225 NAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             hcCCCCCCceee--ecceEeeeeccCCCCcCccccc-ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence            655432222222  235799999943221 122222 46788889999999988888875 55899999999999995 6


Q ss_pred             CcEEEEeccccccc
Q 013354          294 GRVKLADFGMAKHI  307 (444)
Q Consensus       294 ~~vkL~DFGla~~~  307 (444)
                      |.+.|+|.+.+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            78999999877644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.59  E-value=0.0003  Score=68.48  Aligned_cols=137  Identities=20%  Similarity=0.183  Sum_probs=80.5

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC--eeeEee------eEEcCC
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN--IVRYYG------SETLDD  230 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~~~  230 (444)
                      ..+.|..|....+|+...  ++..+++|+...     .   ....+..|+.++..+.+.+  +.+++.      +....+
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCC-----C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            356678888789998753  345788887642     1   1234556777777774322  344433      123345


Q ss_pred             EEEEEEeccCCCCHHH-----------HH---Hhc-CCCC--------HHHHH------------HHHHHHHHHHHHHHH
Q 013354          231 KLYIYLEYVSGGSIYK-----------IL---QDY-GQLG--------ESAIR------------SYTQQILSGLEYLHA  275 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~-----------~l---~~~-~~l~--------~~~~~------------~i~~qi~~aL~~LH~  275 (444)
                      ..++|++|++|..+..           .+   +.. ..+.        .....            .....+..++.++.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999998866421           11   000 0000        00000            011123344555543


Q ss_pred             -------CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 -------KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 -------~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                             .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                   369999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.0013  Score=64.57  Aligned_cols=140  Identities=19%  Similarity=0.188  Sum_probs=79.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC--eeeEeee------EEc
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN--IVRYYGS------ETL  228 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~  228 (444)
                      ....+.++.|....+|+... . +..+++|+....    ...   ..+..|+.++..|....  +.+++..      ...
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~----~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~   94 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKR----VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL   94 (307)
T ss_pred             ceeccccCCccccceEEEEe-C-CCcEEEEEecCC----CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence            33456678888789998753 3 446778876421    111   23445666666663222  3343331      123


Q ss_pred             CCEEEEEEeccCCCCHH-----------HHH---Hhc-CCC--------CHHHH-----H----------HHHHHHHHHH
Q 013354          229 DDKLYIYLEYVSGGSIY-----------KIL---QDY-GQL--------GESAI-----R----------SYTQQILSGL  270 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~-----------~~l---~~~-~~l--------~~~~~-----~----------~i~~qi~~aL  270 (444)
                      ++..+++++|++|..+.           ..+   +.. ..+        .....     .          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            56678999999885431           111   100 001        00100     0          0011233445


Q ss_pred             HHHHH-------CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          271 EYLHA-------KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       271 ~~LH~-------~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      +++..       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            55542       479999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.48  E-value=0.0026  Score=62.63  Aligned_cols=29  Identities=24%  Similarity=0.337  Sum_probs=25.4

Q ss_pred             CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          277 NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      ++||+|+.+.||+++.+...-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            79999999999999866656899999764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0017  Score=63.46  Aligned_cols=74  Identities=15%  Similarity=0.181  Sum_probs=44.0

Q ss_pred             eeecccCceEEEEEEEcC------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEE
Q 013354          161 RLLGRGTFGHVYLGFNSE------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLY  233 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~  233 (444)
                      +.|..|--..||+.....      +++.+++|+.....      .......+|..++..+....+ .++++.+. +   .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFP-N---G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeC-C---C
Confidence            445666666889886543      25788899764211      112345567777777753333 34555443 2   3


Q ss_pred             EEEeccCCCCH
Q 013354          234 IYLEYVSGGSI  244 (444)
Q Consensus       234 lv~e~~~ggsL  244 (444)
                      +|+||++|..+
T Consensus        74 ~v~e~i~G~~l   84 (302)
T cd05156          74 RIEEFIPSRTL   84 (302)
T ss_pred             chhheeCCCcC
Confidence            58899887665

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.13  E-value=0.0029  Score=61.09  Aligned_cols=30  Identities=37%  Similarity=0.501  Sum_probs=25.0

Q ss_pred             CcccCCCCCCceEECCCCc-EEEEecccccc
Q 013354          277 NTVHRDIKGANILVDPSGR-VKLADFGMAKH  306 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~-vkL~DFGla~~  306 (444)
                      .++|+|+++.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999997754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.05  E-value=0.0013  Score=67.14  Aligned_cols=163  Identities=18%  Similarity=0.241  Sum_probs=104.6

Q ss_pred             HHHHHHHHHHHccCCCCeeeEeeeEEcC-CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 013354          202 QQLGQEIALLSRLRHPNIVRYYGSETLD-DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH  280 (444)
Q Consensus       202 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  280 (444)
                      .++.-...+++.+.|+|...++++-... ....+|||++ +.+|++++..+. +-.....              .+++.|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~   90 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH   90 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence            3455667889999999999999876543 4578899999 789999987643 2111111              122221


Q ss_pred             CCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 013354          281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY  360 (444)
Q Consensus       281 ~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~  360 (444)
                      -     |       .++.+| .++..               |  |-.      ..+++|||++|.++.|+..|...|...
T Consensus        91 ~-----~-------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   91 L-----N-------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             e-----h-------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            1     1       233333 11100               0  110      124899999999999999998877654


Q ss_pred             CChhhhHHhcCCCCCC----------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          361 EGVPAMFKIGNSKELP----------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       361 ~~~~~~~~~~~~~~~~----------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ...+....+.+....+          .+.-.++....++++.|+...|..||...++.+++-|.+.
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            4444443333222111          1123457778899999999999999999999999988653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.98  E-value=0.0051  Score=60.27  Aligned_cols=143  Identities=17%  Similarity=0.276  Sum_probs=81.3

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC--CCeeeEeeeEEcCC--EEEE
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNIVRYYGSETLDD--KLYI  234 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~~l  234 (444)
                      +.+.+..|.--.+|.....  ++.+++..-.    ............+|+.+|+.+.-  --+...++.|..+.  ..|.
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~----~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLRKPP----RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEecCC----ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            3344433433345555433  6777777211    12334455667788888888753  23445666666655  6799


Q ss_pred             EEeccCCCCHH------------------HHHHhc-----------CC---CCHHHHHHHHHHH--------------HH
Q 013354          235 YLEYVSGGSIY------------------KILQDY-----------GQ---LGESAIRSYTQQI--------------LS  268 (444)
Q Consensus       235 v~e~~~ggsL~------------------~~l~~~-----------~~---l~~~~~~~i~~qi--------------~~  268 (444)
                      ||+|++|..+.                  ++|..-           +.   +...++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            99999873221                  111110           00   0011111111111              22


Q ss_pred             HHHHHHHC--------CcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          269 GLEYLHAK--------NTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       269 aL~~LH~~--------~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      -..+|+.+        .++|||+.+.||++++++.+-|+||+++..-
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            33444432        4899999999999999888999999998754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.91  E-value=0.0063  Score=60.57  Aligned_cols=78  Identities=15%  Similarity=0.164  Sum_probs=47.2

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeecccc--cccHHHHHHHHHHHHHHHccC--CC-CeeeEeeeEEcCCEEEEEE
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD--AKSKESAQQLGQEIALLSRLR--HP-NIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lv~  236 (444)
                      .||.|....||++.+...++.++||.-......  ..-.-...+..-|...|+...  .| .+++++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999987543368999964211110  011222344556777776653  23 4555554  3455567899


Q ss_pred             eccCC
Q 013354          237 EYVSG  241 (444)
Q Consensus       237 e~~~g  241 (444)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.85  E-value=0.029  Score=54.85  Aligned_cols=29  Identities=28%  Similarity=0.414  Sum_probs=25.1

Q ss_pred             CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.64  E-value=0.03  Score=56.72  Aligned_cols=78  Identities=14%  Similarity=0.167  Sum_probs=48.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc--HHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcCCEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS--KESAQQLGQEIALLSRLR---HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+.||.|....||+..+.  ++.++||.-.........  .....+...|+..|+.+.   ..++++++.++.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            577899999999998763  556889964321110000  012334444566665553   357788887766  44678


Q ss_pred             EEeccCC
Q 013354          235 YLEYVSG  241 (444)
Q Consensus       235 v~e~~~g  241 (444)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.61  E-value=0.048  Score=53.47  Aligned_cols=29  Identities=21%  Similarity=0.221  Sum_probs=26.7

Q ss_pred             CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          277 NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      +++|+|+.+.|||++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999999899999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.57  E-value=0.011  Score=59.62  Aligned_cols=80  Identities=15%  Similarity=0.108  Sum_probs=50.4

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-cccHHHHHHHHHHHHHHHccC--CC-CeeeEeeeEEcCCEEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AKSKESAQQLGQEIALLSRLR--HP-NIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lv  235 (444)
                      .+.||.|.-..||++.+...++.++||.-...... ..-.-..++..-|...|+...  .| .+++++.  .+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            57789999999999987544577999963221111 111223455666777777663  33 4566664  345556789


Q ss_pred             EeccCC
Q 013354          236 LEYVSG  241 (444)
Q Consensus       236 ~e~~~g  241 (444)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998853

>PLN02236 choline kinase

Probab=96.57  E-value=0.014  Score=58.31  Aligned_cols=135  Identities=13%  Similarity=0.149  Sum_probs=74.5

Q ss_pred             eeecccCceEEEEEEEcC----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEEEE
Q 013354          161 RLLGRGTFGHVYLGFNSE----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLYIY  235 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv  235 (444)
                      +.|-.|-.-.+|++....    .++.|++|+.....     . ..-...+|..+++.+...++ .++++.+. ++   .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----E-LFFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----C-eeechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eE
Confidence            345457777899986432    24678888764311     1 11122468888888754443 34555543 22   57


Q ss_pred             EeccCCCCHHHH--------------HHh---cC-C----CC-HHHHHHHHHHH-----------------HHHHHHH--
Q 013354          236 LEYVSGGSIYKI--------------LQD---YG-Q----LG-ESAIRSYTQQI-----------------LSGLEYL--  273 (444)
Q Consensus       236 ~e~~~ggsL~~~--------------l~~---~~-~----l~-~~~~~~i~~qi-----------------~~aL~~L--  273 (444)
                      .+|+++.+|...              +.+   .. .    .. ...+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            888877665311              111   00 0    11 12222332111                 1111122  


Q ss_pred             --H----HCCcccCCCCCCceEECC-CCcEEEEeccccc
Q 013354          274 --H----AKNTVHRDIKGANILVDP-SGRVKLADFGMAK  305 (444)
Q Consensus       274 --H----~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~  305 (444)
                        .    ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence              1    125899999999999976 4679999998775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.30  E-value=0.016  Score=57.60  Aligned_cols=28  Identities=21%  Similarity=0.538  Sum_probs=24.6

Q ss_pred             cccCCCCCCceEECC-CCcEEEEeccccc
Q 013354          278 TVHRDIKGANILVDP-SGRVKLADFGMAK  305 (444)
Q Consensus       278 ivH~Dlkp~NIll~~-~~~vkL~DFGla~  305 (444)
                      ++|.|+.+.|||+++ ++.++|+||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999974 4689999998775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.13  E-value=0.025  Score=54.86  Aligned_cols=76  Identities=16%  Similarity=0.158  Sum_probs=45.6

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEcCCEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+..+.|+.|....+|+..  .+++.+.+|+-..        .....+..|..-|+.|   ..-.+++.+++...++.-+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecCh--------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            3445678999999999975  6688899997541        1123456677777777   3456778888887777779


Q ss_pred             EEEeccCCC
Q 013354          234 IYLEYVSGG  242 (444)
Q Consensus       234 lv~e~~~gg  242 (444)
                      |||||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=96.06  E-value=0.061  Score=61.33  Aligned_cols=31  Identities=45%  Similarity=0.712  Sum_probs=25.9

Q ss_pred             CCcccCCCCCCceEECCCC--cEE-EEecccccc
Q 013354          276 KNTVHRDIKGANILVDPSG--RVK-LADFGMAKH  306 (444)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~--~vk-L~DFGla~~  306 (444)
                      .++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998775  555 999997753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.96  E-value=0.02  Score=57.34  Aligned_cols=60  Identities=20%  Similarity=0.292  Sum_probs=45.6

Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCceEEC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH-AKNTVHRDIKGANILVD  291 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~  291 (444)
                      ...++-+|..|.++..+++. ...++....+++.-.+.|+-.+- -.+++|.|+.|.||++-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            34567778889999999986 35666667777766666665544 45899999999999993

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.95  E-value=0.22  Score=49.26  Aligned_cols=27  Identities=26%  Similarity=0.309  Sum_probs=23.2

Q ss_pred             CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          277 NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      ++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            689999999999995 4 58899999664

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.92  E-value=0.035  Score=54.92  Aligned_cols=133  Identities=21%  Similarity=0.290  Sum_probs=76.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC------eeeEeee--EEcCC--EE
Q 013354          163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN------IVRYYGS--ETLDD--KL  232 (444)
Q Consensus       163 LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~--~~~~~--~~  232 (444)
                      |.+ .-..||+....+ |+ +++|+....       ....++..|+..|..|.-..      +...-|-  ....+  ..
T Consensus        34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~-------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~  103 (331)
T COG2334          34 LNS-EENSNFRVQTED-GR-YILKIYRPG-------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP  103 (331)
T ss_pred             ccc-ccCceEEEEecC-CC-eEEEEecCC-------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence            444 445789886543 44 488877631       23345666777777774222      2222221  12234  78


Q ss_pred             EEEEeccCCCCHHH-----HHH--------------hcC--C---C---CHH----H---------HHHHHHHHHHHHHH
Q 013354          233 YIYLEYVSGGSIYK-----ILQ--------------DYG--Q---L---GES----A---------IRSYTQQILSGLEY  272 (444)
Q Consensus       233 ~lv~e~~~ggsL~~-----~l~--------------~~~--~---l---~~~----~---------~~~i~~qi~~aL~~  272 (444)
                      +.+++|++|..+..     .+.              ...  .   +   .+.    .         -.....++...++.
T Consensus       104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~  183 (331)
T COG2334         104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR  183 (331)
T ss_pred             EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence            88999998877762     110              110  0   0   111    0         00133344555555


Q ss_pred             HHHC--------C--cccCCCCCCceEECCCCc-EEEEeccccc
Q 013354          273 LHAK--------N--TVHRDIKGANILVDPSGR-VKLADFGMAK  305 (444)
Q Consensus       273 LH~~--------~--ivH~Dlkp~NIll~~~~~-vkL~DFGla~  305 (444)
                      +.+.        +  +||+|+.+.||+++.+.. +.++||+.+.
T Consensus       184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            5532        3  999999999999998875 9999999764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.87  E-value=0.06  Score=50.02  Aligned_cols=68  Identities=16%  Similarity=0.213  Sum_probs=46.4

Q ss_pred             EEEEEEEcCC-CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcCCEEEEEEeccCCCCHH
Q 013354          170 HVYLGFNSES-GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPNIVRYYGSETLDDKLYIYLEYVSGGSIY  245 (444)
Q Consensus       170 ~Vy~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~  245 (444)
                      .|..|....+ ...+.+|+        ...+....|..|+.-|..+.   .-.+.+++.+....+..|+||||++-+.+.
T Consensus        28 ~inea~~v~dg~~~~FvK~--------n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          28 DINEAWRLRDGTDPFFVKC--------NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cccceeEeecCCcceEEEe--------cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4444433333 45677884        33455567777877766664   356788888888899999999999865553

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.80  E-value=0.026  Score=55.75  Aligned_cols=103  Identities=24%  Similarity=0.304  Sum_probs=68.5

Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ....|++|++- |++|.-.    .....+++..++.+.+..++-+..+ .+-|||+.-.||||+ +|+|.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34567778775 5555432    1234577888888888888877766 789999999999999 899999999999843


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHH
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSL  343 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSl  343 (444)
                      ..+..-    .....--|-.+.+..  +..-|||-+
T Consensus       372 ~~q~~i----sy~rldhp~lF~G~d--d~QFeIYrl  401 (488)
T COG5072         372 YSQGII----SYNRLDHPDLFNGVD--DYQFEIYRL  401 (488)
T ss_pred             cCCcee----eccccCchhhhcCcc--ceeeeHHHH
Confidence            332211    111233444554332  556677764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.75  E-value=0.045  Score=53.11  Aligned_cols=76  Identities=13%  Similarity=0.081  Sum_probs=43.3

Q ss_pred             cccCceEEEEEEEcC----CC----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-------------CCCeeeE
Q 013354          164 GRGTFGHVYLGFNSE----SG----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-------------HPNIVRY  222 (444)
Q Consensus       164 G~G~fg~Vy~a~~~~----~g----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-------------hpnIv~l  222 (444)
                      |.|-.|.+|++.-.-    ++    ..++||.................+.+|+.+.+.+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677788888886532    22    35677765311111122223456777888766541             1245666


Q ss_pred             eeeEEcCCEEEEEEecc
Q 013354          223 YGSETLDDKLYIYLEYV  239 (444)
Q Consensus       223 ~~~~~~~~~~~lv~e~~  239 (444)
                      +.........+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66655555678888865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.51  E-value=0.052  Score=50.15  Aligned_cols=119  Identities=15%  Similarity=0.126  Sum_probs=72.9

Q ss_pred             HHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--Ccc
Q 013354          202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--NTV  279 (444)
Q Consensus       202 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iv  279 (444)
                      ..+..+..++.++  ..|+++..-  ..-.+.++.|+|-..         .-...    .++..=+.+|.-.|+.  +.+
T Consensus       103 ~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~---------~i~~~----N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKI---------KINFS----NFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCc---------ccchh----HHHHHhHHHHHHhhccCCCee
Confidence            3456677777766  367777742  445678999998321         00111    1111114566777844  799


Q ss_pred             cCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc
Q 013354          280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT  352 (444)
Q Consensus       280 H~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt  352 (444)
                      |||..|+||+-|..|.+||.|=+.--  .         .+..|.--|+    ...+.++.+=+|-.-++++..
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~Ll--~---------~~V~~vN~~Y----~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVCLL--E---------NQVNMVNIEY----ESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhhhh--h---------heeeEEeeec----cccChHHHHHHHHHHHHHHHH
Confidence            99999999999999999999976321  1         1122333221    124666777666666666655

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.37  E-value=0.05  Score=50.09  Aligned_cols=29  Identities=41%  Similarity=0.631  Sum_probs=20.6

Q ss_pred             CcccCCCCCCceEE-CCCCcEEEEeccccc
Q 013354          277 NTVHRDIKGANILV-DPSGRVKLADFGMAK  305 (444)
Q Consensus       277 ~ivH~Dlkp~NIll-~~~~~vkL~DFGla~  305 (444)
                      -++|.|+.+.|||+ +.++.++|+||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 788999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	444
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-48
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-47
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-46
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-46
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-46
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-46
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-46
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-46
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-46
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-44
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-44
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-42
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-42
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-41
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-40
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-40
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-40
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-39
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-39
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-39
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-39
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-39
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-39
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-38
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-37
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-37
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-36
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-36
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-36
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-36
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-36
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-36
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-36
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-36
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-36
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-36
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-36
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-36
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-36
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-36
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-35
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-35
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-35
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-35
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-35
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-35
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-35
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-35
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-35
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-35
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-34
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-34
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-33
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-32
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-32
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-32
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-32
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-32
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-32
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-32
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-32
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-32
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-32
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-32
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-32
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-32
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-32
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-32
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-32
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-32
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-32
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-32
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-32
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-32
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-32
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-32
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-32
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-32
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-32
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-32
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-32
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-32
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-32
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-32
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-32
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-32
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-32
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-32
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-32
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-31
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-31
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-31
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-31
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-31
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-31
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-31
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-31
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-31
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-31
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-31
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-31
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-31
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-31
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-31
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-31
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-31
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-31
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-31
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-30
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-30
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-30
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-30
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-30
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-30
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-30
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-30
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-30
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-30
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-30
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-30
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-30
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-29
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-29
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-29
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-29
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-29
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-29
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-29
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-29
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-29
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-29
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-29
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-29
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-29
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-29
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-29
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-29
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-29
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-29
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-29
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-29
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-29
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-29
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-29
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-29
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-29
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-29
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-29
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-29
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-29
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-29
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-29
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-29
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-29
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-29
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-29
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-29
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-29
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-29
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-29
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-29
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-29
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-29
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-29
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-29
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-29
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-29
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-29
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-28
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-28
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-28
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-28
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-28
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-28
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-28
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-28
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-28
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-28
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-28
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-28
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-28
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-28
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-28
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-28
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-28
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-28
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-28
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-28
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-28
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-27
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-27
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-27
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-27
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-27
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-27
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-27
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-27
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-27
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-27
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-27
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-27
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-27
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-27
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-27
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-27
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-27
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-27
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-27
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-27
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-27
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-27
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-27
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-27
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-27
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-27
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-27
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-27
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-27
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-27
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-27
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-27
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-27
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-27
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-27
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-26
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-26
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-26
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-26
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-26
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-26
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-26
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-26
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-26
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-26
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-26
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-26
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-26
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-26
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-26
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-26
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-26
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-26
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-26
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-25
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-25
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-25
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-25
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-25
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-25
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-25
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-25
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-25
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-24
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-24
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-24
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-24
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-24
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-24
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-24
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-24
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-24
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-24
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-24
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-24
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-24
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-24
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-24
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-24
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-23
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-23
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-23
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-23
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-23
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-23
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-23
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-23
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-23
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-23
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-23
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-23
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-23
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-23
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-23
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-23
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-23
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-23
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-23
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-23
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-23
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-23
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-23
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-23
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-23
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-23
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-23
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-23
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-23
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-23
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-23
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-23
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-23
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-23
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-23
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-23
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-23
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-23
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-23
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-23
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-23
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-22
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-22
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-22
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-22
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-22
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-22
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-22
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-22
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-22
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-22
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-22
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-22
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-22
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-22
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-22
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-22
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-22
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-22
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-22
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-22
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-22
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-22
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-22
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-22
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-22
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-22
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-22
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-22
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-22
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-22
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-22
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-21
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-21
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-21
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-21
3soa_A	444	Full-Length Human Camkii Length = 444		2e-21
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-21
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-21
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-21
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-21
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-21
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-21
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-21
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-21
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-21
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-21
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-21
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-21
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-21
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-21
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-21
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-21
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-21
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-21
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-21
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-21
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-21
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-21
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-21
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-21
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-21
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-21
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-21
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-21
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-21
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-21
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-20
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-20
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-20
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-20
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-20
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-20
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-20
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-20
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-19
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-19
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-19
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-19
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-19
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-19
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-19
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-19
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-19
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-19
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-19
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-19
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-19
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-19
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-19
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-19
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-19
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-19
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-19
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-19
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-18
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-18
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-18
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-18
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-18
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-18
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-17
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-17
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-17
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-17
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-17
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-16
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-16
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-16
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-16
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-16
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-16
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-16
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-15
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-15
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-15
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-15
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-15
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-15
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-15
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-14
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-13
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-13
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-13
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-13
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-13
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-13
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-12

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 105/257 (40%), Positives = 153/257 (59%), Gaps = 11/257 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G++G VY   + E+G++ A+K+V + SD        Q++ +EI+++ +   P++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKY 89
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHR 281
           YGS   +  L+I +EY   GS+  I++   + L E  I +  Q  L GLEYLH    +HR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNSNGCNLAVDI 340
           DIK  NIL++  G  KLADFG+A  +T      + + G+P+WMAPEVI+   G N   DI
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-GYNCVADI 208
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKI-GNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           WSLG T IEMA  KPP++    + A+F I  N       P+  SD   DFV++CL ++P 
Sbjct: 209 WSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268
Query: 400 HRPTAAWLLEHPFVGNA 416
            R TA  LL+HPFV +A
Sbjct: 269 QRATATQLLQHPFVRSA 285

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 107/280 (38%), Positives = 162/280 (57%), Gaps = 8/280 (2%)
Query: 135 ATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           A SP     PG       P   + K   +G+G+FG V+ G ++ + ++ A+K + L    
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL---- 57
Query: 195 AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQL 254
            ++++  + + QEI +LS+   P + +YYGS   D KL+I +EY+ GGS   +L+  G L
Sbjct: 58  EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPL 116
Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
            E+ I +  ++IL GL+YLH++  +HRDIK AN+L+   G VKLADFG+A  +T      
Sbjct: 117 DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 315 S-IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
           +   G+P+WMAPEVIK S   +   DIWSLG T IE+A  +PP S+   +  +F I  + 
Sbjct: 177 NXFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             P +  + S   K+FV  CL + P  RPTA  LL+H F+
Sbjct: 236 P-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 115/281 (40%), Positives = 166/281 (59%), Gaps = 21/281 (7%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +LG+GT+G VY G +  +    A+KE+       +    +Q L +EIAL   L+H NIV+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-----ERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQL--GESAIRSYTQQILSGLEYLHAKNT 278
           Y GS + +  + I++E V GGS+  +L+  +G L   E  I  YT+QIL GL+YLH    
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 279 VHRDIKGANILVDP-SGRVKLADFGMAKHITGQS-CPLSIKGSPYWMAPEVI-KNSNGCN 335
           VHRDIKG N+L++  SG +K++DFG +K + G + C  +  G+  +MAPE+I K   G  
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQY-EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A DIWSLGCT+IEMAT KPP+ +  E   AMFK+G  K  P IP+ +S E K F+ KC 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTL 435
           + +P  R  A  LL   F+          +S++  +T+P L
Sbjct: 264 EPDPDKRACANDLLVDEFLK---------VSSKKKKTQPKL 295

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 157/263 (59%), Gaps = 8/263 (3%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
            P   + K   +G+G+FG V+ G ++ + ++ A+K + L     ++++  + + QEI +L
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVL 79
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           S+   P + +YYGS   D KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL+
Sbjct: 80  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 138
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKN 330
           YLH++  +HRDIK AN+L+   G VKLADFG+A  +T       +  G+P+WMAPEVIK 
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S   +   DIWSLG T IE+A  +PP S+   +  +F I  +   P +  + S   K+FV
Sbjct: 199 S-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 256
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
             CL + P  RPTA  LL+H F+
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFI 279

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 111/259 (42%), Positives = 157/259 (60%), Gaps = 12/259 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +LG+GT+G VY G +  +    A+KE+       +    +Q L +EIAL   L+H NIV+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-----ERDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQL--GESAIRSYTQQILSGLEYLHAKNT 278
           Y GS + +  + I++E V GGS+  +L+  +G L   E  I  YT+QIL GL+YLH    
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 279 VHRDIKGANILVDP-SGRVKLADFGMAKHITGQS-CPLSIKGSPYWMAPEVI-KNSNGCN 335
           VHRDIKG N+L++  SG +K++DFG +K + G + C  +  G+  +MAPE+I K   G  
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQY-EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A DIWSLGCT+IEMAT KPP+ +  E   AMFK+G  K  P IP+ +S E K F+ KC 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 395 QRNPLHRPTAAWLLEHPFV 413
           + +P  R  A  LL   F+
Sbjct: 250 EPDPDKRACANDLLVDEFL 268

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 157/263 (59%), Gaps = 8/263 (3%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
            P   + K   +G+G+FG V+ G ++ + ++ A+K + L     ++++  + + QEI +L
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVL 59
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           S+   P + +YYGS   D KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL+
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKN 330
           YLH++  +HRDIK AN+L+   G VKLADFG+A  +T       +  G+P+WMAPEVIK 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S   +   DIWSLG T IE+A  +PP S+   +  +F I  +   P +  + S   K+FV
Sbjct: 179 S-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 236
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
             CL + P  RPTA  LL+H F+
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 157/263 (59%), Gaps = 8/263 (3%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
            P   + K   +G+G+FG V+ G ++ + ++ A+K + L     ++++  + + QEI +L
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVL 59
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           S+   P + +YYGS   D KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL+
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKN 330
           YLH++  +HRDIK AN+L+   G VKLADFG+A  +T      +   G+P+WMAPEVIK 
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S   +   DIWSLG T IE+A  +PP S+   +  +F I  +   P +  + S   K+FV
Sbjct: 179 S-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 236
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
             CL + P  RPTA  LL+H F+
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFI 259

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 103/282 (36%), Positives = 160/282 (56%), Gaps = 8/282 (2%)
Query: 133 STATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS 192
           S A SP   + PG   N   P   + K   +G+G+FG V+ G ++ + ++ A+K + L  
Sbjct: 1   SMAHSPVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-- 58
Query: 193 DDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG 252
              ++++  + + QEI +LS+     + +YYGS     KL+I +EY+ GGS   +L+  G
Sbjct: 59  --EEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-AG 115
Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
              E  I +  ++IL GL+YLH++  +HRDIK AN+L+   G VKLADFG+A  +T    
Sbjct: 116 PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175
Query: 313 PL-SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN 371
              +  G+P+WMAPEVI+ S   +   DIWSLG T IE+A  +PP S    +  +F I  
Sbjct: 176 KRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 234
Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           +   P +    +   K+F+  CL ++P  RPTA  LL+H F+
Sbjct: 235 NNP-PTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 104/264 (39%), Positives = 155/264 (58%), Gaps = 8/264 (3%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
             P   + K   +G+G+FG VY G ++ + E+ A+K + L     ++++  + + QEI +
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDL----EEAEDEIEDIQQEITV 70
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           LS+   P I RY+GS     KL+I +EY+ GGS   +L+  G L E+ I +  ++IL GL
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGL 129
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIK 329
           +YLH++  +HRDIK AN+L+   G VKLADFG+A  +T      +   G+P+WMAPEVIK
Sbjct: 130 DYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 189
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
            S   +   DIWSLG T IE+A  +PP S    +  +F I  +   P +    S   K+F
Sbjct: 190 QS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQHSKPFKEF 247
Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           V  CL ++P  RPTA  LL+H F+
Sbjct: 248 VEACLNKDPRFRPTAKELLKHKFI 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 104/282 (36%), Positives = 153/282 (54%), Gaps = 14/282 (4%)
Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           R    V     P   W+    LG G FG VY   N E+G + A K +     + KS+E  
Sbjct: 6   REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEEL 60
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIR 260
           +    EI +L+   HP IV+  G+   D KL+I +E+  GG++  I+ +  + L E  I+
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGS 319
              +Q+L  L +LH+K  +HRD+K  N+L+   G ++LADFG+ AK++       S  G+
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 320 PYWMAPEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
           PYWMAPEV+          +   DIWSLG T+IEMA  +PP  +   +  + KI  S + 
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DP 239
Query: 376 PAI--PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
           P +  P   S E +DF++  L +NP  RP+AA LLEHPFV +
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 152/277 (54%), Gaps = 14/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V     P   W+    LG G FG VY   N E+G + A K +     + KS+E  +    
Sbjct: 3   VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIV 57
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HP IV+  G+   D KL+I +E+  GG++  I+ +  + L E  I+   +Q
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 117
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMA 324
           +L  L +LH+K  +HRD+K  N+L+   G ++LADFG+ AK++       S  G+PYWMA
Sbjct: 118 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 325 PEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-- 378
           PEV+          +   DIWSLG T+IEMA  +PP  +   +  + KI  S + P +  
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT 236
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
           P   S E +DF++  L +NP  RP+AA LLEHPFV +
Sbjct: 237 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 155/296 (52%), Gaps = 16/296 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V    +P   W+    LG G FG VY   N E+  + A K +     D KS+E  +    
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMV 83
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HPNIV+   +   ++ L+I +E+ +GG++  ++ +  + L ES I+   +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMA 324
            L  L YLH    +HRD+K  NIL    G +KLADFG+ AK+        S  G+PYWMA
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMA 203
Query: 325 PEVIKNSNG----CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-- 378
           PEV+          +   D+WSLG T+IEMA  +PP  +   +  + KI  S E P +  
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQ 262
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETK 432
           P   S   KDF++KCL++N   R T + LL+HPF  V +  P+   I  A+   T+
Sbjct: 263 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 155/296 (52%), Gaps = 16/296 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V    +P   W+    LG G FG VY   N E+  + A K +     D KS+E  +    
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMV 83
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HPNIV+   +   ++ L+I +E+ +GG++  ++ +  + L ES I+   +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMA 324
            L  L YLH    +HRD+K  NIL    G +KLADFG+ AK+        S  G+PYWMA
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 203
Query: 325 PEVIKNSNG----CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-- 378
           PEV+          +   D+WSLG T+IEMA  +PP  +   +  + KI  S E P +  
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQ 262
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETK 432
           P   S   KDF++KCL++N   R T + LL+HPF  V +  P+   I  A+   T+
Sbjct: 263 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 154/296 (52%), Gaps = 16/296 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V    +P   W+    LG G FG VY   N E+  + A K +     D KS+E  +    
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMV 83
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HPNIV+   +   ++ L+I +E+ +GG++  ++ +  + L ES I+   +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM-AKHITGQSCPLSIKGSPYWMA 324
            L  L YLH    +HRD+K  NIL    G +KLADFG+ AK+           G+PYWMA
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMA 203
Query: 325 PEVIKNSNG----CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-- 378
           PEV+          +   D+WSLG T+IEMA  +PP  +   +  + KI  S E P +  
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQ 262
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETK 432
           P   S   KDF++KCL++N   R T + LL+HPF  V +  P+   I  A+   T+
Sbjct: 263 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTE 318

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 145/262 (55%), Gaps = 11/262 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L +LRHPN +
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTV 279
           +Y G    +   ++ +EY  G S   +L+ + + L E  I + T   L GL YLH+ N +
Sbjct: 118 QYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLA 337
           HRD+K  NIL+   G VKL DFG A  +   +      G+PYWMAPEVI   +    +  
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD-HLSDEGKDFVRKCLQR 396
           VD+WSLG T IE+A  KPP      + A++ I  + E PA+   H S+  ++FV  CLQ+
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFRNFVDSCLQK 292
Query: 397 NPLHRPTAAWLLEHPFVGNAAP 418
            P  RPT+  LL+H FV    P
Sbjct: 293 IPQDRPTSEVLLKHRFVLRERP 314

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 99/271 (36%), Positives = 147/271 (54%), Gaps = 11/271 (4%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
            P   +   R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFL 69
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGL 270
            +LRHPN ++Y G    +   ++ +EY  G S   +L+ + + L E  I + T   L GL
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI-- 328
            YLH+ N +HRD+K  NIL+   G VKL DFG A  +   +      G+PYWMAPEVI  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILA 185
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD-HLSDEGK 387
            +    +  VD+WSLG T IE+A  KPP      + A++ I  + E PA+   H S+  +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFR 244
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           +FV  CLQ+ P  RPT+  LL+H FV    P
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 161/296 (54%), Gaps = 16/296 (5%)
Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A++++ L     + +   
Sbjct: 10  RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKK 61
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 120
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSP 320
             ++ L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT  QS   ++ G+P
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I  +   EL   
Sbjct: 181 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN- 238
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSETK 432
           P+ LS   +DF+ +CL  +   R +A  LL+H F+  A PL    P+++A    TK
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 161/296 (54%), Gaps = 16/296 (5%)
Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A++++ L     + +   
Sbjct: 10  RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKK 61
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 120
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSP 320
             ++ L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT  QS    + G+P
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP 180
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I  +   EL   
Sbjct: 181 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN- 238
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSETK 432
           P+ LS   +DF+ +CL+ +   R +A  LL+H F+  A PL    P+++A    TK
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 146/279 (52%), Gaps = 28/279 (10%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
            ++G G    V   + +   E  A+K + L     K + S  +L +EI  +S+  HPNIV
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------GQLGESAIRSYTQQILSGLEY 272
            YY S  + D+L++ ++ +SGGS+  I++          G L ES I +  +++L GLEY
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPE 326
           LH    +HRD+K  NIL+   G V++ADFG++        IT      +  G+P WMAPE
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE- 385
           V++   G +   DIWS G T IE+AT   P+ +Y  +  +  +    + P++   + D+ 
Sbjct: 192 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPPSLETGVQDKE 250
Query: 386 -----GKDF---VRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                GK F   +  CLQ++P  RPTAA LL H F   A
Sbjct: 251 MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 147/284 (51%), Gaps = 30/284 (10%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
            ++G G    V   + +   E  A+K + L     K + S  +L +EI  +S+  HPNIV
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------GQLGESAIRSYTQQILSGLEY 272
            YY S  + D+L++ ++ +SGGS+  I++          G L ES I +  +++L GLEY
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPE 326
           LH    +HRD+K  NIL+   G V++ADFG++        IT      +  G+P WMAPE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDE 385
           V++   G +   DIWS G T IE+AT   P+ +Y  +   M  + N    P++   + D+
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--PSLETGVQDK 254
Query: 386 ------GKDF---VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
                 GK F   +  CLQ++P  RPTAA LL H F   A   E
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 160/296 (54%), Gaps = 16/296 (5%)
Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A++++ L     + +   
Sbjct: 10  RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKK 61
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 120
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSP 320
             ++ L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT  QS    + G+P
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTP 180
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I  +   EL   
Sbjct: 181 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN- 238
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSETK 432
           P+ LS   +DF+ +CL  +   R +A  LL+H F+  A PL    P+++A    TK
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 161/296 (54%), Gaps = 16/296 (5%)
Query: 142 RSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           RS   V +P    +R++K   +G+G  G VY   +  +G+  A++++ L     + +   
Sbjct: 11  RSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKK 62
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           + +  EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 121
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSP 320
             ++ L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT  QS    + G+P
Sbjct: 122 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP 181
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAI 378
           YWMAPEV+         VDIWSLG   IEM   +PP+     + A++ I  +   EL   
Sbjct: 182 YWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN- 239
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSETK 432
           P+ LS   +DF+ +CL+ +   R +A  L++H F+  A PL    P+++A    TK
Sbjct: 240 PEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/286 (32%), Positives = 156/286 (54%), Gaps = 13/286 (4%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
            P  ++ +   +G+G  G VY   +  +G+  A++++ L     + +   + +  EI ++
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVM 72
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
              ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +  ++ L  LE
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALE 131
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKN 330
           +LH+   +HR+IK  NIL+   G VKL DFG    IT  QS   ++ G+PYWMAPEV+  
Sbjct: 132 FLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-T 190
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAIPDHLSDEGKD 388
                  VDIWSLG   IEM   +PP+     + A++ I  +   EL   P+ LS   +D
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIFRD 249
Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSETK 432
           F+ +CL+ +   R +A  L++H F+  A PL    P+++A    TK
Sbjct: 250 FLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/254 (35%), Positives = 140/254 (55%), Gaps = 11/254 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+ G V L     SG   A+K +     D + ++  + L  E+ ++   +H N+V  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           Y S  + ++L++ +E++ GG++  I+    +L E  I +  + +L  L YLHA+  +HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCP--LSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           IK  +IL+   GRVKL+DFG    I+ +  P    + G+PYWMAPEVI  S      VDI
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYAT-EVDI 224
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFVRKCLQRNPL 399
           WSLG  VIEM   +PP+     V AM ++ +S        H +S   +DF+ + L R+P 
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 400 HRPTAAWLLEHPFV 413
            R TA  LL+HPF+
Sbjct: 285 ERATAQELLDHPFL 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 143 VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 197
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 256
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 257 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 315
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 316 PELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 372
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 149/278 (53%), Gaps = 25/278 (8%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           L+G GT+G VY G + ++G++ A+K + +  D+       +++ QEI +L +   H NI 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIA 84
Query: 221 RYYGSET------LDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEY 272
            YYG+        +DD+L++ +E+   GS+  ++++     L E  I    ++IL GL +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVI- 328
           LH    +HRDIKG N+L+  +  VKL DFG++  +    G+    +  G+PYWMAPEVI 
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 202
Query: 329 --KNSNGC-NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
             +N +   +   D+WSLG T IEMA   PP      + A+F I  +          S +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262
Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
            + F+  CL +N   RP    L++HPF+ +  P ER +
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRD-QPNERQV 299

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 145/263 (55%), Gaps = 12/263 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           + ++  + +GRG F  VY       G   A+K+V +F   DAK++    +   EI LL +
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 88
Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSG 269
           L HPN+++YY S   D++L I LE    G + ++++ + +    + E  +  Y  Q+ S 
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVI 328
           LE++H++  +HRDIK AN+ +  +G VKL D G+ +  + ++    S+ G+PY+M+PE I
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIP-DHLSDEG 386
            + NG N   DIWSLGC + EMA  + P +     + ++ K     + P +P DH S+E 
Sbjct: 209 -HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 387 KDFVRKCLQRNPLHRPTAAWLLE 409
           +  V  C+  +P  RP   ++ +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 23  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 77
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 136
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 137 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 195
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 196 PELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 252
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 253 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 289

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 21  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 75
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 134
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 135 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 193
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 194 PELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 250
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 251 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 66  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 120
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 179
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 180 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 238
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 239 PELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 295
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 12  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 66
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 125
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 126 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 184
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 185 PELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 241
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 149/277 (53%), Gaps = 15/277 (5%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P S       +G G+ G V +     SG++ A+K++     D + ++  + L  
Sbjct: 16  VVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM-----DLRKQQRRELLFN 70
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++   +H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 129
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMA 324
           L  L  LHA+  +HRDIK  +IL+   GRVKL+DFG    ++ +  P    + G+PYWMA
Sbjct: 130 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMA 188
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-- 382
           PE+I         VDIWSLG  VIEM   +PP+     + AM  I ++  LP    +L  
Sbjct: 189 PELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--LPPRLKNLHK 245
Query: 383 -SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            S   K F+ + L R+P  R TAA LL+HPF+  A P
Sbjct: 246 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 156
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 214
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 215 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 273 QRPMLREVLEHPWI 286

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 134/254 (52%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G +YK LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPEMIEGRMH-DEKVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G +YK LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSCHAPS-SRRTTLSGTLDYLPPEMIEGRMH-DEKVD 189
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 11/271 (4%)
Query: 148 ENPTSPGSRW-----KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ 202
           +N  S   +W     + GR LG+G FG+VYL    +S  + A+K   LF    +      
Sbjct: 13  KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEH 70
Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSY 262
           QL +E+ + S LRHPNI+R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 130
Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYW 322
             ++ + L Y H+K  +HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  +
Sbjct: 131 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDY 189
Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
           + PE+I+     +  VD+WSLG    E    KPP+          +I  S+     PD +
Sbjct: 190 LPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFV 246
Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           ++  +D + + L+ NP  RP    +LEHP++
Sbjct: 247 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 156
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPEMIEGRMH-DEKVD 214
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 215 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 273 QRPMLREVLEHPWI 286

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 134
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 193 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 250
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 251 QRPMLREVLEHPWI 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 70  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 129
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 188 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 245
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 246 QRPMLREVLEHPWI 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEXIEGRXH-DEKVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 252 QRPXLREVLEHPWI 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPEMIEGRMH-DEKVD 190
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 249 QRPMLREVLEHPWI 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 252 QRPMLREVLEHPWI 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMH-DEKVD 189
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL     S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQDTYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDTLCGTLDYLPPEMIEGRMH-DEKVD 189
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 248 QRPMLREVLEHPWI 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIEGRMH-DEKVD 188
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 247 QRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S    + G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+A+FG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMH-DEKVD 190
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 249 QRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+A+FG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 191
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 250 QRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 135/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +   + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 68  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 127
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 185
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E    KPP+          +I  S+     PD +++  +D + + L+ NP 
Sbjct: 186 LWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPS 243
Query: 400 HRPTAAWLLEHPFV 413
            RP    +LEHP++
Sbjct: 244 QRPMLREVLEHPWI 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALK--VLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E     PP+  +       +I  S+     PD +++  +D + + L+ N  
Sbjct: 193 LWSLGVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNAS 250
Query: 400 HRPTAAWLLEHPFV 413
            R T A +LEHP++
Sbjct: 251 QRLTLAEVLEHPWI 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/254 (33%), Positives = 136/254 (53%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALK--VLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+  +G +K+ADFG + H    S   ++ G+  ++ PE+I+     +  VD
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMH-DEKVD 192
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WSLG    E     PP+  +       +I  S+     PD +++  +D + + L+ N  
Sbjct: 193 LWSLGVLCYEFLVGMPPFEAHTYQETYRRI--SRVEFTFPDFVTEGARDLISRLLKHNAS 250
Query: 400 HRPTAAWLLEHPFV 413
            R T A +LEHP++
Sbjct: 251 QRLTLAEVLEHPWI 264

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 142/275 (51%), Gaps = 11/275 (4%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V +P  P         +G G+ G V +     +G+  A+K++     D + ++  + L  
Sbjct: 37  VVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM-----DLRKQQRRELLFN 91
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E+ ++    H N+V  Y S  + D+L++ +E++ GG++  I+  + ++ E  I +    +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSV 150
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAP 325
           L  L YLH +  +HRDIK  +IL+   GR+KL+DFG    ++ +      + G+PYWMAP
Sbjct: 151 LRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAP 210
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLS 383
           EVI         VDIWSLG  VIEM   +PP+     + AM +I +S   P + D   +S
Sbjct: 211 EVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLP-PRVKDLHKVS 268
Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
              + F+   L R P  R TA  LL HPF+  A P
Sbjct: 269 SVLRGFLDLMLVREPSQRATAQELLGHPFLKLAGP 303

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 140/262 (53%), Gaps = 8/262 (3%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++ + + +G G+FG   L  ++E G    +KE+ +    +K +E +++   E+A+L+ ++
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMK 81
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEYL 273
           HPNIV+Y  S   +  LYI ++Y  GG ++K +  Q      E  I  +  QI   L+++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKNSN 332
           H +  +HRDIK  NI +   G V+L DFG+A+ +        +  G+PY+++PE+ +N  
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
             N + DIW+LGC + E+ T K  +        + KI  S   P +  H S + +  V +
Sbjct: 202 YNNKS-DIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQ 259
Query: 393 CLQRNPLHRPTAAWLLEHPFVG 414
             +RNP  RP+   +LE  F+ 
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIA 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   E +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 133/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L+  G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 136/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + +G G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 81
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 198
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 256
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 257 RNLLQVDLTKR 267

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 130/245 (53%), Gaps = 7/245 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQ 395
           R  LQ
Sbjct: 270 RNLLQ 274

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 115
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 232
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 290
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 291 RNLLQVDLTKR 301

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + +G G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EY+ GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 89
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 206
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 264
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 265 RNLLQVDLTKR 275

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + +G G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EY+ GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 131/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 115
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G +  L   G+P ++APE+I  
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC--GTPEYLAPEIIL- 232
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 290
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 291 RNLLQVDLTKR 301

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 17  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 74
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 134
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLA 192
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 193 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 249
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 250 DLKDLLRNLLQVDLTKR 266

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 138/257 (53%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK +       K KE    L
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK-ILDKQKVVKLKEIEHTL 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
            ++  +L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 90  NEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG+AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+++D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIII- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 131/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ R LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 38  TAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
              +  P +V+   S   +  LY+ LEY  GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +K+ADFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + +MA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 87
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 204
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 262
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 263 RNLLQVDLTKR 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 131/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P  +APE+I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEALAPEIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 87
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 204
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 262
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 263 RNLLQVDLTKR 273

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 58  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 115
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV GG ++  L+  G+  E   R Y  QI+   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 232
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 290
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 291 RNLLQVDLTKR 301

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 138/257 (53%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK +       K KE    L
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK-ILDKQKVVKLKEIEHTL 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
            ++  +L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 90  NEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +++ DFG+AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 127/254 (50%), Gaps = 6/254 (2%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    ++  + A+K   LF    + +    QL +EI + S LRHPNI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R Y       ++Y+ LE+   G +YK LQ +G+  E    ++ +++   L Y H +  +
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 137
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRDIK  N+L+   G +K+ADFG + H         + G+  ++ PE+I+     +  VD
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRXMCGTLDYLPPEMIEGKTH-DEKVD 195
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +W  G    E     PP+          +I N       P  LSD  KD + K L+ +P 
Sbjct: 196 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPP 253
Query: 400 HRPTAAWLLEHPFV 413
            R     ++EHP+V
Sbjct: 254 QRLPLKGVMEHPWV 267

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 134/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 131/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 94
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+L+D  G +++ DFG AK + G++  L   G+P ++AP +I  
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPAIIL- 211
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 134/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 131/251 (52%), Gaps = 7/251 (2%)
Query: 151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +    E  +
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRI 95
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  QI+   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++APE+I  
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIL- 212
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 270
Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 271 RNLLQVDLTKR 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 134/257 (52%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 31  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 88
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P +V+   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +++ DFG AK + G++  L   G+P ++A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLA 206
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 263
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P + +   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P + +   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 126/253 (49%), Gaps = 6/253 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R LG+G FG+VYL    ++  + A+K   LF    + +    QL +EI + S LRHPNI+
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           R Y       ++Y+ LE+   G +YK LQ +G+  E    ++ +++   L Y H +  +H
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RDIK  N+L+   G +K+ADFG + H         + G+  ++ PE+I+     +  VD+
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRXMCGTLDYLPPEMIEGKTH-DEKVDL 195
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
           W  G    E     PP+          +I N       P  LSD  KD + K L+ +P  
Sbjct: 196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQ 253
Query: 401 RPTAAWLLEHPFV 413
           R     ++EHP+V
Sbjct: 254 RLPLKGVMEHPWV 266

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 10/257 (3%)
Query: 148 ENP---TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ENP   T+   ++++ + LG G+FG V L  + E+G   AMK   L        +  +  
Sbjct: 32  ENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT 89
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ 264
             E  +L  +  P + +   S   +  LY+ +EY  GG ++  L+  G+  E   R Y  
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA 149
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           QI+   EYLH+ + ++RD+K  N+++D  G +K+ DFG AK + G++  L   G+P ++A
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLA 207
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE+I  S G N AVD W+LG  + EMA   PP+   + +    KI + K     P H S 
Sbjct: 208 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSS 264
Query: 385 EGKDFVRKCLQRNPLHR 401
           + KD +R  LQ +   R
Sbjct: 265 DLKDLLRNLLQVDLTKR 281

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 128/259 (49%), Gaps = 4/259 (1%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G  LG GTFG V +G +  +G   A+K   L     +S +   ++ +EI  L   RHP+I
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y   +     ++ +EYVSGG ++  +  +G++ E   R   QQILS ++Y H    V
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D     K+ADFG++  ++      +  GSP + APEVI         VD
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           IWS G  +  +     P+   E VP +FK         IP++L+      +   LQ +PL
Sbjct: 194 IWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPL 251
Query: 400 HRPTAAWLLEHPFVGNAAP 418
            R T   + EH +     P
Sbjct: 252 KRATIKDIREHEWFKQDLP 270

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 136/266 (51%), Gaps = 18/266 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+FG V+       G   A+K   L   D  + E   +  +E+A++ RLRHPNIV +
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVK--ILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLF 99
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKN-- 277
            G+ T    L I  EY+S GS+Y++L   G   QL E    S    +  G+ YLH +N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSPYWMAPEVIKNSNGC 334
            VHR++K  N+LVD    VK+ DFG+++     S  LS K   G+P WMAPEV+++    
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDE-PS 216
Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           N   D++S G  + E+AT + PW        +  +G   +   IP +L+ +    +  C 
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 395 QRNPLHRPTAAWLLE--HPFVGNAAP 418
              P  RP+ A +++   P + +A P
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 134/250 (53%), Gaps = 7/250 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ-QLGQEIALLSRLRHPNI 219
           + LG G+FG V L +++ +G+  A+K   + +    +K   Q ++ +EI+ L  LRHP+I
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y      D++ + +EY +G  ++  +    ++ E   R + QQI+S +EY H    V
Sbjct: 67  IKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 125
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D    VK+ADFG++  +T  +   +  GSP + APEVI         VD
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 185
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS G  +  M   + P+   E +P +FK   S  +  +P  LS      +++ L  NPL
Sbjct: 186 VWSCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPL 243
Query: 400 HRPTAAWLLE 409
           +R +   +++
Sbjct: 244 NRISIHEIMQ 253

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 135/266 (50%), Gaps = 18/266 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+FG V+       G   A+K   L   D  + E   +  +E+A++ RLRHPNIV +
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVK--ILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLF 99
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKN-- 277
            G+ T    L I  EY+S GS+Y++L   G   QL E    S    +  G+ YLH +N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSPYWMAPEVIKNSNGC 334
            VHRD+K  N+LVD    VK+ DFG+++     S  L  K   G+P WMAPEV+++    
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPEVLRDE-PS 216
Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           N   D++S G  + E+AT + PW        +  +G   +   IP +L+ +    +  C 
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 395 QRNPLHRPTAAWLLE--HPFVGNAAP 418
              P  RP+ A +++   P + +A P
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 134/250 (53%), Gaps = 7/250 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ-QLGQEIALLSRLRHPNI 219
           + LG G+FG V L +++ +G+  A+K   + +    +K   Q ++ +EI+ L  LRHP+I
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y      D++ + +EY +G  ++  +    ++ E   R + QQI+S +EY H    V
Sbjct: 71  IKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 129
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D    VK+ADFG++  +T  +   +  GSP + APEVI         VD
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 189
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS G  +  M   + P+   E +P +FK   S  +  +P  LS      +++ L  NPL
Sbjct: 190 VWSCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPL 247
Query: 400 HRPTAAWLLE 409
           +R +   +++
Sbjct: 248 NRISIHEIMQ 257

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 127/259 (49%), Gaps = 4/259 (1%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G  LG GTFG V +G +  +G   A+K   L     +S +   ++ +EI  L   RHP+I
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y   +     ++ +EYVSGG ++  +  +G++ E   R   QQILS ++Y H    V
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D     K+ADFG++  ++         GSP + APEVI         VD
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           IWS G  +  +     P+   E VP +FK         IP++L+      +   LQ +PL
Sbjct: 194 IWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPL 251
Query: 400 HRPTAAWLLEHPFVGNAAP 418
            R T   + EH +     P
Sbjct: 252 KRATIKDIREHEWFKQDLP 270

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 134/250 (53%), Gaps = 7/250 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ-QLGQEIALLSRLRHPNI 219
           + LG G+FG V L +++ +G+  A+K   + +    +K   Q ++ +EI+ L  LRHP+I
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHI 75
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y      D++ + +EY +G  ++  +    ++ E   R + QQI+S +EY H    V
Sbjct: 76  IKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 134
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D    VK+ADFG++  +T  +   +  GSP + APEVI         VD
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 194
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS G  +  M   + P+   E +P +FK   S  +  +P  LS      +++ L  NPL
Sbjct: 195 VWSCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPL 252
Query: 400 HRPTAAWLLE 409
           +R +   +++
Sbjct: 253 NRISIHEIMQ 262

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 146/280 (52%), Gaps = 15/280 (5%)
Query: 143 SPGR-VENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +PG  V++ T+  S R+K  R+LG+G+FG V L  +  +G+ CA+K ++      K K  
Sbjct: 35  TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 92
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESA 258
            + L +E+ LL +L HPNI++ Y  E  +DK Y YL  E  +GG ++  +    +  E  
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 150
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLS 315
                +Q+LSG+ Y+H    VHRD+K  N+L++   +   +++ DFG++ H         
Sbjct: 151 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 210
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+ Y++APEV+  +   +   D+WS G  +  + +  PP++       + K+   K  
Sbjct: 211 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 268
Query: 376 PAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             +P    +S+  KD +RK L   P  R +A   L+H ++
Sbjct: 269 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 134/250 (53%), Gaps = 7/250 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ-QLGQEIALLSRLRHPNI 219
           + LG G+FG V L +++ +G+  A+K   + +    +K   Q ++ +EI+ L  LRHP+I
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLRHPHI 76
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y      D++ + +EY +G  ++  +    ++ E   R + QQI+S +EY H    V
Sbjct: 77  IKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV 135
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D    VK+ADFG++  +T  +   +  GSP + APEVI         VD
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVD 195
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS G  +  M   + P+   E +P +FK   S  +  +P  LS      +++ L  NPL
Sbjct: 196 VWSCGVILYVMLCRRLPFDD-ESIPVLFK-NISNGVYTLPKFLSPGAAGLIKRMLIVNPL 253
Query: 400 HRPTAAWLLE 409
           +R +   +++
Sbjct: 254 NRISIHEIMQ 263

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 146/280 (52%), Gaps = 15/280 (5%)
Query: 143 SPGR-VENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +PG  V++ T+  S R+K  R+LG+G+FG V L  +  +G+ CA+K ++      K K  
Sbjct: 36  TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 93
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESA 258
            + L +E+ LL +L HPNI++ Y  E  +DK Y YL  E  +GG ++  +    +  E  
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 151
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLS 315
                +Q+LSG+ Y+H    VHRD+K  N+L++   +   +++ DFG++ H         
Sbjct: 152 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 211
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+ Y++APEV+  +   +   D+WS G  +  + +  PP++       + K+   K  
Sbjct: 212 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 269
Query: 376 PAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             +P    +S+  KD +RK L   P  R +A   L+H ++
Sbjct: 270 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 146/280 (52%), Gaps = 15/280 (5%)
Query: 143 SPGR-VENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +PG  V++ T+  S R+K  R+LG+G+FG V L  +  +G+ CA+K ++      K K  
Sbjct: 12  TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 69
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESA 258
            + L +E+ LL +L HPNI++ Y  E  +DK Y YL  E  +GG ++  +    +  E  
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLS 315
                +Q+LSG+ Y+H    VHRD+K  N+L++   +   +++ DFG++ H         
Sbjct: 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+ Y++APEV+  +   +   D+WS G  +  + +  PP++       + K+   K  
Sbjct: 188 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 376 PAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             +P    +S+  KD +RK L   P  R +A   L+H ++
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 143/275 (52%), Gaps = 14/275 (5%)
Query: 147 VENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG 205
           V++ T+  S R+K  R+LG+G+FG V L  +  +G+ CA+K ++      K K   + L 
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 80
Query: 206 QEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYT 263
           +E+ LL +L HPNI++ Y  E  +DK Y YL  E  +GG ++  +    +  E       
Sbjct: 81  REVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 138
Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSP 320
           +Q+LSG+ Y+H    VHRD+K  N+L++   +   +++ DFG++ H           G+ 
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 198
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           Y++APEV+  +   +   D+WS G  +  + +  PP++       + K+   K    +P 
Sbjct: 199 YYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 256
Query: 381 --HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              +S+  KD +RK L   P  R +A   L+H ++
Sbjct: 257 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 128/259 (49%), Gaps = 4/259 (1%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G  LG GTFG V +G +  +G   A+K   L     +S +   ++ +EI  L   RHP+I
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVK--ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           ++ Y   +    +++ +EYVSGG ++  +   G+L E   R   QQILSG++Y H    V
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           HRD+K  N+L+D     K+ADFG++  ++         GSP + APEVI         VD
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVD 198
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           IWS G  +  +     P+   + VP +FK      +   P +L+      ++  LQ +P+
Sbjct: 199 IWSSGVILYALLCGTLPFDD-DHVPTLFK-KICDGIFYTPQYLNPSVISLLKHMLQVDPM 256
Query: 400 HRPTAAWLLEHPFVGNAAP 418
            R T   + EH +     P
Sbjct: 257 KRATIKDIREHEWFKQDLP 275

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 134/256 (52%), Gaps = 5/256 (1%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G+FG V L  + ++ +  A+K ++      K  +   ++ +EI+ L  LRHP+I++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           Y   T    + + +EY +GG ++  + +  ++ E   R + QQI+  +EY H    VHRD
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRD 133
Query: 283 IKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWS 342
           +K  N+L+D +  VK+ADFG++  +T  +   +  GSP + APEVI         VD+WS
Sbjct: 134 LKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 343 LGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRP 402
            G  +  M   + P+   E +P +FK  NS  +  +PD LS   +  +R+ +  +P+ R 
Sbjct: 194 CGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRI 251
Query: 403 TAAWLLEHPFVGNAAP 418
           T   +   P+     P
Sbjct: 252 TIQEIRRDPWFNVNLP 267

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 141/293 (48%), Gaps = 32/293 (10%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            +++K   +G GT+G V+   N E+ E+ A+K V L  DD     SA +   EI LL  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +H NIVR +     D KL +  E+             G L    ++S+  Q+L GL + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNG 333
           ++N +HRD+K  N+L++ +G +KLADFG+A+       C  +   + ++  P+V+  +  
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW-------SQYEGV------------PAMFKIGNSKE 374
            + ++D+WS GC   E+A    P         Q + +            P+M K+ + K 
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 375 LPAIPD---------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            P  P           L+  G+D ++  L+ NP+ R +A   L+HP+  +  P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 144/280 (51%), Gaps = 15/280 (5%)
Query: 143 SPGR-VENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +PG  V++ T+  S R+K  R+LG+G+FG V L  +  +G+ CA+K ++      K K  
Sbjct: 12  TPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 69
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESA 258
            + L +E+ LL +L HPNI + Y  E  +DK Y YL  E  +GG ++  +    +  E  
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLS 315
                +Q+LSG+ Y H    VHRD+K  N+L++   +   +++ DFG++ H         
Sbjct: 128 AARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD 187
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+ Y++APEV+  +   +   D+WS G  +  + +  PP++       + K+   K  
Sbjct: 188 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 376 PAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             +P    +S+  KD +RK L   P  R +A   L+H ++
Sbjct: 246 FELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 13/273 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV---TLFSDDAKSKESAQQLGQEIALL 211
            R+ +GR LG+G F   Y   + ++ E+ A K V    L     K K S      EIA+ 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST-----EIAIH 96
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             L +P++V ++G    DD +Y+ LE     S+ ++ +    + E   R + +Q + G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKN 330
           YLH    +HRD+K  N+ ++    VK+ DFG+A  I        ++ G+P ++APEV+  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL-C 215
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G +  VDIWSLGC +  +   KPP+          +I  ++   ++P H++      +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALI 273
Query: 391 RKCLQRNPLHRPTAAWLL-EHPFVGNAAPLERP 422
           R+ L  +P  RP+ A LL +  F    AP+  P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 139/262 (53%), Gaps = 13/262 (4%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA---QQLGQEIALLSR 213
           +K G LLG+G+F  VY   +  +G   A+K +     D K+   A   Q++  E+ +  +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-----DKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEY 272
           L+HP+I+  Y      + +Y+ LE    G + + L++  +   E+  R +  QI++G+ Y
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNS 331
           LH+   +HRD+  +N+L+  +  +K+ADFG+A  +        ++ G+P +++PE+   S
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
               L  D+WSLGC    +   +PP+        + K+  +     +P  LS E KD + 
Sbjct: 188 -AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLIH 244
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L+RNP  R + + +L+HPF+
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFM 266

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 145/310 (46%), Gaps = 55/310 (17%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 51
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
             +EI+LL  L HPNIV+       ++KLY+  E+V         QD  +  +++     
Sbjct: 52  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD--------QDLKKFMDASALTGI 103
Query: 259 ----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 315 SIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
             +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
Query: 374 ELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
             P         ++PD+                  L ++G+  + + L  +P  R +A  
Sbjct: 224 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 283
Query: 407 LLEHPFVGNA 416
            L HPF  + 
Sbjct: 284 ALAHPFFQDV 293

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/316 (27%), Positives = 146/316 (46%), Gaps = 54/316 (17%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P      ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+
Sbjct: 2   PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 58
Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IR 260
           LL  L HPNIV+       ++KLY+  E++         QD  +  +++         I+
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIK 110
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
           SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +   
Sbjct: 111 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--- 376
            W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P   
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 377 ------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 ++PD+                  L ++G+  + + L  +P  R +A   L HPF
Sbjct: 231 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 413 VGNAAP------LERP 422
             +         LERP
Sbjct: 291 FQDVTKPVPHLRLERP 306

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 13/273 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV---TLFSDDAKSKESAQQLGQEIALL 211
            R+ +GR LG+G F   Y   + ++ E+ A K V    L     K K S      EIA+ 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST-----EIAIH 96
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             L +P++V ++G    DD +Y+ LE     S+ ++ +    + E   R + +Q + G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKN 330
           YLH    +HRD+K  N+ ++    VK+ DFG+A  I         + G+P ++APEV+  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-C 215
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G +  VDIWSLGC +  +   KPP+          +I  ++   ++P H++      +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALI 273
Query: 391 RKCLQRNPLHRPTAAWLL-EHPFVGNAAPLERP 422
           R+ L  +P  RP+ A LL +  F    AP+  P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 13/273 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV---TLFSDDAKSKESAQQLGQEIALL 211
            R+ +GR LG+G F   Y   + ++ E+ A K V    L     K K S      EIA+ 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST-----EIAIH 96
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             L +P++V ++G    DD +Y+ LE     S+ ++ +    + E   R + +Q + G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKN 330
           YLH    +HRD+K  N+ ++    VK+ DFG+A  I         + G+P ++APEV+  
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL-C 215
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G +  VDIWSLGC +  +   KPP+          +I  ++   ++P H++      +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALI 273
Query: 391 RKCLQRNPLHRPTAAWLL-EHPFVGNAAPLERP 422
           R+ L  +P  RP+ A LL +  F    AP+  P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 55/310 (17%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 50
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
             +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++     
Sbjct: 51  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGI 102
Query: 259 ----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 315 SIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
             +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
Query: 374 ELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
             P         ++PD+                  L ++G+  + + L  +P  R +A  
Sbjct: 223 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 282
Query: 407 LLEHPFVGNA 416
            L HPF  + 
Sbjct: 283 ALAHPFFQDV 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 55/310 (17%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 51
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
             +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++     
Sbjct: 52  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGI 103
Query: 259 ----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 315 SIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
             +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
Query: 374 ELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
             P         ++PD+                  L ++G+  + + L  +P  R +A  
Sbjct: 224 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 283
Query: 407 LLEHPFVGNA 416
            L HPF  + 
Sbjct: 284 ALAHPFFQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 55/310 (17%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 50
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
             +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++     
Sbjct: 51  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGI 102
Query: 259 ----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 315 SIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
             +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
Query: 374 ELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
             P         ++PD+                  L ++G+  + + L  +P  R +A  
Sbjct: 223 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 282
Query: 407 LLEHPFVGNA 416
            L HPF  + 
Sbjct: 283 ALAHPFFQDV 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 142/304 (46%), Gaps = 43/304 (14%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 2   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 51
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES---AIR 260
             +EI+LL  L HPNIV+       ++KLY+  E++      K   D   L       I+
Sbjct: 52  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD--LKTFMDASALTGIPLPLIK 109
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
           SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +   
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--- 376
            W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P   
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 377 ------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 ++PD+                  L ++G+  + + L  +P  R +A   L HPF
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 413 VGNA 416
             + 
Sbjct: 290 FQDV 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 55/310 (17%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++     
Sbjct: 1   PGSMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPST 50
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
             +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++     
Sbjct: 51  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGI 102
Query: 259 ----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+         
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 315 SIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
             +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  + 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
Query: 374 ELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
             P         ++PD+                  L ++G+  + + L  +P  R +A  
Sbjct: 223 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 282
Query: 407 LLEHPFVGNA 416
            L HPF  + 
Sbjct: 283 ALAHPFFQDV 292

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 142/289 (49%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  GSP + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 246
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P ++  P    P  T  M
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVAPLPDYKDPRRTELM 295

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 13/273 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV---TLFSDDAKSKESAQQLGQEIALL 211
            R+ +GR LG+G F   Y   + ++ E+ A K V    L     K K S      EIA+ 
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST-----EIAIH 80
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             L +P++V ++G    DD +Y+ LE     S+ ++ +    + E   R + +Q + G++
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 140
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPYWMAPEVIKN 330
           YLH    +HRD+K  N+ ++    VK+ DFG+A  I         + G+P ++APEV+  
Sbjct: 141 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL-C 199
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G +  VDIWSLGC +  +   KPP+          +I  ++   ++P H++      +
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHINPVASALI 257
Query: 391 RKCLQRNPLHRPTAAWLL-EHPFVGNAAPLERP 422
           R+ L  +P  RP+ A LL +  F    AP+  P
Sbjct: 258 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 143/303 (47%), Gaps = 46/303 (15%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P      ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--------IRS 261
           LL  L HPNIV+       ++KLY+  E++S       L+D+  +  SA        I+S
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDF--MDASALTGIPLPLIKS 110
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY 321
           Y  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---- 376
           W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 377 -----AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                ++PD+                  L ++G+  + + L  +P  R +A   L HPF 
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 414 GNA 416
            + 
Sbjct: 291 QDV 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P      ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQIL 267
           LL  L HPNIV+       ++KLY+  E++S   + K +      G     I+SY  Q+L
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 141/289 (48%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  GSP + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 246
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P +   P    P  T  M
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELM 295

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 87/311 (27%), Positives = 146/311 (46%), Gaps = 55/311 (17%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ 202
           SP  +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++    
Sbjct: 5   SPEFMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPS 54
Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---- 258
              +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++    
Sbjct: 55  TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTG 106
Query: 259 -----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+        
Sbjct: 107 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 314 LSIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS 372
            + +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +
Sbjct: 167 YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 226
Query: 373 KELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAA 405
              P         ++PD+                  L ++G+  + + L  +P  R +A 
Sbjct: 227 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 286
Query: 406 WLLEHPFVGNA 416
             L HPF  + 
Sbjct: 287 AALAHPFFQDV 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 87/311 (27%), Positives = 146/311 (46%), Gaps = 55/311 (17%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ 202
           SP  +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++    
Sbjct: 5   SPEFMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPS 54
Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---- 258
              +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++    
Sbjct: 55  TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTG 106
Query: 259 -----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+        
Sbjct: 107 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 314 LSIKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS 372
            + +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +
Sbjct: 167 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 226
Query: 373 KELP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAA 405
              P         ++PD+                  L ++G+  + + L  +P  R +A 
Sbjct: 227 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 286
Query: 406 WLLEHPFVGNA 416
             L HPF  + 
Sbjct: 287 AALAHPFFQDV 297

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G   A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIV 74
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   RS  +QI+S ++Y H K  VH
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T      +  GSP + APE+ +        VD+
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDV 194
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ +++
Sbjct: 195 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 244
Query: 393 CLQRNPLHRPTAAWLLEHPFV 413
            L  NP+ R T   +++  ++
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 138/291 (47%), Gaps = 36/291 (12%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES---AIRSYTQQILSGLEYL 273
           PNIV+       ++KLY+  E+V      K   D   L       I+SY  Q+L GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQD--LKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSN 332
           H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE++    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------AIPDH-- 381
             + AVDIWSLGC   EM T +  +     +  +F+I  +   P         ++PD+  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 382 ----------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                           L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 142/296 (47%), Gaps = 46/296 (15%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--------IRSYTQQILS 268
           PNIV+       ++KLY+  E++S       L+D+  +  SA        I+SY  Q+L 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMD-----LKDF--MDASALTGIPLPLIKSYLFQLLQ 116
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEV 327
           GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------AI 378
           +      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         ++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 379 PDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 141/293 (48%), Gaps = 32/293 (10%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            +++K   +G GT+G V+   N E+ E+ A+K V L  DD     SA +   EI LL  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +H NIVR +     D KL +  E+             G L    ++S+  Q+L GL + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNG 333
           ++N +HRD+K  N+L++ +G +KLA+FG+A+       C  +   + ++  P+V+  +  
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW-------SQYEGV------------PAMFKIGNSKE 374
            + ++D+WS GC   E+A    P         Q + +            P+M K+ + K 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 375 LPAIPD---------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
            P  P           L+  G+D ++  L+ NP+ R +A   L+HP+  +  P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 141/298 (47%), Gaps = 48/298 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  +  
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 140/289 (48%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A   V +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  GSP + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 246
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P +   P    P  T  M
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELM 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 139/290 (47%), Gaps = 34/290 (11%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLH 274
           PNIV+       ++KLY+  E++S   + K +      G     I+SY  Q+L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNG 333
           +   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE++     
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------AIPDH--- 381
            + AVDIWSLGC   EM T +  +     +  +F+I  +   P         ++PD+   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 382 ---------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                          L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G++G          G++   KE+   S    ++   Q L  E+ LL  L+HPNIVRY
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 223 YGS--ETLDDKLYIYLEYVSGGSIYKIL----QDYGQLGESAIRSYTQQILSGLEYLHAK 276
           Y    +  +  LYI +EY  GG +  ++    ++   L E  +     Q+   L+  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 277 N-----TVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKN 330
           +      +HRD+K AN+ +D    VKL DFG+A+ +    S   +  G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-N 189
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            + L     HRP+   +LE+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 48/304 (15%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P      ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IR 260
           LL  L HPNIV+       ++KLY+  E++         QD  +  +++         I+
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIK 109
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
           SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +   
Sbjct: 110 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--- 376
            W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P   
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 377 ------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 ++PD+                  L ++G+  + + L  +P  R +A   L HPF
Sbjct: 230 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 413 VGNA 416
             + 
Sbjct: 290 FQDV 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 143/296 (48%), Gaps = 46/296 (15%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--------IRSYTQQILS 268
           PNIV+       ++KLY+  E+     +++ L+D+  +  SA        I+SY  Q+L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKDF--MDASALTGIPLPLIKSYLFQLLQ 114
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEV 327
           GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------AI 378
           +      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         ++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 379 PDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G++G          G++   KE+   S    ++   Q L  E+ LL  L+HPNIVRY
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 223 YGS--ETLDDKLYIYLEYVSGGSIYKIL----QDYGQLGESAIRSYTQQILSGLEYLHAK 276
           Y    +  +  LYI +EY  GG +  ++    ++   L E  +     Q+   L+  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 277 N-----TVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKN 330
           +      +HRD+K AN+ +D    VKL DFG+A+ +    S   +  G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-N 189
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            + L     HRP+   +LE+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 48/304 (15%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P      ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+
Sbjct: 2   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 58
Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IR 260
           LL  L HPNIV+       ++KLY+  E++         QD  +  +++         I+
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIK 110
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
           SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +   
Sbjct: 111 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--- 376
            W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P   
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 377 ------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 ++PD+                  L ++G+  + + L  +P  R +A   L HPF
Sbjct: 231 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 413 VGNA 416
             + 
Sbjct: 291 FQDV 294

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 141/289 (48%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  G+P + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 246
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P +   P    P  T  M
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELM 295

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G   A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   RS  +QI+S ++Y H K  VH
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T      +  G+P + APE+ +        VD+
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ +++
Sbjct: 198 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247
Query: 393 CLQRNPLHRPTAAWLLEHPFV 413
            L  NP+ R T   +++  ++
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI 268

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 139/289 (48%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A   V +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVA---VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +      GSP + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 246
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P +   P    P  T  M
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELM 295

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 15/269 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G FG   L  + +S E+ A+K +       + ++ A  + +EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIAANVKREIINHRSL 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNIVR+         L I +EY SGG +++ + + G+  E   R + QQ++SG+ Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 275 AKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           A    HRD+K  N L+D  P+ R+K+ DFG +K     S P S  G+P ++APEV+    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPD--HLSDEGK 387
                 D+WS G T+  M     P+   E  P  F+    + L    AIPD  H+S E +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
             + +    +P  R +   +  H  F+ N
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 55/309 (17%)
Query: 145 GRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           G +EN       ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++      
Sbjct: 1   GHMEN-------FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTA 50
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA------ 258
            +EI+LL  L HPNIV+       ++KLY+  E++         QD  +  +++      
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIP 102
Query: 259 ---IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS 315
              I+SY  Q+L GL + H+   +HRD+K  N+L++  G +KLADFG+A+          
Sbjct: 103 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 316 IKGSPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
            +    W  APE++      + AVDIWSLGC   EM T +  +     +  +F+I  +  
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222
Query: 375 LP---------AIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWL 407
            P         ++PD+                  L ++G+  + + L  +P  R +A   
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 408 LEHPFVGNA 416
           L HPF  + 
Sbjct: 283 LAHPFFQDV 291

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 134/269 (49%), Gaps = 15/269 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G FG   L  + ++ E+ A+K +       + ++  + + +EI     L
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNIVR+         L I +EY SGG +++ + + G+  E   R + QQ++SG+ Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 275 AKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           A    HRD+K  N L+D  P+ R+K+ADFG +K     S P S  G+P ++APEV+    
Sbjct: 133 AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPD--HLSDEGK 387
                 D+WS G T+  M     P+   E  P  F+    + L    AIPD  H+S E +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
             + +    +P  R +   +  H  F+ N
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 127/263 (48%), Gaps = 17/263 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G++G          G++   KE+   S    ++   Q L  E+ LL  L+HPNIVRY
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 223 YGS--ETLDDKLYIYLEYVSGGSIYKIL----QDYGQLGESAIRSYTQQILSGLEYLHAK 276
           Y    +  +  LYI +EY  GG +  ++    ++   L E  +     Q+   L+  H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 277 N-----TVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKN 330
           +      +HRD+K AN+ +D    VKL DFG+A+ +   +       G+PY+M+PE + N
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM-N 189
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               N   DIWSLGC + E+    PP++ +       KI   K    IP   SDE  + +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDELNEII 248
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            + L     HRP+   +LE+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 48/296 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+           +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 140/289 (48%), Gaps = 23/289 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A+K   +      +  S Q+L +E+ ++  L HPNIV
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 69
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+ +EY SGG ++  L  +G + E   R+  +QI+S ++Y H K  VH
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVH 129
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  GSP + APE+ +        VD+
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDV 189
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP ++S + ++ ++K
Sbjct: 190 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 239
Query: 393 CLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPTLTVAM 439
            L  NP  R T   +++  +  VG+     +P +   P    P  T  M
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELM 288

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 15/269 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G FG   L  + +S E+ A+K +       + ++  + + +EI     L
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 71
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNIVR+         L I +EY SGG +++ + + G+  E   R + QQ++SG+ Y H
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 275 AKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           A    HRD+K  N L+D  P+ R+K+ DFG +K     S P S  G+P ++APEV+    
Sbjct: 132 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPD--HLSDEGK 387
                 D+WS G T+  M     P+   E  P  F+    + L    AIPD  H+S E +
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
             + +    +P  R +   +  H  F+ N
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+ ++ L   D +++       +EI+LL  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   +G GT+G VY   N  +GE+ A+ ++ L   D +++       +EI+LL  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA---------IRSYTQQIL 267
           PNIV+       ++KLY+  E++         QD  +  +++         I+SY  Q+L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APE 326
            GL + H+   +HRD+K  N+L++  G +KLADFG+A+         + +    W  APE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---------A 377
           ++      + AVDIWSLGC   EM T +  +     +  +F+I  +   P         +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 378 IPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +PD+                  L ++G+  + + L  +P  R +A   L HPF  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 135/263 (51%), Gaps = 17/263 (6%)
Query: 161 RLLGRGTFGHVY-----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+LG+G +G V+      G N+  G++ AMK +        +K++A     E  +L  ++
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANT--GKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVK 79
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP IV    +     KLY+ LEY+SGG ++  L+  G   E     Y  +I   L +LH 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           K  ++RD+K  NI+++  G VKL DFG+ K  I   +   +  G+  +MAPE++  S G 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GH 198
Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           N AVD WSLG  + +M T  PP++       + KI   K    +P +L+ E +D ++K L
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEARDLLKKLL 256
Query: 395 QRNPLHR-----PTAAWLLEHPF 412
           +RN   R       A  +  HPF
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPF 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+   S  G+  +++PE++   + 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 213 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 266
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 267 EKLLVLDATKR 277

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 11/258 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 71
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 72  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 131
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N    AVD
Sbjct: 132 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 190
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 191 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 248
Query: 400 HR-----PTAAWLLEHPF 412
            R       A  ++EH F
Sbjct: 249 QRLGGGPSDAKEVMEHRF 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 134/263 (50%), Gaps = 17/263 (6%)
Query: 161 RLLGRGTFGHVY-----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+LG+G +G V+      G N+  G++ AMK +        +K++A     E  +L  ++
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANT--GKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVK 79
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP IV    +     KLY+ LEY+SGG ++  L+  G   E     Y  +I   L +LH 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           K  ++RD+K  NI+++  G VKL DFG+ K  I   +      G+  +MAPE++  S G 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS-GH 198
Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           N AVD WSLG  + +M T  PP++       + KI   K    +P +L+ E +D ++K L
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEARDLLKKLL 256
Query: 395 QRNPLHR-----PTAAWLLEHPF 412
           +RN   R       A  +  HPF
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPF 279

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 11/258 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 400 HR-----PTAAWLLEHPF 412
            R       A  ++EH F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 11/258 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 400 HR-----PTAAWLLEHPF 412
            R       A  ++EH F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 128/241 (53%), Gaps = 7/241 (2%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R LG G+FG V+L  +  +G   AMK   L  +     +  +    E  +LS + HP I+
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMK--VLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           R +G+     ++++ ++Y+ GG ++ +L+   +      + Y  ++   LEYLH+K+ ++
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 129
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  NIL+D +G +K+ DFG AK++   +  L   G+P ++APEV+ ++   N ++D 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC--GTPDYIAPEVV-STKPYNKSIDW 186
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
           WS G  + EM     P+     +    KI N++     P   +++ KD + + + R+   
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQ 244
Query: 401 R 401
           R
Sbjct: 245 R 245

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 132/251 (52%), Gaps = 10/251 (3%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S ++  ++LG+G+FG V+L       +SG + AMK +   +   + +   +    E  +L
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM---ERDIL 84
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           + + HP +V+ + +   + KLY+ L+++ GG ++  L       E  ++ Y  ++  GL+
Sbjct: 85  ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKN 330
           +LH+   ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+ N
Sbjct: 145 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-N 203
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G + + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK--LGMPQFLSTEAQSLL 261
Query: 391 RKCLQRNPLHR 401
           R   +RNP +R
Sbjct: 262 RALFKRNPANR 272

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 190 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 243
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 244 EKLLVLDATKR 254

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+   S  G+  +++PE++   + 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 209 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 262
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 263 EKLLVLDATKR 273

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+   +  G+  +++PE++   + 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 210 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 263
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 264 EKLLVLDATKR 274

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 187 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 240
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 241 EKLLVLDATKR 251

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 189 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 242
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 243 EKLLVLDATKR 253

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 212 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 265
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 266 EKLLVLDATKR 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 188 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 241
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 242 EKLLVLDATKR 252

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 212 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 265
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 266 EKLLVLDATKR 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 213 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 266
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 267 EKLLVLDATKR 277

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 130/258 (50%), Gaps = 11/258 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +      G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 400 HR-----PTAAWLLEHPF 412
            R       A  ++EH F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 210 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 263
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 264 EKLLVLDATKR 274

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 130/258 (50%), Gaps = 11/258 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +      G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 400 HR-----PTAAWLLEHPF 412
            R       A  ++EH F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 210 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 263
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 264 EKLLVLDATKR 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 152/297 (51%), Gaps = 19/297 (6%)
Query: 143 SPGRVENPTSPGS---RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
           S GR EN    G+   R+    +LG+G+FG V    +  + +  A+K +   S  AK+K+
Sbjct: 8   SSGR-ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKD 64
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGES 257
           ++  L +E+ LL +L HPNI++ +  E L+D    YI  E  +GG ++  +    +  E 
Sbjct: 65  TSTIL-REVELLKKLDHPNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPL 314
                 +Q+ SG+ Y+H  N VHRD+K  NIL++   +   +K+ DFG++      +   
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
              G+ Y++APEV++ +   +   D+WS G  +  + +  PP+        + ++   K 
Sbjct: 182 DRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 375 LPAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
              +P    +SD+ KD +RK L  +P  R TA   LEHP++   +  E P +S  PS
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS-ETPTISDLPS 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 212 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 265
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 266 EKLLVLDATKR 276

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 132/269 (49%), Gaps = 15/269 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G FG   L  + +S E+ A+K +       + ++  + + +EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNIVR+         L I +EY SGG +++ + + G+  E   R + QQ++SG+ Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 275 AKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           A    HRD+K  N L+D  P+ R+K+  FG +K     S P S  G+P ++APEV+    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPD--HLSDEGK 387
                 D+WS G T+  M     P+   E  P  F+    + L    AIPD  H+S E +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
             + +    +P  R +   +  H  F+ N
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 134/271 (49%), Gaps = 11/271 (4%)
Query: 149 NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           +P    + +   +LLG+GTFG V L     +G   AMK   L  +   +K+       E 
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTES 61
Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +L   RHP +     +    D+L   +EY +GG ++  L       E   R Y  +I+S
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 121
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEV 327
            LEYLH+++ V+RDIK  N+++D  G +K+ DFG+ K  I+  +      G+P ++APEV
Sbjct: 122 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 181
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
           +++ N    AVD W LG  + EM   + P+   +    +F++   +E+   P  LS E K
Sbjct: 182 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAK 238
Query: 388 DFVRKCLQRNPLHR-----PTAAWLLEHPFV 413
             +   L+++P  R       A  ++EH F 
Sbjct: 239 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 146/314 (46%), Gaps = 37/314 (11%)
Query: 144 PGRVENPTSPGSRWKKGR----------LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
           PG VE P     RWK+            +LG G F  V L  +  + ++ A+K +     
Sbjct: 2   PGAVEGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KK 54
Query: 194 DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD------KLYIYLEYVSGGSIYKI 247
             + KE + +   EIA+L +++HPNIV       LDD       LY+ ++ VSGG ++  
Sbjct: 55  ALEGKEGSME--NEIAVLHKIKHPNIV------ALDDIYESGGHLYLIMQLVSGGELFDR 106
Query: 248 LQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL---VDPSGRVKLADFGMA 304
           + + G   E        Q+L  ++YLH    VHRD+K  N+L   +D   ++ ++DFG++
Sbjct: 107 IVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
           K     S   +  G+P ++APEV+        AVD WS+G     +    PP+       
Sbjct: 167 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAK 225
Query: 365 AMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERP 422
              +I  ++     P  D +SD  KDF+R  ++++P  R T    L+HP++     L++ 
Sbjct: 226 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 285
Query: 423 ILSAEPSETKPTLT 436
           I  +   + K    
Sbjct: 286 IHQSVSEQIKKNFA 299

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 194 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 247
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 248 EKLLVLDATKR 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 130/259 (50%), Gaps = 11/259 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +      G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
            W LG  + EM   + P+   +    +F++   +E+   P  LS E K  +   L+++P 
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 400 HR-----PTAAWLLEHPFV 413
            R       A  ++EH F 
Sbjct: 246 QRLGGGPSDAKEVMEHRFF 264

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 123/256 (48%), Gaps = 24/256 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDE 385
           C  + D+W+LGC + ++    PP          F+ GN   + A         P+    +
Sbjct: 212 CK-SSDLWALGCIIYQLVAGLPP----------FRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 386 GKDFVRKCLQRNPLHR 401
            +D V K L  +   R
Sbjct: 261 ARDLVEKLLVLDATKR 276

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 123/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y     D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 217 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 270
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 271 EKLLVLDATKR 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 209 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 262
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 263 EKLLVLDATKR 273

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--------------------- 201
           +G+G++G V L +N       AMK   + S     +++                      
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMK---VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 202 ---QQLGQEIALLSRLRHPNIVRYYGSETLDD----KLYIYLEYVSGGSIYKILQDYGQL 254
              +Q+ QEIA+L +L HPN+V+    E LDD     LY+  E V+ G + ++      L
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPL 134
Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
            E   R Y Q ++ G+EYLH +  +HRDIK +N+LV   G +K+ADFG++    G    L
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 315 S-IKGSPYWMAPEVIKNSNGC--NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI-G 370
           S   G+P +MAPE +  +       A+D+W++G T+      + P+     +    KI  
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            + E P  PD ++++ KD + + L +NP  R     +  HP+V
Sbjct: 255 QALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     P IV +
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVGF 88
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV-HR 281
           YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K+ + HR
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 148
Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
           D+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  ++  DIW
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YSVQSDIW 206
Query: 342 SLGCTVIEMATTKPPWSQYEGVPAMFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRN 397
           S+G +++EMA  + P     G  A+F++ +   ++  P +P  + S E +DFV KCL +N
Sbjct: 207 SMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 266
Query: 398 PLHRPTAAWLLEHPFV 413
           P  R     L+ H F+
Sbjct: 267 PAERADLKQLMVHAFI 282

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 137/258 (53%), Gaps = 14/258 (5%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +GRG+F  VY G ++E+    A  E+    D   +K   Q+  +E   L  L+HPNIVR+
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL---QDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 223 YGS--ETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN- 277
           Y S   T+  K  I L  E  + G++   L+ +       +RS+ +QIL GL++LH +  
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 278 -TVHRDIKGANILVD-PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             +HRD+K  NI +  P+G VK+ D G+A  +   S   ++ G+P + APE  +     +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY--D 207
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD-EGKDFVRKCL 394
            +VD+++ G   +E AT++ P+S+ +    +++   S   PA  D ++  E K+ +  C+
Sbjct: 208 ESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 395 QRNPLHRPTAAWLLEHPF 412
           ++N   R +   LL H F
Sbjct: 268 RQNKDERYSIKDLLNHAF 285

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 6/204 (2%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW 357
           C  + D+W+LGC + ++    PP+
Sbjct: 215 CK-SSDLWALGCIIYQLVAGLPPF 237

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 132/254 (51%), Gaps = 10/254 (3%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S+++  ++LG+G+FG V+L      S++ ++ AMK +   +   + +   +    E  +L
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDIL 80
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             + HP IV+ + +   + KLY+ L+++ GG ++  L       E  ++ Y  ++   L+
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKN 330
           +LH+   ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+ N
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-N 199
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLL 257
Query: 391 RKCLQRNPLHRPTA 404
           R   +RNP +R  A
Sbjct: 258 RMLFKRNPANRLGA 271

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 123/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F    L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           C  + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 210 CK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 263
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 264 EKLLVLDATKR 274

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 11/258 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG +G V    +  SG++ A+K +        S+E  + L      +  +  P  V +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRA---TVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 223 YGSETLDDKLYIYLEYV--SGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAK-NT 278
           YG+   +  ++I +E +  S    YK + D GQ + E  +      I+  LE+LH+K + 
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSNGCN 335
           +HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G +
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYS 235
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCL 394
           +  DIWSLG T+IE+A  + P+  +       K    +  P +P D  S E  DF  +CL
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 295
Query: 395 QRNPLHRPTAAWLLEHPF 412
           ++N   RPT   L++HPF
Sbjct: 296 KKNSKERPTYPELMQHPF 313

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 15/269 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G FG   L  + +S E+ A+K +       + ++  + + +EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNIVR+         L I +EY SGG +++ + + G+  E   R + QQ++SG+ Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 275 AKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           A    HRD+K  N L+D  P+ R+K+  FG +K     S P    G+P ++APEV+    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP---AIPD--HLSDEGK 387
                 D+WS G T+  M     P+   E  P  F+    + L    AIPD  H+S E +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
             + +    +P  R +   +  H  F+ N
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S+++  ++LG+G+FG V+L      S++ ++ AMK +   +   + +   +    E  +L
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDIL 81
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             + HP IV+ + +   + KLY+ L+++ GG ++  L       E  ++ Y  ++   L+
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKN 330
           +LH+   ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+ N
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-N 200
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLL 258
Query: 391 RKCLQRNPLHRPTAA 405
           R   +RNP +R  A 
Sbjct: 259 RMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S+++  ++LG+G+FG V+L      S++ ++ AMK +   +   + +   +    E  +L
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDIL 80
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             + HP IV+ + +   + KLY+ L+++ GG ++  L       E  ++ Y  ++   L+
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKN 330
           +LH+   ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+ N
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-N 199
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
             G   + D WS G  + EM T   P+   +    M  I  +K    +P  LS E +  +
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLL 257
Query: 391 RKCLQRNPLHRPTAA 405
           R   +RNP +R  A 
Sbjct: 258 RMLFKRNPANRLGAG 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           L+G G++G V    N ++G + A+K+     DD   K+ A +   EI LL +LRH N+V 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLRHENLVN 88
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKN 277
                    + Y+  E+V     + IL D       L    ++ Y  QI++G+ + H+ N
Sbjct: 89  LLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCNL 336
            +HRDIK  NILV  SG VKL DFG A+ +         + +  W  APE++        
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GN----------------SKELP 376
           AVD+W++GC V EM   +P +     +  ++ I    GN                   LP
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 377 AIPDH---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
            I +          LS+   D  +KCL  +P  RP  A LL H F       ER
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 145 GRVENPTSPGSRWKKGR----------LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           G VE P     RWK+            +LG G F  V L  +  + ++ A+K +    + 
Sbjct: 3   GAVEGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KEA 55
Query: 195 AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD------KLYIYLEYVSGGSIYKIL 248
            + KE + +   EIA+L +++HPNIV       LDD       LY+ ++ VSGG ++  +
Sbjct: 56  LEGKEGSME--NEIAVLHKIKHPNIV------ALDDIYESGGHLYLIMQLVSGGELFDRI 107
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL---VDPSGRVKLADFGMAK 305
            + G   E        Q+L  ++YLH    VHRD+K  N+L   +D   ++ ++DFG++K
Sbjct: 108 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                S   +  G+P ++APEV+        AVD WS+G     +    PP+        
Sbjct: 168 MEDPGSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKL 226
Query: 366 MFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
             +I  ++     P  D +SD  KDF+R  ++++P  R T    L+HP++     L++ I
Sbjct: 227 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 286
Query: 424 LSAEPSETKPTLT 436
             +   + K    
Sbjct: 287 HQSVSEQIKKNFA 299

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 87/313 (27%), Positives = 146/313 (46%), Gaps = 37/313 (11%)
Query: 145 GRVENPTSPGSRWKKGR----------LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           G VE P     RWK+            +LG G F  V L  +  + ++ A+K +    + 
Sbjct: 3   GAVEGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KEA 55
Query: 195 AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD------KLYIYLEYVSGGSIYKIL 248
            + KE + +   EIA+L +++HPNIV       LDD       LY+ ++ VSGG ++  +
Sbjct: 56  LEGKEGSME--NEIAVLHKIKHPNIV------ALDDIYESGGHLYLIMQLVSGGELFDRI 107
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL---VDPSGRVKLADFGMAK 305
            + G   E        Q+L  ++YLH    VHRD+K  N+L   +D   ++ ++DFG++K
Sbjct: 108 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                S   +  G+P ++APEV+        AVD WS+G     +    PP+        
Sbjct: 168 MEDPGSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKL 226
Query: 366 MFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
             +I  ++     P  D +SD  KDF+R  ++++P  R T    L+HP++     L++ I
Sbjct: 227 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 286
Query: 424 LSAEPSETKPTLT 436
             +   + K    
Sbjct: 287 HQSVSEQIKKNFA 299

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+   S  G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
              + D+W+LGC + ++    PP+   ++Y     + K+         P+    + +D V
Sbjct: 212 SK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLV 265
Query: 391 RKCLQRNPLHR 401
            K L  +   R
Sbjct: 266 EKLLVLDATKR 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 3/202 (1%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++  + +G+G F  V L  +  +G   A+K   +      +  S Q+L +E+ ++  L H
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNIV+ +     +  LY+ +EY SGG ++  L  +G++ E   R+  +QI+S ++Y H K
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             VHRD+K  N+L+D    +K+ADFG +   T  +   +  GSP + APE+ +       
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGP 193
Query: 337 AVDIWSLGCTVIEMATTKPPWS 358
            VD+WSLG  +  + +   P+ 
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A+K ++        A+  + A  +  
Sbjct: 11  PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 130 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 189
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 249
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 250 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 21/251 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           + +G+G F  V L  +  +G+  A+K   +      +  S Q+L +E+ +   L HPNIV
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIXKVLNHPNIV 76
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +     +  LY+  EY SGG ++  L  +G+  E   R+  +QI+S ++Y H K  VH
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDI 340
           RD+K  N+L+D    +K+ADFG +   T  +   +  G+P + APE+ +        VD+
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDV 196
Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDEGKDFVRK 392
           WSLG  +  + +   P          F   N KEL          IP + S + ++ ++K
Sbjct: 197 WSLGVILYTLVSGSLP----------FDGQNLKELRERVLRGKYRIPFYXSTDCENLLKK 246
Query: 393 CLQRNPLHRPT 403
            L  NP  R T
Sbjct: 247 FLILNPSKRGT 257

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A+K ++        A+  + A  +  
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 138/303 (45%), Gaps = 46/303 (15%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S  S++K+   LG GT+  VY G N  +G   A+KEV L S++     + +    EI+L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLM 57
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ 264
             L+H NIVR Y     ++KL +  E++      K   D   +G +        ++ +  
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDND--LKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM- 323
           Q+L GL + H    +HRD+K  N+L++  G++KL DFG+A+         S +    W  
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS-------- 372
           AP+V+  S   + ++DIWS GC + EM T KP +   +  E +  +F I  +        
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 373 ----------------KEL-----PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
                           ++L     P   + L     DF+   LQ NP  R +A   L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 412 FVG 414
           +  
Sbjct: 296 WFA 298

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 143/300 (47%), Gaps = 37/300 (12%)
Query: 145 GRVENPTSPGSRWKKGR----------LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           G VE P     RWK+            +LG G F  V L  +  + ++ A+K +    + 
Sbjct: 3   GAVEGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KEA 55
Query: 195 AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD------KLYIYLEYVSGGSIYKIL 248
            + KE + +   EIA+L +++HPNIV       LDD       LY+ ++ VSGG ++  +
Sbjct: 56  LEGKEGSME--NEIAVLHKIKHPNIV------ALDDIYESGGHLYLIMQLVSGGELFDRI 107
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL---VDPSGRVKLADFGMAK 305
            + G   E        Q+L  ++YLH    VHRD+K  N+L   +D   ++ ++DFG++K
Sbjct: 108 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                S   +  G+P ++APEV+        AVD WS+G     +    PP+        
Sbjct: 168 MEDPGSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKL 226
Query: 366 MFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
             +I  ++     P  D +SD  KDF+R  ++++P  R T    L+HP++     L++ I
Sbjct: 227 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 286

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 3/210 (1%)
Query: 149 NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           NP +  S +   +++G+G+FG V L  +       A+K V       K KE    + +  
Sbjct: 32  NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERN 90
Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            LL  ++HP +V  + S    DKLY  L+Y++GG ++  LQ      E   R Y  +I S
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 150
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEV 327
            L YLH+ N V+RD+K  NIL+D  G + L DFG+ K +I   S   +  G+P ++APEV
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           + +    +  VD W LG  + EM    PP+
Sbjct: 211 L-HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A+K ++        A+  + A  +  
Sbjct: 4   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 123 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 182
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 242
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 243 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 145/281 (51%), Gaps = 18/281 (6%)
Query: 143 SPGRVENPTSPGS---RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
           S GR EN    G+   R+    +LG+G+FG V    +  + +  A+K +   S  AK+K+
Sbjct: 8   SSGR-ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKD 64
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGES 257
           ++  L +E+ LL +L HPNI++ +  E L+D    YI  E  +GG ++  +    +  E 
Sbjct: 65  TSTIL-REVELLKKLDHPNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPL 314
                 +Q+ SG+ Y+H  N VHRD+K  NIL++   +   +K+ DFG++      +   
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
              G+ Y++APEV++ +   +   D+WS G  +  + +  PP+        + ++   K 
Sbjct: 182 DRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 375 LPAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              +P    +SD+ KD +RK L  +P  R TA   LEHP++
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 145/281 (51%), Gaps = 18/281 (6%)
Query: 143 SPGRVENPTSPGS---RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
           S GR EN    G+   R+    +LG+G+FG V    +  + +  A+K +   S  AK+K+
Sbjct: 8   SSGR-ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKD 64
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGES 257
           ++  L +E+ LL +L HPNI++ +  E L+D    YI  E  +GG ++  +    +  E 
Sbjct: 65  TSTIL-REVELLKKLDHPNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPL 314
                 +Q+ SG+ Y+H  N VHRD+K  NIL++   +   +K+ DFG++      +   
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
              G+ Y++APEV++ +   +   D+WS G  +  + +  PP+        + ++   K 
Sbjct: 182 DRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 375 LPAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              +P    +SD+ KD +RK L  +P  R TA   LEHP++
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 148/268 (55%), Gaps = 17/268 (6%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 181
Query: 336 LAVDIWSLGCTVIEMATTK----PPWSQYEGVP--AMFKIGN---SKELPAIPDHL-SDE 385
           +  DIWS+G +++EMA  +    PP ++ +  P  A+F++ +   ++  P +P  + S E
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 241
Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +DFV KCL +NP  R     L+ H F+
Sbjct: 242 FQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 11/258 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG +G V    +  SG++ A+K +        S+E  + L      +  +  P  V +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA---TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 223 YGSETLDDKLYIYLEYV--SGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAK-NT 278
           YG+   +  ++I +E +  S    YK + D GQ + E  +      I+  LE+LH+K + 
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSNGCN 335
           +HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCL 394
           +  DIWSLG T+IE+A  + P+  +       K    +  P +P D  S E  DF  +CL
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251
Query: 395 QRNPLHRPTAAWLLEHPF 412
           ++N   RPT   L++HPF
Sbjct: 252 KKNSKERPTYPELMQHPF 269

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 134/263 (50%), Gaps = 26/263 (9%)
Query: 157 WKKGRL-LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           W   +L LGRG+FG V+   + ++G  CA+K+V L    A          +E+   + L 
Sbjct: 94  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA----------EELMACAGLT 143
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
            P IV  YG+      + I++E + GGS+ +++++ G L E     Y  Q L GLEYLH+
Sbjct: 144 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHS 203
Query: 276 KNTVHRDIKGANILVDPSG-RVKLADFGMAKHIT----GQSCPLS--IKGSPYWMAPEVI 328
           +  +H D+K  N+L+   G    L DFG A  +     G+S      I G+   MAPEV+
Sbjct: 204 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----KELPAIPDHLSD 384
              + C+  VD+WS  C ++ M     PW+Q+   P   KI +     +E+P     L+ 
Sbjct: 264 LGRS-CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTA 322
Query: 385 EGKDFVRKCLQRNPLHRPTAAWL 407
           +    +++ L++ P+HR +AA L
Sbjct: 323 QA---IQEGLRKEPIHRVSAAEL 342

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 24/256 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH K
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             +HRD+K  NIL++    +++ DFG AK +   + Q+      G+  +++PE++   + 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--------IPDHLSDE 385
              + D+W+LGC + ++    PP          F+ GN   + A         P+    +
Sbjct: 212 XK-SSDLWALGCIIYQLVAGLPP----------FRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 386 GKDFVRKCLQRNPLHR 401
            +D V K L  +   R
Sbjct: 261 ARDLVEKLLVLDATKR 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A++ ++        A+  + A  +  
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 133/273 (48%), Gaps = 12/273 (4%)
Query: 149 NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           +P    + ++  +LLG+GTFG V L     +G   AMK   L  +   +K+       E 
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTEN 61
Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +L   RHP +     S    D+L   +EY +GG ++  L       E   R Y  +I+S
Sbjct: 62  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 121
Query: 269 GLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPE 326
            L+YLH+ KN V+RD+K  N+++D  G +K+ DFG+ K  I   +      G+P ++APE
Sbjct: 122 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           V+++ N    AVD W LG  + EM   + P+   +    +F++   +E+   P  L  E 
Sbjct: 182 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEA 238
Query: 387 KDFVRKCLQRNPLHR-----PTAAWLLEHPFVG 414
           K  +   L+++P  R       A  +++H F  
Sbjct: 239 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 34/267 (12%)
Query: 157 WKKGRL-LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           W   +L LGRG+FG V+   + ++G  CA+K+V L    A          +E+   + L 
Sbjct: 75  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA----------EELMACAGLT 124
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
            P IV  YG+      + I++E + GGS+ +++++ G L E     Y  Q L GLEYLH+
Sbjct: 125 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHS 184
Query: 276 KNTVHRDIKGANILVDPSG-RVKLADFGMA----------KHITGQSCPLSIKGSPYWMA 324
           +  +H D+K  N+L+   G    L DFG A            +TG   P    G+   MA
Sbjct: 185 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP----GTETHMA 240
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----KELPAIPD 380
           PEV+   + C+  VD+WS  C ++ M     PW+Q+   P   KI +     +E+P    
Sbjct: 241 PEVVLGRS-CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCA 299
Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWL 407
            L+ +    +++ L++ P+HR +AA L
Sbjct: 300 PLTAQA---IQEGLRKEPIHRVSAAEL 323

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 12/261 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTV 279
               S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ KN V
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 271
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+++D  G +K+ DFG+ K  I   +   +  G+P ++APEV+++ N    AV
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAV 330
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           D W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+++P
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 388
Query: 399 LHR-----PTAAWLLEHPFVG 414
             R       A  +++H F  
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFA 409

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 12/261 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 214
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTV 279
               S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ KN V
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 274
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+++D  G +K+ DFG+ K  I   +   +  G+P ++APEV+++ N    AV
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAV 333
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           D W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+++P
Sbjct: 334 DWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 391
Query: 399 LHR-----PTAAWLLEHPFVG 414
             R       A  +++H F  
Sbjct: 392 KQRLGGGSEDAKEIMQHRFFA 412

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 12/277 (4%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQ 206
           P +    +   + LG G  G V L F  ++ +  A++ ++        A+  + A  +  
Sbjct: 144 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI +L +L HP I++       +D  YI LE + GG ++  +    +L E+  + Y  Q+
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 267 LSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
           L  ++YLH    +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++
Sbjct: 263 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 322
Query: 324 APEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---GVPAMFKIGNSKELPAI 378
           APEV+ +  + G N AVD WSLG  +    +  PP+S++     +      G    +P +
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 382
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
              +S++  D V+K L  +P  R T    L HP++ +
Sbjct: 383 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 142/262 (54%), Gaps = 15/262 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 66
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +  +       G+  +M+PE ++ ++  +
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQGTH-YS 184
Query: 336 LAVDIWSLGCTVIEMATT---KPPWSQYEGVPAMFKIGNSKELPAIPDHL-SDEGKDFVR 391
           +  DIWS+G +++EMA     +PP + +E +  +     ++  P +P  + S E +DFV 
Sbjct: 185 VQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIV----NEPPPKLPSAVFSLEFQDFVN 240
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           KCL +NP  R     L+ H F+
Sbjct: 241 KCLIKNPAERADLKQLMVHAFI 262

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 17/248 (6%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V+L    ++ +  A+K    +V L  DD +       + ++  L     H
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVLSLAWEH 78
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   + +    + L+  +EY++GG +   +Q   +   S    Y  +I+ GL++LH+K
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 138
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             V+RD+K  NIL+D  G +K+ADFGM K ++ G +      G+P ++APE++      N
Sbjct: 139 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YN 197
Query: 336 LAVDIWSLGCTVIEMATTKPPW--SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +VD WS G  + EM   + P+     E +    ++ N    P  P  L  E KD + K 
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----PFYPRWLEKEAKDLLVKL 253
Query: 394 LQRNPLHR 401
             R P  R
Sbjct: 254 FVREPEKR 261

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 17/248 (6%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++LG+G+FG V+L    ++ +  A+K    +V L  DD +       + ++  L     H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVLSLAWEH 77
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +   + +    + L+  +EY++GG +   +Q   +   S    Y  +I+ GL++LH+K
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             V+RD+K  NIL+D  G +K+ADFGM K ++ G +      G+P ++APE++      N
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YN 196
Query: 336 LAVDIWSLGCTVIEMATTKPPW--SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +VD WS G  + EM   + P+     E +    ++ N    P  P  L  E KD + K 
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----PFYPRWLEKEAKDLLVKL 252
Query: 394 LQRNPLHR 401
             R P  R
Sbjct: 253 FVREPEKR 260

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 135/264 (51%), Gaps = 19/264 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           R+LG+G+FG V L    E+G++ A+K    +V L  DD +   + ++    I  L+R  H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR----ILSLAR-NH 83
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P + + +      D+L+  +E+V+GG +   +Q   +  E+  R Y  +I+S L +LH K
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  N+L+D  G  KLADFGM K  I       +  G+P ++APE+++      
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYG 202
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD W++G  + EM     P+ + E    +F+   + E+   P  L ++    ++  + 
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMT 260
Query: 396 RNPLHRPTAAW------LLEHPFV 413
           +NP  R  +        +L HPF 
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G +LG+G FG      + E+GE+  MKE+  F +     E+ +   +E+ ++  L HPN+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-----ETQRTFLKEVKVMRCLEHPNV 69
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNT 278
           +++ G    D +L    EY+ GG++  I++    Q   S   S+ + I SG+ YLH+ N 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP---------------LSIKGSPYWM 323
           +HRD+   N LV  +  V +ADFG+A+ +  +                   ++ G+PYWM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 324 APEVIKNSNGCNLAVDIWSLG---CTVIEMATTKPPW 357
           APE+I N    +  VD++S G   C +I      P +
Sbjct: 190 APEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 72
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTV 279
               S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ KN V
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 132
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+++D  G +K+ DFG+ K  I   +      G+P ++APEV+++ N    AV
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED-NDYGRAV 191
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           D W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+++P
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 249
Query: 399 LHR-----PTAAWLLEHPFVG 414
             R       A  +++H F  
Sbjct: 250 KQRLGGGSEDAKEIMQHRFFA 270

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 136/262 (51%), Gaps = 12/262 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G+G F  V    N E+G+  A+K V +    +    S + L +E ++   L+HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 222 YYGSETLDDKLYIYLEYVSGGSI-YKILQ--DYGQLGESAIRS-YTQQILSGLEYLHAKN 277
              + + D  LY+  E++ G  + ++I++  D G +   A+ S Y +QIL  L Y H  N
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKNSN 332
            +HRD+K  N+L+   + S  VKL DFG+A  + G+S  ++    G+P++MAPEV+K   
Sbjct: 151 IIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 333 GCNLAVDIWSLGCTV-IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
                VD+W  G  + I ++   P +   E +      G  K  P    H+S+  KD VR
Sbjct: 210 -YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L  +P  R T    L HP++
Sbjct: 269 RMLMLDPAERITVYEALNHPWL 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 25/293 (8%)
Query: 140 VPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-------LFS 192
           V +  G++      G  + K R LG G +G V L          A+K +         +S
Sbjct: 27  VRKKEGKI------GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 193 DDAKSKESA-QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQ 249
           DD K+ E   +++  EI+LL  L HPNI++ +  +  +DK Y YL  E+  GG +++ + 
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQII 138
Query: 250 DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKH 306
           +  +  E    +  +QILSG+ YLH  N VHRDIK  NIL++       +K+ DFG++  
Sbjct: 139 NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM 366
            +         G+ Y++APEV+K     N   D+WS G  +  +    PP+        +
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256
Query: 367 FKIGNSKELPAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
            K+   K      D  ++SDE K+ ++  L  +   R TA   L   ++   A
Sbjct: 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 71
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTV 279
               S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ KN V
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 131
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKH-ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+++D  G +K+ DFG+ K  I   +      G+P ++APEV+++ N    AV
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED-NDYGRAV 190
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
           D W LG  + EM   + P+   +    +F++   +E+   P  L  E K  +   L+++P
Sbjct: 191 DWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 248
Query: 399 LHR-----PTAAWLLEHPFVG 414
             R       A  +++H F  
Sbjct: 249 KQRLGGGSEDAKEIMQHRFFA 269

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 85
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+    ++ G+P ++APEV+ +  G +  VD
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVD 203
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 204 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 261
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 262 ARPTINELLNDEF 274

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+   + + G+P ++APEV+ +  G +  VD
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVD 223
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 281
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 282 ARPTINELLNDEF 294

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+    ++ G+P ++APEV+ +  G +  VD
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 257
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 258 ARPTINELLNDEF 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+    ++ G+P ++APEV+ +  G +  VD
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 257
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 258 ARPTINELLNDEF 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 103
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 163
Query: 282 DIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+   + + G+P ++APEV+ +  G +  VD
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVD 221
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 222 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 279
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 280 ARPTINELLNDEF 292

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 111/224 (49%), Gaps = 9/224 (4%)
Query: 141 PRSPGRVENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
           P + G ++ P    S R+   + +G G FG   L  +  + E+ A+K +       +   
Sbjct: 5   PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI------ERGAA 58
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
             + + +EI     LRHPNIVR+         L I +EY SGG +Y+ + + G+  E   
Sbjct: 59  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIK 317
           R + QQ+LSG+ Y H+    HRD+K  N L+D  P+ R+K+ DFG +K     S P S  
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE 361
           G+P ++APEV+          D+WS G T+  M     P+   E
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 126/260 (48%), Gaps = 12/260 (4%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++ GR LG+G FG+VYL    +S  + A+K   LF    + +    QL +EI + + L H
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALK--VLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNI+R Y       ++Y+ LEY   G +YK LQ      E    +  +++   L Y H K
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             +HRDIK  N+L+   G +K+ADFG + H        ++ G+  ++ PE+I+     N 
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK-TMCGTLDYLPPEMIEGRMH-NE 200
Query: 337 AVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            VD+W +G    E+    PP+   S  E    + K+         P  +    +D + K 
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVD-----LKFPASVPTGAQDLISKL 255
Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           L+ NP  R   A +  HP+V
Sbjct: 256 LRHNPSERLPLAQVSAHPWV 275

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 128/253 (50%), Gaps = 8/253 (3%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
            LG+G F   +   ++++ E+ A K V             +++  EI++   L H ++V 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVP--KSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           ++G    +D +++ LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HR
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 282 DIKGANILVDPSGRVKLADFGMAKHIT--GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  N+ ++    VK+ DFG+A  +   G+   + + G+P ++APEV+ +  G +  VD
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVD 197
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPL 399
           +WS+GC +  +   KPP+          +I  ++   +IP H++      ++K LQ +P 
Sbjct: 198 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPT 255
Query: 400 HRPTAAWLLEHPF 412
            RPT   LL   F
Sbjct: 256 ARPTINELLNDEF 268

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 138/283 (48%), Gaps = 22/283 (7%)
Query: 143 SPGRVENPTSPG--SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           S GR EN    G   R+++ + LG G +G V L  +  +G   A+K +   S    S   
Sbjct: 8   SSGR-ENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG 66
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDK--LYIYLEYVSGGSIYK---ILQDYGQLG 255
           A  L  E+A+L +L HPNI++ Y  E  +DK   Y+ +E   GG ++    + Q + ++ 
Sbjct: 67  A--LLDEVAVLKQLDHPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD 122
Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSC 312
            + I    +Q+LSG  YLH  N VHRD+K  N+L++   R   +K+ DFG++ H      
Sbjct: 123 AAVI---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK 179
Query: 313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS 372
                G+ Y++APEV++     +   D+WS G  +  +    PP+        + ++   
Sbjct: 180 MKERLGTAYYIAPEVLRKKY--DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKG 237
Query: 373 KELPAIPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           K     PD   +SDE K  V+  L   P  R +A   L HP++
Sbjct: 238 KFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEIXINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEIXINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 139/297 (46%), Gaps = 48/297 (16%)
Query: 163 LGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLR---H 216
           +G G +G V+   + ++G    A+K V +     ++ E    L   +E+A+L  L    H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 217 PNIVRYYGSETL-----DDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSG 269
           PN+VR +   T+     + KL +  E+V    +   L    + G     I+    Q+L G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L++LH+   VHRD+K  NILV  SG++KLADFG+A+  + Q    S+  + ++ APEV+ 
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--------- 380
            S+     VD+WS+GC   EM   KP +     V  + KI +   LP   D         
Sbjct: 193 QSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 381 ----------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
                            + + GKD + KCL  NP  R +A   L HP+  +   LER
Sbjct: 252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---LER 305

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 108/206 (52%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI + + L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINAMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 62
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 9/221 (4%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+ +L  +RHPNI+  +        + + LE VSGG ++  L +   L E   
Sbjct: 51  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 110
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
             + +QIL G+ YLH+K   H D+K  NI L+D   P+ R+KL DFG+A  I   +   +
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS 372
           I G+P ++APE++ N     L  D+WS+G     + +   P+   ++ E +  +  +   
Sbjct: 171 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +     +  S+  KDF+R+ L ++P  R T A  LEH ++
Sbjct: 230 FDEEYFSN-TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 139/297 (46%), Gaps = 48/297 (16%)
Query: 163 LGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLR---H 216
           +G G +G V+   + ++G    A+K V +     ++ E    L   +E+A+L  L    H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 217 PNIVRYYGSETL-----DDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSG 269
           PN+VR +   T+     + KL +  E+V    +   L    + G     I+    Q+L G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L++LH+   VHRD+K  NILV  SG++KLADFG+A+  + Q    S+  + ++ APEV+ 
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--------- 380
            S+     VD+WS+GC   EM   KP +     V  + KI +   LP   D         
Sbjct: 193 QSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 381 ----------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
                            + + GKD + KCL  NP  R +A   L HP+  +   LER
Sbjct: 252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---LER 305

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEIXINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 64
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 110
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 170 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 229
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 273

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 135/288 (46%), Gaps = 45/288 (15%)
Query: 163 LGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLG--QEIALLSRLR---H 216
           +G G +G V+   + ++G    A+K V +     ++ E    L   +E+A+L  L    H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 217 PNIVRYYGSETL-----DDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSG 269
           PN+VR +   T+     + KL +  E+V    +   L    + G     I+    Q+L G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L++LH+   VHRD+K  NILV  SG++KLADFG+A+  + Q    S+  + ++ APEV+ 
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--------- 380
            S+     VD+WS+GC   EM   KP +     V  + KI +   LP   D         
Sbjct: 193 QSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 381 ----------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                            + + GKD + KCL  NP  R +A   L HP+
Sbjct: 252 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 135/296 (45%), Gaps = 33/296 (11%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            +++K   +G G++G V+   N ++G++ A+K+     DD   K+ A +   EI +L +L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQL 59
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +HPN+V          +L++  EY     ++++ +    + E  ++S T Q L  + + H
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNG 333
             N +HRD+K  NIL+     +KL DFG A+ +TG S     + +  W  +PE++     
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELP--------------- 376
               VD+W++GC   E+ +  P W     V  ++ I  +    +P               
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 377 AIPD------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
            IPD            ++S      ++ CL  +P  R T   LL HP+  N   +E
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 106
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 108
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 168 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 227
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 271

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 106
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 100
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 160 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 219
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 263

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 140/307 (45%), Gaps = 36/307 (11%)
Query: 143 SPGRVENPTSPG--SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           S GR EN    G   +++K   +G GT+G VY   +S+ G + A+K + L ++D     +
Sbjct: 8   SSGR-ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPST 65
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
           A +   EI+LL  L HPNIV        +  L +  E++       + ++   L +S I+
Sbjct: 66  AIR---EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIK 122
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
            Y  Q+L G+ + H    +HRD+K  N+L++  G +KLADFG+A+         + +   
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------------------------ 355
            W  AP+V+  S   + +VDIWS+GC   EM T KP                        
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 356 PWSQYEGVPA----MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
            W Q + +P      F++   K   +I      EG D +   L  +P  R +A   + HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 412 FVGNAAP 418
           +  +  P
Sbjct: 303 YFKDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 140/307 (45%), Gaps = 36/307 (11%)
Query: 143 SPGRVENPTSPG--SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           S GR EN    G   +++K   +G GT+G VY   +S+ G + A+K + L ++D     +
Sbjct: 8   SSGR-ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPST 65
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
           A +   EI+LL  L HPNIV        +  L +  E++       + ++   L +S I+
Sbjct: 66  AIR---EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIK 122
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
            Y  Q+L G+ + H    +HRD+K  N+L++  G +KLADFG+A+         + +   
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 321 YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------------------------ 355
            W  AP+V+  S   + +VDIWS+GC   EM T KP                        
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 356 PWSQYEGVPA----MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
            W Q + +P      F++   K   +I      EG D +   L  +P  R +A   + HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 412 FVGNAAP 418
           +  +  P
Sbjct: 303 YFKDLDP 309

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 151
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 211 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 314

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 132/267 (49%), Gaps = 12/267 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G F  V L     +G++ A+K +       K KES+  +  EIA+L +++H NIV  
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIP--KKALKGKESS--IENEIAVLRKIKHENIVAL 85
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
                  + LY+ ++ VSGG ++  + + G   E    +  +Q+L  + YLH    VHRD
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRD 145
Query: 283 IKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L    D   ++ ++DFG++K + G+   +S   G+P ++APEV+      + AV
Sbjct: 146 LKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEVLAQ-KPYSKAV 203
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQR 396
           D WS+G     +    PP+          +I  ++     P  D +SD  KDF+R  +++
Sbjct: 204 DCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEK 263
Query: 397 NPLHRPTAAWLLEHPFVGNAAPLERPI 423
           +P  R T      HP++     L + I
Sbjct: 264 DPNKRYTCEQAARHPWIAGDTALNKNI 290

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 77
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 137 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 240

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 84
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 84
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 22/254 (8%)
Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V++G+  NS    +  +K  T+         S Q   +E  L+  L+H  +V
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLV 71
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ--DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           R Y   T ++ +YI  EY++ GS+   L+  + G++    +  ++ QI  G+ Y+  KN 
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGC- 334
           +HRD++ AN+LV  S   K+ADFG+A+ I       + +G+ +   W APE I  + GC 
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGCF 188
Query: 335 NLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +  D+WS G  + E+ T  K P+        M  +     +P + ++  DE  D ++ C
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-ENCPDELYDIMKMC 247
Query: 394 LQRNPLHRPTAAWL 407
            +     RPT  +L
Sbjct: 248 WKEKAEERPTFDYL 261

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 80
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 140 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 243

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 91
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 151 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 85
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 145 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 248

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 73
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 133 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 76
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 136 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 239

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 19/269 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R+++ + LG G +G V L  +  +G   A+K +   S    S   A  L  E+A+L +L
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQL 61
Query: 215 RHPNIVRYYGSETLDDK--LYIYLEYVSGGSIYK---ILQDYGQLGESAIRSYTQQILSG 269
            HPNI++ Y  E  +DK   Y+ +E   GG ++    + Q + ++  + I    +Q+LSG
Sbjct: 62  DHPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLSG 116
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
             YLH  N VHRD+K  N+L++   R   +K+ DFG++ H           G+ Y++APE
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSD 384
           V++     +   D+WS G  +  +    PP+        + ++   K     PD   +SD
Sbjct: 177 VLRKKY--DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 234
Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E K  V+  L   P  R +A   L HP++
Sbjct: 235 EAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 7/206 (3%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W   + LG G  G V L  N  + E  A+K V    D  ++ +  + + +EI +   L H
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLNH 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH  
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
              HRDIK  N+L+D    +K++DFG+A   ++   +     + G+  ++APE++K    
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQ 359
               VD+WS G  +  M   + PW Q
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 133/264 (50%), Gaps = 14/264 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +++ + LG G +G V L  +  +    A+K   +    + S  S  +L +E+A+L  L H
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 217 PNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           PNI++ Y  +  +DK   Y+ +E   GG ++  +    +  E       +Q+LSG+ YLH
Sbjct: 96  PNIMKLY--DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 275 AKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
             N VHRD+K  N+L++   +   +K+ DFG++     Q       G+ Y++APEV++  
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK 213
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDF 389
              +   D+WS+G  +  +    PP+        + K+   K     P+  ++S+  KD 
Sbjct: 214 --YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           +++ LQ +   R +A   LEHP++
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWI 295

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 134/282 (47%), Gaps = 40/282 (14%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQEIALLSRLRHP 217
            +LG G F  V+L     +G++ A+K +     F D +        L  EIA+L +++H 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--------LENEIAVLKKIKHE 66
Query: 218 NIVRYYGSETLDD------KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           NIV      TL+D        Y+ ++ VSGG ++  + + G   E       QQ+LS ++
Sbjct: 67  NIV------TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 272 YLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKH----ITGQSCPLSIKGSPYWMA 324
           YLH    VHRD+K  N+L    + + ++ + DFG++K     I   +C     G+P ++A
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPGYVA 175
Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF---KIGNSKELPAIPDH 381
           PEV+        AVD WS+G     +    PP+ + E    +F   K G  +      D 
Sbjct: 176 PEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDD 233
Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
           +S+  KDF+   L+++P  R T    L HP++     L R I
Sbjct: 234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDI 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 116/221 (52%), Gaps = 9/221 (4%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+ +L  +RHPNI+  +        + + LE VSGG ++  L +   L E   
Sbjct: 58  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 117
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
             + +QIL G+ YLH+K   H D+K  NI L+D   P+ R+KL DFG+A  I   +   +
Sbjct: 118 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS 372
           I G+P ++APE++ N     L  D+WS+G     + +   P+   ++ E +  +  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 236
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +     +  S+  KDF+R+ L ++P  R   A  LEH ++
Sbjct: 237 FDEEYFSN-TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG+FG V+   + ++G  CA+K+V L               +E+   + L  P IV  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----------EELVACAGLSSPRIVPL 129
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           YG+      + I++E + GGS+ ++++  G L E     Y  Q L GLEYLH +  +H D
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 283 IKGANILVDPSG-RVKLADFGMA----------KHITGQSCPLSIKGSPYWMAPEVIKNS 331
           +K  N+L+   G R  L DFG A            +TG   P    G+   MAPEV+   
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP----GTETHMAPEVVMGK 245
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFV 390
             C+  VDIWS  C ++ M     PW+QY   P   KI +            +      +
Sbjct: 246 P-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 304
Query: 391 RKCLQRNPLHRPTAAWL 407
           ++ L++ P+HR +A  L
Sbjct: 305 QEGLRKEPVHRASAMEL 321

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 117/224 (52%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFK------NRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D +Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 116/221 (52%), Gaps = 9/221 (4%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+ +L  +RHPNI+  +        + + LE VSGG ++  L +   L E   
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
             + +QIL G+ YLH+K   H D+K  NI L+D   P+ R+KL DFG+A  I   +   +
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS 372
           I G+P ++APE++ N     L  D+WS+G     + +   P+   ++ E +  +  +   
Sbjct: 192 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 250
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +     +  S+  KDF+R+ L ++P  R   A  LEH ++
Sbjct: 251 FDEEYFSN-TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V          +      +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---------QGKAFKNRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N+  GE  A+K++ L  +D     +  +   EI++L  L+H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y       +L +  E++      K L D   G L     +S+  Q+L+G+ Y H +  +H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCNLAVD 339
           RD+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 340 IWSLGCTVIEMATTKPPW---SQYEGVPAMFKIG---NSKELPAIPDH------------ 381
           IWS+GC   EM    P +   S+ + +  +F+I    NSK  P + +             
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 382 ---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                    L + G D + K L+ +P  R TA   LEH +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +GRG+FG V+   + ++G  CA+K+V L               +E+   + L  P IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----------EELVACAGLSSPRIVPL 115
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           YG+      + I++E + GGS+ ++++  G L E     Y  Q L GLEYLH +  +H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 283 IKGANILVDPSG-RVKLADFGMA----------KHITGQSCPLSIKGSPYWMAPEVIKNS 331
           +K  N+L+   G R  L DFG A            +TG   P    G+   MAPEV+   
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP----GTETHMAPEVVMGK 231
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFV 390
             C+  VDIWS  C ++ M     PW+QY   P   KI +            +      +
Sbjct: 232 P-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 391 RKCLQRNPLHRPTAAWL 407
           ++ L++ P+HR +A  L
Sbjct: 291 QEGLRKEPVHRASAMEL 307

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N+  GE  A+K++ L  +D     +  +   EI++L  L+H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y       +L +  E++      K L D   G L     +S+  Q+L+G+ Y H +  +H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCNLAVD 339
           RD+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 340 IWSLGCTVIEMATTKPPW---SQYEGVPAMFKIG---NSKELPAIPDH------------ 381
           IWS+GC   EM    P +   S+ + +  +F+I    NSK  P + +             
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 382 ---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                    L + G D + K L+ +P  R TA   LEH +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 121/229 (52%), Gaps = 17/229 (7%)
Query: 141 PRSPGRVE----NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK 196
           P  PG VE     P   G R+ + + +G G +G V   ++       A+K+++ F    +
Sbjct: 25  PGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPF----E 80
Query: 197 SKESAQQLGQEIALLSRLRHPNIV---RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYG 252
            +   Q+  +EI +L R RH N++       + TL+    +Y+ + +    +YK+L+   
Sbjct: 81  HQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-Q 139
Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-- 310
           QL    I  +  QIL GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+    +  
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHD 199
Query: 311 --SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
                     + ++ APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 200 HTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +GRG+FG V+   + ++G  CA+K+V L               +E+   + L  P IV  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----------EELVACAGLSSPRIVPL 131
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           YG+      + I++E + GGS+ ++++  G L E     Y  Q L GLEYLH +  +H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 283 IKGANILVDPSG-RVKLADFGMA----------KHITGQSCPLSIKGSPYWMAPEVIKNS 331
           +K  N+L+   G R  L DFG A            +TG   P    G+   MAPEV+   
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP----GTETHMAPEVVMGK 247
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-LSDEGKDFV 390
             C+  VDIWS  C ++ M     PW+QY   P   KI +            +      +
Sbjct: 248 P-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 306
Query: 391 RKCLQRNPLHRPTAAWL 407
           ++ L++ P+HR +A  L
Sbjct: 307 QEGLRKEPVHRASAMEL 323

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 125/258 (48%), Gaps = 11/258 (4%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG +G V    +  SG++ A+K +        S+E  + L         +  P  V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRA---TVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 223 YGSETLDDKLYIYLEY--VSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAK-NT 278
           YG+   +  ++I  E    S    YK + D GQ + E  +      I+  LE+LH+K + 
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSNGCN 335
           +HRD+K +N+L++  G+VK  DFG++ ++          G   + APE I    N  G +
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYS 218
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCL 394
           +  DIWSLG T IE+A  + P+  +       K    +  P +P D  S E  DF  +CL
Sbjct: 219 VKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 278
Query: 395 QRNPLHRPTAAWLLEHPF 412
           ++N   RPT   L +HPF
Sbjct: 279 KKNSKERPTYPELXQHPF 296

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT+G VY   N+  GE  A+K++ L  +D     +  +   EI++L  L+H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y       +L +  E++      K L D   G L     +S+  Q+L+G+ Y H +  +H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIKNSNGCNLAVD 339
           RD+K  N+L++  G +K+ADFG+A+         + +    W  AP+V+  S   +  +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 340 IWSLGCTVIEMATTKPPW---SQYEGVPAMFKIG---NSKELPAIPDH------------ 381
           IWS+GC   EM    P +   S+ + +  +F+I    NSK  P + +             
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 382 ---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                    L + G D + K L+ +P  R TA   LEH +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V          +      +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---------QGKAFKNRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G+G F  V    N E+G+  A+K V +    +    S + L +E ++   L+HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 222 YYGSETLDDKLYIYLEYVSGGSI-YKILQ--DYGQLGESAIRS-YTQQILSGLEYLHAKN 277
              + + D  LY+  E++ G  + ++I++  D G +   A+ S Y +QIL  L Y H  N
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKNSN 332
            +HRD+K   +L+   + S  VKL  FG+A  + G+S  ++    G+P++MAPEV+K   
Sbjct: 153 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREP 211
Query: 333 GCNLAVDIWSLGCTV-IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
                VD+W  G  + I ++   P +   E +      G  K  P    H+S+  KD VR
Sbjct: 212 -YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVR 270
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L  +P  R T    L HP++
Sbjct: 271 RMLMLDPAERITVYEALNHPWL 292

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 21/224 (9%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG VY     +SGE+ A+K+V          +      +E+ ++ +L H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---------QGKAFKNRELQIMRKLDH 72
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
            NIVR    +Y S    D++Y+   L+YV   ++Y++ + Y +  ++     ++ Y  Q+
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAP 325
              L Y+H+    HRDIK  N+L+DP   V KL DFG AK +      +S   S Y+ AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
           E+I  +     ++D+WS GC + E+   +P +    GV  + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 161 RLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH- 216
           ++LG G +G V+L       ++G++ AMK +   +   K+K + +    E  +L  +R  
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQS 118
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +V  + +   + KL++ L+Y++GG ++  L    +  E  ++ Y  +I+  LE+LH  
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--GSPYWMAPEVIKNSN-G 333
             ++RDIK  NIL+D +G V L DFG++K         +    G+  +MAP++++  + G
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDEGKDFVR 391
            + AVD WSLG  + E+ T   P++      +  +I     K  P  P  +S   KD ++
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 298
Query: 392 KCLQRNPLHR 401
           + L ++P  R
Sbjct: 299 RLLMKDPKKR 308

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 126/264 (47%), Gaps = 19/264 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG    VY      + +  A+K +       K     + +  EI +L RL HPNI++ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVL-------KKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
                   ++ + LE V+GG ++  + + G   E       +QIL  + YLH    VHRD
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 283 IKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA-- 337
           +K  N+L     P   +K+ADFG++K +  Q    ++ G+P + APE+++   GC     
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR---GCAYGPE 230
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIP--DHLSDEGKDFVRKCL 394
           VD+WS+G     +     P+    G   MF +I N +     P  D +S   KD VRK +
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLI 290
Query: 395 QRNPLHRPTAAWLLEHPFV-GNAA 417
             +P  R T    L+HP+V G AA
Sbjct: 291 VLDPKKRLTTFQALQHPWVTGKAA 314

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 129/253 (50%), Gaps = 31/253 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---- 216
           R++GRG FG VY    +++G+M AMK +     D K  +  Q  G+ +AL  R+      
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQ--GETLALNERIMLSLVS 246
Query: 217 ----PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
               P IV    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE+
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           +H +  V+RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++   
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV 365
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--------AIPDHLSD 384
             + + D +SLGC + ++     P+ Q+       K  +  E+          +PD  S 
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSP 418
Query: 385 EGKDFVRKCLQRN 397
           E +  +   LQR+
Sbjct: 419 ELRSLLEGLLQRD 431

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 129/253 (50%), Gaps = 31/253 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---- 216
           R++GRG FG VY    +++G+M AMK +     D K  +  Q  G+ +AL  R+      
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQ--GETLALNERIMLSLVS 247
Query: 217 ----PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
               P IV    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE+
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           +H +  V+RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV 366
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--------AIPDHLSD 384
             + + D +SLGC + ++     P+ Q+       K  +  E+          +PD  S 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 385 EGKDFVRKCLQRN 397
           E +  +   LQR+
Sbjct: 420 ELRSLLEGLLQRD 432

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 129/253 (50%), Gaps = 31/253 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---- 216
           R++GRG FG VY    +++G+M AMK +     D K  +  Q  G+ +AL  R+      
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQ--GETLALNERIMLSLVS 247
Query: 217 ----PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
               P IV    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE+
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           +H +  V+RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV 366
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--------AIPDHLSD 384
             + + D +SLGC + ++     P+ Q+       K  +  E+          +PD  S 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 385 EGKDFVRKCLQRN 397
           E +  +   LQR+
Sbjct: 420 ELRSLLEGLLQRD 432

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 129/253 (50%), Gaps = 31/253 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---- 216
           R++GRG FG VY    +++G+M AMK +     D K  +  Q  G+ +AL  R+      
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQ--GETLALNERIMLSLVS 247
Query: 217 ----PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
               P IV    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE+
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           +H +  V+RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++   
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGV 366
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--------AIPDHLSD 384
             + + D +SLGC + ++     P+ Q+       K  +  E+          +PD  S 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQH-------KTKDKHEIDRMTLTMAVELPDSFSP 419
Query: 385 EGKDFVRKCLQRN 397
           E +  +   LQR+
Sbjct: 420 ELRSLLEGLLQRD 432

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G+G F  V    N E+G+  A+K V +    +    S + L +E ++   L+HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 222 YYGSETLDDKLYIYLEYVSGGSI-YKILQ--DYGQLGESAIRS-YTQQILSGLEYLHAKN 277
              + + D  LY+  E++ G  + ++I++  D G +   A+ S Y +QIL  L Y H  N
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKNSN 332
            +HRD+K   +L+   + S  VKL  FG+A  + G+S  ++    G+P++MAPEV+K   
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 333 GCNLAVDIWSLGCTV-IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
                VD+W  G  + I ++   P +   E +      G  K  P    H+S+  KD VR
Sbjct: 210 -YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L  +P  R T    L HP++
Sbjct: 269 RMLMLDPAERITVYEALNHPWL 290

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 149/318 (46%), Gaps = 55/318 (17%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           GSR+   + LG G  G V+   +++  +  A+K++ L        +S +   +EI ++ R
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRR 64
Query: 214 LRHPNIVRYY------GSETLDD--------KLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           L H NIV+ +      GS+  DD         +YI  EY+    +  +L+  G L E   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHA 122
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAK----HITGQSCPL 314
           R +  Q+L GL+Y+H+ N +HRD+K AN+ ++    V K+ DFG+A+    H + +    
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS----------QYEGVP 364
               + ++ +P ++ + N    A+D+W+ GC   EM T K  ++            E +P
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 365 AMFKIGNSKELPAIPDH------------------LSDEGKDFVRKCLQRNPLHRPTAAW 406
            + +    + L  IP +                  +S E  DF+ + L  +P+ R TA  
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
Query: 407 LLEHPFVG-NAAPLERPI 423
            L HP++   + P++ PI
Sbjct: 303 ALSHPYMSIYSFPMDEPI 320

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 127/254 (50%), Gaps = 22/254 (8%)
Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V++G+  NS    +  +K  T+         S Q   +E  L+  L+H  +V
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLV 70
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ--DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           R Y   T ++ +YI  E+++ GS+   L+  + G++    +  ++ QI  G+ Y+  KN 
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 130
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGC- 334
           +HRD++ AN+LV  S   K+ADFG+A+ I       + +G+ +   W APE I  + GC 
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGCF 187
Query: 335 NLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            +  ++WS G  + E+ T  K P+        M  +     +P + ++  DE  D ++ C
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-ENCPDELYDIMKMC 246
Query: 394 LQRNPLHRPTAAWL 407
            +     RPT  +L
Sbjct: 247 WKEKAEERPTFDYL 260

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 146/300 (48%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 125
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 243
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA----------------- 365
           +  DIWS+G +++EMA  + P               Q EG  A                 
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 303
Query: 366 --------MFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                   +F++ +   ++  P +P  + S E +DFV KCL +NP  R     L+ H F+
Sbjct: 304 MDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 363

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 27/250 (10%)
Query: 149 NPTSPGSRWKKG-RLLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R  K  R LG+G FG V    Y      +GE+ A+K++        ++E  + 
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRD 60
Query: 204 LGQEIALLSRLRHPNIVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIR 260
             +EI +L  L+H NIV+Y G         L + +E++  GS+ + LQ + + +    + 
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLL 120
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--- 317
            YT QI  G+EYL  K  +HRD+   NILV+   RVK+ DFG+ K +        +K   
Sbjct: 121 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 318 GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNS 372
            SP +W APE +  S   ++A D+WS G  + E+ T    +K P +++     M  IGN 
Sbjct: 181 ESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGND 234
Query: 373 KELPAIPDHL 382
           K+   I  HL
Sbjct: 235 KQGQMIVFHL 244

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----IRNQIIRELQVLHECNS 90
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 208
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA------------MFKIG 370
           +  DIWS+G +++EMA  + P               Q EG  A            + K G
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 371 NSKELPAIPDHLSD-----------------EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                P     L D                 E +DFV KCL +NP  R     L+ H F+
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 14/260 (5%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVR 221
           LGRG F  V    +  +G+  A K         + ++   ++  EIA+L   +  P ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKI-LQDYGQL-GESAIRSYTQQILSGLEYLHAKNTV 279
            +       ++ + LEY +GG I+ + L +  ++  E+ +    +QIL G+ YLH  N V
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 280 HRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCN 335
           H D+K  NIL+    P G +K+ DFGM++ I G +C L  I G+P ++APE++ N +   
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEIL-NYDPIT 211
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--NSKELPAIPDHLSDEGKDFVRKC 393
            A D+W++G     + T   P+   +       I   N          +S    DF++  
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           L +NP  RPTA   L H ++
Sbjct: 272 LVKNPEKRPTAEICLSHSWL 291

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 29/270 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +GRG +G V    +  SG++ A+K +    D+   KE  Q L     ++     P IV++
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 223 YGSETLDDKLYIYLEYVSGG------SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           YG+   +   +I +E +S         +Y +L D   + E  +   T   +  L +L   
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV--IPEEILGKITLATVKALNHLKEN 144
Query: 277 -NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS---N 332
              +HRDIK +NIL+D SG +KL DFG++  +          G   +MAPE I  S    
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF---------KIGNSKELPAIPDHLS 383
           G ++  D+WSLG T+ E+AT + P+ ++  V             ++ NS+E    P  + 
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI- 263
Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               +FV  CL ++   RP    LL+HPF+
Sbjct: 264 ----NFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 197 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 245

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 135/291 (46%), Gaps = 38/291 (13%)
Query: 145 GRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--- 201
           G V    +    +  G  LG G F  V       +G   A K    F    ++K S    
Sbjct: 1   GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGV 56
Query: 202 --QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
             + + +E+++L  ++HPN++  +        + + LE V+GG ++  L +   L E   
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
             + +QIL+G+ YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE- 374
           I G+P ++APE++ N     L  D+WS+G     + +   P+           +G++K+ 
Sbjct: 177 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQE 224
Query: 375 ----LPAIPDHLSDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               + A+     DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 193 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 241

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 224 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 272

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 192 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 240

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 235
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 198 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 246

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 196 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 244

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 235
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 196 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 244

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 200 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 248

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 193 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 241

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 199 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 247

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 193 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 241

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 191 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 49/294 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +++G G+FG V+     ES E+ A+K+V     D + K       +E+ ++  ++H
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVL---QDKRFK------NRELQIMRIVKH 91
Query: 217 PNIVR----YYGSETLDDKLYI--YLEYVSGGSIYKILQDYGQLGESA----IRSYTQQI 266
           PN+V     +Y +    D++++   LEYV   ++Y+  + Y +L ++     I+ Y  Q+
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
           L  L Y+H+    HRDIK  N+L+DP SG +KL DFG AK +      +S   S Y+ AP
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAP 210
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----SKE------ 374
           E+I  +      +DIWS GC + E+   +P +    G+  + +I       S+E      
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 375 -------LPAIPDH---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                   P I  H            +  D + + L+  P  R TA   L HPF
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 38/279 (13%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
             ++HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 272 YLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
           YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHL 382
           + N     L  D+WS+G     + +   P+           +G++K+     + A+    
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNYEF 236
Query: 383 SDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 211 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 259

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 135/291 (46%), Gaps = 38/291 (13%)
Query: 145 GRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--- 201
           G V    +    +  G  LG G F  V       +G   A K    F    ++K S    
Sbjct: 1   GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGV 56
Query: 202 --QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
             + + +E+++L  ++HPN++  +        + + LE V+GG ++  L +   L E   
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
             + +QIL+G+ YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE- 374
           I G+P ++APE++ N     L  D+WS+G     + +   P+           +G++K+ 
Sbjct: 177 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQE 224
Query: 375 ----LPAIPDHLSDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               + A+     DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 146/300 (48%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 181
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA----------------- 365
           +  DIWS+G +++EMA  + P               Q EG  A                 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 366 --------MFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                   +F++ +   ++  P +P  + S E +DFV KCL +NP  R     L+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 114/212 (53%), Gaps = 13/212 (6%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 97
Query: 214 LRHPNIV---RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
            RH NI+       + T++    +YL  ++ G  +YK+L+    L    I  +  QIL G
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRG 156
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWMAP 325
           L+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ AP
Sbjct: 157 LKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           E++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 14/272 (5%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G GT G V+     ++G + A+K++    +  ++K     L     +L     P IV+ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQC 89
Query: 223 YGSETLDDKLYIYLEYVS--GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN-TV 279
           +G+   +  ++I +E +      + K +Q  G + E  +   T  I+  L YL  K+  +
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK----NSNGCN 335
           HRD+K +NIL+D  G++KL DFG++  +          G   +MAPE I          +
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG--KDFVRKC 393
           +  D+WSLG +++E+AT + P+   +    +      +E P +P H+   G  + FV+ C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 394 LQRNPLHRPTAAWLLEHPFVGNAAPLERPILS 425
           L ++   RP    LLEH F+     LE  + S
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKRYETLEVDVAS 299

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HRD+   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 211 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 259

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 146/300 (48%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 181
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA----------------- 365
           +  DIWS+G +++EMA  + P               Q EG  A                 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 366 --------MFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                   +F++ +   ++  P +P  + S E +DFV KCL +NP  R     L+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 128/258 (49%), Gaps = 7/258 (2%)
Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           EN       ++  R +G+G+FG V +   +++ +M AMK +         +   + + +E
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN--KQKCVERNEVRNVFKE 65
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
           + ++  L HP +V  + S   ++ +++ ++ + GG +   LQ      E  ++ +  +++
Sbjct: 66  LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
             L+YL  +  +HRD+K  NIL+D  G V + DF +A  +  ++   ++ G+  +MAPE+
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185
Query: 328 IKNSNGC--NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLS 383
             +  G   + AVD WSLG T  E+   + P+       +  +I ++ E   +  P   S
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-EIVHTFETTVVTYPSAWS 244
Query: 384 DEGKDFVRKCLQRNPLHR 401
            E    ++K L+ NP  R
Sbjct: 245 QEMVSLLKKLLEPNPDQR 262

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 19  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 77
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 78  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 254
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 255 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 84
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY---------------- 251
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ                  
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R LG G FG V+L     SG    +K +    +  +S+   +Q+  EI +L  L HPNI+
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTI----NKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 221 RYYGSETLDD--KLYIYLEYVSGGSIYKIL---QDYGQ-LGESAIRSYTQQILSGLEYLH 274
           + +  E  +D   +YI +E   GG + + +   Q  G+ L E  +    +Q+++ L Y H
Sbjct: 84  KIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 275 AKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           +++ VH+D+K  NIL     P   +K+ DFG+A+         +  G+  +MAPEV K  
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPW--SQYEGV--PAMFKIGNSKELPAIPDHLSDEGK 387
                  DIWS G  +  + T   P+  +  E V   A +K  N   +   P  L+ +  
Sbjct: 202 --VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-VECRP--LTPQAV 256
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           D +++ L ++P  RP+AA +L H +   A
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 127/262 (48%), Gaps = 11/262 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLR-HP 217
           ++GRG    V    +  +G   A+K + + ++     + +E  +   +E  +L ++  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           +I+    S      +++  + +  G ++  L +   L E   RS  + +L  + +LHA N
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN----- 332
            VHRD+K  NIL+D + +++L+DFG + H+        + G+P ++APE++K S      
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFV 390
           G    VD+W+ G  +  +    PP+     +  +  I   +   + P  D  S   KD +
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340
Query: 391 RKCLQRNPLHRPTAAWLLEHPF 412
            + LQ +P  R TA   L+HPF
Sbjct: 341 SRLLQVDPEARLTAEQALQHPF 362

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 18  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 76
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 77  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 253
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 254 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 20/262 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V       +G+  A K   + +    S    Q+L +E  +   L+HPNIVR 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+      QQIL  + + H    VHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRD 128
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++  +     V
Sbjct: 129 LKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPV 187
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           D+W+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E KD + 
Sbjct: 188 DMWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPSPEWDTVTPEAKDLIN 242
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           K L  NP  R TA+  L+HP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 123/238 (51%), Gaps = 12/238 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  + ++ AMK ++ F  +   +  +    +E  +++    P +V
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   R YT +++  L+ +H+   +H
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIH 191
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNGCNL- 336
           RD+K  N+L+D SG +KLADFG    +  +    C  ++ G+P +++PEV+K+  G    
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 250
Query: 337 --AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFV 390
               D WS+G  + EM     P+     V    KI N K     PD   +S E K+ +
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 67  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 125
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 302
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 84
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 84
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 15  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 73
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 74  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 250
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 251 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 123/238 (51%), Gaps = 12/238 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  + ++ AMK ++ F  +   +  +    +E  +++    P +V
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   R YT +++  L+ +H+   +H
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIH 196
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNL- 336
           RD+K  N+L+D SG +KLADFG    +  +    C  ++ G+P +++PEV+K+  G    
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 255
Query: 337 --AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFV 390
               D WS+G  + EM     P+     V    KI N K     PD   +S E K+ +
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 69
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DY--------- 251
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 246
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 20/262 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V       +G+  A K   + +    S    Q+L +E  +   L+HPNIVR 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+      QQIL  + + H    VHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRD 128
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++  +     V
Sbjct: 129 LKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPV 187
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           D+W+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E KD + 
Sbjct: 188 DMWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPSPEWDTVTPEAKDLIN 242
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           K L  NP  R TA+  L+HP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 146/300 (48%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 181
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA----------------- 365
           +  DIWS+G +++EMA  + P               Q EG  A                 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 366 --------MFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                   +F++ +   ++  P +P  + S E +DFV KCL +NP  R     L+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 146/300 (48%), Gaps = 49/300 (16%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++K   LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNS 63
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 277 NTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
           + + HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ ++  +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-YS 181
Query: 336 LAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPA----------------- 365
           +  DIWS+G +++EMA  + P               Q EG  A                 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 366 --------MFKIGN---SKELPAIPDHL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                   +F++ +   ++  P +P  + S E +DFV KCL +NP  R     L+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 123/238 (51%), Gaps = 12/238 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  + ++ AMK ++ F  +   +  +    +E  +++    P +V
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   R YT +++  L+ +H+   +H
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIH 196
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNL- 336
           RD+K  N+L+D SG +KLADFG    +  +    C  ++ G+P +++PEV+K+  G    
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 255
Query: 337 --AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFV 390
               D WS+G  + EM     P+     V    KI N K     PD   +S E K+ +
Sbjct: 256 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++   +ALL +   P
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRV---LALLDK--PP 80
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +LH + 
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG 140
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K H+          G+P ++APE+I        
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIA-YQPYGK 199
Query: 337 AVDIWSLGCTVIEMATTKPPWS 358
           +VD W+ G  + EM   +PP+ 
Sbjct: 200 SVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 42/281 (14%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALL 211
           +  G  LG G F  V       +G   A K    F    ++K S      + + +E+++L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 212 SRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
             ++HPN++  +  E  ++K  + L  E V+GG ++  L +   L E     + +QIL+G
Sbjct: 69  KEIQHPNVITLH--EVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 270 LEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
           + YLH+    H D+K  NI L+D   P  R+K+ DFG+A  I   +   +I G+P ++AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPD 380
           E++ N     L  D+WS+G     + +   P+           +G++K+     + A+  
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANVSAVNY 234
Query: 381 HLSDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              DE         KDF+R+ L ++P  R T    L+HP++
Sbjct: 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 108/231 (46%), Gaps = 10/231 (4%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           SR++    +G G +G VY   +  SG   A+K V + +             +E+ALL RL
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 215 R---HPNIVRYY---GSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQ 265
               HPN+VR      +   D ++ + L +       +   D      L    I+   +Q
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
            L GL++LHA   VHRD+K  NILV   G VKLADFG+A+  + Q     +  + ++ AP
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           EV+  S      VD+WS+GC   EM   KP +        + KI +   LP
Sbjct: 189 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  R   G+ LG G FG V L    G + +         V +   DA  K+ +  L  E+
Sbjct: 26  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEM 84
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DY--------- 251
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ       +Y         
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HIT 308
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+   HI 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                 + +    WMAPE + +    + + D+WS G  + E+ T     S Y GVP   +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGG--SPYPGVPVEEL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 262 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 12/236 (5%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV-- 220
           +G G +G V    +  +G   A+K++       +S+  A++  +E+ LL  +RH N++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 221 --RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
              +   ETLDD    YL     G+    L  + +LGE  I+    Q+L GL Y+HA   
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +HRD+K  N+ V+    +K+ DFG+A+    +     +  + ++ APEVI N       V
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTV 207
Query: 339 DIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
           DIWS+GC + EM T K  +      + +  + K+  +     +    SDE K++++
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 19/283 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V+      +G   A K V    +  K     + + +EI  +S LRHP +V  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEIQTMSVLRHPTLVNL 219
Query: 223 YGSETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           + +   D+++ +  E++SGG ++ K+  ++ ++ E     Y +Q+  GL ++H  N VH 
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 282 DIKGANILVDP--SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  NI+     S  +KL DFG+  H+  +       G+  + APEV +         D
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-GKPVGYYTD 338
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-----LSDEGKDFVRKCL 394
           +WS+G     + +   P+    G      + N K      D      +S++GKDF+RK L
Sbjct: 339 MWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 395 QRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETKPTL 435
             +P  R T    LEHP++  GNA   +  I S+  ++ + ++
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 438

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 29/292 (9%)
Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG-QEIAL 210
           S   R++K   LG G F  VY   +  + ++ A+K++ L    +++K+   +   +EI L
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKL 65
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           L  L HPNI+    +      + +  +++       I  +   L  S I++Y    L GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-APEVIK 329
           EYLH    +HRD+K  N+L+D +G +KLADFG+AK     +     +    W  APE++ 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS-------------- 372
            +    + VD+W++GC + E+    P     S  + +  +F+   +              
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 373 ----KELPAIPDH-----LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               K  P IP H       D+  D ++     NP  R TA   L+  +  N
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 19/283 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V+      +G   A K V    +  K     + + +EI  +S LRHP +V  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEIQTMSVLRHPTLVNL 113
Query: 223 YGSETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHR 281
           + +   D+++ +  E++SGG ++ K+  ++ ++ E     Y +Q+  GL ++H  N VH 
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 173
Query: 282 DIKGANILVDP--SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           D+K  NI+     S  +KL DFG+  H+  +       G+  + APEV +         D
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-GKPVGYYTD 232
Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-----LSDEGKDFVRKCL 394
           +WS+G     + +   P+    G      + N K      D      +S++GKDF+RK L
Sbjct: 233 MWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 395 QRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETKPTL 435
             +P  R T    LEHP++  GNA   +  I S+  ++ + ++
Sbjct: 290 LADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 332

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V       +G+  A K   + +    S    Q+L +E  +   L+HPNIVR 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+      QQIL  + + H    VHRD
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 146
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++  +     V
Sbjct: 147 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPV 205
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           D+W+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E KD + 
Sbjct: 206 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPSPEWDTVTPEAKDLIN 260
Query: 392 KCLQRNPLHRPTAAWLLEHPFVGN 415
           K L  NP  R TAA  L+HP++ +
Sbjct: 261 KMLTINPSKRITAAEALKHPWISH 284

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 9/221 (4%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+++L ++ H N++  +        + + LE VSGG ++  L     L E   
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
            S+ +QIL G+ YLH K   H D+K  NI L+D   P   +KL DFG+A  I       +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS 372
           I G+P ++APE++ N     L  D+WS+G     + +   P+   ++ E +  +  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +      H S+  KDF+RK L +    R T    L HP++
Sbjct: 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 118/235 (50%), Gaps = 26/235 (11%)
Query: 163 LGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V    Y      +GE+ A+K++        ++E  +   +EI +L  L+H N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 219 IVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHA 275
           IV+Y G         L + +EY+  GS+   LQ + + +    +  YT QI  G+EYL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           K  +HR++   NILV+   RVK+ DFG+ K +        +K    SP +W APE +  S
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAIPDHL 382
              ++A D+WS G  + E+ T    +K P +++     M  IGN K+   I  HL
Sbjct: 194 K-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMIGNDKQGQMIVFHL 242

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 10/262 (3%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK-ESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G   A K +      A  +  S +++ +E+++L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           ++  +        + + LE VSGG ++  L     L E    S+ +QIL G+ YLH K  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 279 VHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            H D+K  NI L+D   P   +KL DFG+A  I       +I G+P ++APE++ N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 335 NLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
            L  D+WS+G     + +   P+   ++ E +  +  +    +      H S+  KDF+R
Sbjct: 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-EEFFSHTSELAKDFIR 254
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           K L +    R T    L HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 18/266 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-----QQLGQEIALLSRL 214
           G  LG G F  V       +G   A K    F    +S+ S      +++ +E+++L ++
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK----FIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            HPNI+  +        + + LE VSGG ++  L     L E    S+ +QIL G+ YLH
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 275 AKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
            K   H D+K  NI L+D   P   +KL DFG+A  I       +I G+P ++APE++ N
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-N 191
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
                L  D+WS+G     + +   P+   ++ E +  +  +    +        S+  K
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-EEFFSQTSELAK 250
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
           DF+RK L +    R T    L HP++
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 9/221 (4%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+++L ++ H N++  +        + + LE VSGG ++  L     L E   
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
            S+ +QIL G+ YLH K   H D+K  NI L+D   P   +KL DFG+A  I       +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNS 372
           I G+P ++APE++ N     L  D+WS+G     + +   P+   ++ E +  +  +   
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +      H S+  KDF+RK L +    R T    L HP++
Sbjct: 237 FD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 5/217 (2%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             R+K    LG G    VYL  ++      A+K   +F    + +E+ ++  +E+   S+
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQ 67
Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           L H NIV     +  DD  Y+ +EY+ G ++ + ++ +G L      ++T QIL G+++ 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKNS 331
           H    VHRDIK  NIL+D +  +K+ DFG+AK ++  S   +  + G+  + +PE  K  
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G 186
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
              +   DI+S+G  + EM   +PP++    V    K
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           SR++    +G G +G VY   +  SG   A+K V + + +     S  +   E+ALL RL
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRL 60
Query: 215 R---HPNIVRYY---GSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQ 265
               HPN+VR      +   D ++ + L +       +   D      L    I+   +Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
            L GL++LHA   VHRD+K  NILV   G VKLADFG+A+  + Q     +  + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           EV+  S      VD+WS+GC   EM   KP +        + KI +   LP
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 230

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 129/264 (48%), Gaps = 12/264 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  S ++ AMK ++ F  +   +  +    +E  +++    P +V
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVV 138
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   + YT +++  L+ +H+   +H
Sbjct: 139 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIH 197
Query: 281 RDIKGANILVDPSGRVKLADFG--MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL-- 336
           RD+K  N+L+D  G +KLADFG  M    TG     +  G+P +++PEV+K+  G     
Sbjct: 198 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYG 257
Query: 337 -AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKC 393
              D WS+G  + EM     P+     V    KI + K     P+   +S   K+ +   
Sbjct: 258 RECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAF 317
Query: 394 LQRNP--LHRPTAAWLLEHPFVGN 415
           L      L R     + +HPF  N
Sbjct: 318 LTDREVRLGRNGVEEIKQHPFFKN 341

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 41/283 (14%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG GT+  VY G +  +  + A+KE+ L  ++     + +    E++LL  L+H NIV  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQL-GESAIRSYTQQILSGLEYLHAKNTVHR 281
           +     +  L +  EY+    + + L D G +     ++ +  Q+L GL Y H +  +HR
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLA 337
           D+K  N+L++  G +KLADFG+A+    +S P     +     ++  P+++  S   +  
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 338 VDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDE--------- 385
           +D+W +GC   EMAT +P +   +  E +  +F+I  +      P  LS+E         
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241
Query: 386 ----------------GKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                           G D + K LQ    +R +A   ++HPF
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 136/272 (50%), Gaps = 25/272 (9%)
Query: 149 NPTSPG-SRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP   +W+  R        LG G +G VY G   +     A+K  TL  D  + +E 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 60
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                +E A++  ++HPN+V+  G  T +   YI +E+++ G++   L++    ++    
Sbjct: 61  ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSK 373
           + +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++    
Sbjct: 177 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKD 233
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 79  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 137
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 258 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 310
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AMK V   L +DD    E    +  E  +  +   HP
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 66
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH + 
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-----GTPNYIAPEILRGE 181
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWS--------QYEGVPAMFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  LS
Sbjct: 182 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLS 239
Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGNA 416
            +    ++  L ++P  R    P   +  +  HPF  N 
Sbjct: 240 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           SR++    +G G +G VY   +  SG   A+K V + + +     S  +   E+ALL RL
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRL 60
Query: 215 R---HPNIVRYY---GSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQ 265
               HPN+VR      +   D ++ + L +       +   D      L    I+   +Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
            L GL++LHA   VHRD+K  NILV   G VKLADFG+A+  + Q     +  + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           EV+  S      VD+WS+GC   EM   KP +        + KI +   LP
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 230

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LGRG FG V+      +G++ A K++       +       + ++I  L+++    IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIV 248
Query: 221 RY-YGSETLDDKLYIYLEYVSGGSI----YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
              Y  ET  D L + +  ++GG I    Y + +D     E     YT QI+SGLE+LH 
Sbjct: 249 SLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +N ++RD+K  N+L+D  G V+++D G+A  +  GQ+      G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 335 NLAVDIWSLGCTVIEMATTKPPW-SQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + +VD ++LG T+ EM   + P+ ++ E V     K    ++    PD  S   KDF   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 393 CLQRNPLHR 401
            LQ++P  R
Sbjct: 427 LLQKDPEKR 435

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 136/272 (50%), Gaps = 25/272 (9%)
Query: 149 NPTSPG-SRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP   +W+  R        LG G +G VY G   +     A+K  TL  D  +    
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME---- 57
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI- 259
            ++  +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++  +   SA+ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 117
Query: 260 -RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
                 QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSK 373
           + +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++    
Sbjct: 177 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKD 233
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LGRG FG V+      +G++ A K++       +       + ++I  L+++    IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIV 248
Query: 221 RY-YGSETLDDKLYIYLEYVSGGSI----YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
              Y  ET  D L + +  ++GG I    Y + +D     E     YT QI+SGLE+LH 
Sbjct: 249 SLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +N ++RD+K  N+L+D  G V+++D G+A  +  GQ+      G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 335 NLAVDIWSLGCTVIEMATTKPPW-SQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + +VD ++LG T+ EM   + P+ ++ E V     K    ++    PD  S   KDF   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 393 CLQRNPLHR 401
            LQ++P  R
Sbjct: 427 LLQKDPEKR 435

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LGRG FG V+      +G++ A K++       +       + ++I  L+++    IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIV 248
Query: 221 RY-YGSETLDDKLYIYLEYVSGGSI----YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
              Y  ET  D L + +  ++GG I    Y + +D     E     YT QI+SGLE+LH 
Sbjct: 249 SLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +N ++RD+K  N+L+D  G V+++D G+A  +  GQ+      G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 335 NLAVDIWSLGCTVIEMATTKPPW-SQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + +VD ++LG T+ EM   + P+ ++ E V     K    ++    PD  S   KDF   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 393 CLQRNPLHR 401
            LQ++P  R
Sbjct: 427 LLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LGRG FG V+      +G++ A K++       +       + ++I  L+++    IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIV 248
Query: 221 RY-YGSETLDDKLYIYLEYVSGGSI----YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
              Y  ET  D L + +  ++GG I    Y + +D     E     YT QI+SGLE+LH 
Sbjct: 249 SLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +N ++RD+K  N+L+D  G V+++D G+A  +  GQ+      G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-Y 366
Query: 335 NLAVDIWSLGCTVIEMATTKPPW-SQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + +VD ++LG T+ EM   + P+ ++ E V     K    ++    PD  S   KDF   
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 393 CLQRNPLHR 401
            LQ++P  R
Sbjct: 427 LLQKDPEKR 435

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA ++E    L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEEDLSDLVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 41/287 (14%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S +++  +LG+G FG V    N+      A+K++        ++E    +  E+ LL+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58
Query: 214 LRHPNIVRYYGS-----------ETLDDK--LYIYLEYVSGGSIYKIL--QDYGQLGESA 258
           L H  +VRYY +             +  K  L+I +EY   G++Y ++  ++  Q  +  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---------TG 309
            R + +QIL  L Y+H++  +HRD+K  NI +D S  VK+ DFG+AK++           
Sbjct: 119 WRLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 310 QSCP------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           Q+ P       S  G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235
Query: 364 PAMFKIGN-SKEL-PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
             + K+ + S E  P   D+     K  +R  +  +P  RP A  LL
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AMK V   L +DD    E    +  E  +  +   HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 70
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH + 
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-----GTPNYIAPEILRGE 185
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWS--------QYEGVPAMFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  LS
Sbjct: 186 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLS 243
Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGNA 416
            +    ++  L ++P  R    P   +  +  HPF  N 
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 312 CPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                        WMAPE + +    + + D+WS G  + E+ T     S Y G+P   +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEEL 268
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 76  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           RD+   N LV  +  VK+ADFG+++ +TG   + P   K    W APE +   N  ++  
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA-YNKFSIKS 194
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
           D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q 
Sbjct: 195 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 252
Query: 397 NPLHRPTAA 405
           NP  RP+ A
Sbjct: 253 NPSDRPSFA 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 72
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLA-YNKFSIK 190
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 191 SDVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 249 WNPSDRPSFA 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/218 (35%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ KK R LG G FG V    Y   N  +GEM A+K   L +D      S  +
Sbjct: 24  DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADAGPQHRSGWK 81
Query: 204 LGQEIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY---GQLGESA 258
             QEI +L  L H +I++Y G   +     L + +EYV  GS    L+DY     +G + 
Sbjct: 82  --QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS----LRDYLPRHSIGLAQ 135
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK- 317
           +  + QQI  G+ YLHA++ +HRD+   N+L+D    VK+ DFG+AK +        ++ 
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 318 --GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
              SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 196 DGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLT 232

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 76
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           RD+   N LV  +  VK+ADFG+++ +TG   + P   K    W APE +   N  ++  
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA-YNKFSIKS 195
Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
           D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q 
Sbjct: 196 DVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 397 NPLHRPTAA 405
           NP  RP+ A
Sbjct: 254 NPSDRPSFA 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 25/254 (9%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G+FG VY G     G++     V +      + E  Q    E+A+L + RH NI+ +
Sbjct: 44  IGSGSFGTVYKG--KWHGDVA----VKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF 97
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSY-----TQQILSGLEYLHAKN 277
            G  T  D L I  ++  G S+YK L     + E+  + +      +Q   G++YLHAKN
Sbjct: 98  MGYMT-KDNLAIVTQWCEGSSLYKHLH----VQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSPYWMAPEVIK--NSN 332
            +HRD+K  NI +     VK+ DFG+A   +  S    ++   GS  WMAPEVI+  ++N
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHLSDEGKD 388
             +   D++S G  + E+ T + P+S        +F +G    S +L  +  +     K 
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272
Query: 389 FVRKCLQRNPLHRP 402
            V  C+++    RP
Sbjct: 273 LVADCVKKVKEERP 286

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 18/256 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +GRG++G V +     +    A K++   F +D        +  QEI ++  L HPNI+R
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV------DRFKQEIEIMKSLDHPNIIR 70
Query: 222 YYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y  ET +D   +Y+ +E  +GG +++ +       ES      + +LS + Y H  N  
Sbjct: 71  LY--ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 280 HRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           HRD+K  N L     P   +KL DFG+A          +  G+PY+++P+V++   G   
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE- 187
Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCL 394
             D WS G  +  +    PP+S       M KI          D  ++S + +  +R+ L
Sbjct: 188 -CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246
Query: 395 QRNPLHRPTAAWLLEH 410
            ++P  R T+   LEH
Sbjct: 247 TKSPKQRITSLQALEH 262

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-----------DYGQLGE 256
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+           D  ++ E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 257 SAIR-----SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             +      S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 312 CPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
                        WMAPE + +    + + D+WS G  + E+ T     S Y G+P   +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEEL 268
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 72
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI +E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLA-YNKFSIK 190
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 191 SDVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 249 WNPSDRPSFA 258

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 149 NPTSPG-SRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP   +W+  R        LG G +G VY G   +     A+K  TL  D  + +E 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 60
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++    ++    
Sbjct: 61  ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAG 176
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSK 373
           + +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++    
Sbjct: 177 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKD 233
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 312 CPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--M 366
              +         WMAPE + +    + + D+WS G  + E+ T     S Y G+P   +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIPVEEL 268
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           SR++    +G G +G VY   +  SG   A+K V + + +     S  +   E+ALL RL
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRL 60
Query: 215 R---HPNIVRYY---GSETLDDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQ 265
               HPN+VR      +   D ++ + L +       +   D      L    I+   +Q
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
            L GL++LHA   VHRD+K  NILV   G VKLADFG+A+  + Q     +  + ++ AP
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           EV+  S      VD+WS+GC   EM   KP +        + KI +   LP
Sbjct: 181 EVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 230

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 128/264 (48%), Gaps = 20/264 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V       +G+  A     + +    S    Q+L +E  +   L+HPNIVR 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+      QQIL  + + H    VHR+
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRN 135
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++  +     V
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPV 194
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           D+W+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E KD + 
Sbjct: 195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-----GAYDFPSPEWDTVTPEAKDLIN 249
Query: 392 KCLQRNPLHRPTAAWLLEHPFVGN 415
           K L  NP  R TAA  L+HP++ +
Sbjct: 250 KMLTINPSKRITAAEALKHPWISH 273

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 25  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 83
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 204 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 256
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 257 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 149 NPTSPG-SRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP   +W+  R        LG G +G VY G   +     A+K  TL  D  + +E 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 60
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++    ++    
Sbjct: 61  ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSK 373
           + +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++    
Sbjct: 177 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKD 233
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 119/256 (46%), Gaps = 18/256 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +GRG++G V +     +    A K++   F +D        +  QEI ++  L HPNI+R
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV------DRFKQEIEIMKSLDHPNIIR 87
Query: 222 YYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y  ET +D   +Y+ +E  +GG +++ +       ES      + +LS + Y H  N  
Sbjct: 88  LY--ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 145
Query: 280 HRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           HRD+K  N L     P   +KL DFG+A          +  G+PY+++P+V++   G   
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPE- 204
Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD--HLSDEGKDFVRKCL 394
             D WS G  +  +    PP+S       M KI          D  ++S + +  +R+ L
Sbjct: 205 -CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 263
Query: 395 QRNPLHRPTAAWLLEH 410
            ++P  R T+   LEH
Sbjct: 264 TKSPKQRITSLQALEH 279

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AMK V   L +DD    E    +  E  +  +   HP
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 81
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH + 
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-----GTPNYIAPEILRGE 196
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWS--------QYEGVPAMFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  +S
Sbjct: 197 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSMS 254
Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGNA 416
            +    ++  L ++P  R    P   +  +  HPF  N 
Sbjct: 255 VKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI +E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRL-RHP 217
           R++GRG++  V L    ++  + AM+ V   L +DD    E    +  E  +  +   HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 113
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            +V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH + 
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKH------ITGQSCPLSIKGSPYWMAPEVIKNS 331
            ++RD+K  N+L+D  G +KL D+GM K        T   C     G+P ++APE+++  
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GTPNYIAPEILRGE 228
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWS--------QYEGVPAMFKIGNSKELPAIPDHLS 383
           +    +VD W+LG  + EM   + P+                +F++   K++  IP  LS
Sbjct: 229 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLS 286
Query: 384 DEGKDFVRKCLQRNPLHR----PTAAW--LLEHPFVGNA 416
            +    ++  L ++P  R    P   +  +  HPF  N 
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 22  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 80
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 201 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 253
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 254 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 12/263 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ----EIALLSRLR-H 216
           +LGRG    V    +  + +  A+K + +    + S E  Q+L +    E+ +L ++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNI++   +   +   ++  + +  G ++  L +   L E   R   + +L  +  LH  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSN- 332
           N VHRD+K  NIL+D    +KL DFG +  +       S+ G+P ++APE+I+   N N 
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNH 203
Query: 333 -GCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF 389
            G    VD+WS G  +  +    PP W + + +   M   GN +      D  SD  KD 
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 390 VRKCLQRNPLHRPTAAWLLEHPF 412
           V + L   P  R TA   L HPF
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPF 286

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 20  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 78
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 199 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 251
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 252 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 77
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 134
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI +E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 17/254 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L     +     +    +Q   G++YLHAK+ 
Sbjct: 83  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  +SN 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S       + ++      S +L  +  +     K  
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 390 VRKCLQRNPLHRPT 403
           + +CL++    RP+
Sbjct: 262 MAECLKKKRDERPS 275

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 77
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 134
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 149 NPTSPG-SRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP   +W+  R        LG G +G VY G   +     A+K  TL  D  + +E 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 60
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++    ++    
Sbjct: 61  ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSK 373
           + +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++    
Sbjct: 177 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKD 233
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
                P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 77
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 134
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 17/254 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 17  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L     +     +    +Q   G++YLHAK+ 
Sbjct: 71  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  +SN 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S       + ++      S +L  +  +     K  
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 249
Query: 390 VRKCLQRNPLHRPT 403
           + +CL++    RP+
Sbjct: 250 MAECLKKKRDERPS 263

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 137/295 (46%), Gaps = 33/295 (11%)
Query: 142 RSPGRVENPTSPGSRW-KKGRLLGRGTFGHVYLG-FNSE---SGEMCAMKEVTLFSDDAK 196
           + P    +PT    R+ K+ R LG G FG V L  ++ E   +GE  A+K +   S    
Sbjct: 7   KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---- 62
Query: 197 SKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKLYIYLEYVSGGSIYKIL-QDYGQ 253
                  L +EI +L  L H NIV+Y G  T D  + + + +E++  GS+ + L ++  +
Sbjct: 63  GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           +       Y  QI  G++YL ++  VHRD+   N+LV+   +VK+ DFG+ K I      
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEX 182
Query: 314 LSIK---GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---------------TK 354
            ++K    SP +W APE +  S    +A D+WS G T+ E+ T                 
Sbjct: 183 XTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 355 PPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           P   Q      +  +   K LP  P +  DE    +RKC +  P +R +   L+E
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 17/260 (6%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G G FG VY  F    G+  A+K      D+  S ++ + + QE  L + L+HPNI+ 
Sbjct: 14  IIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNIIA 70
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV-- 279
             G    +  L + +E+  GG + ++L    ++    + ++  QI  G+ YLH +  V  
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 280 -HRDIKGANILV-------DPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
            HRD+K +NIL+       D S ++ K+ DFG+A+    ++  +S  G+  WMAPEVI+ 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIRA 188
Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           S       D+WS G  + E+ T + P+   +G+   + +  +K    IP    +     +
Sbjct: 189 SMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247
Query: 391 RKCLQRNPLHRPTAAWLLEH 410
             C   +P  RP+   +L+ 
Sbjct: 248 EDCWNPDPHSRPSFTNILDQ 267

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 97
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 154
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 79
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 136
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 77
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 134
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 82
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 139
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 140 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 75
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 132
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 133 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 82
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 139
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 140 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 28  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 83
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 140
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 141 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 19  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 74
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 131
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 132 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 30  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 85
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 142
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 143 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 77
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 134
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYXQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 17/254 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L     +     +    +Q   G++YLHAK+ 
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  +SN 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S       + ++      S +L  +  +     K  
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 390 VRKCLQRNPLHRPT 403
           + +CL++    RP+
Sbjct: 262 MAECLKKKRDERPS 275

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 75
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 132
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 133 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ +EY S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +++ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI +E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 76  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLA-YNKFSIK 193
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 194 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 252 WNPSDRPSFA 261

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 29/231 (12%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S +++ +E+++L ++ H N++  +        + + LE VSGG ++  L     L E   
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLS 315
            S+ +QIL G+ YLH K   H D+K  NI L+D   P   +KL DFG+A  I       +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE- 374
           I G+P ++APE++ N     L  D+WS+G     + +   P+           +G++K+ 
Sbjct: 178 IFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPF-----------LGDTKQE 225
Query: 375 ----LPAIPDHLSDE--------GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               + A+     +E         KDF+RK L +    R T    L HP++
Sbjct: 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLK-CQHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 113/218 (51%), Gaps = 23/218 (10%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ KK R LG G FG V    Y   N  +GEM A+K   L +D      S  +
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADCGPQHRSGWK 64
Query: 204 LGQEIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY---GQLGESA 258
             QEI +L  L H +I++Y G   +  +  L + +EYV  GS    L+DY     +G + 
Sbjct: 65  --QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS----LRDYLPRHSIGLAQ 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK- 317
           +  + QQI  G+ YLHA++ +HR++   N+L+D    VK+ DFG+AK +        ++ 
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 318 --GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
              SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 179 DGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 72
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFT-AHAGAKFPIKWTAPESLA-YNKFSIK 190
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 191 SDVWAFGVLLWEIATYGM--SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 249 WNPSDRPSFA 258

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 30/272 (11%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK-ESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G   A K +      A  +  S +++ +E+++L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           ++  +        + + LE VSGG ++  L     L E    S+ +QIL G+ YLH K  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 279 VHRDIKGANI-LVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            H D+K  NI L+D   P   +KL DFG+A  I       +I G+P ++APE++ N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-----LPAIPDHLSDE---- 385
            L  D+WS+G     + +   P+           +G++K+     + A+     +E    
Sbjct: 196 GLEADMWSIGVITYILLSGASPF-----------LGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 386 ----GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                KDF+RK L +    R T    L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V    +  +G   A K   + +    S    Q+L +E  +  +L+HPNIVR 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S   +   Y+  + V+GG +++ +       E+      QQIL  + Y H+   VHR+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +K  N+L+    +   VKLADFG+A  +          G+P +++PEV+K  +  +  VD
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVD 212
Query: 340 IWSLGCTVIEMATTKPP-WSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           IW+ G  +  +    PP W + +  + A  K G         D ++ E K  +   L  N
Sbjct: 213 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 272
Query: 398 PLHRPTAAWLLEHPFVGN 415
           P  R TA   L+ P++ N
Sbjct: 273 PKKRITADQALKVPWICN 290

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V    +  +G   A K   + +    S    Q+L +E  +  +L+HPNIVR 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S   +   Y+  + V+GG +++ +       E+      QQIL  + Y H+   VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +K  N+L+    +   VKLADFG+A  +          G+P +++PEV+K  +  +  VD
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVD 189
Query: 340 IWSLGCTVIEMATTKPP-WSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           IW+ G  +  +    PP W + +  + A  K G         D ++ E K  +   L  N
Sbjct: 190 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 249
Query: 398 PLHRPTAAWLLEHPFVGN 415
           P  R TA   L+ P++ N
Sbjct: 250 PKKRITADQALKVPWICN 267

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V    +  +G   A K   + +    S    Q+L +E  +  +L+HPNIVR 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S   +   Y+  + V+GG +++ +       E+      QQIL  + Y H+   VHR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +K  N+L+    +   VKLADFG+A  +          G+P +++PEV+K  +  +  VD
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVD 188
Query: 340 IWSLGCTVIEMATTKPP-WSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           IW+ G  +  +    PP W + +  + A  K G         D ++ E K  +   L  N
Sbjct: 189 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 248
Query: 398 PLHRPTAAWLLEHPFVGN 415
           P  R TA   L+ P++ N
Sbjct: 249 PKKRITADQALKVPWICN 266

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V    +  +G   A K   + +    S    Q+L +E  +  +L+HPNIVR 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S   +   Y+  + V+GG +++ +       E+      QQIL  + Y H+   VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           +K  N+L+    +   VKLADFG+A  +          G+P +++PEV+K  +  +  VD
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVD 189
Query: 340 IWSLGCTVIEMATTKPP-WSQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           IW+ G  +  +    PP W + +  + A  K G         D ++ E K  +   L  N
Sbjct: 190 IWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN 249
Query: 398 PLHRPTAAWLLEHPFVGN 415
           P  R TA   L+ P++ N
Sbjct: 250 PKKRITADQALKVPWICN 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 114/214 (53%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+++++ F    + +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPF----EHQTYCQRTLREIKILLR 81
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHVYLG-FNSE---SGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ K+ R LG G FG V L  ++ E   +GE  A+K +   S           
Sbjct: 2   DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIAD 57
Query: 204 LGQEIALLSRLRHPNIVRYYGSETLD--DKLYIYLEYVSGGSIYKIL-QDYGQLGESAIR 260
           L +EI +L  L H NIV+Y G  T D  + + + +E++  GS+ + L ++  ++      
Sbjct: 58  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 117
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--- 317
            Y  QI  G++YL ++  VHRD+   N+LV+   +VK+ DFG+ K I       ++K   
Sbjct: 118 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 318 GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---------------TKPPWSQYE 361
            SP +W APE +  S    +A D+WS G T+ E+ T                 P   Q  
Sbjct: 178 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 236
Query: 362 GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
               +  +   K LP  P +  DE    +RKC +  P +R +   L+E
Sbjct: 237 VTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 12/263 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ----EIALLSRLR-H 216
           +LGRG    V    +  + +  A+K + +    + S E  Q+L +    E+ +L ++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNI++   +   +   ++  + +  G ++  L +   L E   R   + +L  +  LH  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSN- 332
           N VHRD+K  NIL+D    +KL DFG +  +        + G+P ++APE+I+   N N 
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 333 -GCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF 389
            G    VD+WS G  +  +    PP W + + +   M   GN +      D  SD  KD 
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 390 VRKCLQRNPLHRPTAAWLLEHPF 412
           V + L   P  R TA   L HPF
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPF 286

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 116/217 (53%), Gaps = 21/217 (9%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  R+ G+GTFG V LG    +G   A+K+V     D + +    Q+ Q++A+L   
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQIMQDLAVL--- 76
Query: 215 RHPNIVR---YYGSETLDDKLYIYL----EYVSGGSIYKILQDYGQLGES----AIRSYT 263
            HPNIV+   Y+ +    D+  IYL    EYV   ++++  ++Y +   +     I+ + 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 264 QQILSGLEYLH--AKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSP 320
            Q++  +  LH  + N  HRDIK  N+LV+ + G +KL DFG AK ++     ++   S 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           Y+ APE+I  +     AVDIWS+GC   EM   +P +
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 24/271 (8%)
Query: 149 NPTSPGSRWKKGRL-------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           +P+    +W+  R        LG G +G VY G   +     A+K  TL  D  + +E  
Sbjct: 4   DPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE-- 59
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAI 259
               +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++    ++    +
Sbjct: 60  --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS 319
                QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +   +  G+
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGA 176
Query: 320 PY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKE 374
            +   W APE +   N  ++  D+W+ G  + E+AT     S Y G+    ++++     
Sbjct: 177 KFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDY 233
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
               P+   ++  + +R C Q NP  RP+ A
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFA 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 12/263 (4%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ----EIALLSRLR-H 216
           +LGRG    V    +  + +  A+K + +    + S E  Q+L +    E+ +L ++  H
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           PNI++   +   +   ++  + +  G ++  L +   L E   R   + +L  +  LH  
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSN- 332
           N VHRD+K  NIL+D    +KL DFG +  +        + G+P ++APE+I+   N N 
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 190
Query: 333 -GCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF 389
            G    VD+WS G  +  +    PP W + + +   M   GN +      D  SD  KD 
Sbjct: 191 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 250
Query: 390 VRKCLQRNPLHRPTAAWLLEHPF 412
           V + L   P  R TA   L HPF
Sbjct: 251 VSRFLVVQPQKRYTAEEALAHPF 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 21/301 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQ 64
Query: 210 LLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   ET    L YI +EYV G ++  I+   G +           
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC--PLSIKGSPY 321
               L + H    +HRD+K ANIL+  +  VK+ DFG+A+ I  +G S     ++ G+  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++      +P    H
Sbjct: 185 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 382 --LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAM 439
             LS +    V K L +NP +R   A  +    V         + + EP E    LT A 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR--------VHNGEPPEAPKVLTDAE 295
Query: 440 R 440
           R
Sbjct: 296 R 296

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 281
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++  +   SA+       QI S +EYL  KN +H
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           R++   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 399
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 400 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 457
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 458 WNPSDRPSFA 467

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 113/218 (51%), Gaps = 23/218 (10%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHV----YLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ KK R LG G FG V    Y   N  +GEM A+K   L +D      S  +
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADCGPQHRSGWK 64
Query: 204 LGQEIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY---GQLGESA 258
             QEI +L  L H +I++Y G   +  +  L + +EYV  GS    L+DY     +G + 
Sbjct: 65  --QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS----LRDYLPRHSIGLAQ 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK- 317
           +  + QQI  G+ YLH+++ +HR++   N+L+D    VK+ DFG+AK +        ++ 
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 318 --GSP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
              SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 179 DGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ + Y S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 192
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 193 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 251 WNPSDRPSFA 260

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S +++  +LG+G FG V    N+      A+K++        ++E    +  E+ LL+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58
Query: 214 LRHPNIVRYYGS-----------ETLDDK--LYIYLEYVSGGSIYKIL--QDYGQLGESA 258
           L H  +VRYY +             +  K  L+I +EY    ++Y ++  ++  Q  +  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---------TG 309
            R + +QIL  L Y+H++  +HRD+K  NI +D S  VK+ DFG+AK++           
Sbjct: 119 WRLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 310 QSCP------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           Q+ P       S  G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235
Query: 364 PAMFKIGN-SKEL-PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
             + K+ + S E  P   D+     K  +R  +  +P  RP A  LL
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYL--EYVSGGSIY-KIL-QDYGQLGESAIR 260
           +EI +L R  +HPNI+     +  DD  Y+Y+  E + GG +  KIL Q +    E++  
Sbjct: 64  EEIEILLRYGQHPNIITL--KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV 121
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANIL-VDPSGR---VKLADFGMAKHITGQSCPLSI 316
            +T  I   +EYLHA+  VHRD+K +NIL VD SG    +++ DFG AK +  ++  L  
Sbjct: 122 LFT--ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 317 KG-SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-----EGVPAMFKIG 370
              +  ++APEV++   G + A DIWSLG  +  M T   P++       E + A    G
Sbjct: 180 PCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                    + +SD  KD V K L  +P  R TAA +L HP++
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 20/262 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G F  V         +  A K   + +    S    Q+L +E  +   L+HPNIVR 
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAK---IINTKKLSARDHQKLEREARICRLLKHPNIVRL 95
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+       QIL  + ++H  + VHRD
Sbjct: 96  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRD 155
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++  +     V
Sbjct: 156 LKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPV 214
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           DIW+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E K+ + 
Sbjct: 215 DIWACGVILYILLVGYPPFWDEDQHKLYQQIKA-----GAYDFPSPEWDTVTPEAKNLIN 269
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L  NP  R TA   L+HP+V
Sbjct: 270 QMLTINPAKRITADQALKHPWV 291

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 76
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 194
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 195 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 253 WNPSDRPSFA 262

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 65  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 244 PKAMKRLMAECLKKKRDERP 263

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 143/315 (45%), Gaps = 43/315 (13%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMK--EVTLF----------SDDAKSKESAQQLGQEI 208
           R L +G F  + L    +  +  A+K  E +L           +D    K        E+
Sbjct: 37  RTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES--------AIR 260
            +++ +++   +   G  T  D++YI  EY+   SI K  + +  L ++         I+
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 261 SYTQQILSGLEYLH-AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS 319
              + +L+   Y+H  KN  HRD+K +NIL+D +GRVKL+DFG ++++  +    S +G+
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-RGT 213
Query: 320 PYWMAPEVIKNSNGCNLA-VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELP 376
             +M PE   N +  N A VDIWSLG  +  M     P+S    +  +F    +K  E P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 377 AIPDH----------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
              +H                LS+E  DF++  L++NP  R T+   L+H ++ +    +
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
Query: 421 RPILSAEPSETKPTL 435
               S E  + +  L
Sbjct: 334 LREFSKELYKKRKKL 348

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 141/313 (45%), Gaps = 47/313 (15%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L  
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLA 79
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 136
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY----------------EGVPA 365
           APE++ NS G   ++DIWS+GC + EM + +P  P   Y                E +  
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 366 MFKIGNSKELPAIPD-----------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG 414
           +  +     L ++P            +   +  D + K L  NP  R      L HP++ 
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316
Query: 415 NAA-PLERPILSA 426
               P + PI  A
Sbjct: 317 QYYDPSDEPIAEA 329

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  +     ++  +E A++  ++HPN+V+ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTME----VEEFLKEAAVMKEIKHPNLVQL 76
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 194
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 195 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 253 WNPSDRPSFA 262

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 8   PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 61
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 62  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 120
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 121 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 241 PKAMKRLMAECLKKKRDERP 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYL----GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P  +   G+ LG G FG V +    G + +  +      V +  DDA  K+ +  L  E+
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEM 91
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++  + +H NI+   G+ T D  LY+ + Y S G++ + L+       +Y         
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-- 309
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 310 -----QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
                 +  L +K    WMAPE + +    + + D+WS G  + E+ T     S Y G+P
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGG--SPYPGIP 264
Query: 365 A--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              +FK+         P + ++E    +R C    P  RPT   L+E
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 113/214 (52%), Gaps = 17/214 (7%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F    + +   Q+  +EI +L  
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLA 79
Query: 214 LRHPNIV------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+      R    E + D +YI ++ +    +YK+L+    L    I  +  QIL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKD-VYI-VQDLMETDLYKLLKT-QHLSNDHICYFLYQIL 136
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSPYWM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 324 APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           APE++ NS G   ++DIWS+GC + EM + +P +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 33  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++YLHAK+ 
Sbjct: 87  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  + N 
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S        +F +G    S +L  +  +     K  
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 265
Query: 390 VRKCLQRNPLHRP 402
           + +CL++    RP
Sbjct: 266 MAECLKKKRDERP 278

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 60  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 239 PKAMKRLMAECLKKKRDERP 258

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++YLHAK+ 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  + N 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S        +F +G    S +L  +  +     K  
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 390 VRKCLQRNPLHRP 402
           + +CL++    RP
Sbjct: 274 MAECLKKKRDERP 286

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 11  PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 65  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 244 PKAMKRLMAECLKKKRDERP 263

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 60  KTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 239 PKAMKRLMAECLKKKRDERP 258

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 87
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 88  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 205
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 206 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 263
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 264 WNPSDRPSFA 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++YLHAK+ 
Sbjct: 95  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  + N 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S        +F +G    S +L  +  +     K  
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 390 VRKCLQRNPLHRP 402
           + +CL++    RP
Sbjct: 274 MAECLKKKRDERP 286

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 17/253 (6%)
Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L + RH NI
Sbjct: 40  GQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLEYLHAKNT 278
           + + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++YLHAK+ 
Sbjct: 94  LLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 279 VHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVIK--NSNG 333
           +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+  + N 
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGN---SKELPAIPDHLSDEGKDF 389
            +   D+++ G  + E+ T + P+S        +F +G    S +L  +  +     K  
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 272
Query: 390 VRKCLQRNPLHRP 402
           + +CL++    RP
Sbjct: 273 MAECLKKKRDERP 285

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 161 RLLGRGTFGHVYLG--FN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG G FG V+L   +N    +   + A+K +   SD+A+     +   +E  LL+ L+
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQ 73
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-------------QLGESAIRSY 262
           H +IV++YG     D L +  EY+  G + K L+ +G             +L +S +   
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLS 315
            QQI +G+ YL +++ VHRD+   N LV  +  VK+ DFGM++ +        G    L 
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKE 374
           I+    WM PE I        + D+WSLG  + E+ T  K PW Q      +  I   + 
Sbjct: 194 IR----WMPPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
           L   P     E  + +  C QR P  R     +  H  + N A
Sbjct: 249 LQR-PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 131/259 (50%), Gaps = 49/259 (18%)
Query: 202 QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
            Q+ +E+ +L     P IV +YG+   D ++ I +E++ GGS+ ++L++  ++ E  +  
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 262 YTQQILSGLEYLHAKNTV-HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
            +  +L GL YL  K+ + HRD+K +NILV+  G +KL DFG++  +   S   S  G+ 
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTR 177
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK----PPWSQ-------------YEGV 363
            +MAPE ++ ++  ++  DIWS+G +++E+A  +    PP ++              EG 
Sbjct: 178 SYMAPERLQGTH-YSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGE 236
Query: 364 P-------------------------AMFKIGN---SKELPAIPDHL-SDEGKDFVRKCL 394
           P                         A+F++ +   ++  P +P+ + + + ++FV KCL
Sbjct: 237 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 296
Query: 395 QRNPLHRPTAAWLLEHPFV 413
            +NP  R     L  H F+
Sbjct: 297 IKNPAERADLKMLTNHTFI 315

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G     G++     V + +  A + +  Q    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG--KWHGDVA----VKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-AIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L       E   +    +Q   G++
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMA---KHITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGN---SKELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S        +F +G    S +L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 383 SDEGKDFVRKCLQRNPLHRP 402
               K  + +CL++    RP
Sbjct: 239 PKAMKRLMAECLKKKRDERP 258

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 21/301 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQ 64
Query: 210 LLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   ET    L YI +EYV G ++  I+   G +           
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC--PLSIKGSPY 321
               L + H    +HRD+K ANI++  +  VK+ DFG+A+ I  +G S     ++ G+  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++      +P    H
Sbjct: 185 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 382 --LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAM 439
             LS +    V K L +NP +R   A  +    V         + + EP E    LT A 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR--------VHNGEPPEAPKVLTDAE 295
Query: 440 R 440
           R
Sbjct: 296 R 296

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
            ++GRG FG V              K+V +   +++S+  A  +  E+  LSR+ HPNIV
Sbjct: 15  EVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIV--ELRQLSRVNHPNIV 65
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQL---GESAIRSYTQQILSGLEYLHA-- 275
           + YG+    + + + +EY  GGS+Y +L     L     +   S+  Q   G+ YLH+  
Sbjct: 66  KLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 276 -KNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
            K  +HRD+K  N+L+   G V K+ DFG A  I  Q+   + KGS  WMAPEV + SN 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNY 181
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSKELPAIPDHLSDEGKDFV 390
                D++S G  + E+ T + P+ +  G PA   M+ + N    P I + L    +  +
Sbjct: 182 SE-KCDVFSWGIILWEVITRRKPFDEIGG-PAFRIMWAVHNGTRPPLIKN-LPKPIESLM 238
Query: 391 RKCLQRNPLHRPTAAWL------LEHPFVGNAAPLERPILSAEP 428
            +C  ++P  RP+   +      L   F G   PL+ P   + P
Sbjct: 239 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 282

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 320
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
            G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN +H
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 380
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           R++   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNKFSIK 438
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++++         P+   ++  + +R C Q
Sbjct: 439 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 496
Query: 396 RNPLHRPTAA 405
            NP  RP+ A
Sbjct: 497 WNPSDRPSFA 506

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 74
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 133
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIML 191
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 75
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CAKLTDDHVQFLIYQILRGL 134
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 192
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLT 214

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           K  +LG G FG V+    + +G   A K +       +  +  +++  EI+++++L H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHAN 147
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           +++ Y +    + + + +EYV GG ++ +I+ +   L E     + +QI  G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 278 TVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
            +H D+K  NIL     + ++K+ DFG+A+    +       G+P ++APEV+ N +  +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVS 266
Query: 336 LAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
              D+WS+G     + +   P+   +  E +  +       E     D +S+E K+F+ K
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-ISEEAKEFISK 325
Query: 393 CLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETK 432
            L +    R +A+  L+HP++ +     R  LSA+  + +
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDHKLHSR--LSAQKKKNR 363

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 21/301 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK--VLRADLARDPSFYLRFRREAQ 64
Query: 210 LLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   ET    L YI +EYV G ++  I+   G +           
Sbjct: 65  NAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC--PLSIKGSPY 321
               L + H    +HRD+K ANI++  +  VK+ DFG+A+ I  +G S     ++ G+  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++      +P    H
Sbjct: 185 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 382 --LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAM 439
             LS +    V K L +NP +R   A  +    V         + + EP E    LT A 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR--------VHNGEPPEAPKVLTDAE 295
Query: 440 R 440
           R
Sbjct: 296 R 296

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
            ++GRG FG V              K+V +   +++S+  A  +  E+  LSR+ HPNIV
Sbjct: 14  EVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIV--ELRQLSRVNHPNIV 64
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQL---GESAIRSYTQQILSGLEYLHA-- 275
           + YG+    + + + +EY  GGS+Y +L     L     +   S+  Q   G+ YLH+  
Sbjct: 65  KLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 276 -KNTVHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
            K  +HRD+K  N+L+   G V K+ DFG A  I  Q+   + KGS  WMAPEV + SN 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSKELPAIPDHLSDEGKDFV 390
                D++S G  + E+ T + P+ +  G PA   M+ + N    P I + L    +  +
Sbjct: 181 SE-KCDVFSWGIILWEVITRRKPFDEIGG-PAFRIMWAVHNGTRPPLIKN-LPKPIESLM 237
Query: 391 RKCLQRNPLHRPTAAWL------LEHPFVGNAAPLERPILSAEP 428
            +C  ++P  RP+   +      L   F G   PL+ P   + P
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 138/312 (44%), Gaps = 42/312 (13%)
Query: 142 RSPGRVENPTSPGS----RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS 197
           + PG +    +P +    R+++   LG GT+G VY   ++ + E  A+K + L  ++   
Sbjct: 17  QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76
Query: 198 KESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES 257
             +A +   E++LL  L+H NI+        + +L++  EY     + K +     +   
Sbjct: 77  PGTAIR---EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR 132
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-----VKLADFGMAKHITGQSC 312
            I+S+  Q+++G+ + H++  +HRD+K  N+L+  S       +K+ DFG+A+       
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 313 PLSIKGSPYWMA-PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN 371
             + +    W   PE++  S   + +VDIWS+ C   EM    P +     +  +FKI  
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252
Query: 372 SKELP---------AIPDHLSD----EGKDFVR---------------KCLQRNPLHRPT 403
              LP         A+PD         GK   R                 L+ +P+ R +
Sbjct: 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312
Query: 404 AAWLLEHPFVGN 415
           A   LEHP+  +
Sbjct: 313 AKNALEHPYFSH 324

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 114/203 (56%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N+   N  VDIWS+GC + E+ T
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLT 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G +G V    +  SGE  A+K++   S   +S+  A++  +E+ LL  ++H N++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 223 YGSETLDDKLYIYLEY-----VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
               T    L  + ++          + KI+    +  E  I+    Q+L GL+Y+H+  
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
            VHRD+K  N+ V+    +K+ DFG+A+H   +     +  + ++ APEVI +    N  
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILSWMHYNQT 222
Query: 338 VDIWSLGCTVIEMATTKPPWS------------QYEGVPA---MFKIGNS------KELP 376
           VDIWS+GC + EM T K  +             +  GVP    + K+ +       + LP
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 377 AIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             P           S +  D + K L+ +   R TAA  L HPF
Sbjct: 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 21/301 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK--VLRADLARDPSFYLRFRREAQ 64
Query: 210 LLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   ET    L YI +EYV G ++  I+   G +           
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC--PLSIKGSPY 321
               L + H    +HRD+K ANI++  +  VK+ DFG+A+ I  +G S     ++ G+  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++      +P    H
Sbjct: 185 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 382 --LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAM 439
             LS +    V K L +NP +R   A  +    V         + + EP E    LT A 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR--------VHNGEPPEAPKVLTDAE 295
Query: 440 R 440
           R
Sbjct: 296 R 296

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 74
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 133
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 191
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 113/219 (51%), Gaps = 31/219 (14%)
Query: 159 KGRLLGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +G  +GRGT+GHVY     +  +    A+K++       +    +    +EIALL  L+H
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-------EGTGISMSACREIALLRELKH 77
Query: 217 PNIV---RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG---------QLGESAIRSYTQ 264
           PN++   + + S   D K+++  +Y     ++ I++ +          QL    ++S   
Sbjct: 78  PNVISLQKVFLSHA-DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 265 QILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLS----I 316
           QIL G+ YLHA   +HRD+K ANILV       GRVK+AD G A+       PL+    +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
             + ++ APE++  +     A+DIW++GC   E+ T++P
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 84
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 143
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 201
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-XQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 97
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 156
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 214
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTK 354
           N    N  VDIWS+GC + E+ T +
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 98
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 157
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 215
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTK 354
           N    N  VDIWS+GC + E+ T +
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G +G VY+G   +     A+K  TL  D  + +E      +E A++  ++HPN+V+ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVK--TLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 93
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI--RSYTQQILSGLEYLHAKNTVH 280
            G  TL+   YI  EY+  G++   L++  +   +A+       QI S +EYL  KN +H
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD+   N LV  +  VK+ADFG+++ +TG +   +  G+ +   W APE +   N  ++ 
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-YNTFSIK 211
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            D+W+ G  + E+AT     S Y G+    ++ +         P+    +  + +R C +
Sbjct: 212 SDVWAFGVLLWEIATYGM--SPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWK 269
Query: 396 RNPLHRPTAA 405
            +P  RP+ A
Sbjct: 270 WSPADRPSFA 279

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 88
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 147
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 205
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLT 228

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 138/308 (44%), Gaps = 43/308 (13%)
Query: 144 PGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           PG+ E+     S      LLG G +  V    + ++G+  A+K +     + ++  S  +
Sbjct: 7   PGKFEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKII-----EKQAGHSRSR 56
Query: 204 LGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSY 262
           + +E+  L + + + NI+        D + Y+  E + GGSI   +Q      E      
Sbjct: 57  VFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRV 116
Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADF--GMAKHITGQSCPLSI- 316
            + + + L++LH K   HRD+K  NIL +   +   VK+ DF  G    +     P++  
Sbjct: 117 VRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 317 -----KGSPYWMAPEVIK----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
                 GS  +MAPEV++     +   +   D+WSLG  +  M +  PP+  + G     
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGW 236
Query: 366 ----MFKIGNSKELPAI-------PD----HLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
               + ++  +K   +I       PD    H+S E KD + K L R+   R +AA +L+H
Sbjct: 237 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 411 PFVGNAAP 418
           P+V   AP
Sbjct: 297 PWVQGQAP 304

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 85
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 144
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 202
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 52/306 (16%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S ++   LLG G +G V    +  +GE+ A+K++  F         A +  +EI +L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL----FALRTLREIKILKH 65
Query: 214 LRHPNIVRYYGSETLD-----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +H NI+  +  +  D     +++YI  E +    +++++     L +  I+ +  Q L 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKG 318
            ++ LH  N +HRD+K +N+L++ +  +K+ DFG+A+ I          TGQ   ++   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 319 SPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY-EGVPAMFKIGNS-- 372
           +  W  APEV+  S   + A+D+WS GC + E+   +P  P   Y   +  +F I  +  
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 373 -----------------KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                            K LP  P          ++ +G D +++ L  +P  R TA   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 408 LEHPFV 413
           LEHP++
Sbjct: 304 LEHPYL 309

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 83
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 142
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 200
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 98
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 157
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX--GXVATRWYRAPEIML 215
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTK 354
           N    N  VDIWS+GC + E+ T +
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 81
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 140
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 198
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-XQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G +G V    +  SGE  A+K++   S   +S+  A++  +E+ LL  ++H N++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 223 YGSETLDDKLYIYLEY-----VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
               T    L  + ++          + KI+    +  E  I+    Q+L GL+Y+H+  
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
            VHRD+K  N+ V+    +K+ DFG+A+H   +     +  + ++ APEVI +    N  
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILSWMHYNQT 204
Query: 338 VDIWSLGCTVIEMATTKPPWS------------QYEGVPA---MFKIGNS------KELP 376
           VDIWS+GC + EM T K  +             +  GVP    + K+ +       + LP
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 377 AIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             P           S +  D + K L+ +   R TAA  L HPF
Sbjct: 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 142/306 (46%), Gaps = 52/306 (16%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S ++   LLG G +G V    +  +GE+ A+K++  F         A +  +EI +L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL----FALRTLREIKILKH 65
Query: 214 LRHPNIVRYYGSETLD-----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +H NI+  +  +  D     +++YI  E +    +++++     L +  I+ +  Q L 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TG-QSCPLSIK 317
            ++ LH  N +HRD+K +N+L++ +  +K+ DFG+A+ I          TG QS  +   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY-EGVPAMFKIGNS-- 372
            + ++ APEV+  S   + A+D+WS GC + E+   +P  P   Y   +  +F I  +  
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 373 -----------------KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                            K LP  P          ++ +G D +++ L  +P  R TA   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 408 LEHPFV 413
           LEHP++
Sbjct: 304 LEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 52/306 (16%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S ++   LLG G +G V    +  +GE+ A+K++  F         A +  +EI +L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL----FALRTLREIKILKH 65
Query: 214 LRHPNIVRYYGSETLD-----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            +H NI+  +  +  D     +++YI  E +    +++++     L +  I+ +  Q L 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKG 318
            ++ LH  N +HRD+K +N+L++ +  +K+ DFG+A+ I          TGQ   ++   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 319 SPYWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY-EGVPAMFKIGNS-- 372
           +  W  APEV+  S   + A+D+WS GC + E+   +P  P   Y   +  +F I  +  
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 373 -----------------KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                            K LP  P          ++ +G D +++ L  +P  R TA   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 408 LEHPFV 413
           LEHP++
Sbjct: 304 LEHPYL 309

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 83
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 142
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 200
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SKPFQSIIHAKRTYRELRLLKHMK 91
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 150
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 208
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLT 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 86
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 145
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLN 203
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 83
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 142
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 200
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 20/262 (7%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G F  V       +G   A K   + +    S    Q+L +E  +   L+H NIVR 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAK---IINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRD 282
           + S + +   Y+  + V+GG +++ +       E+      QQIL  + + H    VHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 128
Query: 283 IKGANILVDPSGR---VKLADFGMAKHITG-QSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +K  N+L+    +   VKLADFG+A  + G Q       G+P +++PEV++        V
Sbjct: 129 LKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EAYGKPV 187
Query: 339 DIWSLGCTVIEMATTKPP-WSQ-----YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
           DIW+ G  +  +    PP W +     Y+ + A      + + P+   D ++ E K+ + 
Sbjct: 188 DIWACGVILYILLVGYPPFWDEDQHKLYQQIKA-----GAYDFPSPEWDTVTPEAKNLIN 242
Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           + L  NP  R TA   L+HP+V
Sbjct: 243 QMLTINPAKRITAHEALKHPWV 264

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 85
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 144
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIML 202
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 85
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 144
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIML 202
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GXVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 89
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 148
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 206
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 80
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 139
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 197
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 122/237 (51%), Gaps = 22/237 (9%)
Query: 132 YSTATSPSVPRSPGRVENPT-----------SPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
           Y  A S + P +    E PT               R++    +G G +G V   ++ +SG
Sbjct: 17  YKKAGSAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSG 76
Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV----RYYGSETLDDKLYIYL 236
              A+K++   S   +S   A++  +E+ LL  ++H N++     +  + +L++   +YL
Sbjct: 77  LKIAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYL 133
Query: 237 -EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR 295
             ++ G  +  I++   +L +  ++    QIL GL+Y+H+ + +HRD+K +N+ V+    
Sbjct: 134 VTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 192
Query: 296 VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
           +K+ DFG+A+H   +        + ++ APE++ N    N+ VDIWS+GC + E+ T
Sbjct: 193 LKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 74
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 133
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 191
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 75
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 134
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 83
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 142
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 200
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 77
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 136
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 194
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 75
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 134
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 84
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 143
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 201
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 80
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 139
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 197
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 85
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 144
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 202
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 101
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 160
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 218
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 115/223 (51%), Gaps = 20/223 (8%)
Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYL--EYVSGGSIY-KIL-QDYGQLGESAIR 260
           +EI +L R  +HPNI+     +  DD  Y+Y+  E   GG +  KIL Q +    E++  
Sbjct: 64  EEIEILLRYGQHPNIITL--KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV 121
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANIL-VDPSGR---VKLADFGMAKHITGQSCPLSI 316
            +T  I   +EYLHA+  VHRD+K +NIL VD SG    +++ DFG AK +  ++  L  
Sbjct: 122 LFT--ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 317 KG-SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-----EGVPAMFKIG 370
              +  ++APEV++   G + A DIWSLG  +    T   P++       E + A    G
Sbjct: 180 PCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSG 238
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                    + +SD  KD V K L  +P  R TAA +L HP++
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 97
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 156
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 214
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTK 354
           N    N  VDIWS+GC + E+ T +
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 84
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 143
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 201
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++   +AL  +   P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV---LALPGK--PP 402
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +L +K 
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K +I          G+P ++APE+I        
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGK 521
Query: 337 AVDIWSLGCTVIEMATTKPPWS 358
           +VD W+ G  + EM   + P+ 
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 77
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 136
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 137 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 194
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLT 216

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 98
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 157
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 215
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 81
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 140
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 198
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 91
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 150
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 208
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 91
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 150
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLN 208
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 89
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 148
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 206
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 15/279 (5%)
Query: 140 VPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
           VPR    +  P+    R++ G +LG G    V+L  +       A+K   L +D A+   
Sbjct: 15  VPRG-SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK--VLRADLARDPS 71
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLG 255
              +  +E    + L HP IV  Y +   ET    L YI +EYV G ++  I+   G + 
Sbjct: 72  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 131
Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC- 312
                         L + H    +HRD+K ANI++  +  VK+ DFG+A+ I  +G S  
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN 371
              ++ G+  +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++   
Sbjct: 192 QTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 250
Query: 372 SKELPAIPDH--LSDEGKDFVRKCLQRNPLHR-PTAAWL 407
              +P    H  LS +    V K L +NP +R  TAA +
Sbjct: 251 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 32/217 (14%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           L+GRG++G+VYL ++  + +  A+K+V    +D       +++ +EI +L+RL+   I+R
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITILNRLKSDYIIR 89
Query: 222 YYGSETLDD-----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            Y     DD     +LYI LE ++   + K+ +    L E  I++    +L G  ++H  
Sbjct: 90  LYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG------------------ 318
             +HRD+K AN L++    VK+ DFG+A+ I  +     +                    
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 319 -----SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
                + ++ APE+I        ++DIWS GC   E+
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 21/301 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQ 64
Query: 210 LLSRLRHPNIVRYYGS---ETLDDKL-YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   ET    L YI +EYV G ++  I+   G +           
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSC--PLSIKGSPY 321
               L + H    +HRD+K ANI++  +  VK+ DFG+A+ I  +G S     ++ G+  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +++PE  +  +  +   D++SLGC + E+ T +PP++        ++      +P    H
Sbjct: 185 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARH 243
Query: 382 --LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAM 439
             LS +    V K L +NP +R   A  +    V         + + EP E    LT A 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR--------VHNGEPPEAPKVLTDAE 295
Query: 440 R 440
           R
Sbjct: 296 R 296

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 112/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 79
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGL 138
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+ +H   +        + ++ APE++ N
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT--GYVATRWYRAPEIMLN 196
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 119/265 (44%), Gaps = 35/265 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA--KSKESAQQ-LGQEIALLSRLRHPNI 219
           LG G FG V+L   +E   +   ++  L +  A  ++ ESA+Q   +E  LL+ L+H +I
Sbjct: 49  LGEGAFGKVFL---AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------------LGESAIRSYTQ 264
           VR++G  T    L +  EY+  G + + L+ +G                LG   + +   
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           Q+ +G+ YL   + VHRD+   N LV     VK+ DFGM++ I        G    L I+
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELP 376
               WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +EL 
Sbjct: 226 ----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE 280
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHR 401
             P     E    +R C QR P  R
Sbjct: 281 R-PRACPPEVYAIMRGCWQREPQQR 304

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 113/202 (55%), Gaps = 11/202 (5%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMK 102
Query: 216 HPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL GL
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGL 161
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ N
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX--GYVATRWYRAPEIMLN 219
Query: 331 SNGCNLAVDIWSLGCTVIEMAT 352
               N  VDIWS+GC + E+ T
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLT 241

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 109
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 169 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 288 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 119/265 (44%), Gaps = 35/265 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA--KSKESAQQ-LGQEIALLSRLRHPNI 219
           LG G FG V+L   +E   +   ++  L +  A  ++ ESA+Q   +E  LL+ L+H +I
Sbjct: 26  LGEGAFGKVFL---AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------------LGESAIRSYTQ 264
           VR++G  T    L +  EY+  G + + L+ +G                LG   + +   
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           Q+ +G+ YL   + VHRD+   N LV     VK+ DFGM++ I        G    L I+
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELP 376
               WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +EL 
Sbjct: 203 ----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE 257
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHR 401
             P     E    +R C QR P  R
Sbjct: 258 R-PRACPPEVYAIMRGCWQREPQQR 281

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 132/275 (48%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI +EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 119/265 (44%), Gaps = 35/265 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA--KSKESAQQ-LGQEIALLSRLRHPNI 219
           LG G FG V+L   +E   +   ++  L +  A  ++ ESA+Q   +E  LL+ L+H +I
Sbjct: 20  LGEGAFGKVFL---AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------------LGESAIRSYTQ 264
           VR++G  T    L +  EY+  G + + L+ +G                LG   + +   
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
           Q+ +G+ YL   + VHRD+   N LV     VK+ DFGM++ I        G    L I+
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELP 376
               WM PE I        + D+WS G  + E+ T  K PW Q     A+  I   +EL 
Sbjct: 197 ----WMPPESILYRKFTTES-DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE 251
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHR 401
             P     E    +R C QR P  R
Sbjct: 252 R-PRACPPEVYAIMRGCWQREPQQR 275

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 132/275 (48%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI +EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 138/293 (47%), Gaps = 56/293 (19%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSRLR-HPN 218
           ++LG G+ G V     S  G   A+K + + F D A           EI LL+    HPN
Sbjct: 21  KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL---------MEIKLLTESDDHPN 70
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR--------SYTQQIL 267
           ++RYY SET D  LYI LE  +       LQD  +   + +  ++        S  +QI 
Sbjct: 71  VIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSG-------------RVKLADFGMAKHI-TGQSCP 313
           SG+ +LH+   +HRD+K  NILV  S              R+ ++DFG+ K + +GQS  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 314 LSIKGSPY----WMAPEVIKNSNGCNL------AVDIWSLGCTVIEMATT-KPPW-SQYE 361
            +   +P     W APE+++ SN          ++DI+S+GC    + +  K P+  +Y 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 362 GVPAMFK-IGNSKELPAIPDH-LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
               + + I +  E+  + D  L  E  D + + +  +PL RPTA  +L HP 
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 60
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 119
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 120 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREG 178
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 179 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 234
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 235 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMK----EVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +LG+G+FG V L     + E+ A+K    +V +  DD +     +++   +AL  +   P
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV---LALPGK--PP 81
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
            + + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +L +K 
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
            ++RD+K  N+++D  G +K+ADFGM K +I          G+P ++APE+I        
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGK 200
Query: 337 AVDIWSLGCTVIEMATTKPPWS 358
           +VD W+ G  + EM   + P+ 
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 10  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 65
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 66  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 124
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 125 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 183
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 243
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 244 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 57
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 117 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREG 175
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 176 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 231
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 232 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 266

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 7   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 59
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 119 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREG 177
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 178 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 233
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 234 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 268

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 144/318 (45%), Gaps = 44/318 (13%)
Query: 122 ISNTCPFSPSYSTATSPS---VPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSE 178
           ++N CP S   +   +     +PR   R+E              LG+G FG V++G  + 
Sbjct: 161 LTNVCPTSKPQTQGLAKDAWEIPRESLRLEVK------------LGQGCFGEVWMGTWNG 208
Query: 179 SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
           +  + A+K +           S +   QE  ++ +LRH  +V+ Y   + ++ +YI  EY
Sbjct: 209 TTRV-AIKTL------KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 260
Query: 239 VSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG 294
           +S GS+   L+  G++G+      +     QI SG+ Y+   N VHRD++ ANILV  + 
Sbjct: 261 MSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 318
Query: 295 RVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMA 351
             K+ADFG+ + I       + +G+ +   W APE         +  D+WS G  + E+ 
Sbjct: 319 VCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELT 376
Query: 352 TT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           T  + P+        + ++     +P  P+   +   D + +C +++P  RPT  +L   
Sbjct: 377 TKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCWRKDPEERPTFEYL--- 432
Query: 411 PFVGNAAPLERPILSAEP 428
                 A LE    S EP
Sbjct: 433 -----QAFLEDYFTSTEP 445

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 53
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 54  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 112
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 113 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREG 171
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 172 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 227
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 228 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 262

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 109
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 169 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 288 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 9   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 61
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 120
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 121 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREG 179
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 180 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 235
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 236 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 270

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIV 220
           +LG G    V    N  + +  A+K +       +S+     + +E+ +L + + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHRNVL 74
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
                   +D+ Y+  E + GGSI   +       E       Q + S L++LH K   H
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 281 RDIKGANILVDPSGR---VKLADFGMAKHI--TGQSCPLSI------KGSPYWMAPEVI- 328
           RD+K  NIL +   +   VK+ DFG+   I   G   P+S        GS  +MAPEV+ 
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 329 ---KNSNGCNLAVDIWSLGCTVIEMATTKPP----------WSQYEGVPA---MFKIGNS 372
              + ++  +   D+WSLG  +  + +  PP          W + E  PA   M      
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 373 KELPAIPD----HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           +     PD    H+S   KD + K L R+   R +AA +L+HP+V   AP
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 81
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 141 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 260 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 109
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 169 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 288 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 5   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 57
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 117 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREG 175
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 176 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 231
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 232 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 266

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 6   KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 61
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 62  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 120
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 121 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 179
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 239
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 240 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ D+G+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P+ P   +    P    K    LG G FG V++G+ +   ++ A+K +       +   S
Sbjct: 4   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMS 56
Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESA 258
                 E  L+ +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + 
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK 115
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG 318
           +     QI  G+ ++  +N +HRD++ ANILV  +   K+ADFG+A+ I       + +G
Sbjct: 116 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREG 174
Query: 319 SPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNS 372
           + +   W APE I N     +  D+WS G  + E+ T  + P   Y G+  P + +    
Sbjct: 175 AKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLER 230
Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 PD+  +E    +R C +  P  RPT  +L
Sbjct: 231 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 265

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK---ESAQQLGQEIALLSRLRHP 217
           R LG G FG V+L   +E   +   K+  L +  A       + +   +E  LL+ L+H 
Sbjct: 21  RELGEGAFGKVFL---AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKIL----------------QDYGQLGESAIRS 261
           +IV++YG     D L +  EY+  G + K L                Q  G+LG S +  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPL 314
              QI SG+ YL +++ VHRD+   N LV  +  VK+ DFGM++ +        G    L
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSK 373
            I+    WM PE I        + D+WS G  + E+ T  K PW Q      +  I   +
Sbjct: 198 PIR----WMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHR 401
            L   P     E  D +  C QR P  R
Sbjct: 253 VLER-PRVCPKEVYDVMLGCWQREPQQR 279

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 62
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +   T      S  G+  +M PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 241 EFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 14/267 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +++ R+LG+G FG V       +G+M A K++       +  E+      E  +L ++  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVNS 243
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS--YTQQILSGLEYLH 274
             +V    +    D L + L  ++GG +   +   GQ G    R+  Y  +I  GLE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNG 333
            +  V+RD+K  NIL+D  G ++++D G+A H+  GQ+    + G+  +MAPEV+KN   
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERY 362
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-SKELP-AIPDHLSDEGKDFVR 391
              + D W+LGC + EM   + P+ Q +      ++    KE+P    +  S + +    
Sbjct: 363 -TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 392 KCLQRNPLHR-----PTAAWLLEHPFV 413
           + L ++P  R      +A  + EHP  
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVCEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ KK R LG G FG V L      N  +GEM A+K +     +    +    
Sbjct: 2   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----EGCGPQLRSG 57
Query: 204 LGQEIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
             +EI +L  L H +IV+Y G   +  +  + + +EYV  GS+   L  +  +G + +  
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLL 116
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---G 318
           + QQI  G+ YLHA++ +HR +   N+L+D    VK+ DFG+AK +        ++    
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 176
Query: 319 SP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
           SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 177 SPVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 149 NPTSPGSRW-KKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQ 203
           +PT    R+ KK R LG G FG V L      N  +GEM A+K   L         S  Q
Sbjct: 1   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKEGCGPQLRSGWQ 58
Query: 204 LGQEIALLSRLRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
             +EI +L  L H +IV+Y G   +  +  + + +EYV  GS+   L  +  +G + +  
Sbjct: 59  --REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLL 115
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---G 318
           + QQI  G+ YLHA++ +HR +   N+L+D    VK+ DFG+AK +        ++    
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 175
Query: 319 SP-YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
           SP +W APE +K       A D+WS G T+ E+ T
Sbjct: 176 SPVFWYAPECLKECKF-YYASDVWSFGVTLYELLT 209

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 18/259 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL-GQEIALLSRLRHPNIVR 221
           LGRG FG V+    + S +       T  +   K K + Q L  +EI++L+  RH NI+ 
Sbjct: 13  LGRGEFGIVHRCVETSSKK-------TYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 222 YYGSETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            + S    ++L +  E++SG  I+ +I     +L E  I SY  Q+   L++LH+ N  H
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 281 RDIKGANILVDP--SGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
            DI+  NI+     S  +K+ +FG A+ +  G +  L +  +P + APEV    +  + A
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEV-HQHDVVSTA 183
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK---ELPAIPDHLSDEGKDFVRKCL 394
            D+WSLG  V  + +   P+        +  I N++   +  A  + +S E  DFV + L
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAMDFVDRLL 242
Query: 395 QRNPLHRPTAAWLLEHPFV 413
            +    R TA+  L+HP++
Sbjct: 243 VKERKSRMTASEALQHPWL 261

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 130/264 (49%), Gaps = 14/264 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     + ++ AMK +  +    +++ +  +  +++ +    +    +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y   +  D+ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H  + V
Sbjct: 140 HYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 280 HRDIKGANILVDPSGRVKLADFGMA-KHITGQSCPLSIK-GSPYWMAPEVIKNSNGCNL- 336
           HRDIK  NIL+D +G ++LADFG   K +   +   S+  G+P +++PE+++   G    
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 337 ---AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD---EGKDFV 390
                D WSLG  + EM   + P+     V    KI N KE    P  ++D     KD +
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 391 RK--CLQRNPLHRPTAAWLLEHPF 412
           R+  C + + L +       +HPF
Sbjct: 318 RRLICSREHRLGQNGIEDFKKHPF 341

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 248 KERPEDRPTFDYL 260

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 14/267 (5%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +++ R+LG+G FG V       +G+M A K++       +  E+      E  +L ++  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVNS 243
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRS--YTQQILSGLEYLH 274
             +V    +    D L + L  ++GG +   +   GQ G    R+  Y  +I  GLE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNG 333
            +  V+RD+K  NIL+D  G ++++D G+A H+  GQ+    + G+  +MAPEV+KN   
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERY 362
Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-SKELP-AIPDHLSDEGKDFVR 391
              + D W+LGC + EM   + P+ Q +      ++    KE+P    +  S + +    
Sbjct: 363 -TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 392 KCLQRNPLHR-----PTAAWLLEHPFV 413
           + L ++P  R      +A  + EHP  
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 67
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 68  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 182
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 241
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 242 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 268

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DF +A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 69
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 70  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 184
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 243
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 244 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 74
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 75  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 133
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI-NYGTFTIK 191
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 192 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 248
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 249 KERPEDRPTFDYL 261

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 16/266 (6%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG F  V +    ++G++ AMK +  +  D   +       +E  +L       I 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTV 279
           + + +   ++ LY+ +EY  GG +  +L  +G+ +     R Y  +I+  ++ +H    V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 280 HRDIKGANILVDPSGRVKLADFG--MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
           HRDIK  NIL+D  G ++LADFG  +     G    L   G+P +++PE+++   G    
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 338 ------VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE---LPAIPDHLSDEGKD 388
                  D W+LG    EM   + P+          KI + KE   LP + + + +E +D
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 389 FVRK--CLQRNPLHRPTAAWLLEHPF 412
           F+++  C     L R  A     HPF
Sbjct: 305 FIQRLLCPPETRLGRGGAGDFRTHPF 330

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 248 KERPEDRPTFDYL 260

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI +EY+S G +   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVMEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 248 KERPEDRPTFDYL 260

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  AM        +  S    ++  QE   + +  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYM-SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 70  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI-NFR 187
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 242
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 243 SLMTKCWAYDPSRRP 257

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 137/285 (48%), Gaps = 31/285 (10%)
Query: 142 RSPGRVENPTSPGSRWKKG--RL--LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS 197
           +SPG   +P+ P S +++   RL  LG G++G V+   + E G + A+K     S     
Sbjct: 42  QSPGY--DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS--MSPFRGP 97
Query: 198 KESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGE 256
           K+ A++L +  +     +HP  VR   +      LY+  E + G S+ +  + +G  L E
Sbjct: 98  KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPE 156
Query: 257 SAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI 316
           + +  Y +  L  L +LH++  VH D+K ANI + P GR KL DFG+   +         
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK------PPWSQYEG--VPAMFK 368
           +G P +MAPE+++ S G   A D++SLG T++E+A           W Q     +P  F 
Sbjct: 217 EGDPRYMAPELLQGSYGT--AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT 274
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            G S EL ++           +   L+ +P  R TA  LL  P +
Sbjct: 275 AGLSSELRSV-----------LVMMLEPDPKLRATAEALLALPVL 308

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 60/290 (20%)
Query: 179 SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
           +GE   ++ + L   +A S E    L  E+ +     HPNIV Y  +   D++L++   +
Sbjct: 35  TGEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 91
Query: 239 VSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV 296
           ++ GS   ++  +    + E AI    Q +L  L+Y+H    VHR +K ++IL+   G+V
Sbjct: 92  MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 151
Query: 297 KL----ADFGMAKHITGQSC-----PLSIKGSPYWMAPEVI-KNSNGCNLAVDIWSLGCT 346
            L    ++  M  H   Q         S+K  P W++PEV+ +N  G +   DI+S+G T
Sbjct: 152 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGIT 210
Query: 347 VIEMATTKPPWSQYEGVPAMFKIGN-------------SKEL------------------ 375
             E+A    P+        + +  N             ++EL                  
Sbjct: 211 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 270
Query: 376 -----------PAIPDH--LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                      P+ P H   S     FV +CLQRNP  RP+A+ LL H F
Sbjct: 271 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 320

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  AM        +  S    ++  QE   + +  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYM-SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 70  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 242
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 243 SLMTKCWAYDPSRRP 257

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 69  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 127
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI-NYGTFTIK 185
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 186 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 242
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 243 KERPEDRPTFDYL 255

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ ++RH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKIRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 124/290 (42%), Gaps = 60/290 (20%)
Query: 179 SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
           +GE   ++ + L   +A S E    L  E+ +     HPNIV Y  +   D++L++   +
Sbjct: 51  TGEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107
Query: 239 VSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV 296
           ++ GS   ++  +    + E AI    Q +L  L+Y+H    VHR +K ++IL+   G+V
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
Query: 297 KL----ADFGMAKHITGQSC-----PLSIKGSPYWMAPEVI-KNSNGCNLAVDIWSLGCT 346
            L    ++  M  H   Q         S+K  P W++PEV+ +N  G +   DI+S+G T
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGIT 226
Query: 347 VIEMATTKPPWSQYEGVPAMFKIGN-------------SKEL------------------ 375
             E+A    P+        + +  N             ++EL                  
Sbjct: 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 286
Query: 376 -----------PAIPDH--LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                      P+ P H   S     FV +CLQRNP  RP+A+ LL H F
Sbjct: 287 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG+G FG V++G  + +  +    +K  T+         S +   QE  ++ +LRH  +V
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLV 325
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAK 276
           + Y   + ++ +YI  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   
Sbjct: 326 QLYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIKN 330
           N VHRD++ ANILV  +   K+ADFG+A+ I        Q     IK    W APE    
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALY 438
Query: 331 SNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
                +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D 
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDL 496
Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEP 428
           + +C ++ P  RPT  +L         A LE    S EP
Sbjct: 497 MCQCWRKEPEERPTFEYL--------QAFLEDYFTSTEP 527

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 34/280 (12%)
Query: 159 KGRL------LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           KGR+      +G G    V+   N E  ++ A+K V L   D ++ +S +    EIA L+
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 81
Query: 213 RLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +L+     I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMAPEV 327
             +H    VH D+K AN L+   G +KL DFG+A  +      +   S  G+  +M PE 
Sbjct: 141 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEA 199
Query: 328 IKN-----SNG-----CNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSK 373
           IK+      NG      +   D+WSLGC +  M   K P+    +Q   + A+    +  
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E P IP+    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 260 EFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 77
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 78  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 194 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 248
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 249 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 79
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 80  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 196 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 250
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 251 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 117
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 118 VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 234 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 288
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 289 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 133/293 (45%), Gaps = 56/293 (19%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSRLR-HPN 218
           ++LG G+ G V     S  G   A+K + + F D A           EI LL+    HPN
Sbjct: 21  KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL---------MEIKLLTESDDHPN 70
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR--------SYTQQIL 267
           ++RYY SET D  LYI LE  +       LQD  +   + +  ++        S  +QI 
Sbjct: 71  VIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSG-------------RVKLADFGMAKHITGQSCPL 314
           SG+ +LH+   +HRD+K  NILV  S              R+ ++DFG+ K +       
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 315 SIK-----GSPYWMAPEVIKNSNGCNL------AVDIWSLGCTVIEMATT-KPPW-SQYE 361
                   G+  W APE+++ SN          ++DI+S+GC    + +  K P+  +Y 
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 362 GVPAMFK-IGNSKELPAIPDH-LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
               + + I +  E+  + D  L  E  D + + +  +PL RPTA  +L HP 
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 78
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 79  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 195 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 249
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 250 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD+  ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 127/261 (48%), Gaps = 21/261 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G FG V+      +G +   K + T +  D  +      +  EI+++++L HP ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT------VKNEISIMNQLHHPKLIN 112
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKIL--QDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
            + +     ++ + LE++SGG ++  +  +DY ++ E+ + +Y +Q   GL+++H  + V
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 280 HRDIKGANILVD--PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
           H DIK  NI+ +   +  VK+ DFG+A  +           +  + APE++ +       
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFY 230
Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH-----LSDEGKDFVRK 392
            D+W++G     + +   P++   G   +  + N K      D      +S E KDF++ 
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 393 CLQRNPLHRPTAAWLLEHPFV 413
            LQ+ P  R T    LEHP++
Sbjct: 288 LLQKEPRKRLTVHDALEHPWL 308

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 71
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 72  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 188 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 242
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 243 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S +++  +LG+G FG V    N+      A+K++        ++E    +  E+ LL+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLAS 58
Query: 214 LRHPNIVRYYGS-----------ETLDDK--LYIYLEYVSGGSIYKIL--QDYGQLGESA 258
           L H  +VRYY +             +  K  L+I  EY    ++Y ++  ++  Q  +  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY 118
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---------TG 309
            R + +QIL  L Y+H++  +HR++K  NI +D S  VK+ DFG+AK++           
Sbjct: 119 WRLF-RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 310 QSCP------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
           Q+ P       S  G+  ++A EV+  +   N  +D +SLG    E     P  +  E V
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE--XIYPFSTGXERV 235
Query: 364 PAMFKIGN-SKEL-PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
             + K+ + S E  P   D+     K  +R  +  +P  RP A  LL
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 87
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 88  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 204 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 258
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 259 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 113/235 (48%), Gaps = 36/235 (15%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           ++N   P + ++   L+GRG++G+VYL ++  + +  A+K+V    +D       +++ +
Sbjct: 21  IKNVKVPDN-YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLID---CKRILR 76
Query: 207 EIALLSRLRHPNIVRYYG----SETLD-DKLYIYLEYVSGGSIYKILQDYGQLGESAIRS 261
           EI +L+RL+   I+R +      + L  D+LYI LE ++   + K+ +    L E  +++
Sbjct: 77  EITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKT 135
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--------HITGQSCP 313
               +L G +++H    +HRD+K AN L++    VK+ DFG+A+        HI      
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 314 LSIKGSP------------------YWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
                 P                  ++ APE+I        ++DIWS GC   E+
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 72
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 73  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 189 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 243
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 244 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSRLR-HPN 218
           ++LG G+ G V     S  G   A+K + + F D A           EI LL+    HPN
Sbjct: 39  KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL---------MEIKLLTESDDHPN 88
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR--------SYTQQIL 267
           ++RYY SET D  LYI LE  +       LQD  +   + +  ++        S  +QI 
Sbjct: 89  VIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSG-------------RVKLADFGMAKHITGQSCPL 314
           SG+ +LH+   +HRD+K  NILV  S              R+ ++DFG+ K +       
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 315 SIK-----GSPYWMAPEVIKNSNGCNL--AVDIWSLGCTVIEMATT-KPPW-SQYEGVPA 365
                   G+  W APE+++ S    L  ++DI+S+GC    + +  K P+  +Y     
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 366 MFK-IGNSKELPAIPDH-LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           + + I +  E+  + D  L  E  D + + +  +PL RPTA  +L HP 
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSRLR-HPN 218
           ++LG G+ G V     S  G   A+K + + F D A           EI LL+    HPN
Sbjct: 39  KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL---------MEIKLLTESDDHPN 88
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR--------SYTQQIL 267
           ++RYY SET D  LYI LE  +       LQD  +   + +  ++        S  +QI 
Sbjct: 89  VIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSG-------------RVKLADFGMAKHITGQSCPL 314
           SG+ +LH+   +HRD+K  NILV  S              R+ ++DFG+ K +       
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 315 SIK-----GSPYWMAPEVIKNSNGCNL--AVDIWSLGCTVIEMATT-KPPW-SQYEGVPA 365
                   G+  W APE+++ S    L  ++DI+S+GC    + +  K P+  +Y     
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 366 MFK-IGNSKELPAIPDH-LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           + + I +  E+  + D  L  E  D + + +  +PL RPTA  +L HP 
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 45/284 (15%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 123
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 124 VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 240 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 294
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
            P+   +S+E K  +R  L+  P  R T    + HP++  +  +
Sbjct: 295 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 337

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 45/284 (15%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 73
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 74  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 190 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 244
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
            P+   +S+E K  +R  L+  P  R T    + HP++  +  +
Sbjct: 245 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 287

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+  FG+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 45/284 (15%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 73
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 74  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 190 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 244
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
            P+   +S+E K  +R  L+  P  R T    + HP++  +  +
Sbjct: 245 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 287

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 121/257 (47%), Gaps = 51/257 (19%)
Query: 132 YSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLF 191
           +S+  + S+PR     + P     R++   L+G G++GHV   ++     + A+K++   
Sbjct: 34  HSSKPTASMPRPHSDWQIP----DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV 89
Query: 192 SDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----------DKLYIYLEYVSG 241
            +D       +++ +EIA+L+RL H ++V+      LD          D+LY+ LE ++ 
Sbjct: 90  FEDLID---CKRILREIAILNRLNHDHVVK-----VLDIVIPKDVEKFDELYVVLE-IAD 140
Query: 242 GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF 301
               K+ +    L E  I++    +L G++Y+H+   +HRD+K AN LV+    VK+ DF
Sbjct: 141 SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 302 GMAKHIT-----GQSCPLSIKG-----------------------SPYWMAPEVIKNSNG 333
           G+A+ +          P+S +                        + ++ APE+I     
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 334 CNLAVDIWSLGCTVIEM 350
              A+D+WS+GC   E+
Sbjct: 261 YTEAIDVWSIGCIFAEL 277

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  AM        +  S    ++  QE   + +  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYM-SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 70  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 242
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 243 SLMTKCWAYDPSRRP 257

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 45/278 (16%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 71
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 72  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +       +PY++APE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPA 377
           V+   K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P 
Sbjct: 188 VLGPEKYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN 242
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            P+   +S+E K  +R  L+  P  R T    + HP++
Sbjct: 243 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 78
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S G +   L+  G++G+      +     QI SG+ Y+   N 
Sbjct: 79  YAVVS-EEPIYIVTEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 193
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 252
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           +++P  RPT  +L         A LE    S EP 
Sbjct: 253 RKDPEERPTFEYL--------QAFLEDYFTSTEPQ 279

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ D G+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 114/251 (45%), Gaps = 15/251 (5%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V LG   +     A+K +       +   S  +  QE   + +L HP +V++
Sbjct: 16  LGSGQFGVVKLG-KWKGQYDVAVKMI------KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHR 281
           YG  + +  +YI  EY+S G +   L+ +G+ L  S +      +  G+ +L +   +HR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLAV 338
           D+   N LVD    VK++DFGM +++       S+ G+ +   W APEV       + + 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKWSAPEVFHYFKYSSKS- 186
Query: 339 DIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           D+W+ G  + E+ +  K P+  Y     + K+     L   P   SD     +  C    
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQIMYSCWHEL 245
Query: 398 PLHRPTAAWLL 408
           P  RPT   LL
Sbjct: 246 PEKRPTFQQLL 256

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIV 220
           +LG G    V    N  + +  A+K +       +S+     + +E+ +L + + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHRNVL 74
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
                   +D+ Y+  E + GGSI   +       E       Q + S L++LH K   H
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 281 RDIKGANILVDPSGR---VKLADFGMAKHI--TGQSCPLSI------KGSPYWMAPEVI- 328
           RD+K  NIL +   +   VK+ DF +   I   G   P+S        GS  +MAPEV+ 
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 329 ---KNSNGCNLAVDIWSLGCTVIEMATTKPP----------WSQYEGVPA---MFKIGNS 372
              + ++  +   D+WSLG  +  + +  PP          W + E  PA   M      
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 373 KELPAIPD----HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           +     PD    H+S   KD + K L R+   R +AA +L+HP+V   AP
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ D G+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 71
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   N 
Sbjct: 72  YAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 186
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 245
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           ++ P  RPT  +L         A LE    S EP 
Sbjct: 246 RKEPEERPTFEYL--------QAFLEDYFTSTEPQ 272

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 29/274 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   N 
Sbjct: 245 YAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 359
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 418
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEP 428
           ++ P  RPT  +L         A LE    S EP
Sbjct: 419 RKEPEERPTFEYL--------QAFLEDYFTSTEP 444

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G FG V LG     G   A+K +       K+  +AQ    E +++++LRH N+V+ 
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNT 278
            G   +++K  LYI  EY++ GS+   L+  G+  LG   +  ++  +   +EYL   N 
Sbjct: 252 LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE ++       
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 366
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           + D+WS G  + E+ +  + P+ +      + ++    ++ A PD       D ++ C  
Sbjct: 367 S-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWH 424
Query: 396 RNPLHRPTAAWL---LEH 410
            +   RPT   L   LEH
Sbjct: 425 LDAATRPTFLQLREQLEH 442

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 29/274 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   N 
Sbjct: 245 YAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 359
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 418
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEP 428
           ++ P  RPT  +L         A LE    S EP
Sbjct: 419 RKEPEERPTFEYL--------QAFLEDYFTSTEP 444

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  +
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHM 78
Query: 215 RHPNIV----RYYGSETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           +H N++     +  + +L++   +YL  ++ G  +  I++   +L +  ++    QIL G
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRG 137
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ D G+A+H   +        + ++ APE++ 
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT--GYVATRWYRAPEIML 195
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT 352
           N    N  VDIWS+GC + E+ T
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/330 (23%), Positives = 146/330 (44%), Gaps = 77/330 (23%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++  + LG+G +G V+   +  +GE+ A+K++    D  ++   AQ+  +EI +L+ L 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF---DAFQNSTDAQRTFREIMILTELS 66
Query: 216 -HPNIVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDYGQLGESAIRSYT-QQILSGLE 271
            H NIV        D+   +Y+  +Y+    ++ +++    + E   + Y   Q++  ++
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR--ANILEPVHKQYVVYQLIKVIK 123
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-----QSCPLSIK--------- 317
           YLH+   +HRD+K +NIL++    VK+ADFG+++          + PLSI          
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 318 --------GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW------SQYEGV 363
                    + ++ APE++  S      +D+WSLGC + E+   KP +      +Q E +
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 364 PAMFKIGNSKELPAIPD---------------------------------------HLSD 384
             +    +++++ +I                                           ++
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVG 414
           E  D + K LQ NP  R +A   L+HPFV 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVS 333

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKV-AVKSL------KQGSMSPDAFLAEANLMKQLQHQRLVRL 69
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 70  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 128
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           R+++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI-NYGTFTIK 186
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 187 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 243
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 244 KERPEDRPTFDYL 256

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           PT     W+    LG G FG+V    + ++GE  A+K+         S ++ ++   EI 
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQ 64
Query: 210 LLSRLRHPNIVRYY----GSETL--DDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR 260
           ++ +L HPN+V       G + L  +D   + +EY  GG + K L  +     L E  IR
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV---KLADFGMAKHITGQSCPLSIK 317
           +    I S L YLH    +HRD+K  NI++ P  +    K+ D G AK +          
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           G+  ++APE+++      + VD WS G    E  T   P+
Sbjct: 185 GTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           PT     W+    LG G FG+V    + ++GE  A+K+         S ++ ++   EI 
Sbjct: 10  PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQ 65
Query: 210 LLSRLRHPNIVRYY----GSETL--DDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIR 260
           ++ +L HPN+V       G + L  +D   + +EY  GG + K L  +     L E  IR
Sbjct: 66  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 125
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV---KLADFGMAKHITGQSCPLSIK 317
           +    I S L YLH    +HRD+K  NI++ P  +    K+ D G AK +          
Sbjct: 126 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 185
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           G+  ++APE+++      + VD WS G    E  T   P+
Sbjct: 186 GTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLRHEKLVQL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY++ GS+   L+  G+ G+      +   + QI SG+ Y+   N 
Sbjct: 76  YAVVS-EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPEAALYGR-FT 190
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 249
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           ++ P  RPT  +L         A LE    S EP 
Sbjct: 250 RKEPEERPTFEYL--------QAFLEDYFTSTEPQ 276

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 98  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 215
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 216 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 270
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 271 SLMTKCWAYDPSRRP 285

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 21/194 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G FG V LG     G   A+K +       K+  +AQ    E +++++LRH N+V+ 
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNT 278
            G   +++K  LYI  EY++ GS+   L+  G+  LG   +  ++  +   +EYL   N 
Sbjct: 71  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 129
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE ++ +   + 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREA-AFST 184
Query: 337 AVDIWSLGCTVIEM 350
             D+WS G  + E+
Sbjct: 185 KSDVWSFGILLWEI 198

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLRHEKLVQL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY++ GS+   L+  G+ G+      +   + QI SG+ Y+   N 
Sbjct: 76  YAVVS-EEPIYIVTEYMNKGSLLDFLK--GETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 190
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 249
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           ++ P  RPT  +L         A LE    S EP 
Sbjct: 250 RKEPEERPTFEYL--------QAFLEDYFTSTEPQ 276

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 75  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 192
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 247
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 248 SLMTKCWAYDPSRRP 262

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 163 LGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V L         +G + A+K++     D +     +   +EI +L  L    
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 69
Query: 219 IVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           IV+Y G      +  L + +EY+  G +   LQ +  +L  S +  Y+ QI  G+EYL +
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           +  VHRD+   NILV+    VK+ADFG+AK +        ++    SP +W APE + + 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD- 188
Query: 332 NGCNLAVDIWSLGCTVIEMAT 352
           N  +   D+WS G  + E+ T
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  AM        +  S    ++  QE   + +  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYM-SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 509 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 567
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 622
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 623 SLMTKCWAYDPSRRP 637

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 70  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 242
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 243 SLMTKCWAYDPSRRP 257

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 72  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 189
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 190 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 244
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 245 SLMTKCWAYDPSRRP 259

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G FG V LG     G   A+K +       K+  +AQ    E +++++LRH N+V+ 
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNT 278
            G   +++K  LYI  EY++ GS+   L+  G+  LG   +  ++  +   +EYL   N 
Sbjct: 65  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 123
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE ++       
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 179
Query: 337 AVDIWSLGCTVIEM 350
           + D+WS G  + E+
Sbjct: 180 S-DVWSFGILLWEI 192

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 239
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 240 SLMTKCWAYDPSRRP 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  A+        +  S    ++  QE   + +  
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYM-SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 73  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 190
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 191 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 245
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 246 SLMTKCWAYDPSRRP 260

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 26/231 (11%)
Query: 163 LGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V L         +G + A+K++     D +     +   +EI +L  L    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 72
Query: 219 IVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           IV+Y G      +  L + +EY+  G +   LQ +  +L  S +  Y+ QI  G+EYL +
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           +  VHRD+   NILV+    VK+ADFG+AK +        ++    SP +W APE + + 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD- 191
Query: 332 NGCNLAVDIWSLGCTVIEMAT----TKPPWSQYEGVPAMFKIGNSKELPAI 378
           N  +   D+WS G  + E+ T    +  P +++     +  +G+ +++PA+
Sbjct: 192 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGSERDVPAL 237

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 29/274 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL------KPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ +YI  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   N 
Sbjct: 245 YAVVS-EEPIYIVGEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FT 359
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P+   +   D + +C 
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHDLMCQCW 418
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEP 428
           ++ P  RPT  +L         A LE    S EP
Sbjct: 419 RKEPEERPTFEYL--------QAFLEDYFTSTEP 444

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 16/255 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R + GR +G G FG V+ G    S E  AM        +  S    ++  QE   + +  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYM-SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLH 274
           HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL 
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PYWMAPEVIKNSN 332
           +K  VHRDI   N+LV  +  VKL DFG+++++   +   + KG     WMAPE I N  
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 567
Query: 333 GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGK 387
               A D+W  G  + E  M   KP    ++GV     + +I N + LP +P +      
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLP-MPPNCPPTLY 622
Query: 388 DFVRKCLQRNPLHRP 402
             + KC   +P  RP
Sbjct: 623 SLMTKCWAYDPSRRP 637

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G FG V LG     G   A+K +       K+  +AQ    E +++++LRH N+V+ 
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 223 YGSETLDDK--LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNT 278
            G   +++K  LYI  EY++ GS+   L+  G+  LG   +  ++  +   +EYL   N 
Sbjct: 80  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE ++       
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 194
Query: 337 AVDIWSLGCTVIEM 350
           + D+WS G  + E+
Sbjct: 195 S-DVWSFGILLWEI 207

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 163 LGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V L         +G + A+K++     D +     +   +EI +L  L    
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 73
Query: 219 IVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           IV+Y G      +  L + +EY+  G +   LQ +  +L  S +  Y+ QI  G+EYL +
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           +  VHRD+   NILV+    VK+ADFG+AK +        ++    SP +W APE + + 
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD- 192
Query: 332 NGCNLAVDIWSLGCTVIEMAT 352
           N  +   D+WS G  + E+ T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 163 LGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           LG+G FG V L         +G + A+K++     D +     +   +EI +L  L    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 85
Query: 219 IVRYYGSETLDDK--LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           IV+Y G      +  L + +EY+  G +   LQ +  +L  S +  Y+ QI  G+EYL +
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP-YWMAPEVIKNS 331
           +  VHRD+   NILV+    VK+ADFG+AK +        ++    SP +W APE + + 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD- 204
Query: 332 NGCNLAVDIWSLGCTVIEMAT 352
           N  +   D+WS G  + E+ T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 16/219 (7%)
Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           E P S G     G  +G G FG VY G+ + +    A+K++    D   ++E  QQ  QE
Sbjct: 29  ERPISVG-----GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQE 80
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQ 264
           I ++++ +H N+V   G  +  D L +   Y+  GS+   L        L         Q
Sbjct: 81  IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLS-IKGSPY 321
              +G+ +LH  + +HRDIK ANIL+D +   K++DFG+A+      Q+   S I G+  
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTA 200
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           +MAPE ++         DI+S G  ++E+ T  P   ++
Sbjct: 201 YMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 120/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V++G+ +   ++ A+K +       +   S      E  L+ +L+H  +VR 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKV-AVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVH 280
           Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+ ++  +N +H
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNLA 337
           RD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE I N     + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 338 VDIWSLGCTVIEMATT-KPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            D+WS G  + E+ T  + P   Y G+  P + +          PD+  +E    +R C 
Sbjct: 191 SDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 395 QRNPLHRPTAAWL 407
           +  P  RPT  +L
Sbjct: 248 KERPEDRPTFDYL 260

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 124/237 (52%), Gaps = 20/237 (8%)
Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYL--EYVSGGSIY-KIL-QDYGQLGESAIR 260
           +EI +L R  +HPNI+     +  DD  ++YL  E + GG +  KIL Q +    E++  
Sbjct: 69  EEIEILLRYGQHPNIITL--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV 126
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANIL-VDPSGR---VKLADFGMAKHITGQSCPLSI 316
            +T  I   +EYLH++  VHRD+K +NIL VD SG    +++ DFG AK +  ++  L  
Sbjct: 127 LHT--IGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 317 KG-SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-EGVPA--MFKIGNS 372
              +  ++APEV+K   G +   DIWSLG  +  M     P++      P   + +IG+ 
Sbjct: 185 PCYTANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSG 243
Query: 373 KELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAE 427
           K   +    + +S+  KD V K L  +P  R TA  +L+HP+V     L +  LS +
Sbjct: 244 KFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQ 300

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           E P S G     G  +G G FG VY G+ + +    A+K++    D   ++E  QQ  QE
Sbjct: 23  ERPISVG-----GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQE 74
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQ 264
           I ++++ +H N+V   G  +  D L +   Y+  GS+   L        L         Q
Sbjct: 75  IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 134
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HITGQSCPLSIKGSPY 321
              +G+ +LH  + +HRDIK ANIL+D +   K++DFG+A+             I G+  
Sbjct: 135 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTA 194
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           +MAPE ++         DI+S G  ++E+ T  P   ++
Sbjct: 195 YMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEH 231

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S+++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A +   EI +L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLL 74
Query: 215 RHPNIV--------------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
           +H N+V              R  GS  L   ++ + E+   G +  +L  +     S I+
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVKFTL---SEIK 128
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKG 318
              Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+   +   S P     
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 319 ---SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
              + ++  PE++         +D+W  GC + EM T  P
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           E P S G     G  +G G FG VY G+ + +    A+K++    D   ++E  QQ  QE
Sbjct: 29  ERPISVG-----GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQE 80
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQ 264
           I ++++ +H N+V   G  +  D L +   Y+  GS+   L        L         Q
Sbjct: 81  IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HITGQSCPLSIKGSPY 321
              +G+ +LH  + +HRDIK ANIL+D +   K++DFG+A+             I G+  
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTA 200
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           +MAPE ++         DI+S G  ++E+ T  P   ++
Sbjct: 201 YMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 124/237 (52%), Gaps = 20/237 (8%)
Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYL--EYVSGGSIY-KIL-QDYGQLGESAIR 260
           +EI +L R  +HPNI+     +  DD  ++YL  E + GG +  KIL Q +    E++  
Sbjct: 69  EEIEILLRYGQHPNIITL--KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV 126
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANIL-VDPSGR---VKLADFGMAKHITGQSCPLSI 316
            +T  I   +EYLH++  VHRD+K +NIL VD SG    +++ DFG AK +  ++  L  
Sbjct: 127 LHT--IGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 317 KG-SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-EGVPA--MFKIGNS 372
              +  ++APEV+K   G +   DIWSLG  +  M     P++      P   + +IG+ 
Sbjct: 185 PCYTANFVAPEVLKR-QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSG 243
Query: 373 KELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAE 427
           K   +    + +S+  KD V K L  +P  R TA  +L+HP+V     L +  LS +
Sbjct: 244 KFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQ 300

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S+++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A +   EI +L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLL 73
Query: 215 RHPNIV--------------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
           +H N+V              R  GS  L   ++ + E+   G +  +L  +     S I+
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVKFTL---SEIK 127
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKG 318
              Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+   +   S P     
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 319 ---SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
              + ++  PE++         +D+W  GC + EM T  P
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K+ ++LG G FG VY G     GE   +       ++    ++  +   E  +++ + HP
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           ++VR  G   L   + +  + +  G + + + ++   +G   + ++  QI  G+ YL  +
Sbjct: 101 HLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNG 333
             VHRD+   N+LV     VK+ DFG+A+ + G     +  G      WMA E I     
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 334 CNLAVDIWSLGCTVIEMATT--KPPWSQYEGVPA 365
            + + D+WS G T+ E+ T   KP    Y+G+P 
Sbjct: 220 THQS-DVWSYGVTIWELMTFGGKP----YDGIPT 248

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ-QLGQEIALLSRL 214
           ++  G LLG G++G V    +SE+  +C      L     +   + +  + +EI LL RL
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSET--LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 215 RHPNIVRY----YGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILS 268
           RH N+++     Y  E    K+Y+ +EY   G + ++L      +        Y  Q++ 
Sbjct: 64  RHKNVIQLVDVLYNEEK--QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----TGQSCPLSIKGSPYWMA 324
           GLEYLH++  VH+DIK  N+L+   G +K++  G+A+ +       +C  S +GSP +  
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQP 179
Query: 325 PEVIKNSNGCN----LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-IGNSKELPAIP 379
           PE+   +NG +      VDIWS G T+  + T   P+ + + +  +F+ IG      AIP
Sbjct: 180 PEI---ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSY--AIP 233
Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGNAAPLERPI 423
                   D ++  L+  P  R +   + +H  F     P E P+
Sbjct: 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 128/274 (46%), Gaps = 25/274 (9%)
Query: 139 SVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCA--MKEVTLFSDDAK 196
           S P+ P   +    P    K  + LG G FG V++   ++  ++    MK  ++      
Sbjct: 166 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------ 219
Query: 197 SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYG-QL 254
              S +    E  ++  L+H  +V+ +   T  + +YI  E+++ GS+   L+ D G + 
Sbjct: 220 ---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ 275
Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               +  ++ QI  G+ ++  +N +HRD++ ANILV  S   K+ADFG+A+   G   P+
Sbjct: 276 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VGAKFPI 333
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSK 373
                  W APE I N     +  D+WS G  ++E+ T  + P+        +  +    
Sbjct: 334 K------WTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 386
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
            +P  P++  +E  + + +C +  P  RPT  ++
Sbjct: 387 RMPR-PENCPEELYNIMMRCWKNRPEERPTFEYI 419

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 29/275 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG+G FG V++G  + +  + A+K +           S +   QE  ++ +LRH  +V+ 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQL 68
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES----AIRSYTQQILSGLEYLHAKNT 278
           Y   + ++ + I  EY+S GS+   L+  G+ G+      +     QI SG+ Y+   N 
Sbjct: 69  YAVVS-EEPIXIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMNY 125
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           VHRD++ ANILV  +   K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGAKFPIKWTAPEAALYGR-FT 183
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D + +C 
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCW 242
Query: 395 QRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           ++ P  RPT  +L         A LE    S EP 
Sbjct: 243 RKEPEERPTFEYL--------QAFLEDYFTSTEPQ 269

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S+++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A +   EI +L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLL 74
Query: 215 RHPNIV--------------RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
           +H N+V              R  GS  L   ++ + E+   G +  +L  +     S I+
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVKFTL---SEIK 128
Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKG 318
              Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+   +   S P     
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 319 ---SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
              + ++  PE++         +D+W  GC + EM T  P
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 20/292 (6%)
Query: 125 TCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKK-------GRLLGRGTFGHVYLGFNS 177
           + P    +  +T   + +  G V +   P  +W         G  +GRG FG V+ G   
Sbjct: 77  SIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR 136
Query: 178 ESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL 236
               + A+K        D K+K       QE  +L +  HPNIVR  G  T    +YI +
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 237 EYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR 295
           E V GG     L+  G +L    +        +G+EYL +K  +HRD+   N LV     
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 296 VKLADFGMAKHITGQSCPLS--IKGSPY-WMAPEVIKNSNGCNLAVDIWSLGCTVIE-MA 351
           +K++DFGM++         S  ++  P  W APE + N    +   D+WS G  + E  +
Sbjct: 252 LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFS 310
Query: 352 TTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
               P+           +     LP  P+   D     + +C    P  RP+
Sbjct: 311 LGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPS 361

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P +R   G+ LG G FG V      E+     +K     +   K  + +  L +  AL+S
Sbjct: 44  PRNRLSFGKTLGAGAFGKV-----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 213 RLR-------HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ---------------- 249
            L+       H NIV   G+ T+     +  EY   G +   L+                
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+HI
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 308 TGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
              S    +KG+      WMAPE I N        D+WS G  + E+ +     S Y G+
Sbjct: 219 KNDS-NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGS--SPYPGM 274
Query: 364 PA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           P     +K+         P+H   E  D ++ C   +PL RPT   +++
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +    +   +A S ++ +++  E  +++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 109 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 168 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 228 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 259

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 12/229 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ 202
           +P + +      +  K+ ++LG G FG VY G     GE   +       ++    ++  
Sbjct: 3   APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRS 261
           +   E  +++ + HP++VR  G   L   + +  + +  G + + + ++   +G   + +
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY 321
           +  QI  G+ YL  +  VHRD+   N+LV     VK+ DFG+A+ + G     +  G   
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 322 ---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT--KPPWSQYEGVPA 365
              WMA E I      + + D+WS G T+ E+ T   KP    Y+G+P 
Sbjct: 182 PIKWMALECIHYRKFTHQS-DVWSYGVTIWELMTFGGKP----YDGIPT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S+++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A +   EI +L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLL 74
Query: 215 RHPNIV------RYYGSETLDDKLYIYL-----EYVSGGSIYKILQDYGQLGESAIRSYT 263
           +H N+V      R   S     K  IYL     E+   G +  +L  +     S I+   
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVM 131
Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKG--- 318
           Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+   +   S P        
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           + ++  PE++         +D+W  GC + EM T  P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 20/292 (6%)
Query: 125 TCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKK-------GRLLGRGTFGHVYLGFNS 177
           + P    +  +T   + +  G V +   P  +W         G  +GRG FG V+ G   
Sbjct: 77  SIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR 136
Query: 178 ESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL 236
               + A+K        D K+K       QE  +L +  HPNIVR  G  T    +YI +
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 237 EYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR 295
           E V GG     L+  G +L    +        +G+EYL +K  +HRD+   N LV     
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 296 VKLADFGMAKHITGQSCPLS--IKGSPY-WMAPEVIKNSNGCNLAVDIWSLGCTVIE-MA 351
           +K++DFGM++         S  ++  P  W APE + N    +   D+WS G  + E  +
Sbjct: 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFS 310
Query: 352 TTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
               P+           +     LP  P+   D     + +C    P  RP+
Sbjct: 311 LGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPS 361

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 126/289 (43%), Gaps = 13/289 (4%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI---KGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +        +   +  P+ W APE +K     + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 197
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 257
Query: 396 RNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMRILVT 444
             P  RPT   L +  F+  A P +   L  +  E    L + M  ++T
Sbjct: 258 HKPEDRPTFVALRD--FLLEAQPTDMRAL--QDFEEPDKLHIQMNDVIT 302

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 137/290 (47%), Gaps = 21/290 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     +  + AMK +  +    +++ +  +  +++ +    +    +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y   +  ++ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H  + V
Sbjct: 156 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 213
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKN-SNGCNL 336
           HRDIK  N+L+D +G ++LADFG    +       S    G+P +++PE+++   +G   
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK 273
Query: 337 ---AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD---EGKDFV 390
                D WSLG  + EM   + P+     V    KI N +E    P H++D   E KD +
Sbjct: 274 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLI 333
Query: 391 RK--CLQRNPLHRPTAAWLLEHPFV-----GNAAPLERPIL--SAEPSET 431
           ++  C +   L +       +H F       N   LE P +   + PS+T
Sbjct: 334 QRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDT 383

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 137/290 (47%), Gaps = 21/290 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     +  + AMK +  +    +++ +  +  +++ +    +    +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
            Y   +  ++ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H  + V
Sbjct: 140 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 197
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPEVIKN-SNGCNL 336
           HRDIK  N+L+D +G ++LADFG    +       S    G+P +++PE+++   +G   
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK 257
Query: 337 ---AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD---EGKDFV 390
                D WSLG  + EM   + P+     V    KI N +E    P H++D   E KD +
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLI 317
Query: 391 RK--CLQRNPLHRPTAAWLLEHPFV-----GNAAPLERPIL--SAEPSET 431
           ++  C +   L +       +H F       N   LE P +   + PS+T
Sbjct: 318 QRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDT 367

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 11/263 (4%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K     + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 396 RNPLHRPTAAWLLEHPFVGNAAP 418
             P  RPT   L +  F+  A P
Sbjct: 254 HKPEDRPTFVALRD--FLLEAQP 274

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 79  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 198 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 229

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 131/277 (47%), Gaps = 21/277 (7%)
Query: 139 SVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCA--MKEVTLFSDDAK 196
           S P+ P   +    P    K  + LG G FG V++   ++  ++    MK  ++      
Sbjct: 172 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------ 225
Query: 197 SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYG-QL 254
              S +    E  ++  L+H  +V+ +   T  + +YI  E+++ GS+   L+ D G + 
Sbjct: 226 ---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQ 281
Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               +  ++ QI  G+ ++  +N +HRD++ ANILV  S   K+ADFG+A+ I       
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 340
Query: 315 SIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIG 370
           + +G+ +   W APE I N     +  D+WS G  ++E+ T  + P+        +  + 
Sbjct: 341 AREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
               +P  P++  +E  + + +C +  P  RPT  ++
Sbjct: 400 RGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYI 435

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 11/263 (4%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +            +  P+ W APE +K     + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263
Query: 396 RNPLHRPTAAWLLEHPFVGNAAP 418
             P  RPT   L +  F+  A P
Sbjct: 264 HKPEDRPTFVALRD--FLLEAQP 284

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 25/217 (11%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  ++    +G G +G V       +G+  A+K++    D   +   A++  +E+ +L  
Sbjct: 54  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKH 110
Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ----DYGQLGESA-------IRSY 262
            +H NI+       + D L   + Y    S+Y +L     D  Q+  S+       +R +
Sbjct: 111 FKHDNII------AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF 164
Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-----QSCPLSIK 317
             Q+L GL+Y+H+   +HRD+K +N+LV+ +  +K+ DFGMA+ +       Q       
Sbjct: 165 LYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK 354
            + ++ APE++ + +    A+D+WS+GC   EM   +
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 116/263 (44%), Gaps = 11/263 (4%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI---KGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +        +   +  P+ W APE +K     + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263
Query: 396 RNPLHRPTAAWLLEHPFVGNAAP 418
             P  RPT   L +  F+  A P
Sbjct: 264 HKPEDRPTFVALRD--FLLEAQP 284

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 76  DNPHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 195 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G++G V +   +++  + A+K +        + +  +++  E+ L+ +L HPNI R 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 223 YGSETLDDKLYIYL--EYVSGGSIYKILQ------------------------------- 249
           Y  E  +D+ YI L  E   GG +   L                                
Sbjct: 94  Y--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 250 ----------DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV--DPSGRVK 297
                     D+ Q  E  I +  +QI S L YLH +   HRDIK  N L   + S  +K
Sbjct: 152 GSIHGFRESLDFVQ-REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 298 LADFGMAKHI----TGQSCPLSIK-GSPYWMAPEVIKNSN-----GCNLAVDIWSLGCTV 347
           L DFG++K       G+   ++ K G+PY++APEV+  +N      C    D WS G  +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGVLL 266
Query: 348 IEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH--LSDEGKDFVRKCLQRNPLHRPTAA 405
             +     P+        + ++ N K     P++  LS   +D +   L RN   R  A 
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 406 WLLEHPFV 413
             L+HP++
Sbjct: 327 RALQHPWI 334

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 18/258 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           LG G FG V+   + E  +   +K +    +  D         ++  EIA+LSR+ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 220 VRYYGSETLDDKLYIYL---EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           ++    +  +++ +  L   ++ SG  ++  +  + +L E       +Q++S + YL  K
Sbjct: 92  IKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           + +HRDIK  NI++     +KL DFG A ++       +  G+  + APEV+  +     
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209
Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL-SDEGKDFVRKCLQ 395
            +++WSLG T+  +   + P+ + E          + E    P +L S E    V   LQ
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCELE---------ETVEAAIHPPYLVSKELMSLVSGLLQ 260
Query: 396 RNPLHRPTAAWLLEHPFV 413
             P  R T   L+  P+V
Sbjct: 261 PVPERRTTLEKLVTDPWV 278

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 126/263 (47%), Gaps = 21/263 (7%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCA--MKEVTLFSDDAKSKESAQQLGQEIAL 210
           P    K  + LG G FG V++   ++  ++    MK  ++         S +    E  +
Sbjct: 13  PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANV 63
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYG-QLGESAIRSYTQQILS 268
           +  L+H  +V+ +   T  + +YI  E+++ GS+   L+ D G +     +  ++ QI  
Sbjct: 64  MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 122
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAP 325
           G+ ++  +N +HRD++ ANILV  S   K+ADFG+A+ I       + +G+ +   W AP
Sbjct: 123 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 181
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           E I N     +  D+WS G  ++E+ T  + P+        +  +     +P  P++  +
Sbjct: 182 EAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPE 239
Query: 385 EGKDFVRKCLQRNPLHRPTAAWL 407
           E  + + +C +  P  RPT  ++
Sbjct: 240 ELYNIMMRCWKNRPEERPTFEYI 262

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 77  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 196 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 78  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 197 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 76  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 135 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 195 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 116/263 (44%), Gaps = 11/263 (4%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI---KGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +        +   +  P+ W APE +K     + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 396 RNPLHRPTAAWLLEHPFVGNAAP 418
             P  RPT   L +  F+  A P
Sbjct: 254 HKPEDRPTFVALRD--FLLEAQP 274

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 25/217 (11%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  ++    +G G +G V       +G+  A+K++    D   +   A++  +E+ +L  
Sbjct: 53  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKH 109
Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ----DYGQLGESA-------IRSY 262
            +H NI+       + D L   + Y    S+Y +L     D  Q+  S+       +R +
Sbjct: 110 FKHDNII------AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF 163
Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-----QSCPLSIK 317
             Q+L GL+Y+H+   +HRD+K +N+LV+ +  +K+ DFGMA+ +       Q       
Sbjct: 164 LYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK 354
            + ++ APE++ + +    A+D+WS+GC   EM   +
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 117/243 (48%), Gaps = 26/243 (10%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W    +LG+G   +V+ G + ++G++ A+K   +F++ +  +    Q+ +E  +L +L H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 217 PNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGL 270
            NIV+ +    ET      + +E+   GS+Y +L++    YG L ES      + ++ G+
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGM 125
Query: 271 EYLHAKNTVHRDIKGANIL----VDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
            +L     VHR+IK  NI+     D     KL DFG A+ +      +S+ G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 327 VIKNS-------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG----VPAMFKIGNSKEL 375
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K  
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 376 PAI 378
            AI
Sbjct: 246 GAI 248

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +K+  L+G G FG V+   +   G+   ++ V         K + ++  +E+  L++
Sbjct: 11  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---------KYNNEKAEREVKALAK 61
Query: 214 LRHPNIVRY--------YGSETLDDKL---------------------YIYLEYVSGGSI 244
           L H NIV Y        Y  ET DD L                     +I +E+   G++
Sbjct: 62  LDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 245 YKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG 302
            + ++     +L +       +QI  G++Y+H+K  +HRD+K +NI +  + +VK+ DFG
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG 362
           +   +         KG+  +M+PE I +S      VD+++LG  + E+        +   
Sbjct: 182 LVTSLKNDGKRTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSK 240
Query: 363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
                + G       I D    + K  ++K L + P  RP  + +L    V   +P
Sbjct: 241 FFTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 290

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 9/248 (3%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI---KGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +        +   +  P+ W APE +K     + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 193
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253
Query: 396 RNPLHRPT 403
             P  RPT
Sbjct: 254 HKPEDRPT 261

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 65/299 (21%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           R LGRG +  V+   N  + E   +K   +     K+K     + +EI +L  LR  PNI
Sbjct: 43  RKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKNK-----IKREIKILENLRGGPNI 94
Query: 220 VRYYGSETLDDKLY--------IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           +      TL D +         +  E+V+     ++   Y  L +  IR Y  +IL  L+
Sbjct: 95  I------TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALD 145
Query: 272 YLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIK 329
           Y H+   +HRD+K  N+++D   R ++L D+G+A+    GQ   + +  S Y+  PE++ 
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLV 204
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEGVPAMFKIGNSKELPAIPD----- 380
           +    + ++D+WSLGC +  M   K P+      Y+ +  + K+  +++L    D     
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 381 --------------------------HL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                                     HL S E  DF+ K L+ +   R TA   +EHP+
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGG-SIYKILQDYGQLGESAIRSYT 263
           +E+ LL     HPN++RY+ +E      YI +E  +     Y   +D+  LG   I +  
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-TLL 124
Query: 264 QQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVK--LADFGMAKHITGQSCPLS--- 315
           QQ  SGL +LH+ N VHRD+K  NIL+   +  G++K  ++DFG+ K +       S   
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 316 -IKGSPYWMAPEVIKNSNGCN--LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGN 371
            + G+  W+APE++      N    VDI+S GC    + +    P+ +     A   +G 
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 372 SKELPAIPDHLSDE-GKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                  P+   D   ++ + K +  +P  RP+A  +L+HPF
Sbjct: 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 16/270 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES-AQQLGQEIALLSR 213
           + ++ G LLG+G FG V+ G         A+K +        S  S +     E+ALL +
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 214 LR----HPNIVRYYGSETLDDKLYIYLEY-VSGGSIYKILQDYGQLGESAIRSYTQQILS 268
           +     HP ++R        +   + LE  +    ++  + + G LGE   R +  Q+++
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 269 GLEYLHAKNTVHRDIKGANILVD-PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
            +++ H++  VHRDIK  NIL+D   G  KL DFG    +  +       G+  +  PE 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDGTRVYSPPEW 209
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
           I       L   +WSLG  + +M     P+ + + +          EL   P H+S +  
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEAEL-HFPAHVSPDCC 261
Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
             +R+CL   P  RP+   +L  P++   A
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 9/248 (3%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
            YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL +K  +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSI---KGSPY-WMAPEVIKNSNGCNL 336
           RD+   N+L+     VK+ DFG+ + +        +   +  P+ W APE +K     + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 197
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           A D W  G T+ EM T  + PW    G   + KI    E    P+    +  + + +C  
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 257
Query: 396 RNPLHRPT 403
             P  RPT
Sbjct: 258 HKPEDRPT 265

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 121/247 (48%), Gaps = 10/247 (4%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R +  R +G G +G V   +++   +  A+K++   S   +S   A++  +E+ LL  L+
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL---SRPFQSLIHARRTYRELRLLKHLK 85
Query: 216 HPNIV----RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           H N++     +  + +++D   +YL     G+    +     L +  ++    Q+L GL+
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLK 145
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           Y+H+   +HRD+K +N+ V+    +++ DFG+A+    +        + ++ APE++ N 
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNW 203
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              N  VDIWS+GC + E+   K  +   + +  + +I      P+ P+ L+    +  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHAR 262
Query: 392 KCLQRNP 398
             +Q  P
Sbjct: 263 TYIQSLP 269

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 160 GRLLGRGTFGHVY--LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           G+ LG G FG V     F+ +         V +  ++A   E  + L  E  +L ++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG-------------------ESA 258
           ++++ YG+ + D  L + +EY   GS+   L++  ++G                   E A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 259 IR-----SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           +      S+  QI  G++YL   + VHRD+   NILV    ++K++DFG+++ +  +   
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS- 205
Query: 314 LSIKGSP-----YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AM 366
             +K S       WMA E + +      + D+WS G  + E+ T     + Y G+P   +
Sbjct: 206 -XVKRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGG--NPYPGIPPERL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
           F +  +      PD+ S+E    + +C ++ P  RP  A
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 81  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 140 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 200 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 231

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 45/284 (15%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K +    D  K++       +E+ L  R    P+I
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXL---QDCPKAR-------REVELHWRASQCPHI 117
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I  E + GG ++  +QD G     E       + I   
Sbjct: 118 VRIVDVYENLYAGRKCL----LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 327 VI---KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV------PAMFKIGNSKELPA 377
           V+   K    C    D WSLG     +    PP+    G+          + G   E P 
Sbjct: 234 VLGPEKYDKSC----DXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQY-EFPN 288
Query: 378 IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
            P+   +S+E K  +R  L+  P  R T      HP++  +  +
Sbjct: 289 -PEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKV 331

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 160 GRLLGRGTFGHVY--LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           G+ LG G FG V     F+ +         V +  ++A   E  + L  E  +L ++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG-------------------ESA 258
           ++++ YG+ + D  L + +EY   GS+   L++  ++G                   E A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 259 IR-----SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           +      S+  QI  G++YL     VHRD+   NILV    ++K++DFG+++ +  +   
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS- 205
Query: 314 LSIKGSP-----YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AM 366
             +K S       WMA E + +      + D+WS G  + E+ T     + Y G+P   +
Sbjct: 206 -XVKRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGG--NPYPGIPPERL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
           F +  +      PD+ S+E    + +C ++ P  RP  A
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 85  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 144 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 204 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 235

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 82  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 201 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 121/247 (48%), Gaps = 10/247 (4%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R +  R +G G +G V   +++   +  A+K++   S   +S   A++  +E+ LL  L+
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL---SRPFQSLIHARRTYRELRLLKHLK 85
Query: 216 HPNIV----RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           H N++     +  + +++D   +YL     G+    +     L +  ++    Q+L GL+
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLK 145
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           Y+H+   +HRD+K +N+ V+    +++ DFG+A+    +        + ++ APE++ N 
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNW 203
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              N  VDIWS+GC + E+   K  +   + +  + +I      P+ P+ L+    +  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHAR 262
Query: 392 KCLQRNP 398
             +Q  P
Sbjct: 263 TYIQSLP 269

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 77  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 196 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 78  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 197 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 77  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 196 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 77  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 196 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 79  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 138 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 198 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 229

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 78  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 197 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 78  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 137 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 197 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 228

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 72  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 131 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 191 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 222

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 20/221 (9%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMC----AMKEVTLFSDDAKSKESAQQLGQEIAL 210
           + +KK ++LG G FG VY G     GE      A+KE+     +A S ++ +++  E  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYV 64
Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSG 269
           ++ + +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G
Sbjct: 65  MASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPE 326
           + YL  +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
            I +    + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 184 SILHRIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 219

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 160 GRLLGRGTFGHVY--LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           G+ LG G FG V     F+ +         V +  ++A   E  + L  E  +L ++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG-------------------ESA 258
           ++++ YG+ + D  L + +EY   GS+   L++  ++G                   E A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 259 IR-----SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           +      S+  QI  G++YL     VHRD+   NILV    ++K++DFG+++ +  +   
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS- 205
Query: 314 LSIKGSP-----YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AM 366
             +K S       WMA E + +      + D+WS G  + E+ T     + Y G+P   +
Sbjct: 206 -YVKRSQGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGG--NPYPGIPPERL 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
           F +  +      PD+ S+E    + +C ++ P  RP  A
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 256 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 100 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 159 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 219 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 250

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 245 -----QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 256 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 121/247 (48%), Gaps = 10/247 (4%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R +  R +G G +G V   +++   +  A+K++   S   +S   A++  +E+ LL  L+
Sbjct: 21  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKL---SRPFQSLIHARRTYRELRLLKHLK 77
Query: 216 HPNIV----RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           H N++     +  + +++D   +YL     G+    +     L +  ++    Q+L GL+
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLK 137
Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           Y+H+   +HRD+K +N+ V+    +++ DFG+A+    +        + ++ APE++ N 
Sbjct: 138 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT--GYVATRWYRAPEIMLNW 195
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
              N  VDIWS+GC + E+   K  +   + +  + +I      P+ P+ L+    +  R
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISSEHAR 254
Query: 392 KCLQRNP 398
             +Q  P
Sbjct: 255 TYIQSLP 261

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 254
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 255 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 256 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P +R   G+ LG G FG V      E+     +K     +   K  + +  L +  AL+S
Sbjct: 21  PRNRLSFGKTLGAGAFGKV-----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 213 RLR-------HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ---------------- 249
            L+       H NIV   G+ T+     +  EY   G +   L+                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 308 TGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
              S    +KG+      WMAPE I N        D+WS G  + E+ +     S Y G+
Sbjct: 196 KNDS-NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGS--SPYPGM 251
Query: 364 PA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           P     +K+         P+H   E  D ++ C   +PL RPT   +++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 17/273 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK--ESAQQLGQE 207
           PT   +  +  + +G+G FG V+ G   +   + A+K + L   + +++  E  Q+  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQI 266
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D    +  S        I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 267 LSGLEYLHAKN--TVHRDIKGANIL---VDPSGRV--KLADFGMAKHITGQSCPLSIKGS 319
             G+EY+  +N   VHRD++  NI    +D +  V  K+ADFG+++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL--GN 189
Query: 320 PYWMAPEVI-KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELP 376
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            IP+      ++ +  C   +P  RP  +++++
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 108/259 (41%), Gaps = 15/259 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES------AQQLGQEIALLSRL 214
           R +  G++G V  G +SE G   A+K V     D ++          +++ +EI LL+  
Sbjct: 28  RFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 215 RHPNI-----VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
            HPNI     +  +  E    KLY+  E +       I      +    I+ +   IL G
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L  LH    VHRD+   NIL+  +  + + DF +A+  T  +         ++ APE++ 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL---SDEG 386
              G    VD+WS GC + EM   K  +        + KI      P I D +   S   
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 387 KDFVRKCLQRNPLHRPTAA 405
           +D++R  L   P    TA 
Sbjct: 267 RDYLRNSLSNVPARAWTAV 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 16/279 (5%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 27  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 203
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
           G+  +  PE I+       +  +WSLG  + +M     P+   E +     IG       
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQV---F 255
Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
               +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 256 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 33  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 209
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 263
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 264 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           ++LG G  G V   F+  +G+ CA+K   L  D  K+++      Q          P+IV
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASG------GPHIV 85
Query: 221 ----RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLH 274
                Y         L I +E + GG ++  +Q+ G     E       + I + +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--- 328
           + N  HRD+K  N+L    +    +KL DFG AK  T Q+   +   +PY++APEV+   
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPE 204
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG---VPAM---FKIGNSKELPAIPDHL 382
           K    C    D+WSLG  +  +    PP+    G    P M    ++G           +
Sbjct: 205 KYDKSC----DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           S++ K  +R  L+ +P  R T    + HP++  +
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 108/259 (41%), Gaps = 15/259 (5%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES------AQQLGQEIALLSRL 214
           R +  G++G V  G +SE G   A+K V     D ++          +++ +EI LL+  
Sbjct: 28  RFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 215 RHPNI-----VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
            HPNI     +  +  E    KLY+  E +       I      +    I+ +   IL G
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L  LH    VHRD+   NIL+  +  + + DF +A+  T  +         ++ APE++ 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL---SDEG 386
              G    VD+WS GC + EM   K  +        + KI      P I D +   S   
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 387 KDFVRKCLQRNPLHRPTAA 405
           +D++R  L   P    TA 
Sbjct: 267 RDYLRNSLSNVPARAWTAV 285

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 116/243 (47%), Gaps = 26/243 (10%)
Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           W    +LG+G   +V+ G + ++G++ A+K   +F++ +  +    Q+ +E  +L +L H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 217 PNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGL 270
            NIV+ +    ET      + +E+   GS+Y +L++    YG L ES      + ++ G+
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGM 125
Query: 271 EYLHAKNTVHRDIKGANIL----VDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
            +L     VHR+IK  NI+     D     KL DFG A+ +      + + G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 327 VIKNS-------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG----VPAMFKIGNSKEL 375
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K  
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 376 PAI 378
            AI
Sbjct: 246 GAI 248

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 245 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 13  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 189
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 243
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 244 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P +R   G+ LG G FG V      E+     +K     +   K  + +  L +  AL+S
Sbjct: 37  PRNRLSFGKTLGAGAFGKV-----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 91
Query: 213 RLR-------HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ---------------- 249
            L+       H NIV   G+ T+     +  EY   G +   L+                
Sbjct: 92  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 151
Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 308 TGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
              S    +KG+      WMAPE I N        D+WS G  + E+ +     S Y G+
Sbjct: 212 KNDS-NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGS--SPYPGM 267
Query: 364 PA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           P     +K+         P+H   E  D ++ C   +PL RPT
Sbjct: 268 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 310

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 14  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 190
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 244
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 245 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P +R   G+ LG G FG V      E+     +K     +   K  + +  L +  AL+S
Sbjct: 44  PRNRLSFGKTLGAGAFGKV-----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 213 RLR-------HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ---------------- 249
            L+       H NIV   G+ T+     +  EY   G +   L+                
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 308 TGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
              S    +KG+      WMAPE I N        D+WS G  + E+ +     S Y G+
Sbjct: 219 KNDS-NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGS--SPYPGM 274
Query: 364 PA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           P     +K+         P+H   E  D ++ C   +PL RPT   +++
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           ++LG G  G V   F+  +G+ CA+K   L  D  K+++      Q          P+IV
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASG------GPHIV 66
Query: 221 ----RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLH 274
                Y         L I +E + GG ++  +Q+ G     E       + I + +++LH
Sbjct: 67  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--- 328
           + N  HRD+K  N+L    +    +KL DFG AK  T Q+   +   +PY++APEV+   
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPE 185
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG---VPAM---FKIGNSKELPAIPDHL 382
           K    C    D+WSLG  +  +    PP+    G    P M    ++G           +
Sbjct: 186 KYDKSC----DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           S++ K  +R  L+ +P  R T    + HP++  +
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 275

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P +R   G+ LG G FG V      E+     +K     +   K  + +  L +  AL+S
Sbjct: 39  PRNRLSFGKTLGAGAFGKV-----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 93
Query: 213 RLR-------HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ---------------- 249
            L+       H NIV   G+ T+     +  EY   G +   L+                
Sbjct: 94  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 153
Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 308 TGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV 363
              S    +KG+      WMAPE I N        D+WS G  + E+ +     S Y G+
Sbjct: 214 KNDS-NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGS--SPYPGM 269
Query: 364 PA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           P     +K+         P+H   E  D ++ C   +PL RPT
Sbjct: 270 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 312

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 26  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 202
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 256
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 257 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++L  G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + + ++ +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 82  DNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 201 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 13  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 189
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 243
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 244 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 41  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 217
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 271
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 272 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 46  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 103
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 104 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 164 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 222
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 276
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 277 -----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESA 201
           +PG+ + P    S+++ G LLG G FG VY G         A+K V      D     + 
Sbjct: 41  APGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 202 QQLGQEIALLSRLR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESA 258
            ++  E+ LL ++      ++R        D   + LE       ++  + + G L E  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIK 317
            RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DFG    +   +      
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFD 217
Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKE 374
           G+  +  PE I+       +  +WSLG  + +M     P+   E +      F+      
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------ 271
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                  +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 272 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 34/283 (12%)
Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +K+  L+G G FG V+   +   G+   +K V         K + ++  +E+  L++
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKAEREVKALAK 60
Query: 214 LRHPNIVRYYG----------------SETLDDKLYIYLEYVSGGSIYKILQDY--GQLG 255
           L H NIV Y G                S +    L+I +E+   G++ + ++     +L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS 315
           +       +QI  G++Y+H+K  ++RD+K +NI +  + +VK+ DFG+   +        
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
            KG+  +M+PE I +S      VD+++LG  + E+        +        + G     
Sbjct: 181 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG----- 234
Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
             I D    + K  ++K L + P  RP  + +L    V   +P
Sbjct: 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 82  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 201 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 77  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG AK +  +      +G      WMA E I +
Sbjct: 136 EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 196 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 17/273 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK--ESAQQLGQE 207
           PT   +  +  + +G+G FG V+ G   +   + A+K + L   + +++  E  Q+  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQI 266
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D    +  S        I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 267 LSGLEYLHAKN--TVHRDIKGANIL---VDPSGRV--KLADFGMAKHITGQSCPLSIKGS 319
             G+EY+  +N   VHRD++  NI    +D +  V  K+ADFG ++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLL--GN 189
Query: 320 PYWMAPEVI-KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELP 376
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            IP+      ++ +  C   +P  RP  +++++
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++L  G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 82  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 141 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 201 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 232

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + +KK ++L  G FG VY G     GE   +        +A S ++ +++  E  +++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ YL
Sbjct: 75  DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKN 330
             +  VHRD+   N+LV     VK+ DFG+AK +  +      +G      WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 331 SNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
               + + D+WS G TV E+ T  +KP    Y+G+PA
Sbjct: 194 RIYTHQS-DVWSYGVTVWELMTFGSKP----YDGIPA 225

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 119/253 (47%), Gaps = 21/253 (8%)
Query: 163 LGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           LG G FG V++G +N  +    A+K +           S +   +E  ++ +L+H  +V+
Sbjct: 17  LGNGQFGEVWMGTWNGNTK--VAIKTLK------PGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKNT 278
            Y   + ++ +YI  EY++ GS+   L+D G+   L    +     Q+ +G+ Y+   N 
Sbjct: 69  LYAVVS-EEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERMNY 126
Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCN 335
           +HRD++ ANILV      K+ADFG+A+ I       + +G+ +   W APE         
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGR-FT 184
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  D+WS G  + E+ T  + P+        + ++     +P  P        + +  C 
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQDCPISLHELMIHCW 243
Query: 395 QRNPLHRPTAAWL 407
           +++P  RPT  +L
Sbjct: 244 KKDPEERPTFEYL 256

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE +     ++  + + G L E   RS+  Q+L  +
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 186
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 235
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           E P S G     G   G G FG VY G+ + +    A+K++    D   ++E  QQ  QE
Sbjct: 20  ERPISVG-----GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQE 71
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQ 264
           I + ++ +H N+V   G  +  D L +   Y   GS+   L        L         Q
Sbjct: 72  IKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQ 131
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLS-IKGSPY 321
              +G+ +LH  + +HRDIK ANIL+D +   K++DFG+A+      Q    S I G+  
Sbjct: 132 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTA 191
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
           + APE ++         DI+S G  ++E+ T  P   ++
Sbjct: 192 YXAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEH 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 120/255 (47%), Gaps = 19/255 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           R++G+G FG VY G   +  +    CA+K ++  ++     +  +   +E  L+  L HP
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLREGLLMRGLNHP 82
Query: 218 NIVRYYGSETLDDKL-YIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHA 275
           N++   G     + L ++ L Y+  G + + ++          + S+  Q+  G+EYL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------WMAPEVIK 329
           +  VHRD+   N ++D S  VK+ADFG+A+ I  +    S++   +      W A E ++
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY-YSVQQHRHARLPVKWTALESLQ 201
Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                  + D+WS G  + E+ T   PP+   +       +   + LP  P++  D    
Sbjct: 202 TYRFTTKS-DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQ 259
Query: 389 FVRKCLQRNPLHRPT 403
            +++C + +P  RPT
Sbjct: 260 VMQQCWEADPAVRPT 274

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 125/273 (45%), Gaps = 17/273 (6%)
Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK--ESAQQLGQE 207
           PT   +  +  + +G+G FG V+ G   +   + A+K + L   + +++  E  Q+  +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQI 266
           + ++S L HPNIV+ YG   + +   + +E+V  G +Y  L D    +  S        I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 267 LSGLEYLHAKN--TVHRDIKGANIL---VDPSGRV--KLADFGMAKHITGQSCPLSIKGS 319
             G+EY+  +N   VHRD++  NI    +D +  V  K+ADF +++        L   G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLL--GN 189
Query: 320 PYWMAPEVI-KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIGNSKELP 376
             WMAPE I           D +S    +  + T + P+ +Y    +  +  I      P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            IP+      ++ +  C   +P  RP  +++++
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 26/294 (8%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 187
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 236
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA------APLERPILSAEPSETKPT 434
           +  +R CL   P  RPT   +  HP++ +       A +    LS  PS++ P+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPS 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 159 KGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           + +++G G FG VY G   + SG+      +         K+    LG E  ++ +  H 
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQFSHH 106
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           NI+R  G  +    + I  EY+  G++ K L++  G+     +    + I +G++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSPYWMAPE 326
           N VHRD+   NILV+ +   K++DFG+++ +          +G   P+       W APE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAPE 220
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
            I      + A D+WS G  + E+ T  + P+ +      M  I +   LP  P      
Sbjct: 221 AISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSA 278
Query: 386 GKDFVRKCLQRNPLHRPTAA 405
               + +C Q+    RP  A
Sbjct: 279 IYQLMMQCWQQERARRPKFA 298

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 116/257 (45%), Gaps = 53/257 (20%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++  G+ LG G+FG V   F+ ESG+  A+K+V     D + K       +E+ ++  L 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---QDPRYK------NRELDIMKVLD 58
Query: 216 HPNIVRY--YGSETLDDK------------------------------------LYIYLE 237
           H NI++   Y   T D++                                    L + +E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 238 YVSGGSIYKILQDYGQLGESA----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-P 292
           YV   +++K+L+ + + G S     I  Y  Q+   + ++H+    HRDIK  N+LV+  
Sbjct: 119 YVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 293 SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT 352
              +KL DFG AK +      ++   S ++ APE++  +     ++D+WS+GC   E+  
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 353 TKPPWSQYEGVPAMFKI 369
            KP +S    +  + +I
Sbjct: 238 GKPLFSGETSIDQLVRI 254

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 14/267 (5%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
                  +  +WSLG  + +M     P+   E +     IG           +S E +  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IGGQ---VFFRQRVSSECQHL 234
Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +R CL   P  RPT   +  HP++ + 
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 187
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 236
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 186
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 235
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 187
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 236
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 109/262 (41%), Gaps = 25/262 (9%)
Query: 163 LGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG   FG VY G  F    GE      +    D A+     ++   E  L +RL+HPN+V
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPNVV 92
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKIL-----------QDYGQLGESAIR-----SYTQ 264
              G  T D  L +   Y S G +++ L            D  +  +SA+          
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY--- 321
           QI +G+EYL + + VH+D+   N+LV     VK++D G+ + +        +  S     
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE I      ++  DIWS G  + E+ +    P+  Y     +  I N + LP  PD
Sbjct: 213 WMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PD 270
Query: 381 HLSDEGKDFVRKCLQRNPLHRP 402
                    + +C    P  RP
Sbjct: 271 DCPAWVYALMIECWNEFPSRRP 292

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 150
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 209
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSXEC 258
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 259 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSXEC 231
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 109/262 (41%), Gaps = 25/262 (9%)
Query: 163 LGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG   FG VY G  F    GE      +    D A+     ++   E  L +RL+HPN+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPNVV 75
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKIL-----------QDYGQLGESAIR-----SYTQ 264
              G  T D  L +   Y S G +++ L            D  +  +SA+          
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY--- 321
           QI +G+EYL + + VH+D+   N+LV     VK++D G+ + +        +  S     
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE I      ++  DIWS G  + E+ +    P+  Y     +  I N + LP  PD
Sbjct: 196 WMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PD 253
Query: 381 HLSDEGKDFVRKCLQRNPLHRP 402
                    + +C    P  RP
Sbjct: 254 DCPAWVYALMIECWNEFPSRRP 275

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L + +E+   G++             YK+      +D+
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 145 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 203 DXVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 258
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 259 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 307

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L + +E+   G++             YK+      +D+
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 136 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 194 DXVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 249
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 250 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 298

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L + +E+   G++             YK+      +D+
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 145 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 203 DXVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 258
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 259 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 307

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 231
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 20/270 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS-DDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 185
Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGNSKELPAIPDHLSDEG 386
                  +  +WSLG  + +M     P+   E +      F+             +S E 
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-----------QRVSSEC 234
Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
           +  +R CL   P  RPT   +  HP++ + 
Sbjct: 235 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
            R+LG G FG VY G + +  GE   +   T   D   + ++ ++   E  ++  L HP+
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPH 86
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKN 277
           IV+  G    ++  +I +E    G +   L+ +   L    +  Y+ QI   + YL + N
Sbjct: 87  IVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 145
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIKGSPY-WMAPEVIKNSNGCN 335
            VHRDI   NILV     VKL DFG++++I  +     S+   P  WM+PE I N     
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI-NFRRFT 204
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A D+W     + E+ +  K P+   E    +  +     LP  PD         + +C 
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCW 263
Query: 395 QRNPLHRP 402
             +P  RP
Sbjct: 264 DYDPSDRP 271

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 50/287 (17%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V+       G + A+K        A S +    L +  A     +H ++VRY
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 223 YGSETLDDKLYIYLEYVSGGSI-------YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           + +   DD + I  EY +GGS+       Y+I+  +    E+ ++    Q+  GL Y+H+
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGRGLRYIHS 129
Query: 276 KNTVHRDIKGANILVD-----------------PSGRV--KLADFGMAKHITGQSCPLSI 316
            + VH DIK +NI +                   S +V  K+ D G   H+T  S P   
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVE 186
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYEGVPAMFKIG 370
           +G   ++A EV++ +       DI++L  TV+  A  +P       W +           
Sbjct: 187 EGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEI---------- 236
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
               LP IP  LS E  + ++  +  +P  RP+A  L++H  + +A+
Sbjct: 237 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 283

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R   G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 26  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 85
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKILQDYGQ--L 254
           +    H N+V   G+ T     L + +E+   G++             YK  +D  +  L
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFL 145
Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
               +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 315 SIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----M 366
             KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV       
Sbjct: 206 R-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC 261
Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
            ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 262 RRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 307

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 27  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 86
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSIYKILQD-------YGQLGESAIRS- 261
           +    H N+V   G+ T     L + +E+   G++   L+        Y +  E   +  
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF 146
Query: 262 --------YTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                   Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 314 LSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---- 365
           +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV      
Sbjct: 207 VR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEF 262
Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
             ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 263 CRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 309

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L + +E+   G++             YK+      +D+
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 145 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 203 DYVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 258
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 259 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 307

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
            R+LG G FG VY G + +  GE   +   T   D   + ++ ++   E  ++  L HP+
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPH 70
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKN 277
           IV+  G    ++  +I +E    G +   L+ +   L    +  Y+ QI   + YL + N
Sbjct: 71  IVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 129
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIKGSPY-WMAPEVIKNSNGCN 335
            VHRDI   NILV     VKL DFG++++I  +     S+   P  WM+PE I N     
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI-NFRRFT 188
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A D+W     + E+ +  K P+   E    +  +     LP  PD         + +C 
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCW 247
Query: 395 QRNPLHRP 402
             +P  RP
Sbjct: 248 DYDPSDRP 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L +  E+   G++             YK+      +D+
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 136 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 194 DXVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 249
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 250 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 298

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 62  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 121
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L + +E+   G++             YK+      +D+
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 181
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 182 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 240 DYVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 295
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 296 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 344

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +K ++LG G FG VY G     GE   +        +  S ++ +++  E  +++ +  P
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 79
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            + R  G   L   + +  + +  G +   + ++ G+LG   + ++  QI  G+ YL   
Sbjct: 80  YVSRLLGI-CLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK---------HITGQSCPLSIKGSPYWMAPEV 327
             VHRD+   N+LV     VK+ DFG+A+         H  G   P+       WMA E 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------WMALES 192
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA 365
           I      + + D+WS G TV E+ T   KP    Y+G+PA
Sbjct: 193 ILRRRFTHQS-DVWSYGVTVWELMTFGAKP----YDGIPA 227

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 10/248 (4%)
Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
            R+LG G FG VY G + +  GE   +   T   D   + ++ ++   E  ++  L HP+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPH 74
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKN 277
           IV+  G    ++  +I +E    G +   L+ +   L    +  Y+ QI   + YL + N
Sbjct: 75  IVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIKGSPY-WMAPEVIKNSNGCN 335
            VHRDI   NILV     VKL DFG++++I  +     S+   P  WM+PE I N     
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI-NFRRFT 192
Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
            A D+W     + E+ +  K P+   E    +  +     LP  PD         + +C 
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCW 251
Query: 395 QRNPLHRP 402
             +P  RP
Sbjct: 252 DYDPSDRP 259

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  +++G+G+FG V   ++ +  +  A+K V         K   +Q  +EI +L  LR
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLR 151
Query: 216 HP------NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--IRSYTQQIL 267
                   N++    + T  + + +  E +S  ++Y++++     G S   +R +   IL
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
             L+ LH    +H D+K  NIL+   GR  +K+ DFG + +   Q     I+ S ++ AP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYTXIQ-SRFYRAP 268
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           EVI  +    + +D+WSLGC + E+ T  P
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HP 217
           K + LG G+F       + +S +  A+K +        SK       +EI  L     HP
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII--------SKRMEANTQKEITALKLCEGHP 66
Query: 218 NIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           NIV+ +  E   D+L+ +L  E ++GG +++ ++      E+      ++++S + ++H 
Sbjct: 67  NIVKLH--EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 276 KNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKG-SPYWMAPEVIKNS 331
              VHRD+K  N+L    + +  +K+ DFG A+     + PL     + ++ APE++ N 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQ 183
Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYE-------GVPAMFKI--GNSKELPAIPDHL 382
           NG + + D+WSLG  +  M + + P+  ++        V  M KI  G+         ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
           S E KD ++  L  +P  R   + L  + ++ + + L
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 50/287 (17%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V+       G + A+K        A S +    L +  A     +H ++VRY
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 223 YGSETLDDKLYIYLEYVSGGSI-------YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           + +   DD + I  EY +GGS+       Y+I+  +    E+ ++    Q+  GL Y+H+
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGRGLRYIHS 131
Query: 276 KNTVHRDIKGANILVD-----------------PSGRV--KLADFGMAKHITGQSCPLSI 316
            + VH DIK +NI +                   S +V  K+ D G   H+T  S P   
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVE 188
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYEGVPAMFKIG 370
           +G   ++A EV++ +       DI++L  TV+  A  +P       W +           
Sbjct: 189 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI---------- 238
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
               LP IP  LS E  + ++  +  +P  RP+A  L++H  + +A+
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 50/287 (17%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V+       G + A+K        A S +    L +  A     +H ++VRY
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 223 YGSETLDDKLYIYLEYVSGGSI-------YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           + +   DD + I  EY +GGS+       Y+I+  +    E+ ++    Q+  GL Y+H+
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGRGLRYIHS 133
Query: 276 KNTVHRDIKGANILVD-----------------PSGRV--KLADFGMAKHITGQSCPLSI 316
            + VH DIK +NI +                   S +V  K+ D G   H+T  S P   
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVE 190
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYEGVPAMFKIG 370
           +G   ++A EV++ +       DI++L  TV+  A  +P       W +           
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI---------- 240
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
               LP IP  LS E  + ++  +  +P  RP+A  L++H  + +A+
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  +++G+G+FG V   ++ +  +  A+K V         K   +Q  +EI +L  LR
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLR 151
Query: 216 HP------NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--IRSYTQQIL 267
                   N++    + T  + + +  E +S  ++Y++++     G S   +R +   IL
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
             L+ LH    +H D+K  NIL+   GR  +K+ DFG + +   Q     I+ S ++ AP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYTXIQ-SRFYRAP 268
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           EVI  +    + +D+WSLGC + E+ T  P
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L +  E+   G++             YK+      +D+
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 136 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 194 DYVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 249
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 250 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 298

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 50/287 (17%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G G FG V+       G + A+K        A S +    L +  A     +H ++VRY
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 223 YGSETLDDKLYIYLEYVSGGSI-------YKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           + +   DD + I  EY +GGS+       Y+I+  +    E+ ++    Q+  GL Y+H+
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGRGLRYIHS 131
Query: 276 KNTVHRDIKGANILVD-----------------PSGRV--KLADFGMAKHITGQSCPLSI 316
            + VH DIK +NI +                   S +V  K+ D G   H+T  S P   
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSPQVE 188
Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYEGVPAMFKIG 370
           +G   ++A EV++ +       DI++L  TV+  A  +P       W +           
Sbjct: 189 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI---------- 238
Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
               LP IP  LS E  + ++  +  +P  RP+A  L++H  + +A+
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 38/292 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +    C    V +  + A   E    + +   L
Sbjct: 16  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 75
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YKI-----LQDY 251
           +    H N+V   G+ T     L +  E+   G++             YK+      +D+
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
             L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I    
Sbjct: 136 LTL--EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-- 365
             +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV    
Sbjct: 194 DYVR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 249
Query: 366 --MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
               ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 250 EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 298

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 39/281 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 100
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYG-------- 252
            ++S L +H NIV   G+ T    + +  EY   G +   L+       +Y         
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPE 160
Query: 253 -QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS 311
            QL    +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I   S
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 312 CPLSIKGSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGV-- 363
             + +KG+      WMAPE I +   C   V  D+WS G  + E+ +     + Y G+  
Sbjct: 221 NYI-VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLG--LNPYPGILV 274
Query: 364 -PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
               +K+       A P          ++ C    P HRPT
Sbjct: 275 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 315

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  +++G+G FG V   ++ +  +  A+K V         K   +Q  +EI +L  LR
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLR 151
Query: 216 HP------NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--IRSYTQQIL 267
                   N++    + T  + + +  E +S  ++Y++++     G S   +R +   IL
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPLSIKGSPYWMAP 325
             L+ LH    +H D+K  NIL+   GR  +K+ DFG + +   Q     I+ S ++ AP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYXXIQ-SRFYRAP 268
Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           EVI  +    + +D+WSLGC + E+ T  P
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYP 297

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 39/202 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+L+D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPF 412
            K L+ +   R TA   +EHP+
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPY 323

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 117/275 (42%), Gaps = 60/275 (21%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI 219
           ++LG G  G V   FN  + E  A+K   +  D  K++       +E+ L  R    P+I
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKAR-------REVELHWRASQCPHI 73
Query: 220 VR--------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSG 269
           VR        Y G + L     I +E + GG ++  +QD G     E       + I   
Sbjct: 74  VRIVDVYENLYAGRKCL----LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 270 LEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  TG+                
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE---------------- 173
Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM---FKIGNSKELPAIPD 380
             K    C    D+WSLG  +  +    PP+    G+   P M    ++G   E P  P+
Sbjct: 174 --KYDKSC----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN-PE 225
Query: 381 --HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              +S+E K  +R  L+  P  R T    + HP++
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 6/199 (3%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +K ++LG G FG V+ G     GE   +       +D   ++S Q +   +  +  L H 
Sbjct: 34  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           +IVR  G       L +  +Y+  GS+   + Q  G LG   + ++  QI  G+ YL   
Sbjct: 94  HIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             VHR++   N+L+    +V++ADFG+A  +     Q      K    WMA E I     
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 334 CNLAVDIWSLGCTVIEMAT 352
            + + D+WS G TV E+ T
Sbjct: 213 THQS-DVWSYGVTVWELMT 230

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 122 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 182 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 301 DKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 128 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 187
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 188 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 246
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 247 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 306
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 307 DKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 122 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 182 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 301 DKLLRYDHQSRLTAREAMEHPYF 323

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 17/256 (6%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ---LGQEIALLSRL 214
           K  +++G G FG V  G     G+    +E+ +     KS  + +Q      E +++ + 
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 91
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYL 273
            HPN++   G  T    + I  E++  GS+   L Q+ GQ     +    + I +G++YL
Sbjct: 92  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ------SCPLSIKGSPYWMAPEV 327
              N VHRD+   NILV+ +   K++DFG+++ +         +  L  K    W APE 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 328 IKNSNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           I+     + A D+WS G  + E M+  + P+        +  I     LP  P       
Sbjct: 212 IQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCPSAL 269
Query: 387 KDFVRKCLQRNPLHRP 402
              +  C Q++  HRP
Sbjct: 270 HQLMLDCWQKDRNHRP 285

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+++ + +G G  G V   F++  G   A+K++   S   +++  A++  +E+ LL  + 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL---SRPFQNQTHAKRAYRELVLLKCVN 79
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +       I   + +L    +     Q+L G
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCG 136
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+  +          + Y+ APEVI 
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 330 NSNGCNLAVDIWSLGCTVIEMA 351
              G    VDIWS+GC + E+ 
Sbjct: 197 GM-GYKENVDIWSVGCIMGELV 217

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 123 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 182
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 183 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 301
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 302 DKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 39/203 (19%)
Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHI 307
           Q Y  L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R ++L D+G+A+  
Sbjct: 121 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 308 T-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----SQYEG 362
             GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   K P+      Y+ 
Sbjct: 181 HPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 363 VPAMFKIGNSKELPAIPD-------------------------------HL-SDEGKDFV 390
           +  + K+  +++L    D                               HL S E  DF+
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            K L+ +   R TA   +EHP+ 
Sbjct: 300 DKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 100
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--------- 258
            ++S L +H NIV   G+ T    + +  EY   G +   L+   ++ E+          
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 259 -----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I   S  
Sbjct: 161 LSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 314 LSIKGSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGV---P 364
           + +KG+      WMAPE I +   C   V  D+WS G  + E+ +     + Y G+    
Sbjct: 221 I-VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSL--GLNPYPGILVNS 274
Query: 365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
             +K+       A P          ++ C    P HRPT
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 6/199 (3%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +K ++LG G FG V+ G     GE   +       +D   ++S Q +   +  +  L H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           +IVR  G       L +  +Y+  GS+   + Q  G LG   + ++  QI  G+ YL   
Sbjct: 76  HIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSNG 333
             VHR++   N+L+    +V++ADFG+A  +     Q      K    WMA E I     
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 334 CNLAVDIWSLGCTVIEMAT 352
            + + D+WS G TV E+ T
Sbjct: 195 THQS-DVWSYGVTVWELMT 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 100
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA--------- 258
            ++S L +H NIV   G+ T    + +  EY   G +   L+   ++ E+          
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 259 -----IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
                +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I   S  
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 314 LSIKGSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGV---P 364
           + +KG+      WMAPE I +   C   V  D+WS G  + E+ +     + Y G+    
Sbjct: 221 I-VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSL--GLNPYPGILVNS 274
Query: 365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
             +K+       A P          ++ C    P HRPT
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 33/275 (12%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 36  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 92
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----------LGES 257
            ++S L +H NIV   G+ T    + +  EY   G +   L+   +          L   
Sbjct: 93  KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 152
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
            +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I   S  + +K
Sbjct: 153 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VK 211
Query: 318 GSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGV---PAMFK 368
           G+      WMAPE I +   C   V  D+WS G  + E+ +     + Y G+      +K
Sbjct: 212 GNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSL--GLNPYPGILVNSKFYK 266
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           +       A P          ++ C    P HRPT
Sbjct: 267 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 301

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 42/275 (15%)
Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           ++G G FG V      + G    M        +  SK+  +    E+ +L +L  HPNI+
Sbjct: 32  VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQD---------YGQLGESAIRSYTQQIL---- 267
              G+      LY+ +EY   G++   L+          +     +A    +QQ+L    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 268 ---SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKGSP 320
               G++YL  K  +HRD+   NILV  +   K+ADFG+++    ++      L ++   
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 206
Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPW------SQYEGVPAMFKIGNSK 373
            WMA E + N +      D+WS G  + E+ +    P+        YE +P  +++    
Sbjct: 207 -WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 262
Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
                P +  DE  D +R+C +  P  RP+ A +L
Sbjct: 263 -----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 46/277 (16%)
Query: 162 LLGRGTFGHVYLGFNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPN 218
           ++G G FG V      + G     A+K +  ++    SK+  +    E+ +L +L  HPN
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPN 77
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQD---------YGQLGESAIRSYTQQIL-- 267
           I+   G+      LY+ +EY   G++   L+          +     +A    +QQ+L  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 268 -----SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKG 318
                 G++YL  K  +HRD+   NILV  +   K+ADFG+++    ++      L ++ 
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 196
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPW------SQYEGVPAMFKIGN 371
              WMA E + N +      D+WS G  + E+ +    P+        YE +P  +++  
Sbjct: 197 ---WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 252
Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
                  P +  DE  D +R+C +  P  RP+ A +L
Sbjct: 253 -------PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 81
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------GQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---- 197
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 255
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPT 278

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 78
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------GQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 139 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---- 194
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 195 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 252
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 253 NCPERVTDLMRMCWQFNPKMRPT 275

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 28/299 (9%)
Query: 131 SYSTATSPSVPRSPGR----VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMK 186
           + S  ++ S PR   +    ++    P  + + G L+G+G FG VY G     GE+    
Sbjct: 5   NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHG--RWHGEVA--- 59
Query: 187 EVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYK 246
            + L   +  +++  +   +E+    + RH N+V + G+      L I      G ++Y 
Sbjct: 60  -IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 247 ILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK 305
           +++D    L  +  R   Q+I+ G+ YLHAK  +H+D+K  N+  D +G+V + DFG+  
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 306 HITG------QSCPLSIK-GSPYWMAPEVIK----NSNGCNLAV----DIWSLGCTVIEM 350
            I+G      +   L I+ G    +APE+I+    ++    L      D+++LG    E+
Sbjct: 178 -ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 351 ATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
              + P+        ++++G   +       +  E  D +  C       RPT   L++
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 123/283 (43%), Gaps = 50/283 (17%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LGRG FG V+   N       A+K + L       + + +++ +E+  L++L HP IVRY
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 223 YG-------SETLDDK-----LYIYLEYVSGGSIYKILQDYGQLGE---SAIRSYTQQIL 267
           +        +E L        LYI ++     ++   +     + E   S       QI 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM--------------------AKHI 307
             +E+LH+K  +HRD+K +NI       VK+ DFG+                    A+H 
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH- 187
Query: 308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF 367
           TGQ       G+  +M+PE I + N  +  VDI+SLG  + E+    P  +Q E V  + 
Sbjct: 188 TGQV------GTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLT 238
Query: 368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
            + N K  P        E    V+  L  +P+ RP A  ++E+
Sbjct: 239 DVRNLKFPPLFTQKYPCEYV-MVQDMLSPSPMERPEAINIIEN 280

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 115
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 176 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 234 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKXV 80
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V+N      R++   L+G+G+FG V   ++    E  A+K +         K    Q   
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQI 99
Query: 207 EIALLSRL-RHPNIVRYYGSE-----TLDDKLYIYLEYVSGGSIYKILQDYGQLGESA-- 258
           E+ LL  + +H   ++YY           + L +  E +S  ++Y +L++    G S   
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158
Query: 259 IRSYTQQILSGLEYLHA--KNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPL 314
            R + QQ+ + L +L     + +H D+K  NIL+    R  +K+ DFG +  + GQ    
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQ 217
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
            I+ S ++ +PEV+      +LA+D+WSLGC ++EM T +P +S    V  M KI     
Sbjct: 218 XIQ-SRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNP 398
           +P  P H+ D+     RK  ++ P
Sbjct: 276 IP--PAHILDQAPK-ARKFFEKLP 296

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 81
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR---- 197
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 198 WMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 255
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPT 278

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 81
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------GQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---- 197
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 255
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPT 278

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V+N      R++   L+G+G+FG V   ++    E  A+K +         K    Q   
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQI 99
Query: 207 EIALLSRL-RHPNIVRYYGSE-----TLDDKLYIYLEYVSGGSIYKILQDYGQLGESA-- 258
           E+ LL  + +H   ++YY           + L +  E +S  ++Y +L++    G S   
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158
Query: 259 IRSYTQQILSGLEYLHA--KNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPL 314
            R + QQ+ + L +L     + +H D+K  NIL+    R  +K+ DFG +  + GQ    
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL-GQRIYQ 217
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
            I+ S ++ +PEV+      +LA+D+WSLGC ++EM T +P +S    V  M KI     
Sbjct: 218 XIQ-SRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNP 398
           +P  P H+ D+     RK  ++ P
Sbjct: 276 IP--PAHILDQAPK-ARKFFEKLP 296

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V+N      R++   L+G+G+FG V   ++    E  A+K +         K    Q   
Sbjct: 27  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQI 80
Query: 207 EIALLSRL-RHPNIVRYYGSE-----TLDDKLYIYLEYVSGGSIYKILQDYGQLGESA-- 258
           E+ LL  + +H   ++YY           + L +  E +S  ++Y +L++    G S   
Sbjct: 81  EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 139
Query: 259 IRSYTQQILSGLEYLHA--KNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPL 314
            R + QQ+ + L +L     + +H D+K  NIL+    R  +K+ DFG +  + GQ    
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQ 198
Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE 374
            I+ S ++ +PEV+      +LA+D+WSLGC ++EM T +P +S    V  M KI     
Sbjct: 199 XIQ-SRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 375 LPAIPDHLSDEGKDFVRKCLQRNP 398
           +P  P H+ D+     RK  ++ P
Sbjct: 257 IP--PAHILDQAPK-ARKFFEKLP 277

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R+++ + +G G  G V   F++  G   A+K++   S   +++  A++  +E+ LL  + 
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL---SRPFQNQTHAKRAYRELVLLKCVN 81
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +       I   + +L    +     Q+L G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+             + Y+ APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 330 NSNGCNLAVDIWSLGCTVIEMA 351
              G    VDIWS+GC + E+ 
Sbjct: 199 GM-GYAANVDIWSVGCIMGELV 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 36/290 (12%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V     F  +         V +  + A   E    + +   L
Sbjct: 27  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 86
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSI-------------YK---ILQDYGQ 253
           +    H N+V   G+ T     L + +E+   G++             YK   + +D+  
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLT 146
Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 147 L--EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 314 LSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---- 365
           +  KG       WMAPE I +     +  D+WS G  + E+ +     S Y GV      
Sbjct: 205 VR-KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEF 260
Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
             ++     + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 261 CRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 307

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 33/275 (12%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 100
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----------LGES 257
            ++S L +H NIV   G+ T    + +  EY   G +   L+   +          L   
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 160
Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
            +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I   S  + +K
Sbjct: 161 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VK 219
Query: 318 GSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGV---PAMFK 368
           G+      WMAPE I +   C   V  D+WS G  + E+ +     + Y G+      +K
Sbjct: 220 GNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSL--GLNPYPGILVNSKFYK 274
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           +       A P          ++ C    P HRPT
Sbjct: 275 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 309

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 81
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 142 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 197
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 198 WMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 255
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPT 278

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 80
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHRD+   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 141 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 196
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 197 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 254
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 255 NCPERVTDLMRMCWQFNPKMRPT 277

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 46  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 99
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 100 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 159
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 160 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 217
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 218 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 256

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 42  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 95
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 96  RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 156 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 214 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 252

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 146 RVENPTSPGSRWKKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           ++E+   P  ++  GR+LG+G FG V       E G    +  V +   D  +    ++ 
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEF 72
Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKL-------YIYLEYVSGGSIYKILQDYGQLGES 257
            +E A +    HP++ +  G  +L  +         + L ++  G ++  L    ++GE+
Sbjct: 73  LREAACMKEFDHPHVAKLVGV-SLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGEN 130
Query: 258 -------AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--- 307
                   +  +   I  G+EYL ++N +HRD+   N ++     V +ADFG+++ I   
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 308 ----TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEG 362
                G +  L +K    W+A E + + N   +  D+W+ G T+ E+ T  + P++  E 
Sbjct: 191 DYYRQGCASKLPVK----WLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
                 +     L   P+ + +E  D + +C   +P  RP+   L
Sbjct: 246 AEIYNYLIGGNRLKQPPECM-EEVYDLMYQCWSADPKQRPSFTCL 289

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 115
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE 175
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 176 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 234 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 53  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 106
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 107 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 166
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 167 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 224
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 225 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 47  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 100
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 101 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 160
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S+ GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 161 TSSV-GSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 219 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 124 NTCPFSPSYSTATSPSVPR----SPGRVENPTSPGSRWKKGRL-------------LGRG 166
           N+  ++P  +  TSP  PR         E+P S     K  +L             LG G
Sbjct: 288 NSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCG 347
Query: 167 TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE 226
            FG V  G      +   +    L       K   +++ +E  ++ +L +P IVR  G  
Sbjct: 348 NFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV- 404
Query: 227 TLDDKLYIYLEYVSGGSIYKILQDYGQLGE---SAIRSYTQQILSGLEYLHAKNTVHRDI 283
              + L + +E   GG ++K L   G+  E   S +     Q+  G++YL  KN VHR++
Sbjct: 405 CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 284 KGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCNLAVD 339
              N+L+      K++DFG++K +       + + +      W APE I N    +   D
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRSD 521
Query: 340 IWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           +WS G T+ E ++  + P+ + +G   M  I   K +   P+
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKXVN 81
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTK 354
               G    VDIWS+GC + EM   K
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 86
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 206 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPS 286

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 200 SAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAI 259
           S  +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L+      E   
Sbjct: 47  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR------EMRH 100
Query: 260 RSYTQQILS-------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
           R  TQQ+L         +EYL +K  +HRD+   N LV+  G VK++DFG+++++     
Sbjct: 101 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 160
Query: 313 PLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFK 368
             S +GS +   W  PEV+  S   + + DIW+ G  + E+ +  K P+ ++        
Sbjct: 161 T-SSRGSKFPVRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEH 218
Query: 369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           I     L   P   S++    +  C       RPT   LL
Sbjct: 219 IAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 42/216 (19%)
Query: 236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR 295
            E+V+     ++ Q    L +  IR Y  +IL  L+Y H+   +HRD+K  N+++D   R
Sbjct: 113 FEHVNNTDFKQLRQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 169
Query: 296 -VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT 353
            ++L D+G+A+    GQ   + +  S Y+  PE++ +    + ++D+WSLGC +  M   
Sbjct: 170 KLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 228
Query: 354 KPPW----SQYEGVPAMFKIGNSKELPAIPD----------------------------- 380
           K P+      Y+ +  + K+  +++L    D                             
Sbjct: 229 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 288
Query: 381 --HL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             HL S E  DF+ K L+ +   R TA   +EHP+ 
Sbjct: 289 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 16  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 71
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 72  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------GQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 132 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR- 190
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 191 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 246
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 247 PDNCPDMLLELMRMCWQYNPKMRPS 271

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 48/219 (21%)
Query: 236 LEYVSG---GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD- 291
            EY++      +Y+IL D+       IR Y  ++L  L+Y H+K  +HRD+K  N+++D 
Sbjct: 114 FEYINNTDFKQLYQILTDFD------IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 167
Query: 292 PSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
              +++L D+G+A+     Q   + +  S Y+  PE++ +    + ++D+WSLGC +  M
Sbjct: 168 QQKKLRLIDWGLAEFYHPAQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226
Query: 351 ATTKPPW----SQYEGVPAMFKIGNSKEL------------PAIPD-------------- 380
              + P+      Y+ +  + K+  ++EL            P   D              
Sbjct: 227 IFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFI 286
Query: 381 -----HL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                HL S E  D + K L+ +   R TA   +EHP+ 
Sbjct: 287 HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 80
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 81  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------GQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 141 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR- 199
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 200 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 255
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPS 280

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 73
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLX 130
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 189
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 190 ILGM-GYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 80
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 42/302 (13%)
Query: 135 ATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           A +  V  +P     P    +  K   ++G G FG V      + G    M        +
Sbjct: 2   ALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKE 59
Query: 195 AKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD--- 250
             SK+  +    E+ +L +L  HPNI+   G+      LY+ +EY   G++   L+    
Sbjct: 60  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 119
Query: 251 ------YGQLGESAIRSYTQQIL-------SGLEYLHAKNTVHRDIKGANILVDPSGRVK 297
                 +     +A    +QQ+L        G++YL  K  +HR++   NILV  +   K
Sbjct: 120 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAK 179
Query: 298 LADFGMAK----HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT 353
           +ADFG+++    ++      L ++    WMA E + N +      D+WS G  + E+ + 
Sbjct: 180 IADFGLSRGQEVYVKKTMGRLPVR----WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSL 234
Query: 354 -KPPW------SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAW 406
              P+        YE +P  +++         P +  DE  D +R+C +  P  RP+ A 
Sbjct: 235 GGTPYCGMTCAELYEKLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQ 287
Query: 407 LL 408
           +L
Sbjct: 288 IL 289

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 80
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 81  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 141 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 199
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 200 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 255
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 256 PDNCPDMLFELMRMCWQYNPKMRPS 280

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 73
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 74  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 134 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 192
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 193 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 248
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 249 PDNCPDMLFELMRMCWQYNPKMRPS 273

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 22  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 77
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 78  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 137
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 138 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 196
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 197 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 252
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 253 PDNCPDMLFELMRMCWQYNPKMRPS 277

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 48/219 (21%)
Query: 236 LEYVSG---GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD- 291
            EY++      +Y+IL D+       IR Y  ++L  L+Y H+K  +HRD+K  N+++D 
Sbjct: 119 FEYINNTDFKQLYQILTDFD------IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 172
Query: 292 PSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
              +++L D+G+A+     Q   + +  S Y+  PE++ +    + ++D+WSLGC +  M
Sbjct: 173 QQKKLRLIDWGLAEFYHPAQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 231
Query: 351 ATTKPPW----SQYEGVPAMFKIGNSKEL------------PAIPD-------------- 380
              + P+      Y+ +  + K+  ++EL            P   D              
Sbjct: 232 IFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFI 291
Query: 381 -----HL-SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
                HL S E  D + K L+ +   R TA   +EHP+ 
Sbjct: 292 HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 79
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 80  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 140 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 198
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 199 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 254
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPS 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 79
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 80  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 140 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 198
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 199 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 254
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 255 PDNCPDMLFELMRMCWQYNPKMRPS 279

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKXVN 81
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTK 354
               G    VDIWS+GC + EM   K
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 74
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 190
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 191 ILGM-GYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 73
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 130
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 189
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 190 ILGM-GYKENVDIWSVGCIMGEMVRHK 215

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 74
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 190
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 191 ILGM-GYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 80
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 79
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 80  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 136
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 195
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 196 ILGM-GYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 81
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 197
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 198 ILGM-GYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 119
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 176
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 235
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTK 354
               G    VDIWS+GC + EM   K
Sbjct: 236 LGM-GYKENVDIWSVGCIMGEMVRHK 260

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 119
Query: 216 HPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLCG 176
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 235
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTK 354
               G    VDIWS+GC + EM   K
Sbjct: 236 LGM-GYKENVDIWSVGCIMGEMVRHK 260

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 80
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 81
Query: 215 RHPNIVRYYG----SETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+         +TL++   +Y+ +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 197
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 198 ILGM-GYKENVDIWSVGCIMGEMVRHK 223

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 109/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 53  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 108
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 109 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 169 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 227
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 228 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 283
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 284 PDNCPDMLFELMRMCWQYNPKMRPS 308

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 110/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 86
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-------QLGESAIRSYTQ---Q 265
             ++VR  G  +      + +E ++ G +   L+           L   ++    Q   +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 206 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPS 286

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R   G+ LGRG FG V     F  +         V +  + A   E    + +   L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSIYKILQD-------YGQLGESAIR-- 260
           +    H N+V   G+ T     L + +E+   G++   L+        Y  L +  +   
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 261 ---SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
               Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      +  K
Sbjct: 145 HLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-K 203
Query: 318 GSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKI 369
           G       WMAPE I +     +  D+WS G  + E+ +     S Y GV        ++
Sbjct: 204 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRL 260
Query: 370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
                + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 261 KEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 303

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 36/262 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKE--VTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG+GTF  ++ G   E G+   + E  V L   D   +  ++   +  +++S+L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR-----SYTQQILSGLEYLHA 275
             YG     D+  +  E+V  GS    L  Y +  ++ I         +Q+ + + +L  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 276 KNTVHRDIKGANIL-VDPSGR-------VKLADFGMA-----KHITGQSCPLSIKGSPYW 322
              +H ++   NIL +    R       +KL+D G++     K I  +  P        W
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP--------W 183
Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           + PE I+N    NLA D WS G T+ E+ +    P S  +    +    +  +LPA    
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK-- 241
Query: 382 LSDEGKDFVRKCLQRNPLHRPT 403
            + E  + +  C+   P HRP+
Sbjct: 242 -AAELANLINNCMDYEPDHRPS 262

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 82
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHR++   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 143 GMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 198
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 199 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 256
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 257 NCPERVTDLMRMCWQFNPNMRPT 279

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 153 PGSRWKKGRLLGRGTFGHVY--LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P    + G++LG G FG V     +      +     V +  + A S E  + L  E+ +
Sbjct: 43  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKM 101
Query: 211 LSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL--------------------- 248
           +++L  H NIV   G+ TL   +Y+  EY   G +   L                     
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 249 --QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH 306
             +D   L    +  +  Q+  G+E+L  K+ VHRD+   N+LV     VK+ DFG+A+ 
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 307 ITGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
           I   S    ++G+      WMAPE +       +  D+WS G  + E+
Sbjct: 222 IMSDS-NYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEI 267

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 161 RLLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           R LG+G+FG VY G   +   GE      V   ++ A  +E  + L  E +++      +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHH 81
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES-------AIRSYTQ---QILS 268
           +VR  G  +      + +E ++ G +   L+      E+        ++   Q   +I  
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPY 321
           G+ YL+AK  VHR++   N +V     VK+ DFGM + I        G    L ++    
Sbjct: 142 GMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 197
Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           WMAPE +K+      + D+WS G  + E+ +  + P+        +  + +   L   PD
Sbjct: 198 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PD 255
Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   D +R C Q NP  RPT
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPT 278

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 153 PGSRWKKGRLLGRGTFGHVYLG--FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           P  R   G+ LGRG FG V     F  +         V +  + A   E    + +   L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 211 LSRLRHPNIVRYYGSETL-DDKLYIYLEYVSGGSIYKILQD-------YGQLGESAIR-- 260
           +    H N+V   G+ T     L + +E+   G++   L+        Y  L +  +   
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 261 ---SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
               Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      +  K
Sbjct: 145 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR-K 203
Query: 318 GSPY----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKI 369
           G       WMAPE I +     +  D+WS G  + E+ +     S Y GV        ++
Sbjct: 204 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFXRRL 260
Query: 370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN 415
                + A PD+ + E    +  C    P  RPT + L+EH  +GN
Sbjct: 261 KEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGN 303

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R +GRG +  V+ G N  + E C +K         K  +  +   +   L + +  PNIV
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKI-------LKPVKKKKIKREIKILQNLMGGPNIV 89
Query: 221 RYYGSETLDDKLY----IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           +    + + D+      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 90  KL--LDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 110/265 (41%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 76
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-------QLGESAIRSYTQ---Q 265
             ++VR  G  +      + +E ++ G +   L+           L   ++    Q   +
Sbjct: 77  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 136
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    L ++ 
Sbjct: 137 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 195
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 196 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 251
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 252 PDNCPDMLFELMRMCWQYNPKMRPS 276

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 83
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 140
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+        +    + Y+ APEVI 
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 330 NSNGCNLAVDIWSLGCTVIEM 350
              G    VDIWS+GC + EM
Sbjct: 201 GM-GYKENVDIWSVGCIMGEM 220

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQLGQEIALLSRLRHPN 218
           R +GRG +  V+ G N  + E C +K +         +E    Q L     ++  L   +
Sbjct: 58  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKLL---D 114
Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++  
Sbjct: 115 IVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQGI 167
Query: 279 VHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    + 
Sbjct: 168 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDYDY 226
Query: 337 AVDIWSLGCTVIEMATTKPPW 357
           ++D+WSLGC    M   K P+
Sbjct: 227 SLDMWSLGCMFAGMIFRKEPF 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG+G+FG VY G        E     A+K V    ++A S     +   E +++    
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEASVMKEFN 73
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE----------SAIRSYTQQ 265
             ++VR  G  +      + +E ++ G +   L+      E          S +     +
Sbjct: 74  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           I  G+ YL+A   VHRD+   N  V     VK+ DFGM + I        G    L ++ 
Sbjct: 134 IADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 192
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
              WM+PE +K+      + D+WS G  + E+AT      Q      + +      L   
Sbjct: 193 ---WMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 248
Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPT 403
           PD+  D   + +R C Q NP  RP+
Sbjct: 249 PDNCPDMLLELMRMCWQYNPKMRPS 273

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 17/256 (6%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ---LGQEIALLSRL 214
           K  +++G G FG V  G     G+    +E+ +     KS  + +Q      E +++ + 
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYL 273
            HPN++   G  T    + I  E++  GS+   L Q+ GQ     +    + I +G++YL
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ------SCPLSIKGSPYWMAPEV 327
              N VHR +   NILV+ +   K++DFG+++ +         +  L  K    W APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 328 IKNSNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           I+     + A D+WS G  + E M+  + P+        +  I     LP  P       
Sbjct: 186 IQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMDCPSAL 243
Query: 387 KDFVRKCLQRNPLHRP 402
              +  C Q++  HRP
Sbjct: 244 HQLMLDCWQKDRNHRP 259

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL----- 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 92  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 38  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL----- 92
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 93  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 145
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 204
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 38  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL----- 92
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 93  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 145
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 204
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL----- 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 92  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 39  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL----- 93
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 94  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 146
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 147 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 205
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 206 DYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL----- 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 92  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 46/288 (15%)
Query: 153 PGSRWKKGRLLGRGTFGHVY----LGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           P +  + G+ LG G FG V      G   E   +    ++   +  A  KE+   L  E+
Sbjct: 29  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMSEL 85
Query: 209 ALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESA------- 258
            ++S L +H NIV   G+ T    + +  EY   G +   L+   +  LG S        
Sbjct: 86  KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE 145
Query: 259 --------------IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA 304
                         +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A
Sbjct: 146 GLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 205
Query: 305 KHITGQSCPLSIKGSPY----WMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWS 358
           + I   S  + +KG+      WMAPE I +   C   V  D+WS G  + E+ +     +
Sbjct: 206 RDIMNDSNYI-VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLG--LN 259
Query: 359 QYEGV---PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            Y G+      +K+       A P          ++ C    P HRPT
Sbjct: 260 PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 307

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL----- 91
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 92  LDIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKVVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA--QQL--GQEIALLSRLRH 216
           R +GRG +  V+ G N  + E C +K +         +E    Q L  G  I  L     
Sbjct: 37  RKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL---- 92
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            +IVR   S+T      +  EYV+    +K+L  Y  L +  IR Y  ++L  L+Y H++
Sbjct: 93  -DIVRDQHSKTPS----LIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 277 NTVHRDIKGANILVDPSGR-VKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNGC 334
             +HRD+K  N+++D   R ++L D+G+A+    G+   + +  S Y+  PE++ +    
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYFKGPELLVDLQDY 203
Query: 335 NLAVDIWSLGCTVIEMATTKPPW 357
           + ++D+WSLGC    M   K P+
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKVVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLVG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 28/268 (10%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G F +V L      G   A+K +     + + +E AQ+   E  +     HPNI+R 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQR---EADMHRLFNHPNILRL 91
Query: 223 YG----SETLDDKLYIYLEYVSGGSIY---KILQDYGQ-LGESAIRSYTQQILSGLEYLH 274
                       + ++ L +   G+++   + L+D G  L E  I      I  GLE +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIKG------SPYWMA 324
           AK   HRD+K  NIL+   G+  L D G       H+ G    L+++       +  + A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 325 PEVIKNSNGCNL--AVDIWSLGCTVIEMATTKPPWSQY--EGVPAMFKIGNSKELPAIPD 380
           PE+    + C +    D+WSLGC +  M   + P+     +G      + N   +P  P 
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR 271
Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
           H S      +   +  +P  RP    LL
Sbjct: 272 H-SSALWQLLNSMMTVDPHQRPHIPLLL 298

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G++LG G FG V  G    E G    +   T+  D++  +E  + L  E A +    HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDFSHPN 97
Query: 219 IVRYYG-----SETLDDKLYIYLEYVSGGSIYKILQDYGQLGE-------SAIRSYTQQI 266
           ++R  G     S     K  + L ++  G ++  L  Y +L           +  +   I
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLETGPKHIPLQTLLKFMVDI 156
Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGS 319
             G+EYL  +N +HRD+   N ++     V +ADFG++K I        G+   + +K  
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 214
Query: 320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT----KPPWSQYEGVPAMFKIGNSKEL 375
             W+A E + +    + + D+W+ G T+ E+AT      P    +E    +      K+ 
Sbjct: 215 --WIAIESLADRVYTSKS-DVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ- 270
Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
              P+   DE  + +  C + +PL RPT + L
Sbjct: 271 ---PEDCLDELYEIMYSCWRTDPLDRPTFSVL 299

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 24/245 (9%)
Query: 130 PSYSTATSPSVPRSPGRVENPTSP---GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMK 186
           P   T   P     P R  +  +     S  K  R++G G FG V  G     G+     
Sbjct: 15  PGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAV 74
Query: 187 EVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYK 246
            +         K+    L  E +++ +  HPN+V   G  T    + I +E++  G++  
Sbjct: 75  AIKTLKVGYTEKQRRDFLC-EASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 247 ILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK 305
            L+ + GQ     +    + I +G+ YL     VHRD+   NILV+ +   K++DFG+++
Sbjct: 134 FLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSR 193
Query: 306 HI----------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--T 353
            I          TG   P+       W APE I+     + A D+WS G  + E+ +   
Sbjct: 194 VIEDDPEAVYTTTGGKIPVR------WTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGE 246
Query: 354 KPPWS 358
           +P W 
Sbjct: 247 RPYWD 251

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 19/253 (7%)
Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +G G FG V+LG+  N +   +  +KE ++  DD           +E  ++ +L HP +V
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEAEVMMKLSHPKLV 85
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           + YG       + +  E++  G +   L+   G      +      +  G+ YL     +
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNL 336
           HRD+   N LV  +  +K++DFGM + +       S  G+ +   W +PEV   S   + 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           + D+WS G  + E+ +  K P+        +  I     L   P   S      +  C +
Sbjct: 205 S-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWK 262
Query: 396 RNPLHRPTAAWLL 408
             P  RP  + LL
Sbjct: 263 ERPEDRPAFSRLL 275

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 14/226 (6%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G FG V  G      +   +    L       K   +++ +E  ++ +L +P IVR 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGE---SAIRSYTQQILSGLEYLHAKNTV 279
            G     + L + +E   GG ++K L   G+  E   S +     Q+  G++YL  KN V
Sbjct: 76  IGV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP----YWMAPEVIKNSNGCN 335
           HRD+   N+L+      K++DFG++K +       + + +      W APE I N    +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFS 191
Query: 336 LAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
              D+WS G T+ E ++  + P+ + +G   M  I   K +   P+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 237

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 110/202 (54%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++ +  + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPEVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
            P   E+PT     + K          +++G G FG V  G      ++ + KE+++   
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIK 79
Query: 194 DAKSKESAQQ----LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
             K   + +Q    LG E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+
Sbjct: 80  TLKVGYTEKQRRDFLG-EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            +  Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+A+ + 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 309 GQ-SCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
                  + +G      W +PE I      + A D+WS G  + E+ +   +P W
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 80
Query: 215 RHPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  +  +  + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VDIWS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDIWSVGCIMGEMVCHK 222

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 36/262 (13%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKE--VTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG+GTF  ++ G   E G+   + E  V L   D   +  ++   +  +++S+L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR-----SYTQQILSGLEYLHA 275
             YG     D+  +  E+V  GS    L  Y +  ++ I         +Q+   + +L  
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAWAMHFLEE 131
Query: 276 KNTVHRDIKGANIL-VDPSGR-------VKLADFGMA-----KHITGQSCPLSIKGSPYW 322
              +H ++   NIL +    R       +KL+D G++     K I  +  P        W
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP--------W 183
Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           + PE I+N    NLA D WS G T+ E+ +    P S  +    +    +  +LPA    
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK-- 241
Query: 382 LSDEGKDFVRKCLQRNPLHRPT 403
            + E  + +  C+   P HRP+
Sbjct: 242 -AAELANLINNCMDYEPDHRPS 262

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 10/231 (4%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K   ++G G FG V  G     G+  +   +         ++  + L  E +++ +  HP
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS-EASIMGQFEHP 77
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAK 276
           NI+R  G  T    + I  E++  G++   L+ + GQ     +    + I SG+ YL   
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP------LSIKGSPYWMAPEVIKN 330
           + VHRD+   NILV+ +   K++DFG+++ +   S        L  K    W APE I  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 331 SNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
               + A D WS G  + E M+  + P+        +  I     LP  PD
Sbjct: 198 RKFTS-ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPD 247

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 57/287 (19%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G +G V+ G  S  GE  A+K  +  S D KS     +L   + L    RH NI+ +
Sbjct: 45  VGKGRYGEVWRG--SWQGENVAVKIFS--SRDEKSWFRETELYNTVML----RHENILGF 96
Query: 223 YGSETLD----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-- 276
             S+        +L++   Y   GS+Y  LQ       S +R     I SGL +LH +  
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIF 155
Query: 277 ------NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-----YWMAP 325
                    HRD+K  NILV  +G+  +AD G+A   +  +  L +  +P      +MAP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 326 EVIKNSNGCNL-----AVDIWSLGCTVIEMA----------TTKPPWSQYEGVPA----- 365
           EV+  +   +       VDIW+ G  + E+A            KPP+  Y+ VP      
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDVVPNDPSFE 273
Query: 366 -MFK-IGNSKELPAIPDH------LSDEGKDFVRKCLQRNPLHRPTA 404
            M K +   ++ P IP+       L+   K  +++C  +NP  R TA
Sbjct: 274 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTA 319

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 86
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 143
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 202
Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTK 354
               G    VD+WS+GC + EM   K
Sbjct: 203 LGM-GYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 74
Query: 215 RHPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 75  NHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEV
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 190
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VD+WS+GC + EM   K
Sbjct: 191 ILGM-GYKENVDLWSVGCIMGEMVCHK 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 125/287 (43%), Gaps = 57/287 (19%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G +G V+ G  S  GE  A+K     S D KS     +L   + L    RH NI+ +
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVK--IFSSRDEKSWFRETELYNTVML----RHENILGF 67
Query: 223 YGSETLD----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-- 276
             S+        +L++   Y   GS+Y  LQ    L   +       I SGL +LH +  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 277 ------NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-----YWMAP 325
                    HRD+K  NILV  +G+  +AD G+A   +  +  L +  +P      +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 326 EVIKNSNGCNL-----AVDIWSLGCTVIEMA----------TTKPPWSQYEGVPA----- 365
           EV+  +   +       VDIW+ G  + E+A            KPP+  Y+ VP      
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDVVPNDPSFE 244
Query: 366 -MFK-IGNSKELPAIPDH------LSDEGKDFVRKCLQRNPLHRPTA 404
            M K +   ++ P IP+       L+   K  +++C  +NP  R TA
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTA 290

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 125/286 (43%), Gaps = 55/286 (19%)
Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           +G+G +G V+ G  S  GE  A+K     S D KS     +L   + L    RH NI+ +
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVK--IFSSRDEKSWFRETELYNTVML----RHENILGF 67
Query: 223 YGSETLD----DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-- 276
             S+        +L++   Y   GS+Y  LQ       S +R     I SGL +LH +  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIF 126
Query: 277 ------NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP-----YWMAP 325
                    HRD+K  NILV  +G+  +AD G+A   +  +  L +  +P      +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 326 EVIKNSNGCNL-----AVDIWSLGCTVIEMA----------TTKPPWSQYEGVPA----- 365
           EV+  +   +       VDIW+ G  + E+A            KPP+  Y+ VP      
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDVVPNDPSFE 244
Query: 366 -MFK-IGNSKELPAIPDH-LSD----EGKDFVRKCLQRNPLHRPTA 404
            M K +   ++ P IP+   SD         +++C  +NP  R TA
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 10/231 (4%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K   ++G G FG V  G     G+  +   +         ++  + L  E +++ +  HP
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS-EASIMGQFEHP 75
Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAK 276
           NI+R  G  T    + I  E++  G++   L+ + GQ     +    + I SG+ YL   
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP------LSIKGSPYWMAPEVIKN 330
           + VHRD+   NILV+ +   K++DFG+++ +   S        L  K    W APE I  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 331 SNGCNLAVDIWSLGCTVIE-MATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
               + A D WS G  + E M+  + P+        +  I     LP  PD
Sbjct: 196 RKFTS-ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPD 245

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLCG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 198 LGM-GYKENVDIWSVGCIMGEM 218

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESG--EMC-AMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           K  +++G G FG V  G     G  E+C A+K +     D + ++       E +++ + 
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD----FLSEASIMGQF 87
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYL 273
            HPNI+   G  T    + I  EY+  GS+   L ++ G+     +    + I SG++YL
Sbjct: 88  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 147
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIK 329
              + VHRD+   NILV+ +   K++DFGM++ +        + +G      W APE I 
Sbjct: 148 SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
                + A D+WS G  + E+ +   +P W 
Sbjct: 208 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 82
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG 139
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+GC + EM
Sbjct: 199 LGM-GYKENVDIWSVGCIMGEM 219

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 16/178 (8%)
Query: 243 SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADF 301
            ++  + + G L E   RS+  Q+L  + + H    +HRDIK  NIL+D + G +KL DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE 361
           G    +   +      G+  +  PE I+       +  +WSLG  + +M     P+   E
Sbjct: 203 GSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261
Query: 362 GV---PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
            +      F+             +S E +  +R CL   P  RPT   +  HP++ + 
Sbjct: 262 EIIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
            P   E+PT     + K          +++G G FG V  G      ++ + KE+++   
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIK 79
Query: 194 DAKSKESAQQ----LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
             K   + +Q    LG E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+
Sbjct: 80  TLKVGYTEKQRRDFLG-EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            +  Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+++ + 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 309 GQ-SCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
                  + +G      W +PE I      + A D+WS G  + E+ +   +P W
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCV 80
Query: 215 RHPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L 
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEV 327
           G+++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  +  +  + Y+ APEV
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEV 196
Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTK 354
           I    G    VD+WS+GC + EM   K
Sbjct: 197 ILGM-GYKENVDLWSVGCIMGEMVCHK 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R++G G FG V  G     G+      +         K+    LG E +++ +  HPNI+
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLG-EASIMGQFDHPNII 86
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
              G  T    + I  EY+  GS+   L+ + GQ     +    + I +G++YL     V
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNSNGCN 335
           HRD+   NIL++ +   K++DFG+++ +        + +G      W APE I      +
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTS 206
Query: 336 LAVDIWSLGCTVIEMAT--TKPPWS 358
            A D+WS G  + E+ +   +P W 
Sbjct: 207 -ASDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
            P   E+PT     + K          +++G G FG V  G      ++ + KE+++   
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIK 79
Query: 194 DAKSKESAQQ----LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
             K   + +Q    LG E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+
Sbjct: 80  TLKVGYTEKQRRDFLG-EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            +  Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+++ + 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 309 GQ-SCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
                  + +G      W +PE I      + A D+WS G  + E+ +   +P W
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
            P   E+PT     + K          +++G G FG V  G      ++ + KE+++   
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIK 79
Query: 194 DAKSKESAQQ----LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
             K   + +Q    LG E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+
Sbjct: 80  TLKVGYTEKQRRDFLG-EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            +  Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+++ + 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 309 GQ-SCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
                  + +G      W +PE I      + A D+WS G  + E+ +   +P W
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALLSRLRH 216
           +++G G FG V  G      ++ + KE+++     K   + +Q    LG E +++ +  H
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQFDH 105
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           PNI+R  G  T    + I  EY+  GS+   L+ +  Q     +    + I SG++YL  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNS 331
              VHRD+   NIL++ +   K++DFG+++ +        + +G      W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 332 NGCNLAVDIWSLGCTVIEMAT--TKPPW 357
              + A D+WS G  + E+ +   +P W
Sbjct: 226 KFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALLSRLRH 216
           +++G G FG V  G      ++ + KE+++     K   + +Q    LG E +++ +  H
Sbjct: 51  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQFDH 105
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           PNI+R  G  T    + I  EY+  GS+   L+ +  Q     +    + I SG++YL  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNS 331
              VHRD+   NIL++ +   K++DFG+++ +        + +G      W +PE I   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 332 NGCNLAVDIWSLGCTVIEMAT--TKPPW 357
              + A D+WS G  + E+ +   +P W
Sbjct: 226 KFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALLSRLRH 216
           +++G G FG V  G      ++ + KE+++     K   + +Q    LG E +++ +  H
Sbjct: 49  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQFDH 103
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           PNI+R  G  T    + I  EY+  GS+   L+ +  Q     +    + I SG++YL  
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 163
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNS 331
              VHRD+   NIL++ +   K++DFG+++ +        + +G      W +PE I   
Sbjct: 164 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 332 NGCNLAVDIWSLGCTVIEMAT--TKPPW 357
              + A D+WS G  + E+ +   +P W
Sbjct: 224 KFTS-ASDVWSYGIVLWEVMSYGERPYW 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALLSRLRH 216
           +++G G FG V  G      ++ + KE+++     K   + +Q    LG E +++ +  H
Sbjct: 39  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQFDH 93
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           PNI+R  G  T    + I  EY+  GS+   L+ +  Q     +    + I SG++YL  
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 153
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNS 331
              VHRD+   NIL++ +   K++DFG+++ +        + +G      W +PE I   
Sbjct: 154 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 332 NGCNLAVDIWSLGCTVIEMAT--TKPPW 357
              + A D+WS G  + E+ +   +P W
Sbjct: 214 KFTS-ASDVWSYGIVLWEVMSYGERPYW 240

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKVVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLVG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+G  + EM
Sbjct: 198 LGM-GYKENVDIWSVGVIMGEM 218

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESG--EMC-AMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           K  +++G G FG V  G     G  E+C A+K +     D + ++       E +++ + 
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD----FLSEASIMGQF 72
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYL 273
            HPNI+   G  T    + I  EY+  GS+   L ++ G+     +    + I SG++YL
Sbjct: 73  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIK 329
              + VHRD+   NILV+ +   K++DFGM++ +        + +G      W APE I 
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
                + A D+WS G  + E+ +   +P W 
Sbjct: 193 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
            P   E+PT     + K          +++G G FG V  G      ++ + KE+++   
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIK 79
Query: 194 DAKSKESAQQ----LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
             K   + +Q    LG E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+
Sbjct: 80  TLKVGYTEKQRRDFLG-EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            +  Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+ + + 
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 309 GQ-SCPLSIKGSPY---WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPW 357
                  + +G      W +PE I      + A D+WS G  + E+ +   +P W
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 41/283 (14%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R +  R+L  G F  VY   +  SG   A+K   L S++   +E  + + QE+  + +L 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNE---EEKNRAIIQEVCFMKKLS 83
Query: 216 -HPNIVRY-----YGSETLD--DKLYIYLEYVSGGSIYKILQDY---GQLGESAIRSYTQ 264
            HPNIV++      G E  D     ++ L  +  G + + L+     G L    +     
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 265 QILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPL 314
           Q    ++++H +    +HRD+K  N+L+   G +KL DFG A  I        + Q   L
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 315 -----SIKGSPYWMAPEVIKNSNGCNLA--VDIWSLGCTVIEMATTKPPWSQYEGVPAMF 367
                +   +P +  PE+I   +   +    DIW+LGC +  +   + P+       A  
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKL 259
Query: 368 KIGNSKELPAIPDHLSDEG--KDFVRKCLQRNPLHRPTAAWLL 408
           +I N K   +IP H +        +R  LQ NP  R + A ++
Sbjct: 260 RIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 158 KKGRLLGRGTFGHVYLGFNSESG--EMC-AMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           K  +++G G FG V  G     G  E+C A+K +     D + ++       E +++ + 
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD----FLSEASIMGQF 66
Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL-QDYGQLGESAIRSYTQQILSGLEYL 273
            HPNI+   G  T    + I  EY+  GS+   L ++ G+     +    + I SG++YL
Sbjct: 67  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIK 329
              + VHRD+   NILV+ +   K++DFGM++ +        + +G      W APE I 
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 330 NSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
                + A D+WS G  + E+ +   +P W 
Sbjct: 187 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQ----LGQEIALLSRLRH 216
           +++G G FG V  G      ++ + KE+++     K   + +Q    LG E +++ +  H
Sbjct: 22  KVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQFDH 76
Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHA 275
           PNI+R  G  T    + I  EY+  GS+   L+ +  Q     +    + I SG++YL  
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-SCPLSIKGSPY---WMAPEVIKNS 331
              VHRD+   NIL++ +   K++DFG+++ +        + +G      W +PE I   
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 332 NGCNLAVDIWSLGCTVIEMAT--TKPPW 357
              + A D+WS G  + E+ +   +P W
Sbjct: 197 KFTS-ASDVWSYGIVLWEVMSYGERPYW 223

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P   GR        SR    +++G G  G V  G     G+    ++V +     K+  +
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKALKAGYT 90
Query: 201 AQQ---LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGE 256
            +Q      E +++ +  HPNI+R  G  T      I  EY+  GS+   L+ + GQ   
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 257 SAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------- 307
             +    + + +G+ YL     VHRD+   N+LVD +   K++DFG+++ +         
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 308 -TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
            TG   P+       W APE I      + A D+WS G  + E+     +P W+
Sbjct: 211 TTGGKIPIR------WTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P   GR        SR    +++G G  G V  G     G+    ++V +     K+  +
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKALKAGYT 90
Query: 201 AQQ---LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGE 256
            +Q      E +++ +  HPNI+R  G  T      I  EY+  GS+   L+ + GQ   
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 257 SAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------- 307
             +    + + +G+ YL     VHRD+   N+LVD +   K++DFG+++ +         
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 308 -TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWS 358
            TG   P+       W APE I      + A D+WS G  + E+     +P W+
Sbjct: 211 TTGGKIPIR------WTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 19/253 (7%)
Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +G G FG V+LG+  N +   +  ++E  +         S +   +E  ++ +L HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLV 65
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           + YG       + +  E++  G +   L+   G      +      +  G+ YL   + +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNL 336
           HRD+   N LV  +  +K++DFGM + +       S  G+ +   W +PEV   S   + 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           + D+WS G  + E+ +  K P+        +  I     L   P   S      +  C +
Sbjct: 185 S-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWK 242
Query: 396 RNPLHRPTAAWLL 408
             P  RP  + LL
Sbjct: 243 ERPEDRPAFSRLL 255

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKVVN 81
Query: 216 HPNIV----RYYGSETLDD--KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+     +   ++L++   +YI +E +   ++ +++Q   +L    +     Q+L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQ--MELDHERMSYLLYQMLVG 138
Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVI 328
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+   G S  ++    + Y+ APEVI
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 329 KNSNGCNLAVDIWSLGCTVIEM 350
               G    VDIWS+G  + EM
Sbjct: 198 LGM-GYKENVDIWSVGVIMGEM 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 106/274 (38%), Gaps = 35/274 (12%)
Query: 161 RLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R LG G FG VY G      N  S    A+K +     +  S++       E  ++S+L 
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP----EVCSEQDELDFLMEALIISKLN 92
Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQILS 268
           H NIVR  G        +I LE ++GG +   L++          L    +    + I  
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 269 GLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHI-------TGQSCPLSIKG 318
           G +YL   + +HRDI   N L+    P    K+ DFGMA+ I        G    L +K 
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK- 211
Query: 319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT--KPPWSQYEGVPAMFKIGNSKELP 376
              WM PE        +   D WS G  + E+ +    P  S+       F     +  P
Sbjct: 212 ---WMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 267
Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             P +        + +C Q  P  RP  A +LE 
Sbjct: 268 --PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 105/253 (41%), Gaps = 19/253 (7%)
Query: 163 LGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +G G FG V+LG+  N +   +  ++E  +         S +   +E  ++ +L HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLV 65
Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           + YG       + +  E++  G +   L+   G      +      +  G+ YL     +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---WMAPEVIKNSNGCNL 336
           HRD+   N LV  +  +K++DFGM + +       S  G+ +   W +PEV   S   + 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           + D+WS G  + E+ +  K P+        +  I     L   P   S      +  C +
Sbjct: 185 S-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNHCWK 242
Query: 396 RNPLHRPTAAWLL 408
             P  RP  + LL
Sbjct: 243 ERPEDRPAFSRLL 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	444
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-155
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-143
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-134
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-120
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-119
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-119
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-116
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-115
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-114
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-94
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-92
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-92
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-92
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-91
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-87
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-87
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-85
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-84
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-81
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-80
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-77
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-77
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-76
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-76
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-76
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-76
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-76
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-75
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-75
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-75
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-75
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-71
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-70
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-68
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-68
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-68
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-66
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-66
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-65
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-64
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-64
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-64
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-63
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-63
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-63
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-63
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-63
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-62
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-62
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-62
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-62
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-62
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-62
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-61
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-61
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-61
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-61
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-61
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-61
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-61
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-61
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-60
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-60
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-60
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-60
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-60
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-60
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-60
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-60
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-59
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-59
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-59
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-59
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-59
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-59
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-59
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-58
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-58
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-58
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-57
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-57
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-57
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-57
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-57
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-56
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-55
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-55
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-55
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-54
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-54
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-54
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-54
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-54
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-53
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-53
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-52
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-52
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-51
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-51
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-51
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-51
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-51
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-51
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-50
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-50
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-50
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-50
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-49
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-49
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-49
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-49
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-49
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-49
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-48
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-48
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-48
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-47
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-46
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-45
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-45
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-44
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-43
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-43
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-42
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-42
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-42
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-41
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-41
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-40
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-40
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-40
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-40
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-39
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-38
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-38
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-37
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-28
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-26
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-26
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-26
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-24
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-22
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-22
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-22
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-20
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-20
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-18
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
3h0g_A	1752	DNA-directed RNA polymerase II subunit RPB1; trans	6e-05
1twf_A	1733	B220, DNA-directed RNA polymerase II largest subun	8e-05
1twf_A	1733	B220, DNA-directed RNA polymerase II largest subun	5e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  439 bits (1132), Expect = e-155
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 13/297 (4%)

Query: 133 STATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS 192
           S  ++         +E             +LG+GT+G VY G +  +    A+KE+    
Sbjct: 1   SMRSTEEGDCESDLLEY-DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-- 57

Query: 193 DDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG 252
              +    +Q L +EIAL   L+H NIV+Y GS + +  + I++E V GGS+  +L+   
Sbjct: 58  ---RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114

Query: 253 ---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHIT 308
              +  E  I  YT+QIL GL+YLH    VHRDIKG N+L++  SG +K++DFG +K + 
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

Query: 309 G-QSCPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQY-EGVPA 365
           G   C  +  G+  +MAPE+I     G   A DIWSLGCT+IEMAT KPP+ +  E   A
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERP 422
           MFK+G  K  P IP+ +S E K F+ KC + +P  R  A  LL   F+  ++  ++ 
Sbjct: 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  411 bits (1058), Expect = e-143
 Identities = 88/338 (26%), Positives = 135/338 (39%), Gaps = 30/338 (8%)

Query: 93  AGGGVSESPSSRPDDVKQQSHRL-PLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPT 151
              G + S +S        S +L  L P T  N                           
Sbjct: 5   VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE----------YR 54

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
                      +GRG+FG V+   + ++G  CA+K+V L        E  +   +E+   
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFRV--EELVAC 104

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           + L  P IV  YG+      + I++E + GGS+ ++++  G L E     Y  Q L GLE
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 272 YLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQSCPL------SIKGSPYWMA 324
           YLH +  +H D+K  N+L+   G R  L DFG A  +              I G+   MA
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLS 383
           PEV+     C+  VDIWS  C ++ M     PW+QY   P   KI +    +  IP   +
Sbjct: 225 PEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
                 +++ L++ P+HR +A  L              
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  387 bits (995), Expect = e-134
 Identities = 78/272 (28%), Positives = 140/272 (51%), Gaps = 15/272 (5%)

Query: 151 TSPGSRW-KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
            S   R+ K    +GRG+F  VY G ++E+    A  E+    D   +K   Q+  +E  
Sbjct: 21  MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL---QDRKLTKSERQRFKEEAE 77

Query: 210 LLSRLRHPNIVRYYGS----ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
           +L  L+HPNIVR+Y S          + +  E ++ G++   L+ +  +    +RS+ +Q
Sbjct: 78  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 137

Query: 266 ILSGLEYLHAKNT--VHRDIKGANILVD-PSGRVKLADFGMAKHITGQSCPLSIKGSPYW 322
           IL GL++LH +    +HRD+K  NI +  P+G VK+ D G+A          ++ G+P +
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEF 196

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-AIPDH 381
           MAPE+ +     + +VD+++ G  ++EMAT++ P+S+ +    +++   S   P +    
Sbjct: 197 MAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              E K+ +  C+++N   R +   LL H F 
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  350 bits (901), Expect = e-120
 Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 13/292 (4%)

Query: 127 PFSPSYSTATSPSVPRSPGRVENPTSPGSR----WKKGRLLGRGTFGHVYLGFNSESGEM 182
              P   +    +         +P+ P S     +++   LG G++G V+   + E G +
Sbjct: 25  QLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL 84

Query: 183 CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG 242
            A+K           K+ A++L +  +     +HP  VR   +      LY+  E   G 
Sbjct: 85  YAVKRSMS--PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGP 141

Query: 243 SIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF 301
           S+ +  + +G  L E+ +  Y +  L  L +LH++  VH D+K ANI + P GR KL DF
Sbjct: 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDF 201

Query: 302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE 361
           G+   +         +G P +MAPE+++       A D++SLG T++E+A         E
Sbjct: 202 GLLVELGTAGAGEVQEGDPRYMAPELLQ--GSYGTAADVFSLGLTILEVACNMELPHGGE 259

Query: 362 GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           G     ++      P     LS E +  +   L+ +P  R TA  LL  P +
Sbjct: 260 G---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  349 bits (897), Expect = e-119
 Identities = 88/296 (29%), Positives = 150/296 (50%), Gaps = 12/296 (4%)

Query: 129 SPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV 188
                       P+   R +   +  + ++  + +GRG F  VY       G   A+K+V
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 189 TLFSD-DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKI 247
            +F   DAK++    +   EI LL +L HPN+++YY S   D++L I LE    G + ++
Sbjct: 66  QIFDLMDAKARADCIK---EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122

Query: 248 LQDYGQLG----ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
           ++ + +      E  +  Y  Q+ S LE++H++  +HRDIK AN+ +  +G VKL D G+
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182

Query: 304 AKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW-SQYE 361
            +  + ++    S+ G+PY+M+PE I   NG N   DIWSLGC + EMA  + P+     
Sbjct: 183 GRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

Query: 362 GVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
            + ++ K     + P +P DH S+E +  V  C+  +P  RP   ++ +     +A
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  347 bits (893), Expect = e-119
 Identities = 68/297 (22%), Positives = 131/297 (44%), Gaps = 34/297 (11%)

Query: 145 GRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           G +   +   + + +   +G G FG V+       G + A+K        +  +++A + 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR- 59

Query: 205 GQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----LGESAI 259
             E+   + L +H ++VRY+ +   DD + I  EY +GGS+   + +  +      E+ +
Sbjct: 60  --EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-------------------VKLAD 300
           +    Q+  GL Y+H+ + VH DIK +NI +  +                      K+ D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY 360
            G    I+    P   +G   ++A EV++ +       DI++L  TV+  A  +P     
Sbjct: 178 LGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
           +      +I   + LP IP  LS E  + ++  +  +P  RP+A  L++H  + +A+
Sbjct: 235 D---QWHEIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  344 bits (884), Expect = e-116
 Identities = 83/362 (22%), Positives = 141/362 (38%), Gaps = 34/362 (9%)

Query: 90  HPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVEN 149
           H     G+    S   +    +  R  +    +        S S     SV         
Sbjct: 3   HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVK-------- 54

Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
               G  +   + +G G    V+   N E  ++ A+K V L   +    ++      EIA
Sbjct: 55  ----GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIA 106

Query: 210 LLSRLRHPN--IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            L++L+  +  I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML 165

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMA 324
             +  +H    VH D+K AN L+   G +KL DFG+A  +   +  +   S  G+  +M 
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 325 PEVIKNSNG----------CNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSK 373
           PE IK+ +            +   D+WSLGC +  M   K P+ Q    +  +  I +  
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKP 433
                PD    + +D ++ CL+R+P  R +   LL HP+V         +      E K 
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344

Query: 434 TL 435
            L
Sbjct: 345 VL 346

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  340 bits (873), Expect = e-115
 Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 22/298 (7%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +   + +G G    V+   N E  ++ A+K V L   +    ++      EIA L++
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNK 63

Query: 214 LRHPN--IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           L+  +  I+R Y  E  D  +Y+ +E      +   L+    +     +SY + +L  + 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMAPEVI 328
            +H    VH D+K AN L+   G +KL DFG+A  +   +  +   S  G+  +M PE I
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 329 KNSNG----------CNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGNSKELPA 377
           K+ +            +   D+WSLGC +  M   K P+ Q    +  +  I +      
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241

Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTL 435
            PD    + +D ++ CL+R+P  R +   LL HP+V         +      E K  L
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  336 bits (865), Expect = e-114
 Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 22/297 (7%)

Query: 133 STATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS 192
             ++   +       ++ +  G  +   + +G G    V+   N E  ++ A+K V L  
Sbjct: 6   HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL-- 62

Query: 193 DDAKSKESAQQLGQEIALLSRLRHPN--IVRYYGSETLDDKLYIYLEYVSGGSIYKILQD 250
            +    ++      EIA L++L+  +  I+R Y  E  D  +Y+ +E      +   L+ 
Sbjct: 63  -EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120

Query: 251 YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ 310
              +     +SY + +L  +  +H    VH D+K AN L+   G +KL DFG+A  +   
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179

Query: 311 SCPL---SIKGSPYWMAPEVIKNSN----------GCNLAVDIWSLGCTVIEMATTKPPW 357
           +  +   S  G+  +M PE IK+ +            +   D+WSLGC +  M   K P+
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

Query: 358 SQYEG-VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            Q    +  +  I +       PD    + +D ++ CL+R+P  R +   LL HP+V
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  291 bits (747), Expect = 1e-96
 Identities = 108/284 (38%), Positives = 163/284 (57%), Gaps = 8/284 (2%)

Query: 135 ATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD 194
           A SP     PG       P   + K   +G+G+FG V+ G ++ + ++ A+K + L    
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL---- 57

Query: 195 AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQL 254
            ++++  + + QEI +LS+   P + +YYGS   D KL+I +EY+ GGS   +L+  G L
Sbjct: 58  EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPL 116

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP- 313
            E+ I +  ++IL GL+YLH++  +HRDIK AN+L+   G VKLADFG+A  +T      
Sbjct: 117 DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

Query: 314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
            +  G+P+WMAPEVIK S   +   DIWSLG T IE+A  +PP S+   +  +F I  + 
Sbjct: 177 NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
             P +  + S   K+FV  CL + P  RPTA  LL+H F+   A
Sbjct: 236 P-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  284 bits (730), Expect = 4e-94
 Identities = 100/288 (34%), Positives = 146/288 (50%), Gaps = 14/288 (4%)

Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
            R    V     P   W+    LG G FG VY   N E+G + A K +   S++      
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---- 60

Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAI 259
            +    EI +L+   HP IV+  G+   D KL+I +E+  GG++  I+ +    L E  I
Sbjct: 61  -EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119

Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-LSIKG 318
           +   +Q+L  L +LH+K  +HRD+K  N+L+   G ++LADFG++           S  G
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179

Query: 319 SPYWMAPEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK- 373
           +PYWMAPEV+          +   DIWSLG T+IEMA  +PP  +   +  + KI  S  
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239

Query: 374 -ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
             L   P   S E +DF++  L +NP  RP+AA LLEHPFV +    +
Sbjct: 240 PTLLT-PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  284 bits (729), Expect = 3e-93
 Identities = 80/278 (28%), Positives = 140/278 (50%), Gaps = 8/278 (2%)

Query: 139 SVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK 198
           S     G          ++ + + +G G+FG   L  ++E G    +KE+ +    +K +
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67

Query: 199 ESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGE 256
           E +++   E+A+L+ ++HPNIV+Y  S   +  LYI ++Y  GG ++K +         E
Sbjct: 68  EESRR---EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 257 SAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-S 315
             I  +  QI   L+++H +  +HRDIK  NI +   G V+L DFG+A+ +        +
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
             G+PY+++PE+ +N    N   DIW+LGC + E+ T K  +        + KI +    
Sbjct: 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-F 242

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           P +  H S + +  V +  +RNP  RP+   +LE  F+
Sbjct: 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  280 bits (718), Expect = 3e-92
 Identities = 91/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)

Query: 149 NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           +   P  ++ +   +G+G  G VY   +  +G+  A++++ L     K     + +  EI
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEI 68

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +   + E  I +  ++ L 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ 127

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEV 327
            LE+LH+   +HRDIK  NIL+   G VKL DFG    IT  QS   ++ G+PYWMAPEV
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDE 385
           +         VDIWSLG   IEM   +PP+     + A++ I  +   P +  P+ LS  
Sbjct: 188 VTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAI 245

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
            +DF+ +CL+ +   R +A  LL+H F+  A PL 
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  280 bits (718), Expect = 4e-92
 Identities = 104/278 (37%), Positives = 155/278 (55%), Gaps = 13/278 (4%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
                 P   +     LG G++G VY   + E+G++ A+K+V +       +   Q++ +
Sbjct: 21  DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIK 73

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQ 265
           EI+++ +   P++V+YYGS   +  L+I +EY   GS+  I++     L E  I +  Q 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-LSIKGSPYWMA 324
            L GLEYLH    +HRDIK  NIL++  G  KLADFG+A  +T       ++ G+P+WMA
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHL 382
           PEVI+   G N   DIWSLG T IEMA  KPP++    + A+F I  +   P    P+  
Sbjct: 194 PEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELW 251

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           SD   DFV++CL ++P  R TA  LL+HPFV +A  + 
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  279 bits (715), Expect = 9e-92
 Identities = 90/300 (30%), Positives = 143/300 (47%), Gaps = 27/300 (9%)

Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQ 202
               +    +    ++   ++G G    V   + +   E  A+K + L     K + S  
Sbjct: 4   DSSALPWSINR-DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMD 58

Query: 203 QLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ--------DYGQL 254
           +L +EI  +S+  HPNIV YY S  + D+L++ ++ +SGGS+  I++          G L
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL 314
            ES I +  +++L GLEYLH    +HRD+K  NIL+   G V++ADFG++  +       
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178

Query: 315 SIK------GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
             K      G+P WMAPEV++   G +   DIWS G T IE+AT   P+ +Y  +  +  
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238

Query: 369 IGNSK--------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
              +         +   +        +  +  CLQ++P  RPTAA LL H F   A   E
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  279 bits (716), Expect = 2e-91
 Identities = 97/271 (35%), Positives = 143/271 (52%), Gaps = 9/271 (3%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   +   R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L 
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQ 109

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           +LRHPN ++Y G    +   ++ +EY  G +   +      L E  I + T   L GL Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS- 331
           LH+ N +HRD+K  NIL+   G VKL DFG A  +   +   S  G+PYWMAPEVI    
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMD 226

Query: 332 -NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI-PDHLSDEGKDF 389
               +  VD+WSLG T IE+A  KPP      + A++ I  ++  PA+   H S+  ++F
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNF 285

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
           V  CLQ+ P  RPT+  LL+H FV    P  
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  278 bits (712), Expect = 4e-91
 Identities = 93/275 (33%), Positives = 141/275 (51%), Gaps = 11/275 (4%)

Query: 149 NPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
           +   P         +G G+ G V L     SG   A+K + L     +     + L  E+
Sbjct: 39  DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-----ELLFNEV 93

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            ++   +H N+V  Y S  + ++L++ +E++ GG++  I+    +L E  I +  + +L 
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQ 152

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSCPLSIKGSPYWMAPEV 327
            L YLHA+  +HRDIK  +IL+   GRVKL+DFG    I+       S+ G+PYWMAPEV
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDE 385
           I  S      VDIWSLG  VIEM   +PP+     V AM ++ +S   P +     +S  
Sbjct: 213 ISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPV 270

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
            +DF+ + L R+P  R TA  LL+HPF+      E
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  275 bits (706), Expect = 3e-90
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 20/285 (7%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   ++   L+G GT+G VY G + ++G++ A+K + +  D+ +       + QEI +L 
Sbjct: 22  PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE------IKQEINMLK 75

Query: 213 RL-RHPNIVRYYGS------ETLDDKLYIYLEYVSGGSIYKILQ--DYGQLGESAIRSYT 263
           +   H NI  YYG+        +DD+L++ +E+   GS+  +++      L E  I    
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135

Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP-LSIKGSPYW 322
           ++IL GL +LH    +HRDIKG N+L+  +  VKL DFG++  +        +  G+PYW
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195

Query: 323 MAPEVIKNSNGC----NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI 378
           MAPEVI          +   D+WSLG T IEMA   PP      + A+F I  +      
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 255

Query: 379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
               S + + F+  CL +N   RP    L++HPF+ +     +  
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVR 300

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  266 bits (683), Expect = 5e-87
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 39/290 (13%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S +++  +LG+G FG V    N+      A+K++        ++E    +  E+ LL+ L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59

Query: 215 RHPNIVRYYGS-------------ETLDDKLYIYLEYVSGGSIYKILQDYGQLG-ESAIR 260
            H  +VRYY +                   L+I +EY   G++Y ++             
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--- 317
              +QIL  L Y+H++  +HRD+K  NI +D S  VK+ DFG+AK++      L +    
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 318 ------------GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                       G+  ++A EV+  +   N  +D++SLG    EM    P  +  E V  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237

Query: 366 MFKI--GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           + K+   + +  P   D+     K  +R  +  +P  RP A  LL   ++
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  266 bits (681), Expect = 6e-87
 Identities = 66/291 (22%), Positives = 127/291 (43%), Gaps = 34/291 (11%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +K+  L+G G FG V+   +   G+   +K V   ++ A+         +E+  L++
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE---------REVKALAK 60

Query: 214 LRHPNIVRYYGS----------------ETLDDKLYIYLEYVSGGSIYKILQDY--GQLG 255
           L H NIV Y G                  +    L+I +E+   G++ + ++     +L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS 315
           +       +QI  G++Y+H+K  ++RD+K +NI +  + +VK+ DFG+   +        
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL 375
            KG+  +M+PE I +       VD+++LG  + E+         +E       + +    
Sbjct: 181 SKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRDGI-- 235

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSA 426
             I D    + K  ++K L + P  RP  + +L    V   +P +    +A
Sbjct: 236 --ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  264 bits (676), Expect = 6e-85
 Identities = 72/336 (21%), Positives = 122/336 (36%), Gaps = 60/336 (17%)

Query: 147 VENPTSPGSRWKKGRLLGRG--TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           + +    G  ++   ++G+G      V L     +GE   ++ + L   +A S E    L
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFL 73

Query: 205 GQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSY 262
             E+ +     HPNIV Y  +   D++L++   +++ GS   ++  +    + E AI   
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG--------MAKHITGQSCPL 314
            Q +L  L+Y+H    VHR +K ++IL+   G+V L+             +       P 
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 315 SIKGSPYWMAPEVIK-NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI---- 369
                  W++PEV++ N  G +   DI+S+G T  E+A    P+        + +     
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 370 ----------------------------------------GNSKELPAIPDHLSDEGKDF 389
                                                                S     F
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILS 425
           V +CLQRNP  RP+A+ LL H F           L 
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 349

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  258 bits (662), Expect = 3e-84
 Identities = 79/274 (28%), Positives = 126/274 (45%), Gaps = 17/274 (6%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S    ++    +G G++G          G++   KE+   S     K+       E+ LL
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLL 59

Query: 212 SRLRHPNIVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQ 265
             L+HPNIVRYY    +  +  LYI +EY  GG +  ++    +      E  +     Q
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 266 ILSGLEYLHAKNT-----VHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGS 319
           +   L+  H ++      +HRD+K AN+ +D    VKL DFG+A+ +    S   +  G+
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP 379
           PY+M+PE +      N   DIWSLGC + E+    PP++ +       KI   K    IP
Sbjct: 180 PYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIP 237

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
              SDE  + + + L     HRP+   +LE+P +
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  253 bits (647), Expect = 1e-81
 Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 36/296 (12%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +  + LGRG FG V+   N       A+K + L + +  ++E   +   E+  L++L HP
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMR---EVKALAKLEHP 63

Query: 218 NIVRYYGS------------ETLDDKLYIYLEYVSGGSIYKILQDYGQLG---ESAIRSY 262
            IVRY+ +             +    LYI ++     ++   +     +     S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-------------G 309
             QI   +E+LH+K  +HRD+K +NI       VK+ DFG+   +               
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
            +      G+  +M+PE I   N  +  VDI+SLG  + E+    P  +Q E V  +  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV 240

Query: 370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILS 425
            N K  P +           V+  L  +P+ RP A  ++E+    +     + +L 
Sbjct: 241 RNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLR 295

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  253 bits (649), Expect = 2e-80
 Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 25/298 (8%)

Query: 136 TSPSV-PRSPGRVENPTSPGS-RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
           +SPS+         +    G   +    +LG G  G +            A+K +     
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI----- 56

Query: 194 DAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG 252
                E      +E+ LL     HPN++RY+ +E      YI +E  +      + Q   
Sbjct: 57  ---LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDF 113

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-----RVKLADFGMAKHI 307
                   +  QQ  SGL +LH+ N VHRD+K  NIL+         +  ++DFG+ K +
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 308 TGQSCPLS----IKGSPYWMAPEVIKNSNGCNL--AVDIWSLGCTVIEMATT-KPPWSQY 360
                  S    + G+  W+APE++      N    VDI+S GC    + +    P+ + 
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233

Query: 361 EGVPAMFKIGN-SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA 417
               A   +G  S +      H     ++ + K +  +P  RP+A  +L+HPF  +  
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  243 bits (622), Expect = 1e-77
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 27/272 (9%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVR 221
           +GRG +G V    +  SG++ A+K +    D+ + K    QL  ++  ++     P IV+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK----QLLMDLDVVMRSSDCPYIVQ 85

Query: 222 YYGSETLDDKLYIYLEYVSGGS--IYKILQDY--GQLGESAIRSYTQQILSGLEYLHAK- 276
           +YG+   +   +I +E +S      YK +       + E  +   T   +  L +L    
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-----GSPYWMAPEVIKNS 331
             +HRDIK +NIL+D SG +KL DFG++  +       SI      G   +MAPE I  S
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPS 200

Query: 332 ---NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSK--ELPAIPDHL-SD 384
               G ++  D+WSLG T+ E+AT + P+ ++  V   + ++      +L    +   S 
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
              +FV  CL ++   RP    LL+HPF+   
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMY 292

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  239 bits (613), Expect = 9e-77
 Identities = 86/277 (31%), Positives = 138/277 (49%), Gaps = 17/277 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S LRHPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H+K  +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQ----SCPLSIKGSPYWMAPEVIKNSNGCN 335
           HRDIK  N+L+  +G +K+ADFG + H         C     G+  ++ PE+I+     +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEMIEGR-MHD 185

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCL 394
             VD+WSLG    E    KPP+ +       + +I   +     PD +++  +D + + L
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVE--FTFPDFVTEGARDLISRLL 242

Query: 395 QRNPLHRPTAAWLLEHP-FVGNAAPLERPILSAEPSE 430
           + NP  RP    +LEHP    N++           S+
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  239 bits (613), Expect = 1e-76
 Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 13/260 (5%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVR 221
           LGRG +G V    +  SG++ A+K +    +  + K    +L  ++   +  +  P  V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK----RLLMDLDISMRTVDCPFTVT 70

Query: 222 YYGSETLDDKLYIYLEYVSGG--SIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAK-N 277
           +YG+   +  ++I +E +       YK ++     + E  +      I+  LE+LH+K +
Sbjct: 71  FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---NSNGC 334
            +HRD+K +N+L++  G+VK+ DFG++ ++          G   +MAPE I    N  G 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
           ++  DIWSLG T+IE+A  + P+  +      + ++          D  S E  DF  +C
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250

Query: 394 LQRNPLHRPTAAWLLEHPFV 413
           L++N   RPT   L++HPF 
Sbjct: 251 LKKNSKERPTYPELMQHPFF 270

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  240 bits (614), Expect = 2e-76
 Identities = 72/268 (26%), Positives = 132/268 (49%), Gaps = 14/268 (5%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVR 221
           +G GT G V+     ++G + A+K++    +  ++K    ++  ++  +L     P IV+
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK----RILMDLDVVLKSHDCPYIVQ 88

Query: 222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVH 280
            +G+   +  ++I +E +   +     +  G + E  +   T  I+  L YL  K   +H
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC----NL 336
           RD+K +NIL+D  G++KL DFG++  +          G   +MAPE I   +      ++
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPDHL--SDEGKDFVRKC 393
             D+WSLG +++E+AT + P+   +     + K+    E P +P H+  S + + FV+ C
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDC 267

Query: 394 LQRNPLHRPTAAWLLEHPFVGNAAPLER 421
           L ++   RP    LLEH F+     LE 
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  238 bits (609), Expect = 4e-76
 Identities = 84/277 (30%), Positives = 133/277 (48%), Gaps = 17/277 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
           GR LG+G FG+VYL    ++  + A+K   LF    + +    QL +EI + S LRHPNI
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           +R Y       ++Y+ LE+   G +YK LQ +G+  E    ++ +++   L Y H +  +
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 136

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQ----SCPLSIKGSPYWMAPEVIKNSNGCN 335
           HRDIK  N+L+   G +K+ADFG + H         C     G+  ++ PE+I+     +
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEG-KTHD 190

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCL 394
             VD+W  G    E     PP+           +I N       P  LSD  KD + K L
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLL 247

Query: 395 QRNPLHRPTAAWLLEHP-FVGNAAPLERPILSAEPSE 430
           + +P  R     ++EHP    N+  +  P+  +  S+
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  238 bits (609), Expect = 5e-76
 Identities = 78/291 (26%), Positives = 140/291 (48%), Gaps = 20/291 (6%)

Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
              P  + +P S   R+ +GR LG+G F   +   ++++ E+ A K   +          
Sbjct: 2   KEIPEVLVDPRS-RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLLKPHQ 58

Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
            +++  EI++   L H ++V ++G    +D +++ LE     S+ ++ +    L E   R
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ------SCPL 314
            Y +QI+ G +YLH    +HRD+K  N+ ++    VK+ DFG+A  +          C  
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-- 176

Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSK 373
              G+P ++APEV+    G +  VD+WS+GC +  +   KPP+ +   +   + +I  ++
Sbjct: 177 ---GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNE 231

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGNAAPLERPI 423
              +IP H++      ++K LQ +P  RPT   LL    F     P   PI
Sbjct: 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  239 bits (611), Expect = 8e-76
 Identities = 83/317 (26%), Positives = 148/317 (46%), Gaps = 21/317 (6%)

Query: 116 PLPPLTISNTCP-FSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLG 174
           P P        P  +   + A +P     P  + +P S   R+ +GR LG+G F   +  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRS-RRRYVRGRFLGKGGFAKCFEI 60

Query: 175 FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI 234
            ++++ E+ A K   +           +++  EI++   L H ++V ++G    +D +++
Sbjct: 61  SDADTKEVFAGK--IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118

Query: 235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG 294
            LE     S+ ++ +    L E   R Y +QI+ G +YLH    +HRD+K  N+ ++   
Sbjct: 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178

Query: 295 RVKLADFGMAKHITGQ------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVI 348
            VK+ DFG+A  +          C     G+P ++APEV+    G +  VD+WS+GC + 
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLC-----GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMY 232

Query: 349 EMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
            +   KPP+ +   +   + +I  ++   +IP H++      ++K LQ +P  RPT   L
Sbjct: 233 TLLVGKPPF-ETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINEL 289

Query: 408 LEHP-FVGNAAPLERPI 423
           L    F     P   PI
Sbjct: 290 LNDEFFTSGYIPARLPI 306

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  236 bits (605), Expect = 1e-75
 Identities = 74/266 (27%), Positives = 134/266 (50%), Gaps = 19/266 (7%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +K G LLG+G+F  VY   +  +G   A+K   +           Q++  E+ +  +L+
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIK--MIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLH 274
           HP+I+  Y      + +Y+ LE    G + + L++      E+  R +  QI++G+ YLH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ------SCPLSIKGSPYWMAPEVI 328
           +   +HRD+  +N+L+  +  +K+ADFG+A  +          C     G+P +++PE+ 
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-----GTPNYISPEIA 184

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGK 387
              +   L  D+WSLGC    +   +PP+   + V     K+  +     +P  LS E K
Sbjct: 185 -TRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADY--EMPSFLSIEAK 240

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
           D + + L+RNP  R + + +L+HPF+
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFM 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  240 bits (613), Expect = 6e-75
 Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 46/299 (15%)

Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
             S  +     ++LG G+ G V     S  G   A+K +          +       EI 
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRM--------LIDFCDIALMEIK 60

Query: 210 LLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA-------IRS 261
           LL+    HPN++RYY SET D  LYI LE     ++  +++      E+          S
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 262 YTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-------------RVKLADFGMAKHIT 308
             +QI SG+ +LH+   +HRD+K  NILV  S              R+ ++DFG+ K + 
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 309 GQSCPLSIK-----GSPYWMAPEVIKNSN------GCNLAVDIWSLGCTVIEMATT-KPP 356
                         G+  W APE+++ SN          ++DI+S+GC    + +  K P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 357 -WSQYEGVPAMFK-IGNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
              +Y     + + I +  E+  +    L  E  D + + +  +PL RPTA  +L HP 
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  237 bits (606), Expect = 8e-75
 Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 49/297 (16%)

Query: 163 LGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRY 222
           LG G  G V+   +  SG + A K + L    A       Q+ +E+ +L     P IV +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPYIVGF 96

Query: 223 YGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHR 281
           YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  K   +HR
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156

Query: 282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
           D+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++ +   ++  DIW
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGT-HYSVQSDIW 214

Query: 342 SLGCTVIEMATTKPPWSQYEGVPA------------------------------------ 365
           S+G +++EMA  + P    +                                        
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274

Query: 366 ------MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
                 +  I N           S E +DFV KCL +NP  R     L+ H F+  +
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  227 bits (580), Expect = 2e-71
 Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 47/299 (15%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W    +LG+G   +V+ G + ++G++ A+K      ++           +E  +L +L 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVDVQMREFEVLKKLN 65

Query: 216 HPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGL 270
           H NIV+ +  E      +  L  E+   GS+Y +L++      L ES      + ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 271 EYLHAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
            +L     VHR+IK  NI+     D     KL DFG A+ +      +S+ G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 327 VIKNSNGC-------NLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKIGNSK-- 373
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K  
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 374 ------------------ELPA---IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
                             ++P    +   L       +   L+ +              
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  224 bits (573), Expect = 2e-70
 Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 28/280 (10%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
              +   + LG G F +V L      G   A+K +         ++  ++  +E  +   
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-----LCHEQQDREEAQREADMHRL 82

Query: 214 LRHPNIVRYYGS----ETLDDKLYIYLEYVSGGSIYKILQDYGQLG----ESAIRSYTQQ 265
             HPNI+R             + ++ L +   G+++  ++     G    E  I      
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK----HITGQSCPLSIK---- 317
           I  GLE +HAK   HRD+K  NIL+   G+  L D G       H+ G    L+++    
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 318 --GSPYWMAPEVIKNSNGC--NLAVDIWSLGCTVIEMATTKPP--WSQYEGVPAMFKIGN 371
              +  + APE+    + C  +   D+WSLGC +  M   + P      +G      + N
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
              +P      S      +   +  +P  RP    LL   
Sbjct: 263 QLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  221 bits (564), Expect = 1e-68
 Identities = 73/302 (24%), Positives = 129/302 (42%), Gaps = 51/302 (16%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMK------------EVTLFSDDAKSKESAQQ 203
            ++  R L +G F  + L    +  +  A+K                 +D    K     
Sbjct: 32  DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 204 LGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA----- 258
              E+ +++ +++   +   G  T  D++YI  EY+   SI K  + +  L ++      
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 259 ---IRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ---- 310
              I+   + +L+   Y+H  KN  HRD+K +NIL+D +GRVKL+DFG ++++  +    
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 311 SCPLSIKGSPYWMAPEVIKNSNGC-NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-K 368
           S      G+  +M PE   N +      VDIWSLG  +  M     P+S    +  +F  
Sbjct: 210 SR-----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 369 IGNSK-----------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
           I                     +     + LS+E  DF++  L++NP  R T+   L+H 
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324

Query: 412 FV 413
           ++
Sbjct: 325 WL 326

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  222 bits (568), Expect = 2e-68
 Identities = 81/322 (25%), Positives = 149/322 (46%), Gaps = 22/322 (6%)

Query: 120 LTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSES 179
           + +S +      +   T       P  + +       +   + LG G  G V L F  ++
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRD------EYIMSKTLGSGACGEVKLAFERKT 159

Query: 180 GEMCAMKEVT---LFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK-LYIY 235
            +  A++ ++        A+  + A  +  EI +L +L HP I++       D +  YI 
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK--NFFDAEDYYIV 217

Query: 236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DP 292
           LE + GG ++  +    +L E+  + Y  Q+L  ++YLH    +HRD+K  N+L+   + 
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277

Query: 293 SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEM 350
              +K+ DFG +K +   S   ++ G+P ++APEV+ +    G N AVD WSLG  +   
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337

Query: 351 ATTKPPWSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
            +  PP+S++    ++  +I + K          +S++  D V+K L  +P  R T    
Sbjct: 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

Query: 408 LEHPFVGNAAPLER--PILSAE 427
           L HP++ +     +   +LS E
Sbjct: 398 LRHPWLQDEDMKRKFQDLLSEE 419

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  221 bits (565), Expect = 2e-68
 Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 47/298 (15%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W    +LG+G   +V+ G + ++G++ A+K      ++           +E  +L +L 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF----NNISFLRPVDVQMREFEVLKKLN 65

Query: 216 HPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGL 270
           H NIV+ +  E      +  L  E+   GS+Y +L++      L ES      + ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 271 EYLHAKNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
            +L     VHR+IK  NI+     D     KL DFG A+ +      +S+ G+  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 327 VIKNSNGC-------NLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKIGNSK-- 373
           + + +             VD+WS+G T    AT   P+  +EG       M+KI   K  
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 374 ------------------ELPA---IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                             ++P    +   L       +   L+ +             
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  214 bits (546), Expect = 1e-66
 Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 26/271 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
            R LG G FG V+L     SG    +K +    +  +S+   +Q+  EI +L  L HPNI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTI----NKDRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 220 VRYYGSETLDDKLYIYL--EYVSGG----SIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           ++ +  E  +D   +Y+  E   GG     I         L E  +    +Q+++ L Y 
Sbjct: 83  IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 274 HAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           H+++ VH+D+K  NIL     P   +K+ DFG+A+         +  G+  +MAPEV K 
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200

Query: 331 SNGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIPDHLSDE 385
                   DIWS G  V+   + T   P          +  K    +         L+ +
Sbjct: 201 DVT--FKCDIWSAG--VVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVECRPLTPQ 254

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA 416
             D +++ L ++P  RP+AA +L H +   A
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  213 bits (544), Expect = 3e-66
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 36/301 (11%)

Query: 143 SPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV-------------- 188
           S G   +      ++     +G+G++G V L +N       AMK +              
Sbjct: 2   SSGSSGDCVQLN-QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60

Query: 189 -------TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----DKLYIYLE 237
                         + +   +Q+ QEIA+L +L HPN+V+    E LD    D LY+  E
Sbjct: 61  PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFE 118

Query: 238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVK 297
            V+ G + ++      L E   R Y Q ++ G+EYLH +  +HRDIK +N+LV   G +K
Sbjct: 119 LVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177

Query: 298 LADFGMAKHITGQSCPLSIK-GSPYWMAPEVIKNSNG--CNLAVDIWSLGCTVIEMATTK 354
           +ADFG++    G    LS   G+P +MAPE +  +       A+D+W++G T+      +
Sbjct: 178 IADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

Query: 355 PPWSQYEGVPAMF-KIGNSK-ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            P+   E +  +  KI +   E P  PD ++++ KD + + L +NP  R     +  HP+
Sbjct: 238 CPFMD-ERIMCLHSKIKSQALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

Query: 413 V 413
           V
Sbjct: 296 V 296

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  209 bits (535), Expect = 4e-65
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 27/278 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK-ESAQQLGQEIALLSRLRHPN 218
              +GRG++G V +     +    A K++       K   E   +  QEI ++  L HPN
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           I+R Y  ET +D   IYL  E  +GG +++ +       ES      + +LS + Y H  
Sbjct: 68  IIRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 277 NTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNG 333
           N  HRD+K  N L     P   +KL DFG+A          +  G+PY+++P+V++   G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYG 185

Query: 334 CNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGK 387
                D WS G  V+   +    PP  +  +    +  KI       P     ++S + +
Sbjct: 186 --PECDEWSAG--VMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLNVSPQAE 239

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHP-FVGNAAPLERPIL 424
             +R+ L ++P  R T+   LEH  F    +   R +L
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  214 bits (547), Expect = 1e-64
 Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 17/273 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
            R+LG+G+FG V L  +  +G+ CA+K   +     K K   + L +E+ LL +L HPNI
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 220 VRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           ++ Y  E  +DK Y YL  E  +GG ++  +    +  E       +Q+LSG+ Y+H   
Sbjct: 89  MKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            VHRD+K  N+L+        +++ DFG++ H           G+ Y++APEV+  +   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD- 205

Query: 335 NLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFV 390
               D+WS G  +  + +  PP     E    +  K+   K          +S+  KD +
Sbjct: 206 -EKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKKVSESAKDLI 262

Query: 391 RKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
           RK L   P  R +A   L+H ++      +  +
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  209 bits (533), Expect = 3e-64
 Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 18/268 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSDDAKSKESAQQLGQEIALLSRLRH 216
            + LG G  G V L F  ++ +  A+K ++        A+  + A  +  EI +L +L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 217 PNIVRYYGSETLDDK-LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           P I++       D +  YI LE + GG ++  +    +L E+  + Y  Q+L  ++YLH 
Sbjct: 75  PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132

Query: 276 KNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
              +HRD+K  N+L+   +    +K+ DFG +K +   S   ++ G+P ++APEV+ +  
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192

Query: 333 --GCNLAVDIWSLGCTVIE--MATTKPPWSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDE 385
             G N AVD WSLG  VI     +  PP+S++    ++  +I + K          +S++
Sbjct: 193 TAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             D V+K L  +P  R T    L HP++
Sbjct: 251 ALDLVKKLLVVDPKARFTTEEALRHPWL 278

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  216 bits (552), Expect = 9e-64
 Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 42/305 (13%)

Query: 145 GRVENPTSPGSR---WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           G   +P+ P      W+    LG G FG+V    + ++GE  A+K+         S ++ 
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC----RQELSPKNR 56

Query: 202 QQLGQEIALLSRLRHPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQ-- 253
           ++   EI ++ +L HPN+V              +D   + +EY  GG + K L  +    
Sbjct: 57  ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116

Query: 254 -LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKHITG 309
            L E  IR+    I S L YLH    +HRD+K  NI++ P       K+ D G AK +  
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176

Query: 310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI 369
                   G+  ++APE+++      + VD WS G    E  T   P+            
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

Query: 370 GNSKELPAI------------------PDHLS----DEGKDFVRKCLQRNPLHRPTAAWL 407
              K    I                  P+HLS     + + +++  L  +   R T    
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295

Query: 408 LEHPF 412
                
Sbjct: 296 PNVGC 300

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  212 bits (541), Expect = 1e-63
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 24/281 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMK--------EVTLFSDDAKSKESAQQLGQEIALL 211
            R LG G +G V L          A+K        +     D+   ++  +++  EI+LL
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
             L HPNI++ +  +  +DK Y YL  E+  GG +++ + +  +  E    +  +QILSG
Sbjct: 101 KSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158

Query: 270 LEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           + YLH  N VHRDIK  NIL+   +    +K+ DFG++   +         G+ Y++APE
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHL 382
           V+K         D+WS G  +  +    PP     +    +  K+   K         ++
Sbjct: 219 VLKKKYNE--KCDVWSCGVIMYILLCGYPPFGG--QNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGNAAPLERP 422
           SDE K+ ++  L  +   R TA   L        A  + + 
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  211 bits (540), Expect = 2e-63
 Identities = 74/266 (27%), Positives = 128/266 (48%), Gaps = 24/266 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK---ESAQQLGQEIALLSRLRH 216
            + LG G +G V L  +  +    A+K +       K+     S  +L +E+A+L  L H
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKII------RKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 217 PNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           PNI++ Y  +  +DK   YL  E   GG ++  +    +  E       +Q+LSG+ YLH
Sbjct: 96  PNIMKLY--DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
             N VHRD+K  N+L+   +    +K+ DFG++     Q       G+ Y++APEV++  
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK 213

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGK 387
              +   D+WS+G  +  +    PP   Q +    +  K+   K    +    ++S+  K
Sbjct: 214 --YDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEKGKYTFDSPEWKNVSEGAK 269

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
           D +++ LQ +   R +A   LEHP++
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWI 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  211 bits (538), Expect = 3e-63
 Identities = 71/271 (26%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK---ESAQQLGQEIALLSRLRH 216
             +LG+G+FG V    +  + +  A+K +       K+    +    + +E+ LL +L H
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVI------NKASAKNKDTSTILREVELLKKLDH 80

Query: 217 PNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           PNI++ +  E L+D    Y+  E  +GG ++  +    +  E       +Q+ SG+ Y+H
Sbjct: 81  PNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
             N VHRD+K  NIL+   +    +K+ DFG++      +      G+ Y++APEV++ +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGK 387
              +   D+WS G  +  + +  PP +   +    +  ++   K          +SD+ K
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYG--KNEYDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
           D +RK L  +P  R TA   LEHP++   + 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  203 bits (519), Expect = 7e-63
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 8/261 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLN 63

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSPYWMAPEVIKNSN 332
               HRDIK  N+L+D    +K++DFG+A      +    +    G+  ++APE++K   
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVR 391
                VD+WS G  +  M   + PW Q       +     K+    P   +       + 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 392 KCLQRNPLHRPTAAWLLEHPF 412
           K L  NP  R T   + +  +
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  205 bits (524), Expect = 7e-63
 Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 58/308 (18%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              +G+G++G V +   +++  + A+K +        + +  +++  E+ L+ +L HPNI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 220 VRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLG---------------------- 255
            R Y  E  +D+ YI L  E   GG +   L  +                          
Sbjct: 91  ARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 256 ------------------ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV--DPSGR 295
                             E  I +  +QI S L YLH +   HRDIK  N L   + S  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 296 VKLADFGMAKHITGQSCPLSIK-----GSPYWMAPEVIKNSNGC-NLAVDIWSLGCTVIE 349
           +KL DFG++K     +           G+PY++APEV+  +N       D WS G  +  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 350 MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAA 405
           +     P     +       ++ N K        + LS   +D +   L RN   R  A 
Sbjct: 269 LLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326

Query: 406 WLLEHPFV 413
             L+HP++
Sbjct: 327 RALQHPWI 334

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  204 bits (520), Expect = 2e-62
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 10/285 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLN 63

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSPYWMAPEVIKNSN 332
               HRDIK  N+L+D    +K++DFG+A      +    +    G+  ++APE++K   
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPW-SQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR 391
                VD+WS G  +  M   + PW    +           K        +       + 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 392 KCLQRNPLHRPTAAWLLEHPF--VGNAAPLERPILSAEPSETKPT 434
           K L  NP  R T   + +  +         +RP +++      P+
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPS 288

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  204 bits (520), Expect = 2e-62
 Identities = 79/296 (26%), Positives = 147/296 (49%), Gaps = 21/296 (7%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            ++  + +G+G F  V L  +  +G   A+K   +      +  S Q+L +E+ ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 72

Query: 216 HPNIVRYYG-SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           HPNIV+ +   ET +  LY+ +EY SGG ++  L  +G++ E   RS  +QI+S ++Y H
Sbjct: 73  HPNIVKLFEVIET-EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQ----SCPLSIKGSPYWMAPEVIK 329
            K  VHRD+K  N+L+D    +K+ADFG +   T G      C     G+P + APE+ +
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPELFQ 186

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKD 388
                   VD+WSLG  +  + +   P+   + +  +  ++   K    IP ++S + ++
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGK--YRIPFYMSTDCEN 243

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETKPTLTVAMRIL 442
            +++ L  NP+ R T   +++  ++  G+     +P +  E   +       M  +
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  202 bits (516), Expect = 5e-62
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 25/289 (8%)

Query: 131 SYSTATSPSVPRSPGRVENPTSPGSRW-------KKGRLLGRGTFGHVYLG-FNSESGEM 182
            +   +   +P +          G               +G G+FG V+   ++   G  
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH---GSD 62

Query: 183 CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG 242
            A+K   +  +     E   +  +E+A++ RLRHPNIV + G+ T    L I  EY+S G
Sbjct: 63  VAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 243 SIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNT--VHRDIKGANILVDPSGRVK 297
           S+Y++L   G   QL E    S    +  G+ YLH +N   VHR++K  N+LVD    VK
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179

Query: 298 LADFGMAKHITGQSCPL-SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVI--EMATTK 354
           + DFG+++          S  G+P WMAPEV+++    N   D++S G  VI  E+AT +
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFG--VILWELATLQ 236

Query: 355 PPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            PW        +  +G   +   IP +L+ +    +  C    P  RP+
Sbjct: 237 QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPS 285

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  201 bits (514), Expect = 6e-62
 Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 28/275 (10%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK---ESAQQLGQEIALLSRLRH 216
             +LG+G+FG V    +  + +  A+K +       K+    +    + +E+ LL +L H
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVI------NKASAKNKDTSTILREVELLKKLDH 80

Query: 217 PNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           PNI++ +  E L+D    Y+  E  +GG ++  +    +  E       +Q+ SG+ Y+H
Sbjct: 81  PNIMKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
             N VHRD+K  NIL+   +    +K+ DFG++      +      G+ Y++APEV++ +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDE 385
                  D+WS G  VI   + +  PP + + E    +  ++   K          +SD+
Sbjct: 199 YD--EKCDVWSAG--VILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRTISDD 252

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
            KD +RK L  +P  R TA   LEHP++   +  E
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  202 bits (515), Expect = 7e-62
 Identities = 78/308 (25%), Positives = 132/308 (42%), Gaps = 38/308 (12%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK-----ESAQQLGQEIAL 210
           ++  G LLG G++G V    +SE+    A+K +       K K          + +EI L
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK------KKKLRRIPNGEANVKKEIQL 59

Query: 211 LSRLRHPNIVRYY---GSETLDDKLYIYLEYVSGGSIYKILQDY---GQLGESAIRSYTQ 264
           L RLRH N+++      +E    K+Y+ +EY   G     + D     +        Y  
Sbjct: 60  LRRLRHKNVIQLVDVLYNEE-KQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFC 116

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--------SCPLSI 316
           Q++ GLEYLH++  VH+DIK  N+L+   G +K++  G+A+ +           S     
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---- 172

Query: 317 KGSPYWMAPEVIKNSNGCN-LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKE 374
            GSP +  PE+    +  +   VDIWS G T+  + T   P+ + + +  +F  IG    
Sbjct: 173 -GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGS- 229

Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPT 434
             AIP        D ++  L+  P  R +   + +H +     P     +   PS     
Sbjct: 230 -YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288

Query: 435 LTVAMRIL 442
              +M ++
Sbjct: 289 RWRSMTVV 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  202 bits (515), Expect = 8e-62
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 38/296 (12%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             +    +LG G F  V+L     +G++ A+K +               L  EIA+L ++
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-----KKSPAFRDSSLENEIAVLKKI 63

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +H NIV            Y+ ++ VSGG ++  + + G   E       QQ+LS ++YLH
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQS----CPLSIKGSPYWMAPEV 327
               VHRD+K  N+L    + + ++ + DFG++K          C     G+P ++APEV
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPGYVAPEV 178

Query: 328 IKNSNGCNLAVDIWSLG-------CTVIEMATTKPP-WSQYEGVPAMF-KIGNSK-ELPA 377
           +      + AVD WS+G       C         PP +   E    +F KI     E  +
Sbjct: 179 LAQ-KPYSKAVDCWSIGVITYILLCGY-------PPFYE--ETESKLFEKIKEGYYEFES 228

Query: 378 IP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETK 432
              D +S+  KDF+   L+++P  R T    L HP++     L R I  +   + +
Sbjct: 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQ 284

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  201 bits (514), Expect = 1e-61
 Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 23/296 (7%)

Query: 133 STATSPSVPRSPGRVENPTSPGSRWK-----KGRLLGRGTFGHVYLGFNSESGEMCAMKE 187
            TA  P       +   P     + +      G++LG G+F  V L     +    A+K 
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK- 61

Query: 188 VTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKI 247
             L       +     + +E  ++SRL HP  V+ Y +   D+KLY  L Y   G + K 
Sbjct: 62  -ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120

Query: 248 LQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
           ++  G   E+  R YT +I+S LEYLH K  +HRD+K  NIL++    +++ DFG AK +
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 308 TGQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP 364
           + +S      S  G+  +++PE++        + D+W+LGC + ++    PP+    G  
Sbjct: 181 SPESKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNE 237

Query: 365 A-MF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAW------LLEHPF 412
             +F KI   +     P+    + +D V K L  +   R           L  HPF
Sbjct: 238 YLIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  200 bits (511), Expect = 1e-61
 Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 21/275 (7%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              LG+G F  V    +  +G   A K   + +    S    Q+L +E  +  +L+HPNI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 220 VRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           VR +  +++ ++ + YL  + V+GG +++ +       E+      QQIL  + Y H+  
Sbjct: 68  VRLH--DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            VHR++K  N+L+        VKLADFG+A  +          G+P +++PEV+K  +  
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPY 184

Query: 335 NLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKD 388
           +  VDIW+ G  VI   +    PP W + +    ++ +I     + P+   D ++ E K 
Sbjct: 185 SKPVDIWACG--VILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKS 240

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
            +   L  NP  R TA   L+ P++ N   +   I
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  201 bits (514), Expect = 2e-61
 Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 23/277 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              LGRG FG V+    + S +    K V               + +EI++L+  RH NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIARHRNI 63

Query: 220 VRYYGS-ETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           +  + S E+  ++L +  E++SG  I+ +I     +L E  I SY  Q+   L++LH+ N
Sbjct: 64  LHLHESFES-MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 278 TVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             H DI+  NI+     S  +K+ +FG A+ +        +  +P + APEV    +  +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-QHDVVS 181

Query: 336 LAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDF 389
            A D+WSLG   +   + +   P  ++      +   I N++          +S E  DF
Sbjct: 182 TATDMWSLG--TLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV-GNAAPLERPILS 425
           V + L +    R TA+  L+HP++      +   ++ 
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  202 bits (516), Expect = 2e-61
 Identities = 78/356 (21%), Positives = 142/356 (39%), Gaps = 43/356 (12%)

Query: 90  HPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVEN 149
             RA   +   P+   +  +     L   P   +N    +   + A          +   
Sbjct: 19  RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78

Query: 150 PTSPGSRWKK----------GRLLGRGTFGHVYLGFNSESGEMCAMKEV---TLFSDDAK 196
           P      W              ++GRG    V    +  +G   A+K +          +
Sbjct: 79  PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138

Query: 197 SKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQ 253
            +E  +   +E  +L ++  HP+I+     ++ +   +++L  + +  G ++  L +   
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLVFDLMRKGELFDYLTEKVA 196

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           L E   RS  + +L  + +LHA N VHRD+K  NIL+D + +++L+DFG + H+      
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256

Query: 314 LSIKGSPYWMAPEVIKNSNGC-----NLAVDIWSLG-------CTVIEMATTKPP-WSQY 360
             + G+P ++APE++K S           VD+W+ G                 PP W + 
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-------PPFWHRR 309

Query: 361 EGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           +    M   I   + +  +   D  S   KD + + LQ +P  R TA   L+HPF 
Sbjct: 310 Q--ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  201 bits (514), Expect = 3e-61
 Identities = 84/340 (24%), Positives = 137/340 (40%), Gaps = 31/340 (9%)

Query: 109 KQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKK----GRLLG 164
               H   +   T +       S + + +P             S              LG
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62

Query: 165 RGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG 224
           RG    VY      + +  A+K +       K     + +  EI +L RL HPNI++   
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVL-------KKTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 225 SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIK 284
                 ++ + LE V+GG ++  + + G   E       +QIL  + YLH    VHRD+K
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175

Query: 285 GANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIW 341
             N+L     P   +K+ADFG++K +  Q    ++ G+P + APE+++        VD+W
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMW 234

Query: 342 SLGCTVIEMATT------KPPWSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRK 392
           S+G  +I    T        P+    G   MF +I N +    +   D +S   KD VRK
Sbjct: 235 SVG--II----TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288

Query: 393 CLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETK 432
            +  +P  R T    L+HP+V   A      +     + +
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTGKAA-NFVHMDTAQKKLQ 327

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  202 bits (514), Expect = 4e-61
 Identities = 55/338 (16%), Positives = 99/338 (29%), Gaps = 48/338 (14%)

Query: 133 STATSPSVPRSPGRVENPTSPGSR-WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLF 191
           +   +     +   V++  S G R  K    L  G    V+L  + E  E  A+K     
Sbjct: 39  AVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK--VFT 96

Query: 192 SDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----------------------- 228
                S+   ++L +     +RL   +         L                       
Sbjct: 97  MGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD 156

Query: 229 ---DDKLYIYLEYVSG------GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
                   + +   S        ++  +    G  G  A+   T Q++     L +K  V
Sbjct: 157 DYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC-NLAV 338
           H      N+ + P GR+ L D      + G   P +      +   E +  S      A+
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKV-GTRGP-ASSVPVTYAPREFLNASTATFTHAL 274

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD-------HLSDEGKDFVR 391
           + W LG ++  +     P+              S  +P            L D  K  + 
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334

Query: 392 KCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
           + L  +   R      +E P       L+  I S+  +
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFLQ---LQNEISSSLST 369

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  201 bits (513), Expect = 4e-61
 Identities = 80/315 (25%), Positives = 133/315 (42%), Gaps = 25/315 (7%)

Query: 137 SPSVPRSPGRVENPTSPGSRWKK----GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS 192
           SP +    G + +       ++       ++G+G F  V    N E+G+  A+K V +  
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61

Query: 193 DDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGG----SIYK 246
             +    S + L +E ++   L+HP+IV     ET      +Y+  E++ G      I K
Sbjct: 62  FTSSPGLSTEDLKREASICHMLKHPHIVELL--ETYSSDGMLYMVFEFMDGADLCFEIVK 119

Query: 247 ILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGM 303
                    E+    Y +QIL  L Y H  N +HRD+K   +L+   + S  VKL  FG+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179

Query: 304 AKHITGQSCPLSIK-GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIE--MATTKPP-WSQ 359
           A  +         + G+P++MAPEV+K        VD+W  G  VI   + +   P +  
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCG--VILFILLSGCLPFYGT 236

Query: 360 YEGVPAMFKIGNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV-GNAA 417
            E +      G   ++      H+S+  KD VR+ L  +P  R T    L HP++     
Sbjct: 237 KERLFEGIIKGKY-KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

Query: 418 PLERPILSAEPSETK 432
              +  L     + +
Sbjct: 296 YAYKIHLPETVEQLR 310

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  199 bits (508), Expect = 6e-61
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 28/283 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMK------EVTLFSDDAKSKESAQQLGQEIALLSR 213
             +LGRG    V    +  + +  A+K        +  +++ +    A    +E+ +L +
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA--TLKEVDILRK 79

Query: 214 L-RHPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           +  HPNI++    +T +   + +L  + +  G ++  L +   L E   R   + +L  +
Sbjct: 80  VSGHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
             LH  N VHRD+K  NIL+D    +KL DFG +  +        + G+P ++APE+I+ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197

Query: 331 SNGCN-----LAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP- 379
           S   N       VD+WS G  VI   +    PP W + +    M   I +   +  +   
Sbjct: 198 SMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEW 253

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERP 422
           D  SD  KD V + L   P  R TA   L HPF       E  
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  200 bits (510), Expect = 2e-60
 Identities = 87/319 (27%), Positives = 139/319 (43%), Gaps = 25/319 (7%)

Query: 138 PSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS 197
             V   P  +        R+   + +G G FG   L  +  + E+ A+K +       + 
Sbjct: 4   APVTTGPLDMPIMHDSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI------ERG 56

Query: 198 KESAQQLGQEIALLSRLRHPNIVRYYGSETLD--DKLYIYLEYVSGGSIYKILQDYGQLG 255
               + + +EI     LRHPNIVR+   E +     L I +EY SGG +Y+ + + G+  
Sbjct: 57  AAIDENVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNAGRFS 114

Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQSCP 313
           E   R + QQ+LSG+ Y H+    HRD+K  N L+D  P+ R+K+ DFG +K     S P
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174

Query: 314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK 373
            S  G+P ++APEV+          D+WS G T+  M     P+ +    P  ++    +
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQR 233

Query: 374 ELPA---IPD--HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGN-----AAPLERP 422
            L     IPD   +S E    + +    +P  R +   +  H  F+ N            
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTG 293

Query: 423 ILSAEPSETKPTLTVAMRI 441
               EP +   +L   M+I
Sbjct: 294 SQFQEPEQPMQSLDTIMQI 312

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  200 bits (510), Expect = 2e-60
 Identities = 78/321 (24%), Positives = 134/321 (41%), Gaps = 32/321 (9%)

Query: 130 PSYSTATSPSVPRSPGRVENPTSPG--SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKE 187
           P  ++ T               S      +     LG+G F  V    +  +G   A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK- 60

Query: 188 VTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL--EYVSGGSIY 245
             + +    S    Q+L +E  +  +L+HPNIVR +  +++ ++ + YL  + V+GG ++
Sbjct: 61  --IINTKKLSARDFQKLEREARICRKLQHPNIVRLH--DSIQEESFHYLVFDLVTGGELF 116

Query: 246 KILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFG 302
           + +       E+      QQIL  + Y H+   VHR++K  N+L+        VKLADFG
Sbjct: 117 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176

Query: 303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT------KPP 356
           +A  +          G+P +++PEV+K  +  +  VDIW+ G  VI            PP
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACG--VI----LYILLVGYPP 229

Query: 357 -WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            W + +    ++ +I     + P+   D ++ E K  +   L  NP  R TA   L+ P+
Sbjct: 230 FWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287

Query: 413 V-GNAAPLERPILSAEPSETK 432
           +                   K
Sbjct: 288 ICNRERVASAIHRQDTVDCLK 308

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  201 bits (512), Expect = 2e-60
 Identities = 68/288 (23%), Positives = 131/288 (45%), Gaps = 24/288 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              LG G FG V+      +G +   K +     +         +  EI+++++L HP +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFI-----NTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 220 VRYYGSETLDDKLYIYL--EYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           +  +  +  +DK  + L  E++SGG ++ +I  +  ++ E+ + +Y +Q   GL+++H  
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 277 NTVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           + VH DIK  NI+     +  VK+ DFG+A  +           +  + APE++ +    
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPV 227

Query: 335 NLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDEGKD 388
               D+W++G  V+   + +   P     E        +     E        +S E KD
Sbjct: 228 GFYTDMWAIG--VLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFV-GNAAPLERPILSAEPSETKPTL 435
           F++  LQ+ P  R T    LEHP++ G+ + L   I S+  ++ +  +
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 331

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  200 bits (509), Expect = 2e-60
 Identities = 53/362 (14%), Positives = 102/362 (28%), Gaps = 57/362 (15%)

Query: 107 DVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSR-WKKGRLLGR 165
           ++  +  +  +   +           ST+        P RVE+      R   +G +LG+
Sbjct: 26  ELFNRIPQANVRTTSEYMQSAADSLVSTSLWN--TGQPFRVESELGERPRTLVRGTVLGQ 83

Query: 166 GTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---------- 215
                     + E+GE   +     +  +     + +Q+ +E+  L  LR          
Sbjct: 84  EDPYAYLEATDQETGESFEVH--VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 216 ---------------HPNIVRYYGSETLDDKLYIYLEY--------VSGGSIYKILQDYG 252
                             ++R    E     L  +  Y          G  +      + 
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
            L   A    T Q++  L  LH    VH  ++  +I++D  G V L  F        +  
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV- 260

Query: 313 PLSIKGSPYWMAPEVIKNSNGC----------NLAVDIWSLGCTVIEMATTKPPWSQYEG 362
                 S  +  PE+                   + D W+LG  +  +     P ++   
Sbjct: 261 --VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318

Query: 363 VPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERP 422
           +     I  S        ++    +  +   L+     R      +E P           
Sbjct: 319 LGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372

Query: 423 IL 424
            L
Sbjct: 373 AL 374

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  198 bits (506), Expect = 3e-60
 Identities = 72/304 (23%), Positives = 134/304 (44%), Gaps = 31/304 (10%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HP 217
           K + LG G+F       + +S +  A+K +      +K  E+  Q  +EI  L     HP
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQ--KEITALKLCEGHP 66

Query: 218 NIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           NIV+ +  E   D+L+ +L  E ++GG +++ ++      E+      ++++S + ++H 
Sbjct: 67  NIVKLH--EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 276 KNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVIKNS 331
              VHRD+K  N+L    + +  +K+ DFG A+     + PL     + ++ APE++   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ- 183

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGV-----PAMF-KIGNSK-ELPAIP-D 380
           NG + + D+WSLG  VI   M + + P  S    +       +  KI             
Sbjct: 184 NGYDESCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241

Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMR 440
           ++S E KD ++  L  +P  R   + L  + ++ + + L    L            V   
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301

Query: 441 ILVT 444
           +  T
Sbjct: 302 VKAT 305

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  198 bits (506), Expect = 4e-60
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 27/308 (8%)

Query: 137 SPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT---LFSD 193
             +V               ++     LG G FG V+   + E  +   +K +    +  D
Sbjct: 7   PKAVELEGLAACEGEYSQ-KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65

Query: 194 DAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLE---YVSGGSIYKILQD 250
                    ++  EIA+LSR+ H NI++    +  +++ +  L    + SG  ++  +  
Sbjct: 66  CWIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDR 123

Query: 251 YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ 310
           + +L E       +Q++S + YL  K+ +HRDIK  NI++     +KL DFG A ++   
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 311 -----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                 C     G+  + APEV+  +      +++WSLG T+  +   + P+ + E    
Sbjct: 184 KLFYTFC-----GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---- 234

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILS 425
             +   +      P  +S E    V   LQ  P  R T   L+  P+V     L      
Sbjct: 235 --ETVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290

Query: 426 AEPSETKP 433
                 KP
Sbjct: 291 EVFRVNKP 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (501), Expect = 4e-60
 Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 17/257 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTL--FSDDAKSKESAQQLGQEIALLSRLRHP 217
            + +G+G FG V+ G   +   + A+K + L     + +  E  Q+  +E+ ++S L HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAK 276
           NIV+ YG     +   + +E+V  G +Y  L D    +  S        I  G+EY+  +
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 277 NT--VHRDIKGANILVDPSGR-----VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           N   VHRD++  NI +           K+ADFG+++          + G+  WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMAPETIG 199

Query: 330 NSNG-CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--MFKIGNSKELPAIPDHLSDEG 386
                     D +S    +  + T + P+ +Y       +  I      P IP+      
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259

Query: 387 KDFVRKCLQRNPLHRPT 403
           ++ +  C   +P  RP 
Sbjct: 260 RNVIELCWSGDPKKRPH 276

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  198 bits (505), Expect = 5e-60
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 30/289 (10%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPN 218
              +G G++       +  +    A+K +       KSK    +   EI +L R  +HPN
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTE---EIEILLRYGQHPN 77

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           I+     +  DD  Y+Y+  E + GG +   +       E    +    I   +EYLHA+
Sbjct: 78  IITLK--DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 277 NTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVIKNS 331
             VHRD+K +NIL          +++ DFG AK +  ++  L     +  ++APEV++  
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER- 194

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-WSQY-EGVPAMF-KIGNSK-ELPAIP-DHLSD 384
            G + A DIWSLG  V+   M T   P  +   +    +  +IG+ K  L     + +SD
Sbjct: 195 QGYDAACDIWSLG--VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL-ERPILSAEPSETK 432
             KD V K L  +P  R TAA +L HP++ +   L +  +   +     
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  197 bits (504), Expect = 5e-60
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 18/285 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G   A K +    S  ++   S +++ +E+++L ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           ++  +  +  +++  + L  E VSGG ++  L     L E    S+ +QIL G+ YLH K
Sbjct: 77  VITLH--DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 277 NTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
              H D+K  NI++     P   +KL DFG+A  I       +I G+P ++APE++ N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYE 193

Query: 333 GCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMFKIGNSK-ELPAIP-DHLSDEGK 387
              L  D+WS+G  VI   + +   P     +    +  I +   +       H S+  K
Sbjct: 194 PLGLEADMWSIG--VITYILLSGASPFLGDTKQE-TLANITSVSYDFDEEFFSHTSELAK 250

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETK 432
           DF+RK L +    R T    L HP++      +  +        +
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  197 bits (503), Expect = 8e-60
 Identities = 71/312 (22%), Positives = 121/312 (38%), Gaps = 43/312 (13%)

Query: 135 ATSPSVPRSPGRVENPTSP------GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV 188
           A   S+  + GR ++            R +  R+L  G F  VY   +  SG   A+K +
Sbjct: 2   AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61

Query: 189 TLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGS-----ETLDDKLYIY--LEYVS 240
                 +  +E  + + QE+  + +L  HPNIV++  +     E  D     +  L  + 
Sbjct: 62  -----LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116

Query: 241 GGSIYKIL---QDYGQLGESAIRSYTQQILSGLEYLHAKNT--VHRDIKGANILVDPSGR 295
            G + + L   +  G L    +     Q    ++++H +    +HRD+K  N+L+   G 
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176

Query: 296 VKLADFGMAKHITGQSCPLSIK-------------GSPYWMAPEVIKNSNGC--NLAVDI 340
           +KL DFG A  I+                       +P +  PE+I   +        DI
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236

Query: 341 WSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
           W+LGC +  +   + P   +E   A  +I N K      D         +R  LQ NP  
Sbjct: 237 WALGCILYLLCFRQHP---FED-GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292

Query: 401 RPTAAWLLEHPF 412
           R + A ++    
Sbjct: 293 RLSIAEVVHQLQ 304

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  200 bits (511), Expect = 1e-59
 Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 31/290 (10%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              LG+G F  V       +G+  A     + +    S    Q+L +E  +   L+HPNI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 220 VRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN 277
           VR +  +++ ++ + YL  + V+GG +++ +       E+      QQIL  + + H   
Sbjct: 73  VRLH--DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 278 TVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNSNG 333
            VHR++K  N+L+        VKLADFG+A  + G+        G+P +++PEV++  + 
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DP 189

Query: 334 CNLAVDIWSLGCTVIEMATT------KPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLS 383
               VD+W+ G  VI            PP W   E    ++ +I     + P+   D ++
Sbjct: 190 YGKPVDLWACG--VI----LYILLVGYPPFWD--EDQHRLYQQIKAGAYDFPSPEWDTVT 241

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFV-GNAAPLERPILSAEPSETK 432
            E KD + K L  NP  R TAA  L+HP++   +               K
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLK 291

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  197 bits (502), Expect = 1e-59
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 26/290 (8%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-P 217
             + LGRG F  V    +  +G+  A K +       + ++   ++  EIA+L   +  P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFL---KKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 218 NIVRYYGSETLDDKLYIYL--EYVSGGSIY-KILQD-YGQLGESAIRSYTQQILSGLEYL 273
            ++  +  E  ++   I L  EY +GG I+   L +    + E+ +    +QIL G+ YL
Sbjct: 90  RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 274 HAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           H  N VH D+K  NIL+    P G +K+ DFGM++ I        I G+P ++APE++ N
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL-N 206

Query: 331 SNGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSD 384
            +    A D+W++G  +I   + T   P   +       +  I     +        +S 
Sbjct: 207 YDPITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEETFSSVSQ 262

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETK 432
              DF++  L +NP  RPTA   L H ++   +   L  P  ++  S+T+
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  195 bits (497), Expect = 1e-59
 Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 16/264 (6%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +  G  LG GTFG V +G +  +G   A+K   L     +S +   ++ +EI  L   R
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP+I++ Y   +     ++ +EYVSGG ++  +  +G++ E   R   QQILS ++Y H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-----SCPLSIKGSPYWMAPEVIKN 330
              VHRD+K  N+L+D     K+ADFG++  ++       SC     GSP + APEVI  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEVISG 184

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDF 389
                  VDIWS G  +  +     P+   E VP +F KI        IP++L+      
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGGV--FYIPEYLNRSVATL 241

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           +   LQ +PL R T   + EH + 
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWF 265

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  197 bits (504), Expect = 2e-59
 Identities = 86/397 (21%), Positives = 163/397 (41%), Gaps = 56/397 (14%)

Query: 37  GHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGG 96
           GH+  H+S G D+  +  +  S  +       S    +    S        P+  +    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRT-- 59

Query: 97  VSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSR 156
            S      P       HR+       +     +  Y+                       
Sbjct: 60  -SALAVDIPAPPAPFDHRI-----VTAKQGAVNSFYTV---------------------- 91

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
             K  +LG G FG V+    + +G   A K +       +  +  +++  EI+++++L H
Sbjct: 92  -SKTEILGGGRFGQVHKCEETATGLKLAAKII-----KTRGMKDKEEVKNEISVMNQLDH 145

Query: 217 PNIVRYYGSETLDDKLYIYL--EYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYL 273
            N+++ Y  +  + K  I L  EYV GG ++ +I+ +   L E     + +QI  G+ ++
Sbjct: 146 ANLIQLY--DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203

Query: 274 HAKNTVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           H    +H D+K  NIL     + ++K+ DFG+A+    +       G+P ++APEV+ N 
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NY 262

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-W--SQYEGVPAMFKIGNSK-ELPAIP-DHLSD 384
           +  +   D+WS+G  VI   + +   P    +  E    +  I   + +L       +S+
Sbjct: 263 DFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAE---TLNNILACRWDLEDEEFQDISE 317

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
           E K+F+ K L +    R +A+  L+HP++ +     R
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  194 bits (496), Expect = 3e-59
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 23/282 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G+  A K +       ++   S +++ +E+ +L  +RHPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           I+  +  +  ++K  + L  E VSGG ++  + +    L E     + +QIL G+ YLH+
Sbjct: 70  IITLH--DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS 126

Query: 276 KNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           K   H D+K  NI++     P+ R+KL DFG+A  I   +   +I G+P ++APE++ N 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NY 185

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDE 385
               L  D+WS+G  VI   + +   P   + +        I     +       + S+ 
Sbjct: 186 EPLGLEADMWSIG--VITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYFSNTSEL 241

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV-GNAAPLERPILSA 426
            KDF+R+ L ++P  R T A  LEH ++        R   S 
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  196 bits (500), Expect = 6e-59
 Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 18/285 (6%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G   A K +    S  ++     +++ +E+++L ++ HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           I+  +  +  +++  + L  E VSGG ++  L     L E    S+ +QIL G+ YLH K
Sbjct: 77  IITLH--DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 277 NTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
              H D+K  NI++     P   +KL DFG+A  I       +I G+P ++APE++ N  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYE 193

Query: 333 GCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMFKIGNSK-ELPAIP-DHLSDEGK 387
              L  D+WS+G  VI   + +   P     +    +  I     +         S+  K
Sbjct: 194 PLGLEADMWSIG--VITYILLSGASPFLGDTKQE-TLANITAVSYDFDEEFFSQTSELAK 250

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETK 432
           DF+RK L +    R T    L HP++      +  +        +
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  194 bits (496), Expect = 7e-59
 Identities = 73/283 (25%), Positives = 130/283 (45%), Gaps = 25/283 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEV-TLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G  LG G F  V       +G   A K +    +  ++   S + + +E+++L  ++HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 219 IVRYYGSETLDDKLYIYL--EYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           ++  +  E  ++K  + L  E V+GG ++  + +    L E     + +QIL+G+ YLH+
Sbjct: 76  VITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS 132

Query: 276 KNTVHRDIKGANILV----DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
               H D+K  NI++     P  R+K+ DFG+A  I   +   +I G+P ++APE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY- 191

Query: 332 NGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSDE 385
               L  D+WS+G  VI   + +   P     +        +     E       + S  
Sbjct: 192 EPLGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFV---GNAAPLERPILS 425
            KDF+R+ L ++P  R T    L+HP++        L R   +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  194 bits (495), Expect = 8e-59
 Identities = 73/327 (22%), Positives = 132/327 (40%), Gaps = 41/327 (12%)

Query: 129 SPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV 188
            P       P  P  P   ++  +  + ++ G LLG+G FG V+ G         A+K +
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64

Query: 189 TLFSDDAKSK-------ESAQQLGQEIALLSRLR----HPNIVRYYGSETLDDKLYIYLE 237
                  +++         +     E+ALL ++     HP ++R        +   + LE
Sbjct: 65  P------RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118

Query: 238 Y-VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGR 295
             +    ++  + + G LGE   R +  Q+++ +++ H++  VHRDIK  NIL+D   G 
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178

Query: 296 VKLADFGMAKHITGQ----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVI--E 349
            KL DFG    +  +           G+  +  PE I       L   +WSLG  ++  +
Sbjct: 179 AKLIDFGSGALLHDEPYTDFD-----GTRVYSPPEWISRHQYHALPATVWSLG--ILLYD 231

Query: 350 MATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           M     P+ + +      +I  ++     P H+S +    +R+CL   P  RP+   +L 
Sbjct: 232 MVCGDIPFERDQ------EILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 410 HP-FVGNAAPLERPILSAEPSETKPTL 435
            P     A  +        P+    +L
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPLAWSL 310

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  196 bits (500), Expect = 1e-58
 Identities = 62/258 (24%), Positives = 123/258 (47%), Gaps = 10/258 (3%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R +G+G+FG V +   +++ +M AMK   +       +   + + +E+ ++  L HP +V
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
             + S   ++ +++ ++ + GG +   LQ      E  ++ +  +++  L+YL  +  +H
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH 138

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI--KNSNGCNLAV 338
           RD+K  NIL+D  G V + DF +A  +  ++   ++ G+  +MAPE+   +   G + AV
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 339 DIWSLGCTVIEMATTKPPW--SQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
           D WSLG T  E+   + P+          +      +      P   S E    ++K L+
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLLKKLLE 256

Query: 396 RNPLHRPTAAW-LLEHPF 412
            NP  R +    +   P+
Sbjct: 257 PNPDQRFSQLSDVQNFPY 274

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  192 bits (491), Expect = 5e-58
 Identities = 78/266 (29%), Positives = 132/266 (49%), Gaps = 21/266 (7%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES--AQQLGQEIALLSR 213
            +     LG G+FG V L  + ++ +  A+K +         K+S    ++ +EI+ L  
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFI----SRQLLKKSDMHMRVEREISYLKL 65

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           LRHP+I++ Y   T    + + +EY  GG ++  + +  ++ E   R + QQI+  +EY 
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-----SCPLSIKGSPYWMAPEVI 328
           H    VHRD+K  N+L+D +  VK+ADFG++  +T       SC     GSP + APEVI
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVI 179

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGK 387
                    VD+WS G  +  M   + P+   E +P +F K+ +      +PD LS   +
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCV--YVMPDFLSPGAQ 236

Query: 388 DFVRKCLQRNPLHRPTAAWLLEHPFV 413
             +R+ +  +P+ R T   +   P+ 
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWF 262

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (485), Expect = 6e-58
 Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 23/258 (8%)

Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
             ++G G FG VY   +    G+  A+K       D    ++ + + QE  L + L+HPN
Sbjct: 12  EEIIGIGGFGKVYRAFWI---GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           I+   G    +  L + +E+  GG + ++L    ++    + ++  QI  G+ YLH +  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 279 ---VHRDIKGANILVDPSGR--------VKLADFGMAKHITGQSCPLSIKGSPYWMAPEV 327
              +HRD+K +NIL+             +K+ DFG+A+    ++  +S  G+  WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEV 185

Query: 328 IKNSNGCNLAVDIWSLGCTVI--EMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
           I+ S   +   D+WS G  V+  E+ T + P+   +G+   + +  +K    IP    + 
Sbjct: 186 IRASM-FSKGSDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242

Query: 386 GKDFVRKCLQRNPLHRPT 403
               +  C   +P  RP+
Sbjct: 243 FAKLMEDCWNPDPHSRPS 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (488), Expect = 7e-58
 Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 23/263 (8%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
             G +LG+G FG      + E+GE+  MKE+  F ++ +     +   +E+ ++  L HP
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-----RTFLKEVKVMRCLEHP 67

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAK 276
           N++++ G    D +L    EY+ GG++  I++    Q   S   S+ + I SG+ YLH+ 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---------------CPLSIKGSPY 321
           N +HRD+   N LV  +  V +ADFG+A+ +  +                   ++ G+PY
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPD 380
           WMAPE+I      +  VD++S G  + E+         Y      F +     L    P 
Sbjct: 188 WMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246

Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
           +          +C   +P  RP+
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPS 269

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  192 bits (489), Expect = 7e-58
 Identities = 74/319 (23%), Positives = 116/319 (36%), Gaps = 29/319 (9%)

Query: 129 SPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEV 188
             S+    +          +      S+++ G LLG G FG VY G         A+K V
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 189 TLFS-DDAKSKESAQQLGQEIALLSRLRH--PNIVRYYGSETLDDKLYIYLEYVSGGSIY 245
                 D     +  ++  E+ LL ++      ++R        D   + LE        
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV--- 133

Query: 246 KILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLAD 300
           + L D+    G L E   RS+  Q+L  + + H    +HRDIK  NIL+D   G +KL D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193

Query: 301 FGMAKHITGQ----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP 356
           FG    +              G+  +  PE I+       +  +WSLG  + +M     P
Sbjct: 194 FGSGALLKDTVYTDFD-----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

Query: 357 WSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP-FVGN 415
           +   E      +I   +        +S E +  +R CL   P  RPT   +  HP     
Sbjct: 249 FEHDE------EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

Query: 416 AAPLERPILSAEPSETKPT 434
             P E   +        P+
Sbjct: 301 LLPQETAEIHLHSLSPGPS 319

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  191 bits (487), Expect = 2e-57
 Identities = 62/331 (18%), Positives = 108/331 (32%), Gaps = 77/331 (23%)

Query: 155 SRW----KKGRLLGRGTFGHVYLGFNSESGEMCAMK----------------EVTLFS-- 192
           SR+    +  + +GRG FG V+   N       A+K                EV   +  
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 193 -----------------------------------DDAKSKESAQQLGQEIALLSRLRHP 217
                                                  S         +I  +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG---ESAIRSYTQQILSGLEYLH 274
           N V      +    LYI ++     ++   +     L             QI   +E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-------------GSPY 321
           +K  +HRD+K +NI       VK+ DFG+   +       ++              G+  
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           +M+PE I  +N  +  VDI+SLG  + E+       +Q E V  +  +  + + P +   
Sbjct: 242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-RNLKFPLLFTQ 297

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
              +    V+  L  +P  RP A  ++E+  
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAI 328

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  190 bits (485), Expect = 4e-57
 Identities = 88/319 (27%), Positives = 131/319 (41%), Gaps = 53/319 (16%)

Query: 136 TSPSVPRSPGRVENPTSPGSR----WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLF 191
                  S G      +   +    ++   L+G G++G V    N ++G + A+K+    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61

Query: 192 SDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY 251
            DD   K+ A +   EI LL +LRH N+V          + Y+  E+V   +I   L+ +
Sbjct: 62  DDDKMVKKIAMR---EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117

Query: 252 GQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ 310
              L    ++ Y  QI++G+ + H+ N +HRDIK  NILV  SG VKL DFG A+     
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR----- 172

Query: 311 SCPLSIKGSPY-------WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW----- 357
              L+  G  Y       W  APE++        AVD+W++GC V EM   +P +     
Sbjct: 173 --TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

Query: 358 ----------------SQYEGVPAM--FKIGNSKELPAIPD------HLSDEGKDFVRKC 393
                              E       F      E+            LS+   D  +KC
Sbjct: 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKC 290

Query: 394 LQRNPLHRPTAAWLLEHPF 412
           L  +P  RP  A LL H F
Sbjct: 291 LHIDPDKRPFCAELLHHDF 309

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  189 bits (483), Expect = 6e-57
 Identities = 76/307 (24%), Positives = 120/307 (39%), Gaps = 49/307 (15%)

Query: 159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK-ESAQQLGQEIALLSRLR-H 216
           +  +LG G    V    N  + +  A+K +       K       ++ +E+ +L + + H
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKII------EKQPGHIRSRVFREVEMLYQCQGH 70

Query: 217 PNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            N++     E  +++   YL  E + GGSI   +       E       Q + S L++LH
Sbjct: 71  RNVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIK--------GSPYWM 323
            K   HRD+K  NIL    +    VK+ DF +   I        I         GS  +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 324 APEVIKNSNGC----NLAVDIWSLGCTVI----------------EMATTKPPWSQYEGV 363
           APEV++  +      +   D+WSLG  VI                         +     
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246

Query: 364 PAMF-KIGNSK-ELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE 420
             +F  I   K E P     H+S   KD + K L R+   R +AA +L+HP+V   AP E
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP-E 305

Query: 421 RPILSAE 427
             + +  
Sbjct: 306 NTLPTPM 312

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  194 bits (494), Expect = 6e-57
 Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 16/279 (5%)

Query: 141 PRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           P +  +  +       +  G  LG GTFG V +G +  +G   A+K   L     +S + 
Sbjct: 2   PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK--ILNRQKIRSLDV 59

Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIR 260
             ++ +EI  L   RHP+I++ Y   +    +++ +EYVSGG ++  +   G+L E   R
Sbjct: 60  VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR 119

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-----SCPLS 315
              QQILSG++Y H    VHRD+K  N+L+D     K+ADFG++  ++       SC   
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--- 176

Query: 316 IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKE 374
             GSP + APEVI         VDIWS G  +  +     P+   + VP +F KI +   
Sbjct: 177 --GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGI- 232

Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
               P +L+      ++  LQ +P+ R T   + EH + 
Sbjct: 233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  190 bits (484), Expect = 8e-57
 Identities = 84/251 (33%), Positives = 130/251 (51%), Gaps = 27/251 (10%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ------EIALLSRL 214
           + LG G+FG V L  + ESG   AMK +         K+   +L Q      E  +L  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKIL--------DKQKVVKLKQIEHTLNEKRILQAV 98

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
             P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   EYLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNS 331
           + + ++RD+K  N+L+D  G +++ DFG AK + G++   C     G+P  +APE+I + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILS- 212

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFV 390
            G N AVD W+LG  + EMA   PP+   +    ++ KI + K     P H S + KD +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269

Query: 391 RKCLQRNPLHR 401
           R  LQ +   R
Sbjct: 270 RNLLQVDLTKR 280

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  195 bits (498), Expect = 1e-56
 Identities = 80/344 (23%), Positives = 144/344 (41%), Gaps = 25/344 (7%)

Query: 98  SESPSSRPDDVKQQSHRLPLPPL--TISNTCPFSPSYSTATSPSVPRSPGRV--ENPTSP 153
             +P   P D +++     +      +      S +Y         +   +         
Sbjct: 96  PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
              +     LG G FG V+      +G   A K V         +   + + +EI  +S 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-----MTPHESDKETVRKEIQTMSV 210

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIY-KILQDYGQLGESAIRSYTQQILSGLEY 272
           LRHP +V  + +   D+++ +  E++SGG ++ K+  ++ ++ E     Y +Q+  GL +
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270

Query: 273 LHAKNTVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +H  N VH D+K  NI+     S  +KL DFG+  H+  +       G+  + APEV   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-E 329

Query: 331 SNGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGVPAMF-KIGNSK-ELPAIP-DHLSD 384
                   D+WS+G  V+   + +   P   + +        + +    +       +S+
Sbjct: 330 GKPVGYYTDMWSVG--VLSYILLSGLSPFGGEND--DETLRNVKSCDWNMDDSAFSGISE 385

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV--GNAAPLERPILSA 426
           +GKDF+RK L  +P  R T    LEHP++  GNA   +  I S+
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 1e-56
 Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 19/255 (7%)

Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G+ +G G+FG VY G ++ +     A+K   + +  A + +  Q    E+ +L + RH N
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD----VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKN 277
           I+ + G  T   +L I  ++  G S+Y  L     +     +    +Q   G++YLHAK+
Sbjct: 82  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK---HITGQSCPLSIKGSPYWMAPEVIKN--SN 332
            +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI+   SN
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSK---ELPAIPDHLSDEGKD 388
             +   D+++ G  + E+ T + P+S        +  +G      +L  +  +     K 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 389 FVRKCLQRNPLHRPT 403
            + +CL++    RP+
Sbjct: 261 LMAECLKKKRDERPS 275

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  188 bits (479), Expect = 2e-56
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 49/295 (16%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K   +G G++G V+   N ++G++ A+K+     DD   K+ A +   EI +L +L+
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLH 274
           HPN+V          +L++  EY    ++   L  Y + + E  ++S T Q L  + + H
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-------WM-APE 326
             N +HRD+K  NIL+     +KL DFG A+        L+     Y       W  +PE
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFAR-------LLTGPSDYYDDEVATRWYRSPE 172

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATTKPPW---------------------SQYEGVPA 365
           ++         VD+W++GC   E+ +  P W                        +    
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

Query: 366 M--------FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                        + + L     ++S      ++ CL  +P  R T   LL HP+
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (477), Expect = 4e-56
 Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 24/260 (9%)

Query: 160 GRLLGRGTFGHVYLGF-NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           G L+G+G FG VY G  + E     A++   L   +  +++  +   +E+    + RH N
Sbjct: 38  GELIGKGRFGQVYHGRWHGE----VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKN 277
           +V + G+      L I      G ++Y +++D    L  +  R   Q+I+ G+ YLHAK 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAK-----HITGQSCPLSI-KGSPYWMAPEVIKNS 331
            +H+D+K  N+  D +G+V + DFG+           +   L I  G    +APE+I+  
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 332 --------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLS 383
                      +   D+++LG    E+   + P+        ++++G   +       + 
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269

Query: 384 DEGKDFVRKCLQRNPLHRPT 403
            E  D +  C       RPT
Sbjct: 270 KEISDILLFCWAFEQEERPT 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (473), Expect = 1e-55
 Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 24/255 (9%)

Query: 158 KKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   ++GRG FG V    +     +  A+K++       +S+   +    E+  LSR+ H
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR---AKDVAIKQI-------ESESERKAFIVELRQLSRVNH 60

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ---QILSGLEYL 273
           PNIV+ YG+    + + + +EY  GGS+Y +L     L             Q   G+ YL
Sbjct: 61  PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 274 HAKNT---VHRDIKGANILVDPSGRV-KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           H+      +HRD+K  N+L+   G V K+ DFG A  I       + KGS  WMAPEV +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFE 176

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSKELPAIPDHLSDEGKD 388
            SN  +   D++S G  + E+ T + P+ +  G    +    ++   P +  +L    + 
Sbjct: 177 GSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235

Query: 389 FVRKCLQRNPLHRPT 403
            + +C  ++P  RP+
Sbjct: 236 LMTRCWSKDPSQRPS 250

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  184 bits (470), Expect = 1e-55
 Identities = 42/254 (16%), Positives = 91/254 (35%), Gaps = 21/254 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              L     G ++ G     G    +K   +      S   ++   +E   L    HPN+
Sbjct: 15  LTKLNENHSGELWKG--RWQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 220 VRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHA 275
           +   G           +   ++  GS+Y +L +     + +S    +   +  G+ +LH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 276 KNT--VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN--S 331
                    +   ++++D     +++   +               +P W+APE ++    
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG----RMYAPAWVAPEALQKKPE 185

Query: 332 NGCNLAVDIWSLGCTVI--EMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
           +    + D+WS    V+  E+ T + P++    +    K+      P IP  +S      
Sbjct: 186 DTNRRSADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243

Query: 390 VRKCLQRNPLHRPT 403
           ++ C+  +P  RP 
Sbjct: 244 MKICMNEDPAKRPK 257

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  185 bits (473), Expect = 2e-55
 Identities = 75/267 (28%), Positives = 134/267 (50%), Gaps = 32/267 (11%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ------EIALLSRL 214
           R LG G+FG V+L  +  +G   AMK   L       KE   +L Q      E  +LS +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMK--VL------KKEIVVRLKQVEHTNDERLMLSIV 63

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            HP I+R +G+     ++++ ++Y+ GG ++ +L+   +      + Y  ++   LEYLH
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNS 331
           +K+ ++RD+K  NIL+D +G +K+ DFG AK++   +   C     G+P ++APEV+ ++
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV-ST 177

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFV 390
              N ++D WS G  + EM     P+         + KI N++     P   +++ KD +
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLL 234

Query: 391 RKCLQRNPLHR-----PTAAWLLEHPF 412
            + + R+   R          +  HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  190 bits (485), Expect = 4e-55
 Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 21/267 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LGRG FG V+      +G++ A K   L     K ++  Q    E  +L+++    IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK--KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248

Query: 221 R-YYGSETLDDKLYIYLEYVSGGS----IYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
              Y  ET    L + +  ++GG     IY + +D     E     YT QI+SGLE+LH 
Sbjct: 249 SLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +N ++RD+K  N+L+D  G V+++D G+A     GQ+      G+P +MAPE++      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366

Query: 335 NLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFV 390
           + +VD ++LG T+ EM   + P+    +      +  ++         PD  S   KDF 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSPASKDFC 424

Query: 391 RKCLQRNPLHR-----PTAAWLLEHPF 412
              LQ++P  R      +   L  HP 
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  186 bits (475), Expect = 5e-55
 Identities = 88/352 (25%), Positives = 144/352 (40%), Gaps = 45/352 (12%)

Query: 108 VKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENP---TSPGSRWKK----- 159
           +     + P  P       P  P+ +    P+ P  P   + P      G + KK     
Sbjct: 2   LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61

Query: 160 -----GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
                 ++LG G  G V   FN  + E  A+K +     D           +E+ L  R 
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPK------ARREVELHWRA 111

Query: 215 -RHPNIVRYYG----SETLDDKLYIYLEYVSGGSIY-KILQ-DYGQLGESAIRSYTQQIL 267
            + P+IVR              L I +E + GG ++ +I         E       + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 268 SGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
             ++YLH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGV--PAMF-KIGNSK-ELPA 377
           PEV+      + + D+WSLG  VI   +    PP +S +     P M  +I   + E P 
Sbjct: 232 PEVLGP-EKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288

Query: 378 IP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL-ERPILSAE 427
                +S+E K  +R  L+  P  R T    + HP++  +  + + P+ ++ 
Sbjct: 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 340

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  183 bits (467), Expect = 2e-54
 Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 41/289 (14%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIV 220
           +LG G  G V   F+  +G+ CA+K +        S +      QE+    +    P+IV
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL------YDSPK----ARQEVDHHWQASGGPHIV 85

Query: 221 RYYG----SETLDDKLYIYLEYVSGGSIY-KILQ-DYGQLGESAIRSYTQQILSGLEYLH 274
                          L I +E + GG ++ +I +       E       + I + +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 275 AKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQS----CPLSIKGSPYWMAPEV 327
           + N  HRD+K  N+L    +    +KL DFG AK  T  +    C      +PY++APEV
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-----YTPYYVAPEV 200

Query: 328 IKNSNGCNLAVDIWSLGCTVIE--MATTKPPW---SQYEGVPAMF-KIGNSK-ELPAIP- 379
           +      + + D+WSLG  VI   +    PP+   +     P M  +I   +   P    
Sbjct: 201 LG-PEKYDKSCDMWSLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL-ERPILSAE 427
             +S++ K  +R  L+ +P  R T    + HP++  +  + + P+ +A 
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTAR 306

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  181 bits (462), Expect = 7e-54
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 19/263 (7%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           ++LG+G+FG V+L      S++ ++ AMK   L     K ++  +    E  +L  + HP
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMK--VLKKATLKVRDRVRTKM-ERDILVEVNHP 86

Query: 218 NIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            IV+ +Y  +T + KLY+ L+++ GG ++  L       E  ++ Y  ++   L++LH+ 
Sbjct: 87  FIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
             ++RD+K  NIL+D  G +KL DFG++K  I  +    S  G+  +MAPEV+    G  
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHT 204

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCL 394
            + D WS G  + EM T   P+   +        I  +K    +P  LS E +  +R   
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAK--LGMPQFLSPEAQSLLRMLF 261

Query: 395 QRNPLHR----PT-AAWLLEHPF 412
           +RNP +R    P     +  H F
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSF 284

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  188 bits (478), Expect = 8e-54
 Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 24/267 (8%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           R+LG+G FG V       +G+M A K   L     K ++       E  +L ++    +V
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247

Query: 221 R-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEYLHAKN 277
              Y  ET  D L + L  ++GG +   +   GQ G  E+    Y  +I  GLE LH + 
Sbjct: 248 SLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHI-----TGQSCPLSIKGSPYWMAPEVIKNSN 332
            V+RD+K  NIL+D  G ++++D G+A H+               G+  +MAPEV+KN  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVVKN-E 360

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDEGKDFV 390
               + D W+LGC + EM   + P+ Q +      ++     +      +  S + +   
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 391 RKCLQRNPLHR-----PTAAWLLEHPF 412
            + L ++P  R      +A  + EHP 
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPL 447

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  182 bits (463), Expect = 9e-54
 Identities = 82/259 (31%), Positives = 130/259 (50%), Gaps = 13/259 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP + 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH+++ V+
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128

Query: 281 RDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVD 339
           RDIK  N+++D  G +K+ DFG+ K  I+  +   +  G+P ++APEV+++ N    AVD
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 187

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNP 398
            W LG  + EM   + P+   +    +F  I   +     P  LS E K  +   L+++P
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDP 244

Query: 399 LHR----PT-AAWLLEHPF 412
             R    P+ A  ++EH F
Sbjct: 245 KQRLGGGPSDAKEVMEHRF 263

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  181 bits (462), Expect = 9e-54
 Identities = 77/333 (23%), Positives = 137/333 (41%), Gaps = 68/333 (20%)

Query: 131 SYSTATSPSVPRSPGRVENPTSPGSR----WKKGRLLGRGTFGHVYLGFNSESGEMCAMK 186
            +   T  +  + PG +    +P +     +++   LG GT+G VY   ++ + E  A+K
Sbjct: 6   HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65

Query: 187 EVTLFSDDAKSKESAQQLG------QEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
            + L  +    +E     G      +E++LL  L+H NI+        + +L++  EY  
Sbjct: 66  RIRLEHE----EE-----GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-----GR 295
              + K +     +    I+S+  Q+++G+ + H++  +HRD+K  N+L+  S       
Sbjct: 117 N-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 296 VKLADFGMAKHITGQSCPLSIKGSPY-------WM-APEVIKNSNGCNLAVDIWSLGCTV 347
           +K+ DFG+A+          I    +       W   PE++  S   + +VDIWS+ C  
Sbjct: 176 LKIGDFGLAR-------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228

Query: 348 IEMATTKP--------------------P----W---SQYEGVPAMFKIGNSKELP-AIP 379
            EM    P                    P    W   +        F     K L   + 
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG 288

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             L DEG D +   L+ +P+ R +A   LEHP+
Sbjct: 289 ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  188 bits (480), Expect = 2e-53
 Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 18/264 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE---IALLSRLRHP 217
           R++GRG FG VY    +++G+M AMK   L     K K+       E   ++L+S    P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252

Query: 218 NIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
            IV   Y   T  DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE++H +
Sbjct: 253 FIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             V+RD+K ANIL+D  G V+++D G+A   + +  P +  G+  +MAPEV++     + 
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDS 370

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEG--VPAMF-KIGNSKELPAIPDHLSDEGKDFVRKC 393
           + D +SLGC + ++     P+ Q++      +            +PD  S E +  +   
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGL 428

Query: 394 LQRNPLHR-----PTAAWLLEHPF 412
           LQR+   R       A  + E PF
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  180 bits (460), Expect = 2e-53
 Identities = 89/265 (33%), Positives = 137/265 (51%), Gaps = 21/265 (7%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDD--AKSKESAQQLGQEIALLSRLR 215
           R+LG+G +G V+       + +G++ AMK   L        +K++A     E  +L  ++
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK--VLKKAMIVRNAKDTAHTKA-ERNILEEVK 79

Query: 216 HPNIVR-YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           HP IV   Y  +T   KLY+ LEY+SGG ++  L+  G   E     Y  +I   L +LH
Sbjct: 80  HPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNG 333
            K  ++RD+K  NI+++  G VKL DFG+ K  I   +   +  G+  +MAPE++   +G
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SG 197

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRK 392
            N AVD WSLG  + +M T  PP++  E       KI   K    +P +L+ E +D ++K
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCK--LNLPPYLTQEARDLLKK 254

Query: 393 CLQRNPLHR----PT-AAWLLEHPF 412
            L+RN   R    P  A  +  HPF
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPF 279

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  179 bits (456), Expect = 6e-52
 Identities = 87/357 (24%), Positives = 146/357 (40%), Gaps = 65/357 (18%)

Query: 102 SSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGR 161
           S RP          P+   +   +   S     +   +V  +PG+  +       +   +
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQE-VSYTDTK 60

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           ++G G+FG VY     +SGE+ A+K+V     D + K       +E+ ++ +L H NIVR
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK------NRELQIMRKLDHCNIVR 111

Query: 222 ----YYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSGLE 271
               +Y S    D++Y+ L  +YV   ++Y++ + Y +    L    ++ Y  Q+   L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 272 YLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQSCPLSIKGSP--------YW 322
           Y+H+    HRDIK  N+L+DP +  +KL DFG AK +        ++G P        Y+
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSYICSRYY 222

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY----------------EGVP 364
            APE+I  +     ++D+WS GC + E+   +P  P                    E + 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 365 AMFKIGNSKELPAIPDH---------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            M       + P I  H            E      + L+  P  R T      H F
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  179 bits (454), Expect = 7e-52
 Identities = 55/371 (14%), Positives = 108/371 (29%), Gaps = 56/371 (15%)

Query: 107 DVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRW-KKGRLLGR 165
           ++  +  +  +   +           ST+        P RVE+      R   +G +LG+
Sbjct: 31  ELFNRIPQANVRTTSEYMQSAADSLVSTSLWN--TGQPFRVESELGERPRTLVRGTVLGQ 88

Query: 166 GTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---------- 215
                     + E+GE   +     +  +     + +Q+ +E+  L  LR          
Sbjct: 89  EDPYAYLEATDQETGESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 216 ------------HPNIVRYYGSETLDDKLYIYLEYVS-----------GGSIYKILQDYG 252
                        P   +       +  +++   +             G  +      + 
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--TGQ 310
            L   A    T Q++  L  LH    VH  ++  +I++D  G V L  F        +  
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266

Query: 311 SCPLSIKGSPYWMAPEVIKNSNG----CNLAVDIWSLGCTVIEMATTKPPW---SQYEGV 363
           S        P   A  ++            A D W+LG  +  +     P    +   G 
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
             +F     +    IP  +    +  +   L+     R      +E P            
Sbjct: 327 EWIF-----RSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 377

Query: 424 LSAEPSETKPT 434
           L    ++ +PT
Sbjct: 378 LPLYQTDGEPT 388

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  179 bits (456), Expect = 1e-51
 Identities = 83/321 (25%), Positives = 141/321 (43%), Gaps = 19/321 (5%)

Query: 105 PDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKG---- 160
           P++ ++ +  +      +         + + +      +     +   P  R        
Sbjct: 93  PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152

Query: 161 -RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
            +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RHP +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNT 278
                S    D+L   +EY +GG ++  L       E   R Y  +I+S L+YLH+ KN 
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
           V+RD+K  N+++D  G +K+ DFG+ K  I   +   +  G+P ++APEV+++ N    A
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 329

Query: 338 VDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
           VD W LG  + EM   + P+   +    +F  I   +     P  L  E K  +   L++
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKK 386

Query: 397 NPLHR----PT-AAWLLEHPF 412
           +P  R       A  +++H F
Sbjct: 387 DPKQRLGGGSEDAKEIMQHRF 407

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  177 bits (450), Expect = 2e-51
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 22/300 (7%)

Query: 127 PFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKG-------RLLGRGTFGHVYLGFNSES 179
           P  P    A +P+ P +P + +    P S            +++G+G+FG V L  +   
Sbjct: 5   PQEPELMNA-NPAPPPAPSQ-QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62

Query: 180 GEMCAMKEVTLFSDD-AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY 238
               A+K   L      K KE    + +   LL  ++HP +V  + S    DKLY  L+Y
Sbjct: 63  EVFYAVK--VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120

Query: 239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKL 298
           ++GG ++  LQ      E   R Y  +I S L YLH+ N V+RD+K  NIL+D  G + L
Sbjct: 121 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180

Query: 299 ADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
            DFG+ K +I   S   +  G+P ++APEV+      +  VD W LG  + EM    PP+
Sbjct: 181 TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPF 239

Query: 358 SQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR----PTAAWLLEHPF 412
                   M+  I N      +  ++++  +  +   LQ++   R         +  H F
Sbjct: 240 YS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  176 bits (448), Expect = 2e-51
 Identities = 75/256 (29%), Positives = 126/256 (49%), Gaps = 10/256 (3%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNI 219
           ++LG+G+FG V+L    ++ +  A+K   L  D     +  +    E  +LS    HP +
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIK--ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
              + +    + L+  +EY++GG +   +Q   +   S    Y  +I+ GL++LH+K  V
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140

Query: 280 HRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  NIL+D  G +K+ADFGM K ++ G +   +  G+P ++APE++      N +V
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSV 199

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           D WS G  + EM   + P+   +    +F  I      P  P  L  E KD + K   R 
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVRE 256

Query: 398 PLHRPTAAW-LLEHPF 412
           P  R      + +HP 
Sbjct: 257 PEKRLGVRGDIRQHPL 272

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  175 bits (447), Expect = 3e-51
 Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 22/288 (7%)

Query: 141 PRSPGRVENPTSPGSRWKKG-------RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD 193
           P+   +  N     S  + G       R+LG+G+FG V L    E+G++ A+K   L  D
Sbjct: 2   PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVK--VLKKD 59

Query: 194 DAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG 252
                +  +    E  +LS    HP + + +      D+L+  +E+V+GG +   +Q   
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQS 311
           +  E+  R Y  +I+S L +LH K  ++RD+K  N+L+D  G  KLADFGM K  I    
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179

Query: 312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIG 370
              +  G+P ++APE+++       AVD W++G  + EM     P+   E    +F  I 
Sbjct: 180 TTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAIL 237

Query: 371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHR----PTAAW--LLEHPF 412
           N +     P  L ++    ++  + +NP  R           +L HPF
Sbjct: 238 NDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  175 bits (446), Expect = 3e-51
 Identities = 69/269 (25%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNI 219
           R++GRG++  V L    ++  + AMK   +  +     E    +  E  +  +   HP +
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMK--VVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH +  +
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 132

Query: 280 HRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+L+D  G +KL D+GM K  +       +  G+P ++APE+++       +V
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV 191

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPA--------MF-KIGNSKELPAIPDHLSDEGKDF 389
           D W+LG  + EM   + P+                +F  I   +    IP  LS +    
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASV 249

Query: 390 VRKCLQRNPLHR----PTAAW--LLEHPF 412
           ++  L ++P  R    P   +  +  HPF
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  175 bits (445), Expect = 5e-51
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 31/274 (11%)

Query: 161 RLLGRGTFGHVYL---GFNSESGEMCAMKEVTLFSDD--AKSKESAQQLGQEIALLSRLR 215
           ++LG G +G V+L       ++G++ AMK   L       K+K +     +   L    +
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMK--VLKKATIVQKAKTTEHTRTERQVLEHIRQ 117

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
            P +V  + +   + KL++ L+Y++GG ++  L    +  E  ++ Y  +I+  LE+LH 
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAK-HITGQS------CPLSIKGSPYWMAPEVI 328
              ++RDIK  NIL+D +G V L DFG++K  +  ++      C     G+  +MAP+++
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-----GTIEYMAPDIV 232

Query: 329 K-NSNGCNLAVDIWSLGCTVIEMATTKPPW---SQYEGVPAMF-KIGNSKELPAIPDHLS 383
           +   +G + AVD WSLG  + E+ T   P+    +      +  +I  S+  P  P  +S
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMS 290

Query: 384 DEGKDFVRKCLQRNPLHR----PT-AAWLLEHPF 412
              KD +++ L ++P  R    P  A  + EH F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  174 bits (443), Expect = 3e-50
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNI 219
           R++GRG++  V L    ++  + AM+   +  +     E    +  E  +  +   HP +
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMR--VVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
           V  +     + +L+  +EYV+GG +   +Q   +L E   R Y+ +I   L YLH +  +
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 175

Query: 280 HRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+L+D  G +KL D+GM K  +       +  G+P ++APE+++       +V
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSV 234

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPA--------MF-KIGNSKELPAIPDHLSDEGKDF 389
           D W+LG  + EM   + P+                +F  I   +    IP  LS +    
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASV 292

Query: 390 VRKCLQRNPLHR----PTAAW--LLEHPF 412
           ++  L ++P  R    P   +  +  HPF
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  171 bits (435), Expect = 3e-50
 Identities = 83/306 (27%), Positives = 135/306 (44%), Gaps = 72/306 (23%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIA 209
           +++K   +G GT+G V+   N E+ E+ A+K V L  D     E     G      +EI 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----DE-----GVPSSALREIC 53

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILS 268
           LL  L+H NIVR +     D KL +  E+     + K        L    ++S+  Q+L 
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------- 321
           GL + H++N +HRD+K  N+L++ +G +KLA+FG+A+          I    Y       
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-------AFGIPVRCYSAEVVTL 165

Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP------------------------ 356
           W   P+V+  +   + ++D+WS GC   E+A    P                        
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

Query: 357 -WSQYEGVPAMFKIGNSKELPAIPD---------HLSDEGKDFVRKCLQRNPLHRPTAAW 406
            W      P+M K+ + K  P  P           L+  G+D ++  L+ NP+ R +A  
Sbjct: 226 QW------PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279

Query: 407 LLEHPF 412
            L+HP+
Sbjct: 280 ALQHPY 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  172 bits (439), Expect = 4e-50
 Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 14/260 (5%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNI 219
            +LG+G+FG V L     + E+ A+K   L  D     +  +    E  +L+   + P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVK--ILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTV 279
            + +      D+LY  +EYV+GG +   +Q  G+  E     Y  +I  GL +L +K  +
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143

Query: 280 HRDIKGANILVDPSGRVKLADFGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAV 338
           +RD+K  N+++D  G +K+ADFGM K +I       +  G+P ++APE+I        +V
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSV 202

Query: 339 DIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
           D W+ G  + EM   + P+   E    +F  I       A P  +S E     +  + ++
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKH 259

Query: 398 PLHR----PT-AAWLLEHPF 412
           P  R    P     + EH F
Sbjct: 260 PGKRLGCGPEGERDIKEHAF 279

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  170 bits (432), Expect = 8e-50
 Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 60/299 (20%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIA 209
           ++     +G GT+G VY   N   GE  A+K++ L  +D    E     G      +EI+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED----E-----GIPSTTIREIS 52

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILS 268
           +L  L+H NIV+ Y       +L +  E++    + K+L      L     +S+  Q+L+
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------- 321
           G+ Y H +  +HRD+K  N+L++  G +K+ADFG+A+          I    Y       
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-------AFGIPVRKYTHEIVTL 164

Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--------------------P---- 356
           W  AP+V+  S   +  +DIWS+GC   EM    P                    P    
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224

Query: 357 WSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           W     +P     F +       +    L + G D + K L+ +P  R TA   LEH +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  172 bits (437), Expect = 2e-49
 Identities = 82/311 (26%), Positives = 133/311 (42%), Gaps = 65/311 (20%)

Query: 148 ENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           +        +   +++G G+FG V+     ES E+ A+K+V     D + K       +E
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQ---DKRFK------NRE 82

Query: 208 IALLSRLRHPNIVR----YYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQ----LGES 257
           + ++  ++HPN+V     +Y +    D++++ L  EYV   ++Y+  + Y +    +   
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPML 141

Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQSCPLSI 316
            I+ Y  Q+L  L Y+H+    HRDIK  N+L+DP SG +KL DFG AK +        I
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--------I 193

Query: 317 KGSPY-------WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQY------ 360
            G P        +  APE+I  +      +DIWS GC + E+   +P  P          
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253

Query: 361 ----------EGVPAMFKIGNSKELPAIPDH---------LSDEGKDFVRKCLQRNPLHR 401
                     E +  M       + P I  H            +  D + + L+  P  R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313

Query: 402 PTAAWLLEHPF 412
            TA   L HPF
Sbjct: 314 LTAIEALCHPF 324

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  170 bits (432), Expect = 2e-49
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 61/300 (20%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEIA 209
            + K   LG GT+  VY G +  +  + A+KE+ L  ++          G      +E++
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----------GAPCTAIREVS 52

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILS 268
           LL  L+H NIV  +     +  L +  EY+    + + L D G  +    ++ +  Q+L 
Sbjct: 53  LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------- 321
           GL Y H +  +HRD+K  N+L++  G +KLADFG+A+         SI    Y       
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPTKTYDNEVVTL 164

Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--------------------P---- 356
           W   P+++  S   +  +D+W +GC   EMAT +P                    P    
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224

Query: 357 WSQYEGVP----AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           W             +    ++ L +    L  +G D + K LQ    +R +A   ++HPF
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  170 bits (432), Expect = 4e-49
 Identities = 80/302 (26%), Positives = 127/302 (42%), Gaps = 61/302 (20%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEI 208
            R++K   LG G F  VY   +  + ++ A+K++ L     ++K+     G      +EI
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-EAKD-----GINRTALREI 63

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQIL 267
            LL  L HPNI+    +      + +  +++    +  I++D    L  S I++Y    L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY------ 321
            GLEYLH    +HRD+K  N+L+D +G +KLADFG+AK            GSP       
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYTHQ 172

Query: 322 ----WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--------------------P 356
               W  APE++  +    + VD+W++GC + E+    P                    P
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232

Query: 357 ----WSQYEGVPA--MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
               W     +P    FK      L  I     D+  D ++     NP  R TA   L+ 
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292

Query: 411 PF 412
            +
Sbjct: 293 KY 294

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  176 bits (448), Expect = 4e-49
 Identities = 81/419 (19%), Positives = 144/419 (34%), Gaps = 30/419 (7%)

Query: 18  KPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGP 77
            P                   +              +    R   + S            
Sbjct: 188 DPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWD 247

Query: 78  SSRIHS----GAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYS 133
                     G+++           +         + +   +P+PP            + 
Sbjct: 248 WDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFE 307

Query: 134 TATSPSVPRSPGRVENPTSPGSRWKKG------------RLLGRGTFGHVYLGFNSESGE 181
            A      ++P      T                      +LG+G+FG V L     + E
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367

Query: 182 MCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETLDDKLYIYLEYVS 240
           + A+K   L  D     +  +    E  +L+   + P + + +      D+LY  +EYV+
Sbjct: 368 LYAVK--ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425

Query: 241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GG +   +Q  G+  E     Y  +I  GL +L +K  ++RD+K  N+++D  G +K+AD
Sbjct: 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 485

Query: 301 FGMAK-HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ 359
           FGM K +I       +  G+P ++APE+I        +VD W+ G  + EM   + P+  
Sbjct: 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

Query: 360 YEGVPAMF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR-----PTAAWLLEHPF 412
            E    +F  I       A P  +S E     +  + ++P  R          + EH F
Sbjct: 545 -EDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  170 bits (433), Expect = 8e-49
 Identities = 69/263 (26%), Positives = 125/263 (47%), Gaps = 16/263 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V L  +  + ++ AMK   L   +   +  +    +E  +++    P +V
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMK--LLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + + +   D  LY+ +EY+ GG +  ++ +Y  + E   R YT +++  L+ +H+   +H
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIH 191

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--GSPYWMAPEVIKNSNGC---N 335
           RD+K  N+L+D SG +KLADFG    +  +         G+P +++PEV+K+  G     
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKELPAIPDH--LSDEGKDFVRK 392
              D WS+G  + EM     P+   + +   + KI N K     PD   +S E K+ +  
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310

Query: 393 CLQRNPLHR---PTAAWLLEHPF 412
               +   R        +  H F
Sbjct: 311 -FLTDREVRLGRNGVEEIKRHLF 332

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  168 bits (427), Expect = 9e-49
 Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 62/316 (19%)

Query: 141 PRSPGRVENPT-SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKE 199
             S GR          +++K   +G GT+G VY   +S  G + A+K + L ++     E
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE----DE 60

Query: 200 SAQQLG------QEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ 253
                G      +EI+LL  L HPNIV        +  L +  E++    + K+L +   
Sbjct: 61  -----GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT 114

Query: 254 -LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC 312
            L +S I+ Y  Q+L G+ + H    +HRD+K  N+L++  G +KLADFG+A+       
Sbjct: 115 GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR------- 167

Query: 313 PLSIKGSPY-------WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--------- 355
              I    Y       W  AP+V+  S   + +VDIWS+GC   EM T KP         
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227

Query: 356 -----------P----WSQYEGVP----AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
                      P    W Q + +P      F++   K   +I      EG D +   L  
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF 287

Query: 397 NPLHRPTAAWLLEHPF 412
           +P  R +A   + HP+
Sbjct: 288 DPNKRISARDAMNHPY 303

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  167 bits (426), Expect = 1e-48
 Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 68/309 (22%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG------QEI 208
           S++K+   LG GT+  VY G N  +G   A+KEV L S++          G      +EI
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----------GTPSTAIREI 54

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGG-----SIYKILQDYGQLGESAIRSYT 263
           +L+  L+H NIVR Y     ++KL +  E++            +      L  + ++ + 
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY-- 321
            Q+L GL + H    +HRD+K  N+L++  G++KL DFG+A+          I  + +  
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------AFGIPVNTFSS 167

Query: 322 -----WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP-------------------- 355
                W  AP+V+  S   + ++DIWS GC + EM T KP                    
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 356 P----W---SQYEGVPAMFKIGNSKELP-----AIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           P    W   ++        +    ++L         + L     DF+   LQ NP  R +
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 404 AAWLLEHPF 412
           A   L HP+
Sbjct: 288 AKQALHHPW 296

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  169 bits (430), Expect = 2e-48
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 20/268 (7%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG F  V +    ++G++ AMK   +   D   +       +E  +L       I 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMK--IMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTV 279
           + + +   ++ LY+ +EY  GG +  +L  +G ++     R Y  +I+  ++ +H    V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184

Query: 280 HRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIKNSNGC--- 334
           HRDIK  NIL+D  G ++LADFG        G    L   G+P +++PE+++   G    
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 335 ---NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKE---LPAIPDHLSDEGK 387
                  D W+LG    EM   + P+   +     + KI + KE   LP + + + +E +
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

Query: 388 DFVRKCLQRNPLHR---PTAAWLLEHPF 412
           DF+++ L   P  R     A     HPF
Sbjct: 304 DFIQR-LLCPPETRLGRGGAGDFRTHPF 330

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  166 bits (422), Expect = 3e-48
 Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 53/287 (18%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPN 218
            ++LG G  G V   FN  + E  A+K +     D           +E+ L  R  + P+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPK------ARREVELHWRASQCPH 72

Query: 219 IVRYYG----SETLDDKLYIYLEYVSGGSIY-KIL-QDYGQLGESAIRSYTQQILSGLEY 272
           IVR              L I +E + GG ++ +I  +      E       + I   ++Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 273 LHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           LH+ N  HRD+K  N+L     P+  +KL DFG AK  TG+          Y        
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK---------Y-------- 175

Query: 330 NSNGCNLAVDIWSLGCTVIE--MATTKPP-WSQYEGV--PAMF-KIGNSK-ELPAIP-DH 381
                + + D+WSLG  VI   +    PP +S +     P M  +I   + E P      
Sbjct: 176 -----DKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV-GNAAPLERPILSAE 427
           +S+E K  +R  L+  P  R T    + HP++  +    + P+ ++ 
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  168 bits (428), Expect = 1e-47
 Identities = 69/265 (26%), Positives = 121/265 (45%), Gaps = 16/265 (6%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           +++GRG FG V +     + ++ AMK   L   +   +       +E  +L       I 
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMK--ILNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
             + +   D+ LY+ ++Y  GG +  +L  +  +L E   R Y  +++  ++ +H  + V
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHI--TGQSCPLSIKGSPYWMAPEVIK----NSNG 333
           HRDIK  NIL+D +G ++LADFG    +   G        G+P +++PE+++        
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKE---LPAIPDHLSDEGKDF 389
                D WSLG  + EM   + P+   E +   + KI N KE    P     +S+  KD 
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316

Query: 390 VRKCLQRNP--LHRPTAAWLLEHPF 412
           +R+ +      L +       +HPF
Sbjct: 317 IRRLICSREHRLGQNGIEDFKKHPF 341

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  162 bits (410), Expect = 7e-46
 Identities = 45/272 (16%), Positives = 86/272 (31%), Gaps = 26/272 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
             LLG G F  VY     +  +    ++  L      +        Q +  L        
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-----LGESAIRSYTQQILSGLEYLH 274
           +++Y +    +   +  E  S G++   +  Y       + +  + S+  ++L  +E +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 275 AKNTVHRDIKGANILV-----------DPSGRVKLADFGMAKHITGQSCPLSIK---GSP 320
               +H DIK  N ++           D S  + L D G +  +              + 
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
            +   E++ N    N  +D + +  TV  M        + EG     +         +P 
Sbjct: 250 GFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE----GLFRRLPH 304

Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
              D   +F    L     H   +  LL    
Sbjct: 305 --LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  158 bits (403), Expect = 2e-45
 Identities = 81/305 (26%), Positives = 121/305 (39%), Gaps = 61/305 (20%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           SR++    +G G +G VY   +  SG   A+K V + +             +E+ALL RL
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 215 R---HPNIVR-----YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQ 264
               HPN+VR            + K+ +  E+V    +   L       L    I+   +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM- 323
           Q L GL++LHA   VHRD+K  NILV   G VKLADFG+A+          I      + 
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR----------IYSYQMALT 177

Query: 324 ---------APEVIKNSNGC--NLAVDIWSLGCTVIEMATTKP----------------- 355
                    APEV+           VD+WS+GC   EM   KP                 
Sbjct: 178 PVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234

Query: 356 ---P----WSQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL 407
              P    W +   +P   F     + + ++   + + G   + + L  NP  R +A   
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294

Query: 408 LEHPF 412
           L+H +
Sbjct: 295 LQHSY 299

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  159 bits (405), Expect = 4e-45
 Identities = 80/311 (25%), Positives = 120/311 (38%), Gaps = 67/311 (21%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R++  R+ G+GTFG V LG    +G   A+K+V    D         +  Q +  L+ L
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD----PRFRNRELQIMQDLAVL 76

Query: 215 RHPNIVR-----YYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLG----ESAIRSYT 263
            HPNIV+     Y   E     +Y+ +  EYV   ++++  ++Y +         I+ + 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 264 QQILSGLEYLHAK--NTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSP 320
            Q++  +  LH    N  HRDIK  N+LV+ + G +KL DFG AK +            P
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--------SPSEP 187

Query: 321 --------YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP----------------- 355
                   Y+ APE+I  +     AVDIWS+GC   EM   +P                 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

Query: 356 -------------PWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRP 402
                        P      +     I  S          + E  D +   LQ  P  R 
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307

Query: 403 TAAWLLEHPFV 413
                L HP+ 
Sbjct: 308 KPYEALCHPYF 318

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  157 bits (400), Expect = 4e-45
 Identities = 75/293 (25%), Positives = 119/293 (40%), Gaps = 57/293 (19%)

Query: 158 KKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKS--KESAQQLGQEIALLSRL 214
                +G+G +G V+ G +    GE  A+K     S D KS  +E       E+     L
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ---GENVAVK--IFSSRDEKSWFRE------TELYNTVML 59

Query: 215 RHPNIVRYYGSETLDD----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           RH NI+ +  S+        +L++   Y   GS+Y  LQ    L   +       I SGL
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGL 118

Query: 271 EYLHAKNT--------VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK----- 317
            +LH +           HRD+K  NILV  +G+  +AD G+A   +  +  L +      
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 318 GSPYWMAPEVIKNS-----NGCNLAVDIWSLGCTVIEMAT----------TKPPWSQYEG 362
           G+  +MAPEV+  +           VDIW+ G  + E+A            KPP+     
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 363 VPAMFK-----IGNSKELPAIPDHLSDEG-----KDFVRKCLQRNPLHRPTAA 405
               F+     +   ++ P IP+    +         +++C  +NP  R TA 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  156 bits (397), Expect = 4e-44
 Identities = 69/327 (21%), Positives = 120/327 (36%), Gaps = 76/327 (23%)

Query: 146 RVENPTSPGSR----WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA 201
           + ++   P       ++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A
Sbjct: 4   QYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 63

Query: 202 QQLGQEIALLSRLRHPNIVR--------YYGSETLDDKLYIYLEYVSGGSIYKILQD--- 250
            +   EI +L  L+H N+V                   +Y+  ++           D   
Sbjct: 64  LR---EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAG 112

Query: 251 -----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK 305
                  +   S I+   Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+
Sbjct: 113 LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172

Query: 306 HITGQSCPLSIKGSPY-------WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP-- 355
                S   + + + Y       W   PE++         +D+W  GC + EM T  P  
Sbjct: 173 AF---SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

Query: 356 ------------------------------PWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
                                            +   +    K      L A        
Sbjct: 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV--RDPY 287

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             D + K L  +P  R  +   L H F
Sbjct: 288 ALDLIDKLLVLDPAQRIDSDDALNHDF 314

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  156 bits (395), Expect = 5e-44
 Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 51/289 (17%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +  + +G+G +G V++G     GE  A+K    F+ +    E++     EI     +RH 
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVK--VFFTTE----EASWFRETEIYQTVLMRHE 91

Query: 218 NIVRYYGSET----LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           NI+ +  ++        +LY+  +Y   GS+Y  L+    L   ++       +SGL +L
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHL 150

Query: 274 HAKNT--------VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-----GSP 320
           H +           HRD+K  NILV  +G   +AD G+A      +  + I      G+ 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 321 YWMAPEVIK-----NSNGCNLAVDIWSLGCTVIEMAT----------TKPPWSQYEGVPA 365
            +M PEV+      N     +  D++S G  + E+A            + P+        
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 366 MFK-----IGNSKELPAIPDHLSDEG-----KDFVRKCLQRNPLHRPTA 404
            ++     +   K  P+ P+  S +         + +C   NP  R TA
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  154 bits (391), Expect = 3e-43
 Identities = 75/307 (24%), Positives = 137/307 (44%), Gaps = 54/307 (17%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
            S ++   LLG G +G V    +  +GE+ A+K++  F         A +  +EI +L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK----PLFALRTLREIKILKH 65

Query: 214 LRHPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            +H NI+  +        E  ++ +YI  E +    +++++     L +  I+ +  Q L
Sbjct: 66  FKHENIITIFNIQRPDSFENFNE-VYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTL 122

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP------- 320
             ++ LH  N +HRD+K +N+L++ +  +K+ DFG+A+ I   +   S            
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 321 ----YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVP 364
               ++ APEV+  S   + A+D+WS GC + E+   +P  P   Y           G P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242

Query: 365 A----MFKIGNSK------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAW 406
                +  I + +       LP  P          ++ +G D +++ L  +P  R TA  
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302

Query: 407 LLEHPFV 413
            LEHP++
Sbjct: 303 ALEHPYL 309

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  152 bits (387), Expect = 6e-43
 Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 51/290 (17%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +   +  RG FG V+        E  A+K       D +S ++      E+  L  ++H 
Sbjct: 27  QLLEVKARGRFGCVWKA--QLLNEYVAVK--IFPIQDKQSWQNEY----EVYSLPGMKHE 78

Query: 218 NIVRYYGSET----LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           NI+++ G+E     +D  L++   +   GS+   L+    +  + +    + +  GL YL
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137

Query: 274 HAKNT----------VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK---GSP 320
           H               HRDIK  N+L+  +    +ADFG+A                G+ 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 321 YWMAPEV----IKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ---------YEGVPA-- 365
            +MAPEV    I       L +D++++G  + E+A+                 E +    
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257

Query: 366 ----MFKIGNSKEL-PAIPDH-LSDEG----KDFVRKCLQRNPLHRPTAA 405
               M ++   K+  P + D+     G     + + +C   +   R +A 
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  152 bits (387), Expect = 6e-43
 Identities = 81/312 (25%), Positives = 127/312 (40%), Gaps = 77/312 (24%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNS-ESGEMCAMKEVTLFSDDAKSKESAQQLG------QE 207
            +++    +G G +G V+   +    G   A+K V + +     +E     G      +E
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG----EE-----GMPLSTIRE 61

Query: 208 IALLSRLR---HPNIVR-----YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGES 257
           +A+L  L    HPN+VR            + KL +  E+V    +   L    +  +   
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120

Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
            I+    Q+L GL++LH+   VHRD+K  NILV  SG++KLADFG+A+          I 
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----------IY 170

Query: 318 GSPYWM----------APEVIKNSNGC--NLAVDIWSLGCTVIEMATTKP---------- 355
                +          APEV+           VD+WS+GC   EM   KP          
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227

Query: 356 ----------P----WSQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
                     P    W +   +P   F   +++ +      + + GKD + KCL  NP  
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287

Query: 401 RPTAAWLLEHPF 412
           R +A   L HP+
Sbjct: 288 RISAYSALSHPY 299

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  153 bits (388), Expect = 1e-42
 Identities = 70/337 (20%), Positives = 122/337 (36%), Gaps = 96/337 (28%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            ++  G+ LG G+FG V   F+ ESG+  A+K+V     D + K       +E+ ++  L
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKN------RELDIMKVL 57

Query: 215 RHPNIVR------------------------------------YYGSETLDDKLYIYL-- 236
            H NI++                                               Y+ +  
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 237 EYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP 292
           EYV   +++K+L+ + +    +  + I  Y  Q+   + ++H+    HRDIK  N+LV+ 
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 293 -SGRVKLADFGMAKHITGQSCPLSIKGSP--------YWMAPEVIKNSNGCNLAVDIWSL 343
               +KL DFG AK +        I   P        ++ APE++  +     ++D+WS+
Sbjct: 177 KDNTLKLCDFGSAKKL--------IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 344 GCTVIEMATTKP--PWSQY----------------EGVPAMFKIGNSKELPAI------- 378
           GC   E+   KP                       E +  M         P +       
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288

Query: 379 --PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
             P+       D + + L+  P  R      + HPF 
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  152 bits (387), Expect = 2e-42
 Identities = 86/320 (26%), Positives = 140/320 (43%), Gaps = 53/320 (16%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F      +   Q+  +EI +L R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH----QTYCQRTLREIKILLR 81

Query: 214 LRHPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
            RH NI+           E + D +YI  + +    +YK+L+    L    I  +  QIL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKD-VYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQIL 138

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY----WM 323
            GL+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+             + Y    W 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-TEYVATRWY 197

Query: 324 -APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE----------GVPA---MF 367
            APE++ NS G   ++DIWS+GC + EM + +P  P   Y           G P+   + 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 368 KIGNSK------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            I N K       LP            +   +  D + K L  NP  R      L HP++
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 414 GNAAPLERPILSAEPSETKP 433
                   P  S EP    P
Sbjct: 318 ---EQYYDP--SDEPIAEAP 332

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  151 bits (384), Expect = 3e-42
 Identities = 83/322 (25%), Positives = 133/322 (41%), Gaps = 62/322 (19%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
              +     +G G +G V    +  SGE  A+K+++  F      +  A++  +E+ LL 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS----EIFAKRAYRELLLLK 78

Query: 213 RLRHPNIVRYY-------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
            ++H N++                D  Y+ + ++    + KI+    +  E  I+    Q
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYD-FYLVMPFM-QTDLQKIMG--LKFSEEKIQYLVYQ 134

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-- 323
           +L GL+Y+H+   VHRD+K  N+ V+    +K+ DFG+A+H   +        + Y +  
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-------TGYVVTR 187

Query: 324 ---APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVP---A 365
              APEVI +    N  VDIWS+GC + EM T K          Q        GVP    
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 366 MFKIGNSK------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
           + K+ +         LP  P           S +  D + K L+ +   R TAA  L HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

Query: 412 FVGNAAPLERPILSAEPSETKP 433
           F     P   P    E    +P
Sbjct: 308 FF---EPFRDP--EEETEAQQP 324

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  149 bits (379), Expect = 5e-42
 Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 22/264 (8%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             R+K    LG G    VYL  ++      A+K   +F    + +E+ ++  +E+   S+
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQ 67

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           L H NIV     +  DD  Y+ +EY+ G ++ + ++ +G L      ++T QIL G+++ 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--PLSIKGSPYWMAPEVIKNS 331
           H    VHRDIK  NIL+D +  +K+ DFG+AK ++  S      + G+  + +PE  K  
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG---VPAMFK-------IGNSKELPAIPDH 381
              +   DI+S+G  + EM   +PP   + G   V    K          +     IP  
Sbjct: 188 A-TDECTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAA 405
           LS    + + +  +++  +R    
Sbjct: 244 LS----NVILRATEKDKANRYKTI 263

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (380), Expect = 5e-42
 Identities = 74/309 (23%), Positives = 122/309 (39%), Gaps = 39/309 (12%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             R++ G +LG G    V+L  +       A+K   L +D A+      +  +E    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQNAAA 68

Query: 214 LRHPNIVRYY--GSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           L HP IV  Y  G          Y+  EYV G ++  I+   G +               
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----SIKGSPYWMAP 325
           L + H    +HRD+K ANI++  +  VK+ DFG+A+ I      +    ++ G+  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--------------VPAMFKIGN 371
           E  +  +  +   D++SLGC + E+ T +PP   + G                       
Sbjct: 189 EQARGDS-VDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPP----- 239

Query: 372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRP-TAAWLLEH-PFVGNAAPLERPILSAEPS 429
           S     +   L       V K L +NP +R  TAA +      V N  P E P +  +  
Sbjct: 240 SARHEGLSADL----DAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAE 295

Query: 430 ETKPTLTVA 438
            T    + A
Sbjct: 296 RTSLLSSAA 304

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  149 bits (379), Expect = 8e-42
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 58/309 (18%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           GSR+   + LG G  G V+   +++  +  A+K++   +D     +S +   +EI ++ R
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTD----PQSVKHALREIKIIRR 64

Query: 214 LRHPNIVR---------------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESA 258
           L H NIV+                     L+  +YI  EY+    +  +L+  G L E  
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNS-VYIVQEYM-ETDLANVLEQ-GPLLEEH 121

Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQSCPLSIK 317
            R +  Q+L GL+Y+H+ N +HRD+K AN+ ++     +K+ DFG+A+ +          
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 318 GSPY----WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE----- 361
            S      W  +P ++ + N    A+D+W+ GC   EM T K          Q +     
Sbjct: 182 -SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 362 -GVPA---MFKIGNS-----KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTA 404
             V       ++ +      +     P          +S E  DF+ + L  +P+ R TA
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 405 AWLLEHPFV 413
              L HP++
Sbjct: 301 EEALSHPYM 309

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  148 bits (375), Expect = 2e-41
 Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 46/279 (16%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K  + LG+G FG V +         +GE+ A+K   L      ++E  +   +EI +L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHS---TEEHLRDFEREIEILKS 67

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
           L+H NIV+Y G         L + +EY+  GS+   LQ +  ++    +  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSP 320
           EYL  K  +HRD+   NILV+   RVK+ DFG+ K +               P  I    
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP--IF--- 182

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT----------------TKPPWSQYEGVP 364
            W APE +   +  ++A D+WS G  + E+ T                      Q     
Sbjct: 183 -WYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            +  + N+  LP  PD   DE    + +C   N   RP+
Sbjct: 241 LIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPS 278

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (376), Expect = 2e-41
 Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 34/288 (11%)

Query: 137 SPSVPRSPGRVENPTS-PGS---RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFS 192
           S  VPR         S  G+    ++  RL+GRG  G VY   ++    + A+K   +  
Sbjct: 12  SGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK--LMSE 69

Query: 193 DDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG 252
             +       ++ +E     RL+ P++V  +    +D +LY+ +  ++G  +  +L+  G
Sbjct: 70  TLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG 129

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK-----HI 307
            L      +  +QI S L+  HA    HRD+K  NILV       L DFG+A       +
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189

Query: 308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS--------- 358
           T      +  G+ Y+MAPE    S+      DI++L C + E  T  PP+          
Sbjct: 190 TQLG---NTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245

Query: 359 -QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA 405
              + +P       S   P IP          + + + +NP  R    
Sbjct: 246 HINQAIPRP-----STVRPGIPVAFD----AVIARGMAKNPEDRYVTC 284

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  149 bits (377), Expect = 2e-41
 Identities = 80/313 (25%), Positives = 127/313 (40%), Gaps = 47/313 (15%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K    LG+G FG V L         +G + A+K   L        +  +   +EI +L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHS---GPDQQRDFQREIQILKA 80

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
           L    IV+Y G         L + +EY+  G +   LQ +  +L  S +  Y+ QI  G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSP 320
           EYL ++  VHRD+   NILV+    VK+ADFG+AK +               P  I    
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IF--- 195

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKP--PWSQYEGVPAMFKIGNSKE-- 374
            W APE + + N  +   D+WS G  + E+ T   K   P +++  +    +   +    
Sbjct: 196 -WYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253

Query: 375 ---------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH--PFVGNAAPLERPI 423
                    LPA P     E  + ++ C   +P  RP+ + L          +   E   
Sbjct: 254 LELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312

Query: 424 LSAEPSETKPTLT 436
            +A P     +L+
Sbjct: 313 FTAHPEGKHHSLS 325

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  147 bits (374), Expect = 3e-41
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 44/278 (15%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K+ R LG G FG V L         +GE  A+K  +L  +          L +EI +L  
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPE--SGGNHIADLKKEIEILRN 79

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
           L H NIV+Y G  +E   + + + +E++  GS+ + L     ++       Y  QI  G+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSP 320
           +YL ++  VHRD+   N+LV+   +VK+ DFG+ K I            +  P  +    
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP--VF--- 194

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---------------TKPPWSQYEGVPA 365
            W APE +   +   +A D+WS G T+ E+ T                 P   Q      
Sbjct: 195 -WYAPECL-MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           +  +   K LP  P +  DE    +RKC +  P +R +
Sbjct: 253 VNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTS 289

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (376), Expect = 3e-41
 Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 51/290 (17%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
                +G+G FG V+ G     GE  A+K   +FS   +     +    EI     LRH 
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVK---IFSSREERSWFREA---EIYQTVMLRHE 96

Query: 218 NIVRYYGSET----LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
           NI+ +  ++        +L++  +Y   GS++  L  Y  +    +        SGL +L
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHL 155

Query: 274 HAKNT--------VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-----GSP 320
           H +           HRD+K  NILV  +G   +AD G+A      +  + I      G+ 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 321 YWMAPEVIKNSNGC-----NLAVDIWSLGCTVIEMAT----------TKPPWSQYEGVPA 365
            +MAPEV+ +S            DI+++G    E+A            + P+        
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 366 MFK-----IGNSKELPAIPDHLSDEG-----KDFVRKCLQRNPLHRPTAA 405
             +     +   K  P IP+              +R+C   N   R TA 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  147 bits (374), Expect = 5e-41
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 53/299 (17%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             ++  R LGRG +  V+   N  + E   +K +       K K       +EI +L  L
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIK-------REIKILENL 87

Query: 215 R-HPNIVRYYGSETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           R  PNI+               L  E+V+     ++ Q    L +  IR Y  +IL  L+
Sbjct: 88  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALD 144

Query: 272 YLHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVIK 329
           Y H+   +HRD+K  N+++D   R ++L D+G+A+         +++  S Y+  PE++ 
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLV 203

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPW-------------SQYEGVPAMFKIGNSKELP 376
           +    + ++D+WSLGC +  M   K P+             ++  G   ++   +   + 
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 377 AIPD-----------------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
             P                         +S E  DF+ K L+ +   R TA   +EHP+
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (377), Expect = 6e-41
 Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 33/297 (11%)

Query: 132 YSTATSPSVPRSPGRVENPTSPGSRW-------KKGRLLGRGTFGHVYLGFNSESGEMCA 184
             +   P   +S   +     P  +W         G  +GRG FG V+ G       + A
Sbjct: 85  LLSTQQPLTKKSGVVLHRA-VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143

Query: 185 MKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSI 244
           +K  +    +    +   +  QE  +L +  HPNIVR  G  T    +YI +E V GG  
Sbjct: 144 VK--SC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199

Query: 245 YKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
              L+  G +L    +        +G+EYL +K  +HRD+   N LV     +K++DFGM
Sbjct: 200 LTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259

Query: 304 AKHI-------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KP 355
           ++         +G    + +K    W APE +      +   D+WS G  + E  +    
Sbjct: 260 SREEADGVYAASGGLRQVPVK----WTAPEALNY-GRYSSESDVWSFGILLWETFSLGAS 314

Query: 356 PWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           P   Y  +        +     LP  P+   D     + +C    P  RP+ + + +
Sbjct: 315 P---YPNLSNQQTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  147 bits (373), Expect = 8e-41
 Identities = 78/279 (27%), Positives = 119/279 (42%), Gaps = 46/279 (16%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           K  + LG+G FG V +         +GE+ A+K   L      ++E  +   +EI +L  
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHS---TEEHLRDFEREIEILKS 98

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGL 270
           L+H NIV+Y G         L + +EY+  GS+   LQ +  ++    +  YT QI  G+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSP 320
           EYL  K  +HRD+   NILV+   RVK+ DFG+ K +               P  I    
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP--IF--- 213

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT----------------TKPPWSQYEGVP 364
            W APE +   +  ++A D+WS G  + E+ T                      Q     
Sbjct: 214 -WYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            +  + N+  LP  PD   DE    + +C   N   RP+
Sbjct: 272 LIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPS 309

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  146 bits (371), Expect = 1e-40
 Identities = 79/277 (28%), Positives = 117/277 (42%), Gaps = 44/277 (15%)

Query: 158 KKGRLLGRGTFGHVYLG----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           KK R LG G FG V L      N  +GEM A+K   L +D     +      QEI +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKAD--AGPQHRSGWKQEIDILRT 89

Query: 214 LRHPNIVRYYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
           L H +I++Y G   +     L + +EYV  GS+   L  +  +G + +  + QQI  G+ 
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----------TGQSCPLSIKGSPY 321
           YLHA++ +HRD+   N+L+D    VK+ DFG+AK +               P  +     
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--VF---- 202

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT---------------TKPPWSQYEGVPAM 366
           W APE +        A D+WS G T+ E+ T                     Q   +   
Sbjct: 203 WYAPECL-KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
             +   + LP  PD    E    ++ C +     RPT
Sbjct: 262 ELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPT 297

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  146 bits (371), Expect = 3e-40
 Identities = 72/301 (23%), Positives = 133/301 (44%), Gaps = 54/301 (17%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLS 212
             R++    +G G +G V   F++++G   A+K+++  F         A++  +E+ LL 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS----IIHAKRTYRELRLLK 83

Query: 213 RLRHPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
            ++H N++          S    + +Y+    + G  +  I++   +L +  ++    QI
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQI 141

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY----W 322
           L GL+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + Y    W
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYVATRW 194

Query: 323 -MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVP---AM 366
             APE++ N    N  VDIWS+GC + E+ T +          Q +      G P    +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254

Query: 367 FKIGNS------KELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
            KI +       + L  +P           +    D + K L  +   R TAA  L H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

Query: 413 V 413
            
Sbjct: 315 F 315

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  148 bits (375), Expect = 4e-40
 Identities = 83/406 (20%), Positives = 137/406 (33%), Gaps = 108/406 (26%)

Query: 127 PFSPSYSTATSPSVPRSPGRVENPTSPGSRW------KKGRLLGRGTFGHVYLGFNSESG 180
             S S           S     +   P S W      +   L+G G++GHV   ++    
Sbjct: 19  TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYY-----GSETLDDKLYIY 235
            + A+K++    +D       +++ +EIA+L+RL H ++V+             D+LY+ 
Sbjct: 79  RVVAIKKILRVFED---LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135

Query: 236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR 295
           LE        K+ +    L E  I++    +L G++Y+H+   +HRD+K AN LV+    
Sbjct: 136 LEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS 194

Query: 296 VKLADFGMAKHITGQSCPLSIKGSPYWM----------------------------APEV 327
           VK+ DFG+A+ +       S                                    APE+
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATT-----------KP--PWSQYEGVPAMFKIGNSKE 374
           I        A+D+WS+GC   E+               P  P S    +    K GN  +
Sbjct: 255 ILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFK 314

Query: 375 LPAIP--DHL-------------------SDEGKDFVR---------------------- 391
                  D L                    ++ K ++R                      
Sbjct: 315 FHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI 374

Query: 392 ----KCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKP 433
               + L  NP  R T    L HPF      +       E + T+ 
Sbjct: 375 HLLKRMLVFNPNKRITINECLAHPFF---KEVRIA--EVETNATEK 415

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (380), Expect = 9e-40
 Identities = 83/392 (21%), Positives = 146/392 (37%), Gaps = 59/392 (15%)

Query: 70  PRMTSPGPSSRIHSGAVTPLH----PRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNT 125
           PR     P   + +  V P         G  V  S S      +                
Sbjct: 13  PRAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEG--------------- 57

Query: 126 CPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSE-SGEMCA 184
             + P   +  S     +PG +        +++    +  G  G +YL  +   +G    
Sbjct: 58  --WCPYCGSPYSFLPQLNPGDI-----VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVV 110

Query: 185 MKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYY-----GSETLDDKLYIYLEYV 239
           +K   + S DA+++  A     E   L+ + HP+IV+ +          D   YI +EYV
Sbjct: 111 LK-GLVHSGDAEAQAMAMA---ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166

Query: 240 SGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA 299
            G S+ +      +L  +   +Y  +IL  L YLH+   V+ D+K  NI++    ++KL 
Sbjct: 167 GGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLI 223

Query: 300 DFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ 359
           D G    I        + G+P + APE+++   G  +A DI+++G T+  +    P    
Sbjct: 224 DLGAVSRINSFG---YLYGTPGFQAPEIVR--TGPTVATDIYTVGRTLAALTLDLPT--- 275

Query: 360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRP-TAAWLLE------HPF 412
             G   +  +     +    D         +R+ +  +P  R  TA  +           
Sbjct: 276 RNGR-YVDGLPEDDPVLKTYDSYG----RLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330

Query: 413 VGNAAPLERPILSAEPSETKPTLTVAMRILVT 444
           V     + RP LS   S ++ T  V + +  T
Sbjct: 331 VAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHT 362

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  145 bits (367), Expect = 2e-39
 Identities = 76/320 (23%), Positives = 123/320 (38%), Gaps = 72/320 (22%)

Query: 158 KKGRLLGRGTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +G  +GRGT+GHVY       +  +  A+K++        +        +EIALL  L+
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-------CREIALLRELK 76

Query: 216 HPNIVRYYG--SETLDDKLYIYLEYVS--------GGSIYKILQDYGQLGESAIRSYTQQ 265
           HPN++          D K+++  +Y               K  +   QL    ++S   Q
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPS----GRVKLADFGMAKHITGQSCPLSIKGSP- 320
           IL G+ YLHA   +HRD+K ANILV       GRVK+AD G A+       PL+      
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 321 --YWM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP---------------------- 355
             +W  APE++  +     A+DIW++GC   E+ T++P                      
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 356 -------P----W---SQYEGVPAMFKIGNSKELPAIP---------DHLSDEGKDFVRK 392
                  P    W    +      + K                         +    ++K
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 393 CLQRNPLHRPTAAWLLEHPF 412
            L  +P+ R T+   ++ P+
Sbjct: 317 LLTMDPIKRITSEQAMQDPY 336

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  144 bits (365), Expect = 2e-39
 Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 56/302 (18%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
            + ++  + +G G +G V    +  +G   A+K++   F      +  A++  +E+ LL 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS----ELFAKRAYRELRLLK 79

Query: 213 RLRHPNIVRYY-------GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
            +RH N++            +   D  Y+ + ++ G  + K+++   +LGE  I+    Q
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTD-FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQ 136

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPY---- 321
           +L GL Y+HA   +HRD+K  N+ V+    +K+ DFG+A+    +        + Y    
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-------TGYVVTR 189

Query: 322 WM-APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVP---A 365
           W  APEVI N       VDIWS+GC + EM T K          Q +      G P    
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 366 MFKIGNSK------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP 411
           + ++ + +       LP +          + S    + + K L  +   R TA   L HP
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 412 FV 413
           + 
Sbjct: 310 YF 311

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  142 bits (360), Expect = 2e-39
 Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 21/256 (8%)

Query: 159 KGRLLGRGTFGHVYLG-FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           + + LG G FG V  G +  +      A+K   L  ++A       +L  E  ++ +L +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK--IL-KNEANDPALKDELLAEANVMQQLDN 77

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P IVR  G     +   + +E    G + K LQ    + +  I     Q+  G++YL   
Sbjct: 78  PYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVI 328
           N VHRD+   N+L+      K++DFG++K +                +K    W APE I
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECI 192

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
            N    +   D+WS G  + E  +  + P+   +G      +   + +   P     E  
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMY 250

Query: 388 DFVRKCLQRNPLHRPT 403
           D +  C   +  +RP 
Sbjct: 251 DLMNLCWTYDVENRPG 266

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (359), Expect = 6e-39
 Identities = 66/295 (22%), Positives = 112/295 (37%), Gaps = 38/295 (12%)

Query: 134 TATSPSVPRSPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGF--NSESGEM 182
               P     P   E P   G  + +          +++G G  G V  G        ++
Sbjct: 19  KLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV 78

Query: 183 -CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSG 241
             A+K   L       ++    L  E +++ +  HPNI+R  G  T      I  EY+  
Sbjct: 79  PVAIK--AL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134

Query: 242 GSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD 300
           GS+   L+ + GQ     +    + + +G+ YL     VHRD+   N+LVD +   K++D
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194

Query: 301 FGMAKHITGQSCP--------LSIKGSPYWMAPEVI---KNSNGCNLAVDIWSLGCTVIE 349
           FG+++ +              + I+    W APE I     S+    A D+WS G  + E
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIR----WTAPEAIAFRTFSS----ASDVWSFGVVMWE 246

Query: 350 MATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           +    + P+        +  +     LPA P          +  C  ++   RP 
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPR 300

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  141 bits (358), Expect = 9e-39
 Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 62/303 (20%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
             L+GRG +G VY G  S      A+K  +  +      E      + I  +  + H NI
Sbjct: 18  LELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINE------KNIYRVPLMEHDNI 69

Query: 220 VRYYGSET-----LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            R+   +         +  + +EY   GS+ K L  +      +       +  GL YLH
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128

Query: 275 AKNT---------VHRDIKGANILVDPSGRVKLADFGMAKHITG---------QSCPLSI 316
            +            HRD+   N+LV   G   ++DFG++  +TG          +  +S 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 317 KGSPYWMAPEVIKNS------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM---- 366
            G+  +MAPEV++ +            VD+++LG    E+          E VP      
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 367 --------------FKIGNSKELPAIPDHLSDEG------KDFVRKCLQRNPLHRPTAAW 406
                           +   K+ P  P+   +        K+ +  C  ++   R TA  
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308

Query: 407 LLE 409
             E
Sbjct: 309 AEE 311

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (355), Expect = 2e-38
 Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 32/263 (12%)

Query: 158 KKGRLLGRGTFGHVYLGF---NSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           KK ++LG G FG VY G      E  ++  A+K   L      S ++ +++  E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREAT--SPKANKEILDEAYVMAS 73

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           + +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAP 325
           L  +  VHRD+   N+LV     VK+ DFG+AK +         +   + IK    WMA 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMAL 188

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPD 380
           E I          D+WS G TV E+ T  +KP    Y+G+PA      +   + LP  P 
Sbjct: 189 ESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQ-PP 242

Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
             + +    +RKC   +   RP 
Sbjct: 243 ICTIDVYMIMRKCWMIDADSRPK 265

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  142 bits (361), Expect = 2e-38
 Identities = 77/366 (21%), Positives = 131/366 (35%), Gaps = 96/366 (26%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
              +    L+GRG++G+VYL ++  + +  A+K+V  +F D        +++ +EI +L+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED----LIDCKRILREITILN 80

Query: 213 RLRHPNIVRYY-----GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQIL 267
           RL+   I+R Y           D+LYI LE      + K+ +    L E  I++    +L
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL 139

Query: 268 SGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM---- 323
            G  ++H    +HRD+K AN L++    VK+ DFG+A+ I  +     +           
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 324 -------------------APEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--- 361
                              APE+I        ++DIWS GC   E+              
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259

Query: 362 -------------------------------------GVP---AMFKIGNSK------EL 375
                                                G P    +  I   +        
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319

Query: 376 PAIP--------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAE 427
           P             +SD+G + +   L+ NP  R T    L+HP++     + +     E
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL---KDVRKK--KLE 374

Query: 428 PSETKP 433
              TK 
Sbjct: 375 NFSTKK 380

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  141 bits (357), Expect = 3e-38
 Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 46/303 (15%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK------SKESAQQLGQE 207
            S +   R +  G++G V  G +SE G   A+K V     D +           +++ +E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 208 IALLSRLRHPNIVRYY------GSETLDDKLYIYLEYVSGGSIYKILQ-DYGQLGESAIR 260
           I LL+   HPNI+             +   LY+  E +    + +++      +    I+
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHK-LYLVTELM-RTDLAQVIHDQRIVISPQHIQ 137

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSP 320
            +   IL GL  LH    VHRD+   NIL+  +  + + DF +A+  T  +         
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVP---A 365
           ++ APE++    G    VD+WS GC + EM   K        ++Q        G P    
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

Query: 366 MFKIGNSK-------ELPAIPD--------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           +    +          L  +P                D + K L+ NP  R +    L H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

Query: 411 PFV 413
           P+ 
Sbjct: 318 PYF 320

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  140 bits (355), Expect = 6e-38
 Identities = 66/313 (21%), Positives = 124/313 (39%), Gaps = 67/313 (21%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
             R++  + +G G  G V   +++      A+K+++  F +    +  A++  +E+ L+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN----QTHAKRAYRELVLMK 79

Query: 213 RLRHPNIVR-------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
            + H NI+            E   D +YI +E +   ++ +++Q   +L    +     Q
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQ--MELDHERMSYLLYQ 135

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-- 323
           +L G+++LH+   +HRD+K +NI+V     +K+ DFG+A+         S   +PY +  
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTR 190

Query: 324 ---APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVP---- 364
              APEVI         VDIWS+GC + EM              Q+       G P    
Sbjct: 191 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249

Query: 365 ------------------------AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLH 400
                                    +F               + + +D + K L  +   
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309

Query: 401 RPTAAWLLEHPFV 413
           R +    L+HP++
Sbjct: 310 RISVDEALQHPYI 322

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (349), Expect = 8e-38
 Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 26/262 (9%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEV-----TLFSDDAKSKESAQQLGQEIALLS 212
                LG+GTF  ++ G   E G+   + E       L   D   +  ++   +  +++S
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMS 67

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLE 271
           +L H ++V  YG     D+  +  E+V  GS+   L+     +         +Q+ + + 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 272 YLHAKNTVHRDIKGANILVDPSGR--------VKLADFGMAKHITGQS-CPLSIKGSPYW 322
           +L     +H ++   NIL+             +KL+D G++  +  +      I     W
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP----W 183

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDH 381
           + PE I+N    NLA D WS G T+ E+ +    P S  +    +    +  +LPA P  
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA-PKA 242

Query: 382 LSDEGKDFVRKCLQRNPLHRPT 403
              E  + +  C+   P HRP+
Sbjct: 243 --AELANLINNCMDYEPDHRPS 262

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (359), Expect = 1e-37
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 34/287 (11%)

Query: 136 TSPSVPRSPGRVENPTSPGSRW-------KKGRLLGRGTFGHVYLGFNSESGEMCAMKEV 188
             P+  R+   +   +    +W            LG G +G VY G   +     A+K  
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-- 251

Query: 189 TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL 248
           TL  D        ++  +E A++  ++HPN+V+  G  T +   YI  E+++ G+    L
Sbjct: 252 TLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN----L 303

Query: 249 QDY------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG 302
            DY       ++    +     QI S +EYL  KN +HR++   N LV  +  VK+ADFG
Sbjct: 304 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363

Query: 303 MAKHITGQSCPLSIKGS-PY-WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQ 359
           +++ +TG +         P  W APE +   N  ++  D+W+ G  + E+AT    P   
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSP--- 419

Query: 360 YEGVP---AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           Y G+        +     +   P+   ++  + +R C Q NP  RP+
Sbjct: 420 YPGIDLSQVYELLEKDYRMER-PEGCPEKVYELMRACWQWNPSDRPS 465

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  137 bits (347), Expect = 2e-37
 Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 23/260 (8%)

Query: 158 KKGRLLGRGTFGHVYLG-FNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           +    LG G+FG V  G +++ SG+    A+K   L  D     E+     +E+  +  L
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            H N++R YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL
Sbjct: 79  DHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAP 325
            +K  +HRD+   N+L+     VK+ DFG+ + +          +   +       W AP
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----WCAP 193

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKE-LPAIPDHLS 383
           E +  +   + A D W  G T+ EM T  + PW    G   + KI    E LP  P+   
Sbjct: 194 ESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCP 251

Query: 384 DEGKDFVRKCLQRNPLHRPT 403
            +  + + +C    P  RPT
Sbjct: 252 QDIYNVMVQCWAHKPEDRPT 271

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  138 bits (350), Expect = 4e-37
 Identities = 76/352 (21%), Positives = 138/352 (39%), Gaps = 84/352 (23%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
             +++  + LG+G +G V+   +  +GE+ A+K++   F +       AQ+  +EI +L+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN----STDAQRTFREIMILT 63

Query: 213 RLR-HPNIVRYYG---SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS 268
            L  H NIV       ++   D +Y+  +Y+    ++ +++    L     +    Q++ 
Sbjct: 64  ELSGHENIVNLLNVLRADNDRD-VYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIK 120

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM----- 323
            ++YLH+   +HRD+K +NIL++    VK+ADFG+++         +             
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 324 -----------------APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP--PWSQYE--- 361
                            APE++  S      +D+WSLGC + E+   KP  P S      
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240

Query: 362 -------GVPA---MFKIGNSK------ELPAIP------------------------DH 381
                    P+   +  I +         L                              
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKP 433
            ++E  D + K LQ NP  R +A   L+HPFV   +    P  + EP+    
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFV---SIFHNP--NEEPNCDHI 347

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  135 bits (342), Expect = 7e-37
 Identities = 71/253 (28%), Positives = 120/253 (47%), Gaps = 21/253 (8%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              LG G +G VY G   +     A+K  TL  +D    E   +  +E A++  ++HPN+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVK--TL-KEDTMEVE---EFLKEAAVMKEIKHPNL 71

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKN 277
           V+  G  T +   YI  E+++ G++   L++    ++    +     QI S +EYL  KN
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS-PY-WMAPEVIKNSNGCN 335
            +HRD+   N LV  +  VK+ADFG+++ +TG +         P  W APE +   N  +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFS 190

Query: 336 LAVDIWSLGCTVIEMAT--TKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDFV 390
           +  D+W+ G  + E+AT    P    Y G+        +     +   P+   ++  + +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMER-PEGCPEKVYELM 245

Query: 391 RKCLQRNPLHRPT 403
           R C Q NP  RP+
Sbjct: 246 RACWQWNPSDRPS 258

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (341), Expect = 1e-36
 Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 22/257 (8%)

Query: 158 KKGRLLGRGTFGHVYLG-FNSESGE--MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
              R+LG G FG VY G + +  GE    A+K  T   D   + ++ ++   E  ++  L
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDC--TLDNKEKFMSEAVIMKNL 70

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            HP+IV+  G    ++  +I +E    G +   L+     L    +  Y+ QI   + YL
Sbjct: 71  DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------TGQSCPLSIKGSPYWMAPEV 327
            + N VHRDI   NILV     VKL DFG++++I            L IK    WM+PE 
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPES 185

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG 386
           I N      A D+W     + E+ +  K P+   E    +  +     LP  PD      
Sbjct: 186 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVL 243

Query: 387 KDFVRKCLQRNPLHRPT 403
              + +C   +P  RP 
Sbjct: 244 YTLMTRCWDYDPSDRPR 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (340), Expect = 1e-36
 Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 23/253 (9%)

Query: 163 LGRGTFGHVYLG-FNSESGEMC-AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V  G +     ++  A+K   L       K   +++ +E  ++ +L +P IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGT--EKADTEEMMREAQIMHQLDNPYIV 73

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
           R  G     + L + +E   GG ++K L     ++  S +     Q+  G++YL  KN V
Sbjct: 74  RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVIKNS 331
           HRD+   N+L+      K++DFG++K +           +    +K    W APE I N 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECI-NF 187

Query: 332 NGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
              +   D+WS G T+ E  +  + P+ + +G   M  I   K +   P     E    +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALM 246

Query: 391 RKCLQRNPLHRPT 403
             C       RP 
Sbjct: 247 SDCWIYKWEDRPD 259

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  134 bits (339), Expect = 2e-36
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 35/259 (13%)

Query: 160 GRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
            + LG G FG V LG +  +     A+K   +  + + S++   +  QE   + +L HP 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQY--DVAVK--MI-KEGSMSED---EFFQEAQTMMKLSHPK 64

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKN 277
           +V++YG  + +  +YI  EY+S G +   L+ +G  L  S +      +  G+ +L +  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 278 TVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMAPEVIK 329
            +HRD+   N LVD    VK++DFGM +++         G   P  +K    W APEV  
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VK----WSAPEVF- 177

Query: 330 NSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSD 384
           +    +   D+W+ G  + E+ +    P    Y+       + K+     L   P   SD
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMP----YDLYTNSEVVLKVSQGHRLYR-PHLASD 232

Query: 385 EGKDFVRKCLQRNPLHRPT 403
                +  C    P  RPT
Sbjct: 233 TIYQIMYSCWHELPEKRPT 251

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (343), Expect = 2e-36
 Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 33/284 (11%)

Query: 143 SPGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLG-FNSESGEM---CAMKEVT 189
                 +P     ++            +++G G FG VY G   + SG+     A+K  T
Sbjct: 23  QGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK--T 80

Query: 190 LFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ 249
           L       K+    L  E  ++ +  H NI+R  G  +    + I  EY+  G++ K L+
Sbjct: 81  L-KAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138

Query: 250 DY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI- 307
           +  G+     +    + I +G++YL   N VHRD+   NILV+ +   K++DFG+++ + 
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198

Query: 308 -------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQ 359
                  T     + I+    W APE I +      A D+WS G  + E+ T  + P+ +
Sbjct: 199 DDPEATYTTSGGKIPIR----WTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253

Query: 360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
                 M  I +   LP  P          + +C Q+    RP 
Sbjct: 254 LSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPK 296

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  140 bits (355), Expect = 2e-36
 Identities = 89/347 (25%), Positives = 144/347 (41%), Gaps = 50/347 (14%)

Query: 80  RIHSGAVT--PLHPRAGGGVSESPSSRPDDVKQQSHR-LPLPPLTISNTCPFSPSYSTAT 136
           R+ +GA     + P+  G  +     +  + ++Q  R   +      +         T T
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378

Query: 137 SPS-----VPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLG--FNSESGEM-CAMKEV 188
            PS     + R             R + GR +G G FG V+ G   + E+  M  A+K  
Sbjct: 379 MPSTRDYEIQRE------------RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-- 424

Query: 189 TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL 248
           T   +        + L QE   + +  HP+IV+  G  T ++ ++I +E  + G +   L
Sbjct: 425 TC-KNCTSDSVREKFL-QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL 481

Query: 249 QDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
           Q     L  +++  Y  Q+ + L YL +K  VHRDI   N+LV  +  VKL DFG+++++
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

Query: 308 ------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQ 359
                       L IK    WMAPE I        A D+W  G  + E+     KP    
Sbjct: 542 EDSTYYKASKGKLPIK----WMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKP---- 592

Query: 360 YEGVP---AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           ++GV     + +I N + LP  P +        + KC   +P  RP 
Sbjct: 593 FQGVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPR 638

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (348), Expect = 2e-36
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 23/255 (9%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +    LG+G FG V++G  + +    A+K  TL         S +   QE  ++ +LRH 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK--TLKPGT----MSPEAFLQEAQVMKKLRHE 239

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHA 275
            +V+ Y   + ++ +YI  EY+S GS+   L+      L    +     QI SG+ Y+  
Sbjct: 240 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIK 329
            N VHRD++ ANILV  +   K+ADFG+A+ I        Q     IK    W APE   
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAA- 353

Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                 +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHD 412

Query: 389 FVRKCLQRNPLHRPT 403
            + +C ++ P  RPT
Sbjct: 413 LMCQCWRKEPEERPT 427

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  133 bits (337), Expect = 3e-36
 Identities = 60/260 (23%), Positives = 106/260 (40%), Gaps = 33/260 (12%)

Query: 158 KKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESA---QQLGQEIALLSR 213
              + +G G FG V+LG + ++     A+K  T+       +E A   +   +E  ++ +
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD--KVAIK--TI-------REGAMSEEDFIEEAEVMMK 59

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           L HP +V+ YG       + +  E++  G +   L+   G      +      +  G+ Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPYWMA 324
           L     +HRD+   N LV  +  +K++DFGM + +        TG   P  +K    W +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VK----WAS 173

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLS 383
           PEV  + +  +   D+WS G  + E+ +  K P+        +  I     L   P   S
Sbjct: 174 PEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLAS 231

Query: 384 DEGKDFVRKCLQRNPLHRPT 403
                 +  C +  P  RP 
Sbjct: 232 THVYQIMNHCWRERPEDRPA 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (343), Expect = 4e-36
 Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 144 PGRVENPTSPGSRWKK---------GRLLGRGTFGHVYLGF--NSESGEM-CAMKEVTLF 191
           P   E+PT     + K          +++G G FG V  G        E+  A+K  TL 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK--TL- 81

Query: 192 SDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY 251
                 K+    L  E +++ +  HPNI+R  G  T    + I  EY+  GS+   L+ +
Sbjct: 82  KVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140

Query: 252 -GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--- 307
             Q     +    + I SG++YL     VHRD+   NIL++ +   K++DFG+ + +   
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

Query: 308 -----TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYE 361
                T +   + I+    W +PE I        A D+WS G  + E+ +  + P+ +  
Sbjct: 201 PEAAYTTRGGKIPIR----WTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

Query: 362 GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
               +  +     LP  P          +  C Q++  +RP 
Sbjct: 256 NQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPK 296

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  132 bits (335), Expect = 7e-36
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 29/261 (11%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
            + +G+G FG V LG     G   A+K   +     K+  +AQ    E +++++LRH N+
Sbjct: 26  LQTIGKGEFGDVMLG--DYRGNKVAVK--CI-----KNDATAQAFLAEASVMTQLRHSNL 76

Query: 220 VRYYGSETLDD-KLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAK 276
           V+  G    +   LYI  EY++ GS+   L+  G   LG   +  ++  +   +EYL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAK--HITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           N VHRD+   N+LV      K++DFG+ K    T  +  L +K    W APE +      
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEAL-REKKF 191

Query: 335 NLAVDIWSLGCTVIEMAT--TKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDF 389
           +   D+WS G  + E+ +    P    Y  +P    + ++    ++ A PD       + 
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPRVEKGYKMDA-PDGCPPAVYEV 246

Query: 390 VRKCLQRNPLHRPTAAWLLEH 410
           ++ C   +   RP+   L E 
Sbjct: 247 MKNCWHLDAAMRPSFLQLREQ 267

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (336), Expect = 1e-35
 Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 53/284 (18%)

Query: 160 GRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R LG+G+FG VY G        E     A+K  T+ ++ A  +E  + L  E +++   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TV-NEAASMRERIEFL-NEASVMKEF 85

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------------GQLGESAIR 260
              ++VR  G  +      + +E ++ G     L+ Y                   S + 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGD----LKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCP 313
               +I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I        G    
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 314 LSIKGSPYWMAPEVIK------NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAM 366
           L ++    WM+PE +K       S       D+WS G  + E+AT  + P+        +
Sbjct: 202 LPVR----WMSPESLKDGVFTTYS-------DVWSFGVVLWEIATLAEQPYQGLSNEQVL 250

Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             +     L   PD+  D   + +R C Q NP  RP+   ++  
Sbjct: 251 RFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 1e-35
 Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 24/259 (9%)

Query: 158 KKGRLLGRGTFGHVYLGF---NSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           +K ++LG G FG V+ G      ES ++   +K   +  +D   ++S Q +   +  +  
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VI--EDKSGRQSFQAVTDHMLAIGS 71

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           L H +IVR  G       L +  +Y+  GS+   ++ + G LG   + ++  QI  G+ Y
Sbjct: 72  LDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS--PY-WMAPEVIK 329
           L     VHR++   N+L+    +V++ADFG+A  +      L    +  P  WMA E I 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI- 189

Query: 330 NSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPDHLSD 384
           +        D+WS G TV E+ T   +P    Y G+        +   + L   P   + 
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP----YAGLRLAEVPDLLEKGERLAQ-PQICTI 244

Query: 385 EGKDFVRKCLQRNPLHRPT 403
           +    + KC   +   RPT
Sbjct: 245 DVYMVMVKCWMIDENIRPT 263

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (335), Expect = 1e-35
 Identities = 62/274 (22%), Positives = 113/274 (41%), Gaps = 32/274 (11%)

Query: 160 GRLLGRGTFGHVYLGF---NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           GR+LG+G FG V          S    A+K   L   D  +    ++  +E A +    H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVK--ML-KADIIASSDIEEFLREAACMKEFDH 84

Query: 217 PNIVRYYG------SETLDDKLYIYLEYVSGGSIYKILQ------DYGQLGESAIRSYTQ 264
           P++ +  G      ++       + L ++  G ++  L       +   L    +  +  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIK 317
            I  G+EYL ++N +HRD+   N ++     V +ADFG+++ I        G +  L +K
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELP 376
               W+A E + + N   +  D+W+ G T+ E+ T  + P++  E       +     L 
Sbjct: 205 ----WLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             P    +E  D + +C   +P  RP+   L   
Sbjct: 260 Q-PPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  131 bits (331), Expect = 2e-35
 Identities = 77/267 (28%), Positives = 121/267 (45%), Gaps = 30/267 (11%)

Query: 158 KKGRLLGRGTFGHVYLG--FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + GR +G G FG V+ G   + E+  +  A+K  T   +        + L QE   + + 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIK--TC-KNCTSDSVREKFL-QEALTMRQF 73

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ + L YL
Sbjct: 74  DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------TGQSCPLSIKGSPYWMAPEV 327
            +K  VHRDI   N+LV  +  VKL DFG+++++            L IK    WMAPE 
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPES 188

Query: 328 IKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVP---AMFKIGNSKELPAIPDHL 382
           I N      A D+W  G  + E+     KP    ++GV     + +I N + LP  P + 
Sbjct: 189 I-NFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERLPM-PPNC 242

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                  + KC   +P  RP    L  
Sbjct: 243 PPTLYSLMTKCWAYDPSRRPRFTELKA 269

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 2e-35
 Identities = 70/278 (25%), Positives = 104/278 (37%), Gaps = 41/278 (14%)

Query: 160 GRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R LG G FG VY G      N  S    A+K  TL  +    ++    L  E  ++S+ 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TL-PEVCSEQDELDFL-MEALIISKF 90

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-----------GQLGESAIRSYT 263
            H NIVR  G        +I +E ++GG     L+ +             L    +    
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGD----LKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 264 QQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHI-------TGQSCP 313
           + I  G +YL   + +HRDI   N L+   G     K+ DFGMA+ I        G    
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNS 372
           L +K    WM PE            D WS G  + E+ +    P+        +  + + 
Sbjct: 207 LPVK----WMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261

Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             +   P +        + +C Q  P  RP  A +LE 
Sbjct: 262 GRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (336), Expect = 3e-35
 Identities = 79/337 (23%), Positives = 119/337 (35%), Gaps = 48/337 (14%)

Query: 100 SPSSRPDDVKQQSHRLPLPPLTIS---NTCPFSPSYSTATSPSVPRSPGRVENPTSPGSR 156
           +  S     + +  +L    +      N C    + S +    VPR              
Sbjct: 25  AMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRK------------N 72

Query: 157 WKKGRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
               R LG G FG VY G      N  S    A+K  TL  +    ++    L  E  ++
Sbjct: 73  ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TL-PEVCSEQDELDFL-MEALII 128

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ-------DYGQLGESAIRSYTQ 264
           S+  H NIVR  G        +I LE ++GG +   L+           L    +    +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 265 QILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHI-------TGQSCPL 314
            I  G +YL   + +HRDI   N L+   G     K+ DFGMA+ I        G    L
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248

Query: 315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSK 373
            +K    WM PE            D WS G  + E+ +    P+        +  + +  
Sbjct: 249 PVK----WMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
            +   P +        + +C Q  P  RP  A +LE 
Sbjct: 304 RMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 3e-35
 Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 33/271 (12%)

Query: 153 PGSRW--KKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQE 207
           P  R      R++G+G FG VY G   +  +    CA+K  +L S   + ++    L +E
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SL-SRITEMQQVEAFL-RE 72

Query: 208 IALLSRLRHPNIVRYYGSETLDD-KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQ 265
             L+  L HPN++   G     +   ++ L Y+  G + + ++          + S+  Q
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---------TGQSCPLSI 316
           +  G+EYL  +  VHRD+   N ++D S  VK+ADFG+A+ I           +   L +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPA---MFKIGNS 372
           K    W A E +  +       D+WS G  + E+ T   PP   Y  +        +   
Sbjct: 193 K----WTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDLTHFLAQG 244

Query: 373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           + LP  P++  D     +++C + +P  RPT
Sbjct: 245 RRLPQ-PEYCPDSLYQVMQQCWEADPAVRPT 274

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (333), Expect = 3e-35
 Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 32/263 (12%)

Query: 158 KKGRLLGRGTFGHVYLGF---NSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           KK ++LG G FG VY G      E  ++  A+K   L   +A S ++ +++  E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--EL--REATSPKANKEILDEAYVMAS 73

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEY 272
           + +P++ R  G   L   + +  + +  G +   ++++   +G   + ++  QI  G+ Y
Sbjct: 74  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAP 325
           L  +  VHRD+   N+LV     VK+ DFG+AK +         +   + IK    WMA 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMAL 188

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPD 380
           E I          D+WS G TV E+ T  +KP    Y+G+PA      +   + LP  P 
Sbjct: 189 ESI-LHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERLPQ-PP 242

Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
             + +    + KC   +   RP 
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPK 265

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  134 bits (339), Expect = 4e-35
 Identities = 68/313 (21%), Positives = 129/313 (41%), Gaps = 67/313 (21%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVT-LFSDDAKSKESAQQLGQEIALLS 212
             R++  + +G G  G V   +++      A+K+++  F +    +  A++  +E+ L+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN----QTHAKRAYRELVLMK 116

Query: 213 RLRHPNIVR-------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
            + H NI+            E   D +Y+ +E +   ++ +++Q   +L    +     Q
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQD-VYLVMELM-DANLCQVIQ--MELDHERMSYLLYQ 172

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM-- 323
           +L G+++LH+   +HRD+K +NI+V     +K+ DFG+A+             +PY +  
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-----TPYVVTR 227

Query: 324 ---APEVIKNSNGCNLAVDIWSLGCTVIEMATTKP------PWSQYE------GVPA--- 365
              APEVI         VDIWS+GC + EM   K          Q+       G P    
Sbjct: 228 YYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286

Query: 366 MFKIGNS-----KELPAIP--------------------DHLSDEGKDFVRKCLQRNPLH 400
           M K+  +     +  P                          + + +D + K L  +P  
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346

Query: 401 RPTAAWLLEHPFV 413
           R +    L+HP++
Sbjct: 347 RISVDDALQHPYI 359

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 5e-35
 Identities = 79/383 (20%), Positives = 139/383 (36%), Gaps = 33/383 (8%)

Query: 33  SPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTSPGPSSRIHSGAVTPLHPR 92
             G+  ++    V           +       +   S    +  P+   H   +T    R
Sbjct: 224 PEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRR 283

Query: 93  AGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTS 152
                S+  +  P  +       P+P  T       S   S  + P   +         +
Sbjct: 284 IDTLNSDGYTPEPARITSPDKPRPMPMDT-------SVFESPFSDPEELKDKKLFLKRDN 336

Query: 153 PGSRWKKGRLLGRGTFGHVYLG-FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIAL 210
                 +   LG G FG V  G +     ++  A+K   L       K   +++ +E  +
Sbjct: 337 LLIADIE---LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGT--EKADTEEMMREAQI 389

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSG 269
           + +L +P IVR  G     + L + +E   GG ++K L     ++  S +     Q+  G
Sbjct: 390 MHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 448

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI--------TGQSCPLSIKGSPY 321
           ++YL  KN VHR++   N+L+      K++DFG++K +           +    +K    
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---- 504

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPD 380
           W APE I N    +   D+WS G T+ E  +  + P+ + +G   M  I   K +   P 
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PP 562

Query: 381 HLSDEGKDFVRKCLQRNPLHRPT 403
               E    +  C       RP 
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPD 585

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  130 bits (328), Expect = 7e-35
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 43/283 (15%)

Query: 145 GRVENPTSPG---SRW-------KKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSD 193
           G    P++ G     W          + LG G FG V  G +  +     A+K   +   
Sbjct: 4   GSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQY--DVAIK--MI--- 56

Query: 194 DAKSKESA---QQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD 250
               KE +    +  +E  ++  L H  +V+ YG  T    ++I  EY++ G +   L++
Sbjct: 57  ----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112

Query: 251 Y-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-- 307
              +     +    + +   +EYL +K  +HRD+   N LV+  G VK++DFG+++++  
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172

Query: 308 ------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQY 360
                  G   P  ++    W  PEV+   +  +   DIW+ G  + E+ +  K P+ ++
Sbjct: 173 DEYTSSVGSKFP--VR----WSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

Query: 361 EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
                   I     L   P   S++    +  C       RPT
Sbjct: 226 TNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPT 267

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (336), Expect = 1e-34
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)

Query: 140 VPRSPGRVENPTSPGSRW-------KKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLF 191
                          S W       K  + +G+G FG V LG +    G   A+K   + 
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVK--CI- 224

Query: 192 SDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-KLYIYLEYVSGGSIYKILQD 250
               K+  +AQ    E +++++LRH N+V+  G    +   LYI  EY++ GS+   L+ 
Sbjct: 225 ----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 251 YG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI- 307
            G   LG   +  ++  +   +EYL   N VHRD+   N+LV      K++DFG+ K   
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340

Query: 308 -TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVP- 364
            T  +  L +K    W APE +      +   D+WS G  + E+ +  + P   Y  +P 
Sbjct: 341 STQDTGKLPVK----WTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPL 392

Query: 365 --AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
              + ++    ++ A PD       D ++ C   +   RPT
Sbjct: 393 KDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPT 432

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  129 bits (327), Expect = 2e-34
 Identities = 75/297 (25%), Positives = 114/297 (38%), Gaps = 69/297 (23%)

Query: 160 GRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           G+ LG G FG V          S++    A+K   L    A   E  + L  E+ +LS L
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--ML-KPSAHLTE-REALMSELKVLSYL 83

Query: 215 -RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY----------------GQLGES 257
             H NIV   G+ T+     +  EY   G     L ++                    + 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGD----LLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 258 AIRSYTQ------QILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT--- 308
                        Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 309 ----GQSCPLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMATT-KPPW 357
                 +  L +K    WMAPE I N      S       D+WS G  + E+ +    P 
Sbjct: 200 NYVVKGNARLPVK----WMAPESIFNCVYTFES-------DVWSYGIFLWELFSLGSSP- 247

Query: 358 SQYEGVPA----MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             Y G+P        I     + + P+H   E  D ++ C   +PL RPT   +++ 
Sbjct: 248 --YPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (327), Expect = 2e-34
 Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 51/313 (16%)

Query: 132 YSTATSPSVPRSPGRVENPTS----PGSRWKKGRLLGRGTFGHVYLGF---NSESGEMCA 184
           +   +S  VPR    ++N         +    G++LG G FG V  G       +    A
Sbjct: 7   HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVA 66

Query: 185 MKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-----KLYIYLEYV 239
           +K  T+  D++  +E  + L  E A +    HPN++R  G           K  + L ++
Sbjct: 67  VK--TMKLDNSSQREIEEFL-SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123

Query: 240 SGGSIYKILQDY----------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL 289
             G     L  Y            +    +  +   I  G+EYL  +N +HRD+   N +
Sbjct: 124 KYGD----LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179

Query: 290 VDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWS 342
           +     V +ADFG++K I        G+   + +K    W+A E +          D+W+
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESL-ADRVYTSKSDVWA 234

Query: 343 LGCTVIEMAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRN 397
            G T+ E+AT    P    Y GV        + +   L   P+   DE  + +  C + +
Sbjct: 235 FGVTMWEIATRGMTP----YPGVQNHEMYDYLLHGHRLKQ-PEDCLDELYEIMYSCWRTD 289

Query: 398 PLHRPTAAWLLEH 410
           PL RPT + L   
Sbjct: 290 PLDRPTFSVLRLQ 302

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (323), Expect = 4e-34
 Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 29/265 (10%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K    LG G FG V++G+ +   +  A+K  +L    + S +       E  L+ +L+H 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVK--SL-KQGSMSPD---AFLAEANLMKQLQHQ 68

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY------GQLGESAIRSYTQQILSGLE 271
            +VR Y   T  + +YI  EY+  GS    L D+       +L  + +     QI  G+ 
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS-PY-WMAPEVIK 329
           ++  +N +HRD++ ANILV  +   K+ADFG+A+ I             P  W APE I 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI- 182

Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDE 385
           N     +  D+WS G  + E+ T  + P   Y G+     +  +     +   PD+  +E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVR-PDNCPEE 238

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEH 410
               +R C +  P  RPT  +L   
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSV 263

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (323), Expect = 4e-34
 Identities = 73/277 (26%), Positives = 107/277 (38%), Gaps = 47/277 (16%)

Query: 160 GRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
              LG   FG VY G        E  +  A+K  TL  D A+     +    E  L +RL
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TL-KDKAEGPLREEFR-HEAMLRARL 69

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------------------GQL 254
           +HPN+V   G  T D  L +   Y S G     L ++                      L
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGD----LHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------- 307
                     QI +G+EYL + + VH+D+   N+LV     VK++D G+ + +       
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAM 366
              +  L I+    WMAPE I      ++  DIWS G  + E+ +    P+  Y     +
Sbjct: 186 LLGNSLLPIR----WMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240

Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
             I N + LP  PD         + +C    P  RP 
Sbjct: 241 EMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPR 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  132 bits (333), Expect = 7e-34
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 23/255 (9%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           +    LG+G FG V++G  + +    A+K  TL         S +   QE  ++ +LRH 
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIK--TLKPGT----MSPEAFLQEAQVMKKLRHE 322

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHA 275
            +V+ Y   + ++ +YI  EY+S GS+   L+      L    +     QI SG+ Y+  
Sbjct: 323 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITG------QSCPLSIKGSPYWMAPEVIK 329
            N VHRD++ ANILV  +   K+ADFG+A+ I        Q     IK    W APE   
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAA- 436

Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                 +  D+WS G  + E+ T  + P+        + ++     +P  P    +   D
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHD 495

Query: 389 FVRKCLQRNPLHRPT 403
            + +C ++ P  RPT
Sbjct: 496 LMCQCWRKEPEERPT 510

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  127 bits (322), Expect = 8e-34
 Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 25/259 (9%)

Query: 160 GRLLGRGTFGHVYLGF---NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
             ++GRG FG VY G    N      CA+K  +L +      E +Q L  E  ++    H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SL-NRITDIGEVSQFL-TEGIIMKDFSH 85

Query: 217 PNIVRYYGSETLDDK-LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           PN++   G     +    + L Y+  G +   +++         +  +  Q+  G++YL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---------TGQSCPLSIKGSPYWMAP 325
           +K  VHRD+   N ++D    VK+ADFG+A+ +               L +K    WMA 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 201

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           E +  +       D+WS G  + E+ T   PP+           +   + L   P++  D
Sbjct: 202 ESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPD 259

Query: 385 EGKDFVRKCLQRNPLHRPT 403
              + + KC       RP+
Sbjct: 260 PLYEVMLKCWHPKAEMRPS 278

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (323), Expect = 8e-34
 Identities = 74/328 (22%), Positives = 124/328 (37%), Gaps = 82/328 (25%)

Query: 141 PRSPGRVENPTSPGSRW-------KKGRLLGRGTFGHVYLG----FNSESGEM-CAMKEV 188
           P S            +W         G+ LG G FG V           +G    A+K  
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-- 59

Query: 189 TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL 248
            L  ++A   E  + L  E  +L ++ HP++++ YG+ + D  L + +EY   GS    L
Sbjct: 60  ML-KENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS----L 113

Query: 249 QDY----------------------------GQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           + +                              L    + S+  QI  G++YL     VH
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCPLSIKGSPYWMAPEVIK---- 329
           RD+   NILV    ++K++DFG+++ +             + +K    WMA E +     
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK----WMAIESLFDHIY 229

Query: 330 --NSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPDHL 382
              S       D+WS G  + E+ T    P    Y G+P       +     +   PD+ 
Sbjct: 230 TTQS-------DVWSFGVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRMER-PDNC 277

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           S+E    + +C ++ P  RP  A + + 
Sbjct: 278 SEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  127 bits (321), Expect = 1e-33
 Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 48/283 (16%)

Query: 160 GRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            R LG G FG V+L        ++   + A+K +   +  A+     +   +E  LL+ L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-----KDFQREAELLTNL 74

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------------------GQL 254
           +H +IV++YG     D L +  EY+  G     L  +                    G+L
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGD----LNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------- 307
           G S +     QI SG+ YL +++ VHRD+   N LV  +  VK+ DFGM++ +       
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAM 366
            G    L I+    WM PE I          D+WS G  + E+ T  K PW Q      +
Sbjct: 191 VGGHTMLPIR----WMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245

Query: 367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
             I   + L   P     E  D +  C QR P  R     + +
Sbjct: 246 ECITQGRVLER-PRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (324), Expect = 1e-33
 Identities = 69/350 (19%), Positives = 133/350 (38%), Gaps = 23/350 (6%)

Query: 65  SPIPSPRMTSPGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISN 124
            P+           + + +G + P       G+           K+            + 
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 125 TCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLG--FNSESGEM 182
                    +A +P + ++   V    S         ++GRG FG VY G   +++  ++
Sbjct: 65  HIDL-----SALNPELVQAVQHVVIGPSS-LIVHFNEVIGRGHFGCVYHGTLLDNDGKKI 118

Query: 183 -CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYG-SETLDDKLYIYLEYVS 240
            CA+K  +L +      E +Q L  E  ++    HPN++   G     +    + L Y+ 
Sbjct: 119 HCAVK--SL-NRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174

Query: 241 GGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLA 299
            G +   +++         +  +  Q+  G+++L +K  VHRD+   N ++D    VK+A
Sbjct: 175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 234

Query: 300 DFGMAKHITGQSCPLSIKGS----PY-WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT- 353
           DFG+A+ +  +        +    P  WMA E +  +       D+WS G  + E+ T  
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRG 293

Query: 354 KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
            PP+           +   + L   P++  D   + + KC       RP+
Sbjct: 294 APPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPS 342

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  130 bits (328), Expect = 2e-33
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 21/254 (8%)

Query: 158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP 217
           K  + LG G FG V++   ++  +  A+K  T+         S +    E  ++  L+H 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVK--TMKPGS----MSVEAFLAEANVMKTLQHD 243

Query: 218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHA 275
            +V+ +   T  + +YI  E+++ GS+   L+     +     +  ++ QI  G+ ++  
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGS-PY-WMAPEVIKNSNG 333
           +N +HRD++ ANILV  S   K+ADFG+A+ I             P  W APE I N   
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGS 361

Query: 334 CNLAVDIWSLGCTVIEMATT-KPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKDF 389
             +  D+WS G  ++E+ T  + P   Y G+     +  +     +P  P++  +E  + 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGYRMPR-PENCPEELYNI 417

Query: 390 VRKCLQRNPLHRPT 403
           + +C +  P  RPT
Sbjct: 418 MMRCWKNRPEERPT 431

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  127 bits (321), Expect = 2e-33
 Identities = 89/349 (25%), Positives = 127/349 (36%), Gaps = 69/349 (19%)

Query: 95  GGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSY-STATSPSVPRSPGRVENPTSP 153
           G +    S  P     +     L    I N     P Y S A    + R           
Sbjct: 1   GAMGSGSSLSP----TEGKGSGLQGHIIEN-----PQYFSDACVHHIKRR---------- 41

Query: 154 GSRWKKGRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
                    LG G FG V+L         +   + A+K +   S+ A+     Q   +E 
Sbjct: 42  --DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-----QDFQREA 94

Query: 209 ALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY----------------- 251
            LL+ L+H +IVR++G  T    L +  EY+  G     L  +                 
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD----LNRFLRSHGPDAKLLAGGEDV 150

Query: 252 --GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-- 307
             G LG   + +   Q+ +G+ YL   + VHRD+   N LV     VK+ DFGM++ I  
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

Query: 308 -----TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYE 361
                 G    L I+    WM PE I          D+WS G  + E+ T  K PW Q  
Sbjct: 211 TDYYRVGGRTMLPIR----WMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

Query: 362 GVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
              A+  I   +EL   P     E    +R C QR P  R +   +   
Sbjct: 266 NTEAIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  127 bits (322), Expect = 3e-33
 Identities = 68/364 (18%), Positives = 121/364 (33%), Gaps = 105/364 (28%)

Query: 150 PTSPGSRWKKGR-----LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQL 204
           P   G  +K  R      LG G F  V+L  +  +    AMK V       +  +   + 
Sbjct: 9   PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEA 61

Query: 205 GQ-EIALLSRLR-----------HPNIVRYYGS---------------ETLDDKLYIYLE 237
            + EI LL R+              +I++                   E L + L   ++
Sbjct: 62  AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121

Query: 238 YVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGR- 295
                       ++  +    ++  ++Q+L GL+Y+H +   +H DIK  N+L++     
Sbjct: 122 K----------YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171

Query: 296 -----VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEM 350
                +K+AD G A           I+ +  + +PEV+  +       DIWS  C + E+
Sbjct: 172 ENLIQIKIADLGNACWYDEHYTNS-IQ-TREYRSPEVLLGA-PWGCGADIWSTACLIFEL 228

Query: 351 ATTKP--------PWS-------QYEGV-----PAMFKIGN------------------- 371
            T            ++       Q   +       + + G                    
Sbjct: 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288

Query: 372 ----SKELPAIPDHLSDEGK---DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPIL 424
                  L        DE K   DF+   LQ +P  R  A  L+ HP++ +   +E   +
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

Query: 425 SAEP 428
               
Sbjct: 349 PDRE 352

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (319), Expect = 4e-33
 Identities = 66/288 (22%), Positives = 110/288 (38%), Gaps = 55/288 (19%)

Query: 160 GRLLGRGTFGHVYLG----FNSESGEM-CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           G+ LG G FG V          E   +  A+K   L    A + E  + L  E+ ++S L
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--ML-KSTAHADEK-EALMSELKIMSHL 106

Query: 215 -RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY------------------GQLG 255
            +H NIV   G+ T    + +  EY   G     L ++                      
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGD----LLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------T 308
              +  ++ Q+  G+ +L +KN +HRD+   N+L+      K+ DFG+A+ I        
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVPA- 365
             +  L +K    WMAPE I +     +  D+WS G  + E+ +    P    Y G+   
Sbjct: 223 KGNARLPVK----WMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNP----YPGILVN 273

Query: 366 ---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                 + +  ++   P          ++ C    P HRPT   +   
Sbjct: 274 SKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  126 bits (318), Expect = 7e-33
 Identities = 74/302 (24%), Positives = 117/302 (38%), Gaps = 74/302 (24%)

Query: 160 GRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           G++LG G FG V          +      A+K   L  + A S E  + L  E+ ++++L
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--ML-KEKADSSE-REALMSELKMMTQL 105

Query: 215 -RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY---------------------- 251
             H NIV   G+ TL   +Y+  EY   G     L +Y                      
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGD----LLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 252 -----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH 306
                  L    +  +  Q+  G+E+L  K+ VHRD+   N+LV     VK+ DFG+A+ 
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 307 IT-------GQSCPLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMATT 353
           I          +  L +K    WMAPE +        S       D+WS G  + E+ + 
Sbjct: 222 IMSDSNYVVRGNARLPVK----WMAPESLFEGIYTIKS-------DVWSYGILLWEIFSL 270

Query: 354 -KPPWSQYEGVPA----MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLL 408
              P   Y G+P        I N  ++   P + ++E    ++ C   +   RP+   L 
Sbjct: 271 GVNP---YPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326

Query: 409 EH 410
             
Sbjct: 327 SF 328

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  126 bits (319), Expect = 8e-33
 Identities = 85/349 (24%), Positives = 140/349 (40%), Gaps = 65/349 (18%)

Query: 109 KQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRW-------KKGR 161
           +Q +          SNT     +   +++   P   G  E       +W         G+
Sbjct: 28  RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87

Query: 162 LLGRGTFGHVYLG-------FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
            LG G FG V +           +     A+K   L  DDA  K+ +  +  E+ ++  +
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--ML-KDDATEKDLSDLV-SEMEMMKMI 143

Query: 215 -RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY--------------------GQ 253
            +H NI+   G+ T D  LY+ +EY S G+    L++Y                     Q
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI------ 307
           +    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I      
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259

Query: 308 -TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGVP 364
               +  L +K    WMAPE + +        D+WS G  + E+ T    P    Y G+P
Sbjct: 260 KKTTNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP----YPGIP 310

Query: 365 A---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                  +     +   P + ++E    +R C    P  RPT   L+E 
Sbjct: 311 VEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  126 bits (319), Expect = 1e-32
 Identities = 80/297 (26%), Positives = 122/297 (41%), Gaps = 70/297 (23%)

Query: 160 GRLLGRGTFGHVYLG-------FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           G+ LG G FG V L                 A+K   L   DA  K+ +  +  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--ML-KSDATEKDLSDLI-SEMEMMK 129

Query: 213 RL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-------------------- 251
            + +H NI+   G+ T D  LY+ +EY S G+    L++Y                    
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPE 185

Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---- 307
            QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+ I    
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 308 ---TGQSCPLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMAT--TKPP 356
                 +  L +K    WMAPE + +      S       D+WS G  + E+ T    P 
Sbjct: 246 YYKKTTNGRLPVK----WMAPEALFDRIYTHQS-------DVWSFGVLLWEIFTLGGSP- 293

Query: 357 WSQYEGVPA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
              Y GVP       +     +   P + ++E    +R C    P  RPT   L+E 
Sbjct: 294 ---YPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (314), Expect = 1e-32
 Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 58/291 (19%)

Query: 160 GRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           G+ LGRG FG V          + +    A+K   L  + A   E  + L  E+ +L  +
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--ML-KEGATHSE-HRALMSELKILIHI 87

Query: 215 -RHPNIVRYYGSETLDDK-LYIYLEYVSGGSIYKILQDY--------------------G 252
             H N+V   G+ T     L + +E+   G+    L  Y                     
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGN----LSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 253 QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----- 307
            L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I     
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 308 --TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEGV 363
                   L +K    WMAPE I +     +  D+WS G  + E+ +    P    Y GV
Sbjct: 204 YVRKGDARLPLK----WMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP----YPGV 254

Query: 364 PA----MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                   ++     + A PD+ + E    +  C    P  RPT + L+EH
Sbjct: 255 KIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  124 bits (314), Expect = 2e-32
 Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 58/291 (19%)

Query: 160 GRLLGRGTFGHVYLG-------FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           G+ LG G FG V +           +     A+K   L  DDA  K+ +  +  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--ML-KDDATEKDLSDLV-SEMEMMK 95

Query: 213 RL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-------------------- 251
            + +H NI+   G+ T D  LY+ +EY S G+    L++Y                    
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPE 151

Query: 252 GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI---- 307
            Q+    + S T Q+  G+EYL ++  +HRD+   N+LV  +  +K+ADFG+A+ I    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 308 ---TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT--TKPPWSQYEG 362
                 +  L +K    WMAPE + +        D+WS G  + E+ T    P    Y G
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP----YPG 262

Query: 363 VPA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           +P       +     +   P + ++E    +R C    P  RPT   L+E 
Sbjct: 263 IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  124 bits (314), Expect = 2e-32
 Identities = 73/351 (20%), Positives = 130/351 (37%), Gaps = 77/351 (21%)

Query: 114 RLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVENPTS-----PGSRWKKGRLLGRGTF 168
            +    +T++ T P            + +    + NP       P +  +  R +G G F
Sbjct: 2   AMESAAVTLT-TLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 60

Query: 169 GHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYY 223
           G V+          E   M A+K   L  ++A +        +E AL++   +PNIV+  
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVK--ML-KEEASADMQ-ADFQREAALMAEFDNPNIVKLL 116

Query: 224 GSETLDDKLYIYLEYVSGGSIYKILQDY----------------------------GQLG 255
           G   +   + +  EY++ G     L ++                              L 
Sbjct: 117 GVCAVGKPMCLLFEYMAYGD----LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 256 ESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------T 308
            +      +Q+ +G+ YL  +  VHRD+   N LV  +  VK+ADFG++++I        
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232

Query: 309 GQSCPLSIKGSPYWMAPEVIK------NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQY- 360
             +  + I+    WM PE I        S       D+W+ G  + E+ +    P+    
Sbjct: 233 DGNDAIPIR----WMPPESIFYNRYTTES-------DVWAYGVVLWEIFSYGLQPYYGMA 281

Query: 361 -EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
            E V    + GN   L   P++   E  + +R C  + P  RP+   +   
Sbjct: 282 HEEVIYYVRDGNI--LAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  122 bits (308), Expect = 5e-32
 Identities = 43/315 (13%), Positives = 82/315 (26%), Gaps = 53/315 (16%)

Query: 135 ATSPSVPRSPGRVENPTS-PGSRWKKGR-----LLGRGTFGHVYLGFNSESGEMCAMKEV 188
           A       S    ++    PG+R   GR       G       +   ++      A+   
Sbjct: 5   ALREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF- 63

Query: 189 TLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKIL 248
            +        +  Q+       LSR+  P + R            +  E++ GGS+ ++ 
Sbjct: 64  -VDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA 122

Query: 249 QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
                    AIR   Q + +  +  H           + + V   G V LA         
Sbjct: 123 DT-SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180

Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
            Q                            DI  +G ++  +   + P  +      +  
Sbjct: 181 PQD---------------------------DIRGIGASLYALLVNRWPLPEAGVRSGLAP 213

Query: 369 IGN---------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL 419
                       +     IP  +S        + +Q +   R  +  L     +  A  +
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQIS----AVAARSVQGDGGIRSASTLLNL---MQQATAV 266

Query: 420 ERPILSAEPSETKPT 434
                   P +  P 
Sbjct: 267 ADRTEVLGPIDEAPV 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (299), Expect = 2e-30
 Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 50/299 (16%)

Query: 137 SPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDD 194
                 +P     P    +  K   ++G G FG V              A+K   +  + 
Sbjct: 7   HHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RM-KEY 63

Query: 195 AKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-- 251
           A   +  +    E+ +L +L  HPNI+   G+      LY+ +EY   G+    L D+  
Sbjct: 64  ASKDD-HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN----LLDFLR 118

Query: 252 ------------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS 293
                               L    +  +   +  G++YL  K  +HRD+   NILV  +
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178

Query: 294 GRVKLADFGMAKHI----TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIE 349
              K+ADFG+++            L ++    WMA E + N +      D+WS G  + E
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESL-NYSVYTTNSDVWSYGVLLWE 233

Query: 350 MAT--TKPPWSQYEGVPA---MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT 403
           + +    P    Y G+       K+     L   P +  DE  D +R+C +  P  RP+
Sbjct: 234 IVSLGGTP----YCGMTCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPS 287

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (287), Expect = 2e-28
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES-AQQLGQEIALLS 212
             R++   L+G+G+FG V   ++    E  A+K +       K+K++   Q   E+ LL 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLE 105

Query: 213 RLRHP------NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES--AIRSYTQ 264
            +          IV         + L +  E +S  ++Y +L++    G S    R + Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 265 QILSGLEYLHAK--NTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCPLSIKGSP 320
           Q+ + L +L     + +H D+K  NIL+    R  +K+ DFG +  +  +        S 
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ--YIQSR 222

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
           ++ +PEV+      +LA+D+WSLGC ++EM T +P
Sbjct: 223 FYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEP 256

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  111 bits (279), Expect = 2e-27
 Identities = 78/334 (23%), Positives = 122/334 (36%), Gaps = 96/334 (28%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ-EIALLSRLRH--- 216
           R +G GTFG V L  + ++ +  A+K V       ++ +   +  + E  +L ++++   
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQNDDI 93

Query: 217 --PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGLEY 272
              NIV+Y+G     D + +  E   G S+Y+I+      G     I+ Y  +IL  L Y
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 273 LHAKNTVHRDIKGANIL-VDP------------------------SGRVKLADFGMA--- 304
           L   +  H D+K  NIL  DP                        S  +KL DFG A   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212

Query: 305 -KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK---PPWSQY 360
             +        SI  +  + APEVI N  G +++ D+WS GC + E+ T           
Sbjct: 213 SDYHG------SIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 361 E---------GVP--AMFKIGNSKE-----------------------------LPAIPD 380
           E               M                                        +  
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 381 HLSDEG-KDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            +  E   DF+   LQ +P  RP+ A LL+H F+
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  110 bits (278), Expect = 6e-27
 Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 42/216 (19%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES-AQQLGQEIALLSRLRH--- 216
           +++G+G+FG V   ++ +  +  A+K V       ++++   +Q  +EI +L  LR    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 217 ---PNIVRYYGS-----------ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSY 262
               N++    +           E L   LY  ++             +       +R +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK----------NKFQGFSLPLVRKF 205

Query: 263 TQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQSCP-LSIKGS 319
              IL  L+ LH    +H D+K  NIL+   GR  +K+ DFG + +   +    +    S
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---S 262

Query: 320 PYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP 355
            ++ APEVI  +    + +D+WSLGC + E+ T  P
Sbjct: 263 RFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYP 297

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 10/27 (37%), Positives = 17/27 (62%)

Query: 387 KDFVRKCLQRNPLHRPTAAWLLEHPFV 413
            DF+++CL+ +P  R T    L HP++
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWL 412

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  108 bits (271), Expect = 1e-26
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 60/289 (20%)

Query: 152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
                   G  +G G FG VY G+   +    A+K++     D  ++E  QQ  QEI ++
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA-MVDITTEELKQQFDQEIKVM 84

Query: 212 SRLRHPNIVRYYG-SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILS-- 268
           ++ +H N+V   G S   DD   +Y  Y+  GS+   L                  LS  
Sbjct: 85  AKCQHENLVELLGFSSDGDDLCLVY-VYMPNGSLLDRLSCLDG----------TPPLSWH 133

Query: 269 -----------GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK--------HITG 309
                      G+ +LH  + +HRDIK ANIL+D +   K++DFG+A+         +T 
Sbjct: 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193

Query: 310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGVP--- 364
           +     I G+  +MAPE ++      +    DI+S G  ++E+ T  P   ++       
Sbjct: 194 R-----IVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 365 --AMFKIGNSKELPAIPD-HLSDEGKDFVRK-------CLQRNPLHRPT 403
                     K +    D  ++D     V         CL      RP 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  107 bits (270), Expect = 2e-26
 Identities = 78/322 (24%), Positives = 126/322 (39%), Gaps = 68/322 (21%)

Query: 129 SPSYSTATSPSVPRSPGRVENPTSPGSRW-------------KKGRLLGRGTFGHVYLGF 175
              YS AT+            P    S                   L+G G FG VY G 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFE--SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59

Query: 176 NSESGEMCAMKEVTLFSDDAKSKESAQQLGQ---EIALLSRLRHPNIVRYYG--SETLDD 230
               G   A+K          + ES+Q + +   EI  LS  RHP++V   G   E  ++
Sbjct: 60  -LRDGAKVALKRR--------TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-NE 109

Query: 231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQ--QIL----SGLEYLHAKNTVHRDIK 284
            + IY +Y+  G++ + L  YG    +   S+ Q  +I      GL YLH +  +HRD+K
Sbjct: 110 MILIY-KYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166

Query: 285 GANILVDPSGRVKLADFGMAK--------HITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
             NIL+D +   K+ DFG++K        H++       +KG+  ++ PE          
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTV-----VKGTLGYIDPEYF-IKGRLTE 220

Query: 337 AVDIWSLGCTVIEMATTKPP---------WSQYEGVPAMFKIGNSKEL--PAIPDHLSDE 385
             D++S G  + E+   +            +  E        G  +++  P + D +  E
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280

Query: 386 G-KDFVR---KCLQRNPLHRPT 403
             + F     KCL  +   RP+
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPS 302

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  107 bits (268), Expect = 6e-26
 Identities = 67/356 (18%), Positives = 109/356 (30%), Gaps = 113/356 (31%)

Query: 161 RLLGRGTFGHVYLGF-NSESGEMCAMKEVTLFSDDAKSKESAQQLGQ-EIALLSRLRHP- 217
             LG GTFG V     ++      A+K +       ++    ++  + EI +L +++   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKD 77

Query: 218 -----NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGES--AIRSYTQQILSGL 270
                  V           + I  E + G + ++ L++          +R    Q+   L
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 271 EYLHAKNTVHRDIKGANILVDPSG-------------------RVKLADFGMAKHITGQS 311
            +LH     H D+K  NIL   S                     +++ADFG A       
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA------- 189

Query: 312 CPLSIKGSPY-----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM 366
                  +       +  PEVI    G     D+WS+GC + E                +
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFT----------L 238

Query: 367 FKIGNSKELPA--------IPDHLSDEGK------------------------------- 387
           F+   ++E           IP H+    +                               
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298

Query: 388 -------------DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI-LSAEPS 429
                        D +R+ L+ +P  R T A  L HPF     P ER    S  PS
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  106 bits (266), Expect = 9e-26
 Identities = 72/339 (21%), Positives = 109/339 (32%), Gaps = 112/339 (33%)

Query: 161 RLLGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLGQ-EIALLSRLRHP- 217
             LG G FG V    + ++G    A+K V       K+ +   +  + EI +L  L    
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHLNTTD 72

Query: 218 -----NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG--ESAIRSYTQQILSGL 270
                  V+          + I  E + G S Y  +++ G L      IR    QI   +
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 271 EYLHAKNTVHRDIKGANILVDPSG-------------------RVKLADFGMAKHITGQS 311
            +LH+    H D+K  NIL   S                     +K+ DFG A       
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA------- 184

Query: 312 CPLSIKGSPY-----WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM 366
                  S       + APEVI    G +   D+WS+GC +IE                +
Sbjct: 185 TYDDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFT----------V 233

Query: 367 FKIGNSKELPA--------IPDHLSDEGK------------------------------- 387
           F   +SKE  A        +P H+  + +                               
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 388 -------------DFVRKCLQRNPLHRPTAAWLLEHPFV 413
                        D ++K L+ +P  R T    L+HPF 
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score =  102 bits (257), Expect = 2e-24
 Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 48/289 (16%)

Query: 123 SNTCPFSPSYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEM 182
            ++             S+P   G+V +    G++W  G+ +G G FG +YL F +   E 
Sbjct: 6   HHSSGVDLGTENLYFQSMPFPEGKVLDDME-GNQWVLGKKIGSGGFGLIYLAFPTNKPEK 64

Query: 183 CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-----------------VRYYGS 225
            A   V +        +    L  E+    R+   +                      G 
Sbjct: 65  DARHVVKV------EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118

Query: 226 ETLDDKLYIYL--EYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDI 283
                + Y ++  E + G  + KI    G   +S +     ++L  LEY+H    VH DI
Sbjct: 119 TEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177

Query: 284 KGANILVDP--SGRVKLADFGMAKH----ITGQSCPL----SIKGSPYWMAPEVIKNSNG 333
           K AN+L+      +V LAD+G++         +           G+  + +   +    G
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDAHKG 234

Query: 334 CNLA--VDIWSLGCTVIEMATTKPPWSQYEGVPAMF------KIGNSKE 374
             L+   D+  LG  ++     K PW Q    P          +    +
Sbjct: 235 VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ 283

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 35/243 (14%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +K GR +G G+FG ++ G N  + +  A+K           +  A QL  E      
Sbjct: 9   GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-------FEPRRSDAPQLRDEYRTYKL 61

Query: 214 LRH-PNI--VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSG 269
           L     I  V Y+G E       + ++ + G S+  +L   G +     +    +Q+L+ 
Sbjct: 62  LAGCTGIPNVYYFGQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118

Query: 270 LEYLHAKNTVHRDIKGANILVDPSG-----RVKLADFGMAK----HITGQSCPL----SI 316
           ++ +H K+ V+RDIK  N L+          + + DFGM K     +T Q  P     ++
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 317 KGSPYWMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGN 371
            G+  +M+   I    G   +   D+ +LG   +       PW   +         +IG 
Sbjct: 179 SGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235

Query: 372 SKE 374
            K+
Sbjct: 236 KKQ 238

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 95.3 bits (238), Expect = 5e-22
 Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 54/279 (19%)

Query: 162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR 221
           +LGRG FG VY G     G + A+K   L  +  +  E   Q   E+ ++S   H N++R
Sbjct: 37  ILGRGGFGKVYKG-RLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 91

Query: 222 YYG--SETLDDKLYIYLEYVSGGSIYKILQDYGQLGES---AIRSYTQQIL----SGLEY 272
             G       ++L +Y  Y++ GS+   L++  +         R   Q+I      GL Y
Sbjct: 92  LRGFCMTP-TERLLVY-PYMANGSVASCLRERPESQPPLDWPKR---QRIALGSARGLAY 146

Query: 273 LHAKNT---VHRDIKGANILVDPSGRVKLADFGMAK-------HITGQSCPLSIKGSPYW 322
           LH       +HRD+K ANIL+D      + DFG+AK       H+T       ++G+   
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGH 201

Query: 323 MAPEVIKNSNG-CNLAVDIWSLGCTVIEMAT-------TKPPWSQYEGVPA----MFKIG 370
           +APE +  S G  +   D++  G  ++E+ T        +        +      + K  
Sbjct: 202 IAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 371 NSKEL--PAIPDHLSDEG-KDFVR---KCLQRNPLHRPT 403
             + L    +  +  DE  +  ++    C Q +P+ RP 
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 33/241 (13%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G+R++ GR +G G+FG +YLG +  +GE  A+K           K    QL  E  +   
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-------LECVKTKHPQLHIESKIYKM 60

Query: 214 LRH-PNI--VRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSG 269
           ++    I  +R+ G+E   D   + +E + G S+  +      +     +     Q++S 
Sbjct: 61  MQGGVGIPTIRWCGAE--GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISR 117

Query: 270 LEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAK----HITGQSCPL----SIKG 318
           +EY+H+KN +HRD+K  N L+        V + DFG+AK      T Q  P     ++ G
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 319 SPYWMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGVPAMFK---IGNSK 373
           +  + +   I    G   +   D+ SLG  ++       PW   +      K   I   K
Sbjct: 178 TARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234

Query: 374 E 374
            
Sbjct: 235 M 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 56/284 (19%), Positives = 92/284 (32%), Gaps = 70/284 (24%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI 208
            + WK G  +G+G FG +YL       +  S   C +K                 L  E+
Sbjct: 34  AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV---------EPSDNGPLFTEL 84

Query: 209 ALLSRLRHPNI-----------------VRYYGSETLDDKLYIYL--EYVSGGSIYKILQ 249
               R   P                       G    + K Y ++  +   G  + KI +
Sbjct: 85  KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143

Query: 250 DYG---------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP--SGRVKL 298
                       QL          +IL  LEY+H    VH DIK +N+L++     +V L
Sbjct: 144 ANAKRFSRKTVLQLSL--------RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYL 195

Query: 299 ADFGMAK----HITGQSCPL----SIKGSPYWMAPEVIKNSNGCNLA--VDIWSLGCTVI 348
            D+G+A         ++          G+  + +   I   NG   +   D+  LG  +I
Sbjct: 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMI 252

Query: 349 EMATTKPPWSQYEGVPAMF---KIGNSKELPAIPDHLSDEGKDF 389
           +  T   PW      P      KI   + + ++         + 
Sbjct: 253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASL-MDKCFPAANA 295

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 56/286 (19%), Positives = 91/286 (31%), Gaps = 50/286 (17%)

Query: 131 SYSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG--------EM 182
            + + T+       G V    S G +WK      R   G +Y    + +         + 
Sbjct: 19  YFQSMTTSLEALPTGTVLTDKS-GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQK 77

Query: 183 CAMK----------EVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL 232
            ++K          E   F   AK  +       +   L       I    G     DK 
Sbjct: 78  FSLKLDAKDGRLFNEQNFFQRAAKPLQV-----NKWKKLYSTPLLAIPTCMGFGVHQDKY 132

Query: 233 YIY-LEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL 289
               L  + G S+   L       L E ++     ++L  LE+LH    VH ++   NI 
Sbjct: 133 RFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191

Query: 290 VDPS--GRVKLADFGMAK-------HI---TGQSCPLSIKGSPYWMAPEVIKNSNGCNLA 337
           VDP    +V LA +G A        H+    G   P    G   +++   +    GC  +
Sbjct: 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPS 246

Query: 338 --VDIWSLGCTVIEMATTKPPWSQYEGVPAMF---KIGNSKELPAI 378
              D+ SLG  +++      PW+            K     +    
Sbjct: 247 RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF 292

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 61/251 (24%), Positives = 101/251 (40%), Gaps = 51/251 (20%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMK-EVTLFSDDAKSKESAQQLGQEIALLS 212
           G  ++ G+ +G G FG + LG N  + E  A+K E          K  A QL  E     
Sbjct: 8   GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRFYK 59

Query: 213 RLRH-PNI--VRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYT------ 263
           +L     I  V Y+G         + LE + G S+  +            R+++      
Sbjct: 60  QLGSGDGIPQVYYFGPC--GKYNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLM 109

Query: 264 --QQILSGLEYLHAKNTVHRDIKGANILVDPSG-----RVKLADFGMAK----HITGQSC 312
              Q++S +EY+H+KN ++RD+K  N L+   G      + + DF +AK      T +  
Sbjct: 110 IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169

Query: 313 P----LSIKGSPYWMAPEVIKNSNGCNLA--VDIWSLGCTVIEMATTKPPWSQYEGVPA- 365
           P     S+ G+  +M+   I    G   +   D+ +LG   +       PW   +     
Sbjct: 170 PYREHKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226

Query: 366 --MFKIGNSKE 374
               KIG++K 
Sbjct: 227 ERYQKIGDTKR 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 87.7 bits (217), Expect = 3e-19
 Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 29/166 (17%)

Query: 261 SYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-------TGQSCP 313
            Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I             
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNS 372
           L +K    WMAPE I +      + D+WS G  + E+ +    P   Y GV       + 
Sbjct: 257 LPLK----WMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASP---YPGVKI-----DE 303

Query: 373 KELPAI--------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           +    +        PD+ + E    +  C    P  RPT + L+EH
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 29/141 (20%), Positives = 52/141 (36%), Gaps = 15/141 (10%)

Query: 160 GRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           G+ LGRG FG V          + +    A+K +    + A   E  + L  E+ +L  +
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEH-RALMSELKILIHI 82

Query: 215 -RHPNIVRYYGSET-LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
             H N+V   G+ T     L + +E+   G+    L  Y +   +    Y  +     + 
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGN----LSTYLRSKRNEFVPYKTKGARFRQG 138

Query: 273 LHAKNTVHRDIKGANILVDPS 293
                 +  D+K     +  S
Sbjct: 139 KDYVGAIPVDLKRRLDSITSS 159

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 81/376 (21%), Positives = 120/376 (31%), Gaps = 122/376 (32%)

Query: 150 PTSPG----SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG 205
               G     R+   R LG G F  V+L ++ +  +  AMK   +        E+A    
Sbjct: 28  LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALD-- 82

Query: 206 QEIALLSRLR-----HPN---IVRYYGSETLDDKLYIYLEYVS---GGSIYKILQ--DYG 252
            EI LL  +R      PN   +V+      +      ++  V    G  + K +   +Y 
Sbjct: 83  -EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ 141

Query: 253 QLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPS------------------ 293
            L    ++   QQ+L GL+YLH K   +H DIK  NIL+  +                  
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 294 -------------------------------GRVKLADFGMAKHITGQSCPLSIKGSPYW 322
                                           +VK+AD G A              +  +
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQY 259

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-------------------V 363
            + EV+  S G N   DIWS  C   E+AT    +  + G                   V
Sbjct: 260 RSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

Query: 364 PAMF------------KIGNSKELPAIPD-----------HLSDEGK----DFVRKCLQR 396
           P               K G+ K +  +               S E      DF+   L+ 
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 397 NPLHRPTAAWLLEHPF 412
            P  R TAA  L HP+
Sbjct: 379 IPEKRATAAECLRHPW 394

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 33/241 (13%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G++++ GR +G G+FG +YLG N ++ E  A+K           K    QL  E  +   
Sbjct: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKIYRI 58

Query: 214 LR-HPNI--VRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSG 269
           L+    I  VR++G E   D   + ++ + G S+  +      +L    +     Q+++ 
Sbjct: 59  LQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAK----HITGQSCPL----SIKG 318
           +E++H+K+ +HRDIK  N L+    R   V + DFG+AK      T Q  P     ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 319 SPYWMAPEVIKNSNGCNLAV--DIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSK 373
           +  + +   +    G   +   D+ SLG  ++       PW   +         KI   K
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232

Query: 374 E 374
            
Sbjct: 233 V 233

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.2 bits (207), Expect = 4e-18
 Identities = 38/215 (17%), Positives = 71/215 (33%), Gaps = 46/215 (21%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---KSKESAQQLGQEIA 209
           P  + ++   +G G FG V+           A+K + +   D      +++ +++  EI 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 210 LLSRL---------RHPNIVRYYG------------------------------SETLDD 230
           +   L         R    +                                      DD
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANIL 289
           +L+I LE+  GG   + ++       +  +S   Q+ + L    A     HRD+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 290 VDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMA 324
           +  +   KL      K  T  SC L +    Y ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS 229

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 2e-06
 Identities = 42/304 (13%), Positives = 99/304 (32%), Gaps = 65/304 (21%)

Query: 170 HVYLGFNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEI-ALLSRLRHPNIVRYYGSE 226
           H ++ F  E+GE        +++F D        + +     ++LS+    +I+    + 
Sbjct: 4   HHHMDF--ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61

Query: 227 TLDDKLYIYLEYVSGGSIYK-----ILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
           +   +L+  L       + +     +L+ +Y  L         Q  +    Y+  ++ ++
Sbjct: 62  SGTLRLFWTLL-SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 281 RD-----------------IKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWM 323
            D                 ++ A + + P+  V +   G+    +G++          W+
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI--DGVLG--SGKT----------WV 166

Query: 324 APEVIKNSN-GCNLAVDI-W-SLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPD 380
           A +V  +    C +   I W +L          +        +   +    S     I  
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS-RSDHSSNIKL 225

Query: 381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLTVAMR 440
            +    +  +R+ L+  P        +L +  V NA                    ++ +
Sbjct: 226 RI-HSIQAELRRLLKSKPY--ENCLLVLLN--VQNAKAWN-------------AFNLSCK 267

Query: 441 ILVT 444
           IL+T
Sbjct: 268 ILLT 271

>3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 44/146 (30%), Positives = 55/146 (37%), Gaps = 16/146 (10%)

Query: 19   PYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFW--PHSRCSPECSPIPSPRMTSPG 76
            PY    ++ SG   SP +   S     G +              SP    + SP  TSP 
Sbjct: 1485 PYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPY-KGVQSPGYTSPF 1543

Query: 77   -----PSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPL---TISNTCPF 128
                 P   + S + +P  P      +  PSS P          P  P    T  +  P 
Sbjct: 1544 SSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSS-PSYSPTSPSYSPTSPSYSPTSPSYSPT 1602

Query: 129  SPSYSTATSPSV-PRSPGRVENPTSP 153
            SPSYS ATSPS  P SP    +PTSP
Sbjct: 1603 SPSYS-ATSPSYSPTSPSY--SPTSP 1625

>1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 34/126 (26%), Positives = 44/126 (34%), Gaps = 6/126 (4%)

Query: 32   SSPGSGHNSGHNSVGGDMSGQLFWPHSRCSP---ECSPIPSPRMTSPGPSSRIHSGAVTP 88
            +  G     G    G   S    +  +  SP     SP  SP   +  P+S  +S     
Sbjct: 1503 AMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPS 1562

Query: 89   LHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYSTATSPSVPRSPGRVE 148
              P +      SPS  P      S   P    T  +  P SPSYS  +    P SP    
Sbjct: 1563 YSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY-- 1619

Query: 149  NPTSPG 154
            +PTSP 
Sbjct: 1620 SPTSPS 1625

>1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 37/142 (26%), Positives = 48/142 (33%), Gaps = 3/142 (2%)

Query: 15   WTGKPYSDIALLGSGHCSSPGSGHNSGHNSVGGDMSGQLFWPHSRCSPECSPIPSPRMTS 74
                 ++       G  +SP   +     S G  +S   F P S      SP  SP   S
Sbjct: 1503 AMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPS 1562

Query: 75   PGPSSRIHSGAVTPLHPRAGGGVSESPSSRPDDVKQQSHRLPLPPLTISNTCPFSPSYST 134
              P+S  +S       P +      SPS  P          P    T  +  P SPSYS 
Sbjct: 1563 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSPTSPSYSP 1621

Query: 135  ATSPSVPRSPGRVENPTSPGSR 156
             +    P SP    +PTSP   
Sbjct: 1622 TSPSYSPTSPS--YSPTSPSYS 1641

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	444
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.72
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.25
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.77
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.55
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.09
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.92
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.57
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.24
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.91
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.83
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	82.93
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.48

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-63  Score=484.70  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=230.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+..  .......+.+.+|+.+|++++|||||++++++++++.+|+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            57999999999999999999999999999999987421  1122335678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      |||||+||+|.+++++.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+....   
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999999875432   


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ...+.+||+.|||||++.+.. |+.++|||||||++|||++|+.||...+....+.++....  ..+|..+++++++||+
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHHHHH
Confidence            334678999999999997665 8999999999999999999999998876666666665544  3578899999999999


Q ss_pred             HHhhhCCCCCcCHHH------HHhCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAW------LLEHPFVGNAA  417 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~e------lL~hp~~~~~~  417 (444)
                      +||++||++|||++|      |++||||++..
T Consensus       267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            999999999999886      79999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-62  Score=471.32  Aligned_cols=257  Identities=28%  Similarity=0.492  Sum_probs=213.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....  .......+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV--LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH--cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999999999999999987422  2223345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||| +|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99999 78999999998899999999999999999999999999999999999999999999999999999876666666


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      +.+||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+....  ..+|..+++++++||++||
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  247 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRML  247 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHS
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence            77899999999999877645789999999999999999999998766555555555443  3577889999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++||++|||++|+|+||||+..
T Consensus       248 ~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          248 IVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHTT
T ss_pred             cCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-62  Score=483.93  Aligned_cols=258  Identities=34%  Similarity=0.571  Sum_probs=227.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++.+....     ..+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35799999999999999999999999999999999753221     2346789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999999999986 679999999999999999999999999999999999999999999999999999875543 3


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~  391 (444)
                      ..+.+||+.|||||++.+.. |+.++|||||||++|||++|++||...+....+..+..... ....+..+++++++||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            45678999999999997665 89999999999999999999999988776666666544322 12334578999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +||++||++|||++|+|+||||++..+
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.5e-62  Score=483.29  Aligned_cols=258  Identities=30%  Similarity=0.549  Sum_probs=224.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..   ......+.+.+|+.+|++|+|||||++++++.+++.+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            468999999999999999999999999999999997532   23445678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ||||||+||+|.++|...+  .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999999997643  47999999999999999999999999999999999999999999999999998765432


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                       .....+||+.|||||++.+.. |+.++|||||||+||||++|+.||...+....+.++..... +.++..+++++++||
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCCHHHHHHH
Confidence             223467999999999998765 99999999999999999999999988776666666665543 567788999999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+||++||++|||++|+|+||||++.
T Consensus       258 ~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.3e-61  Score=464.06  Aligned_cols=254  Identities=29%  Similarity=0.523  Sum_probs=220.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----CCEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----DDKL  232 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~  232 (444)
                      |++.+.||+|+||+||+|+++.++..||+|++...   .......+.+.+|+.+|++++|||||++++++..    +..+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            47888999999999999999999999999998642   2344556789999999999999999999999865    3568


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEEC-CCCcEEEEeccccccccC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVD-PSGRVKLADFGMAKHITG  309 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~  309 (444)
                      |||||||+||+|.+++++.+.+++..++.++.||+.||+|||+++  ||||||||+||||+ .++.+||+|||+|+....
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999999999889999999999999999999999998  99999999999997 478999999999986543


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCCCCCCCCCCCCHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                       ....+.+||+.|||||++.+ . |+.++|||||||+||||++|+.||........+ ..+......+.++..+++++++
T Consensus       185 -~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 -SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             -CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence             33456789999999999864 4 899999999999999999999999876655444 4444444444566778999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||.+||++||++|||++|+|+||||++.
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-61  Score=489.46  Aligned_cols=258  Identities=34%  Similarity=0.571  Sum_probs=228.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ...|++.+.||+|+||.||+|+++.+|+.||||++.+....     ..+.+.+|+.+|+.++|||||++++++..++.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            45799999999999999999999999999999999753221     2346789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||||+||+|.++++. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999999999999976 579999999999999999999999999999999999999999999999999999875543 3


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~Li~  391 (444)
                      ....+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+....+..+..... ....+..+++++++||.
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            45678999999999997665 89999999999999999999999988776666666544322 22345678999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +||++||++|||++|+|+||||++..+
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.5e-61  Score=468.32  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=220.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .++|++.+.||+|+||+||+|++.   .+++.||||+++........   ..++.+|+.+|++++|||||++++++.+++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            468999999999999999999884   46889999998753222111   235778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-  309 (444)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999999999989999999999999999999999999999999999999999999999999999986543 


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .....+.+||+.|||||++.+.. |+.++|||||||++|||++|+.||...+..+.+..+....  ..+|..+++++++|
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSL  256 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred             CccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCcCCHHHHHH
Confidence            33445678999999999997766 8999999999999999999999998877666666665543  35788899999999


Q ss_pred             HHHHhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      |++||++||++|||     ++|+++||||++.
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            99999999999998     5899999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5e-60  Score=465.75  Aligned_cols=251  Identities=32%  Similarity=0.539  Sum_probs=220.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++++...          ..+|+.+|+.++|||||++++++.+++.+||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            569999999999999999999999999999999974211          2369999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEeccccccccCCCC-
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~~-  312 (444)
                      |||||+||+|.++|++.+.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+..... 
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999989999999999999999999999999999999999999999887 599999999987654321 


Q ss_pred             -----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHH
Q 013354          313 -----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEG  386 (444)
Q Consensus       313 -----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l  386 (444)
                           ....+||+.|||||++.+.. |+.++|||||||+||||++|+.||........+.++..... ...++..+++++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             cceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence                 22357999999999998765 99999999999999999999999988776666666554432 235778899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHH-------------HhCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWL-------------LEHPFVGNA  416 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~el-------------L~hp~~~~~  416 (444)
                      ++||.+||++||++|||+.||             |+|||+.+.
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            999999999999999999998             579998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-58  Score=465.93  Aligned_cols=260  Identities=23%  Similarity=0.399  Sum_probs=221.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----  228 (444)
                      .+++|++.+.||+|+||+||+|+++.+|+.||||+++..   .......+.+.+|+.+|+.++|||||++++++..    
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence            457899999999999999999999999999999998642   2334456788899999999999999999998653    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                        .+.+|||||||. |+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence              367999999995 68999999888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCC-----CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC------
Q 013354          307 ITGQ-----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL------  375 (444)
Q Consensus       307 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~------  375 (444)
                      +...     ....+.+||+.|+|||++.+...++.++||||+||++|||++|++||...+....+..+......      
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            6432     23345789999999999987776899999999999999999999999877655555443211100      


Q ss_pred             ---------------C--------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          376 ---------------P--------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       376 ---------------~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                     +        .+...+++++++||.+||++||++|||++|+|+||||++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                           0        1123578999999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-58  Score=449.89  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-----
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-----  230 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  230 (444)
                      +|++.+.||+|+||+||+|+++.+|+.||||+++..    ......+.+.+|+.+|++++|||||++++++...+     
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            599999999999999999999999999999998753    23445578899999999999999999999987543     


Q ss_pred             -------EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEe
Q 013354          231 -------KLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       231 -------~~~lv~e~~~ggsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                             .+|+|||||.+|+|.+++.....   ..+..++.++.||+.||+|||++|||||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   47999999999999999987654   45567899999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCC-------------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hhhh
Q 013354          301 FGMAKHITGQSC-------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAM  366 (444)
Q Consensus       301 FGla~~~~~~~~-------------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~  366 (444)
                      ||+|+.+.....             ....+||+.|||||++.+.. |+.++|||||||++|||++   ||..... ...+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            999987654321             12356999999999998765 9999999999999999996   7754221 1222


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       367 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ..+... ..|......++++++||++||++||++|||+.|+|+||||++....
T Consensus       238 ~~~~~~-~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          238 TDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHTT-CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHhcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            333322 2233334557788999999999999999999999999999986543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-57  Score=441.64  Aligned_cols=254  Identities=29%  Similarity=0.444  Sum_probs=219.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ..++|.+.+.||+|+||+||+|++.     .++..||||+++.     ......++|.+|+.+|++++|||||++++++.
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4467999999999999999999875     3578999999863     23455678999999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDY-------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG  294 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  294 (444)
                      +++.+|||||||++|+|.++|++.             ..+++..++.++.||+.||+|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999764             2589999999999999999999999999999999999999999


Q ss_pred             cEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhc
Q 013354          295 RVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIG  370 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~  370 (444)
                      .+||+|||+|+........   ....||+.|||||++.+.. |+.++|||||||+||||+| |+.||...+..+.+..+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999876443321   2345899999999998766 9999999999999999999 999999887777777776


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .... +..|..+++++.+||.+||+.||++|||+.||++  |+++
T Consensus       245 ~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~  286 (299)
T 4asz_A          245 QGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQN  286 (299)
T ss_dssp             HTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             cCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            6554 4678899999999999999999999999999843  5543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-56  Score=442.08  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=213.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ..++|.+.+.||+|+||+||+|+++     .+++.||||+++.     ......++|.+|+.+|++++|||||++++++.
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3467999999999999999999875     3688999999863     34455678999999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDY---------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP  292 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  292 (444)
                      +.+.+|||||||++|+|.+++++.               ..+++..++.++.||+.||+|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999763               34899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHH
Q 013354          293 SGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFK  368 (444)
Q Consensus       293 ~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~  368 (444)
                      ++.+||+|||+++.+.....   .....||+.|||||++.+.. ++.++|||||||+||||+| |+.||......+.+..
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999987644332   23456999999999998766 9999999999999999999 9999998877777776


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          369 IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       369 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +..... +..|..+++++.+||.+||+.||++|||+.||+++
T Consensus       273 i~~g~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCC-CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCC-CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            665554 46788999999999999999999999999998864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-56  Score=437.83  Aligned_cols=252  Identities=27%  Similarity=0.378  Sum_probs=218.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ..+++++.+.||+|+||+||+|++.     .+++.||||+++..    ......+.|.+|+.+|++++|||||+++|++.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~----~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK----AEGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-----CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc----cChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            3457899999999999999999863     46789999988632    22234467999999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD  291 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  291 (444)
                      .++.++||||||++|+|.++|...                ..+++..++.++.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999753                3489999999999999999999999999999999999999


Q ss_pred             CCCcEEEEeccccccccCCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhH
Q 013354          292 PSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMF  367 (444)
Q Consensus       292 ~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~  367 (444)
                      .++.+||+|||+++.+....   ......||+.|||||++.+.. |+.++|||||||+||||+| |+.||......+...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998764432   223456999999999998776 9999999999999999998 899999887777777


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       368 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+...... ..|..++.++.+||.+||+.||++|||+.||+++
T Consensus       259 ~i~~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77665554 5788999999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-56  Score=433.27  Aligned_cols=249  Identities=30%  Similarity=0.461  Sum_probs=207.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+++++.+.||+|+||+||+|+++   ..||||+++..   ....+..+.|.+|+.+|++++|||||++++++.. +.+
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~---~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVV---DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEec---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            4568899999999999999999764   35999988643   2345567889999999999999999999998764 568


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||||||++|+|.++|... ..+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+......
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999999999764 569999999999999999999999999999999999999999999999999998764322


Q ss_pred             ---CcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHH-hcCCCC---CCCCCCCC
Q 013354          312 ---CPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-IGNSKE---LPAIPDHL  382 (444)
Q Consensus       312 ---~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~~~~---~~~~~~~~  382 (444)
                         .....+||+.|||||++...  ..|+.++|||||||+||||++|+.||...+....+.. +.....   .+.++..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence               23446799999999998643  2389999999999999999999999988766554433 333322   23566789


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHH
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLL  408 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL  408 (444)
                      ++++++||.+||+.||++|||+.||+
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~  292 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQIL  292 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            99999999999999999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.9e-55  Score=464.60  Aligned_cols=261  Identities=29%  Similarity=0.413  Sum_probs=223.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.++||+|+||.||+|+++.+|+.||||++.+.... ...........+++.+++.++|||||+++++|.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            346899999999999999999999999999999999743211 1223333444556778888999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +|+|||||.||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998775443


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                       ..+.+||+.|||||++..+..|+.++|||||||+||||++|++||.......   ....+...  ...+|..+++++++
T Consensus       347 -~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          347 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRS  423 (689)
T ss_dssp             -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred             -CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHHHHH
Confidence             4567899999999999766569999999999999999999999997543221   22222222  23578889999999


Q ss_pred             HHHHHhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      ||.+||++||++|++     ++||++||||++.
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            999999999999998     7999999999964

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-55  Score=438.52  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=208.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  229 (444)
                      .++|++.+.||+|+||+||+|+++   .+++.||+|.+...    .   ...++.+|+++|+.+ +||||+++++++..+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----S---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----S---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----c---CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            357999999999999999999875   45789999987531    1   124577899999998 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~  308 (444)
                      +.+|+|||||+|++|.++++   .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999999999984   59999999999999999999999999999999999999876 799999999997543


Q ss_pred             CCC-----------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 013354          309 GQS-----------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ  359 (444)
Q Consensus       309 ~~~-----------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  359 (444)
                      ...                             .....+||+.|+|||++.+...|+.++||||+||++|||++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            321                             112356999999999998776689999999999999999999999965


Q ss_pred             CCCh-hhhHHhcC----------------------------------------------------CCCCCCCCCCCCHHH
Q 013354          360 YEGV-PAMFKIGN----------------------------------------------------SKELPAIPDHLSDEG  386 (444)
Q Consensus       360 ~~~~-~~~~~~~~----------------------------------------------------~~~~~~~~~~~s~~l  386 (444)
                      .... ..+..+..                                                    ..........+++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            4322 22111100                                                    000001234579999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +|||++||++||++|+|++|+|+||||++.
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.5e-55  Score=461.69  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=229.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++..     ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec-----cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3589999999999999999999999999999999864     22334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC--CcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS--GRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~vkL~DFGla~~~~~~  310 (444)
                      ||||||+||+|.++|.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999999999964 4579999999999999999999999999999999999999754  78999999999998777


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~  388 (444)
                      ......+||+.|||||++.+.. |+.++|||||||+||||++|+.||...+....+..+......  ......+++++++
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            6666778999999999998765 899999999999999999999999987777777766554322  2334678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||++||++|||+.|+|+||||+..
T Consensus       390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-55  Score=436.77  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=215.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~  226 (444)
                      +.++|++++.||+|+||+||+|++..+     ++.||||.++.    .......+.+.+|+.+|.+++| ||||+++++|
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~----~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            456899999999999999999998654     36799998863    2334456789999999999976 8999999998


Q ss_pred             Ec-CCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceE
Q 013354          227 TL-DDKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL  289 (444)
Q Consensus       227 ~~-~~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  289 (444)
                      .. ++.+++|||||++|+|.++|++.                ..+++..++.++.||+.||+|||+++||||||||+|||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence            66 45789999999999999999763                23889999999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhh
Q 013354          290 VDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPA  365 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  365 (444)
                      ++.++.+||+|||+|+.+.....   .....||+.|||||++.+.. |+.++|||||||+||||+| |+.||........
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987654432   23456899999999998766 9999999999999999998 9999988765554


Q ss_pred             hHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       366 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.........+..|..+++++++||.+||+.||++|||+.||++|
T Consensus       297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            443333333456788999999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-52  Score=412.63  Aligned_cols=259  Identities=27%  Similarity=0.464  Sum_probs=232.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            45799999999999999999999999999999998742   234456678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999887666656


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...+||+.|+|||++.+....+.++|||||||++|||++|+.||...+.......+.....  .+|..++.++.+||++|
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~  248 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDCENLLKRF  248 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence            6678999999999998777456899999999999999999999988766555555554432  56778999999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      |+.||++|||++|+++||||+...
T Consensus       249 L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          249 LVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             CCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999998643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-51  Score=406.26  Aligned_cols=258  Identities=30%  Similarity=0.460  Sum_probs=226.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...  .......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            357999999999999999999999999999999986421  111223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~  312 (444)
                      +||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999986433 333


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..++.++++||.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence            45667999999999997665 8999999999999999999999998766555555544332  35678899999999999


Q ss_pred             HhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ||++||++||     +++|+++||||++.
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     99999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-52  Score=405.61  Aligned_cols=247  Identities=27%  Similarity=0.356  Sum_probs=195.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC----
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD----  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  230 (444)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++...      .........|+..+.+++|||||++++++..++    
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            4688999999999999999987  4899999988531      112223345777778899999999999987653    


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceEECCCCcEEEEecc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--------NTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                      .+|||||||++|+|.++|++ ..+++..+.+++.|++.||+|||++        +||||||||+||||+.++.+||+|||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            68999999999999999987 5799999999999999999999987        99999999999999999999999999


Q ss_pred             ccccccCCCCc-----ccccCCCcccCcccccCcC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCC----------
Q 013354          303 MAKHITGQSCP-----LSIKGSPYWMAPEVIKNSN-----GCNLAVDIWSLGCTVIEMATTKPPWSQYEG----------  362 (444)
Q Consensus       303 la~~~~~~~~~-----~~~~gt~~y~APE~~~~~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~----------  362 (444)
                      +++........     ...+||+.|||||++.+..     .++.++|||||||+||||++|..||.....          
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876554322     2356999999999986542     267899999999999999999876643221          


Q ss_pred             ----hhhhH-HhcCCCCCCCCCCC-----CCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          363 ----VPAMF-KIGNSKELPAIPDH-----LSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       363 ----~~~~~-~~~~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                          ...+. .+......|.+|..     ++..+.+||.+||+.||++|||+.||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                11122 22223333445443     23578999999999999999999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=411.35  Aligned_cols=259  Identities=28%  Similarity=0.464  Sum_probs=223.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++...  .......+.+.+|..++..+ +||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            3468999999999999999999999999999999987421  12233446778899999988 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-C
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-Q  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~  310 (444)
                      +|+||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999999999999999988999999999999999999999999999999999999999999999999999986432 2


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.....  .++..++.++++||
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li  255 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLHEDATGIL  255 (353)
T ss_dssp             -------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence            3344567999999999997665 89999999999999999999999988776666666655433  56788999999999


Q ss_pred             HHHhhhCCCCCcCH------HHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTA------AWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~------~elL~hp~~~~~  416 (444)
                      ++||++||++||++      +|+++||||++.
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999999      899999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.4e-51  Score=408.48  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=228.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc-cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK-SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++........ .....+.+.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            34679999999999999999999999999999999975432211 11124578899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC----cEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~  307 (444)
                      +++||||+.|++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++...
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999999998888899999999999999999999999999999999999998776    7999999999987


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHH
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDE  385 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~  385 (444)
                      ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........+..+......  +.....++.+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  248 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL  248 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred             CCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            6665556677999999999997655 899999999999999999999999887666666555543321  1223578999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +++||++||.+||++|||+.|+|+||||++.
T Consensus       249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-50  Score=409.73  Aligned_cols=258  Identities=27%  Similarity=0.459  Sum_probs=221.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+|++.++||+|+||+||+|+++.+++.||+|+++...  .......+.+.+|..++.++ +||||+++++++...+.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--TC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            468999999999999999999999999999999987432  22334445678899999887 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc-cCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~-~~~~  311 (444)
                      |+||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. ....
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999863 3344


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC--------hh-hhHHhcCCCCCCCCCCCC
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG--------VP-AMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~--------~~-~~~~~~~~~~~~~~~~~~  382 (444)
                      .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....        .. ....+...  ...+|..+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~  285 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL  285 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--CCCCCTTS
T ss_pred             ccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--ccCCCCcC
Confidence            455678999999999997765 89999999999999999999999964221        11 12222222  23577889


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCH------HHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTA------AWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~------~elL~hp~~~~~  416 (444)
                      +.++++||++||++||++||++      +||++||||++.
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999984      799999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-51  Score=406.28  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=225.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+.+|+.+++.++||||+++++++...+.+++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL--LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            57999999999999999999999999999999986311  1111223578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            99999 78999999888899999999999999999999999999999999999999999999999999998876666566


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ..+||+.|+|||++.+....+.++|||||||++|+|++|+.||...........+...  ...++..++.++++||++||
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L  243 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDFLSPGAQSLIRRMI  243 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS--CCCCCTTSCHHHHHHHHTTS
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCCcccCCHHHHHHHHHHc
Confidence            6779999999999987664478999999999999999999999775544444333322  23567889999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      +.||++|||++|+++||||+...
T Consensus       244 ~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          244 VADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             CCChhHCcCHHHHHhChhhccCC
Confidence            99999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.7e-51  Score=396.01  Aligned_cols=258  Identities=33%  Similarity=0.616  Sum_probs=224.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||+||+|++..+++.||+|++.....     ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            4589999999999999999999999999999999874321     12356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +||||+.+++|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            99999999999999987 4799999999999999999999999999999999999999999999999999987654432 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-CCCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-SKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~Li~  391 (444)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.. .......+..++.++++||.
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             cCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            34456999999999997766 89999999999999999999999987665544443322 22223456789999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +||+.||++|||++|+|+||||+...+
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHccCChhHCcCHHHHhhChhhcccCc
Confidence            999999999999999999999987644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-50  Score=398.91  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=226.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|+++....  ......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            3579999999999999999999999999999999864211  11123467788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~  160 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T  160 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--c
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999876432  3


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++++||++|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            4567999999999997665 8999999999999999999999998766666665555443  256788999999999999


Q ss_pred             hhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          394 LQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      |+.||++||     +++++++||||++.
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999999     99999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-50  Score=398.86  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=223.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|+++..  ........+.+.+|+.++.++ +||||+++++++..++.+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE--LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG--GSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhH--HhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            35799999999999999999999999999999998742  223455667888999999988 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~~  311 (444)
                      |+||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ...
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999998643 233


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC--------Chh-hhHHhcCCCCCCCCCCCC
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--------GVP-AMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~--------~~~-~~~~~~~~~~~~~~~~~~  382 (444)
                      .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....        ... ....+...  ...++..+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTTS
T ss_pred             cccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCCC
Confidence            345567999999999997665 8999999999999999999999996421        111 12222222  23567889


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCH------HHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTA------AWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~------~elL~hp~~~~~  416 (444)
                      +.++++||++||++||++||++      +|+++||||++.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999999999999999995      899999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.8e-50  Score=389.82  Aligned_cols=259  Identities=29%  Similarity=0.501  Sum_probs=214.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++....   ......+.+.+|+.++++++||||+++++++..++.+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            47999999999999999999999999999999987532   233345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQ-DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+.+ +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999976 5555554 45679999999999999999999999999999999999999999999999999998765332 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hhhhHHhcC--------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIGN--------------------  371 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~--------------------  371 (444)
                      .....||+.|+|||++.+...++.++|||||||++|||++|..||..... ...+..+..                    
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            33456899999999997766689999999999999999998877543332 222222211                    


Q ss_pred             -------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          372 -------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       372 -------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                             ..........++.++++||++||+.||++|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                   0011122346899999999999999999999999999999999753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.1e-51  Score=404.09  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=226.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.+.||+|+||.||+|+++.+++.||||+++....  ......+.+..|..++..+ +||||+++++++...+.
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34689999999999999999999999999999999874211  1112345677888988877 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-C
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-Q  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~  310 (444)
                      +|+||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999986432 3


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  +.++..++.++++||
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  249 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLL  249 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCCCcccCHHHHHHH
Confidence            3345667999999999997765 8999999999999999999999998776666666555433  356788999999999


Q ss_pred             HHHhhhCCCCCcCHH-HHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAA-WLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~-elL~hp~~~~~  416 (444)
                      ++||+.||++||++. +|++||||++.
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhcCCHhHcCCChHHHHcCccccCC
Confidence            999999999999998 99999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-50  Score=404.99  Aligned_cols=260  Identities=28%  Similarity=0.444  Sum_probs=218.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHH-HHccCCCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIAL-LSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|+++...  .......+.+.+|..+ ++.++||||+++++++...+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGG--BC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            34568999999999999999999999999999999987532  1223334566677776 57789999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-C
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-G  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~  309 (444)
                      .+|+||||+.|++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999999988889999999999999999999999999999999999999999999999999998643 3


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+....+..+....  ..++..++.++++|
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~l  269 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHL  269 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHHH
Confidence            33445677999999999997665 8999999999999999999999998766666665555433  24677899999999


Q ss_pred             HHHHhhhCCCCCcCH----HHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTA----AWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~----~elL~hp~~~~~  416 (444)
                      |++||++||++||++    +++++||||++.
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999986    699999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-50  Score=403.97  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=225.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999987422   234456788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~~~~~  311 (444)
                      ||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.......
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            999999999999998878899999999999999999999999999999999999997654   59999999998876655


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC--CCCCCCCHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLSDEGKDF  389 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~L  389 (444)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.......  .....++.++++|
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  264 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL  264 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred             ccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            555677999999999997665 8999999999999999999999998766655555554433221  1224689999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      |.+||+.||++|||+.|+|+||||.+
T Consensus       265 i~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          265 IDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-50  Score=401.53  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=225.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|+++....  ......+.+.+|..++..+ +||||+++++++...+.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            34689999999999999999999999999999999874211  1122345678899999988 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-C
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-Q  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~  310 (444)
                      +|+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999986432 3


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++++||
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            3345667999999999997665 8999999999999999999999998766666666655433  356788999999999


Q ss_pred             HHHhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      ++||++||++||+     +++|++||||++.
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999994     6999999999853

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-50  Score=401.12  Aligned_cols=256  Identities=31%  Similarity=0.506  Sum_probs=227.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....  .......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH--hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            468999999999999999999999999999999986421  111223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999876543  3


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++++||++|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~l  272 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHH
T ss_pred             ccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHH
Confidence            4567999999999997665 8999999999999999999999998766666666655443  356788999999999999


Q ss_pred             hhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          394 LQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       394 L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      |+.||++||+     ++||++||||++.
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999998     9999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-50  Score=399.08  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=224.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++...      ......+.+|+.+++.++||||+++++++...+.++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            46899999999999999999999999999999988631      223456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC--CCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999999999997653 6999999999999999999999999999999999999987  789999999999887665


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC--CCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+.......  .....++.++++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            5555567999999999997665 8999999999999999999999998766655555554433221  112468999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||.+||..||++|||+.|+|+||||++.
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            9999999999999999999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-50  Score=395.75  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=226.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc-cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK-SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++........ .....+.+.+|+.+++.++||||+++++++.....+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3579999999999999999999999999999999875432211 111246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC----cEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~  308 (444)
                      ++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998878899999999999999999999999999999999999998877    79999999998876


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEG  386 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l  386 (444)
                      .........||+.|+|||++.... ++.++|||||||++|+|++|..||........+..+......  ......++.++
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  248 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence            555555667999999999997665 899999999999999999999999876655555444332211  12235689999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ++||++||+.||++|||+.|+|+||||++..
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-50  Score=396.70  Aligned_cols=260  Identities=26%  Similarity=0.438  Sum_probs=220.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++....    .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            468999999999999999999999999999999986422    2223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--  311 (444)
                      +||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....  
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999999999887789999999999999999999999999999999999999999999999999998653322  


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                       ......||+.|+|||++.+...++.++|||||||++|||++|+.||........ ................++.++.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence             223456999999999998776458899999999999999999999987554422 222222222223335689999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      |.+||+.||++|||++|+++||||++..
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=408.73  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=223.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++....   ......+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            57999999999999999999999999999999987432   233445778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC---CCCcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~~~~~  311 (444)
                      ||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            999999999999999988999999999999999999999999999999999999998   46789999999998765543


Q ss_pred             C-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHH
Q 013354          312 C-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~  388 (444)
                      . .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+......  ......+++++++
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  246 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD  246 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence            2 34567999999999997665 899999999999999999999999887666666655544332  1223468999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ||.+||+.||++|||+.|+|+||||++
T Consensus       247 li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          247 LINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHcCCChhHCCCHHHHhcCccccC
Confidence            999999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-49  Score=381.55  Aligned_cols=264  Identities=27%  Similarity=0.409  Sum_probs=229.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++...   .......+.+.+|+.++++++|+||+++++++...+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG---GCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecc---cCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            356899999999999999999999999999999998742   23445567888999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc---EEEEeccccccccC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHITG  309 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~~~~  309 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999999988888999999999999999999999999999999999999976655   99999999987766


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGK  387 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~  387 (444)
                      ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+......  ......+++++.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            65555677999999999997665 899999999999999999999999876655555544433221  222357899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCCc
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~~  420 (444)
                      +||.+||+.||++|||++|+|+||||++.....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            999999999999999999999999998764443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=404.65  Aligned_cols=261  Identities=24%  Similarity=0.453  Sum_probs=226.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++....  .......+.+.+|+.+|+.++||||+++++++...+.
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh--cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34568999999999999999999999999999999986421  1112234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999999877666


Q ss_pred             CcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcCCCCCCCCCCCCCHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ......||+.|+|||++...  ..++.++|||||||++|||++|+.||.......   ....+..  ....++..++.++
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~  247 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQEM  247 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHHH
Confidence            66677899999999998642  348899999999999999999999997543322   2222222  2235678899999


Q ss_pred             HHHHHHHhhhCCCCCcC-HHHHHhCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPT-AAWLLEHPFVGNA  416 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt-~~elL~hp~~~~~  416 (444)
                      .+||++||+.||++||+ ++++++||||++.
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999998 8999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.6e-50  Score=401.02  Aligned_cols=258  Identities=29%  Similarity=0.403  Sum_probs=208.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++.....      ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            45689999999999999999999999999999999864211      124577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc--EEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~~~~~  310 (444)
                      ++||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999999998889999999999999999999999999999999999999987765  999999999865544


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh----hHHhcCCCCCCCCCCCCCHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA----MFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      .......||+.|+|||++.+....+.++|||||||++|+|++|+.||........    ...+............++.++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence            4445567999999999998776334559999999999999999999986544322    222322222222234689999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++||.+||+.||++|||+.|+++||||...
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-50  Score=392.34  Aligned_cols=263  Identities=29%  Similarity=0.470  Sum_probs=217.0

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      +...++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+.+|+.++++++||||+++++++..++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            345678999999999999999999986 48999999986422   22334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9999999997 48888887643 599999999999999999999999999999999999999999999999999987653


Q ss_pred             CC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC---CCC-----------
Q 013354          310 QS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---SKE-----------  374 (444)
Q Consensus       310 ~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---~~~-----------  374 (444)
                      .. ......||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+..   ...           
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            32 233456899999999997766689999999999999999999999987665544433211   000           


Q ss_pred             --------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          375 --------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       375 --------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                                    ...+...+++++.+||++||+.||++|||++|+|+||||++..+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                          00112457899999999999999999999999999999998654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8e-50  Score=397.43  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=207.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|+++.+++.||||+++..       ...+.+.+|+.++++++||||+++++++...+.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence            346799999999999999999999999999999998632       1235677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccccccccC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGMAKHITG  309 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~~~~~  309 (444)
                      ++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999999999988888999999999999999999999999999999999999975   78999999999987765


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhcCCCC--CCCCCCCCCHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSKE--LPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~--~~~~~~~~s~~l  386 (444)
                      ........||+.|+|||++.+.. ++.++|||||||++|||++|..||....... .+..+.....  .......++.++
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          204 QVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ---------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             ccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            54445567999999999997665 8999999999999999999999998766554 3333333222  123346789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ++||++||+.||++|||+.|+|+||||.+...
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            99999999999999999999999999987544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-50  Score=391.34  Aligned_cols=263  Identities=30%  Similarity=0.466  Sum_probs=213.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~  229 (444)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...............+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35689999999999999999999999999999999875432222211223455666666655   599999999998875


Q ss_pred             C-----EEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          230 D-----KLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       230 ~-----~~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                      .     .+++||||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            5     5899999996 699999987654  9999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC------C-
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE------L-  375 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------~-  375 (444)
                      +++............||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+.....      . 
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            998876665556677999999999998766 89999999999999999999999987665554443321100      0 


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          376 ------------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       376 ------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                        ..+...+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                              011245789999999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-49  Score=393.93  Aligned_cols=259  Identities=27%  Similarity=0.496  Sum_probs=228.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||++++..+++.||+|++...  ........+.+.+|+.+++.++|+||+++++++...+.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechh--hhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            456899999999999999999999999999999998642  223455667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999998764332 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+....  ..++..++.++.+||+
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQ  273 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHHH
Confidence            233456999999999997665 8999999999999999999999998766555544444332  2467789999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||+.||++|||++|+|+||||...
T Consensus       274 ~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          274 KMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-49  Score=400.01  Aligned_cols=263  Identities=27%  Similarity=0.439  Sum_probs=220.4

Q ss_pred             CCCCCeeeeeeeccc--CceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          152 SPGSRWKKGRLLGRG--TFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G--~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..+.+|++.+.||+|  +||+||+|+++.+++.||||++...   .......+.+.+|+.+++.++||||+++++++..+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE---ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            456789999999999  9999999999999999999999752   23455677889999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      +.+++||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999999999875  56999999999999999999999999999999999999999999999999988654


Q ss_pred             cCC--------CCcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC----
Q 013354          308 TGQ--------SCPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE----  374 (444)
Q Consensus       308 ~~~--------~~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----  374 (444)
                      ...        .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........+..+.....    
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            221        112234689999999999763 3489999999999999999999999987665544433221110    


Q ss_pred             ----------------------------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          375 ----------------------------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       375 ----------------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                                                              ....+..++.++++||++||+.||++|||+.|+|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    0123456889999999999999999999999999999998


Q ss_pred             CCC
Q 013354          415 NAA  417 (444)
Q Consensus       415 ~~~  417 (444)
                      +..
T Consensus       339 ~~~  341 (389)
T 3gni_B          339 QIK  341 (389)
T ss_dssp             GC-
T ss_pred             HHh
Confidence            753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.4e-50  Score=396.47  Aligned_cols=261  Identities=26%  Similarity=0.470  Sum_probs=211.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..   .......+.+.+|+.++++++||||+++++++..++.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE---HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC---C--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc---ccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            346899999999999999999999999999999998642   22333456778999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-----CCCcEEEEeccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-----PSGRVKLADFGMAKHI  307 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-----~~~~vkL~DFGla~~~  307 (444)
                      ++||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999997 59999999988899999999999999999999999999999999999994     4556999999999876


Q ss_pred             cCCC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-----------
Q 013354          308 TGQS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-----------  375 (444)
Q Consensus       308 ~~~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------  375 (444)
                      .... ......||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+......           
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            5332 2234558999999999987666899999999999999999999999876655444433211000           


Q ss_pred             --------CC---------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          376 --------PA---------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       376 --------~~---------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                              +.         ++..++.++++||.+||+.||++|||++|+|+||||++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                    00         0112789999999999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-49  Score=392.33  Aligned_cols=260  Identities=31%  Similarity=0.484  Sum_probs=215.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..++|++.+.||+|+||.||+|++.   .+++.||+|+++..... ........+.+|+.+++.++||||+++++++..+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            3568999999999999999999985   68999999998742211 1223445678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +.+|+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999976433


Q ss_pred             C-CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          310 Q-SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       310 ~-~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      . .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..++.++++
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~  250 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEARD  250 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSCHHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHH
Confidence            2 2234466999999999997665 8999999999999999999999998766655555554433  2567789999999


Q ss_pred             HHHHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ||.+||+.||++||     +++|+++||||++.
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999     89999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-50  Score=411.29  Aligned_cols=259  Identities=29%  Similarity=0.460  Sum_probs=217.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|+++.+++.||||++...  ..........+.+|+.+++.++||||+++++++...+.+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh--hhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            346899999999999999999999999999999998632  112334456778899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccC-C
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-Q  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~  310 (444)
                      ++||||+.+++|.+++.+...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.... .
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999988899999999999999999999998 9999999999999999999999999999986433 2


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....  ..++..+++++++||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            3344567999999999997766 8999999999999999999999998766655555554333  246778999999999


Q ss_pred             HHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      .+||++||++||     +++|+++||||++.
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999     99999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-50  Score=413.57  Aligned_cols=260  Identities=30%  Similarity=0.474  Sum_probs=230.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|.+++.||+|+||.||+|++..+|+.||||++....  .......+.+.+|+.+++.++||||+++++++...+.+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH--HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3468999999999999999999999999999999986321  11112346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999988766555


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ....+||+.|+|||++.+....+.++|||||||++|||++|+.||...........+....  ...+..++.++++||++
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCHHHHHHHHH
Confidence            5667799999999999876645789999999999999999999998876666666665443  24677899999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||+.||++|||++|+++||||+..
T Consensus       250 ~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          250 MLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HcCCCchhCcCHHHHHhCHHhhhc
Confidence            999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-50  Score=388.90  Aligned_cols=260  Identities=28%  Similarity=0.482  Sum_probs=213.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc---------------------ccHHHHHHHHHHHHHHH
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA---------------------KSKESAQQLGQEIALLS  212 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~---------------------~~~~~~~~~~~Ei~~l~  212 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.......                     ......+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            358999999999999999999999999999999987432111                     01123467889999999


Q ss_pred             ccCCCCeeeEeeeEEc--CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE
Q 013354          213 RLRHPNIVRYYGSETL--DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV  290 (444)
Q Consensus       213 ~l~hpnIv~l~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  290 (444)
                      +++||||+++++++..  .+.+++||||+.+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999886  6789999999999999886543 579999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCC-cccccCCCcccCcccccCcCC--CChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH
Q 013354          291 DPSGRVKLADFGMAKHITGQSC-PLSIKGSPYWMAPEVIKNSNG--CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF  367 (444)
Q Consensus       291 ~~~~~vkL~DFGla~~~~~~~~-~~~~~gt~~y~APE~~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  367 (444)
                      +.++.+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|||++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            9999999999999987654332 234569999999999976542  4789999999999999999999998765444444


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       368 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      .+............+++++++||.+||+.||++|||+.|+++||||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            44333222223457899999999999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-49  Score=399.43  Aligned_cols=258  Identities=22%  Similarity=0.405  Sum_probs=224.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++..     ........+.+|+.+|+.++||||+++++++.....++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecc-----cchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999864     22334457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC--CCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.....
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999999999997654 6999999999999999999999999999999999999974  467999999999987665


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC--CCCCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK--ELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+....+..+....  ..+.....++.++++
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence            5555567999999999997665 8999999999999999999999998766555555444322  122344578999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||++||+.||++|||+.|+|+||||++..
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-50  Score=399.59  Aligned_cols=261  Identities=28%  Similarity=0.427  Sum_probs=217.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.............+.+.+|+.+++.++||||+++++++..++.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999999999999999998642211111112467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc---EEEEecccccc
Q 013354          234 IYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKH  306 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~  306 (444)
                      +||||+++++|.+++.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999888653    24899999999999999999999999999999999999976654   99999999987


Q ss_pred             ccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCC
Q 013354          307 ITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLS  383 (444)
Q Consensus       307 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s  383 (444)
                      ...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ......+......  +.....++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence            755433 33456999999999997665 8999999999999999999999997632 2233333322221  11125689


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .++++||++||+.||++|||+.|+|+||||++.
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            999999999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-49  Score=384.65  Aligned_cols=257  Identities=29%  Similarity=0.497  Sum_probs=212.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++......   ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            4799999999999999999998 57899999998753322   2223567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+.+ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999965 999999864 569999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC----------------C---
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----------------K---  373 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------------~---  373 (444)
                      .....+|+.|+|||++.+...++.++|||||||++|||++|+.||........+..+...                .   
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            234468999999999976666899999999999999999999999876544433322110                0   


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          374 --------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       374 --------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                              ....+...++.++++||++||+.||++|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                    0011234689999999999999999999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-50  Score=408.50  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=222.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|+++....  ......+.+.+|+.+++.++||||+++++++.+++.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            34689999999999999999999999999999999864111  0111123577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |+||||+.||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999999986 5799999999999999999999999999999999999999999999999999987655432


Q ss_pred             --cccccCCCcccCcccccCcCC---CChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC--CCCCCHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSNG---CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDE  385 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~~---~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~  385 (444)
                        ....+||+.|+|||++.+...   ++.++|||||||+||||++|+.||...+....+..+........+  ...++.+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence              335679999999999975432   678999999999999999999999877666666665543211122  3468999


Q ss_pred             HHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      +++||++||+.+|++  |++++||++||||++.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999998  9999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=399.45  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=215.6

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYL  236 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~  236 (444)
                      |...+.||+|+||.||+|++..+|+.||+|+++.     ......+.+.+|+.++++++||||+++++++...+.+++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc-----cccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            3446789999999999999999999999999874     22344567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE--CCCCcEEEEeccccccccCCCCc
Q 013354          237 EYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV--DPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       237 e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||+  +.++.+||+|||+++.+......
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999999999988764 469999999999999999999999999999999999999  56788999999999987666555


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~Li~  391 (444)
                      ....||+.|+|||++.... ++.++|||||||++|||++|+.||...+....+..+......  ......+++++++||.
T Consensus       246 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            5667999999999997655 899999999999999999999999887666555555433221  1223568999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||+.||++|||+.|+|+||||++.
T Consensus       325 ~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          325 KLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-49  Score=380.59  Aligned_cols=257  Identities=27%  Similarity=0.455  Sum_probs=212.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|.+.+.||+|+||.||+|.++.+++.+|+|++.....    ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            3579999999999999999999999999999999875322    222467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEecccccc
Q 013354          234 IYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKH  306 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~  306 (444)
                      +||||+.+++|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999999998653    579999999999999999999999999999999999999   4567899999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCCCCCCCHH
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHLSDE  385 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~  385 (444)
                      ...........||+.|+|||++.. . ++.++|||||||++|||++|+.||................ ........++++
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFKR-D-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ----------CTTGGGCCHHHHTT-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             cCCcccCcCcccccCcCChHHhcc-C-CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            766555556679999999999853 3 7999999999999999999999998766544443332222 222223457999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +.+||++||+.||++|||+.|+|+||||+++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-50  Score=411.06  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=223.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.++||+|+||+||+|+++.+++.||+|++.....  ......+.+.+|+.++..++||||+++++++.+++.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            34689999999999999999999999999999999863111  1111123478899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |+||||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999987 4679999999999999999999999999999999999999999999999999998765443


Q ss_pred             C--cccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---CCCCCCCCCC
Q 013354          312 C--PLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---KELPAIPDHL  382 (444)
Q Consensus       312 ~--~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~  382 (444)
                      .  ....+||+.|+|||++..    ...++.++|||||||+||||++|+.||...+....+..+...   ...+.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence            2  233579999999999862    334899999999999999999999999887766666555432   2334444568


Q ss_pred             CHHHHHHHHHHhhhCCCC--CcCHHHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLH--RPTAAWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~--Rpt~~elL~hp~~~~~  416 (444)
                      ++++++||++||..+|++  |++++|+++||||++.
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            999999999999888888  9999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.6e-49  Score=382.31  Aligned_cols=262  Identities=26%  Similarity=0.469  Sum_probs=217.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .......+.+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            5799999999999999999999999999999988642   2344556778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~  313 (444)
                      ||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999998765332 22


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------------CC
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------SK  373 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------~~  373 (444)
                      ....||+.|+|||++.+...++.++|||||||++|+|++|+.||...........+..                    ..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            3456899999999998756689999999999999999999999987654443322211                    01


Q ss_pred             CCCCC---------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          374 ELPAI---------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       374 ~~~~~---------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ..+..         ...++.++.+||++||+.||++|||++|+|+||||++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            11110         14578999999999999999999999999999999987544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-49  Score=390.63  Aligned_cols=259  Identities=31%  Similarity=0.497  Sum_probs=204.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++.....    ...+.+.+|+.++++++||||+++++++..++.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT----CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            35799999999999999999999999999999998753321    12346778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          234 IYLEYVSGGSIYKILQDY------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      +||||+. ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9999997 6999999764      35899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------------
Q 013354          308 TGQS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------------  372 (444)
Q Consensus       308 ~~~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------  372 (444)
                      .... ......||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+...              
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            4332 2334568999999999976655899999999999999999999999876554433322110              


Q ss_pred             --CC----------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 --KE----------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 --~~----------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                        ..                .+..+..++.++++||.+||+.||++|||++|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence              00                0112235789999999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.7e-49  Score=400.83  Aligned_cols=252  Identities=28%  Similarity=0.441  Sum_probs=203.5

Q ss_pred             CCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHH-HccCCCCeeeEeeeEEc----
Q 013354          155 SRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL-SRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       155 ~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~----  228 (444)
                      .+|.+. ++||+|+||+||+|+++.+++.||||++..      .    ..+.+|+.++ +..+||||+++++++..    
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------c----hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            467776 789999999999999999999999998852      1    2456778876 44589999999998875    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGM  303 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGl  303 (444)
                      ...+|+||||+.+++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            567899999999999999998753  4999999999999999999999999999999999999987   78899999999


Q ss_pred             cccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh----hhHHhcCCCCC--CC
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP----AMFKIGNSKEL--PA  377 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~--~~  377 (444)
                      ++...........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......    ....+......  ..
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            98776555555677999999999997655 8999999999999999999999997654322    22222222211  12


Q ss_pred             CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       378 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ....++.++++||++||+.||++|||+.|+|+||||.+..
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            2256899999999999999999999999999999997643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.9e-49  Score=386.01  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=227.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc-cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK-SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++........ .....+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3579999999999999999999999999999999875432211 111246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC----cEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~  308 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999887    79999999998876


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEG  386 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l  386 (444)
                      .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+......  +.+...++.++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             ccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            655555667999999999997665 899999999999999999999999876655555555433221  12235789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ++||++||+.||++|||+.|+|+||||++..
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=405.06  Aligned_cols=261  Identities=25%  Similarity=0.436  Sum_probs=221.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|+++...  .......+.+.+|..++..++|+||+++++++.+++.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3468999999999999999999999999999999986311  11122234578899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      |+||||+.|++|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998764 79999999999999999999999999999999999999999999999999998765543


Q ss_pred             C--cccccCCCcccCcccccC------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---CCCCCCCC
Q 013354          312 C--PLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---KELPAIPD  380 (444)
Q Consensus       312 ~--~~~~~gt~~y~APE~~~~------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~  380 (444)
                      .  ....+||+.|+|||++..      ...++.++|||||||++|||++|+.||...+....+..+...   ...+.++.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            3  234679999999999873      234899999999999999999999999887666655555432   23344557


Q ss_pred             CCCHHHHHHHHHHhhhCCCCC---cCHHHHHhCCCCCCC
Q 013354          381 HLSDEGKDFVRKCLQRNPLHR---PTAAWLLEHPFVGNA  416 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~R---pt~~elL~hp~~~~~  416 (444)
                      .++.++++||++||. +|++|   ++++|+++||||++.
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            899999999999999 99998   599999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-49  Score=407.04  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=201.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----  228 (444)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++..   ........+++.+|+.+|+.++|+||+++++++..    
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEech---hhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            34689999999999999999999999999999998863   22345556789999999999999999999999843    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 -DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 -~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                       ...+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++..
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence             35799999998 6799999998888999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC----------------------------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-------
Q 013354          308 TGQS----------------------------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-------  352 (444)
Q Consensus       308 ~~~~----------------------------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-------  352 (444)
                      ....                            .....+||+.|+|||++.....++.++|||||||+||||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4221                            12335689999999987655569999999999999999999       


Q ss_pred             ----CCCCCCCCCCh--------------------hhhHHhc-----------------------------CCCCCCCCC
Q 013354          353 ----TKPPWSQYEGV--------------------PAMFKIG-----------------------------NSKELPAIP  379 (444)
Q Consensus       353 ----G~~Pf~~~~~~--------------------~~~~~~~-----------------------------~~~~~~~~~  379 (444)
                          |+++|.+....                    ..+..+.                             ....+....
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                66666543210                    0000000                             000111223


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ..++.++.+||++||..||++|||++|+|+||||++.
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            4569999999999999999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-49  Score=380.91  Aligned_cols=256  Identities=26%  Similarity=0.453  Sum_probs=224.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|.++.++..+|+|++.....     ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            3579999999999999999999999999999998864221     12457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999999999988889999999999999999999999999999999999999   77889999999999887766


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC--CCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+.  ++.++||||||+++|||++|+.||...........+.........  ...+++++.+
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            666667799999999998643  789999999999999999999999887666655555443322111  1268999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||.+||+.||++|||+.|+|+||||++.
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-49  Score=377.94  Aligned_cols=261  Identities=30%  Similarity=0.463  Sum_probs=218.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+.+|+.+++.++||||+++++++...+..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            3468999999999999999999999999999999986321  11122346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987765544


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....+++.|+|||++.+....+.++||||||+++|+|++|+.||...........+....  ..++..++.++.+||.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccCchhcCHHHHHHHHH
Confidence            4556689999999999876644789999999999999999999998765555444444332  24677889999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||+.||++|||+.|+++||||++..
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-49  Score=380.86  Aligned_cols=260  Identities=31%  Similarity=0.573  Sum_probs=223.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....  .........+.+|+.++++++||||+++++++...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            3468999999999999999999999999999999986311  11222346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999986554332 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+....  ..++..++.++++||.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  240 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISR  240 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCCcCCHHHHHHHHH
Confidence            33456899999999997665 8899999999999999999999998766555555544332  25677899999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||+.||++|||+.|+|+||||++...
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999987543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2e-48  Score=376.14  Aligned_cols=259  Identities=29%  Similarity=0.514  Sum_probs=222.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc---
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL---  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---  228 (444)
                      ..+..|++.+.||+|+||.||+|.+..++..||+|++...   .......+.+.+|+.+++.++||||+++++++..   
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch---hhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            3456799999999999999999999999999999988742   2345556788999999999999999999998765   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEEC-CCCcEEEEecccc
Q 013354          229 -DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVD-PSGRVKLADFGMA  304 (444)
Q Consensus       229 -~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~vkL~DFGla  304 (444)
                       ...+++||||+.+++|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence             4568999999999999999998889999999999999999999999999  99999999999997 7889999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCCCCCCCCCCCC
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLS  383 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~s  383 (444)
                      ...... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||......... ..+........++...+
T Consensus       180 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (290)
T 1t4h_A          180 TLKRAS-FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             GGCCTT-SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             cccccc-ccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence            765433 2334569999999999863 3 799999999999999999999999876555444 33444434445566788


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            999999999999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=383.41  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=209.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+|++.+.||+|+||+||+|+++.+++.||||++....   ...........|+..+..+ +|+||+++++++..++.++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF---RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC---CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc---cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            57999999999999999999999999999999875321   2223334444555555544 9999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+ +++|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 779998887654 599999999999999999999999999999999999999999999999999987766555


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....||+.|+|||++.+ . ++.++|||||||++|||++|..||..   ......+......+.++..++.++.+||.+
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~el~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-S-YGTAADVFSLGLTILEVACNMELPHG---GEGWQQLRQGYLPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-C-CSTHHHHHHHHHHHHHHHHTCCCCSS---HHHHHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred             CcccCCCccccCHhHhcC-C-CCchhhHHHHHHHHHHHHhCCCCCCC---ccHHHHHhccCCCcccccCCCHHHHHHHHH
Confidence            555679999999999875 3 89999999999999999999766643   233334433333344567789999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ||+.||++|||++|+|+||||++
T Consensus       288 ~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999976

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-49  Score=396.58  Aligned_cols=257  Identities=27%  Similarity=0.469  Sum_probs=208.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCC--E
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDD--K  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~  231 (444)
                      .+|++.+.||+|+||.||+|+++.+++.||||++..   ........+.+.+|+.+++.+. |+||+++++++..++  .
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecc---cccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            579999999999999999999999999999998853   2234555678889999999997 999999999987544  7


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC-
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ-  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-  310 (444)
                      +|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+... 
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            899999996 699999987 57999999999999999999999999999999999999999999999999999865321 


Q ss_pred             ---------------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh
Q 013354          311 ---------------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI  369 (444)
Q Consensus       311 ---------------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  369 (444)
                                           ......+||+.|+|||++.+...++.++|||||||++|||++|++||...+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                 11233569999999999987566899999999999999999999999876655544433


Q ss_pred             cCCCCCC---------------------------------------------CCCCCCCHHHHHHHHHHhhhCCCCCcCH
Q 013354          370 GNSKELP---------------------------------------------AIPDHLSDEGKDFVRKCLQRNPLHRPTA  404 (444)
Q Consensus       370 ~~~~~~~---------------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~  404 (444)
                      ......|                                             ..+..+++++.+||++||+.||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            2110000                                             0123679999999999999999999999


Q ss_pred             HHHHhCCCCCCC
Q 013354          405 AWLLEHPFVGNA  416 (444)
Q Consensus       405 ~elL~hp~~~~~  416 (444)
                      +|+|+||||+..
T Consensus       324 ~e~l~Hp~~~~~  335 (388)
T 3oz6_A          324 NDALKHPFVSIF  335 (388)
T ss_dssp             HHHTTSTTTTTT
T ss_pred             HHHhCCHHHHHh
Confidence            999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-48  Score=377.40  Aligned_cols=259  Identities=27%  Similarity=0.496  Sum_probs=227.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+.+|+.+++.++|+||+++++++..++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechh--hccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            456899999999999999999999999999999998642  223445667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999998764322 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+....  ..++..++.++.+||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCccccCHHHHHHHH
Confidence            233456899999999997655 8999999999999999999999998766555555444332  3567789999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||+.||++|||++|+++||||.+.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHcccChhhCcCHHHHhhChheecC
Confidence            9999999999999999999999764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=392.61  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=221.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc---cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK---SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      .+|++.+.||+|+||.||+|+++.+++.||||++........   .....+.+.+|+.++++++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            479999999999999999999999999999999875322111   11123456779999999999999999999999999


Q ss_pred             EEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGG-SIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~gg-sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++||||+.++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            99999998666 99999998888999999999999999999999999999999999999999999999999999987766


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      .......||+.|+|||++.+...++.++|||||||++|||++|+.||.....      ..  ......+..++.++.+||
T Consensus       184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~~l~~li  255 (335)
T 3dls_A          184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--EAAIHPPYLVSKELMSLV  255 (335)
T ss_dssp             CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT--TTCCCCSSCCCHHHHHHH
T ss_pred             CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH--hhccCCCcccCHHHHHHH
Confidence            6556677999999999998776458999999999999999999999965221      11  111234567899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      .+||+.||++|||++++++||||++...
T Consensus       256 ~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          256 SGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHccCChhhCcCHHHHhcCccccCCcc
Confidence            9999999999999999999999987543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-48  Score=376.59  Aligned_cols=265  Identities=26%  Similarity=0.395  Sum_probs=227.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc----cccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD----AKSKESAQQLGQEIALLSRLR-HPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~  227 (444)
                      ...+|++.+.||+|+||.||+|+++.+++.||||++......    .......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            346899999999999999999999999999999998754321    112344567889999999995 999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .++..++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCcccccCCCcccCccccc-----CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCC--CCC
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIK-----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA--IPD  380 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~  380 (444)
                      ..........+++.|+|||++.     ....++.++||||||+++|||++|+.||...........+........  ...
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            6655555667999999999985     233478999999999999999999999987665555544443332211  224


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            6899999999999999999999999999999999754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-48  Score=390.30  Aligned_cols=261  Identities=26%  Similarity=0.448  Sum_probs=225.3

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++......   ....+..+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999999999999999998754322   12233456788999999999 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999887766


Q ss_pred             CCcccccCCCcccCcccccCc-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC--CCCCC
Q 013354          311 SCPLSIKGSPYWMAPEVIKNS-----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLS  383 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~-----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s  383 (444)
                      .......||+.|+|||++.+.     ..++.++|||||||++|||++|+.||...........+.........  ...++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  333 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS  333 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence            555667799999999998632     23788999999999999999999999876655555444433322111  24688


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      .++.+||.+||+.||++|||++|+|+||||+.
T Consensus       334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          334 STVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999963

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.9e-49  Score=376.49  Aligned_cols=258  Identities=28%  Similarity=0.542  Sum_probs=199.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh--hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            57999999999999999999999999999999986311  1111224678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            99999999999999875 569999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+....  ...+..++.++++||.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTSCHHHHHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccccCHHHHHHHHH
Confidence            33456899999999997655 7899999999999999999999998755444444333222  24567899999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||+.||++|||+.++++||||.+..
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-48  Score=384.11  Aligned_cols=255  Identities=35%  Similarity=0.580  Sum_probs=220.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|+..+.||+|+||.||+|+++.+|+.||||++.....     ...+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            48888999999999999999999999999999864221     2235678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Ccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~~  314 (444)
                      |||+.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence            999999999999875 579999999999999999999999999999999999999999999999999998765432 234


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-CCCCCCCCHHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~Li~~~  393 (444)
                      ...||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...... ......++.++++||.+|
T Consensus       200 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            556999999999997665 899999999999999999999999876655555444332221 122346899999999999


Q ss_pred             hhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          394 LQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       394 L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      |+.||++|||+.|+++||||....
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-48  Score=373.27  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=214.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  233 (444)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....   ........+.+|+..+..+ +||||+++++++..++..+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            57999999999999999999999999999999987422   2223456778899999999 9999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC----------------
Q 013354          234 IYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS----------------  293 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----------------  293 (444)
                      +||||+++++|.+++.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999999875    569999999999999999999999999999999999999844                


Q ss_pred             ---CcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc
Q 013354          294 ---GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG  370 (444)
Q Consensus       294 ---~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~  370 (444)
                         ..+||+|||++.......   ...||+.|+|||++.+...++.++|||||||++|||++|.+++....   ....+.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~  241 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIR  241 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHH
T ss_pred             CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHH
Confidence               479999999998765433   33489999999999876557789999999999999999998775432   233333


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      . ...+.++..++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus       242 ~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          242 Q-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             T-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             c-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            2 334577888999999999999999999999999999999998753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-49  Score=386.87  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC----
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD----  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  230 (444)
                      .+|++.+.||+|+||.||+|+++.+++.||||+++...    .....+.+.+|+.++++++||||+++++++.+..    
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            46999999999999999999999999999999987532    2334567899999999999999999999875543    


Q ss_pred             -----------------------------------------------------EEEEEEeccCCCCHHHHHHhcCC---C
Q 013354          231 -----------------------------------------------------KLYIYLEYVSGGSIYKILQDYGQ---L  254 (444)
Q Consensus       231 -----------------------------------------------------~~~lv~e~~~ggsL~~~l~~~~~---l  254 (444)
                                                                           .+++||||+++++|.+++.+...   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 38999999999999999987543   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-------------CcccccCCCc
Q 013354          255 GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-------------CPLSIKGSPY  321 (444)
Q Consensus       255 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-------------~~~~~~gt~~  321 (444)
                      .+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......             ......||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            666789999999999999999999999999999999999999999999998765542             2233569999


Q ss_pred             ccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 013354          322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHR  401 (444)
Q Consensus       322 y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R  401 (444)
                      |+|||++.+.. ++.++|||||||++|||++|..|+..  .......+.. ...+......++++.+||.+||+.||++|
T Consensus       242 y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             ccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc-cCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            99999997765 89999999999999999998776522  1112222222 22233334567889999999999999999


Q ss_pred             cCHHHHHhCCCCCCC
Q 013354          402 PTAAWLLEHPFVGNA  416 (444)
Q Consensus       402 pt~~elL~hp~~~~~  416 (444)
                      ||++|+|+||||++.
T Consensus       318 ps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          318 PEATDIIENAIFENL  332 (332)
T ss_dssp             CCHHHHHHSTTCCCC
T ss_pred             CCHHHHhhchhhhcC
Confidence            999999999999873

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-48  Score=372.89  Aligned_cols=260  Identities=26%  Similarity=0.442  Sum_probs=221.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....    .....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            47999999999999999999999999999999986422    22345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......   
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            99999999999999877789999999999999999999999999999999999999999999999999997653322   


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ......|++.|+|||++.+...++.++||||||+++|||++|+.||....... .+...............++.++++||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            22345689999999999776645789999999999999999999998755432 22222222222223356899999999


Q ss_pred             HHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          391 RKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      .+||+.||++|||++|+++||||++...
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999999999999999999987643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.2e-49  Score=377.77  Aligned_cols=260  Identities=30%  Similarity=0.527  Sum_probs=225.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....  ......+.+.+|+.+++.++|+||+++++++...+..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34689999999999999999999999999999998863211  1112246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+....  ..++..++.++++||.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCCCcCCHHHHHHHHH
Confidence            33456899999999997665 8999999999999999999999998766555555544332  25677899999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||+.||++|||+.++++||||++...
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999986543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.9e-48  Score=394.87  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=212.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  229 (444)
                      ....+|++.+.||+|+||.||+|+++.+++.||||++..   ........+.+.+|+.+|++++|+||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---TTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCc---hhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            345789999999999999999999999999999999863   223455667899999999999999999999998765  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          230 ---DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       230 ---~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                         ..+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               57999999995 69999999877899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC-----------------------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCC------
Q 013354          307 ITGQSC-----------------------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW------  357 (444)
Q Consensus       307 ~~~~~~-----------------------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf------  357 (444)
                      ......                       ....+||+.|+|||++.....++.++|||||||++|||++|..||      
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            644321                       245669999999999766666999999999999999999854443      


Q ss_pred             -----CCCCC-----------------hhhh------------------------HHhcCCCCCCC-----CCCCCCHHH
Q 013354          358 -----SQYEG-----------------VPAM------------------------FKIGNSKELPA-----IPDHLSDEG  386 (444)
Q Consensus       358 -----~~~~~-----------------~~~~------------------------~~~~~~~~~~~-----~~~~~s~~l  386 (444)
                           .....                 ...+                        ..+........     ....+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence                 33211                 0000                        00000000001     114589999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .+||++||+.||++|||++|+|+||||++.
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            999999999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-48  Score=388.51  Aligned_cols=264  Identities=27%  Similarity=0.449  Sum_probs=213.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|++.............+.+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            34689999999999999999999999999999999875322222223345788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999975 8998887643 58999999999999999999999999999999999999999999999999998764432


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC------CCC---------
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS------KEL---------  375 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------~~~---------  375 (444)
                       ......||+.|+|||++.+...++.++|||||||++|||++|.+||........+..+...      ...         
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence             2344568999999999976666899999999999999999999999876655444333210      000         


Q ss_pred             ------CC-----CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          376 ------PA-----IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       376 ------~~-----~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                            +.     +...++.++++||++||+.||++|||+.|+|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                  00     1145689999999999999999999999999999998753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-49  Score=390.81  Aligned_cols=264  Identities=25%  Similarity=0.431  Sum_probs=218.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.............+.+.+|+.++++++||||+++++++...+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            35799999999999999999999999999999998743222223345678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 013354          234 IYLEYVSGGSIYKILQDY----------------------------------------GQLGESAIRSYTQQILSGLEYL  273 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~aL~~L  273 (444)
                      +||||+.+++|.+++...                                        ..+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521                                        1136788999999999999999


Q ss_pred             HHCCcccCCCCCCceEECCCC--cEEEEeccccccccCCC-----CcccccCCCcccCcccccCc-CCCChhhhHHHHHH
Q 013354          274 HAKNTVHRDIKGANILVDPSG--RVKLADFGMAKHITGQS-----CPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGC  345 (444)
Q Consensus       274 H~~~ivH~Dlkp~NIll~~~~--~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGv  345 (444)
                      |+++|+||||||+|||++.++  .+||+|||++..+....     ......||+.|+|||++... ..++.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  89999999998653321     12345699999999998642 44889999999999


Q ss_pred             HHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          346 TVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       346 il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ++|||++|+.||...........+.........+  ..+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            9999999999998877666665554433322222  34799999999999999999999999999999998754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-48  Score=405.84  Aligned_cols=259  Identities=27%  Similarity=0.498  Sum_probs=224.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||||++......   ....+.+.+|+.++++++||||+++++++.....++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            35899999999999999999999999999999998642211   112467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC---CCCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999999998888999999999999999999999999999999999999995   4567999999999877666


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||........+..+.........+  ..+++++++
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CccCCCcCCCCCCCHHHhCC-C-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            55556679999999999965 3 8999999999999999999999998877666666665544332222  468999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||++||+.||++|||+.|+|+||||+...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999998653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.4e-49  Score=399.62  Aligned_cols=262  Identities=29%  Similarity=0.499  Sum_probs=209.4

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++......   .........+.+|+.+|++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            46899999999999999999999999999999998753221   1122233467899999999999999999999754 5


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEeccccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKHI  307 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~  307 (444)
                      ..++||||+.+++|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999998888899999999999999999999999999999999999997544   5999999999987


Q ss_pred             cCCCCcccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH-HhcCCCC--CCCCCCCC
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-KIGNSKE--LPAIPDHL  382 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~--~~~~~~~~  382 (444)
                      ..........||+.|+|||++.+  ...++.++|||||||++|||++|+.||........+. .+.....  .+.....+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            66555556779999999999853  3447899999999999999999999998755443332 2222221  12223568


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++++.+||++||+.||++|||++|+|+||||++.
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            9999999999999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=390.83  Aligned_cols=257  Identities=28%  Similarity=0.462  Sum_probs=214.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ...+|++.+.||+|+||.||+|+++.+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...+  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            356899999999999999999999999999999988532   234555678899999999999999999999987653  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          231 ----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                          .+|+||||+ +++|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                469999999 8899999987 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC---------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---------------  371 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------------  371 (444)
                      ....  .....+|+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+..               
T Consensus       178 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            6433  33456899999999998755589999999999999999999999987665444332211               


Q ss_pred             --------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 --------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 --------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                    ......+...+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                          111223445679999999999999999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=387.91  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....    .......+.+|+.+++.++||||+++++++..++..++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc----ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            47999999999999999999999999999999986422    11122245579999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      ||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            999996 58999888754 49999999999999999999999999999999999999999999999999998654332 2


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---C---CCC----------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---K---ELP----------  376 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---~---~~~----------  376 (444)
                      .....||+.|+|||++.+...++.++|||||||++|||++|+.||...........+...   .   ..+          
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            234468999999999977666899999999999999999999999876544433332110   0   000          


Q ss_pred             ------------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          377 ------------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       377 ------------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                                  .....++.++++||.+||+.||++|||++|+|+||||.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                        1123578999999999999999999999999999999876443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.7e-48  Score=376.31  Aligned_cols=259  Identities=28%  Similarity=0.455  Sum_probs=222.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....     ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            357999999999999999999999999999999987421     223356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999999999888889999999999999999999999999999999999999   77889999999998765432


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC--CCCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE--LPAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~  388 (444)
                       ......|++.|+|||++.+.. ++.++|||||||++|||++|..||...........+.....  .......++.++.+
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             -ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence             223345899999999997665 89999999999999999999999987665555544443322  22344678999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ||.+||+.||++|||++|+|+||||++....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence            9999999999999999999999999876443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-48  Score=381.15  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=209.1

Q ss_pred             CCCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          154 GSRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       154 ~~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      .++|++. ++||+|+||+||+|++..+++.||||++....     ....+.+.+|+.++.++ +||||+++++++..++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            4578884 78999999999999999999999999986422     12245788999999885 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc---EEEEecccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHIT  308 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~~~  308 (444)
                      +++||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999999998888999999999999999999999999999999999999988766   9999999987653


Q ss_pred             CCC--------CcccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh------------
Q 013354          309 GQS--------CPLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP------------  364 (444)
Q Consensus       309 ~~~--------~~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~------------  364 (444)
                      ...        ......||+.|+|||++...    ..++.++|||||||++|||++|+.||.......            
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            221        12234599999999998641    237889999999999999999999997654211            


Q ss_pred             ---hhHHhcCCCCCCCCC----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          365 ---AMFKIGNSKELPAIP----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       365 ---~~~~~~~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                         ....+.....  .++    ..++.++++||++||+.||++|||+.|+|+||||++..
T Consensus       246 ~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          246 QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence               1222222221  222    45899999999999999999999999999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-48  Score=419.22  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=228.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|++.++||+|+||.||+|+++.+++.||||+++...  .......+.+..|..++..+ +|++|+++++++...+.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH--HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            3468999999999999999999999999999999987421  11122345677899999988 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc-CC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~-~~  310 (444)
                      +|+||||+.+++|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++... ..
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999999998899999999999999999999999999999999999999999999999999998643 33


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li  390 (444)
                      ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+..+....  ..+|..++.++++||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHH
Confidence            3445677999999999997665 8999999999999999999999998877767777766544  367889999999999


Q ss_pred             HHHhhhCCCCCcCH-----HHHHhCCCCCCC
Q 013354          391 RKCLQRNPLHRPTA-----AWLLEHPFVGNA  416 (444)
Q Consensus       391 ~~~L~~dP~~Rpt~-----~elL~hp~~~~~  416 (444)
                      ++||++||++|+++     +||++||||++.
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999997     999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-48  Score=385.92  Aligned_cols=258  Identities=37%  Similarity=0.636  Sum_probs=223.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|+..+.||+|+||+||+|++..+++.||||++....  .......+.+.+|+.++++++||||+++++++..++..++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            46999999999999999999999999999999987422  2334556788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          235 YLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      ||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            999996 688887754 457999999999999999999999999999999999999999999999999999876433   


Q ss_pred             ccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ....||+.|+|||++..  ...++.++|||||||++|||++|+.||........+..+.........+..++.++++||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  287 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  287 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            34569999999999852  3348899999999999999999999998776665555555444444456678999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +||+.||++|||++++++||||....+
T Consensus       288 ~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          288 SCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHcccChhhCcCHHHHhhChhhhccCC
Confidence            999999999999999999999976543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-48  Score=410.94  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=224.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ....+|++.++||+|+||.||+|+++.+|+.||+|++.....  ........+.+|+.+|+.++||||+++++++...+.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            345679999999999999999999999999999999864211  111223567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +|+||||+.||+|.+++...+.  +++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999999999987544  99999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhh-HHhcCCCCCCCCCCCCCHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAM-FKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~-~~~~~~~~~~~~~~~~s~~  385 (444)
                      .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......   ..+ ..+...  ...++..++.+
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~  415 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQ  415 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             CccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHH
Confidence            55555667999999999997665 899999999999999999999999765421   222 222221  23567889999


Q ss_pred             HHHHHHHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +++||++||++||++||     +++|+++||||++.
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999999     89999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-48  Score=387.08  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=214.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.....         ...+|+.++.++ +||||+++++++.+.+.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            4579999999999999999999999999999999864221         234577888887 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC----CcEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS----GRVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~~~  308 (444)
                      |+||||+.|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..+    +.+||+|||+++...
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999999999988889999999999999999999999999999999999998443    349999999998765


Q ss_pred             CCC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC---hhhhHHhcCCCC--CCCCCCCC
Q 013354          309 GQS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG---VPAMFKIGNSKE--LPAIPDHL  382 (444)
Q Consensus       309 ~~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~--~~~~~~~~  382 (444)
                      ... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.....   ......+.....  .......+
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            433 334567899999999997655 88999999999999999999999976322   223333333222  12234678


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++++++||++||+.||++|||+.|+++||||.+.
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-48  Score=383.49  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=196.7

Q ss_pred             Ceeee---eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCE
Q 013354          156 RWKKG---RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDK  231 (444)
Q Consensus       156 ~~~~~---~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~  231 (444)
                      +|.+.   +.||+|+||.||+|+++.+++.||||++..     .   ....+.+|+.+++.+. ||||+++++++..+..
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----R---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----G---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----h---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            45554   789999999999999999999999999863     1   2345678999999997 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEecccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADFGMAKHIT  308 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~~  308 (444)
                      .|+||||+.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999988899999999999999999999999999999999999997665   79999999998664


Q ss_pred             CCC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-------hhhhHHhcCCCCCCC--C
Q 013354          309 GQS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-------VPAMFKIGNSKELPA--I  378 (444)
Q Consensus       309 ~~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~~--~  378 (444)
                      ... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.       ...+..+........  .
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             C----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            433 223456899999999997665 89999999999999999999999976432       223334433322111  1


Q ss_pred             CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          379 PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       379 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ...+++++++||.+||+.||++|||+.|+++||||++...
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            1358999999999999999999999999999999998644

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-48  Score=390.55  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=218.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC--CCCeeeEeeeEEcCC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR--HPNIVRYYGSETLDD  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~  230 (444)
                      .+.+|++.+.||+|+||.||+|.+.. ++.||||++....   ......+.+.+|+.+|++++  |+||+++++++..++
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc---ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            34579999999999999999998865 8999999987532   34556678999999999996  599999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .+|+||| +.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9999999 55889999999988899999999999999999999999999999999999995 578999999999876543


Q ss_pred             CC---cccccCCCcccCcccccCc----------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCC
Q 013354          311 SC---PLSIKGSPYWMAPEVIKNS----------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELP  376 (444)
Q Consensus       311 ~~---~~~~~gt~~y~APE~~~~~----------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~  376 (444)
                      ..   .....||+.|+|||++.+.          ..++.++|||||||+||||++|+.||...... ..+..+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            32   2345699999999998652          24889999999999999999999999765433 3344444444444


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .++...+.++++||++||+.||++|||+.|+|+||||+...
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            56777899999999999999999999999999999997643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-48  Score=386.66  Aligned_cols=253  Identities=30%  Similarity=0.434  Sum_probs=213.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-----CCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-----HPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||+||+|++..+++.||||+++      ......+.+..|+.+++.+.     |+||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR------NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC------SCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEec------cchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            34568999999999999999999999999999999886      23344566778999999986     99999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC------------
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP------------  292 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------------  292 (444)
                      ...+.+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.            
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999999 999999998754  4999999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 013354          293 -------------SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ  359 (444)
Q Consensus       293 -------------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  359 (444)
                                   ++.+||+|||++......  .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCC
Confidence                         788999999999865432  33456899999999998766 89999999999999999999999987


Q ss_pred             CCChhhhHHhcCCCC--------------------------------------------CCCCCCCCCHHHHHHHHHHhh
Q 013354          360 YEGVPAMFKIGNSKE--------------------------------------------LPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       360 ~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      .+....+..+.....                                            .+.++...++++.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            554433322211000                                            001111234788899999999


Q ss_pred             hCCCCCcCHHHHHhCCCCC
Q 013354          396 RNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       396 ~dP~~Rpt~~elL~hp~~~  414 (444)
                      .||++|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-48  Score=380.26  Aligned_cols=261  Identities=31%  Similarity=0.543  Sum_probs=215.7

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .....+|++.+.||+|+||+||+|++  +++.||+|++...   .......+.+.+|+.++++++||||+++++++...+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQ---DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCC---CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCC---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34567899999999999999999976  5889999988642   234555678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEEEeccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      .+++||||+.+++|.+++.+...   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999999987543   999999999999999999999999  9999999999999999999999999997


Q ss_pred             cccCCC-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          306 HITGQS-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       306 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+........++..++.
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             --------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             cccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            654332 223456999999999997766 899999999999999999999999887766665555444445577889999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHh--CCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLE--HPFVGNAA  417 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~--hp~~~~~~  417 (444)
                      ++.+||.+||+.||++|||+.++++  .++++...
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999988  56666543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.4e-48  Score=404.33  Aligned_cols=256  Identities=27%  Similarity=0.467  Sum_probs=220.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||+||+|+++.++..||+|++......   ......+.+|+.+++.++||||+++++++.....+++
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS---TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC---chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4799999999999999999999999999999998753221   1224578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC---CcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS---GRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~~~~~~  311 (444)
                      |||||.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++.......
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            99999999999999888899999999999999999999999999999999999999764   459999999998877666


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC--CCCCCHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--PDHLSDEGKDF  389 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~L  389 (444)
                      ......||+.|+|||++.. . ++.++|||||||++|+|++|..||........+..+.........  ...++.++++|
T Consensus       194 ~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLRK-K-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL  271 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred             cccccCCCcCeeCHHHHcc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence            5666779999999999863 3 899999999999999999999999887766666666554432222  24689999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      |++||+.||++|||+.|+|+||||++
T Consensus       272 i~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHCCCChhhCccHHHHhcCccccc
Confidence            99999999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=383.25  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=216.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC--CCeeeEeeeEEcC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNIVRYYGSETLD  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~  229 (444)
                      ..+.+|++.+.||+|+||.||+|.+. +++.||||++...   .......+.+.+|+.+++.++|  +||+++++++..+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecc---ccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            34678999999999999999999875 5899999998753   2345566788999999999986  9999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..+++|||+ .+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             CEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999999995 5889999999988899999999999999999999999999999999999997 67899999999987654


Q ss_pred             CCC---cccccCCCcccCcccccC----------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCC
Q 013354          310 QSC---PLSIKGSPYWMAPEVIKN----------SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKEL  375 (444)
Q Consensus       310 ~~~---~~~~~gt~~y~APE~~~~----------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~  375 (444)
                      ...   .....||+.|+|||++.+          ...++.++|||||||++|||++|+.||...... ..+..+......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            332   234569999999999864          134889999999999999999999999765443 333344333444


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ..++...+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            46777889999999999999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.7e-48  Score=400.87  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|++.+.||+|+||+||+|++..+++.||||++...   .......+++.+|+.+|+.++||||+++++++...    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            46899999999999999999999999999999998642   23455667889999999999999999999998654    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ..+|+||||+.+ +|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence              467999999965 57777653  5999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-------------  374 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  374 (444)
                      ..........||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+..+.....             
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            6655556677999999999998765 89999999999999999999999987665444433221000             


Q ss_pred             -------CCCC---------CCC-----------CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          375 -------LPAI---------PDH-----------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       375 -------~~~~---------~~~-----------~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                             .+..         +..           .+.++++||++||+.||++|||++|+|+||||+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                   0000         000           1567999999999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-48  Score=373.86  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=205.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..   .......+.+.++...++.++||||+++++++..++..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc---cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            456899999999999999999999999999999998642   22333445556666678889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          233 YIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ++||||+. ++|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999996 588877754    45799999999999999999999998 9999999999999999999999999999877


Q ss_pred             cCCCCcccccCCCcccCccccc---CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCCCCCCC
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIK---NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~---~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ..........||+.|+|||++.   ....++.++|||||||++|||++|+.||...... ..................++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            6655555567999999999972   3444899999999999999999999999864433 23333333333333446789


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .++.+||.+||+.||++|||+.|+++||||+..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            999999999999999999999999999999753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-48  Score=405.57  Aligned_cols=259  Identities=29%  Similarity=0.518  Sum_probs=228.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++.....  ......+.+.+|+.++++++||||+++++++...+.++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4579999999999999999999999999999999864322  11223467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~~~  310 (444)
                      +||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999988899999999999999999999999999999999999999   56788999999999887666


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||........+..+.........+  ..+++++++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             cccccCCCCccccCceeecC-C-CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            55556679999999999865 3 8999999999999999999999998877666666665554433333  468999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||++||++|||+.|+|+||||+..
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            9999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-48  Score=373.32  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=220.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc-cHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK-SKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++....... .....+.+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            469999999999999999999999999999999875432211 1112467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC----cEEEEeccccccccC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHITG  309 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~~  309 (444)
                      +||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999999888899999999999999999999999999999999999998876    799999999987765


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGK  387 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~  387 (444)
                      ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+......  ......++.++.
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            55445566999999999997665 899999999999999999999999876655555444333221  122356899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||++||+.||++|||+.|+|+||||++.
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-48  Score=404.15  Aligned_cols=263  Identities=28%  Similarity=0.447  Sum_probs=225.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc--------ccHHHHHHHHHHHHHHHccCCCCeeeEee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA--------KSKESAQQLGQEIALLSRLRHPNIVRYYG  224 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~--------~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~  224 (444)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++.......        ......+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4568999999999999999999999999999999987532111        01123467889999999999999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cEEEEec
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RVKLADF  301 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~vkL~DF  301 (444)
                      ++.....+++|||||.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999999888999999999999999999999999999999999999998775   6999999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCC--C
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAI--P  379 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~  379 (444)
                      |++.............||+.|+|||++.. . ++.++|||||||++|+|++|..||........+..+.........  .
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-K-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW  271 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-C-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            99998776655566779999999999863 3 899999999999999999999999887766666666554432211  2


Q ss_pred             CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       380 ~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ..++.++++||++||+.||++|||++|+|+||||++..
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            56899999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.9e-48  Score=385.98  Aligned_cols=259  Identities=30%  Similarity=0.479  Sum_probs=220.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+.+|+.+++.++||||+++++++..++.+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            456899999999999999999999999999999998742    2455667899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+++++|.+++.+...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999999999999988999999999999999999999996 99999999999999999999999999997653322


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH------------------------
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF------------------------  367 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~------------------------  367 (444)
                       .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+......                        
T Consensus       187 -~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          187 -ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -ccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             23456899999999997765 8999999999999999999999997644322111                        


Q ss_pred             ------------------HhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          368 ------------------KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       368 ------------------~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                        .+............++.++++||++||+.||++|||++|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                              11111222222345799999999999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.5e-49  Score=384.01  Aligned_cols=261  Identities=25%  Similarity=0.412  Sum_probs=216.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-  230 (444)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...  ........+.+.+|+.++++++||||+++++++.... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT--TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc--ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            3457899999999999999999999999999999998642  2234566678999999999999999999999887643 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                         ..|+||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence               35999999999999999998889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC--CCCCC
Q 013354          308 TGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDH  381 (444)
Q Consensus       308 ~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~  381 (444)
                      .....    .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..................+  .....
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             cccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            44322    22345899999999998765 8999999999999999999999998766555444433332221  22356


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ++.++.+||.+||+.||++||++.+++.|+|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            8999999999999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-48  Score=384.93  Aligned_cols=261  Identities=30%  Similarity=0.482  Sum_probs=218.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+.+|+.++++++||||+++++++...+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence            346899999999999999999999999999999988642   24455567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999999999998877789999999999999999999999999999999999999999999999999998654432 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc--------------------C
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG--------------------N  371 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------------------~  371 (444)
                      ......||+.|+|||++.+...++.++|||||||++|||++|+.||...........+.                    .
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            23345689999999999876558999999999999999999999998766544332221                    0


Q ss_pred             CCCCCCC---------CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 SKELPAI---------PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ~~~~~~~---------~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ....+.+         ...+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            1111111         13579999999999999999999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-47  Score=382.83  Aligned_cols=258  Identities=26%  Similarity=0.470  Sum_probs=218.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD---  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---  229 (444)
                      .+.+|++.+.||+|+||.||+|++..+++.||||++..    .......+.+.+|+.++++++||||+++++++...   
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            45689999999999999999999999999999999863    23445567889999999999999999999998654   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ...++||||+. ++|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence              46899999996 599999976 57999999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-----------
Q 013354          308 TGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-----------  372 (444)
Q Consensus       308 ~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------  372 (444)
                      .....    .....||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+...           
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43322    234569999999999876666899999999999999999999999876655444333210           


Q ss_pred             ------------------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ------------------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ------------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                        .....+...++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                              00011225678999999999999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-48  Score=380.77  Aligned_cols=261  Identities=30%  Similarity=0.507  Sum_probs=213.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ++|++.+.||+|+||.||+|+++.+++.||||++......   .........+.+|+.++++++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            5799999999999999999999999999999998643211   112233456889999999999999999999987665 


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc---EEEEecccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFGMAKHIT  308 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~~~  308 (444)
                      .++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988888999999999999999999999999999999999999987654   9999999998775


Q ss_pred             CCCCcccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCC--CCCCCCCCCC
Q 013354          309 GQSCPLSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSK--ELPAIPDHLS  383 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~--~~~~~~~~~s  383 (444)
                      .........||+.|+|||++.  ....++.++|||||||++|+|++|..||........+ ..+....  ..+.....++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            543334456899999999974  2344889999999999999999999999765443222 2222221  1222335689


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .++.+||.+||+.||++|||+.++|+||||++.
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            999999999999999999999999999999853

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-48  Score=378.36  Aligned_cols=262  Identities=34%  Similarity=0.637  Sum_probs=216.7

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc-
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL-  228 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-  228 (444)
                      .....+|++.+.||+|+||.||+|++..+++.||||++.....      ..+.+.+|+.+++++ +||||+++++++.. 
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3456789999999999999999999999999999999864221      225678899999999 79999999999876 


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          229 -----DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       229 -----~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                           .+.+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence                 56899999999999999999874  46999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCC-CcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC
Q 013354          302 GMAKHITGQS-CPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP  376 (444)
Q Consensus       302 Gla~~~~~~~-~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~  376 (444)
                      |++....... ......|++.|+|||++..    ...++.++|||||||++|+|++|..||...........+.......
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  253 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  253 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence            9988764332 2234568999999999862    2337899999999999999999999998766555555444443333


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ..+..++.++++||.+||..||++||++.++++||||++...
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            445678999999999999999999999999999999987644

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-48  Score=387.64  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=213.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----  228 (444)
                      ...+|++.+.||+|+||+||+|++..+|+.||||++.....         ...+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34689999999999999999999999999999998864221         12369999999999999999998843    


Q ss_pred             ----------------------------------CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 013354          229 ----------------------------------DDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGL  270 (444)
Q Consensus       229 ----------------------------------~~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL  270 (444)
                                                        +..+++||||+. ++|.+.+..    ...+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              345899999997 587777654    46799999999999999999


Q ss_pred             HHHHHCCcccCCCCCCceEEC-CCCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHH
Q 013354          271 EYLHAKNTVHRDIKGANILVD-PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIE  349 (444)
Q Consensus       271 ~~LH~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~e  349 (444)
                      +|||++||+||||||+|||++ .++.+||+|||+++.+..........+|+.|+|||++.+...++.++|||||||++||
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            999999999999999999997 6889999999999987666666667799999999998776668999999999999999


Q ss_pred             HHcCCCCCCCCCChhhhHHhcCC------------------CCCC---------CCCCCCCHHHHHHHHHHhhhCCCCCc
Q 013354          350 MATTKPPWSQYEGVPAMFKIGNS------------------KELP---------AIPDHLSDEGKDFVRKCLQRNPLHRP  402 (444)
Q Consensus       350 lltG~~Pf~~~~~~~~~~~~~~~------------------~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rp  402 (444)
                      |++|+.||........+..+...                  ...+         .++..++.++.+||.+||+.||++||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999876655544333210                  0011         14556899999999999999999999


Q ss_pred             CHHHHHhCCCCCCC
Q 013354          403 TAAWLLEHPFVGNA  416 (444)
Q Consensus       403 t~~elL~hp~~~~~  416 (444)
                      |+.|+|+||||++.
T Consensus       315 t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          315 NPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHTSGGGHHH
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.1e-48  Score=403.34  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=221.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.++||+|+||.||+|+++.+|+.||+|++....  .......+.+.+|+.++++++||||+++++++...+.+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR--LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH--hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            3468999999999999999999999999999999986421  11112346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDY----GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      |+||||+.|++|.+++.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999999864    359999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC----hhhhHHhcCCCCCCCCCCCCC
Q 013354          309 GQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG----VPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       309 ~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      .... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....    ......+...  ...++..++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s  417 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFS  417 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSC
T ss_pred             CCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccC
Confidence            5433 33457999999999997755 89999999999999999999999976532    1222233222  235678899


Q ss_pred             HHHHHHHHHHhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      .++++||++||++||++||+     +++|++||||++.
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            99999999999999999996     5899999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-47  Score=389.74  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=211.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc------CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL------RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~  226 (444)
                      ...+|++.+.||+|+||+||+|++..+++.||||+++.      .....+.+.+|+.+++.+      +|+||+++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            34689999999999999999999999999999999862      334456677788888777      577999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc--EEEEecc
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--VKLADFG  302 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--vkL~DFG  302 (444)
                      .....+++||||+. ++|.+++....  .+++..++.++.||+.||+|||+++|+||||||+||||+.++.  +||+|||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999999995 69999998754  4999999999999999999999999999999999999999887  9999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC----------
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----------  372 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------  372 (444)
                      +++.....  .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+..+...          
T Consensus       248 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEHQR--VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETTCC--CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecCCc--ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            99765432  33556999999999998766 899999999999999999999999876544333221100          


Q ss_pred             -----------CCC------------------------------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHH
Q 013354          373 -----------KEL------------------------------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAA  405 (444)
Q Consensus       373 -----------~~~------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~  405 (444)
                                 ...                                    ..++...++++.+||++||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                       000                                    011234588999999999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 013354          406 WLLEHPFVGNAAP  418 (444)
Q Consensus       406 elL~hp~~~~~~~  418 (444)
                      |+|+||||++..+
T Consensus       405 e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          405 QALRHPWLRRRLP  417 (429)
T ss_dssp             HHHTSTTTC----
T ss_pred             HHhCChhhccCCC
Confidence            9999999997543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.6e-48  Score=383.53  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=212.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----  228 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|++......   ......+.+|+.+++.++|+||+++++++..     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS---SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc---ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            35899999999999999999999999999999988643222   2223466789999999999999999999877     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                         .+.+++||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               4568999999965 777777654 56999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-----CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--CCCCCC
Q 013354          305 KHITGQ-----SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPA  377 (444)
Q Consensus       305 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~  377 (444)
                      +.+...     .......||+.|+|||++.+...++.++|||||||++|||++|+.||...........+..  ....+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            876422     1223456899999999997766689999999999999999999999987655444333221  000011


Q ss_pred             CCCC----------------------------CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          378 IPDH----------------------------LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       378 ~~~~----------------------------~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ....                            .++++++||.+||+.||++|||++|+|+||||.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            1000                            278899999999999999999999999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-48  Score=380.10  Aligned_cols=260  Identities=26%  Similarity=0.426  Sum_probs=217.8

Q ss_pred             CCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEE
Q 013354          155 SRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       155 ~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  232 (444)
                      .+|.+. +.||+|+||.||+|+++.+++.||+|++.......   .....+.+|+.++..+ +||||+++++++...+.+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            467777 89999999999999999999999999987533222   2345788899999999 469999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGMAKHI  307 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~~~  307 (444)
                      ++||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999999998653  56999999999999999999999999999999999999987   789999999999887


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--CCCCCCCCCCCHH
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAIPDHLSDE  385 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~s~~  385 (444)
                      ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...  .........++.+
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL  263 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             CCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence            6655555667999999999997665 899999999999999999999999876655554444322  2223444678999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      +++||.+||+.||++|||++|+|+||||++...
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            999999999999999999999999999987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-47  Score=372.86  Aligned_cols=257  Identities=40%  Similarity=0.725  Sum_probs=224.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ....|++.+.||+|+||.||+|++..+++.||+|++.....    ....+.+.+|+.+++.++|+||+++++++..+...
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            34579999999999999999999999999999999874321    22356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999999999975 579999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...........+.... .+.++..++.++.+||.
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHH
Confidence            233456899999999997665 8899999999999999999999998766555444443332 34667789999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||+.||++|||+.++++||||...
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999999999754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-47  Score=369.79  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=216.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...  ........+.+.+|+.++++++||||+++++++..++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECC--SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccC--ccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            356899999999999999999999999999999998643  234456678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      ++||||+++++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999987644322


Q ss_pred             --cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC---CCCCCCCCHHHH
Q 013354          313 --PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL---PAIPDHLSDEGK  387 (444)
Q Consensus       313 --~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~l~  387 (444)
                        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..................   ...+..+++++.
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             --------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence              22356899999999998766 899999999999999999999999876655444333322221   124567899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      ++|.+||++||++||+..+.+.+.|..
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999666666655543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-47  Score=375.08  Aligned_cols=268  Identities=22%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             CCCCCCCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       150 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ......+|++.+.||+|+||.||+|++..+++   .||+|+++..   .......+.+.+|+.++++++||||+++++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD---IIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc---ccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34456789999999999999999999887665   8999988642   12233467889999999999999999999999


Q ss_pred             EcCCEE------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC
Q 013354          227 TLDDKL------YIYLEYVSGGSIYKILQDYG------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG  294 (444)
Q Consensus       227 ~~~~~~------~lv~e~~~ggsL~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  294 (444)
                      ......      ++||||+.+++|.+++....      .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            877655      99999999999999997543      589999999999999999999999999999999999999999


Q ss_pred             cEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhc
Q 013354          295 RVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIG  370 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~  370 (444)
                      .+||+|||+++........   ....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+.
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            9999999999876443322   2234678899999997665 8999999999999999999 999998877766666655


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcC-------HHHHHhCCCCCCCCCCcCC
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPT-------AAWLLEHPFVGNAAPLERP  422 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-------~~elL~hp~~~~~~~~~~~  422 (444)
                      .... ...+..++.++.+||.+||+.||++|||       ++++++|+|+......+-.
T Consensus       254 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          254 GGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             TTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             cCCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            4443 3567789999999999999999999999       7889999999987655443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-47  Score=373.85  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=213.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEc--C
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETL--D  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~  229 (444)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++.     ..   .+.+.+|+.++++++ |+||+++++++..  .
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VK---KKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            34689999999999999999999999999999998862     11   256789999999997 9999999999987  6


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~  308 (444)
                      ...++||||+.+++|.++++   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            77999999999999999885   489999999999999999999999999999999999998776 89999999998876


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHh-------------cCCC-
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKI-------------GNSK-  373 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~-------------~~~~-  373 (444)
                      .........++..|+|||++.+...++.++|||||||++|||++|+.||...... ..+..+             .... 
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            6655566679999999999977566899999999999999999999999543322 111110             0000 


Q ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          374 ---------------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       374 ---------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                           .....+..++.++++||.+||+.||++|||++|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                                 00112233799999999999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=377.01  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=212.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ...+|++.++||+|+||+||+|++..+++.||||++.....    ....+.+.+|+.++++++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            35689999999999999999999999999999999864221    122456778999999999999999999988654  


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE----CCCCcEEEEeccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFGM  303 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~vkL~DFGl  303 (444)
                      ..++||||+.+++|.+++.....   +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999987543   9999999999999999999999999999999999999    7778899999999


Q ss_pred             cccccCCCCcccccCCCcccCcccccC-------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh----hhHHhcCC
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKN-------SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP----AMFKIGNS  372 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~~  372 (444)
                      ++............||+.|+|||++..       ...++.++|||||||++|||++|+.||.......    .+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            998776666666779999999999862       2448899999999999999999999997544322    22222111


Q ss_pred             CC-----------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCC
Q 013354          373 KE-----------------------LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       373 ~~-----------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~  412 (444)
                      ..                       ...++..++..+.+||++||+.||++|||++|+|+||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            10                       01223345678899999999999999999999999973

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-47  Score=391.38  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=209.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------  228 (444)
                      .+|++.+.||+|+||.||+|+++.+++.||||++.....         ...+|+.+|+.++|+||+++++++..      
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            469999999999999999999999999999998864211         23369999999999999999998743      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEeccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGM  303 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGl  303 (444)
                      ...+++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            2247799999965 67766643    3579999999999999999999999999999999999999865 5689999999


Q ss_pred             cccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC------------
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------------  371 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------  371 (444)
                      ++.+..........||+.|+|||++.+...++.++|||||||+||||++|+.||...+....+..+..            
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            99876655556677999999999997765689999999999999999999999987665444433211            


Q ss_pred             ------CCCCCC---------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 ------SKELPA---------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ------~~~~~~---------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                            ....+.         ++..++.++++||.+||++||++|||+.|+|+||||++.
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                  001111         234678999999999999999999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-47  Score=368.25  Aligned_cols=258  Identities=31%  Similarity=0.542  Sum_probs=220.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE--cCCE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET--LDDK  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~  231 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+.+|+.++++++||||+++++++.  ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            358999999999999999999999999999999987422   23455678999999999999999999999874  4678


Q ss_pred             EEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCceEECCCCcEEEEecc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG----QLGESAIRSYTQQILSGLEYLHAKN-----TVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                      +++||||+++++|.+++....    .+++..++.++.||+.||.|||+++     |+||||||+|||++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999999997642    3999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC
Q 013354          303 MAKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH  381 (444)
Q Consensus       303 la~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  381 (444)
                      ++........ .....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... .+.++..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYR  239 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCTT
T ss_pred             hheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCcc
Confidence            9987654322 12345899999999997765 8999999999999999999999998766555555544433 3467788


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++.++.+||.+||+.||++|||+.|||+|+|+.+.
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            99999999999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-47  Score=370.60  Aligned_cols=257  Identities=28%  Similarity=0.500  Sum_probs=222.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      .+|++.+.||+|+||.||+|++..+++.||+|++......   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            5799999999999999999999999999999998743222   2234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC---CcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS---GRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~~~~~~  311 (444)
                      ||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.......
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            99999999999999888889999999999999999999999999999999999999754   469999999998776555


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCC--CCCCHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLSDEGKDF  389 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~L  389 (444)
                      ......+++.|+|||++.+ . ++.++||||||+++|+|++|..||...........+.........+  ..++.++.+|
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             ccccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence            4455568999999999864 3 7899999999999999999999998866655555554443322222  5689999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |++||+.||++|||+.|+|+||||++.
T Consensus       257 i~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-47  Score=380.48  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=217.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-------ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYG  224 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  224 (444)
                      ..++|++++.||+|+||.||+|++.       .++..||+|+++..    ......+.+.+|+.+++.+ +||||+++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3468999999999999999999874       34567999988632    3445567899999999999 8999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ++..++.+|+||||+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                378999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      ||+.++.+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986654322   22344778999999997765 8999999999999999999 999998876655


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ....+.... .+..+..++.++.+||.+||+.||++|||+.|++++
T Consensus       314 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555554443 346778899999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=370.32  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=217.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE--cCCE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET--LDDK  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~  231 (444)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+.+|+.+++.++|+||+++++++.  ....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            35799999999999999999999999999999998642111 11234567899999999999999999999984  4567


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .++||||+.++ |.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            89999999766 87877763  4699999999999999999999999999999999999999999999999999987643


Q ss_pred             CC---CcccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          310 QS---CPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       310 ~~---~~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ..   ......||+.|+|||++.+.. .++.++||||||+++|||++|+.||...........+....  ..++..++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~  239 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPGDCGPP  239 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCCSSSCHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CCCCCccCHH
Confidence            22   223455899999999987543 24789999999999999999999998766555555544432  2567789999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      +.+||++||+.||++|||+.|+++||||++....
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            9999999999999999999999999999876443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.2e-48  Score=373.20  Aligned_cols=262  Identities=34%  Similarity=0.611  Sum_probs=198.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ....+|++.+.||+|+||.||+|++..+++.||||++...    ......+.+.+|+.++++++||||+++++++...+.
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE----KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhh----hcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            3456899999999999999999999889999999987532    123345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          232 LYIYLEYVSGGSIYKILQD--------YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      .++||||+.+++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999999974        34589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC----
Q 013354          304 AKHITGQS------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK----  373 (444)
Q Consensus       304 a~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~----  373 (444)
                      +.......      ......||+.|+|||++.....++.++|||||||++|||++|+.||................    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            87654321      12234589999999998764448899999999999999999999998766544433222111    


Q ss_pred             ----CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          374 ----ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       374 ----~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                          ..+.....++.++.+||.+||+.||++|||+.++++||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence                11233457899999999999999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=372.80  Aligned_cols=250  Identities=28%  Similarity=0.481  Sum_probs=211.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++++.||+|+||+||+|.+..+++.||+|++..     ......+.+.+|+.++++++||||+++++++..++..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            4689999999999999999999999999999998752     34556678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+++|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 45799999999999999999999999999999999999999999999999999986643322


Q ss_pred             c---------------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc-CCCCCC
Q 013354          313 P---------------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG-NSKELP  376 (444)
Q Consensus       313 ~---------------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~~~~~~  376 (444)
                      .               ....||+.|+|||++.+.. ++.++|||||||++|||++|..||............. ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            1               1456999999999997665 8999999999999999999999987543221110000 000001


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            346678999999999999999999999999887

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=374.04  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=216.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ....+|++.+.||+|+||.||+|++..+++   .||||+++.    .......+.+.+|+.++++++||||+++++++..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA----GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC----CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            345789999999999999999999986555   499998863    2344556789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999764 57999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCC
Q 013354          308 TGQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       308 ~~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  382 (444)
                      ......    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||...........+...... ..+..+
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  279 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-PAPMGC  279 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-CCCTTC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-CCCCCc
Confidence            543221    2233677899999997655 8999999999999999999 99999887766666666555443 567789


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.++.+||.+||+.||++|||+.+|++
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.3e-47  Score=370.46  Aligned_cols=263  Identities=37%  Similarity=0.635  Sum_probs=218.4

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .....+|++.+.||+|+||.||+|++..+++.||+|++...     .....+.+.+|+.+++.++||||+++++++..++
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            34557899999999999999999999999999999988632     2223467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999999876 35699999999999999999999999999999999999999999999999998764321


Q ss_pred             C-CCcccccCCCcccCccccc----CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC-CCCCCCCC
Q 013354          310 Q-SCPLSIKGSPYWMAPEVIK----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL-PAIPDHLS  383 (444)
Q Consensus       310 ~-~~~~~~~gt~~y~APE~~~----~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~s  383 (444)
                      . .......|++.|+|||++.    ....++.++||||||+++|+|++|..||...........+...... ...+..++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence            1 1122345899999999984    2334789999999999999999999999876655554444333221 23456789


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      .++.+||.+||+.||++|||+.++++||||++...
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            99999999999999999999999999999998644

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.4e-47  Score=370.41  Aligned_cols=261  Identities=31%  Similarity=0.512  Sum_probs=215.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc-CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEE--
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS-ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSET--  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~--  227 (444)
                      ..+|++.+.||+|+||.||+|++. .+++.||+|++........   ....+.+|+.+++.+   +||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS---CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc---CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            468999999999999999999995 6789999999875332211   112344566666655   8999999999987  


Q ss_pred             ---cCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecc
Q 013354          228 ---LDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       228 ---~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                         ....+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence               5567899999997 69999998754  39999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------  371 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------  371 (444)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||........+..+..           
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            998765544445567899999999997665 89999999999999999999999987655444333211           


Q ss_pred             --------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          372 --------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       372 --------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                                    ......+...++.++++||.+||+.||++|||+.|+|+||||++....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                          001112346789999999999999999999999999999999987544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.7e-47  Score=381.15  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=205.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...   .......+.+.+|+.+++.++||||+++++++...+   
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---cCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            35899999999999999999999999999999998742   233455678889999999999999999999987654   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                         .+++||||+. ++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             cccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence               7899999996 57888886  46999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC-----------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-----------  376 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------  376 (444)
                      ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+......+           
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             ccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            6554445567999999999997765 8999999999999999999999998766554444332211100           


Q ss_pred             ---------CC--------------CC------CCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          377 ---------AI--------------PD------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       377 ---------~~--------------~~------~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                               ..              +.      ..+.++++||++||+.||++|||++|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                     00              00      125689999999999999999999999999999854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-48  Score=391.82  Aligned_cols=252  Identities=15%  Similarity=0.136  Sum_probs=204.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHH---HHHHccCCCCeeeEe------
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEI---ALLSRLRHPNIVRYY------  223 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hpnIv~l~------  223 (444)
                      ...+|++.+.||+|+||+||+|+++.+|+.||||++.....  ......+.+.+|+   .++++++||||++++      
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            34689999999999999999999999999999999874322  2233457788999   555666899999998      


Q ss_pred             -eeEEcCC-----------------EEEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCc
Q 013354          224 -GSETLDD-----------------KLYIYLEYVSGGSIYKILQDYGQLGE-------SAIRSYTQQILSGLEYLHAKNT  278 (444)
Q Consensus       224 -~~~~~~~-----------------~~~lv~e~~~ggsL~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~LH~~~i  278 (444)
                       +++...+                 ..|+||||+ +|+|.+++.+.+.+++       ..++.++.||+.||+|||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence             6655543                 288999999 6899999987655665       7888899999999999999999


Q ss_pred             ccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCc----------CCCChhhhHHHHHHHHH
Q 013354          279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS----------NGCNLAVDIWSLGCTVI  348 (444)
Q Consensus       279 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~----------~~~s~~sDvwSlGvil~  348 (444)
                      +||||||+||||+.++.+||+|||+++....  ......| +.|+|||++.+.          ..++.++|||||||+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986433  2334557 999999999766          13899999999999999


Q ss_pred             HHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          349 EMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       349 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++|+.||...........+..      ....+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999976554443333322      235789999999999999999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.8e-47  Score=374.97  Aligned_cols=260  Identities=25%  Similarity=0.454  Sum_probs=215.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  229 (444)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++..    .........+.+|+.++++++||||+++++++..+  
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----cccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            345789999999999999999999999999999998863    23345567788999999999999999999987654  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          230 ---DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       230 ---~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                         ...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence               67899999996 699999987 5799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC-----------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC----
Q 013354          307 ITGQSC-----------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----  371 (444)
Q Consensus       307 ~~~~~~-----------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----  371 (444)
                      ......           .....||+.|+|||++.....++.++|||||||++|||++|+.||...+....+..+..    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            643221           12346899999999987655589999999999999999999999987654332221110    


Q ss_pred             ---------------------CCCC-----CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          372 ---------------------SKEL-----PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       372 ---------------------~~~~-----~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                           ....     ......++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                                 0000     011246899999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.1e-48  Score=386.11  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=199.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD----  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----  229 (444)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...    
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            46899999999999999999999999999999988532   23445567888999999999999999999998654    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                        ..+++|||++ +++|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence              5689999999 7899999876 67999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------  372 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------  372 (444)
                      ...  .....||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+...               
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          183 ADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             ccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            433  234568999999999987556899999999999999999999999876654433322110               


Q ss_pred             ---------CCCC-----CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          373 ---------KELP-----AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       373 ---------~~~~-----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                               ...+     .+...++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                     0001     1123578999999999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-48  Score=383.33  Aligned_cols=260  Identities=27%  Similarity=0.469  Sum_probs=216.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  229 (444)
                      ..+|++.+.||+|+||.||+|++.   .+++.||||+++..... ......+.+.+|+.+++++ +|+||+++++++..+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            368999999999999999999984   57999999998642211 1111224566799999999 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +.+++||||+.+++|.+++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999986543


Q ss_pred             CC--CcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---h-hHHhcCCCCCCCCCCCC
Q 013354          310 QS--CPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---A-MFKIGNSKELPAIPDHL  382 (444)
Q Consensus       310 ~~--~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~-~~~~~~~~~~~~~~~~~  382 (444)
                      ..  ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   . ...+..  ..+.++..+
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~  289 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEM  289 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCccc
Confidence            22  22345699999999999753 337889999999999999999999997543221   1 122211  234567889


Q ss_pred             CHHHHHHHHHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      +..+++||.+||+.||++||     +++|+++||||++.
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            99999999999999999999     99999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-47  Score=383.05  Aligned_cols=254  Identities=30%  Similarity=0.474  Sum_probs=208.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      ..+|++.+.||+|+||+||+|++..+++ +|+|++.....         ...+|+.+++.++||||+++++++...+   
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3479999999999999999999987665 88887753211         1236999999999999999999985433   


Q ss_pred             ---EEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-CCCcEEEEecc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQ----DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-PSGRVKLADFG  302 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~vkL~DFG  302 (444)
                         .+++||||+.++ +.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus       109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence               388999999764 444333    245799999999999999999999999999999999999998 78999999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC----------
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS----------  372 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------  372 (444)
                      +++............+|+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+...          
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9998766666666779999999999977666899999999999999999999999876655444332210          


Q ss_pred             --------CCCC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          373 --------KELP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       373 --------~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                              ...+         .++..+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                    1111         123458899999999999999999999999999999997543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.1e-47  Score=365.91  Aligned_cols=259  Identities=41%  Similarity=0.678  Sum_probs=213.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      +|....+||+|+||.||+|++..+++.||+|++...     .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            344455899999999999999999999999988642     223446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-CCcEEEEeccccccccCCC
Q 013354          236 LEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-SGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~  311 (444)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||++||+|+||||+||+++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999998752   4678999999999999999999999999999999999987 8899999999998765432


Q ss_pred             -CcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                       ......|++.|+|||++.+. ..++.++||||||+++|||++|+.||........ ..........+.++..++.++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence             22345689999999998654 2378999999999999999999999976443322 22222223445678889999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ||.+||+.||++||+++++|+||||+.....
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            9999999999999999999999999876443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=370.15  Aligned_cols=259  Identities=40%  Similarity=0.684  Sum_probs=216.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++....       ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            34568999999999999999999999999999999886421       13567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999999999974 457999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCCCCCCCHHHHH
Q 013354          311 S-CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~-~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~  388 (444)
                      . ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... .....+..++.++.+
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence            2 233456899999999997665 8999999999999999999999998766544443332222 112335568999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||.+||+.||++|||+.++++||||++...
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            999999999999999999999999987643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-47  Score=379.39  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=215.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||.||+|+     +..+++.||||+++.    .......+.+.+|+.++.++ +||||+++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecC----cCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            45789999999999999999998     455679999999863    23344567889999999999 789999999998


Q ss_pred             EcCC-EEEEEEeccCCCCHHHHHHhcCC----------------------------------------------------
Q 013354          227 TLDD-KLYIYLEYVSGGSIYKILQDYGQ----------------------------------------------------  253 (444)
Q Consensus       227 ~~~~-~~~lv~e~~~ggsL~~~l~~~~~----------------------------------------------------  253 (444)
                      ...+ .+++||||+.+++|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 48999999999999999987543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC---cccc
Q 013354          254 --------------LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC---PLSI  316 (444)
Q Consensus       254 --------------l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~---~~~~  316 (444)
                                    +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   ....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          89999999999999999999999999999999999999999999999999986644322   2234


Q ss_pred             cCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhh
Q 013354          317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ  395 (444)
Q Consensus       317 ~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~  395 (444)
                      .||+.|+|||++.+.. ++.++|||||||++|||++ |..||.....................+..+++++.+||.+||+
T Consensus       256 ~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             EECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            5788999999997655 8999999999999999998 9999987665554444333334456778899999999999999


Q ss_pred             hCCCCCcCHHHHHhC
Q 013354          396 RNPLHRPTAAWLLEH  410 (444)
Q Consensus       396 ~dP~~Rpt~~elL~h  410 (444)
                      .||++|||+.|+++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-47  Score=382.21  Aligned_cols=257  Identities=29%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.....      ....+.+|+..+..++||||+++++++...+   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT------CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc------ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3589999999999999999999999999999998864221      1234556788888899999999999986533   


Q ss_pred             ----EEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCceEECC-CCcEEEE
Q 013354          231 ----KLYIYLEYVSGGSIYKILQ----DYGQLGESAIRSYTQQILSGLEYLH--AKNTVHRDIKGANILVDP-SGRVKLA  299 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~-~~~vkL~  299 (444)
                          .+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                38899999975 5554443    3456899999999999999999999  999999999999999986 8999999


Q ss_pred             eccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-------
Q 013354          300 DFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-------  372 (444)
Q Consensus       300 DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------  372 (444)
                      |||++.............||+.|+|||++.+...++.++|||||||++|||++|+.||........+..+...       
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            9999998776666666779999999999876666899999999999999999999999876654443332210       


Q ss_pred             -----------------------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 -----------------------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 -----------------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                             ...+.....++.++++||.+||+.||++|||+.|+|+||||++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                                   001123334678999999999999999999999999999998753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-47  Score=379.94  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=212.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE-
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL-  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-  232 (444)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            46899999999999999999999999999999988642   23455667889999999999999999999999877654 


Q ss_pred             -----EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          233 -----YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       233 -----~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                           ++||||+. ++|.+++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                 99999996 68888874  35999999999999999999999999999999999999999999999999999866


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------  372 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------  372 (444)
                      ...  .....||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+...               
T Consensus       195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            443  234568999999999987555899999999999999999999999876544433332110               


Q ss_pred             --------------CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 --------------KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 --------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                    .....+...++.++++||++||+.||++|||++|+|+||||++..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                          000112346799999999999999999999999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=371.41  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=209.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE-----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET-----  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-----  227 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++..     ......+.+.+|+.++++++||||+++++++.     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec-----CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            45789999999999999999999999999999998864     23455678899999999999999999999873     


Q ss_pred             ---------cCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-CCCcEE
Q 013354          228 ---------LDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-PSGRVK  297 (444)
Q Consensus       228 ---------~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~vk  297 (444)
                               .....++||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     3468899999997 699999975 6799999999999999999999999999999999999997 567899


Q ss_pred             EEeccccccccCCC----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC
Q 013354          298 LADFGMAKHITGQS----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK  373 (444)
Q Consensus       298 L~DFGla~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~  373 (444)
                      |+|||++.......    ......++..|+|||++.....++.++|||||||++|||++|+.||........+..+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998764321    12234578999999998765558999999999999999999999998766544333322110


Q ss_pred             ----------------------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          374 ----------------------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       374 ----------------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                                  ....+...++.++++||++||+.||++|||++|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                                        0011235689999999999999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-46  Score=364.20  Aligned_cols=253  Identities=29%  Similarity=0.484  Sum_probs=207.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------  228 (444)
                      ++|++.+.||+|+||.||+|++..+++.||||++..      .....+.+.+|+.++++++||||+++++++..      
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            479999999999999999999999999999998862      34456788999999999999999999998754      


Q ss_pred             -------CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEe
Q 013354          229 -------DDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       229 -------~~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                             ....++||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   457899999999999999998644 578899999999999999999999999999999999999999999999


Q ss_pred             ccccccccCC---------------CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCC-hh
Q 013354          301 FGMAKHITGQ---------------SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEG-VP  364 (444)
Q Consensus       301 FGla~~~~~~---------------~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-~~  364 (444)
                      ||++......               .......|++.|+|||++.+...++.++|||||||++|||++   ||..... ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9999765422               112334589999999999766558999999999999999998   5543211 12


Q ss_pred             hhHHhcC--CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          365 AMFKIGN--SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       365 ~~~~~~~--~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ....+..  ....+.++...+.++++||++||+.||++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2222222  122334566778899999999999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7e-47  Score=377.04  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=208.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc------cccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD------AKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~------~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||.||+|.+.. ++.||||++......      .......+.+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34689999999999999999998865 999999998653221      13345567899999999999999999999998


Q ss_pred             Ec-----CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEe
Q 013354          227 TL-----DDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       227 ~~-----~~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                      ..     ...+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            43     347899999996 68888887543 699999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--------
Q 013354          301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--------  372 (444)
Q Consensus       301 FGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------  372 (444)
                      ||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||........+..+...        
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999987655555555679999999999987556899999999999999999999999875543333222110        


Q ss_pred             --------------CCC--------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          373 --------------KEL--------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       373 --------------~~~--------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                    ...        ......+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                          000        112345789999999999999999999999999999999763

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-47  Score=380.89  Aligned_cols=257  Identities=17%  Similarity=0.142  Sum_probs=193.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc--CCCCeeeEe-------ee
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL--RHPNIVRYY-------GS  225 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~l~-------~~  225 (444)
                      ..|++.+.||+|+||.||+|++..+++.||||++.....  ......+.+.+|+.+++.+  +||||++++       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            459999999999999999999999999999999975321  2344556777885544444  699988755       44


Q ss_pred             EEcC-----------------CEEEEEEeccCCCCHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCcccC
Q 013354          226 ETLD-----------------DKLYIYLEYVSGGSIYKILQDYG-QLGESAI------RSYTQQILSGLEYLHAKNTVHR  281 (444)
Q Consensus       226 ~~~~-----------------~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~------~~i~~qi~~aL~~LH~~~ivH~  281 (444)
                      +...                 ..+|+||||+. ++|.+++...+ .+.+..+      +.++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            4332                 34899999998 89999998743 3444445      6777999999999999999999


Q ss_pred             CCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 013354          282 DIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWSQY  360 (444)
Q Consensus       282 Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~  360 (444)
                      ||||+||||+.++.+||+|||+++......  ....+|+.|+|||++.+. ..++.++|||||||+||||++|+.||...
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999998764322  134477999999999751 34899999999999999999999999765


Q ss_pred             CChhh--hHH---hc--CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          361 EGVPA--MFK---IG--NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       361 ~~~~~--~~~---~~--~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      .....  +..   ..  ...........++.++++||.+||+.||++|||+.|+|+||||++.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            32211  111   11  1111112235789999999999999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=378.97  Aligned_cols=257  Identities=26%  Similarity=0.373  Sum_probs=218.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|+     +..+++.||||+++.    .........+.+|+.++++++||||+++++++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc----ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            345689999999999999999999     445788999998852    23344556788999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---cE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG-------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---RV  296 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~v  296 (444)
                      ......++||||+.+++|.+++....       .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999998753       489999999999999999999999999999999999998554   59


Q ss_pred             EEEeccccccccCC---CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCC
Q 013354          297 KLADFGMAKHITGQ---SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       297 kL~DFGla~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~  372 (444)
                      ||+|||+++.....   .......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||...........+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999854322   2223345789999999997665 8999999999999999998 99999887766666666554


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      .. ...+..++.++.+||.+||+.||++|||+.+|+++.++.
T Consensus       303 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            43 356778999999999999999999999999999997764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-46  Score=368.34  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=211.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEE-cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC------CeeeEeee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFN-SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP------NIVRYYGS  225 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~-~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp------nIv~l~~~  225 (444)
                      ...+|++.+.||+|+||.||+|.+ +.+++.||+|+++.      .....+.+.+|+.+++.++|+      +|++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            456899999999999999999998 56789999998862      234456788899999888765      49999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-----------
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-----------  292 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----------  292 (444)
                      +...+.+++||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999999 899999998765  5899999999999999999999999999999999999987           


Q ss_pred             --------CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh
Q 013354          293 --------SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP  364 (444)
Q Consensus       293 --------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  364 (444)
                              ++.+||+|||++......  .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+...
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    667999999999865432  33456899999999997665 8999999999999999999999998765443


Q ss_pred             hhHHhcCCC------------------------------------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCc
Q 013354          365 AMFKIGNSK------------------------------------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRP  402 (444)
Q Consensus       365 ~~~~~~~~~------------------------------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp  402 (444)
                      ....+....                                          .....+...++++.+||.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            322211000                                          00011223467899999999999999999


Q ss_pred             CHHHHHhCCCCCCC
Q 013354          403 TAAWLLEHPFVGNA  416 (444)
Q Consensus       403 t~~elL~hp~~~~~  416 (444)
                      |+.|+|+||||+..
T Consensus       322 t~~ell~hp~f~~~  335 (339)
T 1z57_A          322 TLREALKHPFFDLL  335 (339)
T ss_dssp             CHHHHTTSGGGGGG
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=371.11  Aligned_cols=253  Identities=24%  Similarity=0.415  Sum_probs=217.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|++.     .+++.||+|+++.    .......+.+.+|+.++++++||||+++++++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34568999999999999999999987     4568999998863    23345567899999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY------------------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRD  282 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  282 (444)
                      ...+..++||||+.+++|.+++...                        ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999874                        4689999999999999999999999999999


Q ss_pred             CCCCceEECCCCcEEEEeccccccccCCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 013354          283 IKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWS  358 (444)
Q Consensus       283 lkp~NIll~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~  358 (444)
                      |||+|||++.++.+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCC
Confidence            99999999999999999999998654332   122345788999999997665 8999999999999999999 999998


Q ss_pred             CCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          359 QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..........+.... .+.++..++.++.+||++||+.||++|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          279 GMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCChHHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            776655555555443 346778899999999999999999999999998874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=373.14  Aligned_cols=256  Identities=28%  Similarity=0.445  Sum_probs=213.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE--
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK--  231 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--  231 (444)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...+.  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            35799999999999999999999999999999988642   2345556788999999999999999999999887653  


Q ss_pred             ----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          232 ----LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ----~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                          +++||||+. ++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                499999996 688887753  5999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC----------------
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----------------  371 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----------------  371 (444)
                      ...  .....+|+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+..                
T Consensus       177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            433  23456899999999987755589999999999999999999999987654333222110                


Q ss_pred             -------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          372 -------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       372 -------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                   ......+...++.++++||.+||+.||++|||+.|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                         1122334567899999999999999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-46  Score=365.45  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=218.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|.+.     .+++.||+|++..    .......+.+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE----NASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            34578999999999999999999883     4568999998863    23455567899999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYGQ------------------------LGESAIRSYTQQILSGLEYLHAKNTVHRD  282 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  282 (444)
                      ..++..++||||+.+++|.+++.....                        +++..++.++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999987543                        88999999999999999999999999999


Q ss_pred             CCCCceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 013354          283 IKGANILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWS  358 (444)
Q Consensus       283 lkp~NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~  358 (444)
                      |||+|||++.++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987644332   22344778899999997655 8999999999999999999 999998


Q ss_pred             CCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          359 QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..........+.... ....+..++.++.+||.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            766655555554433 346678899999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.7e-47  Score=379.73  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=217.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|+++.+++.||||+++.    .......+.+.+|+.+|++++||||+++++++..++.
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT----TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc----cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            345689999999999999999999998999999998763    2334555678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      +++||||+.+++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999999999998754 5999999999999999999999999999999999999999999999999999865432


Q ss_pred             CCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          311 SCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       311 ~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...   ....+++.|+|||++.... ++.++|||||||++|||++ |..||...........+...... ..+..+++++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-PCPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence            211   1122567899999997665 8999999999999999998 99999887766655555554443 5678899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||.+||+.||++|||+.+|++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=371.36  Aligned_cols=257  Identities=26%  Similarity=0.473  Sum_probs=208.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-ccHHHHHHHHHHHHHHHcc----CCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-KSKESAQQLGQEIALLSRL----RHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~~~~~Ei~~l~~l----~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....... ........+.+|+.++.++    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34568999999999999999999999999999999986432211 1112234566789999988    899999999999


Q ss_pred             EcCCEEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-CCCcEEEEecccc
Q 013354          227 TLDDKLYIYLEY-VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-PSGRVKLADFGMA  304 (444)
Q Consensus       227 ~~~~~~~lv~e~-~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla  304 (444)
                      ...+..++|||+ +.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            998999999999 78999999999888899999999999999999999999999999999999998 7899999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ....... .....|+..|+|||++.+....+.++|||||||++|||++|+.||....   ....   .  ...++..++.
T Consensus       188 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~---~--~~~~~~~~~~  258 (312)
T 2iwi_A          188 ALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---EILE---A--ELHFPAHVSP  258 (312)
T ss_dssp             EECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHHH---T--CCCCCTTSCH
T ss_pred             hhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---HHhh---h--ccCCcccCCH
Confidence            8765433 3445699999999998766644669999999999999999999996421   1111   1  1245678999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ++++||.+||+.||++|||++|+++||||+...
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            999999999999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-46  Score=357.91  Aligned_cols=249  Identities=23%  Similarity=0.408  Sum_probs=214.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|++.. ++.||+|++....   ..   .+.+.+|+.++++++||||+++++++..++..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA---MS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS---BC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc---cC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            34689999999999999999999874 7889999986321   11   24688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999999999999999998664432


Q ss_pred             --CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                        ......+++.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..++.++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-CCCCCcCCHHHHH
Confidence              122344678899999997665 8999999999999999999 9999988766666655554433 3567778999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ||.+||+.||++|||+.|+++|
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-46  Score=372.27  Aligned_cols=259  Identities=29%  Similarity=0.444  Sum_probs=218.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc------------HHHHHHHHHHHHHHHccCCCCeee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS------------KESAQQLGQEIALLSRLRHPNIVR  221 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~------------~~~~~~~~~Ei~~l~~l~hpnIv~  221 (444)
                      ..+|++.+.||+|+||.||+|++  +++.||+|++.........            ....+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999998  7999999998642111000            011267889999999999999999


Q ss_pred             EeeeEEcCCEEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECC
Q 013354          222 YYGSETLDDKLYIYLEYVSGGSIYKI------LQD--YGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDP  292 (444)
Q Consensus       222 l~~~~~~~~~~~lv~e~~~ggsL~~~------l~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~  292 (444)
                      +++++...+..++||||+.+++|.++      +.+  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999998      665  4679999999999999999999999 99999999999999999


Q ss_pred             CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCCh-hhhHHHHHHHHHHHHcCCCCCCCCCC-hhhhHHhc
Q 013354          293 SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL-AVDIWSLGCTVIEMATTKPPWSQYEG-VPAMFKIG  370 (444)
Q Consensus       293 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~-~sDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~  370 (444)
                      ++.+||+|||++...... ......|++.|+|||++.+...++. ++|||||||++|||++|+.||..... ......+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999876543 3344569999999999987644666 99999999999999999999987665 44444443


Q ss_pred             CCCCCCCCC-------------------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          371 NSKELPAIP-------------------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       371 ~~~~~~~~~-------------------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ....  .++                   ..++.++.+||.+||+.||++|||+.|+++||||++..
T Consensus       267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          267 TKNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             SCCC--CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccCc--CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            3322  222                   56899999999999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-46  Score=360.66  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=213.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++.....   .   .+.+.+|+.++++++|+||+++++++...+.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---C---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---C---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            45578999999999999999999876 578899999863211   1   2467899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      .++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999999999987 457999999999999999999999999999999999999999999999999999866443


Q ss_pred             C--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 S--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .  ......+|+.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..+++++.
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  251 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPHLASEKVY  251 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHH
T ss_pred             ccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-CCCCCcCCHHHH
Confidence            2  122334678899999997665 8999999999999999998 9999988776666666554433 355778899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +||.+||+.||++|||+.++++|
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.3e-46  Score=364.82  Aligned_cols=262  Identities=27%  Similarity=0.446  Sum_probs=215.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC--CCCeeeEeeeEEcC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR--HPNIVRYYGSETLD  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~  229 (444)
                      ..+.+|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+.+|+.++++++  |+||+++++++..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            44568999999999999999999886 48999999987422   33556678899999999997  59999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +.+++||| +.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999999 45889999999888899999999999999999999999999999999999996 48899999999987654


Q ss_pred             CCC---cccccCCCcccCcccccCc----------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCC
Q 013354          310 QSC---PLSIKGSPYWMAPEVIKNS----------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKEL  375 (444)
Q Consensus       310 ~~~---~~~~~gt~~y~APE~~~~~----------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~  375 (444)
                      ...   .....|++.|+|||++.+.          ..++.++|||||||++|||++|+.||...... ..+..+......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            332   1234589999999998651          24789999999999999999999999765433 233333333334


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL  419 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~~  419 (444)
                      ..++...+.++.+||.+||+.||++||++.|+|+||||+.....
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            45677789999999999999999999999999999999876443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-46  Score=356.91  Aligned_cols=252  Identities=27%  Similarity=0.523  Sum_probs=206.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|.+.  ++.||+|+++..... ......+.+.+|+.+++.++||||+++++++..++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            3568999999999999999999875  889999988642211 2233356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCCCceEECC--------CCcEEEEec
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN---TVHRDIKGANILVDP--------SGRVKLADF  301 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~--------~~~vkL~DF  301 (444)
                      ++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999999864 58999999999999999999999999   899999999999986        678999999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCC
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDH  381 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  381 (444)
                      |++........ ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.........+..
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST  238 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence            99987654332 3456899999999997665 899999999999999999999999887766666666555555677889


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +++++.+||.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.6e-47  Score=380.68  Aligned_cols=252  Identities=27%  Similarity=0.389  Sum_probs=206.3

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC--------CCCeeeEeee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR--------HPNIVRYYGS  225 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~  225 (444)
                      ..+|++.+.||+|+||+||+|++..+++.||||++..      .....+.+.+|+.+++.++        |+||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            4689999999999999999999999999999999862      2445567889999999985        7889999999


Q ss_pred             EE----cCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCC----
Q 013354          226 ET----LDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSG----  294 (444)
Q Consensus       226 ~~----~~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~----  294 (444)
                      +.    ....+++||||+ +++|.+++.+.  ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            87    556899999999 66776666554  4699999999999999999999999 999999999999998775    


Q ss_pred             ---------------------------------------------cEEEEeccccccccCCCCcccccCCCcccCccccc
Q 013354          295 ---------------------------------------------RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK  329 (444)
Q Consensus       295 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~  329 (444)
                                                                   .+||+|||++......  .....||+.|+|||++.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence                                                         7999999999876433  33456899999999998


Q ss_pred             CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh------hhHHhc---C-------------------CCC---C---
Q 013354          330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP------AMFKIG---N-------------------SKE---L---  375 (444)
Q Consensus       330 ~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~------~~~~~~---~-------------------~~~---~---  375 (444)
                      +.. ++.++|||||||+||||++|+.||.......      .+..+.   .                   ...   .   
T Consensus       267 ~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          267 GSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             TSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             CCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            766 8999999999999999999999997644321      111000   0                   000   0   


Q ss_pred             ------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          376 ------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       376 ------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                                  ...+..++.++++||.+||+.||++|||++|+|+||||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                        0112334577899999999999999999999999999964

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=371.34  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=218.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEe
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYY  223 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~  223 (444)
                      ...++|++.+.||+|+||.||+|++..       ++..||+|+++.    .......+.+.+|+.+++++ +||||++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecc----ccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            345789999999999999999999753       335799998863    23455567899999999999 999999999


Q ss_pred             eeEEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 013354          224 GSETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGAN  287 (444)
Q Consensus       224 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  287 (444)
                      +++..++..++||||+.+++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999998754                48999999999999999999999999999999999


Q ss_pred             eEECCCCcEEEEeccccccccCCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 013354          288 ILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGV  363 (444)
Q Consensus       288 Ill~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  363 (444)
                      |||+.++.+||+|||+++......   ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||......
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998764432   223345788999999998765 8999999999999999999 99999877655


Q ss_pred             hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .....+.... ....+..++.++.+||.+||+.||++|||+.|++++
T Consensus       301 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5555554443 345678899999999999999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=382.20  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=192.2

Q ss_pred             CCeee-eeeecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE--cC
Q 013354          155 SRWKK-GRLLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET--LD  229 (444)
Q Consensus       155 ~~~~~-~~~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~  229 (444)
                      +.|++ +++||+|+||+||+|+++  .+++.||||++....   .    ...+.+|+.+|+.++||||+++++++.  .+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---I----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---C----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---C----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            34666 568999999999999976  568999999885321   1    135778999999999999999999985  47


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE----CCCCcE
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY---------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV----DPSGRV  296 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~v  296 (444)
                      ..+++||||+. ++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            78999999995 5888887632         149999999999999999999999999999999999999    677899


Q ss_pred             EEEeccccccccCCC----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---------
Q 013354          297 KLADFGMAKHITGQS----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---------  363 (444)
Q Consensus       297 kL~DFGla~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------  363 (444)
                      ||+|||+++.+....    ......||+.|+|||++.+...++.++|||||||+||||++|+.||......         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998764432    2234568999999999987666899999999999999999999999654321         


Q ss_pred             hhhHHhcCCCCCC------------------------------------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHH
Q 013354          364 PAMFKIGNSKELP------------------------------------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL  407 (444)
Q Consensus       364 ~~~~~~~~~~~~~------------------------------------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~el  407 (444)
                      ..+..+......+                                    ......+.++.+||.+||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            1111111000000                                    0111237789999999999999999999999


Q ss_pred             HhCCCCCCCC
Q 013354          408 LEHPFVGNAA  417 (444)
Q Consensus       408 L~hp~~~~~~  417 (444)
                      |+||||.+..
T Consensus       332 L~hp~f~~~~  341 (405)
T 3rgf_A          332 MQDPYFLEDP  341 (405)
T ss_dssp             HTSGGGTSSS
T ss_pred             hcChhhccCC
Confidence            9999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-46  Score=366.56  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=192.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHH-HHHccCCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA-LLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++...    .......++.+|+. +++.++||||+++++++..++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            346899999999999999999999999999999998742    22333345555555 7788899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD-----YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      .++||||+.+ +|.+++..     ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999974 88888864     45799999999999999999999999 99999999999999999999999999998


Q ss_pred             cccCCCCcccccCCCcccCccccc---CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-hhhHHhcCCCCCCCC---
Q 013354          306 HITGQSCPLSIKGSPYWMAPEVIK---NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-PAMFKIGNSKELPAI---  378 (444)
Q Consensus       306 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~---  378 (444)
                      ............||+.|+|||++.   ....++.++|||||||++|||++|+.||...... ..+..+.... .+.+   
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  253 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD-PPQLSNS  253 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC-CCCCCCC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC-CCCCCCc
Confidence            775554444456999999999984   2333789999999999999999999999764432 2222222211 1122   


Q ss_pred             -CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          379 -PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       379 -~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                       ...++.++.+||.+||+.||++|||+.++++||||.+.
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence             24689999999999999999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-46  Score=367.73  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=206.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEE----EEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMC----AMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~v----aiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ...+|++.+.||+|+||+||+|++..+++.+    |+|.++    ........+.+.+|+.++++++||||+++++++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecc----cccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            3468999999999999999999998888766    555443    12233445788999999999999999999999987


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .. .++|+||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            65 78899999999999999874 56999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          308 TGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       308 ~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ......   ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+..... ...+..++
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  245 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPICT  245 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTBC
T ss_pred             cCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-CCCCccCC
Confidence            544322   2234678999999998665 8999999999999999999 9999987766555555544443 35677899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++||++.+++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.7e-46  Score=358.12  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=205.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ....+|++.+.||+|+||.||+|++..+   +..||+|++..    .......+.+.+|+.++++++||||+++++++. 
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            4457899999999999999999998654   45689997652    234556678999999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ++..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            456899999999999999998754 6999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          308 TGQSCP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       308 ~~~~~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ......  ....+++.|+|||++.... ++.++|||||||++|||++ |..||...........+..... ..++..++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~  244 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPP  244 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTCCH
T ss_pred             CcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-CCCCCCCCH
Confidence            543321  2234678899999997655 8999999999999999997 9999988776666666655443 356788999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.+||.+||+.||++|||+.|++++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999998864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-46  Score=363.43  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=216.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeee
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGS  225 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  225 (444)
                      ....+|++.+.||+|+||.||+|++     ..+++.||+|++...    ......+.+.+|+.+++++ +||||++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            3456899999999999999999985     456789999988632    2334557889999999999 99999999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCc
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGAN  287 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  287 (444)
                      +...+..++||||+.+++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  38999999999999999999999999999999999


Q ss_pred             eEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 013354          288 ILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGV  363 (444)
Q Consensus       288 Ill~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~  363 (444)
                      ||++.++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            9999999999999999987654432   12344678899999987665 8999999999999999999 99999876655


Q ss_pred             hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...............+..++.++.+||.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            54444333333345567899999999999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.9e-46  Score=355.76  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=214.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|+++....      ..+.+.+|+.++++++||||+++++++..+...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            4568999999999999999999876 477899999864221      124688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 49999999999999999999999999999999999999999999999999998765433


Q ss_pred             C--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 C--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      .  .....+++.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..+++++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  236 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-LYRPHLASDTIYQ  236 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTSCHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-CCCCCcChHHHHH
Confidence            2  22334677899999997655 8899999999999999999 9999988776666655554443 3556778999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ||.+||+.||++|||+.|++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=369.48  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=214.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||.||+|++.     .++..||+|++...    ......+.+.+|+.+++++ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4568999999999999999999973     45678999998632    2233456888999999999 899999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG-----------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDI  283 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  283 (444)
                      ...+..++||||+.+++|.+++....                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999998653                       2789999999999999999999999999999


Q ss_pred             CCCceEECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 013354          284 KGANILVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQ  359 (444)
Q Consensus       284 kp~NIll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~  359 (444)
                      ||+|||++.++.+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999986644332   12344778999999997665 8999999999999999998 9999988


Q ss_pred             CCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCC
Q 013354          360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP  411 (444)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp  411 (444)
                      ...................+..++.++.+||.+||+.||++|||+.++++|-
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            7655555444444444566788999999999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-45  Score=354.23  Aligned_cols=253  Identities=25%  Similarity=0.443  Sum_probs=213.0

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHH---HHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES---AQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++...... .....   .+.+.+|+.++++++||||+++++++..
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE-GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTT-CCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccc-cchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4457899999999999999999999999999999988653322 12222   2678899999999999999999999876


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCc-----EEEEe
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGR-----VKLAD  300 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-----vkL~D  300 (444)
                      ..  ++||||+.+++|.+++.+. ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            65  6999999999999988764 46999999999999999999999999  999999999999988776     99999


Q ss_pred             ccccccccCCCCcccccCCCcccCcccccC-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh--hHHhcCCCCCCC
Q 013354          301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKN-SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA--MFKIGNSKELPA  377 (444)
Q Consensus       301 FGla~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~  377 (444)
                      ||+++....  ......||+.|+|||++.. ...++.++|||||||++|||++|+.||........  ...+......+.
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            999975433  2334569999999999842 23378999999999999999999999987654433  333444445567


Q ss_pred             CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       378 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++..+++++.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            78899999999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-46  Score=368.10  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=217.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc-cHHHHHHHHHHHHHHHccC--CCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK-SKESAQQLGQEIALLSRLR--HPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~  228 (444)
                      ...++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+.+|+.++++++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            345689999999999999999999999999999999875322110 0012235667999999996  5999999999999


Q ss_pred             CCEEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC-CCCcEEEEecccccc
Q 013354          229 DDKLYIYLEYVSG-GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD-PSGRVKLADFGMAKH  306 (444)
Q Consensus       229 ~~~~~lv~e~~~g-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~  306 (444)
                      .+..++|||++.+ ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999999999976 89999999888999999999999999999999999999999999999998 778999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      .... ......||+.|+|||++.+...++.++|||||||++|||++|+.||....   ...   ...  ..++..++.++
T Consensus       200 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~---~~~--~~~~~~~~~~~  270 (320)
T 3a99_A          200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EII---RGQ--VFFRQRVSSEC  270 (320)
T ss_dssp             CCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHH---HCC--CCCSSCCCHHH
T ss_pred             cccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---hhh---ccc--ccccccCCHHH
Confidence            6543 23345699999999998766645789999999999999999999996421   111   111  23567789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .+||++||+.||++|||++|+++||||++..
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=392.94  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=208.6

Q ss_pred             CCCeeeee-eecccCceEEEEEEEcC--CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGR-LLGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~-~LG~G~fg~Vy~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..++.+.+ .||+|+||.||+|.++.  ++..||||+++..    ......+.+.+|+.+|++++||||+++++++.. +
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC----CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            34566665 89999999999998763  4667999988642    122345678899999999999999999999876 5


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            599999999999999999754 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc----cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QSCPL----SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~~~~----~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      .....    ...+++.|+|||++.... ++.++|||||||+||||++ |+.||......+....+.....+ ..+..++.
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-~~p~~~~~  566 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPP  566 (613)
T ss_dssp             -------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-CCCTTCCH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCCCcCCH
Confidence            33221    223568899999997665 8999999999999999998 99999988887777777666544 56788999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++.+||.+||+.||++||++.+|++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999998743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.2e-46  Score=365.78  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=213.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEE--EEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMC--AMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~v--aiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  228 (444)
                      ...++|++.+.||+|+||.||+|+++.++..+  |+|.+...    ......+.+.+|+.+++++ +||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            44568999999999999999999999888865  88887632    2334456788999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP  292 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  292 (444)
                      .+..++||||+++++|.+++.+..                .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            999999999999999999998754                6999999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcC
Q 013354          293 SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGN  371 (444)
Q Consensus       293 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  371 (444)
                      ++.+||+|||+++............+++.|+|||++.... ++.++|||||||++|||++ |..||...........+..
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            9999999999997544333333445788999999997655 8999999999999999998 9999988766555555554


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ... ...+..++.++.+||.+||+.||++|||+.|++++
T Consensus       257 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433 35677899999999999999999999999998876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-46  Score=356.93  Aligned_cols=250  Identities=26%  Similarity=0.450  Sum_probs=217.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ....+|++.+.||+|+||.||+|.++.+++.||+|++..      .....+.+.+|+.++++++|+||+++++++..++.
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS------CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            456789999999999999999999999999999998863      12234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .++||||+.+++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999999998743  499999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+.......+..... ...+..+++++
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  241 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPEGCPEKV  241 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CCCCTTCCHHH
T ss_pred             CccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-CCCCCCCCHHH
Confidence            432  22344678899999997665 8999999999999999999 9999988766555555544333 35678899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||++||+.||++|||+.++++
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999876

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=361.34  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=197.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++....   ......+.+.++..+++.++||||+++++++..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            457999999999999999999999999999999987422   22333445556666788899999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      +||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999999 6677766654 45799999999999999999999996 99999999999999999999999999998765555


Q ss_pred             CcccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhcCCCCCCCCC--CCCCH
Q 013354          312 CPLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIGNSKELPAIP--DHLSD  384 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~--~~~s~  384 (444)
                      ......+++.|+|||++..    ...++.++|||||||++|||++|+.||....... .+..+.... .+.++  ..++.
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  258 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSG  258 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCSSSCCCH
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCccCCCCH
Confidence            4455669999999999852    3347889999999999999999999998754432 233332222 22223  45899


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ++.+||.+||+.||++||+++|+++||||++.
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999854

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-45  Score=351.50  Aligned_cols=249  Identities=16%  Similarity=0.320  Sum_probs=215.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC--
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD--  229 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--  229 (444)
                      ...++|++.+.||+|+||.||+|++.  ++.||+|+++..   .......+.+.+|+.++++++||||+++++++...  
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCT---TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            34568999999999999999999885  889999998752   23345567899999999999999999999999886  


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEEEeccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      ...++||||+++++|.+++.+..  .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78899999999999999998765  4899999999999999999999999  9999999999999999999999999876


Q ss_pred             cccCCCCcccccCCCcccCcccccCcCC--CChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          306 HITGQSCPLSIKGSPYWMAPEVIKNSNG--CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       306 ~~~~~~~~~~~~gt~~y~APE~~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ....    ....||+.|+|||++.+...  ++.++|||||||++|||++|+.||...........+......+.++..++
T Consensus       162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3kmu_A          162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS  237 (271)
T ss_dssp             TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred             eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence            5332    23458999999999976541  34489999999999999999999988776666566555555567888999


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          238 PHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999886

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.6e-46  Score=372.95  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CC-----CeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HP-----NIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.      .......+.+|+.+++.++ |+     +|+++++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            34689999999999999999999999999999999862      3344567778888888875 44     499999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCCCceEEC--CCCcEEEEe
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLH--AKNTVHRDIKGANILVD--PSGRVKLAD  300 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~--~~~~vkL~D  300 (444)
                      ...+.+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999995 5999999875  35999999999999999999999  56999999999999995  467899999


Q ss_pred             ccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC----
Q 013354          301 FGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP----  376 (444)
Q Consensus       301 FGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~----  376 (444)
                      ||+++.....  .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+......+    
T Consensus       205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTCC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceecccc--cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999876433  33456999999999998766 8999999999999999999999998765544333221100000    


Q ss_pred             ------------CC------------------CC----------------------------CCCHHHHHHHHHHhhhCC
Q 013354          377 ------------AI------------------PD----------------------------HLSDEGKDFVRKCLQRNP  398 (444)
Q Consensus       377 ------------~~------------------~~----------------------------~~s~~l~~Li~~~L~~dP  398 (444)
                                  .+                  +.                            ..+.++++||.+||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                        00                  00                            001478999999999999


Q ss_pred             CCCcCHHHHHhCCCCCCC
Q 013354          399 LHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       399 ~~Rpt~~elL~hp~~~~~  416 (444)
                      ++|||++|+|+||||++.
T Consensus       362 ~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC-
T ss_pred             hhCCCHHHHhcCcccccC
Confidence            999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5e-46  Score=368.01  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=185.0

Q ss_pred             CCCCCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--
Q 013354          152 SPGSRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--  228 (444)
Q Consensus       152 ~~~~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  228 (444)
                      ...++|.+. ++||+|+||.||+|+++.+++.||||++..      .....+   +....++.++|+||+++++++..  
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ---EVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES------SHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC------cHHHHH---HHHHHHHhcCCCChHHHHHHHhhcc
Confidence            345689995 579999999999999999999999999862      122222   22334567799999999999876  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEec
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADF  301 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DF  301 (444)
                        +..+++||||+.+++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998764  5999999999999999999999999999999999999976   445999999


Q ss_pred             cccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh----HHhcC--CCCC
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM----FKIGN--SKEL  375 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~--~~~~  375 (444)
                      |++....... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.........    ..+..  ....
T Consensus       176 g~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          176 GFAKETTQNA-LQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TTCEEC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             ccceeccccc-cccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            9998665332 33456899999999986655 889999999999999999999999765433221    11111  1111


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ......++.++++||.+||+.||++|||+.|+|+||||++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            12235789999999999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.1e-46  Score=359.17  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=206.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ....+|++.+.||+|+||+||+|+    +..+++.||+|++..     ......+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345789999999999999999998    566899999998863     34555678999999999999999999999986


Q ss_pred             c--CCEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          228 L--DDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       228 ~--~~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      .  ...+++||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            5  356899999999999999998754 4999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh----------------h
Q 013354          305 KHITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV----------------P  364 (444)
Q Consensus       305 ~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----------------~  364 (444)
                      ........    .....++..|+|||++.+.. ++.++||||||+++|||++|..||......                .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            87654322    12334677899999997665 899999999999999999999998642110                1


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+... .....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11112222 233567889999999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-45  Score=363.17  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      .+.+|++.+.||+|+||.||+|++..+++.||||++.....       .+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            45789999999999999999999999999999998864221       13577899999999 99999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc-----EEEEeccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-----VKLADFGMAK  305 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-----vkL~DFGla~  305 (444)
                      .++||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999999 99999999874 57999999999999999999999999999999999999998887     9999999998


Q ss_pred             cccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh---hHHhcCCC-
Q 013354          306 HITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGNSK-  373 (444)
Q Consensus       306 ~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~~-  373 (444)
                      .+.....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........   +..+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            7644332        23566999999999998765 89999999999999999999999987543322   22221111 


Q ss_pred             --CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          374 --ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       374 --~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                        ....+...++ ++.+||..||+.||++||++.+|++
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1011123345 9999999999999999999998766

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-46  Score=369.11  Aligned_cols=251  Identities=26%  Similarity=0.378  Sum_probs=209.9

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ...+|++.+.||+|+||.||+|++..+++.    ||+|.+...    ......+.+.+|+.++++++||||+++++++. 
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK----SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT----TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc----ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            346899999999999999999999888877    555655321    11222345678999999999999999999886 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      ++..++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            45689999999999999999874 46999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          308 TGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       308 ~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      .....   .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||...........+..... ...+..++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  243 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-LAQPQICT  243 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-CCCCTTBC
T ss_pred             CcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCCCCcCc
Confidence            54432   23345788999999997666 8999999999999999999 9999988766655555554433 35677789


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++|||+.+++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999886

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.9e-46  Score=367.39  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=211.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC-cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC------eeeEeee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG-EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN------IVRYYGS  225 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~  225 (444)
                      ...+|++.+.||+|+||.||+|++..++ +.||+|+++.      .....+.+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            3568999999999999999999998777 6899999862      2344567788999999887655      8999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE-------------
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV-------------  290 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------------  290 (444)
                      +...+.+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+             
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            99999999999999 677777776643  69999999999999999999999999999999999999             


Q ss_pred             ------CCCCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh
Q 013354          291 ------DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP  364 (444)
Q Consensus       291 ------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  364 (444)
                            +.++.+||+|||+++.....  .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                  56788999999999865433  23456999999999997665 8999999999999999999999998765443


Q ss_pred             hhHHhcCCC-CC-----------------------------------------CCCCCCCCHHHHHHHHHHhhhCCCCCc
Q 013354          365 AMFKIGNSK-EL-----------------------------------------PAIPDHLSDEGKDFVRKCLQRNPLHRP  402 (444)
Q Consensus       365 ~~~~~~~~~-~~-----------------------------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rp  402 (444)
                      ....+.... ..                                         .......+.++.+||++||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            322211100 00                                         001112346889999999999999999


Q ss_pred             CHHHHHhCCCCCCCCCCcC
Q 013354          403 TAAWLLEHPFVGNAAPLER  421 (444)
Q Consensus       403 t~~elL~hp~~~~~~~~~~  421 (444)
                      |+.|+|+||||++.....+
T Consensus       327 t~~e~l~hp~f~~~~~~~~  345 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPEER  345 (355)
T ss_dssp             CHHHHTTSGGGGGCCHHHH
T ss_pred             CHHHHhcChhhcCCChhhc
Confidence            9999999999998765443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-45  Score=357.89  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=206.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...  ........+.+.+|+.++++++||||+++++++..++.++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG--GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc--cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            46899999999999999999999999999999988632  2334556688999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-  312 (444)
                      +||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999986644321 


Q ss_pred             -cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCC-CCCCCCCCCCHHHHHHH
Q 013354          313 -PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK-ELPAIPDHLSDEGKDFV  390 (444)
Q Consensus       313 -~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~Li  390 (444)
                       .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||...........+.... .....+..++.++.+||
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  269 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI  269 (309)
T ss_dssp             ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred             cccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence             22445899999999997665 8899999999999999999999997654332222222221 12245677899999999


Q ss_pred             HHHhhhCCCCCc-CHHHHHh
Q 013354          391 RKCLQRNPLHRP-TAAWLLE  409 (444)
Q Consensus       391 ~~~L~~dP~~Rp-t~~elL~  409 (444)
                      .+||+.||++|| +++++++
T Consensus       270 ~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          270 ARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHTCSSGGGSCSSHHHHHH
T ss_pred             HHhccCCHHHHHHhHHHHHH
Confidence            999999999999 8888775

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=363.85  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=206.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.+++|+..+...........+.+.+|+.++++++||||+++++++.... .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            356899999999999999999999988887654433221111222234467889999999999999999999998765 7


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|+||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            8999999999999999874 469999999999999999999999999999999999999999999999999998764433


Q ss_pred             Cc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          312 CP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       312 ~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ..   ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||...........+..... ...+..++.++.
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  249 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPICTIDVY  249 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTBCHHHH
T ss_pred             ccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCccCCHHHH
Confidence            22   2234678899999997665 8999999999999999999 9999988766665555554443 356778999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +||++||+.||++|||+.|+++.
T Consensus       250 ~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999998863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6e-46  Score=371.11  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-----------CCCeeeE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-----------HPNIVRY  222 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l  222 (444)
                      ..+|++.+.||+|+||+||+|++..+++.||||++..      .....+.+.+|+.++++++           |+||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            4689999999999999999999999999999998862      3344567788999988886           8899999


Q ss_pred             eeeEEcCC----EEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEEC----
Q 013354          223 YGSETLDD----KLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVD----  291 (444)
Q Consensus       223 ~~~~~~~~----~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~----  291 (444)
                      ++++...+    .+++||||+ +++|.+++.+.  ..+++..++.++.||+.||+|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    789999999 89999999874  3599999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-----
Q 013354          292 --PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-----  364 (444)
Q Consensus       292 --~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-----  364 (444)
                        ..+.+||+|||++......  .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......     
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              4457999999999876433  23456899999999998766 8999999999999999999999997543211     


Q ss_pred             -hhHHhcC----------------------C---C---------------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcC
Q 013354          365 -AMFKIGN----------------------S---K---------------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPT  403 (444)
Q Consensus       365 -~~~~~~~----------------------~---~---------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt  403 (444)
                       .+..+..                      .   .               ....++..++.++.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence             1111000                      0   0               001233455788999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCc
Q 013354          404 AAWLLEHPFVGNAAPLE  420 (444)
Q Consensus       404 ~~elL~hp~~~~~~~~~  420 (444)
                      ++|+|+||||++....+
T Consensus       328 ~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHHHTCGGGTTCTTCT
T ss_pred             HHHHhhChhhhcccCcc
Confidence            99999999999865443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.6e-46  Score=359.00  Aligned_cols=247  Identities=22%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC-------cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG-------EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGS  225 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~  225 (444)
                      ..++|++.+.||+|+||+||+|+++.++       ..||+|++..     ......+.+.+|+.++++++||||++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-----AHRNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-----GGGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-----ccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            3568999999999999999999998877       4699998853     222344678899999999999999999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc--------E
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR--------V  296 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--------v  296 (444)
                      +...+..++||||+.+++|.+++.+... +++..++.++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999988877        9


Q ss_pred             EEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCChhhhHHhcCCCCC
Q 013354          297 KLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKEL  375 (444)
Q Consensus       297 kL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~  375 (444)
                      ||+|||++......   ....+|+.|+|||++.+...++.++|||||||++|||++| .+||...+..........   .
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---~  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---R  234 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---T
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---c
Confidence            99999998765332   2344788999999998745589999999999999999995 555554443333333222   2


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..++...+.++.+||.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            34566778899999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.6e-45  Score=354.73  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=213.6

Q ss_pred             CCCCCeeeee-eecccCceEEEEEEE--cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGR-LLGRGTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~-~LG~G~fg~Vy~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ....+|++.+ .||+|+||.||+|.+  ..+++.||+|+++..   .......+.+.+|+.+++.++||||+++++++ .
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc---ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3456899998 999999999999954  566789999988642   22234467899999999999999999999998 5


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      .+..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            56789999999999999999988889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          309 GQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       309 ~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      .....    ....+++.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+.... .+..+..++
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  246 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCP  246 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCC
Confidence            44322    1233678899999997655 8899999999999999999 999998876655555555443 346678899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.+||.+||+.||++||++.++++
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.6e-46  Score=361.03  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=213.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      ..++|++.+.||+|+||.||+|++     ..+++.||+|+++.    .......+.+.+|+.++.++ +||||+++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEeccc----CCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            456899999999999999999985     35678999998863    23344557889999999999 789999999998


Q ss_pred             EcCC-EEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceE
Q 013354          227 TLDD-KLYIYLEYVSGGSIYKILQDYGQ----------------LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANIL  289 (444)
Q Consensus       227 ~~~~-~~~lv~e~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  289 (444)
                      ...+ .+++||||+.+++|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 58999999999999999987544                889999999999999999999999999999999999


Q ss_pred             ECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhh
Q 013354          290 VDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPA  365 (444)
Q Consensus       290 l~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~  365 (444)
                      ++.++.+||+|||+++........   ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||........
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            999999999999999876443321   2344788999999997665 8999999999999999998 9999987665444


Q ss_pred             hHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       366 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .............+..++.++.+||.+||+.||++|||+.|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333322223345677899999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-45  Score=362.67  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=216.2

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeee
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGE-----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGS  225 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  225 (444)
                      ....+|++.+.||+|+||.||+|.+..+++     .||+|.+..    .......+.+.+|+.+++.+ +||||++++++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS----TAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccc----ccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345789999999999999999999976654     799998863    22344567889999999999 89999999999


Q ss_pred             EEcCCEEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC
Q 013354          226 ETLDDKLYIYLEYVSGGSIYKILQDY--------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD  291 (444)
Q Consensus       226 ~~~~~~~~lv~e~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  291 (444)
                      +...+.+++||||+.+++|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999999753              3579999999999999999999999999999999999999


Q ss_pred             CCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhH
Q 013354          292 PSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMF  367 (444)
Q Consensus       292 ~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~  367 (444)
                      .++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||..........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999986544322   12344678899999987665 8999999999999999998 999998766555444


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       368 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .+.........+..++.++.+||.+||+.||++|||+.|++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            4433333445677889999999999999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=358.88  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=210.2

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCC----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESG----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ....+|++.+.||+|+||.||+|+++.++    ..||+|+++..    ........+.+|+.++++++||||+++++++.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            45678999999999999999999987653    35999988632    23445567899999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      ..+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999999999875 5699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCC
Q 013354          307 ITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDH  381 (444)
Q Consensus       307 ~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  381 (444)
                      ......    .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+...... ..+..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~  274 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-PTPMD  274 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CCCTT
T ss_pred             hccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-CCccc
Confidence            644321    11233678899999997665 8999999999999999999 99999877666666665554433 45678


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.++.+||.+||+.||++||++.+++++
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999998775

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-45  Score=371.26  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=204.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS---ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ...+|++.+.||+|+||.||+|+++   .++..||||+++..    ......+.+.+|+.++++++||||+++++++...
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            3468999999999999999999886   45778999988632    2345567899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +..++||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998754 69999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          309 GQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       309 ~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      .....    ....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+...... ..+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~  276 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-PPPMDCP  276 (373)
T ss_dssp             ---------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-CCCTTCB
T ss_pred             cCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCcccc
Confidence            43211    1223567899999997665 8999999999999999998 99999877665555555444333 4466789


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.+||.+||+.||++||++.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999998765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.7e-45  Score=361.88  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=214.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-------ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYG  224 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  224 (444)
                      ..++|++.+.||+|+||.||+|++.       .++..||+|++..    .......+.+.+|+.+++++ +||||+++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc----CCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            4568999999999999999999985       4577899998863    23445567889999999999 8999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ++..++.+++||||+.+++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998753                389999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      |++.++.+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999987654332   22344778899999987655 8999999999999999999 999998766555


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ....+.... ....+..++.++.+||.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            444444333 345677899999999999999999999999998875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-44  Score=352.97  Aligned_cols=255  Identities=32%  Similarity=0.582  Sum_probs=203.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+.+|+.+++.++|+||+++++++..++..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTT--SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehh--hccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            345799999999999999999999999999999988642  223455667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      ++||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999999975    3458999999999999999999999999999999999999999999999999988664


Q ss_pred             CCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--hhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--PAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      .... .....|++.|+|||++.+.. ++.++||||||+++|||++|..||......  .....+......+.....++.+
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             -----------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            4322 23345899999999997665 899999999999999999999999754322  2233333333333334678999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||.+||+.||++|||+.+++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999998873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-45  Score=354.98  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=209.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++.....       .+.+.+|+.+++.+ +|+||+++++++.....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            45689999999999999999999999999999998863221       23567899999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc-----EEEEeccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR-----VKLADFGMAK  305 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-----vkL~DFGla~  305 (444)
                      .++||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 999999998754 5999999999999999999999999999999999999987765     9999999998


Q ss_pred             cccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcC---
Q 013354          306 HITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGN---  371 (444)
Q Consensus       306 ~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~---  371 (444)
                      .......        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......   .+..+..   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            7654322        23456999999999997666 8999999999999999999999998754322   1222111   


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ....+.+...+++++.+||.+||+.||++|||+.+|++.
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111223345789999999999999999999999987753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.7e-45  Score=375.26  Aligned_cols=245  Identities=27%  Similarity=0.469  Sum_probs=211.8

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-  230 (444)
                      ...++|++.+.||+|+||.||+|.+.  ++.||||+++...       ..+.+.+|+.+|++++||||+++++++.... 
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            34568999999999999999999875  7899999986321       3357889999999999999999999977654 


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      .+++||||+.+++|.+++.+.+.  +++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            79999999999999999987654  7999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ...  ....++..|+|||++.+.. ++.++|||||||+||||++ |+.||...........+...... ..+..++.++.
T Consensus       341 ~~~--~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~  416 (450)
T 1k9a_A          341 STQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGCPPAVY  416 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred             ccc--cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence            322  2235788999999998766 8999999999999999998 99999887776666666655443 56788999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +||.+||+.||++|||+.++++
T Consensus       417 ~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          417 DVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-45  Score=358.13  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=216.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|+++     .+++.||+|++..    .........+.+|+.+++.++|+||+++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc----ccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            44578999999999999999999886     4578899998863    23344556788999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY----------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV  296 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~v  296 (444)
                      ...+..++||||+.+++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999999999763          356899999999999999999999999999999999999999999


Q ss_pred             EEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCC
Q 013354          297 KLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       297 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~  372 (444)
                      ||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||...........+...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            9999999986543321   12334688999999997665 8999999999999999999 89999876655555554443


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      . ....+..++.++.+||.+||+.||++|||+.|++++
T Consensus       257 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          257 G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3 345678899999999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-45  Score=381.67  Aligned_cols=250  Identities=26%  Similarity=0.440  Sum_probs=217.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ....+|++.+.||+|+||.||+|+++.++..||||+++...      ...+.+.+|+.+|++++||||+++++++...+.
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            34567999999999999999999999989999999886321      124678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +++||||+.+++|.+++.+.  ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999999874  3589999999999999999999999999999999999999999999999999987644


Q ss_pred             CCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...  .....++..|+|||++.... ++.++|||||||+||||++ |..||...+.......+..... ...+..++.++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  448 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPEGCPEKV  448 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CCCCTTCCHHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHH
Confidence            321  22334678899999997665 8999999999999999999 9999988776666655555443 35678899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||.+||+.||++|||+.+|++
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-45  Score=349.16  Aligned_cols=249  Identities=23%  Similarity=0.404  Sum_probs=214.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....   ..   .+.+.+|+.++++++||||+++++++..++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT---BC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            3468999999999999999999987 57889999986421   11   25688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999999999875 458999999999999999999999999999999999999999999999999998664322


Q ss_pred             --CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 --CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 --~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                        ......++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..++.++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~  236 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQ  236 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-CCCCccCcHHHHH
Confidence              112344778899999997655 8999999999999999999 9999987666555555554433 3456778999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ||.+||+.||++|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-45  Score=354.34  Aligned_cols=252  Identities=30%  Similarity=0.459  Sum_probs=207.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ...+|++.+.||+|+||.||+|+    +..+++.||+|++....    .....+.+.+|+.+++.++|+||+++++++..
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            34579999999999999999998    56789999999986422    22234678899999999999999999999987


Q ss_pred             C--CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          229 D--DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       229 ~--~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      .  ..+++||||+.+++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  6689999999999999999554 569999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC--------------ChhhhH
Q 013354          306 HITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE--------------GVPAMF  367 (444)
Q Consensus       306 ~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~--------------~~~~~~  367 (444)
                      .......    .....+|..|+|||++.+.. ++.++||||||+++|||++|..||....              ......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            7655432    22345788899999997665 8899999999999999999998864211              111111


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          368 KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       368 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ...........+..+++++.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            112222334567889999999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.6e-45  Score=375.72  Aligned_cols=249  Identities=25%  Similarity=0.463  Sum_probs=213.6

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ....++|++.+.||+|+||.||+|.+.. +..||||+++...      ...+.+.+|+.+|++++||||+++++++. ++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3456789999999999999999999864 7889999986421      12467889999999999999999999986 56


Q ss_pred             EEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      .+++||||+.+++|.++++..  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999999754  368999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQS--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ...  ......++..|+|||++.... ++.++|||||||+||||++ |+.||...........+...... ..+..++++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~~~  413 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-PRPENCPEE  413 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred             CCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHH
Confidence            322  112334678899999997665 8999999999999999999 99999887766666666555444 457789999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.+||.+||+.||++|||+++|++
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-45  Score=361.93  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC-
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD-  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-  230 (444)
                      ....+|++.+.||+|+||+||+|++.  ++.||||++..      .........+|+.++++++||||+++++++.... 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI------QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeec------CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            44568999999999999999999875  79999999863      1223345566999999999999999999988743 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccCCCCCCceEECCCCcEE
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK----------NTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~ivH~Dlkp~NIll~~~~~vk  297 (444)
                         .+++||||+.+++|.+++++ ..+++..++.++.||+.||+|||+.          +|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence               47999999999999999987 5699999999999999999999999          999999999999999999999


Q ss_pred             EEeccccccccCCCC---cccccCCCcccCcccccCc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh-------
Q 013354          298 LADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNS----NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV-------  363 (444)
Q Consensus       298 L~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~----~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-------  363 (444)
                      |+|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|||++|+.||......       
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999987654332   2335689999999999763    23567899999999999999999999753321       


Q ss_pred             --------hhh-HHhcCCCCCCCCCC-----CCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          364 --------PAM-FKIGNSKELPAIPD-----HLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       364 --------~~~-~~~~~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                              ..+ ..+......+.++.     ..+.++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    111 11222222233322     23456999999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-45  Score=361.26  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=213.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGF-----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ....+|++.+.||+|+||.||+|+     +..+++.||+|++..    .........+.+|+.++++++||||+++++++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc----ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            455789999999999999999998     556788999998852    23344556788999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG-------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRV  296 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~v  296 (444)
                      ...+..++||||+.+++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.   +..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999998753       3899999999999999999999999999999999999984   4469


Q ss_pred             EEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCC
Q 013354          297 KLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       297 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~  372 (444)
                      ||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||...........+...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            9999999976543321   22345788999999997665 8999999999999999998 99999876655555555444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      .. ...+..++.++.+||.+||+.||++||++.+++++.|+.
T Consensus       262 ~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 GR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            33 356778999999999999999999999999999998864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.8e-45  Score=354.14  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             CCCCCCCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSE---SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       150 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      ......+|++.+.||+|+||.||+|++..   +++.||+|++...   .......+.+.+|+.++++++||||+++++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc---ccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            33456789999999999999999998865   4568999988642   23445567889999999999999999999998


Q ss_pred             EcCC-----EEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          227 TLDD-----KLYIYLEYVSGGSIYKILQD------YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       227 ~~~~-----~~~lv~e~~~ggsL~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                      ...+     ..++||||+.+++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            7754     35999999999999999953      245999999999999999999999999999999999999999999


Q ss_pred             EEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcC
Q 013354          296 VKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGN  371 (444)
Q Consensus       296 vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  371 (444)
                      +||+|||++........   .....+++.|+|||++.+.. ++.++||||||+++|||++ |..||...........+..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            99999999987644321   12334788999999997665 8999999999999999999 9999988766665555544


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ... +..+..++.++.+||.+||+.||++|||+.+++++
T Consensus       265 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 GHR-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCC-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCC-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            433 45678899999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.3e-45  Score=358.04  Aligned_cols=253  Identities=26%  Similarity=0.435  Sum_probs=211.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGF----NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|++..     ......+.+.+|+.++++++|+||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-----SGPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc-----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            345689999999999999999998    467899999998863     33455677899999999999999999999886


Q ss_pred             --cCCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          228 --LDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       228 --~~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                        ....+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence              456799999999999999999874 46999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--------------hhh
Q 013354          305 KHITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--------------PAM  366 (444)
Q Consensus       305 ~~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--------------~~~  366 (444)
                      ........    .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||......              ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            87654332    22345788899999997665 899999999999999999999998542211              111


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       367 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ............+..+++++.+||.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11222223345678899999999999999999999999998654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-44  Score=347.95  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=210.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..++|++.+.||+|+||+||+|++..+   +..||+|++...    ......+.+.+|+.+++.++||||+++++++..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            456899999999999999999987543   346999987632    2344567899999999999999999999998654


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                       ..++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence             5689999999999999998754 59999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ....  .....+++.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..++++
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  242 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-LPKPDLCPPV  242 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-CCCCTTCCHH
T ss_pred             cccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-CCCCCCCCHH
Confidence            4332  22344788999999997655 8999999999999999998 9999987666555555544433 3456789999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||.+||+.||++|||+.|++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-45  Score=350.30  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=215.0

Q ss_pred             CCCeeeee-eecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGR-LLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~-~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||+|+++..    ......+.+.+|+.++++++||||+++++++. .+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence            45677776 9999999999999864  46788999998642    34556678999999999999999999999984 55


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            689999999999999999754 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ....    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||...........+..... +.++..++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~  240 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPP  240 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CCCCTTCCH
T ss_pred             CcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-CCCCCCcCH
Confidence            3322    2234688999999997555 8999999999999999998 9999988777666666555443 466788999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEHPF  412 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~hp~  412 (444)
                      ++.+||.+||+.||++||++.+++++.+
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999998743

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-45  Score=369.16  Aligned_cols=255  Identities=20%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEEeecccccccH-H-----HHHHHHHHHHHHHccCCCCeee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES-----GEMCAMKEVTLFSDDAKSK-E-----SAQQLGQEIALLSRLRHPNIVR  221 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~-----g~~vaiK~i~~~~~~~~~~-~-----~~~~~~~Ei~~l~~l~hpnIv~  221 (444)
                      ...+|++.+.||+|+||.||+|.+..+     ++.||||++.........+ .     ....+.+|+..++.++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999998764     5889999886432111000 0     1123445667788889999999


Q ss_pred             EeeeEEcC----CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC--CCC
Q 013354          222 YYGSETLD----DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSG  294 (444)
Q Consensus       222 l~~~~~~~----~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~  294 (444)
                      +++++...    ...++||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    5589999999 99999999876 5799999999999999999999999999999999999998  889


Q ss_pred             cEEEEeccccccccCCCCc--------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh
Q 013354          295 RVKLADFGMAKHITGQSCP--------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM  366 (444)
Q Consensus       295 ~vkL~DFGla~~~~~~~~~--------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~  366 (444)
                      .+||+|||+++.+......        ....||+.|+|||++.+.. ++.++|||||||+||||++|+.||.........
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999765433211        2345999999999997766 899999999999999999999999853332221


Q ss_pred             HHhcC---CCCCC------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          367 FKIGN---SKELP------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       367 ~~~~~---~~~~~------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .....   ....+      .....++.++.+||..||+.||++||++.+|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11100   00000      012567999999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=366.32  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=201.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEEeecccccccHH------HHHHHHHHHHHHHccCCCCeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSE---SGEMCAMKEVTLFSDDAKSKE------SAQQLGQEIALLSRLRHPNIVRY  222 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~---~g~~vaiK~i~~~~~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l  222 (444)
                      ....+|++.+.||+|+||.||+|++..   ++..+|+|++.........+.      ....+.+|+..++.++|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345789999999999999999999987   788999998874322111110      11346688999999999999999


Q ss_pred             eeeEEc----CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC--cE
Q 013354          223 YGSETL----DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG--RV  296 (444)
Q Consensus       223 ~~~~~~----~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~v  296 (444)
                      ++++..    ....++||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999887    78899999999 999999998877899999999999999999999999999999999999998877  99


Q ss_pred             EEEeccccccccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hH
Q 013354          297 KLADFGMAKHITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MF  367 (444)
Q Consensus       297 kL~DFGla~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~  367 (444)
                      ||+|||+++.+.....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ..
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999986643221        13456999999999998765 89999999999999999999999964322211 11


Q ss_pred             HhcCCCCCCCCC---------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          368 KIGNSKELPAIP---------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       368 ~~~~~~~~~~~~---------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .... .....++         ..++.++++||.+||+.||++|||+++|++.
T Consensus       272 ~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKT-NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHH-HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHH-hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            1110 0001112         2789999999999999999999999998763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=347.74  Aligned_cols=249  Identities=25%  Similarity=0.443  Sum_probs=208.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      .|+..++||+|+||+||+|++..+++   .||+|++..    .......+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            57888999999999999999765554   799998753    23445667889999999999999999999999876554


Q ss_pred             -EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 -YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 -~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                       ++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             9999999999999999873 46899999999999999999999999999999999999999999999999999765432


Q ss_pred             C-----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          311 S-----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       311 ~-----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      .     ......+++.|+|||++.+.. ++.++|||||||++|+|++ +.+||...+.......+..... ...+..+++
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  255 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LPQPEYCPD  255 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CCCCTTCCH
T ss_pred             cccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CCCCccchH
Confidence            2     223345788999999997665 8999999999999999999 4555555554444444444333 456778999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.+||.+||+.||++|||+.++++.
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999988763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.1e-46  Score=363.50  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=207.9

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .....+|++.+.||+|+||.||+|++. +++.||+|++...     .....+.+.+|+.+++.++||||+++++++...+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            345578999999999999999999865 6899999987532     2234567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG----QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      ..++||||+.+++|.+++....    .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999999987543    489999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH-------HhcC-----
Q 013354          307 ITGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF-------KIGN-----  371 (444)
Q Consensus       307 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-------~~~~-----  371 (444)
                      .....   ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........       ....     
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             cccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            54322   123345899999999997665 8999999999999999999999997543322110       0000     


Q ss_pred             ---CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCC
Q 013354          372 ---SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP  411 (444)
Q Consensus       372 ---~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp  411 (444)
                         ......++..++.++.+||.+||+.||++|||+.|++++-
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence               1111122334567899999999999999999999999763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-45  Score=351.23  Aligned_cols=246  Identities=25%  Similarity=0.436  Sum_probs=211.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----  228 (444)
                      +.+|++.+.||+|+||.||+|++..+++.||+|++....         +.+.+|+.+++.++||||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            357999999999999999999999999999999987421         245689999999999999999998754     


Q ss_pred             -----------CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc
Q 013354          229 -----------DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR  295 (444)
Q Consensus       229 -----------~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  295 (444)
                                 ...+++||||+.+++|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence                       45589999999999999999764  56999999999999999999999999999999999999999999


Q ss_pred             EEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC
Q 013354          296 VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL  375 (444)
Q Consensus       296 vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~  375 (444)
                      +||+|||++.............|++.|+|||++.+.. ++.++||||||+++|||++|..||...  ......+..    
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----  233 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD----  233 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----
Confidence            9999999998876655555667999999999997665 899999999999999999999887431  112222222    


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ..++..++.++++||.+||+.||++|||+.|++++.|.-.
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1345678999999999999999999999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.2e-45  Score=350.71  Aligned_cols=252  Identities=27%  Similarity=0.498  Sum_probs=200.6

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .....+|++.+.||+|+||+||+|++.   ..||+|+++..   .......+.+.+|+.++++++|+||+++++++ ...
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEecc---CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            455678999999999999999999754   35999988643   23455667899999999999999999999965 456


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            689999999999999999643 4699999999999999999999999999999999999999999999999999976543


Q ss_pred             C---CCcccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc-CC---CCCCCCCC
Q 013354          310 Q---SCPLSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG-NS---KELPAIPD  380 (444)
Q Consensus       310 ~---~~~~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~~---~~~~~~~~  380 (444)
                      .   .......||+.|+|||++.  ....++.++|||||||++|||++|+.||............. ..   .....+..
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS  252 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence            2   2223456899999999986  23347899999999999999999999998766654443322 22   22234456


Q ss_pred             CCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          381 HLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       381 ~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+++++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          253 NCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            78999999999999999999999999886

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-44  Score=348.64  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE-cCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET-LDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~  230 (444)
                      .+|++.+.||+|+||+||+|++..++   ..+|+|.+..    .......+.+.+|+.++++++||||+++++++. .++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            47999999999999999999975433   3588887753    234556678999999999999999999999854 456


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            789999999999999999864 4589999999999999999999999999999999999999999999999999986644


Q ss_pred             CCC-----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          310 QSC-----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       310 ~~~-----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ...     .....+|+.|+|||++.+.. ++.++||||||+++|||++ +.+||...........+..... ...+..++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  258 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCP  258 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-CCCCTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-CCCCccCC
Confidence            321     22344778999999997665 8999999999999999999 6777877666555555544433 35577899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .++.+||.+||+.||++|||+.|+++
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999886

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=354.86  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=206.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE----c
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET----L  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~  228 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++..     ......+.+.+|+.+++.++||||+++++++.    .
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            45689999999999999999999999999999998864     33455678899999999999999999999886    3


Q ss_pred             CCEEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      ....++||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            4578999999999999999986    356999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCCC----------cccccCCCcccCcccccCcC--CCChhhhHHHHHHHHHHHHcCCCCCCCCC--ChhhhHHhc
Q 013354          305 KHITGQSC----------PLSIKGSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEMATTKPPWSQYE--GVPAMFKIG  370 (444)
Q Consensus       305 ~~~~~~~~----------~~~~~gt~~y~APE~~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~  370 (444)
                      ........          .....||+.|+|||++....  .++.++|||||||++|||++|+.||....  .......+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            75432111          01234799999999986443  26889999999999999999999995311  111122222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          371 NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       371 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .... ...+..++.++.+||.+||+.||++|||+.+++++
T Consensus       262 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 NQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2222 23346789999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=371.03  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=208.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ...+|++.++||+|+||+||+|++..+++.||||++.....    ....+.+.+|+.++++++||||+++++++....  
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            35689999999999999999999999999999999864221    122456778999999999999999999988754  


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE----CCCCcEEEEeccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQ---LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV----DPSGRVKLADFGM  303 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~vkL~DFGl  303 (444)
                      ..++||||+.+++|.+++.+...   +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999999976433   9999999999999999999999999999999999999    7777899999999


Q ss_pred             cccccCCCCcccccCCCcccCcccccCc-------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC----hhhhHHhcCC
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKNS-------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG----VPAMFKIGNS  372 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~  372 (444)
                      ++............||+.|+|||++...       ..++.++|||||||++|||++|+.||.....    ...+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            9887666655667799999999998641       2378899999999999999999999975332    2223332222


Q ss_pred             CCC-----------------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          373 KEL-----------------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       373 ~~~-----------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ...                       ..+...++..+.+||++||+.||++||++.|+++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            110                       1122345678899999999999999999998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=355.51  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=190.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEE----
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSET----  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~----  227 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++..     ......+.+.+|+.++.++. ||||+++++++.    
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC-----CchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            34589999999999999999999999999999998853     34455678889999999996 999999999984    


Q ss_pred             ----cCCEEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEECCCCcEEE
Q 013354          228 ----LDDKLYIYLEYVSGGSIYKILQD---YGQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVDPSGRVKL  298 (444)
Q Consensus       228 ----~~~~~~lv~e~~~ggsL~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~vkL  298 (444)
                          ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                3456899999995 799998865   456999999999999999999999999  999999999999999999999


Q ss_pred             EeccccccccCCCCc-------------ccccCCCcccCccccc--CcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh
Q 013354          299 ADFGMAKHITGQSCP-------------LSIKGSPYWMAPEVIK--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV  363 (444)
Q Consensus       299 ~DFGla~~~~~~~~~-------------~~~~gt~~y~APE~~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~  363 (444)
                      +|||+++........             ....||+.|+|||++.  ....++.++|||||||++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221             1345899999999983  2333789999999999999999999999764433


Q ss_pred             hhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCC
Q 013354          364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHP  411 (444)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp  411 (444)
                      ....    .......+..++.++.+||++||+.||++|||+.|++++-
T Consensus       260 ~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          260 RIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             Hhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            2221    1122233566788899999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.5e-44  Score=383.41  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=208.8

Q ss_pred             eee-eeeecccCceEEEEEEE--cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          157 WKK-GRLLGRGTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       157 ~~~-~~~LG~G~fg~Vy~a~~--~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      +.+ .+.||+|+||.||+|.+  +.+++.||||+++..   .......+.+.+|+.+|++++|||||++++++.. +.++
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  445 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM  445 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence            444 34799999999999965  456789999988642   2233345778999999999999999999999875 4588


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +||||+.+++|.+++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999876543321


Q ss_pred             ----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          314 ----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       314 ----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                          ....+|+.|+|||++.+.. ++.++|||||||+||||++ |+.||...........+..... ...+..++.++.+
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~  603 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGCPREMYD  603 (635)
T ss_dssp             ---------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHH
Confidence                2234678899999997655 8999999999999999998 9999998777666666665554 3667889999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ||.+||+.||++||++.+|++
T Consensus       604 li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.9e-45  Score=350.05  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=207.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcC-CCc--EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSE-SGE--MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ....+|++.+.||+|+||+||+|++.. +++  .||+|+++...  .......+.+.+|+.++++++||||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            345689999999999999999998643 333  68999876321  1233456788999999999999999999999887


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .. .++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            65 88999999999999999874 46999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCC
Q 013354          308 TGQSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       308 ~~~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  382 (444)
                      ......    ....++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+.........+..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC  250 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence            544321    2334778899999997655 8999999999999999999 999998877666666665555555667789


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.++.+||.+||+.||++|||+.+++++
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-44  Score=345.36  Aligned_cols=248  Identities=29%  Similarity=0.495  Sum_probs=210.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++....   .   ..+.+.+|+.+++.++||||+++++++.. +.
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---M---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---c---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            34578999999999999999999876 47789999886321   1   23568899999999999999999998764 45


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .++||||+.+++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999997543  699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...  .....++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+..... ...+..++.++
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  239 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-MVRPDNCPEEL  239 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHH
T ss_pred             cccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-CCCcccccHHH
Confidence            322  12334678899999997655 8999999999999999999 9999987666555555544433 35677899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHh
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+||.+||+.||++|||+.++++
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccChhhCCCHHHHHH
Confidence            99999999999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-44  Score=369.87  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=212.7

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...++|++.+.||+|+||.||+|.+.. +..||||+++...   .   ..+.+.+|+.+|++++||||+++++++.. +.
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---M---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---C---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            445789999999999999999999875 5679999886321   1   13568899999999999999999999876 66


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      +++||||+.+++|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            89999999999999999753  4699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          310 QSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       310 ~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ...  .....++..|+|||++.... ++.++|||||||+||||++ |+.||......+....+...... ..+..++.++
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l  410 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPESL  410 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCTTSCHHH
T ss_pred             CceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence            321  12334678899999997665 8999999999999999999 99999887766666666655443 4677899999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhC--CCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEH--PFVGNAA  417 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~h--p~~~~~~  417 (444)
                      .+||.+||+.||++|||+++|++.  .++....
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            999999999999999999998874  6665543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-45  Score=360.46  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ....+|++.+.||+|+||.||+|++. +++.||+|++.....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC----chHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            45578999999999999999999754 589999998864221    1122357899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCceEECCCCcEEEEecccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG----QLGESAIRSYTQQILSGLEYLHAK---NTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                      .++||||+.+++|.+++....    .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            999999999999999998753    389999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCC-----CCChhhhHHh---cCCC-
Q 013354          305 KHITGQSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQ-----YEGVPAMFKI---GNSK-  373 (444)
Q Consensus       305 ~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~-----~~~~~~~~~~---~~~~-  373 (444)
                      ........  .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..     .........+   .... 
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            87643332  23345999999999997665 89999999999999999999999952     1111111111   0111 


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          374 --------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       374 --------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                              .....+...+.++.+||.+||+.||++|||+.|+++|-+-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                    1112223345789999999999999999999999998653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=363.09  Aligned_cols=250  Identities=23%  Similarity=0.395  Sum_probs=201.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-CC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-DD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~  230 (444)
                      ..|++.+.||+|+||+||+|++..++   ..||+|.++.    .......+.+.+|+.++++++||||+++++++.. ++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS----CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            36889999999999999999876433   4578887753    2233456789999999999999999999998654 56


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++||||+.+++|.+++++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            7899999999999999998653 589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCC-----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCC
Q 013354          310 QSC-----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       310 ~~~-----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  383 (444)
                      ...     .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||...........+..... ...+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-CCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-CCCCCCCC
Confidence            321     12334678899999997665 8999999999999999999 7888987666555555554443 35577899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++|||+.|++++
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-44  Score=345.49  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=203.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC-CE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD-DK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~  231 (444)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|+++..       ...+.+.+|+.++++++|+||+++++++... +.
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            4568999999999999999999874  889999987531       1346788999999999999999999987554 47


Q ss_pred             EEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .++||||+.+++|.+++.+...  +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999987543  89999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          310 QSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       310 ~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....+++.|+|||++.+.. ++.++||||||+++|||++ |+.||...........+.... ....+..++.++.+
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  245 (278)
T 1byg_A          170 TQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYE  245 (278)
T ss_dssp             --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCCCCTTCCHHHHH
T ss_pred             cc--cCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCcccCCHHHHH
Confidence            32  2335788999999997655 8999999999999999998 999998776655555554443 34567889999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ||++||+.||++|||+.|+++
T Consensus       246 li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          246 VMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-44  Score=346.16  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=201.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeee-EEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGS-ETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~-~~~~~~  231 (444)
                      .+++|++.+.||+|+||.||+|++..+++.||+|++....       ..+.+.+|+.+++.++|++++..+.. +...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-------cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            4578999999999999999999999999999999865321       22357789999999998876666655 466788


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~  307 (444)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999999 9999999985 3569999999999999999999999999999999999999   78889999999999876


Q ss_pred             cCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh---hhHHhcC---CC
Q 013354          308 TGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGN---SK  373 (444)
Q Consensus       308 ~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~---~~  373 (444)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......   .+..+..   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            54322        22456899999999998766 8999999999999999999999997644321   2221111   11


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..+.....+++++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            111233567999999999999999999999998876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.7e-44  Score=348.40  Aligned_cols=246  Identities=29%  Similarity=0.438  Sum_probs=196.5

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc--cCCCCeeeEeeeEEc--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR--LRHPNIVRYYGSETL--  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~--  228 (444)
                      ..++|++.+.||+|+||+||+|++  +++.||||++..     .   ....+.+|.+++..  ++||||+++++++..  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----R---DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----G---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----c---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            456899999999999999999987  589999998853     1   12334455666555  899999999998654  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCceEECCCCcEEE
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH--------AKNTVHRDIKGANILVDPSGRVKL  298 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~NIll~~~~~vkL  298 (444)
                        ...+++||||+.+++|.++++. ..+++..++.++.||+.||+|||        +++|+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999965 57999999999999999999999        999999999999999999999999


Q ss_pred             EeccccccccCCCCc-----ccccCCCcccCcccccCcC-----CCChhhhHHHHHHHHHHHHcC----------CCCCC
Q 013354          299 ADFGMAKHITGQSCP-----LSIKGSPYWMAPEVIKNSN-----GCNLAVDIWSLGCTVIEMATT----------KPPWS  358 (444)
Q Consensus       299 ~DFGla~~~~~~~~~-----~~~~gt~~y~APE~~~~~~-----~~s~~sDvwSlGvil~elltG----------~~Pf~  358 (444)
                      +|||+++........     ....||+.|+|||++.+..     .++.++|||||||++|||++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999766443322     2346999999999997653     245799999999999999999          88886


Q ss_pred             CCCCh----hhhHH-hcCCCCCCCCC-----CCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          359 QYEGV----PAMFK-IGNSKELPAIP-----DHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       359 ~~~~~----~~~~~-~~~~~~~~~~~-----~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .....    ..... .......+.++     ..++.++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            53321    22222 22222223333     235678999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-43  Score=343.19  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeee-EEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGS-ETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~-~~~~~~  231 (444)
                      .+++|++.+.||+|+||.||+|++..+++.||+|++.....       .+.+.+|+.+++.++|++++..+.. +.....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-------hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            35789999999999999999999999999999998864221       1357789999999998876665554 466788


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC---CCCcEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~  307 (444)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 9999999984 35699999999999999999999999999999999999994   7889999999999876


Q ss_pred             cCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---hhhHHhcC---CC
Q 013354          308 TGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---PAMFKIGN---SK  373 (444)
Q Consensus       308 ~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~---~~  373 (444)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......   ..+..+..   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            55432        23456999999999998766 899999999999999999999999864322   22222111   11


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ..+.+...+++++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111234678999999999999999999999998776

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=377.56  Aligned_cols=255  Identities=27%  Similarity=0.464  Sum_probs=216.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++...   .   ..+.+.+|+.+|++++|+||+++++++.. +.+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---M---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---C---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            34679999999999999999999875 5679999986421   1   13568899999999999999999999876 668


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++||||+.+++|.++++..  ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999999753  46999999999999999999999999999999999999999999999999999876432


Q ss_pred             C--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 S--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .  ......++..|+|||++.... ++.++|||||||+||||++ |+.||......+....+.....+ ..+..++.++.
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~  494 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPESLH  494 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred             ceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence            1  112334678899999997665 8999999999999999999 99999887766666666655444 45778999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhC--CCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEH--PFVGNAA  417 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~h--p~~~~~~  417 (444)
                      +||.+||+.||++|||+++|++.  .+|....
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            99999999999999999998875  6665543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.4e-44  Score=351.83  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=206.1

Q ss_pred             CeeeeeeecccCceEEEEEEE----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--C
Q 013354          156 RWKKGRLLGRGTFGHVYLGFN----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--D  229 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~  229 (444)
                      .|++.+.||+|+||+||++.+    ..+++.||||+++..    ......+.+.+|+.++++++||||+++++++..  .
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            349999999999999988754    457899999998632    334556789999999999999999999999987  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..+++||||+.+++|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            6899999999999999999764 699999999999999999999999999999999999999999999999999987755


Q ss_pred             CCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCCh--------------hhhHHhcC
Q 013354          310 QSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGV--------------PAMFKIGN  371 (444)
Q Consensus       310 ~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--------------~~~~~~~~  371 (444)
                      ...    .....++..|+|||++.+.. ++.++|||||||++|||++|..||......              ........
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            432    22345788899999997665 889999999999999999999998642211              01111222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .......+..++.++.+||++||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            23334567889999999999999999999999999885

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=347.61  Aligned_cols=243  Identities=30%  Similarity=0.522  Sum_probs=198.8

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||.||+|++.  ++.||+|++..       ....+.+.+|+.++++++||||+++++++.+  ..
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            4468999999999999999999875  78999998742       1234678899999999999999999998764  47


Q ss_pred             EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCCCceEECCCCc-EEEEeccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHA---KNTVHRDIKGANILVDPSGR-VKLADFGMAK  305 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~-vkL~DFGla~  305 (444)
                      ++||||+++++|.+++....   .+++..++.++.||+.||+|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998754   37899999999999999999999   89999999999999988876 7999999997


Q ss_pred             cccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh--hhHHhcCCCCCCCCCCCCC
Q 013354          306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP--AMFKIGNSKELPAIPDHLS  383 (444)
Q Consensus       306 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~s  383 (444)
                      ......  ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......  ....+.. ...+..+..++
T Consensus       155 ~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  230 (307)
T 2eva_A          155 DIQTHM--TNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLP  230 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCC
T ss_pred             cccccc--ccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccC
Confidence            654322  2345899999999997665 8999999999999999999999997654332  2222222 23345677899


Q ss_pred             HHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          384 DEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .++.+||.+||+.||++|||+.+++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999998873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=356.41  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=201.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC--------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeee---
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE--------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVR---  221 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~---  221 (444)
                      .+.+|++.+.||+|+||.||+|++..        +++.||+|++...          +.+.+|+.++++++||||++   
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhh
Confidence            35789999999999999999999987        4889999988631          35778999999999999887   


Q ss_pred             ------------EeeeEEc-CCEEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 013354          222 ------------YYGSETL-DDKLYIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGA  286 (444)
Q Consensus       222 ------------l~~~~~~-~~~~~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  286 (444)
                                  +++++.. +...++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                        5666665 78899999999 99999999985  67999999999999999999999999999999999


Q ss_pred             ceEECCCC--cEEEEeccccccccCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCC
Q 013354          287 NILVDPSG--RVKLADFGMAKHITGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP  356 (444)
Q Consensus       287 NIll~~~~--~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~P  356 (444)
                      |||++.++  .+||+|||+++.+.....        .....||+.|+|||++.+.. ++.++|||||||+||||++|+.|
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            99999988  899999999986543221        12346999999999997765 89999999999999999999999


Q ss_pred             CCCCC-ChhhhHHhcC--CCCCCCCC------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          357 WSQYE-GVPAMFKIGN--SKELPAIP------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       357 f~~~~-~~~~~~~~~~--~~~~~~~~------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      |.... ..........  ......+.      ..++.++.+||.+||+.||++|||+++|++.
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            97654 2222211110  01111111      2569999999999999999999999988663

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.9e-44  Score=350.25  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=195.4

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc---
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL---  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---  228 (444)
                      ...++|++.+.||+|+||.||+|++  +++.||||++...     .. .......|+..+..++|+||+++++.+..   
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----ch-hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            4457899999999999999999976  5899999998631     11 11122234444556899999999985432   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccCCCCCCceEECCCCcEE
Q 013354          229 --DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK---------NTVHRDIKGANILVDPSGRVK  297 (444)
Q Consensus       229 --~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~NIll~~~~~vk  297 (444)
                        ...+++||||+++++|.+++.. ...++..++.++.||+.||.|||++         +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence              3367899999999999999977 4569999999999999999999999         999999999999999999999


Q ss_pred             EEeccccccccCCC---------CcccccCCCcccCcccccCc------CCCChhhhHHHHHHHHHHHHcCCCCCCCCCC
Q 013354          298 LADFGMAKHITGQS---------CPLSIKGSPYWMAPEVIKNS------NGCNLAVDIWSLGCTVIEMATTKPPWSQYEG  362 (444)
Q Consensus       298 L~DFGla~~~~~~~---------~~~~~~gt~~y~APE~~~~~------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  362 (444)
                      |+|||+++.+....         ......||+.|+|||++.+.      ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764322         12244699999999998762      2366799999999999999999776643221


Q ss_pred             hh-----------------hh-HHhcCCCCCCCCCCC------CCHHHHHHHHHHhhhCCCCCcCHHHH------HhCCC
Q 013354          363 VP-----------------AM-FKIGNSKELPAIPDH------LSDEGKDFVRKCLQRNPLHRPTAAWL------LEHPF  412 (444)
Q Consensus       363 ~~-----------------~~-~~~~~~~~~~~~~~~------~s~~l~~Li~~~L~~dP~~Rpt~~el------L~hp~  412 (444)
                      ..                 .. .........+.++..      +++++.+||.+||+.||++|||+.|+      +.++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            11                 00 111122223344443      34589999999999999999999998      55788


Q ss_pred             CCCCC
Q 013354          413 VGNAA  417 (444)
Q Consensus       413 ~~~~~  417 (444)
                      -++..
T Consensus       321 ~~~~~  325 (336)
T 3g2f_A          321 ERNKS  325 (336)
T ss_dssp             CC---
T ss_pred             Hhccc
Confidence            77653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-43  Score=343.43  Aligned_cols=231  Identities=28%  Similarity=0.464  Sum_probs=190.4

Q ss_pred             CCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHH-HccCCCCeeeEeeeEEc----
Q 013354          155 SRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALL-SRLRHPNIVRYYGSETL----  228 (444)
Q Consensus       155 ~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~----  228 (444)
                      .+|.+. ++||+|+||.||+|.++.+++.||+|++..      .    ..+.+|+.++ +.++||||+++++++..    
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------c----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            467777 889999999999999999999999998852      1    2456788877 66699999999999876    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGM  303 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGl  303 (444)
                      +..+++||||+.+++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            678999999999999999998864  5999999999999999999999999999999999999988   78899999998


Q ss_pred             cccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCC--
Q 013354          304 AKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIP--  379 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~--  379 (444)
                      +.....                      ..++.++|||||||++|||++|+.||..................  ..++  
T Consensus       167 a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          167 AKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             CEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            865431                      22688999999999999999999999765443322211111111  1222  


Q ss_pred             --CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          380 --DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       380 --~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                        ..++.++++||.+||+.||++|||+.|+|+||||++..
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              56899999999999999999999999999999998754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=364.97  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=196.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|...++||+|+||+||. ....+++.||||++.....        ..+.+|+.+|+.+ +||||+++++++.....
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            345799999999999999764 3456799999998853211        1245799999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-----CCcEEEEeccccc
Q 013354          232 LYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-----SGRVKLADFGMAK  305 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----~~~vkL~DFGla~  305 (444)
                      .|+||||+. ++|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.     ...+||+|||+++
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            999999995 69999998753 3566677899999999999999999999999999999953     2358899999998


Q ss_pred             cccCCC----CcccccCCCcccCcccccC--cCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCC-
Q 013354          306 HITGQS----CPLSIKGSPYWMAPEVIKN--SNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPA-  377 (444)
Q Consensus       306 ~~~~~~----~~~~~~gt~~y~APE~~~~--~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~-  377 (444)
                      ......    ......||+.|+|||++.+  ...++.++|||||||++|||++ |..||...........+.. ..... 
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~  250 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA-CSLDCL  250 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC-CCCTTS
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc-CCcccc
Confidence            765432    2234569999999999974  2347889999999999999999 9999965443332222221 11111 


Q ss_pred             -CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          378 -IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       378 -~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                       .....+..+++||.+||+.||++|||++|+++||||.+
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence             12334667899999999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-43  Score=361.42  Aligned_cols=253  Identities=30%  Similarity=0.447  Sum_probs=195.5

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCC
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDD  230 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  230 (444)
                      .....|...++||+|+||+||.+ ...+|+.||||++...        ..+.+.+|+.+++++ +||||+++++++..++
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34567888899999999999875 4567999999988631        124567899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC----------
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQL-------GESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS----------  293 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l-------~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----------  293 (444)
                      .+++||||+. ++|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999995 6999999875432       233457899999999999999999999999999999654          


Q ss_pred             ---CcEEEEeccccccccCCCC-----cccccCCCcccCcccccC------cCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 013354          294 ---GRVKLADFGMAKHITGQSC-----PLSIKGSPYWMAPEVIKN------SNGCNLAVDIWSLGCTVIEMAT-TKPPWS  358 (444)
Q Consensus       294 ---~~vkL~DFGla~~~~~~~~-----~~~~~gt~~y~APE~~~~------~~~~s~~sDvwSlGvil~ellt-G~~Pf~  358 (444)
                         +.+||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4799999999987654332     123469999999999865      2348899999999999999999 999997


Q ss_pred             CCCChhhhHHhcCCCCCCCC----CCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          359 QYEGVPAMFKIGNSKELPAI----PDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~----~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ....... ..+......+..    +..++.++++||.+||+.||++|||+.++++||||.+
T Consensus       242 ~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          242 DKYSRES-NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             STTTHHH-HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CchhhHH-HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            6443321 111111111111    1234688999999999999999999999999999974

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-43  Score=346.43  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=194.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc--cCCCCeeeEeeeEEcC--
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR--LRHPNIVRYYGSETLD--  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~--  229 (444)
                      .++|++.+.||+|+||.||+|+++  ++.||||++..     . ..  ....+|.+++..  ++|+||+++++++...  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~-~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----T-EE--ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----G-GH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----c-cc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            458999999999999999999875  89999998852     1 11  233344555544  4899999999998877  


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccCCCCCCceEECCCCcEEEE
Q 013354          230 --DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK--------NTVHRDIKGANILVDPSGRVKLA  299 (444)
Q Consensus       230 --~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~~~~vkL~  299 (444)
                        ..+++||||+.+++|.++++. ..+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              789999999999999999976 4799999999999999999999999        99999999999999999999999


Q ss_pred             eccccccccCCCCc-----ccccCCCcccCcccccCcCCCCh------hhhHHHHHHHHHHHHcC----------CCCCC
Q 013354          300 DFGMAKHITGQSCP-----LSIKGSPYWMAPEVIKNSNGCNL------AVDIWSLGCTVIEMATT----------KPPWS  358 (444)
Q Consensus       300 DFGla~~~~~~~~~-----~~~~gt~~y~APE~~~~~~~~s~------~sDvwSlGvil~elltG----------~~Pf~  358 (444)
                      |||++..+......     ....||+.|+|||++.+.. ...      ++|||||||++|||++|          ..||.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999766443322     2456999999999997654 333      49999999999999999          67775


Q ss_pred             CCCCh----hhhHH-hcCCCCCCCCCC-----CCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          359 QYEGV----PAMFK-IGNSKELPAIPD-----HLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       359 ~~~~~----~~~~~-~~~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .....    ..... +......+.++.     .+++++.+||.+||+.||++|||+.|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            53221    11221 222222233332     466789999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=352.59  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             CCCCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          151 TSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       151 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ....++|++.+.||+|+||.||+|++..   .+|+|+++.....   ....+.+.+|+.++++++|+||+++++++...+
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN---EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC---CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC---HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3456789999999999999999998854   4999988753221   122345678999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+++||||+.+++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            9999999999999999998754 699999999999999999999999999999999999998 67899999999875432


Q ss_pred             C------CCcccccCCCcccCcccccC--------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC
Q 013354          310 Q------SCPLSIKGSPYWMAPEVIKN--------SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL  375 (444)
Q Consensus       310 ~------~~~~~~~gt~~y~APE~~~~--------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~  375 (444)
                      .      .......|++.|+|||++..        ...++.++|||||||++|||++|+.||...........+......
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence            1      12223458999999999864        234789999999999999999999999877666555555555444


Q ss_pred             CCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       376 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ...+..++.++.+||.+||+.||++|||+.++++.
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            44445789999999999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-43  Score=344.83  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=204.8

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... .......+.+.+|+.++++++||||+++++++...+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence            355568999999999999975  588999998864322 22344567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          236 LEYVSGGSIYKILQDY---GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |||+.+++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            9999999999999743   4599999999999999999999999999999999999999999999999999986544322


Q ss_pred             ---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh----cC---------CCCCC
Q 013354          313 ---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI----GN---------SKELP  376 (444)
Q Consensus       313 ---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~---------~~~~~  376 (444)
                         .....||+.|+|||++.+.  ++.++||||||+++|+|++|..||...........+    ..         ....+
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               2234689999999998643  789999999999999999999999765433222111    11         11222


Q ss_pred             CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       377 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..+..++.++.+||.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3344556789999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=347.98  Aligned_cols=250  Identities=30%  Similarity=0.445  Sum_probs=207.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEE----cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFN----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ...+|++.+.||+|+||.||+|++    ..+++.||+|++..     ......+.+.+|+.++++++|+||+++++++..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            456799999999999999999984    56799999998863     233455788999999999999999999998866


Q ss_pred             CC--EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          229 DD--KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       229 ~~--~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      .+  .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            43  689999999999999999875 359999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCC----------Ch------hh
Q 013354          306 HITGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE----------GV------PA  365 (444)
Q Consensus       306 ~~~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~----------~~------~~  365 (444)
                      .......    .....++..|+|||++.+.. ++.++|||||||++|||++|..||....          ..      ..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            7654432    12234677899999997655 8999999999999999999999885321          00      01


Q ss_pred             hHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       366 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ...+.... ....+..++.++.+||++||+.||++|||+.|+++
T Consensus       273 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11122222 23457789999999999999999999999999885

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.9e-43  Score=362.08  Aligned_cols=248  Identities=22%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~  231 (444)
                      .+.+|++.++||+|+||.||+|++..+++.||||++......       +++.+|+.+++.++| ++|..+..++...+.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            356899999999999999999999999999999987643221       246789999999987 566666667778889


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE---CCCCcEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~  307 (444)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||   +.++.+||+|||+++.+
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99999999 9999999986 4579999999999999999999999999999999999999   57889999999999876


Q ss_pred             cCCCCc--------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh---hHHhcC---CC
Q 013354          308 TGQSCP--------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGN---SK  373 (444)
Q Consensus       308 ~~~~~~--------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~---~~  373 (444)
                      ......        ....||+.|+|||++.+.. ++.++|||||||+||||++|+.||........   +..+..   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            544321        2456999999999998766 89999999999999999999999987554322   111111   11


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+...++.++.+||..||+.||++||++.+|++
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            112333678999999999999999999999987654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=352.94  Aligned_cols=243  Identities=18%  Similarity=0.214  Sum_probs=195.9

Q ss_pred             CCCCCeeeeeeecccCceEEEEE-----EEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC---CCCeeeEe
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPNIVRYY  223 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a-----~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~  223 (444)
                      ....+|++.+.||+|+||+||+|     .+..+++.||+|++..     ..   ...+.+|+.++..++   |+||++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~---~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----AN---PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            34578999999999999999999     4677899999998863     11   234566777777776   99999999


Q ss_pred             eeEEcCCEEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC------
Q 013354          224 GSETLDDKLYIYLEYVSGGSIYKILQD-----YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP------  292 (444)
Q Consensus       224 ~~~~~~~~~~lv~e~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------  292 (444)
                      +++...+..++||||+.+++|.+++..     ...+++..++.++.||+.||+|||++|||||||||+||||+.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999975     346999999999999999999999999999999999999988      


Q ss_pred             -----CCcEEEEecccccccc---CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh
Q 013354          293 -----SGRVKLADFGMAKHIT---GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP  364 (444)
Q Consensus       293 -----~~~vkL~DFGla~~~~---~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  364 (444)
                           ++.+||+|||+++.+.   .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                 8999999999997543   223334567999999999998766 8999999999999999999999995432211


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .  .+  .......  ..++.+.+++..||+.+|.+|++..+.+.
T Consensus       293 ~--~~--~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          293 C--KP--EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             E--EE--CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             e--ee--chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            1  11  1111111  34788999999999999999965544333

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-44  Score=380.23  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=209.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------  228 (444)
                      .+|++.+.||+|+||.||+|.+..+|+.||||+++.    .......+.+.+|+.++++++||||+++++++..      
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~----~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS----CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            579999999999999999999999999999998763    1344556788999999999999999999998765      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCc---EEEEecc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYG---QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGR---VKLADFG  302 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---vkL~DFG  302 (444)
                      .+..++||||+.+++|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999998754   5899999999999999999999999999999999999987665   9999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH--------------H
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF--------------K  368 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~--------------~  368 (444)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|||++|..||........+.              .
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             cccccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            999876665556677999999999997665 8999999999999999999999996532111100              0


Q ss_pred             hcC-----CC---CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          369 IGN-----SK---ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       369 ~~~-----~~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ...     ..   ....+...++.++.+||.+||..||++|||+.|+++||||+.
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            000     00   011233446789999999999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-42  Score=342.71  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=200.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc--cCCCCeeeEeeeEEcCC--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR--LRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~--  230 (444)
                      .+|++.+.||+|+||.||+|++  +++.||||++..     .   ..+.+.+|++++..  ++||||+++++++....  
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----R---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----G---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----h---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            5799999999999999999987  489999998852     1   12456678888877  78999999999998875  


Q ss_pred             --EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccCCCCCCceEECCCCcEEEEe
Q 013354          231 --KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH--------AKNTVHRDIKGANILVDPSGRVKLAD  300 (444)
Q Consensus       231 --~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~NIll~~~~~vkL~D  300 (444)
                        .+++||||+.+++|.+++.+ ..+++..++.++.||+.||.|||        +++|+||||||+|||++.++.+||+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence              79999999999999999986 57999999999999999999999        89999999999999999999999999


Q ss_pred             ccccccccCCCC-----cccccCCCcccCcccccCcCC-----CChhhhHHHHHHHHHHHHcC----------CCCCCCC
Q 013354          301 FGMAKHITGQSC-----PLSIKGSPYWMAPEVIKNSNG-----CNLAVDIWSLGCTVIEMATT----------KPPWSQY  360 (444)
Q Consensus       301 FGla~~~~~~~~-----~~~~~gt~~y~APE~~~~~~~-----~s~~sDvwSlGvil~elltG----------~~Pf~~~  360 (444)
                      ||++........     .....||+.|+|||++.+...     ++.++|||||||++|||++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999987655432     234569999999999876532     33789999999999999999          7888664


Q ss_pred             CC----hhhh-HHhcCCCCCCCCCC-----CCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          361 EG----VPAM-FKIGNSKELPAIPD-----HLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       361 ~~----~~~~-~~~~~~~~~~~~~~-----~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ..    ...+ ..+......+.++.     .++..+.+||.+||+.||++|||+.|+++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            32    1222 22222223333332     344689999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-42  Score=371.24  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=211.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSES---GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ...+|++.+.||+|+||.||+|++..+   +..||+|.++.    .......+.+.+|+.++++++||||+++++++. +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS----TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            346899999999999999999998654   45788887653    234455678999999999999999999999985 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            56899999999999999998654 58999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQSCP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      .....  ....+++.|+|||++.... ++.++|||||||++|||++ |..||...........+...... .++..++.+
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~  620 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPT  620 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-CCCTTCCHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCccccHH
Confidence            43322  2234678999999997655 8999999999999999997 99999887766666666554443 567889999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.+||.+||+.||++|||+.++++
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-41  Score=329.22  Aligned_cols=226  Identities=15%  Similarity=0.132  Sum_probs=189.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ...+|++.+.||+|+||.||+|++..+++.||||++...  .....+..+.+.+|+.++.+++|+||+++++++..++..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ--GVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTT--CCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcc--cccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            446899999999999999999999999999999988642  223355668899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      |+||||++|++|.+++++  ......+..++.||+.||+|||++||+||||||+|||++.++.+||++++          
T Consensus       107 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999999999964  34666788999999999999999999999999999999999999997543          


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhH---HhcCCCCC--CCCCCCCCHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMF---KIGNSKEL--PAIPDHLSDEGK  387 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~~~~~~~--~~~~~~~s~~l~  387 (444)
                               |++|        ++.++|||||||++|||++|+.||........+.   +.......  ..+...+++++.
T Consensus       175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                     3332        6889999999999999999999998755433221   11111111  123467899999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +||.+||++||++| |+.|+++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999 99998874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-43  Score=356.90  Aligned_cols=250  Identities=17%  Similarity=0.155  Sum_probs=194.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCe--------------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNI--------------  219 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnI--------------  219 (444)
                      ..|+.+++||+|+||+||+|++..+|+.||||++.....  ......+.+.+|+.+++.++| .|+              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            458999999999999999999999999999998863222  222335678899999999977 221              


Q ss_pred             -eeE------eeeEEc-----CCEEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 013354          220 -VRY------YGSETL-----DDKLYIYLEYVSGGSIYKILQDY-------GQLGESAIRSYTQQILSGLEYLHAKNTVH  280 (444)
Q Consensus       220 -v~l------~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  280 (444)
                       +.+      +.++..     ...++++|+++ +++|.++++..       ..+++..++.++.||+.||+|||++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence             111      111111     22467788876 68999998521       23778889999999999999999999999


Q ss_pred             CCCCCCceEECCCCcEEEEeccccccccCCCCcccccCCCcccCccccc---------CcCCCChhhhHHHHHHHHHHHH
Q 013354          281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK---------NSNGCNLAVDIWSLGCTVIEMA  351 (444)
Q Consensus       281 ~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~---------~~~~~s~~sDvwSlGvil~ell  351 (444)
                      |||||+||||+.++.+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999998865433  344567 9999999983         2333889999999999999999


Q ss_pred             cCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          352 TTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       352 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +|+.||...........+..      ....+++++++||.+||+.||++||++.++++||||++.
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999976554333333322      123578999999999999999999999999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.3e-44  Score=352.95  Aligned_cols=247  Identities=18%  Similarity=0.246  Sum_probs=191.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHccC---------CCCeee
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLR---------HPNIVR  221 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l~---------hpnIv~  221 (444)
                      ..+|++.+.||+|+||+||+|++  +|+.||||++......   .......+.+.+|+.+++.++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            45799999999999999999988  6899999999864321   012223456778888888885         777776


Q ss_pred             EeeeE-----------------Ec-------------CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013354          222 YYGSE-----------------TL-------------DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE  271 (444)
Q Consensus       222 l~~~~-----------------~~-------------~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~  271 (444)
                      +.+++                 ..             .+.+|+||||+.+|++.+.+.+ ..+++..++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            66653                 22             6789999999999976666644 57899999999999999999


Q ss_pred             HHH-HCCcccCCCCCCceEECCCC--------------------cEEEEeccccccccCCCCcccccCCCcccCcccccC
Q 013354          272 YLH-AKNTVHRDIKGANILVDPSG--------------------RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN  330 (444)
Q Consensus       272 ~LH-~~~ivH~Dlkp~NIll~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~  330 (444)
                      ||| ++||+||||||+||||+.++                    .+||+|||+++.....    ...||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999998887                    8999999999877543    3469999999999975


Q ss_pred             cCCCChhhhHHHHHHH-HHHHHcCCCCCCCCCChh-hhHHhcCC-----CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcC
Q 013354          331 SNGCNLAVDIWSLGCT-VIEMATTKPPWSQYEGVP-AMFKIGNS-----KELPAIPDHLSDEGKDFVRKCLQRNPLHRPT  403 (444)
Q Consensus       331 ~~~~s~~sDvwSlGvi-l~elltG~~Pf~~~~~~~-~~~~~~~~-----~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt  403 (444)
                      ..  +.++|||||+++ .++++.|..||....... ....+...     ......+..+++++++||++||++|     |
T Consensus       252 ~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            54  889999998777 778888999985321100 11111111     1111123357899999999999977     9


Q ss_pred             HHHHH-hCCCCC
Q 013354          404 AAWLL-EHPFVG  414 (444)
Q Consensus       404 ~~elL-~hp~~~  414 (444)
                      ++|+| +||||+
T Consensus       325 a~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 ATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHCGGGC
T ss_pred             HHHHHhcCCCcC
Confidence            99999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-41  Score=366.33  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSE-SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  231 (444)
                      ...+|++.+.||+|+||+||+|++.. +++.||||++..    .......+.+.+|+.++++++||||+++++++...+.
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            34689999999999999999999976 789999998753    2334556788899999999999999999999887654


Q ss_pred             -----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          232 -----LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       232 -----~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                           .|+||||+.|++|.+++..  .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++.
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999998765  79999999999999999999999999999999999999875 899999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHH
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|..||.......        ..........+.++
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTYDSY  297 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHCHHH
T ss_pred             cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccCHHH
Confidence            6543   345699999999998654  4899999999999999999999886421100        00000011246789


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      .+||.+||++||++||+..+.+.|+|+.
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999988888874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=8.3e-35  Score=306.86  Aligned_cols=189  Identities=15%  Similarity=0.099  Sum_probs=138.5

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEEeeccc-----ccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEcCCEEEEE
Q 013354          162 LLGRGTFGHVYLGFNSESGEMCAMKEVTLFSD-----DAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       162 ~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~-----~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv  235 (444)
                      .++.|++|.+..++....|+.|++|++.....     ....+...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46788888888888888899999999875321     122344557899999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Ccc
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPL  314 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~~  314 (444)
                      ||||+|++|.++|.+.+.+++.   +|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...... ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            9999999999999998888875   478999999999999999999999999999999999999999998765433 334


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCC
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKP  355 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~  355 (444)
                      +.+||+.|+|||++.+.  +..++|+|++|+++++|.++..
T Consensus       398 t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          398 NLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             CceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence            56799999999999754  5678999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.1e-29  Score=260.58  Aligned_cols=189  Identities=16%  Similarity=0.185  Sum_probs=146.0

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc---cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          158 KKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD---AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       158 ~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~---~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ...++||+|+||.||+|  ...++.+++|........   .......+++.+|+.++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            45678999999999999  345788999986542211   1222335678999999999999999955555556667799


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC--
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC--  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--  312 (444)
                      ||||+++++|.+++.+        ++.++.||+.||+|||++||+||||||+|||++.  .+||+|||+++.......  
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999999876        5689999999999999999999999999999998  999999999998755322  


Q ss_pred             ------cccccCCCcccCcccccCc-CCCChhhhHHHHHHHHHHHHcCCCCCC
Q 013354          313 ------PLSIKGSPYWMAPEVIKNS-NGCNLAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       313 ------~~~~~gt~~y~APE~~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~  358 (444)
                            .....||+.|+|||++... ..|+..+|+|+..+-.++.+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  1245699999999999751 237788999999998888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.7e-25  Score=215.58  Aligned_cols=150  Identities=17%  Similarity=0.229  Sum_probs=118.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc----cH---------HHHHHHHHHHHHHHccCCCCeee
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK----SK---------ESAQQLGQEIALLSRLRHPNIVR  221 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~----~~---------~~~~~~~~Ei~~l~~l~hpnIv~  221 (444)
                      ..|.+++.||+|+||.||+|.+ .+|+.||+|+++.......    ..         .....+.+|+.+|++++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3455669999999999999999 7899999999864221100    00         24567889999999998  4 66


Q ss_pred             EeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEec
Q 013354          222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADF  301 (444)
Q Consensus       222 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DF  301 (444)
                      +.+++.. +..++||||++|++|.+ +.    .  .....++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            6665544 44699999999999988 42    1  23557999999999999999999999999999999 999999999


Q ss_pred             cccccccCCCCcccccCCCcccCccccc
Q 013354          302 GMAKHITGQSCPLSIKGSPYWMAPEVIK  329 (444)
Q Consensus       302 Gla~~~~~~~~~~~~~gt~~y~APE~~~  329 (444)
                      |+++..            ..|+|||++.
T Consensus       237 G~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             TTCEET------------TSTTHHHHHH
T ss_pred             CCCeEC------------CCCCHHHHHH
Confidence            998743            3478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.3e-21  Score=185.88  Aligned_cols=144  Identities=17%  Similarity=0.230  Sum_probs=111.0

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcE--EEEEEEeecccccc-------------------cHHHHHHHHHHHHHHHc
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEM--CAMKEVTLFSDDAK-------------------SKESAQQLGQEIALLSR  213 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~--vaiK~i~~~~~~~~-------------------~~~~~~~~~~Ei~~l~~  213 (444)
                      .-|.+.+.||+|+||.||+|.+..+|+.  ||||+++.......                   .......+.+|+.+|..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3478899999999999999998778999  99998754211100                   11223467889999999


Q ss_pred             cCCCCe--eeEeeeEEcCCEEEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCC
Q 013354          214 LRHPNI--VRYYGSETLDDKLYIYLEYVSG-G----SIYKILQDYGQLGESAIRSYTQQILSGLEYLH-AKNTVHRDIKG  285 (444)
Q Consensus       214 l~hpnI--v~l~~~~~~~~~~~lv~e~~~g-g----sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp  285 (444)
                      +.|++|  +.+++.    ...++||||+.+ |    +|.++...   .++..+..++.||+.+|.||| ++||+||||||
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            988754  344432    246899999942 3    77776533   335567889999999999999 99999999999


Q ss_pred             CceEECCCCcEEEEeccccccc
Q 013354          286 ANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       286 ~NIll~~~~~vkL~DFGla~~~  307 (444)
                      +|||++.  .++|+|||++...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  8999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=3.8e-18  Score=169.84  Aligned_cols=144  Identities=14%  Similarity=0.109  Sum_probs=102.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc------------cccH-HH----HHHHHHHHHHHHccCCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD------------AKSK-ES----AQQLGQEIALLSRLRHP  217 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~------------~~~~-~~----~~~~~~Ei~~l~~l~hp  217 (444)
                      .-|++++.||+|+||.||+|.+. +|+.||||+++.....            .... ..    .....+|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            45899999999999999999875 5999999987632110            0000 11    11123577777777554


Q ss_pred             CeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC---
Q 013354          218 NIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG---  294 (444)
Q Consensus       218 nIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---  294 (444)
                      ++.-..-+....  .+|||||++|.+|.++..      ......++.||+.+|.+||++|||||||||.|||+++++   
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            432211111222  379999999988865432      234567889999999999999999999999999998776   


Q ss_pred             -------cEEEEeccccccc
Q 013354          295 -------RVKLADFGMAKHI  307 (444)
Q Consensus       295 -------~vkL~DFGla~~~  307 (444)
                             .+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999977654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=8.1e-13  Score=124.77  Aligned_cols=138  Identities=13%  Similarity=0.098  Sum_probs=108.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l  234 (444)
                      .|++...++.|+++.||++..  .++.+++|+......     .....+.+|+.+++.+. +..+.++++++...+..|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            588888899999999999864  368899998753110     11235778999999884 6678889999888899999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA---------------------------------------  275 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------  275 (444)
                      ||||++|.+|.+.+.     +......++.+++.+|+.||+                                       
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999987631     122344678899999999998                                       


Q ss_pred             --------------------CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 --------------------KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 --------------------~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                                          ..++|+|+++.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                348999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.7e-11  Score=114.82  Aligned_cols=134  Identities=16%  Similarity=0.102  Sum_probs=96.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC--eeeEeeeEEcCCEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN--IVRYYGSETLDDKLY  233 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~  233 (444)
                      .+.+..+.+.|..+.||++.. .+|+.+++|+....        ....+.+|+.+++.+.+.+  +.+++++....+..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            455544445666799999853 45788999986521        1135677888888885444  566888888778899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN------------------------------------  277 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  277 (444)
                      +||||++|.+|.  .   .....   ..++.+++..|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998884  1   11221   245667777777777643                                    


Q ss_pred             ----------------------cccCCCCCCceEECCCCcEEEEecccccc
Q 013354          278 ----------------------TVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       278 ----------------------ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                                            ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  99999999999998776677999997653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=7.3e-11  Score=116.73  Aligned_cols=140  Identities=14%  Similarity=0.251  Sum_probs=103.7

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEe--ecccccccHHHHHHHHHHHHHHHccC--CCCeeeEeeeEEcC---CE
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVT--LFSDDAKSKESAQQLGQEIALLSRLR--HPNIVRYYGSETLD---DK  231 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~--~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~~  231 (444)
                      ..+.|+.|.++.||+....  +..+++|+..  ..    ........+.+|+.+++.+.  +..+++++.++...   +.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~----~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS----KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC----CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            3567899999999998653  4678888653  11    11122356788999999997  34578888887765   45


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013354          232 LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA------------------------------------  275 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------  275 (444)
                      .|+||||++|..+.+..  ...++......++.+++..|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            88999999988775421  2347788888999999999999997                                    


Q ss_pred             ----------------------CCcccCCCCCCceEECCCCc--EEEEecccccc
Q 013354          276 ----------------------KNTVHRDIKGANILVDPSGR--VKLADFGMAKH  306 (444)
Q Consensus       276 ----------------------~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~  306 (444)
                                            ..++|||+++.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  35899999999999987753  69999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=1.4e-10  Score=112.13  Aligned_cols=180  Identities=17%  Similarity=0.205  Sum_probs=121.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCC--eeeEeeeEEcCC---EEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPN--IVRYYGSETLDD---KLYI  234 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpn--Iv~l~~~~~~~~---~~~l  234 (444)
                      +.++.|....||+.     +..+++|+..       .......+.+|+.+|+.+. +..  +.+++......+   ..|+
T Consensus        26 ~~~~~G~~n~v~~v-----~~~~vlR~~~-------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           26 EISGEGNDCIAYEI-----NRDFIFKFPK-------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CEEEECSSEEEEES-----TTSEEEEEES-------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             EecCCCCcceEEEE-----CCEEEEEecC-------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            55899999999986     2568888753       1234567889999998873 322  344444433332   3488


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA---------------------------------------  275 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------  275 (444)
                      ||++++|.+|.+...  ..++..+...++.+++..|+.||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999999998876443  257788888888899988888886                                       


Q ss_pred             -------------------CCcccCCCCCCceEECC--CCcEEEEeccccccccCCCCccccc-----CCC--------c
Q 013354          276 -------------------KNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQSCPLSIK-----GSP--------Y  321 (444)
Q Consensus       276 -------------------~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~~~~~~~~-----gt~--------~  321 (444)
                                         ..++|+|+++.||+++.  +..+.|+||+.+..-..........     ...        .
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                               13699999999999987  4568899999886532211000000     000        0


Q ss_pred             c--cC-cccccCcCCCChhhhHHHHHHHHHHHHcCCCCC
Q 013354          322 W--MA-PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW  357 (444)
Q Consensus       322 y--~A-PE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf  357 (444)
                      |  .. |+....   .....+.|+++.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1  11 222111   123468999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.72  E-value=1.7e-07  Score=90.50  Aligned_cols=134  Identities=22%  Similarity=0.189  Sum_probs=94.9

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC---CeeeEeeeEE-cCCEEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP---NIVRYYGSET-LDDKLYIY  235 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lv  235 (444)
                      .+.++.|....||+.     +..+++|+..       .......+.+|+.+|+.+.+.   .+.+.+.++. ..+..++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            456888998999987     5678888642       223456788999999999652   3556666654 45667899


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 013354          236 LEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK---------------------------------------  276 (444)
Q Consensus       236 ~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------------------  276 (444)
                      ||+++|.+|.+..-  ..++......++.++...|+.||+.                                       
T Consensus        92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            99999988876422  2345555555555555555555542                                       


Q ss_pred             ---------------------CcccCCCCCCceEECC---CCc-EEEEeccccccc
Q 013354          277 ---------------------NTVHRDIKGANILVDP---SGR-VKLADFGMAKHI  307 (444)
Q Consensus       277 ---------------------~ivH~Dlkp~NIll~~---~~~-vkL~DFGla~~~  307 (444)
                                           .++|+|+++.||+++.   ++. +.|+||+.+..-
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                 3589999999999987   455 589999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=2.3e-07  Score=87.42  Aligned_cols=132  Identities=16%  Similarity=0.199  Sum_probs=95.7

Q ss_pred             ecccCce-EEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEEEEeccC
Q 013354          163 LGRGTFG-HVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYIYLEYVS  240 (444)
Q Consensus       163 LG~G~fg-~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  240 (444)
                      +..|..+ .||+......+..+++|+-..        .....+.+|...|+.+. +--+.+++.++...+..++|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            3445444 699987777778899997541        13456788999998884 3336778888888899999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 013354          241 GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA---------------------------------------------  275 (444)
Q Consensus       241 ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------------  275 (444)
                      |.++.+.....    ......+..++...|..||.                                             
T Consensus       104 G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          104 GKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             SEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             CccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            99888766431    12233455566666666663                                             


Q ss_pred             ------C-------CcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          276 ------K-------NTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       276 ------~-------~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                            .       .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                  0       278999999999999877778999987753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.25  E-value=1.2e-06  Score=87.39  Aligned_cols=81  Identities=16%  Similarity=0.174  Sum_probs=48.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeeccccccc--HHHHHHHHHHHHHHHccCC--C-CeeeEeeeEEcCCEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKS--KESAQQLGQEIALLSRLRH--P-NIVRYYGSETLDDKLYI  234 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h--p-nIv~l~~~~~~~~~~~l  234 (444)
                      .+.||.|.++.||++....+++.+++|...........  .....++..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            46799999999999976656788999976421100000  0112345678888877632  3 34456543  2344579


Q ss_pred             EEeccCCC
Q 013354          235 YLEYVSGG  242 (444)
Q Consensus       235 v~e~~~gg  242 (444)
                      |||++.+.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.17  E-value=2.4e-05  Score=75.72  Aligned_cols=30  Identities=20%  Similarity=0.323  Sum_probs=27.0

Q ss_pred             CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            479999999999999878889999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=1.1e-06  Score=86.29  Aligned_cols=86  Identities=10%  Similarity=0.060  Sum_probs=53.0

Q ss_pred             eeeeeee-cccCceEEEEEEEc--C----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC---CCeeeEeeeE
Q 013354          157 WKKGRLL-GRGTFGHVYLGFNS--E----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---PNIVRYYGSE  226 (444)
Q Consensus       157 ~~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~  226 (444)
                      ....+.| +.|....+|+....  .    +++.+++|+.........  .....+.+|+.+++.+..   -.+.+++.++
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~--~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV--FPTYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS--SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc--CchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            4445778 88989999988653  1    156788886542110000  001345667777777742   3466777766


Q ss_pred             EcC---CEEEEEEeccCCCCH
Q 013354          227 TLD---DKLYIYLEYVSGGSI  244 (444)
Q Consensus       227 ~~~---~~~~lv~e~~~ggsL  244 (444)
                      ...   +..++||||++|..+
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCC
T ss_pred             cCCCccCCceEEEEecCCCCh
Confidence            554   356899999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.95  E-value=0.00012  Score=66.33  Aligned_cols=137  Identities=19%  Similarity=0.116  Sum_probs=93.0

Q ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcccccC
Q 013354          241 GGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG  318 (444)
Q Consensus       241 ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~g  318 (444)
                      ..+|.++|+.++ +++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ ..+.           ..
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~   99 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG   99 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence            347999998764 69999999999999999887632 2212333456889999999988763 1110           02


Q ss_pred             CCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhh--
Q 013354          319 SPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR--  396 (444)
Q Consensus       319 t~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~--  396 (444)
                      ...+.|||...  ...+.+.=|||||++||..+--..|                   +..+..+|+.+..||..|..-  
T Consensus       100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~  158 (229)
T 2yle_A          100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVE  158 (229)
T ss_dssp             -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC
T ss_pred             ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhccc
Confidence            23467898863  2357899999999999999973322                   133456899999999999765  


Q ss_pred             -----------------------CCCCCcCHHHHHhC
Q 013354          397 -----------------------NPLHRPTAAWLLEH  410 (444)
Q Consensus       397 -----------------------dP~~Rpt~~elL~h  410 (444)
                                             .+..|.++++||+.
T Consensus       159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             --------------------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCcCCHHHHHHH
Confidence                                   24577888887763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.77  E-value=8.6e-05  Score=74.62  Aligned_cols=78  Identities=9%  Similarity=-0.063  Sum_probs=48.0

Q ss_pred             HCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCccccc--CCCcccCcccccCcC--CCChhhhHHHHHHHHHHH
Q 013354          275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK--GSPYWMAPEVIKNSN--GCNLAVDIWSLGCTVIEM  350 (444)
Q Consensus       275 ~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~--gt~~y~APE~~~~~~--~~s~~sDvwSlGvil~el  350 (444)
                      ...++|||+++.|||++.++ ++|+||+.+..-..........  -...|++|+......  ......++..+...+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45799999999999998776 9999999886532111000000  113466666543111  112345666788888887


Q ss_pred             HcC
Q 013354          351 ATT  353 (444)
Q Consensus       351 ltG  353 (444)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.62  E-value=8.1e-05  Score=71.15  Aligned_cols=71  Identities=6%  Similarity=-0.023  Sum_probs=42.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEEEEEec
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  238 (444)
                      .+.|+.|....+|+.      +.+++|+.......      .....+|+.+++.+...++ .+++...  .+.-++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence            678999999999998      45888876521111      1122346766666642222 4555433  3334689999


Q ss_pred             c-CCCCH
Q 013354          239 V-SGGSI  244 (444)
Q Consensus       239 ~-~ggsL  244 (444)
                      + .|.+|
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 66544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.55  E-value=0.00078  Score=64.90  Aligned_cols=76  Identities=16%  Similarity=0.141  Sum_probs=58.3

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC---CCCeeeEeeeEEcCCEEEEE
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR---HPNIVRYYGSETLDDKLYIY  235 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv  235 (444)
                      ..+.|+.|.+..+|+...  ++..+++|+...     .   ....+.+|...|+.|.   ...+++++.+....+..++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-----S---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----G---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----c---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            356789999999999853  467888997642     1   1456778888888874   35678888888878889999


Q ss_pred             EeccCCCCH
Q 013354          236 LEYVSGGSI  244 (444)
Q Consensus       236 ~e~~~ggsL  244 (444)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00031  Score=66.61  Aligned_cols=80  Identities=16%  Similarity=0.065  Sum_probs=53.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC---CCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH---PNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~~~  230 (444)
                      +.+....+.+|.|..+.||+... .+|+.|++|+....  ...   ....+..|+..|+.|..   -.+++++.+.  + 
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~-   84 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D-   84 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T-
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--Ccc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C-
Confidence            44567778899999999999975 46899999965321  111   12346779988888842   2344555432  2 


Q ss_pred             EEEEEEeccCCCC
Q 013354          231 KLYIYLEYVSGGS  243 (444)
Q Consensus       231 ~~~lv~e~~~ggs  243 (444)
                       -++||||+.++.
T Consensus        85 -~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 -RTLAMEWVDERP   96 (288)
T ss_dssp             -TEEEEECCCCCC
T ss_pred             -ceEEEEeecccC
Confidence             368999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.38  E-value=0.00045  Score=66.52  Aligned_cols=75  Identities=15%  Similarity=0.024  Sum_probs=45.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCC--CeeeEeee-----EEcCCEEE
Q 013354          161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHP--NIVRYYGS-----ETLDDKLY  233 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~-----~~~~~~~~  233 (444)
                      ..|+ |....||+... .+|+.+++|......   ..   ...+..|..+++.+...  .+++++..     ...++..+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~  103 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  103 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence            4566 77889998743 346679999875211   11   23455677777766321  23334332     23356778


Q ss_pred             EEEeccCCCC
Q 013354          234 IYLEYVSGGS  243 (444)
Q Consensus       234 lv~e~~~ggs  243 (444)
                      ++|++++|..
T Consensus       104 ~l~~~i~G~~  113 (328)
T 1zyl_A          104 AVFPSVGGRQ  113 (328)
T ss_dssp             EEEECCCCEE
T ss_pred             EEEEecCCCC
Confidence            9999998743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.00045  Score=66.86  Aligned_cols=31  Identities=42%  Similarity=0.502  Sum_probs=26.8

Q ss_pred             CCcccCCCCCCceEECCC----CcEEEEecccccc
Q 013354          276 KNTVHRDIKGANILVDPS----GRVKLADFGMAKH  306 (444)
Q Consensus       276 ~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~  306 (444)
                      ..++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            369999999999999874    6799999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.36  E-value=0.00091  Score=64.16  Aligned_cols=140  Identities=14%  Similarity=0.120  Sum_probs=77.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC--eeeEee------eEEc
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN--IVRYYG------SETL  228 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~------~~~~  228 (444)
                      ....+.|+.|....+|+....  +..+++|+....       ...+.+..|+.++..|...+  +.+++.      +...
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             ceEeeccCCCcccceEEEEeC--CccEEEEEeCCC-------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            344567888888999998653  336889977531       11224455777766663212  233332      1223


Q ss_pred             CCEEEEEEeccCCCCHH-----------HH---HHhc-CCC--------CHHHHHH---------------HHHHHHHHH
Q 013354          229 DDKLYIYLEYVSGGSIY-----------KI---LQDY-GQL--------GESAIRS---------------YTQQILSGL  270 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~-----------~~---l~~~-~~l--------~~~~~~~---------------i~~qi~~aL  270 (444)
                      .+..+++|+|++|..+.           ..   ++.. ..+        .......               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            46789999999876431           11   1111 011        1111010               011234455


Q ss_pred             HHHHH-------CCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          271 EYLHA-------KNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       271 ~~LH~-------~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      +.+.+       .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            55553       368999999999999877656899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.09  E-value=0.0004  Score=68.82  Aligned_cols=135  Identities=15%  Similarity=0.148  Sum_probs=77.6

Q ss_pred             eeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeEEcCCEE
Q 013354          161 RLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSETLDDKL  232 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~  232 (444)
                      +.|..|-...+|++....       +++.+++|+...   ..   .....+.+|..+++.|.. .-..++++.+..    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---IL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---cc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            456667778899987642       357888886421   11   112345578888887742 223566665543    


Q ss_pred             EEEEeccCCCCHH--------------HHHHh---c----C-CCC--HHHHHHHHHHHHH-------------------H
Q 013354          233 YIYLEYVSGGSIY--------------KILQD---Y----G-QLG--ESAIRSYTQQILS-------------------G  269 (444)
Q Consensus       233 ~lv~e~~~ggsL~--------------~~l~~---~----~-~l~--~~~~~~i~~qi~~-------------------a  269 (444)
                      .+||||++|.+|.              +.|.+   .    + ...  ...+.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2899999875542              11111   0    0 111  3445555544422                   2


Q ss_pred             HHHHH----HC----CcccCCCCCCceEECCC----CcEEEEeccccc
Q 013354          270 LEYLH----AK----NTVHRDIKGANILVDPS----GRVKLADFGMAK  305 (444)
Q Consensus       270 L~~LH----~~----~ivH~Dlkp~NIll~~~----~~vkL~DFGla~  305 (444)
                      +..|.    ..    .++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33332    22    48999999999999876    689999998875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0007  Score=68.25  Aligned_cols=73  Identities=15%  Similarity=0.137  Sum_probs=46.8

Q ss_pred             eeeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCE
Q 013354          160 GRLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDK  231 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~  231 (444)
                      .+.|+.|....||++....       +++.+++|+....    ..   ...+.+|+.+++.|...++ +++++.+.  + 
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-
Confidence            4568888889999997642       2578888876310    11   1234468888887753333 56666543  2 


Q ss_pred             EEEEEeccCCCC
Q 013354          232 LYIYLEYVSGGS  243 (444)
Q Consensus       232 ~~lv~e~~~ggs  243 (444)
                       .+|+||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             38999997633

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.92  E-value=0.00053  Score=67.44  Aligned_cols=74  Identities=8%  Similarity=-0.006  Sum_probs=41.1

Q ss_pred             eeeecccCceEEEEEEEcC--------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCC
Q 013354          160 GRLLGRGTFGHVYLGFNSE--------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDD  230 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~  230 (444)
                      .+.|+.|....+|+.....        .++.+++|+.......      ......|..+++.+...+ +.++++..  .+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE------LYNTISEFEVYKTMSKYKIAPQLLNTF--NG  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG------TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc------eecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence            4567888888999987643        1267888865421111      112346777777774333 34566543  22


Q ss_pred             EEEEEEeccCCCC
Q 013354          231 KLYIYLEYVSGGS  243 (444)
Q Consensus       231 ~~~lv~e~~~ggs  243 (444)
                        ++||||++|..
T Consensus       110 --~~v~e~i~G~~  120 (369)
T 3c5i_A          110 --GRIEEWLYGDP  120 (369)
T ss_dssp             --EEEEECCCSEE
T ss_pred             --cEEEEEecCCc
Confidence              68999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.59  E-value=0.012  Score=59.79  Aligned_cols=75  Identities=13%  Similarity=0.060  Sum_probs=46.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEEcCCEEEEEEec
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  238 (444)
                      .+.|+.|-...+|++.....+..+++|+.........+      ..+|..+++.|...++ .++++.+.  +  .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence            45688888899999976544578889876421111111      1468888888865444 56776652  2  259999


Q ss_pred             cCCCCH
Q 013354          239 VSGGSI  244 (444)
Q Consensus       239 ~~ggsL  244 (444)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.57  E-value=0.015  Score=56.35  Aligned_cols=30  Identities=23%  Similarity=0.354  Sum_probs=26.9

Q ss_pred             CcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          277 NTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            589999999999998878899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.24  E-value=0.25  Score=49.32  Aligned_cols=74  Identities=8%  Similarity=0.007  Sum_probs=44.0

Q ss_pred             eeeecccCceEEEEEEEcCC-------CcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCCE
Q 013354          160 GRLLGRGTFGHVYLGFNSES-------GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDDK  231 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~-------g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~  231 (444)
                      .+.|..|-...+|+......       ++.+++|+........      -...+|..+++.+...+ ..++++.+  .+ 
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~--~~-  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADF--PE-  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence            35567777888999876521       5778888753211111      12245777777764222 34555533  22 


Q ss_pred             EEEEEeccCCCC
Q 013354          232 LYIYLEYVSGGS  243 (444)
Q Consensus       232 ~~lv~e~~~ggs  243 (444)
                       ++||||++|..
T Consensus       146 -~~I~efI~G~~  156 (424)
T 3mes_A          146 -GRIEEFIDGEP  156 (424)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -CEEEEEeCCcc
Confidence             68899998865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.91  E-value=0.15  Score=50.47  Aligned_cols=28  Identities=29%  Similarity=0.475  Sum_probs=24.3

Q ss_pred             cccCCCCCCceEE------CCCCcEEEEeccccc
Q 013354          278 TVHRDIKGANILV------DPSGRVKLADFGMAK  305 (444)
Q Consensus       278 ivH~Dlkp~NIll------~~~~~vkL~DFGla~  305 (444)
                      ++|+|+.+.|||+      +.+..+.|+||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      445679999999875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.83  E-value=0.096  Score=53.04  Aligned_cols=62  Identities=10%  Similarity=0.024  Sum_probs=16.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEE------EEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAM------KEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vai------K~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      .+.||   ||.||++........||+      |..+   ......+....+.+|..+++.++|+|+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~---~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTG---QDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccc---cccccccccccccccccccccccccccCCCcceEE
Confidence            34565   999999988765567888      5443   12233444567888999999999999999887643

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=82.93  E-value=20  Score=37.79  Aligned_cols=79  Identities=22%  Similarity=0.333  Sum_probs=46.5

Q ss_pred             EeeeEEcCCEEEEEEeccCCCCHHHHHHhcCC---------------C--CHHHHHHHHHHHH--HHHHHHHHCCcccCC
Q 013354          222 YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ---------------L--GESAIRSYTQQIL--SGLEYLHAKNTVHRD  282 (444)
Q Consensus       222 l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~---------------l--~~~~~~~i~~qi~--~aL~~LH~~~ivH~D  282 (444)
                      .|.+........+ .|+++..+|.+++.+++.               +  .......+++.++  +.+.|+=  |  -+|
T Consensus       478 ~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--G--lGD  552 (696)
T 2x6h_A          478 PYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--G--VGD  552 (696)
T ss_dssp             CCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--T--CCC
T ss_pred             ccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--c--CCC
Confidence            3444444333333 455555566666554321               1  1233445555542  3344442  2  269


Q ss_pred             CCCCceEECCCCcEEEEeccccc
Q 013354          283 IKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       283 lkp~NIll~~~~~vkL~DFGla~  305 (444)
                      -.++||||+.+|.+.-+|||.+.
T Consensus       553 RH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          553 RHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCcceEEeCCCCEEEEeehhhh
Confidence            99999999999999999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.65  E-value=2.6  Score=37.71  Aligned_cols=115  Identities=12%  Similarity=0.066  Sum_probs=78.4

Q ss_pred             CCCCeeeEeeeEEcCCEEEEEEeccC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC
Q 013354          215 RHPNIVRYYGSETLDDKLYIYLEYVS-GGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       215 ~hpnIv~l~~~~~~~~~~~lv~e~~~-ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      .||+++.. .+...++.+.+.++.-. ..++.. +   ..++....++++.+|+....+++  .-+|--|.|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence            58888876 46667777777777654 222222 2   35788889999999988775443  33677799999999999


Q ss_pred             CcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 013354          294 GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~  358 (444)
                      +.+++.=.|+-..                ++|.-      .+...=+-.+=|++..+++++..|.
T Consensus       116 ~~p~i~~RGik~~----------------l~P~~------~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQNV----------------VDPLP------VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETTT----------------BSCCC------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCccC----------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999976664332                23321      2333334456688999999988874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.48  E-value=5.1  Score=35.87  Aligned_cols=115  Identities=9%  Similarity=0.079  Sum_probs=76.2

Q ss_pred             CCCCeeeEeeeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCcccCCCCCCceEECCC
Q 013354          215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE-YLHAKNTVHRDIKGANILVDPS  293 (444)
Q Consensus       215 ~hpnIv~l~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~ivH~Dlkp~NIll~~~  293 (444)
                      .||++  -..+...++.+.+.++.-+++.=+..++   .++....++++.+|+.... ++  ..-+|--|.|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57887  3334467788888887664433333343   5788888988888877655 33  345677899999999999


Q ss_pred             CcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 013354          294 GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWS  358 (444)
Q Consensus       294 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~  358 (444)
                      +.++|.=.|+-.                -++|.-+      +...=+-.+=|++..++.++..|.
T Consensus       121 ~~p~i~hRGi~~----------------~lpP~e~------~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          121 LEPFFLHVGVKE----------------SLPPDEW------DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CCEEESCCEETT----------------TBSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CcEEEEEcCCcc----------------cCCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999997666432                2344322      222223455578888888887763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	444
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-87
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-87
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-87
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-84
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-83
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-81
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-81
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-80
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-80
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-80
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-79
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-79
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-77
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-74
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-73
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-73
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-72
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-70
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-67
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-67
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-67
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-66
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-65
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-65
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-64
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-64
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-63
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-63
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-62
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-62
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-62
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-62
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-27

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  265 bits (679), Expect = 2e-87
 Identities = 84/264 (31%), Positives = 139/264 (52%), Gaps = 7/264 (2%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             ++ GR LG+G FG+VYL    +S  + A+K   LF    +      QL +E+ + S L
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           RHPNI+R YG      ++Y+ LEY   G++Y+ LQ   +  E    +Y  ++ + L Y H
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +K  +HRDIK  N+L+  +G +K+ADFG + H        ++ G+  ++ PE+I+     
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEG-RMH 181

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
           +  VD+WSLG    E    KPP+          +I   +     PD +++  +D + + L
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLL 239

Query: 395 QRNPLHRPTAAWLLEHPFV-GNAA 417
           + NP  RP    +LEHP++  N++
Sbjct: 240 KHNPSQRPMLREVLEHPWITANSS 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  266 bits (682), Expect = 2e-87
 Identities = 95/273 (34%), Positives = 142/273 (52%), Gaps = 7/273 (2%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P   +   R +G G+FG VY   +  + E+ A+K+++      +S E  Q + +E+  L 
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQ 70

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           +LRHPN ++Y G    +   ++ +EY  G +   +      L E  I + T   L GL Y
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 273 LHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           LH+ N +HRD+K  NIL+   G VKL DFG A  +   +   S  G+PYWMAPEVI   +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMD 187

Query: 333 --GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
               +  VD+WSLG T IE+A  KPP      + A++ I  ++       H S+  ++FV
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 391 RKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPI 423
             CLQ+ P  RPT+  LL+H FV    P    +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  265 bits (679), Expect = 4e-87
 Identities = 103/295 (34%), Positives = 152/295 (51%), Gaps = 19/295 (6%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           V    +P   W+    LG G FG VY   N E+  + A K +     D KS+E  +    
Sbjct: 4   VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-----DTKSEEELEDYMV 58

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQ 265
           EI +L+   HPNIV+   +   ++ L+I +E+ +GG++  ++ +  + L ES I+   +Q
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL-SIKGSPYWMA 324
            L  L YLH    +HRD+K  NIL    G +KLADFG++   T       S  G+PYWMA
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 325 PEVI----KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-AIP 379
           PEV+          +   D+WSLG T+IEMA  +PP  +   +  + KI  S+    A P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETK 432
              S   KDF++KCL++N   R T + LL+HPFV   +  P+   I     +E K
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI-----AEAK 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (658), Expect = 3e-84
 Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 8/262 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            W   + LG G +G V L  N  + E  A+K V    D  ++ +  + + +EI +   L 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV----DMKRAVDCPENIKKEICINKMLN 61

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H N+V++YG     +  Y++LEY SGG ++  ++    + E   + +  Q+++G+ YLH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI---TGQSCPLSIKGSPYWMAPEVIKNSN 332
               HRDIK  N+L+D    +K++DFG+A        +     + G+  ++APE++K   
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-IGNSKELPAIPDHLSDEGKDFVR 391
                VD+WS G  +  M   + PW Q       +      K        +       + 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 392 KCLQRNPLHRPTAAWLLEHPFV 413
           K L  NP  R T   + +  + 
Sbjct: 242 KILVENPSARITIPDIKKDRWY 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  255 bits (653), Expect = 3e-83
 Identities = 91/289 (31%), Positives = 152/289 (52%), Gaps = 11/289 (3%)

Query: 147 VENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ 206
           + +   P  ++ +   +G+G  G VY   +  +G+  A++++ L     + +   + +  
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIIN 66

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           EI ++   ++PNIV Y  S  + D+L++ +EY++GGS+  ++ +     E  I +  ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCREC 125

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAP 325
           L  LE+LH+   +HRDIK  NIL+   G VKL DFG    IT +    S + G+PYWMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP-AIPDHLSD 384
           EV+         VDIWSLG   IEM   +PP+     + A++ I  +       P+ LS 
Sbjct: 186 EVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLE--RPILSAEPSET 431
             +DF+ +CL  +   R +A  LL+H F+  A PL    P+++A    T
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  252 bits (645), Expect = 2e-81
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 13/287 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +     LG G FG V+      +G   A K V         +   + + +EI  +S LR
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-----MTPHESDKETVRKEIQTMSVLR 81

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLH 274
           HP +V  + +   D+++ +  E++SGG +++ + D + ++ E     Y +Q+  GL ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 275 AKNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
             N VH D+K  NI+     S  +KL DFG+  H+  +       G+  + APEV +   
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-K 200

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--GNSKELPAIPDHLSDEGKDFV 390
                 D+WS+G     + +   P+        +  +   +     +    +S++GKDF+
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 391 RKCLQRNPLHRPTAAWLLEHPFV--GNAAPLERPILSAEPSETKPTL 435
           RK L  +P  R T    LEHP++  GNA   +  I S+  ++ + ++
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  249 bits (636), Expect = 7e-81
 Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 12/269 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQ----EIALL 211
            ++   +LGRG    V    +  + +  A+K + +    + S E  Q+L +    E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 212 SRLR-HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
            ++  HPNI++   +   +   ++  + +  G ++  L +   L E   R   + +L  +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK- 329
             LH  N VHRD+K  NIL+D    +KL DFG +  +        + G+P ++APE+I+ 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183

Query: 330 ----NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIP--DHLS 383
               N  G    VD+WS G  +  +    PP+   + +  +  I +       P  D  S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           D  KD V + L   P  R TA   L HPF
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPF 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (630), Expect = 5e-80
 Identities = 80/269 (29%), Positives = 129/269 (47%), Gaps = 17/269 (6%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++    +G G++G          G++   KE+      + ++   Q L  E+ LL  L+H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 217 PNIVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQ----LGESAIRSYTQQILSGL 270
           PNIVRYY    +  +  LYI +EY  GG +  ++    +    L E  +     Q+   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 271 EYLHAKNT-----VHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMA 324
           +  H ++      +HRD+K AN+ +D    VKL DFG+A+ +    S   +  G+PY+M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD 384
           PE + N    N   DIWSLGC + E+    PP++ +       KI   K    IP   SD
Sbjct: 183 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSD 240

Query: 385 EGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           E  + + + L     HRP+   +LE+P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  249 bits (636), Expect = 6e-80
 Identities = 68/321 (21%), Positives = 143/321 (44%), Gaps = 19/321 (5%)

Query: 122 ISNTCPFSPS-YSTATSPSVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESG 180
           I++   F    +       V    G V +       +     LG G FG V+      +G
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYD------YYDILEELGSGAFGVVHRCVEKATG 54

Query: 181 EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVS 240
            +   K +     +         +  EI+++++L HP ++  + +     ++ + LE++S
Sbjct: 55  RVFVAKFI-----NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109

Query: 241 GGSIYK-ILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSGRVK 297
           GG ++  I  +  ++ E+ + +Y +Q   GL+++H  + VH DIK  NI+ +   +  VK
Sbjct: 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 169

Query: 298 LADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPW 357
           + DFG+A  +           +  + APE++ +        D+W++G     + +   P+
Sbjct: 170 IIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPF 228

Query: 358 SQYEGVPAMFKI--GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV-G 414
           +  + +  +  +   + +        +S E KDF++  LQ+ P  R T    LEHP++ G
Sbjct: 229 AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288

Query: 415 NAAPLERPILSAEPSETKPTL 435
           + + L   I S+  ++ +  +
Sbjct: 289 DHSNLTSRIPSSRYNKIRQKI 309

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  247 bits (632), Expect = 7e-80
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 10/283 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +    +LG G F  V L  +  + ++ A+K +   + + K       +  EIA+L +++
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHKIK 65

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HPNIV           LY+ ++ VSGG ++  + + G   E        Q+L  ++YLH 
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 276 KNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
              VHRD+K  N+L    D   ++ ++DFG++K     S   +  G+P ++APEV+    
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-K 184

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--GNSKELPAIPDHLSDEGKDFV 390
             + AVD WS+G     +    PP+          +I     +      D +SD  KDF+
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 391 RKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKP 433
           R  ++++P  R T    L+HP++     L++ I  +   + K 
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 1e-79
 Identities = 77/271 (28%), Positives = 143/271 (52%), Gaps = 15/271 (5%)

Query: 151 TSPGSRWKK-GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
            S   R+ K    +GRG+F  VY G ++E+    A  E+    D   +K   Q+  +E  
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL---QDRKLTKSERQRFKEEAE 60

Query: 210 LLSRLRHPNIVRYYGS----ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
           +L  L+HPNIVR+Y S          + +  E ++ G++   L+ +  +    +RS+ +Q
Sbjct: 61  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120

Query: 266 ILSGLEYLHAKNT--VHRDIKGANILV-DPSGRVKLADFGMAKHITGQSCPLSIKGSPYW 322
           IL GL++LH +    +HRD+K  NI +  P+G VK+ D G+A  +   S   ++ G+P +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEF 179

Query: 323 MAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-IGNSKELPAIPDH 381
           MAPE+ +     + +VD+++ G  ++EMAT++ P+S+ +    +++ + +  +  +    
Sbjct: 180 MAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237

Query: 382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
              E K+ +  C+++N   R +   LL H F
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 5e-79
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 14/266 (5%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            +K G++LG G+F  V L     +    A+K   L       +     + +E  ++SRL 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLD 66

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           HP  V+ Y +   D+KLY  L Y   G + K ++  G   E+  R YT +I+S LEYLH 
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSN 332
           K  +HRD+K  NIL++    +++ DFG AK ++ +S      S  G+  +++PE++    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-K 185

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
               + D+W+LGC + ++    PP+          KI   +     P+    + +D V K
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVEK 243

Query: 393 CLQRNPLHRPTAA------WLLEHPF 412
            L  +   R           L  HPF
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPF 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (618), Expect = 1e-77
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 49/301 (16%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            ++K   LG G  G V+   +  SG + A K + L            Q+ +E+ +L    
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHECN 62

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
            P IV +YG+   D ++ I +E++ GGS+ ++L+  G++ E  +   +  ++ GL YL  
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 276 KNT-VHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           K+  +HRD+K +NILV+  G +KL DFG++  +   S   S  G+  +M+PE ++     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG-THY 180

Query: 335 NLAVDIWSLGCTVIEMATTKPPWS------------------------------------ 358
           ++  DIWS+G +++EMA  + P                                      
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 359 ------QYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                        +  I N           S E +DFV KCL +NP  R     L+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 413 V 413
           +
Sbjct: 301 I 301

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (606), Expect = 2e-76
 Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 17/268 (6%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P  +   G+ +G G+FG VY G   +     A+K + +    A + +  Q    E+ +L 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNV---TAPTPQQLQAFKNEVGVLR 59

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLE 271
           + RH NI+ + G  T   +L I  ++  G S+Y  L     +     +    +Q   G++
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK---HITGQSCPLSIKGSPYWMAPEVI 328
           YLHAK+ +HRD+K  NI +     VK+ DFG+A      +G      + GS  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 329 K--NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSK----ELPAIPDHL 382
           +  + N  +   D+++ G  + E+ T + P+S       +  +        +L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 383 SDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
               K  + +CL++    RP    +L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 3e-75
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 12/263 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++     LGRG FG V+    + S +    K V               + +EI++L+  R
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIAR 59

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLH 274
           H NI+  + S    ++L +  E++SG  I++ +     +L E  I SY  Q+   L++LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 275 AKNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSN 332
           + N  H DI+  NI+     S  +K+ +FG A+ +        +  +P + APEV ++ +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-D 178

Query: 333 GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLSDEGKDFV 390
             + A D+WSLG  V  + +   P+        +  I N++          +S E  DFV
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 391 RKCLQRNPLHRPTAAWLLEHPFV 413
            + L +    R TA+  L+HP++
Sbjct: 239 DRLLVKERKSRMTASEALQHPWL 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 7e-74
 Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 8/260 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-L 214
            +   ++LG+G+FG V+L    ++ +  A+K   L  D     +  +    E  +LS   
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
            HP +   + +    + L+  +EY++GG +   +Q   +   S    Y  +I+ GL++LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT-GQSCPLSIKGSPYWMAPEVIKNSNG 333
           +K  V+RD+K  NIL+D  G +K+ADFGM K    G +   +  G+P ++APE++     
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QK 179

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
            N +VD WS G  + EM   + P+   +       I      P  P  L  E KD + K 
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKL 237

Query: 394 LQRNPLHRPTAAW-LLEHPF 412
             R P  R      + +HP 
Sbjct: 238 FVREPEKRLGVRGDIRQHPL 257

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 1e-73
 Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 28/288 (9%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPN 218
            ++LG G  G V   FN  + E  A+K +          +   +  +E+ L  R  + P+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQCPH 66

Query: 219 IVRYYG----SETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLEY 272
           IVR              L I +E + GG ++  +QD G     E       + I   ++Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 273 LHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           LH+ N  HRD+K  N+L     P+  +KL DFG AK  T  +   +   +PY++APEV+ 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 185

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPW------SQYEGVPAMFKIGNSKELPAIPDHLS 383
                + + D+WSLG  +  +    PP+      +   G+    ++G  +        +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPL-ERPILSAEPSE 430
           +E K  +R  L+  P  R T    + HP++  +  + + P+ ++   +
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  231 bits (590), Expect = 7e-73
 Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 10/265 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES-AQQLGQEIALLSRL 214
            +   R++GRG FG VY    +++G+M AMK +       K  E+ A      ++L+S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
             P IV    +    DKL   L+ ++GG ++  L  +G   E+ +R Y  +I+ GLE++H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGC 334
            +  V+RD+K ANIL+D  G V+++D G+A     +  P +  G+  +MAPEV++     
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAY 183

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQY--EGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK 392
           + + D +SLGC + ++     P+ Q+  +    + ++  +  +  +PD  S E +  +  
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEG 242

Query: 393 CLQRNPLHRPTAAW-----LLEHPF 412
            LQR+   R          + E PF
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPF 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 3e-72
 Identities = 67/264 (25%), Positives = 110/264 (41%), Gaps = 14/264 (5%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSR 213
           S+++ G LLG G FG VY G         A+K V      D     +  ++  E+ LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 214 LR--HPNIVRYYGSETLDDKLYIYLEYVSGGS-IYKILQDYGQLGESAIRSYTQQILSGL 270
           +      ++R        D   + LE       ++  + + G L E   RS+  Q+L  +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 271 EYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
            + H    +HRDIK  NIL+D + G +KL DFG    +   +      G+  +  PE I+
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIR 182

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF 389
                  +  +WSLG  + +M     P+   E +         +        +S E +  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHL 234

Query: 390 VRKCLQRNPLHRPTAAWLLEHPFV 413
           +R CL   P  RPT   +  HP++
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWM 258

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 6e-72
 Identities = 69/265 (26%), Positives = 126/265 (47%), Gaps = 8/265 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL-FSDDAKSKESAQQLGQEIALLSRL 214
            +  G  LG G F  V       +G   A K +    +  ++   S + + +E+++L  +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLH 274
           +HPN++  +        + + LE V+GG ++  L +   L E     + +QIL+G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 275 AKNTVHRDIKGANILVD----PSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
           +    H D+K  NI++     P  R+K+ DFG+A  I   +   +I G+P ++APE++ N
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-N 189

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--GNSKELPAIPDHLSDEGKD 388
                L  D+WS+G     + +   P+        +  +   N +       + S   KD
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249

Query: 389 FVRKCLQRNPLHRPTAAWLLEHPFV 413
           F+R+ L ++P  R T    L+HP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 5e-70
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 17/260 (6%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
              K  + +G+G FG V LG     G   A+K +       K+  +AQ    E +++++L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQL 57

Query: 215 RHPNIVRYYGSETLDD-KLYIYLEYVSGGSIYKILQDYGQ--LGESAIRSYTQQILSGLE 271
           RH N+V+  G    +   LYI  EY++ GS+   L+  G+  LG   +  ++  +   +E
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
           YL   N VHRD+   N+LV      K++DFG+ K  +  S   + K    W APE ++  
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALRE- 174

Query: 332 NGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
              +   D+WS G  + E+ +  + P+ +      + ++    ++   PD       + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-APDGCPPAVYEVM 233

Query: 391 RKCLQRNPLHRPTAAWLLEH 410
           + C   +   RP+   L E 
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 6e-70
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 27/296 (9%)

Query: 161 RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
             LG G F  VY   +  + ++ A+K++ L           +   +EI LL  L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVH 280
               +      + +  +++       I  +   L  S I++Y    L GLEYLH    +H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 281 RDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK-GSPYWMAPEVIKNSNGCNLAVD 339
           RD+K  N+L+D +G +KLADFG+AK     +   + +  + ++ APE++  +    + VD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 340 IWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------------------SK 373
           +W++GC + E+    P       +  + +I                              
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPS 429
            L  I     D+  D ++     NP  R TA   L+  +  N            P+
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPN 299

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  222 bits (566), Expect = 7e-70
 Identities = 70/261 (26%), Positives = 132/261 (50%), Gaps = 12/261 (4%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           ++  R LG G+FG V+L  +  +G   AMK   L  +     +  +    E  +LS + H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMK--VLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P I+R +G+     ++++ ++Y+ GG ++ +L+   +      + Y  ++   LEYLH+K
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNL 336
           + ++RD+K  NIL+D +G +K+ DFG AK++       ++ G+P ++APEV+      N 
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST-KPYNK 180

Query: 337 AVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQR 396
           ++D WS G  + EM     P+     +    KI N++     P   +++ KD + + + R
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLITR 238

Query: 397 NPLHR-----PTAAWLLEHPF 412
           +   R          +  HP+
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPW 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 4e-69
 Identities = 61/262 (23%), Positives = 106/262 (40%), Gaps = 16/262 (6%)

Query: 161 RLLGRGTFGHVYLGF--NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN 218
           + LG G FG V  G+    +  +  A+K   +  ++A       +L  E  ++ +L +P 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 219 IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNT 278
           IVR  G     +   + +E    G + K LQ    + +  I     Q+  G++YL   N 
Sbjct: 70  IVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITG----QSCPLSIKGSPYWMAPEVIKNSNGC 334
           VHRD+   N+L+      K++DFG++K +             K    W APE I      
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKF 187

Query: 335 NLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
           +   D+WS G  + E  +  + P+   +G      +   + +   P     E  D +  C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-CPAGCPREMYDLMNLC 246

Query: 394 LQRNPLHRPTAA---WLLEHPF 412
              +  +RP  A     L + +
Sbjct: 247 WTYDVENRPGFAAVELRLRNYY 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  217 bits (554), Expect = 1e-68
 Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 13/274 (4%)

Query: 150 PTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
           P+    R++ G +LG G    V+L  +       A+K   L +D A+      +  +E  
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVK--VLRADLARDPSFYLRFRREAQ 59

Query: 210 LLSRLRHPNIVRYYGSETLDDK----LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQ 265
             + L HP IV  Y +   +       YI +EYV G ++  I+   G +           
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119

Query: 266 ILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----SIKGSPY 321
               L + H    +HRD+K ANI++  +  VK+ DFG+A+ I      +    ++ G+  
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIP 379
           +++PE  +  +  +   D++SLGC + E+ T +PP++    V   ++      +P  A  
Sbjct: 180 YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 380 DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV 413
           + LS +    V K L +NP +R   A  +    V
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 1e-67
 Identities = 73/267 (27%), Positives = 113/267 (42%), Gaps = 16/267 (5%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P    K    LG G FG V++G+        A+K +       +   S      E  L+ 
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK------QGSMSPDAFLAEANLMK 63

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGL 270
           +L+H  +VR Y   T  + +YI  EY+  GS+   L+     +L  + +     QI  G+
Sbjct: 64  QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEVI 328
            ++  +N +HRD++ ANILV  +   K+ADFG+A+ I           K    W APE I
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                  +  D+WS G  + E+ T           P + +          PD+  +E   
Sbjct: 183 NY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 389 FVRKCLQRNPLHRPTAAWL---LEHPF 412
            +R C +  P  RPT  +L   LE  F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 2e-67
 Identities = 76/311 (24%), Positives = 137/311 (44%), Gaps = 43/311 (13%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G R+     +G G +G V   +++ +    A+K+++ F      +   Q+  +EI +L R
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH----QTYCQRTLREIKILLR 62

Query: 214 LRHPNIVRYYG---SETLDDKLYIYL-EYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
            RH NI+       + T++    +YL  ++ G  +YK+L+    L    I  +  QIL G
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRG 121

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----TGQSCPLSIKGSPYWMAP 325
           L+Y+H+ N +HRD+K +N+L++ +  +K+ DFG+A+                 + ++ AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI---------------- 369
           E++ NS G   ++DIWS+GC + EM + +P +     +  +  I                
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 370 -------------GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV-GN 415
                         N      +  +   +  D + K L  NP  R      L HP++   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 416 AAPLERPILSA 426
             P + PI  A
Sbjct: 302 YDPSDEPIAEA 312

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 3e-67
 Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 11/262 (4%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +   +LLG+GTFG V L     +G   AMK   L  +   +K+       E  +L   RH
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P +     +    D+L   +EY +GG ++  L       E   R Y  +I+S LEYLH++
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS-IKGSPYWMAPEVIKNSNGCN 335
           + V+RDIK  N+++D  G +K+ DFG+ K        +    G+P ++APEV+++ N   
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 183

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD W LG  + EM   + P+   +       I   +     P  LS E K  +   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 241

Query: 396 RNPLHRP-----TAAWLLEHPF 412
           ++P  R       A  ++EH F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRF 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 2e-66
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 9/262 (3%)

Query: 156 RWKKGRLLGRGTFGHVYLG-FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
             +    LG G+FG V  G +++ SG+  ++    L  D     E+     +E+  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYL 273
            H N++R YG   L   + +  E    GS+   L+ + G      +  Y  Q+  G+ YL
Sbjct: 69  DHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI----TGQSCPLSIKGSPYWMAPEVIK 329
            +K  +HRD+   N+L+     VK+ DFG+ + +             K    W APE +K
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 330 NSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                + A D W  G T+ EM T  + PW    G   + KI    E    P+    +  +
Sbjct: 188 T-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246

Query: 389 FVRKCLQRNPLHRPTAAWLLEH 410
            + +C    P  RPT   L + 
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDF 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 4e-66
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 14/265 (5%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
              R + GR +G G FG V+ G            A+K       +  S    ++  QE  
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQEAL 60

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILS 268
            + +  HP+IV+  G  T ++ ++I +E  + G +   LQ     L  +++  Y  Q+ +
Sbjct: 61  TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--IKGSPYWMAPE 326
            L YL +K  VHRDI   N+LV  +  VKL DFG+++++   +   +   K    WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 327 VIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
            I N      A D+W  G  + E+      P+   +    + +I N + LP +P +    
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-MPPNCPPT 237

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEH 410
               + KC   +P  RP    L   
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 1e-65
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 18/269 (6%)

Query: 163 LGRGTFGHVYLGFN--SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIV 220
           LG G FG V  G     +     A+K +         K   +++ +E  ++ +L +P IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVL----KQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 221 RYYGSETLDDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTV 279
           R  G     + L + +E   GG ++K L     ++  S +     Q+  G++YL  KN V
Sbjct: 73  RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 280 HRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL----SIKGSPYWMAPEVIKNSNGCN 335
           HRD+   N+L+      K++DFG++K +           + K    W APE I      +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190

Query: 336 LAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL 394
              D+WS G T+ E  +  + P+ + +G   M  I   K +   P     E    +  C 
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-CPPECPPELYALMSDCW 249

Query: 395 QRNPLHRPTAA---WLLEHPFVGNAAPLE 420
                 RP        +   +   A+ +E
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (534), Expect = 1e-65
 Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)

Query: 149 NPTSPG--------SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKES 200
           +P+SP         +       LG G +G VY G   +     A+K +       +    
Sbjct: 3   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTME 56

Query: 201 AQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ--LGESA 258
            ++  +E A++  ++HPN+V+  G  T +   YI  E+++ G++   L++  +  +    
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116

Query: 259 IRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLS--I 316
           +     QI S +EYL  KN +HRD+   N LV  +  VK+ADFG+++ +TG +       
Sbjct: 117 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
           K    W APE +   N  ++  D+W+ G  + E+AT          +  ++++       
Sbjct: 177 KFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
             P+   ++  + +R C Q NP  RP+ A + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 58/260 (22%), Positives = 105/260 (40%), Gaps = 13/260 (5%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           S     + +G G FG V+LG+   + +  A+K +       +   S +   +E  ++ +L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57

Query: 215 RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG-ESAIRSYTQQILSGLEYL 273
            HP +V+ YG       + +  E++  G +   L+    L     +      +  G+ YL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 274 HAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIKNS 331
                +HRD+   N LV  +  +K++DFGM + +     +     K    W +PEV  + 
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SF 176

Query: 332 NGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFV 390
           +  +   D+WS G  + E+ +  K P+        +  I     L   P   S      +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIM 235

Query: 391 RKCLQRNPLHRPTAAWLLEH 410
             C +  P  RP  + LL  
Sbjct: 236 NHCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 60/255 (23%), Positives = 109/255 (42%), Gaps = 13/255 (5%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
            + LG G FG V  G         A+K +       +   S  +  +E  ++  L H  +
Sbjct: 9   LKELGTGQFGVVKYGKW-RGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 220 VRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNT 278
           V+ YG  T    ++I  EY++ G +   L++   +     +    + +   +EYL +K  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 279 VHRDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIKNSNGCNL 336
           +HRD+   N LV+  G VK++DFG+++++     +  +  K    W  PEV+   +  + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSS 180

Query: 337 AVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
             DIW+ G  + E+ +  K P+ ++        I     L   P   S++    +  C  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWH 239

Query: 396 RNPLHRPTAAWLLEH 410
                RPT   LL +
Sbjct: 240 EKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-65
 Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 30/287 (10%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESA-QQLGQEIALL 211
           P    + G++LG G FG V         +     +V +     K+  S  + L  E+ ++
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 212 SRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ--------------------- 249
           ++L  H NIV   G+ TL   +Y+  EY   G +   L+                     
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 250 --DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI 307
             D   L    +  +  Q+  G+E+L  K+ VHRD+   N+LV     VK+ DFG+A+ I
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 308 TGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGV 363
              S      + +    WMAPE +       +  D+WS G  + E+ +    P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 364 PAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
              +K+  +      P + ++E    ++ C   +   RP+   L   
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 6e-65
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 32/286 (11%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            ++K   +G GT+G VY   N  +GE+ A+K++ L   D +++       +EI+LL  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKI-LQDYGQLGESAIRSYTQQILSGLEYLH 274
           HPNIV+       ++KLY+  E++       +       +    I+SY  Q+L GL + H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNG 333
           +   +HRD+K  N+L++  G +KLADFG+A+              + ++ APE++     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN---------------------- 371
            + AVDIWSLGC   EM T +  +     +  +F+I                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 372 -----SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                 ++   +   L ++G+  + + L  +P  R +A   L HPF
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-64
 Identities = 66/310 (21%), Positives = 118/310 (38%), Gaps = 47/310 (15%)

Query: 147 VENPT-SPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLG 205
           VE P     S+++K   +G+GTFG V+   + ++G+  A+K+V + ++      +A +  
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-- 58

Query: 206 QEIALLSRLRHPNIVRYYGS--------ETLDDKLYIYLEYVSGGSIYKILQDYGQLGES 257
            EI +L  L+H N+V                   +Y+  ++        +     +   S
Sbjct: 59  -EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 117

Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI-----TGQSC 312
            I+   Q +L+GL Y+H    +HRD+K AN+L+   G +KLADFG+A+       +  + 
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS 372
             +   + ++  PE++         +D+W  GC + EM T  P          +  I   
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 373 KELPAIPDH------------------------------LSDEGKDFVRKCLQRNPLHRP 402
                                                        D + K L  +P  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 403 TAAWLLEHPF 412
            +   L H F
Sbjct: 298 DSDDALNHDF 307

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 3e-64
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 38/291 (13%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           + ++  + +G G +G V    +  +G   A+K++       +S+  A++  +E+ LL  +
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 74

Query: 215 RHPNIVRYYGS----ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGL 270
           RH N++         ETLDD    YL     G+    L  + +LGE  I+    Q+L GL
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKN 330
            Y+HA   +HRD+K  N+ V+    +K+ DFG+A+    +        + ++ APEVI N
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVILN 192

Query: 331 SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------------------- 371
                  VDIWS+GC + EM T K  +   + +  + +I                     
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 372 ----------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                      K+  +I  + S    + + K L  +   R TA   L HP+
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  206 bits (525), Expect = 3e-64
 Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 32/285 (11%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++     +G GT+G VY   N+  GE  A+K++ L  +D     +  +   EI++L  L+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELK 58

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H NIV+ Y       +L +  E++       +    G L     +S+  Q+L+G+ Y H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-TGQSCPLSIKGSPYWMAPEVIKNSNGC 334
           +  +HRD+K  N+L++  G +K+ADFG+A+              + ++ AP+V+  S   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----------------------- 371
           +  +DIWS+GC   EM    P +        + +I                         
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 372 ----SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                    +    L + G D + K L+ +P  R TA   LEH +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 9e-64
 Identities = 77/311 (24%), Positives = 125/311 (40%), Gaps = 47/311 (15%)

Query: 139 SVPRSPGRVENPTSPGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSK 198
           +V  +PG+  +     S +   +++G G+FG VY     +SGE+ A+K+V          
Sbjct: 5   TVVATPGQGPDRPQEVS-YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------L 54

Query: 199 ESAQQLGQEIALLSRLRHPNIVRYYG----SETLDDKLYIYL--EYVSGG---SIYKILQ 249
           +  +   +E+ ++ +L H NIVR       S    D++Y+ L  +YV            +
Sbjct: 55  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114

Query: 250 DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV-KLADFGMAKHIT 308
               L    ++ Y  Q+   L Y+H+    HRDIK  N+L+DP   V KL DFG AK + 
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

Query: 309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK 368
                +S   S Y+ APE+I  +     ++D+WS GC + E+   +P +    GV  + +
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

Query: 369 IGNSKELPA---------------------------IPDHLSDEGKDFVRKCLQRNPLHR 401
           I      P                                   E      + L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

Query: 402 PTAAWLLEHPF 412
            T      H F
Sbjct: 295 LTPLEACAHSF 305

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (522), Expect = 1e-63
 Identities = 55/291 (18%), Positives = 101/291 (34%), Gaps = 29/291 (9%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G+R++ GR +G G+FG +YLG +  +GE  A+K           K    QL  E  +   
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-------CVKTKHPQLHIESKIYKM 58

Query: 214 LRHPN-IVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
           ++    I          D   + +E +             +     +     Q++S +EY
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118

Query: 273 LHAKNTVHRDIKGANILV---DPSGRVKLADFGMAKHITGQS--------CPLSIKGSPY 321
           +H+KN +HRD+K  N L+        V + DFG+AK                 ++ G+  
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 322 WMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE------L 375
           + +          +   D+ SLG  ++       PW   +      K     E      +
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 376 PAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWL---LEHPFVGNAAPLERPI 423
             +      E   ++  C       +P  ++L     + F       +   
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-63
 Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 4/283 (1%)

Query: 157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
           +KK ++LG G FG VY G     GE   +        +A S ++ +++  E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 217 PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK 276
           P++ R  G         I      G  +  + +    +G   + ++  QI  G+ YL  +
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 277 NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL---SIKGSPYWMAPEVIKNSNG 333
             VHRD+   N+LV     VK+ DFG+AK +  +         K    WMA E I +   
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RI 189

Query: 334 CNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC 393
                D+WS G TV E+ T             +  I    E    P   + +    + KC
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 394 LQRNPLHRPTAAWLLEHPFVGNAAPLERPILSAEPSETKPTLT 436
              +   RP    L+         P    ++  +     P+ T
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-63
 Identities = 79/292 (27%), Positives = 134/292 (45%), Gaps = 32/292 (10%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           +++K   +G GT+G V+   N E+ E+ A+K V L  DD     SA +   EI LL  L+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 59

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           H NIVR +     D KL +  E+             G L    ++S+  Q+L GL + H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKG-SPYWMAPEVIKNSNGC 334
           +N +HRD+K  N+L++ +G +KLA+FG+A+         S +  + ++  P+V+  +   
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 335 NLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFK-------------------------- 368
           + ++D+WS GC   E+A    P      V    K                          
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 369 --IGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP 418
                +  L  +   L+  G+D ++  L+ NP+ R +A   L+HP+  +  P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 9e-63
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 17/267 (6%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALL 211
           S  K  +++G G FG V  G     G+     A+K +        +++  +    E +++
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIM 81

Query: 212 SRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKI-LQDYGQLGESAIRSYTQQILSGL 270
            +  HPN++   G  T    + I  E++  GS+     Q+ GQ     +    + I +G+
Sbjct: 82  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS------CPLSIKGSPYWMA 324
           +YL   N VHRD+   NILV+ +   K++DFG+++ +   +        L  K    W A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 325 PEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLS 383
           PE I+       A D+WS G  + E+ +  + P+        +  I     LP  P    
Sbjct: 202 PEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-PPMDCP 259

Query: 384 DEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                 +  C Q++  HRP    ++  
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 1e-62
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 33/289 (11%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSES-GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           +++    +G G +G V+   + ++ G   A+K V + + +     S  +    +  L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 215 RHPNIVRYYGSETL-----DDKLYIYLEYVSGGSI-YKILQDYGQLGESAIRSYTQQILS 268
            HPN+VR +   T+     + KL +  E+V      Y        +    I+    Q+L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 269 GLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVI 328
           GL++LH+   VHRD+K  NILV  SG++KLADFG+A+  + Q    S+  + ++ APEV+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI------------------- 369
             S      VD+WS+GC   EM   KP +     V  + KI                   
Sbjct: 188 LQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 370 ------GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                  +++ +      + + GKD + KCL  NP  R +A   L HP+
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 17/277 (6%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
           P    +    LG+G FG V++G  + +  + A+K +           S +   QE  ++ 
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK------PGTMSPEAFLQEAQVMK 67

Query: 213 RLRHPNIVRYYGSETLDDKLYIYLEYVSGGSI--YKILQDYGQLGESAIRSYTQQILSGL 270
           +LRH  +V+ Y   + ++ +YI  EY+S GS+  +   +    L    +     QI SG+
Sbjct: 68  KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 271 EYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL--SIKGSPYWMAPEVI 328
            Y+   N VHRD++ ANILV  +   K+ADFG+A+ I           K    W APE  
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 329 KNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK 387
                  +  D+WS G  + E+ T  + P+        + ++     +P  P    +   
Sbjct: 187 LYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLH 244

Query: 388 DFVRKCLQRNPLHRPTAAWLLE--HPFVGNAAPLERP 422
           D + +C ++ P  RPT  +L      +  +  P  +P
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-62
 Identities = 72/271 (26%), Positives = 134/271 (49%), Gaps = 15/271 (5%)

Query: 156 RWKKGRLLGRGTFGHVYLG---FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS 212
            ++  ++LG G +G V+L       ++G++ AMK +   +   +  ++ +    E  +L 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLE 83

Query: 213 RLRH-PNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLE 271
            +R  P +V  + +   + KL++ L+Y++GG ++  L    +  E  ++ Y  +I+  LE
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 272 YLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ--SCPLSIKGSPYWMAPEVIK 329
           +LH    ++RDIK  NIL+D +G V L DFG++K              G+  +MAP++++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 330 NSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI--GNSKELPAIPDHLSDEG 386
             + G + AVD WSLG  + E+ T   P++      +  +I     K  P  P  +S   
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263

Query: 387 KDFVRKCLQRNPLHRPTAAW-----LLEHPF 412
           KD +++ L ++P  R          + EH F
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-62
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 20/273 (7%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           +  K   ++G G FG V      + G         +   +  SK+  +    E+ +L +L
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKL 67

Query: 215 -RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDY----------------GQLGES 257
             HPNI+   G+      LY+ +EY   G++   L+                    L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 258 AIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIK 317
            +  +   +  G++YL  K  +HRD+   NILV  +   K+ADFG+++           +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA 377
               WMA E + N +      D+WS G  + E+ +             +++         
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 378 IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
            P +  DE  D +R+C +  P  RP+ A +L  
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 4e-62
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 12/262 (4%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           ++ + + LG G+FG V L  + ESG   AMK   L        +  +    E  +L  + 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 216 HPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
            P +V+   S   +  LY+ +EYV+GG ++  L+  G+  E   R Y  QI+   EYLH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 276 KNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCN 335
            + ++RD+K  N+L+D  G +++ DFG AK + G++   ++ G+P  +APE+I +  G N
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILS-KGYN 216

Query: 336 LAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQ 395
            AVD W+LG  + EMA   PP+   + +    KI + K     P H S + KD +R  LQ
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQ 274

Query: 396 RNPLHR-----PTAAWLLEHPF 412
            +   R          +  H +
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKW 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  201 bits (511), Expect = 1e-61
 Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 51/297 (17%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
            ++  R LGRG +  V+   N  + E   +K +             +++ +EI +L  LR
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLR 87

Query: 216 -HPNIVRYYGS--ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEY 272
             PNI+       + +     +  E+V+     ++ Q    L +  IR Y  +IL  L+Y
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 144

Query: 273 LHAKNTVHRDIKGANILVDPSGR-VKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNS 331
            H+   +HRD+K  N+++D   R ++L D+G+A+             S Y+  PE++ + 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 332 NGCNLAVDIWSLGCTVIEMATTKPPWSQYE-------------GVPAMFKIGNSKELPAI 378
              + ++D+WSLGC +  M   K P+                 G   ++   +   +   
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 379 PD-----------------------HLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
           P                         +S E  DF+ K L+ +   R TA   +EHP+
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 3e-61
 Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 39/290 (13%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           P +  +  R +G G FG V+          E   M A+K +     +  S +      +E
Sbjct: 11  PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQRE 66

Query: 208 IALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ-------------- 253
            AL++   +PNIV+  G   +   + +  EY++ G + + L+                  
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 254 ----------LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM 303
                     L  +      +Q+ +G+ YL  +  VHRD+   N LV  +  VK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 304 AKHITGQSCPL---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQ 359
           +++I          +      WM PE I   N      D+W+ G  + E+ +    P+  
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                 ++ + +   + A P++   E  + +R C  + P  RP+   +  
Sbjct: 246 MAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-61
 Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 17/262 (6%)

Query: 160 GRLLGRGTFGHVYLGF---NSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH 216
             ++GRG FG VY G    N      CA+K +   +D  +      Q   E  ++    H
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSH 87

Query: 217 PNIVRYYGSETLDD-KLYIYLEYVSGGSIYKILQDYGQ-LGESAIRSYTQQILSGLEYLH 274
           PN++   G     +    + L Y+  G +   +++         +  +  Q+  G+++L 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 275 AKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-----CPLSIKGSPYWMAPEVIK 329
           +K  VHRD+   N ++D    VK+ADFG+A+ +  +           K    WMA E ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 330 NSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD 388
                    D+WS G  + E+ T   PP+           +   + L   P++  D   +
Sbjct: 208 T-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLYE 265

Query: 389 FVRKCLQRNPLHRPTAAWLLEH 410
            + KC       RP+ + L+  
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-60
 Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 14/264 (5%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIAL 210
           S   + +++G G FG VY G    S        A+K +        +++       E  +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL----KAGYTEKQRVDFLGEAGI 62

Query: 211 LSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSG 269
           + +  H NI+R  G  +    + I  EY+  G++ K L++  G+     +    + I +G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS----CPLSIKGSPYWMAP 325
           ++YL   N VHRD+   NILV+ +   K++DFG+++ +             K    W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 326 EVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE 385
           E I        A D+WS G  + E+ T             + K  N       P      
Sbjct: 183 EAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLE 409
               + +C Q+    RP  A ++ 
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 6e-60
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 33/285 (11%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLG-----FNSESGEMCAMKEVTLFSDDAKSKESAQQLGQE 207
           P +R   G+ LG G FG V          S++    A+K +      +      + L  E
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTEREALMSE 76

Query: 208 IALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQ----------------- 249
           + +LS L  H NIV   G+ T+     +  EY   G +   L+                 
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 250 -DYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
            D   L    + S++ Q+  G+ +L +KN +HRD+   NIL+      K+ DFG+A+ I 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 309 GQSCPLS---IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
             S  +     +    WMAPE I N        D+WS G  + E+ +          V +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 366 MF-KIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
            F K+         P+H   E  D ++ C   +PL RPT   +++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-57
 Identities = 65/292 (22%), Positives = 127/292 (43%), Gaps = 38/292 (13%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
             R++    +G G +G V   F++++G   A+K++   S   +S   A++  +E+ LL  
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKH 73

Query: 214 LRHPNIVRYYGS----ETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           ++H N++          +L++   +YL     G+    +    +L +  ++    QIL G
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           L+Y+H+ + +HRD+K +N+ V+    +K+ DFG+A+H   +        + ++ APE++ 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 191

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------------------ 371
           N    N  VDIWS+GC + E+ T +  +   + +  +  I                    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 372 -----------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPF 412
                            +    +    D + K L  +   R TAA  L H +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  186 bits (473), Expect = 2e-56
 Identities = 50/275 (18%), Positives = 100/275 (36%), Gaps = 26/275 (9%)

Query: 154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR 213
           G  +K GR +G G+FG ++ G N  + +  A+K     SD  + ++  +       LL+ 
Sbjct: 4   GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR----TYKLLAG 59

Query: 214 LRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYL 273
                 V Y+G E       + ++ +       +     +     +    +Q+L+ ++ +
Sbjct: 60  CTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 274 HAKNTVHRDIKGANILVD-----PSGRVKLADFGMAKHI--------TGQSCPLSIKGSP 320
           H K+ V+RDIK  N L+       +  + + DFGM K                 ++ G+ 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 321 YWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP---AMFKIGNSKE--- 374
            +M+          +   D+ +LG   +       PW   +         +IG  K+   
Sbjct: 178 RYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 375 LPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
           L  +     +E   ++           P   +L  
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-56
 Identities = 74/285 (25%), Positives = 116/285 (40%), Gaps = 32/285 (11%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFN-------SESGEMCAMKEVTLFSDDAKSKESAQQLG 205
           P  R   G+ LG G FG V L                 A+K +        +++    L 
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLSDLI 66

Query: 206 QEIALLSRL-RHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYG------------ 252
            E+ ++  + +H NI+   G+ T D  LY+ +EY S G++ + LQ               
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 253 ----QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT 308
               QL    + S   Q+  G+EYL +K  +HRD+   N+LV     +K+ADFG+A+ I 
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 309 GQSCPLS---IKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA 365
                      +    WMAPE + +        D+WS G  + E+ T          V  
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245

Query: 366 MFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
           +FK+         P + ++E    +R C    P  RPT   L+E 
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-56
 Identities = 65/274 (23%), Positives = 106/274 (38%), Gaps = 23/274 (8%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFN-----SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIA 209
            +    R LG+G+FG VY G        E     A+K V    ++A S     +   E +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIEFLNEAS 75

Query: 210 LLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQ----------LGESAI 259
           ++      ++VR  G  +      + +E ++ G +   L+                 S +
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 260 RSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---CPLSI 316
                +I  G+ YL+A   VHRD+   N +V     VK+ DFGM + I            
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 317 KGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP 376
                WM+PE +K+        D+WS G  + E+AT      Q      + +      L 
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 377 AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
             PD+  D   + +R C Q NP  RP+   ++  
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-55
 Identities = 62/304 (20%), Positives = 118/304 (38%), Gaps = 53/304 (17%)

Query: 156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR 215
           R++  + +G G  G V   +++      A+K++   S   +++  A++  +E+ L+  + 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 74

Query: 216 HPNIVRYYGSETLDDK------LYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSG 269
           H NI+      T          +Y+ +E +       I  +        +     Q+L G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCG 131

Query: 270 LEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIK 329
           +++LH+   +HRD+K +NI+V     +K+ DFG+A+             + Y+ APEVI 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 330 NSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPA------------ 377
              G    VDIWS+GC + EM   K  +   + +    K+      P             
Sbjct: 192 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 378 ----------------------------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE 409
                                            + + +D + K L  +P  R +    L+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 410 HPFV 413
           HP++
Sbjct: 311 HPYI 314

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 24/281 (8%)

Query: 153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTL--FSDDAKSKESAQQLGQEIAL 210
           P  R K G+ LGRG FG V         +    + V +    + A   E    + +   L
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 211 LSRLRHPNIVRYYGSETLDD-KLYIYLEYVSGGSIYKILQDYGQ---------------- 253
           +    H N+V   G+ T     L + +E+   G++   L+                    
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 254 LGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP 313
           L    +  Y+ Q+  G+E+L ++  +HRD+   NIL+     VK+ DFG+A+ I      
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 314 L---SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKI 369
           +     +    WMAPE I +     +  D+WS G  + E+ +    P+   +      + 
Sbjct: 191 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 370 GNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH 410
                    PD+ + E    +  C    P  RPT + L+EH
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 9e-54
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 51/292 (17%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI 219
              +G+G FG V+ G     GE  A+K  +   + +  +E       EI     LRH NI
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENI 59

Query: 220 VRYYGSETLDD----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA 275
           + +  ++  D+    +L++  +Y   GS++  L  Y  +    +        SGL +LH 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHM 118

Query: 276 --------KNTVHRDIKGANILVDPSGRVKLADFGMAKHI-----TGQSCPLSIKGSPYW 322
                       HRD+K  NILV  +G   +AD G+A        T    P    G+  +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 323 MAPEVIKNSNGCNL-----AVDIWSLGCTVIEMATTKPPWSQYEGVPAMF---------- 367
           MAPEV+ +S            DI+++G    E+A        +E     +          
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 368 -----KIGNSKELPAIPDHLS-----DEGKDFVRKCLQRNPLHRPTAAWLLE 409
                 +   K  P IP+              +R+C   N   R TA  + +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (385), Expect = 5e-43
 Identities = 64/336 (19%), Positives = 115/336 (34%), Gaps = 78/336 (23%)

Query: 155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL 214
           +R+   R LG G F  V+L  +  +    AMK V         K   +    EI LL R+
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRV 66

Query: 215 RHPNIVR-------------YYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLG---ESA 258
              +  +              + +    + +++ + +   G     L    +        
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 259 IRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSG------RVKLADFGMAKHITGQS 311
           ++  ++Q+L GL+Y+H +   +H DIK  N+L++         ++K+AD G A       
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYE---------- 361
                  +  + +PEV+  +       DIWS  C + E+ T    +   E          
Sbjct: 187 TN--SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 362 --------GVPAMFKIGNSK----------------------------ELPAIPDHLSDE 385
                   G    + + N K                            E        + E
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 386 GKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAPLER 421
             DF+   LQ +P  R  A  L+ HP++ +   +E 
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  105 bits (262), Expect = 3e-27
 Identities = 31/212 (14%), Positives = 68/212 (32%), Gaps = 47/212 (22%)

Query: 160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTL-------------FSDDAKSKESAQQLGQ 206
           G+L+G G    V+  ++ E    C +K   +             + D   S  + +    
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 207 EIALLSRLRHPNIVRYYGSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQI 266
           E   L +L+   + + Y      +   + +E +    +Y++  +               I
Sbjct: 64  EFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVEN-------PDEVLDMI 112

Query: 267 LSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPE 326
           L  +   + +  VH D+   N+LV   G + + DF  +  +                  E
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG------------EEGWRE 159

Query: 327 VIKNSNGC---------NLAVDIWSLGCTVIE 349
           +++                  DI S    +++
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	444
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.56
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.78
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.64

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-61  Score=457.30  Aligned_cols=259  Identities=26%  Similarity=0.442  Sum_probs=221.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....    ..+..+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            357999999999999999999999999999999987422    2233467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC--
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS--  311 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~--  311 (444)
                      +|||||++|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....  
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999999999887889999999999999999999999999999999999999999999999999998764332  


Q ss_pred             -CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          312 -CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 -~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                       .....+||+.|+|||++.+...++.++|||||||++|||++|+.||........ ................+++++++|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence             234567999999999998776457889999999999999999999976554333 233333333333446789999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |++||++||++|||++|+|+||||++.
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=454.74  Aligned_cols=255  Identities=32%  Similarity=0.589  Sum_probs=227.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++....  .......+.+.+|+.++++++|||||++++++.+++.+|+
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH--ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999999999999999986421  1122234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      |||||++|+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... ..
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~  162 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RT  162 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CE
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-cc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999998765433 34


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+..+....  ..+|..+++++++||.+||
T Consensus       163 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLL  239 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHT
T ss_pred             ccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHHc
Confidence            567999999999998765 8999999999999999999999998766666666655443  3577889999999999999


Q ss_pred             hhCCCCCcCHHHHHhCCCCCC
Q 013354          395 QRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       395 ~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      ++||++|||++|+|+||||..
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-60  Score=456.67  Aligned_cols=257  Identities=33%  Similarity=0.605  Sum_probs=225.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.....  .   ..+.+.+|+.+|++++|||||++++++..++.+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--P---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--S---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--h---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            3579999999999999999999999999999999875321  1   2357889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      +|||||.||+|.+++.+ ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+.... .
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999999999998876 579999999999999999999999999999999999999999999999999998775433 3


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC-CCCCCCCCCCCHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS-KELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li~  391 (444)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+... ......+..+++++++||.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            44567999999999998765 899999999999999999999999876665555444332 2223456789999999999


Q ss_pred             HHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      +||++||++|||++|+|+||||+...
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-59  Score=454.41  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=211.6

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.....    ....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4579999999999999999999999999999999874221    222356789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC---CCCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD---PSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~~~~  310 (444)
                      +|||||+|++|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+.   .++.+||+|||+++.....
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999999999888999999999999999999999999999999999999994   5788999999999887666


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~  388 (444)
                      ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+......  ...+..+++++++
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ---------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence            5556678999999999998765 899999999999999999999999887666666555544332  2344679999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ||++||++||++|||++|+|+||||++...
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~~~~  272 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTA  272 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence            999999999999999999999999986543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=441.71  Aligned_cols=254  Identities=29%  Similarity=0.514  Sum_probs=220.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc----CC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL----DD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~  230 (444)
                      ..|++.+.||+|+||+||+|+++.+++.||+|++...   .......+.+.+|+++|++++|||||++++++..    +.
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            3457888999999999999999999999999998742   2234556789999999999999999999999864    45


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCceEEC-CCCcEEEEeccccccc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKN--TVHRDIKGANILVD-PSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~  307 (444)
                      .+|+|||||++|+|.+++.+...+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            68999999999999999999889999999999999999999999998  99999999999996 5789999999999865


Q ss_pred             cCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhh-HHhcCCCCCCCCCCCCCHHH
Q 013354          308 TGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAM-FKIGNSKELPAIPDHLSDEG  386 (444)
Q Consensus       308 ~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l  386 (444)
                      ... ......||+.|+|||++.+ . ++.++|||||||++|||++|+.||........+ ..+......+.++..+++++
T Consensus       166 ~~~-~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         166 RAS-FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             CTT-SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             cCC-ccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            433 3345679999999999864 3 899999999999999999999999876655444 44444444445667789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVG  414 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~  414 (444)
                      ++||.+||++||++|||++|+|+||||+
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-59  Score=451.64  Aligned_cols=258  Identities=29%  Similarity=0.507  Sum_probs=226.4

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++++.||+|+||+||+|+++.+++.||||++....  .......+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH--ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            57999999999999999999999999999999986421  1122234678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC---
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS---  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~---  311 (444)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+....   
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999998765432   


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVR  391 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~  391 (444)
                      ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+.++....  ..+|..+++++++||+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHHHHHHH
T ss_pred             ccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCCccCCHHHHHHHH
Confidence            233467999999999998766 8999999999999999999999998876666666665543  3577889999999999


Q ss_pred             HHhhhCCCCCcCHHH------HHhCCCCCCCC
Q 013354          392 KCLQRNPLHRPTAAW------LLEHPFVGNAA  417 (444)
Q Consensus       392 ~~L~~dP~~Rpt~~e------lL~hp~~~~~~  417 (444)
                      +||++||++|||++|      +++||||++..
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            999999999999986      68999998753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-59  Score=444.65  Aligned_cols=254  Identities=31%  Similarity=0.554  Sum_probs=212.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc--CCEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL--DDKL  232 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  232 (444)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++....   ..+...+.+.+|+.+|++++|||||++++++.+  ++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            57999999999999999999999999999999987532   234556789999999999999999999998864  4568


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCCCceEECCCCcEEEEeccc
Q 013354          233 YIYLEYVSGGSIYKILQD----YGQLGESAIRSYTQQILSGLEYLHAKN-----TVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      |+|||||++|+|.+++.+    ...+++..++.++.||+.||+|||+++     ||||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999999864    356999999999999999999999976     99999999999999999999999999


Q ss_pred             cccccCCCC-cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCC
Q 013354          304 AKHITGQSC-PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       304 a~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  382 (444)
                      ++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+.... .+.++..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~  238 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRY  238 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTS
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence            988755432 34567999999999997665 8999999999999999999999998876666666655443 34678889


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhCCCC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEHPFV  413 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~  413 (444)
                      ++++++||++||+.||++|||+.|||+|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-59  Score=448.46  Aligned_cols=257  Identities=37%  Similarity=0.613  Sum_probs=223.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      +.|++.+.||+|+||+||+|+++.+++.||+|++....     ....+.+.+|+.+|++++|||||++++++..++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            56999999999999999999999999999999987422     2234578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          235 YLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      |||||++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999999999998764 469999999999999999999999999999999999999999999999999997653321 2


Q ss_pred             cccccCCCcccCcccccC----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC-CCCCCCCCCHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKN----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE-LPAIPDHLSDEGK  387 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~  387 (444)
                      .....||+.|+|||++..    ...|+.++|||||||++|||++|+.||........+..+..... ....+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            234669999999999842    33478999999999999999999999988777776666554432 2244568999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      +||++||++||++|||++|+|+||||+..
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-58  Score=449.44  Aligned_cols=257  Identities=36%  Similarity=0.612  Sum_probs=228.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ..|+..+.||+|+||+||+|+++.+++.||||++...  ........+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--SSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--hccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            3599999999999999999999999999999998742  22334556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      |||||.+|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....   .
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~  169 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N  169 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---C
Confidence            9999999999888888788999999999999999999999999999999999999999999999999999876443   3


Q ss_pred             cccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ...||+.|+|||++.+.  ..|+.++|||||||++|||++|+.||........+..+.........+..+++++++||.+
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  249 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  249 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            45699999999998642  3488999999999999999999999988776666666655555445566789999999999


Q ss_pred             HhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||++|||++|+|+||||...
T Consensus       250 ~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         250 CLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HCcCChhHCcCHHHHHhCHHhcCC
Confidence            999999999999999999999764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-58  Score=445.35  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=230.5

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-ccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-KSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..... ......+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999999999999999997543222 2222356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC----cEEEEecccccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG----RVKLADFGMAKHIT  308 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~  308 (444)
                      |+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||+++|+||||||+|||++.++    .+||+|||++....
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999999888999999999999999999999999999999999999998776    49999999999887


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEG  386 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l  386 (444)
                      .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+.+..+......  +..+..++.++
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  247 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  247 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence            666666777999999999997665 899999999999999999999999887766666665544322  22346789999


Q ss_pred             HHHHHHHhhhCCCCCcCHHHHHhCCCCCCCCC
Q 013354          387 KDFVRKCLQRNPLHRPTAAWLLEHPFVGNAAP  418 (444)
Q Consensus       387 ~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~~  418 (444)
                      ++||++||++||++|||++|+|+||||++...
T Consensus       248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            99999999999999999999999999987543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=451.27  Aligned_cols=258  Identities=30%  Similarity=0.456  Sum_probs=229.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++++...  ......+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            3579999999999999999999999999999999874211  11223567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC-CCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG-QSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~-~~~  312 (444)
                      +|||||.||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.... ...
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987644 334


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+.......+....  ..+|..+++++++||++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence            45678999999999998766 8999999999999999999999998877666666655443  36788999999999999


Q ss_pred             HhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ||++||++|+     +++|+++||||++.
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999     49999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.1e-58  Score=453.80  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=227.9

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++..     ......+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc-----cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3589999999999999999999999999999999864     22344577889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC--CCcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP--SGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~  310 (444)
                      +|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||++.  ++.+||+|||+++.+...
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999999999954 457999999999999999999999999999999999999954  578999999999988776


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~~  388 (444)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+.+..+......  ......+++++++
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            6666778999999999998766 899999999999999999999999877666666665543322  2233568999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      ||++||++||++|||++|+|+||||++..
T Consensus       259 li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.5e-58  Score=452.20  Aligned_cols=256  Identities=23%  Similarity=0.408  Sum_probs=227.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4799999999999999999999999999999998742     23334678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEEC--CCCcEEEEeccccccccCCC
Q 013354          235 YLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVD--PSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~vkL~DFGla~~~~~~~  311 (444)
                      |||||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+||||+  .++.+||+|||+++.+....
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999999999999876544 699999999999999999999999999999999999997  56899999999999887766


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC--CCCCCCCCCHHHHHH
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE--LPAIPDHLSDEGKDF  389 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~~l~~L  389 (444)
                      ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.....  .......+++++++|
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            666678999999999997766 89999999999999999999999988776666666554332  233456799999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      |++||++||++|||++|+|+||||++.
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=452.03  Aligned_cols=257  Identities=30%  Similarity=0.503  Sum_probs=218.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++...    .....+++.+|+.+|++++|||||++++++..++.+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468999999999999999999999999999999987532    2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAK-NTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+.+.... 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            9999999999999999988999999999999999999999974 99999999999999999999999999998764332 


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh-----------------------
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI-----------------------  369 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----------------------  369 (444)
                      ..+.+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+........                       
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             cccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            34567999999999998766 999999999999999999999999764432211000                       


Q ss_pred             ------------------cCCCCCCCCC-CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          370 ------------------GNSKELPAIP-DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       370 ------------------~~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                        ......+.++ ..++.++++||.+||+.||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                              0001111222 2468999999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-57  Score=434.53  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=230.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccc----cHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEc
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAK----SKESAQQLGQEIALLSRLR-HPNIVRYYGSETL  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~  228 (444)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+......    .+...+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3689999999999999999999999999999999976443222    2334567889999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      ++.+|+||||+++|+|.++|+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcccccCCCcccCcccccC-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCC--CCCCCC
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKN-----SNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKEL--PAIPDH  381 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~-----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~  381 (444)
                      .........||+.|+|||++.+     ...++.++||||+||++|||++|+.||...+.......+......  ......
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            6655666779999999999862     334788999999999999999999999887766655555544332  223347


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                      +|+++++||++||++||++|||++|+|+||||+.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            9999999999999999999999999999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-57  Score=444.83  Aligned_cols=255  Identities=27%  Similarity=0.509  Sum_probs=228.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  .......+.+.+|+.+|++++|||||++++++..++.+|+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            57999999999999999999999999999999986421  1122235678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      |||||.|++|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....  ..
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~  159 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  159 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cc
Confidence            9999999999999999889999999999999999999999999999999999999999999999999999876543  34


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+.++....  ..++..+++++++||++||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence            567999999999997665 8999999999999999999999998877666666665543  2567889999999999999


Q ss_pred             hhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          395 QRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       395 ~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ++||++|+     |++++|+||||++.
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hhCHHhccccchhhHHHHHcCcccccC
Confidence            99999996     99999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-56  Score=445.82  Aligned_cols=261  Identities=29%  Similarity=0.412  Sum_probs=223.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-cccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ++|++.++||+|+||.||+|+++.+|+.||||++...... ...........+|+.+++.++|||||++++++..++.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999999999999999998642211 122223334445678888889999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP  313 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~  313 (444)
                      +|||||.||+|.+++.+...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.... .
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~  162 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P  162 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-C
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-c
Confidence            999999999999999998899999999999999999999999999999999999999999999999999998775443 3


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh-cCCCCCCCCCCCCCHHHHHHHHH
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI-GNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      ....||+.|+|||++.....++.++|||||||+||||++|+.||............ ........++..+++++++||.+
T Consensus       163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG  242 (364)
T ss_dssp             CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHH
T ss_pred             cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHH
Confidence            45679999999999976666899999999999999999999999875543322211 12233346778899999999999


Q ss_pred             HhhhCCCCCcC-----HHHHHhCCCCCCC
Q 013354          393 CLQRNPLHRPT-----AAWLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rpt-----~~elL~hp~~~~~  416 (444)
                      ||++||++|||     ++|+++||||++.
T Consensus       243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         243 LLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            99999999999     7999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-57  Score=445.88  Aligned_cols=255  Identities=31%  Similarity=0.513  Sum_probs=227.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++....  .......+.+.+|+.+|+.++|||||++++++.....+++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            58999999999999999999999999999999986321  1112234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCcc
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCPL  314 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~  314 (444)
                      ||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...  ..
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~  196 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW  196 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cc
Confidence            9999999999999999889999999999999999999999999999999999999999999999999999987543  34


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHh
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCL  394 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L  394 (444)
                      ...||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  ..++..+++++.+||++||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHh
Confidence            567999999999998765 8999999999999999999999998876666666665543  3567889999999999999


Q ss_pred             hhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          395 QRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       395 ~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ++||++|+     |+++|++||||++.
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999995     99999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=438.54  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=214.7

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          159 KGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       159 ~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      ..++||+|+||+||+|+++.+|+.||||+++............+.+.+|+.+|++++|||||++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46889999999999999999999999999875433323333446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-Cccccc
Q 013354          239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-CPLSIK  317 (444)
Q Consensus       239 ~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~~~~~~  317 (444)
                      +.++++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            9988888777766789999999999999999999999999999999999999999999999999998765433 334567


Q ss_pred             CCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC---------------------CCCC
Q 013354          318 GSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS---------------------KELP  376 (444)
Q Consensus       318 gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------------~~~~  376 (444)
                      ||+.|+|||++.....++.++|||||||++|||++|.+||......+.+..+...                     ...+
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            9999999999987766899999999999999999999999876655544433210                     0001


Q ss_pred             C-----CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          377 A-----IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       377 ~-----~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                      .     +...+++++++||++||++||++|||++|+|+||||++..
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            1     1135789999999999999999999999999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=437.11  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=224.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHH-ccCCCCeeeEeeeEEcCCEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLS-RLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      ++|++++.||+|+||+||+|+++.+++.||||++++...  ......+.+.+|..++. .++|||||++++++.+++.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            579999999999999999999999999999999874211  11122345556666654 689999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-C
Q 013354          234 IYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-C  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-~  312 (444)
                      +||||+++|+|.+++.....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            999999999999999998999999999999999999999999999999999999999999999999999998765433 3


Q ss_pred             cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 013354          313 PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRK  392 (444)
Q Consensus       313 ~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~  392 (444)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+....  +.+|..+++++++||++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             ccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHH
Confidence            34467999999999998766 8999999999999999999999998876666666665443  46788899999999999


Q ss_pred             HhhhCCCCCcCHH-HHHhCCCCCCC
Q 013354          393 CLQRNPLHRPTAA-WLLEHPFVGNA  416 (444)
Q Consensus       393 ~L~~dP~~Rpt~~-elL~hp~~~~~  416 (444)
                      ||++||++||+++ |+++||||++.
T Consensus       237 ~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         237 LFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             hcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999996 89999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=439.54  Aligned_cols=256  Identities=27%  Similarity=0.378  Sum_probs=225.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      -++|++++.||+|+||+||+|+++.+++.||||+++..      ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999999999999999998742      122356789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC--CcEEEEeccccccccCC
Q 013354          234 IYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS--GRVKLADFGMAKHITGQ  310 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~vkL~DFGla~~~~~~  310 (444)
                      +|||||+|++|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999999998765 69999999999999999999999999999999999999754  47999999999887666


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC--CCCCCCCHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~  388 (444)
                      .......+|+.|+|||.+.+.. ++.++|||||||++|||++|..||........+..+.......  .....+++++++
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            5556667999999999997665 8999999999999999999999998877666666665443321  122468999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||++||++|||++|+|+||||+..
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-56  Score=423.23  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=216.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeeccccc-ccHHHHHHHHHHHHHHHccC--CCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDA-KSKESAQQLGQEIALLSRLR--HPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~  230 (444)
                      .++|+++++||+|+||+||+|+++.+|+.||||++....... .......++.+|+.+|++++  |||||++++++...+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999999999999999987532211 11112234668999999997  899999999999999


Q ss_pred             EEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCC-CcEEEEecccccccc
Q 013354          231 KLYIYLEYVSG-GSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPS-GRVKLADFGMAKHIT  308 (444)
Q Consensus       231 ~~~lv~e~~~g-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~~  308 (444)
                      ..++||||+.+ +++.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999975 6889999888899999999999999999999999999999999999999854 789999999998754


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      .. ......||+.|+|||++.+...++.++|||||||++|||++|+.||...+   .   +....  ..++..+|+++++
T Consensus       163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~---i~~~~--~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E---IIRGQ--VFFRQRVSSECQH  233 (273)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HHHCC--CCCSSCCCHHHHH
T ss_pred             cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---H---Hhhcc--cCCCCCCCHHHHH
Confidence            33 34456799999999999877656788999999999999999999996521   1   11111  2466789999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ||++||++||++|||++|+|+||||++.
T Consensus       234 li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=422.82  Aligned_cols=258  Identities=30%  Similarity=0.540  Sum_probs=213.9

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...   ..+...+++.+|+.+|++++|||||++++++..++.+|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            57999999999999999999999999999999986422   222335678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC-
Q 013354          235 YLEYVSGGSIYKILQ-D-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS-  311 (444)
Q Consensus       235 v~e~~~ggsL~~~l~-~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~-  311 (444)
                      ||||+.+ .+.+++. . ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... 
T Consensus        79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9999965 4444443 3 3469999999999999999999999999999999999999999999999999998775433 


Q ss_pred             CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC----------------CCCC
Q 013354          312 CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----------------SKEL  375 (444)
Q Consensus       312 ~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----------------~~~~  375 (444)
                      ......||+.|+|||++.....++.++|||||||++|+|++|+.||...+....+..+..                ....
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            344556999999999987777678999999999999999999999987654443332210                0000


Q ss_pred             CC-----------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          376 PA-----------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       376 ~~-----------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                      ..           ....++.++++||++||++||++|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00           113568999999999999999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-55  Score=419.83  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=215.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++...   .   ..+++.+|+.+|++++|||||++++++.+++.+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---M---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---c---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            4568999999999999999999999999999999876321   1   235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++|||||++|+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            9999999999999999764  45899999999999999999999999999999999999999999999999999876554


Q ss_pred             CCc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          311 SCP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       311 ~~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ...  ....|++.|+|||++.+.. ++.++|||||||++|||++|..||........+..+......+.++..+++++++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            322  2344789999999998766 8999999999999999999766655444444444333333445778899999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHh
Q 013354          389 FVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ||.+||+.||++|||+.||++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-54  Score=418.67  Aligned_cols=252  Identities=25%  Similarity=0.429  Sum_probs=207.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGE---MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      ..++|++.++||+|+||+||+|+++.+++   .||||.+..    .......+.+.+|+.+|++++|||||++++++..+
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            34689999999999999999999987765   477776542    23345567899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +.+++|||||++|+|.+++... +.+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999999998874 469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc------ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCC
Q 013354          309 GQSCP------LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDH  381 (444)
Q Consensus       309 ~~~~~------~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  381 (444)
                      .....      ....||+.|+|||++.+.. ++.++|||||||+||||++ |+.||......+....+...... ..+..
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~  257 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-PPPMD  257 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CCCTT
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCcc
Confidence            43322      1234789999999998766 8999999999999999998 89999887777766666665544 56788


Q ss_pred             CCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          382 LSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       382 ~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++.++.+||.+||+.||++|||+.||+++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999988764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=427.74  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             CCCeeee-eeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHc-cCCCCeeeEeeeEEc---
Q 013354          154 GSRWKKG-RLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSR-LRHPNIVRYYGSETL---  228 (444)
Q Consensus       154 ~~~~~~~-~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~---  228 (444)
                      .++|++. ++||+|+||+||+|+++.+++.||||+++.      .    ..+.+|+.++.+ ++|||||++++++.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------c----HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            3579876 579999999999999999999999999862      1    346679988655 489999999999865   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEecc
Q 013354          229 -DDKLYIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFG  302 (444)
Q Consensus       229 -~~~~~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFG  302 (444)
                       +..+|+|||||+||+|.+++.+.+  .+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467899999999999999998753  5999999999999999999999999999999999999975   4579999999


Q ss_pred             ccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCC--CCCCC-
Q 013354          303 MAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKE--LPAIP-  379 (444)
Q Consensus       303 la~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~-  379 (444)
                      +++............||+.|+|||++.+.. |+.++|||||||++|||++|+.||...........+.....  ...++ 
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            999887766667778999999999997665 89999999999999999999999976554333222211111  11222 


Q ss_pred             ---CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          380 ---DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       380 ---~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                         ..+++++++||++||++||++|||+.|+|+||||.+.
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence               3589999999999999999999999999999999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=425.60  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=216.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGE-----MCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      +.++|++++.||+|+||+||+|++..+++     .||+|.+...    ......+.+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            34689999999999999999999876544     6889987532    2233446788999999998 899999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG-----------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDI  283 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  283 (444)
                      ...+.+++|||||++|+|.++|+...                       .+++..++.++.||+.||+|||+++||||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            99999999999999999999997642                       3789999999999999999999999999999


Q ss_pred             CCCceEECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 013354          284 KGANILVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQ  359 (444)
Q Consensus       284 kp~NIll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~  359 (444)
                      ||+|||++.++.+||+|||+|+........   ....||+.|+|||++.+.. ++.++|||||||+||||++ |+.||..
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999876544322   2455799999999997666 8999999999999999998 8999988


Q ss_pred             CCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ......+.++......+..|..+++++++||.+||+.||++|||++||++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            776666655554445557788999999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-54  Score=417.65  Aligned_cols=257  Identities=27%  Similarity=0.456  Sum_probs=215.6

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++....   .....+++.+|+.+|++++||||+++++++..++..++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            58999999999999999999986 689999999875332   22234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      +||++.++.+..+....+.+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||++........ .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence            999998877777777778899999999999999999999999999999999999999999999999999987654332 3


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC----------------------
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN----------------------  371 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----------------------  371 (444)
                      ....+++.|+|||.+.+...++.++|||||||++|||++|+.||........+.++..                      
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            3456899999999998777689999999999999999999999987654443332210                      


Q ss_pred             -----CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          372 -----SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       372 -----~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                           ..........+++++++||++||++||++|||++|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                 00011234567999999999999999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=416.93  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEEEEec
Q 013354          161 RLLGRGTFGHVYLGFNS--ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYIYLEY  238 (444)
Q Consensus       161 ~~LG~G~fg~Vy~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  238 (444)
                      +.||+|+||+||+|.++  .+++.||||+++..   .......+.+.+|+.+|++++|||||++++++..+ ..++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh---hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence            57999999999999864  35678999998632   22334557899999999999999999999998754 57899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCCc----c
Q 013354          239 VSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSCP----L  314 (444)
Q Consensus       239 ~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~----~  314 (444)
                      +++|+|.+++.+...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++.+......    .
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            999999999999888999999999999999999999999999999999999999999999999999876544322    2


Q ss_pred             cccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHH
Q 013354          315 SIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKC  393 (444)
Q Consensus       315 ~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~  393 (444)
                      ...||+.|+|||++.+.. ++.++|||||||++|||++ |+.||......+....+..... +.+|..+++++++||.+|
T Consensus       169 ~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             --CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHHHHHHHHHH
Confidence            345899999999997666 8999999999999999998 8999998776666666665544 467889999999999999


Q ss_pred             hhhCCCCCcCHHHH---HhCCCC
Q 013354          394 LQRNPLHRPTAAWL---LEHPFV  413 (444)
Q Consensus       394 L~~dP~~Rpt~~el---L~hp~~  413 (444)
                      |+.||++|||+.+|   |+|+|+
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999997   466654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=415.00  Aligned_cols=251  Identities=28%  Similarity=0.477  Sum_probs=207.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      +.++|++.+.||+|+||+||+|+++   ..||||+++...   ......+.+.+|+.+|++++|||||++++++.. +.+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS---CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            3567999999999999999999753   359999986532   223456788999999999999999999998754 568


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||||++|+|.+++... ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+++......
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999765 469999999999999999999999999999999999999999999999999998764332


Q ss_pred             ---CcccccCCCcccCcccccCc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh-cCCCC---CCCCCCCC
Q 013354          312 ---CPLSIKGSPYWMAPEVIKNS--NGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI-GNSKE---LPAIPDHL  382 (444)
Q Consensus       312 ---~~~~~~gt~~y~APE~~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~~~~---~~~~~~~~  382 (444)
                         ......||+.|+|||++...  ..++.++|||||||+||||++|+.||........+... .....   ...++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence               22345699999999998643  23799999999999999999999999887665544332 22222   23456789


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ++++++||.+||+.||++|||+.||+++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=411.23  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=205.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      +.++|++.+.||+|+||+||+|+++ +++.||||+++..   ...   .+++.+|+.++++++|||||++++++..++.+
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   75 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCc---HHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence            3468999999999999999999986 4788999988632   111   25688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999999999998765 458999999999999999999999999999999999999999999999999998765443


Q ss_pred             Cc--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHH
Q 013354          312 CP--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKD  388 (444)
Q Consensus       312 ~~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  388 (444)
                      ..  ....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||...........+..... +..|..+++++.+
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~  233 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQ  233 (263)
T ss_dssp             ---------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-CCCCTTSCHHHHH
T ss_pred             ceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHH
Confidence            22  2356899999999998766 8999999999999999999 5666666555455555555443 4567889999999


Q ss_pred             HHHHHhhhCCCCCcCHHHHHhC
Q 013354          389 FVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       389 Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ||.+||+.||++|||++||++|
T Consensus       234 li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=415.42  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=218.4

Q ss_pred             CCCeeeeee-ecccCceEEEEEEEcC--CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRL-LGRGTFGHVYLGFNSE--SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~-LG~G~fg~Vy~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      .++|.+.++ ||+|+||+||+|.++.  ++..||||+++.    .......+.+.+|+.+|++++|||||++++++..+ 
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh----hcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            356888885 9999999999998754  455799999863    23455667899999999999999999999998754 


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+|+|||||++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            589999999999999998653 5699999999999999999999999999999999999999999999999999987755


Q ss_pred             CCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ....    ....||+.|+|||++.... ++.++|||||||++|||++ |+.||......+....+..+.. +.+|..+++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~  239 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPP  239 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CCCCTTCCH
T ss_pred             cccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCH
Confidence            4322    2345889999999997665 8999999999999999998 9999998877777676666554 467889999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHH---HhCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWL---LEHPFVG  414 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~el---L~hp~~~  414 (444)
                      ++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999877   6778763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=416.32  Aligned_cols=259  Identities=31%  Similarity=0.504  Sum_probs=211.7

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc---CCCCeeeEeeeEEc--
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSES-GEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL---RHPNIVRYYGSETL--  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~--  228 (444)
                      ++|++.+.||+|+||+||+|++..+ ++.||||+++.......   ....+.+|+.+|+.|   +||||+++++++..  
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS---CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch---HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            5899999999999999999999765 67899999875332211   122344566666555   89999999998853  


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMA  304 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla  304 (444)
                         +..++++|||+.++.+...... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence               3578999999988777655443 345999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-------------
Q 013354          305 KHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-------------  371 (444)
Q Consensus       305 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------  371 (444)
                      +............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+..             
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            8776666666778999999999997766 89999999999999999999999987655444333211             


Q ss_pred             ------------CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCCC
Q 013354          372 ------------SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNAA  417 (444)
Q Consensus       372 ------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~~  417 (444)
                                  ......+...+++++++||++||++||++|||++|+|+||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                        1111234467899999999999999999999999999999999863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-54  Score=406.28  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=218.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLY  233 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  233 (444)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++....   .   .+.+.+|+.++++++||||+++++++.+++.++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---C---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            468999999999999999999985 688999999874221   1   246889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC
Q 013354          234 IYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC  312 (444)
Q Consensus       234 lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~  312 (444)
                      +||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999999999999765 35699999999999999999999999999999999999999999999999999987654332


Q ss_pred             c--ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          313 P--LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       313 ~--~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                      .  ....||+.|+|||++.+.. ++.++|||||||++|||++ |+.||......+....+..... ...|..++.++++|
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~l  233 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPHLASEKVYTI  233 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccccHHHHHH
Confidence            2  2355899999999998766 8999999999999999998 8999998887777777766554 46788999999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      |++||+.||++|||+++||+|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5e-54  Score=412.10  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=212.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC---
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD---  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  230 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..  ...+....+.+.+|+.+++.++||||+++++++..++   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            46899999999999999999999999999999998742  2344566778999999999999999999999987643   


Q ss_pred             -EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 -KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 -~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                       .+|+||||++|++|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.+.....
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence             4899999999999999999988999999999999999999999999999999999999999999999999999875533


Q ss_pred             CC----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCCCCCC--CCCCCCC
Q 013354          310 QS----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNSKELP--AIPDHLS  383 (444)
Q Consensus       310 ~~----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s  383 (444)
                      ..    ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+......++......+  .....+|
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             ccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence            22    233456999999999997765 8999999999999999999999998766655555544433322  3456789


Q ss_pred             HHHHHHHHHHhhhCCCCCc-CHHHHHhCCCC
Q 013354          384 DEGKDFVRKCLQRNPLHRP-TAAWLLEHPFV  413 (444)
Q Consensus       384 ~~l~~Li~~~L~~dP~~Rp-t~~elL~hp~~  413 (444)
                      +++++||++||++||++|| |++++ .|+|.
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            9999999999999999999 55554 45543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=412.02  Aligned_cols=252  Identities=29%  Similarity=0.491  Sum_probs=213.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      +.++|++.+.||+|+||+||+|+++ +++.||||+++...   .   ..+.+.+|+.+|++++|||||++++++.. +.+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---M---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---C---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            4568999999999999999999976 47889999886321   1   23568999999999999999999998754 557


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDY--GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999999977543  35999999999999999999999999999999999999999999999999999877543


Q ss_pred             CC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 SC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      ..  .....||+.|+|||++.... ++.++|||||||++|||+|| .+||........+..+..... +..|..++++++
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~  240 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-MVRPDNCPEELY  240 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTCCHHHH
T ss_pred             ccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CCCcccChHHHH
Confidence            32  23456899999999997665 89999999999999999995 555555554455555555443 467889999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh--CCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE--HPFVG  414 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~--hp~~~  414 (444)
                      +||++||+.||++|||+.||++  |+||.
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999998  77774

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=404.07  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC----cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG----EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL  228 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  228 (444)
                      ..++|+..++||+|+||.||+|+++.++    ..||||++..    ........++.+|+.+|++++|||||++++++..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc----ccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            4568999999999999999999987654    4699998863    2334445678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                      .+.+++||||+.+++|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999999999988765 56999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCC-CCCCCChhhhHHhcCCCCCCCCCCCC
Q 013354          308 TGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIPDHL  382 (444)
Q Consensus       308 ~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~  382 (444)
                      .....    .....||+.|+|||++.+.. ++.++|||||||++|||+++..| |........+..+..... +..+..+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~  238 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LPTPMDC  238 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTC
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CCCchhh
Confidence            44322    12345899999999998766 89999999999999999995554 544444444555544443 4678889


Q ss_pred             CHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          383 SDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       383 s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      +.++++||.+||+.||++|||+.||++
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=404.05  Aligned_cols=259  Identities=28%  Similarity=0.467  Sum_probs=222.1

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEEEE
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  234 (444)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...   ......+++.+|+.+|+.++|+||+++++++......++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            58999999999999999999999999999999997532   233456788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCCC-c
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQSC-P  313 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-~  313 (444)
                      |+|++.+++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.++....... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            999999999999999888999999999999999999999999999999999999999999999999999987654432 3


Q ss_pred             ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh-hhHHhc----------------------
Q 013354          314 LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP-AMFKIG----------------------  370 (444)
Q Consensus       314 ~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~----------------------  370 (444)
                      ....+++.|+|||++.....++.++|||||||++|||++|+.||....... .+..+.                      
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            344578899999998877767999999999999999999999875433322 222210                      


Q ss_pred             -----CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 -----NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 -----~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                           ...........++.++++||++||++||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                 0112223445678999999999999999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=416.53  Aligned_cols=252  Identities=28%  Similarity=0.427  Sum_probs=210.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------C
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------D  229 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~  229 (444)
                      +|+..++||+|+||+||+|+++.+|+.||||++.....         .+.+|+.+|++++|+||+++++++..      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            69999999999999999999999999999999874321         22369999999999999999998854      3


Q ss_pred             CEEEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEeccccc
Q 013354          230 DKLYIYLEYVSGGSIYKIL---QDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAK  305 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~  305 (444)
                      ..+++|||||.++.+..+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            3589999999765433333   2345699999999999999999999999999999999999998775 89999999999


Q ss_pred             cccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--------------
Q 013354          306 HITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--------------  371 (444)
Q Consensus       306 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------  371 (444)
                      .+..........||+.|+|||.+.+...++.++|||||||++|||++|+.||...+....+..+..              
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            887666667778999999999987766689999999999999999999999987665444333211              


Q ss_pred             ----CCCCC---------CCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 ----SKELP---------AIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ----~~~~~---------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                          ....+         .....+++++++||.+||++||++|||+.|+|+||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                00111         1234579999999999999999999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-53  Score=415.69  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=214.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||+++.   ........+.+.+|+.+|++++|||||++++++...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSS---TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEch---hhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            35689999999999999999999999999999999864   2234556678999999999999999999999987654  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          231 ----KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       231 ----~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                          .+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence                579999999 6788887765 6899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhc----------------
Q 013354          307 ITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIG----------------  370 (444)
Q Consensus       307 ~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----------------  370 (444)
                      ....  .....||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+..+.                
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            6543  3456699999999999876668999999999999999999999998765443322211                


Q ss_pred             -------------CCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          371 -------------NSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       371 -------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                   .......+...+++++++||++||+.||++|||+.|+|+||||++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                         1111223446789999999999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=404.57  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=211.0

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCCEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDDKL  232 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  232 (444)
                      ..++|++++.||+|+||.||+|+++.+ +.||||+++...   ..   .+.+.+|+.+|++++|+|||++++++.+ +.+
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~   86 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   86 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence            356899999999999999999998764 679999886321   11   2568899999999999999999999865 558


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQD--YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++||||+.+|+|..++..  ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999999988854  356999999999999999999999999999999999999999999999999999876433


Q ss_pred             C--CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCC-CCCCCChhhhHHhcCCCCCCCCCCCCCHHHH
Q 013354          311 S--CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPP-WSQYEGVPAMFKIGNSKELPAIPDHLSDEGK  387 (444)
Q Consensus       311 ~--~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  387 (444)
                      .  ......||+.|+|||++.+.. ++.++|||||||++|||++|..| |......+.+..+..... +.++..++++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~  244 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESLH  244 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCCTTSCHHHH
T ss_pred             CceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CCCCcccCHHHH
Confidence            2  223356899999999998766 89999999999999999996555 444444445555554443 457889999999


Q ss_pred             HHHHHHhhhCCCCCcCHHHHHh--CCCCCCCCCC
Q 013354          388 DFVRKCLQRNPLHRPTAAWLLE--HPFVGNAAPL  419 (444)
Q Consensus       388 ~Li~~~L~~dP~~Rpt~~elL~--hp~~~~~~~~  419 (444)
                      +||.+||+.||++||++++|++  ++||....+.
T Consensus       245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             HHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            9999999999999999999998  8999876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=401.42  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=206.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcC
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLD  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  229 (444)
                      +.++|++++.||+|+||.||+|++..++   ..||||.++.    .......+.+.+|+.+|++++|||||++++++. +
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3468999999999999999999986543   4577777642    234555678999999999999999999999986 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++||||||||+||+++.++.+||+|||+++.+.
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            6789999999999999987654 469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          309 GQSC--PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       309 ~~~~--~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||......+.+..+...... .++..++++
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-~~~~~~~~~  237 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPT  237 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred             CCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHH
Confidence            4332  23355899999999997666 8999999999999999998 89999888777777777665544 678899999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +++||.+||+.||++|||+.||++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=409.51  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=210.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----  228 (444)
                      -++|++.+.||+|+||+||+|+++.+|+.||||++.....   .....+++.+|+.+|++++|+||+++++++..     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            4689999999999999999999999999999998865322   22234567899999999999999999998755     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          229 ---DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       229 ---~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                         +..+++||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               34689999999877777666666789999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCC-----CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcCC--CCCCCC
Q 013354          306 HITGQS-----CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGNS--KELPAI  378 (444)
Q Consensus       306 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~  378 (444)
                      ......     ......||+.|+|||++.+...++.++|||||||++|||++|+.||...........+...  ...+..
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            654322     2334569999999999987766899999999999999999999999875544433322110  000000


Q ss_pred             -------------------C---------CCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          379 -------------------P---------DHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       379 -------------------~---------~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                         .         ...+.++++||.+||++||++|||++|+|+||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence                               0         0137788999999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=411.62  Aligned_cols=258  Identities=27%  Similarity=0.491  Sum_probs=211.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC--
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD--  230 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--  230 (444)
                      .+++|++.+.||+|+||+||+|+++.+|+.||||++...    ......+.+.+|+.+|++++||||+++++++....  
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence            456899999999999999999999999999999998642    34555678899999999999999999999987543  


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccc
Q 013354          231 ---KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHI  307 (444)
Q Consensus       231 ---~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~  307 (444)
                         .++++ +++.+++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence               34555 55669999999976 57999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCC----cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC------------
Q 013354          308 TGQSC----PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN------------  371 (444)
Q Consensus       308 ~~~~~----~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------  371 (444)
                      .....    .....||+.|+|||++.....++.++||||+||++|||++|+.||...+..........            
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            44322    23456999999999997777689999999999999999999999976553322211100            


Q ss_pred             ---------------CC--CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 ---------------SK--ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 ---------------~~--~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                                     ..  ....+...++.++++||.+||++||++|||++|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                           00  0011234678999999999999999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=406.10  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEM----CAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ++|++.++||+|+||+||+|++..+|+.    ||+|.++.    .......+.+.+|+.++++++|||||++++++.++.
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4799999999999999999999888774    67776642    122334567899999999999999999999998654


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                       .++++||+.+++|.+++... ..+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++....
T Consensus        85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence             67888999999999888764 4699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          310 QSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       310 ~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ....   ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...........+..... +..+..++.+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHH
Confidence            3322   2345899999999998776 8999999999999999998 8999987766665555555444 4667889999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||.+||+.||++|||+.||++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.3e-52  Score=405.97  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=212.6

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEc--C
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETL--D  229 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~  229 (444)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||+++..     .   .+++.+|+.+|+.++ ||||+++++++..  .
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----H---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            346899999999999999999999999999999998631     1   246788999999995 9999999999874  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCC-cEEEEecccccccc
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSG-RVKLADFGMAKHIT  308 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~  308 (444)
                      ..+++|||||.+++|..+.   +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+++...
T Consensus       105 ~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             CceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            5699999999999987763   4699999999999999999999999999999999999998655 69999999999877


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh-hHHh------------------
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA-MFKI------------------  369 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~------------------  369 (444)
                      .........+|+.|+|||.+.+...++.++||||+||++|||++|+.||........ ...+                  
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            666666777999999999988777689999999999999999999999976543221 0000                  


Q ss_pred             ---------cCCC--------CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          370 ---------GNSK--------ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       370 ---------~~~~--------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                               ....        ........+++++++||++||++||++|||++|+|+||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                     0000        0011224578999999999999999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=408.44  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=220.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEE---cCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeEEcC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFN---SESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSETLD  229 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~---~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~  229 (444)
                      .++|++.+.||+|+||+||+|++   +.+|+.||||+++...... .....+.+.+|+.+|++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-chHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            46799999999999999999987   4468999999986432211 11223567889999999976 8999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          230 DKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       230 ~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      ..++++|||+.+++|.+++...+.+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            99999999999999999999989999999999999999999999999999999999999999999999999999987644


Q ss_pred             CC--CcccccCCCcccCcccccCcC-CCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC--CCCCCCCCCCCCH
Q 013354          310 QS--CPLSIKGSPYWMAPEVIKNSN-GCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN--SKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~--~~~~~~gt~~y~APE~~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~s~  384 (444)
                      ..  ......|++.|+|||.+.... .++.++|||||||+||||++|+.||...........+..  ....+.++..+++
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            32  234466999999999987543 368899999999999999999999977554433322221  1223456778999


Q ss_pred             HHHHHHHHHhhhCCCCCc-----CHHHHHhCCCCCCC
Q 013354          385 EGKDFVRKCLQRNPLHRP-----TAAWLLEHPFVGNA  416 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rp-----t~~elL~hp~~~~~  416 (444)
                      ++++||++||++||++||     |++|+++||||++.
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            999999999999999999     58999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=400.25  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=204.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSE-----SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSET  227 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  227 (444)
                      .++|++.+.||+|+||.||+|++..     +++.||||+++.    .......+.+.+|..++.++ +|+||+.+++++.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            4689999999999999999999754     457899998763    23344456777788877777 6899999999876


Q ss_pred             c-CCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEE
Q 013354          228 L-DDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILV  290 (444)
Q Consensus       228 ~-~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  290 (444)
                      . +..+++|||||++|+|.++++...                .+++..++.++.||+.||+|||+++||||||||+||||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 456899999999999999997532                38899999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCChhhh
Q 013354          291 DPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAM  366 (444)
Q Consensus       291 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~  366 (444)
                      +.++.+||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++| .+||........+
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999986544332   23456999999999998766 89999999999999999986 5688776655555


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          367 FKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       367 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      .........+.++..+++++++||.+||+.||++|||++||++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44433344457788999999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-52  Score=402.43  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=214.6

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEcCCCcE--EEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeEEc
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNSESGEM--CAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSETL  228 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~--vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  228 (444)
                      .+-++|++.++||+|+||.||+|+++.++..  ||||.++.    ....+..+.+.+|+++|+++ +|||||++++++..
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC----C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc----ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            3446899999999999999999999988875  56666542    12333456799999999999 79999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDY----------------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP  292 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  292 (444)
                      ++.+++||||+++|+|.++|++.                ..+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence            99999999999999999999754                46899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCC-CCCCCCCChhhhHHhcC
Q 013354          293 SGRVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQYEGVPAMFKIGN  371 (444)
Q Consensus       293 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~  371 (444)
                      ++.+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|||++|. +||...+....+..+..
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            9999999999998765555555566999999999997766 899999999999999999964 67877666666666655


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          372 SKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       372 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      ... +..+..+++++++||.+||+.||++|||+.||+++
T Consensus       242 ~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444 56788899999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-51  Score=398.18  Aligned_cols=251  Identities=24%  Similarity=0.427  Sum_probs=216.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSET  227 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  227 (444)
                      +.++|++.+.||+|+||+||+|+++     .+++.||||+++.    .......+++.+|+.+|++++||||+++++++.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh----hcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            3568999999999999999999875     3568899998763    233455678999999999999999999999999


Q ss_pred             cCCEEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 013354          228 LDDKLYIYLEYVSGGSIYKILQDYG------------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDI  283 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  283 (444)
                      ..+..+++|||+.+|+|.+++....                        .+++..++.++.||+.||+|||+++||||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            9999999999999999999997532                        3788999999999999999999999999999


Q ss_pred             CCCceEECCCCcEEEEeccccccccCCC---CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCC-CCCCC
Q 013354          284 KGANILVDPSGRVKLADFGMAKHITGQS---CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTK-PPWSQ  359 (444)
Q Consensus       284 kp~NIll~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~-~Pf~~  359 (444)
                      ||+||||+.++.+||+|||+++.+....   ......|++.|+|||++.+.. ++.++|||||||++|||++|. +||..
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999998664332   223456889999999998666 899999999999999999975 67887


Q ss_pred             CCChhhhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          360 YEGVPAMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+....+.... .+.++..+++++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77667667766655 45778899999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=394.36  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=208.0

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCC-C--cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSES-G--EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD  230 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-g--~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  230 (444)
                      ..+|++.+.||+|+||.||+|++..+ +  ..||||+++..  .....+..+.+.+|+.+|++++||||+++++++.+ .
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~--~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD--VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChh--hcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            45799999999999999999987533 3  36899987642  22334456789999999999999999999999965 4


Q ss_pred             EEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccC
Q 013354          231 KLYIYLEYVSGGSIYKILQDY-GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITG  309 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~  309 (444)
                      .+++||||+++++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            678999999999999887654 4699999999999999999999999999999999999999999999999999997755


Q ss_pred             CCCc----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCH
Q 013354          310 QSCP----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSD  384 (444)
Q Consensus       310 ~~~~----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  384 (444)
                      ....    ....|+..|+|||++.+.. ++.++|||||||++|||++ |+.||...+..+....+......+..+..++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            4322    2344788999999998766 8999999999999999998 89999988877777777666666677889999


Q ss_pred             HHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          385 EGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       385 ~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ++++||.+||+.||++|||+.||++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=390.37  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=204.7

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-CCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-DDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~  232 (444)
                      .++|++.+.||+|+||.||+|+++  |..||||+++..       ...+.+.+|++++++++||||+++++++.+ ++.+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            457999999999999999999884  788999988531       123568899999999999999999998854 4668


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG--QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQ  310 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~  310 (444)
                      ++||||+++|+|.+++.+..  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999997643  4899999999999999999999999999999999999999999999999999876443


Q ss_pred             CCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChhhhHHhcCCCCCCCCCCCCCHHHHHH
Q 013354          311 SCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVPAMFKIGNSKELPAIPDHLSDEGKDF  389 (444)
Q Consensus       311 ~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L  389 (444)
                        .....++..|+|||++.+.. ++.++|||||||++|||++ |++||...........+..... +.++..+++++++|
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l  232 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAPDGCPPAVYEV  232 (262)
T ss_dssp             -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-CCCCTTCCHHHHHH
T ss_pred             --CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCccCCHHHHHH
Confidence              23445889999999998766 8999999999999999998 7888887766666666665544 56788999999999


Q ss_pred             HHHHhhhCCCCCcCHHHHHhC
Q 013354          390 VRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       390 i~~~L~~dP~~Rpt~~elL~h  410 (444)
                      |++||+.||++|||+.+|+++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=406.27  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-----
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-----  228 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----  228 (444)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .......+++.+|+.+|++++|+|||++++++..     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            46899999999999999999999999999999998642   2344556788999999999999999999999863     


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      +...+++|+++.+++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence            2334566777789999999965 579999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------------
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------------  371 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------  371 (444)
                      .  ......|++.|+|||++.+...++.++|||||||++|+|++|+.||...+.......+..                 
T Consensus       173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence            3  234556899999999987776678999999999999999999999987554333222211                 


Q ss_pred             -------CCCCCC-----CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCCC
Q 013354          372 -------SKELPA-----IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGNA  416 (444)
Q Consensus       372 -------~~~~~~-----~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~~  416 (444)
                             ....+.     ....+++++++||++||+.||++|||++|+|+||||++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                   001111     124579999999999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=393.33  Aligned_cols=251  Identities=29%  Similarity=0.459  Sum_probs=211.2

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCC-------cEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEee
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESG-------EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYG  224 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~  224 (444)
                      +.++|++++.||+|+||.||+|++..++       ..||||+++.    ........++.+|...+.++ +|||||++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc----ccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            4568999999999999999999876544       4799998763    23344557788898888888 7999999999


Q ss_pred             eEEcCCEEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          225 SETLDDKLYIYLEYVSGGSIYKILQDYG----------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       225 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ++.+++.+++||||+++|+|.++|....                .+++..++.++.||+.||+|||+++||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999999997543                489999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      |++.++.+||+|||+++.......   .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            999999999999999987654332   23356899999999998766 9999999999999999998 799998766665


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      ....+... ..+..+..+++++++||.+||+.||++|||+.||++
T Consensus       246 ~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            55555554 445778899999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=405.32  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=199.8

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc------
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL------  228 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------  228 (444)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   .......+++.+|+.++++++||||+++++++..      
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            5799999999999999999999999999999998742   2345556788999999999999999999999864      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEecccccccc
Q 013354          229 DDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHIT  308 (444)
Q Consensus       229 ~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~  308 (444)
                      ...+|+||||+.++ +.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            46899999999654 545443  479999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHhcC-----------------
Q 013354          309 GQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKIGN-----------------  371 (444)
Q Consensus       309 ~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------  371 (444)
                      .........+|+.|+|||++.+.. ++.++||||+||++|||++|+.||...+......++..                 
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            666666777999999999998765 89999999999999999999999976554333222110                 


Q ss_pred             ------CCCCCC-----------------CCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHhCCCCCC
Q 013354          372 ------SKELPA-----------------IPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLEHPFVGN  415 (444)
Q Consensus       372 ------~~~~~~-----------------~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~hp~~~~  415 (444)
                            ......                 .....+.++++||++||+.||++|||++|+|+||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                  000000                 00124678999999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=392.63  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=217.7

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHcc-CCCCeeeEeeeE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRL-RHPNIVRYYGSE  226 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  226 (444)
                      +.++|++++.||+|+||.||+|++.     .+++.||||+++..    ........+.+|+.+++.+ +|||||++++++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            3468999999999999999999863     46789999998642    2344556788999999999 699999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCce
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDYG------------------QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANI  288 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  288 (444)
                      ...+.+++|||||.+|+|.+++.+..                  .+++..++.++.||+.||+|||+++||||||||+||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI  176 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence            99999999999999999999997643                  488999999999999999999999999999999999


Q ss_pred             EECCCCcEEEEeccccccccCCCCc---ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 013354          289 LVDPSGRVKLADFGMAKHITGQSCP---LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMAT-TKPPWSQYEGVP  364 (444)
Q Consensus       289 ll~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~  364 (444)
                      |++.++.+||+|||+++........   ....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||......+
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543322   2356899999999998665 8999999999999999999 677777766666


Q ss_pred             hhHHhcCCCCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          365 AMFKIGNSKELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .+.++......+..+..++.++.+||.+||+.||++|||++||++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            665555455556778889999999999999999999999999886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=389.44  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=221.1

Q ss_pred             CCCCCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeE
Q 013354          152 SPGSRWKKGRLLGRGTFGHVYLGFNS-----ESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSE  226 (444)
Q Consensus       152 ~~~~~~~~~~~LG~G~fg~Vy~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  226 (444)
                      .+.++|++++.||+|+||+||+|+++     .++..||||+++.    .........+.+|+.++++++||||+++++++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~----~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc----ccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            34578999999999999999999875     2357899998863    23344556789999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcE
Q 013354          227 TLDDKLYIYLEYVSGGSIYKILQDY----------GQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRV  296 (444)
Q Consensus       227 ~~~~~~~lv~e~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~v  296 (444)
                      ..++..++||||+.+|+|.+++...          ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999998643          236889999999999999999999999999999999999999999


Q ss_pred             EEEeccccccccCCCC---cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcC-CCCCCCCCChhhhHHhcCC
Q 013354          297 KLADFGMAKHITGQSC---PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATT-KPPWSQYEGVPAMFKIGNS  372 (444)
Q Consensus       297 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~  372 (444)
                      ||+|||+++.+.....   .....||+.|+|||.+.+.. ++.++|||||||++|||++| .+||......+.+..+...
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999986644332   22345899999999998766 89999999999999999997 5788877766666666655


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh------CCCCCC
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE------HPFVGN  415 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~------hp~~~~  415 (444)
                      .. +..+..++.++++||.+||+.||++|||++||++      +|+|++
T Consensus       252 ~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         252 GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            54 5678899999999999999999999999999998      666653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=387.12  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCC---cEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEc-CCEE
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESG---EMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETL-DDKL  232 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~  232 (444)
                      +...++||+|+||+||+|++..++   ..||||+++.    .......+++.+|+++|++++||||+++++++.. ++.+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence            344788999999999999986643   3689998863    2345566889999999999999999999998765 5689


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccccccccCCC
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGMAKHITGQS  311 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~  311 (444)
                      ++|||||++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999999999999998643 47788999999999999999999999999999999999999999999999998764432


Q ss_pred             Cc-----ccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCC-CChhhhHHhcCCCCCCCCCCCCCHH
Q 013354          312 CP-----LSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQY-EGVPAMFKIGNSKELPAIPDHLSDE  385 (444)
Q Consensus       312 ~~-----~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~s~~  385 (444)
                      ..     ....||+.|+|||.+.... ++.++||||||+++|||++|..||... +.......+..+.. +..|..++++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~~p~~~~~~  262 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDP  262 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CCCCTTCCHH
T ss_pred             cccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCcccCcHH
Confidence            22     2345899999999998766 899999999999999999977766543 33334444444443 4678889999


Q ss_pred             HHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          386 GKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       386 l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                      +.+||.+||+.||++||++.||++|
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-47  Score=370.40  Aligned_cols=254  Identities=22%  Similarity=0.331  Sum_probs=202.4

Q ss_pred             CCCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCC-eeeEeeeEEcCCE
Q 013354          153 PGSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPN-IVRYYGSETLDDK  231 (444)
Q Consensus       153 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~  231 (444)
                      .+++|++.+.||+|+||.||+|++..+|+.||||++.....       .+++.+|+++++.++|+| |+.+.+++...+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-------CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            35689999999999999999999999999999998864221       134678999999998766 5555666778889


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC---CCcEEEEeccccccc
Q 013354          232 LYIYLEYVSGGSIYKILQD-YGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP---SGRVKLADFGMAKHI  307 (444)
Q Consensus       232 ~~lv~e~~~ggsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~~~  307 (444)
                      .++||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++|||||||||+|||++.   +..+||+|||+++.+
T Consensus        78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999999 5666666554 457999999999999999999999999999999999999864   456999999999876


Q ss_pred             cCCCC--------cccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhhhHHh---c---CCC
Q 013354          308 TGQSC--------PLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPAMFKI---G---NSK  373 (444)
Q Consensus       308 ~~~~~--------~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---~---~~~  373 (444)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+   .   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            54322        23456999999999998766 899999999999999999999999775543322111   1   111


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHH---HHHhCCCCCC
Q 013354          374 ELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAA---WLLEHPFVGN  415 (444)
Q Consensus       374 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~---elL~hp~~~~  415 (444)
                      ..+.+...+++++.+||..||+.||++||++.   ++|+|+|.+.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            12234567899999999999999999999987   5678877543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=372.45  Aligned_cols=247  Identities=28%  Similarity=0.364  Sum_probs=193.2

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCeeeEeeeEEcCC----
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNIVRYYGSETLDD----  230 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----  230 (444)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++..      .........|+..+.+++||||+++++++..++    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            3688999999999999999986  5899999988531      111222334666667889999999999987653    


Q ss_pred             EEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCceEECCCCcEEEEecc
Q 013354          231 KLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA--------KNTVHRDIKGANILVDPSGRVKLADFG  302 (444)
Q Consensus       231 ~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivH~Dlkp~NIll~~~~~vkL~DFG  302 (444)
                      .+++||||+++|+|.+++++ ..+++..++.++.|++.||.|||+        +|||||||||+||||+.++.+||+|||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            68999999999999999987 479999999999999999999996        599999999999999999999999999


Q ss_pred             ccccccCCCC-----cccccCCCcccCcccccCcC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCCCh---------
Q 013354          303 MAKHITGQSC-----PLSIKGSPYWMAPEVIKNSN-----GCNLAVDIWSLGCTVIEMATTKPPWSQYEGV---------  363 (444)
Q Consensus       303 la~~~~~~~~-----~~~~~gt~~y~APE~~~~~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---------  363 (444)
                      +++.......     .....||+.|+|||++.+..     .++.++|||||||+||||++|..||......         
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987654332     23456999999999986543     1567999999999999999998877432211         


Q ss_pred             -----hhhHH-hcCCCCCCCCCCC-----CCHHHHHHHHHHhhhCCCCCcCHHHHHhC
Q 013354          364 -----PAMFK-IGNSKELPAIPDH-----LSDEGKDFVRKCLQRNPLHRPTAAWLLEH  410 (444)
Q Consensus       364 -----~~~~~-~~~~~~~~~~~~~-----~s~~l~~Li~~~L~~dP~~Rpt~~elL~h  410 (444)
                           ..... .......|.++..     ...++.+||.+||+.||++|||+.||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 11111 1122222333332     23568999999999999999999998763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-46  Score=363.39  Aligned_cols=247  Identities=22%  Similarity=0.307  Sum_probs=204.8

Q ss_pred             CCCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC-CCeeeEeeeEEcCCEE
Q 013354          154 GSRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH-PNIVRYYGSETLDDKL  232 (444)
Q Consensus       154 ~~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~  232 (444)
                      +.+|++++.||+|+||+||+|++..+|+.||||++....+       ...+.+|++.++.+.| +||+.+++++..+...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            5789999999999999999999999999999998764222       1246678888888865 8999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECC-----CCcEEEEecccccc
Q 013354          233 YIYLEYVSGGSIYKILQDYG-QLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDP-----SGRVKLADFGMAKH  306 (444)
Q Consensus       233 ~lv~e~~~ggsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----~~~vkL~DFGla~~  306 (444)
                      ++||||+ +++|.+++...+ .+++..+..++.|++.||+|||++|||||||||+|||++.     ++.+||+|||+++.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 789999997754 6999999999999999999999999999999999999964     56799999999987


Q ss_pred             ccCCC--------CcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChhh---hHHhcC---C
Q 013354          307 ITGQS--------CPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVPA---MFKIGN---S  372 (444)
Q Consensus       307 ~~~~~--------~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~---~  372 (444)
                      +....        ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........   ..++..   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64332        123456999999999998765 89999999999999999999999976543322   222211   1


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhhCCCCCcCHHHHHh
Q 013354          373 KELPAIPDHLSDEGKDFVRKCLQRNPLHRPTAAWLLE  409 (444)
Q Consensus       373 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~elL~  409 (444)
                      .....+...+++++.+|+..|+..+|++||+++.+.+
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1122344678999999999999999999999876543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-45  Score=362.53  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             CCeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-----------CCCeeeEe
Q 013354          155 SRWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-----------HPNIVRYY  223 (444)
Q Consensus       155 ~~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~  223 (444)
                      .+|++++.||+|+||+||+|+++.+|+.||||+++.      .....+.+.+|+.+++.++           |+||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            469999999999999999999999999999999863      2333456778888888775           57899999


Q ss_pred             eeEEc--CCEEEEEEeccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCceEECCCC---
Q 013354          224 GSETL--DDKLYIYLEYVSGGS-IYKILQ--DYGQLGESAIRSYTQQILSGLEYLHA-KNTVHRDIKGANILVDPSG---  294 (444)
Q Consensus       224 ~~~~~--~~~~~lv~e~~~ggs-L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~---  294 (444)
                      +++..  ....+++|+++..+. ......  ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  355666766665443 333332  23468999999999999999999998 8999999999999997654   


Q ss_pred             ---cEEEEeccccccccCCCCcccccCCCcccCcccccCcCCCChhhhHHHHHHHHHHHHcCCCCCCCCCChh------h
Q 013354          295 ---RVKLADFGMAKHITGQSCPLSIKGSPYWMAPEVIKNSNGCNLAVDIWSLGCTVIEMATTKPPWSQYEGVP------A  365 (444)
Q Consensus       295 ---~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~------~  365 (444)
                         .++|+|||.+.....  ......||+.|+|||++.... ++.++||||+||+++||++|+.||...+...      .
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               399999999876543  334566999999999998766 8999999999999999999999997543211      0


Q ss_pred             hHH---h-c---------------------CCCCC---------------CCCCCCCCHHHHHHHHHHhhhCCCCCcCHH
Q 013354          366 MFK---I-G---------------------NSKEL---------------PAIPDHLSDEGKDFVRKCLQRNPLHRPTAA  405 (444)
Q Consensus       366 ~~~---~-~---------------------~~~~~---------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~  405 (444)
                      +..   + .                     .....               .......+.++++||.+||++||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            000   0 0                     00000               011233467899999999999999999999


Q ss_pred             HHHhCCCCCCCCCC
Q 013354          406 WLLEHPFVGNAAPL  419 (444)
Q Consensus       406 elL~hp~~~~~~~~  419 (444)
                      |+|+||||++....
T Consensus       324 e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         324 GLVNHPWLKDTLGM  337 (362)
T ss_dssp             HHHTCGGGTTCTTC
T ss_pred             HHhcCcccCCCCCc
Confidence            99999999976443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8.1e-26  Score=202.97  Aligned_cols=170  Identities=16%  Similarity=0.197  Sum_probs=123.8

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-------------cccHHHHHHHHHHHHHHHccCCCCeeeEe
Q 013354          157 WKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-------------AKSKESAQQLGQEIALLSRLRHPNIVRYY  223 (444)
Q Consensus       157 ~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~  223 (444)
                      +.+++.||+|+||+||+|++. +|+.||||+++.....             ...........+|+..+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999885 5899999987532110             01112234556789999999999999888


Q ss_pred             eeEEcCCEEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCceEECCCCcEEEEeccc
Q 013354          224 GSETLDDKLYIYLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHAKNTVHRDIKGANILVDPSGRVKLADFGM  303 (444)
Q Consensus       224 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~vkL~DFGl  303 (444)
                      ++..    .+++|||+.+..+.       .+++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    26999999875442       35556678899999999999999999999999999999865 499999999


Q ss_pred             cccccCCCCcccccCCCcccC------cccccCcCCCChhhhHHHHHHHHH
Q 013354          304 AKHITGQSCPLSIKGSPYWMA------PEVIKNSNGCNLAVDIWSLGCTVI  348 (444)
Q Consensus       304 a~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~~s~~sDvwSlGvil~  348 (444)
                      |.........       .|..      .|.+ . +.|+.++|+||+.--+.
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHHh
Confidence            9776433211       1211      1122 1 23678899999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=1.1e-07  Score=86.77  Aligned_cols=138  Identities=14%  Similarity=0.111  Sum_probs=89.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccC-CCCeeeEeeeEEcCCEEEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLR-HPNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l  234 (444)
                      .|+..+..+-++.+.||+..  .+++.+++|+.....     ......+.+|...+..+. +--+.+++.+...++..++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~-----~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY-----KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG-----TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc-----ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            56666655545557899874  346677888764211     112234567888877774 3335677888888899999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 013354          235 YLEYVSGGSIYKILQDYGQLGESAIRSYTQQILSGLEYLHA---------------------------------------  275 (444)
Q Consensus       235 v~e~~~ggsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------  275 (444)
                      ||++++|.++.+....  ..   ....++.++...++.||+                                       
T Consensus        88 v~~~l~G~~~~~~~~~--~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYED--EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTT--CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccc--cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            9999999887654321  11   112223334444444442                                       


Q ss_pred             --------------C------CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          276 --------------K------NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       276 --------------~------~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                                    .      .++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                          1      27899999999999877666799998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=4.3e-06  Score=81.16  Aligned_cols=82  Identities=16%  Similarity=0.183  Sum_probs=47.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEEeecccc-cc-cHHHHHHHHHHHHHHHccC-C--CCeeeEeeeEEcCCEEEE
Q 013354          160 GRLLGRGTFGHVYLGFNSESGEMCAMKEVTLFSDD-AK-SKESAQQLGQEIALLSRLR-H--PNIVRYYGSETLDDKLYI  234 (444)
Q Consensus       160 ~~~LG~G~fg~Vy~a~~~~~g~~vaiK~i~~~~~~-~~-~~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~~~~~l  234 (444)
                      .+.||.|....||+..+..+++.+++|.-...... .. -.....+...|+..|+.+. +  ..+++++.+.  .+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            45689999999999988777888999964321100 00 0111234456777776663 2  3456666543  344578


Q ss_pred             EEeccCCCC
Q 013354          235 YLEYVSGGS  243 (444)
Q Consensus       235 v~e~~~ggs  243 (444)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=6.8e-06  Score=74.14  Aligned_cols=135  Identities=16%  Similarity=0.073  Sum_probs=79.2

Q ss_pred             ecccC-ceEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCC--CCeeeEeeeEEcCCEEEEEEecc
Q 013354          163 LGRGT-FGHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRH--PNIVRYYGSETLDDKLYIYLEYV  239 (444)
Q Consensus       163 LG~G~-fg~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~  239 (444)
                      +..|. -+.||+... .++..+++|......        ...+.+|...++.+..  -.+.+++.+..+.+..++||+++
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            34444 367898864 346778888754211        1235567777776643  23567788778888899999999


Q ss_pred             CCCCHHH--------------HHHhcCC-------C--CHHHHHHHHH--------------------HHHHHHHHHHHC
Q 013354          240 SGGSIYK--------------ILQDYGQ-------L--GESAIRSYTQ--------------------QILSGLEYLHAK  276 (444)
Q Consensus       240 ~ggsL~~--------------~l~~~~~-------l--~~~~~~~i~~--------------------qi~~aL~~LH~~  276 (444)
                      +|.++.+              .+.+-..       +  .......-..                    .....+..+.+.
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            8765422              1111000       0  0000000000                    012233333332


Q ss_pred             -------CcccCCCCCCceEECCCCcEEEEecccccc
Q 013354          277 -------NTVHRDIKGANILVDPSGRVKLADFGMAKH  306 (444)
Q Consensus       277 -------~ivH~Dlkp~NIll~~~~~vkL~DFGla~~  306 (444)
                             .++|+|+.+.|||++++..+.|+||+.+..
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   379999999999998876678999987643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.56  E-value=5.8e-05  Score=70.87  Aligned_cols=67  Identities=16%  Similarity=0.114  Sum_probs=42.3

Q ss_pred             eEEEEEEEcCCCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-----eeEe--eeEEcCCEEEEEEeccCC
Q 013354          169 GHVYLGFNSESGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-----VRYY--GSETLDDKLYIYLEYVSG  241 (444)
Q Consensus       169 g~Vy~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-----v~l~--~~~~~~~~~~lv~e~~~g  241 (444)
                      -.||++.. .+|..|++|+.+..      ....+++..|+..+..|....|     +..-  ..+..++..+.+++++.|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~------~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPE------RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTT------TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCC------CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            47999865 46889999987531      1123456678888777742222     1111  134557788999999876


Q ss_pred             C
Q 013354          242 G  242 (444)
Q Consensus       242 g  242 (444)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.78  E-value=0.0014  Score=60.41  Aligned_cols=29  Identities=24%  Similarity=0.263  Sum_probs=26.3

Q ss_pred             CcccCCCCCCceEECCCCcEEEEeccccc
Q 013354          277 NTVHRDIKGANILVDPSGRVKLADFGMAK  305 (444)
Q Consensus       277 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~  305 (444)
                      |+||+|+.++||+++.+...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            79999999999999988777899999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.64  E-value=0.0014  Score=62.77  Aligned_cols=77  Identities=14%  Similarity=0.185  Sum_probs=47.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEEeecccccccHHHHHHHHHHHHHHHccCCCCe-eeEeeeEE
Q 013354          156 RWKKGRLLGRGTFGHVYLGFNSE-------SGEMCAMKEVTLFSDDAKSKESAQQLGQEIALLSRLRHPNI-VRYYGSET  227 (444)
Q Consensus       156 ~~~~~~~LG~G~fg~Vy~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~  227 (444)
                      .+++ +.|+.|---.+|++....       ..+.|.+++.-   . ...   .....+|..+++.+.-.++ .++++++.
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---N-PET---ESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---S-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC---C-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            3444 567888888999987653       23556666543   1 111   1234568888887753343 46777664


Q ss_pred             cCCEEEEEEeccCCCCH
Q 013354          228 LDDKLYIYLEYVSGGSI  244 (444)
Q Consensus       228 ~~~~~~lv~e~~~ggsL  244 (444)
                      .    ++|+||++|..|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            2    578999976543